Citrus Sinensis ID: 003644
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 805 | 2.2.26 [Sep-21-2011] | |||||||
| P32361 | 1115 | Serine/threonine-protein | yes | no | 0.489 | 0.353 | 0.354 | 8e-81 | |
| Q09499 | 967 | Serine/threonine-protein | yes | no | 0.470 | 0.391 | 0.399 | 6e-80 | |
| O94537 | 1072 | Serine/threonine-protein | yes | no | 0.551 | 0.414 | 0.334 | 2e-73 | |
| Q55GJ2 | 984 | Probable serine/threonine | yes | no | 0.495 | 0.405 | 0.366 | 8e-73 | |
| Q76MJ5 | 926 | Serine/threonine-protein | yes | no | 0.481 | 0.419 | 0.351 | 1e-70 | |
| Q9EQY0 | 977 | Serine/threonine-protein | yes | no | 0.477 | 0.393 | 0.329 | 5e-68 | |
| O75460 | 977 | Serine/threonine-protein | no | no | 0.474 | 0.390 | 0.330 | 1e-67 | |
| Q9Z2E3 | 911 | Serine/threonine-protein | no | no | 0.477 | 0.421 | 0.334 | 2e-67 | |
| Q55DJ9 | 1505 | Probable serine/threonine | no | no | 0.475 | 0.254 | 0.298 | 7e-46 | |
| Q559A2 | 1431 | Probable serine/threonine | no | no | 0.475 | 0.267 | 0.299 | 4e-43 |
| >sp|P32361|IRE1_YEAST Serine/threonine-protein kinase/endoribonuclease IRE1 OS=Saccharomyces cerevisiae (strain ATCC 204508 / S288c) GN=IRE1 PE=1 SV=2 | Back alignment and function desciption |
|---|
Score = 302 bits (773), Expect = 8e-81, Method: Compositional matrix adjust.
Identities = 169/477 (35%), Positives = 256/477 (53%), Gaps = 83/477 (17%)
Query: 374 IGKLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIV 433
+ LVV K + GS+GTVV +G+++GR VAVKR++ D+AL EI+ L SD HPN++
Sbjct: 670 LKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVI 729
Query: 434 RWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVME 493
R+Y E+ F+Y++LE C +L DL+ E N +++ L E P+
Sbjct: 730 RYYCSETTDRFLYIALELCNLNLQDLV--------ESKNVSDENLKLQKEYN----PI-- 775
Query: 494 NTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAK-- 551
+ R I SG++HLH + +IHRDLKPQN+L+S F A
Sbjct: 776 -------------------SLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQ 816
Query: 552 ---------LSDMGISKRLQGDMSCLTQNATG-YGSSGWQAPEQLLQG------------ 589
+SD G+ K+L S N G+SGW+APE L +
Sbjct: 817 TGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQCQVETEHS 876
Query: 590 -------------------RQTRAIDLFSLGCILFFCITGGKHPYGESFERDANIVK--- 627
R TR+ID+FS+GC+ ++ ++ GKHP+G+ + R++NI++
Sbjct: 877 SSRHTVVSSDSFYDPFTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNIIRGIF 936
Query: 628 ---DRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTADTRLSFLRDVSDR 684
+ K L I EA DL ++++D +P RP A VL HP FW +L FL VSDR
Sbjct: 937 SLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWPKSKKLEFLLKVSDR 996
Query: 685 VELEDRESDSKLLRALE-GIALVALNGKWDEKMETKFIENIGRYRRYKYDNVRDLLRVIR 743
+E+E+R+ S LL + G V +G W K + F++N+ RYR+Y + DLLR +R
Sbjct: 997 LEIENRDPPSALLMKFDAGSDFVIPSGDWTVKFDKTFMDNLERYRKYHSSKLMDLLRALR 1056
Query: 744 NKSNHFRELPQDIQELLGSHPEGFYNYFSCRFPKLLIEVYNVIFTYCKGEEVFHKYV 800
NK +HF +LP+DI EL+G P+GFY+YF+ RFP LLI VY ++ +++ +++
Sbjct: 1057 NKYHHFMDLPEDIAELMGPVPDGFYDYFTKRFPNLLIGVYMIVKENLSDDQILREFL 1113
|
Senses unfolded proteins in the lumen of the endoplasmic reticulum via its N-terminal domain which leads to enzyme auto-activation. The active endoribonuclease domain splices HAC1 precursor mRNA to produce the mature form which then induces transcription of UPR target genes. Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (taxid: 559292) EC: 3EC: .EC: 1EC: .EC: 2EC: 6EC: .EC: - |
| >sp|Q09499|IRE1_CAEEL Serine/threonine-protein kinase/endoribonuclease ire-1 OS=Caenorhabditis elegans GN=ire-1 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 299 bits (765), Expect = 6e-80, Method: Compositional matrix adjust.
Identities = 171/428 (39%), Positives = 246/428 (57%), Gaps = 49/428 (11%)
Query: 384 IAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYGVESDQD 443
+ G GTVV G ++GR VAVKR+V A +E L SD HP+++R++ +ESD
Sbjct: 524 LGTGCEGTVVYRGTFDGREVAVKRVVSEFVKFAHREADLLRESDTHPHVIRYFCMESDSQ 583
Query: 444 FVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKA 503
F YL+LE C SLND + EQ KE N V I L +M+ D
Sbjct: 584 FRYLALELCIASLNDYV--------EQ---KEVQQN----VTIALRDIMKQATD------ 622
Query: 504 NGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLI---SKDKSFCAKLSDMGISKR 560
GL+HLH ++HRD+KPQNVLI S+ A +SD G+ KR
Sbjct: 623 -----------------GLAHLHASKIVHRDMKPQNVLITMASQRGEMRAVISDFGLCKR 665
Query: 561 LQGDMSCLTQN-ATGY-GSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGES 618
+Q + +++ A+G G+ GW APE L+ + +D+FSLGCI ++ +T G HP+G+S
Sbjct: 666 VQPGKNSISRGIASGLAGTDGWIAPEVLISASTSYPVDIFSLGCIFYYVLTSGTHPFGKS 725
Query: 619 FERDANIVKDRKDLFLVEHIPE---AVDLFTRLLDPNPDLRPKAQNVLNHPFFWTADTRL 675
R ANIV L + + + A DL + +L+ P R A VLNHPFFWT++ RL
Sbjct: 726 LHRQANIVNGEYTLNKLADLDDWSLADDLISSMLNVEPLHRLTADAVLNHPFFWTSEKRL 785
Query: 676 SFLRDVSDRVELEDRESDSKLLRALEGIALVALNGKWDEKMETKFIENIGRYRRYKYDNV 735
++ DVSDRVE E E +S ++R +E A + + G W EK+ E++ ++R YK +V
Sbjct: 786 AYFSDVSDRVEKE--EDNSPVVRRIETDARIVVCGGWREKICDALKEDLRKFRTYKSFSV 843
Query: 736 RDLLRVIRNKSNHFRELPQDIQELLGSHPEGFYNYFSCRFPKLLIEVYNVIFTYCKGEEV 795
RDLLR +RNK +H+RELP+D+++ LG P+ F +YF+ RFP+LL+ VY YC GE V
Sbjct: 844 RDLLRAMRNKKHHYRELPEDVRQSLGDIPDQFLHYFTSRFPRLLLHVYKAT-EYCSGEAV 902
Query: 796 FHKYVTND 803
F +Y ++D
Sbjct: 903 FKRYYSDD 910
|
Senses unfolded proteins in the lumen of the endoplasmic reticulum via its N-terminal domain which leads to enzyme auto-activation. The active endoribonuclease domain splices xbp-1 precursor mRNA to produce the mature form which then induces transcription of UPR target genes. Unfolded protein response (UPR) transcripional activation by ire-1, as well as translational attenuation by pek-1 in a complementary pathway, maintains ER homeostasis. Ire-1 and pek-1 are redundant genes that control a pathway essential for larval development and survival. Caenorhabditis elegans (taxid: 6239) EC: 3 EC: . EC: 1 EC: . EC: 2 EC: 6 EC: . EC: - |
| >sp|O94537|PPK4_SCHPO Serine/threonine-protein kinase ppk4 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=ppk4 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 277 bits (709), Expect = 2e-73, Method: Compositional matrix adjust.
Identities = 172/514 (33%), Positives = 270/514 (52%), Gaps = 70/514 (13%)
Query: 318 RPGYNRNTTNSEKMQNIIPNESKVGETDGLSHITGNGEKFLLTFTDLIDDRVDGRRIGKL 377
+ + +N T +NI+ + K TD L + K L +I + + L
Sbjct: 596 QASFEQNQTLDILSENIVEIQDK--STDPLQKSLDSSLKSHLPEATVIQNTDGSVTVNSL 653
Query: 378 VVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYG 437
V+ + I GS+GT+V G YE R VAVKR++ +D+A +EI L SD HPNIVR+Y
Sbjct: 654 TVYPEVIGYGSHGTIVYRGVYEDREVAVKRVLMEFYDLASREITLLQQSDNHPNIVRYYC 713
Query: 438 VESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKD 497
+ F+Y+ +E C C+L+DLI E+ A +
Sbjct: 714 KQKSDQFLYIVIELCKCNLSDLI--------EKPIAYD---------------------- 743
Query: 498 IELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKS-------FCA 550
+L+K S L+ + I G+SHLH + L+HRDLKPQN+L+ + S A
Sbjct: 744 -DLFK-----SIDLVSLLYQIAFGVSHLHSLDLVHRDLKPQNILLVVNNSPNLSKTRVRA 797
Query: 551 KLSDMGISKRLQGDMSCLTQNAT--GYGSSGWQAPEQL------------LQGRQTR--- 593
+SD G+SK+L + S L +N T GS GW++PE L ++ R+ R
Sbjct: 798 LISDFGLSKKLDFNQSSL-RNTTFEAAGSYGWRSPEILSGSLSQQSKEIQVKTREGRIRQ 856
Query: 594 ---AIDLFSLGCILFFCITGGKHPYGESFERDANIVKDRKDLFLVEHIPE----AVDLFT 646
A D+F+LGCI ++ +TGG HP+G ++ + NI+K L ++ + E A DL
Sbjct: 857 ASHATDIFALGCIFYYTLTGGMHPFGSHYDCEGNILKGNYCLVHLQSLGECGVLAADLIE 916
Query: 647 RLLDPNPDLRPKAQNVLNHPFFWTADTRLSFLRDVSDRVELEDRESDSKLLRALEGIALV 706
++ P RP + VLNHP FW +L FL DVSDR E+E+R+ S LL+ LE +
Sbjct: 917 DMIAFEPSKRPTIEVVLNHPLFWDYAKKLDFLIDVSDRFEVEERDPPSPLLQMLENNSKS 976
Query: 707 ALNGKWDEKMETKFIENIGRYRRYKYDNVRDLLRVIRNKSNHFRELPQDIQELLGSHPEG 766
+ W + + ++N+G+YR+Y + D+LRV+RNK +H+++LP+ ++ +LG P+G
Sbjct: 977 VIGENWTTCLHSSLVDNLGKYRKYDGSKILDILRVLRNKRHHYQDLPESVRRVLGDLPDG 1036
Query: 767 FYNYFSCRFPKLLIEVYNVIFTYCKGEEVFHKYV 800
F +YF +FP LL+ Y+++ E F +Y+
Sbjct: 1037 FTSYFVEKFPMLLLHCYHLVKDVLYEESQFKRYL 1070
|
Schizosaccharomyces pombe (strain 972 / ATCC 24843) (taxid: 284812) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q55GJ2|IREA_DICDI Probable serine/threonine-protein kinase ireA OS=Dictyostelium discoideum GN=ireA PE=3 SV=1 | Back alignment and function description |
|---|
Score = 275 bits (704), Expect = 8e-73, Method: Compositional matrix adjust.
Identities = 162/442 (36%), Positives = 249/442 (56%), Gaps = 43/442 (9%)
Query: 373 RIGKL-VVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPN 431
+IGKL ++ NK + GS GT+V EG EGR VAVKR++ A +E+ LI SD+H N
Sbjct: 569 KIGKLEIITNKILGTGSCGTIVYEGKMEGRKVAVKRMLSQFVKFADREVSILIHSDEHTN 628
Query: 432 IVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPV 491
+VR+Y E D +F+YL++ C SL+ +YV + Q++ + S +
Sbjct: 629 VVRYYAKEEDDEFIYLAISFCQKSLD--MYV-QQTLSLQISPTDSPS------------I 673
Query: 492 MENTKDIELWKANGHPSAQLL------KVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKD 545
+ + N + + Q++ ++ ++ GL HLH + ++HRD+KP NVLI D
Sbjct: 674 QSSNNNGNGNNGNNNNNNQIIIDNKTKQMILELFKGLEHLHSLNIVHRDIKPHNVLI--D 731
Query: 546 KSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG--RQTRAIDLFSLGCI 603
+ K+SDMG+ K L D LT + S GWQ P + L G R T+ +D+FSLGC+
Sbjct: 732 PNNRVKISDMGLGKLLDNDDQSLTFTS---DSHGWQ-PAEYLNGTNRNTKKVDIFSLGCV 787
Query: 604 LFFCITGGKHPYGESFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVL 663
+++ +TG HP+G + R+ N++K + D+ ++H+P+ L ++ P+ RP +
Sbjct: 788 VYYLLTGA-HPFGHRYNREKNVLKGKFDIDQIKHLPDIHQLVHSMIQFEPEKRPDIGECI 846
Query: 664 NHPFFWTADTRLSFLRDVSDRVELE------DRESDSKLLRALEGIALVALNGKWDEKME 717
NHPFFW +LSFL SD +E E + E DS + +G +G W K++
Sbjct: 847 NHPFFWEVHKKLSFLVAASDYLEFEKPTSPLNLEIDSHVDLVTDG------SGDWWLKID 900
Query: 718 TKFIENIGRYRRYKYDNVRDLLRVIRNKSNHFRELPQDIQELLGSHPEGFYNYFSCRFPK 777
I+NIGRYR+Y ++RDLLRVIRNK NH+R+L + Q LG P+GF+NYF +FP+
Sbjct: 901 QVLIDNIGRYRKYNGKSIRDLLRVIRNKFNHYRDLSPEEQTCLGILPDGFFNYFDLKFPQ 960
Query: 778 LLIEVYNVIFTYCKGEEVFHKY 799
L I Y I K ++ F +Y
Sbjct: 961 LFIVTYLFILKNLKNDQYFVQY 982
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q76MJ5|ERN2_HUMAN Serine/threonine-protein kinase/endoribonuclease IRE2 OS=Homo sapiens GN=ERN2 PE=1 SV=4 | Back alignment and function description |
|---|
Score = 268 bits (686), Expect = 1e-70, Method: Compositional matrix adjust.
Identities = 155/441 (35%), Positives = 233/441 (52%), Gaps = 53/441 (12%)
Query: 374 IGKLVVFNKEI-AKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNI 432
+GK+ K++ +G+ GT V G +EGR+VAVKRL++ + +E+Q L SD+HPN+
Sbjct: 515 VGKISFNPKDVLGRGAGGTFVFRGQFEGRAVAVKRLLRECFGLVRREVQLLQESDRHPNV 574
Query: 433 VRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVM 492
+R++ E F Y++LE C SL + + N L EV
Sbjct: 575 LRYFCTERGPQFHYIALELCRASLQEYVE----------NPDLDRGGLEPEV-------- 616
Query: 493 ENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFC--- 549
V + ++SGL+HLH + ++HRDLKP N+LI+ S
Sbjct: 617 ---------------------VLQQLMSGLAHLHSLHIVHRDLKPGNILITGPDSQGLGR 655
Query: 550 AKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPE--QLLQG-RQTRAIDLFSLGCILFF 606
LSD G+ K+L + ++ G+ GW APE QLL T A+D+FS GC+ ++
Sbjct: 656 VVLSDFGLCKKLPAGRCSFSLHSGIPGTEGWMAPELLQLLPPDSPTSAVDIFSAGCVFYY 715
Query: 607 CITGGKHPYGESFERDANIVKDRKDL-FLVEHIPEAV---DLFTRLLDPNPDLRPKAQNV 662
++GG HP+G+S R ANI+ L L E + + V DL +L P P RP A V
Sbjct: 716 VLSGGSHPFGDSLYRQANILTGAPCLAHLEEEVHDKVVARDLVGAMLSPLPQPRPSAPQV 775
Query: 663 LNHPFFWTADTRLSFLRDVSDRVELEDRESDSKLLRALEGIALVALNGKWDEKMETKFIE 722
L HPFFW+ +L F +DVSD +E E + L+RALE + W E +
Sbjct: 776 LAHPFFWSRAKQLQFFQDVSDWLEKESEQE--PLVRALEAGGCAVVRDNWHEHISMPLQT 833
Query: 723 NIGRYRRYKYDNVRDLLRVIRNKSNHFRELPQDIQELLGSHPEGFYNYFSCRFPKLLIEV 782
++ ++R YK +VRDLLR +RNK +H+RELP ++++ LG P+GF YF+ RFP+LL+
Sbjct: 834 DLRKFRSYKGTSVRDLLRAVRNKKHHYRELPVEVRQALGQVPDGFVQYFTNRFPRLLLHT 893
Query: 783 YNVIFTYCKGEEVFHKYVTND 803
+ + + C E +F Y D
Sbjct: 894 HRAMRS-CASESLFLPYYPPD 913
|
Induces translational repression through 28S ribosomal RNA cleavage in response to ER stress. Pro-apoptotic. Appears to play no role in the unfolded-protein response, unlike closely related proteins. Homo sapiens (taxid: 9606) EC: 3 EC: . EC: 1 EC: . EC: 2 EC: 6 EC: . EC: - |
| >sp|Q9EQY0|ERN1_MOUSE Serine/threonine-protein kinase/endoribonuclease IRE1 OS=Mus musculus GN=Ern1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 259 bits (663), Expect = 5e-68, Method: Compositional matrix adjust.
Identities = 144/437 (32%), Positives = 230/437 (52%), Gaps = 53/437 (12%)
Query: 374 IGKLVVFNKEI-AKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNI 432
+GK+ K++ G+ GT+V +G ++ R VAVKR++ A +E+Q L SD+HPN+
Sbjct: 566 VGKISFCPKDVLGHGAEGTIVYKGMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNV 625
Query: 433 VRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVM 492
+R++ E D+ F Y+++E C +L + YV F
Sbjct: 626 IRYFCTEKDRQFQYIAIELCAATLQE--YVEQKDF------------------------- 658
Query: 493 ENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKS---FC 549
H + + + SGL+HLH + ++HRDLKP N+L+S +
Sbjct: 659 ------------AHLGLEPITLLHQTTSGLAHLHSLNIVHRDLKPHNILLSMPNAHGRIK 706
Query: 550 AKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQL---LQGRQTRAIDLFSLGCILFF 606
A +SD G+ K+L ++ + G+ GW APE L + T +D+FS GC+ ++
Sbjct: 707 AMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKDNPTYTVDIFSAGCVFYY 766
Query: 607 CITGGKHPYGESFERDANIV--KDRKDLFLVEHIPEAV--DLFTRLLDPNPDLRPKAQNV 662
I+ G HP+G+S +R ANI+ D F + + + +L +++ +P RP A++V
Sbjct: 767 VISEGNHPFGKSLQRQANILLGACNLDCFHSDKHEDVIARELIEKMIAMDPQQRPSAKHV 826
Query: 663 LNHPFFWTADTRLSFLRDVSDRVELEDRESDSKLLRALEGIALVALNGKWDEKMETKFIE 722
L HPFFW+ + +L F +DVSDR+E E D ++R LE + W E +
Sbjct: 827 LKHPFFWSLEKQLQFFQDVSDRIEKE--ALDGPIVRQLERGGRAVVKMDWRENITVPLQT 884
Query: 723 NIGRYRRYKYDNVRDLLRVIRNKSNHFRELPQDIQELLGSHPEGFYNYFSCRFPKLLIEV 782
++ ++R YK +VRDLLR +RNK +H+RELP ++QE LGS P+ F YF+ RFP LL
Sbjct: 885 DLRKFRTYKGGSVRDLLRAMRNKKHHYRELPVEVQETLGSIPDDFVRYFTSRFPHLLSHT 944
Query: 783 YNVIFTYCKGEEVFHKY 799
Y + C+ E +F Y
Sbjct: 945 YQAM-ELCRHERLFQTY 960
|
Senses unfolded proteins in the lumen of the endoplasmic reticulum via its N-terminal domain which leads to enzyme auto-activation. The active endoribonuclease domain splices XBP1 mRNA to generate a new C-terminus, converting it into a potent unfolded-protein response transcriptional activator and triggering growth arrest and apoptosis. Mus musculus (taxid: 10090) EC: 3 EC: . EC: 1 EC: . EC: 2 EC: 6 EC: . EC: - |
| >sp|O75460|ERN1_HUMAN Serine/threonine-protein kinase/endoribonuclease IRE1 OS=Homo sapiens GN=ERN1 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 258 bits (660), Expect = 1e-67, Method: Compositional matrix adjust.
Identities = 145/439 (33%), Positives = 229/439 (52%), Gaps = 57/439 (12%)
Query: 374 IGKLVVFNKEI-AKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNI 432
+GK+ K++ G+ GT+V G ++ R VAVKR++ A +E+Q L SD+HPN+
Sbjct: 566 VGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNV 625
Query: 433 VRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVM 492
+R++ E D+ F Y+++E C +L + YV F
Sbjct: 626 IRYFCTEKDRQFQYIAIELCAATLQE--YVEQKDF------------------------- 658
Query: 493 ENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKS---FC 549
H + + + + SGL+HLH + ++HRDLKP N+LIS +
Sbjct: 659 ------------AHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIK 706
Query: 550 AKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQL---LQGRQTRAIDLFSLGCILFF 606
A +SD G+ K+L ++ + G+ GW APE L + T +D+FS GC+ ++
Sbjct: 707 AMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYY 766
Query: 607 CITGGKHPYGESFERDANIVKDRKDLFLVEHIPE------AVDLFTRLLDPNPDLRPKAQ 660
I+ G HP+G+S +R ANI+ L + PE A +L +++ +P RP A+
Sbjct: 767 VISEGSHPFGKSLQRQANILLGACSLDCLH--PEKHEDVIARELIEKMIAMDPQKRPSAK 824
Query: 661 NVLNHPFFWTADTRLSFLRDVSDRVELEDRESDSKLLRALEGIALVALNGKWDEKMETKF 720
+VL HPFFW+ + +L F +DVSDR+E E D +++ LE + W E +
Sbjct: 825 HVLKHPFFWSLEKQLQFFQDVSDRIEKESL--DGPIVKQLERGGRAVVKMDWRENITVPL 882
Query: 721 IENIGRYRRYKYDNVRDLLRVIRNKSNHFRELPQDIQELLGSHPEGFYNYFSCRFPKLLI 780
++ ++R YK +VRDLLR +RNK +H+RELP +++E LGS P+ F YF+ RFP LL
Sbjct: 883 QTDLRKFRTYKGGSVRDLLRAMRNKKHHYRELPAEVRETLGSLPDDFVCYFTSRFPHLLA 942
Query: 781 EVYNVIFTYCKGEEVFHKY 799
Y + C E +F Y
Sbjct: 943 HTYRAM-ELCSHERLFQPY 960
|
Senses unfolded proteins in the lumen of the endoplasmic reticulum via its N-terminal domain which leads to enzyme auto-activation. The active endoribonuclease domain splices XBP1 mRNA to generate a new C-terminus, converting it into a potent unfolded-protein response transcriptional activator and triggering growth arrest and apoptosis. Homo sapiens (taxid: 9606) EC: 3 EC: . EC: 1 EC: . EC: 2 EC: 6 EC: . EC: - |
| >sp|Q9Z2E3|ERN2_MOUSE Serine/threonine-protein kinase/endoribonuclease IRE2 OS=Mus musculus GN=Ern2 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 258 bits (658), Expect = 2e-67, Method: Compositional matrix adjust.
Identities = 146/436 (33%), Positives = 228/436 (52%), Gaps = 52/436 (11%)
Query: 374 IGKLVVFNKEI-AKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNI 432
+GK+ K++ +G+ GT V G +EGR+VAVKRL++ + +E+Q L SD+HPN+
Sbjct: 503 VGKISFNPKDVLGRGAGGTFVFRGQFEGRAVAVKRLLRECFGLVRREVQLLQESDRHPNV 562
Query: 433 VRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVM 492
+R++ E F Y++LE C SL + +
Sbjct: 563 LRYFCTEHGPQFHYIALELCQASLQEYV-------------------------------- 590
Query: 493 ENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAK- 551
+ D++ W + V + ++SGL+HLH + ++HRDLKP N+L++ S
Sbjct: 591 -ESPDLDRW------GLEPTTVLQQMMSGLAHLHSLHIVHRDLKPANILMAGPDSQGQGR 643
Query: 552 --LSDMGISKRLQGDMSCLTQNATGYGSSGWQAPE--QLLQGRQTRAIDLFSLGCILFFC 607
+SD G+ K+L + ++ G+ GW APE QL T A+D+FS GC+ ++
Sbjct: 644 VVISDFGLCKKLPVGRCSFSLHSGIPGTEGWMAPELLQLPPDSPTSAVDIFSAGCVFYYV 703
Query: 608 ITGGKHPYGESFERDANIVKDRKDLFLVEHIPE----AVDLFTRLLDPNPDLRPKAQNVL 663
++GG HP+GES R ANI+ L ++ A+DL +L P RP A VL
Sbjct: 704 LSGGSHPFGESLYRQANILSGDPCLAQLQEETHDKVVALDLVRAMLSLLPQDRPSAGWVL 763
Query: 664 NHPFFWTADTRLSFLRDVSDRVELEDRESDSKLLRALEGIALVALNGKWDEKMETKFIEN 723
HP FW+ L F +DVSD +E E + L+ ALE + + W + + +
Sbjct: 764 AHPLFWSRAKELQFFQDVSDWLEKEPDQG--PLVSALEAGSYKVVREDWHKHISAPLQAD 821
Query: 724 IGRYRRYKYDNVRDLLRVIRNKSNHFRELPQDIQELLGSHPEGFYNYFSCRFPKLLIEVY 783
+ R+R YK +VRDLLR +RNK +H+RELP ++++ LG P GF YF+ RFP+LL+ +
Sbjct: 822 LKRFRSYKGTSVRDLLRAMRNKKHHYRELPAEVRQTLGQLPAGFIQYFTQRFPRLLLHTH 881
Query: 784 NVIFTYCKGEEVFHKY 799
+ T C E +F Y
Sbjct: 882 RAMRT-CASESLFLPY 896
|
Role in expression of the DDIT3 transcription factor, required for the unfolded-protein response, growth arrest and apoptosis. Has no effect on 28S ribosomal RNA cleavage, unlike the corresponding human protein. Mus musculus (taxid: 10090) EC: 3 EC: . EC: 1 EC: . EC: 2 EC: 6 EC: . EC: - |
| >sp|Q55DJ9|IRLD_DICDI Probable serine/threonine-protein kinase irlD OS=Dictyostelium discoideum GN=irlD PE=3 SV=1 | Back alignment and function description |
|---|
Score = 186 bits (472), Expect = 7e-46, Method: Compositional matrix adjust.
Identities = 139/465 (29%), Positives = 225/465 (48%), Gaps = 82/465 (17%)
Query: 374 IGKLVVFNKE---IAKGSNGTVVLEGNYEGR-SVAVKRLVKTHHDVALKEIQNLIA--SD 427
IGK K+ I +GSNGT+V +G + R VA+K++ K + + KEI+ LI +
Sbjct: 1047 IGKFKFSRKDEFIIGRGSNGTLVFKGIWNDRIPVAIKQMHKAFNPLISKEIEVLITLTNK 1106
Query: 428 QHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIR 487
NIVR+ E D FVYL L C SL +L+ K+ + NL++
Sbjct: 1107 NCNNIVRYIDQEEDDMFVYLGLTLCNGSLQNLV------------EKDLEINLISTSNNE 1154
Query: 488 LLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKS 547
+ I +LL++ +DIV G+ LH+ G++H DL P+N+LI D+
Sbjct: 1155 NNNNNKLKNFI-------GSELRLLELIKDIVYGIQFLHQQGIVHNDLNPRNILIKDDRF 1207
Query: 548 FCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFC 607
+SD+G+SK T +A G G+ E LL+ R+T+++D+FS+GCILF+
Sbjct: 1208 I---ISDLGLSKMEVTSSYSFTMHAPT-GQEGFHPAEVLLEKRKTKSVDIFSMGCILFYL 1263
Query: 608 ITGGKHPYGESFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPF 667
+TGG+HP+G+ F R ANI+ D+ L ++H A DL ++++ N RP +N+L HPF
Sbjct: 1264 MTGGQHPFGDKFFRMANILTDKPILEPLKHNLVACDLISQMISKNESDRPTTENILLHPF 1323
Query: 668 FWTADTRLSFLRDVSDRVELEDRESDSKLLRAL------EGIALVA---LNGKWDEKMET 718
FW + ++ F+ + + + SKL + + +G+ + L+ W++ ++
Sbjct: 1324 FWNHEKKVKFIDASLNLFKDSNGLFTSKLNKLINQFQDTDGVNTTSTPFLSKPWNQLIDP 1383
Query: 719 KFIENIG-------------------------RYRRYKYDNVRDLLRVIRNKSNHFRELP 753
IE+I ++ Y Y V+DL+R IRN H +E
Sbjct: 1384 TLIEHITNKQNQLSGGSSIGNNNNNSLTLSGKKFYFYDYSQVKDLVRCIRNTIQHHKE-- 1441
Query: 754 QDIQELLGSHP---------------EGFYNYFSCRFPKLLIEVY 783
IQ L+ P E +YF + P LL+ +Y
Sbjct: 1442 --IQRLISQSPSSSNKQEVLDCLESQELVLSYFEEKVPDLLLFLY 1484
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q559A2|IRLA_DICDI Probable serine/threonine-protein kinase irlA OS=Dictyostelium discoideum GN=irlA PE=3 SV=1 | Back alignment and function description |
|---|
Score = 177 bits (448), Expect = 4e-43, Method: Compositional matrix adjust.
Identities = 133/444 (29%), Positives = 221/444 (49%), Gaps = 61/444 (13%)
Query: 381 NKEIAKGSNGTVVLEGNYEGR-SVAVKRLVKTHHDVALKEIQNLI--ASDQHPNIVRWYG 437
N I +GSNGT+V G + R VAVK++ K + KEI+ LI S+ N++R+
Sbjct: 990 NNIIGRGSNGTLVFRGIWNDRIPVAVKQMQKAFNPHISKEIEVLIRLTSNNCSNMIRYID 1049
Query: 438 VESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKD 497
E DQ FVYL L C SL DL+ S ++E + E+ + + EN +
Sbjct: 1050 QEEDQLFVYLGLTLCEESLQDLME--SKRYKEFI---EKTTTTNITTTFNNNIIDENLYE 1104
Query: 498 IELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGI 557
++L + +D+++G++ LH ++H DL P+N+L+ K +SD+G+
Sbjct: 1105 -----------QRILSLFKDVINGINFLHCQDIVHNDLNPRNILVHKGNFV---ISDLGL 1150
Query: 558 SKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGE 617
SK +Q + S N G G+ E L + R+T+++D+FSLGCILF+ +T G+HP+G
Sbjct: 1151 SK-MQVETSYSFTNNAPTGQEGYHPIEVLQEKRKTKSVDIFSLGCILFYLLTNGQHPFGN 1209
Query: 618 S-FERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTADTRLS 676
+ R ANIV D+ DL ++ A+DL ++ + RP +LNHP FW+ + ++
Sbjct: 1210 NKLLRVANIVYDKPDLEPLKFNAPALDLVRLMISQDEKKRPTIDTILNHPLFWSTNEKIK 1269
Query: 677 FLRDVSDRVELED--RESDSKLLRALEGI---ALVALNGKWDEKMETKFIENIGRYRR-- 729
F + ++ + + SKLL + ++ L+ W++ ++ I+++
Sbjct: 1270 FYESSLNLLKDPNNSQSKHSKLLNYYQNDNSGGVLFLSKPWNQIIDPFLIDHVENNNNNN 1329
Query: 730 -----------------YKYDNVRDLLRVIRNKSNHFRELPQDI--QELLGSHPEGFYN- 769
Y+YD VRDL+R IRN H +++ + I Q+ L + F N
Sbjct: 1330 NNNNNNKQNSKKLAIVAYQYDQVRDLVRCIRNSLVHHKDILRSITQQQNLPPSSKEFAND 1389
Query: 770 ----------YFSCRFPKLLIEVY 783
YF C+FP LL +Y
Sbjct: 1390 CLKSQESVLLYFECKFPDLLFHLY 1413
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 805 | ||||||
| 225457602 | 925 | PREDICTED: uncharacterized protein LOC10 | 0.937 | 0.816 | 0.549 | 0.0 | |
| 297745578 | 827 | unnamed protein product [Vitis vinifera] | 0.864 | 0.841 | 0.546 | 0.0 | |
| 225438442 | 957 | PREDICTED: uncharacterized protein LOC10 | 0.940 | 0.791 | 0.514 | 0.0 | |
| 224086074 | 496 | predicted protein [Populus trichocarpa] | 0.613 | 0.995 | 0.728 | 0.0 | |
| 224074275 | 822 | predicted protein [Populus trichocarpa] | 0.916 | 0.897 | 0.505 | 0.0 | |
| 10177897 | 939 | unnamed protein product [Arabidopsis tha | 0.918 | 0.787 | 0.487 | 0.0 | |
| 297808453 | 871 | hypothetical protein ARALYDRAFT_489300 [ | 0.894 | 0.826 | 0.480 | 0.0 | |
| 255561453 | 911 | kinase, putative [Ricinus communis] gi|2 | 0.940 | 0.830 | 0.494 | 0.0 | |
| 356495301 | 895 | PREDICTED: uncharacterized protein LOC10 | 0.922 | 0.830 | 0.5 | 0.0 | |
| 334187908 | 867 | protein inositol requiring 1-1 [Arabidop | 0.918 | 0.852 | 0.483 | 0.0 |
| >gi|225457602|ref|XP_002272934.1| PREDICTED: uncharacterized protein LOC100247854 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 841 bits (2173), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 453/824 (54%), Positives = 567/824 (68%), Gaps = 69/824 (8%)
Query: 19 KKLSSSAEEYIRRMPYISKDGGVTLGAMKTSVFLVDVKSGRVVDNYVLDFSASTPGFQSD 78
+KL + E+Y+ PY+SKDG VT+G+ KT+VFLVD KSG +++ + D S GFQSD
Sbjct: 124 EKLLLTPEKYVEGAPYVSKDG-VTVGSKKTTVFLVDAKSGTIINTFRSDASPLIGGFQSD 182
Query: 79 ENKHVVPVDGYEELVESGVGNLKRIRQLVYIMRTDYVLQSTSQDSGEVLWNVAYADFKAE 138
E ++ + EEL+E G +L+++ +YIMRTDYVLQ S SG+VLWNV +AD +A
Sbjct: 183 EENPILSREEIEELIEPGDVDLQKVELPLYIMRTDYVLQHFSPTSGKVLWNVKFADIEAV 242
Query: 139 FRCQEVGKSFSGYHFNSGSELGMDLIGDVESHLPCHTQMTASVYRLRDNSL--------- 189
F+C G+E+G + + D+ES P H Q ASVYR+R+ SL
Sbjct: 243 FQC-------------PGTEIGSEYMSDIES--PLHCQTRASVYRIREPSLLDSFPMHDR 287
Query: 190 -PEFLSVIGKVA----------------------------GWISLPGSSQNSLLGPVDR- 219
P+ L + ++ +SLP S SL PV R
Sbjct: 288 LPKTLPAVEVLSLPASEPKSHSLLDSFPMHDRLPKALPAVEVLSLPASEPKSLSQPVGRL 347
Query: 220 NSPLFLPDKVDRPPLALPSTETEIPWTLGMPGGSVSEINKKHAFVEGFRSYIQSFIVLFI 279
P L +P LALP +E TL + GG SE++ + I+ +
Sbjct: 348 PGPHHLGQ--GKPLLALPLSEG----TLSVHGGDASEMD----IMSIVSDNIEKLGIWAA 397
Query: 280 ALCPIIGFLFYHSKQVKSKKQNEEHITKT-GI-PKKKKSRRPGYNRNTTNSEKMQNIIPN 337
L I+GF+ Y V+ ++ +K GI PKKKK+R+ N+N ++EK I +
Sbjct: 398 PLLFIVGFIIYQFFAVREPGKSRPKDSKVQGISPKKKKARKSVINKNNASNEKRHGNISH 457
Query: 338 ESKVGETDGLSHITGNGEKFLLTFTDLIDDRVDGRRIGKLVVFNKEIAKGSNGTVVLEGN 397
ESKV + +GLS + N K L L D V R+IGK++V KEIAKGSNGT+VLEG
Sbjct: 458 ESKVADNNGLSQVERNEIKLELNSNSLADVHVGERKIGKMLVSKKEIAKGSNGTIVLEGI 517
Query: 398 YEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCSLN 457
Y+GR VAVKRLV+THHDVALKEIQNLIASDQHPNIVRW+GVE DQDFVYLSLERC CSL+
Sbjct: 518 YDGRPVAVKRLVRTHHDVALKEIQNLIASDQHPNIVRWHGVEYDQDFVYLSLERCNCSLS 577
Query: 458 DLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRD 517
DLIY+ S S ++QL ++ DSN+LNE +RL +M+ KD ELWK NG+PS QLLK+ RD
Sbjct: 578 DLIYLCSDS-QDQLVNQDWDSNILNEYIVRLHSIMDPNKDFELWKTNGYPSPQLLKLMRD 636
Query: 518 IVSGLSHLHEIGLIHRDLKPQNVLIS-KDKSFCAKLSDMGISKRLQGDMSCLTQNATGYG 576
+VSGL+HLHE+G+IHRDLKPQN+LI K KS AKLSDMGISKRL GDMS LT + TGYG
Sbjct: 637 VVSGLAHLHELGIIHRDLKPQNILIIIKGKSLSAKLSDMGISKRLLGDMSSLTHHGTGYG 696
Query: 577 SSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDRKDLFLVE 636
SSGWQAPEQL GRQTRA+DLFSLGC+LFFC+TGGKHPYG++ ERD NIV +RKDLFL+E
Sbjct: 697 SSGWQAPEQLRHGRQTRAVDLFSLGCVLFFCLTGGKHPYGDNLERDVNIVNNRKDLFLIE 756
Query: 637 HIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTADTRLSFLRDVSDRVELEDRESDSKL 696
+IPEAVDLF+ LL+P+PDLRPKA +VL+HPFFW+++ RLSFLRDVSDRVELEDRE++S+L
Sbjct: 757 NIPEAVDLFSLLLEPDPDLRPKAMDVLHHPFFWSSEMRLSFLRDVSDRVELEDRENESQL 816
Query: 697 LRALEGIALVALNGKWDEKMETKFIENIGRYRRYKYDNVRDLLRVIRNKSNHFRELPQDI 756
L+ LE I +ALNGKWDEKME FI NIGRYRRYK+D+VRDLLRVIRNK NH+RELP DI
Sbjct: 817 LKQLESIGTLALNGKWDEKMEGAFINNIGRYRRYKFDSVRDLLRVIRNKLNHYRELPSDI 876
Query: 757 QELLGSHPEGFYNYFSCRFPKLLIEVYNVIFTYCKGEEVFHKYV 800
QE+LG PEGF YFS RFP+ LIEVY VI T+C+ EE F KY+
Sbjct: 877 QEILGPVPEGFNLYFSSRFPRFLIEVYKVIHTHCREEEFFQKYI 920
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297745578|emb|CBI40743.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 796 bits (2055), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 429/785 (54%), Positives = 533/785 (67%), Gaps = 89/785 (11%)
Query: 19 KKLSSSAEEYIRRMPYISKDGGVTLGAMKTSVFLVDVKSGRVVDNYVLDFSASTPGFQSD 78
+KL + E+Y+ PY+SKDG VT+G+ KT+VFLVD KSG +++ + D S GFQSD
Sbjct: 124 EKLLLTPEKYVEGAPYVSKDG-VTVGSKKTTVFLVDAKSGTIINTFRSDASPLIGGFQSD 182
Query: 79 ENKHVVPVDGYEELVESGVGNLKRIRQLVYIMRTDYVLQSTSQDSGEVLWNVAYADFKAE 138
E ++ + EEL+E G +L+++ +YIMRTDYVLQ S SG+VLWNV +AD +A
Sbjct: 183 EENPILSREEIEELIEPGDVDLQKVELPLYIMRTDYVLQHFSPTSGKVLWNVKFADIEAV 242
Query: 139 FRCQEVGKSFSGYHFNSGSELGMDLIGDVESHLPCHTQMTASVYRLRDNSLPEFLSVIGK 198
F+C G+E+G + + D+ES L C T+ S +G+
Sbjct: 243 FQC-------------PGTEIGSEYMSDIESPLHCQTRA----------------SPVGR 273
Query: 199 VAGWISLPGSSQNSLLGPVDRNSPLFLPDKVDRPPLALPSTETEIPWTLGMPGGSVSEIN 258
LPG LG +P LALP +E TL + GG SE++
Sbjct: 274 ------LPGPHH---LGQ-------------GKPLLALPLSEG----TLSVHGGDASEMD 307
Query: 259 KKHAFVEGFRSYIQSFIVLFIALCPIIGFLFYHSKQVKSKKQNEEHITKT-GI-PKKKKS 316
+ I+ + L I+GF+ Y V+ ++ +K GI PKKKK+
Sbjct: 308 ----IMSIVSDNIEKLGIWAAPLLFIVGFIIYQFFAVREPGKSRPKDSKVQGISPKKKKA 363
Query: 317 RRPGYNRNTTNSEKMQNIIPNESKVGETDGLSHITGNGEKFLLTFTDLIDDRVDGRRIGK 376
R+ N+N ++EK I +ESKV + +GLS + N K L L D V R+IGK
Sbjct: 364 RKSVINKNNASNEKRHGNISHESKVADNNGLSQVERNEIKLELNSNSLADVHVGERKIGK 423
Query: 377 LVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWY 436
++V KEIAKGSNGT+VLEG Y+GR VAVKRLV+THHDVALKEIQNLIASDQHPNIVRW+
Sbjct: 424 MLVSKKEIAKGSNGTIVLEGIYDGRPVAVKRLVRTHHDVALKEIQNLIASDQHPNIVRWH 483
Query: 437 GVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTK 496
GVE DQDFVYLSLERC CSL+DLIY+ S S ++QL
Sbjct: 484 GVEYDQDFVYLSLERCNCSLSDLIYLCSDS-QDQL------------------------- 517
Query: 497 DIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLIS-KDKSFCAKLSDM 555
D ELWK NG+PS QLLK+ RD+VSGL+HLHE+G+IHRDLKPQN+LI K KS AKLSDM
Sbjct: 518 DFELWKTNGYPSPQLLKLMRDVVSGLAHLHELGIIHRDLKPQNILIIIKGKSLSAKLSDM 577
Query: 556 GISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY 615
GISKRL GDMS LT + TGYGSSGWQAPEQL GRQTRA+DLFSLGC+LFFC+TGGKHPY
Sbjct: 578 GISKRLLGDMSSLTHHGTGYGSSGWQAPEQLRHGRQTRAVDLFSLGCVLFFCLTGGKHPY 637
Query: 616 GESFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTADTRL 675
G++ ERD NIV +RKDLFL+E+IPEAVDLF+ LL+P+PDLRPKA +VL+HPFFW+++ RL
Sbjct: 638 GDNLERDVNIVNNRKDLFLIENIPEAVDLFSLLLEPDPDLRPKAMDVLHHPFFWSSEMRL 697
Query: 676 SFLRDVSDRVELEDRESDSKLLRALEGIALVALNGKWDEKMETKFIENIGRYRRYKYDNV 735
SFLRDVSDRVELEDRE++S+LL+ LE I +ALNGKWDEKME FI NIGRYRRYK+D+V
Sbjct: 698 SFLRDVSDRVELEDRENESQLLKQLESIGTLALNGKWDEKMEGAFINNIGRYRRYKFDSV 757
Query: 736 RDLLRVIRNKSNHFRELPQDIQELLGSHPEGFYNYFSCRFPKLLIEVYNVIFTYCKGEEV 795
RDLLRVIRNK NH+RELP DIQE+LG PEGF YFS RFP+ LIEVY VI T+C+ EE
Sbjct: 758 RDLLRVIRNKLNHYRELPSDIQEILGPVPEGFNLYFSSRFPRFLIEVYKVIHTHCREEEF 817
Query: 796 FHKYV 800
F KY+
Sbjct: 818 FQKYI 822
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225438442|ref|XP_002275036.1| PREDICTED: uncharacterized protein LOC100249111 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 759 bits (1960), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 419/815 (51%), Positives = 533/815 (65%), Gaps = 58/815 (7%)
Query: 20 KLSSSAEEYIRRMPYISKDGGVTLGAMKTSVFLVDVKSGRVVDNYVLDFSASTPGFQSDE 79
KL +AEE+I P++S+DGGV LG+ +T+VFL++ K+G+++ +Y S TP S++
Sbjct: 162 KLPMTAEEFISSTPHVSEDGGVILGSKQTTVFLLNAKTGKLIHSYRSLESPPTP--LSNK 219
Query: 80 NKHVVPVDGYEELVESGVGNLKRIRQLVYIMRTDYVLQSTSQDSGEVLWNVAYADFKAEF 139
+ VV EE V+SG NL + +YI RTDY LQS +Q S +VLWN+ A+ A F
Sbjct: 220 EESVVHDKDIEEWVDSGSTNLNIVEPRLYITRTDYSLQSFAQGSDKVLWNMTVAEIGAAF 279
Query: 140 RCQEVGKSFSGYHFNSGSELGMDLIGDVESHLPCHTQMTASVYRLRDNSLPE------FL 193
CQ FS N G ELG + D E LPC Q A VYR R +++ E L
Sbjct: 280 LCQGTENLFSRPPLNLGCELGPEYNCDFEMPLPC--QSKAVVYRYRGHTMLEPFPRHDRL 337
Query: 194 SVIGKVAGWISLPGSSQNSLLGPVDRNSPLFLPDKVDRPPLALPS-------------TE 240
+ + P + P D P +P+ + LPS +
Sbjct: 338 QEAHQEDRLLLQPNIDKTLDFHPQDMMLPAVVPNHM------LPSEPKDEISLNFQDNND 391
Query: 241 TEIPWTLGMP---GGSVSEINKKHAFVEGFR-----SYIQSFIVLFIAL--------CPI 284
+E L P +S+ N + + +G S + S IV + L P+
Sbjct: 392 SEAVLPLSPPKIKNSGISDQNVQMPYNDGLSMFSGGSILFSLIVFIVILLVSVIYCCTPV 451
Query: 285 IGFLFYHSKQVKSKKQNEEHITKTGIPKKKKSRRPGYNRNTTNSEKMQNIIPNESKVGET 344
G +KQ N +P KK+ R N ++ +K ++++ +E+K
Sbjct: 452 AGEQGEMNKQPNDSDSN-------SVPSKKRKIRKSAKNNISSGKKDEHVL-SENK---- 499
Query: 345 DGLSHITGNGEKFLLTFTDLIDDRVDGRRIGKLVVFNKEIAKGSNGTVVLEGNYEGRSVA 404
DG +HI + +L L+D +GR +GKL V N IAKGSNGT+VLEG +EGRSVA
Sbjct: 500 DGSAHIASDNSPWL-NLNGLVDGDTNGRIVGKLFVSNIVIAKGSNGTIVLEGIHEGRSVA 558
Query: 405 VKRLVKTHHDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLS 464
VKRLV+ HHDVA KEIQNLIASD+HPNIVRWYGVE DQDFVYLSLERCTCSLNDL+ + S
Sbjct: 559 VKRLVRAHHDVAFKEIQNLIASDRHPNIVRWYGVEYDQDFVYLSLERCTCSLNDLLQIHS 618
Query: 465 GSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSH 524
S + + +Q + + E RI+L V +DI+LWK+NG+PS+ LL + RD+VSGL H
Sbjct: 619 NSSQNPGFSMDQATKAMMEYRIQLDSVKCIVQDIKLWKSNGYPSSVLLSLMRDVVSGLVH 678
Query: 525 LHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPE 584
LH++G+IHRDLKPQNVLI K+KS CAKLSDMGISKRL GDMS L +ATGYGSSGWQAPE
Sbjct: 679 LHDLGIIHRDLKPQNVLIIKEKSLCAKLSDMGISKRLVGDMSSLGHHATGYGSSGWQAPE 738
Query: 585 QLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDRKDLFLVEHIPEAVDL 644
QLL GRQTRA+DLFSLGCILF CITGG+HP+G+ ERD NIVK++ DLFLVE IPEA+DL
Sbjct: 739 QLLHGRQTRAVDLFSLGCILFSCITGGRHPFGDPLERDVNIVKNKPDLFLVEFIPEALDL 798
Query: 645 FTRLLDPNPDLRPKAQNVLNHPFFWTADTRLSFLRDVSDRVELEDRESDSKLLRALEGIA 704
F RLLDP P+LRPKA VL HP FW+++ RLSFLRD SDRVELEDRES+S +L+ALEG A
Sbjct: 799 FARLLDPKPELRPKASEVLYHPLFWSSELRLSFLRDASDRVELEDRESNSHVLKALEGTA 858
Query: 705 LVALNGKWDEKMETKFIENIGRYRRYKYDNVRDLLRVIRNKSNHFRELPQDIQELLGSHP 764
AL GKW+EKME F+ +IGRYRRYK+D+VRDLLRVIRNK NH+RELP++IQE+LGS P
Sbjct: 859 PTALGGKWNEKMEPAFLADIGRYRRYKFDSVRDLLRVIRNKWNHYRELPREIQEILGSVP 918
Query: 765 EGFYNYFSCRFPKLLIEVYNVIFTYCKGEEVFHKY 799
EGF +YFS RFP+LLIEVY V+ +CKGEE F KY
Sbjct: 919 EGFDSYFSSRFPRLLIEVYKVVSRHCKGEECFQKY 953
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224086074|ref|XP_002307805.1| predicted protein [Populus trichocarpa] gi|222857254|gb|EEE94801.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 756 bits (1951), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 360/494 (72%), Positives = 424/494 (85%)
Query: 310 IPKKKKSRRPGYNRNTTNSEKMQNIIPNESKVGETDGLSHITGNGEKFLLTFTDLIDDRV 369
+PKKKK+RR G N++ N+ K Q + +SKVGE + L+ + + K LLTFTD +D RV
Sbjct: 1 MPKKKKNRRSGNNKSNPNNLKNQKYLSLQSKVGEINELTRVERDERKLLLTFTDHVDGRV 60
Query: 370 DGRRIGKLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQNLIASDQH 429
DGRRIGKL+V NKEIAKGSNGTVVLEG Y+GR VAVKRLV++HHDVALKEIQNLIASDQH
Sbjct: 61 DGRRIGKLLVSNKEIAKGSNGTVVLEGIYDGRHVAVKRLVQSHHDVALKEIQNLIASDQH 120
Query: 430 PNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLL 489
PNIVRWYGVE DQDFVYL+LERCTCSLNDLIYV S SF+ Q+ +K+ DSN L E +RL
Sbjct: 121 PNIVRWYGVEYDQDFVYLALERCTCSLNDLIYVNSESFQNQIPSKDMDSNRLPEYMVRLH 180
Query: 490 PVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFC 549
+ E+ +++ELWKANG+PS QLLK+ RD+VSGL+HLHE+G++HRD+KPQNVLI +KSFC
Sbjct: 181 SMPEHNRNVELWKANGYPSVQLLKLMRDVVSGLAHLHELGIVHRDMKPQNVLIISEKSFC 240
Query: 550 AKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCIT 609
AKLSDMGISKRL GDMS LTQ+ TGYGSSGWQAPEQLL GRQTRA+DLFSLGC+LFFCIT
Sbjct: 241 AKLSDMGISKRLLGDMSSLTQHPTGYGSSGWQAPEQLLHGRQTRALDLFSLGCVLFFCIT 300
Query: 610 GGKHPYGESFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFW 669
GGKHP+G++ ERD NIV DRKDLFLVE+IPEA+DLFT LLDP+P+ RPKAQ VLNHP FW
Sbjct: 301 GGKHPFGDNIERDVNIVNDRKDLFLVENIPEALDLFTCLLDPDPEKRPKAQEVLNHPLFW 360
Query: 670 TADTRLSFLRDVSDRVELEDRESDSKLLRALEGIALVALNGKWDEKMETKFIENIGRYRR 729
T++ RLSFL+DVSDRVELEDRE+ S+LL LE A +ALNGKWDEKME FI NIGRYRR
Sbjct: 361 TSEKRLSFLQDVSDRVELEDRENASELLDTLESTATMALNGKWDEKMEAAFINNIGRYRR 420
Query: 730 YKYDNVRDLLRVIRNKSNHFRELPQDIQELLGSHPEGFYNYFSCRFPKLLIEVYNVIFTY 789
YK+D++RDLLRVIRNKS+H+RELPQ+I+ELLGSHPEGF +YFS RFPKLLIEVY VI+ Y
Sbjct: 421 YKFDSIRDLLRVIRNKSHHYRELPQEIKELLGSHPEGFESYFSRRFPKLLIEVYKVIYRY 480
Query: 790 CKGEEVFHKYVTND 803
CK EE F KY+ ++
Sbjct: 481 CKEEEFFRKYIDSN 494
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224074275|ref|XP_002304333.1| predicted protein [Populus trichocarpa] gi|222841765|gb|EEE79312.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 702 bits (1813), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 401/794 (50%), Positives = 525/794 (66%), Gaps = 56/794 (7%)
Query: 20 KLSSSAEEYIRRMPYISKDGGVTLGAMKTSVFLVDVKSGRVVDNY-VLDFSASTPGFQSD 78
KL + E++I+ P++S+DG V LG+ KT+VF+V+ K+GR++ + D +S F+
Sbjct: 74 KLPMNIEDFIKITPHMSEDGAVMLGSKKTTVFVVEAKTGRLIRTFKSPDSPSSLQSFEEG 133
Query: 79 ENKHVVPVDGYEELVESGVGNLKRIRQLVYIMRTDYVLQSTSQDSGEVLWNVAYADFKAE 138
H ++ ++L++SG N Q++YI+RTDY LQ+ +S +V W+ A A
Sbjct: 134 SGLHD-DLNNNKDLLKSGSSN---TAQVIYILRTDYALQTFGPNSDKVSWSTKVATIGAT 189
Query: 139 FRCQEVGKSFSGYHFNSGSELGMDLIGDVESHLPCHTQMTASVYRLRDNSLPEFLSVIGK 198
F C++V + SE+ +L +++S P Q V + +D S ++ S G
Sbjct: 190 FLCKDV---------ENPSEV-FNLSFELDSDTPLSCQSRRIVVQRQDKS--QYSS--GD 235
Query: 199 VAGWISLPGSSQNSLLGP---VDRNSPLFLPDKVDRPPLALPSTETEIPWTLGMPGGSVS 255
+ G LP S+ N +L V+++ L D R LA PS + L +P S +
Sbjct: 236 IHGEDKLPLSAPNLMLTTQPGVEKS----LDDHHARMLLAAPSEHGKE--MLALPSASAA 289
Query: 256 -EINKKHAFVEGFRSYIQSFIVLFIALCPIIGFLFYHSKQVKSKKQNEEHITKTGIPKKK 314
E++ + + + S QSFI LF+ + ++ F+ Y SK+ + E +T TG+
Sbjct: 290 GEVHYRFGMLLMW-STTQSFI-LFVGIL-LLCFVLYLSKESFTL---EGQLTGTGLKASS 343
Query: 315 KSRR----PGYNRNTTNSEKMQNIIPNESKVGETDGLSHITGNGEKFLLTFTDLIDDRVD 370
++ PG +N + E I P E K L L+D +
Sbjct: 344 SKKKKAKKPG--KNNVSVENGNEIAPGEGV--------------NKTLSDLNKLVDGGAN 387
Query: 371 GRRIGKLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQNLIASDQHP 430
GRRIGKL V N EIAKGSNGTVVLEG YEGR VAVKRLV+THHDVA KEIQNLIASD+HP
Sbjct: 388 GRRIGKLFVSNTEIAKGSNGTVVLEGVYEGRLVAVKRLVQTHHDVAWKEIQNLIASDRHP 447
Query: 431 NIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLP 490
NIVRWYGVE D+DFVYLSLERCTCSL+DLI + S S + K++ S E ++RL
Sbjct: 448 NIVRWYGVEYDEDFVYLSLERCTCSLDDLIQIYSDSSLNPVYGKDRTSRAAIEHKLRLDS 507
Query: 491 VMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCA 550
V +D+ LWKA GHPS LL + RD+VSGL HLHE+G+IHRDLKPQNVLI K++S CA
Sbjct: 508 VKGVMQDLNLWKATGHPSPLLLTLMRDMVSGLVHLHELGIIHRDLKPQNVLIIKERSLCA 567
Query: 551 KLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG 610
KLSDMGISKRL GDMS L +ATG GSSGWQAPEQL R+TRA+DLFSLGC+LF+CITG
Sbjct: 568 KLSDMGISKRLLGDMSSLAYHATGSGSSGWQAPEQLHHRRETRAVDLFSLGCVLFYCITG 627
Query: 611 GKHPYGESFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWT 670
G+HP+G+ ERD NIVK++KDLFLVE+IPEA DL +RLL+P+P+LRPKA VL+HP FW
Sbjct: 628 GRHPFGDHLERDVNIVKNQKDLFLVEYIPEAEDLISRLLNPDPELRPKALEVLHHPMFWN 687
Query: 671 ADTRLSFLRDVSDRVELEDRESDSKLLRALEGIALVAL-NGKWDEKMETKFIENIGRYRR 729
++ RLSFLRD SDRVELEDR SDS +L+ALEGIA AL GKW+EKME FI +IGR+RR
Sbjct: 688 SELRLSFLRDTSDRVELEDRVSDSDILKALEGIAPTALGGGKWNEKMEPAFITDIGRHRR 747
Query: 730 YKYDNVRDLLRVIRNKSNHFRELPQDIQELLGSHPEGFYNYFSCRFPKLLIEVYNVIFTY 789
YK+D +RDLLRVIRNK NH+RELP +IQEL+G PEG+ NYF+ RFPKLLIEVY V+ Y
Sbjct: 748 YKFDGIRDLLRVIRNKLNHYRELPNEIQELVGPVPEGYDNYFASRFPKLLIEVYKVVRKY 807
Query: 790 CKGEEVFHKYVTND 803
C+ EE F KY+ ++
Sbjct: 808 CREEEWFQKYIKSN 821
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|10177897|dbj|BAB11229.1| unnamed protein product [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 697 bits (1799), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 380/780 (48%), Positives = 494/780 (63%), Gaps = 41/780 (5%)
Query: 25 AEEYIRRMPYISKDGGVTLGAMKTSVFLVDVKSGRVVDNYVLDFSASTPGFQSDENKHVV 84
A E+I +PY S D + LG TSVFL+D K+G++V Y +D S ++D+ K +V
Sbjct: 190 ASEFIGTLPYTSTDR-IVLGKKDTSVFLLDWKTGKLVKRYRMDELYSNTVVENDKEKAIV 248
Query: 85 PVDGYEELVESGVGNLKRIRQLVYIMRTDYVLQSTSQDSGEVLWNVAYADFKAEFRCQEV 144
L SG + +LVYI R D+ +Q S+ G+VLW+V+YA +A+ + E
Sbjct: 249 LSKEAPLLFGSGFKKSEDFPELVYIERKDFKIQCISK-FGDVLWSVSYAKMEAKLQNHES 307
Query: 145 GKSFSGYHFNSGSELGMDLIGDVESHLPCHTQMTASVYRLRDNSLPEFLSVIGKVAGWIS 204
+ SG + G ++ P + + +LR+ +G + +
Sbjct: 308 VQFISGLSSSVG-----------KNQFPLSYTTSVPMVQLRNVKYETLFPRLGFLDEALY 356
Query: 205 LPGSSQNSLLGPVDRNSPLFLP-DKVDRPPLALPSTETEIPWTLGMPGGSVSEINKKHAF 263
LP + + + L LP +K L+LP ET I + GS +
Sbjct: 357 LPFQDRKPNQLAIGDGNQLTLPGNKEAEEVLSLPLPETVISQITDIIDGSTKQ------- 409
Query: 264 VEGFRSYIQSFIVLFIALC----PIIGFLFYHSKQVKSKKQNEEHITKTGIPKKKKSRRP 319
GF S IVL C + G FY +Q S + E ++++ I KK +
Sbjct: 410 -AGFASKFSGLIVLIFGFCVTMLSVCGLFFYRLRQ--SIRIKEPYVSEVPIATPKKKKSK 466
Query: 320 GYNRNTTNSEKMQNIIPNESKVGETDGLSHITGNGEKFLLTFTDLIDDRVDGRRIGKLVV 379
+K I G SH N ++ L F L + +G R+GKL V
Sbjct: 467 KNGTTKAVHKKENGFIS-----GGNKDPSH-EENEKRLLTAFPGLNNSSAEGYRVGKLFV 520
Query: 380 FNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYGVE 439
NKEIAKGSNGTVVLEG+YEGR VAVKRLV++HHDVA KEI NL+ASD+H NIVRWYGV+
Sbjct: 521 SNKEIAKGSNGTVVLEGSYEGRLVAVKRLVQSHHDVAQKEILNLMASDKHSNIVRWYGVD 580
Query: 440 SDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIE 499
D+ F+Y+SLE C CSLNDLIY S E + + S I++ P+ EN K +E
Sbjct: 581 QDEHFIYISLELCACSLNDLIYASSALLESPMASSSIHS-------IQINPIFENGKGVE 633
Query: 500 LWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISK 559
LWK NGHPS LLK+ RDIV+GL HLH+IG++HRDLKPQNVLI K+ S CAKLSDMGISK
Sbjct: 634 LWKENGHPSPVLLKLMRDIVAGLVHLHDIGIVHRDLKPQNVLIVKNSSLCAKLSDMGISK 693
Query: 560 RLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESF 619
RL D S LT+N+TG GSSGWQAPEQL RQTRA+DLFSLGC+LFFC+TGGKHPYG+++
Sbjct: 694 RLPADTSALTRNSTGSGSSGWQAPEQLRNERQTRAVDLFSLGCVLFFCMTGGKHPYGDNY 753
Query: 620 ERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTADTRLSFLR 679
ERD N++ D+KDLFL+E +PEAV L T LL+P+P+LRP+AQ+V++HP FW +D RLSFLR
Sbjct: 754 ERDVNVLNDQKDLFLIESLPEAVHLLTGLLNPDPNLRPRAQDVMHHPLFWNSDMRLSFLR 813
Query: 680 DVSDRVELEDRESDSKLLRALEGIALVALNGKWDEKMETKFIENIGRYRRYKYDNVRDLL 739
D SDRVELE+RE S+LL ALE A V LNG+WDEK+++ F++NIGRYRRYK+D++RDLL
Sbjct: 814 DASDRVELENREEGSQLLAALESTAAVTLNGRWDEKLDSIFLDNIGRYRRYKFDSIRDLL 873
Query: 740 RVIRNKSNHFRELPQDIQELLGSHPEGFYNYFSCRFPKLLIEVYNVIFTYCKGEEVFHKY 799
RVIRNK NH+RELP+++QELLGS PEGF YFS RFPKLLI+VY V+F YC EE F KY
Sbjct: 874 RVIRNKLNHYRELPKELQELLGSVPEGFERYFSSRFPKLLIQVYTVLFDYCNNEEFFFKY 933
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297808453|ref|XP_002872110.1| hypothetical protein ARALYDRAFT_489300 [Arabidopsis lyrata subsp. lyrata] gi|297317947|gb|EFH48369.1| hypothetical protein ARALYDRAFT_489300 [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 685 bits (1767), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 380/791 (48%), Positives = 489/791 (61%), Gaps = 71/791 (8%)
Query: 25 AEEYIRRMPYISKDGGVTLGAMKTSVFLVDVKSGRVVDNYVLDFSASTPGFQSDENKHVV 84
A E+I +PY S D + LG TSVFL+D K+G++V Y +D S ++D+ K +V
Sbjct: 130 ASEFIGTLPYTSTDR-IVLGKKDTSVFLLDWKTGKLVKRYRMDELYSNTVVENDKEKAIV 188
Query: 85 PVDGYEELVESGVGNLKRIRQLVYIMRTDYVLQSTSQDSGEVLWNVAYADFKAEFRCQEV 144
L SG + + +LVYI R D+ +Q S+ G+VLW+V+YA +A+ + E
Sbjct: 189 LSKEAPILFGSGFKESEDLPELVYIERKDFKIQCISK-FGDVLWSVSYAKMEAKLQNHES 247
Query: 145 GKSFSGYHFNSGSELGMDLIGDVESHLPCHTQMTASVYRLRDNSLPEFLSVIGKVAGWIS 204
G + G + ++HLP + V +LR+ + +G + +
Sbjct: 248 VHLMGGLSSSDGIPIRTSW---GKNHLPLSYTTSVPVVQLRNVNYETLFPRLGFLDEALY 304
Query: 205 LPGSSQNSLLGPVDRNSPLFLPDKVDRPPLALPSTETEIPWTLGMPGGSVSEINKKHAFV 264
LP DR P D LALPS + +++I
Sbjct: 305 LPFQ---------DRKPNRLAPG--DGKHLALPSNKE---------AEEITDIIDGSTTQ 344
Query: 265 EGFRSYIQSFIVLFIALC----PIIGFLFYHSKQ---VKSKKQNEEHIT--------KTG 309
GF S IVL C + G F +Q +K +E I K G
Sbjct: 345 AGFASKFSGLIVLLFGFCVTMLSVCGIFFCRLRQGMWIKDPYVSEVPIAIPKKKKSKKNG 404
Query: 310 IPKKKKSRRPGYNRNTTNSEKMQNIIPNESKVGETDGLSHITGNGEKFLLTFTDLIDDR- 368
KK+ G N++ +N E N ++ L F L ++
Sbjct: 405 THKKENGLISGGNKDPSNEE-----------------------NDKRLLTAFPGLNNNSS 441
Query: 369 VDGRRIGKLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQNLIASDQ 428
+G R+GKL V NKEIAKGSNGTVVLEG+YEGR VAVKRLV++HHDVA KEI NL+ASD+
Sbjct: 442 AEGYRVGKLFVSNKEIAKGSNGTVVLEGSYEGRLVAVKRLVQSHHDVAQKEILNLMASDK 501
Query: 429 HPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRL 488
HPNIVRWYGV+ D+ F+Y+SLERC CSLNDLIY S E + + I+
Sbjct: 502 HPNIVRWYGVDQDEHFIYISLERCACSLNDLIYASSALLESPVASSSIQP-------IQR 554
Query: 489 LPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSF 548
P+ EN K +ELWK NGHPS LLK+ DIV+GL HLH+IG++HRDLKPQNVLI K+ S
Sbjct: 555 NPIFENGKGVELWKENGHPSPVLLKLMSDIVAGLVHLHDIGIVHRDLKPQNVLIVKNSSV 614
Query: 549 CAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCI 608
CAKLSDMGISKRL D S LT+N+TG GSSGWQAPEQL RQTRA+DLFSLGC+LFFC+
Sbjct: 615 CAKLSDMGISKRLPADTSALTRNSTGSGSSGWQAPEQLRNERQTRAVDLFSLGCVLFFCM 674
Query: 609 TGGKHPYGESFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 668
T GKHPYG+++ERD N++ DRKDLFL+E +PEAV L + LL+P+P+LRP+AQ VL+HP F
Sbjct: 675 TAGKHPYGDNYERDVNVLNDRKDLFLIESLPEAVHLLSGLLNPDPNLRPRAQEVLHHPLF 734
Query: 669 WTADTRLSFLRDVSDRVELEDRESDSKLLRALEGIALVALNGKWDEKMETKFIENIGRYR 728
W +D RLSFLRD SDRVELE+RE S+LL ALE A V LNG+WDEK+++ F++NIGRYR
Sbjct: 735 WNSDMRLSFLRDASDRVELENREEGSQLLAALESTAAVTLNGRWDEKLDSIFLDNIGRYR 794
Query: 729 RYKYDNVRDLLRVIRNKSNHFRELPQDIQELLGSHPEGFYNYFSCRFPKLLIEVYNVIFT 788
RYK+D++RDLLRVIRNK NH+RELP+++QELLGS PEGF YFS RFPKLLI+VY V+F
Sbjct: 795 RYKFDSIRDLLRVIRNKLNHYRELPKELQELLGSVPEGFERYFSSRFPKLLIQVYTVLFD 854
Query: 789 YCKGEEVFHKY 799
YC EE F KY
Sbjct: 855 YCNNEEFFFKY 865
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255561453|ref|XP_002521737.1| kinase, putative [Ricinus communis] gi|223539128|gb|EEF40724.1| kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 684 bits (1766), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 391/790 (49%), Positives = 515/790 (65%), Gaps = 33/790 (4%)
Query: 20 KLSSSAEEYIRRMPYISKDGGVTLGAMKTSVFLVDVKSGRVVDNY-VLDFSASTPGFQSD 78
KLS + E+++ P++S+DG V LG+ T+VF+V+ K+GR+V Y LD +S Q D
Sbjct: 139 KLSMNIEDFMIITPHVSEDGAVILGSKITTVFVVEAKTGRLVQTYKSLDPPSS---LQRD 195
Query: 79 ENKHV-VPVDGYEELVESGVGNLKRIRQLVYIMRTDYVLQSTSQDSGEVLWNVAYADFKA 137
E + + + +L+ + + QL+YI RTDY LQ+ +S ++ WN+ A +A
Sbjct: 196 EEGNAFLNENRNNDLI---ISDSATSAQLIYITRTDYTLQNFGPNSDKISWNMKVAMIEA 252
Query: 138 EFRCQEV-GKSFSGYHFNSGSELGMDLIGDVESHLPCHTQMTASVYRLRDNSLPEFLSVI 196
F C++V G+S + S ++ + + ++ T L +L L
Sbjct: 253 AFLCKDVEGRSNFDMPLSCQSR---RMVVRRQGNPQSSSEATHGDEMLPVPALDLVLPSQ 309
Query: 197 GKVAGWISLPGSSQNSLLGPVDRNSPLFLPDKVDRPPLALPSTETEIPWTLGMPGGS--V 254
+V SL + +L + L L KVD P P+ ++E L +P S
Sbjct: 310 PRVGK--SLQDHHEGRMLSGSASDFVLPLQSKVDELPTFHPTDDSE--GMLALPNDSEGF 365
Query: 255 SEINKKHAFVEGF-----RSYIQSFIVLFIALCPIIGFLFYHSKQVKSKKQNEEHITKTG 309
N + AF + RS SF +F + ++GF FY S V K E ++
Sbjct: 366 DAHNARVAFDDWLNILIKRSTTLSF--MFFIVIILLGFNFYPSNLVGKSKVASEGLSSDS 423
Query: 310 IPKKKKSRRPGYNRNTTNSEKMQNIIPNESKVGETDGLSHITGNGEKFLLTFTDLIDDRV 369
K S+R ++ + K +P E+ G T ++ + +K LL +D V
Sbjct: 424 SSKASSSKRKKSRKSGKKNGK---DVPFENDDGPT-----LSDSSDKKLLDLNKHVDRGV 475
Query: 370 DGRRIGKLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQNLIASDQH 429
+GRRIGKL V N EIAKGSNGT+VLEG YEGR VAVKRLV+ HH+VA KEIQNLIASD+H
Sbjct: 476 NGRRIGKLFVSNAEIAKGSNGTIVLEGIYEGRPVAVKRLVQAHHEVAFKEIQNLIASDRH 535
Query: 430 PNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLL 489
PNIVRWYGVE+D DFVYLSLERCTCSL+DLI + S Q+ +++Q + + ++RL
Sbjct: 536 PNIVRWYGVENDNDFVYLSLERCTCSLDDLIQIYCDSSFNQVFSEDQATRVATNYKLRLN 595
Query: 490 PVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFC 549
V +D+ LWK+NGHPS +L + RD+V GL HLHE+G+IHRDLKPQNVLI K++S
Sbjct: 596 KVKGILQDLNLWKSNGHPSPLMLLLMRDVVCGLVHLHELGIIHRDLKPQNVLILKERSLS 655
Query: 550 AKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCIT 609
AKLSDMGISKRL GDMS L +ATG GSSGWQAPE LLQGRQTRA+DLFSLGC+LFFCIT
Sbjct: 656 AKLSDMGISKRLLGDMSSLGYHATGCGSSGWQAPELLLQGRQTRAVDLFSLGCVLFFCIT 715
Query: 610 GGKHPYGESFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFW 669
GG+HP+G+ ERD NIVK++ DLFLVE+ PEA DL +RLL+ +P+LRPKA VL+HP FW
Sbjct: 716 GGRHPFGDRLERDVNIVKNKMDLFLVEYFPEAGDLISRLLNHDPELRPKALEVLHHPMFW 775
Query: 670 TADTRLSFLRDVSDRVELEDRESDSKLLRALEGIALVALNGKWDEKMETKFIENIGRYRR 729
+++ RLSFLR+ SDRVELEDRES S LL+ALE IA AL GKWDEKME FI NIG YRR
Sbjct: 776 SSEMRLSFLRETSDRVELEDRESGSVLLKALESIASTALGGKWDEKMEPAFITNIGHYRR 835
Query: 730 YKYDNVRDLLRVIRNKSNHFRELPQDIQELLGSHPEGFYNYFSCRFPKLLIEVYNVIFTY 789
YKYD+VRDLLRV+RNK NH+RELP++IQEL+G PEG+ YF+ RFPKLLIEVY V++ +
Sbjct: 836 YKYDSVRDLLRVLRNKLNHYRELPKEIQELVGPIPEGYDGYFASRFPKLLIEVYKVVYRF 895
Query: 790 CKGEEVFHKY 799
C+ E+ FHKY
Sbjct: 896 CREEDCFHKY 905
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356495301|ref|XP_003516517.1| PREDICTED: uncharacterized protein LOC100785363 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 680 bits (1754), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 405/810 (50%), Positives = 504/810 (62%), Gaps = 67/810 (8%)
Query: 20 KLSSSAEEYIRRMPYISKDGGVTLGAMKTSVFLVDVKSGRVV-DNYVLDFSASTPGFQSD 78
+LS S Y+ P +K+G G+ K ++F VD K+G +V +Y LD +AS D
Sbjct: 118 RLSESIANYVALTPTETKEGASIFGSKKDTMFEVDAKTGALVRTHYDLD-NASNVVLSGD 176
Query: 79 ENKHVVPVDGYEELVESGVGNLKRIRQLVYIMRTDYVLQSTSQDSGEVLWNVAYADFKAE 138
+ V ELV+ L L+ I R+DYVL+S + +G VLW + A+FKA
Sbjct: 177 DRLQRVTTTKNNELVDPA--QLDSPEFLLKITRSDYVLKSLGK-AGIVLWTMNVAEFKAR 233
Query: 139 FRCQEVGKSFSGYHFNSGSELGMDLIGDVESHLPCHTQMTASVYRLRDNSLPEFLSVIGK 198
CQ F++ +D D C VYR R N L
Sbjct: 234 LICQHNENPSGRDSFDAEDGYVVDRGLDFAMPYACWDMKLNEVYRQRKNFLLH------- 286
Query: 199 VAGWISLPGSSQNSLLGPVDRNSPLFLPDKVDRP------------PL----ALPSTETE 242
A L G Q +++ P S L LP + D PL +LPS + +
Sbjct: 287 PADPGRLSGIYQENIMLPF-HTSELMLPSQPDMDGFILGQGGNMMLPLPISNSLPSLQQK 345
Query: 243 I------------PWTLGMPGGSVSEINKKHAFVEGFRSYIQSFIVLFIALCPIIGFLFY 290
+ PW L M + E++ K +E + +F+ F+FY
Sbjct: 346 LDFCESNDNVAMLPWPL-MEISTQEEVDPKKV-IEWSTTLPLILFTIFLGF-----FVFY 398
Query: 291 HSKQVKSKKQNEEHITKTGIPKKKKSRRPGYNRNTTNSEKMQNIIPNESKVGETDGLSHI 350
H V +K QN E +++ PKKKK+R+ N T ++ + + P S E D L+
Sbjct: 399 HYLVVTNKDQNRELNSRSLPPKKKKARKSVKNNITIDNRQDK---PMSS--AEEDKLARK 453
Query: 351 TGNGEKFLLTFTDLIDDRVDGRRIGKLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVK 410
N + T+T + +VDGRRIGKL V NKEIAKGSNGT+V EG YEGR VAVKRLVK
Sbjct: 454 ETNTD----TYTQM---QVDGRRIGKLFVSNKEIAKGSNGTIVFEGTYEGRVVAVKRLVK 506
Query: 411 THHDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQ 470
HHDVA KEIQNLIASD+HPNIVRWYGVE D DFVYL+LERCTC+L+DLI++ S E
Sbjct: 507 AHHDVAHKEIQNLIASDRHPNIVRWYGVECDHDFVYLALERCTCNLDDLIHMYSDISENP 566
Query: 471 LNAKEQDSNLLNEVRIRLLPVMENTKDIE-LWKANGHPSAQLLKVTRDIVSGLSHLHEIG 529
++Q SN RI + D+ LWKANG PS LLK+ RD+VSGL HLHE+G
Sbjct: 567 TICEDQYSNFFKNARI------DTRNDMRYLWKANGFPSPLLLKLMRDVVSGLVHLHELG 620
Query: 530 LIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG 589
+IHRDLKPQNVLI K+KS CAKLSDMGISKRL DMS L TG GSSGWQAPEQL+QG
Sbjct: 621 IIHRDLKPQNVLILKEKSLCAKLSDMGISKRLLEDMSSLGHTVTGCGSSGWQAPEQLVQG 680
Query: 590 RQTRAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDRKDLFLVEHIPEAVDLFTRLL 649
RQTRA+DLFSLGC+LFFC+TGG+HP+GE ERD NIVK++KDLFLVE IPEA DL + LL
Sbjct: 681 RQTRAVDLFSLGCVLFFCMTGGRHPFGERLERDFNIVKNQKDLFLVEFIPEADDLISCLL 740
Query: 650 DPNPDLRPKAQNVLNHPFFWTADTRLSFLRDVSDRVELEDRESDSKLLRALEGIALVALN 709
+PNPDLR A VL+HP FW+++ RLSFLRDVSDRVELEDRE DS LL+ALE IA +AL
Sbjct: 741 NPNPDLRLTAIEVLHHPLFWSSEMRLSFLRDVSDRVELEDREIDSDLLKALESIAPLALG 800
Query: 710 GKWDEKMETKFIENIGRYRRYKYDNVRDLLRVIRNKSNHFRELPQDIQELLGSHPEGFYN 769
KWDEK++ FI NIGRYRRYKYD+VR LLRV+RNK NH+RELPQ+IQEL+G PEGF +
Sbjct: 801 AKWDEKLDPDFITNIGRYRRYKYDSVRHLLRVMRNKLNHYRELPQEIQELIGPVPEGFND 860
Query: 770 YFSCRFPKLLIEVYNVIFTYCKGEEVFHKY 799
YF+ RFP+LLIEVY VI+ CK +E F +Y
Sbjct: 861 YFASRFPRLLIEVYKVIYKSCKDDECFQRY 890
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|334187908|ref|NP_001190383.1| protein inositol requiring 1-1 [Arabidopsis thaliana] gi|332005920|gb|AED93303.1| protein inositol requiring 1-1 [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 677 bits (1748), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 378/782 (48%), Positives = 492/782 (62%), Gaps = 43/782 (5%)
Query: 25 AEEYIRRMPYISKDGGVTLGAMKTSVFLVDVKSGRVVDNYVLDFSASTPGFQSDENKHVV 84
A E+I +PY S D + LG TSVFL+D K+G++V Y +D S ++D+ K +V
Sbjct: 116 ASEFIGTLPYTSTDR-IVLGKKDTSVFLLDWKTGKLVKRYRMDELYSNTVVENDKEKAIV 174
Query: 85 PVDGYEELVESGVGNLKRIRQLVYIMRTDYVLQSTSQDSGEVLWNVAYADFKAEFRCQEV 144
L SG + +LVYI R D+ +Q S+ G+VLW+V+YA +A+ + E
Sbjct: 175 LSKEAPLLFGSGFKKSEDFPELVYIERKDFKIQCISK-FGDVLWSVSYAKMEAKLQNHES 233
Query: 145 GKSFSGYHFNSGSELGMDLIGDVESHLPCHTQMTASVYRLRDNSLPEFLSVIGKVAGWIS 204
+ SG + G ++ P + + +LR+ +G + +
Sbjct: 234 VQFISGLSSSVG-----------KNQFPLSYTTSVPMVQLRNVKYETLFPRLGFLDEALY 282
Query: 205 LPGSSQNSLLGPVDRNSPLFLP-DKVDRPPLALPSTETEIPWTLGMPGGSVSEINKKHAF 263
LP + + + L LP +K L+LP ET I + GS +
Sbjct: 283 LPFQDRKPNQLAIGDGNQLTLPGNKEAEEVLSLPLPETVISQITDIIDGSTKQ------- 335
Query: 264 VEGFRSYIQSFIVLFIALC----PIIGFLFYHSKQVKSKKQNEEHITKTGIPKKKKSRRP 319
GF S IVL C + G FY +Q S + E ++++ I KK +
Sbjct: 336 -AGFASKFSGLIVLIFGFCVTMLSVCGLFFYRLRQ--SIRIKEPYVSEVPIATPKKKKSK 392
Query: 320 GYNRNTTNSEKMQNIIPNESKVGETDGLSHITGNGEKFLLTFTDLIDDRVDGRRIGKLVV 379
+K I G SH N ++ L F L + +G R+GKL V
Sbjct: 393 KNGTTKAVHKKENGFIS-----GGNKDPSH-EENEKRLLTAFPGLNNSSAEGYRVGKLFV 446
Query: 380 FNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYGVE 439
NKEIAKGSNGTVVLEG+YEGR VAVKRLV++HHDVA KEI NL+ASD+H NIVRWYGV+
Sbjct: 447 SNKEIAKGSNGTVVLEGSYEGRLVAVKRLVQSHHDVAQKEILNLMASDKHSNIVRWYGVD 506
Query: 440 SDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIE 499
D+ F+Y+SLE C CSLNDLIY S E + + S I++ P+ EN K +E
Sbjct: 507 QDEHFIYISLELCACSLNDLIYASSALLESPMASSSIHS-------IQINPIFENGKGVE 559
Query: 500 LWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISK 559
LWK NGHPS LLK+ RDIV+GL HLH+IG++HRDLKPQNVLI K+ S CAKLSDMGISK
Sbjct: 560 LWKENGHPSPVLLKLMRDIVAGLVHLHDIGIVHRDLKPQNVLIVKNSSLCAKLSDMGISK 619
Query: 560 RLQGDMSCLTQNATGYGSSG--WQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGE 617
RL D S LT+N+TG GS WQAPEQL RQTRA+DLFSLGC+LFFC+TGGKHPYG+
Sbjct: 620 RLPADTSALTRNSTGLGSGSSGWQAPEQLRNERQTRAVDLFSLGCVLFFCMTGGKHPYGD 679
Query: 618 SFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTADTRLSF 677
++ERD N++ D+KDLFL+E +PEAV L T LL+P+P+LRP+AQ+V++HP FW +D RLSF
Sbjct: 680 NYERDVNVLNDQKDLFLIESLPEAVHLLTGLLNPDPNLRPRAQDVMHHPLFWNSDMRLSF 739
Query: 678 LRDVSDRVELEDRESDSKLLRALEGIALVALNGKWDEKMETKFIENIGRYRRYKYDNVRD 737
LRD SDRVELE+RE S+LL ALE A V LNG+WDEK+++ F++NIGRYRRYK+D++RD
Sbjct: 740 LRDASDRVELENREEGSQLLAALESTAAVTLNGRWDEKLDSIFLDNIGRYRRYKFDSIRD 799
Query: 738 LLRVIRNKSNHFRELPQDIQELLGSHPEGFYNYFSCRFPKLLIEVYNVIFTYCKGEEVFH 797
LLRVIRNK NH+RELP+++QELLGS PEGF YFS RFPKLLI+VY V+F YC EE F
Sbjct: 800 LLRVIRNKLNHYRELPKELQELLGSVPEGFERYFSSRFPKLLIQVYTVLFDYCNNEEFFF 859
Query: 798 KY 799
KY
Sbjct: 860 KY 861
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 805 | ||||||
| TAIR|locus:2053928 | 841 | IRE1A [Arabidopsis thaliana (t | 0.598 | 0.573 | 0.616 | 1.9e-171 | |
| WB|WBGene00002147 | 967 | ire-1 [Caenorhabditis elegans | 0.360 | 0.299 | 0.421 | 4.2e-88 | |
| DICTYBASE|DDB_G0267650 | 984 | ireA "IRE family protein kinas | 0.608 | 0.497 | 0.346 | 7.2e-80 | |
| TAIR|locus:2081551 | 554 | AT3G11870 [Arabidopsis thalian | 0.568 | 0.826 | 0.395 | 5.1e-74 | |
| UNIPROTKB|F1NPU5 | 946 | Gga.10887 "Uncharacterized pro | 0.371 | 0.316 | 0.368 | 2e-71 | |
| UNIPROTKB|E7ETG2 | 874 | ERN2 "Endoribonuclease" [Homo | 0.356 | 0.328 | 0.39 | 2.5e-69 | |
| UNIPROTKB|Q76MJ5 | 926 | ERN2 "Serine/threonine-protein | 0.356 | 0.309 | 0.39 | 9.4e-69 | |
| MGI|MGI:1930134 | 977 | Ern1 "endoplasmic reticulum (E | 0.359 | 0.295 | 0.369 | 1.4e-68 | |
| RGD|1559716 | 963 | Ern1 "endoplasmic reticulum to | 0.359 | 0.300 | 0.369 | 1.5e-68 | |
| UNIPROTKB|F1RSL5 | 914 | ERN1 "Uncharacterized protein" | 0.356 | 0.314 | 0.373 | 2.1e-68 |
| TAIR|locus:2053928 IRE1A [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1523 (541.2 bits), Expect = 1.9e-171, Sum P(3) = 1.9e-171
Identities = 307/498 (61%), Positives = 368/498 (73%)
Query: 307 KTGIPKKKKSRRPGYNRNTTNSEKMQNIIPNESKVGETDGLSHITGNGEKFLLTFTDLID 366
K G KKKK+R+ + TN + +P G+ D I G + LL F +
Sbjct: 357 KAGPSKKKKNRK---SAKDTNRQS----VPR----GQ-DQFELIEGG--QMLLGFNNFQS 402
Query: 367 DRVDGRRIGKLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQNLIAS 426
DGR+IGKL + +KEIAKGSNGTVV EG YEGR VAVKRLV++HH+VA KEIQNLIAS
Sbjct: 403 GATDGRKIGKLFLSSKEIAKGSNGTVVFEGIYEGRPVAVKRLVRSHHEVAFKEIQNLIAS 462
Query: 427 DQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIY-VLSGSFEEQLNAKEQDSNLLNEVR 485
DQH NI+RWYGVE DQDFVYLSLERCTCSL+DLI L S + L + + +
Sbjct: 463 DQHTNIIRWYGVEYDQDFVYLSLERCTCSLDDLIKSYLEFSMTKVLENNDSTEGVA-AYK 521
Query: 486 IRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKD 545
I+L + K WK GHPS +LK+ RDIV G+ HLHE+G++HRDLKPQNVLISKD
Sbjct: 522 IQLDSLEGVIKGNNFWKVGGHPSPLMLKLMRDIVCGIVHLHELGIVHRDLKPQNVLISKD 581
Query: 546 KSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILF 605
+ AKLSDMGISKR+ DMS L ATG GSSGWQAPEQLLQGRQTRA+D+FSLGC++F
Sbjct: 582 MTLSAKLSDMGISKRMSRDMSSLGHLATGSGSSGWQAPEQLLQGRQTRAVDMFSLGCVIF 641
Query: 606 FCITGGKHPYGESFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNH 665
+ ITG KHP+G+ ERD NIVK++ DLFLVEH+PEA DL +RLL+P+PDLRP A VL H
Sbjct: 642 YTITGCKHPFGDDLERDVNIVKNKVDLFLVEHVPEASDLISRLLNPDPDLRPSATEVLLH 701
Query: 666 PFFWTADTRLSFLRDVSDRVELEDRESDSKLLRALEGIALVALNGKWDEKMETKFIENIG 725
P FW ++ RLSFLRD SDRVELE+RE+DS++L+A+E A VA+ GKWDEK+E FI NIG
Sbjct: 702 PMFWNSEMRLSFLRDASDRVELENREADSEILKAMESTAPVAIGGKWDEKLEPVFITNIG 761
Query: 726 RYRRYKYDNVRDLLRVIRNKSNHFRELPQDIQELLGSHPEGFYNYFSCRFPKLLIEVYNV 785
RYRRYKYD++RDLLRVIRNK NH RELP +IQEL+G+ PEGF YF+ RFPKLLIEVY V
Sbjct: 762 RYRRYKYDSIRDLLRVIRNKLNHHRELPPEIQELVGTVPEGFDEYFAVRFPKLLIEVYRV 821
Query: 786 IFTYCKGEEVFHKYVTND 803
I +C+ EEVF KY D
Sbjct: 822 ISLHCREEEVFRKYFKCD 839
|
|
| WB|WBGene00002147 ire-1 [Caenorhabditis elegans (taxid:6239)] | Back alignment and assigned GO terms |
|---|
Score = 617 (222.3 bits), Expect = 4.2e-88, Sum P(5) = 4.2e-88
Identities = 127/301 (42%), Positives = 189/301 (62%)
Query: 511 LLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLI---SKDKSFCAKLSDMGISKRLQGDMSC 567
L + + GL+HLH ++HRD+KPQNVLI S+ A +SD G+ KR+Q +
Sbjct: 613 LRDIMKQATDGLAHLHASKIVHRDMKPQNVLITMASQRGEMRAVISDFGLCKRVQPGKNS 672
Query: 568 LTQN-ATGY-GSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERDANI 625
+++ A+G G+ GW APE L+ + +D+FSLGCI ++ +T G HP+G+S R ANI
Sbjct: 673 ISRGIASGLAGTDGWIAPEVLISASTSYPVDIFSLGCIFYYVLTSGTHPFGKSLHRQANI 732
Query: 626 VKDRKDLFLVEHIPE---AVDLFTRLLDPNPDLRPKAQNVLNHPFFWTADTRLSFLRDVS 682
V L + + + A DL + +L+ P R A VLNHPFFWT++ RL++ DVS
Sbjct: 733 VNGEYTLNKLADLDDWSLADDLISSMLNVEPLHRLTADAVLNHPFFWTSEKRLAYFSDVS 792
Query: 683 DRVELEDRESDSKLLRALEGIALVALNGKWDEKMETKFIENIGRYRRYKYDNVRDLLRVI 742
DRVE E E +S ++R +E A + + G W EK+ E++ ++R YK +VRDLLR +
Sbjct: 793 DRVEKE--EDNSPVVRRIETDARIVVCGGWREKICDALKEDLRKFRTYKSFSVRDLLRAM 850
Query: 743 RNKSNHFRELPQDIQELLGSHPEGFYNYFSCRFPKLLIEVYNVIFTYCKGEEVFHKYVTN 802
RNK +H+RELP+D+++ LG P+ F +YF+ RFP+LL+ VY YC GE VF +Y ++
Sbjct: 851 RNKKHHYRELPEDVRQSLGDIPDQFLHYFTSRFPRLLLHVYKAT-EYCSGEAVFKRYYSD 909
Query: 803 D 803
D
Sbjct: 910 D 910
|
|
| DICTYBASE|DDB_G0267650 ireA "IRE family protein kinase" [Dictyostelium discoideum (taxid:44689)] | Back alignment and assigned GO terms |
|---|
Score = 737 (264.5 bits), Expect = 7.2e-80, Sum P(3) = 7.2e-80
Identities = 184/531 (34%), Positives = 286/531 (53%)
Query: 291 HSKQVKSKKQNEEH-ITKTGIPKKKKSRRPGYNRNTTNSEKMQNIIPNESKVGETDGLSH 349
++ Q ++ N+ + I PKKKK ++ N N E +N I N + + D +
Sbjct: 471 NNNQNNNQNSNQNNNINNKKTPKKKKKKQKNKNNKNNNDEDDENEIENYND-NQNDLIDE 529
Query: 350 -ITGNG--------EKFLLTFTDLIDD---RV---DGR-RIGKL-VVFNKEIAKGSNGTV 392
I+ N ++ L+ ++ I++ ++ +G +IGKL ++ NK + GS GT+
Sbjct: 530 FISTNSVIQQQQQQQQQLINSSNKINNGSGKIILDNGNVKIGKLEIITNKILGTGSCGTI 589
Query: 393 VLEGNYEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERC 452
V EG EGR VAVKR++ A +E+ LI SD+H N+VR+Y E D +F+YL++ C
Sbjct: 590 VYEGKMEGRKVAVKRMLSQFVKFADREVSILIHSDEHTNVVRYYAKEEDDEFIYLAISFC 649
Query: 453 TCSLNDLIY-VLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQL 511
SL+ + LS + Q SN N + ++ N + Q+
Sbjct: 650 QKSLDMYVQQTLSLQISPTDSPSIQSSNNNGNGNNG-----NNNNNNQIIIDN--KTKQM 702
Query: 512 LKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQN 571
+ ++ GL HLH + ++HRD+KP NVLI D + K+SDMG+ K L D LT
Sbjct: 703 IL---ELFKGLEHLHSLNIVHRDIKPHNVLI--DPNNRVKISDMGLGKLLDNDDQSLTFT 757
Query: 572 ATGYGSSGWQAPEQLLQG--RQTRAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDR 629
+ S GWQ P + L G R T+ +D+FSLGC++++ +TG HP+G + R+ N++K +
Sbjct: 758 SD---SHGWQ-PAEYLNGTNRNTKKVDIFSLGCVVYYLLTGA-HPFGHRYNREKNVLKGK 812
Query: 630 KDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTADTRLSFLRDVSDRVELED 689
D+ ++H+P+ L ++ P+ RP +NHPFFW +LSFL SD +E E
Sbjct: 813 FDIDQIKHLPDIHQLVHSMIQFEPEKRPDIGECINHPFFWEVHKKLSFLVAASDYLEFEK 872
Query: 690 RESDSKLLRALEGIALVAL-NGKWDEKMETKFIENIGRYRRYKYDNVRDLLRVIRNKSNH 748
S L + LV +G W K++ I+NIGRYR+Y ++RDLLRVIRNK NH
Sbjct: 873 PTSPLNL-EIDSHVDLVTDGSGDWWLKIDQVLIDNIGRYRKYNGKSIRDLLRVIRNKFNH 931
Query: 749 FRELPQDIQELLGSHPEGFYNYFSCRFPKLLIEVYNVIFTYCKGEEVFHKY 799
+R+L + Q LG P+GF+NYF +FP+L I Y I K ++ F +Y
Sbjct: 932 YRDLSPEEQTCLGILPDGFFNYFDLKFPQLFIVTYLFILKNLKNDQYFVQY 982
|
|
| TAIR|locus:2081551 AT3G11870 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 747 (268.0 bits), Expect = 5.1e-74, P = 5.1e-74
Identities = 200/506 (39%), Positives = 280/506 (55%)
Query: 320 GYNRNTTNSEKMQNIIPNESKVGETDGLSHITGNGEKFLLTFTDLIDDRVDGRRIGK-LV 378
G TNSE +P++ + +T L + + E L D ++ G+ + + L+
Sbjct: 69 GEENEKTNSESKVLSVPSDQNINKT--LPVMLPSLE---LRKYD--ENETPGKVVNRRLL 121
Query: 379 VFNKEIAKGSNGTVVLEGNYEGRS-VAVKRLVKTHHDVAL--KEIQNLIASDQHPNIVRW 435
V E+ G NG V +G Y RS VAVK L H A EI N D H NI+R+
Sbjct: 122 VSTNEMKYGRNGYEVFQGVYGRRSSVAVKCLDLAHTTEAFIQNEIDNHCLCDDHSNIIRF 181
Query: 436 YGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENT 495
+G+E DQ F Y+ LE CSL+DLI + + ++D+ + V L VM
Sbjct: 182 HGLEQDQSFAYICLEPWKCSLDDLIKL-------SVRRTKRDTQAVAPVD-DLEKVM--- 230
Query: 496 KDIELWKANGHPS--AQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLIS-KDKSFCAKL 552
K I+ WK G P +LK+ RD+V GL+HLH++ IHR+L PQNVLI KD + AK+
Sbjct: 231 KRIKFWKEKGKPLPLTPMLKLMRDVVCGLAHLHKLKTIHRNLNPQNVLIIVKDMTLTAKI 290
Query: 553 SDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRA---IDLFSLGCILFFCIT 609
SDM +SK L G S AT GSSGWQAPEQL + ++ + D+F+ GC+L + +
Sbjct: 291 SDMSLSKHLGGKKSSYKHLATCSGSSGWQAPEQLNKDKKKKEDFPADMFNFGCLLHYAVM 350
Query: 610 GGKHPYGESFERDANIVKDRK-DLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 668
G HP+G ERD NI + K +L LV ++ EA++L +LL+ PDLRP A VL HP F
Sbjct: 351 G-THPFGSPSERDTNIKTNNKTNLSLVTNL-EAINLIEQLLNYKPDLRPSATQVLLHPLF 408
Query: 669 WTADTRLSFLRDVSDRVELEDRESDSKLLRALEGIALVALNGKWDEKMETKFI---ENIG 725
W ++ RL FLR+ SDR+EL D L + + L + W K+ FI EN+
Sbjct: 409 WDSEKRLFFLREASDRIEL-DITMWGDLNKTIAPRVL-GESKDWASKLGKTFITHIENLA 466
Query: 726 R---------YRR-YKYDNVRDLLRVIRNKSNHFRELPQD--IQELLGSHPEGFYNYFSC 773
+ Y R YKY ++R LLR+IRN +H RE+ D I+E++G PEG +F+
Sbjct: 467 QAQPGQESRQYNRSYKYWSLRHLLRLIRNILSHHREILDDPKIKEMVGKVPEGLDIFFTA 526
Query: 774 RFPKLLIEVYNVIFTYCKGEEVFHKY 799
RFP L++E+Y I +CKGEE F KY
Sbjct: 527 RFPNLMMEIYAFISMHCKGEEAFEKY 552
|
|
| UNIPROTKB|F1NPU5 Gga.10887 "Uncharacterized protein" [Gallus gallus (taxid:9031)] | Back alignment and assigned GO terms |
|---|
Score = 544 (196.6 bits), Expect = 2.0e-71, Sum P(4) = 2.0e-71
Identities = 115/312 (36%), Positives = 177/312 (56%)
Query: 502 KANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFC---AKLSDMGIS 558
KA H Q + + + SGL++LH + ++HRDLKP N+LIS + A +SD G+
Sbjct: 627 KAFSHHGLQPIALLQQTTSGLAYLHSLSIVHRDLKPHNILISMPNAHGKVKAMISDFGLC 686
Query: 559 KRLQGDMSCLTQNATGYGSSGWQAPEQLLQG---RQTRAIDLFSLGCILFFCITGGKHPY 615
K+L ++ + G+ GW APE L + T +D+FS GC+ ++ ++ G HP+
Sbjct: 687 KKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVVSEGSHPF 746
Query: 616 GESFERDANIVKDRKDL-FLVEHIPEAV---DLFTRLLDPNPDLRPKAQNVLNHPFFWTA 671
G+S +R ANI+ L FL E + DL ++++ +P RP A VL HPFFW+
Sbjct: 747 GKSLQRQANILLGAYSLEFLDAGRHEDIVARDLIEQMINMDPQKRPSASCVLKHPFFWSL 806
Query: 672 DTRLSFLRDVSDRVELEDRESDSKLLRALEGIALVALNGKWDEKMETKFIENIGRYRRYK 731
+ +L F +DVSDR+E E D +++ LE + W E + ++ ++R YK
Sbjct: 807 EKQLQFFQDVSDRIEKE--ALDGPIVKQLERGGREVVKMDWREHITVPLQTDLRKFRSYK 864
Query: 732 YDNVRDLLRVIRNKSNHFRELPQDIQELLGSHPEGFYNYFSCRFPKLLIEVYNVIFTYCK 791
+VRDLLR +RNK +H+RELP ++QE LGS P+ F YF+ RFP LL+ Y+ + C+
Sbjct: 865 GGSVRDLLRAMRNKKHHYRELPPEVQETLGSIPDDFVCYFTARFPHLLLHTYHAMRICCQ 924
Query: 792 GEEVFHKYVTND 803
E +F Y D
Sbjct: 925 -ERLFQHYYQQD 935
|
|
| UNIPROTKB|E7ETG2 ERN2 "Endoribonuclease" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
Score = 550 (198.7 bits), Expect = 2.5e-69, Sum P(4) = 2.5e-69
Identities = 117/300 (39%), Positives = 174/300 (58%)
Query: 514 VTRDIVSGLSHLHEIGLIHRDLKPQNVLIS-KDKSFCAK--LSDMGISKRLQGDMSCLTQ 570
V + ++SGL+HLH + ++HRDLKP N+LI+ D + LSD G+ K+L +
Sbjct: 565 VLQQLMSGLAHLHSLHIVHRDLKPGNILITGPDSQGLGRVVLSDFGLCKKLPAGRCSFSL 624
Query: 571 NATGYGSSGWQAPE--QLLQ-GRQTRAIDLFSLGCILFFCITGGKHPYGESFERDANIVK 627
++ G+ GW APE QLL T A+D+FS GC+ ++ ++GG HP+G+S R ANI+
Sbjct: 625 HSGIPGTEGWMAPELLQLLPPDSPTSAVDIFSAGCVFYYVLSGGSHPFGDSLYRQANILT 684
Query: 628 DRKDL-FLVEHIPEAV---DLFTRLLDPNPDLRPKAQNVLNHPFFWTADTRLSFLRDVSD 683
L L E + + V DL +L P P RP A VL HPFFW+ +L F +DVSD
Sbjct: 685 GAPCLAHLEEEVHDKVVARDLVGAMLSPLPQPRPSAPQVLAHPFFWSRAKQLQFFQDVSD 744
Query: 684 RVELEDRESDSKLLRALEGIALVALNGKWDEKMETKFIENIGRYRRYKYDNVRDLLRVIR 743
+E E + L+RALE + W E + ++ ++R YK +VRDLLR +R
Sbjct: 745 WLEKESEQEP--LVRALEAGGCAVVRDNWHEHISMPLQTDLRKFRSYKGTSVRDLLRAVR 802
Query: 744 NKSNHFRELPQDIQELLGSHPEGFYNYFSCRFPKLLIEVYNVIFTYCKGEEVFHKYVTND 803
NK +H+RELP ++++ LG P+GF YF+ RFP+LL+ + + + C E +F Y D
Sbjct: 803 NKKHHYRELPVEVRQALGQVPDGFVQYFTNRFPRLLLHTHRAMRS-CASESLFLPYYPPD 861
|
|
| UNIPROTKB|Q76MJ5 ERN2 "Serine/threonine-protein kinase/endoribonuclease IRE2" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
Score = 550 (198.7 bits), Expect = 9.4e-69, Sum P(4) = 9.4e-69
Identities = 117/300 (39%), Positives = 174/300 (58%)
Query: 514 VTRDIVSGLSHLHEIGLIHRDLKPQNVLIS-KDKSFCAK--LSDMGISKRLQGDMSCLTQ 570
V + ++SGL+HLH + ++HRDLKP N+LI+ D + LSD G+ K+L +
Sbjct: 617 VLQQLMSGLAHLHSLHIVHRDLKPGNILITGPDSQGLGRVVLSDFGLCKKLPAGRCSFSL 676
Query: 571 NATGYGSSGWQAPE--QLLQ-GRQTRAIDLFSLGCILFFCITGGKHPYGESFERDANIVK 627
++ G+ GW APE QLL T A+D+FS GC+ ++ ++GG HP+G+S R ANI+
Sbjct: 677 HSGIPGTEGWMAPELLQLLPPDSPTSAVDIFSAGCVFYYVLSGGSHPFGDSLYRQANILT 736
Query: 628 DRKDL-FLVEHIPEAV---DLFTRLLDPNPDLRPKAQNVLNHPFFWTADTRLSFLRDVSD 683
L L E + + V DL +L P P RP A VL HPFFW+ +L F +DVSD
Sbjct: 737 GAPCLAHLEEEVHDKVVARDLVGAMLSPLPQPRPSAPQVLAHPFFWSRAKQLQFFQDVSD 796
Query: 684 RVELEDRESDSKLLRALEGIALVALNGKWDEKMETKFIENIGRYRRYKYDNVRDLLRVIR 743
+E E + L+RALE + W E + ++ ++R YK +VRDLLR +R
Sbjct: 797 WLEKESEQEP--LVRALEAGGCAVVRDNWHEHISMPLQTDLRKFRSYKGTSVRDLLRAVR 854
Query: 744 NKSNHFRELPQDIQELLGSHPEGFYNYFSCRFPKLLIEVYNVIFTYCKGEEVFHKYVTND 803
NK +H+RELP ++++ LG P+GF YF+ RFP+LL+ + + + C E +F Y D
Sbjct: 855 NKKHHYRELPVEVRQALGQVPDGFVQYFTNRFPRLLLHTHRAMRS-CASESLFLPYYPPD 913
|
|
| MGI|MGI:1930134 Ern1 "endoplasmic reticulum (ER) to nucleus signalling 1" [Mus musculus (taxid:10090)] | Back alignment and assigned GO terms |
|---|
Score = 542 (195.9 bits), Expect = 1.4e-68, Sum P(4) = 1.4e-68
Identities = 113/306 (36%), Positives = 177/306 (57%)
Query: 506 HPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKS---FCAKLSDMGISKRLQ 562
H + + + SGL+HLH + ++HRDLKP N+L+S + A +SD G+ K+L
Sbjct: 660 HLGLEPITLLHQTTSGLAHLHSLNIVHRDLKPHNILLSMPNAHGRIKAMISDFGLCKKLA 719
Query: 563 GDMSCLTQNATGYGSSGWQAPEQLLQG---RQTRAIDLFSLGCILFFCITGGKHPYGESF 619
++ + G+ GW APE L + T +D+FS GC+ ++ I+ G HP+G+S
Sbjct: 720 VGRHSFSRRSGVPGTEGWIAPEMLSEDCKDNPTYTVDIFSAGCVFYYVISEGNHPFGKSL 779
Query: 620 ERDANIVKD--RKDLFLVEHIPEAV--DLFTRLLDPNPDLRPKAQNVLNHPFFWTADTRL 675
+R ANI+ D F + + + +L +++ +P RP A++VL HPFFW+ + +L
Sbjct: 780 QRQANILLGACNLDCFHSDKHEDVIARELIEKMIAMDPQQRPSAKHVLKHPFFWSLEKQL 839
Query: 676 SFLRDVSDRVELEDRESDSKLLRALE--GIALVALNGKWDEKMETKFIENIGRYRRYKYD 733
F +DVSDR+E E D ++R LE G A+V ++ W E + ++ ++R YK
Sbjct: 840 QFFQDVSDRIEKE--ALDGPIVRQLERGGRAVVKMD--WRENITVPLQTDLRKFRTYKGG 895
Query: 734 NVRDLLRVIRNKSNHFRELPQDIQELLGSHPEGFYNYFSCRFPKLLIEVYNVIFTYCKGE 793
+VRDLLR +RNK +H+RELP ++QE LGS P+ F YF+ RFP LL Y + C+ E
Sbjct: 896 SVRDLLRAMRNKKHHYRELPVEVQETLGSIPDDFVRYFTSRFPHLLSHTYQAM-ELCRHE 954
Query: 794 EVFHKY 799
+F Y
Sbjct: 955 RLFQTY 960
|
|
| RGD|1559716 Ern1 "endoplasmic reticulum to nucleus signaling 1" [Rattus norvegicus (taxid:10116)] | Back alignment and assigned GO terms |
|---|
Score = 541 (195.5 bits), Expect = 1.5e-68, Sum P(4) = 1.5e-68
Identities = 113/306 (36%), Positives = 177/306 (57%)
Query: 506 HPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKS---FCAKLSDMGISKRLQ 562
H + + + SGL+HLH + ++HRDLKP N+L+S + A +SD G+ K+L
Sbjct: 646 HLGLEPITLLHQTTSGLAHLHSLNIVHRDLKPHNILLSMPNAHGRIKAMISDFGLCKKLA 705
Query: 563 GDMSCLTQNATGYGSSGWQAPEQLLQG---RQTRAIDLFSLGCILFFCITGGKHPYGESF 619
++ + G+ GW APE L + T +D+FS GC+ ++ I+ G HP+G+S
Sbjct: 706 VGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGNHPFGKSL 765
Query: 620 ERDANIVKDR--KDLFLVEHIPEAV--DLFTRLLDPNPDLRPKAQNVLNHPFFWTADTRL 675
+R ANI+ D F + + + +L +++ +P RP A++VL HPFFW+ + +L
Sbjct: 766 QRQANILLGACSLDCFHSDKHEDVIARELIEKMIAMDPQQRPSAKHVLKHPFFWSLEKQL 825
Query: 676 SFLRDVSDRVELEDRESDSKLLRALE--GIALVALNGKWDEKMETKFIENIGRYRRYKYD 733
F +DVSDR+E E D ++R LE G A+V ++ W E + ++ ++R YK
Sbjct: 826 QFFQDVSDRIEKESL--DGPIVRQLERGGRAVVKMD--WRENITVPLQTDLRKFRTYKGG 881
Query: 734 NVRDLLRVIRNKSNHFRELPQDIQELLGSHPEGFYNYFSCRFPKLLIEVYNVIFTYCKGE 793
+VRDLLR +RNK +H+RELP ++QE LGS P+ F YF+ RFP LL Y + C+ E
Sbjct: 882 SVRDLLRAMRNKRHHYRELPLEVQETLGSIPDDFVRYFTSRFPHLLSHTYRAM-ELCRHE 940
Query: 794 EVFHKY 799
+F Y
Sbjct: 941 RLFQTY 946
|
|
| UNIPROTKB|F1RSL5 ERN1 "Uncharacterized protein" [Sus scrofa (taxid:9823)] | Back alignment and assigned GO terms |
|---|
Score = 545 (196.9 bits), Expect = 2.1e-68, Sum P(4) = 2.1e-68
Identities = 115/308 (37%), Positives = 179/308 (58%)
Query: 506 HPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKS---FCAKLSDMGISKRLQ 562
H + + + + SGL+HLH + ++HRDLKP N+L+S + A +SD G+ K+L
Sbjct: 598 HLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILLSMPNAHGRIKAMISDFGLCKKLA 657
Query: 563 GDMSCLTQNATGYGSSGWQAPEQLLQG---RQTRAIDLFSLGCILFFCITGGKHPYGESF 619
++ + G+ GW APE L + T +D+FS GC+ ++ ++ G HP+G+S
Sbjct: 658 VGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVVSEGSHPFGKSL 717
Query: 620 ERDANIVKDRKDLFLVEHIPE------AVDLFTRLLDPNPDLRPKAQNVLNHPFFWTADT 673
+R ANI+ L + H PE A +L +++ +P RP A++VL HPFFW+ +
Sbjct: 718 QRQANILLGAYSLDCL-H-PEKHEDVIARELIEKMISMDPQKRPSAKHVLKHPFFWSLEK 775
Query: 674 RLSFLRDVSDRVELEDRESDSKLLRALE--GIALVALNGKWDEKMETKFIENIGRYRRYK 731
+L F +DVSDR+E E D +++ LE G A+V ++ W E + ++ ++R YK
Sbjct: 776 QLQFFQDVSDRIEKESL--DGPIVQQLERGGRAVVRMD--WRENITVPLQTDLRKFRTYK 831
Query: 732 YDNVRDLLRVIRNKSNHFRELPQDIQELLGSHPEGFYNYFSCRFPKLLIEVYNVIFTYCK 791
+VRDLLR +RNK +H+RELP D+QE LG+ P+GF YF+ RFP LL Y + C+
Sbjct: 832 GGSVRDLLRAMRNKKHHYRELPVDVQETLGTLPDGFVRYFTSRFPHLLAHTYRAM-ELCR 890
Query: 792 GEEVFHKY 799
E F Y
Sbjct: 891 HERPFQPY 898
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 3rd Layer | 3.1.26 | LOW CONFIDENCE prediction! |
| 4th Layer | 2.7.11.1 | 0.737 |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 805 | |||
| cd10422 | 129 | cd10422, RNase_Ire1, RNase domain (also known as t | 1e-59 | |
| pfam06479 | 127 | pfam06479, Ribonuc_2-5A, Ribonuclease 2-5A | 1e-55 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-44 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 9e-43 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-39 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 3e-39 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-33 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 6e-29 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 6e-28 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-27 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 3e-26 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 7e-26 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-25 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-24 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 6e-24 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 7e-24 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 9e-24 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-23 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-23 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 6e-23 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-22 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 3e-22 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-21 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-21 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-21 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-21 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-21 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 6e-21 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 6e-21 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 4e-20 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 4e-20 | |
| cd09213 | 312 | cd09213, Luminal_IRE1_like, The Luminal domain, a | 7e-20 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 9e-20 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-19 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-19 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-19 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 3e-19 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 4e-19 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 7e-19 | |
| cd10321 | 127 | cd10321, RNase_Ire1_like, RNase domain (also known | 2e-18 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 5e-18 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 6e-18 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-17 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 3e-17 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 6e-17 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 6e-17 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 7e-17 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 5e-16 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 6e-16 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 6e-16 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 1e-15 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 1e-15 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-15 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-15 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 3e-15 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 4e-15 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 5e-15 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-14 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 1e-14 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-14 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-14 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 1e-14 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-14 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-14 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-14 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 3e-14 | |
| smart00580 | 57 | smart00580, PUG, domain in protein kinases, N-glyc | 6e-14 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 7e-14 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 9e-14 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 1e-13 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-13 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-13 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-13 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-13 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 4e-13 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 4e-13 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 5e-13 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 7e-13 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 9e-13 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 9e-13 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-12 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 1e-12 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 1e-12 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 1e-12 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 1e-12 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-12 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-12 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 1e-12 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-12 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-12 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-12 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-12 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-12 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-12 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-12 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-12 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 3e-12 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 3e-12 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 3e-12 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 4e-12 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 4e-12 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 4e-12 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 5e-12 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 5e-12 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 5e-12 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 6e-12 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 6e-12 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 8e-12 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-11 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 1e-11 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-11 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 1e-11 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 1e-11 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-11 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-11 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-11 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 2e-11 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 2e-11 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-11 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 3e-11 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 3e-11 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 3e-11 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 3e-11 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 5e-11 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 5e-11 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 6e-11 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 8e-11 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 8e-11 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 9e-11 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 9e-11 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 1e-10 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-10 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 1e-10 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-10 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 2e-10 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-10 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-10 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-10 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-10 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-10 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 3e-10 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 3e-10 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 3e-10 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 3e-10 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 4e-10 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 4e-10 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 5e-10 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 5e-10 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 5e-10 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 7e-10 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 7e-10 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 7e-10 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 8e-10 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 8e-10 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 8e-10 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 8e-10 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 9e-10 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 9e-10 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 9e-10 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 9e-10 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 1e-09 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 1e-09 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 1e-09 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 1e-09 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 1e-09 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-09 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-09 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 2e-09 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-09 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 2e-09 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-09 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 3e-09 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 3e-09 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 3e-09 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 3e-09 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 3e-09 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 4e-09 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 4e-09 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 4e-09 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 5e-09 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 5e-09 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 5e-09 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 5e-09 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 6e-09 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 6e-09 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 6e-09 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 6e-09 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 7e-09 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 8e-09 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 8e-09 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 9e-09 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 1e-08 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 1e-08 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 1e-08 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 1e-08 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-08 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 1e-08 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 2e-08 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-08 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-08 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-08 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 3e-08 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 3e-08 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 3e-08 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 3e-08 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 3e-08 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 3e-08 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 3e-08 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 4e-08 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 4e-08 | |
| cd10423 | 119 | cd10423, RNase_RNase-L, RNase domain (also known a | 4e-08 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 4e-08 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 4e-08 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 4e-08 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 4e-08 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 5e-08 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 5e-08 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 6e-08 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 6e-08 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 6e-08 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 7e-08 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 8e-08 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 9e-08 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 9e-08 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 9e-08 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 1e-07 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 1e-07 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 1e-07 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 1e-07 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 1e-07 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 1e-07 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 1e-07 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 2e-07 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-07 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-07 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-07 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-07 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-07 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 2e-07 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 3e-07 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 3e-07 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 3e-07 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 3e-07 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 4e-07 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 4e-07 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 4e-07 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 5e-07 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 5e-07 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 6e-07 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 6e-07 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 7e-07 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 7e-07 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 7e-07 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 8e-07 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 9e-07 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 9e-07 | |
| cd09769 | 295 | cd09769, Luminal_IRE1, The Luminal domain, a dimer | 9e-07 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 9e-07 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 9e-07 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 1e-06 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-06 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 1e-06 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 1e-06 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 2e-06 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-06 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 3e-06 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 3e-06 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 3e-06 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 3e-06 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 3e-06 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 3e-06 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 5e-06 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 7e-06 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 9e-06 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 1e-05 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 1e-05 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 1e-05 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 1e-05 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-05 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-05 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-05 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 2e-05 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-05 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 2e-05 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-05 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 3e-05 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 3e-05 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 3e-05 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 4e-05 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 4e-05 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 5e-05 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 6e-05 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 7e-05 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 1e-04 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-04 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 2e-04 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 3e-04 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 3e-04 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 3e-04 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 4e-04 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 6e-04 | |
| COG4248 | 637 | COG4248, COG4248, Uncharacterized protein with pro | 9e-04 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 0.002 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 0.002 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 0.003 |
| >gnl|CDD|199217 cd10422, RNase_Ire1, RNase domain (also known as the kinase extension nuclease domain) of Ire1 | Back alignment and domain information |
|---|
Score = 197 bits (504), Expect = 1e-59
Identities = 70/126 (55%), Positives = 87/126 (69%)
Query: 674 RLSFLRDVSDRVELEDRESDSKLLRALEGIALVALNGKWDEKMETKFIENIGRYRRYKYD 733
RLSFL+DVSDR E E R+ S LL ALE A + G W EK++ FI+N+G+YR+YK
Sbjct: 3 RLSFLQDVSDRFEKEPRDPPSPLLLALESGADEVVGGDWREKLDKTFIDNLGKYRKYKGS 62
Query: 734 NVRDLLRVIRNKSNHFRELPQDIQELLGSHPEGFYNYFSCRFPKLLIEVYNVIFTYCKGE 793
+VRDLLR +RNK +H+RELP D+QELLG P+GF YF+ RFP LLI VY + K E
Sbjct: 63 SVRDLLRALRNKKHHYRELPPDVQELLGPLPDGFLRYFTSRFPNLLIHVYRAVSDSLKNE 122
Query: 794 EVFHKY 799
F KY
Sbjct: 123 STFKKY 128
|
The model represents the C-terminal endoribonuclease domain of the multi-functional protein Ire1; Ire1 in addition contains a type I transmembrane serine/threonine protein kinase (STK) domain, and a Luminal dimerization domain. Ire1 is essential for the endoplasmic reticulum (ER) unfolded protein response (UPR), which acts as an ER stress sensor and is the oldest and most conserved component of the UPR in eukaryotes. During ER stress, IRE1 dimerizes through its N-terminal luminal domain and forms oligomers, promoting trans-autophosphorylation by its cytosolic kinase domain. This leads to a conformational change that stimulates its endoribonuclease (RNase) activity and results in the cleavage of its mRNA substrate, Hac1 in yeast and Xbp1 in metazoans, thus promoting a splicing event that enables translation into a transcription factor which activates the UPR. This RNase domain is homologous to the RNase domain of RNase L, and possesses a novel fold for a nuclease and appears to be rigid irrespective of the activation state of IRE1. Structural analysis and mutational studies have revealed that an early stage 'phosphoryl-transfer' competent conformation of IRE1 favors face-to-face dimerization of the kinase domains which precedes and is distinct from the RNase 'active' back-to-back conformation. Furthermore, in yeast IRE1, the flavonol quercetin activates the RNase and potentiates activation of the protein kinase by ADP, hinting at the possible existence of endogenous cytoplasmic ligands that may function along with stress signals from ER lumen in order to modulate IRE1 activity, thus identifying IRE1 as a target for development of ATP-competitive inhibitors to modulate the UPR with specific relevance for multiple myeloma. Length = 129 |
| >gnl|CDD|219051 pfam06479, Ribonuc_2-5A, Ribonuclease 2-5A | Back alignment and domain information |
|---|
Score = 186 bits (475), Expect = 1e-55
Identities = 65/126 (51%), Positives = 94/126 (74%), Gaps = 1/126 (0%)
Query: 674 RLSFLRDVSDRVELEDRESDSKLLRALEGIALVALNGKWDEKMETKFIENIGRYRRYKYD 733
RLSFL DVSDR E+EDR+ S LL+ LE + + G W +K++ F++++G++R+YK D
Sbjct: 2 RLSFLCDVSDRFEIEDRDPPSPLLKLLERTSRAVVGGDWTKKLDKAFMDDLGKFRKYKGD 61
Query: 734 NVRDLLRVIRNKSNHFRELPQDIQELLGSHPEGFYNYFSCRFPKLLIEVYNVIFTYCKGE 793
+VRDLLR IRNK +H+RELP++++E+LG P+GF YF+ RFP LLI VY V+ C+ E
Sbjct: 62 SVRDLLRAIRNKKHHYRELPEELKEILGDLPDGFLQYFTERFPDLLIHVYTVLK-NCEYE 120
Query: 794 EVFHKY 799
++F KY
Sbjct: 121 KLFPKY 126
|
This domain is a endoribonuclease. Specifically it cleaves an intron from Hac1 mRNA in humans, which causes it to be much more efficiently translated. Length = 127 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 160 bits (408), Expect = 1e-44
Identities = 90/299 (30%), Positives = 135/299 (45%), Gaps = 61/299 (20%)
Query: 382 KEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHDV----ALKEIQNLIASDQHPNIVRWY 436
+++ +GS G V L G+ VA+K + K L+EI+ L HPNIVR Y
Sbjct: 5 EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLK-HPNIVRLY 63
Query: 437 GVESDQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENT 495
V D+D +YL +E C L DL+ + L+E R
Sbjct: 64 DVFEDEDKLYLVMEYCEGGDLFDLL---------------KKRGRLSEDEAR-------- 100
Query: 496 KDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDM 555
R I+S L +LH G++HRDLKP+N+L+ D+ KL+D
Sbjct: 101 -----------------FYLRQILSALEYLHSKGIVHRDLKPENILL--DEDGHVKLADF 141
Query: 556 GISKRLQGDMSCLTQNATGY-GSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP 614
G++++L + T + G+ + APE LL +A+D++SLG IL+ +T GK P
Sbjct: 142 GLARQLDP-----GEKLTTFVGTPEYMAPEVLLGKGYGKAVDIWSLGVILYELLT-GKPP 195
Query: 615 YGESFERDA--NIVKDRKDLFLVEHI---PEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 668
+ + + K F PEA DL +LL +P+ R A+ L HPFF
Sbjct: 196 FPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 154 bits (391), Expect = 9e-43
Identities = 85/290 (29%), Positives = 126/290 (43%), Gaps = 82/290 (28%)
Query: 384 IAKGSNGTVVL-EGNYEGRSVAVKRLVK----THHDVALKEIQNLIASDQHPNIVRWYGV 438
+ +G GTV L G+ VA+K + K + + L+EI+ L HPNIV+ YGV
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEIL-KKLNHPNIVKLYGV 59
Query: 439 ESDQDFVYLSLERCT-CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKD 497
D++ +YL +E C SL DL+ G E
Sbjct: 60 FEDENHLYLVMEYCEGGSLKDLLKENEGKLSED--------------------------- 92
Query: 498 IELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGI 557
++L++ I+ GL +LH G+IHRDLKP+N+L+ D + KL+D G+
Sbjct: 93 ------------EILRILLQILEGLEYLHSNGIIHRDLKPENILLDSD-NGKVKLADFGL 139
Query: 558 SKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ-GRQTRAIDLFSLGCILFFCITGGKHPYG 616
SK L D S L T G+ + APE LL G + D++SLG IL+
Sbjct: 140 SKLLTSDKSLLK---TIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYE---------- 186
Query: 617 ESFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHP 666
+PE DL ++L +P+ RP A+ +L H
Sbjct: 187 ---------------------LPELKDLIRKMLQKDPEKRPSAKEILEHL 215
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 146 bits (371), Expect = 1e-39
Identities = 88/307 (28%), Positives = 130/307 (42%), Gaps = 65/307 (21%)
Query: 379 VFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNI 432
+++ GS GTV + G+ VAVK L K A +EI+ L HPNI
Sbjct: 2 ELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRIL-RRLSHPNI 60
Query: 433 VRWYGVESDQDFVYLSLERC-TCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPV 491
VR D+D +YL +E C L D + G E
Sbjct: 61 VRLIDAFEDKDHLYLVMEYCEGGDLFDYL-SRGGPLSED--------------------- 98
Query: 492 MENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAK 551
+ K+ I+ GL +LH G+IHRDLKP+N+L+ ++ K
Sbjct: 99 ------------------EAKKIALQILRGLEYLHSNGIIHRDLKPENILLDENGVV--K 138
Query: 552 LSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGR-QTRAIDLFSLGCILFFCITG 610
++D G++K+L S LT G+ + APE LL G +D++SLG IL + +
Sbjct: 139 IADFGLAKKLLKSSSSLTTFV---GTPWYMAPEVLLGGNGYGPKVDVWSLGVIL-YELLT 194
Query: 611 GKHPYGESFERDANIVKDRKDL---------FLVEHIPEAVDLFTRLLDPNPDLRPKAQN 661
GK P+ D + R+ L EA DL + L+ +P RP A+
Sbjct: 195 GKPPFSGENILDQ-LQLIRRILGPPLEFDEPKWSSGSEEAKDLIKKCLNKDPSKRPTAEE 253
Query: 662 VLNHPFF 668
+L HP+F
Sbjct: 254 ILQHPWF 260
|
Length = 260 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 146 bits (370), Expect = 3e-39
Identities = 90/300 (30%), Positives = 131/300 (43%), Gaps = 58/300 (19%)
Query: 382 KEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHDVA--LKEIQNLIA---SDQHPNIVRW 435
+ + +GS G+V L G +AVK V+ D L+ ++ I S QHPNIVR+
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKS-VELSGDSEEELEALEREIRILSSLQHPNIVRY 64
Query: 436 YGVESD--QDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVM 492
YG E D ++ + + LE + SL+ L+ G E + IR
Sbjct: 65 YGSERDEEKNTLNIFLEYVSGGSLSSLLK-KFGKLPEPV--------------IR----- 104
Query: 493 ENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKL 552
K TR I+ GL++LH G++HRD+K N+L+ D KL
Sbjct: 105 --------------------KYTRQILEGLAYLHSNGIVHRDIKGANILV--DSDGVVKL 142
Query: 553 SDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGK 612
+D G +KRL + G+ W APE + RA D++SLGC + T GK
Sbjct: 143 ADFGCAKRLGDIE-TGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMAT-GK 200
Query: 613 HPYGESFERDAN---IVKDRKDLFLVEHI-PEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 668
P+ E A I + + EH+ EA D + L +P RP A +L HPF
Sbjct: 201 PPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQHPFL 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 128 bits (325), Expect = 2e-33
Identities = 80/308 (25%), Positives = 125/308 (40%), Gaps = 82/308 (26%)
Query: 382 KEIAKGSNGTVVLEGNYEGRS------VAVKRL---VKTHHDVALKEIQNLIASDQHPNI 432
++I KG G V Y+ R VA+K + K + + EIQ ++ +HPNI
Sbjct: 6 EKIGKGGFGEV-----YKARHKRTGKEVAIKVIKLESKEKKEKIINEIQ-ILKKCKHPNI 59
Query: 433 VRWYGVESDQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPV 491
V++YG +D +++ +E C+ SL DL+ + + E
Sbjct: 60 VKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTES--------------------- 98
Query: 492 MENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAK 551
Q+ V ++++ GL +LH G+IHRD+K N+L++ D K
Sbjct: 99 ------------------QIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGE--VK 138
Query: 552 LSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGG 611
L D G+S +L + T G+ W APE + D++SLG G
Sbjct: 139 LIDFGLSAQLSDTKARNTM----VGTPYWMAPEVINGKPYDYKADIWSLGITAIELAE-G 193
Query: 612 KHPYGESFERDANIVKDRKDLFLVEHIP------------EAVDLFTRLLDPNPDLRPKA 659
K PY E + K LF + E D + L NP+ RP A
Sbjct: 194 KPPYSEL-----PPM---KALFKIATNGPPGLRNPEKWSDEFKDFLKKCLQKNPEKRPTA 245
Query: 660 QNVLNHPF 667
+ +L HPF
Sbjct: 246 EQLLKHPF 253
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 116 bits (294), Expect = 6e-29
Identities = 83/326 (25%), Positives = 139/326 (42%), Gaps = 86/326 (26%)
Query: 382 KEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVRWY 436
K++ G+ G+V L N E G VA+K++ K + + L+E+++L ++HPNIV+
Sbjct: 5 KQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLK 64
Query: 437 GVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTK 496
V + D +Y E +L L+ K++ +E IR
Sbjct: 65 EVFRENDELYFVFEYMEGNLYQLM-------------KDRKGKPFSESVIR--------- 102
Query: 497 DIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMG 556
+ I+ GL+H+H+ G HRDLKP+N+L+S K++D G
Sbjct: 103 ----------------SIIYQILQGLAHIHKHGFFHRDLKPENLLVS--GPEVVKIADFG 144
Query: 557 ISKRLQGDMSCLTQNATGYGSSGW-QAPEQLLQGRQT---RAIDLFSLGCIL-------- 604
+++ ++ S T Y S+ W +APE LL R T +D+++LGCI+
Sbjct: 145 LAREIR---SRPPY--TDYVSTRWYRAPEILL--RSTSYSSPVDIWALGCIMAELYTLRP 197
Query: 605 ----------FFCI-----TGGKHPYGESFE--RDANIVKDRKDLFLVEHI-----PEAV 642
+ I T K + E ++ + + + PEA+
Sbjct: 198 LFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAI 257
Query: 643 DLFTRLLDPNPDLRPKAQNVLNHPFF 668
DL +L +P RP A L HP+F
Sbjct: 258 DLIKDMLRWDPKKRPTASQALQHPYF 283
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 6e-28
Identities = 85/298 (28%), Positives = 130/298 (43%), Gaps = 62/298 (20%)
Query: 383 EIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHHDV-ALKEIQ---NLIASDQHPNIVRWYG 437
I +G+ G V N E G VA+K++ ALK I +L+ + +HPNIV++ G
Sbjct: 7 LIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIG 66
Query: 438 VESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKD 497
D +Y+ LE Y +GS L
Sbjct: 67 SIETSDSLYIILE----------YAENGS-------------LRQ--------------- 88
Query: 498 IELWKANGHPSAQLLKV-TRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMG 556
+ K G L+ V ++ GL++LHE G+IHRD+K N+L +KD KL+D G
Sbjct: 89 --IIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGV--VKLADFG 144
Query: 557 ISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYG 616
++ +L G+ W APE + + A D++SLGC + +T G PY
Sbjct: 145 VATKLNDVSKDDASVV---GTPYWMAPEVIEMSGASTASDIWSLGCTVIELLT-GNPPY- 199
Query: 617 ESFERDA-----NIVKDRKDLFLVEHI-PEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 668
++ + IV+D L E I PE D + +P+LRP A+ +L HP+
Sbjct: 200 --YDLNPMAALFRIVQDD-HPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI 254
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 2e-27
Identities = 87/299 (29%), Positives = 132/299 (44%), Gaps = 64/299 (21%)
Query: 384 IAKGSNGTVVLEGNYE-GRSVAVKRLVKTHHDV----ALKEIQ---NLIASDQHPNIVRW 435
+ GS G+V N + G AVK + A+K+++ L++ QHPNIV++
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 436 YGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENT 495
G E ++D +Y+ LE V GS + L + E IRL
Sbjct: 68 LGTEREEDNLYIFLE----------LVPGGSLAKLL----KKYGSFPEPVIRLY------ 107
Query: 496 KDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDM 555
TR I+ GL +LH+ +HRD+K N+L+ D + KL+D
Sbjct: 108 -------------------TRQILLGLEYLHDRNTVHRDIKGANILV--DTNGVVKLADF 146
Query: 556 GISKRL--QGDMSCLTQNATGYGSSGWQAPEQLL-QGRQTRAIDLFSLGCILFFCITGGK 612
G++K++ GS W APE + QG A D++SLGC + T GK
Sbjct: 147 GMAKQVVEFSFAKSFK------GSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMAT-GK 199
Query: 613 HPYGESFERDA--NIVKDRKDLFLV-EHI-PEAVDLFTRLLDPNPDLRPKAQNVLNHPF 667
P+ + A I + K+L + +H+ EA D + L +P LRP A +L HPF
Sbjct: 200 PPWSQLEGVAAVFKIGRS-KELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEHPF 257
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 108 bits (273), Expect = 3e-26
Identities = 79/323 (24%), Positives = 128/323 (39%), Gaps = 81/323 (25%)
Query: 380 FNKEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTH------HDVALKEIQNLIASDQHPNI 432
F K I +GS TVVL + + A+K L K E + L + HP I
Sbjct: 5 FGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGI 64
Query: 433 VRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVM 492
++ Y D++ +Y LE G + + L+E R
Sbjct: 65 IKLYYTFQDEENLYFVLEYAPN----------GELLQYIR----KYGSLDEKCTRFY--- 107
Query: 493 ENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKL 552
+A+ I+ L +LH G+IHRDLKP+N+L+ KD K+
Sbjct: 108 ---------------AAE-------ILLALEYLHSKGIIHRDLKPENILLDKDMH--IKI 143
Query: 553 SDMGISKRLQGD----------MSCLTQNATGY-------GSSGWQAPEQLLQGRQTRAI 595
+D G +K L + + +Q G++ + +PE L + ++
Sbjct: 144 TDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSS 203
Query: 596 DLFSLGCILFFCITGGKHP-YGES----FERDANIVKDRKDLFLVEHIPE-AVDLFTRLL 649
DL++LGCI++ +T GK P G + F++ + + F + P A DL +LL
Sbjct: 204 DLWALGCIIYQMLT-GKPPFRGSNEYLTFQK----ILKLEYSFP-PNFPPDAKDLIEKLL 257
Query: 650 DPNPDLRP----KAQNVLNHPFF 668
+P R + HPFF
Sbjct: 258 VLDPQDRLGVNEGYDELKAHPFF 280
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 7e-26
Identities = 75/297 (25%), Positives = 127/297 (42%), Gaps = 54/297 (18%)
Query: 382 KEIAKGSNGTVVL-EGNYEGRSVAVKR-----LVKTHHDVALKEIQNLIASDQHPNIVRW 435
K+I KGS G V L +G+ +K + + + AL E++ ++ HPNI+++
Sbjct: 6 KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVK-ILKKLNHPNIIKY 64
Query: 436 YGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENT 495
Y ++ + + +E Y G +++ ++++ E +I
Sbjct: 65 YESFEEKGKLCIVME----------YADGGDLSQKIKKQKKEGKPFPEEQI--------- 105
Query: 496 KDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDM 555
L + L +LH ++HRD+KPQN+ ++ + KL D
Sbjct: 106 ----------------LDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGL--VKLGDF 147
Query: 556 GISKRLQGDMSCL-TQNATGYGSSGWQAPEQLLQGRQ-TRAIDLFSLGCILFFCITGGKH 613
GISK L + T T Y S PE L Q + D++SLGC+L+ T KH
Sbjct: 148 GISKVLSSTVDLAKTVVGTPYYLS----PE-LCQNKPYNYKSDIWSLGCVLYELCT-LKH 201
Query: 614 P-YGESFERDA-NIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 668
P GE+ A I+K + ++ E +L + LL +P+ RP +L PF
Sbjct: 202 PFEGENLLELALKILKGQYPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQSPFI 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 109 bits (271), Expect = 2e-25
Identities = 84/338 (24%), Positives = 131/338 (38%), Gaps = 64/338 (18%)
Query: 382 KEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDV------ALKEIQNLIASDQHPNIVRW 435
+++ +GS G V L + + VA+K L K L+EIQ L + + PNIV+
Sbjct: 6 RKLGEGSFGEVYL--ARDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKL 63
Query: 436 YGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENT 495
Y D+ +YL +E YV GS E+ L + L
Sbjct: 64 YDFFQDEGSLYLVME----------YVDGGSLEDLLKKIGRKGPL--------------- 98
Query: 496 KDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDM 555
++ L + I+S L +LH G+IHRD+KP+N+L+ +D KL D
Sbjct: 99 -----------SESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRD-GRVVKLIDF 146
Query: 556 GISKRLQGDMSCLTQNA---TGYGSSGWQAPEQLLQ---GRQTRAIDLFSLGCILFFCIT 609
G++K L S + A T G+ G+ APE LL + + D++SLG L+ +T
Sbjct: 147 GLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLT 206
Query: 610 GGKHPYGESFERDANIV-------------KDRKDLFLVEHIPEAVDLFTRLLDPNPDLR 656
G GE + A DL +LL +P R
Sbjct: 207 GLPPFEGEKNSSATSQTLKIILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNR 266
Query: 657 PKAQNVLNHPFFWTADTRLSFLRDVSDRVELEDRESDS 694
+ + L+H + S L D+ +
Sbjct: 267 LSSSSDLSHDLLAHLKLKESDLSDLLKPDDSAPLRLSL 304
|
Length = 384 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 70/303 (23%), Positives = 122/303 (40%), Gaps = 66/303 (21%)
Query: 378 VVFNKEIAKGSNGTVVLEGNYEGRS------VAVKRLVKTHHDVALKEIQN---LIASDQ 428
+ K++ +G+ G V +G +G+ VAVK L + + ++E ++
Sbjct: 1 LTLGKKLGEGAFG-EVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLD 59
Query: 429 HPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRL 488
HPN+V+ GV ++++ +Y+ +E Y+ G L ++ L
Sbjct: 60 HPNVVKLLGVCTEEEPLYIVME----------YMEGGDLLSYL--RKNRPKL-------- 99
Query: 489 LPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSF 548
+ LL I G+ +L IHRDL +N L+ ++
Sbjct: 100 ------------------SLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENL-- 139
Query: 549 CAKLSDMGISKRLQGDMSCLTQNATGYGSSG------WQAPEQLLQGRQTRAIDLFSLGC 602
K+SD G+S+ L D Y G W APE L +G+ T D++S G
Sbjct: 140 VVKISDFGLSRDLYDDDY--------YRKRGGKLPIRWMAPESLKEGKFTSKSDVWSFGV 191
Query: 603 ILFFCITGGKHPYGE-SFERDANIVKDRKDLFLVEHIPEAV-DLFTRLLDPNPDLRPKAQ 660
+L+ T G+ PY S E +K+ L + P + DL + +P+ RP
Sbjct: 192 LLWEIFTLGEQPYPGMSNEEVLEYLKNGYRLPQPPNCPPELYDLMLQCWAEDPEDRPTFS 251
Query: 661 NVL 663
++
Sbjct: 252 ELV 254
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 6e-24
Identities = 68/303 (22%), Positives = 118/303 (38%), Gaps = 63/303 (20%)
Query: 378 VVFNKEIAKGSNGTVVL-----EGNYEGRSVAVKRLVKTHHDVALKEIQN---LIASDQH 429
+ K++ +G+ G V +G+ + VAVK L + + ++E ++ H
Sbjct: 1 LTLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDH 60
Query: 430 PNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLL 489
PNIV+ GV ++++ + + +E Y+ G + L
Sbjct: 61 PNIVKLLGVCTEEEPLMIVME----------YMPGGDLLDYL------------------ 92
Query: 490 PVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFC 549
+ EL + LL I G+ +L IHRDL +N L+ ++
Sbjct: 93 ---RKNRPKEL------SLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENL--V 141
Query: 550 AKLSDMGISKRLQGDMSCLTQNATGYGSSG------WQAPEQLLQGRQTRAIDLFSLGCI 603
K+SD G+S+ L D Y G W APE L +G+ T D++S G +
Sbjct: 142 VKISDFGLSRDLYDDDY--------YKVKGGKLPIRWMAPESLKEGKFTSKSDVWSFGVL 193
Query: 604 LFFCITGGKHPYGE-SFERDANIVKDRKDLFLVEHIPEAV-DLFTRLLDPNPDLRPKAQN 661
L+ T G+ PY S +K L + P + L + +P+ RP
Sbjct: 194 LWEIFTLGEEPYPGMSNAEVLEYLKKGYRLPKPPNCPPELYKLMLQCWAEDPEDRPTFSE 253
Query: 662 VLN 664
++
Sbjct: 254 LVE 256
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 7e-24
Identities = 87/308 (28%), Positives = 132/308 (42%), Gaps = 61/308 (19%)
Query: 373 RIGKLVVFNKEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHHDVAL-KEIQ------NLI 424
R GKL + +G+ G V L + + GR +AVK++ KE+ L+
Sbjct: 5 RRGKL------LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLL 58
Query: 425 ASDQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEV 484
+ QH IV++YG D + + + +E Y+ GS ++QL A L E
Sbjct: 59 KNLQHERIVQYYGCLRDDETLSIFME----------YMPGGSVKDQLKA----YGALTET 104
Query: 485 RIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISK 544
R K TR I+ G+ +LH ++HRD+K N+L +
Sbjct: 105 VTR-------------------------KYTRQILEGVEYLHSNMIVHRDIKGANIL--R 137
Query: 545 DKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCIL 604
D + KL D G SKRLQ S T + G+ W +PE + R D++S+GC +
Sbjct: 138 DSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTV 197
Query: 605 FFCITGGKHPYGESFERDA---NIVKDRKDLFLVEHI-PEAVDLFTRLLDPNPDLRPKAQ 660
+T K P+ E FE A I + L H+ P+A + R N RP A+
Sbjct: 198 VEMLT-EKPPWAE-FEAMAAIFKIATQPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAE 255
Query: 661 NVLNHPFF 668
+L H F
Sbjct: 256 ELLRHFFV 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (255), Expect = 9e-24
Identities = 78/309 (25%), Positives = 121/309 (39%), Gaps = 96/309 (31%)
Query: 409 VKTHHDVALKEIQNLIASD----------------QHPNIVRWYGVESDQDFVYLSLERC 452
KT VALK+I+ + +HPNIV+ V + +YL E C
Sbjct: 21 KKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80
Query: 453 TCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLL 512
L + G N ++ + QLL
Sbjct: 81 DMDLKKYLDKRPGPLSP------------NLIKSIMY--------------------QLL 108
Query: 513 KVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQN- 571
GL++ H ++HRDLKPQN+LI++D KL+D G+++ + T
Sbjct: 109 -------RGLAYCHSHRILHRDLKPQNILINRDG--VLKLADFGLARAFGIPLRTYTHEV 159
Query: 572 ATGYGSSGWQAPEQLLQGRQ-TRAIDLFSLGCILFFCITGGKHP--YGES--------FE 620
T + ++APE LL + + A+D++S+GCI ITG P G+S F+
Sbjct: 160 VTLW----YRAPEILLGSKHYSTAVDIWSVGCIFAEMITG--KPLFPGDSEIDQLFKIFQ 213
Query: 621 ----------RDANIVKDRKDLF-------LVEHIP----EAVDLFTRLLDPNPDLRPKA 659
+ D K F L + +P E +DL +++L NP R A
Sbjct: 214 ILGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISA 273
Query: 660 QNVLNHPFF 668
+ L HP+F
Sbjct: 274 KEALKHPYF 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 88/299 (29%), Positives = 133/299 (44%), Gaps = 63/299 (21%)
Query: 384 IAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHDVALKEIQ------NLIASDQHPNIVR-W 435
+ KGS G V+L G+ A+K L K + KE++ N+++ HP IV+
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKI-IKRKEVEHTLTERNILSRINHPFIVKLH 59
Query: 436 YGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENT 495
Y + ++ +YL LE +L L +E R R
Sbjct: 60 YAFQ-TEEKLYLVLEYAPG--GELFSHL------------SKEGRFSEERARF------- 97
Query: 496 KDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDM 555
+ A +IV L +LH +G+I+RDLKP+N+L+ D KL+D
Sbjct: 98 -----YAA-------------EIVLALEYLHSLGIIYRDLKPENILLDADGH--IKLTDF 137
Query: 556 GISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP- 614
G++K L + S G+ + APE LL +A+D +SLG +L+ +T GK P
Sbjct: 138 GLAKELSSEGSRTNTFC---GTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLT-GKPPF 193
Query: 615 YGESFER-DANIVKDRKDLFLVEHI-PEAVDLFTRLLDPNPDLR---PKAQNVLNHPFF 668
Y E + I+KD L E + PEA DL + LL +P R A+ + HPFF
Sbjct: 194 YAEDRKEIYEKILKD--PLRFPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF 250
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 84/309 (27%), Positives = 137/309 (44%), Gaps = 74/309 (23%)
Query: 382 KEIAKGSNGTVVLEGNYE-GRSVAVK--RLVKTHHDVALKEIQ---NLIASDQHPNIVRW 435
+I G+ G V N + G +AVK R+ +KEI ++ +HPN+V++
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPK-TIKEIADEMKVLELLKHPNLVKY 64
Query: 436 YGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENT 495
YGVE ++ VY+ +E C+ G+ EE L +L+E IR+
Sbjct: 65 YGVEVHREKVYIFMEYCS----------GGTLEELLEHGR----ILDEHVIRVY------ 104
Query: 496 KDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDM 555
+ QLL+ GL++LH G++HRD+KP N+ + D + KL D
Sbjct: 105 ------------TLQLLE-------GLAYLHSHGIVHRDIKPANIFL--DHNGVIKLGDF 143
Query: 556 GISKRLQ-GDMSCLTQNATGYGSSGWQAPEQLLQGRQT---RAIDLFSLGCILFFCITGG 611
G + +L+ + + + G+ + APE + G+ RA D++SLGC++ T G
Sbjct: 144 GCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMAT-G 202
Query: 612 KHPYGESFERDANIV-------------KDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPK 658
K P+ E + + I+ + PE D R L+ +P RP
Sbjct: 203 KRPWSE-LDNEFQIMFHVGAGHKPPIPDSLQLS-------PEGKDFLDRCLESDPKKRPT 254
Query: 659 AQNVLNHPF 667
A +L HPF
Sbjct: 255 ASELLQHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 99.3 bits (248), Expect = 6e-23
Identities = 79/323 (24%), Positives = 134/323 (41%), Gaps = 83/323 (25%)
Query: 384 IAKGSNGTVVLEGNYE-GRSVAVKRL-VKTHHD----VALKEIQNLIASDQHPNIVRWYG 437
I +G++G V + E G +VA+K++ ++ AL+EI+ L A QHP +V+
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQAC-QHPYVVKLLD 66
Query: 438 VESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKD 497
V L +E L++++ ++++ L
Sbjct: 67 VFPHGSGFVLVMEYMPSDLSEVL-------------RDEERPL----------------- 96
Query: 498 IELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGI 557
P AQ+ R ++ G++++H G++HRDLKP N+LIS D K++D G+
Sbjct: 97 ---------PEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADG--VLKIADFGL 145
Query: 558 SKRLQGDMSCLTQNATGYGSSGW-QAPEQLLQGRQ-TRAIDLFSLGCILFFCITGGKHPY 615
++ + L + + W +APE L R+ +DL+++GCI + G
Sbjct: 146 ARLFSEEEPRLYSHQVA---TRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFP 202
Query: 616 GES----------------------FER--DANIV--KDRKDLFLVEHIP----EAVDLF 645
GE+ D N + + K + L E P EA+DL
Sbjct: 203 GENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLL 262
Query: 646 TRLLDPNPDLRPKAQNVLNHPFF 668
LL +P R A L HP+F
Sbjct: 263 KGLLVYDPSKRLSAAEALRHPYF 285
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 96.9 bits (242), Expect = 2e-22
Identities = 76/318 (23%), Positives = 121/318 (38%), Gaps = 98/318 (30%)
Query: 382 KEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQ----------------NLIA 425
K + +GS+G V + T ALK+I L +
Sbjct: 7 KVLGQGSSGVV---------YKVRHK--PTGKIYALKKIHVDGDEEFRKQLLRELKTLRS 55
Query: 426 SDQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVR 485
+ P +V+ YG + + + LE Y+ GS L ++
Sbjct: 56 C-ESPYVVKCYGAFYKEGEISIVLE----------YMDGGS--------------LADLL 90
Query: 486 IRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI-GLIHRDLKPQNVLISK 544
++ + E L + R I+ GL +LH +IHRD+KP N+LI+
Sbjct: 91 KKVGKIPEP---------------VLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINS 135
Query: 545 DKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCIL 604
K++D GISK L+ + L Q T G+ + +PE++ + A D++SLG L
Sbjct: 136 KG--EVKIADFGISKVLE---NTLDQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTL 190
Query: 605 FFCITGGKHPYGESFERDANIVKDRKDLF-LVEHI--------------PEAVDLFTRLL 649
C GK P+ + + F L++ I PE D + L
Sbjct: 191 LECAL-GKFPF---------LPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDFISACL 240
Query: 650 DPNPDLRPKAQNVLNHPF 667
+P RP A +L HPF
Sbjct: 241 QKDPKKRPSAAELLQHPF 258
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 96.8 bits (241), Expect = 3e-22
Identities = 88/306 (28%), Positives = 129/306 (42%), Gaps = 69/306 (22%)
Query: 384 IAKGSNGTVVLEGN-YEGRSVAVKRLVKTHHDV-----------ALKEIQNLIASDQHPN 431
I GS G+V L N G +AVK++ AL L+ QH N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 432 IVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPV 491
IV++ G D D + + LE YV GS LN + E +R
Sbjct: 68 IVQYLGSSLDADHLNIFLE----------YVPGGSVAALLN----NYGAFEETLVR---- 109
Query: 492 MENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAK 551
R I+ GL++LH G+IHRD+K N+L+ D K
Sbjct: 110 ---------------------NFVRQILKGLNYLHNRGIIHRDIKGANILV--DNKGGIK 146
Query: 552 LSDMGISKRLQGDMSCLTQNA---TGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCI 608
+SD GISK+L+ + N + GS W APE + Q TR D++SLGC++ +
Sbjct: 147 ISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEML 206
Query: 609 TGGKHPYGES------FERDANIVKDRKDLFLVEHIP-EAVDLFTRLLDPNPDLRPKAQN 661
T GKHP+ + F+ N + + +I EA+D + + + + RP A
Sbjct: 207 T-GKHPFPDCTQLQAIFKIGENASPE-----IPSNISSEAIDFLEKTFEIDHNKRPTAAE 260
Query: 662 VLNHPF 667
+L HPF
Sbjct: 261 LLKHPF 266
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 94.9 bits (237), Expect = 1e-21
Identities = 70/298 (23%), Positives = 116/298 (38%), Gaps = 52/298 (17%)
Query: 382 KEIAKGSNGTV----VLEGNYEGRSVAVKRLVKTHHDVALKEIQNLIA---SDQHPNIVR 434
K++ +G+ G V + + + VAVK L + + K+ HPN+VR
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 435 WYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMEN 494
GV ++++ +YL LE Y+ G +LL+ +R
Sbjct: 61 LLGVCTEEEPLYLVLE----------YMEGG-------------DLLDYLRKSRPVFPSP 97
Query: 495 TKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSD 554
K LL I G+ +L +HRDL +N L+ +D K+SD
Sbjct: 98 EKST-------LSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDL--VVKISD 148
Query: 555 MGISKRLQGDMSCLTQNATGYGSSG-----WQAPEQLLQGRQTRAIDLFSLGCILFFCIT 609
G+S+ + D + + G W APE L G T D++S G +L+ T
Sbjct: 149 FGLSRDVYDDDYYRKK------TGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFT 202
Query: 610 GGKHPYGE-SFERDANIVKDRKDLFLVEHIPEAV-DLFTRLLDPNPDLRPKAQNVLNH 665
G PY S E ++ L E+ P+ + +L +P+ RP ++
Sbjct: 203 LGATPYPGLSNEEVLEYLRKGYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVER 260
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 95.0 bits (237), Expect = 1e-21
Identities = 56/162 (34%), Positives = 85/162 (52%), Gaps = 14/162 (8%)
Query: 518 IVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISK-----RLQGDMSCLTQNA 572
IV L +LH G+IHRDLKP N+LI + KL+D G+SK R ++
Sbjct: 102 IVLALEYLHSNGIIHRDLKPDNILIDSNGHL--KLTDFGLSKVGLVRRQINLNDDEKEDK 159
Query: 573 TGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERD--ANIVKDRK 630
G+ + APE +L ++ +D +SLGCIL+ + G P+ + NI+ +
Sbjct: 160 RIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLV-GIPPFHGETPEEIFQNILNGKI 218
Query: 631 D-LFLVEHIPEAVDLFTRLLDPNPDLRPKA---QNVLNHPFF 668
+ VE EA+DL ++LL P+P+ R A + + NHPFF
Sbjct: 219 EWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFF 260
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.0 bits (237), Expect = 2e-21
Identities = 86/323 (26%), Positives = 132/323 (40%), Gaps = 78/323 (24%)
Query: 383 EIAKGSNGTVVLEGN-YEGRSVAVKRL-VKTHHD----VALKEIQNL--IASDQHPNIVR 434
EI +G+ GTV + GR VA+K++ V + L+EI L + S +HPNIVR
Sbjct: 6 EIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVR 65
Query: 435 WYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMEN 494
V +R L V FE +QD L +
Sbjct: 66 LLDV-----CHGPRTDREL----KLTLV----FEHV----DQD----------LATYLSK 98
Query: 495 TKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSD 554
G P + + R ++ G+ LH ++HRDLKPQN+L++ D K++D
Sbjct: 99 CP------KPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQV--KIAD 150
Query: 555 MGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCI---------LF 605
G+++ +M+ + T + ++APE LLQ +D++S+GCI LF
Sbjct: 151 FGLARIYSFEMALTSVVVTLW----YRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLF 206
Query: 606 ------------FCITG----GKHPYGESFERDA---NIVKDRKDLFLVEHI-PEAVDLF 645
F + G + P S R + + K V I E +DL
Sbjct: 207 RGTSEADQLDKIFDVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKS--FVPEICEEGLDLL 264
Query: 646 TRLLDPNPDLRPKAQNVLNHPFF 668
++L NP R A L HP+F
Sbjct: 265 KKMLTFNPHKRISAFEALQHPYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 94.5 bits (235), Expect = 2e-21
Identities = 84/306 (27%), Positives = 129/306 (42%), Gaps = 65/306 (21%)
Query: 384 IAKGSNGTVVLEGNYE-GRSVAVK-----RLVKTHHDVALKEIQNLIASD-------QHP 430
I KG+ G V L N G +AVK + HD K++ + S+ H
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 431 NIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLP 490
NIV++ G E+ ++++ + LE G FEEQL +R
Sbjct: 69 NIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQL--------------VRFF- 113
Query: 491 VMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCA 550
T ++ GL++LH G++HRDLK N+L+ D C
Sbjct: 114 ------------------------TEQVLEGLAYLHSKGILHRDLKADNLLVDAD-GIC- 147
Query: 551 KLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQL-LQGRQTRA-IDLFSLGCILFFCI 608
K+SD GISK+ D+ QN + GS W APE + + A +D++SLGC++ +
Sbjct: 148 KISDFGISKK-SDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLE-M 205
Query: 609 TGGKHPYG--ESFERDANIVKDRKDLFLVEHI-----PEAVDLFTRLLDPNPDLRPKAQN 661
G+ P+ E+ + R + + P A+D NPD RP A+
Sbjct: 206 FAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARE 265
Query: 662 VLNHPF 667
+L HPF
Sbjct: 266 LLQHPF 271
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.1 bits (234), Expect = 2e-21
Identities = 82/306 (26%), Positives = 134/306 (43%), Gaps = 64/306 (20%)
Query: 382 KEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHDVALKEIQNLIA-------SDQHPNIV 433
K I+KG+ G+V L + G A+K L K+ A ++ N+ A + P +
Sbjct: 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMI-AKNQVTNVKAERAIMMIQGESPYVA 60
Query: 434 RWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVME 493
+ Y +D++YL +E Y+ G L+ +
Sbjct: 61 KLYYSFQSKDYLYLVME----------YLNGGDCAS------------------LIKTL- 91
Query: 494 NTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLS 553
G P + ++V G+ LH+ G+IHRD+KP+N+LI D++ KL+
Sbjct: 92 ----------GGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLI--DQTGHLKLT 139
Query: 554 DMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKH 613
D G+S+ G N G+ + APE +L + D +SLGC++F + G
Sbjct: 140 DFGLSR--NGLE-----NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPP 192
Query: 614 PYGESFERD-ANIVKDRKDL--FLVEHI-PEAVDLFTRLLDPNPDLRPKA---QNVLNHP 666
+ E+ + NI+ R + + E PEAVDL RLL +P R A Q + +HP
Sbjct: 193 FHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHP 252
Query: 667 FFWTAD 672
FF + +
Sbjct: 253 FFKSIN 258
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 93.0 bits (232), Expect = 6e-21
Identities = 71/298 (23%), Positives = 119/298 (39%), Gaps = 67/298 (22%)
Query: 378 VVFNKEIAKGSNGTVVL-----EGNYEGRSVAVKRLVKTHHDVA----LKEIQNLIASDQ 428
+ K++ +G+ G V +G VAVK L + + L+E +
Sbjct: 1 LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLS- 59
Query: 429 HPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRL 488
HPNIVR GV + + +Y+ E Y+ G + L ++ L
Sbjct: 60 HPNIVRLLGVCTQGEPLYIVTE----------YMPGGDLLDFL--RKHGEKL-------- 99
Query: 489 LPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSF 548
LL++ I G+ +L +HRDL +N L++++
Sbjct: 100 ------------------TLKDLLQMALQIAKGMEYLESKNFVHRDLAARNCLVTENL-- 139
Query: 549 CAKLSDMGISKRLQGDMSCLTQNATGYGSSG-------WQAPEQLLQGRQTRAIDLFSLG 601
K+SD G+S+ + D Y G W APE L G+ T D++S G
Sbjct: 140 VVKISDFGLSRDIYEDDY--------YRKRGGGKLPIKWMAPESLKDGKFTSKSDVWSFG 191
Query: 602 CILFFCITGGKHPY-GESFERDANIVKDRKDLFLVEHIPEAV-DLFTRLLDPNPDLRP 657
+L+ T G+ PY G S E +++D L E+ P+ + +L + +P+ RP
Sbjct: 192 VLLWEIFTLGEQPYPGMSNEEVLELLEDGYRLPRPENCPDELYELMLQCWAYDPEDRP 249
|
Length = 258 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 93.5 bits (233), Expect = 6e-21
Identities = 83/309 (26%), Positives = 126/309 (40%), Gaps = 90/309 (29%)
Query: 400 GRSVAVKRLVKTHHDVA----LKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCS 455
G+ A+K + K + L+EIQ L HPNI+R + ++ +R T
Sbjct: 24 GKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRL------IEVLF---DRKTGR 74
Query: 456 LNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVT 515
L L++ L D NL ++ R P+ E ++ QLLK
Sbjct: 75 LA-LVFEL------------MDMNLYELIKGRKRPLPEKRVKSYMY--------QLLK-- 111
Query: 516 RDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLT----QN 571
L H+H G+ HRD+KP+N+LI D KL+D G SC
Sbjct: 112 -----SLDHMHRNGIFHRDIKPENILIKDD---ILKLADFG---------SCRGIYSKPP 154
Query: 572 ATGYGSSGW-QAPEQLL-QGRQTRAIDLFSLGCILFFCIT-----GGKH----------- 613
T Y S+ W +APE LL G +D++++GC+ F ++ G +
Sbjct: 155 YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDV 214
Query: 614 ---PYGE-------SFERDANIVKDRKDLFLVEHIP----EAVDLFTRLLDPNPDLRPKA 659
P E S + N +K L + +P E +DL +LL +PD R A
Sbjct: 215 LGTPDAEVLKKFRKSRHMNYNFPS-KKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITA 273
Query: 660 QNVLNHPFF 668
+ L HP+F
Sbjct: 274 KQALRHPYF 282
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.2 bits (227), Expect = 4e-20
Identities = 77/325 (23%), Positives = 133/325 (40%), Gaps = 84/325 (25%)
Query: 382 KEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHHD-----VALKEIQNLIASDQHPNIVRW 435
+I +G+ G V + G VA+K++ AL+EI+ L+ HPNI++
Sbjct: 5 GKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIK-LLKELNHPNIIKL 63
Query: 436 YGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENT 495
V + +YL E D++L ++ R + E+
Sbjct: 64 LDVFRHKGDLYLVFEFM------------------------DTDLYKLIKDRQRGLPESL 99
Query: 496 KDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDM 555
L+ QLL+ GL+ H G++HRDLKP+N+LI+ + KL+D
Sbjct: 100 IKSYLY--------QLLQ-------GLAFCHSHGILHRDLKPENLLINTEGVL--KLADF 142
Query: 556 GISKRLQGDMSCLTQNATGYGSSGW-QAPEQLLQGRQ-TRAIDLFSLGCILFFCITG--- 610
G+++ + T Y + W +APE LL + + +D++S+GCI ++
Sbjct: 143 GLARSFGSPVRPYTH----YVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPL 198
Query: 611 --GKH--------------------PYGESFERDANI-VKDRKDLFLVEHIP----EAVD 643
GK P S R+ + + L + P +A+D
Sbjct: 199 FPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALD 258
Query: 644 LFTRLLDPNPDLRPKAQNVLNHPFF 668
L +++L +P R A+ L HP+F
Sbjct: 259 LLSQMLHYDPHKRITAEQALAHPYF 283
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 92.2 bits (230), Expect = 4e-20
Identities = 82/329 (24%), Positives = 126/329 (38%), Gaps = 80/329 (24%)
Query: 380 FNKEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHDV-----ALKEIQNLIASDQHPNIV 433
K I G+ G V GR VA+K++ D+ L+EI+ L+ +H NI+
Sbjct: 4 LLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIK-LLRHLRHENII 62
Query: 434 RWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVME 493
+ S E ND +Y+++ E L+ + L + I+
Sbjct: 63 GLLDI-----LRPPSPE----DFND-VYIVTELMETDLHKVIKSPQPLTDDHIQYF---- 108
Query: 494 NTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFC-AKL 552
Q+L+ GL +LH +IHRDLKP N+L++ + C K+
Sbjct: 109 --------------LYQILR-------GLKYLHSANVIHRDLKPSNILVNSN---CDLKI 144
Query: 553 SDMGISKRLQGDMSCLTQNATGYGSSGW-QAPEQLLQGRQ-TRAIDLFSLGCILFFCITG 610
D G++ R T Y + W +APE LL + T+AID++S+GCI +T
Sbjct: 145 CDFGLA-RGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTR 203
Query: 611 -----GKH--------------PYGE--SFERDANIVKDRKDLFLVEHIP---------- 639
G+ P E F K L P
Sbjct: 204 KPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASP 263
Query: 640 EAVDLFTRLLDPNPDLRPKAQNVLNHPFF 668
EA+DL ++L +P R A L HP+
Sbjct: 264 EAIDLLEKMLVFDPKKRITADEALAHPYL 292
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|188873 cd09213, Luminal_IRE1_like, The Luminal domain, a dimerization domain, of Inositol-requiring protein 1-like proteins | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 7e-20
Identities = 44/135 (32%), Positives = 69/135 (51%), Gaps = 15/135 (11%)
Query: 18 IKKLSSSAEEYIRRMPYISK---DGGVTLGAMKTSVFLVDVKSGRVVDNYVLDFSASTPG 74
+++L + E+ + P +S D V +G+ +TSVF +D K+G+++ Y D ST G
Sbjct: 70 LQRLPLTIEDLVEASPLVSDTNEDDVVVVGSKRTSVFALDAKTGKIIKTYRADGLPSTGG 129
Query: 75 FQSDENKHVVPVDGYEELVESGVGNLKRIRQLVYIMRTDYVLQSTSQDSGEVLWNVAYAD 134
SD N P + EE +L+YI RTDYVLQ+ SG+ LWNV Y +
Sbjct: 130 SDSDGNSTPGPDELQEE------------EELLYIGRTDYVLQAIDPRSGKELWNVTYGE 177
Query: 135 FKAEFRCQEVGKSFS 149
++A + + S
Sbjct: 178 YEALTLDADELGTSS 192
|
The Luminal domain is a dimerization domain present in Inositol-requiring protein 1 (IRE1), eukaryotic translation Initiation Factor 2-Alpha Kinase 3 (EIF2AK3), and similar proteins. IRE1 and EIF2AK3 are serine/threonine protein kinases (STKs) and are type I transmembrane proteins that are localized in the endoplasmic reticulum (ER). They are kinase receptors that are activated through the release of BiP, a chaperone bound to their luminal domains under unstressed conditions. This results in dimerization through their luminal domains, allowing trans-autophosphorylation of their kinase domains and activation. They play roles in the signaling of the unfolded protein response (UPR), which is activated when protein misfolding is detected in the ER in order to decrease the synthesis of new proteins and increase the capacity of the ER to cope with the stress. IRE1, also called Endoplasmic reticulum (ER)-to-nucleus signaling protein (or ERN), contains an endoribonuclease domain in its cytoplasmic side and acts as an ER stress sensor. It is the oldest and most conserved component of the UPR in eukaryotes. Its activation results in the cleavage of its mRNA substrate, HAC1 in yeast and Xbp1 in metazoans, promoting a splicing event that enables translation into a transcription factor which activates the UPR. EIF2AK3, also called PKR-like Endoplasmic Reticulum Kinase (PERK), phosphorylates the alpha subunit of eIF-2, resulting in the downregulation of protein synthesis. It functions as the central regulator of translational control during the UPR pathway. In addition to the eIF-2 alpha subunit, EIF2AK3 also phosphorylates Nrf2, a leucine zipper transcription factor which regulates cellular redox status and promotes cell survival during the UPR. Length = 312 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 89.6 bits (223), Expect = 9e-20
Identities = 78/304 (25%), Positives = 126/304 (41%), Gaps = 68/304 (22%)
Query: 384 IAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHDVALKEIQNLIASDQ-------HPNIVRW 435
+ G G V L + + R+ A+K VK H V Q I S++ HP IV+
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKC-VKKRHIVETG-QQEHIFSEKEILEECNHPFIVKL 58
Query: 436 YGVESDQDFVYLSLERCT-CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMEN 494
Y D+ ++Y+ +E C L ++ +D L +E
Sbjct: 59 YRTFKDKKYIYMLMEYCLGGELWTIL---------------RDRGLFDE----------- 92
Query: 495 TKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSD 554
+A+ +V +LH G+I+RDLKP+N+L+ D + KL D
Sbjct: 93 ------------YTARFY--IACVVLAFEYLHNRGIIYRDLKPENLLL--DSNGYVKLVD 136
Query: 555 MGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP 614
G +K+L+ + T G+ + APE +L ++D +SLG +L+ +TG P
Sbjct: 137 FGFAKKLKSG----QKTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRP-P 191
Query: 615 YGES----FERDANIVKDRKDLFLVEHI-PEAVDLFTRLLDPNPDLRPKAQN-----VLN 664
+GE E +I+K L +I A DL +LL NP+ R +
Sbjct: 192 FGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251
Query: 665 HPFF 668
H +F
Sbjct: 252 HKWF 255
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 88.9 bits (221), Expect = 1e-19
Identities = 73/305 (23%), Positives = 128/305 (41%), Gaps = 79/305 (25%)
Query: 384 IAKGSNGTVVLEGNYE-GRSVAVKRL-VKTHHDVALKEIQNLIASDQHPNIVRWYGVESD 441
+ +GS G+V + E G+ VA+K + V+ +KEI L D P IV++YG
Sbjct: 11 LGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCD-SPYIVKYYGSYFK 69
Query: 442 QDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIEL 500
+++ +E C S++D++ + + + E+
Sbjct: 70 NTDLWIVMEYCGAGSVSDIMKITNKTLTEE------------------------------ 99
Query: 501 WKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKR 560
++ + + GL +LH IHRD+K N+L++++ AKL+D G+S +
Sbjct: 100 ---------EIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQ--AKLADFGVSGQ 148
Query: 561 LQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG-----GKHPY 615
L M+ + T G+ W APE + + D++SLG IT GK PY
Sbjct: 149 LTDTMA---KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLG------ITAIEMAEGKPPY 199
Query: 616 GESFERDANIVKDRKDLFLVEHIP------------EAVDLFTRLLDPNPDLRPKAQNVL 663
+ + + +F++ + P E D + L +P+ RP A +L
Sbjct: 200 SD--------IHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLL 251
Query: 664 NHPFF 668
HPF
Sbjct: 252 QHPFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 89.2 bits (222), Expect = 2e-19
Identities = 85/340 (25%), Positives = 146/340 (42%), Gaps = 76/340 (22%)
Query: 355 EKFLLTFTDLIDDRVDGRRIGKLVVFNKEIAKGSNGTV-VLEGNYEGRSVAVK--RLVKT 411
E+ D++ + G K I +G++G V G+ VA+K RL K
Sbjct: 2 EELKAALKDIVSE---GDPRELYKNLEK-IGEGASGEVYKATDRATGKEVAIKKMRLRKQ 57
Query: 412 HHDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQL 471
+ ++ + EI ++ +HPNIV +Y D +++ +E Y+ GS + +
Sbjct: 58 NKELIINEIL-IMKDCKHPNIVDYYDSYLVGDELWVVME----------YMDGGSLTDII 106
Query: 472 NAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLI 531
+NE Q+ V R+++ GL +LH +I
Sbjct: 107 TQNFVR---MNE-------------------------PQIAYVCREVLQGLEYLHSQNVI 138
Query: 532 HRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ 591
HRD+K N+L+SKD S KL+D G + +L + S + + G+ W APE + +
Sbjct: 139 HRDIKSDNILLSKDGS--VKLADFGFAAQLTKEKS---KRNSVVGTPYWMAPEVIKRKDY 193
Query: 592 TRAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDR--KDLFLV--EHIP-------- 639
+D++SLG I+ + G+ PY +++ + LFL+ + IP
Sbjct: 194 GPKVDIWSLG-IMCIEMAEGEPPY----------LREPPLRALFLITTKGIPPLKNPEKW 242
Query: 640 --EAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTADTRLSF 677
E D + L +P+ RP A+ +L HPF A + F
Sbjct: 243 SPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKKACPKEEF 282
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 88.5 bits (220), Expect = 2e-19
Identities = 74/312 (23%), Positives = 117/312 (37%), Gaps = 83/312 (26%)
Query: 382 KEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALK--------EIQNLIASD------ 427
E+ G++G V T +A+K IQ I +
Sbjct: 7 GELGAGNSGVVSK-----------VLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHK 55
Query: 428 -QHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRI 486
P IV +YG + + + +E GS ++ +L EV+
Sbjct: 56 CNSPYIVGFYGAFYNNGDISICMEYMDG----------GSLDK----------ILKEVQG 95
Query: 487 RLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE-IGLIHRDLKPQNVLISKD 545
R+ P L K+ ++ GL++LHE +IHRD+KP N+L++
Sbjct: 96 RI------------------PERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSR 137
Query: 546 KSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILF 605
KL D G+S +L ++ T G+S + APE++ + D++SLG L
Sbjct: 138 GQI--KLCDFGVSGQLVNSLA-----KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLI 190
Query: 606 FCITGGKHPYGES-------FERDANIVKDRKDLFLVEHI--PEAVDLFTRLLDPNPDLR 656
TG + PY FE IV + L P+ D L +P R
Sbjct: 191 ELATG-RFPYPPENDPPDGIFELLQYIVNEPPPR-LPSGKFSPDFQDFVNLCLIKDPRER 248
Query: 657 PKAQNVLNHPFF 668
P + +L HPF
Sbjct: 249 PSYKELLEHPFI 260
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 87.8 bits (218), Expect = 3e-19
Identities = 66/244 (27%), Positives = 104/244 (42%), Gaps = 57/244 (23%)
Query: 378 VVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQNLIASD------QHPN 431
+ I KG G V + G+Y G+ VAVK L K Q +A +HPN
Sbjct: 8 LKLGATIGKGEFGDV-MLGDYRGQKVAVKCL-KDD----STAAQAFLAEASVMTTLRHPN 61
Query: 432 IVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPV 491
+V+ GV + +Y+ E Y+ G +L++ +R R V
Sbjct: 62 LVQLLGVVLQGNPLYIVTE----------YMAKG-------------SLVDYLRSRGRAV 98
Query: 492 MENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAK 551
+ AQ L D+ G+ +L E +HRDL +NVL+S+D AK
Sbjct: 99 IT--------------LAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSED--LVAK 142
Query: 552 LSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGG 611
+SD G++K + Q +G W APE L + + + D++S G +L+ + G
Sbjct: 143 VSDFGLAKE-----ASQGQ-DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFG 196
Query: 612 KHPY 615
+ PY
Sbjct: 197 RVPY 200
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 87.8 bits (218), Expect = 4e-19
Identities = 75/303 (24%), Positives = 131/303 (43%), Gaps = 62/303 (20%)
Query: 380 FNKEIAKGSNGTV-VLEGNYEGRSVAVKRLVKTHHDVALKEIQN------LIASDQHPNI 432
+ I KG+ G V +++ + A+K + K V ++N ++ HP +
Sbjct: 4 LLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKC-VEKGSVRNVLNERRILQELNHPFL 62
Query: 433 VR-WYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPV 491
V WY + D++ +YL + DL+ L G L+ K + +E +++
Sbjct: 63 VNLWYSFQ-DEENMYLVV--------DLL--LGGDLRYHLSQKVK----FSEEQVKFWIC 107
Query: 492 MENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAK 551
+IV L +LH G+IHRD+KP N+L+ D+
Sbjct: 108 -------------------------EIVLALEYLHSKGIIHRDIKPDNILL--DEQGHVH 140
Query: 552 LSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGG 611
++D I+ ++ D T + G+ G+ APE L + + A+D +SLG + C+ G
Sbjct: 141 ITDFNIATKVTPD----TLTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLR-G 195
Query: 612 KHPY-GESFERDANIV---KDRKDLFLVEHIPEAVDLFTRLLDPNPDLR--PKAQNVLNH 665
K PY G S I + L+ EA+D +LL+ +P R +++ NH
Sbjct: 196 KRPYRGHSRTIRDQIRAKQETADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNH 255
Query: 666 PFF 668
P+F
Sbjct: 256 PYF 258
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 7e-19
Identities = 56/187 (29%), Positives = 89/187 (47%), Gaps = 23/187 (12%)
Query: 505 GHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGD 564
G P A+ + I+ GL HLH+ +++RDLKP+NVL+ + ++SD+G++ L+G
Sbjct: 91 GFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGN--VRISDLGLAVELKGG 148
Query: 565 MSCLTQNATGY-GSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERDA 623
+ G G+ G+ APE L ++D F+LGC L+ I G+ P+ + E+
Sbjct: 149 -----KKIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIA-GRSPFRQRKEKVE 202
Query: 624 NIVKDRKDLFLVEHI-------PEAVDLFTRLLDPNPDLR-----PKAQNVLNHPFFWTA 671
++ K L + PEA DL LL +P+ R A V HP F
Sbjct: 203 K--EELKRRTLEMAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDL 260
Query: 672 DTRLSFL 678
+ R
Sbjct: 261 NWRRLEA 267
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|199216 cd10321, RNase_Ire1_like, RNase domain (also known as the kinase extension nuclease domain) of Ire1 and RNase L | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 2e-18
Identities = 35/123 (28%), Positives = 62/123 (50%), Gaps = 13/123 (10%)
Query: 674 RLSFLRDVSDRVELEDRESDSKLLRALEGI----ALVALNGKWDEKMETKFIENIGRYRR 729
++ F+ V + ++ + S L + L + L+ W+ ++ ++++ + R
Sbjct: 3 KIQFIDAVLNLLKDSN-LPPSTLNKLLNPGSDTVSSSFLSKPWNTLIDKNLMDDLSNFVR 61
Query: 730 --YKYDNVRDLLRVIRNKSNHFRE----LPQDIQELLG--SHPEGFYNYFSCRFPKLLIE 781
Y YD V+DL+R IRN H +E LP+ +E+L + F+NYF RFP LLI
Sbjct: 62 RTYNYDQVKDLIRCIRNTIQHHKEIKNQLPEKNKEILESLKSQDSFFNYFESRFPNLLIF 121
Query: 782 VYN 784
+Y
Sbjct: 122 LYY 124
|
This RNase domain is found in the multi-functional protein Ire1; Ire1 also contains a type I transmembrane serine/threonine protein kinase (STK) domain, and a Luminal dimerization domain. Ire1 is essential for the endoplasmic reticulum (ER) unfolded protein response (UPR). The UPR is activated when protein misfolding is detected in the ER in order to reduce the synthesis of new proteins and increase the capacity of the ER to cope with the stress. IRE1 acts as an ER stress sensor; IRE1 dimerizes through its N-terminal luminal domain and forms oligomers, promoting trans-autophosphorylation by its cytosolic kinase domain which stimulates its endoribonuclease (RNase) activity and results in the cleavage of its mRNA substrate, Hac1 in yeast and Xbp1 in metazoans, thus promoting a splicing event that enables translation into a transcription factor which activates the UPR. This RNase domain is also found in Ribonuclease L (RNase L), sometimes referred to as the 2-5A-dependent RNase. RNase L is a highly regulated, latent endoribonuclease widely expressed in most mammalian tissues. It is involved in the mediation of the antiviral and pro-apoptotic activities of the interferon-inducible 2-5A system; the interferon (IFN)-inducible 2'-5'-oligoadenylate synthetase (OAS)/RNase L pathway blocks infections by certain types of viruses through cleavage of viral and cellular single-stranded RNA. RNase L has been shown to have an impact on the pathogenesis of prostate cancer; the RNase L gene, RNASEL, has been identified as a strong candidate for the hereditary prostate cancer 1 (HPC1) allele. Length = 127 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.3 bits (209), Expect = 5e-18
Identities = 76/313 (24%), Positives = 124/313 (39%), Gaps = 86/313 (27%)
Query: 382 KEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHHDVALKEIQNLIASDQ---HPNIVRWYG 437
+ I G+ G V + G VA+K ++K + IQ I+ + HPNIV ++G
Sbjct: 9 QRIGSGTYGDVYKARDIATGELVAIK-VIKLEPGDDFEIIQQEISMLKECRHPNIVAYFG 67
Query: 438 VESDQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTK 496
+D +++ +E C SL D+ V G E
Sbjct: 68 SYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSEL-------------------------- 101
Query: 497 DIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMG 556
Q+ V R+ + GL++LHE G IHRD+K N+L+++D KL+D G
Sbjct: 102 -------------QIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDG--DVKLADFG 146
Query: 557 ISKRLQGDMSCLTQNATGYGSSGWQAPE---QLLQGRQTRAIDLFSLGCILFFCITG--- 610
+S +L ++ + + G+ W APE +G D+++LG IT
Sbjct: 147 VSAQLTATIA---KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALG------ITAIEL 197
Query: 611 --GKHPYGESFERDANIVKDRKDLFLV------------EHI--PEAVDLFTRLLDPNPD 654
+ P + + + LFL+ + P D + L +P
Sbjct: 198 AELQPPMFD--------LHPMRALFLISKSNFPPPKLKDKEKWSPVFHDFIKKCLTKDPK 249
Query: 655 LRPKAQNVLNHPF 667
RP A +L HPF
Sbjct: 250 KRPTATKLLQHPF 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 85.7 bits (213), Expect = 6e-18
Identities = 86/323 (26%), Positives = 132/323 (40%), Gaps = 108/323 (33%)
Query: 404 AVKRLVKTHHDVALKEI----QNLIASD---------------QHPNIVRWYGV---ESD 441
A+ R +T VALK+I +N A+D HPNIV+ V E+D
Sbjct: 26 AIDR--RTKEVVALKKIFDAFRN--ATDAQRTFREIMFLQELGDHPNIVKLLNVIKAEND 81
Query: 442 QDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELW 501
+D +YL E L+ +I +N+L +V R + ++
Sbjct: 82 KD-IYLVFEYMETDLHAVI----------------RANILEDVHKRYI----------MY 114
Query: 502 KANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFC-AKLSDMGISKR 560
QLLK + I SG +IHRDLKP N+L++ D C KL+D G+++
Sbjct: 115 --------QLLKALKYIHSG-------NVIHRDLKPSNILLNSD---CRVKLADFGLARS 156
Query: 561 LQGDMSCLTQNA-TGYGSSGW-QAPEQLLQGRQ-TRAIDLFSLGCILFFCITGG------ 611
L T Y ++ W +APE LL + T+ +D++S+GCIL + G
Sbjct: 157 LSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGT 216
Query: 612 ------------------------KHPYGESFERDANIVKDRKDL--FLVEHIPEAVDLF 645
K P+ + + RK L L + +A+DL
Sbjct: 217 STLNQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLP-SRPRKPLDELLPKASDDALDLL 275
Query: 646 TRLLDPNPDLRPKAQNVLNHPFF 668
+LL NP+ R A+ L HP+
Sbjct: 276 KKLLVFNPNKRLTAEEALEHPYV 298
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 2e-17
Identities = 59/196 (30%), Positives = 92/196 (46%), Gaps = 29/196 (14%)
Query: 507 PSAQLLKVTRDIVSGLSHLHE-IGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDM 565
P L K+ IV L +LH + +IHRD+KP NVLI+++ KL D GIS L +
Sbjct: 101 PEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQV--KLCDFGISGYLVDSV 158
Query: 566 SCLTQNATGYGSSGWQAPEQL-----LQGRQTRAIDLFSLGCILFFCITGGKHPY---GE 617
+ T +A G + APE++ +G ++ D++SLG I + G+ PY
Sbjct: 159 A-KTIDA---GCKPYMAPERINPELNQKGYDVKS-DVWSLG-ITMIELATGRFPYDSWKT 212
Query: 618 SFERDANIVKDR-----KDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTAD 672
F++ +V++ + F PE D + L N RP +L HPFF
Sbjct: 213 PFQQLKQVVEEPSPQLPAEKF----SPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHL 268
Query: 673 TRLSFLRDVSDRVELE 688
++ + DV+ V L
Sbjct: 269 SKNT---DVASFVSLI 281
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 3e-17
Identities = 79/302 (26%), Positives = 131/302 (43%), Gaps = 63/302 (20%)
Query: 384 IAKGSNGTVVLEGNYEGRSVAVKRLV--KTHHDVALKEIQ------NLIASDQHPNIVRW 435
+ KG+ GTV +G+ +AVK++ ++ A KE + +L+ S +H NIV++
Sbjct: 8 LGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQY 67
Query: 436 YGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENT 495
G L+ T S+ + +V GS LN R P+
Sbjct: 68 LGT---------CLDDNTISIF-MEFVPGGSISSILN--------------RFGPL---- 99
Query: 496 KDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDM 555
P K T+ I+ G+++LH ++HRD+K NV++ + KL D
Sbjct: 100 -----------PEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNG--IIKLIDF 146
Query: 556 GISKRL-----QGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG 610
G ++RL G S + ++ +G+ W APE + + R D++S+GC +F TG
Sbjct: 147 GCARRLAWVGLHGTHSNMLKSM--HGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATG 204
Query: 611 GKHPYGESFERDANIVKDRKDLFLVEHIPE-----AVDLFTRLLDPNPDLRPKAQNVLNH 665
P S +R A + L+ +P+ A+D T L + RP A +L H
Sbjct: 205 --KPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRH 262
Query: 666 PF 667
F
Sbjct: 263 DF 264
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 6e-17
Identities = 77/308 (25%), Positives = 116/308 (37%), Gaps = 64/308 (20%)
Query: 380 FNKEIAKGSNGTVVL-----EGNYEGRSVAVKRL----VKTHHDVALKEIQNLIASDQHP 430
F K++ +G G V L G+ G VAVK L + H +EI+ L + H
Sbjct: 8 FIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEIL-RTLDHE 66
Query: 431 NIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLP 490
NIV++ GV L L + Y+ SGS + L + +D L
Sbjct: 67 NIVKYKGVCEKPGGRSLRLI--------MEYLPSGSLRDYLQ-RHRDQINL--------- 108
Query: 491 VMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCA 550
+LL + I G+ +L IHRDL +N+L+ +
Sbjct: 109 ------------------KRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESED--LV 148
Query: 551 KLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG 610
K+SD G++K L D G W APE L + + A D++S G L+ T
Sbjct: 149 KISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTY 208
Query: 611 G---KHPYGESF-----ERDANIV-------KDRKDLFLVEHIPEAV-DLFTRLLDPNPD 654
G + P E + IV K+ + L P+ V DL + P
Sbjct: 209 GDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQ 268
Query: 655 LRPKAQNV 662
RP ++
Sbjct: 269 DRPSFADL 276
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 6e-17
Identities = 90/338 (26%), Positives = 138/338 (40%), Gaps = 86/338 (25%)
Query: 387 GSNGTVVLEGNYE-GRSVAVKRLVKTH-HDV--ALKEIQNLIASDQHPNIVRWYGVESDQ 442
GSNG V + + + VAVK++V T V AL+EI+ +I H NIV+ Y V
Sbjct: 16 GSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIK-IIRRLDHDNIVKVYEVLGP- 73
Query: 443 DFVYLSLERCTCSLNDL-----IYVLSGSFEEQL-NAKEQDSNLLNEVRIRLLPVMENTK 496
S T + L +Y++ E L N EQ L+E RL
Sbjct: 74 -----SGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQ--GPLSEEHARLF------- 119
Query: 497 DIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMG 556
QLL+ GL ++H ++HRDLKP NV I+ + K+ D G
Sbjct: 120 -----------MYQLLR-------GLKYIHSANVLHRDLKPANVFINTE-DLVLKIGDFG 160
Query: 557 ISKRLQGDMS---CLTQNATGYGSSGWQAPEQLLQGRQ-TRAIDLFSLGCILFFCITG-- 610
+++ + S L++ + +++P LL T+AID+++ GCI +TG
Sbjct: 161 LARIVDPHYSHKGYLSEGLV---TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKP 217
Query: 611 ---GKH------------PYGESFERD-------ANIVKD----RKDL--FLVEHIPEAV 642
G H P +R+ + + D R+ L L PEA+
Sbjct: 218 LFAGAHELEQMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEAL 277
Query: 643 DLFTRLLDPNPDLRPKAQNVLNHPFFWTADTRLSFLRD 680
D ++L NP R A+ L HP+ + S D
Sbjct: 278 DFLEQILTFNPMDRLTAEEALMHPYM----SCYSCPFD 311
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 81.5 bits (202), Expect = 7e-17
Identities = 81/312 (25%), Positives = 126/312 (40%), Gaps = 91/312 (29%)
Query: 400 GRSVAVKRLVKTHHD-----VALKEIQNLIASDQHPNIV--RWYGVESDQDFVYLSLERC 452
G VA+K+L +L+EI L+ QHPNIV + V S+ D +Y+ +E
Sbjct: 30 GEIVALKKLKMEKEKEGFPITSLREINILLKL-QHPNIVTVKEVVVGSNLDKIYMVMEYV 88
Query: 453 TCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLL 512
L L+ + F L +EV+ +L QLL
Sbjct: 89 EHDLKSLMETMKQPF------------LQSEVKCLML--------------------QLL 116
Query: 513 KVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNA 572
SG++HLH+ ++HRDLK N+L++ K+ D G+++ + TQ
Sbjct: 117 -------SGVAHLHDNWILHRDLKTSNLLLN--NRGILKICDFGLAREYGSPLKPYTQLV 167
Query: 573 TGYGSSGW-QAPEQLL-QGRQTRAIDLFSLGCI---------LF------------FCIT 609
+ W +APE LL + AID++S+GCI LF F +
Sbjct: 168 V----TLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLL 223
Query: 610 GGKHPYGESFERDANIVKDRKDLF-------LVEHIPE------AVDLFTRLLDPNPDLR 656
G P + + + + +K F L + P DL RLL +P R
Sbjct: 224 GT--PTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKR 281
Query: 657 PKAQNVLNHPFF 668
A++ L HP+F
Sbjct: 282 ISAEDALKHPYF 293
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 5e-16
Identities = 86/301 (28%), Positives = 134/301 (44%), Gaps = 66/301 (21%)
Query: 384 IAKGSNGTVVLEGNYEGR------SVAVKRL-VKTHHDVA-LKEIQNLIASDQHPNIVRW 435
+ KG+ G V Y R +A+K + + V L E L + +H NIV++
Sbjct: 16 LGKGTYGIV-----YAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQY 70
Query: 436 YGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENT 495
G +S+ F + +E+ V GS S LL R + P+ +N
Sbjct: 71 LGSDSENGFFKIFMEQ----------VPGGSL----------SALL---RSKWGPLKDNE 107
Query: 496 KDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDM 555
+ I + T+ I+ GL +LH+ ++HRD+K NVL++ K+SD
Sbjct: 108 QTIIFY-------------TKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVV-KISDF 153
Query: 556 GISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ--TRAIDLFSLGCILFFCITGGKH 613
G SKRL G C T+ T G+ + APE + +G + D++SLGC + T GK
Sbjct: 154 GTSKRLAGINPC-TETFT--GTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMAT-GKP 209
Query: 614 PYGESFERDANIVKDRKDLFLVEH--IPEAV-----DLFTRLLDPNPDLRPKAQNVLNHP 666
P+ E E A + K H IPE++ + R +P+PD R A ++L P
Sbjct: 210 PFIELGEPQAAMFKVG---MFKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQDP 266
Query: 667 F 667
F
Sbjct: 267 F 267
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 6e-16
Identities = 80/308 (25%), Positives = 130/308 (42%), Gaps = 77/308 (25%)
Query: 383 EIAKGSNGTVVLEGNYE-GRSVAVKRLVK--------THHDVALKEIQNLIASDQHPNIV 433
++ +G G V L + G VA+KR+ K H + ++I + + + +V
Sbjct: 8 QVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDI---LTTTKSEWLV 64
Query: 434 RWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVME 493
+ D +++YL++E YV G F LN +L+E R
Sbjct: 65 KLLYAFQDDEYLYLAME----------YVPGGDFRTLLNNL----GVLSEDHARFYMA-- 108
Query: 494 NTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLS 553
++ + LHE+G IHRDLKP+N LI D S KL+
Sbjct: 109 -----------------------EMFEAVDALHELGYIHRDLKPENFLI--DASGHIKLT 143
Query: 554 DMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ-TRAIDLFSLGCILFFCITG-- 610
D G+SK +T + GS + APE +L+G+ +D +SLGC+L+ + G
Sbjct: 144 DFGLSK------GIVTYANSVVGSPDYMAPE-VLRGKGYDFTVDYWSLGCMLYEFLCGFP 196
Query: 611 ---GKHPYGESFERDANIVKDRKDL-------FLVEHIPEAVDLFTRLLDPNPDLRPKAQ 660
G P E++E N+ ++ L EA DL T+L++ +
Sbjct: 197 PFSGSTP-NETWE---NLKYWKETLQRPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLE 252
Query: 661 NVLNHPFF 668
++ NHPFF
Sbjct: 253 DIKNHPFF 260
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 6e-16
Identities = 48/195 (24%), Positives = 85/195 (43%), Gaps = 33/195 (16%)
Query: 503 ANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQ 562
P+ + ++ G++H H+ G++HRDLKPQN+L+ K K K++D+G+ +
Sbjct: 104 GRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLL-KIADLGLGRAFS 162
Query: 563 GDMSCLTQNATGYGSSGWQAPEQLLQGRQ-TRAIDLFSLGCILFFCITGGKHPYGES-FE 620
+ T + ++APE LL + +D++S+GCI G+S +
Sbjct: 163 IPVKSYTHEIV---TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQ 219
Query: 621 RDANI--------------VKDRKDL------------FLVEHI-PEAVDLFTRLLDPNP 653
+ +I V +D V + PE +DL ++L +P
Sbjct: 220 QLLHIFKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDP 279
Query: 654 DLRPKAQNVLNHPFF 668
R A+ L HP+F
Sbjct: 280 AKRISAKAALTHPYF 294
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 1e-15
Identities = 85/297 (28%), Positives = 131/297 (44%), Gaps = 52/297 (17%)
Query: 382 KEIAKGSNGTVVLEGNYE-GRSVAVKRLV------KTHHDVALKEIQ-NLIASDQHPNIV 433
K + +G+ G V L + + GR +A K++ +T +V+ E + L+ + QH IV
Sbjct: 8 KLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIV 67
Query: 434 RWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVME 493
++YG D+ L++ + Y+ GS ++QL A L E R
Sbjct: 68 QYYGCLRDRAEKTLTIF--------MEYMPGGSVKDQLKA----YGALTESVTR------ 109
Query: 494 NTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLS 553
K TR I+ G+S+LH ++HRD+K N+L +D + KL
Sbjct: 110 -------------------KYTRQILEGMSYLHSNMIVHRDIKGANIL--RDSAGNVKLG 148
Query: 554 DMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKH 613
D G SKRLQ T + G+ W +PE + R D++SLGC + +T K
Sbjct: 149 DFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLT-EKP 207
Query: 614 PYGESFERDANIVK---DRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPF 667
P+ E +E A I K + L HI E F + RP A+ +L HPF
Sbjct: 208 PWAE-YEAMAAIFKIATQPTNPQLPSHISEHARDFLGCIFVEARHRPSAEELLRHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.7 bits (192), Expect = 1e-15
Identities = 70/326 (21%), Positives = 122/326 (37%), Gaps = 85/326 (26%)
Query: 383 EIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHHD-----VALKEIQNLIASDQHPNIVRWY 436
+ +G+ G V+ N G VA+K+ ++ D AL+E++ L +H NIV
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQL-RHENIVNLK 66
Query: 437 GVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTK 496
+ +YL E +L +L+ E L +R
Sbjct: 67 EAFRRKGRLYLVFEYVERTLLELL--------------EASPGGLPPDAVRSY------- 105
Query: 497 DIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMG 556
+W QLL+ +++ H +IHRD+KP+N+L+S+ KL D G
Sbjct: 106 ---IW--------QLLQ-------AIAYCHSHNIIHRDIKPENILVSESGV--LKLCDFG 145
Query: 557 ISKRLQGDMSCLTQNATGYGSSGW-QAPEQLLQGRQ-TRAIDLFSLGCILFFCITG---- 610
++ L+ T Y ++ W +APE L+ + +D++++GCI+ + G
Sbjct: 146 FARALRARP---ASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLF 202
Query: 611 ----------------GKHP--YGESFERDAN----IVKDRKDLFLVEHIPE------AV 642
G P + E F + + +E A+
Sbjct: 203 PGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPAL 262
Query: 643 DLFTRLLDPNPDLRPKAQNVLNHPFF 668
D L +P R +L HP+F
Sbjct: 263 DFLKACLRMDPKERLTCDELLQHPYF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.6 bits (192), Expect = 2e-15
Identities = 74/318 (23%), Positives = 115/318 (36%), Gaps = 103/318 (32%)
Query: 400 GRSVAVKRLVKTHHDV------ALKEIQNLIASDQHPNIVRWYGV--ESDQDFVYLSLER 451
G VA+K+ ++ ++ A++EI+ L+ +HPNIVR + + +Y+ E
Sbjct: 24 GELVALKK-IRMENEKEGFPITAIREIK-LLQKLRHPNIVRLKEIVTSKGKGSIYMVFEY 81
Query: 452 CTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQL 511
L L+ F E K QL
Sbjct: 82 MDHDLTGLLDSPEVKFTES-QIK-------------------------------CYMKQL 109
Query: 512 LKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMG----ISKRLQGDMS- 566
L+ GL +LH G++HRD+K N+LI+ D KL+D G +KR D +
Sbjct: 110 LE-------GLQYLHSNGILHRDIKGSNILINNDGV--LKLADFGLARPYTKRNSADYTN 160
Query: 567 ---CLTQNATGYGSSGWQAPEQLLQG--RQTRAIDLFSLGCILFFCITGG---------- 611
L W P +LL G R +D++S+GCIL G
Sbjct: 161 RVITL-----------WYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELE 209
Query: 612 ---------------------KHPYGESFERDANIVKDRKDLFLVEHIPEAVDLFTRLLD 650
K P+ E+ + + ++ F P A+DL +LL
Sbjct: 210 QLEKIFELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLT 269
Query: 651 PNPDLRPKAQNVLNHPFF 668
+P R A L H +F
Sbjct: 270 LDPKKRISADQALQHEYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 2e-15
Identities = 74/290 (25%), Positives = 121/290 (41%), Gaps = 50/290 (17%)
Query: 382 KEIAKGSNGTVVLEGNYEGR-SVAVK--RLVKTHHDVA--LKEIQNLIASDQHPNIVRWY 436
++I KG+ G V +G +G VAVK R L+E + L D HPNIV+
Sbjct: 1 EKIGKGNFGDV-YKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYD-HPNIVKLI 58
Query: 437 GVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTK 496
GV + +Y+ +E V GS L +R
Sbjct: 59 GVCVQKQPIYIVME----------LVPGGSL-------------LTFLRK---------- 85
Query: 497 DIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMG 556
K N +LL+++ D +G+ +L IHRDL +N L+ ++ K+SD G
Sbjct: 86 -----KKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVL--KISDFG 138
Query: 557 ISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY- 615
+S+ +G + + + W APE L GR T D++S G +L+ + G PY
Sbjct: 139 MSREEEGGIYTV-SDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYP 197
Query: 616 GESFERDANIVKDRKDLFLVEHIPEAV-DLFTRLLDPNPDLRPKAQNVLN 664
G S ++ ++ + + PE + L + +P+ RP + N
Sbjct: 198 GMSNQQTRERIESGYRMPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYN 247
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.5 bits (189), Expect = 3e-15
Identities = 77/317 (24%), Positives = 128/317 (40%), Gaps = 85/317 (26%)
Query: 382 KEIAKGSNGTVVLEGNYE-GRSVAVK--RLVKTHHDVALKEIQNLIASDQHPNIVRWYGV 438
+ I +G+ G V + + G+ VA+K +++ + +E L HPNI +YG
Sbjct: 12 EVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGA 71
Query: 439 ------ESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVM 492
+ D ++L +E C GS ++L+ +R + +
Sbjct: 72 FIKKNPPGNDDQLWLVMELCG----------GGSV----------TDLVKGLRKKGKRLK 111
Query: 493 ENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKL 552
E + + R+ + GL++LHE +IHRD+K QN+L++K+ KL
Sbjct: 112 EE---------------WIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKN--AEVKL 154
Query: 553 SDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRA-----IDLFSLGCILFFC 607
D G+S +L S L + T G+ W APE + Q A D++SLG
Sbjct: 155 VDFGVSAQLD---STLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLG------ 205
Query: 608 ITG-----GKHPYGESFERDANIVKDRKDLFLVEHIP------------EAVDLFTRLLD 650
IT GK P + + + LF + P + D + L
Sbjct: 206 ITAIELADGKPPLCD--------MHPMRALFKIPRNPPPTLKSPENWSKKFNDFISECLI 257
Query: 651 PNPDLRPKAQNVLNHPF 667
N + RP + +L HPF
Sbjct: 258 KNYEQRPFMEELLEHPF 274
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 77.3 bits (191), Expect = 4e-15
Identities = 54/186 (29%), Positives = 86/186 (46%), Gaps = 46/186 (24%)
Query: 518 IVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCA-KLSDMGISKRLQGDMSCLTQNATGYG 576
I+ GL ++H G+IHRDLKP N+ +++D C K+ D G+++ +M TGY
Sbjct: 127 ILRGLKYIHSAGIIHRDLKPSNIAVNED---CELKILDFGLARHTDDEM-------TGYV 176
Query: 577 SSGW-QAPEQLLQGRQ-TRAIDLFSLGCILFFCITG-----GKHPY-------------G 616
++ W +APE +L + +D++S+GCI+ +TG G
Sbjct: 177 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPD 236
Query: 617 ESF------ERDANIV--------KDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNV 662
E E N + KD K++F P A+DL ++L +PD R A
Sbjct: 237 EELLQKISSESARNYIQSLPQMPKKDFKEVF-SGANPLAIDLLEKMLVLDPDKRITAAEA 295
Query: 663 LNHPFF 668
L HP+
Sbjct: 296 LAHPYL 301
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 76.1 bits (188), Expect = 5e-15
Identities = 76/315 (24%), Positives = 119/315 (37%), Gaps = 100/315 (31%)
Query: 400 GRSVAVKRLVKTH--------HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLER 451
GR VA+K++ + AL+EI+ L+ +HPNI+ V + + L E
Sbjct: 25 GRIVAIKKIKLGERKEAKDGINFTALREIK-LLQELKHPNIIGLLDVFGHKSNINLVFE- 82
Query: 452 CTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQL 511
+ E+ ++ + I L P DI+ +
Sbjct: 83 ----------FMETDLEK----------VIKDKSIVLTP-----ADIKSY------MLMT 111
Query: 512 LKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQN 571
L+ GL +LH ++HRDLKP N+LI+ D KL+D G+++ +T
Sbjct: 112 LR-------GLEYLHSNWILHRDLKPNNLLIASDG--VLKLADFGLARSFGSPNRKMTHQ 162
Query: 572 ATGYGSSGW-QAPEQLLQGRQ-TRAIDLFSLGCIL--------FFCITGGKHPYGES--- 618
+ W +APE L R +D++S+GCI F G+S
Sbjct: 163 VV----TRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFL--------PGDSDID 210
Query: 619 -----F-------ERDANIVKDRKDLFLVEHIP-------------EAVDLFTRLLDPNP 653
F E + V D + P +A+DL RLL NP
Sbjct: 211 QLGKIFEALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNP 270
Query: 654 DLRPKAQNVLNHPFF 668
+ R A+ L HP+F
Sbjct: 271 NKRITARQALEHPYF 285
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 1e-14
Identities = 78/299 (26%), Positives = 128/299 (42%), Gaps = 64/299 (21%)
Query: 382 KEIAKGSNGTVVL-EGNYEGRSVAVKRL------VKTHHDVALKEIQNLIASDQHPNIVR 434
K++ KGS G+V + + + A+K + K D A+ EI+ ++AS HPNI+
Sbjct: 6 KKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKERED-AVNEIR-ILASVNHPNIIS 63
Query: 435 WYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMEN 494
+ D + + + +E DL +S ++ L+ E I
Sbjct: 64 YKEAFLDGNKLCIVME--YAPFGDLSKAISKR--------KKKRKLIPEQEI-------- 105
Query: 495 TKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSD 554
W+ QLL+ GL LHE ++HRDLK N+L+ + K+ D
Sbjct: 106 ------WRI----FIQLLR-------GLQALHEQKILHRDLKSANILLVANDLV--KIGD 146
Query: 555 MGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ-TRAIDLFSLGCILFFCITGGKH 613
+GISK L+ +M+ T G+ + APE + +GR + D++SLGC+L+ T
Sbjct: 147 LGISKVLKKNMA-----KTQIGTPHYMAPE-VWKGRPYSYKSDIWSLGCLLYEMAT-FAP 199
Query: 614 PY-GESFERDANIVKDRKDLFLVEHIP-----EAVDLFTRLLDPNPDLRPKAQNVLNHP 666
P+ S + V+ K IP + + +L P LRP +L P
Sbjct: 200 PFEARSMQDLRYKVQRGK----YPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILASP 254
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 1e-14
Identities = 74/297 (24%), Positives = 123/297 (41%), Gaps = 62/297 (20%)
Query: 384 IAKGSNGTVVLEGNYEGRSVAV------KRLVKTHHDVALKEIQNLIASDQHPNIVRWYG 437
+ KG+ G L E S+ V RL + AL EI +++ QHPNI+ +Y
Sbjct: 8 LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEI-VILSLLQHPNIIAYYN 66
Query: 438 VESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKD 497
D + + + +E G+ +++ Q L E
Sbjct: 67 HFMDDNTLLIEMEYAN----------GGTLYDKIV--RQKGQLFEE-------------- 100
Query: 498 IELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGI 557
+L IVS +S++H+ G++HRD+K N+ ++K KL D GI
Sbjct: 101 -----------EMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAG--LIKLGDFGI 147
Query: 558 SKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRA-IDLFSLGCILFFCITGGKHPYG 616
SK L + S T G+ + +PE L QG + D+++LGC+L+ +T +
Sbjct: 148 SKILGSEYS---MAETVVGTPYYMSPE-LCQGVKYNFKSDIWALGCVLYELLTLKR---- 199
Query: 617 ESFERD------ANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPF 667
+F+ IV+ + + E + L LL +P+ RP A VL+ P
Sbjct: 200 -TFDATNPLNLVVKIVQGNYTPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQPL 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.6 bits (184), Expect = 1e-14
Identities = 54/177 (30%), Positives = 82/177 (46%), Gaps = 16/177 (9%)
Query: 514 VTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNAT 573
+ R+++ GL +LHE G IHRD+K N+L+S++ KL+D G+S +L MS + T
Sbjct: 103 ILREVLLGLEYLHEEGKIHRDIKAANILLSEEGD--VKLADFGVSGQLTSTMS---KRNT 157
Query: 574 GYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG-----GKHPYGESFERDANIVKD 628
G+ W APE + Q D++SLG G HP F I K+
Sbjct: 158 FVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFL----IPKN 213
Query: 629 RKDLFLVEHIPEAVDLFTRL-LDPNPDLRPKAQNVLNHPFFWTADTRLSFLRDVSDR 684
+ F L L+ +P RP A+ +L H F A + S+L + +R
Sbjct: 214 NPPSLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLKHKFIKKA-KKTSYLTLLIER 269
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.8 bits (187), Expect = 1e-14
Identities = 52/202 (25%), Positives = 82/202 (40%), Gaps = 38/202 (18%)
Query: 518 IVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRL-----QGDMSCLTQNA 572
+V L +H++G IHRD+KP N+LI D KL+D G+ K++ + + N
Sbjct: 110 LVLALDSVHKLGFIHRDIKPDNILIDADGHI--KLADFGLCKKMNKAKDREYYLNDSHNL 167
Query: 573 TGY---------------------GSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGG 611
G+ + APE L D +SLG IL+ + G
Sbjct: 168 LFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGF 227
Query: 612 KHPYGESFERDAN-IVKDRKDLFLVEHI---PEAVDLFTRLLDPNPDLRPKAQNVLNHPF 667
Y ++ + N I+ ++ L PEA+DL RLL D + + +HPF
Sbjct: 228 PPFYSDTLQETYNKIINWKESLRFPPDPPVSPEAIDLICRLLCDPEDRLGSFEEIKSHPF 287
Query: 668 F----WTADTRLS--FLRDVSD 683
F W F+ ++S
Sbjct: 288 FKGIDWENLRETKPPFVPELSS 309
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 1e-14
Identities = 55/161 (34%), Positives = 86/161 (53%), Gaps = 18/161 (11%)
Query: 517 DIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKR-LQGDMSCLTQNATGY 575
+I L HLH+ G+I+RDLKP+N+L+ D KL+D G+ K + T T
Sbjct: 108 EISLALEHLHQQGIIYRDLKPENILL--DAQGHVKLTDFGLCKESIHEG----TVTHTFC 161
Query: 576 GSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERDAN-IVKDRKDL-- 632
G+ + APE L++ +A+D +SLG +++ +TG E+ ++ + I+K + +L
Sbjct: 162 GTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPP 221
Query: 633 FLVEHIPEAVDLFTRLLDPNPDLR-----PKAQNVLNHPFF 668
+L PEA DL +LL NP R A V +HPFF
Sbjct: 222 YLT---PEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFF 259
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 74.5 bits (184), Expect = 2e-14
Identities = 78/317 (24%), Positives = 135/317 (42%), Gaps = 84/317 (26%)
Query: 380 FNKEIAKGSNGTVVL---EGNYEGRSVAVKRLVKTHHDVALKEIQNLIA------SDQHP 430
F K + GS G V+L +G+ G+ A+K L K V LK++++++ S +HP
Sbjct: 5 FIKTLGTGSFGRVMLVRHKGS--GKYYALKILSK-AKIVKLKQVEHVLNEKRILQSIRHP 61
Query: 431 NIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLP 490
+V YG D +YL +E YV G L + P
Sbjct: 62 FLVNLYGSFQDDSNLYLVME----------YVPGGELFSHLR------------KSGRFP 99
Query: 491 VMENTKDIELWKANGHPSAQLLKVTR----DIVSGLSHLHEIGLIHRDLKPQNVLISKDK 546
V R +V L +LH + +++RDLKP+N+L+ D
Sbjct: 100 ---------------------EPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDG 138
Query: 547 SFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFF 606
K++D G +KR++G L G+ + APE +L +A+D ++LG +++
Sbjct: 139 YI--KITDFGFAKRVKGRTYTLC------GTPEYLAPEIILSKGYGKAVDWWALGILIYE 190
Query: 607 CITGGKHP--YGES----FERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPD-----L 655
+ G +P + ++ +E+ I++ + F P+A DL LL + L
Sbjct: 191 MLAG--YPPFFDDNPIQIYEK---ILEGKVR-FPSFFSPDAKDLIRNLLQVDLTKRLGNL 244
Query: 656 RPKAQNVLNHPFFWTAD 672
+ ++ NHP+F D
Sbjct: 245 KNGVNDIKNHPWFAGID 261
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 2e-14
Identities = 50/166 (30%), Positives = 88/166 (53%), Gaps = 17/166 (10%)
Query: 515 TRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATG 574
+ I G+ HLH + +++RD+KP+NVL+ D+ C +LSD+G++ L+ + +TQ A
Sbjct: 101 SAQITCGILHLHSMDIVYRDMKPENVLLD-DQGNC-RLSDLGLAVELKDGKT-ITQRA-- 155
Query: 575 YGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFER-DANIVKDR--KD 631
G++G+ APE L + + +D F++GC ++ + G+ P+ + E+ +K R +D
Sbjct: 156 -GTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMV-AGRTPFKDHKEKVAKEELKRRTLED 213
Query: 632 LFLVEH---IPEAVDLFTRLLDPNPDLR----PKAQNVLNHPFFWT 670
EH E+ D+ L P+ R K + H FF T
Sbjct: 214 EVKFEHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKT 259
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 73.4 bits (181), Expect = 2e-14
Identities = 69/317 (21%), Positives = 120/317 (37%), Gaps = 89/317 (28%)
Query: 382 KEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQ----------------NLIA 425
+ I KGS GTV V+R + KEI N++
Sbjct: 6 ETIGKGSFGTVRK----------VRR-KSDGKILVWKEIDYGNMTEKEKQQLVSEVNILR 54
Query: 426 SDQHPNIVRWYG--VESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNE 483
+HPNIVR+Y ++ +Y+ +E C DL ++ K++ +
Sbjct: 55 ELKHPNIVRYYDRIIDRSNQTLYIVME--YCEGGDLAQLIQ-------KCKKERKYI--- 102
Query: 484 VRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG-----LIHRDLKPQ 538
+ ++ ++ L H ++HRDLKP
Sbjct: 103 -----------------------EEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPA 139
Query: 539 NVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGY-GSSGWQAPEQLLQGRQTRAIDL 597
N+ + + KL D G++K L D + A Y G+ + +PEQL D+
Sbjct: 140 NIFLDANN--NVKLGDFGLAKILGHD----SSFAKTYVGTPYYMSPEQLNHMSYDEKSDI 193
Query: 598 FSLGCILF-FCITGGKHPY-GESFERDANIVKDRKDLFLVEHIPE--AVDLF---TRLLD 650
+SLGC+++ C P+ + + A+ +K+ K IP + +L +L+
Sbjct: 194 WSLGCLIYELC--ALSPPFTARNQLQLASKIKEGK----FRRIPYRYSSELNEVIKSMLN 247
Query: 651 PNPDLRPKAQNVLNHPF 667
+PD RP + +L P
Sbjct: 248 VDPDKRPSTEELLQLPL 264
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 3e-14
Identities = 38/106 (35%), Positives = 56/106 (52%), Gaps = 5/106 (4%)
Query: 518 IVSGLSHLHEIGLIHRDLKPQNVLIS-KDKSFCAKLSDMGISKRLQG----DMSCLTQNA 572
++ L+ H G++HRDLKPQN+++S AK+ D GI L G D++ LT+
Sbjct: 88 VLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTT 147
Query: 573 TGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGES 618
G+ + APEQL T DL++ G I C+TG + G S
Sbjct: 148 EVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTGQRVVQGAS 193
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|197798 smart00580, PUG, domain in protein kinases, N-glycanases and other nuclear proteins | Back alignment and domain information |
|---|
Score = 66.6 bits (163), Expect = 6e-14
Identities = 28/55 (50%), Positives = 34/55 (61%), Gaps = 3/55 (5%)
Query: 735 VRDLLRVIRNKSNHFREL--PQDIQELLGSHPEGFYNYFSCRFPKLLI-EVYNVI 786
VRDLLR +RN +H RE I+E LG P GF YF+ FP+LLI EVY +
Sbjct: 2 VRDLLRALRNILHHPREEKGNPAIKERLGPVPGGFELYFTVGFPRLLISEVYTLP 56
|
Length = 57 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 7e-14
Identities = 73/296 (24%), Positives = 124/296 (41%), Gaps = 57/296 (19%)
Query: 382 KEIAKGSNGTVVLEGNYE-GRSVAVKR--LVKTHH-DVALKEIQNLIASD-QHPNIVRWY 436
+I +GS G V + + GR VAVK+ L K ++ E+ +I D QHPNIV Y
Sbjct: 25 VKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEV--VIMRDYQHPNIVEMY 82
Query: 437 GVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTK 496
D +++ +E ++ G+ ++++ R+
Sbjct: 83 SSYLVGDELWVVME----------FLEGGAL----------TDIVTHTRMN--------- 113
Query: 497 DIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMG 556
Q+ V ++ LS LH G+IHRD+K ++L++ D KLSD G
Sbjct: 114 -----------EEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGR--VKLSDFG 160
Query: 557 ISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY- 615
++ ++ + + G+ W APE + + +D++SLG I+ + G+ PY
Sbjct: 161 FCAQVSKEVP---RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLG-IMVIEMVDGEPPYF 216
Query: 616 GESFERDANIVKDRKDLFLVEHI---PEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 668
E + ++D L P R+L +P R A +LNHPF
Sbjct: 217 NEPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFL 272
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 9e-14
Identities = 62/234 (26%), Positives = 100/234 (42%), Gaps = 51/234 (21%)
Query: 384 IAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYGVESDQD 443
I +G G V L+G Y G+ VAVK + A E ++ H N+VR GV
Sbjct: 14 IGEGEFGAV-LQGEYTGQKVAVKNIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVILHNG 72
Query: 444 FVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKA 503
+Y+ +E + NL+N +R R ++
Sbjct: 73 -LYIVMELMS-----------------------KGNLVNFLRTRGRALV----------- 97
Query: 504 NGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISK--RL 561
QLL+ + D+ G+ +L L+HRDL +N+L+S+D AK+SD G+++ +
Sbjct: 98 ---SVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDG--VAKVSDFGLARVGSM 152
Query: 562 QGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY 615
D S L W APE L + + D++S G +L+ + G+ PY
Sbjct: 153 GVDNSKLPVK--------WTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPY 198
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 1e-13
Identities = 54/189 (28%), Positives = 85/189 (44%), Gaps = 42/189 (22%)
Query: 510 QLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLT 569
QLLK G++ HE ++HRDLKPQN+LI+K KL+D G+++ ++ +
Sbjct: 108 QLLK-------GIAFCHENRVLHRDLKPQNLLINKRGEL--KLADFGLARAFGIPVNTFS 158
Query: 570 QNATGYGSSGWQAPEQLLQGRQ-TRAIDLFSLGCILFFCITGGKHPYGES---------- 618
+ ++AP+ LL R + +ID++S+GCI+ ITG G +
Sbjct: 159 NEVV---TLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFR 215
Query: 619 ------------------FERDANIVKDRKDLFLVEHI-PEAVDLFTRLLDPNPDLRPKA 659
++ + L H P +DL RLL NP+LR A
Sbjct: 216 IMGTPTESTWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISA 275
Query: 660 QNVLNHPFF 668
+ L HP+F
Sbjct: 276 HDALQHPWF 284
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 2e-13
Identities = 87/307 (28%), Positives = 139/307 (45%), Gaps = 60/307 (19%)
Query: 373 RIGKLVVFNKEIAKGSNGTVVLEGNYE-GRSVAVKRL------VKTHHDV-ALK-EIQNL 423
R+GKL + +G+ G V L + + GR +AVK++ +T +V AL+ EIQ L
Sbjct: 5 RLGKL------LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQ-L 57
Query: 424 IASDQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNE 483
+ + +H IV++YG D + LS+ + Y+ GS ++QL A L E
Sbjct: 58 LKNLRHDRIVQYYGCLRDPEEKKLSIF--------VEYMPGGSIKDQLKA----YGALTE 105
Query: 484 VRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLIS 543
R + TR I+ G+S+LH ++HRD+K N+L
Sbjct: 106 NVTR-------------------------RYTRQILQGVSYLHSNMIVHRDIKGANIL-- 138
Query: 544 KDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCI 603
+D + KL D G SKR+Q T + G+ W +PE + R D++S+ C
Sbjct: 139 RDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACT 198
Query: 604 LFFCITGGKHPYGESFERDANIVK---DRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQ 660
+ +T K P+ E +E A I K L + + +A F + + RP A+
Sbjct: 199 VVEMLT-EKPPWAE-YEAMAAIFKIATQPTKPMLPDGVSDACRDFLKQIFVEEKRRPTAE 256
Query: 661 NVLNHPF 667
+L HPF
Sbjct: 257 FLLRHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 2e-13
Identities = 57/179 (31%), Positives = 91/179 (50%), Gaps = 26/179 (14%)
Query: 505 GHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGD 564
G P + T I+SGL HLH+ +I+RDLKP+NVL+ D + ++SD+G++ L+
Sbjct: 93 GFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGN--VRISDLGLAVELKDG 150
Query: 565 MSCLTQNAT-GY-GSSGWQAPEQLLQGRQ-TRAIDLFSLGCILFFCITGGKHPYGESFER 621
Q+ T GY G+ G+ APE LLQG + ++D F+LG L+ I + P+ E+
Sbjct: 151 -----QSKTKGYAGTPGFMAPE-LLQGEEYDFSVDYFALGVTLYEMI-AARGPFRARGEK 203
Query: 622 DANIVKDRKDLFLVEHI-------PEAVDLFTRLLDPNPDLRPKAQN-----VLNHPFF 668
N K+ K L + + P + LL +P+ R ++ + HP F
Sbjct: 204 VEN--KELKQRILNDSVTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLF 260
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 70.8 bits (174), Expect = 2e-13
Identities = 73/292 (25%), Positives = 118/292 (40%), Gaps = 73/292 (25%)
Query: 400 GRSVAVKRL----VKTHHDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCS 455
VA+KR+ +T D KE+Q ++ HPN+V++Y D ++L + +
Sbjct: 26 NEKVAIKRIDLEKCQTSVDELRKEVQ-AMSQCNHPNVVKYYTSFVVGDELWLVMPYLSG- 83
Query: 456 LNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVT 515
GS LL +M+++ + G A + V
Sbjct: 84 ---------GS---------------------LLDIMKSS-----YPRGGLDEAIIATVL 108
Query: 516 RDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQ--GDMSCLTQNAT 573
++++ GL +LH G IHRD+K N+L+ +D S K++D G+S L GD + + T
Sbjct: 109 KEVLKGLEYLHSNGQIHRDIKAGNILLGEDGS--VKIADFGVSASLADGGDRTRKVRK-T 165
Query: 574 GYGSSGWQAPEQLLQGRQ-TRAIDLFSLGCILFFCITGGKHPYGE--------------- 617
G+ W APE + Q D++S G I + G PY +
Sbjct: 166 FVGTPCWMAPEVMEQVHGYDFKADIWSFG-ITAIELATGAAPYSKYPPMKVLMLTLQNDP 224
Query: 618 -SFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 668
S E A+ K K + + L +P RP A+ +L H FF
Sbjct: 225 PSLETGADYKKYSKSF---------RKMISLCLQKDPSKRPTAEELLKHKFF 267
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 2e-13
Identities = 56/173 (32%), Positives = 87/173 (50%), Gaps = 18/173 (10%)
Query: 517 DIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYG 576
+I+ GL H+H +++RDLKP N+L+ D+ ++SD+G L D S +A+ G
Sbjct: 105 EIILGLEHMHNRFVVYRDLKPANILL--DEHGHVRISDLG----LACDFSKKKPHAS-VG 157
Query: 577 SSGWQAPEQLLQG-RQTRAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDRKDLFLV 635
+ G+ APE L +G + D FSLGC+LF + G P+ + +D + + V
Sbjct: 158 THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLR-GHSPFRQHKTKDKHEIDRMTLTMAV 216
Query: 636 E----HIPEAVDLFTRLLDPNPDLR-----PKAQNVLNHPFFWTADTRLSFLR 679
E PE L LL + + R AQ V HPFF + D ++ FL+
Sbjct: 217 ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLDWQMVFLQ 269
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 4e-13
Identities = 92/311 (29%), Positives = 139/311 (44%), Gaps = 68/311 (21%)
Query: 373 RIGKLVVFNKEIAKGSNGTVVLEGNYE-GRSVAVKRLV------KTHHDV-ALK-EIQNL 423
R+GKL + +G+ G V L + + GR +AVK++ +T +V AL+ EIQ L
Sbjct: 5 RLGKL------LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQ-L 57
Query: 424 IASDQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNE 483
+ + H IV++YG D LS+ + ++ GS ++QL + L E
Sbjct: 58 LKNLLHERIVQYYGCLRDPMERTLSIF--------MEHMPGGSIKDQLKS----YGALTE 105
Query: 484 VRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLIS 543
R K TR I+ G+S+LH ++HRD+K N+L
Sbjct: 106 NVTR-------------------------KYTRQILEGVSYLHSNMIVHRDIKGANIL-- 138
Query: 544 KDKSFCAKLSDMGISKRLQGDMSCLTQNATGY----GSSGWQAPEQLLQGRQTRAIDLFS 599
+D KL D G SKRLQ CL+ TG G+ W +PE + R D++S
Sbjct: 139 RDSVGNVKLGDFGASKRLQ--TICLS--GTGMKSVTGTPYWMSPEVISGEGYGRKADIWS 194
Query: 600 LGCILFFCITGGKHPYGESFERDANIVK---DRKDLFLVEHIPEAVDLFTRLLDPNPDLR 656
+GC + +T K P+ E FE A I K + L H+ + F + + LR
Sbjct: 195 VGCTVVEMLT-EKPPWAE-FEAMAAIFKIATQPTNPVLPPHVSDHCRDFLKRIFVEAKLR 252
Query: 657 PKAQNVLNHPF 667
P A +L H F
Sbjct: 253 PSADELLRHTF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 70.1 bits (172), Expect = 4e-13
Identities = 83/327 (25%), Positives = 140/327 (42%), Gaps = 91/327 (27%)
Query: 384 IAKGSNGTVVLEGNYE-GRSVAVKRLVKTHHD-----VALKEIQNLIASDQHPNIVRWYG 437
+ +GS G V+ + E G+ VA+K+ +++ D +A++EI+ ++ +H N+V
Sbjct: 9 VGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIR-MLKQLRHENLVNLIE 67
Query: 438 VESDQDFVYLSLERCTCS-LNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTK 496
V + +YL E + L+DL E+ N L+E R+R
Sbjct: 68 VFRRKKRLYLVFEFVDHTVLDDL---------------EKYPNGLDESRVR--------- 103
Query: 497 DIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMG 556
K I+ G+ H +IHRD+KP+N+L+S +S KL D G
Sbjct: 104 ----------------KYLFQILRGIEFCHSHNIIHRDIKPENILVS--QSGVVKLCDFG 145
Query: 557 ISKRLQGDMSCLTQNATGYGSSGW-QAPEQLLQG--RQTRAIDLFSLGCILFFCITGGKH 613
++ L + T Y ++ W +APE LL G + RA+D++++GC++ +TG
Sbjct: 146 FARTLAAP----GEVYTDYVATRWYRAPE-LLVGDTKYGRAVDIWAVGCLVTEMLTGEPL 200
Query: 614 PYGES---------------FERDANIVKDRKDLFLVEHIPEA----------------- 641
G+S R I + LF +PE
Sbjct: 201 FPGDSDIDQLYHIIKCLGNLIPRHQEIF-QKNPLFAGMRLPEVKEIEPLEKRFPKLSGLV 259
Query: 642 VDLFTRLLDPNPDLRPKAQNVLNHPFF 668
+DL + L +PD RP + +L+H FF
Sbjct: 260 LDLAKQCLRIDPDDRPSSSQLLHHEFF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.8 bits (174), Expect = 5e-13
Identities = 53/188 (28%), Positives = 84/188 (44%), Gaps = 46/188 (24%)
Query: 518 IVSGLSHLHEIGLIHRDLKPQNVLISKDKSFC-AKLSDMGISKRLQGDMSCLTQNATGYG 576
I+ GL ++H ++HRDLKP N+L++ + C K+ D G++ R+ T T Y
Sbjct: 115 ILRGLKYIHSANVLHRDLKPSNLLLNTN---CDLKICDFGLA-RIADPEHDHTGFLTEYV 170
Query: 577 SSGW-QAPEQLLQGRQ-TRAIDLFSLGCILFFCITG-----GKH--------------PY 615
++ W +APE +L + T+AID++S+GCIL ++ GK P
Sbjct: 171 ATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPS 230
Query: 616 GESFERDANIVKDR----------------KDLFLVEHIPEAVDLFTRLLDPNPDLRPKA 659
E I+ R LF P+A+DL ++L NP R
Sbjct: 231 QEDLN---CIISLRARNYIKSLPFKPKVPWNKLF-PNADPKALDLLDKMLTFNPHKRITV 286
Query: 660 QNVLNHPF 667
+ L HP+
Sbjct: 287 EEALAHPY 294
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 7e-13
Identities = 43/133 (32%), Positives = 73/133 (54%), Gaps = 4/133 (3%)
Query: 492 MEN-TKDIELWKANGHPSA-QLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFC 549
MEN + D L K +G + QL+ + R I SG+ +L ++G +HRDL +N+L+ + +
Sbjct: 87 MENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILV--NSNLV 144
Query: 550 AKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCIT 609
K+SD G+S+ L+ D G W APE + + T A D++S G +++ ++
Sbjct: 145 CKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS 204
Query: 610 GGKHPYGESFERD 622
G+ PY E +D
Sbjct: 205 YGERPYWEMSNQD 217
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 9e-13
Identities = 50/165 (30%), Positives = 80/165 (48%), Gaps = 21/165 (12%)
Query: 517 DIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGY- 575
+IV L HLH++G+I+RD+K +N+L+ + L+D G+SK + + A +
Sbjct: 113 EIVLALDHLHQLGIIYRDIKLENILLDSEGH--VVLTDFGLSKEFLAEE---EERAYSFC 167
Query: 576 GSSGWQAPEQLLQGR--QTRAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDRKDLF 633
G+ + APE + G +A+D +SLG + F +TG P+ E+ N +
Sbjct: 168 GTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGAS-PFTVDGEQ--NSQSEISRRI 224
Query: 634 LVEHIP-------EAVDLFTRLLDPNPDLR---PKAQNVLNHPFF 668
L P EA D +LL+ +P R A + NHPFF
Sbjct: 225 LKSKPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFF 269
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.6 bits (171), Expect = 9e-13
Identities = 49/206 (23%), Positives = 83/206 (40%), Gaps = 61/206 (29%)
Query: 518 IVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCA--KLSDMGISKRLQGDMSCLTQNATGY 575
I++G+ +LH ++HRDLKP N+L+ + K+ D+G+++ + L A
Sbjct: 117 ILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFN---APLKPLADLD 173
Query: 576 G---SSGWQAPEQLLQGRQ-TRAIDLFSLGCI---------LFFCITGGKHP----YGES 618
+ ++APE LL R T+AID++++GCI +F +
Sbjct: 174 PVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQ 233
Query: 619 FERDANIVK-----DRKDLFLVEHIPE-------------------------------AV 642
ER I + KD ++ +PE
Sbjct: 234 LER---IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGF 290
Query: 643 DLFTRLLDPNPDLRPKAQNVLNHPFF 668
DL +LL+ +P R A+ L HP+F
Sbjct: 291 DLLRKLLEYDPTKRITAEEALEHPYF 316
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 1e-12
Identities = 86/347 (24%), Positives = 137/347 (39%), Gaps = 94/347 (27%)
Query: 382 KEIAKGSNGTVVLEGNYE---GRSVAVKRLVKTHHDV-----ALKEIQNLIASDQHPNIV 433
KE+ +G+ G V N E +VA+K++ AL+E++ L H NI
Sbjct: 6 KELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNIT 65
Query: 434 RWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVME 493
Y D D V+ + N+L Y+ +EE + A L+++ IR
Sbjct: 66 CLY----DMDIVFPG------NFNEL-YL----YEELMEAD------LHQI-IR------ 97
Query: 494 NTKDIELWKANGHP--SAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAK 551
+G P A I+ GL ++H ++HRDLKP N+L++ D K
Sbjct: 98 ----------SGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNAD--CELK 145
Query: 552 LSDMGISKRLQGDMSCLTQNATGYGSSGW-QAPEQLLQGRQ-TRAIDLFSLGCIL----- 604
+ D G+++ + T Y ++ W +APE +L + T+AID++S+GCIL
Sbjct: 146 ICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLG 205
Query: 605 ----------------FFCITGGKHPYGESFERDA------------NIVKDRKDLFLVE 636
+ G P E+ R NI K +
Sbjct: 206 RKPVFKGKDYVDQLNQILQVLGT--PDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPN 263
Query: 637 HIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTADTRLSFLRDVSD 683
P A+DL +LL +P R + L HP+ L+ D D
Sbjct: 264 ANPLALDLLEKLLAFDPTKRISVEEALEHPY-------LAIWHDPDD 303
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 1e-12
Identities = 49/178 (27%), Positives = 83/178 (46%), Gaps = 31/178 (17%)
Query: 509 AQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCL 568
A ++ T ++ GLS+LHE +IHRD+K N+LI +++D G + RL +
Sbjct: 103 AVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQR-LRIADFGAAARLAAKGT-- 159
Query: 569 TQNATG------YGSSGWQAPEQLLQGRQ-TRAIDLFSLGCILFFCITGGKHPYGESFER 621
G G+ + APE +L+G Q R+ D++S+GC++ T K P+
Sbjct: 160 ---GAGEFQGQLLGTIAFMAPE-VLRGEQYGRSCDVWSVGCVIIEMAT-AKPPWNAE--- 211
Query: 622 DANIVKDRKDLFLV----------EHIPEAV-DLFTRLLDPNPDLRPKAQNVLNHPFF 668
+F + EH+ + D+ R L+ P+ RP ++ +L HP F
Sbjct: 212 --KHSNHLALIFKIASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHPVF 267
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 1e-12
Identities = 76/297 (25%), Positives = 129/297 (43%), Gaps = 41/297 (13%)
Query: 378 VVFNKEIAKGSNGTVV------LEGNYEGRSVAVKRLVKTHHDVALKEIQ---NLIASDQ 428
+V K + +G G VV L+G +VAVK L + L+++ NL+
Sbjct: 2 LVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVN 61
Query: 429 HPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRL 488
HP++++ YG S + L +E Y GS + L E R ++
Sbjct: 62 HPHVIKLYGACSQDGPLLLIVE----------YAKYGSLR----------SFLRESR-KV 100
Query: 489 LPVMENTKDIELWKANGHPSAQ------LLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLI 542
P + +P + L+ I G+ +L E+ L+HRDL +NVL+
Sbjct: 101 GPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLV 160
Query: 543 SKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGC 602
++ + K+SD G+S+ + + S + + + G W A E L T D++S G
Sbjct: 161 AEGRK--MKISDFGLSRDVYEEDSYV-KRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGV 217
Query: 603 ILFFCITGGKHPY-GESFERDANIVKDRKDLFLVEHIPEAV-DLFTRLLDPNPDLRP 657
+L+ +T G +PY G + ER N++K + E+ E + +L PD RP
Sbjct: 218 LLWEIVTLGGNPYPGIAPERLFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRP 274
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 1e-12
Identities = 77/306 (25%), Positives = 130/306 (42%), Gaps = 69/306 (22%)
Query: 379 VFNKEIAKGSNGTVVL-EGNYEGRSVAVKRL-----VKTHHDVALKEIQNLIASDQHPNI 432
F + + KGS G V L +G+ +K+L + A +E Q L++ +HPNI
Sbjct: 3 CFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQ-LLSQLKHPNI 61
Query: 433 V----RWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRL 488
V W G E ++ + C DL + L KEQ LL
Sbjct: 62 VAYRESWEG-EDGLLYIVMGF----CEGGDLYHKL----------KEQKGKLL------- 99
Query: 489 LPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSF 548
P Q+++ I L +LHE ++HRDLK QNV ++ ++
Sbjct: 100 ------------------PENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLT--RTN 139
Query: 549 CAKLSDMGISKRL--QGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFF 606
K+ D+GI++ L Q DM+ +T G+ + +PE D+++LGC ++
Sbjct: 140 IIKVGDLGIARVLENQCDMA-----STLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYE 194
Query: 607 CITGGKHPYGESFERDAN-----IVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQN 661
T KH + +D N I++ + ++ PE +L +L P+ RP ++
Sbjct: 195 MAT-LKHAFN---AKDMNSLVYRIIEGKLPPMPKDYSPELGELIATMLSKRPEKRPSVKS 250
Query: 662 VLNHPF 667
+L P+
Sbjct: 251 ILRQPY 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 1e-12
Identities = 81/324 (25%), Positives = 133/324 (41%), Gaps = 82/324 (25%)
Query: 382 KEIAKGSNGTVVLEGNYE-GRSVAVK--RLVKTHHDV---ALKEIQNLIASDQHPNIVRW 435
++I +G+ G V N G VA+K RL V A++EI +L+ HPNIV+
Sbjct: 6 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREI-SLLKELNHPNIVKL 64
Query: 436 YGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENT 495
V ++ +YL E F Q K D++ L+ +
Sbjct: 65 LDVIHTENKLYLVFE----------------FLHQDLKKFMDASPLSGI----------- 97
Query: 496 KDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDM 555
P + ++ GL+ H ++HRDLKPQN+LI+ + + KL+D
Sbjct: 98 -----------PLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAI--KLADF 144
Query: 556 GISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGR-QTRAIDLFSLGCILFFCITGGKHP 614
G+++ + T + ++APE LL + + A+D++SLGCI +T
Sbjct: 145 GLARAFGVPVRTYTHEVV---TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALF 201
Query: 615 YGESFERD-------------------ANIVKDRKDLF-------LVEHIP----EAVDL 644
G+S E D + D K F + +P + DL
Sbjct: 202 PGDS-EIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDL 260
Query: 645 FTRLLDPNPDLRPKAQNVLNHPFF 668
+++L +P+ R A+ L HPFF
Sbjct: 261 LSQMLHYDPNKRISAKAALAHPFF 284
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 1e-12
Identities = 73/295 (24%), Positives = 122/295 (41%), Gaps = 51/295 (17%)
Query: 382 KEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHDVALKEIQN----LIASDQHPNIVRWY 436
K+I +GS G + L + + +K + T V KE L+A +HPNIV ++
Sbjct: 6 KKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFF 65
Query: 437 GVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTK 496
+ +++ +E C G +++N Q L +E
Sbjct: 66 ASFQENGRLFIVMEYCD----------GGDLMKRIN--RQRGVLFSE------------- 100
Query: 497 DIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMG 556
Q+L I GL H+H+ ++HRD+K QN+ +SK+ AKL D G
Sbjct: 101 ------------DQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKN-GMVAKLGDFG 147
Query: 557 ISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILF-FCITGGKHPY 615
I+++L M L T G+ + +PE D++SLGC+L+ C KHP+
Sbjct: 148 IARQLNDSME-LAY--TCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTL--KHPF 202
Query: 616 -GESFERDA-NIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 668
G + + I + + L ++L +P RP ++L PF
Sbjct: 203 EGNNLHQLVLKICQGYFAPISPNFSRDLRSLISQLFKVSPRDRPSITSILKRPFL 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 1e-12
Identities = 64/250 (25%), Positives = 101/250 (40%), Gaps = 67/250 (26%)
Query: 380 FNKEIAKGSNGTVVLEGNYEG-RSVAVKRLVKTHHDVALKE---IQ--NLIASDQHPNIV 433
F KE+ G G V L G + G VA+K + + A+ E I+ ++ HPN+V
Sbjct: 8 FLKELGSGQFGVVHL-GKWRGKIDVAIKMI----REGAMSEDDFIEEAKVMMKLSHPNLV 62
Query: 434 RWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVME 493
+ YGV + Q +++ E Y+ +G LLN +R R
Sbjct: 63 QLYGVCTKQRPIFIVTE----------YMANGC-------------LLNYLRER--KGKL 97
Query: 494 NTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLS 553
T LL + D+ + +L G IHRDL +N L+ +D K+S
Sbjct: 98 GT-------------EWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGED--NVVKVS 142
Query: 554 DMGISKRLQGDMSCLTQNATGYGSSG-------WQAPEQLLQGRQTRAIDLFSLGCILFF 606
D G+++ + D Y SS W PE R + D++S G +++
Sbjct: 143 DFGLARYVLDDQ---------YTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWE 193
Query: 607 CITGGKHPYG 616
+ GK PY
Sbjct: 194 VFSEGKMPYE 203
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 1e-12
Identities = 59/202 (29%), Positives = 91/202 (45%), Gaps = 37/202 (18%)
Query: 519 VSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGY--- 575
V L +LH G++HRDLKP N+LI+ KL+D G+SK G MS T G+
Sbjct: 111 VLALEYLHNYGIVHRDLKPDNLLITSMGHI--KLTDFGLSK--IGLMSLTTNLYEGHIEK 166
Query: 576 -----------GSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFER-DA 623
G+ + APE +L+ + +D +++G IL+ + G +G++ E
Sbjct: 167 DTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFG 226
Query: 624 NIVKDRKDLFLVEH----IPEAVDLFTRLLDPNPDLR---PKAQNVLNHPFF----WTAD 672
++ D D+ E +A DL +RLL NP R A V H FF W
Sbjct: 227 QVISD--DIEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLDWN-- 282
Query: 673 TRLSFLRDVSDRVELEDRESDS 694
LR ++ + + E D+
Sbjct: 283 ---GLLRQKAEFIPQLESEDDT 301
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-12
Identities = 55/197 (27%), Positives = 91/197 (46%), Gaps = 24/197 (12%)
Query: 498 IELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGI 557
++L +A Q+ + ++I+ GL +LH IHRD+K NVL+S+ KL+D G+
Sbjct: 90 LDLLRAGPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGD--VKLADFGV 147
Query: 558 SKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGE 617
+ +L + T G+ W APE + Q D++SLG IT + GE
Sbjct: 148 AGQLTDTQ---IKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLG------ITAIELAKGE 198
Query: 618 SFERDANIVKDRKDLFLVEHI--PEAVDLFTR--------LLDPNPDLRPKAQNVLNHPF 667
D + + + LFL+ P F++ L+ +P RP A+ +L H F
Sbjct: 199 PPNSDMHPM---RVLFLIPKNNPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKF 255
Query: 668 FWTADTRLSFLRDVSDR 684
+ S+L ++ DR
Sbjct: 256 IVKNAKKTSYLTELIDR 272
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 2e-12
Identities = 86/349 (24%), Positives = 137/349 (39%), Gaps = 81/349 (23%)
Query: 335 IPNESKVGETDGLSHITGNGEKFLLTFTDLIDDRVDGRRIGKLVVFNKEIAKGSNGTV-V 393
+P S + S +G+ + ++L +RV RIG G+ GTV
Sbjct: 47 LPPPSSSSSSSSSSSASGSAPSAAKSLSEL--ERV--NRIGS----------GAGGTVYK 92
Query: 394 LEGNYEGRSVAVKRLVKTHHDVALKEIQNLIA---SDQHPNIVRWYGVESDQDFVYLSLE 450
+ GR A+K + H D ++I I HPN+V+ + + + + LE
Sbjct: 93 VIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLE 152
Query: 451 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQ 510
++ GS E A EQ
Sbjct: 153 ----------FMDGGSLEGTHIADEQ---------------------------------F 169
Query: 511 LLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMS-CLT 569
L V R I+SG+++LH ++HRD+KP N+LI+ K+ K++D G+S+ L M C
Sbjct: 170 LADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKN--VKIADFGVSRILAQTMDPC-- 225
Query: 570 QNATGYGSSGWQAPEQ----LLQGR-QTRAIDLFSLG-CILFFCITGGKHPYGESFERD- 622
N++ G+ + +PE+ L G A D++SLG IL F + G+ P+G + D
Sbjct: 226 -NSS-VGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYL--GRFPFGVGRQGDW 281
Query: 623 ----ANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPF 667
I + E + L P R A +L HPF
Sbjct: 282 ASLMCAICMSQPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPF 330
|
Length = 353 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 52/197 (26%), Positives = 87/197 (44%), Gaps = 24/197 (12%)
Query: 498 IELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGI 557
++L K + + R+I+ GL +LH IHRD+K NVL+S+ KL+D G+
Sbjct: 90 LDLLKPGPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGD--VKLADFGV 147
Query: 558 SKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGE 617
+ +L + T G+ W APE + Q D++SLG I + G+ P +
Sbjct: 148 AGQLTDTQ---IKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLG-ITAIELAKGEPPNSD 203
Query: 618 SFERDANIVKDRKDLFLV----------EHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPF 667
+ + LFL+ ++ + L+ +P RP A+ +L H F
Sbjct: 204 --------LHPMRVLFLIPKNSPPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKF 255
Query: 668 FWTADTRLSFLRDVSDR 684
+ SFL ++ DR
Sbjct: 256 ITRYTKKTSFLTELIDR 272
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 67.7 bits (166), Expect = 2e-12
Identities = 37/114 (32%), Positives = 64/114 (56%), Gaps = 15/114 (13%)
Query: 510 QLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLT 569
QL+ + R I SG+ +L E+ +HRDL +N+L++ + K+SD G+S+RL+
Sbjct: 107 QLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSN--LVCKVSDFGLSRRLE------D 158
Query: 570 QNATGYGSSG------WQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGE 617
AT Y + G W APE + + T A D++S G +++ ++ G+ PY +
Sbjct: 159 SEAT-YTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWD 211
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 2e-12
Identities = 51/170 (30%), Positives = 83/170 (48%), Gaps = 20/170 (11%)
Query: 517 DIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYG 576
+I+ L HLH++G+++RD+K +N+L+ + L+D G+SK + T + G
Sbjct: 113 EIILALEHLHKLGIVYRDIKLENILLDSEGHVV--LTDFGLSKEFLSEEKERTYSFC--G 168
Query: 577 SSGWQAPEQLL-QGRQTRAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDRKDLFLV 635
+ + APE + +G +A+D +SLG ++F +TG P+ ER+ R+ L
Sbjct: 169 TIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGAS-PFTLEGERNTQSEVSRRILKCD 227
Query: 636 EHIP-----EAVDLFTRLLDPNPDLR-----PKAQNVLNHPFF----WTA 671
P EA DL +LL +P R A + HPFF W A
Sbjct: 228 PPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLDWEA 277
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 2e-12
Identities = 83/303 (27%), Positives = 128/303 (42%), Gaps = 60/303 (19%)
Query: 383 EIAKGSNGTV-VLEGNYEGRSVAVKRL----VKTHHDVALKEIQNLIASDQHPNIVRWYG 437
EI +G+ GTV + G +AVKR+ + L ++ ++ S P IV++YG
Sbjct: 11 EIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYG 70
Query: 438 VESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKD 497
+ ++ +E SL D Y V E K
Sbjct: 71 ALFREGDCWICMELMDISL-DKFYKY---------------------------VYEVLKS 102
Query: 498 IELWKANGHPSAQLLKVTRDIVSGLSHL-HEIGLIHRDLKPQNVLISKDKSFCAKLSDMG 556
+ P L K+ V L++L E+ +IHRD+KP N+L+ D++ KL D G
Sbjct: 103 V-------IPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILL--DRNGNIKLCDFG 153
Query: 557 ISKRLQGDMSCLTQNATGYGSSGWQAPEQLL----QGRQTRAIDLFSLGCILFFCITGGK 612
IS +L D T++A G + APE++ G R+ D++SLG I + + GK
Sbjct: 154 ISGQLV-DSIAKTRDA---GCRPYMAPERIDPSARDGYDVRS-DVWSLG-ITLYEVATGK 207
Query: 613 HPY---GESFERDANIVK-DRKDL---FLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNH 665
PY F++ +VK D L E P V+ L + RPK + +L H
Sbjct: 208 FPYPKWNSVFDQLTQVVKGDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267
Query: 666 PFF 668
PF
Sbjct: 268 PFI 270
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 2e-12
Identities = 60/216 (27%), Positives = 104/216 (48%), Gaps = 48/216 (22%)
Query: 488 LLPVMENTKDIELWKANGHPSAQ--LLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKD 545
++P M+ +L K GHP ++ + + ++ GL ++H G+IHRDLKP N+ +++D
Sbjct: 98 VMPYMQ----TDLQKIMGHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNED 153
Query: 546 KSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGW-QAPEQLLQGRQ-TRAIDLFSLGCI 603
K+ D G+++ +M TGY + W +APE +L + +D++S+GCI
Sbjct: 154 CEL--KILDFGLARHADAEM-------TGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCI 204
Query: 604 LFFCITG-----GK--------------HPYGESFER-----DANIVKD-----RKDLFL 634
+ +TG GK P E ++ + +K RKD
Sbjct: 205 MAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFST 264
Query: 635 V--EHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 668
+ + P+AVDL ++L+ + D R A L HP+F
Sbjct: 265 LFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYF 300
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 2e-12
Identities = 66/255 (25%), Positives = 108/255 (42%), Gaps = 53/255 (20%)
Query: 378 VVFNKEIAKGSNGTVVLEGNYEGRS------VAVKRLVKTHHDVALKEIQ---NLIASDQ 428
+V +E+ +G+ G V L Y VAVK L +T + A K+ + L+ + Q
Sbjct: 7 IVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQ 66
Query: 429 HPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRL 488
H NIV++YGV ++ D + E Y+ G + L + D+ L
Sbjct: 67 HENIVKFYGVCTEGDPPIMVFE----------YMEHGDLNKFLRSHGPDAAFL------- 109
Query: 489 LPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSF 548
++ EL + QLL++ I SG+ +L +HRDL +N L+ D
Sbjct: 110 --KSPDSPMGELTLS------QLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYD--L 159
Query: 549 CAKLSDMGISKRLQGDMSCLTQNATGYGSSG--------WQAPEQLLQGRQTRAIDLFSL 600
K+ D G+S+ + T Y G W PE ++ + T D++S
Sbjct: 160 VVKIGDFGMSRDVY---------TTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSF 210
Query: 601 GCILFFCITGGKHPY 615
G +L+ T GK P+
Sbjct: 211 GVVLWEIFTYGKQPW 225
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 68.5 bits (168), Expect = 3e-12
Identities = 51/191 (26%), Positives = 83/191 (43%), Gaps = 49/191 (25%)
Query: 518 IVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGS 577
++ GL ++H +IHRDLKP N+L+++D ++ D G+++ L + T Y +
Sbjct: 116 LLRGLKYIHSANVIHRDLKPSNLLVNEDCEL--RIGDFGMARGLSSSPTEHKYFMTEYVA 173
Query: 578 SGW-QAPEQLLQ-GRQTRAIDLFSLGCI---------LFFCITGGKHP------------ 614
+ W +APE LL T AID++S+GCI LF GK+
Sbjct: 174 TRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLF----PGKNYVHQLKLILSVLG 229
Query: 615 -----------------YGESFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRP 657
Y ++ R +F PEA+DL +++L +P+ R
Sbjct: 230 SPSEEVLNRIGSDRVRKYIQNLPRKQ--PVPWSKIFPKAS-PEALDLLSQMLQFDPEERI 286
Query: 658 KAQNVLNHPFF 668
+ L HPF
Sbjct: 287 TVEQALQHPFL 297
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 67.3 bits (165), Expect = 3e-12
Identities = 58/226 (25%), Positives = 97/226 (42%), Gaps = 45/226 (19%)
Query: 393 VLEGNYEGRS-VAVKRLVKTHHDVA--LKEIQNLIASDQHPNIVRWYGVESDQDFVYLSL 449
V G + G + VAVK L L+E Q ++ +H +V+ Y V S+++ +Y+
Sbjct: 22 VWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQ-IMKKLRHDKLVQLYAVCSEEEPIYIVT 80
Query: 450 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSA 509
E Y+ GS + L K + L LP
Sbjct: 81 E----------YMSKGSLLDFL--KSGEGKKLR------LP------------------- 103
Query: 510 QLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLT 569
QL+ + I G+++L IHRDL +N+L+ ++ K++D G+++ ++ D
Sbjct: 104 QLVDMAAQIAEGMAYLESRNYIHRDLAARNILVG--ENLVCKIADFGLARLIEDDEYTAR 161
Query: 570 QNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY 615
+ A W APE GR T D++S G +L +T G+ PY
Sbjct: 162 EGAK--FPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPY 205
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 3e-12
Identities = 50/157 (31%), Positives = 77/157 (49%), Gaps = 8/157 (5%)
Query: 515 TRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATG 574
T +++ L +LH+ +I+RDLKP+N+L+ D L D G+ K +M + T
Sbjct: 99 TAELLCALENLHKFNVIYRDLKPENILL--DYQGHIALCDFGLCKL---NMKDDDKTNTF 153
Query: 575 YGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDRKDLFL 634
G+ + APE LL T+A+D ++LG +L+ +TG Y E+ + F
Sbjct: 154 CGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFP 213
Query: 635 VEHIPEAVDLFTRLLDPNPDLR---PKAQNVLNHPFF 668
+A DL LL +P R AQ + NHPFF
Sbjct: 214 DGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFF 250
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 4e-12
Identities = 50/178 (28%), Positives = 85/178 (47%), Gaps = 25/178 (14%)
Query: 505 GHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGD 564
G + + +I GL LH+ +++RDLKP+N+L+ ++SD+G++ +
Sbjct: 98 GFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHI--RISDLGLAVHVPEG 155
Query: 565 MSCLTQNATG-YGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYG------- 616
Q G G+ G+ APE + R T + D ++LGC+L+ I G+ P+
Sbjct: 156 -----QTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIA-GQSPFQQRKKKIK 209
Query: 617 -ESFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLR-----PKAQNVLNHPFF 668
E ER +VK+ ++ + + P+A L LL +P R A+ V HP F
Sbjct: 210 REEVER---LVKEVQEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLF 264
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 4e-12
Identities = 60/239 (25%), Positives = 97/239 (40%), Gaps = 58/239 (24%)
Query: 429 HPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRL 488
HPNIV+ GV + + +Y+ +E V G F L K+ +
Sbjct: 51 HPNIVKLIGVCTQRQPIYIVME----------LVPGGDFLSFLRKKKDELKT-------- 92
Query: 489 LPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSF 548
QL+K D +G+++L IHRDL +N L+ ++
Sbjct: 93 --------------------KQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVL 132
Query: 549 CAKLSDMGISKRLQGDMSCLTQNATGYGSSG-------WQAPEQLLQGRQTRAIDLFSLG 601
K+SD G+S++ + Y SSG W APE L GR + D++S G
Sbjct: 133 --KISDFGMSRQEDDGI---------YSSSGLKQIPIKWTAPEALNYGRYSSESDVWSYG 181
Query: 602 CILFFCITGGKHPY-GESFERDANIVKDRKDLFLVEHIPEAV-DLFTRLLDPNPDLRPK 658
+L+ + G PY G + ++ V+ + + P+ V + R D P+ RPK
Sbjct: 182 ILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQKCPDDVYKVMQRCWDYKPENRPK 240
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 4e-12
Identities = 49/175 (28%), Positives = 78/175 (44%), Gaps = 20/175 (11%)
Query: 505 GHPSAQLLKVTRDIVSGLSHLHE-IGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQG 563
G P L ++T +V GL L E +IHRD+KP NVL++ + KL D G+S L
Sbjct: 98 GIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQ--VKLCDFGVSGNLVA 155
Query: 564 DMSCLTQNATGYGSSGWQAPEQLLQGRQTRAI------DLFSLGCILFFCITGGKHPY-- 615
++ T G + APE++ G + D++SLG + G++PY
Sbjct: 156 SLA-----KTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMAL-GRYPYPP 209
Query: 616 ---GESFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPF 667
F + + IV + +A D + L+ P+ RP +L HP+
Sbjct: 210 ETYANIFAQLSAIVDGDPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPW 264
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.0 bits (164), Expect = 5e-12
Identities = 73/313 (23%), Positives = 124/313 (39%), Gaps = 91/313 (29%)
Query: 397 NYEGRSVAVKRLVKTHHD-----VALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLER 451
G VA+K++ D A++EI +L+ HPNIVR V ++ +YL E
Sbjct: 21 KLTGEIVALKKIRLETEDEGVPSTAIREI-SLLKELNHPNIVRLLDVVHSENKLYLVFE- 78
Query: 452 CTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQL 511
F + K DS P+ + +
Sbjct: 79 ---------------FLDLDLKKYMDS----------SPLTGLDPPL------------I 101
Query: 512 LKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQN 571
++ G+++ H ++HRDLKPQN+LI ++ + KL+D G+++ + T
Sbjct: 102 KSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGAL--KLADFGLARAFGVPVRTYTHE 159
Query: 572 ATGYGSSGW-QAPEQLLQGRQ-TRAIDLFSLGCILFFCITGGKHPYGESFERDANI---- 625
+ W +APE LL RQ + +D++S+GCI + + P F D+ I
Sbjct: 160 VV----TLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVN--RRPL---FPGDSEIDQLF 210
Query: 626 -------------------VKDRKDLF-------LVEHIP----EAVDLFTRLLDPNPDL 655
+ D K F L + +P + +DL +++L +P
Sbjct: 211 RIFRTLGTPDEDVWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAK 270
Query: 656 RPKAQNVLNHPFF 668
R A+ L HP+F
Sbjct: 271 RISAKAALQHPYF 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 5e-12
Identities = 48/165 (29%), Positives = 83/165 (50%), Gaps = 19/165 (11%)
Query: 517 DIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGY- 575
+IV L HLH++G+I+RD+K +N+L+ + L+D G+SK D + A +
Sbjct: 113 EIVLALEHLHKLGIIYRDIKLENILLDSNGHVV--LTDFGLSKEFHEDE---VERAYSFC 167
Query: 576 GSSGWQAPEQLLQGR--QTRAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDRKDL- 632
G+ + AP+ + G +A+D +S+G +++ +TG P+ E+++ R+ L
Sbjct: 168 GTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGAS-PFTVDGEKNSQAEISRRILK 226
Query: 633 ----FLVEHIPEAVDLFTRLLDPNPDLR----PK-AQNVLNHPFF 668
+ E A D+ RLL +P R P A + HPFF
Sbjct: 227 SEPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFF 271
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 5e-12
Identities = 64/231 (27%), Positives = 107/231 (46%), Gaps = 48/231 (20%)
Query: 383 EIAKGSNGTVVLEGNYE--GRSVAVKRL-VKTHHD----VALKEIQNL--IASDQHPNIV 433
EI +G+ G V + + GR VA+KR+ V+T + ++E+ L + + +HPN+V
Sbjct: 8 EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 67
Query: 434 RWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVME 493
R + V CT S D L+ FE +QD L ++
Sbjct: 68 RLFDV-------------CTVSRTDRETKLTLVFEHV----DQD----------LTTYLD 100
Query: 494 NTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLS 553
+ G P+ + + ++ GL LH ++HRDLKPQN+L++ KL+
Sbjct: 101 KVPE------PGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQI--KLA 152
Query: 554 DMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCIL 604
D G+++ M+ + T + ++APE LLQ +DL+S+GCI
Sbjct: 153 DFGLARIYSFQMALTSVVVTLW----YRAPEVLLQSSYATPVDLWSVGCIF 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 6e-12
Identities = 57/204 (27%), Positives = 92/204 (45%), Gaps = 49/204 (24%)
Query: 518 IVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGS 577
++ GL ++H G+IHRDLKP N+ +++D K+ D G++++ +M TGY
Sbjct: 127 MLKGLKYIHAAGIIHRDLKPGNLAVNEDCEL--KILDFGLARQTDSEM-------TGYVV 177
Query: 578 SGW-QAPEQLLQG-RQTRAIDLFSLGCILFFCIT------GGKH-------------PYG 616
+ W +APE +L T+ +D++S+GCI+ +T G H P
Sbjct: 178 TRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSK 237
Query: 617 ESFER----DA-NIVK-----DRKDL--FLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 664
E ++ DA N VK +KD L P AV++ ++L + + R A L
Sbjct: 238 EFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA 297
Query: 665 HPFFWTADTRLSFLRDVSDRVELE 688
HP+F D D E
Sbjct: 298 HPYF-------EEFHDPEDETEAP 314
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 67.0 bits (164), Expect = 6e-12
Identities = 60/192 (31%), Positives = 90/192 (46%), Gaps = 45/192 (23%)
Query: 517 DIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKR--LQGDMSCLTQNATG 574
+IV GL LHE G+I+RDLK NVL+ + K++D G+ K L G + +T
Sbjct: 104 EIVLGLQFLHERGIIYRDLKLDNVLLDSE-GHI-KIADFGMCKEGILGGVTT-----STF 156
Query: 575 YGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDRKDLF- 633
G+ + APE L A+D ++LG +L + + G+ P FE D D +LF
Sbjct: 157 CGTPDYIAPEILSYQPYGPAVDWWALG-VLLYEMLAGQSP----FEGD-----DEDELFQ 206
Query: 634 -LVE---HIP-----EAVDLFTRLLDPNPDLR----PKA-QNVLNHPFFWTADTRLSFLR 679
++E P EA + L NP+ R P Q++ HPFF R
Sbjct: 207 SILEDEVRYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFF----------R 256
Query: 680 DVSDRVELEDRE 691
++ D +LE +E
Sbjct: 257 EI-DWDKLERKE 267
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 8e-12
Identities = 66/255 (25%), Positives = 111/255 (43%), Gaps = 55/255 (21%)
Query: 378 VVFNKEIAKGSNGTVVLEGNY------EGRSVAVKRLVKTHHDVALKEIQ---NLIASDQ 428
+V +E+ +G+ G V L Y + VAVK L K D A K+ L+ + Q
Sbjct: 7 IVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTL-KDASDNARKDFHREAELLTNLQ 65
Query: 429 HPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRL 488
H +IV++YGV + D + + E Y+ G + L A D+ L+ E
Sbjct: 66 HEHIVKFYGVCVEGDPLIMVFE----------YMKHGDLNKFLRAHGPDAVLMAEGN--- 112
Query: 489 LPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSF 548
E T+ +Q+L + + I +G+ +L +HRDL +N L+ ++
Sbjct: 113 -RPAELTQ------------SQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGEN--L 157
Query: 549 CAKLSDMGISKRLQGDMSCLTQNATGYGSSG--------WQAPEQLLQGRQTRAIDLFSL 600
K+ D G+S+ + +T Y G W PE ++ + T D++SL
Sbjct: 158 LVKIGDFGMSRDVY---------STDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSL 208
Query: 601 GCILFFCITGGKHPY 615
G +L+ T GK P+
Sbjct: 209 GVVLWEIFTYGKQPW 223
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 1e-11
Identities = 61/235 (25%), Positives = 100/235 (42%), Gaps = 42/235 (17%)
Query: 382 KEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDV-ALKEIQNLIASDQHPNIVRWYGVES 440
K++ G G V + VAVK L V A E NL+ + QH +VR Y V +
Sbjct: 12 KKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVT 71
Query: 441 DQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIEL 500
++ +Y+ E Y+ GS + L + E LL
Sbjct: 72 KEEPIYIITE----------YMAKGSLLDFLKSDEGGKVLL------------------- 102
Query: 501 WKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKR 560
+L+ + I G++++ IHRDL+ NVL+S +S K++D G+++
Sbjct: 103 --------PKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVS--ESLMCKIADFGLARV 152
Query: 561 LQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY 615
++ + + A W APE + G T D++S G +L+ +T GK PY
Sbjct: 153 IEDNEYTAREGAK--FPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPY 205
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 1e-11
Identities = 80/325 (24%), Positives = 127/325 (39%), Gaps = 87/325 (26%)
Query: 384 IAKGSNGTVVLEGNYE-GRSVAVKRLVKTHHD-----VALKEIQNLIASDQHPNIVRWYG 437
I +GS G V N E G+ VA+K+ V++ D +AL+EI+ L +HPN+V
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRML-KQLKHPNLVNLIE 67
Query: 438 VESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKD 497
V + ++L E C D +LNE+
Sbjct: 68 VFRRKRKLHLVFEYC------------------------DHTVLNELEKN---------- 93
Query: 498 IELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGI 557
G P + K+ + ++ H+ IHRD+KP+N+LI+K KL D G
Sbjct: 94 -----PRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQI--KLCDFGF 146
Query: 558 SKRLQGDMSCLTQNATGYGSSGW-QAPEQLLQGRQ-TRAIDLFSLGCILFFCITG----- 610
++ L G + T Y ++ W +APE L+ Q +D++++GC+ +TG
Sbjct: 147 ARILTGP----GDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWP 202
Query: 611 GK----------HPYGESFERDANIVKDRKDLFLVEHIPE-----------------AVD 643
GK G+ R I + F IPE A+
Sbjct: 203 GKSDVDQLYLIRKTLGDLIPRHQQIFSTNQ-FFKGLSIPEPETREPLESKFPNISSPALS 261
Query: 644 LFTRLLDPNPDLRPKAQNVLNHPFF 668
L +P R + +L HP+F
Sbjct: 262 FLKGCLQMDPTERLSCEELLEHPYF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 1e-11
Identities = 72/312 (23%), Positives = 122/312 (39%), Gaps = 78/312 (25%)
Query: 382 KEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQ------NLIASDQHPNIVRW 435
K + G+ G V L + +++ + LK+ Q ++ HP I+R
Sbjct: 7 KTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRL 66
Query: 436 YGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENT 495
+ E DQ F+Y+ +E YV G L + SN
Sbjct: 67 FWTEHDQRFLYMLME----------YVPGGELFSYLRNSGRFSNSTG------------- 103
Query: 496 KDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDM 555
L +IV L +LH +++RDLKP+N+L+ K+ KL+D
Sbjct: 104 ----------------LFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHI--KLTDF 145
Query: 556 GISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG----- 610
G +K+L+ + T G+ + APE + +A+D ++LG +++ + G
Sbjct: 146 GFAKKLR------DRTWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFF 199
Query: 611 GKHPYG---------ESFERDAN-IVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQ 660
+P+G F R + KD LV VD RL +++ A
Sbjct: 200 DDNPFGIYEKILAGKLEFPRHLDLYAKDLIKKLLV------VDRTRRL----GNMKNGAD 249
Query: 661 NVLNHPFFWTAD 672
+V NH +F + D
Sbjct: 250 DVKNHRWFKSVD 261
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 1e-11
Identities = 86/330 (26%), Positives = 133/330 (40%), Gaps = 93/330 (28%)
Query: 382 KEIAKGSNGTVVLEGNYE--GRSVAVK--RLVKTHHDV---ALKEIQNLIASDQHPNIVR 434
++I +G+ G VV +G + G+ VA+K RL V A++EI +L+ QHPNIV
Sbjct: 6 EKIGEGTYG-VVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREI-SLLKELQHPNIVC 63
Query: 435 WYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMEN 494
V + +YL E + L K DS LP
Sbjct: 64 LQDVLMQESRLYLIFEFLSMDLK----------------KYLDS----------LP---- 93
Query: 495 TKDIELWKANGHPSAQLLK-VTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLS 553
+ A+L+K I+ G+ H ++HRDLKPQN+LI D KL+
Sbjct: 94 --------KGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLI--DNKGVIKLA 143
Query: 554 DMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG-RQTRAIDLFSLGCILFFCITGGK 612
D G+++ + T + ++APE LL R + +D++S+G I F K
Sbjct: 144 DFGLARAFGIPVRVYTHEVV---TLWYRAPEVLLGSPRYSTPVDIWSIGTI--FAEMATK 198
Query: 613 HPYGESFERDANI-----------------------VKDRKDLF-------LVEHIP--- 639
P F D+ I + D K+ F L +
Sbjct: 199 KPL---FHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLD 255
Query: 640 -EAVDLFTRLLDPNPDLRPKAQNVLNHPFF 668
+ +DL ++L +P R A+ LNHP+F
Sbjct: 256 EDGLDLLEKMLIYDPAKRISAKKALNHPYF 285
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 1e-11
Identities = 59/263 (22%), Positives = 106/263 (40%), Gaps = 70/263 (26%)
Query: 426 SDQHPNIVRWYG--VESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNE 483
S + P IV++YG ++ + +++E C GS + ++ +
Sbjct: 55 SCKSPYIVKYYGAFLDESSSSIGIAMEYCE----------GGSLD----------SIYKK 94
Query: 484 VRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLIS 543
V+ R + E L K+ ++ GLS+LH +IHRD+KP N+L++
Sbjct: 95 VKKRGGRIGEKV---------------LGKIAESVLKGLSYLHSRKIIHRDIKPSNILLT 139
Query: 544 KDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCI 603
+ KL D G+S L + T G+S + APE++ + D++SLG
Sbjct: 140 RKGQ--VKLCDFGVSGEL-----VNSLAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLT 192
Query: 604 LFFCITGGKHPYGESFERDANIVKDRKDLFLVEHI-----PEAVD--------------L 644
L + + P+ E ++ L+ +I PE D
Sbjct: 193 LLE-VAQNRFPFPPEGEPPLGPIE------LLSYIVNMPNPELKDEPGNGIKWSEEFKDF 245
Query: 645 FTRLLDPNPDLRPKAQNVLNHPF 667
+ L+ +P RP ++L HP+
Sbjct: 246 IKQCLEKDPTRRPTPWDMLEHPW 268
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 1e-11
Identities = 82/307 (26%), Positives = 117/307 (38%), Gaps = 75/307 (24%)
Query: 383 EIAKGSNGTVV-LEGNYEGRSVAVKRLVKTHHDVALKEI----QNLIASDQHPNIVRWYG 437
EI G+ G V + G +AVK++ +T + K I ++ S P IV+ YG
Sbjct: 22 EIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYG 81
Query: 438 V---ESDQDFVYLSLE---RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPV 491
+SD V++ +E C L I
Sbjct: 82 YFITDSD---VFICMELMSTCLDKLLKRIQ------------------------------ 108
Query: 492 MENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI-GLIHRDLKPQNVLISKDKSFCA 550
P L K+T IV L +L E G+IHRD+KP N+L+ D S
Sbjct: 109 ------------GPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILL--DASGNV 154
Query: 551 KLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQT-----RAIDLFSLGCILF 605
KL D GIS RL + G + + APE++ RA D++SLG L
Sbjct: 155 KLCDFGISGRLVDSKA----KTRSAGCAAYMAPERIDPPDPNPKYDIRA-DVWSLGISLV 209
Query: 606 FCITGGKHPYGE---SFERDANIVKDR-KDLFLVEHI-PEAVDLFTRLLDPNPDLRPKAQ 660
T G+ PY FE I+++ L E P+ L + RPK +
Sbjct: 210 ELAT-GQFPYKNCKTEFEVLTKILQEEPPSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYR 268
Query: 661 NVLNHPF 667
+L HPF
Sbjct: 269 ELLQHPF 275
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 2e-11
Identities = 43/163 (26%), Positives = 79/163 (48%), Gaps = 10/163 (6%)
Query: 507 PSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMS 566
P Q+ + I+ GL+HLH ++HRD+K N+ + + K+ D+G++K L D +
Sbjct: 99 PEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDN--VKIGDLGVAKLL-SDNT 155
Query: 567 CLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERDANIV 626
T G+ + +PE D+++LG +L+ C T GKHP+ ++ + A I+
Sbjct: 156 NFAN--TIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCT-GKHPF-DANNQGALIL 211
Query: 627 KDRKDLFL---VEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHP 666
K + +F + + L + L + RP +L +P
Sbjct: 212 KIIRGVFPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRNP 254
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 65.8 bits (161), Expect = 2e-11
Identities = 78/325 (24%), Positives = 125/325 (38%), Gaps = 102/325 (31%)
Query: 400 GRSVAVKR-LVKTHHD----VALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTC 454
GR VA+K+ L+ D AL+EI+ ++ +HPN+V
Sbjct: 33 GRVVALKKILMHNEKDGFPITALREIK-ILKKLKHPNVVP-------------------- 71
Query: 455 SLNDLIYVLSGSFEEQLNA-------KEQD-SNLLNEVRIRLLPVMENTKDIELWKANGH 506
L D+ + + + + D S LL ++L K L
Sbjct: 72 -LIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKL--TESQIKCYML------ 122
Query: 507 PSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGI-------SK 559
QLL+ G+++LHE ++HRD+K N+LI D K++D G+
Sbjct: 123 ---QLLE-------GINYLHENHILHRDIKAANILI--DNQGILKIADFGLARPYDGPPP 170
Query: 560 RLQGDMSCLTQNATGYGSSGW-QAPEQLLQGRQ-TRAIDLFSLGCIL--FFC---ITGGK 612
+G T+ T + W + PE LL R+ T A+D++ +GC+ F I GK
Sbjct: 171 NPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGK 230
Query: 613 H--------------------------PYGE---SFERDANIVKDRKDLFLVEHIPEAVD 643
P E SF +++R + PE +D
Sbjct: 231 SDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEER----FGKLGPEGLD 286
Query: 644 LFTRLLDPNPDLRPKAQNVLNHPFF 668
L ++LL +P R A + L HP+F
Sbjct: 287 LLSKLLSLDPYKRLTASDALEHPYF 311
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 2e-11
Identities = 79/324 (24%), Positives = 122/324 (37%), Gaps = 84/324 (25%)
Query: 383 EIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHHD-----VALKEIQNLIASDQHPNIVRWY 436
+I +G+ GTV N E VA+KR+ D AL+EI L+ +H NIVR Y
Sbjct: 7 KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREI-CLLKELKHKNIVRLY 65
Query: 437 GVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTK 496
V + L E C L +G + ++ V+ +
Sbjct: 66 DVLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEI------------VKSFMF------- 106
Query: 497 DIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMG 556
QLLK GL+ H ++HRDLKPQN+LI+K+ KL+D G
Sbjct: 107 -------------QLLK-------GLAFCHSHNVLHRDLKPQNLLINKNGEL--KLADFG 144
Query: 557 ISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ--TRAIDLFSLGCILFFCITGGKHP 614
+++ + C + + W P +L G + + +ID++S GCI G+
Sbjct: 145 LARAFGIPVRCYSAEVV----TLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 200
Query: 615 Y-GESFERDANIV------------------KDRKDLFLV------EHI-----PEAVDL 644
+ G + + D K + ++ DL
Sbjct: 201 FPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDL 260
Query: 645 FTRLLDPNPDLRPKAQNVLNHPFF 668
LL NP R A+ L HP+F
Sbjct: 261 LQNLLVCNPVQRISAEEALQHPYF 284
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 2e-11
Identities = 69/297 (23%), Positives = 128/297 (43%), Gaps = 61/297 (20%)
Query: 383 EIAKGSNGTVVL-EGNYEGRSVAVKRL---VKTHHDVALKEIQNLIASD-QHPNIVRWYG 437
+I +GS G V + + GR VAVK + + ++ E+ +I D QH N+V Y
Sbjct: 28 KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEV--VIMRDYQHQNVVEMYK 85
Query: 438 VESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKD 497
+ +++ +E ++ G+ ++++++ R+
Sbjct: 86 SYLVGEELWVLME----------FLQGGAL----------TDIVSQTRLN---------- 115
Query: 498 IELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGI 557
Q+ V ++ L +LH G+IHRD+K ++L++ D KLSD G
Sbjct: 116 ----------EEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGR--VKLSDFGF 163
Query: 558 SKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY-G 616
++ D+ + + G+ W APE + + +D++SLG I+ + G+ PY
Sbjct: 164 CAQISKDVP---KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLG-IMVIEMVDGEPPYFS 219
Query: 617 ESFERDANIVKDR-----KDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 668
+S + ++D K+ + P D R+L P R AQ +L+HPF
Sbjct: 220 DSPVQAMKRLRDSPPPKLKNAHKIS--PVLRDFLERMLTREPQERATAQELLDHPFL 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 2e-11
Identities = 55/161 (34%), Positives = 85/161 (52%), Gaps = 20/161 (12%)
Query: 518 IVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGS 577
+V GL +LHE +++RDLK N+L+ + K++D G+ K M + +T G+
Sbjct: 110 VVLGLQYLHENKIVYRDLKLDNLLLDTEGFV--KIADFGLCKE---GMGFGDRTSTFCGT 164
Query: 578 SGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY-GESFER--DANIVKD--RKDL 632
+ APE L + TRA+D + LG +L + + G+ P+ G+ E D+ IV D R
Sbjct: 165 PEFLAPEVLTETSYTRAVDWWGLG-VLIYEMLVGESPFPGDDEEEVFDS-IVNDEVRYPR 222
Query: 633 FLVEHIPEAVDLFTRLLDPNPDLR----PK-AQNVLNHPFF 668
FL EA+ + RLL NP+ R K A++V PFF
Sbjct: 223 FLSR---EAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFF 260
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 3e-11
Identities = 65/256 (25%), Positives = 105/256 (41%), Gaps = 73/256 (28%)
Query: 376 KLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQNLIASD-------- 427
K + F KE+ G G VV G + G+ +DVA+K I+ S+
Sbjct: 4 KDLTFLKELGTGQFG-VVKYGKWRGQ-----------YDVAIKMIKEGSMSEDEFIEEAK 51
Query: 428 -----QHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLN 482
H +V+ YGV + Q +Y+ E Y+ +G N L
Sbjct: 52 VMMKLSHEKLVQLYGVCTKQRPIYIVTE----------YMSNGCL----------LNYLR 91
Query: 483 EVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLI 542
E R P +QLL++ +D+ G+++L IHRDL +N L+
Sbjct: 92 EHGKRFQP------------------SQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLV 133
Query: 543 SKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSS---GWQAPEQLLQGRQTRAIDLFS 599
D C K+SD G+S+ + D + + GS W PE LL + + D+++
Sbjct: 134 --DDQGCVKVSDFGLSRYVLDD-----EYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWA 186
Query: 600 LGCILFFCITGGKHPY 615
G +++ + GK PY
Sbjct: 187 FGVLMWEVYSLGKMPY 202
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 3e-11
Identities = 53/185 (28%), Positives = 86/185 (46%), Gaps = 24/185 (12%)
Query: 510 QLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLT 569
Q+ + R+I+ GL +LH IHRD+K NVL+S+ KL+D G++ +L
Sbjct: 102 QIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGE--VKLADFGVAGQLTDTQ---I 156
Query: 570 QNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDR 629
+ T G+ W APE + Q D++SLG I + G+ P+ E +
Sbjct: 157 KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLG-ITAIELAKGEPPHSE--------LHPM 207
Query: 630 KDLFLV-EHIPEAV---------DLFTRLLDPNPDLRPKAQNVLNHPFFWTADTRLSFLR 679
K LFL+ ++ P + + L+ P RP A+ +L H F + S+L
Sbjct: 208 KVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIVRFAKKTSYLT 267
Query: 680 DVSDR 684
++ DR
Sbjct: 268 ELIDR 272
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 3e-11
Identities = 53/173 (30%), Positives = 83/173 (47%), Gaps = 22/173 (12%)
Query: 521 GLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGY---GS 577
L HLH +G+I+RDLKP+N+L+ D+ KL+D G+SK + Y G+
Sbjct: 110 ALDHLHSLGIIYRDLKPENILL--DEEGHIKLTDFGLSKE------SIDHEKKAYSFCGT 161
Query: 578 SGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERDAN-IVKDRKDL--FL 634
+ APE + + T++ D +S G ++F +TG G+ + I+K + + FL
Sbjct: 162 VEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQFL 221
Query: 635 VEHIPEAVDLFTRLLDPNPDLRPKA-----QNVLNHPFFWTADTRLSFLRDVS 682
PEA L L NP R A + + HPFF T D + R++
Sbjct: 222 S---PEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFSTIDWNKLYRREIK 271
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 3e-11
Identities = 67/255 (26%), Positives = 108/255 (42%), Gaps = 52/255 (20%)
Query: 378 VVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLV--KTHHD---VALKEIQ---NLIASDQH 429
+V +E+ +G+ G V L Y K LV K D A K+ Q L+ + QH
Sbjct: 7 IVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQH 66
Query: 430 PNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLL 489
+IV++YGV D D + + E Y+ G + L A D+ +L + + R
Sbjct: 67 EHIVKFYGVCGDGDPLIMVFE----------YMKHGDLNKFLRAHGPDAMILVDGQPR-- 114
Query: 490 PVMENTKDIELWKANGHPS-AQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSF 548
+A G +Q+L + I SG+ +L +HRDL +N L+ +
Sbjct: 115 ------------QAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGAN--L 160
Query: 549 CAKLSDMGISKRLQGDMSCLTQNATGYGSSG--------WQAPEQLLQGRQTRAIDLFSL 600
K+ D G+S+ + +T Y G W PE ++ + T D++S
Sbjct: 161 LVKIGDFGMSRDVY---------STDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSF 211
Query: 601 GCILFFCITGGKHPY 615
G IL+ T GK P+
Sbjct: 212 GVILWEIFTYGKQPW 226
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 5e-11
Identities = 73/293 (24%), Positives = 121/293 (41%), Gaps = 45/293 (15%)
Query: 383 EIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEI---QNLIASDQHPNIVRWYGVE 439
E+ +G+ ++ G+ R VAVK L K D KE +L+++ HPNIV+ GV
Sbjct: 10 EVYEGTATDILGPGSGPIR-VAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVC 68
Query: 440 SDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIE 499
+ Y+ +E DL+ L + E+ LL + E
Sbjct: 69 LLNEPQYIIMELMEGG--DLLSYLRDARVERFGPP-------------LLTLKE------ 107
Query: 500 LWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFC---AKLSDMG 556
LL + D+ G +L ++ IHRDL +N L+S+ K+ D G
Sbjct: 108 -----------LLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFG 156
Query: 557 ISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY- 615
+++ + + G W APE LL G+ T D++S G +++ +T G+ PY
Sbjct: 157 LARDIYKS-DYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYP 215
Query: 616 GESFERDANIVKDRKDLFLVEHIPEAV-DLFTRLLDPNPDLRP---KAQNVLN 664
+ + V L E+ P+ + L T +P RP + Q +L
Sbjct: 216 ALNNQEVLQHVTAGGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 5e-11
Identities = 52/191 (27%), Positives = 81/191 (42%), Gaps = 33/191 (17%)
Query: 505 GHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGD 564
G P+ + + R + GL LH ++HRDLKP+N+L++ KL+D G+++
Sbjct: 104 GLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQ--VKLADFGLARIYSCQ 161
Query: 565 MSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCIL--------FFCITGGKHPYG 616
M+ T + ++APE LLQ +D++S+GCI FC G
Sbjct: 162 MALTPVVVTLW----YRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLG 217
Query: 617 ESFERDANIVKDR--KDLFLVEH-------------IPE----AVDLFTRLLDPNPDLRP 657
+ F+ +D +D+ L +PE L +L NP R
Sbjct: 218 KIFDLIGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRI 277
Query: 658 KAQNVLNHPFF 668
A L HPFF
Sbjct: 278 SAFRALQHPFF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 6e-11
Identities = 78/322 (24%), Positives = 129/322 (40%), Gaps = 93/322 (28%)
Query: 380 FNKEIAKGSNGTVVL----EGNYEGRSVAVKRLVKTH--------HDVALKEIQNLIASD 427
F + + GS G V+L ++ VA+KR K+ H + ++I N I
Sbjct: 34 FIRTLGTGSFGRVILATYKNEDFP--PVAIKRFEKSKIIKQKQVDHVFSERKILNYI--- 88
Query: 428 QHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIR 487
HP V YG D+ ++YL LE +V+ G F L ++ N
Sbjct: 89 NHPFCVNLYGSFKDESYLYLVLE----------FVIGGEFFTFLRRNKRFPN-------- 130
Query: 488 LLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKS 547
D+ + A AQ++ + +L + +++RDLKP+N+L+ KD
Sbjct: 131 ---------DVGCFYA-----AQIVLI-------FEYLQSLNIVYRDLKPENLLLDKDGF 169
Query: 548 FCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFC 607
K++D G +K + T+ T G+ + APE LL +A D ++LG ++
Sbjct: 170 I--KMTDFGFAKVVD------TRTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEI 221
Query: 608 ITGGKHPYGESFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPN--------------- 652
+ G Y + L + + I E + F + LD N
Sbjct: 222 LVGCPPFYAN------------EPLLIYQKILEGIIYFPKFLDNNCKHLMKKLLSHDLTK 269
Query: 653 --PDLRPKAQNVLNHPFFWTAD 672
+L+ AQNV HP+F D
Sbjct: 270 RYGNLKKGAQNVKEHPWFGNID 291
|
Length = 340 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 8e-11
Identities = 62/255 (24%), Positives = 103/255 (40%), Gaps = 53/255 (20%)
Query: 378 VVFNKEIAKGSNGTVVLEG------NYEGRSVAVKRLVKTHHDVALKEIQ---NLIASDQ 428
+V E+ +G+ G V L + VAVK L K + A ++ Q L+ Q
Sbjct: 7 IVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKAL-KEASESARQDFQREAELLTVLQ 65
Query: 429 HPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRL 488
H +IVR+YGV ++ + + E Y+ G L + D+ +L
Sbjct: 66 HQHIVRFYGVCTEGRPLLMVFE----------YMRHGDLNRFLRSHGPDAKILAGGE--- 112
Query: 489 LPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSF 548
+ L Q+L + I SG+ +L + +HRDL +N L+ +
Sbjct: 113 ---DVAPGQLTL--------GQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQG--L 159
Query: 549 CAKLSDMGISKRLQGDMSCLTQNATGYGSSG--------WQAPEQLLQGRQTRAIDLFSL 600
K+ D G+S+ + +T Y G W PE +L + T D++S
Sbjct: 160 VVKIGDFGMSRDIY---------STDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSF 210
Query: 601 GCILFFCITGGKHPY 615
G +L+ T GK P+
Sbjct: 211 GVVLWEIFTYGKQPW 225
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 8e-11
Identities = 64/233 (27%), Positives = 103/233 (44%), Gaps = 47/233 (20%)
Query: 384 IAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYGV-ESDQ 442
I KG G V+L G+Y G VAVK + A +++ +H N+V+ GV ++
Sbjct: 14 IGKGEFGDVML-GDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEK 72
Query: 443 DFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWK 502
+Y+ E Y+ GS L++ +R R V+
Sbjct: 73 GGLYIVTE----------YMAKGS-------------LVDYLRSRGRSVLGGDC------ 103
Query: 503 ANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQ 562
LLK + D+ + +L +HRDL +NVL+S+D AK+SD G++K
Sbjct: 104 --------LLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDN--VAKVSDFGLTKEAS 153
Query: 563 GDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY 615
TQ+ TG W APE L + + + D++S G +L+ + G+ PY
Sbjct: 154 S-----TQD-TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPY 200
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 9e-11
Identities = 44/171 (25%), Positives = 85/171 (49%), Gaps = 18/171 (10%)
Query: 507 PSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMS 566
P L ++ +V GL++L + ++HRD+KP N+L++ KL D G+S +L ++
Sbjct: 93 PEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQ--VKLCDFGVSTQLVNSIA 150
Query: 567 CLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERDANIV 626
T G++ + APE++ + D++SLG I F + G+ PY + + +++
Sbjct: 151 -----KTYVGTNAYMAPERISGEQYGIHSDVWSLG-ISFMELALGRFPYPQIQKNQGSLM 204
Query: 627 ----------KDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPF 667
+D L + + + V T+ + P RP +N+++HPF
Sbjct: 205 PLQLLQCIVDEDPPVLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPF 255
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 9e-11
Identities = 50/181 (27%), Positives = 87/181 (48%), Gaps = 19/181 (10%)
Query: 505 GHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGD 564
G + + +I GL LH +++RDLKP+N+L+ D ++SD+G++ +
Sbjct: 98 GFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILL--DDYGHIRISDLGLAVEIPEG 155
Query: 565 MSCLTQNATG-YGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP---YGESFE 620
+ G G+ G+ APE + R T + D + LGC+++ I GK P E +
Sbjct: 156 -----ETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIE-GKSPFRQRKEKVK 209
Query: 621 RDA--NIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLR-----PKAQNVLNHPFFWTADT 673
R+ VK+ ++ + + A + +LL +P R A+ V HPFF TA+
Sbjct: 210 REEVERRVKEDQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANF 269
Query: 674 R 674
+
Sbjct: 270 K 270
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 33/110 (30%), Positives = 62/110 (56%), Gaps = 2/110 (1%)
Query: 508 SAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSC 567
S QL+ + R I +G+ +L ++ +HRDL +N+L+ + + K+SD G+S+ L+ D
Sbjct: 106 SYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILV--NSNLECKVSDFGLSRVLEDDPEG 163
Query: 568 LTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGE 617
+ G W APE + + T A D++S G +++ ++ G+ PY +
Sbjct: 164 TYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWD 213
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 1e-10
Identities = 48/168 (28%), Positives = 82/168 (48%), Gaps = 24/168 (14%)
Query: 517 DIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYG 576
+IVS L +LH +++RDLK +N+++ KD K++D G+ K +S T G
Sbjct: 103 EIVSALGYLHSCDVVYRDLKLENLMLDKDGHI--KITDFGLCKE---GISDGATMKTFCG 157
Query: 577 SSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDRKDLFLVE 636
+ + APE L RA+D + LG +++ + G+ P+ + +D + +L L+E
Sbjct: 158 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMC-GRLPF---YNQDHEKL---FELILME 210
Query: 637 HI-------PEAVDLFTRLLDPNPDLR-----PKAQNVLNHPFFWTAD 672
I PEA L LL +P R A+ ++ H FF + +
Sbjct: 211 EIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASIN 258
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 1e-10
Identities = 63/269 (23%), Positives = 108/269 (40%), Gaps = 33/269 (12%)
Query: 403 VAVKRLVKTHHDVALKEIQN---LIASDQHPNIVRWYGVESDQDFVYLSLERCTCSLNDL 459
VAVK L + + Q L+A HPNIV+ GV + + L E
Sbjct: 38 VAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLLFE--------- 88
Query: 460 IYVLSGSFEEQL---NAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTR 516
Y+ G E L + + Q S + R N + + L + +
Sbjct: 89 -YMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCG--LNPLPLS--------CTEQLCIAK 137
Query: 517 DIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRL-QGDMSCLTQNATGY 575
+ +G+++L E +HRDL +N L+ ++ K++D G+S+ + D ++N
Sbjct: 138 QVAAGMAYLSERKFVHRDLATRNCLVGEN--MVVKIADFGLSRNIYSADYYKASEN--DA 193
Query: 576 GSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY-GESFERDANIVKDRKDLFL 634
W PE + R T D+++ G +L+ + G PY G + E V+D L
Sbjct: 194 IPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVIYYVRDGNVLSC 253
Query: 635 VEHIP-EAVDLFTRLLDPNPDLRPKAQNV 662
++ P E +L P RP ++
Sbjct: 254 PDNCPLELYNLMRLCWSKLPSDRPSFASI 282
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 2e-10
Identities = 51/167 (30%), Positives = 82/167 (49%), Gaps = 26/167 (15%)
Query: 517 DIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYG 576
+I+ GL LH+ G+I+RDLK NVL+ KD K++D G+ K +M+ + +T G
Sbjct: 104 EIICGLQFLHKKGIIYRDLKLDNVLLDKDGHI--KIADFGMCKE---NMNGEGKASTFCG 158
Query: 577 SSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDRKDLF--- 633
+ + APE L + ++D +S G +L+ + G +GE D +LF
Sbjct: 159 TPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGE----------DEDELFDSI 208
Query: 634 LVE--HIP-----EAVDLFTRLLDPNPDLR-PKAQNVLNHPFFWTAD 672
L + H P EA D ++L + +P R ++ HPFF D
Sbjct: 209 LNDRPHFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQHPFFRGID 255
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 2e-10
Identities = 45/164 (27%), Positives = 81/164 (49%), Gaps = 21/164 (12%)
Query: 517 DIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRL-QGDMSCLTQNATGY 575
+I+ GL LH ++RDLKP+N+L+ ++SD+G++ ++ +G+
Sbjct: 110 EILCGLEDLHRENTVYRDLKPENILLDDYGHI--RISDLGLAVKIPEGESI-----RGRV 162
Query: 576 GSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFER------DANIVKDR 629
G+ G+ APE L R T + D + LGC+++ I G+ P+ E+ D +++
Sbjct: 163 GTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIE-GQSPFRGRKEKVKREEVDRRVLET- 220
Query: 630 KDLFLVEHIPEAVDLFTRLLDPNPDLR-----PKAQNVLNHPFF 668
++++ + EA + LL +P R A V HPFF
Sbjct: 221 EEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFF 264
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 2e-10
Identities = 49/185 (26%), Positives = 87/185 (47%), Gaps = 44/185 (23%)
Query: 518 IVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGS 577
++ GL ++H G+IHRDLKP NV +++D ++ D G++++ +M TGY +
Sbjct: 127 LLRGLKYIHSAGIIHRDLKPSNVAVNEDCEL--RILDFGLARQADDEM-------TGYVA 177
Query: 578 SGW-QAPEQLLQGRQ-TRAIDLFSLGCILFFCITGGK----HPYGESFERDANIV----- 626
+ W +APE +L + +D++S+GCI+ + G + Y + +R +V
Sbjct: 178 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSP 237
Query: 627 -----------------------KDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVL 663
+D K +F + P A+DL ++L + D R A L
Sbjct: 238 EVLKKISSEHARKYIQSLPHMPQQDLKKIFRGAN-PLAIDLLEKMLVLDSDKRISASEAL 296
Query: 664 NHPFF 668
HP+F
Sbjct: 297 AHPYF 301
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 2e-10
Identities = 68/250 (27%), Positives = 100/250 (40%), Gaps = 66/250 (26%)
Query: 382 KEIAKGSNGTV-----VLEGNYEGRSVAVKRLVKTHHDVALKEIQN---LIASDQHPNIV 433
K + G+ GTV + EG VA+K L + A KEI + ++AS HP++V
Sbjct: 13 KVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVV 72
Query: 434 RWYGVESDQDFVYLSLERCTCSLNDLI--YVLSGSFEEQLNAKEQDSNLLNEVRIRLLPV 491
R G+ C S LI + G LL+ VR
Sbjct: 73 RLLGI-------------CLSSQVQLITQLMPLGC-------------LLDYVR------ 100
Query: 492 MENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAK 551
+ +I S LL I G+S+L E L+HRDL +NVL+ + K
Sbjct: 101 -NHKDNIG--------SQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQH--VK 149
Query: 552 LSDMGISKRLQGDMSCLTQNATGYGSSG------WQAPEQLLQGRQTRAIDLFSLGCILF 605
++D G++K L D Y + G W A E +L T D++S G ++
Sbjct: 150 ITDFGLAKLLDVD-------EKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVW 202
Query: 606 FCITGGKHPY 615
+T G PY
Sbjct: 203 ELMTFGAKPY 212
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 2e-10
Identities = 37/119 (31%), Positives = 66/119 (55%), Gaps = 12/119 (10%)
Query: 510 QLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLT 569
QL+ + R I +G+ +L E+ +HRDL +N+L+ + + K+SD G+S+ L+ D S
Sbjct: 107 QLVGMLRGIAAGMKYLSEMNYVHRDLAARNILV--NSNLVCKVSDFGLSRFLEDDTS--- 161
Query: 570 QNATGYGSSG------WQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERD 622
+ T S G W APE + + T A D++S G +++ ++ G+ PY + +D
Sbjct: 162 -DPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD 219
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 2e-10
Identities = 62/270 (22%), Positives = 116/270 (42%), Gaps = 50/270 (18%)
Query: 401 RSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLI 460
+ + V+++ K A E Q ++ HPNI+ +Y + + + +E
Sbjct: 31 KQIPVEQMTKDERLAAQNECQ-VLKLLSHPNIIEYYENFLEDKALMIVME---------- 79
Query: 461 YVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVS 520
Y G+ E + ++ ++LL+E I L I+
Sbjct: 80 YAPGGTLAEYIQ--KRCNSLLDEDTI-------------------------LHFFVQILL 112
Query: 521 GLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGW 580
L H+H ++HRDLK QN+L+ K K K+ D GISK L S ++ T G+ +
Sbjct: 113 ALHHVHTKLILHRDLKTQNILLDKHKMV-VKIGDFGISKIL----SSKSKAYTVVGTPCY 167
Query: 581 QAPEQLLQGRQ-TRAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDRKDLF--LVEH 637
+PE L +G+ + D+++LGC+L+ + + + A ++K F + +
Sbjct: 168 ISPE-LCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLP--ALVLKIMSGTFAPISDR 224
Query: 638 I-PEAVDLFTRLLDPNPDLRPKAQNVLNHP 666
P+ L +L+ +P RP+ ++ P
Sbjct: 225 YSPDLRQLILSMLNLDPSKRPQLSQIMAQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 2e-10
Identities = 62/246 (25%), Positives = 109/246 (44%), Gaps = 38/246 (15%)
Query: 378 VVFNKEIAKGSNGTVV---LEGNYEGRSVAVKRLVK-----THHDVALKEIQNLIASDQH 429
+ F I +G+ G V+ ++ + + A+K L + H D A E++ L H
Sbjct: 4 IKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFA-GELEVLCKLGHH 62
Query: 430 PNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLL 489
PNI+ G ++ ++Y+++E Y G NLL+ +R +
Sbjct: 63 PNIINLLGACENRGYLYIAIE----------YAPYG-------------NLLDFLRKSRV 99
Query: 490 PVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFC 549
+ E A+ S QLL+ D+ +G+ +L E IHRDL +NVL+ ++
Sbjct: 100 LETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGEN--LA 157
Query: 550 AKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCIT 609
+K++D G+S+ G+ + G W A E L T D++S G +L+ ++
Sbjct: 158 SKIADFGLSR---GE-EVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
Query: 610 GGKHPY 615
G PY
Sbjct: 214 LGGTPY 219
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 3e-10
Identities = 63/237 (26%), Positives = 102/237 (43%), Gaps = 68/237 (28%)
Query: 384 IAKGSNGTVVLEGNYEGRS------VAVKRLVKTHHD------VALKEIQNLIASDQHPN 431
I +G+ G V Y R VA+K+ V+ ++ +L+EI L+ +HPN
Sbjct: 15 IGEGTYGIV-----YRARDTTSGEIVALKK-VRMDNERDGIPISSLREITLLLNL-RHPN 67
Query: 432 IVRWYGVESDQ--DFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLL 489
IV V + D ++L +E C L L+ + F E
Sbjct: 68 IVELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPTPFSE-------------------- 107
Query: 490 PVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFC 549
+Q+ + ++ GL +LHE +IHRDLK N+L++ DK C
Sbjct: 108 -------------------SQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLT-DKG-C 146
Query: 550 AKLSDMGISKRLQGDMSCLTQNATGYGSSGW-QAPEQLLQGR-QTRAIDLFSLGCIL 604
K++D G+++ +T + W +APE LL T AID++++GCIL
Sbjct: 147 LKIADFGLARTYGLPAKPMTPKVV----TLWYRAPELLLGCTTYTTAIDMWAVGCIL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 3e-10
Identities = 49/166 (29%), Positives = 79/166 (47%), Gaps = 14/166 (8%)
Query: 509 AQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCL 568
Q+ V R+ + L LH +IHRD+K N+L+ D S KL+D G ++ + S
Sbjct: 115 GQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGS--VKLTDFGFCAQITPEQS-- 170
Query: 569 TQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY-GESFERDANIVK 627
+ +T G+ W APE + + +D++SLG I+ + G+ PY E+ R ++
Sbjct: 171 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLG-IMAIEMVEGEPPYLNENPLRALYLIA 228
Query: 628 DRKDLFLVEHIPEAV-----DLFTRLLDPNPDLRPKAQNVLNHPFF 668
L PE + D R L+ + D R A+ +L HPF
Sbjct: 229 TNGTPELQN--PERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFL 272
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 3e-10
Identities = 47/185 (25%), Positives = 85/185 (45%), Gaps = 44/185 (23%)
Query: 518 IVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGS 577
I+ GL ++H +IHRDLKP N+ +++D K+ D G+++ +M TGY +
Sbjct: 129 ILRGLKYIHSADIIHRDLKPSNLAVNEDCEL--KILDFGLARHTDDEM-------TGYVA 179
Query: 578 SGW-QAPEQLLQGRQ-TRAIDLFSLGCILFFCITGGK-HPYGESFERDANIVK------- 627
+ W +APE +L + +D++S+GCI+ +TG P + ++ I++
Sbjct: 180 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGA 239
Query: 628 ------------------------DRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVL 663
+ ++F+ + P AVDL ++L + D R A L
Sbjct: 240 ELLKKISSESARNYIQSLTQMPKMNFANVFIGAN-PLAVDLLEKMLVLDSDKRITAAQAL 298
Query: 664 NHPFF 668
H +F
Sbjct: 299 AHAYF 303
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 3e-10
Identities = 57/198 (28%), Positives = 92/198 (46%), Gaps = 46/198 (23%)
Query: 508 SAQLLKV-TRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCA-KLSDMGISKRLQGDM 565
S+ +KV I+ GL +LH G++HRD+KP N+L++ + C K+ D G+++ + D
Sbjct: 101 SSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSN---CVLKICDFGLARVEEPDE 157
Query: 566 SC-LTQN-ATGYGSSGWQAPEQLLQGRQ-TRAIDLFSLGCILFFCITGGK---------- 612
S +TQ T Y ++APE L+ R T A+D++S+GCI F + G +
Sbjct: 158 SKHMTQEVVTQY----YRAPEILMGSRHYTSAVDIWSVGCI-FAELLGRRILFQAQSPIQ 212
Query: 613 ----------HPYGESFE-----------RDANIVKDRKDLFLV--EHIPEAVDLFTRLL 649
P E+ R + L+ + + EAV L R+L
Sbjct: 213 QLDLITDLLGTPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRML 272
Query: 650 DPNPDLRPKAQNVLNHPF 667
+PD R A + L HP+
Sbjct: 273 VFDPDKRISAADALAHPY 290
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 4e-10
Identities = 57/174 (32%), Positives = 87/174 (50%), Gaps = 20/174 (11%)
Query: 517 DIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYG 576
+I+ GL H+H +++RDLKP N+L+ D+ ++SD+G L D S +A+ G
Sbjct: 105 EIILGLEHMHNRFVVYRDLKPANILL--DEHGHVRISDLG----LACDFSKKKPHAS-VG 157
Query: 577 SSGWQAPEQLLQGRQ-TRAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDRKDLFL- 634
+ G+ APE L +G + D FSLGC+LF + G P+ + +D + + DR L +
Sbjct: 158 THGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLR-GHSPFRQHKTKDKHEI-DRMTLTVN 215
Query: 635 VE----HIPEAVDLFTRLLDPNPDLR-----PKAQNVLNHPFFWTADTRLSFLR 679
VE PE L LL + R AQ V H FF D + +L+
Sbjct: 216 VELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGIDWQQVYLQ 269
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 4e-10
Identities = 46/157 (29%), Positives = 76/157 (48%), Gaps = 10/157 (6%)
Query: 517 DIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYG 576
+IVS L +LH +++RD+K +N+++ KD K++D G+ K D + + T G
Sbjct: 103 EIVSALEYLHSRDVVYRDIKLENLMLDKDGHI--KITDFGLCKEGISDGATMK---TFCG 157
Query: 577 SSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDRKDLFLVE 636
+ + APE L RA+D + LG +++ + G Y + ER ++ + F
Sbjct: 158 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRT 217
Query: 637 HIPEAVDLFTRLLDPNPDLR-----PKAQNVLNHPFF 668
PEA L LL +P R A+ V+ H FF
Sbjct: 218 LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 254
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 5e-10
Identities = 65/209 (31%), Positives = 88/209 (42%), Gaps = 56/209 (26%)
Query: 514 VTR----DIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGIS----------- 558
VTR + V + +H++G IHRD+KP N+LI + KLSD G+S
Sbjct: 102 VTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHI--KLSDFGLSTGFHKQHDSAY 159
Query: 559 --KRLQGD--------------------MSCLTQNAT--------GYGSSG---WQAPEQ 585
K LQG MS Q AT Y + G + APE
Sbjct: 160 YQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEI 219
Query: 586 LLQGRQTRAIDLFSLGCILFFCITGGKHPYGE-SFERDANIVKDRKDLFLVEHI---PEA 641
LQ + D +SLG I+F C+ G E S E I+ R+ L+ + I EA
Sbjct: 220 FLQQGYGQECDWWSLGAIMFECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEA 279
Query: 642 VDLFTRLL-DPNPDL-RPKAQNVLNHPFF 668
DL RL+ + L R A + +HPFF
Sbjct: 280 EDLIRRLITNAENRLGRGGAHEIKSHPFF 308
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 5e-10
Identities = 74/297 (24%), Positives = 122/297 (41%), Gaps = 77/297 (25%)
Query: 382 KEIAKGSNGTVVLEGNYEGR------SVAVKRLVKT-HHDVALKEIQN--LIASDQHPNI 432
+ I +G+ G V + GR VAVK +T D+ K +Q ++ HPNI
Sbjct: 1 ERIGRGNFGEV-----FSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNI 55
Query: 433 VRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNE-VRIRLLPV 491
VR GV + + +Y+ +E V G F + L E R+++
Sbjct: 56 VRLIGVCTQKQPIYIVME----------LVQGGDFL---------TFLRTEGPRLKV--- 93
Query: 492 MENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAK 551
+L+++ + +G+ +L IHRDL +N L+++ K
Sbjct: 94 -----------------KELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVL--K 134
Query: 552 LSDMGISKRLQGDMSCLTQNATG-YGSSG--------WQAPEQLLQGRQTRAIDLFSLGC 602
+SD G+S+ + G Y S+G W APE L GR + D++S G
Sbjct: 135 ISDFGMSR----------EEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGI 184
Query: 603 ILFFCITGGKHPYGE-SFERDANIVKDRKDLFLVEHIPEAV-DLFTRLLDPNPDLRP 657
+L+ + G PY S ++ ++ L E P+AV L R + +P RP
Sbjct: 185 LLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCPELCPDAVYRLMERCWEYDPGQRP 241
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 5e-10
Identities = 46/180 (25%), Positives = 77/180 (42%), Gaps = 23/180 (12%)
Query: 513 KVTRDIVSGLSHLHEI-GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQN 571
K+ +V GL++L+ + ++HRD+KP N+L++ KL D G+S L ++
Sbjct: 107 KIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQI--KLCDFGVSGELINSIA----- 159
Query: 572 ATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDRKD 631
T G+S + +PE++ G+ T D++SLG + GK P+ S D
Sbjct: 160 DTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELAL-GKFPFAFSNIDDDGQDDPMGI 218
Query: 632 LFLVEHI--------------PEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTADTRLSF 677
L L++ I + D L +P RP Q + P F A +
Sbjct: 219 LDLLQQIVQEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQALRASNV 278
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 7e-10
Identities = 79/301 (26%), Positives = 128/301 (42%), Gaps = 66/301 (21%)
Query: 382 KEIAKGSNGTVV-LEGNYEGRSVAVKRL-------VKTHHDVALKEIQNLIASDQHPNIV 433
K+I KG V +GR VA+K++ K D LKEI +L+ HPN++
Sbjct: 8 KKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQD-CLKEI-DLLKQLDHPNVI 65
Query: 434 RWYGVESDQDFVYLSLERCTCSLNDLIYVL----SGSFEEQL-NAKEQDSNLLNEVRIRL 488
++ F+ N+L VL +G + + K+Q RL
Sbjct: 66 KYLA-----SFIEN---------NELNIVLELADAGDLSRMIKHFKKQK---------RL 102
Query: 489 LPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSF 548
+P E T +WK + S L H+H ++HRD+KP NV I+
Sbjct: 103 IP--ERT----IWK-----------YFVQLCSALEHMHSKRIMHRDIKPANVFITATGVV 145
Query: 549 CAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCI 608
KL D+G+ + S T + G+ + +PE++ + D++SLGC+L+ +
Sbjct: 146 --KLGDLGLGRFFS---SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYE-M 199
Query: 609 TGGKHP-YGES---FERDANIVK-DRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVL 663
+ P YG+ + I K D L + E DL +R ++P+P+ RP VL
Sbjct: 200 AALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVL 259
Query: 664 N 664
Sbjct: 260 Q 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 7e-10
Identities = 56/217 (25%), Positives = 93/217 (42%), Gaps = 35/217 (16%)
Query: 404 AVKRLVK-----THHDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCSLND 458
A+KR+ + H D A E++ L HPNI+ G + ++YL++E
Sbjct: 38 AIKRMKEYASKDDHRDFA-GELEVLCKLGHHPNIINLLGACEHRGYLYLAIE-------- 88
Query: 459 LIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDI 518
Y G NLL+ +R + + I A+ S QLL D+
Sbjct: 89 --YAPHG-------------NLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 133
Query: 519 VSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSS 578
G+ +L + IHRDL +N+L+ ++ + AK++D G+S+ + G
Sbjct: 134 ARGMDYLSQKQFIHRDLAARNILVGEN--YVAKIADFGLSR----GQEVYVKKTMGRLPV 187
Query: 579 GWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY 615
W A E L T D++S G +L+ ++ G PY
Sbjct: 188 RWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPY 224
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 60.5 bits (146), Expect = 7e-10
Identities = 69/303 (22%), Positives = 120/303 (39%), Gaps = 67/303 (22%)
Query: 382 KEIAKGSNGTVVLEGNYEGRSVAVKRLVKTH--HDVALKEIQNLIASD-QHPNIVRWYGV 438
+ I G+ G V N +A +++K D A+ + + ++ D +H NIV ++G
Sbjct: 15 QRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGS 74
Query: 439 ESDQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKD 497
+D +++ +E C SL D IY ++G E
Sbjct: 75 YLRRDKLWICMEFCGGGSLQD-IYHVTGPLSE---------------------------- 105
Query: 498 IELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGI 557
+Q+ V+R+ + GL +LH G +HRD+K N+L++ + KL+D G+
Sbjct: 106 -----------SQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGH--VKLADFGV 152
Query: 558 SKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ-------------TRAIDLFSLGCIL 604
S ++ + + + + G+ W APE R+ AI+L L +
Sbjct: 153 SAQIT---ATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPM 209
Query: 605 FFCITGGKHPYGESFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 664
F HP F + + K ++ L NP RP A+ +L
Sbjct: 210 F-----DLHPMRALFLMTKSNFQPPKLKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264
Query: 665 HPF 667
HPF
Sbjct: 265 HPF 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 8e-10
Identities = 65/242 (26%), Positives = 104/242 (42%), Gaps = 48/242 (19%)
Query: 376 KLVVFNKEIAKGSNGTVVLEGNYEG-RSVAVKRLVK-THHDVALKEIQNLIASDQHPNIV 433
KLV K++ G G V + G Y G VA+K L + + A NL+ QHP +V
Sbjct: 9 KLV---KKLGAGQFGEVWM-GYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLV 64
Query: 434 RWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVME 493
R Y V + Q+ +Y+ E Y+ +GS + L E
Sbjct: 65 RLYAVVT-QEPIYIITE----------YMENGSLVDFLKTPE------------------ 95
Query: 494 NTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLS 553
+ + K L+ + I G++ + IHRDL+ N+L+S ++ C K++
Sbjct: 96 -GIKLTINK--------LIDMAAQIAEGMAFIERKNYIHRDLRAANILVS--ETLCCKIA 144
Query: 554 DMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKH 613
D G++ RL D + + W APE + G T D++S G +L +T G+
Sbjct: 145 DFGLA-RLIEDNEYTAREGAKFPIK-WTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRI 202
Query: 614 PY 615
PY
Sbjct: 203 PY 204
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 8e-10
Identities = 48/176 (27%), Positives = 88/176 (50%), Gaps = 15/176 (8%)
Query: 498 IELWKANGH--PSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDM 555
+E K G Q+ + ++ G+ ++H+ ++HRDLK +N+ + + K+ D
Sbjct: 93 LEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKNN---LLKIGDF 149
Query: 556 GISKRLQGDMSCLTQNATGYGSSGWQAPEQLL-QGRQTRAIDLFSLGCILF-FCITGGKH 613
G+S+ L G T T G+ + +PE L QG +++ D++SLGCIL+ C H
Sbjct: 150 GVSRLLMGSCDLAT---TFTGTPYYMSPEALKHQGYDSKS-DIWSLGCILYEMCCL--AH 203
Query: 614 PY-GESFERDANIVKDRKDLFLVEHIPEAVD-LFTRLLDPNPDLRPKAQNVLNHPF 667
+ G++F + + L E ++ + +L+ +P LRP A +L +PF
Sbjct: 204 AFEGQNFLSVVLRIVEGPTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPF 259
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 60.5 bits (146), Expect = 8e-10
Identities = 50/166 (30%), Positives = 80/166 (48%), Gaps = 14/166 (8%)
Query: 509 AQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCL 568
AQ+ V R+ + L LH +IHRD+K NVL+ D S KL+D G ++ + S
Sbjct: 115 AQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGS--VKLTDFGFCAQITPEQS-- 170
Query: 569 TQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY-GESFERDANIVK 627
+ +T G+ W APE + + +D++SLG I+ + G+ PY E+ R ++
Sbjct: 171 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLG-IMAIEMVEGEPPYLNENPLRALYLIA 228
Query: 628 DRKDLFLVEHIPEAV-----DLFTRLLDPNPDLRPKAQNVLNHPFF 668
L PE + D R L+ + + R A+ +L HPF
Sbjct: 229 TNGTPELQN--PEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFL 272
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 8e-10
Identities = 46/167 (27%), Positives = 81/167 (48%), Gaps = 11/167 (6%)
Query: 510 QLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLT 569
+++++ +I G+++L+ +HRDL +N +++ D F K+ D G+++ + +
Sbjct: 120 EMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHD--FTVKIGDFGMTRDIY-ETDYYR 176
Query: 570 QNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY-GESFERDANIVKD 628
+ G W APE L G T + D++S G +L+ + + PY G S E+ V D
Sbjct: 177 KGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMD 236
Query: 629 RKDLFLVEHIPEAV-DLFTRLLDPNPDLRPKAQNVLN------HPFF 668
L ++ PE V DL NP +RP ++N HP F
Sbjct: 237 GGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSF 283
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 9e-10
Identities = 32/99 (32%), Positives = 60/99 (60%), Gaps = 8/99 (8%)
Query: 514 VTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNAT 573
+ R+++ L ++H++G+IHRD+K N+L++ + KL D G++ L + S + +T
Sbjct: 106 IIREVLVALKYIHKVGVIHRDIKAANILVTNTGN--VKLCDFGVAALLNQNSS---KRST 160
Query: 574 GYGSSGWQAPEQLLQGRQ--TRAIDLFSLGCILFFCITG 610
G+ W APE + +G+ T+A D++SLG ++ TG
Sbjct: 161 FVGTPYWMAPEVITEGKYYDTKA-DIWSLGITIYEMATG 198
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 9e-10
Identities = 66/240 (27%), Positives = 106/240 (44%), Gaps = 46/240 (19%)
Query: 403 VAVKRL----VKTHHDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCSLND 458
VAVK L KT + LKEI+ +++ ++PNI+R GV D + + E
Sbjct: 47 VAVKMLRADVTKTARNDFLKEIK-IMSRLKNPNIIRLLGVCVSDDPLCMITE-------- 97
Query: 459 LIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPS---AQLLKVT 515
Y+ +G + L+ +E +S AN PS A LL +
Sbjct: 98 --YMENGDLNQFLSQREIESTFT--------------------HANNIPSVSIANLLYMA 135
Query: 516 RDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRL-QGDMSCLTQNATG 574
I SG+ +L + +HRDL +N L+ + K++D G+S+ L GD + A
Sbjct: 136 VQIASGMKYLASLNFVHRDLATRNCLV--GNHYTIKIADFGMSRNLYSGDYYRIQGRAV- 192
Query: 575 YGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGK-HPYGESFERDANIVKDRKDLF 633
W A E +L G+ T A D+++ G L+ T K PY S D ++++ + F
Sbjct: 193 -LPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPY--SLLSDEQVIENTGEFF 249
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 9e-10
Identities = 46/167 (27%), Positives = 78/167 (46%), Gaps = 12/167 (7%)
Query: 510 QLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLT 569
Q+ V ++ LS LH G+IHRD+K ++L++ D KLSD G ++ ++
Sbjct: 117 QIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGR--VKLSDFGFCAQVSKEVP--- 171
Query: 570 QNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDR 629
+ + G+ W APE + + +D++SLG ++ + G + E + +++D
Sbjct: 172 RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDN 231
Query: 630 -----KDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTA 671
K+L V P RLL +P R A +L HPF A
Sbjct: 232 LPPKLKNLHKVS--PSLKGFLDRLLVRDPAQRATAAELLKHPFLAKA 276
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 9e-10
Identities = 72/298 (24%), Positives = 122/298 (40%), Gaps = 58/298 (19%)
Query: 383 EIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALK----EIQNLIASDQHPNIVRWYGV 438
E+ G+ G V N E ++A ++++T + L+ EI+ ++A+ HP IV+ G
Sbjct: 19 ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIE-ILATCNHPYIVKLLGA 77
Query: 439 ESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDI 498
+++ +E C D I + E D L E +I++
Sbjct: 78 FYWDGKLWIMIEFCPGGAVDAIML------------ELDRGL-TEPQIQV---------- 114
Query: 499 ELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGIS 558
+ R ++ L +LH + +IHRDLK NVL++ D KL+D G+S
Sbjct: 115 ---------------ICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDI--KLADFGVS 157
Query: 559 KRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRA-----IDLFSLGCILFFCITGGKH 613
+ ++ L + + G+ W APE ++ D++SLG I + +
Sbjct: 158 AK---NVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLG-ITLIEMAQIEP 213
Query: 614 PYGE--SFERDANIVKDRKDLFLV--EHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPF 667
P+ E I K + E D LD +P+ RP A +L HPF
Sbjct: 214 PHHELNPMRVLLKIAKSEPPTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPF 271
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 1e-09
Identities = 56/233 (24%), Positives = 98/233 (42%), Gaps = 59/233 (25%)
Query: 393 VLEGNYEGRS-VAVKRL---VKTHHDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLS 448
V EG ++ R VA+K L KE+Q L +H +++ + V
Sbjct: 22 VWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQAL-KRLRHKHLISLFAV---------- 70
Query: 449 LERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPS 508
CS+ + +Y+++ +L K L ++LPV
Sbjct: 71 -----CSVGEPVYIIT-----ELMEKGSLLAFLRSPEGQVLPV----------------- 103
Query: 509 AQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCL 568
A L+ + + G+++L E IHRDL +N+L+ +D K++D G+++ ++ D+
Sbjct: 104 ASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGED--LVCKVADFGLARLIKEDV--- 158
Query: 569 TQNATGYGSSG------WQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY 615
Y SS W APE G + D++S G +L+ T G+ PY
Sbjct: 159 ------YLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPY 205
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 1e-09
Identities = 52/194 (26%), Positives = 79/194 (40%), Gaps = 44/194 (22%)
Query: 513 KVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMG----ISKRLQGDMSCL 568
KV + +++GL ++H ++HRD+K N+LI+KD KL+D G S +
Sbjct: 123 KVMKMLLNGLYYIHRNKILHRDMKAANILITKDGIL--KLADFGLARAFSLSKNSKPNRY 180
Query: 569 TQN-ATGYGSSGWQAPEQLLQGRQ-TRAIDLFSLGCIL---------------------- 604
T T + ++ PE LL R ID++ GCI+
Sbjct: 181 TNRVVTLW----YRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLI 236
Query: 605 -FFC--ITGGKHPYGESFERDANIV-----KDRKDLFLVEHI--PEAVDLFTRLLDPNPD 654
C IT P + E + K + L ++ P A+DL +LL +P
Sbjct: 237 SQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPA 296
Query: 655 LRPKAQNVLNHPFF 668
R A LNH FF
Sbjct: 297 KRIDADTALNHDFF 310
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 1e-09
Identities = 50/194 (25%), Positives = 77/194 (39%), Gaps = 44/194 (22%)
Query: 516 RDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDM---------- 565
I++GL+ LH+ +HRDL P N+ I+ K C K++D G+++R
Sbjct: 126 LQILNGLNVLHKWYFMHRDLSPANIFIN-SKGIC-KIADFGLARRYGYPPYSDTLSKDET 183
Query: 566 SCLTQNATGYGSSGWQAPEQLLQG--RQTRAIDLFSLGCILFFCITGGKHPYGES----- 618
+ T + W +LL G + A+D++S+GCI +TG GE+
Sbjct: 184 MQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQL 243
Query: 619 ------------------------FERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPD 654
E KD K +F +A+DL LL NP
Sbjct: 244 GRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNAS-DDAIDLLQSLLKLNPL 302
Query: 655 LRPKAQNVLNHPFF 668
R A+ L H +F
Sbjct: 303 ERISAKEALKHEYF 316
|
Length = 335 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 1e-09
Identities = 49/169 (28%), Positives = 80/169 (47%), Gaps = 14/169 (8%)
Query: 509 AQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCL 568
Q+ V R+ + L LH +IHRD+K N+L+ D S KL+D G ++ + S
Sbjct: 115 GQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGS--VKLTDFGFCAQITPEQS-- 170
Query: 569 TQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY-GESFERDANIVK 627
+ +T G+ W APE + + +D++SLG I+ + G+ PY E+ R ++
Sbjct: 171 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLG-IMAIEMVEGEPPYLNENPLRALYLIA 228
Query: 628 DRKDLFLVEHIPEAV-----DLFTRLLDPNPDLRPKAQNVLNHPFFWTA 671
L PE + D R L+ + + R A+ +L HPF A
Sbjct: 229 TNGTPELQN--PEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIA 275
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 1e-09
Identities = 41/150 (27%), Positives = 73/150 (48%), Gaps = 6/150 (4%)
Query: 510 QLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLT 569
QL+ + I G++++ + IHRDL+ N+L+ + K++D G+++ ++ +
Sbjct: 103 QLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDN--LVCKIADFGLARLIEDNEYTAR 160
Query: 570 QNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDR 629
Q A W APE L GR T D++S G +L +T G+ PY R+ +R
Sbjct: 161 QGAKF--PIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVER 218
Query: 630 K-DLFLVEHIPEAV-DLFTRLLDPNPDLRP 657
+ + PE++ +L +PD RP
Sbjct: 219 GYRMPCPQGCPESLHELMKLCWKKDPDERP 248
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 2e-09
Identities = 54/204 (26%), Positives = 88/204 (43%), Gaps = 30/204 (14%)
Query: 412 HHDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQL 471
H D A E++ L HPNI+ G + ++YL++E Y G
Sbjct: 39 HRDFA-GELEVLCKLGHHPNIINLLGACEHRGYLYLAIE----------YAPHG------ 81
Query: 472 NAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLI 531
NLL+ +R + + I A+ S QLL D+ G+ +L + I
Sbjct: 82 -------NLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFI 134
Query: 532 HRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ 591
HRDL +N+L+ ++ + AK++D G+S+ G + G W A E L
Sbjct: 135 HRDLAARNILVGEN--YVAKIADFGLSR---GQ-EVYVKKTMGRLPVRWMAIESLNYSVY 188
Query: 592 TRAIDLFSLGCILFFCITGGKHPY 615
T D++S G +L+ ++ G PY
Sbjct: 189 TTNSDVWSYGVLLWEIVSLGGTPY 212
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 2e-09
Identities = 81/346 (23%), Positives = 134/346 (38%), Gaps = 88/346 (25%)
Query: 383 EIAKGSNGTVVLEGN-YEGRSVAVKRLV----KTH---HDVALKEIQNLIASDQHPNIVR 434
EI GS G V N + VAVK++ +T+ D+ +KE++ + +HPN +
Sbjct: 28 EIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDI-IKEVK-FLQQLKHPNTIE 85
Query: 435 WYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMEN 494
+ G + +L +E C S +DL+ V +E
Sbjct: 86 YKGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQE------------------------- 120
Query: 495 TKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSD 554
++ +T + GL++LH +IHRD+K N+L+++ KL+D
Sbjct: 121 --------------VEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQ--VKLAD 164
Query: 555 MGISKRLQGDMSCLTQNATGYGSSGWQAPEQLL---QGRQTRAIDLFSLGCILFFCITGG 611
G S + + G+ W APE +L +G+ +D++SLG CI
Sbjct: 165 F-------GSASKSSPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT---CI--- 211
Query: 612 KHPYGESFERDANIVKDRKDLFLVEHIP----------EAVDLFTRLLD----PNPDLRP 657
E ER + + + + HI E D F +D P RP
Sbjct: 212 -----ELAERKPPLF-NMNAMSALYHIAQNDSPTLQSNEWTDSFRGFVDYCLQKIPQERP 265
Query: 658 KAQNVLNHPFFWTADTRLSFLRDVSDRVELEDRESDSKLLRALEGI 703
+ +L H F D L D+ R + RE D+ R ++ I
Sbjct: 266 ASAELLRHDFVRR-DRPARVLIDLIQRTKDAVRELDNLQYRKMKKI 310
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 2e-09
Identities = 59/198 (29%), Positives = 86/198 (43%), Gaps = 54/198 (27%)
Query: 510 QLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCA-KLSDMGISKRLQGDMSCL 568
QLL+ L ++H + HRDLKP+N+L + D C K+ D G+++ D
Sbjct: 111 QLLR-------ALKYIHTANVFHRDLKPKNILANAD---CKLKICDFGLARVAFND---- 156
Query: 569 TQNA---TGYGSSGW-QAPEQL--LQGRQTRAIDLFSLGCILFFCITG-----GKH---- 613
T A T Y ++ W +APE + T AID++S+GCI +TG GK+
Sbjct: 157 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQ 216
Query: 614 ----------PYGESFERDANIVKDRKDLFLVEHI-------------PEAVDLFTRLLD 650
P E+ R N K R+ L + P A+ L RLL
Sbjct: 217 LDLITDLLGTPSPETISRVRN-EKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLA 275
Query: 651 PNPDLRPKAQNVLNHPFF 668
+P RP A+ L P+F
Sbjct: 276 FDPKDRPTAEEALADPYF 293
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 2e-09
Identities = 73/308 (23%), Positives = 120/308 (38%), Gaps = 66/308 (21%)
Query: 382 KEIAKGSNGTVVL-----EGNYEGRSVAVKRL---VKTHHDVALKEIQNLIASDQHPNIV 433
+++ +G G V L EG+ G VAVK L +H LK+ ++ + H NIV
Sbjct: 10 RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 69
Query: 434 RWYGV--ESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPV 491
++ G+ E + + L +E ++ SGS +E L + NL
Sbjct: 70 KYKGICTEDGGNGIKLIME----------FLPSGSLKEYLPRNKNKINL----------- 108
Query: 492 MENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAK 551
Q LK I G+ +L +HRDL +NVL+ + K
Sbjct: 109 -----------------KQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQ--VK 149
Query: 552 LSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCIT-- 609
+ D G++K ++ D T W APE L+Q + A D++S G L+ +T
Sbjct: 150 IGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYC 209
Query: 610 -GGKHPYGE------------SFERDANIVKDRKDLFLVEHIPEAVD-LFTRLLDPNPDL 655
P + R ++++ K L + PE V L + + P
Sbjct: 210 DSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSK 269
Query: 656 RPKAQNVL 663
R QN++
Sbjct: 270 RTTFQNLI 277
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 2e-09
Identities = 63/250 (25%), Positives = 104/250 (41%), Gaps = 38/250 (15%)
Query: 378 VVFNKEIAKGSNGTVVLEGNY--------EGRSVAVKRLVK--THHDVA--LKEIQNLIA 425
+V K + +G G VV Y + +VAVK L T D+A + E++ +
Sbjct: 14 LVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKL 73
Query: 426 SDQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVR 485
+H NI+ GV + + +Y+ +E Y G+ E L R
Sbjct: 74 IGKHKNIINLLGVCTQEGPLYVIVE----------YAAKGNLREFL-------------R 110
Query: 486 IRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKD 545
R P + T DI L+ + G+ +L IHRDL +NVL+++D
Sbjct: 111 ARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTED 170
Query: 546 KSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILF 605
K++D G+++ + D+ + + G W APE L T D++S G +++
Sbjct: 171 NVM--KIADFGLARGVH-DIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMW 227
Query: 606 FCITGGKHPY 615
T G PY
Sbjct: 228 EIFTLGGSPY 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 2e-09
Identities = 70/329 (21%), Positives = 127/329 (38%), Gaps = 85/329 (25%)
Query: 378 VVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVK-THHDVALKEIQNLIASDQHPNIVRWY 436
+ +EI G G V L E R VA+K + + + E ++ HP +V+ Y
Sbjct: 6 LTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLY 65
Query: 437 GVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTK 496
GV +++ + L E ++ G + L A+
Sbjct: 66 GVCTERSPICLVFE----------FMEHGCLSDYLRAQR--------------------- 94
Query: 497 DIELWKANGHPSAQ-LLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDM 555
G S + LL + D+ G+++L +IHRDL +N L+ +++ K+SD
Sbjct: 95 --------GKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQ--VVKVSDF 144
Query: 556 GISKRLQGDMSCLTQNATGYGSS---GWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGK 612
G+++ + D Q + G+ W +PE + + D++S G +++ + GK
Sbjct: 145 GMTRFVLDD-----QYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGK 199
Query: 613 HPYGESFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKA-QNVLNHPFFWTA 671
PY ++R + +VE I L+ P L ++ ++ H +
Sbjct: 200 TPY-----------ENRSNSEVVETINAGFRLY------KPRLASQSVYELMQHCW---- 238
Query: 672 DTRLSFLRDVSDRVELEDRESDSKLLRAL 700
+ EDR S S LL L
Sbjct: 239 ------------KERPEDRPSFSLLLHQL 255
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 3e-09
Identities = 49/161 (30%), Positives = 77/161 (47%), Gaps = 17/161 (10%)
Query: 517 DIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGY- 575
++V L HLH+ +++RDLKP+N+L+ L D G+SK + LT N T
Sbjct: 104 ELVLALEHLHKYDIVYRDLKPENILLDATGHIA--LCDFGLSK------ANLTDNKTTNT 155
Query: 576 --GSSGWQAPEQLLQGR-QTRAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDRKDL 632
G++ + APE LL + T+ +D +SLG ++F G Y E ++ + K
Sbjct: 156 FCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVR 215
Query: 633 FLVEHIPEAVDLFTR-LLDPNPDLR----PKAQNVLNHPFF 668
F + + F + LL+ NP R A + HPFF
Sbjct: 216 FPKNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFF 256
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 3e-09
Identities = 52/166 (31%), Positives = 82/166 (49%), Gaps = 22/166 (13%)
Query: 517 DIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKR-LQGDMSCLTQNATGY 575
+IV GL LH G+I+RDLK NV++ +D K++D G+ K + GD + +T
Sbjct: 104 EIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHI--KIADFGMCKENVFGD----NRASTFC 157
Query: 576 GSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDRKDLFLV 635
G+ + APE L + T ++D +S G +L+ + G +G+ + D R D
Sbjct: 158 GTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGD--DEDELFESIRVD---T 212
Query: 636 EHIP-----EAVDLFTRLLDPNPDLRPKAQ-NVLNHPFF----WTA 671
H P E+ D+ +L + +P R N+ HPFF WTA
Sbjct: 213 PHYPRWITKESKDILEKLFERDPTRRLGVVGNIRGHPFFKTINWTA 258
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 3e-09
Identities = 77/333 (23%), Positives = 123/333 (36%), Gaps = 88/333 (26%)
Query: 373 RIGKLVVFN------------KEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEI 420
GK ++F+ + I KG+ G V N + S A +++ HD+ +EI
Sbjct: 3 LSGKTIIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDID-EEI 61
Query: 421 QN----LIASDQHPNIVRWYGVESDQDFV-----YLSLERCTCSLNDLIYVLSGSFEEQL 471
+ L A HPN+V++YG+ +D +L LE C GS + +
Sbjct: 62 EAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCN----------GGSVTDLV 111
Query: 472 NAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLI 531
+ + E I + + + GL HLH I
Sbjct: 112 KGFLKRGERMEEPIIAY-------------------------ILHEALMGLQHLHVNKTI 146
Query: 532 HRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAP-----EQL 586
HRD+K N+L++ + KL D G+S +L S + T G+ W AP EQ
Sbjct: 147 HRDVKGNNILLTTEGG--VKLVDFGVSAQL---TSTRLRRNTSVGTPFWMAPEVIACEQQ 201
Query: 587 LQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDRKDLFLVEHIP------- 639
L D++SLG I + G P + + + LF + P
Sbjct: 202 LDSTYDARCDVWSLG-ITAIELGDGDPPLAD--------LHPMRALFKIPRNPPPTLHQP 252
Query: 640 -----EAVDLFTRLLDPNPDLRPKAQNVLNHPF 667
E D + L + + RP ++L H F
Sbjct: 253 ELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVF 285
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 3e-09
Identities = 46/165 (27%), Positives = 78/165 (47%), Gaps = 14/165 (8%)
Query: 510 QLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLT 569
Q+ V ++ LS+LH G+IHRD+K ++L++ D KLSD G ++ ++
Sbjct: 119 QIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRI--KLSDFGFCAQVSKEVP--- 173
Query: 570 QNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDR 629
+ + G+ W APE + + +D++SLG ++ I G + E + ++D
Sbjct: 174 KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDN 233
Query: 630 -----KDLFLVEHIPEA-VDLFTRLLDPNPDLRPKAQNVLNHPFF 668
KD V + +DL +L P R AQ +L HPF
Sbjct: 234 LPPRVKDSHKVSSVLRGFLDL---MLVREPSQRATAQELLQHPFL 275
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 3e-09
Identities = 49/183 (26%), Positives = 81/183 (44%), Gaps = 42/183 (22%)
Query: 518 IVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGS 577
I+ GL ++H G++HRDLKP N+LI+++ K+ D G+++ M TGY S
Sbjct: 117 ILRGLKYVHSAGVVHRDLKPSNILINENCDL--KICDFGLARIQDPQM-------TGYVS 167
Query: 578 SG-WQAPEQLLQGRQ-TRAIDLFSLGCILFFCITG-----GKHPYGE------------- 617
+ ++APE +L ++ +D++S GCI + G GK +
Sbjct: 168 TRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPD 227
Query: 618 ------SFERDANIVKD---RKDLFLVEHI----PEAVDLFTRLLDPNPDLRPKAQNVLN 664
E V+ R+ + E P A+DL ++L +P R A L
Sbjct: 228 DVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALA 287
Query: 665 HPF 667
HP+
Sbjct: 288 HPY 290
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 4e-09
Identities = 82/332 (24%), Positives = 139/332 (41%), Gaps = 97/332 (29%)
Query: 382 KEIAKGSNGTVVLEGNYEGR------SVAVKRLVKTHHD-----VALKEIQNLIASDQHP 430
++I +G+ G V Y+ R ++A+K++ D A++EI +L+ QH
Sbjct: 8 EKIGEGTYGVV-----YKARDRVTNETIALKKIRLEQEDEGVPSTAIREI-SLLKEMQHG 61
Query: 431 NIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLP 490
NIVR V + +YL E Y+ L+ K+
Sbjct: 62 NIVRLQDVVHSEKRLYLVFE----------YL-------DLDLKKH-------------- 90
Query: 491 VMENTKDIELWKANGHPSAQLLKV-TRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFC 549
M+++ D A +L+K I+ G+++ H ++HRDLKPQN+LI + +
Sbjct: 91 -MDSSPDF----AKNP---RLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTN-A 141
Query: 550 AKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ-TRAIDLFSLGCI----- 603
KL+D G+++ + T + ++APE LL R + +D++S+GCI
Sbjct: 142 LKLADFGLARAFGIPVRTFTHEVV---TLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMV 198
Query: 604 ----LF------------FCITGGKHPYGESFERDANIVKDRKDLF----------LVEH 637
LF F I G P E++ + D K F +V
Sbjct: 199 NQKPLFPGDSEIDELFKIFRILGT--PNEETW-PGVTSLPDYKSAFPKWPPKDLATVVPT 255
Query: 638 I-PEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 668
+ P VDL +++L +P R A+ L H +F
Sbjct: 256 LEPAGVDLLSKMLRLDPSKRITARAALEHEYF 287
|
Length = 294 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 4e-09
Identities = 63/261 (24%), Positives = 101/261 (38%), Gaps = 40/261 (15%)
Query: 403 VAVKRLVKTHHDVALKEIQ---NLIASDQHPNIVRWYGVESDQDFVYLSLERCTCSLNDL 459
V VK L KT + E + ++ H N+VR G+ + + Y+ LE
Sbjct: 38 VLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILE--------- 88
Query: 460 IYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIV 519
Y G ++ L A E K + Q + + I
Sbjct: 89 -YTDLGDLKQFLRA--------------------TKSKDEKLKPPPLSTKQKVALCTQIA 127
Query: 520 SGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSG 579
G+ HL +HRDL +N L+S K+S + +SK + +NA
Sbjct: 128 LGMDHLSNARFVHRDLAARNCLVSSQ--REVKVSLLSLSKDVYNSEYYKLRNA--LIPLR 183
Query: 580 WQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGE-SFERDANIVKDRK-DLFLVEH 637
W APE + + + D++S G +++ T G+ P+ S E N ++ K +L + E
Sbjct: 184 WLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELPVPEG 243
Query: 638 IPEAV-DLFTRLLDPNPDLRP 657
P + L TR NP RP
Sbjct: 244 CPSRLYKLMTRCWAVNPKDRP 264
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 4e-09
Identities = 60/250 (24%), Positives = 103/250 (41%), Gaps = 38/250 (15%)
Query: 378 VVFNKEIAKGSNGTVVL--------EGNYEGRSVAVKRLVK--THHDVA--LKEIQNLIA 425
+ K + +G G VV+ + E +VAVK L T D++ + E++ +
Sbjct: 17 LTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKM 76
Query: 426 SDQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVR 485
+H NI+ G + +Y+ +E Y G+ E L R
Sbjct: 77 IGKHKNIINLLGACTQDGPLYVIVE----------YASKGNLREYL-------------R 113
Query: 486 IRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKD 545
R P ME + DI L+ T + G+ +L IHRDL +NVL++++
Sbjct: 114 ARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTEN 173
Query: 546 KSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILF 605
K++D G+++ + ++ + G W APE L T D++S G +++
Sbjct: 174 NVM--KIADFGLARDVN-NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMW 230
Query: 606 FCITGGKHPY 615
T G PY
Sbjct: 231 EIFTLGGSPY 240
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 57.8 bits (139), Expect = 5e-09
Identities = 32/106 (30%), Positives = 57/106 (53%), Gaps = 4/106 (3%)
Query: 510 QLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLT 569
QL+ + I SG++++ + +HRDL+ N+L+ ++ K++D G+++ ++ +
Sbjct: 103 QLVDMAAQIASGMAYVERMNYVHRDLRAANILVGEN--LVCKVADFGLARLIEDNEYTAR 160
Query: 570 QNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY 615
Q A W APE L GR T D++S G +L T G+ PY
Sbjct: 161 QGAKF--PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY 204
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 5e-09
Identities = 60/229 (26%), Positives = 99/229 (43%), Gaps = 49/229 (21%)
Query: 382 KEIAKGSNGTVVLE-GNYEGRSVAVKRLVK-----THHDVALKEIQNLIASDQHPNIVRW 435
K I G+ G V G +VAVK+L + TH A +E+ L+ H NI+
Sbjct: 27 KPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELV-LLKCVNHKNIISL 85
Query: 436 YGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENT 495
V + Q SLE D+ V+ + D+NL + + L
Sbjct: 86 LNVFTPQK----SLEE----FQDVYLVM----------ELMDANLCQVIHMEL------- 120
Query: 496 KDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDM 555
D E ++ + ++ G+ HLH G+IHRDLKP N+++ D + K+ D
Sbjct: 121 -DHE----------RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTL--KILDF 167
Query: 556 GISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCIL 604
G+++ + T Y ++APE +L +D++S+GCI+
Sbjct: 168 GLARTACTNFMMTPYVVTRY----YRAPEVILGMGYKENVDIWSVGCIM 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 5e-09
Identities = 54/186 (29%), Positives = 77/186 (41%), Gaps = 44/186 (23%)
Query: 515 TRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATG 574
T ++V L +H +G IHRD+KP N+L+ DKS KL+D G ++ D + + + T
Sbjct: 148 TAEVVLALDAIHSMGFIHRDVKPDNMLL--DKSGHLKLADFGTCMKM--DANGMVRCDTA 203
Query: 575 YGSSGWQAPEQLLQGRQT----RAIDLFSLGCILFFCITGGKHPYGES------------ 618
G+ + +PE L R D +S+G L+ + G Y +S
Sbjct: 204 VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHK 263
Query: 619 ----FERDANIVKDRKDL---FLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFF--- 668
F D I K KDL FL D RL R + +HPFF
Sbjct: 264 NSLTFPDDIEISKQAKDLICAFL-------TDREVRL------GRNGVDEIKSHPFFKND 310
Query: 669 -WTADT 673
WT D
Sbjct: 311 QWTFDN 316
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 5e-09
Identities = 58/244 (23%), Positives = 92/244 (37%), Gaps = 53/244 (21%)
Query: 382 KEIAKGSNGTVVLEG---NYEGR--SVAVK-----RLVKTHHDVALKEIQNLIASDQHPN 431
K++ GS G VV G G+ VAVK +L D LKE ++ S H N
Sbjct: 1 KKLGDGSFG-VVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDF-LKEA-AIMHSLDHEN 57
Query: 432 IVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPV 491
++R YGV + ++ E GS ++L + + L+
Sbjct: 58 LIRLYGVVLTHPLMMVT-ELAPL----------GSLLDRLR--------KDALGHFLIST 98
Query: 492 MENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAK 551
L + Q I +G+ +L IHRDL +N+L++ D K
Sbjct: 99 --------LC----DYAVQ-------IANGMRYLESKRFIHRDLAARNILLASDDK--VK 137
Query: 552 LSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGG 611
+ D G+ + L + W APE L + A D++ G L+ T G
Sbjct: 138 IGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYG 197
Query: 612 KHPY 615
+ P+
Sbjct: 198 EEPW 201
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 57.8 bits (139), Expect = 6e-09
Identities = 53/182 (29%), Positives = 80/182 (43%), Gaps = 30/182 (16%)
Query: 502 KANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRL 561
K N + + R+I+ GLSHLH+ +IHRD+K QNVL++++ KL D G+S +L
Sbjct: 104 KGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAE--VKLVDFGVSAQL 161
Query: 562 QGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAI-----DLFSLGCILFFCITGGKHPYG 616
D + +N T G+ W APE + A DL+SLG I + G P
Sbjct: 162 --DRTVGRRN-TFIGTPYWMAPEVIACDENPDATYDFKSDLWSLG-ITAIEMAEGAPPLC 217
Query: 617 ESFERDANIVKDRKDLFLVEHIP-----------EAVDLFTRLLDPNPDLRPKAQNVLNH 665
+ + + LFL+ P + L N RP + ++ H
Sbjct: 218 D--------MHPMRALFLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKH 269
Query: 666 PF 667
PF
Sbjct: 270 PF 271
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 6e-09
Identities = 47/186 (25%), Positives = 78/186 (41%), Gaps = 41/186 (22%)
Query: 516 RDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGY 575
+ ++ GL++ H+ +HRD+K N+L++ KL+D G+++ + S N
Sbjct: 123 KQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQI--KLADFGLARLYNSEESRPYTNKV-- 178
Query: 576 GSSGWQAPEQLLQG--RQTRAIDLFSLGCIL--FFC-------------------ITGG- 611
+ W P +LL G R AID++S GCIL F + G
Sbjct: 179 -ITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSP 237
Query: 612 ---------KHPYGESFERDANIVKDRKDLFLVEHIP-EAVDLFTRLLDPNPDLRPKAQN 661
K PY + + + ++ F IP A+DL +L +P R A+
Sbjct: 238 CPAVWPDVIKLPYFNTMKPKKQYRRRLREEF--SFIPTPALDLLDHMLTLDPSKRCTAEE 295
Query: 662 VLNHPF 667
LN P+
Sbjct: 296 ALNSPW 301
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 6e-09
Identities = 63/284 (22%), Positives = 110/284 (38%), Gaps = 59/284 (20%)
Query: 400 GRSVAVKRLVKTHHDVALKEIQNLIASDQ------HPNIVRWYGVESDQDFVYLSLERCT 453
G A+K L K + +K++Q++ HP IV D++ VY LE
Sbjct: 43 GEYYAIKCL-KKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLE--- 98
Query: 454 CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLK 513
+V+ G L +R KA P+
Sbjct: 99 -------FVVGGE-------------LFTHLR----------------KAGRFPNDVAKF 122
Query: 514 VTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNAT 573
++V +LH +I+RDLKP+N+L+ K++D G +K++ + T
Sbjct: 123 YHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHV--KVTDFGFAKKVP------DRTFT 174
Query: 574 GYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDRKDLF 633
G+ + APE + +A+D +++G +L+ I G + ++ R + + F
Sbjct: 175 LCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKF 234
Query: 634 LVEHIPEAVDLFTRLLDPNP-----DLRPKAQNVLNHPFFWTAD 672
A DL LL + L+ +V NHP+F A+
Sbjct: 235 PNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGAN 278
|
Length = 329 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 6e-09
Identities = 64/294 (21%), Positives = 123/294 (41%), Gaps = 52/294 (17%)
Query: 382 KEIAKGSNGTVVLEGNYE-GRSVAVK-----RLVKTHHDVALKEIQNLIASDQHPNIVRW 435
K+I +GS G +L + E G+ +K ++ + + KE+ ++++ +HPNIV++
Sbjct: 6 KKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVA-VLSNMKHPNIVQY 64
Query: 436 YGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENT 495
+ +Y+ ++ C G +++NA+
Sbjct: 65 QESFEENGNLYIVMDYCE----------GGDLYKKINAQ--------------------- 93
Query: 496 KDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDM 555
+ P Q+L I L H+H+ ++HRD+K QN+ ++KD + KL D
Sbjct: 94 ------RGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTI--KLGDF 145
Query: 556 GISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY 615
GI++ L + T G+ + +PE D+++LGC+L+ T KH +
Sbjct: 146 GIARVLNSTVELAR---TCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCT-LKHAF 201
Query: 616 --GESFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPF 667
G I++ + + +L ++L NP RP ++L F
Sbjct: 202 EAGNMKNLVLKIIRGSYPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEKNF 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 7e-09
Identities = 44/158 (27%), Positives = 75/158 (47%), Gaps = 8/158 (5%)
Query: 517 DIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKR-LQGDMSCLTQNATGY 575
+I+ GL LH G+++RDLK N+L+ D K++D G+ K + GD + T
Sbjct: 104 EIICGLQFLHSKGIVYRDLKLDNILLDTDGHI--KIADFGMCKENMLGD----AKTCTFC 157
Query: 576 GSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDRKDLFLV 635
G+ + APE LL + ++D +S G +L+ + G +G E ++ +
Sbjct: 158 GTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPR 217
Query: 636 EHIPEAVDLFTRLLDPNPDLRPKAQ-NVLNHPFFWTAD 672
EA D+ +L P+ R + ++ HPFF D
Sbjct: 218 WLTREAKDILVKLFVREPERRLGVKGDIRQHPFFREID 255
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 8e-09
Identities = 46/158 (29%), Positives = 78/158 (49%), Gaps = 11/158 (6%)
Query: 517 DIVSGLSHLH-EIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGY 575
+IVS L +LH E +++RDLK +N+++ KD K++D G+ K D + + T
Sbjct: 103 EIVSALDYLHSEKNVVYRDLKLENLMLDKDGHI--KITDFGLCKEGIKDGATMK---TFC 157
Query: 576 GSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDRKDLFLV 635
G+ + APE L RA+D + LG +++ + G Y + E+ ++ + F
Sbjct: 158 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPR 217
Query: 636 EHIPEAVDLFTRLLDPNPDLR-----PKAQNVLNHPFF 668
PEA L + LL +P R A+ ++ H FF
Sbjct: 218 TLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFF 255
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 8e-09
Identities = 33/102 (32%), Positives = 57/102 (55%), Gaps = 6/102 (5%)
Query: 504 NGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQG 563
NG P ++ ++ + H+ ++HRD+KP+N+LIS + KL D G ++ L
Sbjct: 95 NGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVL--KLCDFGFARNLSE 152
Query: 564 DMSCLTQNATGYGSSGW-QAPEQLLQGRQTRAIDLFSLGCIL 604
+ N T Y ++ W ++PE LL +A+D++S+GCIL
Sbjct: 153 GSNA---NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCIL 191
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 9e-09
Identities = 64/241 (26%), Positives = 105/241 (43%), Gaps = 59/241 (24%)
Query: 382 KEIAKGSNGTV------VLEGNYEGRSVAVKRLVK-----THHDVALKEIQNLIASDQHP 430
K I G+ G V +LE R+VA+K+L + TH A +E+ L+ H
Sbjct: 30 KPIGSGAQGIVCAAYDAILE-----RNVAIKKLSRPFQNQTHAKRAYRELV-LMKCVNHK 83
Query: 431 NIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLP 490
NI+ V + Q SLE D+ V+ + D+NL +++ L
Sbjct: 84 NIIGLLNVFTPQK----SLEE----FQDVYIVM----------ELMDANLCQVIQMEL-- 123
Query: 491 VMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCA 550
D E ++ + ++ G+ HLH G+IHRDLKP N+++ D +
Sbjct: 124 ------DHE----------RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTL-- 165
Query: 551 KLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG 610
K+ D G+++ T Y ++APE +L +D++S+GCI+ I G
Sbjct: 166 KILDFGLARTAGTSFMMTPYVVTRY----YRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221
Query: 611 G 611
G
Sbjct: 222 G 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 1e-08
Identities = 41/122 (33%), Positives = 65/122 (53%), Gaps = 8/122 (6%)
Query: 510 QLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRL-QGDMSCL 568
QL+ + I G+S+LH+ G+IH+D+ +N +I D+ K++D +S+ L D CL
Sbjct: 118 QLVHMAIQIACGMSYLHKRGVIHKDIAARNCVI--DEELQVKITDNALSRDLFPMDYHCL 175
Query: 569 TQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGE--SFERDANIV 626
N W A E L+ + A D++S G +L+ +T G+ PY E FE A +
Sbjct: 176 GDNE--NRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEM-AAYL 232
Query: 627 KD 628
KD
Sbjct: 233 KD 234
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 1e-08
Identities = 48/183 (26%), Positives = 83/183 (45%), Gaps = 38/183 (20%)
Query: 518 IVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGS 577
++ GLS+ H+ ++HRDLKPQN+LI++ KL+D G+++ S T+ +
Sbjct: 112 LLRGLSYCHKRKILHRDLKPQNLLINEKGEL--KLADFGLARA----KSVPTKTYSNEVV 165
Query: 578 SGWQAPEQLLQGRQ--TRAIDLFSLGCILFFCITGGKHPYGESFERDANIV--------- 626
+ W P +L G + ID++ +GCIL+ TG G + + + +++
Sbjct: 166 TLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTE 225
Query: 627 ----------KDRKDLF-------LVEHIP----EAVDLFTRLLDPNPDLRPKAQNVLNH 665
+ R LF L+ H P + +DL + LL R A+ L H
Sbjct: 226 ETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH 285
Query: 666 PFF 668
+F
Sbjct: 286 SYF 288
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 1e-08
Identities = 32/106 (30%), Positives = 57/106 (53%), Gaps = 4/106 (3%)
Query: 510 QLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLT 569
L+ + + +G++++ + IHRDL+ N+L+ D C K++D G+++ ++ +
Sbjct: 103 NLVDMAAQVAAGMAYIERMNYIHRDLRSANILVG-DGLVC-KIADFGLARLIEDNEYTAR 160
Query: 570 QNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY 615
Q A W APE L GR T D++S G +L +T G+ PY
Sbjct: 161 QGAKF--PIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPY 204
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-08
Identities = 58/208 (27%), Positives = 91/208 (43%), Gaps = 34/208 (16%)
Query: 515 TRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATG 574
T ++V L +H +GLIHRD+KP N+L+ DK KL+D G ++ D + + + T
Sbjct: 148 TAEVVLALDAIHSMGLIHRDVKPDNMLL--DKHGHLKLADFGTCMKM--DETGMVRCDTA 203
Query: 575 YGSSGWQAPEQLLQ----GRQTRAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDRK 630
G+ + +PE L G R D +S+G LF + G Y +S + + D K
Sbjct: 204 VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHK 263
Query: 631 DLFLVEHIPEAVDLFTR--------LLDPNPDL-RPKAQNVLNHPFF----WTADT---- 673
+ + PE V++ L D L R + + HPFF W D
Sbjct: 264 NSL---NFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKNDQWNWDNIRET 320
Query: 674 ------RLSFLRDVSDRVELEDRESDSK 695
LS D S+ ++ED + D +
Sbjct: 321 AAPVVPELSSDIDSSNFDDIEDDKGDVE 348
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 1e-08
Identities = 48/160 (30%), Positives = 76/160 (47%), Gaps = 17/160 (10%)
Query: 517 DIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYG 576
+I S L +LH + +I+RDLKP+N+L+ D L+D G+ K + +T G
Sbjct: 104 EIASALGYLHSLNIIYRDLKPENILL--DSQGHVVLTDFGLCKE---GIEHSKTTSTFCG 158
Query: 577 SSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDR---KDLF 633
+ + APE L + R +D + LG +L+ + G P+ + RD + D K L
Sbjct: 159 TPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLY-GLPPF---YSRDTAEMYDNILNKPLR 214
Query: 634 LVEHI-PEAVDLFTRLLDPNPDLRPKAQN----VLNHPFF 668
L +I A L LL + R A++ + NH FF
Sbjct: 215 LKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFF 254
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 1e-08
Identities = 71/297 (23%), Positives = 116/297 (39%), Gaps = 68/297 (22%)
Query: 393 VLEGNYEGR---SVAVKRLVKTHHDVALKEIQN-------LIASDQHPNIVRWYGVESDQ 442
V EG Y GR +V ++ VKT + ++ ++ +++ H NIVR GV ++
Sbjct: 22 VYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFER 81
Query: 443 DFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWK 502
++ LE +++G + K + L E R R
Sbjct: 82 LPRFILLE-----------LMAGG-----DLK----SFLRENRPRP-------------- 107
Query: 503 ANGHPSA----QLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLIS-KDKSFCAKLSDMGI 557
PS+ LL RD+ G +L E IHRD+ +N L++ K AK++D G+
Sbjct: 108 --ERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGM 165
Query: 558 SKRLQGDMSCLTQNATGYGSSG-------WQAPEQLLQGRQTRAIDLFSLGCILFFCITG 610
++ + A+ Y G W PE L G T D++S G +L+ +
Sbjct: 166 ARDIYR--------ASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSL 217
Query: 611 GKHPY-GESFERDANIVKDRKDLFLVEHIPEAV-DLFTRLLDPNPDLRPKAQNVLNH 665
G PY G + + V L + P V + T P+ RP +L
Sbjct: 218 GYMPYPGRTNQEVMEFVTGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER 274
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 55.8 bits (135), Expect = 2e-08
Identities = 65/244 (26%), Positives = 98/244 (40%), Gaps = 51/244 (20%)
Query: 382 KEIAKGSNGTVVLEGNYEGRS-----VAVKRLVKTHHDVALKEI---QNLIASDQHPNIV 433
KE+ G+ G+VV +G Y +S VAVK L + H KE +++A HP IV
Sbjct: 1 KELGHGNFGSVV-KGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIV 59
Query: 434 RWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVME 493
R GV C L+ V+ + L + R +PV
Sbjct: 60 RLIGV---------------CKGEPLMLVMELAPLGPLLKYLKKR--------REIPV-- 94
Query: 494 NTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLS 553
D++ +V G+++L +HRDL +NVL+ AK+S
Sbjct: 95 --SDLKEL---------AHQVAM----GMAYLESKHFVHRDLAARNVLLVNRHQ--AKIS 137
Query: 554 DMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKH 613
D G+S+ L G W APE + G+ + D++S G L+ + G
Sbjct: 138 DFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAK 197
Query: 614 PYGE 617
PYGE
Sbjct: 198 PYGE 201
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 2e-08
Identities = 70/312 (22%), Positives = 117/312 (37%), Gaps = 72/312 (23%)
Query: 383 EIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALK----EIQNLIASDQHPNIVRWYGV 438
E+ G+ G V + E A ++++ + L+ EI ++++ +HPNIV Y
Sbjct: 12 ELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEI-DILSECKHPNIVGLYEA 70
Query: 439 ESDQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKD 497
++ +++ +E C +L+ ++ L E
Sbjct: 71 YFYENKLWILIEFCDGGALDSIMLELERGLTE---------------------------- 102
Query: 498 IELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGI 557
Q+ V R ++ L+ LH +IHRDLK N+L++ D KL+D G+
Sbjct: 103 -----------PQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGD--VKLADFGV 149
Query: 558 SKRLQGDMSCLTQNATGYGSSGWQAPEQLL------QGRQTRAIDLFSLGCILFFCITGG 611
S + + S L + T G+ W APE + +A D++SLG IT
Sbjct: 150 SAKNK---STLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKA-DIWSLG------ITLI 199
Query: 612 KHPYGESFERDAN-------IVKDRKDLFLVEHI--PEAVDLFTRLLDPNPDLRPKAQNV 662
+ E + N I+K D L +PD RP A +
Sbjct: 200 ELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAEL 259
Query: 663 LNHPFFWTADTR 674
L HPF
Sbjct: 260 LKHPFVSDQSDN 271
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 56.3 bits (135), Expect = 2e-08
Identities = 49/169 (28%), Positives = 79/169 (46%), Gaps = 14/169 (8%)
Query: 509 AQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCL 568
Q+ V R+ + L LH +IHRD+K N+L+ D S KL+D G ++ + S
Sbjct: 116 GQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGS--VKLTDFGFCAQITPEQS-- 171
Query: 569 TQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY-GESFERDANIVK 627
+ +T G+ W APE + + +D++SLG I+ + G+ PY E+ R ++
Sbjct: 172 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLG-IMAIEMIEGEPPYLNENPLRALYLIA 229
Query: 628 DRKDLFLVEHIPEAV-----DLFTRLLDPNPDLRPKAQNVLNHPFFWTA 671
L PE + D R LD + + R A+ +L H F A
Sbjct: 230 TNGTPELQN--PEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIA 276
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 2e-08
Identities = 55/235 (23%), Positives = 96/235 (40%), Gaps = 63/235 (26%)
Query: 382 KEIAKGSNGTVVLEGN-YEGRSVAVKRL-------VKTHHDVALKEIQNLIASDQHPNIV 433
+EI GS G V + VA+K++ + D+ +KE++ + +HPN +
Sbjct: 21 REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDI-IKEVR-FLQQLRHPNTI 78
Query: 434 RWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVME 493
+ G + +L +E C S +D++ V L EV I
Sbjct: 79 EYKGCYLREHTAWLVMEYCLGSASDILEVHKKP--------------LQEVEIA------ 118
Query: 494 NTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLS 553
+ + GL++LH IHRD+K N+L+++ + KL+
Sbjct: 119 -------------------AICHGALQGLAYLHSHERIHRDIKAGNILLTEPGT--VKLA 157
Query: 554 DMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLL---QGRQTRAIDLFSLG--CI 603
D G S ++ + G+ W APE +L +G+ +D++SLG CI
Sbjct: 158 DF-------GSASLVSPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCI 205
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 3e-08
Identities = 63/263 (23%), Positives = 101/263 (38%), Gaps = 79/263 (30%)
Query: 380 FNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQNLIASDQ----------- 428
F KE+ G G V L G + + VA+K I S++
Sbjct: 8 FMKELGSGQFGVVHL-GKW-----------RAQIKVAIKAINEGAMSEEDFIEEAKVMMK 55
Query: 429 --HPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRI 486
HP +V+ YGV + Q +Y+ E F E + LLN +R
Sbjct: 56 LSHPKLVQLYGVCTQQKPLYIVTE----------------FME-------NGCLLNYLRQ 92
Query: 487 RLLPVMENTKDIELWKANGHPSAQ-LLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKD 545
R G S LL + +D+ G+ +L IHRDL +N L+S
Sbjct: 93 R----------------QGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVS-- 134
Query: 546 KSFCAKLSDMGISKRLQGDMSCLTQNATGYGSS---GWQAPEQLLQGRQTRAIDLFSLGC 602
+ K+SD G+++ + D + + G+ W PE + + D++S G
Sbjct: 135 STGVVKVSDFGMTRYVLDD-----EYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGV 189
Query: 603 ILFFCITGGKHPYGESFERDANI 625
+++ T GK P FE+ +N
Sbjct: 190 LMWEVFTEGKMP----FEKKSNY 208
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 3e-08
Identities = 60/231 (25%), Positives = 97/231 (41%), Gaps = 55/231 (23%)
Query: 393 VLEGNYEGR-SVAVKRLVKTHHDVA--LKEIQNLIASDQHPNIVRWYGVESDQDFVYLSL 449
V EG + VAVK L D L E Q ++ +HP +++ Y V
Sbjct: 22 VWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQ-IMKKLRHPKLIQLYAV----------- 69
Query: 450 ERCTCSLNDLIYVLS-----GSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKAN 504
C+L + IY+++ GS E L R LP
Sbjct: 70 ----CTLEEPIYIVTELMKYGSLLEYLQGGAG--------RALKLP-------------- 103
Query: 505 GHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGD 564
QL+ + + SG+++L IHRDL +NVL+ + + C K++D G+++ ++ D
Sbjct: 104 -----QLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVG-ENNIC-KVADFGLARVIKED 156
Query: 565 MSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY 615
+ + A W APE L R + D++S G +L +T G+ PY
Sbjct: 157 IYEAREGAK--FPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPY 205
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 3e-08
Identities = 43/157 (27%), Positives = 76/157 (48%), Gaps = 10/157 (6%)
Query: 517 DIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYG 576
+IVS L +LH +++RDLK +N+++ KD K++D G+ K D + + T G
Sbjct: 103 EIVSALDYLHSGKIVYRDLKLENLMLDKDGHI--KITDFGLCKEGITDAATMK---TFCG 157
Query: 577 SSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDRKDLFLVE 636
+ + APE L RA+D + LG +++ + G Y + E+ ++ F
Sbjct: 158 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRT 217
Query: 637 HIPEAVDLFTRLLDPNPDLR-----PKAQNVLNHPFF 668
+A L + LL +P+ R A+ ++ H FF
Sbjct: 218 LSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFF 254
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 3e-08
Identities = 46/186 (24%), Positives = 81/186 (43%), Gaps = 41/186 (22%)
Query: 518 IVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGS 577
++ GL+++H ++HRDLKPQN+LIS KL+D G+++ S +Q +
Sbjct: 112 LLRGLAYIHGQHILHRDLKPQNLLISYLGEL--KLADFGLAR----AKSIPSQTYSSEVV 165
Query: 578 SGWQAPEQLLQGRQ--TRAIDLFSLGCILFFCITGGKH--------------------PY 615
+ W P +L G + A+D++ GCI + G P
Sbjct: 166 TLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPT 225
Query: 616 GESFERDANIVKDRKDLFL-------------VEHIPEAVDLFTRLLDPNPDLRPKAQNV 662
+++ + + + + FL + P+A DL +++L P R AQ+
Sbjct: 226 EDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDA 285
Query: 663 LNHPFF 668
L HP+F
Sbjct: 286 LLHPYF 291
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 3e-08
Identities = 38/136 (27%), Positives = 66/136 (48%), Gaps = 9/136 (6%)
Query: 500 LWKANGHPSA-QLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGIS 558
L K G A QL+ + + SG+ +L E+G +H+ L VL++ D K+S
Sbjct: 97 LRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSD--LVCKISGFR-- 152
Query: 559 KRLQGD-MSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGE 617
RLQ D + +G W APE + + A D++S G +++ ++ G+ PY +
Sbjct: 153 -RLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWD 211
Query: 618 SFERDANIVKDRKDLF 633
+D ++K +D F
Sbjct: 212 MSGQD--VIKAVEDGF 225
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 3e-08
Identities = 38/160 (23%), Positives = 78/160 (48%), Gaps = 5/160 (3%)
Query: 507 PSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMS 566
+++++ +I G+++L+ +HRDL +N ++++D F K+ D G+++ + +
Sbjct: 117 SLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAED--FTVKIGDFGMTRDIY-ETD 173
Query: 567 CLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY-GESFERDANI 625
+ G W +PE L G T D++S G +L+ T + PY G S E+
Sbjct: 174 YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRF 233
Query: 626 VKDRKDLFLVEHIPEAV-DLFTRLLDPNPDLRPKAQNVLN 664
V + L ++ P+ + +L NP +RP +++
Sbjct: 234 VMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 273
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 3e-08
Identities = 49/196 (25%), Positives = 82/196 (41%), Gaps = 40/196 (20%)
Query: 518 IVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGS 577
++ GL++ H ++HRDLKPQN+LI++ KL+D G+++ S T+ +
Sbjct: 113 LLRGLNYCHRRKVLHRDLKPQNLLINERGEL--KLADFGLARA----KSIPTKTYSNEVV 166
Query: 578 SGWQAPEQLLQGRQ--TRAIDLFSLGCILFFCITGGKHPYGESFERDANIV--------- 626
+ W P +L G + ID++ +GCI + TG G + E + +
Sbjct: 167 TLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTE 226
Query: 627 ------------------KDRKDLFLVEHIP----EAVDLFTRLLDPNPDLRPKAQNVLN 664
K R D L H P + +L ++LL R A+ +
Sbjct: 227 ETWPGILSNEEFKSYNYPKYRADC-LHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285
Query: 665 HPFFWTADTRLSFLRD 680
HP+F R+ L D
Sbjct: 286 HPYFHCLGERIHKLPD 301
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 4e-08
Identities = 63/236 (26%), Positives = 102/236 (43%), Gaps = 63/236 (26%)
Query: 382 KEIAKGSNGTVVLEGNY-EGRSVAVKRLVK-----THHDVALKEIQNLIASDQHPNIVRW 435
K I G+ G V + G++VA+K+L + TH A +E+ L+ H NI+
Sbjct: 22 KPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELV-LMKLVNHKNIIGL 80
Query: 436 YGV----ESDQDF--VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLL 489
V +S ++F VYL +E +L +I + L+ R+ L
Sbjct: 81 LNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMD-----------------LDHERMSYL 123
Query: 490 PVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFC 549
L+ Q+L G+ HLH G+IHRDLKP N+++ KS C
Sbjct: 124 ----------LY--------QML-------CGIKHLHSAGIIHRDLKPSNIVV---KSDC 155
Query: 550 A-KLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCIL 604
K+ D G+++ T Y ++APE +L +D++S+GCI+
Sbjct: 156 TLKILDFGLARTAGTSFMMTPYVVTRY----YRAPEVILGMGYKENVDIWSVGCIM 207
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 4e-08
Identities = 83/315 (26%), Positives = 122/315 (38%), Gaps = 88/315 (27%)
Query: 384 IAKGSNGTVVLEGNYEGRSVAVKRL-------VKTHHDVALK-EIQNLIASDQHPNIVRW 435
+ G+ G V Y+GR V +L V + +K EI L H NI +
Sbjct: 24 VGNGTYGQV-----YKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATY 78
Query: 436 YGV------ESDQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRL 488
YG D ++L +E C S+ DL+ G NA ++D
Sbjct: 79 YGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKG------NALKED----------- 121
Query: 489 LPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSF 548
W A + R+I+ GL+HLH +IHRD+K QNVL++++
Sbjct: 122 ------------WIA---------YICREILRGLAHLHAHKVIHRDIKGQNVLLTENAE- 159
Query: 549 CAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAI-----DLFSLGCI 603
KL D G+S +L D + +N T G+ W APE + A D++SLG I
Sbjct: 160 -VKLVDFGVSAQL--DRTVGRRN-TFIGTPYWMAPEVIACDENPDATYDYRSDIWSLG-I 214
Query: 604 LFFCITGGKHPYGESFERDANIVKDRKDLFLVEHIP-----------EAVDLFTRLLDPN 652
+ G P + A LFL+ P + +D L N
Sbjct: 215 TAIEMAEGAPPLCDMHPMRA--------LFLIPRNPPPKLKSKKWSKKFIDFIEGCLVKN 266
Query: 653 PDLRPKAQNVLNHPF 667
RP + +L HPF
Sbjct: 267 YLSRPSTEQLLKHPF 281
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|199218 cd10423, RNase_RNase-L, RNase domain (also known as the kinase extension nuclease domain) of RNase L | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 4e-08
Identities = 33/119 (27%), Positives = 58/119 (48%), Gaps = 11/119 (9%)
Query: 673 TRLSFLRDVSDRVELEDRESDSKLLRAL--EGIALVALNGKWDEKMETKFIENIGRY--- 727
R LR+V + +++ R+ S +LR L W K++ + ++ + ++
Sbjct: 2 NRYRTLRNVGNESDIKTRDDKSDILRLLQAGKSECSRSFPNWTSKIDKEVMDIMNKFYEK 61
Query: 728 RRYKY-DNVRDLLRVIRNKSNHFRELP-QDIQELLGSHPEGFYNYFSCRFPKLLIEVYN 784
+++ Y D V DLL+ IRN H E + ++E++G E YF FP L+I VY
Sbjct: 62 KKFFYQDTVGDLLKFIRNLGEHIDEEKNKRMKEIIGDPSE----YFQKTFPDLVIYVYK 116
|
Ribonuclease L (RNase L), sometimes referred to as the 2-5A-dependent RNase, is a highly regulated, latent endoribonuclease (thus the 'L' in RNase L) and is widely expressed in most mammalian tissues. It is involved in the mediation of the antiviral and pro-apoptotic activities of the interferon-inducible 2-5A system, which blocks infections by certain types of viruses through cleavage of viral and cellular single-stranded RNA. RNase L is unique in that it is composed of three major domains; N-terminus regulatory ankyrin repeat domain (ARD), followed by a linker, a protein kinase (PK)-like domain and a C-terminal ribonuclease (RNase) domain. The RNase domain has homology with IRE1, also containing both a kinase and an endoribonuclease, that functions in the unfolded protein response (UPR). RNase L has been shown to have an impact on the pathogenesis of prostate cancer; the RNase L gene, RNASEL, has been identified as a strong candidate for the hereditary prostate cancer 1 (HPC1) allele. The broad range of biological functions of RNase offers a possibility for RNase L as a therapeutic target. Length = 119 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 4e-08
Identities = 46/151 (30%), Positives = 74/151 (49%), Gaps = 6/151 (3%)
Query: 518 IVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGS 577
++ + H+H +IHRD+K N+L+ + KL D G SK +S T G+
Sbjct: 152 VLLAVHHVHSKHMIHRDIKSANILLCSNG--LVKLGDFGFSKMYAATVSD-DVGRTFCGT 208
Query: 578 SGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY-GESFERDAN-IVKDRKDLFLV 635
+ APE + ++ D+FSLG +L+ +T K P+ GE+ E + + R D
Sbjct: 209 PYYVAPEIWRRKPYSKKADMFSLGVLLYELLT-LKRPFDGENMEEVMHKTLAGRYDPLPP 267
Query: 636 EHIPEAVDLFTRLLDPNPDLRPKAQNVLNHP 666
PE ++ T LL +P RP + +LN P
Sbjct: 268 SISPEMQEIVTALLSSDPKRRPSSSKLLNMP 298
|
Length = 496 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 4e-08
Identities = 52/237 (21%), Positives = 97/237 (40%), Gaps = 43/237 (18%)
Query: 380 FNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDV-ALKEIQNLIASDQHPNIVRWYGV 438
K++ G G V + + VAVK + V A N++ + QH +V+ + V
Sbjct: 10 LEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAV 69
Query: 439 ESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDI 498
+ + +Y+ E ++ GS + L + E
Sbjct: 70 VTKEP-IYIITE----------FMAKGSLLDFLKSDE----------------------- 95
Query: 499 ELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGIS 558
+ P +L+ + I G++ + + IHRDL+ N+L+S S K++D G++
Sbjct: 96 ----GSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVS--ASLVCKIADFGLA 149
Query: 559 KRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY 615
+ ++ + + A W APE + G T D++S G +L +T G+ PY
Sbjct: 150 RVIEDNEYTAREGAK--FPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPY 204
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 4e-08
Identities = 61/253 (24%), Positives = 97/253 (38%), Gaps = 44/253 (17%)
Query: 378 VVFNKEIAKGSNGTVVL--------EGNYEGRSVAVKRLVKTHHDVALKEIQNLIAS--- 426
+V K + +G G VV+ E VAVK L D K++ +LI+
Sbjct: 20 LVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKML---KSDATEKDLSDLISEMEM 76
Query: 427 ----DQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLN 482
+H NI+ G + +Y+ +E Y G+ E L
Sbjct: 77 MKMIGKHKNIINLLGACTQDGPLYVIVE----------YASKGNLREYL----------- 115
Query: 483 EVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLI 542
R R P ME + L+ + G+ +L IHRDL +NVL+
Sbjct: 116 --RARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV 173
Query: 543 SKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGC 602
++D K++D G+++ + + + G W APE L T D++S G
Sbjct: 174 TEDNVM--KIADFGLARDIH-HIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGV 230
Query: 603 ILFFCITGGKHPY 615
+L+ T G PY
Sbjct: 231 LLWEIFTLGGSPY 243
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 55.0 bits (133), Expect = 4e-08
Identities = 69/308 (22%), Positives = 117/308 (37%), Gaps = 77/308 (25%)
Query: 378 VVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHD--VALKEIQNLIASDQH------ 429
+ +E+ +GS G V YEG K +VK + VA+K + + +
Sbjct: 8 ITLIRELGQGSFGMV-----YEG---LAKGVVKGEPETRVAIKTVNENASMRERIEFLNE 59
Query: 430 ---------PNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNL 480
++VR GV S + +E + G + L ++ +
Sbjct: 60 ASVMKEFNCHHVVRLLGVVSTGQPTLVVME----------LMAKGDLKSYLRSRRPE--- 106
Query: 481 LNEVRIRLLPVMENTKDIELWKANGHPSAQ-LLKVTRDIVSGLSHLHEIGLIHRDLKPQN 539
L P+ Q +++ +I G+++L +HRDL +N
Sbjct: 107 --AENNPGLGP---------------PTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARN 149
Query: 540 VLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGY---GSSG-----WQAPEQLLQGRQ 591
++++D K+ D G+++ + T Y G G W APE L G
Sbjct: 150 CMVAED--LTVKIGDFGMTRDI---------YETDYYRKGGKGLLPVRWMAPESLKDGVF 198
Query: 592 TRAIDLFSLGCILFFCITGGKHPY-GESFERDANIVKDRKDLFLVEHIPEAV-DLFTRLL 649
T D++S G +L+ T + PY G S E V D L L E+ P+ + +L
Sbjct: 199 TTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGGHLDLPENCPDKLLELMRMCW 258
Query: 650 DPNPDLRP 657
NP +RP
Sbjct: 259 QYNPKMRP 266
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 5e-08
Identities = 47/164 (28%), Positives = 78/164 (47%), Gaps = 19/164 (11%)
Query: 517 DIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYG 576
++V + +H++G +HRD+KP+NVLI D++ KL+D G + RL + ++ G
Sbjct: 110 ELVLAIHSVHQMGYVHRDIKPENVLI--DRTGHIKLADFGSAARLTANKMVNSKLPV--G 165
Query: 577 SSGWQAPEQLLQGRQTRA-------IDLFSLGCILFFCITGGKHPYGE--SFERDANIVK 627
+ + APE +L D +SLG I + I G+ P+ E S + NI+
Sbjct: 166 TPDYIAPE-VLTTMNGDGKGTYGVECDWWSLGVIAYEMIY-GRSPFHEGTSAKTYNNIMN 223
Query: 628 DRKDLFLVEHIP---EAVDLFTRLLDPNPDLRPKAQNVLNHPFF 668
++ L E + +DL LL R + + HPFF
Sbjct: 224 FQRFLKFPEDPKVSSDFLDLIQSLL-CGQKERLGYEGLCCHPFF 266
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 5e-08
Identities = 32/109 (29%), Positives = 54/109 (49%), Gaps = 4/109 (3%)
Query: 507 PSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMS 566
+ LL + I S + +L + IHRDL +N L+ ++ K++D G+S+ + GD
Sbjct: 102 NAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENH--LVKVADFGLSRLMTGDT- 158
Query: 567 CLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY 615
T +A W APE L + + D+++ G +L+ T G PY
Sbjct: 159 -YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 206
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 6e-08
Identities = 66/278 (23%), Positives = 117/278 (42%), Gaps = 30/278 (10%)
Query: 390 GTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQ---NLIASDQHPNIVRWYGVESDQDFVY 446
G + L G + VA+K L ++ E Q +L+A HPNIV GV + + V
Sbjct: 24 GHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVC 83
Query: 447 LSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGH 506
+ E Y+ G E L + S++ + +D + + H
Sbjct: 84 MLFE----------YLNQGDLHEFLIMRSPHSDV----------GCSSDEDGTVKSSLDH 123
Query: 507 PSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMS 566
L + I +G+ +L +H+DL +N+LI + K+SD+G+S+ +
Sbjct: 124 --GDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGE--QLHVKISDLGLSREIYSADY 179
Query: 567 CLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP-YGESFERDANI 625
Q + W PE ++ G+ + D++S G +L+ + G P YG S + +
Sbjct: 180 YRVQPKSLLPIR-WMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEM 238
Query: 626 VKDRKDLFLVEHIPEAV-DLFTRLLDPNPDLRPKAQNV 662
V+ R+ L E P + L T P RP+ +++
Sbjct: 239 VRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDI 276
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 6e-08
Identities = 48/193 (24%), Positives = 83/193 (43%), Gaps = 38/193 (19%)
Query: 518 IVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGS 577
I+ GL++ H ++HRDLKPQN+LI++ KL+D G+++ S T+ +
Sbjct: 113 ILRGLAYCHRRKVLHRDLKPQNLLINERGEL--KLADFGLARA----KSVPTKTYSNEVV 166
Query: 578 SGWQAPEQLLQGRQ--TRAIDLFSLGCILFFCITGGKHPYGESFERDANIV--------- 626
+ W P +L G + ID++ +GCI F +G G + E + +++
Sbjct: 167 TLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTE 226
Query: 627 -----------------KDRKDLFLVEHIP----EAVDLFTRLLDPNPDLRPKAQNVLNH 665
K L+ H P E ++L T+ L R A+ + H
Sbjct: 227 ETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKH 286
Query: 666 PFFWTADTRLSFL 678
+F + TR+ L
Sbjct: 287 AYFRSLGTRIHSL 299
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 6e-08
Identities = 74/309 (23%), Positives = 126/309 (40%), Gaps = 57/309 (18%)
Query: 378 VVFNKEIAKGSNGTV------VLEGNYEGRSVAVKRLVKTHHDVALK-EIQN---LIASD 427
V F +E+ +G+ G V SVA+K L K + + ++ E + L++
Sbjct: 7 VRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTL-KENAEPKVQQEFRQEAELMSDL 65
Query: 428 QHPNIVRWYGVESDQDFVYLSLERCTCSLNDL-IYVLSGSFEEQLNAKEQDSNLLNEVRI 486
QHPNIV GV + + + E + DL +++ S + A+ D
Sbjct: 66 QHPNIVCLLGVCTKEQPTCMLFE--YLAHGDLHEFLVRNSPHSDVGAESGD--------- 114
Query: 487 RLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDK 546
E K L + L + I +G+ +L +HRDL +N L+ +
Sbjct: 115 ------ETVKSS-LD------CSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGL 161
Query: 547 SFCAKLSDMGISK--------RLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLF 598
+ K+SD G+S+ R+Q S L W PE +L G+ T D++
Sbjct: 162 T--VKISDFGLSRDIYSADYYRVQSK-SLLPVR--------WMPPEAILYGKFTTESDIW 210
Query: 599 SLGCILFFCITGGKHPY-GESFERDANIVKDRKDLFLVEHIPEAV-DLFTRLLDPNPDLR 656
S G +L+ + G PY G S + +++ R+ L E P V L + P R
Sbjct: 211 SFGVVLWEIFSYGLQPYYGFSNQEVIEMIRSRQLLPCPEDCPARVYALMIECWNEIPARR 270
Query: 657 PKAQNVLNH 665
P+ +++
Sbjct: 271 PRFKDIHTR 279
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 7e-08
Identities = 40/154 (25%), Positives = 72/154 (46%), Gaps = 7/154 (4%)
Query: 507 PSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRL-QGDM 565
P L++ DI SG+ +L IHRDL +N +++++ + C ++D G+SK++ GD
Sbjct: 111 PLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVC--VADFGLSKKIYSGDY 168
Query: 566 SCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYG--ESFERDA 623
Q W A E L T D+++ G ++ +T G+ PY E+ E
Sbjct: 169 --YRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYN 226
Query: 624 NIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRP 657
++K + + + + +L + P P RP
Sbjct: 227 YLIKGNRLKQPPDCLEDVYELMCQCWSPEPKCRP 260
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 8e-08
Identities = 54/201 (26%), Positives = 87/201 (43%), Gaps = 50/201 (24%)
Query: 518 IVSGLSHLHEIGLIHRDLKPQNVLISKDKSFC-AKLSDMGISKRLQGDMSCLTQNATGYG 576
++ GL ++H ++HRDLKP N+L++ + C K+ D G+++ +T+ Y
Sbjct: 117 LLRGLKYIHSANVLHRDLKPSNLLLNAN---CDLKICDFGLARTTSEKGDFMTE----YV 169
Query: 577 SSGW-QAPEQLLQGRQ-TRAIDLFSLGCILFFCITGGK--------------------HP 614
+ W +APE LL + T AID++S+GCI F + G K P
Sbjct: 170 VTRWYRAPELLLNCSEYTTAIDVWSVGCI-FAELLGRKPLFPGKDYVHQLKLITELLGSP 228
Query: 615 YGES--FERDANIVKDRKDLFLVEHI----------PEAVDLFTRLLDPNPDLRPKAQNV 662
E F R+ + + L P A+DL ++L +P R +
Sbjct: 229 SEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEA 288
Query: 663 LNHPFFWTADTRLSFLRDVSD 683
L HP+ L+ L D SD
Sbjct: 289 LAHPY-------LASLHDPSD 302
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 9e-08
Identities = 31/101 (30%), Positives = 56/101 (55%), Gaps = 3/101 (2%)
Query: 507 PSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKD--KSFCAKLSDMGISKRLQGD 564
P + + + I+ G+ +LH ++HRDLKP N+L+ + + K++DMG ++
Sbjct: 106 PRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSP 165
Query: 565 MSCLTQNATGYGSSGWQAPEQLLQGRQ-TRAIDLFSLGCIL 604
+ L + ++APE LL R T+AID++++GCI
Sbjct: 166 LKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIF 206
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 9e-08
Identities = 33/100 (33%), Positives = 54/100 (54%), Gaps = 9/100 (9%)
Query: 509 AQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCL 568
AQ+ V R ++S + ++H G+IHRD+K +NVL++ + C L D G + +G S
Sbjct: 260 AQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDIC--LGDFGAACFARGSWS-- 315
Query: 569 TQNATGYGSSG---WQAPEQLLQGRQTRAIDLFSLGCILF 605
YG +G APE L T ++D++S G ++F
Sbjct: 316 --TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIF 353
|
Length = 461 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 9e-08
Identities = 34/114 (29%), Positives = 60/114 (52%), Gaps = 9/114 (7%)
Query: 494 NTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKD--KSFCAK 551
N K ++L P + + I+ G+ +LH ++HRDLKP N+L+ + + K
Sbjct: 99 NKKPVQL------PRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVK 152
Query: 552 LSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ-TRAIDLFSLGCIL 604
++DMG ++ + L + ++APE LL R T+AID++++GCI
Sbjct: 153 IADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIF 206
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 1e-07
Identities = 43/150 (28%), Positives = 64/150 (42%), Gaps = 30/150 (20%)
Query: 508 SAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSC 567
S LL I G+S+L E+ L+HRDL +NVL+ K++D G+++ L D
Sbjct: 108 SQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNH--VKITDFGLARLLDID--- 162
Query: 568 LTQNATGYGSSG------WQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFER 621
T Y + G W A E +L R T D++S G ++ +T G PY
Sbjct: 163 ----ETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPY------ 212
Query: 622 DANIVKDRKDLFLVEHIPEAVDLFTRLLDP 651
D IP+ ++ RL P
Sbjct: 213 ---------DGIPAREIPDLLEKGERLPQP 233
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.3 bits (131), Expect = 1e-07
Identities = 46/189 (24%), Positives = 72/189 (38%), Gaps = 51/189 (26%)
Query: 525 LHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQ-------------------GDM 565
+H++G IHRD+KP N+L+ D KLSD G+ L+ D
Sbjct: 117 IHKLGYIHRDIKPDNLLL--DAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDF 174
Query: 566 SCLTQNATGYGSSGWQ-----------------APEQLLQGRQTRAIDLFSLGCILFFCI 608
++ + W+ APE LQ + D +SLG I++ +
Sbjct: 175 ISKPMSSKRKAET-WKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEML 233
Query: 609 TGGKHP---YGESFERDANIVKDRKDLFLVEHIP---EAVDLFTRLLDPNPDLR---PKA 659
G +P E I+ ++ L + +P EA DL RL + R
Sbjct: 234 VG--YPPFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLC-CEAERRLGNNGV 290
Query: 660 QNVLNHPFF 668
+ +HPFF
Sbjct: 291 NEIKSHPFF 299
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 1e-07
Identities = 30/109 (27%), Positives = 53/109 (48%), Gaps = 2/109 (1%)
Query: 507 PSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMS 566
+ ++++ + G+ +L +HRDL +NVL+ AK+SD G+SK L D S
Sbjct: 93 TVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHY--AKISDFGLSKALGADDS 150
Query: 567 CLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY 615
+ G W APE + + + D++S G ++ + G+ PY
Sbjct: 151 YYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPY 199
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 1e-07
Identities = 28/87 (32%), Positives = 48/87 (55%), Gaps = 6/87 (6%)
Query: 518 IVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGS 577
++ G+ HLH G+IHRDLKP N+++ D + K+ D G+++ T Y
Sbjct: 128 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTL--KILDFGLARTAGTSFMMTPYVVTRY-- 183
Query: 578 SGWQAPEQLLQGRQTRAIDLFSLGCIL 604
++APE +L +D++S+GCI+
Sbjct: 184 --YRAPEVILGMGYKENVDIWSVGCIM 208
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 1e-07
Identities = 50/165 (30%), Positives = 80/165 (48%), Gaps = 18/165 (10%)
Query: 517 DIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYG 576
++V + +H++G +HRD+KP NVL+ DK+ +L+D G RL D + Q+ G
Sbjct: 110 EMVLAIDSVHQLGYVHRDIKPDNVLL--DKNGHIRLADFGSCLRLLADGT--VQSNVAVG 165
Query: 577 SSGWQAPEQLL-----QGRQTRAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDRKD 631
+ + +PE L +GR D +SLG ++ + G Y ES + + K+
Sbjct: 166 TPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKE 225
Query: 632 LF----LVEHIPE-AVDLFTRLLDPNPDLR---PKAQNVLNHPFF 668
F V + E A DL RL+ P+ R Q+ +HPFF
Sbjct: 226 HFQFPPDVTDVSEEAKDLIRRLICS-PETRLGRNGLQDFKDHPFF 269
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 1e-07
Identities = 34/110 (30%), Positives = 55/110 (50%), Gaps = 5/110 (4%)
Query: 507 PSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRL-QGDM 565
P+ L+K DI SG+ +L IHRDL +N +++++ + C ++D G+SK++ GD
Sbjct: 110 PTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVC--VADFGLSKKIYNGDY 167
Query: 566 SCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY 615
Q W A E L T D++S G ++ T G+ PY
Sbjct: 168 --YRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPY 215
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 1e-07
Identities = 73/304 (24%), Positives = 117/304 (38%), Gaps = 65/304 (21%)
Query: 378 VVFNKEIAKGSNGTVVLEGNYEGRS-------VAVKRLVKTHH----DVALKEIQNLIAS 426
+ F K + G+ G VV E G S VAVK L T H + + E++ +
Sbjct: 37 LSFGKTLGAGAFGKVV-EATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHL 95
Query: 427 DQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRI 486
H NIV G + + + E C Y +LLN +R
Sbjct: 96 GNHENIVNLLGACTIGGPILVITEYCC-------Y----------------GDLLNFLR- 131
Query: 487 RLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDK 546
R +D LL + + G++ L IHRDL +NVL++ K
Sbjct: 132 RKRESFLTLED-------------LLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGK 178
Query: 547 SFCAKLSDMGISKRLQGDMSCLTQNATGYGSS----GWQAPEQLLQGRQTRAIDLFSLGC 602
K+ D G+++ + D N G++ W APE + T D++S G
Sbjct: 179 --IVKICDFGLARDIMND-----SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGI 231
Query: 603 ILFFCITGGKHPYGESFERDANIVKDRKDLFLV---EHIPEAV-DLFTRLLDPNPDLRPK 658
+L+ + G +PY D+ K K+ + + EH P + D+ D +P RP
Sbjct: 232 LLWEIFSLGSNPY-PGMPVDSKFYKLIKEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPT 290
Query: 659 AQNV 662
+ +
Sbjct: 291 FKQI 294
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.4 bits (129), Expect = 2e-07
Identities = 77/334 (23%), Positives = 120/334 (35%), Gaps = 95/334 (28%)
Query: 382 KEIAKGSNGTVVL-EGNYEGRSVAVKRLVK--------THHDVALKEIQNLIASDQHPNI 432
K + KG G V L G+ A+K L K L E + L D HP +
Sbjct: 7 KLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKR--VLTEQEILATLD-HPFL 63
Query: 433 VRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVM 492
Y + ++ L ++ C +L +L + Q L+E R
Sbjct: 64 PTLYASFQTETYLCLVMD--YCPGGELFRLL----------QRQPGKCLSEEVARF---- 107
Query: 493 ENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKL 552
+ A +++ L +LH +G+++RDLKP+N+L+ + L
Sbjct: 108 --------YAA-------------EVLLALEYLHLLGIVYRDLKPENILLHESGHI--ML 144
Query: 553 SDMGISKRLQGDMSCLTQNATGYGSSGWQ---------------------------APEQ 585
SD +SK+ A GS APE
Sbjct: 145 SDFDLSKQS-DVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEV 203
Query: 586 LLQGRQTRAIDLFSLGCILFFCITGGKHPY-GESFERDA---NIVKDRKDLFLVEHIP-- 639
+ A+D ++LG IL + + G P+ G + RD NI+K K++ P
Sbjct: 204 ISGDGHGSAVDWWTLG-ILLYEMLYGTTPFKGSN--RDETFSNILK--KEVTFPGSPPVS 258
Query: 640 -EAVDLFTRLLDPNPDLR----PKAQNVLNHPFF 668
A DL +LL +P R A + HPFF
Sbjct: 259 SSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFF 292
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 2e-07
Identities = 53/201 (26%), Positives = 81/201 (40%), Gaps = 47/201 (23%)
Query: 518 IVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGS 577
++ GLS++H+ ++HRDLKPQN+LIS KL+D G+++ S + +
Sbjct: 112 LLRGLSYIHQRYILHRDLKPQNLLISDTGEL--KLADFGLARA----KSVPSHTYSNEVV 165
Query: 578 SGWQAPEQLLQGRQ--TRAIDLFSLGCILFFCITG-----GKHPYGESFER--------- 621
+ W P +L G + +D++ +GCI I G G + ER
Sbjct: 166 TLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPN 225
Query: 622 ----------------------DANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKA 659
N+ + L V H A DL ++LL P R A
Sbjct: 226 EDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNH---AEDLASKLLQCFPKNRLSA 282
Query: 660 QNVLNHPFFWTADTRLSFLRD 680
Q L+H +F RL L D
Sbjct: 283 QAALSHEYFSDLPPRLWELTD 303
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 66/297 (22%), Positives = 117/297 (39%), Gaps = 56/297 (18%)
Query: 383 EIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQ---NLIASDQHPNIVRWYGVE 439
E+ G+ G V N E +A +++ T + L++ +++AS HPNIV+
Sbjct: 12 ELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71
Query: 440 SDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIE 499
++ +++ +E C D + +E
Sbjct: 72 YYENNLWILIEFCAGGAVDAVM------------------------------------LE 95
Query: 500 LWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISK 559
L + P ++ V + + L++LHE +IHRDLK N+L + D KL+D G+S
Sbjct: 96 LERPLTEPQIRV--VCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDI--KLADFGVSA 151
Query: 560 RLQGDMSCLTQNATGYGSSGWQAPEQLL-QGRQTR----AIDLFSLGCILFFCITGGKHP 614
+ + + + + G+ W APE ++ + + R D++SLG I + + P
Sbjct: 152 K---NTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLG-ITLIEMAQIEPP 207
Query: 615 YGE--SFERDANIVKDRKDLFL--VEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPF 667
+ E I K E D + L+ N D R +L HPF
Sbjct: 208 HHELNPMRVLLKIAKSEPPTLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPF 264
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 2e-07
Identities = 30/95 (31%), Positives = 48/95 (50%), Gaps = 2/95 (2%)
Query: 521 GLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGW 580
G+ +L E +HRDL +NVL+ AK+SD G+SK L D + G W
Sbjct: 107 GMKYLEETNFVHRDLAARNVLLVTQHY--AKISDFGLSKALGADENYYKAKTHGKWPVKW 164
Query: 581 QAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY 615
APE + + + D++S G +++ + G+ PY
Sbjct: 165 YAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPY 199
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 2e-07
Identities = 48/162 (29%), Positives = 80/162 (49%), Gaps = 19/162 (11%)
Query: 517 DIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYG 576
+I S L LH+ G+I+RDLK NVL+ + C KL+D G+ K + T +T G
Sbjct: 104 EITSALMFLHDKGIIYRDLKLDNVLLDHE-GHC-KLADFGMCKEGIFN-GKTT--STFCG 158
Query: 577 SSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERD--ANIVKDR--KDL 632
+ + APE L + ++D +++G +L + + G P+ E D I+ D
Sbjct: 159 TPDYIAPEILQEMLYGPSVDWWAMG-VLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPT 217
Query: 633 FLVEHIPEAVDLFTRLLDPNPDLRPKA------QNVLNHPFF 668
+L + +AVD+ + NP +R + + +L HPFF
Sbjct: 218 WLSQ---DAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFF 256
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 2e-07
Identities = 34/106 (32%), Positives = 56/106 (52%), Gaps = 8/106 (7%)
Query: 497 DIELWKANGHPSAQLLKVTRDIVSGLSHLHE-IGLIHRDLKPQNVLISKDKSFCAKLSDM 555
D L KA P L K++ ++ GL++L E ++HRD+KP N+L++ KL D
Sbjct: 87 DQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEI--KLCDF 144
Query: 556 GISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLG 601
G+S +L M+ + G+ + +PE+L T D++SLG
Sbjct: 145 GVSGQLIDSMA-----NSFVGTRSYMSPERLQGTHYTVQSDIWSLG 185
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 2e-07
Identities = 63/225 (28%), Positives = 89/225 (39%), Gaps = 44/225 (19%)
Query: 482 NEVRIRLLPVMENT-----KDIELWKANGHPSAQLLK--VTRDIVSGLSHLHEIGLIHRD 534
NE I L VME K ++ + N H L + + L+++H + HRD
Sbjct: 136 NEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRD 195
Query: 535 LKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGY-GSSGWQAPEQLLQGRQ-T 592
LKPQN+LI + KL D G +K L Q + Y S ++APE +L T
Sbjct: 196 LKPQNLLIDP-NTHTLKLCDFGSAKNLLAG-----QRSVSYICSRFYRAPELMLGATNYT 249
Query: 593 RAIDLFSLGCILFFCITGGKHPYGESF--------------------ERDANIV------ 626
IDL+SLGCI+ I G G+S E + N
Sbjct: 250 THIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYADIKFPD 309
Query: 627 ---KDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 668
KD K +F +A++ ++ L P R L PFF
Sbjct: 310 VKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFF 354
|
Length = 440 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 3e-07
Identities = 80/347 (23%), Positives = 134/347 (38%), Gaps = 76/347 (21%)
Query: 376 KLVVFNKEIAKGSNGTVVLEGNYEGRSV-AVKRLV-------KTHHDVALKEIQNLIASD 427
KL +EI GS G V + V A+K++ + D+ +KE++ +
Sbjct: 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDI-IKEVR-FLQKL 72
Query: 428 QHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIR 487
+HPN +++ G + +L +E C S +DL+ V +E
Sbjct: 73 RHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQE------------------ 114
Query: 488 LLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKS 547
++ VT + GL++LH +IHRD+K N+L+S+
Sbjct: 115 ---------------------VEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGL 153
Query: 548 FCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLL---QGRQTRAIDLFSLGCIL 604
KL D G S + G+ W APE +L +G+ +D++SLG
Sbjct: 154 --VKLGDF-------GSASIMAPANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT- 203
Query: 605 FFCITGG--KHPYGESFERDA-----NIVKDRKDLFLVEHIPEAVDLFT-RLLDPNPDLR 656
CI K P F +A +I ++ H E F L P R
Sbjct: 204 --CIELAERKPPL---FNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDR 258
Query: 657 PKAQNVLNHPFFWTADTRLSFLRDVSDRVELEDRESDSKLLRALEGI 703
P ++ +L H F + + + D+ R + RE D+ R ++ I
Sbjct: 259 PTSEVLLKHRFV-LRERPPTVIMDLIQRTKDAVRELDNLQYRKMKKI 304
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 3e-07
Identities = 58/210 (27%), Positives = 92/210 (43%), Gaps = 50/210 (23%)
Query: 384 IAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQ---NLIAS-DQHPNIVRWYGV- 438
I KG+ G V N + S+A +++ DV +EI+ N++ S HPN+V++YG+
Sbjct: 30 IGKGTYGKVYKVTNKKDGSLAAVKILDPISDVD-EEIEAEYNILQSLPNHPNVVKFYGMF 88
Query: 439 -ESDQ---DFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMEN 494
++D+ ++L LE C GS E + L+E I +
Sbjct: 89 YKADKLVGGQLWLVLELCN----------GGSVTELVKGLLICGQRLDEAMISYI----- 133
Query: 495 TKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSD 554
L+ A + GL HLH +IHRD+K N+L++ + KL D
Sbjct: 134 -----LYGA---------------LLGLQHLHNNRIIHRDVKGNNILLTTEGG--VKLVD 171
Query: 555 MGISKRLQGDMSCLTQNATGYGSSGWQAPE 584
G+S +L S + T G+ W APE
Sbjct: 172 FGVSAQL---TSTRLRRNTSVGTPFWMAPE 198
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 3e-07
Identities = 55/210 (26%), Positives = 84/210 (40%), Gaps = 45/210 (21%)
Query: 515 TRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATG 574
T ++V L +H +G IHRD+KP N+L+ DKS KL+D G ++ + + + T
Sbjct: 148 TAEVVLALDAIHSMGFIHRDVKPDNMLL--DKSGHLKLADFGTCMKMNKE--GMVRCDTA 203
Query: 575 YGSSGWQAPEQLLQ----GRQTRAIDLFSLGCILFFCITGGKHPYGES------------ 618
G+ + +PE L G R D +S+G L+ + G Y +S
Sbjct: 204 VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHK 263
Query: 619 ----FERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFF----WT 670
F D +I K+ K+L V L R + + H FF W
Sbjct: 264 NSLTFPDDNDISKEAKNLICAFLTDREVRLG----------RNGVEEIKRHLFFKNDQWA 313
Query: 671 ----ADTRLSFLRDVS---DRVELEDRESD 693
DT + D+S D +D E D
Sbjct: 314 WETLRDTVAPVVPDLSSDIDTSNFDDIEED 343
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 3e-07
Identities = 63/252 (25%), Positives = 108/252 (42%), Gaps = 61/252 (24%)
Query: 384 IAKGSNGTVVLEGNYE---GRSVAVKRLVKTHHDVA------LKEIQNLIASD-QHPNIV 433
I KG G V L Y+ R VA+K++ + + L+E + IA+D HP IV
Sbjct: 10 IGKGGMGEVYLA--YDPVCSRRVALKKIREDLSENPLLKKRFLREAK--IAADLIHPGIV 65
Query: 434 RWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQL-NAKEQDSNLLNEVRIRLLPVM 492
Y + SD D VY ++ Y+ + + L + +++S L
Sbjct: 66 PVYSICSDGDPVYYTMP----------YIEGYTLKSLLKSVWQKES----------LS-- 103
Query: 493 ENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKL 552
K++ A L + I + + ++H G++HRDLKP N+L+ +
Sbjct: 104 ---KEL----AEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGE--VVI 154
Query: 553 SDMG--ISKRLQGD-------------MSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDL 597
D G I K+L+ + S +T G+ + APE+LL + + D+
Sbjct: 155 LDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDI 214
Query: 598 FSLGCILFFCIT 609
++LG IL+ +T
Sbjct: 215 YALGVILYQMLT 226
|
Length = 932 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 4e-07
Identities = 54/188 (28%), Positives = 90/188 (47%), Gaps = 11/188 (5%)
Query: 518 IVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGS 577
IV L +H ++HRDLK N+ + + KL D G SK+ +S L ++ G+
Sbjct: 178 IVLALDEVHSRKMMHRDLKSANIFLM--PTGIIKLGDFGFSKQYSDSVS-LDVASSFCGT 234
Query: 578 SGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERD--ANIVKDRKDLFLV 635
+ APE + R ++ D++SLG IL+ +T + P+ +R+ ++ + D F
Sbjct: 235 PYYLAPELWERKRYSKKADMWSLGVILYELLTLHR-PFKGPSQREIMQQVLYGKYDPFPC 293
Query: 636 EHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFF-WTADTRLSFLRDVSDRVELEDRESDS 694
L LL NP LRP Q +L+ F + A+ +R S+ + DRE
Sbjct: 294 PVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKYVANLFQDIVRH-SETISPHDRE--- 349
Query: 695 KLLRALEG 702
++LR L+
Sbjct: 350 EILRQLQE 357
|
Length = 478 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 4e-07
Identities = 70/277 (25%), Positives = 124/277 (44%), Gaps = 37/277 (13%)
Query: 401 RSVAVKRLVKTHHDVALKEI----QNLIASDQHPNIVRWYG-VESDQDFVYLSLERCTCS 455
++VA+K L K + L+E + + QHPNIV G V +Q LS+ CS
Sbjct: 36 QAVAIKTL-KDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQP---LSMIFSYCS 91
Query: 456 LNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVT 515
+DL E L + S++ +T D + K+ P A + +
Sbjct: 92 HSDL--------HEFLVMRSPHSDV------------GSTDDDKTVKSTLEP-ADFVHIV 130
Query: 516 RDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRL-QGDMSCLTQNATG 574
I +G+ L ++H+DL +NVL+ DK K+SD+G+ + + D L N+
Sbjct: 131 TQIAAGMEFLSSHHVVHKDLATRNVLVF-DK-LNVKISDLGLFREVYAADYYKLMGNSLL 188
Query: 575 YGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY-GESFERDANIVKDRKDLF 633
W +PE ++ G+ + D++S G +L+ + G PY G S + ++++R+ L
Sbjct: 189 --PIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRNRQVLP 246
Query: 634 LVEHIPEAV-DLFTRLLDPNPDLRPKAQNVLNHPFFW 669
+ P V L + P RP+ +++ + W
Sbjct: 247 CPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRTW 283
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 4e-07
Identities = 67/230 (29%), Positives = 103/230 (44%), Gaps = 39/230 (16%)
Query: 399 EGRS--VAVKRL----VKTHHDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERC 452
+GR VAVK L K + LKE++ +++ + PNI+R GV D+D + + E
Sbjct: 43 KGRPLLVAVKILRPDANKNARNDFLKEVK-ILSRLKDPNIIRLLGVCVDEDPLCMITEYM 101
Query: 453 TCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLL 512
DL LS L+ KE++ N L + + S LL
Sbjct: 102 ENG--DLNQFLS---SHHLDDKEENGNDAVPPAHCLPAI-------------SYSS--LL 141
Query: 513 KVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRL-QGDMSCLTQN 571
V I SG+ +L + +HRDL +N L+ ++ K++D G+S+ L GD +
Sbjct: 142 HVALQIASGMKYLSSLNFVHRDLATRNCLVGEN--LTIKIADFGMSRNLYAGDYYRIQGR 199
Query: 572 ATGYGSSGWQAPEQLLQGRQTRAIDLFSLGC----ILFFCITGGKHPYGE 617
A W A E +L G+ T A D+++ G IL C + PYGE
Sbjct: 200 AV--LPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLC---KEQPYGE 244
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 5e-07
Identities = 58/253 (22%), Positives = 100/253 (39%), Gaps = 44/253 (17%)
Query: 378 VVFNKEIAKGSNGTVVL--------EGNYEGRSVAVKRLVKTHHDVALKEIQNLIAS--- 426
+ K + +G G VV+ + + +VAVK L D K++ +L++
Sbjct: 14 LTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKML---KDDATDKDLSDLVSEMEM 70
Query: 427 ----DQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLN 482
+H NI+ G + +Y+ +E Y G+ E L
Sbjct: 71 MKMIGKHKNIINLLGACTQDGPLYVLVE----------YASKGNLREYL----------- 109
Query: 483 EVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLI 542
R R P M+ + D L+ + G+ +L IHRDL +NVL+
Sbjct: 110 --RARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLV 167
Query: 543 SKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGC 602
++D K++D G+++ + ++ + G W APE L T D++S G
Sbjct: 168 TEDNVM--KIADFGLARDVH-NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGV 224
Query: 603 ILFFCITGGKHPY 615
+L+ T G PY
Sbjct: 225 LLWEIFTLGGSPY 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 5e-07
Identities = 39/153 (25%), Positives = 72/153 (47%), Gaps = 12/153 (7%)
Query: 511 LLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQ 570
LL T + G+ L +HRDL +NVL+++ K K+ D G+++ + D + +++
Sbjct: 239 LLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGK--IVKICDFGLARDIMHDSNYVSK 296
Query: 571 NATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY-----GESFERDANI 625
+T + W APE + T D++S G +L+ + G PY +F N
Sbjct: 297 GST-FLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTF---YNK 352
Query: 626 VKDRKDLFLVEHIPEAV-DLFTRLLDPNPDLRP 657
+K + +H + V D+ + + P+ RP
Sbjct: 353 IKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRP 385
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 6e-07
Identities = 46/170 (27%), Positives = 77/170 (45%), Gaps = 36/170 (21%)
Query: 517 DIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKR--LQGDMSCLTQNATG 574
+I GL LH G+I+RDLK NV++ + K++D G+ K G + T
Sbjct: 109 EIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHI--KIADFGMCKENIFGGKTTR-----TF 161
Query: 575 YGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY-GESFERDANIVKDRKDLF 633
G+ + APE + +++D ++ G +L + + G+ P+ GE D +LF
Sbjct: 162 CGTPDYIAPEIIAYQPYGKSVDWWAFG-VLLYEMLAGQPPFDGE----------DEDELF 210
Query: 634 --LVEHIP--------EAVDLFTRLLDPNPDLR----PKA-QNVLNHPFF 668
++EH EAV + LL +P R P +++ H FF
Sbjct: 211 QSIMEHNVSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFF 260
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 6e-07
Identities = 41/155 (26%), Positives = 71/155 (45%), Gaps = 9/155 (5%)
Query: 507 PSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMS 566
P + K + S + H+H ++HRD+KP NV I+ + KL D+G+ + S
Sbjct: 104 PERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFIT--ATGVVKLGDLGLGRFFS---S 158
Query: 567 CLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGES---FERDA 623
T + G+ + +PE++ + D++SLGC+L+ YG+ F
Sbjct: 159 KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQ 218
Query: 624 NIVKDRKDLFLVEHIPEAV-DLFTRLLDPNPDLRP 657
I + EH E + +L + + P+PD RP
Sbjct: 219 KIEQCDYPPLPTEHYSEKLRELVSMCIYPDPDQRP 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 51.6 bits (124), Expect = 7e-07
Identities = 55/230 (23%), Positives = 91/230 (39%), Gaps = 56/230 (24%)
Query: 403 VAVKRLVKTHHDVALKEIQNLIAS-------DQHPNIVRWYGVESDQDFVYLSLERCTCS 455
VAVK L + K++ +L++ +H NI+ GV + + +Y+ +E
Sbjct: 45 VAVKMLKDDATE---KDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYA--- 98
Query: 456 LNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVT 515
NL + +R R P + D P + L
Sbjct: 99 --------------------AHGNLRDFLRARRPPGEYASPDDP------RPPEETLT-Q 131
Query: 516 RDIVS-------GLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCL 568
+D+VS G+ L IHRDL +NVL+++D K++D G+++ D+ +
Sbjct: 132 KDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTED--HVMKIADFGLAR----DIHHI 185
Query: 569 ---TQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY 615
+ G W APE L T D++S G +L+ T G PY
Sbjct: 186 DYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPY 235
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 7e-07
Identities = 62/247 (25%), Positives = 92/247 (37%), Gaps = 79/247 (31%)
Query: 517 DIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGI---------SKRLQ-GD-- 564
++ + +H++G IHRD+KP N+LI +D KL+D G+ SK Q GD
Sbjct: 109 ELTCAIESVHKMGFIHRDIKPDNILIDRDGHI--KLTDFGLCTGFRWTHDSKYYQKGDHH 166
Query: 565 ------------------------------MSCLTQNATGYGSSGWQAPEQLLQGRQTRA 594
CL + G + + APE LL+ T+
Sbjct: 167 RQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPN--YIAPEVLLRTGYTQL 224
Query: 595 IDLFSLGCILFFCITGGKHPY--GESFERDANIVKDRKDLFLVEHIP-------EAVDLF 645
D +S+G IL+ + G+ P+ E ++ L HIP EA DL
Sbjct: 225 CDWWSVGVILYEMLV-GQPPFLADTPAETQLKVINWETTL----HIPSQAKLSREASDLI 279
Query: 646 TRLLDPNPDLR---PKAQNVLNHPFFWTAD-------------TRLSFLRDVS--DRVEL 687
RL + R A + HPFF D +++ D S D V+
Sbjct: 280 LRLC-CGAEDRLGKNGADEIKAHPFFKGIDFASLIRRQKAPYIPKITHPTDTSNFDPVDP 338
Query: 688 EDRESDS 694
E SD
Sbjct: 339 EKLRSDD 345
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.2 bits (123), Expect = 7e-07
Identities = 44/194 (22%), Positives = 77/194 (39%), Gaps = 48/194 (24%)
Query: 510 QLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLT 569
QLL+ GL++ H+ ++HRDLKPQN+LIS+ KL+D G+++ S +
Sbjct: 111 QLLR-------GLAYCHQRRVLHRDLKPQNLLISERGEL--KLADFGLARA----KSVPS 157
Query: 570 QNATGYGSSGWQAPEQLLQGRQ--TRAIDLFSLGCILFFCITG----------------- 610
+ + + W P +L G + ++D++ +GCI + TG
Sbjct: 158 KTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKI 217
Query: 611 ---------GKHPYGESFE--RDANIVKDRKDLFL-----VEHIPEAVDLFTRLLDPNPD 654
P S + + + ++ IP +L + L P
Sbjct: 218 FRVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPK 277
Query: 655 LRPKAQNVLNHPFF 668
R A + HP+F
Sbjct: 278 KRISAAEAMKHPYF 291
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 8e-07
Identities = 29/102 (28%), Positives = 48/102 (47%), Gaps = 12/102 (11%)
Query: 507 PSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMS 566
P Q L + + I+ GL +LH +IHRD+K +N+ I+ C + D+G ++
Sbjct: 155 PIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVC--IGDLGAAQ------- 205
Query: 567 CLTQNATGYGSSG---WQAPEQLLQGRQTRAIDLFSLGCILF 605
G +G APE L + + D++S G +LF
Sbjct: 206 FPVVAPAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLF 247
|
Length = 357 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 9e-07
Identities = 69/253 (27%), Positives = 101/253 (39%), Gaps = 52/253 (20%)
Query: 373 RIGKLVVFNKE--IAKGSNGTV-----VLEGNYEGRSVAVKRLVKTHHDVALKEIQN--- 422
RI K F K + G+ GTV + EG VA+K L + A KEI +
Sbjct: 2 RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 61
Query: 423 LIASDQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLN 482
++AS +P++ R G+ C S LI L LL+
Sbjct: 62 VMASVDNPHVCRLLGI-------------CLTSTVQLITQLMPF-----------GCLLD 97
Query: 483 EVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLI 542
VR E+ +I S LL I G+++L E L+HRDL +NVL+
Sbjct: 98 YVR-------EHKDNI--------GSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLV 142
Query: 543 SKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGC 602
+ K++D G++K L D G W A E +L T D++S G
Sbjct: 143 KTPQH--VKITDFGLAKLLGADEKEY-HAEGGKVPIKWMALESILHRIYTHQSDVWSYGV 199
Query: 603 ILFFCITGGKHPY 615
++ +T G PY
Sbjct: 200 TVWELMTFGSKPY 212
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 9e-07
Identities = 55/202 (27%), Positives = 93/202 (46%), Gaps = 24/202 (11%)
Query: 487 RLLPVME--NTKDI--ELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLI 542
RL VME N D+ ++ ++ + ++ L LH G+I+RDLK N+L+
Sbjct: 70 RLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILL 129
Query: 543 SKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGC 602
+ C KL+D G+ K +G ++ +T T G+ + APE L + ++D ++LG
Sbjct: 130 DAE-GHC-KLADFGMCK--EGILNGVT-TTTFCGTPDYIAPEILQELEYGPSVDWWALG- 183
Query: 603 ILFFCITGGKHPYGESFERD--ANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLR---- 656
+L + + G+ P+ E D +I+ D L+ V EAV + + NP+ R
Sbjct: 184 VLMYEMMAGQPPFEADNEDDLFESILHD-DVLYPVWLSKEAVSILKAFMTKNPNKRLGCV 242
Query: 657 ---PKAQNVLNHPFF----WTA 671
+ HPFF W
Sbjct: 243 ASQGGEDAIKQHPFFKEIDWVL 264
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|188875 cd09769, Luminal_IRE1, The Luminal domain, a dimerization domain, of the Serine/Threonine protein kinase, Inositol-requiring protein 1 | Back alignment and domain information |
|---|
Score = 51.2 bits (123), Expect = 9e-07
Identities = 28/120 (23%), Positives = 50/120 (41%), Gaps = 13/120 (10%)
Query: 18 IKKLSSSAEEYIRRMPYISKDGGVTLGAMKTSVFLVDVKSGRVVDNYVLDFSASTPGFQS 77
+KKL + + ++ P S DG + G+ +T+ + VD ++G + + S
Sbjct: 68 LKKLPFTIPQLVQSSPCRSSDGILYTGSKQTTWYTVDPRTGEKIQVLGSGGADSN----- 122
Query: 78 DENKHVVPVDGYEELVESGVGNLKRIRQLVYIMRTDYVLQSTSQDSGEVLWNVAYADFKA 137
V P D + S +YI RT+Y + + E +WNV Y+D+
Sbjct: 123 CPESCVDPDDDEQSECSS--------SSTIYIGRTEYTVTIYDSKTREPIWNVTYSDYTP 174
|
The Luminal domain is a dimerization domain present in Inositol-requiring protein 1 (IRE1), a serine/threonine protein kinase (STK) and a type I transmembrane protein that is localized in the endoplasmic reticulum (ER). IRE1, also called Endoplasmic reticulum (ER)-to-nucleus signaling protein (or ERN), is a kinase receptor that also contains an endoribonuclease domain in the cytoplasmic side. It plays roles in the signaling of the unfolded protein response (UPR), which is activated when protein misfolding is detected in the ER in order to decrease the synthesis of new proteins and increase the capacity of the ER to cope with the stress. IRE1 acts as an ER stress sensor and is the oldest and most conserved component of the UPR in eukaryotes. During ER stress, IRE1 dimerizes through its luminal domain and forms oligomers, allowing the kinase domain to undergo trans-autophosphorylation. This leads to a conformational change that stimulates its endoribonuclease activity and results in the cleavage of its mRNA substrate, HAC1 in yeast and Xbp1 in metazoans, promoting a splicing event that enables translation into a transcription factor which activates the UPR. Mammals contain two IRE1 proteins, IRE1alpha (or ERN1) and IRE1beta (or ERN2). IRE1alpha is expressed in all cells and tissues while IRE1beta is found only in intestinal epithelial cells. Length = 295 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 9e-07
Identities = 58/261 (22%), Positives = 103/261 (39%), Gaps = 48/261 (18%)
Query: 407 RLVKTHHDV--ALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLS 464
RL K+ V + KE L+A +HPNIV + +Y+ +E C
Sbjct: 34 RLPKSSSAVEDSRKEAV-LLAKMKHPNIVAFKESFEADGHLYIVMEYC------------ 80
Query: 465 GSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSH 524
+L+ + I+L + P +L+ + G+ H
Sbjct: 81 -----------DGGDLMQK--------------IKLQRGKLFPEDTILQWFVQMCLGVQH 115
Query: 525 LHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPE 584
+HE ++HRD+K +N+ ++++ KL D G ++ L + T G+ + PE
Sbjct: 116 IHEKRVLHRDIKSKNIFLTQNGK--VKLGDFGSARLLTSPGA---YACTYVGTPYYVPPE 170
Query: 585 QLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERD--ANIVKDRKDLFLVEHIPEAV 642
D++SLGCIL+ T KHP+ + ++ + + + E
Sbjct: 171 IWENMPYNNKSDIWSLGCILYELCT-LKHPFQANSWKNLILKVCQGSYKPLPSHYSYELR 229
Query: 643 DLFTRLLDPNPDLRPKAQNVL 663
L ++ NP RP A +L
Sbjct: 230 SLIKQMFKRNPRSRPSATTIL 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 9e-07
Identities = 33/122 (27%), Positives = 53/122 (43%), Gaps = 20/122 (16%)
Query: 507 PSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMS 566
+L + R ++ + +LHE +IHRD+K +N+ I+ C L D G +
Sbjct: 180 AICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVC--LGDFG--------AA 229
Query: 567 CLTQNATGYGSSGW------QAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFE 620
C + GW APE L + A+D++S G +LF T + FE
Sbjct: 230 CFPVDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATC----HDSLFE 285
Query: 621 RD 622
+D
Sbjct: 286 KD 287
|
Length = 391 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 1e-06
Identities = 43/163 (26%), Positives = 78/163 (47%), Gaps = 19/163 (11%)
Query: 517 DIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRL-QGDMSCLTQNATG- 574
++ GL L +++RDLKP+N+L+ D ++SD+G++ ++ +G + G
Sbjct: 110 ELCCGLEDLQRERIVYRDLKPENILL--DDRGHIRISDLGLAVQIPEG------ETVRGR 161
Query: 575 YGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGK--HPYGESFERDA--NIVKDRK 630
G+ G+ APE + + T + D + LGC+++ I G E +R+ VK+ +
Sbjct: 162 VGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQ 221
Query: 631 DLFLVEHIPEAVDLFTRLLDPNPDLR-----PKAQNVLNHPFF 668
+ + + +A + LL NP R A V HP F
Sbjct: 222 EEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIF 264
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 1e-06
Identities = 40/159 (25%), Positives = 72/159 (45%), Gaps = 17/159 (10%)
Query: 507 PSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMS 566
P + K + S L H+H ++HRD+KP NV I+ + KL D+G+ + S
Sbjct: 104 PEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFIT--ATGVVKLGDLGLGRFFS---S 158
Query: 567 CLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERDANIV 626
T + G+ + +PE++ + D++SLGC+L+ YG+ N+
Sbjct: 159 KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----NLY 214
Query: 627 KDRKDLFLVEHIPEAVDLFTRLL--------DPNPDLRP 657
K + ++ P D ++ L +P+P+ RP
Sbjct: 215 SLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRP 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 1e-06
Identities = 63/301 (20%), Positives = 109/301 (36%), Gaps = 59/301 (19%)
Query: 382 KEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQNLIASD------QHPNIVRW 435
+EI G G V+L Y VA + + + + KE + QHPNI++
Sbjct: 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQC 60
Query: 436 YGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENT 495
G + L E C L DL LS
Sbjct: 61 LGQCVEAIPYLLVFE--YCELGDLKSYLSQ------------------------------ 88
Query: 496 KDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDM 555
E W L ++ +I +G++H+H+ +H DL +N ++ D K+ D
Sbjct: 89 ---EQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSD--LTVKVGDY 143
Query: 556 GIS-KRLQGDMSCLTQNATGYGSSGWQAPE-------QLLQGRQTRAIDLFSLGCILFFC 607
GI R + D + W APE L+ QT+ ++++LG L+
Sbjct: 144 GIGPSRYKEDY--IETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWEL 201
Query: 608 ITGGKHPYGESFERDA--NIVKDRKDLFLVEHIPEAV-DLFTRLLD---PNPDLRPKAQN 661
PY +R+ +++KD++ + + + +L +P+ R A+
Sbjct: 202 FENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELPYSERWYEVLQFCWLSPEKRATAEE 261
Query: 662 V 662
V
Sbjct: 262 V 262
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 50.9 bits (121), Expect = 1e-06
Identities = 52/231 (22%), Positives = 94/231 (40%), Gaps = 61/231 (26%)
Query: 382 KEIAKGSNGTVVLEGNYE-GRSVAVKRL-------VKTHHDVALKEIQNLIASDQHPNIV 433
+EI GS G V + VA+K++ + D+ +KE++ + +HPN +
Sbjct: 31 REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDI-IKEVK-FLQRIKHPNSI 88
Query: 434 RWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVME 493
+ G + +L +E C S +DL+ V +E
Sbjct: 89 EYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQE------------------------ 124
Query: 494 NTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLS 553
++ +T + GL++LH +IHRD+K N+L+++ KL+
Sbjct: 125 ---------------VEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQ--VKLA 167
Query: 554 DMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLL---QGRQTRAIDLFSLG 601
D G S + + G+ W APE +L +G+ +D++SLG
Sbjct: 168 DF-------GSASIASPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLG 211
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 2e-06
Identities = 57/207 (27%), Positives = 85/207 (41%), Gaps = 54/207 (26%)
Query: 517 DIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGI---------SKRLQ----- 562
++ + +H++G IHRD+KP N+LI D KL+D G+ SK Q
Sbjct: 109 ELTLAIESVHKMGFIHRDIKPDNILIDLDGHI--KLTDFGLCTGFRWTHNSKYYQKGSHI 166
Query: 563 -------------------GD-MSCLTQNATG----------YGSSGWQAPEQLLQGRQT 592
GD + L Q AT G+ + APE LL+ T
Sbjct: 167 RQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYT 226
Query: 593 RAIDLFSLGCILFFCITGGKHPY--GESFERDANIVKDRKDLFLVEHI---PEAVDLFTR 647
+ D +S+G ILF + G+ P+ E ++ L + + PEAVDL T+
Sbjct: 227 QLCDWWSVGVILFEMLV-GQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITK 285
Query: 648 LLDPNPDL--RPKAQNVLNHPFFWTAD 672
L + R A ++ HPFF D
Sbjct: 286 LCCSAEERLGRNGADDIKAHPFFSEVD 312
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 2e-06
Identities = 60/236 (25%), Positives = 96/236 (40%), Gaps = 51/236 (21%)
Query: 380 FNKEIAKGSNGTVVL-----EGNYEGRSVAVKRL---VKTHHDVALKEIQNLIASDQHPN 431
F +++ KG+ G+V L + G VAVK+L H +EI+ L S QH N
Sbjct: 8 FIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEIL-KSLQHDN 66
Query: 432 IVRWYGV--ESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLL 489
IV++ GV + + + L +E Y+ GS + L + R+
Sbjct: 67 IVKYKGVCYSAGRRNLRLVME----------YLPYGSLRDYLQK--------HRERLD-- 106
Query: 490 PVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFC 549
H LL I G+ +L +HRDL +N+L+ +
Sbjct: 107 ----------------HRK--LLLYASQICKGMEYLGSKRYVHRDLATRNILVESE--NR 146
Query: 550 AKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILF 605
K+ D G++K L D G W APE L + + + A D++S G +L+
Sbjct: 147 VKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLY 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 3e-06
Identities = 32/101 (31%), Positives = 50/101 (49%), Gaps = 2/101 (1%)
Query: 509 AQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCL 568
AQLL + I G+++LH IHRDL +NVL+ D+ K+ D G++K +
Sbjct: 107 AQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDR--LVKIGDFGLAKAVPEGHEYY 164
Query: 569 TQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCIT 609
G W A E L + + + A D++S G L+ +T
Sbjct: 165 RVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 3e-06
Identities = 31/107 (28%), Positives = 55/107 (51%), Gaps = 3/107 (2%)
Query: 511 LLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQ 570
L+ + + +G+ L +HRDL +NVLI + K K+ D G+++ + D + +++
Sbjct: 241 LVGFSYQVANGMEFLASKNCVHRDLAARNVLICEGK--LVKICDFGLARDIMRDSNYISK 298
Query: 571 NATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGE 617
+T + W APE + T D++S G +L+ T G PY E
Sbjct: 299 GST-FLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPE 344
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 3e-06
Identities = 54/209 (25%), Positives = 85/209 (40%), Gaps = 58/209 (27%)
Query: 517 DIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGI---------SKRLQ----- 562
++ + +H++G IHRD+KP N+LI +D KL+D G+ SK Q
Sbjct: 109 ELTCAVESVHKMGFIHRDIKPDNILIDRDGHI--KLTDFGLCTGFRWTHDSKYYQSGDHV 166
Query: 563 -----------GDMS---------------------CLTQNATGYGSSGWQAPEQLLQGR 590
GD + CL + G+ + APE LL+
Sbjct: 167 RQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLV--GTPNYIAPEVLLRTG 224
Query: 591 QTRAIDLFSLGCILFFCITGGKHPY--GESFERDANIVKDRKDLFL---VEHIPEAVDLF 645
T+ D +S+G IL+ + G+ P+ E ++ + L + + PEA DL
Sbjct: 225 YTQLCDWWSVGVILYEMLV-GQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLI 283
Query: 646 TRLL-DPNPDL-RPKAQNVLNHPFFWTAD 672
+L P L + A + HPFF T D
Sbjct: 284 IKLCRGPEDRLGKNGADEIKAHPFFKTID 312
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 3e-06
Identities = 72/349 (20%), Positives = 123/349 (35%), Gaps = 118/349 (33%)
Query: 383 EIAKG-SNGTVVLEGNYE--GRSVAVKRL---VKTHHDVALKEIQNLI---ASDQHPNIV 433
I K + +V ++ VAVK++ + D LK +Q I QHPNI+
Sbjct: 5 LIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKED--LKLLQQEIITSRQLQHPNIL 62
Query: 434 RWYGVESDQDFVYLSLERCTCSLNDLIYVLS-----GSFEEQLNAKEQDSNLLNEVRIRL 488
+ F+ + +YV+S GS E+ L K L E+ I
Sbjct: 63 PYV-----TSFIV----------DSELYVVSPLMAYGSCEDLL--KTHFPEGLPELAIAF 105
Query: 489 LPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSF 548
+ +D+++ L ++H G IHR +K ++L+S D
Sbjct: 106 -------------------------ILKDVLNALDYIHSKGFIHRSVKASHILLSGDGK- 139
Query: 549 CAKLSDMGIS-------KRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ--TRAIDLFS 599
LS + S KR Q + +++ + W +PE L Q Q D++S
Sbjct: 140 -VVLSGLRYSVSMIKHGKR-QRVVHDFPKSSV--KNLPWLSPEVLQQNLQGYNEKSDIYS 195
Query: 600 LGCILFFCIT-----GGKHPYGE----------------------SFERDANIVKDRKDL 632
+G IT G P+ + ++ + + +
Sbjct: 196 VG------ITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSS 249
Query: 633 FLVEHIPEAVD-LFTRLLDP------------NPDLRPKAQNVLNHPFF 668
+ ++VD +TR +P+ RP A +LNH FF
Sbjct: 250 NEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFF 298
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 3e-06
Identities = 45/207 (21%), Positives = 86/207 (41%), Gaps = 49/207 (23%)
Query: 382 KEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQN---LIASDQHPNIVRWYGV 438
+ + G+ G V N +A +++K IQ ++ +H NIV ++G
Sbjct: 15 QRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGS 74
Query: 439 ESDQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKD 497
++ +++ +E C SL D IY ++G E
Sbjct: 75 YLSREKLWICMEYCGGGSLQD-IYHVTGPLSE---------------------------- 105
Query: 498 IELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGI 557
Q+ V R+ + GL++LH G +HRD+K N+L++ + KL+D G+
Sbjct: 106 -----------LQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGD--VKLADFGV 152
Query: 558 SKRLQGDMSCLTQNATGYGSSGWQAPE 584
+ ++ ++ + + G+ W APE
Sbjct: 153 AAKITATIA---KRKSFIGTPYWMAPE 176
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 3e-06
Identities = 43/160 (26%), Positives = 72/160 (45%), Gaps = 17/160 (10%)
Query: 517 DIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYG 576
+I S L +LH I +++RDLKP+N+L+ D L+D G+ K ++ T G
Sbjct: 104 EIASALGYLHSINIVYRDLKPENILL--DSQGHVVLTDFGLCKE---GIAQSDTTTTFCG 158
Query: 577 SSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERDANIVKD---RKDLF 633
+ + APE + + +D + LG +L+ + G P+ + RD + D K L
Sbjct: 159 TPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLY-GLPPF---YCRDVAEMYDNILHKPLV 214
Query: 634 LVEHIPEAV-DLFTRLLDPNPDLRPKAQN----VLNHPFF 668
L + LL+ + R A+ + HPFF
Sbjct: 215 LRPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFF 254
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 48.7 bits (117), Expect = 5e-06
Identities = 48/179 (26%), Positives = 90/179 (50%), Gaps = 20/179 (11%)
Query: 499 ELWKANGH-PSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVL--ISKDKSFCAKLSDM 555
+L K G A++ K+ R +V L+ LH+ +IH D+K +NVL +KD+ + L D
Sbjct: 98 DLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIY---LCDY 154
Query: 556 GISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY 615
G+ K + G SC G+ + +PE++ + D +++G +L + + GKHP+
Sbjct: 155 GLCKII-GTPSCYD------GTLDYFSPEKIKGHNYDVSFDWWAVG-VLTYELLTGKHPF 206
Query: 616 GESFERDANI--VKDR--KDLFLVEHIPE-AVDLFTRLLDPNPDLR-PKAQNVLNHPFF 668
E + + ++ + R K L ++++ + A D +L N + R ++ HPF
Sbjct: 207 KEDEDEELDLESLLKRQQKKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFL 265
|
Length = 267 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 7e-06
Identities = 73/305 (23%), Positives = 115/305 (37%), Gaps = 66/305 (21%)
Query: 382 KEIAKGSNGTVVLEGNYEGRSVA---VKRLVKT----HHDVALKEIQNLIASDQHPNIVR 434
EI G G V+L + G S A VK L + + L+E+Q HPN+++
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYREL-NHPNVLQ 59
Query: 435 WYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMEN 494
G + L LE C L DL L + ++D
Sbjct: 60 CLGQCIESIPYLLVLE--FCPLGDLKNYLRSNRGMVAQMAQKDV---------------- 101
Query: 495 TKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSD 554
L ++ ++ SGL LH+ IH DL +N ++ D S K+ D
Sbjct: 102 ----------------LQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLS--VKIGD 143
Query: 555 MGISKRLQGDMSCLTQNATGYGSSGWQAPE-------QLLQGRQTRAIDLFSLGCILFFC 607
G++ + +T++ W APE LL QT+ +++SLG ++
Sbjct: 144 YGLALEQYPEDYYITKDCHAVPLR-WLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWEL 202
Query: 608 ITGGKHPYGES----------FERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRP 657
T PY + E+D + K + DL + E V F L +P+ RP
Sbjct: 203 FTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDLKYSDRWYE-VMQFCWL---DPETRP 258
Query: 658 KAQNV 662
A+ V
Sbjct: 259 TAEEV 263
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 9e-06
Identities = 29/94 (30%), Positives = 51/94 (54%), Gaps = 5/94 (5%)
Query: 517 DIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYG 576
+I S L +LH + +++RDLKP+N+L+ D L+D G+ K ++ +T G
Sbjct: 104 EIASALGYLHSLNIVYRDLKPENILL--DSQGHIVLTDFGLCKE---NIEHNGTTSTFCG 158
Query: 577 SSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG 610
+ + APE L + R +D + LG +L+ + G
Sbjct: 159 TPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 1e-05
Identities = 38/128 (29%), Positives = 65/128 (50%), Gaps = 18/128 (14%)
Query: 517 DIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKR--LQGDMSCLTQNATG 574
+I L+ LHE G+I+RDLK NVL+ D KL+D G+ K GD + +T
Sbjct: 104 EICIALNFLHERGIIYRDLKLDNVLLDADGHI--KLTDYGMCKEGLGPGDTT-----STF 156
Query: 575 YGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDRKDLFL 634
G+ + APE L ++D ++LG +L F + G+ P+ +I+ D D+
Sbjct: 157 CGTPNYIAPEILRGEEYGFSVDWWALG-VLMFEMMAGRSPF--------DIITDNPDMNT 207
Query: 635 VEHIPEAV 642
+++ + +
Sbjct: 208 EDYLFQVI 215
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 1e-05
Identities = 28/94 (29%), Positives = 50/94 (53%), Gaps = 5/94 (5%)
Query: 517 DIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYG 576
++ S + +LH + +I+RDLKP+N+L+ D L+D G+ K + +T G
Sbjct: 104 EVASAIGYLHSLNIIYRDLKPENILL--DSQGHVVLTDFGLCKE---GVEPEETTSTFCG 158
Query: 577 SSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG 610
+ + APE L + R +D + LG +L+ + G
Sbjct: 159 TPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 1e-05
Identities = 29/105 (27%), Positives = 50/105 (47%), Gaps = 3/105 (2%)
Query: 511 LLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQ 570
LL I G+ +L E ++HR+L +N+L+ D +++D G++ L D
Sbjct: 111 LLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSD--SIVQIADFGVADLLYPDDKKYFY 168
Query: 571 NATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY 615
+ W A E +L GR T D++S G ++ ++ G PY
Sbjct: 169 SEHK-TPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPY 212
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 47.4 bits (112), Expect = 1e-05
Identities = 33/108 (30%), Positives = 52/108 (48%), Gaps = 3/108 (2%)
Query: 508 SAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSC 567
S LL I G+ +L E L+HRDL +NVL+ K++D G+++ L+GD
Sbjct: 108 SQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNH--VKITDFGLARLLEGDEKE 165
Query: 568 LTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY 615
+ G W A E + + T D++S G ++ +T G PY
Sbjct: 166 YNADG-GKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPY 212
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 2e-05
Identities = 39/140 (27%), Positives = 66/140 (47%), Gaps = 21/140 (15%)
Query: 497 DIELWKANGHPSAQLLKVTRDIVSGLSHLHEI-GLIHRDLKPQNVLISKDKSFCAKLSDM 555
D L KA P L KV+ ++ GL++L E ++HRD+KP N+L++ KL D
Sbjct: 91 DQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEI--KLCDF 148
Query: 556 GISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP- 614
G+S +L M+ + G+ + +PE+L + D++S+G L + G++P
Sbjct: 149 GVSGQLIDSMA-----NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVE-MAIGRYPI 202
Query: 615 -----------YGESFERDA 623
+G E D
Sbjct: 203 PPPDAKELELMFGCPVEGDP 222
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 47.4 bits (112), Expect = 2e-05
Identities = 43/168 (25%), Positives = 77/168 (45%), Gaps = 16/168 (9%)
Query: 517 DIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYG 576
++V + +H++ +HRD+KP N+L+ D + +L+D G +L D + Q++ G
Sbjct: 110 EMVIAIDSVHQLHYVHRDIKPDNILM--DMNGHIRLADFGSCLKLMEDGT--VQSSVAVG 165
Query: 577 SSGWQAPEQLL-----QGRQTRAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDRKD 631
+ + +PE L +G+ D +SLG ++ + G Y ES + + K+
Sbjct: 166 TPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKE 225
Query: 632 LF----LVEHIPE-AVDLFTRLLDPNPDL--RPKAQNVLNHPFFWTAD 672
F V + E A DL RL+ + ++ HPFF D
Sbjct: 226 RFQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGID 273
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 2e-05
Identities = 52/175 (29%), Positives = 84/175 (48%), Gaps = 28/175 (16%)
Query: 517 DIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKR--LQGDMSCLTQNATG 574
+I L+ LHE G+I+RDLK NVL+ + KL+D G+ K GD + +T
Sbjct: 104 EISLALNFLHERGIIYRDLKLDNVLLDAEGHI--KLTDYGMCKEGIRPGDTT-----STF 156
Query: 575 YGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY---GESFERDANIVKDRKD 631
G+ + APE L ++D ++LG +L F + G+ P+ G S D N +D
Sbjct: 157 CGTPNYIAPEILRGEDYGFSVDWWALG-VLMFEMMAGRSPFDIVGMSDNPDQN-TEDYLF 214
Query: 632 LFLVE---HIP-----EAVDLFTRLLDPNPDLR----PKA--QNVLNHPFFWTAD 672
++E IP +A + L+ +P R P+ +++ +HPFF D
Sbjct: 215 QVILEKQIRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNID 269
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 2e-05
Identities = 55/206 (26%), Positives = 91/206 (44%), Gaps = 28/206 (13%)
Query: 517 DIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYG 576
++V + +H++ +HRD+KP NVL+ D + +L+D G ++ D + Q++ G
Sbjct: 110 EMVLAIHSIHQLHYVHRDIKPDNVLL--DMNGHIRLADFGSCLKMNQDGT--VQSSVAVG 165
Query: 577 SSGWQAPEQLLQ------GRQTRAIDLFSLGCILFFCITGGKHPYGESF-ERDANIVKDR 629
+ + +PE +LQ G+ D +SLG ++ + G Y ES E I+
Sbjct: 166 TPDYISPE-ILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHE 224
Query: 630 KDLFLVEHI----PEAVDLFTRLLDPNPDLRPKAQNVLN----HPFF----WTADTRLS- 676
+ HI EA DL RL+ R QN + H FF W L
Sbjct: 225 ERFQFPSHITDVSEEAKDLIQRLICSRE--RRLGQNGIEDFKKHAFFEGIDWENIRNLEA 282
Query: 677 -FLRDVSDRVELEDRESDSKLLRALE 701
++ DVS + + + D +LR E
Sbjct: 283 PYIPDVSSPSDTSNFDVDDDVLRNPE 308
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 46.6 bits (111), Expect = 2e-05
Identities = 55/259 (21%), Positives = 98/259 (37%), Gaps = 74/259 (28%)
Query: 376 KLVVFNKEIAKGSNGTVVLEGNY-----EGRSVAVKRLVKTHHDVALKE--------IQN 422
+ + + I +G G V +G Y E +VAVK K +++E ++
Sbjct: 6 EDITLGRCIGEGQFGDV-YQGVYMSPENEKIAVAVK-TCKNCTSPSVREKFLQEAYIMRQ 63
Query: 423 LIASDQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLN 482
HP+IV+ GV ++ V++ +E G L + + L
Sbjct: 64 F----DHPHIVKLIGVITENP-VWIVMELAP----------LGELRSYL---QVNKYSL- 104
Query: 483 EVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLI 542
A L+ + + + L++L +HRD+ +NVL+
Sbjct: 105 ------------------------DLASLILYSYQLSTALAYLESKRFVHRDIAARNVLV 140
Query: 543 SKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSS------GWQAPEQLLQGRQTRAID 596
S C KL D G+S+ L+ + + Y +S W APE + R T A D
Sbjct: 141 SSPD--CVKLGDFGLSRYLEDE--------SYYKASKGKLPIKWMAPESINFRRFTSASD 190
Query: 597 LFSLGCILFFCITGGKHPY 615
++ G ++ + G P+
Sbjct: 191 VWMFGVCMWEILMLGVKPF 209
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 2e-05
Identities = 42/186 (22%), Positives = 71/186 (38%), Gaps = 33/186 (17%)
Query: 491 VMENTK----DIELWKANGHPSAQ-LLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKD 545
V E K D+ L + + S L V + + S L +L + L+H ++ +N+L+++
Sbjct: 78 VEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARY 137
Query: 546 K-----SFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQL--LQGRQTRAIDLF 598
KLSD GI + + + W APE + Q T A D +
Sbjct: 138 GLNEGYVPFIKLSDPGIPITVLSREERVER-------IPWIAPECIRNGQASLTIAADKW 190
Query: 599 SLGCILFFCITGGKHPYG-------ESFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDP 651
S G L + G+ P E F +D + + + E +L +
Sbjct: 191 SFGTTLLEICSNGEEPLSTLSSSEKERFYQDQHRLP-------MPDCAELANLINQCWTY 243
Query: 652 NPDLRP 657
+P RP
Sbjct: 244 DPTKRP 249
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 2e-05
Identities = 50/174 (28%), Positives = 80/174 (45%), Gaps = 26/174 (14%)
Query: 517 DIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKR--LQGDMSCLTQNATG 574
+I L++LHE G+I+RDLK NVL+ + KL+D G+ K GD + +T
Sbjct: 104 EISLALNYLHERGIIYRDLKLDNVLLDSEGHI--KLTDYGMCKEGLRPGDTT-----STF 156
Query: 575 YGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY---GESFERDANIVKDRKD 631
G+ + APE L ++D ++LG +L F + G+ P+ G S D N
Sbjct: 157 CGTPNYIAPEILRGEDYGFSVDWWALG-VLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQ 215
Query: 632 LFLVEHIP-------EAVDLFTRLLDPNPDLR----PKA--QNVLNHPFFWTAD 672
+ L + I +A + L+ +P R P+ ++ HPFF D
Sbjct: 216 VILEKQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVD 269
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 46.6 bits (111), Expect = 3e-05
Identities = 54/230 (23%), Positives = 91/230 (39%), Gaps = 57/230 (24%)
Query: 403 VAVKRLVKTHHDVALKEIQN---LIASDQHPNIVRWYGVESDQDFVYLSLERCTCSLNDL 459
VAVK L D A ++ +++ PNI R GV + + + +E
Sbjct: 49 VAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIME--------- 99
Query: 460 IYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIV 519
Y+ +G + L +++ L N+K + + LL + I
Sbjct: 100 -YMENGDLNQFLQKHVAETSGLAC----------NSKSL--------SFSTLLYMATQIA 140
Query: 520 SGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRL-QGDMSCLTQNATGYGSS 578
SG+ +L + +HRDL +N L+ K++ K++D G+S+ L D Y
Sbjct: 141 SGMRYLESLNFVHRDLATRNCLV--GKNYTIKIADFGMSRNLYSSDY---------YRVQ 189
Query: 579 G-------WQAPEQLLQGRQTRAIDLFSLGC----ILFFCITGGKHPYGE 617
G W A E +L G+ T D+++ G IL C + PY
Sbjct: 190 GRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLC---REQPYEH 236
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 3e-05
Identities = 34/110 (30%), Positives = 52/110 (47%), Gaps = 5/110 (4%)
Query: 507 PSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRL-QGDM 565
P LLK DI G+ +L IHRDL +N ++ +D + C ++D G+SK++ GD
Sbjct: 111 PLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVC--VADFGLSKKIYSGDY 168
Query: 566 SCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY 615
Q W A E L T D+++ G ++ T G+ PY
Sbjct: 169 --YRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPY 216
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 3e-05
Identities = 22/48 (45%), Positives = 31/48 (64%), Gaps = 2/48 (4%)
Query: 512 LKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISK 559
+K ++ L +LH G+IHRDLKP N+LIS + KL+D G+SK
Sbjct: 107 VKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHI--KLTDFGLSK 152
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 4e-05
Identities = 50/178 (28%), Positives = 74/178 (41%), Gaps = 39/178 (21%)
Query: 507 PSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMG------ISKR 560
P + + ++V L LH G++ RDL P N+L L D G S+
Sbjct: 83 PEECVKRWAAEMVVALDALHREGIVCRDLNPNNIL----------LDDRGHIQLTYFSRW 132
Query: 561 LQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGK----HPYG 616
+ + SC + + + APE +T A D +SLG ILF +TG HP G
Sbjct: 133 SEVEDSCDGEAV----ENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG 188
Query: 617 ESFERDANIVKDRKDLFLVEHIP-EAVDLFTRLLDPNPDLRPKA-----QNVLNHPFF 668
+ L + E + EA L +LL NP R A +++ +HPFF
Sbjct: 189 ---------INTHTTLNIPEWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF 237
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 4e-05
Identities = 53/237 (22%), Positives = 92/237 (38%), Gaps = 54/237 (22%)
Query: 429 HPNIVRWYGVESDQDFVYLSLERCT-CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIR 487
HPNIVR+Y + D +Y+ ++ L + L KE+ E
Sbjct: 68 HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSL----------KEKKQRFTEE---- 113
Query: 488 LLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH-EIGLIHRDLKPQNVLISKDK 546
+W + +V L +LH E ++HRDL P N+++ +D
Sbjct: 114 -----------RIWN-----------IFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDD 151
Query: 547 SFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFF 606
++D G++K+ + S LT G+ + PE + D+++ GCIL+
Sbjct: 152 K--VTITDFGLAKQ-KQPESKLTSVV---GTILYSCPEIVKNEPYGEKADVWAFGCILYQ 205
Query: 607 CITGGKHPYGESFERDANIVKDRKDLFLVEHIPEAV------DLFTRLLDPNPDLRP 657
T Y + A + + E +PE + D+ T L P+ + RP
Sbjct: 206 MCTLQPPFYSTNMLSLATKIVEAV----YEPLPEGMYSEDVTDVITSCLTPDAEARP 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 5e-05
Identities = 39/141 (27%), Positives = 71/141 (50%), Gaps = 7/141 (4%)
Query: 521 GLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYG-SSG 579
G+ +L +HRDL +N ++ D+SF K++D G+++ + N TG
Sbjct: 110 GMEYLASKKFVHRDLAARNCML--DESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVK 167
Query: 580 WQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGE--SFERDANIVKDRKDLFLVEH 637
W A E L + T D++S G +L+ +T G PY + SF+ +++ R+ L E+
Sbjct: 168 WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRR-LLQPEY 226
Query: 638 IPEAV-DLFTRLLDPNPDLRP 657
P+ + ++ P P++RP
Sbjct: 227 CPDPLYEVMLSCWHPKPEMRP 247
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 6e-05
Identities = 19/45 (42%), Positives = 28/45 (62%), Gaps = 3/45 (6%)
Query: 513 KVTRDIVSGLSHLHEIGLIHRDLKPQNVLIS-KDKSFCAKLSDMG 556
+ R I+ L LH G++HRD+KPQN++ S SF K+ D+G
Sbjct: 259 TIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGSF--KIIDLG 301
|
Length = 566 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 7e-05
Identities = 31/109 (28%), Positives = 53/109 (48%), Gaps = 11/109 (10%)
Query: 511 LLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQ 570
LL+ + + G+ L IHRD+ +NVL++ + AK+ D G+++ + D
Sbjct: 214 LLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGR--VAKICDFGLARDIMND-----S 266
Query: 571 NATGYGSS----GWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY 615
N G++ W APE + T D++S G +L+ + GK PY
Sbjct: 267 NYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPY 315
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 1e-04
Identities = 19/43 (44%), Positives = 30/43 (69%), Gaps = 2/43 (4%)
Query: 514 VTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMG 556
V R +++GL LH IG++HRD+KP+N+L++ D K+ D G
Sbjct: 314 VMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQ--VKIIDFG 354
|
Length = 507 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 2e-04
Identities = 33/109 (30%), Positives = 57/109 (52%), Gaps = 8/109 (7%)
Query: 497 DIELWKANGHPSAQLLKVTRDIVSGLSHLHEI-GLIHRDLKPQNVLISKDKSFCAKLSDM 555
D L +A P L KV+ ++ GL++L E ++HRD+KP N+L++ KL D
Sbjct: 91 DQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEI--KLCDF 148
Query: 556 GISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCIL 604
G+S +L M+ + G+ + +PE+L + D++S+G L
Sbjct: 149 GVSGQLIDSMA-----NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSL 192
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 2e-04
Identities = 41/155 (26%), Positives = 68/155 (43%), Gaps = 16/155 (10%)
Query: 511 LLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQ 570
LL + + G+S L IHRDL +N+L++ + K+ D G+++ ++ D
Sbjct: 216 LLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGR--ITKICDFGLARDIRND-----S 268
Query: 571 NATGYGSS----GWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERDANIV 626
N G++ W APE + T D++S G +L+ + G PY D+
Sbjct: 269 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPY-PGMPVDSKFY 327
Query: 627 KDRKD---LFLVEHIP-EAVDLFTRLLDPNPDLRP 657
K K+ + E P E D+ D +P RP
Sbjct: 328 KMIKEGYRMLSPECAPSEMYDIMKSCWDADPLKRP 362
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 3e-04
Identities = 33/112 (29%), Positives = 53/112 (47%), Gaps = 10/112 (8%)
Query: 511 LLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQ 570
L ++ +I GL HLH+ IH DL +N L++ D + K+ D G+S + +T
Sbjct: 102 LQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLT--VKIGDYGLSHNKYKEDYYVTP 159
Query: 571 NATGYGSSGWQAPE-------QLLQGRQTRAIDLFSLGCILFFCITGGKHPY 615
+ + W APE LL QT+ +++SLG ++ G PY
Sbjct: 160 DQL-WVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPY 210
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 3e-04
Identities = 31/100 (31%), Positives = 51/100 (51%), Gaps = 5/100 (5%)
Query: 507 PSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMS 566
P Q + + R ++ L++LH G+IHRD+K +N+ + D+ A L D G + +L D
Sbjct: 183 PLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFL--DEPENAVLGDFGAACKL--DAH 238
Query: 567 CLTQNATGY-GSSGWQAPEQLLQGRQTRAIDLFSLGCILF 605
T G+ G+ +PE L D++S G +LF
Sbjct: 239 PDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLF 278
|
Length = 392 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 3e-04
Identities = 55/221 (24%), Positives = 94/221 (42%), Gaps = 39/221 (17%)
Query: 403 VAVKRLV----KTHHDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCSLND 458
VAVK L K + LKEI+ +++ + PNI+R V D + + E
Sbjct: 49 VAVKMLREDANKNARNDFLKEIK-IMSRLKDPNIIRLLAVCITSDPLCMITE-------- 99
Query: 459 LIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDI 518
Y+ +G + L+ E + I + L+ + I
Sbjct: 100 --YMENGDLNQFLSRHEPQEA----------AEKADVVTISY--------STLIFMATQI 139
Query: 519 VSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRL-QGDMSCLTQNATGYGS 577
SG+ +L + +HRDL +N L+ K+ + K++D G+S+ L GD + A
Sbjct: 140 ASGMKYLSSLNFVHRDLATRNCLVGKN--YTIKIADFGMSRNLYSGDYYRIQGRAV--LP 195
Query: 578 SGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGK-HPYGE 617
W + E +L G+ T A D+++ G L+ +T K PY +
Sbjct: 196 IRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQ 236
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 4e-04
Identities = 46/172 (26%), Positives = 78/172 (45%), Gaps = 32/172 (18%)
Query: 517 DIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYG 576
+I GL LH G+I+RDLK NV++ + K++D G+ K D T G
Sbjct: 109 EISVGLFFLHRRGIIYRDLKLDNVMLDSEGHI--KIADFGMCKEHMVDGVT---TRTFCG 163
Query: 577 SSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY-GESFERDANIVKDRKDLF-- 633
+ + APE + +++D ++ G +L + + G+ P+ GE D +LF
Sbjct: 164 TPDYIAPEIIAYQPYGKSVDWWAYG-VLLYEMLAGQPPFDGE----------DEDELFQS 212
Query: 634 LVEH--------IPEAVDLFTRLLDPNPDLR----PKAQ-NVLNHPFFWTAD 672
++EH EAV + L+ +P R P+ + ++ H FF D
Sbjct: 213 IMEHNVSYPKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRRID 264
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.2 bits (101), Expect = 6e-04
Identities = 46/184 (25%), Positives = 84/184 (45%), Gaps = 37/184 (20%)
Query: 511 LLKVTRDIVSGLSHLHEIG-------LIHRDLKPQNVLISK---------------DKSF 548
++ +TR ++ L++ H + ++HRDLKPQN+ +S +
Sbjct: 120 IVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRP 179
Query: 549 CAKLSDMGISKRLQGDM---SCLTQNATGYGSSGWQAPEQLLQGRQT--RAIDLFSLGCI 603
AK+ D G+SK + + SC+ G+ + +PE LL ++ D+++LGCI
Sbjct: 180 IAKIGDFGLSKNIGIESMAHSCV-------GTPYYWSPELLLHETKSYDDKSDMWALGCI 232
Query: 604 LFFCITGGKHPY--GESFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQN 661
++ + GK P+ +F + + +K DL + E L LL+ + RP A
Sbjct: 233 IYE-LCSGKTPFHKANNFSQLISELKRGPDLPIKGKSKELNILIKNLLNLSAKERPSALQ 291
Query: 662 VLNH 665
L +
Sbjct: 292 CLGY 295
|
Length = 1021 |
| >gnl|CDD|226699 COG4248, COG4248, Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 9e-04
Identities = 31/119 (26%), Positives = 47/119 (39%), Gaps = 29/119 (24%)
Query: 511 LLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQ 570
LL+V R++ S + LHE G + D+ + L+S D + D +
Sbjct: 119 LLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDD----------SKVVLVDSDSFQINA 168
Query: 571 NATGY----GSSGWQAPEQLLQGRQTRAI----------DLFSLGCILFFCITGGKHPY 615
N T + G S + PE QT D F L ++F + GG+HPY
Sbjct: 169 NGTLHLCPVGVSEFTPPE-----LQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPY 222
|
Length = 637 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.002
Identities = 28/102 (27%), Positives = 49/102 (48%), Gaps = 11/102 (10%)
Query: 518 IVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGS 577
+ G+ L IHRDL +N+L+S++ K+ D G+++ + D + + GS
Sbjct: 183 VARGMEFLASRKCIHRDLAARNILLSENN--VVKICDFGLARDIYKDPDYVRK-----GS 235
Query: 578 S----GWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY 615
+ W APE + T D++S G +L+ + G PY
Sbjct: 236 ARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPY 277
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.002
Identities = 46/194 (23%), Positives = 76/194 (39%), Gaps = 40/194 (20%)
Query: 517 DIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQ-------------- 562
+ V + +H++G IHRD+KP N+L+ D KLSD G+ L+
Sbjct: 109 ETVLAIDAIHQLGFIHRDIKPDNLLL--DAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHN 166
Query: 563 --GDMSCLTQNA----------------TGYGSSGWQAPEQLLQGRQTRAIDLFSLGCIL 604
D S N+ + G+ + APE +Q + D +SLG I+
Sbjct: 167 PPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIM 226
Query: 605 FFCITGGKHPYGESFERDANIVKD-RKDLFLVEHIP---EAVDLFTRLL--DPNPDLRPK 658
+ + G E+ + V + ++ L +P +A DL R N
Sbjct: 227 YEMLIGYPPFCSETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCTDSENRIGSNG 286
Query: 659 AQNVLNHPFFWTAD 672
+ + +HPFF D
Sbjct: 287 VEEIKSHPFFEGVD 300
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.003
Identities = 31/126 (24%), Positives = 52/126 (41%), Gaps = 34/126 (26%)
Query: 517 DIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMG----------------ISKR 560
+ V + +H++G IHRD+KP N+L+ D KLSD G ++
Sbjct: 109 ETVLAIDSIHQLGFIHRDIKPDNLLL--DSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHS 166
Query: 561 LQGDMSCLTQNA----------------TGYGSSGWQAPEQLLQGRQTRAIDLFSLGCIL 604
L D + N+ + G+ + APE +Q + D +SLG I+
Sbjct: 167 LPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIM 226
Query: 605 FFCITG 610
+ + G
Sbjct: 227 YEMLIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 805 | |||
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.98 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.98 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.98 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.97 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.97 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.97 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.97 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.97 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.96 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.96 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.96 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.96 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.95 | |
| PF06479 | 129 | Ribonuc_2-5A: Ribonuclease 2-5A; InterPro: IPR0105 | 99.95 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.95 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.94 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.94 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.94 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.91 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.91 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.91 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.86 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.85 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.85 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.84 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.84 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.83 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.83 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.82 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.81 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.76 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.75 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.74 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.73 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.73 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.73 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.73 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.68 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.68 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.68 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.64 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.59 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.55 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.54 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.54 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.52 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.52 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.46 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.42 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.37 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.33 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.23 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.22 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.17 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.1 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.0 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 98.94 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 98.93 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.87 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 98.83 | |
| smart00580 | 58 | PUG domain in protein kinases, N-glycanases and ot | 98.83 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.74 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.64 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.55 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.45 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.39 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.37 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 98.24 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.23 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.14 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.0 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 97.96 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 97.89 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 97.86 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.74 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.52 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 97.42 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 97.29 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 97.26 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 97.15 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.13 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 97.11 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.09 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 96.96 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 96.92 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 96.88 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 96.67 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 96.61 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 96.61 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 96.37 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 96.0 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 95.95 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 95.81 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 95.76 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 95.52 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 95.36 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 95.3 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 94.4 | |
| PF14593 | 104 | PH_3: PH domain; PDB: 1W1H_D 1W1D_A 1W1G_A 2VKI_A. | 94.09 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 93.89 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 93.68 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 93.45 | |
| PF12799 | 44 | LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_ | 93.36 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 93.29 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 92.63 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 92.51 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 92.32 | |
| PF01102 | 122 | Glycophorin_A: Glycophorin A; InterPro: IPR001195 | 92.26 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 92.07 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 90.96 | |
| PF04478 | 154 | Mid2: Mid2 like cell wall stress sensor; InterPro: | 90.56 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 90.45 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 89.89 | |
| cd01262 | 89 | PH_PDK1 3-Phosphoinositide dependent protein kinas | 89.56 | |
| PLN02236 | 344 | choline kinase | 89.55 |
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-82 Score=714.80 Aligned_cols=387 Identities=52% Similarity=0.932 Sum_probs=357.2
Q ss_pred EEeEeeccCCceEEEEEEeeCCcEEEEEEeecCCchHHHHHHHHHHHhCCCCCeeeecccccCCceEEEecccccCChhh
Q 003644 379 VFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCSLND 458 (805)
Q Consensus 379 ~~~~~LG~GsfGtVy~a~~~~g~~VAVK~l~~~~~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~E~~~~sL~d 458 (805)
.-.+.+|.|+.|+|++.+.++|+.||||++.....+.+.+|+..++....||||||+||..++..++||+.|+|.++|.|
T Consensus 512 ~~~eilG~Gs~Gt~Vf~G~ye~R~VAVKrll~e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~~sL~d 591 (903)
T KOG1027|consen 512 SPKEILGYGSNGTVVFRGVYEGREVAVKRLLEEFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCACSLQD 591 (903)
T ss_pred ccHHHcccCCCCcEEEEEeeCCceehHHHHhhHhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhhhhHHH
Confidence 34457999999999888999999999999998888899999999999999999999999999999999999999999999
Q ss_pred HHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCCCc
Q 003644 459 LIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQ 538 (805)
Q Consensus 459 ~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~IvHrDLKp~ 538 (805)
++..... +..+.. .-..+.++.|++.||+|||+.+||||||||+
T Consensus 592 lie~~~~---d~~~~~---------------------------------~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQ 635 (903)
T KOG1027|consen 592 LIESSGL---DVEMQS---------------------------------DIDPISVLSQIASGLAHLHSLKIVHRDLKPQ 635 (903)
T ss_pred HHhcccc---chhhcc---------------------------------cccHHHHHHHHHHHHHHHHhcccccccCCCc
Confidence 9965411 111000 0123678999999999999999999999999
Q ss_pred eEEecC---CCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCCC
Q 003644 539 NVLISK---DKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY 615 (805)
Q Consensus 539 NILl~~---~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~elltG~~~Pf 615 (805)
||||+. ++.++++|+|||+++++..+.+......+..||.+|+|||++.....+.++|||||||++|++++||.+||
T Consensus 636 NILI~~~~~~~~~ra~iSDfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpF 715 (903)
T KOG1027|consen 636 NILISVPSADGTLRAKISDFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPF 715 (903)
T ss_pred eEEEEccCCCcceeEEecccccccccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCC
Confidence 999976 67789999999999999988887777777889999999999999999999999999999999999999999
Q ss_pred CCchHHHHHHHhhccccccccCCh--HHHHHHHHhcCCCCCCCCChhhhhcCccccccccchhhhhhccccchhccccch
Q 003644 616 GESFERDANIVKDRKDLFLVEHIP--EAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTADTRLSFLRDVSDRVELEDRESD 693 (805)
Q Consensus 616 ~~~~~~~~~~~~~~~~~~~~~~~~--~~~dLi~~~L~~dP~~Rps~~ell~Hpff~~~~~~~~~l~~~~~~~e~~~~~~~ 693 (805)
++..+++.+|+.........+..+ ++.|||.+|+++||..||+|.+||.|||||+.++|+.|+++++||+|+|.++..
T Consensus 716 Gd~~~R~~NIl~~~~~L~~L~~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~~ekrL~Fl~dvSDRvE~e~r~~~ 795 (903)
T KOG1027|consen 716 GDSLERQANILTGNYTLVHLEPLPDCEAKDLISRMLNPDPQLRPSATDVLNHPLFWDSEKRLSFLRDVSDRVEKENRDSP 795 (903)
T ss_pred CchHHhhhhhhcCccceeeeccCchHHHHHHHHHhcCCCcccCCCHHHHhCCCccCChHHHHHHHHhhhhhhhhhhccCc
Confidence 999999999999888776665556 999999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHHHHHHhcCCcchHHHhHHHHhhhhhhcccCCCCHHHHHHHHhhcccccccCChhHHhhhCCCCccccccccc
Q 003644 694 SKLLRALEGIALVALNGKWDEKMETKFIENIGRYRRYKYDNVRDLLRVIRNKSNHFRELPQDIQELLGSHPEGFYNYFSC 773 (805)
Q Consensus 694 ~~l~~~le~~~~~~~~~~w~~~~~~~~~~~~~~~r~~~~~~~~dllr~irn~~~h~~e~~~~~~~l~g~~p~~f~~yf~~ 773 (805)
+++++++|..+..+..++|+++++..+++++++||+|+++++|||||+||||+|||+|+|++++|++|.+|+||..||++
T Consensus 796 s~lL~~le~~~~~vv~~~W~~kl~~~~~~~l~kyR~Yk~~svrDLLR~iRNk~hHyrELp~~v~ellG~vPdgF~~YFt~ 875 (903)
T KOG1027|consen 796 SELLRALEAGARVVVSGDWTEKLDKTFMDNLRKYRSYKGSSVRDLLRAIRNKKHHYRELPPEVRELLGDVPDGFDLYFTK 875 (903)
T ss_pred hHHHHhhccCCceEecCchhhhhCHHHHHHHHHhcCcccccHHHHHHHHHhhhhhhhhcCHHHHHhcCCCCcHHHHHHHH
Confidence 99999999888888899999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cCCccHHHHHHHHHhhhcccchhhccccc
Q 003644 774 RFPKLLIEVYNVIFTYCKGEEVFHKYVTN 802 (805)
Q Consensus 774 ~fp~ll~~~y~~~~~~~~~~~~~~~y~~~ 802 (805)
|||+||+|||.+++. |+.|+.|++||..
T Consensus 876 RFP~Lli~vY~~~~~-c~~E~~F~~Y~~~ 903 (903)
T KOG1027|consen 876 RFPNLLIHVYTVLSD-CSGEEIFKKYYSP 903 (903)
T ss_pred hhhHHHHHHHHHHHH-ccchhhhhhccCC
Confidence 999999999999987 9999999999973
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-48 Score=425.72 Aligned_cols=386 Identities=25% Similarity=0.367 Sum_probs=286.6
Q ss_pred ccccceEEEeEeeccCCceEEEEE-EeeCCcEEEEEEeecCCc------hHHHHHHHHHHHhCCCCCeeeecccccCCce
Q 003644 372 RRIGKLVVFNKEIAKGSNGTVVLE-GNYEGRSVAVKRLVKTHH------DVALKEIQNLIASDQHPNIVRWYGVESDQDF 444 (805)
Q Consensus 372 ~~i~~~~~~~~~LG~GsfGtVy~a-~~~~g~~VAVK~l~~~~~------~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~ 444 (805)
++-..+|.|++.||+|+|.+||+| ...+++++|||++.+... ....+|-..|...-.||.||+||..|+|+..
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s 148 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES 148 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence 344567999999999999999998 456799999999965431 1222333323333399999999999999999
Q ss_pred EEEecccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHH
Q 003644 445 VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSH 524 (805)
Q Consensus 445 l~LV~E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~y 524 (805)
+|+|+| |.++|.|.++++. .+.+++.+++.++.||+.||+|
T Consensus 149 LYFvLe----------~A~nGdll~~i~K-----------------------------~Gsfde~caR~YAAeIldAley 189 (604)
T KOG0592|consen 149 LYFVLE----------YAPNGDLLDLIKK-----------------------------YGSFDETCARFYAAEILDALEY 189 (604)
T ss_pred eEEEEE----------ecCCCcHHHHHHH-----------------------------hCcchHHHHHHHHHHHHHHHHH
Confidence 999999 7777777776643 3457778889999999999999
Q ss_pred hhhcceeccCCCCceEEecCCCCceEEEeccCccccccCCCcc----------ccccccccCCCCCCChhhhhcCCCCCc
Q 003644 525 LHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSC----------LTQNATGYGSSGWQAPEQLLQGRQTRA 594 (805)
Q Consensus 525 LH~~~IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~----------~~~~~~~~gt~~y~APE~l~~~~~t~~ 594 (805)
||+.|||||||||+||||+.|++ +||+|||.|+.+.+.... ..+..+++||..|++||+|..+..+..
T Consensus 190 lH~~GIIHRDlKPENILLd~dmh--ikITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~ 267 (604)
T KOG0592|consen 190 LHSNGIIHRDLKPENILLDKDGH--IKITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPS 267 (604)
T ss_pred HHhcCceeccCChhheeEcCCCc--EEEeeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcc
Confidence 99999999999999999988887 899999999988653221 111245789999999999999999999
Q ss_pred chHHHHHHHHHHHHhCCCCCCCCchHHH-HHHHhhccccccccCChHHHHHHHHhcCCCCCCCCChhhhhcCcccccccc
Q 003644 595 IDLFSLGCILFFCITGGKHPYGESFERD-ANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTADT 673 (805)
Q Consensus 595 sDVwSlGvil~elltG~~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dP~~Rps~~ell~Hpff~~~~~ 673 (805)
+|+|+||||+|.|+.| .|||....+.. .+.+......++...++.+.|||+++|..||.+|+|+++|.+||||.+.++
T Consensus 268 sDiWAlGCilyQmlaG-~PPFra~NeyliFqkI~~l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vdw 346 (604)
T KOG0592|consen 268 SDLWALGCILYQMLAG-QPPFRAANEYLIFQKIQALDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVDW 346 (604)
T ss_pred cchHHHHHHHHHHhcC-CCCCccccHHHHHHHHHHhcccCCCCCCHHHHHHHHHHHccCccccccHHHHhhCcccccCCh
Confidence 9999999999999997 88998766544 344555556678888899999999999999999999999999999955433
Q ss_pred ch----------hhhhhccccch----h-------ccc---------------c-----chHHHH---------------
Q 003644 674 RL----------SFLRDVSDRVE----L-------EDR---------------E-----SDSKLL--------------- 697 (805)
Q Consensus 674 ~~----------~~l~~~~~~~e----~-------~~~---------------~-----~~~~l~--------------- 697 (805)
.- .|....+-..+ . ..+ . ...+..
T Consensus 347 ~nlw~~~PP~l~py~p~~~~s~e~~s~~~~~~~~~~~~~~~~~~~~~S~s~~~psn~~~~~~~~~~~~~~~~~~s~~~~~ 426 (604)
T KOG0592|consen 347 ENLWQQTPPKLQPYKPATSISPEYYSAYTPLEPGLDERALFQVPSSASQSSALPSNVTHNGDKVAQPVAPSASSSESKND 426 (604)
T ss_pred hhhhhcCCCcccCCCCcccCCcccCcccccccCCccccccccccccccccccCCCcccccccchhhccccccccccCcch
Confidence 21 11100000000 0 000 0 000000
Q ss_pred -HHHHHHHHHhcCCcchHHHhHHHHhhhhhh--cccCCCCHHHHHHHHhhcccccccCChhHHhhhCCCC---------c
Q 003644 698 -RALEGIALVALNGKWDEKMETKFIENIGRY--RRYKYDNVRDLLRVIRNKSNHFRELPQDIQELLGSHP---------E 765 (805)
Q Consensus 698 -~~le~~~~~~~~~~w~~~~~~~~~~~~~~~--r~~~~~~~~dllr~irn~~~h~~e~~~~~~~l~g~~p---------~ 765 (805)
..+..+........|+...+..++.+.+.. |+..++..|+++.+-. .|+-+.++...++.|++| +
T Consensus 427 ~~R~q~le~~~~~~~w~~f~~~~~i~k~~~l~k~~~lf~rkr~lllTn~---~rll~~~~~~~~lk~eip~~~~~~~e~~ 503 (604)
T KOG0592|consen 427 TARLQSLESQSKDNPWHQFLEGSLILKEGALEKRQGLFARKRMLLLTNG---PRLLYVDPQNLVLKGEIPWSPDLRVELK 503 (604)
T ss_pred hhhhhhccccccCccHHHhhhhhhHHhHHHHHhhhhhhhceeEEEecCC---CeEEEEecccceeccccccCcccceeec
Confidence 011122223345679999987777776644 4556666677654433 345567777788899999 8
Q ss_pred cccccccccCC--ccHHHHHHHHHhhhcc-cchhhccccc
Q 003644 766 GFYNYFSCRFP--KLLIEVYNVIFTYCKG-EEVFHKYVTN 802 (805)
Q Consensus 766 ~f~~yf~~~fp--~ll~~~y~~~~~~~~~-~~~~~~y~~~ 802 (805)
++..+|.+++. ++|++.-+.+..||++ +.+.++|...
T Consensus 504 n~~~~~i~TP~k~~~l~d~~~~as~w~~ai~~~~~~~~~~ 543 (604)
T KOG0592|consen 504 NSSTFFIHTPNKVYYLEDPEQRASVWCKAIETVRKRYSGT 543 (604)
T ss_pred cCcceEEECCccceeccCcccchhHHHHhhhhhhhcccCC
Confidence 89999999999 8999999999999998 7776555543
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-48 Score=412.46 Aligned_cols=256 Identities=30% Similarity=0.500 Sum_probs=210.3
Q ss_pred ccccceEEEeEeeccCCceEEEEE-EeeCCcEEEEEEeecCCc----------hHHHHHHHHHHHhCCCCCeeeeccccc
Q 003644 372 RRIGKLVVFNKEIAKGSNGTVVLE-GNYEGRSVAVKRLVKTHH----------DVALKEIQNLIASDQHPNIVRWYGVES 440 (805)
Q Consensus 372 ~~i~~~~~~~~~LG~GsfGtVy~a-~~~~g~~VAVK~l~~~~~----------~~~~~Ei~~ll~~l~HpNIV~l~g~~~ 440 (805)
+.+.+.|.+.+.||+|+||.|-+| ...+|+.||||++.+... ....+|+ +++++++|||||++++++.
T Consensus 168 ks~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~Ei-eILkkL~HP~IV~~~d~f~ 246 (475)
T KOG0615|consen 168 KSFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEI-EILKKLSHPNIVRIKDFFE 246 (475)
T ss_pred chhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHH-HHHHhcCCCCEEEEeeeee
Confidence 446678899999999999999888 566899999999965421 1123455 4889999999999999999
Q ss_pred CCceEEEecccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHH
Q 003644 441 DQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVS 520 (805)
Q Consensus 441 ~~~~l~LV~E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~ 520 (805)
+.+..||||| |+.+|.|.+++-.. ..+.+.....+++|++.
T Consensus 247 ~~ds~YmVlE----------~v~GGeLfd~vv~n-----------------------------k~l~ed~~K~~f~Qll~ 287 (475)
T KOG0615|consen 247 VPDSSYMVLE----------YVEGGELFDKVVAN-----------------------------KYLREDLGKLLFKQLLT 287 (475)
T ss_pred cCCceEEEEE----------EecCccHHHHHHhc-----------------------------cccccchhHHHHHHHHH
Confidence 9999999999 88888888876433 23444556789999999
Q ss_pred HHHHhhhcceeccCCCCceEEecCC-CCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCC---CCcch
Q 003644 521 GLSHLHEIGLIHRDLKPQNVLISKD-KSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ---TRAID 596 (805)
Q Consensus 521 gL~yLH~~~IvHrDLKp~NILl~~~-~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~---t~~sD 596 (805)
|+.|||+.||+||||||+|||+..+ ..+.+||+|||+|+.... .+...+.||||.|.|||++....+ ..++|
T Consensus 288 avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~~g~----~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVD 363 (475)
T KOG0615|consen 288 AVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKVSGE----GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVD 363 (475)
T ss_pred HHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhcccc----ceehhhhcCCccccChhheecCCeecccchhe
Confidence 9999999999999999999999765 557799999999998763 355678999999999999987653 45889
Q ss_pred HHHHHHHHHHHHhCCCCCCCCchHHH---HHHHhhccccc---cccCChHHHHHHHHhcCCCCCCCCChhhhhcCccccc
Q 003644 597 LFSLGCILFFCITGGKHPYGESFERD---ANIVKDRKDLF---LVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWT 670 (805)
Q Consensus 597 VwSlGvil~elltG~~~Pf~~~~~~~---~~~~~~~~~~~---~~~~~~~~~dLi~~~L~~dP~~Rps~~ell~Hpff~~ 670 (805)
+||+||+||-|++| .+||.+..... .++.++..... ..+.+.++++||.+||..||++|||++|+|+||||..
T Consensus 364 iWSlGcvLfvcLsG-~pPFS~~~~~~sl~eQI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~ 442 (475)
T KOG0615|consen 364 IWSLGCVLFVCLSG-YPPFSEEYTDPSLKEQILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFKD 442 (475)
T ss_pred eeeccceEEEEecc-CCCcccccCCccHHHHHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhc
Confidence 99999999999997 88998765432 45555554433 2345689999999999999999999999999999986
Q ss_pred cc
Q 003644 671 AD 672 (805)
Q Consensus 671 ~~ 672 (805)
.+
T Consensus 443 ~~ 444 (475)
T KOG0615|consen 443 AP 444 (475)
T ss_pred cc
Confidence 55
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-47 Score=418.47 Aligned_cols=249 Identities=33% Similarity=0.531 Sum_probs=215.9
Q ss_pred ceEEEeEeeccCCceEEEEEEe-eCCcEEEEEEeecC------CchHHHHHHHHHHHhCCCCCeeeecccccCCceEEEe
Q 003644 376 KLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKT------HHDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLS 448 (805)
Q Consensus 376 ~~~~~~~~LG~GsfGtVy~a~~-~~g~~VAVK~l~~~------~~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV 448 (805)
+.|...+.||+|+|++||.+.. .+|..||+|++.+. ..+...+||+ +.+.++|||||+++++|+|.+++|||
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIe-IHr~L~HpnIV~f~~~FEDs~nVYiv 96 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIE-IHRSLKHPNIVQFYHFFEDSNNVYIV 96 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHH-HHHhcCCCcEEeeeeEeecCCceEEE
Confidence 6688899999999999999976 78999999998652 2345677876 88999999999999999999999999
Q ss_pred cccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhc
Q 003644 449 LERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI 528 (805)
Q Consensus 449 ~E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~ 528 (805)
+|+|. +|+|.+++. +.+.+++++++.+++||+.||.|||++
T Consensus 97 LELC~----------~~sL~el~K-----------------------------rrk~ltEpEary~l~QIv~GlkYLH~~ 137 (592)
T KOG0575|consen 97 LELCH----------RGSLMELLK-----------------------------RRKPLTEPEARYFLRQIVEGLKYLHSL 137 (592)
T ss_pred EEecC----------CccHHHHHH-----------------------------hcCCCCcHHHHHHHHHHHHHHHHHHhc
Confidence 99775 455554432 235688899999999999999999999
Q ss_pred ceeccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHHHHH
Q 003644 529 GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCI 608 (805)
Q Consensus 529 ~IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~ell 608 (805)
+|||||||-.|++|+++. .+||+|||||..+..+. ....+.||||.|+|||++....++..+||||+||+||-||
T Consensus 138 ~IiHRDLKLGNlfL~~~~--~VKIgDFGLAt~le~~~---Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL 212 (592)
T KOG0575|consen 138 GIIHRDLKLGNLFLNENM--NVKIGDFGLATQLEYDG---ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLL 212 (592)
T ss_pred CceecccchhheeecCcC--cEEecccceeeeecCcc---cccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhh
Confidence 999999999999997664 49999999999987542 3457789999999999999999999999999999999999
Q ss_pred hCCCCCCCCc-hHHHHHHHhhccccccccCChHHHHHHHHhcCCCCCCCCChhhhhcCccccc
Q 003644 609 TGGKHPYGES-FERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWT 670 (805)
Q Consensus 609 tG~~~Pf~~~-~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dP~~Rps~~ell~Hpff~~ 670 (805)
.| +|||... .......++......|...+.+++|||.+||++||.+|||+++||.|+||.+
T Consensus 213 ~G-~PPFetk~vkety~~Ik~~~Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~~ 274 (592)
T KOG0575|consen 213 VG-RPPFETKTVKETYNKIKLNEYSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFFKS 274 (592)
T ss_pred hC-CCCcccchHHHHHHHHHhcCcccccccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhhhC
Confidence 97 8899876 4555566777777778888999999999999999999999999999999943
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-46 Score=389.93 Aligned_cols=261 Identities=30% Similarity=0.382 Sum_probs=214.5
Q ss_pred cceEEEeEeeccCCceEEEEEEe-eCCcEEEEEEeecCCc------hHHHHHHHHHHHhCCCCCeeeecccccCCceEEE
Q 003644 375 GKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH------DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYL 447 (805)
Q Consensus 375 ~~~~~~~~~LG~GsfGtVy~a~~-~~g~~VAVK~l~~~~~------~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~L 447 (805)
.++|.+.+.||+|+||+|+.+.. .+++.+|+|++++... .....|. .++..++||.||+++..|++.+.+||
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er-~IL~~v~hPFiv~l~ysFQt~~kLyl 102 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAER-NILSKIKHPFIVKLIYSFQTEEKLYL 102 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHH-HHHHhCCCCcEeeeEEecccCCeEEE
Confidence 35688899999999999999754 5699999999976432 2233344 47777999999999999999999999
Q ss_pred ecccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhh
Q 003644 448 SLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE 527 (805)
Q Consensus 448 V~E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~ 527 (805)
|+| |+.+|.|..+|..+ +.+++..++-++.+|+.||.|||+
T Consensus 103 Vld----------~~~GGeLf~hL~~e-----------------------------g~F~E~~arfYlaEi~lAL~~LH~ 143 (357)
T KOG0598|consen 103 VLD----------YLNGGELFYHLQRE-----------------------------GRFSEDRARFYLAEIVLALGYLHS 143 (357)
T ss_pred EEe----------ccCCccHHHHHHhc-----------------------------CCcchhHHHHHHHHHHHHHHHHHh
Confidence 999 89999999887543 457788899999999999999999
Q ss_pred cceeccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHHHH
Q 003644 528 IGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFC 607 (805)
Q Consensus 528 ~~IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~el 607 (805)
+|||||||||+||||+.+|+ ++|+|||||+..... ...+.+.|||+.|||||++.+..|+.++|+||||+++|||
T Consensus 144 ~gIiyRDlKPENILLd~~GH--i~LtDFgL~k~~~~~---~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeM 218 (357)
T KOG0598|consen 144 KGIIYRDLKPENILLDEQGH--IKLTDFGLCKEDLKD---GDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEM 218 (357)
T ss_pred CCeeeccCCHHHeeecCCCc--EEEeccccchhcccC---CCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHH
Confidence 99999999999999999988 899999999965433 2345668999999999999999999999999999999999
Q ss_pred HhCCCCCCC-CchHHHHHHHhhcc-ccccccCChHHHHHHHHhcCCCCCCCC----ChhhhhcCccccccccchhhhhhc
Q 003644 608 ITGGKHPYG-ESFERDANIVKDRK-DLFLVEHIPEAVDLFTRLLDPNPDLRP----KAQNVLNHPFFWTADTRLSFLRDV 681 (805)
Q Consensus 608 ltG~~~Pf~-~~~~~~~~~~~~~~-~~~~~~~~~~~~dLi~~~L~~dP~~Rp----s~~ell~Hpff~~~~~~~~~l~~~ 681 (805)
++| .+||. .+.......+...+ ...+.-.+++++|+++++|..||++|. ++.++.+||||...++..-+.+.+
T Consensus 219 L~G-~pPF~~~~~~~~~~~I~~~k~~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~inW~~l~~k~l 297 (357)
T KOG0598|consen 219 LTG-KPPFYAEDVKKMYDKILKGKLPLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGINWEKLLAKKL 297 (357)
T ss_pred hhC-CCCCcCccHHHHHHHHhcCcCCCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCcccccCCHHHHHhcCC
Confidence 998 55554 44444444444444 444444788999999999999999995 688999999998877655444333
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-45 Score=388.87 Aligned_cols=245 Identities=29% Similarity=0.456 Sum_probs=206.5
Q ss_pred EeEeeccCCceEEEEE-EeeCCcEEEEEEeecCC----chHHHHHHHHHHHhCCCCCeeeecccccCCc-eEEEeccccc
Q 003644 380 FNKEIAKGSNGTVVLE-GNYEGRSVAVKRLVKTH----HDVALKEIQNLIASDQHPNIVRWYGVESDQD-FVYLSLERCT 453 (805)
Q Consensus 380 ~~~~LG~GsfGtVy~a-~~~~g~~VAVK~l~~~~----~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~-~l~LV~E~~~ 453 (805)
..+.||+|..|+||++ +..+++.+|+|.+.... ..+..+|++ ++...+||+||.+||.|.+++ .++|+||
T Consensus 83 ~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~-il~~~~spyIV~~ygaF~~~~~~isI~mE--- 158 (364)
T KOG0581|consen 83 RLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELE-ILRSCQSPYIVGFYGAFYSNGEEISICME--- 158 (364)
T ss_pred hhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHH-HHhhCCCCCeeeEeEEEEeCCceEEeehh---
Confidence 3467999999999998 45679999999994332 345678887 455669999999999999998 5999999
Q ss_pred CChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhh-cceec
Q 003644 454 CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE-IGLIH 532 (805)
Q Consensus 454 ~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~-~~IvH 532 (805)
||.+|+|+..+.. .+.+++..+-+|+.++++||.|||+ .+|||
T Consensus 159 -------YMDgGSLd~~~k~-----------------------------~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIH 202 (364)
T KOG0581|consen 159 -------YMDGGSLDDILKR-----------------------------VGRIPEPVLGKIARAVLRGLSYLHEERKIIH 202 (364)
T ss_pred -------hcCCCCHHHHHhh-----------------------------cCCCCHHHHHHHHHHHHHHHHHHhhccCeee
Confidence 8888888886532 2457889999999999999999995 89999
Q ss_pred cCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHHHHHhCCC
Q 003644 533 RDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGK 612 (805)
Q Consensus 533 rDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~elltG~~ 612 (805)
|||||+|||++..|+ +||||||.++.+... ...+.+||..|||||.+.+..|+.++||||||+.++||.+| +
T Consensus 203 RDIKPsNlLvNskGe--VKicDFGVS~~lvnS-----~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~G-r 274 (364)
T KOG0581|consen 203 RDIKPSNLLVNSKGE--VKICDFGVSGILVNS-----IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIG-R 274 (364)
T ss_pred ccCCHHHeeeccCCC--EEeccccccHHhhhh-----hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhC-C
Confidence 999999999999887 999999999988753 45678899999999999999999999999999999999997 6
Q ss_pred CCCCCc-------hHHHHHHHhhcccccccc-CChHHHHHHHHhcCCCCCCCCChhhhhcCccccccc
Q 003644 613 HPYGES-------FERDANIVKDRKDLFLVE-HIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTAD 672 (805)
Q Consensus 613 ~Pf~~~-------~~~~~~~~~~~~~~~~~~-~~~~~~dLi~~~L~~dP~~Rps~~ell~Hpff~~~~ 672 (805)
.||... .+-...++...+...+.. +++++++||..||++||.+||++.|+++|||+...+
T Consensus 275 fP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~ 342 (364)
T KOG0581|consen 275 FPYPPPNPPYLDIFELLCAIVDEPPPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFE 342 (364)
T ss_pred CCCCCcCCCCCCHHHHHHHHhcCCCCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhcc
Confidence 677653 122234555555555665 899999999999999999999999999999996543
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-44 Score=384.45 Aligned_cols=251 Identities=32% Similarity=0.521 Sum_probs=205.0
Q ss_pred ceEEEeEeeccCCceEEEEEE-eeCCcEEEEEEeecCC-----chHHHHHHHHHHHhCCCCCeeeecccccCCceEEEec
Q 003644 376 KLVVFNKEIAKGSNGTVVLEG-NYEGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSL 449 (805)
Q Consensus 376 ~~~~~~~~LG~GsfGtVy~a~-~~~g~~VAVK~l~~~~-----~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~ 449 (805)
..|.+.++||+|+||+||+|. ..++.+||||.+.+.. .+...+|+. +++.++|||||+|++++++++++||||
T Consensus 10 ~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~-iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 10 GDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIK-ILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred ccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHH-HHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 346777889999999999985 4568999999996652 234466775 788999999999999999999999999
Q ss_pred cccc-CChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhc
Q 003644 450 ERCT-CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI 528 (805)
Q Consensus 450 E~~~-~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~ 528 (805)
|||. |+|.+|+ + +.+++++..++.++.|||.||++||++
T Consensus 89 EyC~gGDLs~yi-----------~-----------------------------~~~~l~e~t~r~Fm~QLA~alq~L~~~ 128 (429)
T KOG0595|consen 89 EYCNGGDLSDYI-----------R-----------------------------RRGRLPEATARHFMQQLASALQFLHEN 128 (429)
T ss_pred EeCCCCCHHHHH-----------H-----------------------------HcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 9886 4565555 2 234578889999999999999999999
Q ss_pred ceeccCCCCceEEecCC-CC---ceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHH
Q 003644 529 GLIHRDLKPQNVLISKD-KS---FCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCIL 604 (805)
Q Consensus 529 ~IvHrDLKp~NILl~~~-~~---~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil 604 (805)
+||||||||+||||+.. +. ..+||+|||+|+.+... ....+.||++.|||||++..++|+.|+|+||+|+|+
T Consensus 129 ~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~~----~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Il 204 (429)
T KOG0595|consen 129 NIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQPG----SMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTIL 204 (429)
T ss_pred CeeeccCCcceEEeccCCCCCCCceEEecccchhhhCCch----hHHHHhhCCccccCHHHHHhccccchhhHHHHHHHH
Confidence 99999999999999764 33 68999999999998743 344677999999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCchHHHHH-HHhhcc---ccccccCChHHHHHHHHhcCCCCCCCCChhhhhcCccccccc
Q 003644 605 FFCITGGKHPYGESFERDAN-IVKDRK---DLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTAD 672 (805)
Q Consensus 605 ~elltG~~~Pf~~~~~~~~~-~~~~~~---~~~~~~~~~~~~dLi~~~L~~dP~~Rps~~ell~Hpff~~~~ 672 (805)
|+|++| ++||......+.. .++... ...+...++...+++...++.+|..|.+..+.+.|+|.|...
T Consensus 205 yq~l~g-~~Pf~a~t~~eL~~~~~k~~~~~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~p 275 (429)
T KOG0595|consen 205 YQCLTG-KPPFDAETPKELLLYIKKGNEIVPVLPAELSNPLRELLISLLQRNPKDRISFEDFFDHPFLAANP 275 (429)
T ss_pred HHHHhC-CCCccccCHHHHHHHHhccccccCchhhhccCchhhhhhHHHhcCccccCchHHhhhhhhcccCc
Confidence 999997 8898865444322 222211 122334456777999999999999999999999999998754
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-44 Score=364.12 Aligned_cols=251 Identities=27% Similarity=0.407 Sum_probs=212.5
Q ss_pred ceEEEeEeeccCCceEEEEEE-eeCCcEEEEEEeecCCch------HHHHHHHHHHHhCCCCCeeeecccccCCceEEEe
Q 003644 376 KLVVFNKEIAKGSNGTVVLEG-NYEGRSVAVKRLVKTHHD------VALKEIQNLIASDQHPNIVRWYGVESDQDFVYLS 448 (805)
Q Consensus 376 ~~~~~~~~LG~GsfGtVy~a~-~~~g~~VAVK~l~~~~~~------~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV 448 (805)
++|.+.+.||.|+||+|.+.+ ..+|..+|+|++.+...- ....| ..+++.+.||+++++++.|.|.+++|||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nE-k~vL~~v~~PFlv~l~~t~~d~~~lymv 122 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNE-KRVLKAVSHPFLVKLYGTFKDNSNLYMV 122 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhH-HHHHhhccCceeEEEEEeeccCCeEEEE
Confidence 446677899999999999975 456899999999765321 12223 3578888999999999999999999999
Q ss_pred cccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhc
Q 003644 449 LERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI 528 (805)
Q Consensus 449 ~E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~ 528 (805)
|| |.++|.|..+|+. .+.++++.++.++.||+.||+|||+.
T Consensus 123 me----------yv~GGElFS~Lrk-----------------------------~~rF~e~~arFYAAeivlAleylH~~ 163 (355)
T KOG0616|consen 123 ME----------YVPGGELFSYLRK-----------------------------SGRFSEPHARFYAAEIVLALEYLHSL 163 (355)
T ss_pred Ee----------ccCCccHHHHHHh-----------------------------cCCCCchhHHHHHHHHHHHHHHHHhc
Confidence 99 8899999988743 45688899999999999999999999
Q ss_pred ceeccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHHHHH
Q 003644 529 GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCI 608 (805)
Q Consensus 529 ~IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~ell 608 (805)
+|++|||||+||||+.+|. +||+|||+|+.+.+ .+.+.||||.|+|||++....|..++|+|||||++|||+
T Consensus 164 ~iiYRDLKPENiLlD~~G~--iKitDFGFAK~v~~------rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMl 235 (355)
T KOG0616|consen 164 DIIYRDLKPENLLLDQNGH--IKITDFGFAKRVSG------RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEML 235 (355)
T ss_pred CeeeccCChHHeeeccCCc--EEEEeccceEEecC------cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHH
Confidence 9999999999999999988 89999999998874 356789999999999999999999999999999999999
Q ss_pred hCCCCCCCCchH-HHHHHHhhccccccccCChHHHHHHHHhcCCCCCCC-----CChhhhhcCccccccccch
Q 003644 609 TGGKHPYGESFE-RDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLR-----PKAQNVLNHPFFWTADTRL 675 (805)
Q Consensus 609 tG~~~Pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dP~~R-----ps~~ell~Hpff~~~~~~~ 675 (805)
.| .+||.+... .....+......+|...+++++|||+++|+.|-.+| ....+|..||||.+.++..
T Consensus 236 aG-~pPF~~~~~~~iY~KI~~~~v~fP~~fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v~W~~ 307 (355)
T KOG0616|consen 236 AG-YPPFYDDNPIQIYEKILEGKVKFPSYFSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGVDWEA 307 (355)
T ss_pred cC-CCCCcCCChHHHHHHHHhCcccCCcccCHHHHHHHHHHHhhhhHhhhcCcCCCccccccCcccccccHHH
Confidence 97 666655443 333444455566788889999999999999999999 4577899999998766544
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=379.68 Aligned_cols=257 Identities=30% Similarity=0.434 Sum_probs=205.9
Q ss_pred cceEEEeEeeccCCceEEEEEEe-eCCcEEEEEEeecCCch-----HHHHHHHHHHHhCCCCCeeeecccccCCceEEEe
Q 003644 375 GKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHHD-----VALKEIQNLIASDQHPNIVRWYGVESDQDFVYLS 448 (805)
Q Consensus 375 ~~~~~~~~~LG~GsfGtVy~a~~-~~g~~VAVK~l~~~~~~-----~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV 448 (805)
-++|...+.||+|+||.||++.. .+|..+|+|+|++.... .-.+.+..++...++|+||+||..|+|.+++|||
T Consensus 140 ~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLi 219 (550)
T KOG0605|consen 140 LDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLI 219 (550)
T ss_pred cccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEE
Confidence 46688889999999999999965 46999999999875421 1123333566778999999999999999999999
Q ss_pred cccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhc
Q 003644 449 LERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI 528 (805)
Q Consensus 449 ~E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~ 528 (805)
|| |.++|++..+|. +.+.+++..++.++.+++.|++-||+.
T Consensus 220 ME----------ylPGGD~mTLL~-----------------------------~~~~L~e~~arfYiaE~vlAI~~iH~~ 260 (550)
T KOG0605|consen 220 ME----------YLPGGDMMTLLM-----------------------------RKDTLTEDWARFYIAETVLAIESIHQL 260 (550)
T ss_pred EE----------ecCCccHHHHHH-----------------------------hcCcCchHHHHHHHHHHHHHHHHHHHc
Confidence 99 888999888773 345688889999999999999999999
Q ss_pred ceeccCCCCceEEecCCCCceEEEeccCccccccCC--------------------Ccccc----c--------------
Q 003644 529 GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGD--------------------MSCLT----Q-------------- 570 (805)
Q Consensus 529 ~IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~--------------------~~~~~----~-------------- 570 (805)
|+|||||||+|+||+..|+ +||+|||||.-+... ..... .
T Consensus 261 gyIHRDIKPdNlLiD~~GH--iKLSDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~ 338 (550)
T KOG0605|consen 261 GYIHRDIKPDNLLIDAKGH--IKLSDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWK 338 (550)
T ss_pred CcccccCChhheeecCCCC--EeeccccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHH
Confidence 9999999999999999998 899999998643210 00000 0
Q ss_pred ------cccccCCCCCCChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHH--HHHHHhhccccc---cccCCh
Q 003644 571 ------NATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFER--DANIVKDRKDLF---LVEHIP 639 (805)
Q Consensus 571 ------~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~elltG~~~Pf~~~~~~--~~~~~~~~~~~~---~~~~~~ 639 (805)
....+|||.|||||++.+..|+..+|+||||||+||||.| .|||...... ..+++.+..... ....++
T Consensus 339 ~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~ImyEmLvG-yPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~ 417 (550)
T KOG0605|consen 339 RNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGCIMYEMLVG-YPPFCSETPQETYRKIVNWRETLKFPEEVDLSD 417 (550)
T ss_pred hhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHHHHHHHHhC-CCCCCCCCHHHHHHHHHHHhhhccCCCcCcccH
Confidence 0124699999999999999999999999999999999997 7777654433 345555553322 234468
Q ss_pred HHHHHHHHhcCCCCCCCCC---hhhhhcCccccccccc
Q 003644 640 EAVDLFTRLLDPNPDLRPK---AQNVLNHPFFWTADTR 674 (805)
Q Consensus 640 ~~~dLi~~~L~~dP~~Rps---~~ell~Hpff~~~~~~ 674 (805)
+++|||.+||. ||++|.. ++||.+||||...++.
T Consensus 418 eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~v~W~ 454 (550)
T KOG0605|consen 418 EAKDLITRLLC-DPENRLGSKGAEEIKKHPFFKGVDWD 454 (550)
T ss_pred HHHHHHHHHhc-CHHHhcCcccHHHHhcCCccccCCcc
Confidence 99999999999 9999975 8999999999766543
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-43 Score=386.96 Aligned_cols=248 Identities=31% Similarity=0.445 Sum_probs=214.1
Q ss_pred eEEEeEeeccCCceEEEEE-EeeCCcEEEEEEeecCC------chHHHHHHHHHHHhCCCCCeeeecccccCCceEEEec
Q 003644 377 LVVFNKEIAKGSNGTVVLE-GNYEGRSVAVKRLVKTH------HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSL 449 (805)
Q Consensus 377 ~~~~~~~LG~GsfGtVy~a-~~~~g~~VAVK~l~~~~------~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~ 449 (805)
-|.+++.||+|+-|.|-+| ...+|+.+|||++.+.. .....+|+. +|+.+.||||++||++|+++.++|||+
T Consensus 13 pwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIv-iMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 13 PWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIV-IMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred ceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhH-HHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 3678899999999999988 56789999999996541 234567876 789999999999999999999999999
Q ss_pred ccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcc
Q 003644 450 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG 529 (805)
Q Consensus 450 E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~ 529 (805)
| |+++|.|+++|. ..+++++.++.++++||+.|+.|||..+
T Consensus 92 E----------yv~gGELFdylv-----------------------------~kG~l~e~eaa~ff~QIi~gv~yCH~~~ 132 (786)
T KOG0588|consen 92 E----------YVPGGELFDYLV-----------------------------RKGPLPEREAAHFFRQILDGVSYCHAFN 132 (786)
T ss_pred E----------ecCCchhHHHHH-----------------------------hhCCCCCHHHHHHHHHHHHHHHHHhhhc
Confidence 9 888888888763 3467889999999999999999999999
Q ss_pred eeccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCC-CCcchHHHHHHHHHHHH
Q 003644 530 LIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ-TRAIDLFSLGCILFFCI 608 (805)
Q Consensus 530 IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~-t~~sDVwSlGvil~ell 608 (805)
|+||||||+|+||+..++ +||+|||+|..-.++ .-..+.||+|.|.|||++.+.+| +.++||||+|||||.||
T Consensus 133 icHRDLKpENlLLd~~~n--IKIADFGMAsLe~~g----klLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALL 206 (786)
T KOG0588|consen 133 ICHRDLKPENLLLDVKNN--IKIADFGMASLEVPG----KLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALL 206 (786)
T ss_pred ceeccCCchhhhhhcccC--EeeeccceeecccCC----ccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHH
Confidence 999999999999988877 999999999865543 34567899999999999999998 68999999999999999
Q ss_pred hCCCCCCCCchHHH-HHHHhhccccccccCChHHHHHHHHhcCCCCCCCCChhhhhcCcccccc
Q 003644 609 TGGKHPYGESFERD-ANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTA 671 (805)
Q Consensus 609 tG~~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dP~~Rps~~ell~Hpff~~~ 671 (805)
|| +.||+++..+. ...++......+...+++++|||.+||..||++|.|++||++|||+...
T Consensus 207 tG-~LPFdDdNir~LLlKV~~G~f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~ 269 (786)
T KOG0588|consen 207 TG-KLPFDDDNIRVLLLKVQRGVFEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGY 269 (786)
T ss_pred hC-CCCCCCccHHHHHHHHHcCcccCCCcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcC
Confidence 97 88998765544 3445555555677788999999999999999999999999999998654
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-43 Score=378.55 Aligned_cols=250 Identities=30% Similarity=0.510 Sum_probs=197.0
Q ss_pred ceEEEeEeeccCCceEEEEEE-eeCCcEEEEEEeecCC----chHHHHHHHHHHHhCCCCCeeeecccccCCc-eEEEec
Q 003644 376 KLVVFNKEIAKGSNGTVVLEG-NYEGRSVAVKRLVKTH----HDVALKEIQNLIASDQHPNIVRWYGVESDQD-FVYLSL 449 (805)
Q Consensus 376 ~~~~~~~~LG~GsfGtVy~a~-~~~g~~VAVK~l~~~~----~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~-~l~LV~ 449 (805)
++|...++||.|+||.||+|. ..+|..||||++++.. +-..+||+..+.+.-.|||||+|..++.|.+ .+|+||
T Consensus 10 ~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fVf 89 (538)
T KOG0661|consen 10 DRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFVF 89 (538)
T ss_pred HHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeeeH
Confidence 446667889999999999984 5679999999997653 2345788885544444999999999999988 999999
Q ss_pred ccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcc
Q 003644 450 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG 529 (805)
Q Consensus 450 E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~ 529 (805)
|+++++|.+++.. +.+.+++..++.|+.||++||+|+|.+|
T Consensus 90 E~Md~NLYqLmK~---------------------------------------R~r~fse~~irnim~QilqGL~hiHk~G 130 (538)
T KOG0661|consen 90 EFMDCNLYQLMKD---------------------------------------RNRLFSESDIRNIMYQILQGLAHIHKHG 130 (538)
T ss_pred HhhhhhHHHHHhh---------------------------------------cCCcCCHHHHHHHHHHHHHHHHHHHhcC
Confidence 9999998877732 1356888999999999999999999999
Q ss_pred eeccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhc-CCCCCcchHHHHHHHHHHHH
Q 003644 530 LIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ-GRQTRAIDLFSLGCILFFCI 608 (805)
Q Consensus 530 IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~t~~sDVwSlGvil~ell 608 (805)
+.|||+||+|||+.. ...+||+||||||.+.+.. +-...+-|.+|+|||+|.. +.|+.++||||+|||++|+.
T Consensus 131 fFHRDlKPENiLi~~--~~~iKiaDFGLARev~Skp----PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~ 204 (538)
T KOG0661|consen 131 FFHRDLKPENILISG--NDVIKIADFGLAREVRSKP----PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELY 204 (538)
T ss_pred cccccCChhheEecc--cceeEecccccccccccCC----CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHH
Confidence 999999999999953 3459999999999887542 2234567999999999875 56899999999999999999
Q ss_pred hCCCCCCCCchHHH-H-HHHh------------------h---ccc--------cccccCChHHHHHHHHhcCCCCCCCC
Q 003644 609 TGGKHPYGESFERD-A-NIVK------------------D---RKD--------LFLVEHIPEAVDLFTRLLDPNPDLRP 657 (805)
Q Consensus 609 tG~~~Pf~~~~~~~-~-~~~~------------------~---~~~--------~~~~~~~~~~~dLi~~~L~~dP~~Rp 657 (805)
+- ++-|....+.+ . .+.. . ... ......++++.++|.+||..||.+||
T Consensus 205 sL-rPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRp 283 (538)
T KOG0661|consen 205 SL-RPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRP 283 (538)
T ss_pred Hh-cccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCc
Confidence 96 55554433222 1 1110 0 000 00112457899999999999999999
Q ss_pred ChhhhhcCcccccc
Q 003644 658 KAQNVLNHPFFWTA 671 (805)
Q Consensus 658 s~~ell~Hpff~~~ 671 (805)
||+++|+||||...
T Consensus 284 TA~~al~~pffq~~ 297 (538)
T KOG0661|consen 284 TASQALQHPFFQVG 297 (538)
T ss_pred cHHHHhcCcccccc
Confidence 99999999999654
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-43 Score=356.93 Aligned_cols=244 Identities=26% Similarity=0.418 Sum_probs=193.0
Q ss_pred eEeeccCCceEEEEEEe-eCCcEEEEEEeecCCch-----HHHHHHHHHHHhCCCCCeeeecccccCCceEEEecccccC
Q 003644 381 NKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHHD-----VALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTC 454 (805)
Q Consensus 381 ~~~LG~GsfGtVy~a~~-~~g~~VAVK~l~~~~~~-----~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~E~~~~ 454 (805)
..++|+|+||.||+.+. .+|+.||||++..+.++ .+.+|+. |++.++|||+|.|+.+|.....++||+|||+-
T Consensus 7 LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIr-mLKqLkH~NLVnLiEVFrrkrklhLVFE~~dh 85 (396)
T KOG0593|consen 7 LGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIR-MLKQLKHENLVNLIEVFRRKRKLHLVFEYCDH 85 (396)
T ss_pred hhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHH-HHHhcccchHHHHHHHHHhcceeEEEeeecch
Confidence 35799999999999854 56999999999877654 3567775 88999999999999999999999999999997
Q ss_pred ChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcceeccC
Q 003644 455 SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRD 534 (805)
Q Consensus 455 sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~IvHrD 534 (805)
++.+.+- ....+++...+.+++.|++.|+.|+|+++|||||
T Consensus 86 TvL~eLe---------------------------------------~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRD 126 (396)
T KOG0593|consen 86 TVLHELE---------------------------------------RYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRD 126 (396)
T ss_pred HHHHHHH---------------------------------------hccCCCCHHHHHHHHHHHHHHhhhhhhcCeeccc
Confidence 6443331 1235678888899999999999999999999999
Q ss_pred CCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhc-CCCCCcchHHHHHHHHHHHHhCCCC
Q 003644 535 LKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ-GRQTRAIDLFSLGCILFFCITGGKH 613 (805)
Q Consensus 535 LKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~t~~sDVwSlGvil~elltG~~~ 613 (805)
|||+||||+..|. +||||||+|+.+......+ ...+.|.+|.|||.+.+ .+|+..+||||+||++.||++| .+
T Consensus 127 IKPENILit~~gv--vKLCDFGFAR~L~~pgd~Y---TDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G-~p 200 (396)
T KOG0593|consen 127 IKPENILITQNGV--VKLCDFGFARTLSAPGDNY---TDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTG-EP 200 (396)
T ss_pred CChhheEEecCCc--EEeccchhhHhhcCCcchh---hhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcC-Cc
Confidence 9999999998876 8999999999887433322 23457999999999988 6799999999999999999998 55
Q ss_pred CCCC-chHHHH---------------HHHhhccc-----cc-----------cccCChHHHHHHHHhcCCCCCCCCChhh
Q 003644 614 PYGE-SFERDA---------------NIVKDRKD-----LF-----------LVEHIPEAVDLFTRLLDPNPDLRPKAQN 661 (805)
Q Consensus 614 Pf~~-~~~~~~---------------~~~~~~~~-----~~-----------~~~~~~~~~dLi~~~L~~dP~~Rps~~e 661 (805)
-|.. +.-.+. ++...... .. ....+..+.|++++||+.||.+|++.++
T Consensus 201 L~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~q 280 (396)
T KOG0593|consen 201 LWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQ 280 (396)
T ss_pred CCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHH
Confidence 5543 322221 11111000 00 0111246789999999999999999999
Q ss_pred hhcCccccc
Q 003644 662 VLNHPFFWT 670 (805)
Q Consensus 662 ll~Hpff~~ 670 (805)
++.||||.+
T Consensus 281 ll~H~yFd~ 289 (396)
T KOG0593|consen 281 LLHHPYFDG 289 (396)
T ss_pred HhcChHHHH
Confidence 999999943
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-43 Score=378.91 Aligned_cols=247 Identities=26% Similarity=0.376 Sum_probs=207.1
Q ss_pred eEEEeEeeccCCceEEEEE-EeeCCcEEEEEEeecCCchH-----HHHHHHHHHHhCCCCCeeeecccccCCceEEEecc
Q 003644 377 LVVFNKEIAKGSNGTVVLE-GNYEGRSVAVKRLVKTHHDV-----ALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 450 (805)
Q Consensus 377 ~~~~~~~LG~GsfGtVy~a-~~~~g~~VAVK~l~~~~~~~-----~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~E 450 (805)
+|.+.+.||+|+||.||+| +.++.+.||+|.+.+..... ..+|+. +++.++|||||.++.+|+...++|+|.|
T Consensus 3 ~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~-i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 3 QYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVR-ILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred chhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHH-HHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 3555678999999999998 56789999999997654322 345554 7899999999999999999999999999
Q ss_pred cccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcce
Q 003644 451 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 530 (805)
Q Consensus 451 ~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~I 530 (805)
||.++|..++ -....+|++.+..|+.+++.||.|||+.+|
T Consensus 82 ~a~g~L~~il----------------------------------------~~d~~lpEe~v~~~a~~LVsaL~yLhs~ri 121 (808)
T KOG0597|consen 82 YAVGDLFTIL----------------------------------------EQDGKLPEEQVRAIAYDLVSALYYLHSNRI 121 (808)
T ss_pred hhhhhHHHHH----------------------------------------HhccCCCHHHHHHHHHHHHHHHHHHHhcCc
Confidence 8888777665 123458899999999999999999999999
Q ss_pred eccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHHHHHhC
Q 003644 531 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG 610 (805)
Q Consensus 531 vHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~elltG 610 (805)
+|||+||+|||+...+. +|+||||+|+....... ......|||-|||||.+.++.|+..+|+||+|||+|||++|
T Consensus 122 lhrd~kPqniLl~~~~~--~KlcdFg~Ar~m~~~t~---vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G 196 (808)
T KOG0597|consen 122 LHRDMKPQNILLEKGGT--LKLCDFGLARAMSTNTS---VLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVG 196 (808)
T ss_pred ccccCCcceeeecCCCc--eeechhhhhhhcccCce---eeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcC
Confidence 99999999999977766 99999999998764322 22334599999999999999999999999999999999998
Q ss_pred CCCCCC-CchHHHHHHHhhccccccccCChHHHHHHHHhcCCCCCCCCChhhhhcCccccc
Q 003644 611 GKHPYG-ESFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWT 670 (805)
Q Consensus 611 ~~~Pf~-~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dP~~Rps~~ell~Hpff~~ 670 (805)
+|||- .+.......+......++...+.++..+++.+|++||.+|.+..+++.|||++.
T Consensus 197 -~PPF~a~si~~Lv~~I~~d~v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~ 256 (808)
T KOG0597|consen 197 -QPPFYARSITQLVKSILKDPVKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKG 256 (808)
T ss_pred -CCCchHHHHHHHHHHHhcCCCCCcccccHHHHHHHHHHhhcChhhcccHHHHhcChHHhh
Confidence 55654 444444555556666677788899999999999999999999999999999754
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-42 Score=382.37 Aligned_cols=254 Identities=26% Similarity=0.404 Sum_probs=210.7
Q ss_pred cceEEEeEeeccCCceEEEEEEe-eCCcEEEEEEeecCCc------hHHHHHHHHHHHhCCCCCeeeecccccCCceEEE
Q 003644 375 GKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH------DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYL 447 (805)
Q Consensus 375 ~~~~~~~~~LG~GsfGtVy~a~~-~~g~~VAVK~l~~~~~------~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~L 447 (805)
-+.|.+.++||+|+||+|+++.. .+++.+|||.+++... +....|-..+...-+||.+++|++.|+..+++|.
T Consensus 367 l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~f 446 (694)
T KOG0694|consen 367 LDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFF 446 (694)
T ss_pred ccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEE
Confidence 46799999999999999999865 4688999999987531 2233343333223379999999999999999999
Q ss_pred ecccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhh
Q 003644 448 SLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE 527 (805)
Q Consensus 448 V~E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~ 527 (805)
||| |..+|++..+. +.+.+++..++.++..|+.||+|||+
T Consensus 447 vme----------y~~Ggdm~~~~------------------------------~~~~F~e~rarfyaAev~l~L~fLH~ 486 (694)
T KOG0694|consen 447 VME----------YVAGGDLMHHI------------------------------HTDVFSEPRARFYAAEVVLGLQFLHE 486 (694)
T ss_pred EEE----------ecCCCcEEEEE------------------------------ecccccHHHHHHHHHHHHHHHHHHHh
Confidence 999 66666632211 12557888999999999999999999
Q ss_pred cceeccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHHHH
Q 003644 528 IGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFC 607 (805)
Q Consensus 528 ~~IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~el 607 (805)
+||||||||-+||||+.+|+ +||+|||+++..... ...+.+.||||.|||||++.+..|+.++|+|||||+||||
T Consensus 487 ~~IIYRDlKLdNiLLD~eGh--~kiADFGlcKe~m~~---g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeM 561 (694)
T KOG0694|consen 487 NGIIYRDLKLDNLLLDTEGH--VKIADFGLCKEGMGQ---GDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEM 561 (694)
T ss_pred cCceeeecchhheEEcccCc--EEecccccccccCCC---CCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHH
Confidence 99999999999999999998 899999999975432 3466889999999999999999999999999999999999
Q ss_pred HhCCCCCCCC-chHHHHHHHhhccccccccCChHHHHHHHHhcCCCCCCCCCh-----hhhhcCccccccccc
Q 003644 608 ITGGKHPYGE-SFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKA-----QNVLNHPFFWTADTR 674 (805)
Q Consensus 608 ltG~~~Pf~~-~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dP~~Rps~-----~ell~Hpff~~~~~~ 674 (805)
|.| ..||.. +.+....-+......++...+.|+.++++++|.++|++|..+ .+|..||||.+.++.
T Consensus 562 L~G-q~PF~gddEee~FdsI~~d~~~yP~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w~ 633 (694)
T KOG0694|consen 562 LVG-ESPFPGDDEEEVFDSIVNDEVRYPRFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSIDWD 633 (694)
T ss_pred HcC-CCCCCCCCHHHHHHHHhcCCCCCCCcccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCccccCCHH
Confidence 997 778874 444445666667777899999999999999999999999875 679999999876654
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-42 Score=365.81 Aligned_cols=253 Identities=30% Similarity=0.495 Sum_probs=198.2
Q ss_pred EEEeEeeccCCceEEEEEEee-CCcEEEEEEeecCC---chHHHHHHHHHHHhCCCCCeeeecccccCCc--eEEEeccc
Q 003644 378 VVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH---HDVALKEIQNLIASDQHPNIVRWYGVESDQD--FVYLSLER 451 (805)
Q Consensus 378 ~~~~~~LG~GsfGtVy~a~~~-~g~~VAVK~l~~~~---~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~--~l~LV~E~ 451 (805)
+...+.||+|+||+||++... +|...|||.+.... .+...+|+. ++..++|||||+++|.....+ .+++.||
T Consensus 19 ~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~-iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE- 96 (313)
T KOG0198|consen 19 WSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIR-ILSRLNHPNIVQYYGSSSSRENDEYNIFME- 96 (313)
T ss_pred hhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHH-HHHhCCCCCEEeeCCccccccCeeeEeeee-
Confidence 345678999999999998654 48999999986553 233456765 778888999999999855554 6999999
Q ss_pred ccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhccee
Q 003644 452 CTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLI 531 (805)
Q Consensus 452 ~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~Iv 531 (805)
|+++|+|.+++.... ..++++.++.+.+||++||+|||++|||
T Consensus 97 ---------y~~~GsL~~~~~~~g----------------------------~~l~E~~v~~ytr~iL~GL~ylHs~g~v 139 (313)
T KOG0198|consen 97 ---------YAPGGSLSDLIKRYG----------------------------GKLPEPLVRRYTRQILEGLAYLHSKGIV 139 (313)
T ss_pred ---------ccCCCcHHHHHHHcC----------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCEe
Confidence 777777777653211 1478899999999999999999999999
Q ss_pred ccCCCCceEEecC-CCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCC-CCCcchHHHHHHHHHHHHh
Q 003644 532 HRDLKPQNVLISK-DKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGR-QTRAIDLFSLGCILFFCIT 609 (805)
Q Consensus 532 HrDLKp~NILl~~-~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~-~t~~sDVwSlGvil~ellt 609 (805)
||||||+|||++. ++. +||+|||+++................||+.|||||++.++. ...++|||||||++.||+|
T Consensus 140 H~DiK~~NiLl~~~~~~--~KlaDFG~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~T 217 (313)
T KOG0198|consen 140 HCDIKPANILLDPSNGD--VKLADFGLAKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLT 217 (313)
T ss_pred ccCcccceEEEeCCCCe--EEeccCccccccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccC
Confidence 9999999999987 454 99999999988775222223344567999999999998643 3459999999999999999
Q ss_pred CCCCCCCCc-hHH--HHHHHhhc-cccccccCChHHHHHHHHhcCCCCCCCCChhhhhcCccccccc
Q 003644 610 GGKHPYGES-FER--DANIVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTAD 672 (805)
Q Consensus 610 G~~~Pf~~~-~~~--~~~~~~~~-~~~~~~~~~~~~~dLi~~~L~~dP~~Rps~~ell~Hpff~~~~ 672 (805)
| .+||.+. ... ...+.... ....+...++++++++.+|+..||++||||+++|+|||.....
T Consensus 218 g-~~PW~~~~~~~~~~~~ig~~~~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~ 283 (313)
T KOG0198|consen 218 G-KPPWSEFFEEAEALLLIGREDSLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNS 283 (313)
T ss_pred C-CCcchhhcchHHHHHHHhccCCCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhccc
Confidence 7 8899873 211 12222222 2244556778999999999999999999999999999986543
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-41 Score=371.97 Aligned_cols=250 Identities=28% Similarity=0.440 Sum_probs=204.0
Q ss_pred cceEEEeEeeccCCceEEEEE-EeeCCcEEEEEEeecC--------CchHHHHHHHHHHHhCC-CCCeeeecccccCCce
Q 003644 375 GKLVVFNKEIAKGSNGTVVLE-GNYEGRSVAVKRLVKT--------HHDVALKEIQNLIASDQ-HPNIVRWYGVESDQDF 444 (805)
Q Consensus 375 ~~~~~~~~~LG~GsfGtVy~a-~~~~g~~VAVK~l~~~--------~~~~~~~Ei~~ll~~l~-HpNIV~l~g~~~~~~~ 444 (805)
...|.+.+.||+|+||+|++| ...+|..||||++.+. ......+|+. +++.++ ||||++++.++.....
T Consensus 16 ~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~-~~~~~~~HpnI~~l~ev~~t~~~ 94 (370)
T KOG0583|consen 16 IGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREIS-ILRRLRSHPNIIRLLEVFATPTK 94 (370)
T ss_pred cCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHH-HHHHhccCCCEeEEEEEEecCCe
Confidence 456888999999999999998 5567899999976543 1233446775 556666 9999999999999999
Q ss_pred EEEecccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHH
Q 003644 445 VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSH 524 (805)
Q Consensus 445 l~LV~E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~y 524 (805)
+|+|||||. +|+|.+++.. .+.+.+.++..+++|++.|++|
T Consensus 95 ~~ivmEy~~----------gGdL~~~i~~-----------------------------~g~l~E~~ar~~F~Qlisav~y 135 (370)
T KOG0583|consen 95 IYIVMEYCS----------GGDLFDYIVN-----------------------------KGRLKEDEARKYFRQLISAVAY 135 (370)
T ss_pred EEEEEEecC----------CccHHHHHHH-----------------------------cCCCChHHHHHHHHHHHHHHHH
Confidence 999999665 4455544422 2456777889999999999999
Q ss_pred hhhcceeccCCCCceEEecCC-CCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCC-CC-CcchHHHHH
Q 003644 525 LHEIGLIHRDLKPQNVLISKD-KSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGR-QT-RAIDLFSLG 601 (805)
Q Consensus 525 LH~~~IvHrDLKp~NILl~~~-~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~-~t-~~sDVwSlG 601 (805)
||+.||+||||||+|||++.+ ++ +||+|||++..... ......+.+||+.|+|||++.+.. |+ .++||||+|
T Consensus 136 ~H~~gi~HRDLK~ENilld~~~~~--~Kl~DFG~s~~~~~---~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~G 210 (370)
T KOG0583|consen 136 CHSRGIVHRDLKPENILLDGNEGN--LKLSDFGLSAISPG---EDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLG 210 (370)
T ss_pred HHhCCEeeCCCCHHHEEecCCCCC--EEEeccccccccCC---CCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhH
Confidence 999999999999999999877 54 99999999987741 123457789999999999999877 75 899999999
Q ss_pred HHHHHHHhCCCCCCCCchHH-HHHHHhhccccccccC-ChHHHHHHHHhcCCCCCCCCChhhhhcCccccc
Q 003644 602 CILFFCITGGKHPYGESFER-DANIVKDRKDLFLVEH-IPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWT 670 (805)
Q Consensus 602 vil~elltG~~~Pf~~~~~~-~~~~~~~~~~~~~~~~-~~~~~dLi~~~L~~dP~~Rps~~ell~Hpff~~ 670 (805)
|+||.|++| ..||.+.... ....+......++... ++++++|+.+||..||.+|+++.++++||||..
T Consensus 211 ViLy~ml~G-~~PF~d~~~~~l~~ki~~~~~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 211 VILYVLLCG-RLPFDDSNVPNLYRKIRKGEFKIPSYLLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQK 280 (370)
T ss_pred HHHHHHHhC-CCCCCCccHHHHHHHHhcCCccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence 999999997 7888874432 3333444555566666 999999999999999999999999999999986
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-42 Score=376.01 Aligned_cols=249 Identities=28% Similarity=0.448 Sum_probs=207.2
Q ss_pred cceEEEeEeeccCCceEEEEE-EeeCCcEEEEEEeecCC---chHHHHHHHHHHHhCCCCCeeeecccccCCceEEEecc
Q 003644 375 GKLVVFNKEIAKGSNGTVVLE-GNYEGRSVAVKRLVKTH---HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 450 (805)
Q Consensus 375 ~~~~~~~~~LG~GsfGtVy~a-~~~~g~~VAVK~l~~~~---~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~E 450 (805)
...|...++||+|+.|.||.| ...+++.||||++.... .+-.+.|+. ++...+|+|||+++..|..++.+|+|||
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~-Vm~~~~H~NiVnfl~Sylv~deLWVVME 350 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEIL-VMRDLHHPNIVNFLDSYLVGDELWVVME 350 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHH-HHHhccchHHHHHHHHhcccceeEEEEe
Confidence 345666788999999999998 45678999999996443 244567776 6678899999999999999999999999
Q ss_pred cccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcce
Q 003644 451 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 530 (805)
Q Consensus 451 ~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~I 530 (805)
||.+|+|.+.+.. ..+++.++..|+++++.||+|||..||
T Consensus 351 ----------ym~ggsLTDvVt~------------------------------~~~~E~qIA~Icre~l~aL~fLH~~gI 390 (550)
T KOG0578|consen 351 ----------YMEGGSLTDVVTK------------------------------TRMTEGQIAAICREILQGLKFLHARGI 390 (550)
T ss_pred ----------ecCCCchhhhhhc------------------------------ccccHHHHHHHHHHHHHHHHHHHhcce
Confidence 8888888776422 236778899999999999999999999
Q ss_pred eccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHHHHHhC
Q 003644 531 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG 610 (805)
Q Consensus 531 vHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~elltG 610 (805)
+|||||.+|||++.+|. +||+|||+|..+..... ...+.+|||.|||||++....|+.++||||||++++||+.|
T Consensus 391 iHrDIKSDnILL~~~g~--vKltDFGFcaqi~~~~~---KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveG 465 (550)
T KOG0578|consen 391 IHRDIKSDNILLTMDGS--VKLTDFGFCAQISEEQS---KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEG 465 (550)
T ss_pred eeeccccceeEeccCCc--EEEeeeeeeeccccccC---ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcC
Confidence 99999999999999987 99999999998875432 45678899999999999999999999999999999999997
Q ss_pred CCCCCC-CchHHHHHHHhhcc---ccccccCChHHHHHHHHhcCCCCCCCCChhhhhcCccccc
Q 003644 611 GKHPYG-ESFERDANIVKDRK---DLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWT 670 (805)
Q Consensus 611 ~~~Pf~-~~~~~~~~~~~~~~---~~~~~~~~~~~~dLi~~~L~~dP~~Rps~~ell~Hpff~~ 670 (805)
.|||- +..-+...++.... ...+...+++++||+.+||+.|+++|+++.|+|+||||..
T Consensus 466 -EPPYlnE~PlrAlyLIa~ng~P~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl~~ 528 (550)
T KOG0578|consen 466 -EPPYLNENPLRALYLIATNGTPKLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEHPFLKM 528 (550)
T ss_pred -CCCccCCChHHHHHHHhhcCCCCcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcChhhhh
Confidence 66665 44444433333221 1234456799999999999999999999999999999943
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-41 Score=369.82 Aligned_cols=240 Identities=29% Similarity=0.459 Sum_probs=195.0
Q ss_pred EeEeeccCCceEEEEEEeeCCcE-EEEEEeecCC-----chHHHHHHHHHHHhCCCCCeeeecccccCCc-eEEEecccc
Q 003644 380 FNKEIAKGSNGTVVLEGNYEGRS-VAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQD-FVYLSLERC 452 (805)
Q Consensus 380 ~~~~LG~GsfGtVy~a~~~~g~~-VAVK~l~~~~-----~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~-~l~LV~E~~ 452 (805)
+.+.||+|+||+||+ +.+.|+. ||||++.... .....+|+. ++.+++|||||+++|+|.+.. .++||||
T Consensus 45 ~~~~iG~G~~g~V~~-~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~-il~~l~HpNIV~f~G~~~~~~~~~~iVtE-- 120 (362)
T KOG0192|consen 45 IEEVLGSGSFGTVYK-GKWRGTDVVAVKIISDPDFDDESRKAFRREAS-LLSRLRHPNIVQFYGACTSPPGSLCIVTE-- 120 (362)
T ss_pred hhhhcccCCceeEEE-EEeCCceeEEEEEecchhcChHHHHHHHHHHH-HHHhCCCCCeeeEEEEEcCCCCceEEEEE--
Confidence 445699999999997 5566666 9999997543 124445554 788899999999999999988 7999999
Q ss_pred cCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcc-ee
Q 003644 453 TCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG-LI 531 (805)
Q Consensus 453 ~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~-Iv 531 (805)
|+++|+|..+|+.. ..+.+++..+++++.|||+||.|||+.+ ||
T Consensus 121 --------y~~~GsL~~~l~~~---------------------------~~~~l~~~~~l~~aldiArGm~YLH~~~~iI 165 (362)
T KOG0192|consen 121 --------YMPGGSLSVLLHKK---------------------------RKRKLPLKVRLRIALDIARGMEYLHSEGPII 165 (362)
T ss_pred --------eCCCCcHHHHHhhc---------------------------ccCCCCHHHHHHHHHHHHHHHHHHhcCCCee
Confidence 89999999988653 1245788899999999999999999999 99
Q ss_pred ccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhh--cCCCCCcchHHHHHHHHHHHHh
Q 003644 532 HRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLL--QGRQTRAIDLFSLGCILFFCIT 609 (805)
Q Consensus 532 HrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~--~~~~t~~sDVwSlGvil~ellt 609 (805)
||||||+|||++.+. .++||+|||+++...... .......||+.|||||++. ...|+.|+||||||+++|||+|
T Consensus 166 HrDLK~~NiLv~~~~-~~~KI~DFGlsr~~~~~~---~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t 241 (362)
T KOG0192|consen 166 HRDLKSDNILVDLKG-KTLKIADFGLSREKVISK---TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLT 241 (362)
T ss_pred ecccChhhEEEcCCC-CEEEECCCccceeecccc---ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHH
Confidence 999999999997775 369999999998776431 1112256999999999999 5689999999999999999999
Q ss_pred CCCCCCCCchHHH--HHHH-hhccccccccCChHHHHHHHHhcCCCCCCCCChhhhh
Q 003644 610 GGKHPYGESFERD--ANIV-KDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVL 663 (805)
Q Consensus 610 G~~~Pf~~~~~~~--~~~~-~~~~~~~~~~~~~~~~dLi~~~L~~dP~~Rps~~ell 663 (805)
| +.||....... ..+. .......+....+.+..+|.+||+.||.+||++.+++
T Consensus 242 ~-~~Pf~~~~~~~~~~~v~~~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~ 297 (362)
T KOG0192|consen 242 G-EIPFEDLAPVQVASAVVVGGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIV 297 (362)
T ss_pred C-CCCCCCCCHHHHHHHHHhcCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHH
Confidence 7 78888765422 1222 3334444555778999999999999999999999986
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=423.26 Aligned_cols=231 Identities=25% Similarity=0.356 Sum_probs=171.6
Q ss_pred EeEeeccCCceEEEEEEe-eCCcEEEEEEeecCCchHHHHHHHHHHHhCCCCCeeeecccccCCceEEEecccccCChhh
Q 003644 380 FNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCSLND 458 (805)
Q Consensus 380 ~~~~LG~GsfGtVy~a~~-~~g~~VAVK~l~~~~~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~E~~~~sL~d 458 (805)
..+.||+|+||.||+|.. .+|+.||||++..... ...+|+ ..++.++|||||+++|+|.+++..|+|||
T Consensus 694 ~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~-~~l~~l~HpnIv~~~~~~~~~~~~~lv~E-------- 763 (968)
T PLN00113 694 EENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS-IPSSEI-ADMGKLQHPNIVKLIGLCRSEKGAYLIHE-------- 763 (968)
T ss_pred cccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc-ccHHHH-HHHhhCCCCCcceEEEEEEcCCCCEEEEe--------
Confidence 446799999999999865 5799999999865432 223344 36678899999999999999999999999
Q ss_pred HHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhh---hcceeccCC
Q 003644 459 LIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH---EIGLIHRDL 535 (805)
Q Consensus 459 ~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH---~~~IvHrDL 535 (805)
|+++|+|.++++ .+++..+.+|+.||++||+||| +.+|+||||
T Consensus 764 --y~~~g~L~~~l~--------------------------------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dl 809 (968)
T PLN00113 764 --YIEGKNLSEVLR--------------------------------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNL 809 (968)
T ss_pred --CCCCCcHHHHHh--------------------------------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCC
Confidence 666777776652 1456677899999999999999 669999999
Q ss_pred CCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCCC
Q 003644 536 KPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY 615 (805)
Q Consensus 536 Kp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~elltG~~~Pf 615 (805)
||+||+++.++. +++. ||........ ....||+.|+|||++.+..++.++|||||||++|||+|| +.||
T Consensus 810 kp~Nil~~~~~~--~~~~-~~~~~~~~~~-------~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg-~~p~ 878 (968)
T PLN00113 810 SPEKIIIDGKDE--PHLR-LSLPGLLCTD-------TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTG-KSPA 878 (968)
T ss_pred CHHhEEECCCCc--eEEE-eccccccccC-------CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhC-CCCC
Confidence 999999987765 4443 5554332211 223588999999999999999999999999999999997 6676
Q ss_pred CCchHHHHHHHhhc-------------ccc------ccccCChHHHHHHHHhcCCCCCCCCChhhhhcC
Q 003644 616 GESFERDANIVKDR-------------KDL------FLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNH 665 (805)
Q Consensus 616 ~~~~~~~~~~~~~~-------------~~~------~~~~~~~~~~dLi~~~L~~dP~~Rps~~ell~H 665 (805)
.........+..+. ... ...+...++.+++.+||+.||++||+++|+++.
T Consensus 879 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 947 (968)
T PLN00113 879 DAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKT 947 (968)
T ss_pred CcccCCCCcHHHHHHHhcCccchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence 43221110000000 000 001112357789999999999999999999854
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=355.64 Aligned_cols=260 Identities=25% Similarity=0.343 Sum_probs=208.4
Q ss_pred ccceEEEeEeeccCCceEEEEEE-eeCCcEEEEEEeecCC----chHHHHHHHHHHHhCCCCCeeeecccccCCceEEEe
Q 003644 374 IGKLVVFNKEIAKGSNGTVVLEG-NYEGRSVAVKRLVKTH----HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLS 448 (805)
Q Consensus 374 i~~~~~~~~~LG~GsfGtVy~a~-~~~g~~VAVK~l~~~~----~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV 448 (805)
..+.|.+.++||.|.-++||+|. ...+..||||++.-.. .+...+|++ .++.++||||++++..|..+..+|+|
T Consensus 24 n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~-~msl~~HPNIv~~~~sFvv~~~LWvV 102 (516)
T KOG0582|consen 24 NAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQ-TMSLIDHPNIVTYHCSFVVDSELWVV 102 (516)
T ss_pred CccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHH-HhhhcCCCCcceEEEEEEecceeEEe
Confidence 35678899999999999999985 4568999999995332 234456665 67889999999999999999999999
Q ss_pred cccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhc
Q 003644 449 LERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI 528 (805)
Q Consensus 449 ~E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~ 528 (805)
|. ||..|++.+.+...- ..++.+..+..|++++++||.|||.+
T Consensus 103 mp----------fMa~GS~ldIik~~~---------------------------~~Gl~E~~Ia~iLre~LkaL~YLH~~ 145 (516)
T KOG0582|consen 103 MP----------FMAGGSLLDIIKTYY---------------------------PDGLEEASIATILREVLKALDYLHQN 145 (516)
T ss_pred eh----------hhcCCcHHHHHHHHc---------------------------cccccHHHHHHHHHHHHHHHHHHHhc
Confidence 99 888888888764422 24588899999999999999999999
Q ss_pred ceeccCCCCceEEecCCCCceEEEeccCccccccCCCcccc-ccccccCCCCCCChhhhhc--CCCCCcchHHHHHHHHH
Q 003644 529 GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLT-QNATGYGSSGWQAPEQLLQ--GRQTRAIDLFSLGCILF 605 (805)
Q Consensus 529 ~IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~-~~~~~~gt~~y~APE~l~~--~~~t~~sDVwSlGvil~ 605 (805)
|.||||||+.||||+.+|. +||+|||.+..+........ ...+.+||+.|||||++.. ..|+.|+||||||+..+
T Consensus 146 G~IHRdvKAgnILi~~dG~--VkLadFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ 223 (516)
T KOG0582|consen 146 GHIHRDVKAGNILIDSDGT--VKLADFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITAC 223 (516)
T ss_pred CceecccccccEEEcCCCc--EEEcCceeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHH
Confidence 9999999999999999988 89999998877754432222 2266789999999999765 45899999999999999
Q ss_pred HHHhCCCCCCCCchHHHHHHHhhccccc-----------cccCChHHHHHHHHhcCCCCCCCCChhhhhcCccccccccc
Q 003644 606 FCITGGKHPYGESFERDANIVKDRKDLF-----------LVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTADTR 674 (805)
Q Consensus 606 elltG~~~Pf~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~dLi~~~L~~dP~~Rps~~ell~Hpff~~~~~~ 674 (805)
||.+| ..||.+-.+-..-...-....+ .......++.+|..||+.||.+|||++++++|+||+....+
T Consensus 224 ELA~G-~aPf~k~pPmkvLl~tLqn~pp~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k~~ 302 (516)
T KOG0582|consen 224 ELAHG-HAPFSKYPPMKVLLLTLQNDPPTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAKSK 302 (516)
T ss_pred HHhcC-CCCcccCChHHHHHHHhcCCCCCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhccch
Confidence 99997 8899875544432222221111 11223578899999999999999999999999999776443
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=335.69 Aligned_cols=249 Identities=24% Similarity=0.349 Sum_probs=198.5
Q ss_pred EEEeEeeccCCceEEEEE-EeeCCcEEEEEEeecCC-----chHHHHHHHHHHHhCCCCCeeeecccccCCceEEEeccc
Q 003644 378 VVFNKEIAKGSNGTVVLE-GNYEGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLER 451 (805)
Q Consensus 378 ~~~~~~LG~GsfGtVy~a-~~~~g~~VAVK~l~~~~-----~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~E~ 451 (805)
|...+.||+|.||.||+| ...+|+.||||+++... ...+.+||. +++.++||||+.|+++|-+.+.+-||+|+
T Consensus 4 Y~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK-~Lqel~h~nIi~LiD~F~~~~~l~lVfEf 82 (318)
T KOG0659|consen 4 YEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIK-LLQELKHPNIIELIDVFPHKSNLSLVFEF 82 (318)
T ss_pred hhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHH-HHHHccCcchhhhhhhccCCCceEEEEEe
Confidence 445578999999999998 45679999999996543 347889997 67888999999999999999999999999
Q ss_pred ccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhccee
Q 003644 452 CTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLI 531 (805)
Q Consensus 452 ~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~Iv 531 (805)
++.+|+..|.- +...+...++..++.++++||+|||++.|+
T Consensus 83 m~tdLe~vIkd---------------------------------------~~i~l~pa~iK~y~~m~LkGl~y~H~~~Il 123 (318)
T KOG0659|consen 83 MPTDLEVVIKD---------------------------------------KNIILSPADIKSYMLMTLKGLAYCHSKWIL 123 (318)
T ss_pred ccccHHHHhcc---------------------------------------cccccCHHHHHHHHHHHHHHHHHHHhhhhh
Confidence 98888877621 123466678899999999999999999999
Q ss_pred ccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcC-CCCCcchHHHHHHHHHHHHhC
Q 003644 532 HRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG-RQTRAIDLFSLGCILFFCITG 610 (805)
Q Consensus 532 HrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~t~~sDVwSlGvil~elltG 610 (805)
||||||.|+|++.+|. +||+|||+|+.+....... ...+-|.+|.|||.+.+. .|+..+||||.|||+.||+-|
T Consensus 124 HRDlKPnNLLis~~g~--lKiADFGLAr~f~~p~~~~---~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr 198 (318)
T KOG0659|consen 124 HRDLKPNNLLISSDGQ--LKIADFGLARFFGSPNRIQ---THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLR 198 (318)
T ss_pred cccCCccceEEcCCCc--EEeecccchhccCCCCccc---ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHcc
Confidence 9999999999999987 8999999999887543222 223679999999999875 589999999999999999996
Q ss_pred CCCCCCC-chHHHHHHHhh------------------------cccc----ccccCChHHHHHHHHhcCCCCCCCCChhh
Q 003644 611 GKHPYGE-SFERDANIVKD------------------------RKDL----FLVEHIPEAVDLFTRLLDPNPDLRPKAQN 661 (805)
Q Consensus 611 ~~~Pf~~-~~~~~~~~~~~------------------------~~~~----~~~~~~~~~~dLi~~~L~~dP~~Rps~~e 661 (805)
.|.|.. +.-.+..++-. .+.. .....++++.||+.+||..||.+|++++|
T Consensus 199 -~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~q 277 (318)
T KOG0659|consen 199 -VPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQ 277 (318)
T ss_pred -CCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHH
Confidence 555533 32222111110 0000 11223467899999999999999999999
Q ss_pred hhcCccccccc
Q 003644 662 VLNHPFFWTAD 672 (805)
Q Consensus 662 ll~Hpff~~~~ 672 (805)
+++||||.+..
T Consensus 278 aL~~~yf~~~P 288 (318)
T KOG0659|consen 278 ALKHPYFKSLP 288 (318)
T ss_pred HhcchhhhcCC
Confidence 99999997643
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-42 Score=340.34 Aligned_cols=257 Identities=27% Similarity=0.384 Sum_probs=201.9
Q ss_pred cceEEEeEeeccCCceEEEEE-EeeCCcEEEEEEeecC----CchHHHHHHHHHHHhCCCCCeeeecccccCCceEEEec
Q 003644 375 GKLVVFNKEIAKGSNGTVVLE-GNYEGRSVAVKRLVKT----HHDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSL 449 (805)
Q Consensus 375 ~~~~~~~~~LG~GsfGtVy~a-~~~~g~~VAVK~l~~~----~~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~ 449 (805)
.+.|.+.+.||+|.|..||+. ...+|+.+|+|++... ..-+.++++..+...++|||||+|...+.+..+.|||+
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 344666788999999999875 5567889999877321 12233334445788999999999999999999999999
Q ss_pred ccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcc
Q 003644 450 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG 529 (805)
Q Consensus 450 E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~ 529 (805)
| .|.+|.|..-+-... -+++..+-.+++||+.+|.|+|..+
T Consensus 90 e----------~m~G~dl~~eIV~R~-----------------------------~ySEa~aSH~~rQiLeal~yCH~n~ 130 (355)
T KOG0033|consen 90 D----------LVTGGELFEDIVARE-----------------------------FYSEADASHCIQQILEALAYCHSNG 130 (355)
T ss_pred e----------cccchHHHHHHHHHH-----------------------------HHHHHHHHHHHHHHHHHHHHHHhcC
Confidence 9 677777665443221 1345667889999999999999999
Q ss_pred eeccCCCCceEEec-CCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHHHHH
Q 003644 530 LIHRDLKPQNVLIS-KDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCI 608 (805)
Q Consensus 530 IvHrDLKp~NILl~-~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~ell 608 (805)
|||||+||+|+||. ++...-+||+|||+|..+.+. .....++|||+|||||++...+|+..+|||+.|||||-|+
T Consensus 131 IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g----~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL 206 (355)
T KOG0033|consen 131 IVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDG----EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILL 206 (355)
T ss_pred ceeccCChhheeeeeccCCCceeecccceEEEeCCc----cccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHH
Confidence 99999999999994 344456999999999988732 2334567999999999999999999999999999999999
Q ss_pred hCCCCCCCCchHHHHH-HHhhccccc---cccCChHHHHHHHHhcCCCCCCCCChhhhhcCccccccccc
Q 003644 609 TGGKHPYGESFERDAN-IVKDRKDLF---LVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTADTR 674 (805)
Q Consensus 609 tG~~~Pf~~~~~~~~~-~~~~~~~~~---~~~~~~~~~dLi~~~L~~dP~~Rps~~ell~Hpff~~~~~~ 674 (805)
.|..|+|+++..+... +++...+.. ....++++++||++||..||.+|.|+.|.|+|||..+.+..
T Consensus 207 ~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~r~~~ 276 (355)
T KOG0033|consen 207 VGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKHPWICNRERV 276 (355)
T ss_pred hCCCCCCCccHHHHHHHHhccccCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhCCchhcchHHH
Confidence 9855555656666544 444433322 23456899999999999999999999999999999765543
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-40 Score=353.58 Aligned_cols=247 Identities=27% Similarity=0.377 Sum_probs=196.5
Q ss_pred eEEEeEeeccCCceEEEEEEee-CCcEEEEEEeecCC------chHHHHHHHHHHHhCCCCCeeeecccccCCceEEEec
Q 003644 377 LVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH------HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSL 449 (805)
Q Consensus 377 ~~~~~~~LG~GsfGtVy~a~~~-~g~~VAVK~l~~~~------~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~ 449 (805)
.|.+.+.||+|+||+||++... +|+.||||++.... .....+|+ .++..++||||+++++++.+++..|+||
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~-~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEK-RVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHH-HHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 4677899999999999998654 68999999986432 11233444 4778899999999999999999999999
Q ss_pred ccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcc
Q 003644 450 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG 529 (805)
Q Consensus 450 E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~ 529 (805)
| |+.+|+|.+++.. .+.+++..++.++.||+.||+|||+.|
T Consensus 81 e----------~~~~~~L~~~~~~-----------------------------~~~~~~~~~~~~~~qi~~~l~~lH~~~ 121 (291)
T cd05612 81 E----------YVPGGELFSYLRN-----------------------------SGRFSNSTGLFYASEIVCALEYLHSKE 121 (291)
T ss_pred e----------CCCCCCHHHHHHH-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 9 5555566555422 123566778899999999999999999
Q ss_pred eeccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHHHHHh
Q 003644 530 LIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCIT 609 (805)
Q Consensus 530 IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~ellt 609 (805)
|+||||||+|||++.++. +||+|||+++..... ....+||+.|+|||++.+..++.++|||||||++|||++
T Consensus 122 i~H~dlkp~NIli~~~~~--~kl~Dfg~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~ 193 (291)
T cd05612 122 IVYRDLKPENILLDKEGH--IKLTDFGFAKKLRDR------TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLV 193 (291)
T ss_pred eeecCCCHHHeEECCCCC--EEEEecCcchhccCC------cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHh
Confidence 999999999999988776 899999999876432 223468999999999998889999999999999999999
Q ss_pred CCCCCCCCchHH-HHHHHhhccccccccCChHHHHHHHHhcCCCCCCCCC-----hhhhhcCccccccc
Q 003644 610 GGKHPYGESFER-DANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPK-----AQNVLNHPFFWTAD 672 (805)
Q Consensus 610 G~~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dP~~Rps-----~~ell~Hpff~~~~ 672 (805)
| ..||...... ....+......++...+++++++|++||+.||.+||+ ++++++||||...+
T Consensus 194 g-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~ 261 (291)
T cd05612 194 G-YPPFFDDNPFGIYEKILAGKLEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKSVD 261 (291)
T ss_pred C-CCCCCCCCHHHHHHHHHhCCcCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccccCCC
Confidence 7 6677554322 2222333333345556789999999999999999995 99999999996544
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=342.89 Aligned_cols=241 Identities=24% Similarity=0.366 Sum_probs=189.2
Q ss_pred eEEEeEeeccCCceEEEEE-EeeCCcEEEEEEeecCC-----chHHHHHHHHHHHhCCCCCeeeecc-cccCCce-EEEe
Q 003644 377 LVVFNKEIAKGSNGTVVLE-GNYEGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYG-VESDQDF-VYLS 448 (805)
Q Consensus 377 ~~~~~~~LG~GsfGtVy~a-~~~~g~~VAVK~l~~~~-----~~~~~~Ei~~ll~~l~HpNIV~l~g-~~~~~~~-l~LV 448 (805)
.|.+.++||+|+||+||++ .+.+|..||.|.+.-.. .+...+|+. +++.++|||||++|+ .+.+++. ++||
T Consensus 20 ~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~-lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 20 DYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEIS-LLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHH-HHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 3556688999999999997 67789999999886222 233456765 889999999999999 5555555 8999
Q ss_pred ccccc-CChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhh
Q 003644 449 LERCT-CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE 527 (805)
Q Consensus 449 ~E~~~-~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~ 527 (805)
||+|+ |+|.++|.. .. ...+.+|++.+++++.|+++||.++|+
T Consensus 99 mE~c~~GDLsqmIk~-----------~K-------------------------~qkr~ipE~~Vwk~f~QL~~AL~~cH~ 142 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKH-----------FK-------------------------KQKRLIPEKTVWKYFVQLCRALYHCHS 142 (375)
T ss_pred HHhhcccCHHHHHHH-----------HH-------------------------hccccCchHHHHHHHHHHHHHHHHHhc
Confidence 99776 455555521 11 123558999999999999999999999
Q ss_pred --cc--eeccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHH
Q 003644 528 --IG--LIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCI 603 (805)
Q Consensus 528 --~~--IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvi 603 (805)
.. |+||||||.||+|+.+|. +||+||||++.+.... +...+.+|||.||+||.+.+..|+.+|||||+||+
T Consensus 143 ~~~r~~VmHRDIKPaNIFl~~~gv--vKLGDfGL~r~l~s~~---tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCl 217 (375)
T KOG0591|consen 143 KIPRGTVMHRDIKPANIFLTANGV--VKLGDFGLGRFLSSKT---TFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCL 217 (375)
T ss_pred cccccceeeccCcchheEEcCCCc--eeeccchhHhHhcchh---HHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHH
Confidence 44 999999999999988876 9999999999987542 33456789999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCchHHHH-HHHhhcccccc-ccCChHHHHHHHHhcCCCCCCCCCh
Q 003644 604 LFFCITGGKHPYGESFERDA-NIVKDRKDLFL-VEHIPEAVDLFTRLLDPNPDLRPKA 659 (805)
Q Consensus 604 l~elltG~~~Pf~~~~~~~~-~~~~~~~~~~~-~~~~~~~~dLi~~~L~~dP~~Rps~ 659 (805)
+|||+.-..|++++...... +|.+......+ ...+.++..+|..|+.+||+.||+.
T Consensus 218 lyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t 275 (375)
T KOG0591|consen 218 LYEMCALQSPFYGDNLLSLCKKIEQGDYPPLPDEHYSTDLRELINMCIAVDPEQRPDT 275 (375)
T ss_pred HHHHHhcCCCcccccHHHHHHHHHcCCCCCCcHHHhhhHHHHHHHHHccCCcccCCCc
Confidence 99999974444455444333 33333333233 4457789999999999999999986
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=360.82 Aligned_cols=246 Identities=26% Similarity=0.376 Sum_probs=195.1
Q ss_pred EeeccCCceEEEEEEe-eCCcEEEEEEeecCC------chHHHHHHHHHHHhCCCCCeeeecccccCCceEEEecccccC
Q 003644 382 KEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH------HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTC 454 (805)
Q Consensus 382 ~~LG~GsfGtVy~a~~-~~g~~VAVK~l~~~~------~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~E~~~~ 454 (805)
+.||+|+||+||++.. .+|+.||||++.+.. .....+|+. ++..++||||+++++++.+++.+|+|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~-~l~~l~hp~i~~~~~~~~~~~~~~lv~e---- 75 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESR-VLQNTRHPFLTALKYSFQTHDRLCFVME---- 75 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHH-HHHhCCCCCCCCEEEEEEcCCEEEEEEe----
Confidence 3699999999999854 578999999987532 112334544 6788899999999999999999999999
Q ss_pred ChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcceeccC
Q 003644 455 SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRD 534 (805)
Q Consensus 455 sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~IvHrD 534 (805)
|+.+|+|.+++.. ...+++..+..++.||+.||+|||+.||+|||
T Consensus 76 ------~~~~~~L~~~l~~-----------------------------~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrD 120 (323)
T cd05571 76 ------YANGGELFFHLSR-----------------------------ERVFSEDRARFYGAEIVSALGYLHSCDVVYRD 120 (323)
T ss_pred ------CCCCCcHHHHHHH-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCC
Confidence 5555666555422 23467788899999999999999999999999
Q ss_pred CCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCC
Q 003644 535 LKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP 614 (805)
Q Consensus 535 LKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~elltG~~~P 614 (805)
|||+|||++.++. +||+|||+++...... ......+||+.|+|||++.+..++.++|||||||++|||++| .+|
T Consensus 121 lkp~NIll~~~~~--~kl~DfG~a~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg-~~P 194 (323)
T cd05571 121 LKLENLMLDKDGH--IKITDFGLCKEGISDG---ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG-RLP 194 (323)
T ss_pred CCHHHEEECCCCC--EEEeeCCCCcccccCC---CcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcC-CCC
Confidence 9999999988776 8999999987543221 122345699999999999999999999999999999999997 667
Q ss_pred CCCc-hHHHHHHHhhccccccccCChHHHHHHHHhcCCCCCCCC-----ChhhhhcCcccccccc
Q 003644 615 YGES-FERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRP-----KAQNVLNHPFFWTADT 673 (805)
Q Consensus 615 f~~~-~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dP~~Rp-----s~~ell~Hpff~~~~~ 673 (805)
|... .......+......++...++++.++|.+||+.||++|| ++.++++||||....+
T Consensus 195 f~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~f~~~~~ 259 (323)
T cd05571 195 FYNQDHEKLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASINW 259 (323)
T ss_pred CCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcCCCcCCCCH
Confidence 6543 333333333333445566788999999999999999999 8999999999976544
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-40 Score=359.84 Aligned_cols=249 Identities=26% Similarity=0.355 Sum_probs=197.8
Q ss_pred ceEEEeEeeccCCceEEEEEEe-eCCcEEEEEEeecCC------chHHHHHHHHHHHhCCCCCeeeecccccCCceEEEe
Q 003644 376 KLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH------HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLS 448 (805)
Q Consensus 376 ~~~~~~~~LG~GsfGtVy~a~~-~~g~~VAVK~l~~~~------~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV 448 (805)
..|.+.+.||+|+||+||++.. .+|+.||||++.+.. .....+|+. ++..++||||+++++++.+++..|+|
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~-~l~~l~hp~iv~~~~~~~~~~~~~lv 96 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKS-ILMELSHPFIVNMMCSFQDENRVYFL 96 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHH-HHHhCCCCCCCcEEEEEEcCCEEEEE
Confidence 4578889999999999999865 468999999986432 122344554 67888999999999999999999999
Q ss_pred cccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhc
Q 003644 449 LERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI 528 (805)
Q Consensus 449 ~E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~ 528 (805)
|||| .+|+|.+++.. ...+++..+..++.||+.||+|||+.
T Consensus 97 ~e~~----------~~~~L~~~l~~-----------------------------~~~~~~~~~~~~~~qi~~aL~~LH~~ 137 (329)
T PTZ00263 97 LEFV----------VGGELFTHLRK-----------------------------AGRFPNDVAKFYHAELVLAFEYLHSK 137 (329)
T ss_pred EcCC----------CCChHHHHHHH-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 9954 45555554422 23456777889999999999999999
Q ss_pred ceeccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHHHHH
Q 003644 529 GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCI 608 (805)
Q Consensus 529 ~IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~ell 608 (805)
+|+||||||+|||++.++. +||+|||+++..... ....+||+.|+|||++.+..++.++|||||||++|||+
T Consensus 138 ~ivH~dlkp~NIll~~~~~--~kl~Dfg~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell 209 (329)
T PTZ00263 138 DIIYRDLKPENLLLDNKGH--VKVTDFGFAKKVPDR------TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFI 209 (329)
T ss_pred CeeecCCCHHHEEECCCCC--EEEeeccCceEcCCC------cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHH
Confidence 9999999999999988876 899999999876432 12356999999999999999999999999999999999
Q ss_pred hCCCCCCCCchH-HHHHHHhhccccccccCChHHHHHHHHhcCCCCCCCCC-----hhhhhcCcccccccc
Q 003644 609 TGGKHPYGESFE-RDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPK-----AQNVLNHPFFWTADT 673 (805)
Q Consensus 609 tG~~~Pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dP~~Rps-----~~ell~Hpff~~~~~ 673 (805)
+| .+||..... .....+.......+...++++++||.+||+.||.+||+ ++++++||||....+
T Consensus 210 tg-~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~~~ 279 (329)
T PTZ00263 210 AG-YPPFFDDTPFRIYEKILAGRLKFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGANW 279 (329)
T ss_pred cC-CCCCCCCCHHHHHHHHhcCCcCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCCCCH
Confidence 97 667755332 22222333333344556788999999999999999997 799999999976543
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=357.77 Aligned_cols=250 Identities=26% Similarity=0.389 Sum_probs=197.2
Q ss_pred EEEeEeeccCCceEEEEE-EeeCCcEEEEEEeecCC-----chHHHHHHHHHHHhCCCCCeeeecccccCC--ceEEEec
Q 003644 378 VVFNKEIAKGSNGTVVLE-GNYEGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQ--DFVYLSL 449 (805)
Q Consensus 378 ~~~~~~LG~GsfGtVy~a-~~~~g~~VAVK~l~~~~-----~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~--~~l~LV~ 449 (805)
|...++||+|.||.||+| ...+|+.||+|++.-.. ...+.+||. ++++++||||++|.+...+. ..+|||+
T Consensus 119 feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~-ILr~l~HpNIikL~eivt~~~~~siYlVF 197 (560)
T KOG0600|consen 119 FEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIK-ILRRLDHPNIIKLEEIVTSKLSGSIYLVF 197 (560)
T ss_pred HHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHH-HHHhcCCCcccceeeEEEecCCceEEEEE
Confidence 444578999999999998 45689999999996443 235678987 78999999999999987776 7899999
Q ss_pred ccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcc
Q 003644 450 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG 529 (805)
Q Consensus 450 E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~ 529 (805)
||++.+|.-++-. ..-.+++.++..+++||+.||+|||+.|
T Consensus 198 eYMdhDL~GLl~~---------------------------------------p~vkft~~qIKc~mkQLl~Gl~~cH~~g 238 (560)
T KOG0600|consen 198 EYMDHDLSGLLSS---------------------------------------PGVKFTEPQIKCYMKQLLEGLEYCHSRG 238 (560)
T ss_pred ecccchhhhhhcC---------------------------------------CCcccChHHHHHHHHHHHHHHHHHhhcC
Confidence 9877666555411 1134778899999999999999999999
Q ss_pred eeccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcC-CCCCcchHHHHHHHHHHHH
Q 003644 530 LIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG-RQTRAIDLFSLGCILFFCI 608 (805)
Q Consensus 530 IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~t~~sDVwSlGvil~ell 608 (805)
|+|||||.+||||+.+|. +||+|||||+++..... ......+-|.+|.|||.|.+. .|+.++|+||.||||.||+
T Consensus 239 vlHRDIK~SNiLidn~G~--LKiaDFGLAr~y~~~~~--~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~ 314 (560)
T KOG0600|consen 239 VLHRDIKGSNILIDNNGV--LKIADFGLARFYTPSGS--APYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELF 314 (560)
T ss_pred eeeccccccceEEcCCCC--EEeccccceeeccCCCC--cccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHH
Confidence 999999999999988876 89999999998875432 223456689999999999985 6999999999999999999
Q ss_pred hCCCCCCCCchHHHH-H-HHh---------hcc-cc------------------ccccCChHHHHHHHHhcCCCCCCCCC
Q 003644 609 TGGKHPYGESFERDA-N-IVK---------DRK-DL------------------FLVEHIPEAVDLFTRLLDPNPDLRPK 658 (805)
Q Consensus 609 tG~~~Pf~~~~~~~~-~-~~~---------~~~-~~------------------~~~~~~~~~~dLi~~~L~~dP~~Rps 658 (805)
+| ++.|....+.++ . |.+ |.. .+ .....++.+.+|+..||..||.+|.|
T Consensus 315 ~g-kPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~t 393 (560)
T KOG0600|consen 315 LG-KPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGT 393 (560)
T ss_pred cC-CCCcCCccHHHHHHHHHHHhCCCChhccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCcccccc
Confidence 97 777765543321 1 111 000 00 01123457889999999999999999
Q ss_pred hhhhhcCccccccc
Q 003644 659 AQNVLNHPFFWTAD 672 (805)
Q Consensus 659 ~~ell~Hpff~~~~ 672 (805)
|.++|+|+||+...
T Consensus 394 A~~aL~seyF~t~p 407 (560)
T KOG0600|consen 394 ASSALQSEYFTTEP 407 (560)
T ss_pred HHHHhcCcccccCC
Confidence 99999999996543
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=331.22 Aligned_cols=248 Identities=26% Similarity=0.388 Sum_probs=207.7
Q ss_pred ceEEEeEeeccCCceEEEEEE-eeCCcEEEEEEeecCCc------hHHHHHHHHHHHhCCCCCeeeecccccCCceEEEe
Q 003644 376 KLVVFNKEIAKGSNGTVVLEG-NYEGRSVAVKRLVKTHH------DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLS 448 (805)
Q Consensus 376 ~~~~~~~~LG~GsfGtVy~a~-~~~g~~VAVK~l~~~~~------~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV 448 (805)
++|.+++.||+|.||.||+|. ..++-.||+|++.+.+. .+..+|++ +.+.++||||+++|++|.|+...||+
T Consensus 22 ~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiE-Iqs~L~hpnilrlY~~fhd~~riyLi 100 (281)
T KOG0580|consen 22 DDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIE-IQSHLRHPNILRLYGYFHDSKRIYLI 100 (281)
T ss_pred hhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeE-eecccCCccHHhhhhheeccceeEEE
Confidence 446778999999999999985 45678999999976542 23445654 77899999999999999999999999
Q ss_pred cccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhc
Q 003644 449 LERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI 528 (805)
Q Consensus 449 ~E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~ 528 (805)
+| |..+|++...|... +...+.+.....++.|+|.||.|+|..
T Consensus 101 lE----------ya~~gel~k~L~~~---------------------------~~~~f~e~~~a~Yi~q~A~Al~y~h~k 143 (281)
T KOG0580|consen 101 LE----------YAPRGELYKDLQEG---------------------------RMKRFDEQRAATYIKQLANALLYCHLK 143 (281)
T ss_pred EE----------ecCCchHHHHHHhc---------------------------ccccccccchhHHHHHHHHHHHHhccC
Confidence 99 88889988877432 223466677789999999999999999
Q ss_pred ceeccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHHHHH
Q 003644 529 GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCI 608 (805)
Q Consensus 529 ~IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~ell 608 (805)
+||||||||+|+|++.++. +||+|||-+.... .....+.|||..|.+||+..+..++..+|+|++|++.||++
T Consensus 144 ~VIhRdiKpenlLlg~~~~--lkiAdfGwsV~~p-----~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yefl 216 (281)
T KOG0580|consen 144 RVIHRDIKPENLLLGSAGE--LKIADFGWSVHAP-----SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFL 216 (281)
T ss_pred CcccCCCCHHHhccCCCCC--eeccCCCceeecC-----CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHH
Confidence 9999999999999988887 8999999876544 23457789999999999999999999999999999999999
Q ss_pred hCCCCCCCCchHHH-HHHHhhccccccccCChHHHHHHHHhcCCCCCCCCChhhhhcCcccc
Q 003644 609 TGGKHPYGESFERD-ANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFW 669 (805)
Q Consensus 609 tG~~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dP~~Rps~~ell~Hpff~ 669 (805)
.| .+||.+....+ ...+......++...+.++.|+|.+||..+|.+|.+..|++.|||..
T Consensus 217 vg-~ppFes~~~~etYkrI~k~~~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~ 277 (281)
T KOG0580|consen 217 VG-LPPFESQSHSETYKRIRKVDLKFPSTISGGAADLISRLLVKNPIERLALTEVMDHPWIV 277 (281)
T ss_pred hc-CCchhhhhhHHHHHHHHHccccCCcccChhHHHHHHHHhccCccccccHHHHhhhHHHH
Confidence 97 78887654332 23444444456667788999999999999999999999999999974
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=349.91 Aligned_cols=252 Identities=24% Similarity=0.314 Sum_probs=192.4
Q ss_pred ceEEEeEeeccCCceEEEEEEee-CCcEEEEEEeecCC----chHHHHHHHHHHHhCCCCCeeeecccccCCceEEEecc
Q 003644 376 KLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH----HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 450 (805)
Q Consensus 376 ~~~~~~~~LG~GsfGtVy~a~~~-~g~~VAVK~l~~~~----~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~E 450 (805)
+.|.+.+.||+|+||+||++... +|+.||||++.... .....+|+. +++.++||||+++++++.+++..|+|||
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREAS-LLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred ccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHH-HHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 45788899999999999998654 68999999986432 123455665 6788999999999999999999999999
Q ss_pred cccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcce
Q 003644 451 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 530 (805)
Q Consensus 451 ~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~I 530 (805)
||.++|.+++... ...+++..+..++.||+.||+|||+.+|
T Consensus 84 ~~~~~l~~~~~~~---------------------------------------~~~~~~~~~~~~~~qi~~al~~lH~~~i 124 (303)
T cd07869 84 YVHTDLCQYMDKH---------------------------------------PGGLHPENVKLFLFQLLRGLSYIHQRYI 124 (303)
T ss_pred CCCcCHHHHHHhC---------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 8877665554211 1235667788999999999999999999
Q ss_pred eccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhc-CCCCCcchHHHHHHHHHHHHh
Q 003644 531 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ-GRQTRAIDLFSLGCILFFCIT 609 (805)
Q Consensus 531 vHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~t~~sDVwSlGvil~ellt 609 (805)
+||||||+|||++.++. +||+|||+++...... .......||+.|+|||++.+ ..++.++|||||||++|||++
T Consensus 125 vH~dlkp~Nill~~~~~--~kl~Dfg~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~ 199 (303)
T cd07869 125 LHRDLKPQNLLISDTGE--LKLADFGLARAKSVPS---HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQ 199 (303)
T ss_pred ecCCCCHHHEEECCCCC--EEECCCCcceeccCCC---ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHh
Confidence 99999999999987776 8999999987543221 11233468999999999875 457899999999999999999
Q ss_pred CCCCCCCCchHHHH---HHHhh--cc------------cc-----------------ccccCChHHHHHHHHhcCCCCCC
Q 003644 610 GGKHPYGESFERDA---NIVKD--RK------------DL-----------------FLVEHIPEAVDLFTRLLDPNPDL 655 (805)
Q Consensus 610 G~~~Pf~~~~~~~~---~~~~~--~~------------~~-----------------~~~~~~~~~~dLi~~~L~~dP~~ 655 (805)
| .+||........ .+... .. .. .....++++.+|+.+||+.||.+
T Consensus 200 g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~ 278 (303)
T cd07869 200 G-VAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKN 278 (303)
T ss_pred C-CCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchh
Confidence 7 778865322111 11000 00 00 00012357889999999999999
Q ss_pred CCChhhhhcCcccccccc
Q 003644 656 RPKAQNVLNHPFFWTADT 673 (805)
Q Consensus 656 Rps~~ell~Hpff~~~~~ 673 (805)
|||++|+++||||.....
T Consensus 279 R~s~~~~l~h~~f~~~~~ 296 (303)
T cd07869 279 RLSAQAALSHEYFSDLPP 296 (303)
T ss_pred ccCHHHHhcCcccccCCh
Confidence 999999999999976543
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=346.81 Aligned_cols=246 Identities=24% Similarity=0.359 Sum_probs=189.9
Q ss_pred eEEEeEeeccCCceEEEEEEe-eCCcEEEEEEeecCC----chHHHHHHHHHHHhCCCCCeeeecccccCCceEEEeccc
Q 003644 377 LVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH----HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLER 451 (805)
Q Consensus 377 ~~~~~~~LG~GsfGtVy~a~~-~~g~~VAVK~l~~~~----~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~E~ 451 (805)
.|.+.+.||+|+||+||++.. .+++.||+|+++... .....+|+. +++.++||||+++++++.+++..|+|||+
T Consensus 6 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 6 TYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVS-LLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred cceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHH-HHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 477889999999999999854 468999999986432 234456765 67888999999999999999999999998
Q ss_pred ccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhccee
Q 003644 452 CTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLI 531 (805)
Q Consensus 452 ~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~Iv 531 (805)
|.++|.+++... ...+++..+..++.||+.||+|||+.||+
T Consensus 85 ~~~~l~~~l~~~---------------------------------------~~~~~~~~~~~~~~qi~~aL~~LH~~~iv 125 (288)
T cd07871 85 LDSDLKQYLDNC---------------------------------------GNLMSMHNVKIFMFQLLRGLSYCHKRKIL 125 (288)
T ss_pred CCcCHHHHHHhc---------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcc
Confidence 777665554211 12246677889999999999999999999
Q ss_pred ccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhc-CCCCCcchHHHHHHHHHHHHhC
Q 003644 532 HRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ-GRQTRAIDLFSLGCILFFCITG 610 (805)
Q Consensus 532 HrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~t~~sDVwSlGvil~elltG 610 (805)
||||||+|||++.++. +||+|||+++....... ......||+.|+|||++.+ ..++.++||||+||++|||++|
T Consensus 126 H~dlkp~Nil~~~~~~--~kl~DfG~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g 200 (288)
T cd07871 126 HRDLKPQNLLINEKGE--LKLADFGLARAKSVPTK---TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATG 200 (288)
T ss_pred cCCCCHHHEEECCCCC--EEECcCcceeeccCCCc---cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhC
Confidence 9999999999988876 89999999976542211 1233458999999999876 4689999999999999999997
Q ss_pred CCCCCCCchHHH-HHHH-hhc------------------cccc-----------cccCChHHHHHHHHhcCCCCCCCCCh
Q 003644 611 GKHPYGESFERD-ANIV-KDR------------------KDLF-----------LVEHIPEAVDLFTRLLDPNPDLRPKA 659 (805)
Q Consensus 611 ~~~Pf~~~~~~~-~~~~-~~~------------------~~~~-----------~~~~~~~~~dLi~~~L~~dP~~Rps~ 659 (805)
.+||....... ...+ ... ...+ ....+++++|||++||+.||.+|||+
T Consensus 201 -~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~ 279 (288)
T cd07871 201 -RPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISA 279 (288)
T ss_pred -CCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCH
Confidence 67775433221 1110 000 0000 11235689999999999999999999
Q ss_pred hhhhcCccc
Q 003644 660 QNVLNHPFF 668 (805)
Q Consensus 660 ~ell~Hpff 668 (805)
+|+++||||
T Consensus 280 ~~~l~hp~f 288 (288)
T cd07871 280 EAALRHSYF 288 (288)
T ss_pred HHHhcCCCC
Confidence 999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=347.43 Aligned_cols=250 Identities=24% Similarity=0.373 Sum_probs=195.7
Q ss_pred EEEeEeeccCCceEEEEEEe-eCCcEEEEEEeecCCc------hHHHHHHHHHHHhCCCCCeeeecccccCCceEEEecc
Q 003644 378 VVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH------DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 450 (805)
Q Consensus 378 ~~~~~~LG~GsfGtVy~a~~-~~g~~VAVK~l~~~~~------~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~E 450 (805)
|...+.||+|+||+||++.. .+|+.||||.+.+... ....+|+. ++..++|+||+++++++.+++..++|||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~-il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKR-ILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHH-HHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 55678899999999999854 5799999999864321 12334544 7788999999999999999999999999
Q ss_pred cccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcce
Q 003644 451 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 530 (805)
Q Consensus 451 ~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~I 530 (805)
|+.+|+|..++... ....+++..++.++.|++.||+|||+.+|
T Consensus 81 ----------~~~~g~L~~~~~~~---------------------------~~~~~~~~~~~~~~~qi~~~l~~lH~~~i 123 (285)
T cd05631 81 ----------IMNGGDLKFHIYNM---------------------------GNPGFDEQRAIFYAAELCCGLEDLQRERI 123 (285)
T ss_pred ----------ecCCCcHHHHHHhh---------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCE
Confidence 44555555443211 11246778889999999999999999999
Q ss_pred eccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHHHHHhC
Q 003644 531 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG 610 (805)
Q Consensus 531 vHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~elltG 610 (805)
+||||||+|||++.++. +||+|||++....... ......||..|+|||++.+..++.++|||||||++|||++|
T Consensus 124 iH~dikp~Nill~~~~~--~kl~Dfg~~~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g 197 (285)
T cd05631 124 VYRDLKPENILLDDRGH--IRISDLGLAVQIPEGE----TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQG 197 (285)
T ss_pred EeCCCCHHHEEECCCCC--EEEeeCCCcEEcCCCC----eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhC
Confidence 99999999999987765 8999999998754321 12234689999999999999999999999999999999996
Q ss_pred CCCCCCCchHH-----HHHHHhhccccccccCChHHHHHHHHhcCCCCCCCCC-----hhhhhcCccccccc
Q 003644 611 GKHPYGESFER-----DANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPK-----AQNVLNHPFFWTAD 672 (805)
Q Consensus 611 ~~~Pf~~~~~~-----~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dP~~Rps-----~~ell~Hpff~~~~ 672 (805)
++||...... ....+......++...++++.+|+++||+.||.+||+ ++++++||||....
T Consensus 198 -~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~ 268 (285)
T cd05631 198 -QSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNIN 268 (285)
T ss_pred -CCCCCCCCcchhHHHHHHHhhcccccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCC
Confidence 7788654321 1112222223344566789999999999999999997 89999999997654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=350.93 Aligned_cols=258 Identities=31% Similarity=0.460 Sum_probs=214.2
Q ss_pred ccccceEEEeEeeccCCceEEEEE-EeeCCcEEEEEEeecCCch-----HHHHHHHHHHHhCCCCCeeeecccccCCceE
Q 003644 372 RRIGKLVVFNKEIAKGSNGTVVLE-GNYEGRSVAVKRLVKTHHD-----VALKEIQNLIASDQHPNIVRWYGVESDQDFV 445 (805)
Q Consensus 372 ~~i~~~~~~~~~LG~GsfGtVy~a-~~~~g~~VAVK~l~~~~~~-----~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l 445 (805)
.+|...|.+.+.||+|.|..|-+| ..++|..||||++.+...+ ..++|+.. ++..+||||||||.+......+
T Consensus 14 gkIAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRC-MKLVQHpNiVRLYEViDTQTKl 92 (864)
T KOG4717|consen 14 GKIAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRC-MKLVQHPNIVRLYEVIDTQTKL 92 (864)
T ss_pred cceeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHH-HHHhcCcCeeeeeehhcccceE
Confidence 456778899999999999999887 6789999999999876533 46788874 5889999999999999999999
Q ss_pred EEecccccC-ChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHH
Q 003644 446 YLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSH 524 (805)
Q Consensus 446 ~LV~E~~~~-sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~y 524 (805)
|||+|+-++ +|.||| ..+ ..++.+..+.+++.||+.|+.|
T Consensus 93 yLiLELGD~GDl~DyI-----------mKH----------------------------e~Gl~E~La~kYF~QI~~AI~Y 133 (864)
T KOG4717|consen 93 YLILELGDGGDLFDYI-----------MKH----------------------------EEGLNEDLAKKYFAQIVHAISY 133 (864)
T ss_pred EEEEEecCCchHHHHH-----------Hhh----------------------------hccccHHHHHHHHHHHHHHHHH
Confidence 999996653 555555 222 2457778889999999999999
Q ss_pred hhhcceeccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCC-CcchHHHHHHH
Q 003644 525 LHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQT-RAIDLFSLGCI 603 (805)
Q Consensus 525 LH~~~IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t-~~sDVwSlGvi 603 (805)
+|+..+|||||||+||.+.+.-. .+||+|||++..+.++ .+..+.||+..|.|||++.+..|+ +++||||||||
T Consensus 134 CHqLHVVHRDLKPENVVFFEKlG-lVKLTDFGFSNkf~PG----~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVI 208 (864)
T KOG4717|consen 134 CHQLHVVHRDLKPENVVFFEKLG-LVKLTDFGFSNKFQPG----KKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVI 208 (864)
T ss_pred HhhhhhhcccCCcceeEEeeecC-ceEeeeccccccCCCc----chhhcccchhhccCchhhhcCccCCcchhhhHHHHH
Confidence 99999999999999999876554 4899999999887754 456788999999999999999885 79999999999
Q ss_pred HHHHHhCCCCCCCCchHHH-HHHHhhccccccccCChHHHHHHHHhcCCCCCCCCChhhhhcCccccccccch
Q 003644 604 LFFCITGGKHPYGESFERD-ANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTADTRL 675 (805)
Q Consensus 604 l~elltG~~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dP~~Rps~~ell~Hpff~~~~~~~ 675 (805)
||.|++| .+||.+....+ .-++..-+...+...+.+++|||..||+.||.+|.+.+|+..|+|.+..+.-.
T Consensus 209 LyMLVCG-q~PFqeANDSETLTmImDCKYtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D~~~ 280 (864)
T KOG4717|consen 209 LYMLVCG-QPPFQEANDSETLTMIMDCKYTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAGDRGL 280 (864)
T ss_pred HHHHHhC-CCccccccchhhhhhhhcccccCchhhhHHHHHHHHHHHhcCchhhccHHHHhccccccCCCCCc
Confidence 9999996 88997754332 33444445556667788999999999999999999999999999997665443
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-40 Score=351.78 Aligned_cols=259 Identities=30% Similarity=0.440 Sum_probs=201.0
Q ss_pred cccccccceEEEeEeeccCCceEEEEEEe-eCCcEEEEEEeecCC-----------------chHHHHHHHHHHHhCCCC
Q 003644 369 VDGRRIGKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH-----------------HDVALKEIQNLIASDQHP 430 (805)
Q Consensus 369 ~~~~~i~~~~~~~~~LG~GsfGtVy~a~~-~~g~~VAVK~l~~~~-----------------~~~~~~Ei~~ll~~l~Hp 430 (805)
.+.+..-..|.+.+.||+|.||.|-+|.. .+++.||||++.+.. .+...+||. +++++.||
T Consensus 90 ~~~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIa-ilKkl~H~ 168 (576)
T KOG0585|consen 90 DQDRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIA-ILKKLHHP 168 (576)
T ss_pred cccceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHH-HHHhcCCc
Confidence 34456667899999999999999999854 579999999996432 135567876 77999999
Q ss_pred CeeeecccccC--CceEEEecccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCC-CC
Q 003644 431 NIVRWYGVESD--QDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANG-HP 507 (805)
Q Consensus 431 NIV~l~g~~~~--~~~l~LV~E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~-l~ 507 (805)
|||+|+.+..| .+.+|||+|||. .|.+... -.... +.
T Consensus 169 nVV~LiEvLDDP~s~~~YlVley~s----------~G~v~w~------------------------------p~d~~els 208 (576)
T KOG0585|consen 169 NVVKLIEVLDDPESDKLYLVLEYCS----------KGEVKWC------------------------------PPDKPELS 208 (576)
T ss_pred CeeEEEEeecCcccCceEEEEEecc----------CCccccC------------------------------CCCccccc
Confidence 99999999876 477999999554 4433210 00122 67
Q ss_pred HHHHHHHHHHHHHHHHHhhhcceeccCCCCceEEecCCCCceEEEeccCccccccCCCc--cccccccccCCCCCCChhh
Q 003644 508 SAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMS--CLTQNATGYGSSGWQAPEQ 585 (805)
Q Consensus 508 ~~~~~~i~~qIa~gL~yLH~~~IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~--~~~~~~~~~gt~~y~APE~ 585 (805)
+.++++|+++++.||+|||.+|||||||||+|+||+.+|. +||+|||.+........ ........+|||.|+|||.
T Consensus 209 ~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~--VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~ 286 (576)
T KOG0585|consen 209 EQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGT--VKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPEL 286 (576)
T ss_pred HHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCc--EEeeccceeeecccCCccccHHHHhhcCCCccccchHh
Confidence 7899999999999999999999999999999999998876 99999999987743211 1122234679999999999
Q ss_pred hhcCC----CCCcchHHHHHHHHHHHHhCCCCCCCCchHH-HHHHHhhcccccccc--CChHHHHHHHHhcCCCCCCCCC
Q 003644 586 LLQGR----QTRAIDLFSLGCILFFCITGGKHPYGESFER-DANIVKDRKDLFLVE--HIPEAVDLFTRLLDPNPDLRPK 658 (805)
Q Consensus 586 l~~~~----~t~~sDVwSlGvil~elltG~~~Pf~~~~~~-~~~~~~~~~~~~~~~--~~~~~~dLi~~~L~~dP~~Rps 658 (805)
+..+. .+.+.||||+||+||.|+.| +.||.+.... ....+......++.. ..++++|||.+||.+||++|.+
T Consensus 287 c~~~~~~~~~g~a~DiWalGVTLYCllfG-~~PF~~~~~~~l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~ 365 (576)
T KOG0585|consen 287 CSGGNSFSYSGFALDIWALGVTLYCLLFG-QLPFFDDFELELFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRIT 365 (576)
T ss_pred hcCCCCccccchhhhhhhhhhhHHHhhhc-cCCcccchHHHHHHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheee
Confidence 98743 36799999999999999997 5566554443 344455544444443 4689999999999999999999
Q ss_pred hhhhhcCcccccc
Q 003644 659 AQNVLNHPFFWTA 671 (805)
Q Consensus 659 ~~ell~Hpff~~~ 671 (805)
..+|..|||....
T Consensus 366 l~~ik~Hpwvt~~ 378 (576)
T KOG0585|consen 366 LPDIKLHPWVTRD 378 (576)
T ss_pred hhhheecceeccC
Confidence 9999999998543
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-40 Score=344.02 Aligned_cols=252 Identities=27% Similarity=0.433 Sum_probs=192.9
Q ss_pred ccceEEEeEeeccCCceEEEEE-EeeCCcEEEEEEeecC-----CchHHHHHHHHHHHhCCCCCeeeecccccC-----C
Q 003644 374 IGKLVVFNKEIAKGSNGTVVLE-GNYEGRSVAVKRLVKT-----HHDVALKEIQNLIASDQHPNIVRWYGVESD-----Q 442 (805)
Q Consensus 374 i~~~~~~~~~LG~GsfGtVy~a-~~~~g~~VAVK~l~~~-----~~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~-----~ 442 (805)
+...|...+.||+|+||.|..| ...+|+.||||++... .....++|+. +++.++|+||+.++.++.. -
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElk-lLr~~~HeNIi~l~di~~p~~~~~f 98 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELK-LLRHLRHENIIGLLDIFRPPSRDKF 98 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHH-HHHHhcCCCcceEEeeccccccccc
Confidence 3444555688999999999987 4567999999998633 2346778887 7788899999999998765 3
Q ss_pred ceEEEecccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHH
Q 003644 443 DFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGL 522 (805)
Q Consensus 443 ~~l~LV~E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL 522 (805)
+.+|+|+|+++.+|.+.+.. ...+....+..++.||++||
T Consensus 99 ~DvYiV~elMetDL~~iik~----------------------------------------~~~L~d~H~q~f~YQiLrgL 138 (359)
T KOG0660|consen 99 NDVYLVFELMETDLHQIIKS----------------------------------------QQDLTDDHAQYFLYQILRGL 138 (359)
T ss_pred ceeEEehhHHhhHHHHHHHc----------------------------------------CccccHHHHHHHHHHHHHhc
Confidence 56899999887777766621 12255567789999999999
Q ss_pred HHhhhcceeccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhc-CCCCCcchHHHHH
Q 003644 523 SHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ-GRQTRAIDLFSLG 601 (805)
Q Consensus 523 ~yLH~~~IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~t~~sDVwSlG 601 (805)
.|+|+.+|+||||||+|+|++.+.. +||+|||+|+..... +........+.|.+|.|||++.. ..|+.++||||.|
T Consensus 139 KyiHSAnViHRDLKPsNll~n~~c~--lKI~DFGLAR~~~~~-~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvG 215 (359)
T KOG0660|consen 139 KYIHSANVIHRDLKPSNLLLNADCD--LKICDFGLARYLDKF-FEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVG 215 (359)
T ss_pred chhhcccccccccchhheeeccCCC--EEeccccceeecccc-CcccchhcceeeeeecCHHHHhccccccchhhhhhhh
Confidence 9999999999999999999977755 799999999988643 22223344568999999999865 5799999999999
Q ss_pred HHHHHHHhCCCCCCC-CchHHHHH------------------------HHhhccc-------cccccCChHHHHHHHHhc
Q 003644 602 CILFFCITGGKHPYG-ESFERDAN------------------------IVKDRKD-------LFLVEHIPEAVDLFTRLL 649 (805)
Q Consensus 602 vil~elltG~~~Pf~-~~~~~~~~------------------------~~~~~~~-------~~~~~~~~~~~dLi~~~L 649 (805)
||+.||++| ++-|. .+.-.+.. .++..+. .......+++.||+++||
T Consensus 216 CI~AEmL~g-kplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL 294 (359)
T KOG0660|consen 216 CILAEMLTG-KPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKML 294 (359)
T ss_pred HHHHHHHcC-CCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHh
Confidence 999999997 54443 32211111 1111110 011244689999999999
Q ss_pred CCCCCCCCChhhhhcCccccc
Q 003644 650 DPNPDLRPKAQNVLNHPFFWT 670 (805)
Q Consensus 650 ~~dP~~Rps~~ell~Hpff~~ 670 (805)
..||.+|+|++|+|.|||+..
T Consensus 295 ~fdP~kRita~eAL~hPYl~~ 315 (359)
T KOG0660|consen 295 VFDPKKRITAEEALAHPYLAP 315 (359)
T ss_pred ccCccccCCHHHHhcChhhhh
Confidence 999999999999999999854
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=356.62 Aligned_cols=249 Identities=28% Similarity=0.383 Sum_probs=197.4
Q ss_pred ceEEEeEeeccCCceEEEEEEeeC--CcEEEEEEeecCC------chHHHHHHHHHHHhCCCCCeeeecccccCCceEEE
Q 003644 376 KLVVFNKEIAKGSNGTVVLEGNYE--GRSVAVKRLVKTH------HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYL 447 (805)
Q Consensus 376 ~~~~~~~~LG~GsfGtVy~a~~~~--g~~VAVK~l~~~~------~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~L 447 (805)
+.|.+.+.||+|+||+||++.... +..||||++.+.. .....+|+ .++..++||||+++++++.+++..|+
T Consensus 30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~-~~l~~l~hp~Iv~~~~~~~~~~~~~l 108 (340)
T PTZ00426 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSER-KILNYINHPFCVNLYGSFKDESYLYL 108 (340)
T ss_pred hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHH-HHHHhCCCCCCcceEEEEEeCCEEEE
Confidence 457888999999999999986443 3689999986431 12233454 47788999999999999999999999
Q ss_pred ecccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhh
Q 003644 448 SLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE 527 (805)
Q Consensus 448 V~E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~ 527 (805)
||| |+.+|+|.+++.. ...+++..+..++.||+.||+|||+
T Consensus 109 v~E----------y~~~g~L~~~i~~-----------------------------~~~~~~~~~~~~~~qi~~aL~~LH~ 149 (340)
T PTZ00426 109 VLE----------FVIGGEFFTFLRR-----------------------------NKRFPNDVGCFYAAQIVLIFEYLQS 149 (340)
T ss_pred EEe----------CCCCCcHHHHHHH-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 999 4455555554422 2346777889999999999999999
Q ss_pred cceeccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHHHH
Q 003644 528 IGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFC 607 (805)
Q Consensus 528 ~~IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~el 607 (805)
.+|+||||||+|||++.++. +||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||
T Consensus 150 ~~ivHrDLkp~NILl~~~~~--ikL~DFG~a~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~el 221 (340)
T PTZ00426 150 LNIVYRDLKPENLLLDKDGF--IKMTDFGFAKVVDTR------TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEI 221 (340)
T ss_pred CCeEccCCCHHHEEECCCCC--EEEecCCCCeecCCC------cceecCChhhcCHHHHhCCCCCccccccchhhHHHHH
Confidence 99999999999999988776 899999999865422 2345699999999999988899999999999999999
Q ss_pred HhCCCCCCCCchH-HHHHHHhhccccccccCChHHHHHHHHhcCCCCCCCC-----ChhhhhcCcccccccc
Q 003644 608 ITGGKHPYGESFE-RDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRP-----KAQNVLNHPFFWTADT 673 (805)
Q Consensus 608 ltG~~~Pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dP~~Rp-----s~~ell~Hpff~~~~~ 673 (805)
++| .+||..... .....+......++...++++.++|++||+.||++|+ +++++++||||.+.++
T Consensus 222 l~G-~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~~ 292 (340)
T PTZ00426 222 LVG-CPPFYANEPLLIYQKILEGIIYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNIDW 292 (340)
T ss_pred hcC-CCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCCCH
Confidence 997 667765433 2223333333334556678999999999999999995 8999999999976543
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-39 Score=352.39 Aligned_cols=251 Identities=25% Similarity=0.366 Sum_probs=189.2
Q ss_pred eEEEeEeeccCCceEEEEEEe-eCCcEEEEEEeecCC-----chHHHHHHHHHHHhCCCCCeeeecccccCC-----ceE
Q 003644 377 LVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQ-----DFV 445 (805)
Q Consensus 377 ~~~~~~~LG~GsfGtVy~a~~-~~g~~VAVK~l~~~~-----~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~-----~~l 445 (805)
+|.+.+.||+|+||.||++.. .+|+.||||++.... .....+|+. +++.++||||+++++++... ...
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~-~l~~l~hpniv~~~~~~~~~~~~~~~~~ 79 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIK-LLRLLRHPDIVEIKHIMLPPSRREFKDI 79 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHH-HHHhCCCCCEeeecceEeccCCCCCceE
Confidence 367889999999999999854 578999999986421 123456665 67889999999999987543 358
Q ss_pred EEecccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHh
Q 003644 446 YLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHL 525 (805)
Q Consensus 446 ~LV~E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yL 525 (805)
|+|||||.++|.+++. ....+++..+..++.||+.||+||
T Consensus 80 ~lv~e~~~~~L~~~l~----------------------------------------~~~~~~~~~~~~i~~qi~~aL~~L 119 (338)
T cd07859 80 YVVFELMESDLHQVIK----------------------------------------ANDDLTPEHHQFFLYQLLRALKYI 119 (338)
T ss_pred EEEEecCCCCHHHHHH----------------------------------------hcccCCHHHHHHHHHHHHHHHHHH
Confidence 9999988766655441 112366778899999999999999
Q ss_pred hhcceeccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhc--CCCCCcchHHHHHHH
Q 003644 526 HEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ--GRQTRAIDLFSLGCI 603 (805)
Q Consensus 526 H~~~IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~--~~~t~~sDVwSlGvi 603 (805)
|+.+|+||||||+|||++.++. +||+|||+++................||+.|+|||++.+ ..++.++|||||||+
T Consensus 120 H~~~ivH~dlkp~NIll~~~~~--~kL~Dfg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvv 197 (338)
T cd07859 120 HTANVFHRDLKPKNILANADCK--LKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCI 197 (338)
T ss_pred HHCCeecCCCCHHHeEECCCCc--EEEccCccccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHH
Confidence 9999999999999999988776 899999999865432221112234569999999999876 678999999999999
Q ss_pred HHHHHhCCCCCCCCchHHH-HHH------------------------Hhh----cccc---ccccCChHHHHHHHHhcCC
Q 003644 604 LFFCITGGKHPYGESFERD-ANI------------------------VKD----RKDL---FLVEHIPEAVDLFTRLLDP 651 (805)
Q Consensus 604 l~elltG~~~Pf~~~~~~~-~~~------------------------~~~----~~~~---~~~~~~~~~~dLi~~~L~~ 651 (805)
+|||++| ++||....... ... ... .... ......+++.++|.+||+.
T Consensus 198 l~el~tg-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 276 (338)
T cd07859 198 FAEVLTG-KPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAF 276 (338)
T ss_pred HHHHHcC-CCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCc
Confidence 9999997 77875432111 000 000 0000 0113456789999999999
Q ss_pred CCCCCCChhhhhcCcccccc
Q 003644 652 NPDLRPKAQNVLNHPFFWTA 671 (805)
Q Consensus 652 dP~~Rps~~ell~Hpff~~~ 671 (805)
||++||+++|+++||||...
T Consensus 277 ~P~~Rpt~~e~l~hp~f~~~ 296 (338)
T cd07859 277 DPKDRPTAEEALADPYFKGL 296 (338)
T ss_pred CcccCCCHHHHhcCchhhhc
Confidence 99999999999999999653
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-40 Score=362.04 Aligned_cols=256 Identities=30% Similarity=0.430 Sum_probs=195.5
Q ss_pred ccchhhhcccccccccccceEEEeEeeccCCceEEEEEEeeCCcEEEEEEeecCCc---hHHHHHHHHHHHhCCCCCeee
Q 003644 358 LLTFTDLIDDRVDGRRIGKLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHH---DVALKEIQNLIASDQHPNIVR 434 (805)
Q Consensus 358 ~~~~~~l~~~~~~~~~i~~~~~~~~~LG~GsfGtVy~a~~~~g~~VAVK~l~~~~~---~~~~~Ei~~ll~~l~HpNIV~ 434 (805)
.+.+.++. ..++.|.-...||+|+||+||+|.+.+|+.||||++..... .++..|+. ++++++|||+|+
T Consensus 64 ~fs~~el~-------~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~-~ls~l~H~Nlv~ 135 (361)
T KOG1187|consen 64 SFSYDELR-------KATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVE-ILSRLRHPNLVK 135 (361)
T ss_pred eeeHHHHH-------HHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHH-HHhcCCCcCccc
Confidence 45666664 33455667789999999999999999999999999976442 34556665 788999999999
Q ss_pred ecccccCCc-eEEEecccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHH
Q 003644 435 WYGVESDQD-FVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLK 513 (805)
Q Consensus 435 l~g~~~~~~-~l~LV~E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 513 (805)
|+|||.+.+ ..+|||| ||++|+|.++|+..... .++|..+++
T Consensus 136 LlGyC~e~~~~~~LVYE----------ym~nGsL~d~L~~~~~~---------------------------~L~W~~R~k 178 (361)
T KOG1187|consen 136 LLGYCLEGGEHRLLVYE----------YMPNGSLEDHLHGKKGE---------------------------PLDWETRLK 178 (361)
T ss_pred EEEEEecCCceEEEEEE----------ccCCCCHHHHhCCCCCC---------------------------CCCHHHHHH
Confidence 999999999 5999999 99999999999764321 578888999
Q ss_pred HHHHHHHHHHHhhhc---ceeccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccc-cCCCCCCChhhhhcC
Q 003644 514 VTRDIVSGLSHLHEI---GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATG-YGSSGWQAPEQLLQG 589 (805)
Q Consensus 514 i~~qIa~gL~yLH~~---~IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~-~gt~~y~APE~l~~~ 589 (805)
|+.++|+||+|||+. .||||||||+|||||++ +.+||+|||+|+...... ....+. .||.+|+|||+...+
T Consensus 179 Ia~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~--~~aKlsDFGLa~~~~~~~---~~~~~~~~gt~gY~~PEy~~~g 253 (361)
T KOG1187|consen 179 IALGAARGLAYLHEGCPPPIIHRDIKSSNILLDED--FNAKLSDFGLAKLGPEGD---TSVSTTVMGTFGYLAPEYASTG 253 (361)
T ss_pred HHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCC--CCEEccCccCcccCCccc---cceeeecCCCCccCChhhhccC
Confidence 999999999999986 49999999999999766 559999999996655311 111112 699999999999999
Q ss_pred CCCCcchHHHHHHHHHHHHhCCCCCCCCch-HH---HH----HHHhhc-----cccc-c-ccC-----ChHHHHHHHHhc
Q 003644 590 RQTRAIDLFSLGCILFFCITGGKHPYGESF-ER---DA----NIVKDR-----KDLF-L-VEH-----IPEAVDLFTRLL 649 (805)
Q Consensus 590 ~~t~~sDVwSlGvil~elltG~~~Pf~~~~-~~---~~----~~~~~~-----~~~~-~-~~~-----~~~~~dLi~~~L 649 (805)
..+.++|||||||++.|++||+ .+.+... .. .. ..+... .+.. . ... ...+..+..+|+
T Consensus 254 ~lt~KsDVySFGVvllElitgr-~~~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~ 332 (361)
T KOG1187|consen 254 KLTEKSDVYSFGVVLLELITGR-KAVDQSRPRGELSLVEWAKPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCL 332 (361)
T ss_pred CcCcccccccchHHHHHHHhCC-cccCCCCCcccccHHHHHHHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHc
Confidence 9999999999999999999985 4444321 00 00 111110 0000 0 111 123557888999
Q ss_pred CCCCCCCCChhhhhc
Q 003644 650 DPNPDLRPKAQNVLN 664 (805)
Q Consensus 650 ~~dP~~Rps~~ell~ 664 (805)
+.+|..||+|.||++
T Consensus 333 ~~~~~~RP~m~~Vv~ 347 (361)
T KOG1187|consen 333 RPDPKERPTMSQVVK 347 (361)
T ss_pred CcCCCcCcCHHHHHH
Confidence 999999999999753
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-40 Score=330.70 Aligned_cols=247 Identities=25% Similarity=0.393 Sum_probs=198.3
Q ss_pred EEEeEeeccCCceEEEEE-EeeCCcEEEEEEeecCC-----------chHHHHHHHHHHHhCCCCCeeeecccccCCceE
Q 003644 378 VVFNKEIAKGSNGTVVLE-GNYEGRSVAVKRLVKTH-----------HDVALKEIQNLIASDQHPNIVRWYGVESDQDFV 445 (805)
Q Consensus 378 ~~~~~~LG~GsfGtVy~a-~~~~g~~VAVK~l~~~~-----------~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l 445 (805)
|.-.+.||+|..++|.+. ...+|++.|||++.... .+...+|+..+.....||||+.+.++++.+.++
T Consensus 19 y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF~ 98 (411)
T KOG0599|consen 19 YEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAFV 98 (411)
T ss_pred cChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcchh
Confidence 445578999999988765 55679999999985321 123456777788888999999999999999999
Q ss_pred EEecccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHh
Q 003644 446 YLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHL 525 (805)
Q Consensus 446 ~LV~E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yL 525 (805)
++|+| .++.|.|+++|... ..++++..++|++|+..|++||
T Consensus 99 FlVFd----------l~prGELFDyLts~-----------------------------VtlSEK~tR~iMrqlfegVeyl 139 (411)
T KOG0599|consen 99 FLVFD----------LMPRGELFDYLTSK-----------------------------VTLSEKETRRIMRQLFEGVEYL 139 (411)
T ss_pred hhhhh----------hcccchHHHHhhhh-----------------------------eeecHHHHHHHHHHHHHHHHHH
Confidence 99999 77888888887543 3467788899999999999999
Q ss_pred hhcceeccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhc------CCCCCcchHHH
Q 003644 526 HEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ------GRQTRAIDLFS 599 (805)
Q Consensus 526 H~~~IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~------~~~t~~sDVwS 599 (805)
|..+||||||||+|||++++.+ +||+|||++..+..+ ......||||+|+|||.+.. ..|+..+|+||
T Consensus 140 Ha~~IVHRDLKpENILlddn~~--i~isDFGFa~~l~~G----ekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa 213 (411)
T KOG0599|consen 140 HARNIVHRDLKPENILLDDNMN--IKISDFGFACQLEPG----EKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWA 213 (411)
T ss_pred HHhhhhhcccChhheeeccccc--eEEeccceeeccCCc----hhHHHhcCCCcccChhheeeecccCCCCccchhhHHH
Confidence 9999999999999999977755 899999999988754 34456799999999999864 35788999999
Q ss_pred HHHHHHHHHhCCCCCCCCchHHHHHHHhhcccccc----ccCChHHHHHHHHhcCCCCCCCCChhhhhcCcccc
Q 003644 600 LGCILFFCITGGKHPYGESFERDANIVKDRKDLFL----VEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFW 669 (805)
Q Consensus 600 lGvil~elltG~~~Pf~~~~~~~~~~~~~~~~~~~----~~~~~~~~dLi~~~L~~dP~~Rps~~ell~Hpff~ 669 (805)
+|||+|-++.|..|+|....--....+......+. .+.+.+++|||.+||+.||.+|.|++|+|.||||.
T Consensus 214 ~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~ 287 (411)
T KOG0599|consen 214 CGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAHPFFI 287 (411)
T ss_pred HHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcChHHH
Confidence 99999999998544444333333333333333222 23456889999999999999999999999999994
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=355.41 Aligned_cols=243 Identities=27% Similarity=0.417 Sum_probs=196.2
Q ss_pred EEeEeeccCCceEEEEEEeeCCcEEEEEEeecCC-c-hHHHHHHHHHHHhCCCCCeeeecccccCCceEEEecccccCCh
Q 003644 379 VFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTH-H-DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCSL 456 (805)
Q Consensus 379 ~~~~~LG~GsfGtVy~a~~~~g~~VAVK~l~~~~-~-~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~E~~~~sL 456 (805)
.+.+.||+|-||.||++.......||||.++... . +...+|++ ++..++|+|||+|+|+|..++.+|||||
T Consensus 209 ~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~~~~f~~Ea~-iMk~L~H~~lV~l~gV~~~~~piyIVtE------ 281 (468)
T KOG0197|consen 209 KLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMSPEAFLREAQ-IMKKLRHEKLVKLYGVCTKQEPIYIVTE------ 281 (468)
T ss_pred HHHHHhcCCccceEEEEEEcCCCcccceEEeccccChhHHHHHHH-HHHhCcccCeEEEEEEEecCCceEEEEE------
Confidence 3457799999999999665555699999997643 2 34445654 7899999999999999999999999999
Q ss_pred hhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCC
Q 003644 457 NDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLK 536 (805)
Q Consensus 457 ~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~IvHrDLK 536 (805)
||++|+|.++|..... ..+...+.+.++.|||+|++||+++++|||||.
T Consensus 282 ----~m~~GsLl~yLr~~~~---------------------------~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLA 330 (468)
T KOG0197|consen 282 ----YMPKGSLLDYLRTREG---------------------------GLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLA 330 (468)
T ss_pred ----ecccCcHHHHhhhcCC---------------------------CccchHHHHHHHHHHHHHHHHHHhCCccchhhh
Confidence 9999999998865221 235567889999999999999999999999999
Q ss_pred CceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q 003644 537 PQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYG 616 (805)
Q Consensus 537 p~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~elltG~~~Pf~ 616 (805)
++||||+++. ++||+|||||+...++. ........-...|.|||.+..+.++.+||||||||+||||+|-|+.||.
T Consensus 331 ARNiLV~~~~--~vKIsDFGLAr~~~d~~--Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~ 406 (468)
T KOG0197|consen 331 ARNILVDEDL--VVKISDFGLARLIGDDE--YTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYP 406 (468)
T ss_pred hhheeeccCc--eEEEcccccccccCCCc--eeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCC
Confidence 9999997764 69999999999554332 2222222346689999999999999999999999999999999999987
Q ss_pred CchHHH-HHHHhhc-cccccccCChHHHHHHHHhcCCCCCCCCChhhhh
Q 003644 617 ESFERD-ANIVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVL 663 (805)
Q Consensus 617 ~~~~~~-~~~~~~~-~~~~~~~~~~~~~dLi~~~L~~dP~~Rps~~ell 663 (805)
.....+ ...+... .-..|..+++++.+++..||..+|++|||.+.+.
T Consensus 407 ~msn~ev~~~le~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~ 455 (468)
T KOG0197|consen 407 GMSNEEVLELLERGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLR 455 (468)
T ss_pred CCCHHHHHHHHhccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHH
Confidence 754333 3444444 3344566778999999999999999999998654
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=341.58 Aligned_cols=247 Identities=25% Similarity=0.371 Sum_probs=190.7
Q ss_pred eEEEeEeeccCCceEEEEEEee-CCcEEEEEEeecCC-----chHHHHHHHHHHHhCCCCCeeeecccccCCceEEEecc
Q 003644 377 LVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 450 (805)
Q Consensus 377 ~~~~~~~LG~GsfGtVy~a~~~-~g~~VAVK~l~~~~-----~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~E 450 (805)
.|.+.+.||+|+||+||++... +++.||||++.... .....+|+. ++..++||||+++++++.+++..|+|||
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~-~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELK-MLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHH-HHHhCCCccccchhhhEecCCEEEEEEe
Confidence 4778899999999999998654 68899999986532 123455665 7788999999999999999999999999
Q ss_pred cccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcce
Q 003644 451 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 530 (805)
Q Consensus 451 ~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~I 530 (805)
||.+++.+.+. .....+++..++.++.||+.||+|||+.+|
T Consensus 81 ~~~~~~l~~~~---------------------------------------~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i 121 (287)
T cd07848 81 YVEKNMLELLE---------------------------------------EMPNGVPPEKVRSYIYQLIKAIHWCHKNDI 121 (287)
T ss_pred cCCCCHHHHHH---------------------------------------hcCCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 77654333221 011346777889999999999999999999
Q ss_pred eccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHHHHHhC
Q 003644 531 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG 610 (805)
Q Consensus 531 vHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~elltG 610 (805)
+||||||+||+++.++. +||+|||+++....... .......||+.|+|||++.+..++.++|||||||++|||++|
T Consensus 122 ~H~dlkp~Nill~~~~~--~kl~Dfg~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g 197 (287)
T cd07848 122 VHRDIKPENLLISHNDV--LKLCDFGFARNLSEGSN--ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDG 197 (287)
T ss_pred ecCCCCHHHEEEcCCCc--EEEeeccCccccccccc--ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhC
Confidence 99999999999987775 89999999987643211 112234689999999999988899999999999999999997
Q ss_pred CCCCCCCchHHHH--HHHhhc--------------c----c-------------cccccCChHHHHHHHHhcCCCCCCCC
Q 003644 611 GKHPYGESFERDA--NIVKDR--------------K----D-------------LFLVEHIPEAVDLFTRLLDPNPDLRP 657 (805)
Q Consensus 611 ~~~Pf~~~~~~~~--~~~~~~--------------~----~-------------~~~~~~~~~~~dLi~~~L~~dP~~Rp 657 (805)
++||........ .+.... . . ......++++.+||++||+.||++||
T Consensus 198 -~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~ 276 (287)
T cd07848 198 -QPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRY 276 (287)
T ss_pred -CCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCC
Confidence 778865322111 000000 0 0 00112356799999999999999999
Q ss_pred ChhhhhcCccc
Q 003644 658 KAQNVLNHPFF 668 (805)
Q Consensus 658 s~~ell~Hpff 668 (805)
|++++++||||
T Consensus 277 s~~~~l~hp~f 287 (287)
T cd07848 277 LTEQCLNHPAF 287 (287)
T ss_pred CHHHHhcCCCC
Confidence 99999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-39 Score=348.70 Aligned_cols=242 Identities=29% Similarity=0.384 Sum_probs=190.7
Q ss_pred eccCCceEEEEEEee-CCcEEEEEEeecCC------chHHHHHHHHHHHhCCCCCeeeecccccCCceEEEecccccCCh
Q 003644 384 IAKGSNGTVVLEGNY-EGRSVAVKRLVKTH------HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCSL 456 (805)
Q Consensus 384 LG~GsfGtVy~a~~~-~g~~VAVK~l~~~~------~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~E~~~~sL 456 (805)
||+|+||+||++... +++.||||++.+.. .....+|+. ++..++||||+++++++.+.+..|+|||
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~-~l~~l~h~~iv~~~~~~~~~~~~~lv~e------ 73 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERT-VLAQVNCPFIVPLKFSFQSPEKLYLVLA------ 73 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHH-HHHhCCCCcEeceeeEEecCCeEEEEEc------
Confidence 799999999998554 68899999986431 122334554 6778899999999999999999999999
Q ss_pred hhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCC
Q 003644 457 NDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLK 536 (805)
Q Consensus 457 ~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~IvHrDLK 536 (805)
|+.+|+|.+++.. ...+++..+..++.||+.||+|||+.+|+|||||
T Consensus 74 ----~~~~g~L~~~l~~-----------------------------~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlk 120 (312)
T cd05585 74 ----FINGGELFHHLQR-----------------------------EGRFDLSRARFYTAELLCALENLHKFNVIYRDLK 120 (312)
T ss_pred ----CCCCCcHHHHHHh-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCC
Confidence 4555666555432 1235677788999999999999999999999999
Q ss_pred CceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q 003644 537 PQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYG 616 (805)
Q Consensus 537 p~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~elltG~~~Pf~ 616 (805)
|+|||++.++. +||+|||+++...... ......+||+.|+|||++.+..++.++|||||||++|||++| .+||.
T Consensus 121 p~Nili~~~~~--~kl~Dfg~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg-~~pf~ 194 (312)
T cd05585 121 PENILLDYQGH--IALCDFGLCKLNMKDD---DKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTG-LPPFY 194 (312)
T ss_pred HHHeEECCCCc--EEEEECcccccCccCC---CccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhC-CCCcC
Confidence 99999988776 8999999987643221 122345699999999999999999999999999999999997 67775
Q ss_pred Cch-HHHHHHHhhccccccccCChHHHHHHHHhcCCCCCCCC---ChhhhhcCcccccc
Q 003644 617 ESF-ERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRP---KAQNVLNHPFFWTA 671 (805)
Q Consensus 617 ~~~-~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dP~~Rp---s~~ell~Hpff~~~ 671 (805)
... ......+.......+...++++.++|.+||+.||.+|| ++.|+++||||...
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~hp~~~~~ 253 (312)
T cd05585 195 DENVNEMYRKILQEPLRFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQL 253 (312)
T ss_pred CCCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcCCCcCCC
Confidence 533 22223333333344556778999999999999999997 57899999999764
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=369.81 Aligned_cols=259 Identities=27% Similarity=0.432 Sum_probs=202.9
Q ss_pred ceEEEeEeeccCCceEEEEEEee------CCcEEEEEEeecCCch----HHHHHHHHHHHhCCCCCeeeecccccCCceE
Q 003644 376 KLVVFNKEIAKGSNGTVVLEGNY------EGRSVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVRWYGVESDQDFV 445 (805)
Q Consensus 376 ~~~~~~~~LG~GsfGtVy~a~~~------~g~~VAVK~l~~~~~~----~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l 445 (805)
..+++.++||+|+||+||+|..+ +...||||.+++.... ++.+|+ ++++.++|||||+|+|+|.+++.+
T Consensus 486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REa-eLla~l~H~nIVrLlGVC~~~~P~ 564 (774)
T KOG1026|consen 486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREA-ELLAELQHPNIVRLLGVCREGDPL 564 (774)
T ss_pred hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHH-HHHHhccCCCeEEEEEEEccCCee
Confidence 34567789999999999998554 3468999999876544 233444 599999999999999999999999
Q ss_pred EEecccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHh
Q 003644 446 YLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHL 525 (805)
Q Consensus 446 ~LV~E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yL 525 (805)
|||+| ||..|+|.++|.........+. .+.+ ....+...+.+.|+.|||.|++||
T Consensus 565 ~MvFE----------Ym~~GDL~eFLra~sP~a~~~~-----------~g~~----~~~~L~~~q~L~iA~QIAaGM~YL 619 (774)
T KOG1026|consen 565 CMVFE----------YMDHGDLHEFLRARSPKADKLA-----------SGQD----TPPPLSTSQFLHIATQIAAGMEYL 619 (774)
T ss_pred EEEEE----------ecccccHHHHHHhhCCcccccc-----------CCCC----CCCCCCHHHHHHHHHHHHHHHHHH
Confidence 99999 8888888888866544332110 0111 134477889999999999999999
Q ss_pred hhcceeccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHH
Q 003644 526 HEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILF 605 (805)
Q Consensus 526 H~~~IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~ 605 (805)
-++.+|||||..+|+||.++ +.+||+||||++.+.+...+ .......-..+||+||.+..+++|.+||||||||+||
T Consensus 620 s~~~FVHRDLATRNCLVge~--l~VKIsDfGLsRdiYssDYY-k~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLW 696 (774)
T KOG1026|consen 620 SSHHFVHRDLATRNCLVGEN--LVVKISDFGLSRDIYSSDYY-KVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLW 696 (774)
T ss_pred HhCcccccchhhhhceeccc--eEEEecccccchhhhhhhhh-cccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhh
Confidence 99999999999999999655 67999999999987654222 2121223467899999999999999999999999999
Q ss_pred HHHhCCCCCCCCc-hHHHHHHHhhc-cccccccCChHHHHHHHHhcCCCCCCCCChhhhh
Q 003644 606 FCITGGKHPYGES-FERDANIVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVL 663 (805)
Q Consensus 606 elltG~~~Pf~~~-~~~~~~~~~~~-~~~~~~~~~~~~~dLi~~~L~~dP~~Rps~~ell 663 (805)
|+++-|+.||..- .+.-...+..+ --..+...++++.+|+..||+.+|.+||+++||-
T Consensus 697 EIFsyG~QPy~glSn~EVIe~i~~g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~ 756 (774)
T KOG1026|consen 697 EIFSYGKQPYYGLSNQEVIECIRAGQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIH 756 (774)
T ss_pred hhhccccCcccccchHHHHHHHHcCCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHH
Confidence 9999888888653 33333444433 3344556677999999999999999999999973
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-39 Score=351.42 Aligned_cols=246 Identities=27% Similarity=0.373 Sum_probs=194.0
Q ss_pred EeeccCCceEEEEEEe-eCCcEEEEEEeecCCc------hHHHHHHHHHHHhCCCCCeeeecccccCCceEEEecccccC
Q 003644 382 KEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH------DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTC 454 (805)
Q Consensus 382 ~~LG~GsfGtVy~a~~-~~g~~VAVK~l~~~~~------~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~E~~~~ 454 (805)
+.||+|+||+||++.. .+|+.||+|++..... ....+|+ .++..++||||+++++++.+.+..|+|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~-~~l~~l~hp~i~~~~~~~~~~~~~~lv~E---- 75 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTES-RVLQNTRHPFLTALKYAFQTHDRLCFVME---- 75 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHH-HHHHhCCCCCCcceeeEEecCCEEEEEEe----
Confidence 3699999999999854 5789999999865311 1223444 47788899999999999999999999999
Q ss_pred ChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcceeccC
Q 003644 455 SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRD 534 (805)
Q Consensus 455 sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~IvHrD 534 (805)
|+.+|+|..++.. ...+++..++.++.||+.||+|||+.||+|||
T Consensus 76 ------~~~~~~L~~~l~~-----------------------------~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~D 120 (323)
T cd05595 76 ------YANGGELFFHLSR-----------------------------ERVFTEERARFYGAEIVSALEYLHSRDVVYRD 120 (323)
T ss_pred ------CCCCCcHHHHHHH-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecC
Confidence 5556666554421 23467788899999999999999999999999
Q ss_pred CCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCC
Q 003644 535 LKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP 614 (805)
Q Consensus 535 LKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~elltG~~~P 614 (805)
|||+|||++.++. +||+|||+++...... .......||+.|+|||++.+..++.++|||||||++|||++| ..|
T Consensus 121 lkp~NIll~~~~~--~kL~Dfg~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g-~~P 194 (323)
T cd05595 121 IKLENLMLDKDGH--IKITDFGLCKEGISDG---ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG-RLP 194 (323)
T ss_pred CCHHHEEEcCCCC--EEecccHHhccccCCC---CccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhC-CCC
Confidence 9999999988776 8999999987543221 112335699999999999998999999999999999999997 667
Q ss_pred CCCch-HHHHHHHhhccccccccCChHHHHHHHHhcCCCCCCCC-----ChhhhhcCcccccccc
Q 003644 615 YGESF-ERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRP-----KAQNVLNHPFFWTADT 673 (805)
Q Consensus 615 f~~~~-~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dP~~Rp-----s~~ell~Hpff~~~~~ 673 (805)
|.... ......+.......+...++++.++|.+||+.||.+|+ ++.++++||||....+
T Consensus 195 f~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~~~~~~~ 259 (323)
T cd05595 195 FYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINW 259 (323)
T ss_pred CCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCCCcCCCCH
Confidence 75433 32223333333334556778999999999999999998 8999999999976543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-39 Score=349.85 Aligned_cols=246 Identities=27% Similarity=0.406 Sum_probs=192.2
Q ss_pred EeeccCCceEEEEEEe-eCCcEEEEEEeecCC------chHHHHHHHHHHHhCCCCCeeeecccccCCceEEEecccccC
Q 003644 382 KEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH------HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTC 454 (805)
Q Consensus 382 ~~LG~GsfGtVy~a~~-~~g~~VAVK~l~~~~------~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~E~~~~ 454 (805)
+.||+|+||+||++.. .+++.||||++.+.. .....+|+..+....+||||+++++++.+.+.+|+|||||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~-- 78 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFV-- 78 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCC--
Confidence 3699999999999865 468999999986431 1233455554545568999999999999999999999954
Q ss_pred ChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcceeccC
Q 003644 455 SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRD 534 (805)
Q Consensus 455 sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~IvHrD 534 (805)
.+|+|..++.. ...+++..++.++.||+.||+|||+.+|+|||
T Consensus 79 --------~~g~L~~~i~~-----------------------------~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~d 121 (320)
T cd05590 79 --------NGGDLMFHIQK-----------------------------SRRFDEARARFYAAEITSALMFLHDKGIIYRD 121 (320)
T ss_pred --------CCchHHHHHHH-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCC
Confidence 45555544421 23467778899999999999999999999999
Q ss_pred CCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCC
Q 003644 535 LKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP 614 (805)
Q Consensus 535 LKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~elltG~~~P 614 (805)
|||+|||++.++. +||+|||+++...... .......||+.|+|||++.+..++.++|||||||++|||++| .+|
T Consensus 122 lkp~NIli~~~~~--~kL~DfG~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g-~~P 195 (320)
T cd05590 122 LKLDNVLLDHEGH--CKLADFGMCKEGIFNG---KTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCG-HAP 195 (320)
T ss_pred CCHHHeEECCCCc--EEEeeCCCCeecCcCC---CcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhC-CCC
Confidence 9999999988876 8999999987543211 112345699999999999988999999999999999999997 778
Q ss_pred CCCchHHH-HHHHhhccccccccCChHHHHHHHHhcCCCCCCCCCh------hhhhcCccccccc
Q 003644 615 YGESFERD-ANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKA------QNVLNHPFFWTAD 672 (805)
Q Consensus 615 f~~~~~~~-~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dP~~Rps~------~ell~Hpff~~~~ 672 (805)
|....... ...+.......+...++++.++|++||+.||.+||++ +++++||||....
T Consensus 196 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f~~~~ 260 (320)
T cd05590 196 FEAENEDDLFEAILNDEVVYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKELD 260 (320)
T ss_pred CCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCCcCCCC
Confidence 86544332 2233333333445567899999999999999999998 8999999996543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-39 Score=352.12 Aligned_cols=246 Identities=26% Similarity=0.355 Sum_probs=194.1
Q ss_pred EeeccCCceEEEEEE-eeCCcEEEEEEeecCC------chHHHHHHHHHHHhCCCCCeeeecccccCCceEEEecccccC
Q 003644 382 KEIAKGSNGTVVLEG-NYEGRSVAVKRLVKTH------HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTC 454 (805)
Q Consensus 382 ~~LG~GsfGtVy~a~-~~~g~~VAVK~l~~~~------~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~E~~~~ 454 (805)
+.||+|+||+||++. ..+|+.||||++.+.. .....+|+ .++..++||||+++++++.+++..|+|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~-~~l~~l~hp~iv~~~~~~~~~~~~~lv~E---- 75 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTES-RVLKNTRHPFLTSLKYSFQTKDRLCFVME---- 75 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHH-HHHHhCCCCCCcceEEEEEcCCEEEEEEe----
Confidence 369999999999985 4578999999997532 11233454 47788999999999999999999999999
Q ss_pred ChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcceeccC
Q 003644 455 SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRD 534 (805)
Q Consensus 455 sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~IvHrD 534 (805)
|+.+|+|..++.. ...+++.+++.++.||+.||+|||+.+|+|||
T Consensus 76 ------y~~~g~L~~~l~~-----------------------------~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrD 120 (328)
T cd05593 76 ------YVNGGELFFHLSR-----------------------------ERVFSEDRTRFYGAEIVSALDYLHSGKIVYRD 120 (328)
T ss_pred ------CCCCCCHHHHHHh-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecc
Confidence 5556666554421 23467788899999999999999999999999
Q ss_pred CCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCC
Q 003644 535 LKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP 614 (805)
Q Consensus 535 LKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~elltG~~~P 614 (805)
|||+|||++.++. +||+|||+++...... ......+||+.|+|||++.+..++.++|||||||++|||++| .+|
T Consensus 121 ikp~NIll~~~~~--~kL~DfG~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG-~~P 194 (328)
T cd05593 121 LKLENLMLDKDGH--IKITDFGLCKEGITDA---ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG-RLP 194 (328)
T ss_pred cCHHHeEECCCCc--EEEecCcCCccCCCcc---cccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhC-CCC
Confidence 9999999987776 8999999987643221 112345699999999999988999999999999999999997 667
Q ss_pred CCCch-HHHHHHHhhccccccccCChHHHHHHHHhcCCCCCCCC-----ChhhhhcCcccccccc
Q 003644 615 YGESF-ERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRP-----KAQNVLNHPFFWTADT 673 (805)
Q Consensus 615 f~~~~-~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dP~~Rp-----s~~ell~Hpff~~~~~ 673 (805)
|.... ......+.......+...++++.++|.+||+.||.+|+ ++.++++||||....+
T Consensus 195 f~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~~ 259 (328)
T cd05593 195 FYNQDHEKLFELILMEDIKFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTGVNW 259 (328)
T ss_pred CCCCCHHHHHHHhccCCccCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCCCcCCCCH
Confidence 75433 22233333333344556778999999999999999997 8999999999976543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=347.78 Aligned_cols=255 Identities=25% Similarity=0.348 Sum_probs=187.3
Q ss_pred eEeeccCCceEEEEEEee---CCcEEEEEEeecCCc-hHHHHHHHHHHHhCCCCCeeeecccccC--CceEEEecccccC
Q 003644 381 NKEIAKGSNGTVVLEGNY---EGRSVAVKRLVKTHH-DVALKEIQNLIASDQHPNIVRWYGVESD--QDFVYLSLERCTC 454 (805)
Q Consensus 381 ~~~LG~GsfGtVy~a~~~---~g~~VAVK~l~~~~~-~~~~~Ei~~ll~~l~HpNIV~l~g~~~~--~~~l~LV~E~~~~ 454 (805)
.++||+|+||+||++... +++.||||.+..... ....+|+. +++.++||||+++++++.+ +...|++||++.+
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 84 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIA-LLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH 84 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCcHHHHHHHH-HHHhcCCCCCcceeeeEecCCCcEEEEEEeccCC
Confidence 357999999999998643 568899999875432 34566775 7788999999999998754 4678999998888
Q ss_pred ChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcceeccC
Q 003644 455 SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRD 534 (805)
Q Consensus 455 sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~IvHrD 534 (805)
+|.+++......... .+...+++..++.++.||+.||+|||+.+|+|||
T Consensus 85 ~l~~~~~~~~~~~~~-------------------------------~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrD 133 (317)
T cd07868 85 DLWHIIKFHRASKAN-------------------------------KKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRD 133 (317)
T ss_pred CHHHHHHhccccccc-------------------------------CCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCC
Confidence 777666332211000 1123477888999999999999999999999999
Q ss_pred CCCceEEecCC--CCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcC-CCCCcchHHHHHHHHHHHHhCC
Q 003644 535 LKPQNVLISKD--KSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG-RQTRAIDLFSLGCILFFCITGG 611 (805)
Q Consensus 535 LKp~NILl~~~--~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~t~~sDVwSlGvil~elltG~ 611 (805)
|||+|||+..+ ....+||+|||+++................||+.|+|||++.+. .++.++||||+||++|||++|
T Consensus 134 lkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g- 212 (317)
T cd07868 134 LKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTS- 212 (317)
T ss_pred CCHHHEEEecCCCCcCcEEEeecCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhC-
Confidence 99999999422 12348999999998765433222233445789999999999874 589999999999999999997
Q ss_pred CCCCCCchHH-----------HHHHHhh--------------cc-----------c------------cccccCChHHHH
Q 003644 612 KHPYGESFER-----------DANIVKD--------------RK-----------D------------LFLVEHIPEAVD 643 (805)
Q Consensus 612 ~~Pf~~~~~~-----------~~~~~~~--------------~~-----------~------------~~~~~~~~~~~d 643 (805)
.+||...... ...+... .. . .......+++.+
T Consensus 213 ~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 292 (317)
T cd07868 213 EPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFH 292 (317)
T ss_pred CCCccCCcccccccccccHHHHHHHHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHH
Confidence 6777532110 0000000 00 0 000112346889
Q ss_pred HHHHhcCCCCCCCCChhhhhcCccc
Q 003644 644 LFTRLLDPNPDLRPKAQNVLNHPFF 668 (805)
Q Consensus 644 Li~~~L~~dP~~Rps~~ell~Hpff 668 (805)
||.+||+.||.+|||++|+++||||
T Consensus 293 li~~mL~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07868 293 LLQKLLTMDPIKRITSEQAMQDPYF 317 (317)
T ss_pred HHHHHhccCcccCCCHHHHhcCCCC
Confidence 9999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=348.08 Aligned_cols=246 Identities=26% Similarity=0.363 Sum_probs=190.9
Q ss_pred EeeccCCceEEEEEEe-eCCcEEEEEEeecCC------chHHHHHHHHHHHhCCCCCeeeecccccCCceEEEecccccC
Q 003644 382 KEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH------HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTC 454 (805)
Q Consensus 382 ~~LG~GsfGtVy~a~~-~~g~~VAVK~l~~~~------~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~E~~~~ 454 (805)
+.||+|+||+||++.. .+|+.||||.+++.. ......|...+....+||||+++++++.++++.|+|||||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~-- 78 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFL-- 78 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCC--
Confidence 3699999999999855 468999999997531 1233445554545679999999999999999999999955
Q ss_pred ChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcceeccC
Q 003644 455 SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRD 534 (805)
Q Consensus 455 sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~IvHrD 534 (805)
.+|+|..++.. ...+++..+..++.||+.||+|||+.||+|||
T Consensus 79 --------~~g~L~~~i~~-----------------------------~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrD 121 (316)
T cd05620 79 --------NGGDLMFHIQD-----------------------------KGRFDLYRATFYAAEIVCGLQFLHSKGIIYRD 121 (316)
T ss_pred --------CCCcHHHHHHH-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecC
Confidence 44555544321 12356677889999999999999999999999
Q ss_pred CCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCC
Q 003644 535 LKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP 614 (805)
Q Consensus 535 LKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~elltG~~~P 614 (805)
|||+|||++.++. +||+|||+++...... ......+||+.|+|||++.+..++.++|||||||++|||++| ..|
T Consensus 122 lkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g-~~P 195 (316)
T cd05620 122 LKLDNVMLDRDGH--IKIADFGMCKENVFGD---NRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIG-QSP 195 (316)
T ss_pred CCHHHeEECCCCC--EEeCccCCCeecccCC---CceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhC-CCC
Confidence 9999999988775 8999999987532211 122345699999999999999999999999999999999997 667
Q ss_pred CCCchHH-HHHHHhhccccccccCChHHHHHHHHhcCCCCCCCCCh-hhhhcCccccccc
Q 003644 615 YGESFER-DANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKA-QNVLNHPFFWTAD 672 (805)
Q Consensus 615 f~~~~~~-~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dP~~Rps~-~ell~Hpff~~~~ 672 (805)
|...... ....+.......+...++++.++|.+||+.||++||++ +++++||||...+
T Consensus 196 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h~~f~~~~ 255 (316)
T cd05620 196 FHGDDEDELFESIRVDTPHYPRWITKESKDILEKLFERDPTRRLGVVGNIRGHPFFKTIN 255 (316)
T ss_pred CCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCCCcCCCC
Confidence 7554332 22333333333445567899999999999999999998 5889999996643
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=347.20 Aligned_cols=247 Identities=26% Similarity=0.402 Sum_probs=191.6
Q ss_pred EeeccCCceEEEEEEe-eCCcEEEEEEeecCC------chHHHHHHHHHHHhCCCCCeeeecccccCCceEEEecccccC
Q 003644 382 KEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH------HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTC 454 (805)
Q Consensus 382 ~~LG~GsfGtVy~a~~-~~g~~VAVK~l~~~~------~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~E~~~~ 454 (805)
+.||+|+||+||++.. .+++.||||+++... ......|...+....+||||+++++++.+++..|+|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e---- 76 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVME---- 76 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEc----
Confidence 3699999999999855 458899999986431 12233455444455689999999999999999999999
Q ss_pred ChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcceeccC
Q 003644 455 SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRD 534 (805)
Q Consensus 455 sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~IvHrD 534 (805)
|+.+|+|..++.. ...+++..+..++.||+.||+|||+.+|+|||
T Consensus 77 ------~~~gg~L~~~~~~-----------------------------~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~d 121 (316)
T cd05592 77 ------YLNGGDLMFHIQS-----------------------------SGRFDEARARFYAAEIICGLQFLHKKGIIYRD 121 (316)
T ss_pred ------CCCCCcHHHHHHH-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCC
Confidence 4555566554422 12467778889999999999999999999999
Q ss_pred CCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCC
Q 003644 535 LKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP 614 (805)
Q Consensus 535 LKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~elltG~~~P 614 (805)
|||+|||++.++. +||+|||+++...... ......+||+.|+|||++.+..++.++|||||||++|||++| ..|
T Consensus 122 lkp~Nill~~~~~--~kL~Dfg~a~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G-~~P 195 (316)
T cd05592 122 LKLDNVLLDKDGH--IKIADFGMCKENMNGE---GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIG-QSP 195 (316)
T ss_pred CCHHHeEECCCCC--EEEccCcCCeECCCCC---CccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhC-CCC
Confidence 9999999988776 8999999997653221 122345699999999999998999999999999999999997 678
Q ss_pred CCCchHH-HHHHHhhccccccccCChHHHHHHHHhcCCCCCCCCChh-hhhcCcccccccc
Q 003644 615 YGESFER-DANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQ-NVLNHPFFWTADT 673 (805)
Q Consensus 615 f~~~~~~-~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dP~~Rps~~-ell~Hpff~~~~~ 673 (805)
|...... ....+.......+...++++.++|.+||+.||.+||++. ++++||||...++
T Consensus 196 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h~~~~~~~~ 256 (316)
T cd05592 196 FHGEDEDELFDSILNDRPHFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQHPFFRGIDW 256 (316)
T ss_pred CCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCcccCCCCH
Confidence 7654332 222233333334455678999999999999999999875 8889999976543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=332.30 Aligned_cols=249 Identities=26% Similarity=0.374 Sum_probs=192.0
Q ss_pred eEEEeEeeccCCceEEEEEE-eeCCcEEEEEEeecCCc-----hHHHHHHHHHHHhCCCCCeeeeccccc--CCceEEEe
Q 003644 377 LVVFNKEIAKGSNGTVVLEG-NYEGRSVAVKRLVKTHH-----DVALKEIQNLIASDQHPNIVRWYGVES--DQDFVYLS 448 (805)
Q Consensus 377 ~~~~~~~LG~GsfGtVy~a~-~~~g~~VAVK~l~~~~~-----~~~~~Ei~~ll~~l~HpNIV~l~g~~~--~~~~l~LV 448 (805)
.|...+.|++|+||.||+|. ..+++.||+|+++-... -..++||. ++...+|||||.+-.+.. +-+.+|||
T Consensus 77 efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIn-iLl~~~H~NIV~vkEVVvG~~~d~iy~V 155 (419)
T KOG0663|consen 77 EFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREIN-ILLKARHPNIVEVKEVVVGSNMDKIYIV 155 (419)
T ss_pred HHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHH-HHHhcCCCCeeeeEEEEeccccceeeee
Confidence 35555789999999999984 55789999999975432 35689997 556778999999988754 34679999
Q ss_pred cccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhc
Q 003644 449 LERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI 528 (805)
Q Consensus 449 ~E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~ 528 (805)
||||+.+|..++-. . ..++...++..++.|+++||+|||..
T Consensus 156 Me~~EhDLksl~d~--------------------------------------m-~q~F~~~evK~L~~QlL~glk~lH~~ 196 (419)
T KOG0663|consen 156 MEYVEHDLKSLMET--------------------------------------M-KQPFLPGEVKTLMLQLLRGLKHLHDN 196 (419)
T ss_pred HHHHHhhHHHHHHh--------------------------------------c-cCCCchHHHHHHHHHHHHHHHHHhhc
Confidence 99988777666521 0 13466778899999999999999999
Q ss_pred ceeccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcC-CCCCcchHHHHHHHHHHH
Q 003644 529 GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG-RQTRAIDLFSLGCILFFC 607 (805)
Q Consensus 529 ~IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~t~~sDVwSlGvil~el 607 (805)
.|+|||||++|+|++..|. +||+|||||+.+.+... .....+-|.+|.|||.+.+. .|+.++|+||+|||+.||
T Consensus 197 wilHRDLK~SNLLm~~~G~--lKiaDFGLAR~ygsp~k---~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~ 271 (419)
T KOG0663|consen 197 WILHRDLKTSNLLLSHKGI--LKIADFGLAREYGSPLK---PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAEL 271 (419)
T ss_pred eeEecccchhheeeccCCc--EEecccchhhhhcCCcc---cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHH
Confidence 9999999999999988876 89999999999876532 33445679999999999885 589999999999999999
Q ss_pred HhCCCCCCCC-chHHHHHHHhhc---c----------------------------cccccc-CChHHHHHHHHhcCCCCC
Q 003644 608 ITGGKHPYGE-SFERDANIVKDR---K----------------------------DLFLVE-HIPEAVDLFTRLLDPNPD 654 (805)
Q Consensus 608 ltG~~~Pf~~-~~~~~~~~~~~~---~----------------------------~~~~~~-~~~~~~dLi~~~L~~dP~ 654 (805)
+++ +|-|.. +...+.+.+-.. + ..+... .+....+|+..+|..||.
T Consensus 272 l~~-kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~ 350 (419)
T KOG0663|consen 272 LTQ-KPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPG 350 (419)
T ss_pred Hhc-CCCCCCCchHHHHHHHHHHhCCCccccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCcc
Confidence 997 555543 322221111000 0 001111 235678999999999999
Q ss_pred CCCChhhhhcCcccccc
Q 003644 655 LRPKAQNVLNHPFFWTA 671 (805)
Q Consensus 655 ~Rps~~ell~Hpff~~~ 671 (805)
+|.||+|.|+|.||...
T Consensus 351 kR~tA~~~L~h~~F~e~ 367 (419)
T KOG0663|consen 351 KRITAEDGLKHEYFRET 367 (419)
T ss_pred ccccHHHhhcccccccC
Confidence 99999999999999763
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=339.15 Aligned_cols=247 Identities=28% Similarity=0.411 Sum_probs=187.1
Q ss_pred eEEEeEeeccCCceEEEEEEe--eCCcEEEEEEeecCC-----chHHHHHHHHH--HHhCCCCCeeeeccccc-----CC
Q 003644 377 LVVFNKEIAKGSNGTVVLEGN--YEGRSVAVKRLVKTH-----HDVALKEIQNL--IASDQHPNIVRWYGVES-----DQ 442 (805)
Q Consensus 377 ~~~~~~~LG~GsfGtVy~a~~--~~g~~VAVK~l~~~~-----~~~~~~Ei~~l--l~~l~HpNIV~l~g~~~-----~~ 442 (805)
+|.+.+.||+|+||+||++.. .+|+.||||++.... .....+|+..+ +..++||||++++++|. ..
T Consensus 2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~ 81 (290)
T cd07862 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE 81 (290)
T ss_pred CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCC
Confidence 477789999999999999865 347889999986432 12344555432 33457999999999874 34
Q ss_pred ceEEEecccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHH
Q 003644 443 DFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGL 522 (805)
Q Consensus 443 ~~l~LV~E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL 522 (805)
..+++|||++.++|.+++.. . ....+++..++.++.||+.||
T Consensus 82 ~~~~lv~e~~~~~l~~~~~~-----------~---------------------------~~~~~~~~~~~~i~~qi~~aL 123 (290)
T cd07862 82 TKLTLVFEHVDQDLTTYLDK-----------V---------------------------PEPGVPTETIKDMMFQLLRGL 123 (290)
T ss_pred CcEEEEEccCCCCHHHHHHh-----------C---------------------------CCCCCCHHHHHHHHHHHHHHH
Confidence 56899999877666655421 0 112367778899999999999
Q ss_pred HHhhhcceeccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHH
Q 003644 523 SHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGC 602 (805)
Q Consensus 523 ~yLH~~~IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGv 602 (805)
+|||+.+|+||||||+|||++.++. +||+|||+++..... .......||+.|+|||++.+..++.++|||||||
T Consensus 124 ~~lH~~~iiH~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~ 197 (290)
T cd07862 124 DFLHSHRVVHRDLKPQNILVTSSGQ--IKLADFGLARIYSFQ----MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGC 197 (290)
T ss_pred HHHHHCCeeeCCCCHHHEEEcCCCC--EEEccccceEeccCC----cccccccccccccChHHHhCCCCCCccchHHHHH
Confidence 9999999999999999999988776 899999999865432 1223446899999999999889999999999999
Q ss_pred HHHHHHhCCCCCCCCchHHH--HHHHhhccc--------------------------cccccCChHHHHHHHHhcCCCCC
Q 003644 603 ILFFCITGGKHPYGESFERD--ANIVKDRKD--------------------------LFLVEHIPEAVDLFTRLLDPNPD 654 (805)
Q Consensus 603 il~elltG~~~Pf~~~~~~~--~~~~~~~~~--------------------------~~~~~~~~~~~dLi~~~L~~dP~ 654 (805)
++|||++| .+||......+ ..+...... ......++.+.+++.+||+.||+
T Consensus 198 il~el~~g-~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~ 276 (290)
T cd07862 198 IFAEMFRR-KPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPA 276 (290)
T ss_pred HHHHHHcC-CCCcCCCCHHHHHHHHHHHhCCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCch
Confidence 99999996 77886543221 111111000 00123446788999999999999
Q ss_pred CCCChhhhhcCccc
Q 003644 655 LRPKAQNVLNHPFF 668 (805)
Q Consensus 655 ~Rps~~ell~Hpff 668 (805)
+|||+.|+++||||
T Consensus 277 ~R~s~~~~l~hp~f 290 (290)
T cd07862 277 KRISAYSALSHPYF 290 (290)
T ss_pred hcCCHHHHhcCCCC
Confidence 99999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=361.78 Aligned_cols=254 Identities=24% Similarity=0.317 Sum_probs=192.3
Q ss_pred ccceEEEeEeeccCCceEEEEEEe-eCCcEEEEEEeecCCchHHHHHHHHHHHhCCCCCeeeecccccC--------Cce
Q 003644 374 IGKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYGVESD--------QDF 444 (805)
Q Consensus 374 i~~~~~~~~~LG~GsfGtVy~a~~-~~g~~VAVK~l~~~~~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~--------~~~ 444 (805)
..+.|.+.+.||+|+||+||++.. .+++.||||++.... ....+|+. ++..++|||||++++++.. ..+
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-~~~~~Ei~-il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 141 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-QYKNRELL-IMKNLNHINIIFLKDYYYTECFKKNEKNIF 141 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-chHHHHHH-HHHhcCCCCCcceeeeEeecccccCCCceE
Confidence 346799999999999999999865 468999999986543 23345665 7788899999999887532 235
Q ss_pred EEEecccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHH
Q 003644 445 VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSH 524 (805)
Q Consensus 445 l~LV~E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~y 524 (805)
+++|||||+++|.+++.... .....+++..++.++.||+.||+|
T Consensus 142 l~lvmE~~~~~l~~~~~~~~------------------------------------~~~~~l~~~~~~~~~~qi~~gL~y 185 (440)
T PTZ00036 142 LNVVMEFIPQTVHKYMKHYA------------------------------------RNNHALPLFLVKLYSYQLCRALAY 185 (440)
T ss_pred EEEEEecCCccHHHHHHHHh------------------------------------hcCCCCCHHHHHHHHHHHHHHHHH
Confidence 78999988877665542100 112346778889999999999999
Q ss_pred hhhcceeccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcC-CCCCcchHHHHHHH
Q 003644 525 LHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG-RQTRAIDLFSLGCI 603 (805)
Q Consensus 525 LH~~~IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~t~~sDVwSlGvi 603 (805)
||+.+|+||||||+|||++.++. .+||+|||+++.+.... ......||+.|+|||++.+. .++.++|||||||+
T Consensus 186 LH~~~IiHrDLKp~NILl~~~~~-~vkL~DFGla~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvi 260 (440)
T PTZ00036 186 IHSKFICHRDLKPQNLLIDPNTH-TLKLCDFGSAKNLLAGQ----RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCI 260 (440)
T ss_pred HHHCCEecCCcCHHHEEEcCCCC-ceeeeccccchhccCCC----CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHH
Confidence 99999999999999999976553 48999999998765321 22334689999999998764 68999999999999
Q ss_pred HHHHHhCCCCCCCCchHHH--HHHHhhc----------------------------cccccccCChHHHHHHHHhcCCCC
Q 003644 604 LFFCITGGKHPYGESFERD--ANIVKDR----------------------------KDLFLVEHIPEAVDLFTRLLDPNP 653 (805)
Q Consensus 604 l~elltG~~~Pf~~~~~~~--~~~~~~~----------------------------~~~~~~~~~~~~~dLi~~~L~~dP 653 (805)
+|||++| .+||......+ ..++... ...++...++++.+||.+||+.||
T Consensus 261 l~elltG-~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP 339 (440)
T PTZ00036 261 IAEMILG-YPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEP 339 (440)
T ss_pred HHHHHhC-CCCCCCCChHHHHHHHHHHhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCCh
Confidence 9999997 67776532211 1111100 001122345789999999999999
Q ss_pred CCCCChhhhhcCcccccc
Q 003644 654 DLRPKAQNVLNHPFFWTA 671 (805)
Q Consensus 654 ~~Rps~~ell~Hpff~~~ 671 (805)
.+|||+.|+++||||...
T Consensus 340 ~~R~ta~e~l~hp~f~~~ 357 (440)
T PTZ00036 340 LKRLNPIEALADPFFDDL 357 (440)
T ss_pred hHCcCHHHHhCChhHHhh
Confidence 999999999999999653
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=357.75 Aligned_cols=248 Identities=21% Similarity=0.268 Sum_probs=190.5
Q ss_pred ceEEEeEeeccCCceEEEEEEe-eCCcEEEEEEeecCCchHHHHHHHHHHHhCCCCCeeeecccccCCceEEEecccccC
Q 003644 376 KLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTC 454 (805)
Q Consensus 376 ~~~~~~~~LG~GsfGtVy~a~~-~~g~~VAVK~l~~~~~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~E~~~~ 454 (805)
..|.+.+.||+|+||.||++.. .+++.||||.... ....+|+. +++.++|||||++++++..++..++|+|++.+
T Consensus 92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~---~~~~~E~~-il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~~ 167 (391)
T PHA03212 92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR---GGTATEAH-ILRAINHPSIIQLKGTFTYNKFTCLILPRYKT 167 (391)
T ss_pred CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh---hhhHHHHH-HHHhCCCCCCCCEeEEEEECCeeEEEEecCCC
Confidence 4588999999999999999854 5689999997643 33456765 77889999999999999999999999997766
Q ss_pred ChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcceeccC
Q 003644 455 SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRD 534 (805)
Q Consensus 455 sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~IvHrD 534 (805)
+|.+++ . ....+++..++.++.||+.||+|||+.+|+|||
T Consensus 168 ~L~~~l-----------~-----------------------------~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrD 207 (391)
T PHA03212 168 DLYCYL-----------A-----------------------------AKRNIAICDILAIERSVLRAIQYLHENRIIHRD 207 (391)
T ss_pred CHHHHH-----------H-----------------------------hcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCC
Confidence 554433 1 123467778899999999999999999999999
Q ss_pred CCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCC
Q 003644 535 LKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP 614 (805)
Q Consensus 535 LKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~elltG~~~P 614 (805)
|||+|||++.++. +||+|||+++...... ........||+.|+|||++.+..++.++|||||||++|||++|..++
T Consensus 208 iKP~NIll~~~~~--vkL~DFG~a~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~ 283 (391)
T PHA03212 208 IKAENIFINHPGD--VCLGDFGAACFPVDIN--ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSL 283 (391)
T ss_pred CChHhEEEcCCCC--EEEEeCCccccccccc--ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCc
Confidence 9999999988876 8999999997543211 11223456999999999999989999999999999999999986555
Q ss_pred CCCch-------HHHH-HHHhh-------------------------ccccc---------cccCChHHHHHHHHhcCCC
Q 003644 615 YGESF-------ERDA-NIVKD-------------------------RKDLF---------LVEHIPEAVDLFTRLLDPN 652 (805)
Q Consensus 615 f~~~~-------~~~~-~~~~~-------------------------~~~~~---------~~~~~~~~~dLi~~~L~~d 652 (805)
|.... .... .++.. ..... ....+.++.+||.+||+.|
T Consensus 284 ~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~d 363 (391)
T PHA03212 284 FEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFD 363 (391)
T ss_pred CCcccccccCchhHHHHHHHHHhcCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCC
Confidence 54211 0000 00000 00000 0012347889999999999
Q ss_pred CCCCCChhhhhcCcccccc
Q 003644 653 PDLRPKAQNVLNHPFFWTA 671 (805)
Q Consensus 653 P~~Rps~~ell~Hpff~~~ 671 (805)
|.+|||++|+|+||||...
T Consensus 364 P~~Rpta~elL~hp~f~~~ 382 (391)
T PHA03212 364 AHHRPSAEALLDFAAFQDI 382 (391)
T ss_pred hhhCCCHHHHhcChhhccC
Confidence 9999999999999999653
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=333.78 Aligned_cols=253 Identities=29% Similarity=0.453 Sum_probs=195.6
Q ss_pred eEeeccCCceEEEEEE-eeCCcEEEEEEeecCCc-----hHHHHHHHHHHHhCCCCC-eeeecccccCCc------eEEE
Q 003644 381 NKEIAKGSNGTVVLEG-NYEGRSVAVKRLVKTHH-----DVALKEIQNLIASDQHPN-IVRWYGVESDQD------FVYL 447 (805)
Q Consensus 381 ~~~LG~GsfGtVy~a~-~~~g~~VAVK~l~~~~~-----~~~~~Ei~~ll~~l~HpN-IV~l~g~~~~~~------~l~L 447 (805)
.++||+|+||+||+|. ..+|+.||+|++.-... ..+.+|+. ++..++|+| ||+|++++...+ .+||
T Consensus 16 ~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREis-llk~L~~~~~iv~L~dv~~~~~~~~~~~~l~l 94 (323)
T KOG0594|consen 16 VEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREIS-LLKRLSHANHIVRLHDVIHTSNNHRGIGKLYL 94 (323)
T ss_pred HHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHH-HHHHhCCCcceEEEEeeeeecccccccceEEE
Confidence 3569999999999984 56799999999964432 35688986 889999999 999999998877 8999
Q ss_pred ecccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhh
Q 003644 448 SLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE 527 (805)
Q Consensus 448 V~E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~ 527 (805)
|+|+++.+|.+++-..... ..+++...++.+++||++||+|||+
T Consensus 95 vfe~~d~DL~~ymd~~~~~------------------------------------~~g~~~~~ik~~m~Qll~gl~~~H~ 138 (323)
T KOG0594|consen 95 VFEFLDRDLKKYMDSLPKK------------------------------------PQGLPPRLIKSFMRQLLRGLAFLHS 138 (323)
T ss_pred EEEeecccHHHHHHhcccc------------------------------------ccCCCHHHHHHHHHHHHHHHHHHHh
Confidence 9999998888876321100 0345667789999999999999999
Q ss_pred cceeccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcC-CCCCcchHHHHHHHHHH
Q 003644 528 IGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG-RQTRAIDLFSLGCILFF 606 (805)
Q Consensus 528 ~~IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~t~~sDVwSlGvil~e 606 (805)
++|+||||||+||||+++|. +||+|||+|+...-... .....++|..|.|||++.+. .|+..+||||+|||+.|
T Consensus 139 ~~IlHRDLKPQNlLi~~~G~--lKlaDFGlAra~~ip~~---~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaE 213 (323)
T KOG0594|consen 139 HGILHRDLKPQNLLISSSGV--LKLADFGLARAFSIPMR---TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAE 213 (323)
T ss_pred CCeecccCCcceEEECCCCc--EeeeccchHHHhcCCcc---cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHH
Confidence 99999999999999999887 79999999996552222 12445689999999999987 68999999999999999
Q ss_pred HHhCCCCCCCCchHHHHH-HHh--hc---------------ccccc------------ccCChHHHHHHHHhcCCCCCCC
Q 003644 607 CITGGKHPYGESFERDAN-IVK--DR---------------KDLFL------------VEHIPEAVDLFTRLLDPNPDLR 656 (805)
Q Consensus 607 lltG~~~Pf~~~~~~~~~-~~~--~~---------------~~~~~------------~~~~~~~~dLi~~~L~~dP~~R 656 (805)
|+++..++-+.+...+.. +.. +. ...++ ....++..|++.+||+.+|.+|
T Consensus 214 m~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R 293 (323)
T KOG0594|consen 214 MFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKR 293 (323)
T ss_pred HHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccC
Confidence 999744333433322211 111 00 00011 1112478999999999999999
Q ss_pred CChhhhhcCccccccccch
Q 003644 657 PKAQNVLNHPFFWTADTRL 675 (805)
Q Consensus 657 ps~~ell~Hpff~~~~~~~ 675 (805)
.|++.+|.||||...+.+.
T Consensus 294 ~Sa~~al~h~yf~~~~~~~ 312 (323)
T KOG0594|consen 294 ISAKGALTHPYFSELPEKS 312 (323)
T ss_pred cCHHHHhcChhhcccccch
Confidence 9999999999997655443
|
|
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-39 Score=349.83 Aligned_cols=246 Identities=27% Similarity=0.367 Sum_probs=192.5
Q ss_pred EeeccCCceEEEEEEe-eCCcEEEEEEeecCC------chHHHHHHHHHHHhCCCCCeeeecccccCCceEEEecccccC
Q 003644 382 KEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH------HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTC 454 (805)
Q Consensus 382 ~~LG~GsfGtVy~a~~-~~g~~VAVK~l~~~~------~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~E~~~~ 454 (805)
+.||+|+||+||++.. .+|+.||||++.+.. ......|+..+++.++||||+++++++.+.+..|+|||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e---- 76 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLD---- 76 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEc----
Confidence 3699999999999865 478999999986432 12334555556788999999999999999999999999
Q ss_pred ChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcceeccC
Q 003644 455 SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRD 534 (805)
Q Consensus 455 sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~IvHrD 534 (805)
|+.+|+|..++.. ...+++..+..++.||+.||+|||+.||+|||
T Consensus 77 ------~~~~g~L~~~l~~-----------------------------~~~~~~~~~~~~~~qi~~~l~~lH~~givH~d 121 (323)
T cd05575 77 ------YVNGGELFFHLQR-----------------------------ERSFPEPRARFYAAEIASALGYLHSLNIIYRD 121 (323)
T ss_pred ------CCCCCCHHHHHHh-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCC
Confidence 5555666554422 13466778889999999999999999999999
Q ss_pred CCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCC
Q 003644 535 LKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP 614 (805)
Q Consensus 535 LKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~elltG~~~P 614 (805)
|||+|||++.++. +||+|||+++...... ......+||+.|+|||++.+..++.++|||||||++|||++| .+|
T Consensus 122 ikp~NIll~~~~~--~kl~Dfg~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g-~~p 195 (323)
T cd05575 122 LKPENILLDSQGH--VVLTDFGLCKEGIEHS---KTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYG-LPP 195 (323)
T ss_pred CCHHHeEECCCCc--EEEeccCCCcccccCC---CccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcC-CCC
Confidence 9999999988776 8999999987543221 122345699999999999999999999999999999999997 667
Q ss_pred CCCch-HHHHHHHhhccccccccCChHHHHHHHHhcCCCCCCCCCh----hhhhcCccccccc
Q 003644 615 YGESF-ERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKA----QNVLNHPFFWTAD 672 (805)
Q Consensus 615 f~~~~-~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dP~~Rps~----~ell~Hpff~~~~ 672 (805)
|.... ......+...........++++.++|.+||+.||.+||++ .++++||||....
T Consensus 196 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~~~~~~~~ 258 (323)
T cd05575 196 FYSRDTAEMYDNILNKPLRLKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSSIN 258 (323)
T ss_pred CCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcCCCcCCCC
Confidence 75533 2222222222333344567899999999999999999998 5999999996643
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=344.32 Aligned_cols=255 Identities=24% Similarity=0.351 Sum_probs=186.0
Q ss_pred eEeeccCCceEEEEEEee---CCcEEEEEEeecCCch-HHHHHHHHHHHhCCCCCeeeeccccc--CCceEEEecccccC
Q 003644 381 NKEIAKGSNGTVVLEGNY---EGRSVAVKRLVKTHHD-VALKEIQNLIASDQHPNIVRWYGVES--DQDFVYLSLERCTC 454 (805)
Q Consensus 381 ~~~LG~GsfGtVy~a~~~---~g~~VAVK~l~~~~~~-~~~~Ei~~ll~~l~HpNIV~l~g~~~--~~~~l~LV~E~~~~ 454 (805)
+.+||+|+||+||++... +++.||||.+...... ...+|+. +++.++||||+++++++. ++...|+||||+.+
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 84 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIA-LLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH 84 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCCcHHHHHHHH-HHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC
Confidence 357999999999998654 4578999998765433 4455654 778899999999999874 45678999998888
Q ss_pred ChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcceeccC
Q 003644 455 SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRD 534 (805)
Q Consensus 455 sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~IvHrD 534 (805)
+|.+++......... .....+++..++.++.||+.||+|||+.+|+|||
T Consensus 85 ~l~~~~~~~~~~~~~-------------------------------~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~D 133 (317)
T cd07867 85 DLWHIIKFHRASKAN-------------------------------KKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRD 133 (317)
T ss_pred cHHHHHHhhhccccC-------------------------------CCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCC
Confidence 777766322111000 1123467788899999999999999999999999
Q ss_pred CCCceEEecCC--CCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcC-CCCCcchHHHHHHHHHHHHhCC
Q 003644 535 LKPQNVLISKD--KSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG-RQTRAIDLFSLGCILFFCITGG 611 (805)
Q Consensus 535 LKp~NILl~~~--~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~t~~sDVwSlGvil~elltG~ 611 (805)
|||+|||+..+ ....+||+|||+++................||+.|+|||++.+. .++.++|||||||++|||+||
T Consensus 134 lkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg- 212 (317)
T cd07867 134 LKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTS- 212 (317)
T ss_pred CCHHHEEEccCCCCCCcEEEeeccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhC-
Confidence 99999999422 12248999999998775433222233345689999999998764 579999999999999999997
Q ss_pred CCCCCCchHHH-----------HHHHhh--------------c-----------c------------ccccccCChHHHH
Q 003644 612 KHPYGESFERD-----------ANIVKD--------------R-----------K------------DLFLVEHIPEAVD 643 (805)
Q Consensus 612 ~~Pf~~~~~~~-----------~~~~~~--------------~-----------~------------~~~~~~~~~~~~d 643 (805)
.+||....+.. ..+... . . ..........+.+
T Consensus 213 ~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (317)
T cd07867 213 EPIFHCRQEDIKTSNPFHHDQLDRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFL 292 (317)
T ss_pred CCCcccccccccccccccHHHHHHHHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHH
Confidence 67775322110 000000 0 0 0000112346889
Q ss_pred HHHHhcCCCCCCCCChhhhhcCccc
Q 003644 644 LFTRLLDPNPDLRPKAQNVLNHPFF 668 (805)
Q Consensus 644 Li~~~L~~dP~~Rps~~ell~Hpff 668 (805)
|+.+||+.||.+|||++|+++||||
T Consensus 293 ll~~~l~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07867 293 LLQKLLTMDPTKRITSEQALQDPYF 317 (317)
T ss_pred HHHHHhccCcccccCHHHHhcCCCC
Confidence 9999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=350.71 Aligned_cols=253 Identities=28% Similarity=0.427 Sum_probs=196.0
Q ss_pred eEEEeEeeccCCceEEEEEEee-CCcEEEEEEeecCC-----chHHHHHHHHHHHhCCCCCeeeecccccCCceEEEecc
Q 003644 377 LVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 450 (805)
Q Consensus 377 ~~~~~~~LG~GsfGtVy~a~~~-~g~~VAVK~l~~~~-----~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~E 450 (805)
.|.+.+.||+|+||+||++... +|+.||||++.+.. ....+.++..++..++||||+++++++.+++..|+|||
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (350)
T cd05573 2 DFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVME 81 (350)
T ss_pred CceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEc
Confidence 4778899999999999998654 68999999986431 12233334457788899999999999999999999999
Q ss_pred cccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcce
Q 003644 451 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 530 (805)
Q Consensus 451 ~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~I 530 (805)
| +.+|+|.+++.. ...+++..++.++.||+.||+|||+.||
T Consensus 82 ~----------~~~~~L~~~l~~-----------------------------~~~l~~~~~~~i~~qi~~aL~~LH~~gi 122 (350)
T cd05573 82 Y----------MPGGDLMNLLIR-----------------------------KDVFPEETARFYIAELVLALDSVHKLGF 122 (350)
T ss_pred C----------CCCCCHHHHHHH-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 4 455555555432 1346777889999999999999999999
Q ss_pred eccCCCCceEEecCCCCceEEEeccCccccccCCCc--------------------------cccccccccCCCCCCChh
Q 003644 531 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMS--------------------------CLTQNATGYGSSGWQAPE 584 (805)
Q Consensus 531 vHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~--------------------------~~~~~~~~~gt~~y~APE 584 (805)
+||||||+|||++.++. +||+|||+++....... .........||+.|+|||
T Consensus 123 iH~Dlkp~NIll~~~~~--~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 200 (350)
T cd05573 123 IHRDIKPDNILIDADGH--IKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPE 200 (350)
T ss_pred eccCCCHHHeEECCCCC--EEeecCCCCccCcccCcccccccccccccccccccccccccccccccccccccCccccCHH
Confidence 99999999999988876 89999999987654320 001123346999999999
Q ss_pred hhhcCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH-H-HHHhhcc-ccccc--cCChHHHHHHHHhcCCCCCCCCC-
Q 003644 585 QLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERD-A-NIVKDRK-DLFLV--EHIPEAVDLFTRLLDPNPDLRPK- 658 (805)
Q Consensus 585 ~l~~~~~t~~sDVwSlGvil~elltG~~~Pf~~~~~~~-~-~~~~~~~-~~~~~--~~~~~~~dLi~~~L~~dP~~Rps- 658 (805)
++.+..++.++|||||||++|||++| .+||....... . .+..... ...+. ..++++.++|.+||. ||.+||+
T Consensus 201 ~~~~~~~~~~~DiwSlG~il~ell~g-~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s 278 (350)
T cd05573 201 VLRGTPYGLECDWWSLGVILYEMLYG-FPPFYSDTLQETYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGS 278 (350)
T ss_pred HHcCCCCCCceeeEecchhhhhhccC-CCCCCCCCHHHHHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCC
Confidence 99999999999999999999999997 66776543322 2 2222111 11222 247899999999997 9999999
Q ss_pred hhhhhcCccccccc
Q 003644 659 AQNVLNHPFFWTAD 672 (805)
Q Consensus 659 ~~ell~Hpff~~~~ 672 (805)
++++++||||...+
T Consensus 279 ~~~ll~hp~~~~~~ 292 (350)
T cd05573 279 FEEIKSHPFFKGID 292 (350)
T ss_pred HHHHhcCCCcCCCC
Confidence 99999999996543
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=349.60 Aligned_cols=247 Identities=24% Similarity=0.334 Sum_probs=191.1
Q ss_pred EeeccCCceEEEEEEe-eCCcEEEEEEeecCCc------hHHHHHHHHHHHhCCCCCeeeecccccCCceEEEecccccC
Q 003644 382 KEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH------DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTC 454 (805)
Q Consensus 382 ~~LG~GsfGtVy~a~~-~~g~~VAVK~l~~~~~------~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~E~~~~ 454 (805)
+.||+|+||+||++.. .+++.||+|++.+... ....+|+..+....+||||+++++++.+++..|+|||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E---- 76 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIE---- 76 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEe----
Confidence 3699999999999864 4688999999975321 1233455545555689999999999999999999999
Q ss_pred ChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcceeccC
Q 003644 455 SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRD 534 (805)
Q Consensus 455 sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~IvHrD 534 (805)
|+.+|+|..++.. ...+++..++.++.||+.||+|||+.+|+|||
T Consensus 77 ------~~~~~~L~~~~~~-----------------------------~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~D 121 (329)
T cd05618 77 ------YVNGGDLMFHMQR-----------------------------QRKLPEEHARFYSAEISLALNYLHERGIIYRD 121 (329)
T ss_pred ------CCCCCCHHHHHHH-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCC
Confidence 5555666544321 23467788899999999999999999999999
Q ss_pred CCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCC
Q 003644 535 LKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP 614 (805)
Q Consensus 535 LKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~elltG~~~P 614 (805)
|||+|||++.++. +||+|||+++...... ......+||+.|+|||++.+..++.++|||||||++|||++| .+|
T Consensus 122 ikp~Nili~~~~~--~kL~DfG~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g-~~P 195 (329)
T cd05618 122 LKLDNVLLDSEGH--IKLTDYGMCKEGLRPG---DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAG-RSP 195 (329)
T ss_pred CCHHHEEECCCCC--EEEeeCCccccccCCC---CccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhC-CCC
Confidence 9999999988876 8999999987543211 122345699999999999999999999999999999999997 778
Q ss_pred CCCc----------hHHHHHHHhhccccccccCChHHHHHHHHhcCCCCCCCCC------hhhhhcCcccccccc
Q 003644 615 YGES----------FERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPK------AQNVLNHPFFWTADT 673 (805)
Q Consensus 615 f~~~----------~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dP~~Rps------~~ell~Hpff~~~~~ 673 (805)
|... .......+.......+...++++.++|++||+.||.+||+ +.++++||||+..++
T Consensus 196 f~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~~~ 270 (329)
T cd05618 196 FDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDW 270 (329)
T ss_pred CccCCCcCCcccccHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCCCH
Confidence 7421 0111122222333345566789999999999999999998 479999999976543
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=347.56 Aligned_cols=246 Identities=25% Similarity=0.360 Sum_probs=191.3
Q ss_pred EeeccCCceEEEEEEee-CCcEEEEEEeecCC------chHHHHHHHHHHHhCCCCCeeeecccccCCceEEEecccccC
Q 003644 382 KEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH------HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTC 454 (805)
Q Consensus 382 ~~LG~GsfGtVy~a~~~-~g~~VAVK~l~~~~------~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~E~~~~ 454 (805)
+.||+|+||+||++... +++.||||++.+.. ......|...+....+||||+++++++.+++..|+|||||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~-- 78 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYV-- 78 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCC--
Confidence 35999999999998554 58899999986531 1223445554444568999999999999999999999955
Q ss_pred ChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcceeccC
Q 003644 455 SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRD 534 (805)
Q Consensus 455 sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~IvHrD 534 (805)
.+|+|..++.. .+.+++..+..++.||+.||+|||+.||+|||
T Consensus 79 --------~~~~L~~~l~~-----------------------------~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrD 121 (321)
T cd05591 79 --------NGGDLMFQIQR-----------------------------SRKFDEPRSRFYAAEVTLALMFLHRHGVIYRD 121 (321)
T ss_pred --------CCCcHHHHHHH-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccC
Confidence 45555544321 23466778889999999999999999999999
Q ss_pred CCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCC
Q 003644 535 LKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP 614 (805)
Q Consensus 535 LKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~elltG~~~P 614 (805)
|||+|||++.++. +||+|||+++...... ......+||+.|+|||++.+..++.++|||||||++|||++| .+|
T Consensus 122 ikp~Nill~~~~~--~kL~Dfg~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg-~~P 195 (321)
T cd05591 122 LKLDNILLDAEGH--CKLADFGMCKEGILNG---VTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAG-QPP 195 (321)
T ss_pred CCHHHeEECCCCC--EEEeecccceecccCC---ccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcC-CCC
Confidence 9999999988876 8999999987543221 112345689999999999988999999999999999999997 778
Q ss_pred CCCchHHH-HHHHhhccccccccCChHHHHHHHHhcCCCCCCCC-------ChhhhhcCccccccc
Q 003644 615 YGESFERD-ANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRP-------KAQNVLNHPFFWTAD 672 (805)
Q Consensus 615 f~~~~~~~-~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dP~~Rp-------s~~ell~Hpff~~~~ 672 (805)
|....... ...+.......+...++++.++|.+||+.||++|| +++++++||||...+
T Consensus 196 f~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~~~~~ 261 (321)
T cd05591 196 FEADNEDDLFESILHDDVLYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKEID 261 (321)
T ss_pred CCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCccCCCC
Confidence 86544332 22222233334455678999999999999999999 899999999996543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=350.86 Aligned_cols=254 Identities=23% Similarity=0.335 Sum_probs=191.6
Q ss_pred eEEEeEeeccCCceEEEEEEe-eCCcEEEEEEeecCCc-----hHHHHHHHHHHHhCCCCCeeeecccccCCceEEEecc
Q 003644 377 LVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH-----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 450 (805)
Q Consensus 377 ~~~~~~~LG~GsfGtVy~a~~-~~g~~VAVK~l~~~~~-----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~E 450 (805)
.|.+.+.||+|+||+||++.. .+++.||||++.+... ...++.+..++..++||||+++++++.+++.+|+|||
T Consensus 2 ~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E 81 (363)
T cd05628 2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIME 81 (363)
T ss_pred CceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEc
Confidence 467789999999999999854 4689999999965321 1122323346778899999999999999999999999
Q ss_pred cccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcce
Q 003644 451 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 530 (805)
Q Consensus 451 ~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~I 530 (805)
| +++|+|.+++.. ...+++..++.++.||+.||+|||+.||
T Consensus 82 ~----------~~gg~L~~~l~~-----------------------------~~~l~~~~~~~~~~qi~~aL~~lH~~gi 122 (363)
T cd05628 82 F----------LPGGDMMTLLMK-----------------------------KDTLTEEETQFYIAETVLAIDSIHQLGF 122 (363)
T ss_pred C----------CCCCcHHHHHHh-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 4 455566555422 2346778889999999999999999999
Q ss_pred eccCCCCceEEecCCCCceEEEeccCccccccCCCcc--------------------------------ccccccccCCC
Q 003644 531 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSC--------------------------------LTQNATGYGSS 578 (805)
Q Consensus 531 vHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~--------------------------------~~~~~~~~gt~ 578 (805)
+||||||+|||++.++. +||+|||+++.+...... .......+||+
T Consensus 123 vHrDlKp~NILi~~~~~--vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~ 200 (363)
T cd05628 123 IHRDIKPDNLLLDSKGH--VKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTP 200 (363)
T ss_pred EecCCCHHHeEECCCCC--EEEeeccCcccccccccccccccccccccccccccccccccccchhhhccccccccccCCc
Confidence 99999999999988876 899999999765321100 00012357999
Q ss_pred CCCChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH--HHHHhhccc-ccc--ccCChHHHHHHHHhcCCCC
Q 003644 579 GWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERD--ANIVKDRKD-LFL--VEHIPEAVDLFTRLLDPNP 653 (805)
Q Consensus 579 ~y~APE~l~~~~~t~~sDVwSlGvil~elltG~~~Pf~~~~~~~--~~~~~~~~~-~~~--~~~~~~~~dLi~~~L~~dP 653 (805)
.|+|||++.+..++.++|||||||++|||++| .+||....... ..+...... .++ ...+++++++|.+|+. +|
T Consensus 201 ~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G-~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~~ 278 (363)
T cd05628 201 DYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG-YPPFCSETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCC-EW 278 (363)
T ss_pred cccCHHHHcCCCCCCchhhhhhHHHHHHHHhC-CCCCCCCCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcC-Ch
Confidence 99999999999999999999999999999997 77886543322 223322111 122 2346799999999765 44
Q ss_pred C---CCCChhhhhcCcccccccc
Q 003644 654 D---LRPKAQNVLNHPFFWTADT 673 (805)
Q Consensus 654 ~---~Rps~~ell~Hpff~~~~~ 673 (805)
. .||+++|+++||||...++
T Consensus 279 ~~r~~r~~~~ei~~hp~f~~~~~ 301 (363)
T cd05628 279 EHRIGAPGVEEIKTNPFFEGVDW 301 (363)
T ss_pred hhcCCCCCHHHHhCCCCCCCCCH
Confidence 4 4689999999999976543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=347.47 Aligned_cols=249 Identities=26% Similarity=0.368 Sum_probs=191.0
Q ss_pred EEEeEeeccCCceEEEEEEe----eCCcEEEEEEeecCC-------chHHHHHHHHHHHhC-CCCCeeeecccccCCceE
Q 003644 378 VVFNKEIAKGSNGTVVLEGN----YEGRSVAVKRLVKTH-------HDVALKEIQNLIASD-QHPNIVRWYGVESDQDFV 445 (805)
Q Consensus 378 ~~~~~~LG~GsfGtVy~a~~----~~g~~VAVK~l~~~~-------~~~~~~Ei~~ll~~l-~HpNIV~l~g~~~~~~~l 445 (805)
|.+.+.||+|+||+||++.. .+|+.||||++.+.. .....+|+. ++..+ +||||+++++++.+++.+
T Consensus 2 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~-~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERN-VLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred ceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHH-HHHhccCCCCcccEEEEEecCCEE
Confidence 66789999999999998754 368999999986421 112334554 44555 699999999999999999
Q ss_pred EEecccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHh
Q 003644 446 YLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHL 525 (805)
Q Consensus 446 ~LV~E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yL 525 (805)
|+|||| +.+|+|.+++.. ...+++..+..++.||+.||+||
T Consensus 81 ~lv~e~----------~~~g~L~~~l~~-----------------------------~~~~~~~~~~~~~~qi~~~l~~l 121 (332)
T cd05614 81 HLILDY----------VSGGEMFTHLYQ-----------------------------RDNFSEDEVRFYSGEIILALEHL 121 (332)
T ss_pred EEEEeC----------CCCCcHHHHHHH-----------------------------cCCCCHHHHHHHHHHHHHHHHHH
Confidence 999994 455565554421 23467788899999999999999
Q ss_pred hhcceeccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcC-CCCCcchHHHHHHHH
Q 003644 526 HEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG-RQTRAIDLFSLGCIL 604 (805)
Q Consensus 526 H~~~IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~t~~sDVwSlGvil 604 (805)
|+.+|+||||||+|||++.++. +||+|||+++....... ......+||+.|+|||++.+. .++.++|||||||++
T Consensus 122 H~~~ivHrDlkp~Nili~~~~~--~kl~DfG~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il 197 (332)
T cd05614 122 HKLGIVYRDIKLENILLDSEGH--VVLTDFGLSKEFLSEEK--ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILI 197 (332)
T ss_pred HHCCcEecCCCHHHeEECCCCC--EEEeeCcCCccccccCC--CccccccCCccccCHHHhcCCCCCCCccccccchhhh
Confidence 9999999999999999988876 89999999986543211 112335699999999999865 478999999999999
Q ss_pred HHHHhCCCCCCCCchH-----HHHHHHhhccccccccCChHHHHHHHHhcCCCCCCCC-----ChhhhhcCcccccc
Q 003644 605 FFCITGGKHPYGESFE-----RDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRP-----KAQNVLNHPFFWTA 671 (805)
Q Consensus 605 ~elltG~~~Pf~~~~~-----~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dP~~Rp-----s~~ell~Hpff~~~ 671 (805)
|||++| ..||..... .....+.......+...++++.+++.+||+.||++|| +++++++||||...
T Consensus 198 ~elltg-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~ 273 (332)
T cd05614 198 FELLTG-ASPFTLEGERNTQSEVSRRILKCDPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGL 273 (332)
T ss_pred hhhhcC-CCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence 999997 778853211 1111122222233445678999999999999999999 78899999999754
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=351.69 Aligned_cols=251 Identities=24% Similarity=0.308 Sum_probs=192.0
Q ss_pred ccceEEEeEeeccCCceEEEEEEee-CCcEEEEEEeecCCchHHHHHHHHHHHhCCCCCeeeecccccCCceEEEecccc
Q 003644 374 IGKLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERC 452 (805)
Q Consensus 374 i~~~~~~~~~LG~GsfGtVy~a~~~-~g~~VAVK~l~~~~~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~E~~ 452 (805)
.+..|.+.+.||+|+||.||++... .++.||||.... ....+|+. +++.++|||||++++++..++..++|||++
T Consensus 167 ~~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~---~~~~~E~~-iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~ 242 (461)
T PHA03211 167 AGLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY---ASSVHEAR-LLRRLSHPAVLALLDVRVVGGLTCLVLPKY 242 (461)
T ss_pred ccCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc---cCHHHHHH-HHHHCCCCCCCcEEEEEEECCEEEEEEEcc
Confidence 4556899999999999999998554 578999996432 23456665 778899999999999999999999999976
Q ss_pred cCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcceec
Q 003644 453 TCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIH 532 (805)
Q Consensus 453 ~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~IvH 532 (805)
.++|.+++. . ....+++.+++.|+.||+.||+|||+.||+|
T Consensus 243 ~~~L~~~l~-----------~----------------------------~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvH 283 (461)
T PHA03211 243 RSDLYTYLG-----------A----------------------------RLRPLGLAQVTAVARQLLSAIDYIHGEGIIH 283 (461)
T ss_pred CCCHHHHHH-----------h----------------------------cCCCCCHHHHHHHHHHHHHHHHHHHHCCEEE
Confidence 655544431 1 1124677888999999999999999999999
Q ss_pred cCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHHHHHhCCC
Q 003644 533 RDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGK 612 (805)
Q Consensus 533 rDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~elltG~~ 612 (805)
|||||+|||++.++. +||+|||+++........ .......||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus 284 rDLKP~NILl~~~~~--vkL~DFGla~~~~~~~~~-~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~ 360 (461)
T PHA03211 284 RDIKTENVLVNGPED--ICLGDFGAACFARGSWST-PFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTA 360 (461)
T ss_pred CcCCHHHEEECCCCC--EEEcccCCceeccccccc-ccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCC
Confidence 999999999987765 899999999876432211 11223469999999999999999999999999999999999866
Q ss_pred CCCCCch--------HHHHHHHhhcc---cccc-------------------------------ccCChHHHHHHHHhcC
Q 003644 613 HPYGESF--------ERDANIVKDRK---DLFL-------------------------------VEHIPEAVDLFTRLLD 650 (805)
Q Consensus 613 ~Pf~~~~--------~~~~~~~~~~~---~~~~-------------------------------~~~~~~~~dLi~~~L~ 650 (805)
++|.... .....++.... ..++ ....+++.+||.+||+
T Consensus 361 ~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~ 440 (461)
T PHA03211 361 SLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALT 440 (461)
T ss_pred CcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcc
Confidence 5554321 11111211100 0000 0123578999999999
Q ss_pred CCCCCCCChhhhhcCccccc
Q 003644 651 PNPDLRPKAQNVLNHPFFWT 670 (805)
Q Consensus 651 ~dP~~Rps~~ell~Hpff~~ 670 (805)
.||.+|||+.|+|+||||++
T Consensus 441 ~DP~~RPsa~elL~hp~f~~ 460 (461)
T PHA03211 441 FDGARRPSAAELLRLPLFQS 460 (461)
T ss_pred cChhhCcCHHHHhhCcccCC
Confidence 99999999999999999964
|
|
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=345.11 Aligned_cols=250 Identities=23% Similarity=0.324 Sum_probs=192.8
Q ss_pred EEEeEeeccCCceEEEEEEee-CCcEEEEEEeecCC------chHHHHHHHHHHHhCC-CCCeeeecccccCCceEEEec
Q 003644 378 VVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH------HDVALKEIQNLIASDQ-HPNIVRWYGVESDQDFVYLSL 449 (805)
Q Consensus 378 ~~~~~~LG~GsfGtVy~a~~~-~g~~VAVK~l~~~~------~~~~~~Ei~~ll~~l~-HpNIV~l~g~~~~~~~l~LV~ 449 (805)
|.+.+.||+|+||+||++... +++.||||++.+.. ......|.. ++..+. |++|+++++++.+.+.+|+||
T Consensus 2 y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~-~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKR-VLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred ceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHH-HHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 677899999999999998554 57899999986431 122344554 445554 456889999999999999999
Q ss_pred ccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcc
Q 003644 450 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG 529 (805)
Q Consensus 450 E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~ 529 (805)
||| .+|+|.+++.. ...+++..++.++.||+.||+|||+.+
T Consensus 81 E~~----------~~g~L~~~~~~-----------------------------~~~~~~~~~~~~~~qi~~al~~lH~~~ 121 (324)
T cd05587 81 EYV----------NGGDLMYHIQQ-----------------------------VGKFKEPHAVFYAAEIAIGLFFLHSKG 121 (324)
T ss_pred cCC----------CCCcHHHHHHH-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 954 45555554421 123567788999999999999999999
Q ss_pred eeccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHHHHHh
Q 003644 530 LIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCIT 609 (805)
Q Consensus 530 IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~ellt 609 (805)
|+||||||+|||++.++. +||+|||+++...... ......+||+.|+|||++.+..++.++|||||||++|||++
T Consensus 122 ivH~dlkp~Nill~~~~~--~kL~Dfg~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ellt 196 (324)
T cd05587 122 IIYRDLKLDNVMLDAEGH--IKIADFGMCKENIFGG---KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLA 196 (324)
T ss_pred eEecCCCHHHeEEcCCCC--EEEeecCcceecCCCC---CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHh
Confidence 999999999999988776 8999999987532211 12234569999999999999999999999999999999999
Q ss_pred CCCCCCCCchHH-HHHHHhhccccccccCChHHHHHHHHhcCCCCCCCCCh-----hhhhcCcccccccc
Q 003644 610 GGKHPYGESFER-DANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKA-----QNVLNHPFFWTADT 673 (805)
Q Consensus 610 G~~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dP~~Rps~-----~ell~Hpff~~~~~ 673 (805)
| .+||...... ....+.......+...++++.+++.+||+.||.+|++. +++++||||...++
T Consensus 197 G-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~~~ 265 (324)
T cd05587 197 G-QPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRRIDW 265 (324)
T ss_pred C-CCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCCCCH
Confidence 6 7788654332 22223333334455677899999999999999999986 79999999976544
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=345.40 Aligned_cols=250 Identities=25% Similarity=0.378 Sum_probs=194.9
Q ss_pred EEEeEeeccCCceEEEEEEe-eCCcEEEEEEeecCC------chHHHHHHH--HHHHhCCCCCeeeecccccCCceEEEe
Q 003644 378 VVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH------HDVALKEIQ--NLIASDQHPNIVRWYGVESDQDFVYLS 448 (805)
Q Consensus 378 ~~~~~~LG~GsfGtVy~a~~-~~g~~VAVK~l~~~~------~~~~~~Ei~--~ll~~l~HpNIV~l~g~~~~~~~l~LV 448 (805)
|.+.+.||+|+||+||++.. .+|+.||||++.+.. .+...+|.. .++..++||||+++++++.+.+..|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 45678999999999999854 468999999997432 112223333 234567899999999999999999999
Q ss_pred cccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhc
Q 003644 449 LERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI 528 (805)
Q Consensus 449 ~E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~ 528 (805)
|||| .+|+|...++ ...+++..++.++.||+.||+|||+.
T Consensus 81 ~E~~----------~~~~L~~~~~------------------------------~~~l~~~~~~~~~~qi~~al~~lH~~ 120 (324)
T cd05589 81 MEYA----------AGGDLMMHIH------------------------------TDVFSEPRAVFYAACVVLGLQYLHEN 120 (324)
T ss_pred EcCC----------CCCcHHHHhh------------------------------cCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 9955 4555544332 12467788899999999999999999
Q ss_pred ceeccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHHHHH
Q 003644 529 GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCI 608 (805)
Q Consensus 529 ~IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~ell 608 (805)
||+||||||+|||++.++. +||+|||+++...... ......+||+.|+|||++.+..++.++|||||||++|||+
T Consensus 121 ~ivHrdlkp~Nill~~~~~--~kL~Dfg~~~~~~~~~---~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~ 195 (324)
T cd05589 121 KIVYRDLKLDNLLLDTEGF--VKIADFGLCKEGMGFG---DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEML 195 (324)
T ss_pred CeEecCCCHHHeEECCCCc--EEeCcccCCccCCCCC---CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHH
Confidence 9999999999999988876 8999999987543221 1223456999999999999989999999999999999999
Q ss_pred hCCCCCCCCchHH-HHHHHhhccccccccCChHHHHHHHHhcCCCCCCCC-----ChhhhhcCcccccccc
Q 003644 609 TGGKHPYGESFER-DANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRP-----KAQNVLNHPFFWTADT 673 (805)
Q Consensus 609 tG~~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dP~~Rp-----s~~ell~Hpff~~~~~ 673 (805)
+| .+||...... ....+.......+...++++.++|.+||+.||.+|| ++.++++||||.....
T Consensus 196 ~G-~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~~~ 265 (324)
T cd05589 196 VG-ESPFPGDDEEEVFDSIVNDEVRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDINW 265 (324)
T ss_pred hC-CCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCCCH
Confidence 97 7788654332 222233333345556678999999999999999999 6899999999976543
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=348.05 Aligned_cols=246 Identities=24% Similarity=0.332 Sum_probs=189.2
Q ss_pred EeeccCCceEEEEEEe-eCCcEEEEEEeecCCc------hHHHHHHHHHHHhCCCCCeeeecccccCCceEEEecccccC
Q 003644 382 KEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH------DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTC 454 (805)
Q Consensus 382 ~~LG~GsfGtVy~a~~-~~g~~VAVK~l~~~~~------~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~E~~~~ 454 (805)
+.||+|+||+||++.. .+++.||||++++... ....+|...+....+||||+++++++.+.+.+|+||||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~--- 77 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEF--- 77 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeC---
Confidence 3699999999999854 4689999999975321 12234544333444899999999999999999999994
Q ss_pred ChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcceeccC
Q 003644 455 SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRD 534 (805)
Q Consensus 455 sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~IvHrD 534 (805)
+++|+|..++. +.+.+++..++.++.||+.||+|||+.+|+|||
T Consensus 78 -------~~~g~L~~~~~-----------------------------~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~d 121 (329)
T cd05588 78 -------VSGGDLMFHMQ-----------------------------RQRKLPEEHARFYSAEISLALNFLHERGIIYRD 121 (329)
T ss_pred -------CCCCCHHHHHH-----------------------------HcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecC
Confidence 45555554432 123577888899999999999999999999999
Q ss_pred CCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCC
Q 003644 535 LKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP 614 (805)
Q Consensus 535 LKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~elltG~~~P 614 (805)
|||+|||++.++. +||+|||+++...... ......+||+.|+|||++.+..++.++|+|||||++|||++| .+|
T Consensus 122 lkp~Nili~~~~~--~kL~Dfg~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g-~~P 195 (329)
T cd05588 122 LKLDNVLLDAEGH--IKLTDYGMCKEGIRPG---DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAG-RSP 195 (329)
T ss_pred CCHHHeEECCCCC--EEECcCccccccccCC---CccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHC-CCC
Confidence 9999999988776 8999999987532211 122345699999999999999999999999999999999997 778
Q ss_pred CCCch----------HHHHHHHhhccccccccCChHHHHHHHHhcCCCCCCCCC------hhhhhcCccccccc
Q 003644 615 YGESF----------ERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPK------AQNVLNHPFFWTAD 672 (805)
Q Consensus 615 f~~~~----------~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dP~~Rps------~~ell~Hpff~~~~ 672 (805)
|.... ......+.......+...++++.++|.+||+.||.+|++ ++++++||||....
T Consensus 196 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~~ 269 (329)
T cd05588 196 FDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNID 269 (329)
T ss_pred cccccccccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCCCC
Confidence 85210 111122222233344556789999999999999999987 78999999996543
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=344.86 Aligned_cols=246 Identities=25% Similarity=0.394 Sum_probs=191.6
Q ss_pred EeeccCCceEEEEEEee-CCcEEEEEEeecCC------chHHHHHHHHHHHhCCCCCeeeecccccCCceEEEecccccC
Q 003644 382 KEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH------HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTC 454 (805)
Q Consensus 382 ~~LG~GsfGtVy~a~~~-~g~~VAVK~l~~~~------~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~E~~~~ 454 (805)
+.||+|+||+||++... +++.||||++.... ......|...+....+||||+++++++.+.+.+|+|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~e---- 76 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVME---- 76 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEe----
Confidence 36999999999998654 57899999987531 12334455544445799999999999999999999999
Q ss_pred ChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcceeccC
Q 003644 455 SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRD 534 (805)
Q Consensus 455 sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~IvHrD 534 (805)
|+.+|+|.+++.. ...+++.++..++.|++.||+|||+.+|+|||
T Consensus 77 ------y~~~g~L~~~l~~-----------------------------~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrd 121 (316)
T cd05619 77 ------YLNGGDLMFHIQS-----------------------------CHKFDLPRATFYAAEIICGLQFLHSKGIVYRD 121 (316)
T ss_pred ------CCCCCcHHHHHHH-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCC
Confidence 5555666555422 12356777889999999999999999999999
Q ss_pred CCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCC
Q 003644 535 LKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP 614 (805)
Q Consensus 535 LKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~elltG~~~P 614 (805)
|||+|||++.++. +||+|||+++...... .......||+.|+|||++.+..++.++|||||||++|||++| ..|
T Consensus 122 ikp~Nil~~~~~~--~kl~Dfg~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G-~~p 195 (316)
T cd05619 122 LKLDNILLDTDGH--IKIADFGMCKENMLGD---AKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIG-QSP 195 (316)
T ss_pred CCHHHEEECCCCC--EEEccCCcceECCCCC---CceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhC-CCC
Confidence 9999999988775 8999999987542211 112345689999999999998999999999999999999997 678
Q ss_pred CCCchHH-HHHHHhhccccccccCChHHHHHHHHhcCCCCCCCCChh-hhhcCccccccc
Q 003644 615 YGESFER-DANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQ-NVLNHPFFWTAD 672 (805)
Q Consensus 615 f~~~~~~-~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dP~~Rps~~-ell~Hpff~~~~ 672 (805)
|...... ....+.......+...+.++.++|.+||+.||.+||++. ++++||||....
T Consensus 196 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h~~~~~~~ 255 (316)
T cd05619 196 FHGHDEEELFQSIRMDNPCYPRWLTREAKDILVKLFVREPERRLGVKGDIRQHPFFREID 255 (316)
T ss_pred CCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHHhccCHhhcCCChHHHHcCcccCCCC
Confidence 7654332 222233333334455678899999999999999999997 899999997644
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=349.84 Aligned_cols=246 Identities=27% Similarity=0.358 Sum_probs=193.2
Q ss_pred EeeccCCceEEEEEE-eeCCcEEEEEEeecCCc------hHHHHHHHHHHHhCCCCCeeeecccccCCceEEEecccccC
Q 003644 382 KEIAKGSNGTVVLEG-NYEGRSVAVKRLVKTHH------DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTC 454 (805)
Q Consensus 382 ~~LG~GsfGtVy~a~-~~~g~~VAVK~l~~~~~------~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~E~~~~ 454 (805)
+.||+|+||+||++. ..+|+.||||++.+... ....+|+ .++..++||||+++++++.+++..|+|||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~-~~l~~~~hp~i~~~~~~~~~~~~~~lv~E---- 75 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTEN-RVLQNSRHPFLTALKYSFQTHDRLCFVME---- 75 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHH-HHHHhCCCCCCCceEEEEEcCCEEEEEEe----
Confidence 369999999999975 45789999999975311 1223344 36778899999999999999999999999
Q ss_pred ChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhh-cceecc
Q 003644 455 SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE-IGLIHR 533 (805)
Q Consensus 455 sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~-~~IvHr 533 (805)
|+.+|+|..++.. ...+++..+..++.||+.||+|||+ .||+||
T Consensus 76 ------~~~~~~L~~~l~~-----------------------------~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHr 120 (325)
T cd05594 76 ------YANGGELFFHLSR-----------------------------ERVFSEDRARFYGAEIVSALDYLHSEKNVVYR 120 (325)
T ss_pred ------CCCCCcHHHHHHh-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHhcCCEEec
Confidence 4555565554421 2346778889999999999999997 799999
Q ss_pred CCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHHHHHhCCCC
Q 003644 534 DLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKH 613 (805)
Q Consensus 534 DLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~elltG~~~ 613 (805)
||||+|||++.++. +||+|||+++...... .......||+.|+|||++.+..++.++|||||||++|||++| ..
T Consensus 121 Dikp~NIll~~~~~--~kL~Dfg~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG-~~ 194 (325)
T cd05594 121 DLKLENLMLDKDGH--IKITDFGLCKEGIKDG---ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG-RL 194 (325)
T ss_pred CCCCCeEEECCCCC--EEEecCCCCeecCCCC---cccccccCCcccCCHHHHccCCCCCccccccccceeeeeccC-CC
Confidence 99999999988876 8999999987543221 112334699999999999998999999999999999999997 66
Q ss_pred CCCCch-HHHHHHHhhccccccccCChHHHHHHHHhcCCCCCCCC-----ChhhhhcCcccccccc
Q 003644 614 PYGESF-ERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRP-----KAQNVLNHPFFWTADT 673 (805)
Q Consensus 614 Pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dP~~Rp-----s~~ell~Hpff~~~~~ 673 (805)
||.... ......+.......+...++++.++|.+||+.||++|+ ++.++++||||.....
T Consensus 195 Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~~ 260 (325)
T cd05594 195 PFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGIVW 260 (325)
T ss_pred CCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCCcCCCCH
Confidence 775433 33333333333344556778999999999999999997 8999999999976443
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=349.28 Aligned_cols=246 Identities=25% Similarity=0.369 Sum_probs=191.9
Q ss_pred EeeccCCceEEEEEE-eeCCcEEEEEEeecCC------chHHHHHHHHHHHhCCCCCeeeecccccCCceEEEecccccC
Q 003644 382 KEIAKGSNGTVVLEG-NYEGRSVAVKRLVKTH------HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTC 454 (805)
Q Consensus 382 ~~LG~GsfGtVy~a~-~~~g~~VAVK~l~~~~------~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~E~~~~ 454 (805)
+.||+|+||+||++. ..+|+.||||++.+.. .....+|...+++.++||||+++++++.+++..|+|||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e---- 76 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLD---- 76 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEc----
Confidence 359999999999985 4578999999986431 12334555556788999999999999999999999999
Q ss_pred ChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcceeccC
Q 003644 455 SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRD 534 (805)
Q Consensus 455 sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~IvHrD 534 (805)
|+.+|+|..++. +...+++..+..++.||+.||+|||+.||+|||
T Consensus 77 ------~~~~~~L~~~l~-----------------------------~~~~~~~~~~~~~~~qi~~al~~lH~~givH~D 121 (325)
T cd05604 77 ------FVNGGELFFHLQ-----------------------------RERSFPEPRARFYAAEIASALGYLHSINIVYRD 121 (325)
T ss_pred ------CCCCCCHHHHHH-----------------------------HcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecC
Confidence 445555554432 123467788899999999999999999999999
Q ss_pred CCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCC
Q 003644 535 LKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP 614 (805)
Q Consensus 535 LKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~elltG~~~P 614 (805)
|||+|||++.++. +||+|||+++...... ......+||+.|+|||++.+..++.++|||||||++|||++| .+|
T Consensus 122 lkp~NIll~~~~~--~kL~DfG~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G-~~p 195 (325)
T cd05604 122 LKPENILLDSQGH--VVLTDFGLCKEGIAQS---DTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYG-LPP 195 (325)
T ss_pred CCHHHeEECCCCC--EEEeecCCcccCCCCC---CCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcC-CCC
Confidence 9999999988876 8999999987543221 122345699999999999999999999999999999999997 667
Q ss_pred CCCch-HHHHHHHhhccccccccCChHHHHHHHHhcCCCCCCCCCh----hhhhcCccccccc
Q 003644 615 YGESF-ERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKA----QNVLNHPFFWTAD 672 (805)
Q Consensus 615 f~~~~-~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dP~~Rps~----~ell~Hpff~~~~ 672 (805)
|.... ......+...........+.++.++|.+||+.||.+||++ .++++||||....
T Consensus 196 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~f~~~~ 258 (325)
T cd05604 196 FYCRDVAEMYDNILHKPLVLRPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFESLS 258 (325)
T ss_pred CCCCCHHHHHHHHHcCCccCCCCCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcCCCcCCCC
Confidence 75543 2222222222223334567889999999999999999987 4899999997543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=344.55 Aligned_cols=250 Identities=24% Similarity=0.355 Sum_probs=194.9
Q ss_pred EEEeEeeccCCceEEEEEEee-CCcEEEEEEeecCCc------hHHHHHHHHHHHhCCCCCeeeecccccCCceEEEecc
Q 003644 378 VVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHH------DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 450 (805)
Q Consensus 378 ~~~~~~LG~GsfGtVy~a~~~-~g~~VAVK~l~~~~~------~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~E 450 (805)
|.+.+.||+|+||+||++... +++.||||++.+... .....|...+....+||+|+++++++.+.+.+|+|||
T Consensus 2 f~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E 81 (323)
T cd05616 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVME 81 (323)
T ss_pred ceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEc
Confidence 567889999999999998544 578999999875321 1233444444444579999999999999999999999
Q ss_pred cccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcce
Q 003644 451 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 530 (805)
Q Consensus 451 ~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~I 530 (805)
|+.+|+|..++.. ...+++..++.++.||+.||+|||+.+|
T Consensus 82 ----------~~~~g~L~~~~~~-----------------------------~~~~~~~~~~~~~~qi~~aL~~LH~~~i 122 (323)
T cd05616 82 ----------YVNGGDLMYQIQQ-----------------------------VGRFKEPHAVFYAAEIAIGLFFLHSKGI 122 (323)
T ss_pred ----------CCCCCCHHHHHHH-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCE
Confidence 4455555554421 1346677889999999999999999999
Q ss_pred eccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHHHHHhC
Q 003644 531 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG 610 (805)
Q Consensus 531 vHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~elltG 610 (805)
+||||||+|||++.++. +||+|||+++...... ......+||+.|+|||++.+..++.++|||||||++|||++|
T Consensus 123 vHrDlkp~Nill~~~~~--~kL~DfG~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg 197 (323)
T cd05616 123 IYRDLKLDNVMLDSEGH--IKIADFGMCKENMWDG---VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAG 197 (323)
T ss_pred EecCCCHHHeEECCCCc--EEEccCCCceecCCCC---CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhC
Confidence 99999999999988876 8999999987543211 122345699999999999999999999999999999999997
Q ss_pred CCCCCCCchHH-HHHHHhhccccccccCChHHHHHHHHhcCCCCCCCCCh-----hhhhcCccccccc
Q 003644 611 GKHPYGESFER-DANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKA-----QNVLNHPFFWTAD 672 (805)
Q Consensus 611 ~~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dP~~Rps~-----~ell~Hpff~~~~ 672 (805)
.+||...... ....+......++...++++.+++.+||+.||.+|+++ .++++||||...+
T Consensus 198 -~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~~ 264 (323)
T cd05616 198 -QAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYID 264 (323)
T ss_pred -CCCCCCCCHHHHHHHHHhCCCCCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcCCCcCCCC
Confidence 7787654332 22333333334556677899999999999999999985 7899999996544
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=338.05 Aligned_cols=256 Identities=29% Similarity=0.411 Sum_probs=192.0
Q ss_pred ccccceEEEeEeeccCCceEEEEEEee-CCcEEEEEEeecCCchHHHHHHHHHHHhCCCCCeeeecccccCC-----ceE
Q 003644 372 RRIGKLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYGVESDQ-----DFV 445 (805)
Q Consensus 372 ~~i~~~~~~~~~LG~GsfGtVy~a~~~-~g~~VAVK~l~~~~~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~-----~~l 445 (805)
+...-.|.-.+.+|.|+||.||.|... +++.||||+..... ...-+|++ ++..++|||||+|..+|... -++
T Consensus 20 ~~~~i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~-r~knrEl~-im~~l~HpNIV~L~~~f~~~~~~d~~~l 97 (364)
T KOG0658|consen 20 KKVEISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDK-RYKNRELQ-IMRKLDHPNIVRLLYFFSSSTESDEVYL 97 (364)
T ss_pred cceEEEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCC-CcCcHHHH-HHHhcCCcCeeeEEEEEEecCCCchhHH
Confidence 344455777889999999999998654 47999999986543 23345766 55699999999999887532 256
Q ss_pred EEecccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHh
Q 003644 446 YLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHL 525 (805)
Q Consensus 446 ~LV~E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yL 525 (805)
.+||||++.+|.+.+... - .....+|.-.++-++.||++||+||
T Consensus 98 nlVleymP~tL~~~~r~~-------~-----------------------------~~~~~mp~~~iKLYt~Qlfrgl~yL 141 (364)
T KOG0658|consen 98 NLVLEYMPETLYRVIRHY-------T-----------------------------RANQRMPLLEIKLYTYQLFRGLAYL 141 (364)
T ss_pred HHHHHhchHHHHHHHHHH-------h-----------------------------hcCCCCceeeeHHHHHHHHHHHHHH
Confidence 789998877776665210 0 1123456667789999999999999
Q ss_pred hhcceeccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcC-CCCCcchHHHHHHHH
Q 003644 526 HEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG-RQTRAIDLFSLGCIL 604 (805)
Q Consensus 526 H~~~IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~t~~sDVwSlGvil 604 (805)
|+.||+||||||+|+|++.+.. .+||||||.|+.+..+. +..+...|..|.|||.+.+. .|+.+.||||.||++
T Consensus 142 h~~~IcHRDIKPqNlLvD~~tg-~LKicDFGSAK~L~~~e----pniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~ 216 (364)
T KOG0658|consen 142 HSHGICHRDIKPQNLLVDPDTG-VLKICDFGSAKVLVKGE----PNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVM 216 (364)
T ss_pred HhcCcccCCCChheEEEcCCCC-eEEeccCCcceeeccCC----CceeEEEeccccCHHHHcCccccCceeEEhhhhHHH
Confidence 9999999999999999998754 59999999999987542 23444578899999999875 589999999999999
Q ss_pred HHHHhCCCCCCCCchHHHH-HHHh--------------hc------------c--ccccccCChHHHHHHHHhcCCCCCC
Q 003644 605 FFCITGGKHPYGESFERDA-NIVK--------------DR------------K--DLFLVEHIPEAVDLFTRLLDPNPDL 655 (805)
Q Consensus 605 ~elltG~~~Pf~~~~~~~~-~~~~--------------~~------------~--~~~~~~~~~~~~dLi~~~L~~dP~~ 655 (805)
.||+-|+..+-+++...+. .+++ .. . ..+.....+++.||+.++|+.+|.+
T Consensus 217 aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~ 296 (364)
T KOG0658|consen 217 AELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSK 296 (364)
T ss_pred HHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhh
Confidence 9999984444343322211 1100 00 0 0123344689999999999999999
Q ss_pred CCChhhhhcCccccc
Q 003644 656 RPKAQNVLNHPFFWT 670 (805)
Q Consensus 656 Rps~~ell~Hpff~~ 670 (805)
|.++.|++.||||..
T Consensus 297 R~~~~~~l~h~fFde 311 (364)
T KOG0658|consen 297 RLSALEALAHPFFDE 311 (364)
T ss_pred cCCHHHHhcchhhHH
Confidence 999999999999943
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=352.11 Aligned_cols=253 Identities=27% Similarity=0.394 Sum_probs=190.5
Q ss_pred eEEEeEeeccCCceEEEEEE-eeCCcEEEEEEeecCCc------hHHHHHHHHHHHhCCCCCeeeecccccCCceEEEec
Q 003644 377 LVVFNKEIAKGSNGTVVLEG-NYEGRSVAVKRLVKTHH------DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSL 449 (805)
Q Consensus 377 ~~~~~~~LG~GsfGtVy~a~-~~~g~~VAVK~l~~~~~------~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~ 449 (805)
.|.+.+.||+|+||+||++. ..+++.||||++.+... ....+|+ .++..++||||+++++++.+.+.+|+||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~-~il~~l~h~~iv~l~~~~~~~~~~~lv~ 80 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAER-DILAEADNEWVVKLYYSFQDKDNLYFVM 80 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHH-HHHHhcCCCCeeeeEEEEecCCEEEEEE
Confidence 36778999999999999984 45689999999965321 1223344 4778899999999999999999999999
Q ss_pred ccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcc
Q 003644 450 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG 529 (805)
Q Consensus 450 E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~ 529 (805)
| |+++|+|.+++.. ...+++..++.++.||+.||+|||+.|
T Consensus 81 E----------~~~gg~L~~~l~~-----------------------------~~~~~e~~~~~~~~qi~~aL~~LH~~g 121 (381)
T cd05626 81 D----------YIPGGDMMSLLIR-----------------------------MEVFPEVLARFYIAELTLAIESVHKMG 121 (381)
T ss_pred e----------cCCCCcHHHHHHh-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 9 5555666555422 123667778899999999999999999
Q ss_pred eeccCCCCceEEecCCCCceEEEeccCccccccCCCcc------------------------------------------
Q 003644 530 LIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSC------------------------------------------ 567 (805)
Q Consensus 530 IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~------------------------------------------ 567 (805)
|+||||||+|||++.++. +||+|||+++........
T Consensus 122 ivHrDlKp~Nili~~~~~--~kL~DFGl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (381)
T cd05626 122 FIHRDIKPDNILIDLDGH--IKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQ 199 (381)
T ss_pred eeecCCcHHHEEECCCCC--EEEeeCcCCcccccccccccccccccccccccCcccccccccccccccccchhhcccccc
Confidence 999999999999987775 899999998643210000
Q ss_pred --ccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH--HHHHhhccc-cc--cccCChH
Q 003644 568 --LTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERD--ANIVKDRKD-LF--LVEHIPE 640 (805)
Q Consensus 568 --~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~elltG~~~Pf~~~~~~~--~~~~~~~~~-~~--~~~~~~~ 640 (805)
.......+||+.|+|||++.+..++.++|||||||++|||++| .+||....... ..+...... .. ....+++
T Consensus 200 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il~elltG-~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 278 (381)
T cd05626 200 HQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVG-QPPFLAPTPTETQLKVINWENTLHIPPQVKLSPE 278 (381)
T ss_pred ccccccccccCCccccCHHHHcCCCCCCccceeehhhHHHHHHhC-CCCCcCCCHHHHHHHHHccccccCCCCCCCCCHH
Confidence 0001234699999999999988899999999999999999997 77886544322 223222211 11 2235789
Q ss_pred HHHHHHHhc--CCCCCCCCChhhhhcCccccccc
Q 003644 641 AVDLFTRLL--DPNPDLRPKAQNVLNHPFFWTAD 672 (805)
Q Consensus 641 ~~dLi~~~L--~~dP~~Rps~~ell~Hpff~~~~ 672 (805)
+.+||.+|+ ..+|..|++++++++||||....
T Consensus 279 ~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~~~ 312 (381)
T cd05626 279 AVDLITKLCCSAEERLGRNGADDIKAHPFFSEVD 312 (381)
T ss_pred HHHHHHHHccCcccccCCCCHHHHhcCcccCCCC
Confidence 999999965 44555699999999999997643
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=350.92 Aligned_cols=252 Identities=27% Similarity=0.424 Sum_probs=193.7
Q ss_pred eEEEeEeeccCCceEEEEEEe-eCCcEEEEEEeecCC-----c-hHHHHHHHHHHHhCCCCCeeeecccccCCceEEEec
Q 003644 377 LVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH-----H-DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSL 449 (805)
Q Consensus 377 ~~~~~~~LG~GsfGtVy~a~~-~~g~~VAVK~l~~~~-----~-~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~ 449 (805)
.|.+.+.||+|+||+||++.. .+|+.||||++.... . ....+|+ .++..++||||+++++++.+++..|+||
T Consensus 2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~-~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 2 DFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAER-DILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHH-HHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 467889999999999999855 468999999997532 1 1123344 4778889999999999999999999999
Q ss_pred ccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcc
Q 003644 450 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG 529 (805)
Q Consensus 450 E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~ 529 (805)
||| .+|+|.+++.. ...+++..++.++.||+.||+|||+.+
T Consensus 81 E~~----------~~g~L~~~l~~-----------------------------~~~l~~~~~~~~~~qi~~aL~~lH~~~ 121 (364)
T cd05599 81 EYL----------PGGDMMTLLMK-----------------------------KDTFTEEETRFYIAETILAIDSIHKLG 121 (364)
T ss_pred CCC----------CCcHHHHHHHH-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 954 45555555422 234677888999999999999999999
Q ss_pred eeccCCCCceEEecCCCCceEEEeccCccccccCCCccc-----------------------------------cccccc
Q 003644 530 LIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCL-----------------------------------TQNATG 574 (805)
Q Consensus 530 IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~-----------------------------------~~~~~~ 574 (805)
|+||||||+|||++.++. +||+|||+++.+....... ......
T Consensus 122 ivH~Dlkp~NIl~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (364)
T cd05599 122 YIHRDIKPDNLLLDAKGH--IKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYST 199 (364)
T ss_pred eEeccCCHHHeEECCCCC--EEEeecccceeccccccccccccccccccccccccccccccccccccchhhccccccccc
Confidence 999999999999988876 8999999987653211000 001124
Q ss_pred cCCCCCCChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH--HHHHhhcccc-cc--ccCChHHHHHHHHhc
Q 003644 575 YGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERD--ANIVKDRKDL-FL--VEHIPEAVDLFTRLL 649 (805)
Q Consensus 575 ~gt~~y~APE~l~~~~~t~~sDVwSlGvil~elltG~~~Pf~~~~~~~--~~~~~~~~~~-~~--~~~~~~~~dLi~~~L 649 (805)
+||+.|+|||++....++.++|||||||++|||++| .+||....... ..+....... .+ ...++++.++|.+|+
T Consensus 200 ~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G-~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll 278 (364)
T cd05599 200 VGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVG-YPPFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLC 278 (364)
T ss_pred ccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcC-CCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHc
Confidence 699999999999999999999999999999999997 77876543322 2232222211 11 134689999999999
Q ss_pred CCCCCCCCC---hhhhhcCccccccc
Q 003644 650 DPNPDLRPK---AQNVLNHPFFWTAD 672 (805)
Q Consensus 650 ~~dP~~Rps---~~ell~Hpff~~~~ 672 (805)
. +|.+|++ +.++++||||...+
T Consensus 279 ~-~p~~R~~~~~~~~ll~h~~~~~~~ 303 (364)
T cd05599 279 C-EAERRLGNNGVNEIKSHPFFKGVD 303 (364)
T ss_pred c-CHhhcCCCCCHHHHhcCCCcCCCC
Confidence 7 9999998 99999999997654
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=344.54 Aligned_cols=245 Identities=30% Similarity=0.425 Sum_probs=191.6
Q ss_pred EeeccCCceEEEEEEe----eCCcEEEEEEeecCCc-------hHHHHHHHHHHHhCCCCCeeeecccccCCceEEEecc
Q 003644 382 KEIAKGSNGTVVLEGN----YEGRSVAVKRLVKTHH-------DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 450 (805)
Q Consensus 382 ~~LG~GsfGtVy~a~~----~~g~~VAVK~l~~~~~-------~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~E 450 (805)
+.||+|+||+||++.. .+++.||||++.+... .....|+ .++..++||||+++++++.+++..|+|||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~-~il~~l~hp~iv~~~~~~~~~~~~~lv~e 80 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAER-NILEAVKHPFIVDLIYAFQTGGKLYLILE 80 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHH-HHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence 5799999999999754 3688999999875321 1223444 47788999999999999999999999999
Q ss_pred cccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcce
Q 003644 451 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 530 (805)
Q Consensus 451 ~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~I 530 (805)
|+.+|+|.+++.. ...+++..+..++.||+.||+|||+.+|
T Consensus 81 ----------~~~~~~L~~~~~~-----------------------------~~~~~~~~~~~~~~qi~~~l~~lH~~~i 121 (323)
T cd05584 81 ----------YLSGGELFMHLER-----------------------------EGIFMEDTACFYLSEISLALEHLHQQGI 121 (323)
T ss_pred ----------CCCCchHHHHHHH-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 4555566554422 1235666778899999999999999999
Q ss_pred eccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHHHHHhC
Q 003644 531 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG 610 (805)
Q Consensus 531 vHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~elltG 610 (805)
+||||||+|||++.++. +||+|||+++...... .......||+.|+|||++.+..++.++|||||||++|||++|
T Consensus 122 vH~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G 196 (323)
T cd05584 122 IYRDLKPENILLDAQGH--VKLTDFGLCKESIHEG---TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTG 196 (323)
T ss_pred ecCCCCHHHeEECCCCC--EEEeeCcCCeecccCC---CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcC
Confidence 99999999999988776 8999999987543221 122345699999999999988899999999999999999997
Q ss_pred CCCCCCCchHHH-HHHHhhccccccccCChHHHHHHHHhcCCCCCCCC-----ChhhhhcCccccccc
Q 003644 611 GKHPYGESFERD-ANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRP-----KAQNVLNHPFFWTAD 672 (805)
Q Consensus 611 ~~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dP~~Rp-----s~~ell~Hpff~~~~ 672 (805)
.+||....... ...+.......+...++++.++|.+||+.||++|| +++++++||||....
T Consensus 197 -~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~~~ 263 (323)
T cd05584 197 -APPFTAENRKKTIDKILKGKLNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHVN 263 (323)
T ss_pred -CCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCCcCCCC
Confidence 77876543322 22222223334455678999999999999999999 899999999996543
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=346.39 Aligned_cols=247 Identities=29% Similarity=0.451 Sum_probs=195.1
Q ss_pred eEEEeEeeccCCceEEEEEEee-CCcEEEEEEeecCC------chHHHHHHHHHHHhCCCCCeeeecccccCCceEEEec
Q 003644 377 LVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH------HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSL 449 (805)
Q Consensus 377 ~~~~~~~LG~GsfGtVy~a~~~-~g~~VAVK~l~~~~------~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~ 449 (805)
.|.+.+.||+|+||.||++... +|+.||||++.+.. .....+|+. ++..++||||+++++++.+.+..|+||
T Consensus 2 ~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~-~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERD-ILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHH-HHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 4778899999999999998654 58999999997532 122334554 677888999999999999999999999
Q ss_pred ccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcc
Q 003644 450 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG 529 (805)
Q Consensus 450 E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~ 529 (805)
| |+.+|+|.+++.. ...+++..++.++.||+.||+|||+.+
T Consensus 81 e----------~~~g~~L~~~l~~-----------------------------~~~l~~~~~~~~~~qi~~~l~~lH~~~ 121 (333)
T cd05600 81 E----------YVPGGDFRTLLNN-----------------------------LGVLSEDHARFYMAEMFEAVDALHELG 121 (333)
T ss_pred e----------CCCCCCHHHHHHH-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 9 5555666555422 123567788899999999999999999
Q ss_pred eeccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHHHHHh
Q 003644 530 LIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCIT 609 (805)
Q Consensus 530 IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~ellt 609 (805)
|+||||||+|||++.++. +||+|||+++.... ......||+.|+|||++.+..++.++|||||||++|||++
T Consensus 122 ivH~dlkp~Nil~~~~~~--~kL~Dfg~a~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~ 193 (333)
T cd05600 122 YIHRDLKPENFLIDASGH--IKLTDFGLSKGIVT------YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLC 193 (333)
T ss_pred ccccCCCHHHEEECCCCC--EEEEeCcCCccccc------ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhh
Confidence 999999999999988876 89999999986543 2234569999999999999999999999999999999999
Q ss_pred CCCCCCCCchHHHH--HHHhhcccc-cc------ccCChHHHHHHHHhcCCCCCCCCChhhhhcCccccccc
Q 003644 610 GGKHPYGESFERDA--NIVKDRKDL-FL------VEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTAD 672 (805)
Q Consensus 610 G~~~Pf~~~~~~~~--~~~~~~~~~-~~------~~~~~~~~dLi~~~L~~dP~~Rps~~ell~Hpff~~~~ 672 (805)
| .+||........ .+....... .+ ...++++.++|.+||..+|.+||+++++++||||....
T Consensus 194 g-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~~~~ 264 (333)
T cd05600 194 G-FPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKEVD 264 (333)
T ss_pred C-CCCCCCCCHHHHHHHHHhccccccCCCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCcccCCCC
Confidence 7 778865433221 121111110 01 13467899999999999999999999999999997643
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-38 Score=342.35 Aligned_cols=247 Identities=26% Similarity=0.364 Sum_probs=191.7
Q ss_pred EeeccCCceEEEEEEee-CCcEEEEEEeecCC------chHHHHHHHHHHHhCCCCCeeeecccccCCceEEEecccccC
Q 003644 382 KEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH------HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTC 454 (805)
Q Consensus 382 ~~LG~GsfGtVy~a~~~-~g~~VAVK~l~~~~------~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~E~~~~ 454 (805)
+.||+|+||+||++... +++.||||++.+.. .....+|+..+....+||||+++++++.+.+.+|+|||||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-- 78 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYV-- 78 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCC--
Confidence 36999999999998554 58899999997531 1223345543433448999999999999999999999955
Q ss_pred ChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcceeccC
Q 003644 455 SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRD 534 (805)
Q Consensus 455 sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~IvHrD 534 (805)
.+|+|..++.. ...+++.++..++.||+.||+|||+.+|+|||
T Consensus 79 --------~~~~L~~~~~~-----------------------------~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~d 121 (318)
T cd05570 79 --------NGGDLMFHIQR-----------------------------SGRFDEPRARFYAAEIVLGLQFLHERGIIYRD 121 (318)
T ss_pred --------CCCCHHHHHHH-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHhCCeEccC
Confidence 45555544321 23467788899999999999999999999999
Q ss_pred CCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCC
Q 003644 535 LKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP 614 (805)
Q Consensus 535 LKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~elltG~~~P 614 (805)
|||+|||++.++. +||+|||+++...... ......+||+.|+|||++.+..++.++|||||||++|||++| ..|
T Consensus 122 lkp~Nill~~~~~--~kl~Dfg~~~~~~~~~---~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G-~~p 195 (318)
T cd05570 122 LKLDNVLLDSEGH--IKIADFGMCKEGILGG---VTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAG-QSP 195 (318)
T ss_pred CCHHHeEECCCCc--EEecccCCCeecCcCC---CcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhC-CCC
Confidence 9999999988876 8999999987532211 122334689999999999999999999999999999999997 678
Q ss_pred CCCchHHH-HHHHhhccccccccCChHHHHHHHHhcCCCCCCCCCh-----hhhhcCcccccccc
Q 003644 615 YGESFERD-ANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKA-----QNVLNHPFFWTADT 673 (805)
Q Consensus 615 f~~~~~~~-~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dP~~Rps~-----~ell~Hpff~~~~~ 673 (805)
|....... ...+.......+...++++.++|++||+.||.+||++ .++++||||...++
T Consensus 196 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~~~~~~~~ 260 (318)
T cd05570 196 FEGDDEDELFQSILEDEVRYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFREIDW 260 (318)
T ss_pred CCCCCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcCCCcCCCCH
Confidence 86543322 2223333333455567899999999999999999999 99999999976543
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=347.54 Aligned_cols=249 Identities=27% Similarity=0.385 Sum_probs=200.4
Q ss_pred EEEeEeeccCCceEEEEEE-eeCCcEEEEEEeecCCc----hHHHHHHHHHHHhCCCCCeeeecccccCCceEEEecccc
Q 003644 378 VVFNKEIAKGSNGTVVLEG-NYEGRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERC 452 (805)
Q Consensus 378 ~~~~~~LG~GsfGtVy~a~-~~~g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~E~~ 452 (805)
|...+.||+|+||.||+|. ..+++.||+|++.-... ++..+|+. +++.++|+||.++||.+..+..++++||
T Consensus 15 ~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~-~Ls~~~~~~it~yygsyl~g~~LwiiMe-- 91 (467)
T KOG0201|consen 15 YTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEIS-VLSQCDSPNITEYYGSYLKGTKLWIIME-- 91 (467)
T ss_pred cccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHH-HHHhcCcchHHhhhhheeecccHHHHHH--
Confidence 4445789999999999984 45789999999964432 23344554 7888999999999999999999999999
Q ss_pred cCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcceec
Q 003644 453 TCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIH 532 (805)
Q Consensus 453 ~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~IvH 532 (805)
|+.+|++.+.|... ..+.+.++.-|+++++.||.|||.++.+|
T Consensus 92 --------y~~gGsv~~lL~~~-----------------------------~~~~E~~i~~ilre~l~~l~ylH~~~kiH 134 (467)
T KOG0201|consen 92 --------YCGGGSVLDLLKSG-----------------------------NILDEFEIAVILREVLKGLDYLHSEKKIH 134 (467)
T ss_pred --------HhcCcchhhhhccC-----------------------------CCCccceeeeehHHHHHHhhhhhhcceec
Confidence 55566665554221 11245566789999999999999999999
Q ss_pred cCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHHHHHhCCC
Q 003644 533 RDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGK 612 (805)
Q Consensus 533 rDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~elltG~~ 612 (805)
||||+.|||+..+|. +|++|||.+..+.... ....+++|||.|||||++....|+.++||||||++.+||++| .
T Consensus 135 rDIKaanil~s~~g~--vkl~DfgVa~ql~~~~---~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~G-e 208 (467)
T KOG0201|consen 135 RDIKAANILLSESGD--VKLADFGVAGQLTNTV---KRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKG-E 208 (467)
T ss_pred ccccccceeEeccCc--EEEEecceeeeeechh---hccccccccccccchhhhccccccchhhhhhhhHHHHHHhcC-C
Confidence 999999999998876 9999999998877542 233778999999999999988999999999999999999997 8
Q ss_pred CCCCCchHHH--HHHHhhccccccccCChHHHHHHHHhcCCCCCCCCChhhhhcCccccccc
Q 003644 613 HPYGESFERD--ANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTAD 672 (805)
Q Consensus 613 ~Pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dP~~Rps~~ell~Hpff~~~~ 672 (805)
||+.+..+-. ..|-+..+......+++.+++||..||+.||+.||+|.++|+|+|.+...
T Consensus 209 PP~s~~hPmrvlflIpk~~PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~FIk~a~ 270 (467)
T KOG0201|consen 209 PPHSKLHPMRVLFLIPKSAPPRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKHKFIKRAK 270 (467)
T ss_pred CCCcccCcceEEEeccCCCCCccccccCHHHHHHHHHHhhcCcccCcCHHHHhhhHHHHhcC
Confidence 8997754421 12223333333445678899999999999999999999999999998743
|
|
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=344.69 Aligned_cols=245 Identities=26% Similarity=0.324 Sum_probs=190.3
Q ss_pred EeeccCCceEEEEEEee-CCcEEEEEEeecCC------chHHHHHHHHHHHhCCCCCeeeecccccCCceEEEecccccC
Q 003644 382 KEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH------HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTC 454 (805)
Q Consensus 382 ~~LG~GsfGtVy~a~~~-~g~~VAVK~l~~~~------~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~E~~~~ 454 (805)
+.||+|+||+||++... +++.||+|++.+.. .....+|+..++..++||||+++++++.+.+..|+|||||
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~-- 78 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYI-- 78 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCC--
Confidence 36999999999998554 67899999986432 1223445555677889999999999999999999999954
Q ss_pred ChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcceeccC
Q 003644 455 SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRD 534 (805)
Q Consensus 455 sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~IvHrD 534 (805)
.+|+|.+++.. ...+++..++.++.||+.||+|||+.||+|||
T Consensus 79 --------~~~~L~~~~~~-----------------------------~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrD 121 (325)
T cd05602 79 --------NGGELFYHLQR-----------------------------ERCFLEPRARFYAAEIASALGYLHSLNIVYRD 121 (325)
T ss_pred --------CCCcHHHHHHh-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecC
Confidence 55555554422 12355667788999999999999999999999
Q ss_pred CCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCC
Q 003644 535 LKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP 614 (805)
Q Consensus 535 LKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~elltG~~~P 614 (805)
|||+|||++.++. +||+|||+++...... ......+||+.|+|||++.+..++.++|||||||++|||++| .+|
T Consensus 122 lkp~Nili~~~~~--~kl~DfG~a~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g-~~p 195 (325)
T cd05602 122 LKPENILLDSQGH--IVLTDFGLCKENIEHN---GTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYG-LPP 195 (325)
T ss_pred CCHHHeEECCCCC--EEEccCCCCcccccCC---CCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcC-CCC
Confidence 9999999988776 8999999987543221 122345699999999999999999999999999999999997 667
Q ss_pred CCCchH-HHHHHHhhccccccccCChHHHHHHHHhcCCCCCCCCChh----hhhcCcccccc
Q 003644 615 YGESFE-RDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQ----NVLNHPFFWTA 671 (805)
Q Consensus 615 f~~~~~-~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dP~~Rps~~----ell~Hpff~~~ 671 (805)
|..... .....+...........++++.++|.+||+.||.+|+++. ++++|+||...
T Consensus 196 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~~~~~~~ 257 (325)
T cd05602 196 FYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSPI 257 (325)
T ss_pred CCCCCHHHHHHHHHhCCcCCCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhcCcccCCC
Confidence 755332 2222222223333445678999999999999999999876 79999999654
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=352.99 Aligned_cols=253 Identities=29% Similarity=0.336 Sum_probs=197.7
Q ss_pred ccccceEEEeEeeccCCceEEEEE-EeeCCcEEEEEEeecCC--chHHHHHHHHHHHhCC-C-----CCeeeecccccCC
Q 003644 372 RRIGKLVVFNKEIAKGSNGTVVLE-GNYEGRSVAVKRLVKTH--HDVALKEIQNLIASDQ-H-----PNIVRWYGVESDQ 442 (805)
Q Consensus 372 ~~i~~~~~~~~~LG~GsfGtVy~a-~~~~g~~VAVK~l~~~~--~~~~~~Ei~~ll~~l~-H-----pNIV~l~g~~~~~ 442 (805)
..++.+|.+.+.||+|+||.|.++ ...+++.||||++++.. ..++..|+. ++..++ | -|||+++++|...
T Consensus 182 d~i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~-iL~~ln~~d~~~~~n~Vrm~d~F~fr 260 (586)
T KOG0667|consen 182 DHIAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIR-ILELLNKHDPDDKYNIVRMLDYFYFR 260 (586)
T ss_pred ceeEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHH-HHHHHhccCCCCCeeEEEeeeccccc
Confidence 445558899999999999999998 45569999999997643 345566665 444444 3 4899999999999
Q ss_pred ceEEEecccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHH
Q 003644 443 DFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGL 522 (805)
Q Consensus 443 ~~l~LV~E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL 522 (805)
+++|||+|+...+|.+++.. .+-.+++...++.|+.||+.||
T Consensus 261 ~HlciVfELL~~NLYellK~--------------------------------------n~f~Glsl~~ir~~~~Qil~~L 302 (586)
T KOG0667|consen 261 NHLCIVFELLSTNLYELLKN--------------------------------------NKFRGLSLPLVRKFAQQILTAL 302 (586)
T ss_pred cceeeeehhhhhhHHHHHHh--------------------------------------cCCCCCCHHHHHHHHHHHHHHH
Confidence 99999999888887777632 2235788899999999999999
Q ss_pred HHhhhcceeccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHH
Q 003644 523 SHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGC 602 (805)
Q Consensus 523 ~yLH~~~IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGv 602 (805)
.+||+.+|||+||||+||||...+...+||+|||.|....... .+.+-+..|.|||++.+.+|+.+.|||||||
T Consensus 303 ~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~q~v------ytYiQSRfYRAPEVILGlpY~~~IDmWSLGC 376 (586)
T KOG0667|consen 303 LFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFESQRV------YTYIQSRFYRAPEVILGLPYDTAIDMWSLGC 376 (586)
T ss_pred HHHHhCCeeeccCChhheeeccCCcCceeEEecccccccCCcc------eeeeeccccccchhhccCCCCCccceeehhh
Confidence 9999999999999999999987777789999999998765431 2445678899999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCchHHHH--HHHh---------------------h------------------------------c
Q 003644 603 ILFFCITGGKHPYGESFERDA--NIVK---------------------D------------------------------R 629 (805)
Q Consensus 603 il~elltG~~~Pf~~~~~~~~--~~~~---------------------~------------------------------~ 629 (805)
|+.||++| .|-|....+.+. .++. . .
T Consensus 377 IlAEL~tG-~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~ 455 (586)
T KOG0667|consen 377 ILAELFTG-EPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARL 455 (586)
T ss_pred hHHhHhcC-ccccCCCCHHHHHHHHHHHhCCCCHHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcc
Confidence 99999998 555543322210 0000 0 0
Q ss_pred ccccc-c----------cCChHHHHHHHHhcCCCCCCCCChhhhhcCccccc
Q 003644 630 KDLFL-V----------EHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWT 670 (805)
Q Consensus 630 ~~~~~-~----------~~~~~~~dLi~~~L~~dP~~Rps~~ell~Hpff~~ 670 (805)
....+ . .....+.|+|++||+.||.+|+|+.++|+||||..
T Consensus 456 ~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp~qal~Hpfl~~ 507 (586)
T KOG0667|consen 456 ERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITPAQALNHPFLTG 507 (586)
T ss_pred cccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCHHHHhcCccccc
Confidence 00001 0 00135789999999999999999999999999964
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=348.48 Aligned_cols=255 Identities=24% Similarity=0.359 Sum_probs=195.3
Q ss_pred cceEEEeEeeccCCceEEEEEEe-eCCcEEEEEEeecCC-----chHHHHHHHHHHHhCCCCCeeeecccccCCceEEEe
Q 003644 375 GKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLS 448 (805)
Q Consensus 375 ~~~~~~~~~LG~GsfGtVy~a~~-~~g~~VAVK~l~~~~-----~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV 448 (805)
.+.|.+.+.||+|+||+||++.. .+++.||||++.+.. ....+.++..+++.++||||+++++++.+++..|+|
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv 121 (370)
T cd05596 42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMV 121 (370)
T ss_pred HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEE
Confidence 45688899999999999999854 468999999986421 112233333578889999999999999999999999
Q ss_pred cccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhc
Q 003644 449 LERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI 528 (805)
Q Consensus 449 ~E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~ 528 (805)
|| |+.+|+|.+++.. ..+++..+..++.||+.||+|||+.
T Consensus 122 ~E----------y~~gg~L~~~l~~------------------------------~~l~~~~~~~~~~qi~~aL~~LH~~ 161 (370)
T cd05596 122 ME----------YMPGGDLVNLMSN------------------------------YDIPEKWARFYTAEVVLALDAIHSM 161 (370)
T ss_pred Ec----------CCCCCcHHHHHHh------------------------------cCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 99 4455566554421 2355667788999999999999999
Q ss_pred ceeccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcC----CCCCcchHHHHHHHH
Q 003644 529 GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG----RQTRAIDLFSLGCIL 604 (805)
Q Consensus 529 ~IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~----~~t~~sDVwSlGvil 604 (805)
+|+||||||+|||++.++. +||+|||++........ ......+||+.|+|||++... .++.++|||||||++
T Consensus 162 ~ivHrDLkp~NILl~~~~~--~kL~DfG~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvil 237 (370)
T cd05596 162 GFIHRDVKPDNMLLDKSGH--LKLADFGTCMKMDANGM--VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFL 237 (370)
T ss_pred CeeccCCCHHHEEEcCCCC--EEEEeccceeeccCCCc--ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHH
Confidence 9999999999999988876 89999999987643211 122345699999999998753 378999999999999
Q ss_pred HHHHhCCCCCCCCchHH-H-HHHHhhcc-ccccc--cCChHHHHHHHHhcCCCCCC--CCChhhhhcCccccccccc
Q 003644 605 FFCITGGKHPYGESFER-D-ANIVKDRK-DLFLV--EHIPEAVDLFTRLLDPNPDL--RPKAQNVLNHPFFWTADTR 674 (805)
Q Consensus 605 ~elltG~~~Pf~~~~~~-~-~~~~~~~~-~~~~~--~~~~~~~dLi~~~L~~dP~~--Rps~~ell~Hpff~~~~~~ 674 (805)
|||++| .+||...... . ..+..... ..++. ..+.++.++|.+||+.+|.+ |++++++++||||+...+.
T Consensus 238 yelltG-~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~~~~ 313 (370)
T cd05596 238 YEMLVG-DTPFYADSLVGTYSKIMDHKNSLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKNDQWT 313 (370)
T ss_pred HHHHhC-CCCcCCCCHHHHHHHHHcCCCcCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccCCCChh
Confidence 999997 6777654322 2 22222211 11222 35689999999999999988 9999999999999765443
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=346.68 Aligned_cols=253 Identities=21% Similarity=0.325 Sum_probs=193.6
Q ss_pred ccceEEEeEeeccCCceEEEEEEe---eCCcEEEEEEeecCCchHHHHHHHHHHHhCCCCCeeeecccccCCceEEEecc
Q 003644 374 IGKLVVFNKEIAKGSNGTVVLEGN---YEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 450 (805)
Q Consensus 374 i~~~~~~~~~LG~GsfGtVy~a~~---~~g~~VAVK~l~~~~~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~E 450 (805)
+...|.+.+.||+|+||+||++.. ..++.||||.+... ....+|+. +++.++|||||++++++.+.+..|+|||
T Consensus 90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~--~~~~~E~~-il~~l~h~~iv~~~~~~~~~~~~~lv~e 166 (392)
T PHA03207 90 VRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG--KTPGREID-ILKTISHRAIINLIHAYRWKSTVCMVMP 166 (392)
T ss_pred ccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc--ccHHHHHH-HHHhcCCCCccceeeeEeeCCEEEEEeh
Confidence 445689999999999999999743 34678999988654 23456765 6788899999999999999999999999
Q ss_pred cccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcce
Q 003644 451 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 530 (805)
Q Consensus 451 ~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~I 530 (805)
++.++|.+++. ....+++..++.++.||+.||+|||+.||
T Consensus 167 ~~~~~l~~~l~----------------------------------------~~~~l~~~~~~~i~~ql~~aL~~LH~~gi 206 (392)
T PHA03207 167 KYKCDLFTYVD----------------------------------------RSGPLPLEQAITIQRRLLEALAYLHGRGI 206 (392)
T ss_pred hcCCCHHHHHH----------------------------------------hcCCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence 77666554441 11346778889999999999999999999
Q ss_pred eccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHHHHHhC
Q 003644 531 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG 610 (805)
Q Consensus 531 vHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~elltG 610 (805)
+||||||+|||++.++. +||+|||+++....... ........||+.|+|||++....++.++|||||||++|||++|
T Consensus 207 vHrDlkp~Nill~~~~~--~~l~DfG~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g 283 (392)
T PHA03207 207 IHRDVKTENIFLDEPEN--AVLGDFGAACKLDAHPD-TPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVK 283 (392)
T ss_pred cccCCCHHHEEEcCCCC--EEEccCccccccCcccc-cccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHC
Confidence 99999999999988776 89999999987654321 1122345699999999999998999999999999999999998
Q ss_pred CCCCCCCchHH----HHHHHhhc---c-----------------------ccc-------cccCChHHHHHHHHhcCCCC
Q 003644 611 GKHPYGESFER----DANIVKDR---K-----------------------DLF-------LVEHIPEAVDLFTRLLDPNP 653 (805)
Q Consensus 611 ~~~Pf~~~~~~----~~~~~~~~---~-----------------------~~~-------~~~~~~~~~dLi~~~L~~dP 653 (805)
+.++++..... ...++... . ..+ ......++.++|.+||+.||
T Consensus 284 ~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp 363 (392)
T PHA03207 284 NVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQ 363 (392)
T ss_pred CCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccCh
Confidence 55544432110 01111000 0 000 01123578899999999999
Q ss_pred CCCCChhhhhcCccccccc
Q 003644 654 DLRPKAQNVLNHPFFWTAD 672 (805)
Q Consensus 654 ~~Rps~~ell~Hpff~~~~ 672 (805)
++||++.|++.||||...+
T Consensus 364 ~~Rpsa~e~l~~p~f~~~~ 382 (392)
T PHA03207 364 EFRPSAQDILSLPLFTKEP 382 (392)
T ss_pred hhCCCHHHHhhCchhhccc
Confidence 9999999999999996543
|
|
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-38 Score=342.71 Aligned_cols=246 Identities=25% Similarity=0.326 Sum_probs=191.3
Q ss_pred EeeccCCceEEEEEEe-eCCcEEEEEEeecCC------chHHHHHHHHHHHhCCCCCeeeecccccCCceEEEecccccC
Q 003644 382 KEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH------HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTC 454 (805)
Q Consensus 382 ~~LG~GsfGtVy~a~~-~~g~~VAVK~l~~~~------~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~E~~~~ 454 (805)
+.||+|+||+||++.. .+|+.||||++.+.. .....+|+..++..++||||+++++++.+.+..|+|||||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~-- 78 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYV-- 78 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCC--
Confidence 3699999999999865 468999999986432 1233455555678899999999999999999999999954
Q ss_pred ChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcceeccC
Q 003644 455 SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRD 534 (805)
Q Consensus 455 sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~IvHrD 534 (805)
.+|+|..++.. ...+++..+..++.||+.||+|||+.+|+|||
T Consensus 79 --------~~~~L~~~l~~-----------------------------~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~D 121 (321)
T cd05603 79 --------NGGELFFHLQR-----------------------------ERCFLEPRARFYAAEVASAIGYLHSLNIIYRD 121 (321)
T ss_pred --------CCCCHHHHHHH-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecc
Confidence 45555544321 12356677888999999999999999999999
Q ss_pred CCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCC
Q 003644 535 LKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP 614 (805)
Q Consensus 535 LKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~elltG~~~P 614 (805)
|||+|||++.++. +||+|||+++...... ......+||+.|+|||++.+..++.++|||||||++|||++| .+|
T Consensus 122 lkp~NIll~~~~~--~kl~Dfg~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g-~~p 195 (321)
T cd05603 122 LKPENILLDSQGH--VVLTDFGLCKEGVEPE---ETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYG-LPP 195 (321)
T ss_pred CCHHHeEECCCCC--EEEccCCCCccCCCCC---CccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcC-CCC
Confidence 9999999988876 8999999987542211 122345689999999999988899999999999999999997 667
Q ss_pred CCCchH-HHHHHHhhccccccccCChHHHHHHHHhcCCCCCCCCCh----hhhhcCccccccc
Q 003644 615 YGESFE-RDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKA----QNVLNHPFFWTAD 672 (805)
Q Consensus 615 f~~~~~-~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dP~~Rps~----~ell~Hpff~~~~ 672 (805)
|..... .....+.......+.....++.++|.+||+.||.+||++ .++++||||....
T Consensus 196 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~~~~~~~~ 258 (321)
T cd05603 196 FYSRDVSQMYDNILHKPLQLPGGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFSPIN 258 (321)
T ss_pred CCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCCCCcCCCC
Confidence 755432 222223233333444567789999999999999999876 4999999996544
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=350.88 Aligned_cols=252 Identities=29% Similarity=0.428 Sum_probs=190.2
Q ss_pred eEEEeEeeccCCceEEEEEE-eeCCcEEEEEEeecCCc------hHHHHHHHHHHHhCCCCCeeeecccccCCceEEEec
Q 003644 377 LVVFNKEIAKGSNGTVVLEG-NYEGRSVAVKRLVKTHH------DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSL 449 (805)
Q Consensus 377 ~~~~~~~LG~GsfGtVy~a~-~~~g~~VAVK~l~~~~~------~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~ 449 (805)
.|.+.+.||+|+||+||++. ..+|+.||||++.+... ....+|+ .++..++|||||++++++.+.++.|+||
T Consensus 2 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~-~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 2 DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAER-DVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHH-HHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 46778999999999999985 45789999999864321 1223344 4678899999999999999999999999
Q ss_pred ccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcc
Q 003644 450 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG 529 (805)
Q Consensus 450 E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~ 529 (805)
||| .+|+|.+++.. ...+++..++.++.|++.||+|||+.|
T Consensus 81 E~~----------~gg~L~~~l~~-----------------------------~~~~~~~~~~~~~~ql~~aL~~LH~~g 121 (377)
T cd05629 81 EFL----------PGGDLMTMLIK-----------------------------YDTFSEDVTRFYMAECVLAIEAVHKLG 121 (377)
T ss_pred eCC----------CCCcHHHHHHh-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 955 45555554421 134667778899999999999999999
Q ss_pred eeccCCCCceEEecCCCCceEEEeccCccccccCCCc------------cc-----------------------------
Q 003644 530 LIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMS------------CL----------------------------- 568 (805)
Q Consensus 530 IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~------------~~----------------------------- 568 (805)
|+||||||+|||++.++. +||+|||+++....... ..
T Consensus 122 ivHrDlkp~NIll~~~~~--~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (377)
T cd05629 122 FIHRDIKPDNILIDRGGH--IKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKK 199 (377)
T ss_pred eeccCCCHHHEEECCCCC--EEEeecccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhh
Confidence 999999999999988776 89999999964321100 00
Q ss_pred ---cccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH--HHHHhhcccc-ccc--cCChH
Q 003644 569 ---TQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERD--ANIVKDRKDL-FLV--EHIPE 640 (805)
Q Consensus 569 ---~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~elltG~~~Pf~~~~~~~--~~~~~~~~~~-~~~--~~~~~ 640 (805)
......+||+.|+|||++.+..++.++|||||||++|||++| .+||....... ..+....... .+. ..+++
T Consensus 200 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG-~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~ 278 (377)
T cd05629 200 NRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFECLIG-WPPFCSENSHETYRKIINWRETLYFPDDIHLSVE 278 (377)
T ss_pred cccccccccCCCccccCHHHHccCCCCCceeeEecchhhhhhhcC-CCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHH
Confidence 000124699999999999998999999999999999999997 77886544322 2222222111 111 34679
Q ss_pred HHHHHHHhcCCCCCCC---CChhhhhcCccccccc
Q 003644 641 AVDLFTRLLDPNPDLR---PKAQNVLNHPFFWTAD 672 (805)
Q Consensus 641 ~~dLi~~~L~~dP~~R---ps~~ell~Hpff~~~~ 672 (805)
+.++|.+||. +|.+| +++.|+++||||...+
T Consensus 279 ~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~~~~~ 312 (377)
T cd05629 279 AEDLIRRLIT-NAENRLGRGGAHEIKSHPFFRGVD 312 (377)
T ss_pred HHHHHHHHhc-CHhhcCCCCCHHHHhcCCCcCCCC
Confidence 9999999998 66665 6999999999997543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=334.04 Aligned_cols=247 Identities=26% Similarity=0.400 Sum_probs=190.1
Q ss_pred eccCCceEEEEEEe-eCCcEEEEEEeecCCc------hHHHHHHHHHHHhCCCCCeeeecccccCCceEEEecccccCCh
Q 003644 384 IAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH------DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCSL 456 (805)
Q Consensus 384 LG~GsfGtVy~a~~-~~g~~VAVK~l~~~~~------~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~E~~~~sL 456 (805)
||+|+||+||++.. .+|+.||||.+.+... .....|+. ++..++||||+++++++.+++..|+|||
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~-il~~l~~~~i~~~~~~~~~~~~~~lv~e------ 73 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKR-ILAKVHSRFIVSLAYAFQTKTDLCLVMT------ 73 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHH-HHHhCCCCcEeeeeEEEcCCCeEEEEEe------
Confidence 79999999999754 4789999999865321 12234544 6788899999999999999999999999
Q ss_pred hhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCC
Q 003644 457 NDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLK 536 (805)
Q Consensus 457 ~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~IvHrDLK 536 (805)
|+.+|+|..++..... ....+++..++.++.||+.||+|||+.+|+|||||
T Consensus 74 ----~~~~g~L~~~~~~~~~-------------------------~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlk 124 (280)
T cd05608 74 ----IMNGGDLRYHIYNVDE-------------------------ENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLK 124 (280)
T ss_pred ----CCCCCCHHHHHHhccc-------------------------cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCC
Confidence 5555555554422110 12346788889999999999999999999999999
Q ss_pred CceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q 003644 537 PQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYG 616 (805)
Q Consensus 537 p~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~elltG~~~Pf~ 616 (805)
|+||+++.++. +||+|||++..+..... ......||+.|+|||++.+..++.++|||||||++|||++| ..||.
T Consensus 125 p~Nili~~~~~--~~l~dfg~~~~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g-~~pf~ 198 (280)
T cd05608 125 PENVLLDNDGN--VRISDLGLAVELKDGQS---KTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAA-RGPFR 198 (280)
T ss_pred HHHEEECCCCC--EEEeeCccceecCCCCc---cccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhC-CCCCC
Confidence 99999987765 89999999976653321 12334689999999999999999999999999999999997 77886
Q ss_pred CchHH--HH---HHHhhccccccccCChHHHHHHHHhcCCCCCCCC-----ChhhhhcCccccccc
Q 003644 617 ESFER--DA---NIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRP-----KAQNVLNHPFFWTAD 672 (805)
Q Consensus 617 ~~~~~--~~---~~~~~~~~~~~~~~~~~~~dLi~~~L~~dP~~Rp-----s~~ell~Hpff~~~~ 672 (805)
..... .. ..+.......+...++++.+++.+||+.||++|| +++++++||||....
T Consensus 199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~~~ 264 (280)
T cd05608 199 ARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRDLN 264 (280)
T ss_pred CCCcchhHHHHHHhhcccCCCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhhhcCC
Confidence 53211 11 1111112223345678999999999999999999 789999999996543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-38 Score=350.84 Aligned_cols=252 Identities=27% Similarity=0.389 Sum_probs=191.5
Q ss_pred eEEEeEeeccCCceEEEEEEe-eCCcEEEEEEeecCCc------hHHHHHHHHHHHhCCCCCeeeecccccCCceEEEec
Q 003644 377 LVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH------DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSL 449 (805)
Q Consensus 377 ~~~~~~~LG~GsfGtVy~a~~-~~g~~VAVK~l~~~~~------~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~ 449 (805)
.|...+.||+|+||+||++.. .+++.||||++.+... ....+|+ .+++.++|||||++++++.+++.+|+||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~-~il~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAER-DILAEADNEWVVRLYYSFQDKDNLYFVM 80 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHH-HHHHhCCCCcCCeEEEEEEeCCEEEEEE
Confidence 367789999999999999854 5688999999865321 1223344 4778899999999999999999999999
Q ss_pred ccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcc
Q 003644 450 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG 529 (805)
Q Consensus 450 E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~ 529 (805)
||| .+|+|.+++.. ...+++..++.++.||+.||+|||+.+
T Consensus 81 E~~----------~gg~L~~~l~~-----------------------------~~~~~e~~~~~~~~qi~~al~~lH~~~ 121 (382)
T cd05625 81 DYI----------PGGDMMSLLIR-----------------------------MGIFPEDLARFYIAELTCAVESVHKMG 121 (382)
T ss_pred eCC----------CCCcHHHHHHh-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 954 55555554422 123567778899999999999999999
Q ss_pred eeccCCCCceEEecCCCCceEEEeccCccccccCCCc-------------------------------------------
Q 003644 530 LIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMS------------------------------------------- 566 (805)
Q Consensus 530 IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~------------------------------------------- 566 (805)
|+||||||+|||++.++. +||+|||+++.......
T Consensus 122 ivHrDlKp~NILl~~~g~--~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (382)
T cd05625 122 FIHRDIKPDNILIDRDGH--IKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQ 199 (382)
T ss_pred eecCCCCHHHEEECCCCC--EEEeECCCCccccccccccccccccccccccccccccccccccccccccccchhhhhccc
Confidence 999999999999988876 89999999754321000
Q ss_pred -cccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH--HHHHhhcccc---ccccCChH
Q 003644 567 -CLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERD--ANIVKDRKDL---FLVEHIPE 640 (805)
Q Consensus 567 -~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~elltG~~~Pf~~~~~~~--~~~~~~~~~~---~~~~~~~~ 640 (805)
........+||+.|+|||++.+..++.++|||||||++|||++| .+||....... ..+....... .....+++
T Consensus 200 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil~elltG-~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~ 278 (382)
T cd05625 200 HQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVG-QPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPE 278 (382)
T ss_pred cccccccccccCcccCCHHHhcCCCCCCeeeEEechHHHHHHHhC-CCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHH
Confidence 00001234699999999999999999999999999999999997 77886543322 2233222111 12345789
Q ss_pred HHHHHHHhcCCCCCCCCC---hhhhhcCccccccc
Q 003644 641 AVDLFTRLLDPNPDLRPK---AQNVLNHPFFWTAD 672 (805)
Q Consensus 641 ~~dLi~~~L~~dP~~Rps---~~ell~Hpff~~~~ 672 (805)
+.++|.+|+ .+|.+|++ ++++++||||....
T Consensus 279 ~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~~ 312 (382)
T cd05625 279 ASDLIIKLC-RGPEDRLGKNGADEIKAHPFFKTID 312 (382)
T ss_pred HHHHHHHHc-cCHhHcCCCCCHHHHhcCCCcCCcC
Confidence 999999987 59999987 99999999996643
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=340.25 Aligned_cols=248 Identities=24% Similarity=0.356 Sum_probs=193.0
Q ss_pred ceEEEeEeeccCCceEEEEEEee-CCcEEEEEEeecCCc----hHHHHHHHHHHHhCCCCCeeeecccccCCceEEEecc
Q 003644 376 KLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 450 (805)
Q Consensus 376 ~~~~~~~~LG~GsfGtVy~a~~~-~g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~E 450 (805)
+.|...+.||+|+||.||++... +|..||+|.+..... ....+|+. ++..++||||+++++++.+++..++|||
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~-~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQ-VLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred ccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHH-HHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 45788899999999999998654 688999999865422 23445554 6788899999999999999999999999
Q ss_pred cccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhc-c
Q 003644 451 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI-G 529 (805)
Q Consensus 451 ~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~-~ 529 (805)
|+.+|+|.+++.. ...+++..+..++.|++.||+|||+. +
T Consensus 84 ----------~~~~~~L~~~l~~-----------------------------~~~~~~~~~~~~~~~i~~~l~~lH~~~~ 124 (331)
T cd06649 84 ----------HMDGGSLDQVLKE-----------------------------AKRIPEEILGKVSIAVLRGLAYLREKHQ 124 (331)
T ss_pred ----------cCCCCcHHHHHHH-----------------------------cCCCCHHHHHHHHHHHHHHHHHHhhcCC
Confidence 5555666655422 12366778899999999999999986 6
Q ss_pred eeccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHHHHHh
Q 003644 530 LIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCIT 609 (805)
Q Consensus 530 IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~ellt 609 (805)
|+||||||+|||++.++. +||+|||++...... ......||+.|+|||++.+..++.++|||||||++|||++
T Consensus 125 ivH~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t 197 (331)
T cd06649 125 IMHRDVKPSNILVNSRGE--IKLCDFGVSGQLIDS-----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAI 197 (331)
T ss_pred EEcCCCChhhEEEcCCCc--EEEccCccccccccc-----ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHh
Confidence 999999999999988876 899999998766432 1233468999999999998899999999999999999999
Q ss_pred CCCCCCCCchHHHHH-HHh-----------------------------------------------hc-cccccccCChH
Q 003644 610 GGKHPYGESFERDAN-IVK-----------------------------------------------DR-KDLFLVEHIPE 640 (805)
Q Consensus 610 G~~~Pf~~~~~~~~~-~~~-----------------------------------------------~~-~~~~~~~~~~~ 640 (805)
| +.||......... ++. .. ........+++
T Consensus 198 g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (331)
T cd06649 198 G-RYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPD 276 (331)
T ss_pred C-CCCCCCCCHHHHHHHhcccccccccCCccccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHH
Confidence 7 7787543222111 000 00 00001124578
Q ss_pred HHHHHHHhcCCCCCCCCChhhhhcCcccccc
Q 003644 641 AVDLFTRLLDPNPDLRPKAQNVLNHPFFWTA 671 (805)
Q Consensus 641 ~~dLi~~~L~~dP~~Rps~~ell~Hpff~~~ 671 (805)
+++||.+||+.||++|||+.|+++||||...
T Consensus 277 l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~ 307 (331)
T cd06649 277 FQEFVNKCLIKNPAERADLKMLMNHTFIKRS 307 (331)
T ss_pred HHHHHHHHccCCcccCCCHHHHhcChHHhhc
Confidence 9999999999999999999999999999653
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=344.24 Aligned_cols=254 Identities=28% Similarity=0.418 Sum_probs=202.0
Q ss_pred ccccceEEEeEeeccCCceEEEEEEee-CCcEEEEEEeecCCc------hHHHHHHHHHHHhCC-CCCeeeecccccCCc
Q 003644 372 RRIGKLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHH------DVALKEIQNLIASDQ-HPNIVRWYGVESDQD 443 (805)
Q Consensus 372 ~~i~~~~~~~~~LG~GsfGtVy~a~~~-~g~~VAVK~l~~~~~------~~~~~Ei~~ll~~l~-HpNIV~l~g~~~~~~ 443 (805)
..+...|.+.+.||+|.||.||++... +|+.+|+|.+.+... ....+|+. ++..+. |||||.+++++++.+
T Consensus 31 ~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~-il~~l~~hpniv~l~~~~e~~~ 109 (382)
T KOG0032|consen 31 EDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVA-ILQQLSGHPNIVQLKDAFEDPD 109 (382)
T ss_pred ccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHH-HHHhccCCCCEEEEEEEEEcCC
Confidence 445677899999999999999998554 599999999976532 35667777 455555 999999999999999
Q ss_pred eEEEecccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHH
Q 003644 444 FVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLS 523 (805)
Q Consensus 444 ~l~LV~E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~ 523 (805)
.+|+|||+|. +|.|.+.+... .+++..+..+++||+.|++
T Consensus 110 ~~~lvmEL~~----------GGeLfd~i~~~------------------------------~~sE~da~~~~~~il~av~ 149 (382)
T KOG0032|consen 110 SVYLVMELCE----------GGELFDRIVKK------------------------------HYSERDAAGIIRQILEAVK 149 (382)
T ss_pred eEEEEEEecC----------CchHHHHHHHc------------------------------cCCHHHHHHHHHHHHHHHH
Confidence 9999999775 44444433211 1667788999999999999
Q ss_pred HhhhcceeccCCCCceEEecCCC--CceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHH
Q 003644 524 HLHEIGLIHRDLKPQNVLISKDK--SFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLG 601 (805)
Q Consensus 524 yLH~~~IvHrDLKp~NILl~~~~--~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlG 601 (805)
|||+.||+||||||+|+|+.... ...+|++|||++...... ......+||+.|+|||++....|+..+||||+|
T Consensus 150 ~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~~----~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~G 225 (382)
T KOG0032|consen 150 YLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKPG----ERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIG 225 (382)
T ss_pred HHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEccCC----ceEeeecCCccccCchhhcCCCCCcccchhHHH
Confidence 99999999999999999996542 246999999999988752 344667899999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCC-CchHHHHH-HHhhcc---ccccccCChHHHHHHHHhcCCCCCCCCChhhhhcCcccccc
Q 003644 602 CILFFCITGGKHPYG-ESFERDAN-IVKDRK---DLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTA 671 (805)
Q Consensus 602 vil~elltG~~~Pf~-~~~~~~~~-~~~~~~---~~~~~~~~~~~~dLi~~~L~~dP~~Rps~~ell~Hpff~~~ 671 (805)
|++|.|++| .+||. +....... +..... .......+..++++|.+||..||.+|+|+.++|+|||+.+.
T Consensus 226 vi~yiLL~G-~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~ 299 (382)
T KOG0032|consen 226 VILYILLSG-VPPFWGETEFEIFLAILRGDFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSI 299 (382)
T ss_pred HHHHHHhhC-CCCCcCCChhHHHHHHHcCCCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCccccCC
Confidence 999999997 55554 44333333 333322 12223346789999999999999999999999999998764
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=344.48 Aligned_cols=247 Identities=27% Similarity=0.389 Sum_probs=188.4
Q ss_pred ccceEEEeEeeccCCceEEEEEEe-eCCcEEEEEEeecCC-----chHHHHHHHHHHHhCCCCCeeeecccccCC-----
Q 003644 374 IGKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQ----- 442 (805)
Q Consensus 374 i~~~~~~~~~LG~GsfGtVy~a~~-~~g~~VAVK~l~~~~-----~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~----- 442 (805)
+.+.|.+.+.||+|+||+||++.. .+|+.||||++.... .....+|+. ++..++||||+++++++...
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~~ 97 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELV-LLKCVNHKNIISLLNVFTPQKSLEE 97 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHH-HHHhCCCCCEeeeeeeeccCCCccc
Confidence 446788899999999999999854 568999999986432 223445654 67888999999999988654
Q ss_pred -ceEEEecccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHH
Q 003644 443 -DFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSG 521 (805)
Q Consensus 443 -~~l~LV~E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~g 521 (805)
...|+|||||.++|.+.+. ..+++..+..++.||+.|
T Consensus 98 ~~~~~lv~e~~~~~l~~~~~------------------------------------------~~~~~~~~~~~~~qi~~~ 135 (359)
T cd07876 98 FQDVYLVMELMDANLCQVIH------------------------------------------MELDHERMSYLLYQMLCG 135 (359)
T ss_pred cceeEEEEeCCCcCHHHHHh------------------------------------------ccCCHHHHHHHHHHHHHH
Confidence 3579999987766544331 124556678899999999
Q ss_pred HHHhhhcceeccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHH
Q 003644 522 LSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLG 601 (805)
Q Consensus 522 L~yLH~~~IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlG 601 (805)
|+|||+.||+||||||+|||++.++. +||+|||+++..... .......||+.|+|||++.+..++.++||||||
T Consensus 136 L~~LH~~~ivHrDlkp~NIl~~~~~~--~kl~Dfg~a~~~~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG 209 (359)
T cd07876 136 IKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTACTN----FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVG 209 (359)
T ss_pred HHHHHhCCcccCCCCHHHEEECCCCC--EEEecCCCccccccC----ccCCCCcccCCCCCchhccCCCCCcchhhHHHH
Confidence 99999999999999999999988876 899999999765432 112334689999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCCchHHHH--H----------------------HHhhcccc-------------------ccccCC
Q 003644 602 CILFFCITGGKHPYGESFERDA--N----------------------IVKDRKDL-------------------FLVEHI 638 (805)
Q Consensus 602 vil~elltG~~~Pf~~~~~~~~--~----------------------~~~~~~~~-------------------~~~~~~ 638 (805)
|++|+|++| .+||........ . ........ ......
T Consensus 210 ~il~el~tg-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (359)
T cd07876 210 CIMGELVKG-SVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKT 288 (359)
T ss_pred HHHHHHHhC-CCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccc
Confidence 999999997 778864322110 0 00000000 000123
Q ss_pred hHHHHHHHHhcCCCCCCCCChhhhhcCccccc
Q 003644 639 PEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWT 670 (805)
Q Consensus 639 ~~~~dLi~~~L~~dP~~Rps~~ell~Hpff~~ 670 (805)
+++++||.+||+.||++|||+.|+++||||..
T Consensus 289 ~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~ 320 (359)
T cd07876 289 SQARDLLSKMLVIDPDKRISVDEALRHPYITV 320 (359)
T ss_pred hhHHHHHHHHhccCcccCCCHHHHhcCchhhh
Confidence 57899999999999999999999999999853
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=339.33 Aligned_cols=250 Identities=24% Similarity=0.352 Sum_probs=192.8
Q ss_pred EEEeEeeccCCceEEEEEEe-eCCcEEEEEEeecCC------chHHHHHHHHHHHhCCCCCeeeecccccCCceEEEecc
Q 003644 378 VVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH------HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 450 (805)
Q Consensus 378 ~~~~~~LG~GsfGtVy~a~~-~~g~~VAVK~l~~~~------~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~E 450 (805)
|.+.+.||+|+||+||++.. .+|+.||||++.+.. ......|...+....+|++|+++++++.+.+.+|+|||
T Consensus 2 f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E 81 (323)
T cd05615 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVME 81 (323)
T ss_pred ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEc
Confidence 56778999999999999854 468999999986431 11233455434334456888899999999999999999
Q ss_pred cccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcce
Q 003644 451 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 530 (805)
Q Consensus 451 ~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~I 530 (805)
| +.+|+|.+++.. ...+++.+++.++.||+.||+|||+.||
T Consensus 82 y----------~~~g~L~~~i~~-----------------------------~~~l~~~~~~~i~~qi~~al~~lH~~~i 122 (323)
T cd05615 82 Y----------VNGGDLMYHIQQ-----------------------------VGKFKEPQAVFYAAEISVGLFFLHRRGI 122 (323)
T ss_pred C----------CCCCcHHHHHHH-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 4 455555554421 2346778889999999999999999999
Q ss_pred eccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHHHHHhC
Q 003644 531 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG 610 (805)
Q Consensus 531 vHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~elltG 610 (805)
+||||||+|||++.++. +||+|||+++...... .......||+.|+|||++.+..++.++|||||||++|||++|
T Consensus 123 vHrDikp~Nill~~~~~--ikL~Dfg~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG 197 (323)
T cd05615 123 IYRDLKLDNVMLDSEGH--IKIADFGMCKEHMVDG---VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAG 197 (323)
T ss_pred eccCCCHHHeEECCCCC--EEEeccccccccCCCC---ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhC
Confidence 99999999999988876 8999999987543221 122345699999999999988899999999999999999997
Q ss_pred CCCCCCCchHHH-HHHHhhccccccccCChHHHHHHHHhcCCCCCCCCC-----hhhhhcCccccccc
Q 003644 611 GKHPYGESFERD-ANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPK-----AQNVLNHPFFWTAD 672 (805)
Q Consensus 611 ~~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dP~~Rps-----~~ell~Hpff~~~~ 672 (805)
.+||....... ...+.......+...++++.+++.+||+.||.+|++ .+++++||||...+
T Consensus 198 -~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~~ 264 (323)
T cd05615 198 -QPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRRID 264 (323)
T ss_pred -CCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcCcccCCCC
Confidence 77886543322 222223333345566789999999999999999997 46899999997644
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=347.15 Aligned_cols=256 Identities=25% Similarity=0.390 Sum_probs=194.5
Q ss_pred ccccceEEEeEeeccCCceEEEEEEe-eCCcEEEEEEeecCC-----chHHHHHHHHHHHhCCCCCeeeecccccCCceE
Q 003644 372 RRIGKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQDFV 445 (805)
Q Consensus 372 ~~i~~~~~~~~~LG~GsfGtVy~a~~-~~g~~VAVK~l~~~~-----~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l 445 (805)
....+.|.+.+.||+|+||+||++.. .+++.||+|.+.+.. ....+.++..+++.++||||+++++++.+++..
T Consensus 39 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~ 118 (370)
T cd05621 39 QMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYL 118 (370)
T ss_pred CCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEE
Confidence 33456788999999999999999855 468899999986421 122344445578889999999999999999999
Q ss_pred EEecccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHh
Q 003644 446 YLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHL 525 (805)
Q Consensus 446 ~LV~E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yL 525 (805)
|+||| |+.+|+|.+++.. ..+++..+..++.||+.||+||
T Consensus 119 ~lv~E----------y~~gg~L~~~l~~------------------------------~~~~~~~~~~~~~qil~aL~~L 158 (370)
T cd05621 119 YMVME----------YMPGGDLVNLMSN------------------------------YDVPEKWAKFYTAEVVLALDAI 158 (370)
T ss_pred EEEEc----------CCCCCcHHHHHHh------------------------------cCCCHHHHHHHHHHHHHHHHHH
Confidence 99999 4455666554421 2356677889999999999999
Q ss_pred hhcceeccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCC----CCCcchHHHHH
Q 003644 526 HEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGR----QTRAIDLFSLG 601 (805)
Q Consensus 526 H~~~IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~----~t~~sDVwSlG 601 (805)
|+.+|+||||||+|||++.++. +||+|||++....... .....+.+||+.|+|||++.... ++.++||||||
T Consensus 159 H~~~IvHrDLKp~NILl~~~~~--~kL~DFG~a~~~~~~~--~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG 234 (370)
T cd05621 159 HSMGLIHRDVKPDNMLLDKHGH--LKLADFGTCMKMDETG--MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVG 234 (370)
T ss_pred HHCCeEecCCCHHHEEECCCCC--EEEEecccceecccCC--ceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeeh
Confidence 9999999999999999988876 8999999998764321 11223457999999999997643 78899999999
Q ss_pred HHHHHHHhCCCCCCCCchH-HHH-HHHhhccc-ccc--ccCChHHHHHHHHhcCCCCCC--CCChhhhhcCccccccc
Q 003644 602 CILFFCITGGKHPYGESFE-RDA-NIVKDRKD-LFL--VEHIPEAVDLFTRLLDPNPDL--RPKAQNVLNHPFFWTAD 672 (805)
Q Consensus 602 vil~elltG~~~Pf~~~~~-~~~-~~~~~~~~-~~~--~~~~~~~~dLi~~~L~~dP~~--Rps~~ell~Hpff~~~~ 672 (805)
|++|||++| .+||..... ... .+...... ..+ ...++.+++++.+||..++.+ |++++|+++||||....
T Consensus 235 ~ilyell~G-~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~~ 311 (370)
T cd05621 235 VFLFEMLVG-DTPFYADSLVGTYSKIMDHKNSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKNDQ 311 (370)
T ss_pred HHHHHHHhC-CCCCCCCCHHHHHHHHHhCCcccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCCCC
Confidence 999999997 667754332 222 22222111 112 234678999999999866544 89999999999997643
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=334.14 Aligned_cols=255 Identities=25% Similarity=0.338 Sum_probs=200.0
Q ss_pred EEEeEeeccCCceEEEEEEeeC-CcEEEEEEeecCCch------HHHHHHHHHHHhCCCCCeeeecccccCCceEEEecc
Q 003644 378 VVFNKEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHHD------VALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 450 (805)
Q Consensus 378 ~~~~~~LG~GsfGtVy~a~~~~-g~~VAVK~l~~~~~~------~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~E 450 (805)
|.+.+.||+|.-|+||++...+ +..+|+|++.+.... .+..| +++++.++||.+..||+.++.+++.|||||
T Consensus 79 f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE-~eIL~~lDHPFlPTLYa~fet~~~~cl~me 157 (459)
T KOG0610|consen 79 FRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTE-REILSLLDHPFLPTLYASFETDKYSCLVME 157 (459)
T ss_pred HHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHH-HHHHHhcCCCccchhhheeeccceeEEEEe
Confidence 4455789999999999997764 589999999764321 12222 347899999999999999999999999999
Q ss_pred cccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcce
Q 003644 451 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 530 (805)
Q Consensus 451 ~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~I 530 (805)
|| ++|+|...++.+. .+.+++..++.++.+++.||+|||-.||
T Consensus 158 yC----------pGGdL~~LrqkQp---------------------------~~~fse~~aRFYaAEvl~ALEYLHmlGi 200 (459)
T KOG0610|consen 158 YC----------PGGDLHSLRQKQP---------------------------GKRFSESAARFYAAEVLLALEYLHMLGI 200 (459)
T ss_pred cC----------CCccHHHHHhhCC---------------------------CCccchhhHHHHHHHHHHHHHHHHhhce
Confidence 55 4566665544322 3458889999999999999999999999
Q ss_pred eccCCCCceEEecCCCCceEEEeccCccccccCCC----------------------c----------c-----------
Q 003644 531 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDM----------------------S----------C----------- 567 (805)
Q Consensus 531 vHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~----------------------~----------~----------- 567 (805)
|+|||||+||||.++|+ +.|+||.|+....... . .
T Consensus 201 vYRDLKPENILvredGH--IMLsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~ 278 (459)
T KOG0610|consen 201 VYRDLKPENILVREDGH--IMLSDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASR 278 (459)
T ss_pred eeccCCcceeEEecCCc--EEeeeccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccc
Confidence 99999999999999998 7799999976542100 0 0
Q ss_pred ----------ccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHH--HHHHHhhccccccc
Q 003644 568 ----------LTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFER--DANIVKDRKDLFLV 635 (805)
Q Consensus 568 ----------~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~elltG~~~Pf~~~~~~--~~~~~~~~~~~~~~ 635 (805)
.......+||-.|+|||++.+...+.++|+|+||+++|||+.| .-||.....+ -.+++... ..++.
T Consensus 279 ~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgsAVDWWtfGIflYEmLyG-~TPFKG~~~~~Tl~NIv~~~-l~Fp~ 356 (459)
T KOG0610|consen 279 SLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGSAVDWWTFGIFLYEMLYG-TTPFKGSNNKETLRNIVGQP-LKFPE 356 (459)
T ss_pred cchhhhcCCCCccccccccccccccceeeecCCCCchhhHHHHHHHHHHHHhC-CCCcCCCCchhhHHHHhcCC-CcCCC
Confidence 0112345799999999999999999999999999999999997 6677554332 23444333 22332
Q ss_pred --cCChHHHHHHHHhcCCCCCCCCC----hhhhhcCccccccccc
Q 003644 636 --EHIPEAVDLFTRLLDPNPDLRPK----AQNVLNHPFFWTADTR 674 (805)
Q Consensus 636 --~~~~~~~dLi~~~L~~dP~~Rps----~~ell~Hpff~~~~~~ 674 (805)
..+..++|||+++|.+||.+|.. |+||.+||||...++.
T Consensus 357 ~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~HpFF~gVnWa 401 (459)
T KOG0610|consen 357 EPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRHPFFEGVNWA 401 (459)
T ss_pred CCcchhHHHHHHHHHhccChhhhhccccchHHhhcCccccCCChh
Confidence 33468999999999999999998 9999999999887765
|
|
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=346.82 Aligned_cols=246 Identities=22% Similarity=0.307 Sum_probs=189.4
Q ss_pred ceEEEeEeeccCCceEEEEEEee-CCcEEEEEEeecCCchHHHHHHHHHHHhCCCCCeeeecccccCCceEEEecccccC
Q 003644 376 KLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTC 454 (805)
Q Consensus 376 ~~~~~~~~LG~GsfGtVy~a~~~-~g~~VAVK~l~~~~~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~E~~~~ 454 (805)
..|.+.+.||+|+||+||++... +++.||+|..... ....|+. ++..++||||+++++++.+.+..|+|+|++.+
T Consensus 66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~---~~~~E~~-~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 141 (357)
T PHA03209 66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG---TTLIEAM-LLQNVNHPSVIRMKDTLVSGAITCMVLPHYSS 141 (357)
T ss_pred cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc---ccHHHHH-HHHhCCCCCCcChhheEEeCCeeEEEEEccCC
Confidence 34888899999999999998554 5788999975443 2345654 77889999999999999999999999997766
Q ss_pred ChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcceeccC
Q 003644 455 SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRD 534 (805)
Q Consensus 455 sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~IvHrD 534 (805)
+|.+++.. ....+++..++.|+.||+.||+|||+.+|+|||
T Consensus 142 ~l~~~l~~---------------------------------------~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrD 182 (357)
T PHA03209 142 DLYTYLTK---------------------------------------RSRPLPIDQALIIEKQILEGLRYLHAQRIIHRD 182 (357)
T ss_pred cHHHHHHh---------------------------------------ccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCC
Confidence 65554411 113467788899999999999999999999999
Q ss_pred CCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCC
Q 003644 535 LKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP 614 (805)
Q Consensus 535 LKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~elltG~~~P 614 (805)
|||+|||++.++. +||+|||+++..... .......||+.|+|||++.+..++.++|||||||++|||++++.++
T Consensus 183 lkp~Nill~~~~~--~kl~DfG~a~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 183 VKTENIFINDVDQ--VCIGDLGAAQFPVVA----PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred CCHHHEEECCCCC--EEEecCccccccccC----cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 9999999987776 899999998754322 1122345899999999999999999999999999999999987777
Q ss_pred CCCchHH-----------HHHHHhh---cccccc------------------------------ccCChHHHHHHHHhcC
Q 003644 615 YGESFER-----------DANIVKD---RKDLFL------------------------------VEHIPEAVDLFTRLLD 650 (805)
Q Consensus 615 f~~~~~~-----------~~~~~~~---~~~~~~------------------------------~~~~~~~~dLi~~~L~ 650 (805)
|...... ...++.. ....++ .....++.+||.+||+
T Consensus 257 f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~ 336 (357)
T PHA03209 257 FEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLT 336 (357)
T ss_pred ccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHc
Confidence 6542111 0011100 000000 1223467789999999
Q ss_pred CCCCCCCChhhhhcCccccc
Q 003644 651 PNPDLRPKAQNVLNHPFFWT 670 (805)
Q Consensus 651 ~dP~~Rps~~ell~Hpff~~ 670 (805)
.||.+|||+.|+++||||.+
T Consensus 337 ~dP~~Rpta~e~l~hp~f~~ 356 (357)
T PHA03209 337 FDAAMRPSAEEILNYPMFAQ 356 (357)
T ss_pred CCcccCcCHHHHhcCchhcc
Confidence 99999999999999999964
|
|
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=341.26 Aligned_cols=247 Identities=23% Similarity=0.316 Sum_probs=190.2
Q ss_pred EeeccCCceEEEEEEe-eCCcEEEEEEeecCCc------hHHHHHHHHHHHhCCCCCeeeecccccCCceEEEecccccC
Q 003644 382 KEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH------DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTC 454 (805)
Q Consensus 382 ~~LG~GsfGtVy~a~~-~~g~~VAVK~l~~~~~------~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~E~~~~ 454 (805)
+.||+|+||+||++.. .+++.||||++.+... ....+|+..+....+||||+++++++.+.+.+|+||||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~--- 77 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEY--- 77 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeC---
Confidence 3699999999999854 4678999999975321 12334554444445799999999999999999999995
Q ss_pred ChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcceeccC
Q 003644 455 SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRD 534 (805)
Q Consensus 455 sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~IvHrD 534 (805)
+.+|+|..++. +.+.+++..++.++.||+.||+|||+.+|+|||
T Consensus 78 -------~~~~~L~~~~~-----------------------------~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrD 121 (327)
T cd05617 78 -------VNGGDLMFHMQ-----------------------------RQRKLPEEHARFYAAEICIALNFLHERGIIYRD 121 (327)
T ss_pred -------CCCCcHHHHHH-----------------------------HcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccC
Confidence 45555554432 123477788899999999999999999999999
Q ss_pred CCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCC
Q 003644 535 LKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP 614 (805)
Q Consensus 535 LKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~elltG~~~P 614 (805)
|||+|||++.++. +||+|||+++...... ......+||+.|+|||++.+..++.++|||||||++|||++| .+|
T Consensus 122 lkp~Nili~~~~~--~kl~Dfg~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g-~~p 195 (327)
T cd05617 122 LKLDNVLLDADGH--IKLTDYGMCKEGLGPG---DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAG-RSP 195 (327)
T ss_pred CCHHHEEEeCCCC--EEEeccccceeccCCC---CceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhC-CCC
Confidence 9999999988876 8999999987533211 122345699999999999999999999999999999999997 778
Q ss_pred CCCc--------hHHHHHHHhhccccccccCChHHHHHHHHhcCCCCCCCCCh------hhhhcCcccccccc
Q 003644 615 YGES--------FERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKA------QNVLNHPFFWTADT 673 (805)
Q Consensus 615 f~~~--------~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dP~~Rps~------~ell~Hpff~~~~~ 673 (805)
|... .......+.......+...++.+.+++.+||+.||.+|+++ +++++||||....+
T Consensus 196 f~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~~~ 268 (327)
T cd05617 196 FDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSIDW 268 (327)
T ss_pred CCccCCCcccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCCCH
Confidence 8421 11112223333333455567889999999999999999984 69999999976543
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=332.98 Aligned_cols=248 Identities=24% Similarity=0.374 Sum_probs=205.9
Q ss_pred cccceEEEeEeeccCCceEEEEEEe-eCCcEEEEEEeecCCch------HHHHHHHHHHHhCCCCCeeeecccccCCceE
Q 003644 373 RIGKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHHD------VALKEIQNLIASDQHPNIVRWYGVESDQDFV 445 (805)
Q Consensus 373 ~i~~~~~~~~~LG~GsfGtVy~a~~-~~g~~VAVK~l~~~~~~------~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l 445 (805)
...-+|.+.+.||+|.||+|-+|.. ..|+.||||.+++.... ...+||+ +++.++||||+.+|.+|+..+.+
T Consensus 50 nlkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIe-IMSsLNHPhII~IyEVFENkdKI 128 (668)
T KOG0611|consen 50 NLKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIE-IMSSLNHPHIIQIYEVFENKDKI 128 (668)
T ss_pred chhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHH-HHhhcCCCceeehhhhhcCCceE
Confidence 3345577778899999999998854 78999999998765321 2346765 78999999999999999999999
Q ss_pred EEecccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHh
Q 003644 446 YLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHL 525 (805)
Q Consensus 446 ~LV~E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yL 525 (805)
.|||| |..+|.|++++.. .+.+++.+++.+++||+.|+.|+
T Consensus 129 vivME----------YaS~GeLYDYiSe-----------------------------r~~LsErEaRhfFRQIvSAVhYC 169 (668)
T KOG0611|consen 129 VIVME----------YASGGELYDYISE-----------------------------RGSLSEREARHFFRQIVSAVHYC 169 (668)
T ss_pred EEEEE----------ecCCccHHHHHHH-----------------------------hccccHHHHHHHHHHHHHHHHHH
Confidence 99999 7788888887743 24578889999999999999999
Q ss_pred hhcceeccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCC-CCcchHHHHHHHH
Q 003644 526 HEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ-TRAIDLFSLGCIL 604 (805)
Q Consensus 526 H~~~IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~-t~~sDVwSlGvil 604 (805)
|.++++|||||-+||||+.+++ +||+||||+..+... ....++||+|-|.+||++.+.+| ++.+|-|||||+|
T Consensus 170 HknrVvHRDLKLENILLD~N~N--iKIADFGLSNly~~~----kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLL 243 (668)
T KOG0611|consen 170 HKNRVVHRDLKLENILLDQNNN--IKIADFGLSNLYADK----KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLL 243 (668)
T ss_pred hhccceecccchhheeecCCCC--eeeeccchhhhhccc----cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHH
Confidence 9999999999999999988876 899999999887653 34567899999999999999988 5899999999999
Q ss_pred HHHHhCCCCCCCCch-HHHHHHHhhccccccccCChHHHHHHHHhcCCCCCCCCChhhhhcCccc
Q 003644 605 FFCITGGKHPYGESF-ERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 668 (805)
Q Consensus 605 ~elltG~~~Pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dP~~Rps~~ell~Hpff 668 (805)
|-|+.| ..||+... .+....+..... ...+.+.++.-||+.||-.+|++|.|..++..|-|.
T Consensus 244 YtLVyG-tMPFDG~Dhk~lvrQIs~GaY-rEP~~PSdA~gLIRwmLmVNP~RRATieDiAsHWWv 306 (668)
T KOG0611|consen 244 YTLVYG-TMPFDGRDHKRLVRQISRGAY-REPETPSDASGLIRWMLMVNPERRATIEDIASHWWV 306 (668)
T ss_pred HHHhhc-ccccCCchHHHHHHHhhcccc-cCCCCCchHHHHHHHHHhcCcccchhHHHHhhhhee
Confidence 999997 77887643 333333333322 223445689999999999999999999999999886
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=334.18 Aligned_cols=252 Identities=23% Similarity=0.336 Sum_probs=192.0
Q ss_pred ceEEEeEeeccCCceEEEEEEe-eCCcEEEEEEeecCCc----hHHHHHHHHHHHhCCCCCeeeecccccCCceEEEecc
Q 003644 376 KLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 450 (805)
Q Consensus 376 ~~~~~~~~LG~GsfGtVy~a~~-~~g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~E 450 (805)
+.|...+.||+|+||+||++.. .+++.||||++..... ....+|+. +++.++||||+++++++.+++..|+|||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~-~l~~l~h~~iv~~~~~~~~~~~~~lv~e 84 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVS-LLKDLKHANIVTLHDIVHTDKSLTLVFE 84 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHH-HHHhCCCCCcceEEEEEeeCCeEEEEEe
Confidence 3478889999999999999854 4688999999864321 23455665 6788899999999999999999999999
Q ss_pred cccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcce
Q 003644 451 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 530 (805)
Q Consensus 451 ~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~I 530 (805)
|+.++|.+++... ...+++..+..++.||+.||+|||+.||
T Consensus 85 ~~~~~l~~~~~~~---------------------------------------~~~~~~~~~~~~~~qi~~aL~~lH~~~i 125 (309)
T cd07872 85 YLDKDLKQYMDDC---------------------------------------GNIMSMHNVKIFLYQILRGLAYCHRRKV 125 (309)
T ss_pred CCCCCHHHHHHhc---------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 8876665554211 1224566778899999999999999999
Q ss_pred eccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhc-CCCCCcchHHHHHHHHHHHHh
Q 003644 531 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ-GRQTRAIDLFSLGCILFFCIT 609 (805)
Q Consensus 531 vHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~t~~sDVwSlGvil~ellt 609 (805)
+||||||+|||++.++. +||+|||+++....... ......+|+.|+|||++.+ ..++.++|||||||++|||++
T Consensus 126 vH~dlkp~Nill~~~~~--~kl~Dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~t 200 (309)
T cd07872 126 LHRDLKPQNLLINERGE--LKLADFGLARAKSVPTK---TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMAS 200 (309)
T ss_pred ecCCCCHHHEEECCCCC--EEECccccceecCCCcc---ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHh
Confidence 99999999999988776 89999999876543211 1123457899999999875 457899999999999999999
Q ss_pred CCCCCCCCchHHH-HHHHhh----------------------cccc--------ccccCChHHHHHHHHhcCCCCCCCCC
Q 003644 610 GGKHPYGESFERD-ANIVKD----------------------RKDL--------FLVEHIPEAVDLFTRLLDPNPDLRPK 658 (805)
Q Consensus 610 G~~~Pf~~~~~~~-~~~~~~----------------------~~~~--------~~~~~~~~~~dLi~~~L~~dP~~Rps 658 (805)
| .+||......+ ...+.. .... .....+++++++|.+||+.||.+|||
T Consensus 201 g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t 279 (309)
T cd07872 201 G-RPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRIS 279 (309)
T ss_pred C-CCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCC
Confidence 7 67876533211 110000 0000 01124568899999999999999999
Q ss_pred hhhhhcCcccccccc
Q 003644 659 AQNVLNHPFFWTADT 673 (805)
Q Consensus 659 ~~ell~Hpff~~~~~ 673 (805)
++|+++||||.....
T Consensus 280 ~~e~l~h~~~~~~~~ 294 (309)
T cd07872 280 AEEAMKHAYFRSLGT 294 (309)
T ss_pred HHHHhcChhhhhccc
Confidence 999999999976543
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=331.23 Aligned_cols=250 Identities=26% Similarity=0.403 Sum_probs=195.5
Q ss_pred EEEeEeeccCCceEEEEEEe-eCCcEEEEEEeecCCc------hHHHHHHHHHHHhCCCCCeeeecccccCCceEEEecc
Q 003644 378 VVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH------DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 450 (805)
Q Consensus 378 ~~~~~~LG~GsfGtVy~a~~-~~g~~VAVK~l~~~~~------~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~E 450 (805)
|...+.||+|+||+||++.. .+++.||||++..... ....+|+. ++..++||||+++++++.+++.+|+|||
T Consensus 2 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~-~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQ-ILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred ceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHH-HHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 55678899999999999854 4689999999864321 12345654 7788899999999999999999999999
Q ss_pred cccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcce
Q 003644 451 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 530 (805)
Q Consensus 451 ~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~I 530 (805)
|+.+|+|..++... ....+++..+..++.|++.||+|||+.+|
T Consensus 81 ----------~~~~~~L~~~~~~~---------------------------~~~~~~~~~~~~~~~qi~~~l~~lH~~~i 123 (285)
T cd05605 81 ----------LMNGGDLKFHIYNM---------------------------GNPGFDEERAVFYAAEITCGLEDLHRERI 123 (285)
T ss_pred ----------ccCCCcHHHHHHhc---------------------------CcCCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence 55555555544221 11346788889999999999999999999
Q ss_pred eccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHHHHHhC
Q 003644 531 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG 610 (805)
Q Consensus 531 vHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~elltG 610 (805)
+||||||+||++++++. ++|+|||++....... ......|++.|+|||++.+..++.++||||+||++|||++|
T Consensus 124 vH~dlkp~Nil~~~~~~--~~l~Dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g 197 (285)
T cd05605 124 VYRDLKPENILLDDYGH--IRISDLGLAVEIPEGE----TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEG 197 (285)
T ss_pred EecCCCHHHEEECCCCC--EEEeeCCCceecCCCC----ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHC
Confidence 99999999999987765 8999999988754321 11234689999999999988899999999999999999997
Q ss_pred CCCCCCCchHHH-----HHHHhhccccccccCChHHHHHHHHhcCCCCCCCC-----ChhhhhcCccccccc
Q 003644 611 GKHPYGESFERD-----ANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRP-----KAQNVLNHPFFWTAD 672 (805)
Q Consensus 611 ~~~Pf~~~~~~~-----~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dP~~Rp-----s~~ell~Hpff~~~~ 672 (805)
..||....... ...+......++...++.+.++|.+||+.||.+|| +++++++||||...+
T Consensus 198 -~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~ 268 (285)
T cd05605 198 -KSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTAN 268 (285)
T ss_pred -CCCCCCCchhhHHHHHHHHhhhcccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccCCC
Confidence 77886543211 11122222333445678899999999999999999 899999999996543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=328.65 Aligned_cols=246 Identities=28% Similarity=0.408 Sum_probs=185.5
Q ss_pred EEEeEeeccCCceEEEEEEe-eCCcEEEEEEeecCC-----chHHHHHHHHH--HHhCCCCCeeeecccccC-----Cce
Q 003644 378 VVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH-----HDVALKEIQNL--IASDQHPNIVRWYGVESD-----QDF 444 (805)
Q Consensus 378 ~~~~~~LG~GsfGtVy~a~~-~~g~~VAVK~l~~~~-----~~~~~~Ei~~l--l~~l~HpNIV~l~g~~~~-----~~~ 444 (805)
|.+.+.||+|+||+||++.. .+|+.||+|.+.... .....+|+..+ +..++||||+++++++.+ ...
T Consensus 2 y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~ 81 (288)
T cd07863 2 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETK 81 (288)
T ss_pred ceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCce
Confidence 66778999999999999855 468999999986432 12344555432 334589999999998764 345
Q ss_pred EEEecccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHH
Q 003644 445 VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSH 524 (805)
Q Consensus 445 l~LV~E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~y 524 (805)
.++|||++.++|.+++. .. ....+++..++.++.||+.||+|
T Consensus 82 ~~lv~e~~~~~l~~~~~-----------~~---------------------------~~~~~~~~~~~~~~~qi~~al~~ 123 (288)
T cd07863 82 VTLVFEHVDQDLRTYLD-----------KV---------------------------PPPGLPAETIKDLMRQFLRGLDF 123 (288)
T ss_pred EEEEEcccccCHHHHHH-----------hc---------------------------CCCCCCHHHHHHHHHHHHHHHHH
Confidence 89999977766555441 10 11236778889999999999999
Q ss_pred hhhcceeccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHH
Q 003644 525 LHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCIL 604 (805)
Q Consensus 525 LH~~~IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil 604 (805)
||+.||+||||||+|||++.++. +||+|||+++...... ......||..|+|||++.+..++.++|||||||++
T Consensus 124 lH~~~ivH~dikp~Nili~~~~~--~kl~dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l 197 (288)
T cd07863 124 LHANCIVHRDLKPENILVTSGGQ--VKLADFGLARIYSCQM----ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIF 197 (288)
T ss_pred HHhCCeecCCCCHHHEEECCCCC--EEECccCccccccCcc----cCCCccccccccCchHhhCCCCCCcchhhhHHHHH
Confidence 99999999999999999988876 8999999998664321 12234589999999999988999999999999999
Q ss_pred HHHHhCCCCCCCCchHHH--HHHHhhc---------c------c-----------cccccCChHHHHHHHHhcCCCCCCC
Q 003644 605 FFCITGGKHPYGESFERD--ANIVKDR---------K------D-----------LFLVEHIPEAVDLFTRLLDPNPDLR 656 (805)
Q Consensus 605 ~elltG~~~Pf~~~~~~~--~~~~~~~---------~------~-----------~~~~~~~~~~~dLi~~~L~~dP~~R 656 (805)
|||++| .+||....... ..+.... . . ........++.++|.+||+.||++|
T Consensus 198 ~~l~~g-~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 276 (288)
T cd07863 198 AEMFRR-KPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKR 276 (288)
T ss_pred HHHHhC-CcCcCCCCHHHHHHHHHHHhCCCChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccC
Confidence 999986 77775543221 1111100 0 0 0011234578999999999999999
Q ss_pred CChhhhhcCccc
Q 003644 657 PKAQNVLNHPFF 668 (805)
Q Consensus 657 ps~~ell~Hpff 668 (805)
||+.|++.||||
T Consensus 277 ~t~~~~l~hp~f 288 (288)
T cd07863 277 ISAFRALQHPFF 288 (288)
T ss_pred CCHHHHhcCCCC
Confidence 999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=340.02 Aligned_cols=275 Identities=23% Similarity=0.339 Sum_probs=189.4
Q ss_pred ceEEEeEeeccCCceEEEEEEe------eCCcEEEEEEeecCCc----hHHHHHHHHHHHhCCCCCeeeecccccCC-ce
Q 003644 376 KLVVFNKEIAKGSNGTVVLEGN------YEGRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQ-DF 444 (805)
Q Consensus 376 ~~~~~~~~LG~GsfGtVy~a~~------~~g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~-~~ 444 (805)
++|.+.+.||+|+||+||++.. .+++.||||++..... ....+|+..+....+||||++++++|.+. +.
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 86 (338)
T cd05102 7 DRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNGP 86 (338)
T ss_pred hHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCCc
Confidence 5678889999999999999853 3457899999865322 23456766444444899999999988764 46
Q ss_pred EEEecccccCChhhHHHHhcCCHHHHHhhhhccchhh----HHHHh-------------------------hhcc-----
Q 003644 445 VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLL----NEVRI-------------------------RLLP----- 490 (805)
Q Consensus 445 l~LV~E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l----~~~~~-------------------------~~~~----- 490 (805)
+|+|||||. +|+|.+++.......... ..... +..+
T Consensus 87 ~~lv~ey~~----------~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (338)
T cd05102 87 LMVIVEFCK----------YGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGS 156 (338)
T ss_pred eEEEEecCC----------CCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcc
Confidence 899999554 444444443221100000 00000 0000
Q ss_pred cccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCCCceEEecCCCCceEEEeccCccccccCCCccccc
Q 003644 491 VMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQ 570 (805)
Q Consensus 491 ~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~ 570 (805)
..........| ...+++..++.++.||+.||+|||+.+|+||||||+|||++.++. +||+|||+++........ ..
T Consensus 157 ~~~~~~~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~--~kl~DfG~a~~~~~~~~~-~~ 232 (338)
T cd05102 157 TNPPQETDDLW-KSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNV--VKICDFGLARDIYKDPDY-VR 232 (338)
T ss_pred cccchhccccc-cCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCc--EEEeecccccccccCcch-hc
Confidence 00000001112 245788899999999999999999999999999999999987765 899999999876433221 11
Q ss_pred cccccCCCCCCChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHH--HHHHHhh-ccccccccCChHHHHHHHH
Q 003644 571 NATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFER--DANIVKD-RKDLFLVEHIPEAVDLFTR 647 (805)
Q Consensus 571 ~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~elltG~~~Pf~~~~~~--~~~~~~~-~~~~~~~~~~~~~~dLi~~ 647 (805)
.....+++.|+|||++.+..++.++|||||||++|||++.+.+||...... ....+.. .....+...++++.+++.+
T Consensus 233 ~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 312 (338)
T cd05102 233 KGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENATPEIYRIMLA 312 (338)
T ss_pred ccCCCCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCCCCCHHHHHHHHH
Confidence 223346788999999999999999999999999999998558888754321 1122222 2222334456789999999
Q ss_pred hcCCCCCCCCChhhhhc
Q 003644 648 LLDPNPDLRPKAQNVLN 664 (805)
Q Consensus 648 ~L~~dP~~Rps~~ell~ 664 (805)
||+.||++|||+.|+++
T Consensus 313 cl~~dp~~RPs~~el~~ 329 (338)
T cd05102 313 CWQGDPKERPTFSALVE 329 (338)
T ss_pred HccCChhhCcCHHHHHH
Confidence 99999999999999974
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=342.37 Aligned_cols=252 Identities=26% Similarity=0.373 Sum_probs=194.5
Q ss_pred eEEEeEeeccCCceEEEEEEe-eCCcEEEEEEeecCC-----chHHHHHHHHHHHhCCCCCeeeecccccCCceEEEecc
Q 003644 377 LVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 450 (805)
Q Consensus 377 ~~~~~~~LG~GsfGtVy~a~~-~~g~~VAVK~l~~~~-----~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~E 450 (805)
.|.+.+.||+|+||+||++.. .+|+.||||++.+.. ....++++..++..++||||+++++++.+++..|+|||
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (330)
T cd05601 2 DFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVME 81 (330)
T ss_pred CceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEEC
Confidence 477889999999999999854 478999999997532 12334444557788999999999999999999999999
Q ss_pred cccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcce
Q 003644 451 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 530 (805)
Q Consensus 451 ~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~I 530 (805)
|+.+|+|.+++... ...+++..+..++.||+.||+|||+.+|
T Consensus 82 ----------~~~~~~L~~~l~~~----------------------------~~~l~~~~~~~~~~qi~~aL~~lH~~~i 123 (330)
T cd05601 82 ----------YQPGGDLLSLLNRY----------------------------EDQFDEDMAQFYLAELVLAIHSVHQMGY 123 (330)
T ss_pred ----------CCCCCCHHHHHHHh----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 45556665554321 1346777888999999999999999999
Q ss_pred eccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhh------cCCCCCcchHHHHHHHH
Q 003644 531 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLL------QGRQTRAIDLFSLGCIL 604 (805)
Q Consensus 531 vHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~------~~~~t~~sDVwSlGvil 604 (805)
+||||||+|||++.++. +||+|||++..+...... ......||+.|+|||++. ...++.++|||||||++
T Consensus 124 ~H~Dlkp~NIll~~~~~--~kL~Dfg~a~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il 199 (330)
T cd05601 124 VHRDIKPENVLIDRTGH--IKLADFGSAARLTANKMV--NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIA 199 (330)
T ss_pred EcccCchHheEECCCCC--EEeccCCCCeECCCCCce--eeecccCCccccCHHHhccccccccCCCCCcceeeccccee
Confidence 99999999999988876 899999999876533211 122346899999999987 45678999999999999
Q ss_pred HHHHhCCCCCCCCchHH-H-HHHHhhccc-ccc--ccCChHHHHHHHHhcCCCCCCCCChhhhhcCccccccc
Q 003644 605 FFCITGGKHPYGESFER-D-ANIVKDRKD-LFL--VEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTAD 672 (805)
Q Consensus 605 ~elltG~~~Pf~~~~~~-~-~~~~~~~~~-~~~--~~~~~~~~dLi~~~L~~dP~~Rps~~ell~Hpff~~~~ 672 (805)
|||++| ..||...... . ..+...... .++ ...++++.+||.+||+ ||.+||+++++++||||...+
T Consensus 200 ~el~~g-~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~~~ 270 (330)
T cd05601 200 YEMIYG-RSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSKID 270 (330)
T ss_pred eeeccC-CCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCCCC
Confidence 999997 6787654322 2 222222111 111 2356789999999998 999999999999999997543
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-38 Score=341.70 Aligned_cols=245 Identities=28% Similarity=0.409 Sum_probs=192.4
Q ss_pred EeeccCCceEEEEEEe----eCCcEEEEEEeecCC-----chHHHHHHHHHHHhCCCCCeeeecccccCCceEEEecccc
Q 003644 382 KEIAKGSNGTVVLEGN----YEGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERC 452 (805)
Q Consensus 382 ~~LG~GsfGtVy~a~~----~~g~~VAVK~l~~~~-----~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~E~~ 452 (805)
+.||+|+||+||++.. .+|+.||||++.+.. .....+|+. ++..++||||+++++++.+++..|+|||
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e-- 78 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERD-ILAEVNHPFIVKLHYAFQTEGKLYLILD-- 78 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHH-HHHhCCCCCcccEEEEEEcCCEEEEEEc--
Confidence 5699999999998753 468999999997532 122334554 7788999999999999999999999999
Q ss_pred cCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcceec
Q 003644 453 TCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIH 532 (805)
Q Consensus 453 ~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~IvH 532 (805)
|+.+|+|.+++.. ...+++..++.++.||+.||+|||+.+|+|
T Consensus 79 --------~~~~~~L~~~l~~-----------------------------~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H 121 (318)
T cd05582 79 --------FLRGGDLFTRLSK-----------------------------EVMFTEEDVKFYLAELALALDHLHSLGIIY 121 (318)
T ss_pred --------CCCCCcHHHHHHH-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCEec
Confidence 4455565554422 134677888999999999999999999999
Q ss_pred cCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHHHHHhCCC
Q 003644 533 RDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGK 612 (805)
Q Consensus 533 rDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~elltG~~ 612 (805)
|||||+|||++.++. +||+|||+++...... .......||+.|+|||++.+..++.++|||||||++|||++| .
T Consensus 122 ~dlkp~Nil~~~~~~--~kL~Dfg~~~~~~~~~---~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg-~ 195 (318)
T cd05582 122 RDLKPENILLDEEGH--IKLTDFGLSKESIDHE---KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG-S 195 (318)
T ss_pred CCCCHHHeEECCCCc--EEEeeccCCcccCCCC---CceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccC-C
Confidence 999999999988776 8999999987654321 122345689999999999988899999999999999999997 7
Q ss_pred CCCCCchHHH-HHHHhhccccccccCChHHHHHHHHhcCCCCCCCCC-----hhhhhcCccccccc
Q 003644 613 HPYGESFERD-ANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPK-----AQNVLNHPFFWTAD 672 (805)
Q Consensus 613 ~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dP~~Rps-----~~ell~Hpff~~~~ 672 (805)
.||....... ...+.......+...++++.++|++||+.||++||+ +.++++||||....
T Consensus 196 ~p~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~~~~~~ 261 (318)
T cd05582 196 LPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFSTID 261 (318)
T ss_pred CCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCCCCcCCCC
Confidence 7886543322 222222223344556789999999999999999999 56799999997654
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=344.33 Aligned_cols=244 Identities=28% Similarity=0.405 Sum_probs=185.9
Q ss_pred EEEeEeeccCCceEEEEEEe-eCCcEEEEEEeecCCch----HHHHHHHHHHHhCCCCCeeeecccccCCceEEEecccc
Q 003644 378 VVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERC 452 (805)
Q Consensus 378 ~~~~~~LG~GsfGtVy~a~~-~~g~~VAVK~l~~~~~~----~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~E~~ 452 (805)
|...+.||+|+||+||++.. .+|+.||||++...... ...+|+. ++..++|+||+++++++.+++.+|+|||||
T Consensus 76 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~-~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 154 (353)
T PLN00034 76 LERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIE-ILRDVNHPNVVKCHDMFDHNGEIQVLLEFM 154 (353)
T ss_pred HhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHH-HHHhCCCCCcceeeeEeccCCeEEEEEecC
Confidence 34557899999999999854 46899999998654332 2344554 678899999999999999999999999955
Q ss_pred cCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcceec
Q 003644 453 TCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIH 532 (805)
Q Consensus 453 ~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~IvH 532 (805)
.+|+|... ....+..+..++.||+.||+|||+.+|+|
T Consensus 155 ----------~~~~L~~~---------------------------------~~~~~~~~~~i~~qi~~aL~~LH~~~ivH 191 (353)
T PLN00034 155 ----------DGGSLEGT---------------------------------HIADEQFLADVARQILSGIAYLHRRHIVH 191 (353)
T ss_pred ----------CCCccccc---------------------------------ccCCHHHHHHHHHHHHHHHHHHHHCCEee
Confidence 44554321 01234456789999999999999999999
Q ss_pred cCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhc-----CCCCCcchHHHHHHHHHHH
Q 003644 533 RDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ-----GRQTRAIDLFSLGCILFFC 607 (805)
Q Consensus 533 rDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~-----~~~t~~sDVwSlGvil~el 607 (805)
|||||+|||++.++. +||+|||+++.+.... .......||..|+|||++.. ...+.++|||||||++|||
T Consensus 192 rDlkp~NIll~~~~~--~kL~DfG~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el 266 (353)
T PLN00034 192 RDIKPSNLLINSAKN--VKIADFGVSRILAQTM---DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEF 266 (353)
T ss_pred cCCCHHHEEEcCCCC--EEEcccccceeccccc---ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHH
Confidence 999999999988776 8999999998765321 11234569999999998743 2345689999999999999
Q ss_pred HhCCCCCCCCchHHH-----HHHHhhccccccccCChHHHHHHHHhcCCCCCCCCChhhhhcCcccccc
Q 003644 608 ITGGKHPYGESFERD-----ANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTA 671 (805)
Q Consensus 608 ltG~~~Pf~~~~~~~-----~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dP~~Rps~~ell~Hpff~~~ 671 (805)
++| +.||......+ ..+............++++++||.+||+.||++||++.|+++||||...
T Consensus 267 ~~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~ 334 (353)
T PLN00034 267 YLG-RFPFGVGRQGDWASLMCAICMSQPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPFILRA 334 (353)
T ss_pred HhC-CCCCCCCCCccHHHHHHHHhccCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCcccccC
Confidence 997 77886322111 1111112222334556799999999999999999999999999999664
|
|
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=347.76 Aligned_cols=252 Identities=25% Similarity=0.356 Sum_probs=191.4
Q ss_pred eEEEeEeeccCCceEEEEEEe-eCCcEEEEEEeecCC------chHHHHHHHHHHHhCCCCCeeeecccccCCceEEEec
Q 003644 377 LVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH------HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSL 449 (805)
Q Consensus 377 ~~~~~~~LG~GsfGtVy~a~~-~~g~~VAVK~l~~~~------~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~ 449 (805)
.|.+.+.||+|+||+||++.. .+++.||||++.+.. .....+|+ .++..++||||+++++++.+++.+|+||
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~-~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAER-DILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHH-HHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 477889999999999999854 568999999986421 12233454 4778899999999999999999999999
Q ss_pred ccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcc
Q 003644 450 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG 529 (805)
Q Consensus 450 E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~ 529 (805)
||| .+|+|.+++.. ...+++..+..++.||+.||+|||+.+
T Consensus 81 E~~----------~~g~L~~~i~~-----------------------------~~~~~~~~~~~~~~qi~~al~~lH~~~ 121 (376)
T cd05598 81 DYI----------PGGDMMSLLIR-----------------------------LGIFEEDLARFYIAELTCAIESVHKMG 121 (376)
T ss_pred eCC----------CCCcHHHHHHh-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 955 45555554422 133566778899999999999999999
Q ss_pred eeccCCCCceEEecCCCCceEEEeccCccccccCCCc----------------------------------------ccc
Q 003644 530 LIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMS----------------------------------------CLT 569 (805)
Q Consensus 530 IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~----------------------------------------~~~ 569 (805)
|+||||||+|||++.++. +||+|||++..+..... ...
T Consensus 122 ivHrDlkp~Nill~~~~~--ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (376)
T cd05598 122 FIHRDIKPDNILIDRDGH--IKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRC 199 (376)
T ss_pred eEeCCCCHHHEEECCCCC--EEEEeCCCCccccccccccccccccccccccccccccccccccccccchhhhhhhhcccc
Confidence 999999999999988876 89999999753310000 000
Q ss_pred ccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHH--HHHhhcccc---ccccCChHHHHH
Q 003644 570 QNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERDA--NIVKDRKDL---FLVEHIPEAVDL 644 (805)
Q Consensus 570 ~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~elltG~~~Pf~~~~~~~~--~~~~~~~~~---~~~~~~~~~~dL 644 (805)
.....+||+.|+|||++.+..++.++|||||||++|||++| .+||........ .+....... .....++++.++
T Consensus 200 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell~G-~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 278 (376)
T cd05598 200 LAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVG-QPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDL 278 (376)
T ss_pred cccccCCCccccCHHHHcCCCCCcceeeeeccceeeehhhC-CCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHH
Confidence 01234699999999999999999999999999999999997 778866543322 222222111 122456899999
Q ss_pred HHHhcCCCCCCCC---ChhhhhcCccccccc
Q 003644 645 FTRLLDPNPDLRP---KAQNVLNHPFFWTAD 672 (805)
Q Consensus 645 i~~~L~~dP~~Rp---s~~ell~Hpff~~~~ 672 (805)
|.+|+ .+|.+|+ ++.++++||||...+
T Consensus 279 i~~l~-~~p~~R~~~~t~~ell~h~~~~~~~ 308 (376)
T cd05598 279 ILRLC-CGAEDRLGKNGADEIKAHPFFKGID 308 (376)
T ss_pred HHHHh-cCHhhcCCCCCHHHHhCCCCcCCCC
Confidence 99976 5999999 999999999997644
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=344.45 Aligned_cols=248 Identities=24% Similarity=0.393 Sum_probs=189.4
Q ss_pred EEEeEeeccCCceEEEEEEe-eCCcEEEEEEeecCCc-----hHHHHHHHHHHHhCCCCCeeeecccccCCc-----eEE
Q 003644 378 VVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH-----DVALKEIQNLIASDQHPNIVRWYGVESDQD-----FVY 446 (805)
Q Consensus 378 ~~~~~~LG~GsfGtVy~a~~-~~g~~VAVK~l~~~~~-----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~-----~l~ 446 (805)
|...+.||+|+||+||++.. .+|+.||||++..... ....+|+. ++..++||||+++++++.+.+ ..|
T Consensus 2 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 2 VEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELK-MLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHH-HHHhCCCCCcCCHhheecCCCccccceEE
Confidence 45668899999999999864 5799999999864321 23455665 677889999999999998876 789
Q ss_pred EecccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhh
Q 003644 447 LSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH 526 (805)
Q Consensus 447 LV~E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH 526 (805)
+|+||+.++|.+.+. ....+++..++.++.||+.||+|||
T Consensus 81 lv~e~~~~~l~~~~~----------------------------------------~~~~l~~~~~~~~~~qi~~aL~~LH 120 (372)
T cd07853 81 VVTELMQSDLHKIIV----------------------------------------SPQPLSSDHVKVFLYQILRGLKYLH 120 (372)
T ss_pred EEeeccccCHHHHHh----------------------------------------cCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 999977665554431 1134667788999999999999999
Q ss_pred hcceeccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcC-CCCCcchHHHHHHHHH
Q 003644 527 EIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG-RQTRAIDLFSLGCILF 605 (805)
Q Consensus 527 ~~~IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~t~~sDVwSlGvil~ 605 (805)
+.+|+||||||+|||++.++. +||+|||+++....... .......+|+.|+|||++.+. .++.++|||||||++|
T Consensus 121 ~~~ivH~dlkp~Nili~~~~~--~kL~Dfg~a~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~ 196 (372)
T cd07853 121 SAGILHRDIKPGNLLVNSNCV--LKICDFGLARVEEPDES--KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFA 196 (372)
T ss_pred hCCeeCCCCChHHEEECCCCC--EEeccccceeecccCcc--ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHH
Confidence 999999999999999988765 89999999986543211 112234578999999999874 4789999999999999
Q ss_pred HHHhCCCCCCCCchHHH-HHHHh-----------------------hccc---------cccccCChHHHHHHHHhcCCC
Q 003644 606 FCITGGKHPYGESFERD-ANIVK-----------------------DRKD---------LFLVEHIPEAVDLFTRLLDPN 652 (805)
Q Consensus 606 elltG~~~Pf~~~~~~~-~~~~~-----------------------~~~~---------~~~~~~~~~~~dLi~~~L~~d 652 (805)
||++| ++||....... ...+. .... ......++++.+||.+||+.|
T Consensus 197 el~~g-~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~d 275 (372)
T cd07853 197 ELLGR-RILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFD 275 (372)
T ss_pred HHHcC-CCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCC
Confidence 99997 77886533211 11000 0000 011234578999999999999
Q ss_pred CCCCCChhhhhcCcccccc
Q 003644 653 PDLRPKAQNVLNHPFFWTA 671 (805)
Q Consensus 653 P~~Rps~~ell~Hpff~~~ 671 (805)
|.+|||+.|+++||||...
T Consensus 276 P~~R~t~~e~l~hp~~~~~ 294 (372)
T cd07853 276 PDKRISAADALAHPYLDEG 294 (372)
T ss_pred hhhCcCHHHHhcCHhhCCC
Confidence 9999999999999999764
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=350.68 Aligned_cols=250 Identities=20% Similarity=0.258 Sum_probs=184.3
Q ss_pred ccceEEEeEeeccCCceEEEEEEe-eCCcEEEEEEeecCC--chHHHHHHHHHHHh------CCCCCeeeecccccCC-c
Q 003644 374 IGKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH--HDVALKEIQNLIAS------DQHPNIVRWYGVESDQ-D 443 (805)
Q Consensus 374 i~~~~~~~~~LG~GsfGtVy~a~~-~~g~~VAVK~l~~~~--~~~~~~Ei~~ll~~------l~HpNIV~l~g~~~~~-~ 443 (805)
..+.|.+.+.||+|+||+||++.. ..++.||||+++... ......|+. ++.. ..|++|+++++++..+ +
T Consensus 127 ~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~-~l~~l~~~~~~~~~~i~~i~~~~~~~~~ 205 (467)
T PTZ00284 127 STQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQ-FMEKVRQADPADRFPLMKIQRYFQNETG 205 (467)
T ss_pred CCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHH-HHHHHhhcCcccCcceeeeEEEEEcCCc
Confidence 356799999999999999999854 468899999986431 122233443 2333 3456799999988754 5
Q ss_pred eEEEecccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHH
Q 003644 444 FVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLS 523 (805)
Q Consensus 444 ~l~LV~E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~ 523 (805)
+.|+|||++.++|.+++. +.+.+++..+..|+.||+.||+
T Consensus 206 ~~~iv~~~~g~~l~~~l~----------------------------------------~~~~l~~~~~~~i~~qi~~aL~ 245 (467)
T PTZ00284 206 HMCIVMPKYGPCLLDWIM----------------------------------------KHGPFSHRHLAQIIFQTGVALD 245 (467)
T ss_pred eEEEEEeccCCCHHHHHH----------------------------------------HcCCCCHHHHHHHHHHHHHHHH
Confidence 789999977666655442 1134667788999999999999
Q ss_pred Hhhh-cceeccCCCCceEEecCCCC--------------ceEEEeccCccccccCCCccccccccccCCCCCCChhhhhc
Q 003644 524 HLHE-IGLIHRDLKPQNVLISKDKS--------------FCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ 588 (805)
Q Consensus 524 yLH~-~~IvHrDLKp~NILl~~~~~--------------~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~ 588 (805)
|||+ .|||||||||+|||++.++. ..+||+|||++..... .....+||+.|+|||++.+
T Consensus 246 yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~------~~~~~~gt~~Y~APE~~~~ 319 (467)
T PTZ00284 246 YFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDERH------SRTAIVSTRHYRSPEVVLG 319 (467)
T ss_pred HHHhcCCeecCCCCHHHEEEecCCcccccccccccCCCCceEEECCCCccccCcc------ccccccCCccccCcHHhhc
Confidence 9998 59999999999999976543 2489999998764321 1234579999999999999
Q ss_pred CCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH-HHHHhhcc------------------------cc-----------
Q 003644 589 GRQTRAIDLFSLGCILFFCITGGKHPYGESFERD-ANIVKDRK------------------------DL----------- 632 (805)
Q Consensus 589 ~~~t~~sDVwSlGvil~elltG~~~Pf~~~~~~~-~~~~~~~~------------------------~~----------- 632 (805)
..++.++|||||||++|||++| ++||......+ ...+.... ..
T Consensus 320 ~~~~~~~DiwSlGvil~elltG-~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 398 (467)
T PTZ00284 320 LGWMYSTDMWSMGCIIYELYTG-KLLYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLAR 398 (467)
T ss_pred CCCCcHHHHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHh
Confidence 9999999999999999999997 77886533211 11100000 00
Q ss_pred -------ccccCChHHHHHHHHhcCCCCCCCCChhhhhcCcccccc
Q 003644 633 -------FLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTA 671 (805)
Q Consensus 633 -------~~~~~~~~~~dLi~~~L~~dP~~Rps~~ell~Hpff~~~ 671 (805)
......+.++|||.+||+.||++|||++|+|+||||...
T Consensus 399 ~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~Hp~~~~~ 444 (467)
T PTZ00284 399 IARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTHPYVLKY 444 (467)
T ss_pred hhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhcCcccccc
Confidence 000012467899999999999999999999999999653
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=341.60 Aligned_cols=247 Identities=26% Similarity=0.379 Sum_probs=187.2
Q ss_pred ccceEEEeEeeccCCceEEEEEEe-eCCcEEEEEEeecCCc-----hHHHHHHHHHHHhCCCCCeeeecccccCC-----
Q 003644 374 IGKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH-----DVALKEIQNLIASDQHPNIVRWYGVESDQ----- 442 (805)
Q Consensus 374 i~~~~~~~~~LG~GsfGtVy~a~~-~~g~~VAVK~l~~~~~-----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~----- 442 (805)
+.++|...+.||+|+||.||++.. ..++.||||++..... ....+|+. +++.++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELV-LMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHH-HHHHhCCCchhceeeeeeccccccc
Confidence 346688899999999999999854 4689999999864321 23445654 67888999999999987643
Q ss_pred -ceEEEecccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHH
Q 003644 443 -DFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSG 521 (805)
Q Consensus 443 -~~l~LV~E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~g 521 (805)
...|+|||+|+++|.+.+. ..+++..+..++.|++.|
T Consensus 94 ~~~~~lv~e~~~~~l~~~~~------------------------------------------~~l~~~~~~~~~~qi~~a 131 (355)
T cd07874 94 FQDVYLVMELMDANLCQVIQ------------------------------------------MELDHERMSYLLYQMLCG 131 (355)
T ss_pred cceeEEEhhhhcccHHHHHh------------------------------------------hcCCHHHHHHHHHHHHHH
Confidence 3579999977665544331 124556678899999999
Q ss_pred HHHhhhcceeccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHH
Q 003644 522 LSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLG 601 (805)
Q Consensus 522 L~yLH~~~IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlG 601 (805)
|+|||+.||+||||||+|||++.++. +||+|||+++..... .......||+.|+|||++.+..++.++||||||
T Consensus 132 L~~LH~~givHrDikp~Nill~~~~~--~kl~Dfg~~~~~~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG 205 (355)
T cd07874 132 IKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTS----FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVG 205 (355)
T ss_pred HHHHHhCCcccCCCChHHEEECCCCC--EEEeeCcccccCCCc----cccCCccccCCccCHHHHcCCCCCchhhHHHHH
Confidence 99999999999999999999988776 899999999865432 112334689999999999998999999999999
Q ss_pred HHHHHHHhCCCCCCCCchHHHH--HHH----------------------hhccc-------------------cccccCC
Q 003644 602 CILFFCITGGKHPYGESFERDA--NIV----------------------KDRKD-------------------LFLVEHI 638 (805)
Q Consensus 602 vil~elltG~~~Pf~~~~~~~~--~~~----------------------~~~~~-------------------~~~~~~~ 638 (805)
|++|+|++| +.||........ ..+ ..... .......
T Consensus 206 ~il~el~~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (355)
T cd07874 206 CIMGEMVRH-KILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKA 284 (355)
T ss_pred HHHHHHHhC-CCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccc
Confidence 999999997 677754321110 000 00000 0001123
Q ss_pred hHHHHHHHHhcCCCCCCCCChhhhhcCccccc
Q 003644 639 PEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWT 670 (805)
Q Consensus 639 ~~~~dLi~~~L~~dP~~Rps~~ell~Hpff~~ 670 (805)
.++++||.+||+.||++|||+.|+++||||..
T Consensus 285 ~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~ 316 (355)
T cd07874 285 SQARDLLSKMLVIDPAKRISVDEALQHPYINV 316 (355)
T ss_pred hHHHHHHHHHhcCCchhcCCHHHHhcCcchhc
Confidence 56899999999999999999999999999953
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=324.48 Aligned_cols=244 Identities=34% Similarity=0.550 Sum_probs=189.2
Q ss_pred EEEeEeeccCCceEEEEEEee-CCcEEEEEEeecCCchHHH-----HHHHHHHHhCCCCCeeeecccccCCceEEEeccc
Q 003644 378 VVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHHDVAL-----KEIQNLIASDQHPNIVRWYGVESDQDFVYLSLER 451 (805)
Q Consensus 378 ~~~~~~LG~GsfGtVy~a~~~-~g~~VAVK~l~~~~~~~~~-----~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~E~ 451 (805)
|++.+.||+|+||+||++... +++.||+|++......... +|+. .+..++||||+++++++.+.+..++|||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~-~~~~l~~~~i~~~~~~~~~~~~~~~v~~~ 79 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIK-ILRRLRHPNIVQILDVFQDDNYLYIVMEY 79 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHH-HHHHHTBTTBCHEEEEEEESSEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhh-ccccccccccccccccccccccccccccc
Confidence 567899999999999998554 5678999999876543332 2444 66677999999999999999999999997
Q ss_pred ccC-ChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcce
Q 003644 452 CTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 530 (805)
Q Consensus 452 ~~~-sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~I 530 (805)
|.+ +|.+++. +...+++..++.++.||++||+|||+.+|
T Consensus 80 ~~~~~L~~~l~----------------------------------------~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i 119 (260)
T PF00069_consen 80 CPGGSLQDYLQ----------------------------------------KNKPLSEEEILKIAYQILEALAYLHSKGI 119 (260)
T ss_dssp ETTEBHHHHHH----------------------------------------HHSSBBHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred ccccccccccc----------------------------------------ccccccccccccccccccccccccccccc
Confidence 765 5555442 12345677889999999999999999999
Q ss_pred eccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhh-cCCCCCcchHHHHHHHHHHHHh
Q 003644 531 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLL-QGRQTRAIDLFSLGCILFFCIT 609 (805)
Q Consensus 531 vHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~-~~~~t~~sDVwSlGvil~ellt 609 (805)
+||||||+||+++.++. ++|+|||++...... ........++..|+|||++. ...++.++||||||+++|+|++
T Consensus 120 ~H~dikp~NIl~~~~~~--~~l~Dfg~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~ 194 (260)
T PF00069_consen 120 VHRDIKPENILLDENGE--VKLIDFGSSVKLSEN---NENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLT 194 (260)
T ss_dssp EESSBSGGGEEESTTSE--EEESSGTTTEESTST---TSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccc--ccccccccccccccc---ccccccccccccccccccccccccccccccccccccccccccc
Confidence 99999999999987765 799999998764211 12234456899999999998 7788999999999999999999
Q ss_pred CCCCCCCCch-HHHHHHH----hhcccc-c--cccCChHHHHHHHHhcCCCCCCCCChhhhhcCccc
Q 003644 610 GGKHPYGESF-ERDANIV----KDRKDL-F--LVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 668 (805)
Q Consensus 610 G~~~Pf~~~~-~~~~~~~----~~~~~~-~--~~~~~~~~~dLi~~~L~~dP~~Rps~~ell~Hpff 668 (805)
| ..||.... ....... ...... . .....+++.++|.+||+.||++||++.++++||||
T Consensus 195 ~-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 195 G-KLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELRDLIKKMLSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp S-SSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred c-ccccccccchhhhhhhhhcccccccccccccchhHHHHHHHHHHHccCChhHCcCHHHHhcCCCC
Confidence 7 66777651 1111111 111100 0 11112789999999999999999999999999997
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=343.46 Aligned_cols=253 Identities=23% Similarity=0.351 Sum_probs=192.3
Q ss_pred eEEEeEeeccCCceEEEEEEe-eCCcEEEEEEeecCC-----c-hHHHHHHHHHHHhCCCCCeeeecccccCCceEEEec
Q 003644 377 LVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH-----H-DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSL 449 (805)
Q Consensus 377 ~~~~~~~LG~GsfGtVy~a~~-~~g~~VAVK~l~~~~-----~-~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~ 449 (805)
.|.+.+.||+|+||+||++.. .+++.||||++.... . ....+|+ .++..++||||+++++++.+++.+|+||
T Consensus 2 ~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~-~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAER-DILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHH-HHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 467789999999999999854 468999999986431 1 1222343 4677889999999999999999999999
Q ss_pred ccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcc
Q 003644 450 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG 529 (805)
Q Consensus 450 E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~ 529 (805)
| |+++|+|.+++.. ...+++..++.++.|++.||+|||+.|
T Consensus 81 E----------~~~gg~L~~~l~~-----------------------------~~~l~~~~~~~~~~qi~~~L~~lH~~g 121 (360)
T cd05627 81 E----------FLPGGDMMTLLMK-----------------------------KDTLSEEATQFYIAETVLAIDAIHQLG 121 (360)
T ss_pred e----------CCCCccHHHHHHh-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 9 4455566555422 234677788999999999999999999
Q ss_pred eeccCCCCceEEecCCCCceEEEeccCccccccCCCcc--------------------------------ccccccccCC
Q 003644 530 LIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSC--------------------------------LTQNATGYGS 577 (805)
Q Consensus 530 IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~--------------------------------~~~~~~~~gt 577 (805)
|+||||||+|||++.++. +||+|||+++.+...... .......+||
T Consensus 122 ivHrDLkp~NIli~~~~~--vkL~DfG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 199 (360)
T cd05627 122 FIHRDIKPDNLLLDAKGH--VKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGT 199 (360)
T ss_pred eEccCCCHHHEEECCCCC--EEEeeccCCcccccccccccccccccCCcccccccccccccccccccccccccccccCCC
Confidence 999999999999988776 899999998765321100 0001234699
Q ss_pred CCCCChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH--HHHHhhcc-ccccc--cCChHHHHHHHHhcCCC
Q 003644 578 SGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERD--ANIVKDRK-DLFLV--EHIPEAVDLFTRLLDPN 652 (805)
Q Consensus 578 ~~y~APE~l~~~~~t~~sDVwSlGvil~elltG~~~Pf~~~~~~~--~~~~~~~~-~~~~~--~~~~~~~dLi~~~L~~d 652 (805)
+.|+|||++.+..++.++|||||||++|||++| .+||....... ..+..... ..++. ..+++++++|.+|+. |
T Consensus 200 ~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG-~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~ 277 (360)
T cd05627 200 PDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG-YPPFCSETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCT-D 277 (360)
T ss_pred ccccCHHHHcCCCCCCcceeccccceeeecccC-CCCCCCCCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhcc-C
Confidence 999999999999999999999999999999997 77886544322 22222111 11222 246799999999875 9
Q ss_pred CCCCCC---hhhhhcCcccccccc
Q 003644 653 PDLRPK---AQNVLNHPFFWTADT 673 (805)
Q Consensus 653 P~~Rps---~~ell~Hpff~~~~~ 673 (805)
|.+|++ ++++++||||...++
T Consensus 278 p~~R~~~~~~~ei~~hp~f~~~~~ 301 (360)
T cd05627 278 SENRIGSNGVEEIKSHPFFEGVDW 301 (360)
T ss_pred hhhcCCCCCHHHHhcCCCCCCCCH
Confidence 999984 799999999976544
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=352.29 Aligned_cols=259 Identities=24% Similarity=0.352 Sum_probs=200.1
Q ss_pred ccccceEEEeEeeccCCceEEEEEE-eeCCcEEEEEEeecCCc-----hHHHHHHHHHHHhCCCCCeeeecccccCCc--
Q 003644 372 RRIGKLVVFNKEIAKGSNGTVVLEG-NYEGRSVAVKRLVKTHH-----DVALKEIQNLIASDQHPNIVRWYGVESDQD-- 443 (805)
Q Consensus 372 ~~i~~~~~~~~~LG~GsfGtVy~a~-~~~g~~VAVK~l~~~~~-----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~-- 443 (805)
+..++.|.+.+.||+|+||+||++. ..+|+.||||++..... ....+|+. .+..++|+||++++..+...+
T Consensus 28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~-~l~~~~h~~iv~~~~~~~~~~~~ 106 (496)
T PTZ00283 28 KEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVC-CLLNCDFFSIVKCHEDFAKKDPR 106 (496)
T ss_pred cccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHH-HHhcCCCCcEEEeecceeccccc
Confidence 3445789999999999999999985 45799999999865421 12334544 567789999999988765332
Q ss_pred ------eEEEecccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHH
Q 003644 444 ------FVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRD 517 (805)
Q Consensus 444 ------~l~LV~E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~q 517 (805)
.+++||| |+.+|+|.+++..... ....+++..+..++.|
T Consensus 107 ~~~~~~~i~lV~E----------y~~~gsL~~~l~~~~~-------------------------~~~~l~e~~~~~i~~q 151 (496)
T PTZ00283 107 NPENVLMIALVLD----------YANAGDLRQEIKSRAK-------------------------TNRTFREHEAGLLFIQ 151 (496)
T ss_pred CcccceEEEEEEe----------CCCCCcHHHHHHHhhc-------------------------cCCCCCHHHHHHHHHH
Confidence 4789999 5666777666543211 1234677888999999
Q ss_pred HHHHHHHhhhcceeccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchH
Q 003644 518 IVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDL 597 (805)
Q Consensus 518 Ia~gL~yLH~~~IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDV 597 (805)
++.||+|||+.+|+||||||+|||++.++. +||+|||+++........ ......+||+.|+|||++.+..++.++||
T Consensus 152 ll~aL~~lH~~~IiHrDLKP~NILl~~~~~--vkL~DFGls~~~~~~~~~-~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DV 228 (496)
T PTZ00283 152 VLLAVHHVHSKHMIHRDIKSANILLCSNGL--VKLGDFGFSKMYAATVSD-DVGRTFCGTPYYVAPEIWRRKPYSKKADM 228 (496)
T ss_pred HHHHHHHHHhCCEecCCCCHHHEEEeCCCC--EEEEecccCeeccccccc-cccccccCCcceeCHHHhCCCCCCcHHHH
Confidence 999999999999999999999999988765 899999999876532211 12234579999999999999999999999
Q ss_pred HHHHHHHHHHHhCCCCCCCCchHHH--HHHHhhccccccccCChHHHHHHHHhcCCCCCCCCChhhhhcCccccc
Q 003644 598 FSLGCILFFCITGGKHPYGESFERD--ANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWT 670 (805)
Q Consensus 598 wSlGvil~elltG~~~Pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dP~~Rps~~ell~Hpff~~ 670 (805)
|||||++|||++| ..||....... ..+........+...++++.+++.+||+.||.+||++.++++|||+..
T Consensus 229 wSlGvilyeLltG-~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~ 302 (496)
T PTZ00283 229 FSLGVLLYELLTL-KRPFDGENMEEVMHKTLAGRYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKL 302 (496)
T ss_pred HHHHHHHHHHHHC-CCCCCCCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHH
Confidence 9999999999997 67886543322 122223333345566789999999999999999999999999999854
|
|
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=342.00 Aligned_cols=244 Identities=27% Similarity=0.341 Sum_probs=184.9
Q ss_pred eccCCceEEEEEEe-eCCcEEEEEEeecCCc------hHHHHHHHHHHHhC--CCCCeeeecccccCCceEEEecccccC
Q 003644 384 IAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH------DVALKEIQNLIASD--QHPNIVRWYGVESDQDFVYLSLERCTC 454 (805)
Q Consensus 384 LG~GsfGtVy~a~~-~~g~~VAVK~l~~~~~------~~~~~Ei~~ll~~l--~HpNIV~l~g~~~~~~~l~LV~E~~~~ 454 (805)
||+|+||+||++.. .+|+.||||++.+... .....|...+.... .||||+++++++.+.+..|+|||
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e---- 76 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTD---- 76 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEc----
Confidence 79999999999854 4689999999864321 12233443333333 79999999999999999999999
Q ss_pred ChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcceeccC
Q 003644 455 SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRD 534 (805)
Q Consensus 455 sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~IvHrD 534 (805)
|+.+|+|..++.. ...+++..++.++.||+.||+|||+.+|+|||
T Consensus 77 ------~~~~g~L~~~l~~-----------------------------~~~~~~~~~~~~~~qil~al~~LH~~~ivHrD 121 (330)
T cd05586 77 ------YMSGGELFWHLQK-----------------------------EGRFSEDRAKFYIAELVLALEHLHKYDIVYRD 121 (330)
T ss_pred ------CCCCChHHHHHHh-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecc
Confidence 5555565554421 23467788899999999999999999999999
Q ss_pred CCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcC-CCCCcchHHHHHHHHHHHHhCCCC
Q 003644 535 LKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG-RQTRAIDLFSLGCILFFCITGGKH 613 (805)
Q Consensus 535 LKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~t~~sDVwSlGvil~elltG~~~ 613 (805)
|||+|||++.++. +||+|||+++...... ......+||+.|+|||++.+. .++.++|||||||++|||++| ..
T Consensus 122 lkp~Nili~~~~~--~kl~Dfg~a~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG-~~ 195 (330)
T cd05586 122 LKPENILLDATGH--IALCDFGLSKANLTDN---KTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCG-WS 195 (330)
T ss_pred CCHHHeEECCCCC--EEEecCCcCcCCCCCC---CCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccC-CC
Confidence 9999999988776 8999999987543221 122345699999999999765 479999999999999999997 66
Q ss_pred CCCCch-HHHHHHHhhcccccc-ccCChHHHHHHHHhcCCCCCCCC----ChhhhhcCccccccc
Q 003644 614 PYGESF-ERDANIVKDRKDLFL-VEHIPEAVDLFTRLLDPNPDLRP----KAQNVLNHPFFWTAD 672 (805)
Q Consensus 614 Pf~~~~-~~~~~~~~~~~~~~~-~~~~~~~~dLi~~~L~~dP~~Rp----s~~ell~Hpff~~~~ 672 (805)
||.... ......+.......+ ...++++.++|++||+.||.+|| ++.++++||||....
T Consensus 196 Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~~~~~~ 260 (330)
T cd05586 196 PFYAEDTQQMYRNIAFGKVRFPKNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFADID 260 (330)
T ss_pred CCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCccccCCC
Confidence 765433 222222222222222 23567899999999999999998 689999999997644
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=342.47 Aligned_cols=257 Identities=23% Similarity=0.347 Sum_probs=194.5
Q ss_pred ccccceEEEeEeeccCCceEEEEEEe-eCCcEEEEEEeecCC-----chHHHHHHHHHHHhCCCCCeeeecccccCCceE
Q 003644 372 RRIGKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQDFV 445 (805)
Q Consensus 372 ~~i~~~~~~~~~LG~GsfGtVy~a~~-~~g~~VAVK~l~~~~-----~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l 445 (805)
+...+.|.+.+.||+|+||+||++.. .+++.||+|++.+.. ....+.++..++..++||||+++++++.+++..
T Consensus 39 ~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~ 118 (371)
T cd05622 39 RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYL 118 (371)
T ss_pred CcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEE
Confidence 44457789999999999999999854 468899999986421 122233444578889999999999999999999
Q ss_pred EEecccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHh
Q 003644 446 YLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHL 525 (805)
Q Consensus 446 ~LV~E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yL 525 (805)
|+||||| .+|+|.+++.. ..+++..+..++.||+.||+||
T Consensus 119 ~lv~Ey~----------~gg~L~~~~~~------------------------------~~~~~~~~~~~~~qi~~aL~~L 158 (371)
T cd05622 119 YMVMEYM----------PGGDLVNLMSN------------------------------YDVPEKWARFYTAEVVLALDAI 158 (371)
T ss_pred EEEEcCC----------CCCcHHHHHHh------------------------------cCCCHHHHHHHHHHHHHHHHHH
Confidence 9999954 45555544321 2356667788999999999999
Q ss_pred hhcceeccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCC----CCCcchHHHHH
Q 003644 526 HEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGR----QTRAIDLFSLG 601 (805)
Q Consensus 526 H~~~IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~----~t~~sDVwSlG 601 (805)
|+.+|+||||||+|||++.++. +||+|||+++....... ......+||+.|+|||++.... ++.++||||||
T Consensus 159 H~~~ivHrDLkp~NIll~~~~~--ikL~DfG~a~~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlG 234 (371)
T cd05622 159 HSMGFIHRDVKPDNMLLDKSGH--LKLADFGTCMKMNKEGM--VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVG 234 (371)
T ss_pred HHCCEEeCCCCHHHEEECCCCC--EEEEeCCceeEcCcCCc--ccccCcccCccccCHHHHhccCCCccCCCccceeehh
Confidence 9999999999999999988876 89999999987653211 1223457999999999997643 78999999999
Q ss_pred HHHHHHHhCCCCCCCCchH-HHH-HHHhhccc-ccc--ccCChHHHHHHHHhcCCCCCC--CCChhhhhcCcccccccc
Q 003644 602 CILFFCITGGKHPYGESFE-RDA-NIVKDRKD-LFL--VEHIPEAVDLFTRLLDPNPDL--RPKAQNVLNHPFFWTADT 673 (805)
Q Consensus 602 vil~elltG~~~Pf~~~~~-~~~-~~~~~~~~-~~~--~~~~~~~~dLi~~~L~~dP~~--Rps~~ell~Hpff~~~~~ 673 (805)
|++|||++| .+||..... ... .+...... .++ ...+++++++|.+||..++.+ |++++++++||||+....
T Consensus 235 vilyell~G-~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~~~ 312 (371)
T cd05622 235 VFLYEMLVG-DTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQW 312 (371)
T ss_pred HHHHHHHhC-CCCCCCCCHHHHHHHHHcCCCcccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCCCh
Confidence 999999997 677765432 222 22222111 112 245789999999999844433 789999999999976543
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-37 Score=340.10 Aligned_cols=247 Identities=25% Similarity=0.378 Sum_probs=187.9
Q ss_pred ccceEEEeEeeccCCceEEEEEEe-eCCcEEEEEEeecCC-----chHHHHHHHHHHHhCCCCCeeeecccccCC-----
Q 003644 374 IGKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQ----- 442 (805)
Q Consensus 374 i~~~~~~~~~LG~GsfGtVy~a~~-~~g~~VAVK~l~~~~-----~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~----- 442 (805)
+.++|.+.+.||+|+||.||++.. ..++.||||++.... .....+|+. +++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~-~l~~l~h~~ii~~~~~~~~~~~~~~ 100 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELV-LMKCVNHKNIIGLLNVFTPQKSLEE 100 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHH-HHHhcCCCCccccceeecccccccc
Confidence 346688899999999999999854 468899999986432 123445554 67888999999999987543
Q ss_pred -ceEEEecccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHH
Q 003644 443 -DFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSG 521 (805)
Q Consensus 443 -~~l~LV~E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~g 521 (805)
...|+||||+.++|.+.+. ..+++..+..++.|++.|
T Consensus 101 ~~~~~lv~e~~~~~l~~~~~------------------------------------------~~~~~~~~~~~~~qi~~a 138 (364)
T cd07875 101 FQDVYIVMELMDANLCQVIQ------------------------------------------MELDHERMSYLLYQMLCG 138 (364)
T ss_pred cCeEEEEEeCCCCCHHHHHH------------------------------------------hcCCHHHHHHHHHHHHHH
Confidence 3579999988766654431 124456678899999999
Q ss_pred HHHhhhcceeccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHH
Q 003644 522 LSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLG 601 (805)
Q Consensus 522 L~yLH~~~IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlG 601 (805)
|+|||+.||+||||||+|||++.++. +||+|||+++...... ......||+.|+|||++.+..++.++||||||
T Consensus 139 L~~LH~~~ivH~Dlkp~NIll~~~~~--~kL~DfG~a~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG 212 (364)
T cd07875 139 IKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSF----MMTPYVVTRYYRAPEVILGMGYKENVDIWSVG 212 (364)
T ss_pred HHHHhhCCeecCCCCHHHEEECCCCc--EEEEeCCCccccCCCC----cccCCcccCCcCCHHHHhCCCCCchhhHHhHH
Confidence 99999999999999999999988765 8999999998654321 12334689999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCCchHHH-H-HHHh----------------------hccc-------------------cccccCC
Q 003644 602 CILFFCITGGKHPYGESFERD-A-NIVK----------------------DRKD-------------------LFLVEHI 638 (805)
Q Consensus 602 vil~elltG~~~Pf~~~~~~~-~-~~~~----------------------~~~~-------------------~~~~~~~ 638 (805)
|++|||++| ..||....... . .++. .... .......
T Consensus 213 ~il~ell~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (364)
T cd07875 213 CIMGEMIKG-GVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKA 291 (364)
T ss_pred HHHHHHHhC-CCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCcccccccccccccccc
Confidence 999999997 66775432211 0 1100 0000 0000113
Q ss_pred hHHHHHHHHhcCCCCCCCCChhhhhcCccccc
Q 003644 639 PEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWT 670 (805)
Q Consensus 639 ~~~~dLi~~~L~~dP~~Rps~~ell~Hpff~~ 670 (805)
.++++||.+||+.||.+|||+.|+++||||..
T Consensus 292 ~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~ 323 (364)
T cd07875 292 SQARDLLSKMLVIDASKRISVDEALQHPYINV 323 (364)
T ss_pred HHHHHHHHHhcCcCcccCCCHHHHhcCccccc
Confidence 47899999999999999999999999999954
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-37 Score=328.78 Aligned_cols=249 Identities=25% Similarity=0.397 Sum_probs=194.3
Q ss_pred EEEeEeeccCCceEEEEEEe-eCCcEEEEEEeecCCc------hHHHHHHHHHHHhCCCCCeeeecccccCCceEEEecc
Q 003644 378 VVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH------DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 450 (805)
Q Consensus 378 ~~~~~~LG~GsfGtVy~a~~-~~g~~VAVK~l~~~~~------~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~E 450 (805)
|...+.||+|+||+||++.. .+++.||||.+..... ....+|+. ++..++|+||+++++.+.+++..|+|||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~-il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQ-ILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHH-HHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 45668899999999999754 4689999999864321 12345654 6788999999999999999999999999
Q ss_pred cccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcce
Q 003644 451 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 530 (805)
Q Consensus 451 ~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~I 530 (805)
|+.+|+|.+++... ....+++..++.++.|++.||+|||+.+|
T Consensus 81 ----------~~~g~~L~~~l~~~---------------------------~~~~l~~~~~~~~~~qi~~~l~~lH~~~i 123 (285)
T cd05630 81 ----------LMNGGDLKFHIYHM---------------------------GEAGFEEGRAVFYAAEICCGLEDLHQERI 123 (285)
T ss_pred ----------ecCCCcHHHHHHHh---------------------------cccCCCHHHHHHHHHHHHHHHHHHHhCCE
Confidence 55556665544221 12346778889999999999999999999
Q ss_pred eccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHHHHHhC
Q 003644 531 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG 610 (805)
Q Consensus 531 vHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~elltG 610 (805)
+||||||+||+++.++. ++|+|||++....... ......||..|+|||++.+..++.++|||||||++|+|++|
T Consensus 124 iH~dikp~Nil~~~~~~--~~l~Dfg~~~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g 197 (285)
T cd05630 124 VYRDLKPENILLDDHGH--IRISDLGLAVHVPEGQ----TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAG 197 (285)
T ss_pred EeCCCCHHHEEECCCCC--EEEeeccceeecCCCc----cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhC
Confidence 99999999999987765 8999999987654321 11234689999999999998999999999999999999996
Q ss_pred CCCCCCCchHH-----HHHHHhhccccccccCChHHHHHHHHhcCCCCCCCCC-----hhhhhcCcccccc
Q 003644 611 GKHPYGESFER-----DANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPK-----AQNVLNHPFFWTA 671 (805)
Q Consensus 611 ~~~Pf~~~~~~-----~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dP~~Rps-----~~ell~Hpff~~~ 671 (805)
.+||...... .................+++.+|+.+||+.||++||| ++|+++||||...
T Consensus 198 -~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~ 267 (285)
T cd05630 198 -QSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQI 267 (285)
T ss_pred -CCCCCCCCccchHHHHHhhhhhhhhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhhcc
Confidence 7788653211 1112222222334456788999999999999999999 8999999999653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-37 Score=327.34 Aligned_cols=244 Identities=24% Similarity=0.432 Sum_probs=186.9
Q ss_pred eccCCceEEEEEEe-eCCcEEEEEEeecCC------chHHHHHHHHHHHhCCCCCeeeecccccCCceEEEecccccCCh
Q 003644 384 IAKGSNGTVVLEGN-YEGRSVAVKRLVKTH------HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCSL 456 (805)
Q Consensus 384 LG~GsfGtVy~a~~-~~g~~VAVK~l~~~~------~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~E~~~~sL 456 (805)
||+|+||+||++.. .+|+.||+|++.... ......|++ ++..++||||+++++++.++...|+|||
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~-il~~l~hp~i~~~~~~~~~~~~~~lv~e------ 73 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKE-ILEKVNSPFIVNLAYAFESKTHLCLVMS------ 73 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHH-HHHhcCCCcEEEEEEEEecCCeEEEEEe------
Confidence 79999999999854 469999999986421 112334554 6788899999999999999999999999
Q ss_pred hhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCC
Q 003644 457 NDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLK 536 (805)
Q Consensus 457 ~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~IvHrDLK 536 (805)
|+.+|+|..++... ...++++..+..++.||+.||+|||+.+|+|||||
T Consensus 74 ----~~~g~~L~~~~~~~---------------------------~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dik 122 (277)
T cd05607 74 ----LMNGGDLKYHIYNV---------------------------GERGLEMERVIHYSAQITCGILHLHSMDIVYRDMK 122 (277)
T ss_pred ----cCCCCCHHHHHHhc---------------------------cccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCC
Confidence 44555555544221 12335677788999999999999999999999999
Q ss_pred CceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q 003644 537 PQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYG 616 (805)
Q Consensus 537 p~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~elltG~~~Pf~ 616 (805)
|+||+++.++. ++|+|||++....... ......|+..|+|||++.+..++.++|||||||++|||++| .+||.
T Consensus 123 p~Nili~~~~~--~~l~Dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g-~~p~~ 195 (277)
T cd05607 123 PENVLLDDQGN--CRLSDLGLAVELKDGK----TITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAG-RTPFK 195 (277)
T ss_pred hHhEEEcCCCC--EEEeeceeeeecCCCc----eeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhC-CCCCC
Confidence 99999988765 8999999988765321 11234589999999999988899999999999999999997 77886
Q ss_pred CchHH--HHHHHh----hccccccccCChHHHHHHHHhcCCCCCCCCCh----hhhhcCccccccc
Q 003644 617 ESFER--DANIVK----DRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKA----QNVLNHPFFWTAD 672 (805)
Q Consensus 617 ~~~~~--~~~~~~----~~~~~~~~~~~~~~~dLi~~~L~~dP~~Rps~----~ell~Hpff~~~~ 672 (805)
..... ...+.. ..........+++++++|.+||+.||++||++ +++++||||...+
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~h~~f~~~~ 261 (277)
T cd05607 196 DHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKTIN 261 (277)
T ss_pred CCcchhhHHHHHHHhhccccccccccCCHHHHHHHHHHhccCHhhCCCCccchhhhhcChhhcCCC
Confidence 53221 111111 11111123456889999999999999999999 6678999996643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-37 Score=352.00 Aligned_cols=255 Identities=24% Similarity=0.353 Sum_probs=198.1
Q ss_pred ceEEEeEeeccCCceEEEEEEee-C-CcEEEEEEeecCCch---HHHHHHHHHHHhCCCCCeeeecccccCCceEEEecc
Q 003644 376 KLVVFNKEIAKGSNGTVVLEGNY-E-GRSVAVKRLVKTHHD---VALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 450 (805)
Q Consensus 376 ~~~~~~~~LG~GsfGtVy~a~~~-~-g~~VAVK~l~~~~~~---~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~E 450 (805)
..|.+.+.||+|+||.||+|... + ++.||+|.+...... ...+|+ .+++.++|||||++++++.+++.+|||||
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~-~~l~~l~Hpniv~~~~~~~~~~~~~lv~E 145 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSEL-HCLAACDHFGIVKHFDDFKSDDKLLLIME 145 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHH-HHHHhCCCCCEeEEEEEEEECCEEEEEEE
Confidence 44888999999999999998543 3 678899876443322 233455 47788999999999999999999999999
Q ss_pred cccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcce
Q 003644 451 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 530 (805)
Q Consensus 451 ~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~I 530 (805)
|+.+|+|.++|.... .....+++..+..++.||+.||+|||+.+|
T Consensus 146 ----------~~~gg~L~~~l~~~~-------------------------~~~~~l~~~~~~~i~~qi~~aL~~lH~~~i 190 (478)
T PTZ00267 146 ----------YGSGGDLNKQIKQRL-------------------------KEHLPFQEYEVGLLFYQIVLALDEVHSRKM 190 (478)
T ss_pred ----------CCCCCCHHHHHHHHH-------------------------hccCCCCHHHHHHHHHHHHHHHHHHHhCCE
Confidence 555666665543211 112346777889999999999999999999
Q ss_pred eccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHHHHHhC
Q 003644 531 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG 610 (805)
Q Consensus 531 vHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~elltG 610 (805)
+||||||+|||++.++. +||+|||+++....... .......+||+.|+|||++.+..++.++|||||||++|||++|
T Consensus 191 vHrDlkp~NIll~~~~~--~kL~DFgla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg 267 (478)
T PTZ00267 191 MHRDLKSANIFLMPTGI--IKLGDFGFSKQYSDSVS-LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTL 267 (478)
T ss_pred EECCcCHHhEEECCCCc--EEEEeCcCceecCCccc-cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhC
Confidence 99999999999988775 89999999987654321 1123345699999999999999999999999999999999997
Q ss_pred CCCCCCCchHHH--HHHHhhccccccccCChHHHHHHHHhcCCCCCCCCChhhhhcCccccc
Q 003644 611 GKHPYGESFERD--ANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWT 670 (805)
Q Consensus 611 ~~~Pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dP~~Rps~~ell~Hpff~~ 670 (805)
..||....... ..+........+...++++.++|.+||+.||++||++++++.|||+..
T Consensus 268 -~~Pf~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~~ 328 (478)
T PTZ00267 268 -HRPFKGPSQREIMQQVLYGKYDPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKY 328 (478)
T ss_pred -CCCCCCCCHHHHHHHHHhCCCCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHhCHHHHH
Confidence 66776543322 122222333334456789999999999999999999999999999854
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=324.26 Aligned_cols=264 Identities=26% Similarity=0.355 Sum_probs=219.0
Q ss_pred ceEEEeEeeccCCceEEEEE-EeeCCcEEEEEEeecCCc----hHH--HHHHHHHHHhCCCCCeeeecccccCCceEEEe
Q 003644 376 KLVVFNKEIAKGSNGTVVLE-GNYEGRSVAVKRLVKTHH----DVA--LKEIQNLIASDQHPNIVRWYGVESDQDFVYLS 448 (805)
Q Consensus 376 ~~~~~~~~LG~GsfGtVy~a-~~~~g~~VAVK~l~~~~~----~~~--~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV 448 (805)
+.|.+.+.||+|.||+|.+. ...+|+.+|+|++++.-. +.+ +.|- ..+...+||.+..|-..|+..+.+|.|
T Consensus 168 ~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~-RVL~~~~HPFLt~LKYsFQt~drlCFV 246 (516)
T KOG0690|consen 168 EDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTEN-RVLQNCRHPFLTSLKYSFQTQDRLCFV 246 (516)
T ss_pred chhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHH-HHHHhccCcHHHHhhhhhccCceEEEE
Confidence 45778899999999999987 456899999999976421 111 2232 467788999999999999999999999
Q ss_pred cccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhc
Q 003644 449 LERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI 528 (805)
Q Consensus 449 ~E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~ 528 (805)
|| |..+|.|.-+|... +.+++..++.+..+|+.||.|||+.
T Consensus 247 Me----------yanGGeLf~HLsre-----------------------------r~FsE~RtRFYGaEIvsAL~YLHs~ 287 (516)
T KOG0690|consen 247 ME----------YANGGELFFHLSRE-----------------------------RVFSEDRTRFYGAEIVSALGYLHSR 287 (516)
T ss_pred EE----------EccCceEeeehhhh-----------------------------hcccchhhhhhhHHHHHHhhhhhhC
Confidence 99 88888888776443 3466777789999999999999999
Q ss_pred ceeccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHHHHH
Q 003644 529 GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCI 608 (805)
Q Consensus 529 ~IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~ell 608 (805)
+||.||||-+|.||++||+ +||+|||||+.-- .......+.||||.|+|||++....|+.++|+|.+||++|||+
T Consensus 288 ~ivYRDlKLENLlLDkDGH--IKitDFGLCKE~I---~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMm 362 (516)
T KOG0690|consen 288 NIVYRDLKLENLLLDKDGH--IKITDFGLCKEEI---KYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMM 362 (516)
T ss_pred CeeeeechhhhheeccCCc--eEeeecccchhcc---cccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHH
Confidence 9999999999999999998 8999999998543 2345567899999999999999999999999999999999999
Q ss_pred hCCCCCCCCchHHHHHHHhhccccccccCChHHHHHHHHhcCCCCCCCCC-----hhhhhcCccccccccchhhhhhccc
Q 003644 609 TGGKHPYGESFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPK-----AQNVLNHPFFWTADTRLSFLRDVSD 683 (805)
Q Consensus 609 tG~~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dP~~Rps-----~~ell~Hpff~~~~~~~~~l~~~~~ 683 (805)
+|+.|+|....+....++......++...+++++.|+..+|.+||.+|.. +.|+++|+||.+.++...+.+.+..
T Consensus 363 CGRLPFyn~dh~kLFeLIl~ed~kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~~~~~Kki~P 442 (516)
T KOG0690|consen 363 CGRLPFYNKDHEKLFELILMEDLKFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDWEATYRKKIEP 442 (516)
T ss_pred hccCcccccchhHHHHHHHhhhccCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCCHHHHHHhccCC
Confidence 98444444555555566666666788889999999999999999999964 7899999999988877666655544
Q ss_pred c
Q 003644 684 R 684 (805)
Q Consensus 684 ~ 684 (805)
.
T Consensus 443 P 443 (516)
T KOG0690|consen 443 P 443 (516)
T ss_pred C
Confidence 3
|
|
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=323.49 Aligned_cols=246 Identities=27% Similarity=0.379 Sum_probs=188.6
Q ss_pred EEEeEeeccCCceEEEEEEe-eCCcEEEEEEeecCCc-----hHHHHHHHHHHHhCCCCCeeeecccccCCceEEEeccc
Q 003644 378 VVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH-----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLER 451 (805)
Q Consensus 378 ~~~~~~LG~GsfGtVy~a~~-~~g~~VAVK~l~~~~~-----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~E~ 451 (805)
|.+.+.||+|+||+||++.. .+|+.||+|++..... ....+|+. ++..++||||+++++++.+.+..|+|+||
T Consensus 2 y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~-~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 2 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREIC-LLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred ceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHH-HHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 66778999999999999855 4689999999864321 23445665 67888999999999999999999999998
Q ss_pred ccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhccee
Q 003644 452 CTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLI 531 (805)
Q Consensus 452 ~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~Iv 531 (805)
|.++|.+++... ...+++..++.++.||+.||+|||+.+|+
T Consensus 81 ~~~~l~~~~~~~---------------------------------------~~~~~~~~~~~~~~qi~~al~~LH~~~i~ 121 (284)
T cd07839 81 CDQDLKKYFDSC---------------------------------------NGDIDPEIVKSFMFQLLKGLAFCHSHNVL 121 (284)
T ss_pred CCCCHHHHHHhc---------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCEe
Confidence 876665544211 12356778899999999999999999999
Q ss_pred ccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCC-CCCcchHHHHHHHHHHHHhC
Q 003644 532 HRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGR-QTRAIDLFSLGCILFFCITG 610 (805)
Q Consensus 532 HrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~-~t~~sDVwSlGvil~elltG 610 (805)
||||||+||+++.++. +||+|||+++....... ......+++.|+|||++.+.. ++.++|||||||++|||++|
T Consensus 122 H~dl~~~nil~~~~~~--~~l~dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg 196 (284)
T cd07839 122 HRDLKPQNLLINKNGE--LKLADFGLARAFGIPVR---CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANA 196 (284)
T ss_pred cCCCCHHHEEEcCCCc--EEECccchhhccCCCCC---CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhc
Confidence 9999999999988776 89999999986543211 112345789999999987654 68999999999999999998
Q ss_pred CCCCCCCchHHH-HH-HHhh-----------------c--c---------ccccccCChHHHHHHHHhcCCCCCCCCChh
Q 003644 611 GKHPYGESFERD-AN-IVKD-----------------R--K---------DLFLVEHIPEAVDLFTRLLDPNPDLRPKAQ 660 (805)
Q Consensus 611 ~~~Pf~~~~~~~-~~-~~~~-----------------~--~---------~~~~~~~~~~~~dLi~~~L~~dP~~Rps~~ 660 (805)
+.++|....... .. +... . . .......++++.++|.+||+.||.+|||++
T Consensus 197 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ 276 (284)
T cd07839 197 GRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAE 276 (284)
T ss_pred CCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHH
Confidence 766665432111 11 0000 0 0 001123457889999999999999999999
Q ss_pred hhhcCccc
Q 003644 661 NVLNHPFF 668 (805)
Q Consensus 661 ell~Hpff 668 (805)
++++||||
T Consensus 277 ~il~h~~f 284 (284)
T cd07839 277 EALQHPYF 284 (284)
T ss_pred HHhcCCCC
Confidence 99999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-37 Score=336.64 Aligned_cols=247 Identities=24% Similarity=0.393 Sum_probs=188.5
Q ss_pred ccceEEEeEeeccCCceEEEEEEe-eCCcEEEEEEeecCCc-----hHHHHHHHHHHHhCCCCCeeeecccccCC-----
Q 003644 374 IGKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH-----DVALKEIQNLIASDQHPNIVRWYGVESDQ----- 442 (805)
Q Consensus 374 i~~~~~~~~~LG~GsfGtVy~a~~-~~g~~VAVK~l~~~~~-----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~----- 442 (805)
+.+.|...+.||+|+||+||++.. .+++.||||++..... ....+|+. ++..++||||+++++++.+.
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~-~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELR-LLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHH-HHHhcCCCchhhhhhhhcccccccc
Confidence 446688889999999999999854 5788999999865321 23445665 67888999999999987643
Q ss_pred -ceEEEecccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHH
Q 003644 443 -DFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSG 521 (805)
Q Consensus 443 -~~l~LV~E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~g 521 (805)
...|+++|++.++|.+++. ...+++..+..++.||+.|
T Consensus 92 ~~~~~~~~~~~~~~l~~~~~-----------------------------------------~~~l~~~~~~~i~~qi~~a 130 (343)
T cd07878 92 FNEVYLVTNLMGADLNNIVK-----------------------------------------CQKLSDEHVQFLIYQLLRG 130 (343)
T ss_pred cCcEEEEeecCCCCHHHHHh-----------------------------------------cCCCCHHHHHHHHHHHHHH
Confidence 4579999977666554431 1236677889999999999
Q ss_pred HHHhhhcceeccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhc-CCCCCcchHHHH
Q 003644 522 LSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ-GRQTRAIDLFSL 600 (805)
Q Consensus 522 L~yLH~~~IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~t~~sDVwSl 600 (805)
|+|||+.+|+||||||+|||++.++. +||+|||+++..... .....||+.|+|||++.+ ..++.++|||||
T Consensus 131 L~~LH~~~ivHrdikp~Nil~~~~~~--~kl~Dfg~~~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~~Diwsl 202 (343)
T cd07878 131 LKYIHSAGIIHRDLKPSNVAVNEDCE--LRILDFGLARQADDE------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSV 202 (343)
T ss_pred HHHHHHCCeecccCChhhEEECCCCC--EEEcCCccceecCCC------cCCccccccccCchHhcCCccCCchhhhHhH
Confidence 99999999999999999999988876 899999999866432 223468999999999877 468999999999
Q ss_pred HHHHHHHHhCCCCCCCCchHHH-H-HHHhh-----------------------ccc-------cccccCChHHHHHHHHh
Q 003644 601 GCILFFCITGGKHPYGESFERD-A-NIVKD-----------------------RKD-------LFLVEHIPEAVDLFTRL 648 (805)
Q Consensus 601 Gvil~elltG~~~Pf~~~~~~~-~-~~~~~-----------------------~~~-------~~~~~~~~~~~dLi~~~ 648 (805)
||++|+|++| .+||......+ . .+... ... .......+.+.+||.+|
T Consensus 203 G~il~el~~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~m 281 (343)
T cd07878 203 GCIMAELLKG-KALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKM 281 (343)
T ss_pred HHHHHHHHHC-CCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHH
Confidence 9999999997 77775432111 0 00000 000 00112345688999999
Q ss_pred cCCCCCCCCChhhhhcCcccccc
Q 003644 649 LDPNPDLRPKAQNVLNHPFFWTA 671 (805)
Q Consensus 649 L~~dP~~Rps~~ell~Hpff~~~ 671 (805)
|+.||.+|||+.|+++||||...
T Consensus 282 L~~dp~~R~s~~ell~hp~~~~~ 304 (343)
T cd07878 282 LVLDSDKRISASEALAHPYFSQY 304 (343)
T ss_pred cCCChhhCCCHHHHhcCcchhcc
Confidence 99999999999999999999653
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=333.40 Aligned_cols=248 Identities=23% Similarity=0.351 Sum_probs=190.3
Q ss_pred ceEEEeEeeccCCceEEEEEEee-CCcEEEEEEeecCCc----hHHHHHHHHHHHhCCCCCeeeecccccCCceEEEecc
Q 003644 376 KLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 450 (805)
Q Consensus 376 ~~~~~~~~LG~GsfGtVy~a~~~-~g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~E 450 (805)
+.|.+.+.||+|+||+||++... +|..||+|.+..... ....+|+. ++..++||||++++++|.+++..|+|||
T Consensus 5 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~-~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQ-VLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHH-HHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 45778899999999999998554 688999998865422 23445554 6778899999999999999999999999
Q ss_pred cccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhc-c
Q 003644 451 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI-G 529 (805)
Q Consensus 451 ~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~-~ 529 (805)
| +.+|+|.+++.. ...+++..+..++.|++.||+|||+. +
T Consensus 84 ~----------~~~~~L~~~l~~-----------------------------~~~~~~~~~~~~~~~l~~~l~~lH~~~~ 124 (333)
T cd06650 84 H----------MDGGSLDQVLKK-----------------------------AGRIPEQILGKVSIAVIKGLTYLREKHK 124 (333)
T ss_pred c----------CCCCcHHHHHHH-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHhcCC
Confidence 4 455555554422 12356677789999999999999985 7
Q ss_pred eeccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHHHHHh
Q 003644 530 LIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCIT 609 (805)
Q Consensus 530 IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~ellt 609 (805)
|+||||||+|||++.++. +||+|||++...... ......||..|+|||++.+..++.++|||||||++|||++
T Consensus 125 ivH~dlkp~Nili~~~~~--~kL~Dfg~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~ 197 (333)
T cd06650 125 IMHRDVKPSNILVNSRGE--IKLCDFGVSGQLIDS-----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAI 197 (333)
T ss_pred EEecCCChhhEEEcCCCC--EEEeeCCcchhhhhh-----ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHH
Confidence 999999999999988776 899999998765432 1123468999999999998889999999999999999999
Q ss_pred CCCCCCCCchHHHHHHH----------------------------------------------hhccccc-cccCChHHH
Q 003644 610 GGKHPYGESFERDANIV----------------------------------------------KDRKDLF-LVEHIPEAV 642 (805)
Q Consensus 610 G~~~Pf~~~~~~~~~~~----------------------------------------------~~~~~~~-~~~~~~~~~ 642 (805)
| +.||........... ....... ....+++++
T Consensus 198 g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (333)
T cd06650 198 G-RYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQ 276 (333)
T ss_pred C-CCCCCCcchhHHHHHhcCcccCCccccccCcccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHH
Confidence 7 667754322211100 0000000 012346889
Q ss_pred HHHHHhcCCCCCCCCChhhhhcCcccccc
Q 003644 643 DLFTRLLDPNPDLRPKAQNVLNHPFFWTA 671 (805)
Q Consensus 643 dLi~~~L~~dP~~Rps~~ell~Hpff~~~ 671 (805)
+||.+||+.||++|||++|+++||||...
T Consensus 277 ~li~~~L~~~P~~Rpt~~ell~h~~~~~~ 305 (333)
T cd06650 277 DFVNKCLIKNPAERADLKQLMVHAFIKRS 305 (333)
T ss_pred HHHHHhccCCcccCcCHHHHhhCHHHhcC
Confidence 99999999999999999999999999643
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=332.06 Aligned_cols=253 Identities=25% Similarity=0.381 Sum_probs=190.5
Q ss_pred eEEEeEeeccCCceEEEEEEe-eCCcEEEEEEeecCC-----chHHHHHHHHHHHhCCCCCeeeecccccCCceEEEecc
Q 003644 377 LVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 450 (805)
Q Consensus 377 ~~~~~~~LG~GsfGtVy~a~~-~~g~~VAVK~l~~~~-----~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~E 450 (805)
.|.+.+.||+|+||+||++.. .+++.||||++.+.. ....++++..++..++||||+++++++.+++++|+|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (331)
T cd05597 2 DFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMD 81 (331)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEe
Confidence 477889999999999999864 468999999986421 12234444457778899999999999999999999999
Q ss_pred cccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcce
Q 003644 451 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 530 (805)
Q Consensus 451 ~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~I 530 (805)
|+.+|+|.+++... ...+++..+..++.||+.||+|||+.+|
T Consensus 82 ----------~~~g~~L~~~l~~~----------------------------~~~~~~~~~~~~~~qi~~~l~~lH~~~i 123 (331)
T cd05597 82 ----------YYVGGDLLTLLSKF----------------------------EDRLPEDMARFYLAEMVLAIDSVHQLGY 123 (331)
T ss_pred ----------cCCCCcHHHHHHHh----------------------------cCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 55566666554321 1236777889999999999999999999
Q ss_pred eccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhc-----CCCCCcchHHHHHHHHH
Q 003644 531 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ-----GRQTRAIDLFSLGCILF 605 (805)
Q Consensus 531 vHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~-----~~~t~~sDVwSlGvil~ 605 (805)
+||||||+|||++.++. +||+|||++..+..... .......||+.|+|||++.. ..++.++|||||||++|
T Consensus 124 vH~dlkp~Nill~~~~~--~kl~Dfg~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~ 199 (331)
T cd05597 124 VHRDIKPDNVLLDKNGH--IRLADFGSCLRLLADGT--VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMY 199 (331)
T ss_pred EECCCCHHHEEECCCCC--EEEEECCceeecCCCCC--ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHH
Confidence 99999999999988876 89999999876643221 11122459999999999873 45788999999999999
Q ss_pred HHHhCCCCCCCCchH-HHH-HHHhhcc-c---cccccCChHHHHHHHHhcCCCCCC--CCChhhhhcCccccccc
Q 003644 606 FCITGGKHPYGESFE-RDA-NIVKDRK-D---LFLVEHIPEAVDLFTRLLDPNPDL--RPKAQNVLNHPFFWTAD 672 (805)
Q Consensus 606 elltG~~~Pf~~~~~-~~~-~~~~~~~-~---~~~~~~~~~~~dLi~~~L~~dP~~--Rps~~ell~Hpff~~~~ 672 (805)
||++| ..||..... ... .+..... . ......+++++++|++||..++++ |+++.++++||||...+
T Consensus 200 el~~g-~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~~ 273 (331)
T cd05597 200 EMLYG-ETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGID 273 (331)
T ss_pred HHhhC-CCCCCCCCHHHHHHHHHcCCCcccCCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCCCC
Confidence 99997 677755332 221 2222111 1 111235678999999998765444 78999999999996543
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-38 Score=344.86 Aligned_cols=249 Identities=31% Similarity=0.462 Sum_probs=201.3
Q ss_pred eeccCCceEEEEEEee-CCcEEEEEEeecCC--chHHHHHHHHHHHhCCCCCeeeecccccCCceEEEecccccCChhhH
Q 003644 383 EIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH--HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCSLNDL 459 (805)
Q Consensus 383 ~LG~GsfGtVy~a~~~-~g~~VAVK~l~~~~--~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~E~~~~sL~d~ 459 (805)
+||+|.||+||-|+.. +...+|||.+.... ..+-+.|+..+.+.++|.|||+++|.|.+++++-|.||
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFME--------- 652 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFME--------- 652 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEee---------
Confidence 5999999999988554 56789999986443 23445565568999999999999999999999999999
Q ss_pred HHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCCCce
Q 003644 460 IYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQN 539 (805)
Q Consensus 460 iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~IvHrDLKp~N 539 (805)
..++|+|...|..+ |..-.-.+..+-.+.+||++||.|||+..|||||||-+|
T Consensus 653 -qVPGGSLSsLLrsk--------------------------WGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDN 705 (1226)
T KOG4279|consen 653 -QVPGGSLSSLLRSK--------------------------WGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDN 705 (1226)
T ss_pred -cCCCCcHHHHHHhc--------------------------cCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCc
Confidence 88899998887543 322222556778899999999999999999999999999
Q ss_pred EEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcC--CCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 003644 540 VLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG--RQTRAIDLFSLGCILFFCITGGKHPYGE 617 (805)
Q Consensus 540 ILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~--~~t~~sDVwSlGvil~elltG~~~Pf~~ 617 (805)
||++.-.. .+||+|||-++++.+-.. .+.++-||..|||||++..+ .|+.++|||||||.+.||.|| +|||-+
T Consensus 706 VLvNTySG-vlKISDFGTsKRLAginP---~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATG-rPPF~E 780 (1226)
T KOG4279|consen 706 VLVNTYSG-VLKISDFGTSKRLAGINP---CTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATG-RPPFVE 780 (1226)
T ss_pred EEEeeccc-eEEecccccchhhccCCc---cccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccC-CCCeee
Confidence 99976443 489999999998875422 23456699999999999875 488999999999999999997 889876
Q ss_pred chHHHHHHHhhc----cccccccCChHHHHHHHHhcCCCCCCCCChhhhhcCccccccc
Q 003644 618 SFERDANIVKDR----KDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTAD 672 (805)
Q Consensus 618 ~~~~~~~~~~~~----~~~~~~~~~~~~~dLi~~~L~~dP~~Rps~~ell~Hpff~~~~ 672 (805)
-...++.+.+-. ....+.+.+.+++.+|.+|+.+||..||+++++|..||.....
T Consensus 781 lgspqAAMFkVGmyKvHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~DpFlq~~~ 839 (1226)
T KOG4279|consen 781 LGSPQAAMFKVGMYKVHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQDPFLQHNN 839 (1226)
T ss_pred cCChhHhhhhhcceecCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhccCcccccCC
Confidence 554444333322 2334556677999999999999999999999999999996653
|
|
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=324.51 Aligned_cols=253 Identities=22% Similarity=0.332 Sum_probs=191.6
Q ss_pred ceEEEeEeeccCCceEEEEEEe-eCCcEEEEEEeecCC----chHHHHHHHHHHHhCCCCCeeeecccccCCceEEEecc
Q 003644 376 KLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH----HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 450 (805)
Q Consensus 376 ~~~~~~~~LG~GsfGtVy~a~~-~~g~~VAVK~l~~~~----~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~E 450 (805)
+.|.+.+.||+|+||.||++.. .+++.||+|.+.... .....+|+. ++..++||||+++++++.+.+..|+|||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~-~l~~l~h~nI~~~~~~~~~~~~~~lv~e 84 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVS-LLKDLKHANIVTLHDIIHTEKSLTLVFE 84 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHH-HHHhcCCCCcceEEEEEecCCeEEEEEe
Confidence 3578889999999999999854 468899999986432 123445654 6788899999999999999999999999
Q ss_pred cccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcce
Q 003644 451 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 530 (805)
Q Consensus 451 ~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~I 530 (805)
||.++|.+++... ...+++..+..++.||+.||+|||+.+|
T Consensus 85 ~~~~~l~~~l~~~---------------------------------------~~~~~~~~~~~~~~qi~~aL~~lH~~~i 125 (301)
T cd07873 85 YLDKDLKQYLDDC---------------------------------------GNSINMHNVKLFLFQLLRGLNYCHRRKV 125 (301)
T ss_pred ccccCHHHHHHhc---------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 7776665544211 1235567788999999999999999999
Q ss_pred eccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcC-CCCCcchHHHHHHHHHHHHh
Q 003644 531 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG-RQTRAIDLFSLGCILFFCIT 609 (805)
Q Consensus 531 vHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~t~~sDVwSlGvil~ellt 609 (805)
+||||||+|||++.++. +||+|||++........ ......+++.|+|||++.+. .++.++|||||||++|||++
T Consensus 126 ~H~dlkp~Nil~~~~~~--~kl~dfg~~~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t 200 (301)
T cd07873 126 LHRDLKPQNLLINERGE--LKLADFGLARAKSIPTK---TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMST 200 (301)
T ss_pred eCCCCCHHHEEECCCCc--EEECcCcchhccCCCCC---cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHh
Confidence 99999999999988776 89999999876542211 11233578999999998764 47889999999999999999
Q ss_pred CCCCCCCCchHHH-HHH-Hh---------------h------ccc--------cccccCChHHHHHHHHhcCCCCCCCCC
Q 003644 610 GGKHPYGESFERD-ANI-VK---------------D------RKD--------LFLVEHIPEAVDLFTRLLDPNPDLRPK 658 (805)
Q Consensus 610 G~~~Pf~~~~~~~-~~~-~~---------------~------~~~--------~~~~~~~~~~~dLi~~~L~~dP~~Rps 658 (805)
| .+||....... ... .. . ... ......++++++||.+||+.||.+|||
T Consensus 201 g-~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t 279 (301)
T cd07873 201 G-RPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRIS 279 (301)
T ss_pred C-CCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcC
Confidence 7 67776533211 100 00 0 000 001134568899999999999999999
Q ss_pred hhhhhcCccccccccc
Q 003644 659 AQNVLNHPFFWTADTR 674 (805)
Q Consensus 659 ~~ell~Hpff~~~~~~ 674 (805)
++|+++||||.....+
T Consensus 280 ~~eil~h~~f~~~~~~ 295 (301)
T cd07873 280 AEEAMKHPYFHCLGER 295 (301)
T ss_pred HHHHhcCcccccccch
Confidence 9999999999665433
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=318.34 Aligned_cols=249 Identities=31% Similarity=0.402 Sum_probs=191.6
Q ss_pred eEEEeEeeccCCceEEEEEEe-eCCcEEEEEEeecCCc--------hHHHHHHHHHHHhCCCCCeeeecccccCCceEEE
Q 003644 377 LVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH--------DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYL 447 (805)
Q Consensus 377 ~~~~~~~LG~GsfGtVy~a~~-~~g~~VAVK~l~~~~~--------~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~L 447 (805)
.|...+.||+|++|.||.+.. .+++.||||.+..... ....+|+. ++..++||||+++++++.+++..|+
T Consensus 3 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~-~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQ-LLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred cccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHH-HHHhCCCCCeeeeEEEEccCCeEEE
Confidence 366778999999999999854 4689999999864321 12334544 6778999999999999999999999
Q ss_pred ecccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhh
Q 003644 448 SLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE 527 (805)
Q Consensus 448 V~E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~ 527 (805)
|+|++ ++++|.+++.. ...+++..+..++.|++.||+|||+
T Consensus 82 v~e~~----------~~~~l~~~~~~-----------------------------~~~~~~~~~~~~~~~l~~~l~~lH~ 122 (263)
T cd06625 82 FMEYM----------PGGSVKDQLKA-----------------------------YGALTETVTRKYTRQILEGVEYLHS 122 (263)
T ss_pred EEEEC----------CCCcHHHHHHH-----------------------------hCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 99944 45555554321 1235667778999999999999999
Q ss_pred cceeccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHHHH
Q 003644 528 IGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFC 607 (805)
Q Consensus 528 ~~IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~el 607 (805)
.+|+||||||+||+++.++. ++|+|||+++................|+..|+|||++.+..++.++|||||||++|||
T Consensus 123 ~~i~H~dl~p~nilv~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el 200 (263)
T cd06625 123 NMIVHRDIKGANILRDSAGN--VKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEM 200 (263)
T ss_pred CCeecCCCCHHHEEEcCCCC--EEEeecccceeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHH
Confidence 99999999999999987766 8999999987664321111111234578899999999998899999999999999999
Q ss_pred HhCCCCCCCCchHHHH--HHHhh-ccccccccCChHHHHHHHHhcCCCCCCCCChhhhhcCccc
Q 003644 608 ITGGKHPYGESFERDA--NIVKD-RKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 668 (805)
Q Consensus 608 ltG~~~Pf~~~~~~~~--~~~~~-~~~~~~~~~~~~~~dLi~~~L~~dP~~Rps~~ell~Hpff 668 (805)
++| ++||........ ..... .....+....+++.++|.+||..+|.+||++.++++||||
T Consensus 201 ~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 201 LTE-KPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred HhC-CCCccccchHHHHHHHhccCCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence 997 678765322221 11111 1222334556789999999999999999999999999997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=321.05 Aligned_cols=247 Identities=28% Similarity=0.371 Sum_probs=188.0
Q ss_pred EEEeEeeccCCceEEEEEEe-eCCcEEEEEEeecCC-----chHHHHHHHHHHHhCCCCCeeeecccccCCceEEEeccc
Q 003644 378 VVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLER 451 (805)
Q Consensus 378 ~~~~~~LG~GsfGtVy~a~~-~~g~~VAVK~l~~~~-----~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~E~ 451 (805)
|.+.+.||+|++|+||++.. .+|..||||++.... .....+|+. ++..++||||+++++++.+++..|+|||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 2 YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREIS-LLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred ceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHH-HHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 56778999999999999865 468999999985432 123445654 67788999999999999999999999997
Q ss_pred ccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhccee
Q 003644 452 CTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLI 531 (805)
Q Consensus 452 ~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~Iv 531 (805)
|.++|.+++. .. .....+++..++.++.||+.||+|||+.+|+
T Consensus 81 ~~~~l~~~~~-----------~~--------------------------~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~ 123 (285)
T cd07861 81 LSMDLKKYLD-----------SL--------------------------PKGQYMDAELVKSYLYQILQGILFCHSRRVL 123 (285)
T ss_pred CCCCHHHHHh-----------cC--------------------------CCCCcCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence 7666555441 10 0113467788899999999999999999999
Q ss_pred ccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcC-CCCCcchHHHHHHHHHHHHhC
Q 003644 532 HRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG-RQTRAIDLFSLGCILFFCITG 610 (805)
Q Consensus 532 HrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~t~~sDVwSlGvil~elltG 610 (805)
||||||+||+++.++. +||+|||++....... .......+++.|+|||++.+. .++.++|||||||++|+|++|
T Consensus 124 H~dl~p~nil~~~~~~--~~l~dfg~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg 198 (285)
T cd07861 124 HRDLKPQNLLIDNKGV--IKLADFGLARAFGIPV---RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATK 198 (285)
T ss_pred ecCCCHHHEEEcCCCc--EEECcccceeecCCCc---ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHC
Confidence 9999999999988876 8999999987654221 111233578999999998754 478999999999999999997
Q ss_pred CCCCCCCchHHHH--HHHhh----------------------------ccccccccCChHHHHHHHHhcCCCCCCCCChh
Q 003644 611 GKHPYGESFERDA--NIVKD----------------------------RKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQ 660 (805)
Q Consensus 611 ~~~Pf~~~~~~~~--~~~~~----------------------------~~~~~~~~~~~~~~dLi~~~L~~dP~~Rps~~ 660 (805)
.+||........ ..... .........+++++++|.+||+.||.+|||+.
T Consensus 199 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ 277 (285)
T cd07861 199 -KPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAK 277 (285)
T ss_pred -CCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHH
Confidence 677765432111 00000 00001123467889999999999999999999
Q ss_pred hhhcCccc
Q 003644 661 NVLNHPFF 668 (805)
Q Consensus 661 ell~Hpff 668 (805)
++++||||
T Consensus 278 ~ll~~~~~ 285 (285)
T cd07861 278 KALNHPYF 285 (285)
T ss_pred HHhcCCCC
Confidence 99999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=331.26 Aligned_cols=253 Identities=22% Similarity=0.358 Sum_probs=191.2
Q ss_pred eEEEeEeeccCCceEEEEEEee-CCcEEEEEEeecCC-----chHHHHHHHHHHHhCCCCCeeeecccccCCceEEEecc
Q 003644 377 LVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 450 (805)
Q Consensus 377 ~~~~~~~LG~GsfGtVy~a~~~-~g~~VAVK~l~~~~-----~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~E 450 (805)
.|.+.+.||+|+||+||++... +++.||+|++.+.. ....++++..++...+|+||+++++++.+.+.+|+|||
T Consensus 2 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (332)
T cd05623 2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMD 81 (332)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEe
Confidence 4778899999999999998544 57889999986421 12224444457778899999999999999999999999
Q ss_pred cccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcce
Q 003644 451 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 530 (805)
Q Consensus 451 ~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~I 530 (805)
|+.+|+|.+++... ...+++..++.++.||+.||+|||+.+|
T Consensus 82 ----------y~~~g~L~~~l~~~----------------------------~~~l~~~~~~~~~~qi~~al~~lH~~~i 123 (332)
T cd05623 82 ----------YYVGGDLLTLLSKF----------------------------EDRLPEDMARFYLAEMVIAIDSVHQLHY 123 (332)
T ss_pred ----------ccCCCcHHHHHHHh----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 56666666665321 1236677888999999999999999999
Q ss_pred eccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhh-----cCCCCCcchHHHHHHHHH
Q 003644 531 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLL-----QGRQTRAIDLFSLGCILF 605 (805)
Q Consensus 531 vHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~-----~~~~t~~sDVwSlGvil~ 605 (805)
+||||||+|||++.++. +||+|||++........ ......+||+.|+|||++. ...++.++|||||||++|
T Consensus 124 iHrDlkp~Nili~~~~~--~kL~DfG~a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ 199 (332)
T cd05623 124 VHRDIKPDNILMDMNGH--IRLADFGSCLKLMEDGT--VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMY 199 (332)
T ss_pred EecCCCHHHEEECCCCC--EEEeecchheecccCCc--ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHH
Confidence 99999999999987766 89999999876543211 1122356999999999986 346789999999999999
Q ss_pred HHHhCCCCCCCCch-HHHHHHHhhccc-----cccccCChHHHHHHHHhcCCCCCC--CCChhhhhcCccccccc
Q 003644 606 FCITGGKHPYGESF-ERDANIVKDRKD-----LFLVEHIPEAVDLFTRLLDPNPDL--RPKAQNVLNHPFFWTAD 672 (805)
Q Consensus 606 elltG~~~Pf~~~~-~~~~~~~~~~~~-----~~~~~~~~~~~dLi~~~L~~dP~~--Rps~~ell~Hpff~~~~ 672 (805)
||++| ++||.... ......+..... ......++++++||++||..++.+ |++++|+++||||....
T Consensus 200 ell~g-~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~~ 273 (332)
T cd05623 200 EMLYG-ETPFYAESLVETYGKIMNHKERFQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGID 273 (332)
T ss_pred HHhcC-CCCCCCCCHHHHHHHHhCCCccccCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCCC
Confidence 99997 66775432 222222221111 112245789999999999765554 68999999999997643
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=320.34 Aligned_cols=251 Identities=27% Similarity=0.408 Sum_probs=187.8
Q ss_pred cceEEEeEeeccCCceEEEEEEe-eCCcEEEEEEeecCC--chHHHHHHHHHHHhCCCCCeeeecccccCC------ceE
Q 003644 375 GKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH--HDVALKEIQNLIASDQHPNIVRWYGVESDQ------DFV 445 (805)
Q Consensus 375 ~~~~~~~~~LG~GsfGtVy~a~~-~~g~~VAVK~l~~~~--~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~------~~l 445 (805)
+..|.+.+.||+|+||+||++.. .+++.||||++.... .....+|+..+....+||||+++++++.+. ...
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~ 84 (272)
T cd06637 5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQL 84 (272)
T ss_pred hhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEE
Confidence 34466678899999999999865 468899999986543 234556766444444899999999998653 468
Q ss_pred EEecccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHh
Q 003644 446 YLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHL 525 (805)
Q Consensus 446 ~LV~E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yL 525 (805)
|++|| |+.+|+|.+++... +...+++..+..++.|++.||+||
T Consensus 85 ~iv~e----------~~~~~~L~~~l~~~---------------------------~~~~l~~~~~~~~~~qi~~~l~~L 127 (272)
T cd06637 85 WLVME----------FCGAGSVTDLIKNT---------------------------KGNTLKEEWIAYICREILRGLSHL 127 (272)
T ss_pred EEEEE----------cCCCCcHHHHHHhc---------------------------cCCCCCHHHHHHHHHHHHHHHHHH
Confidence 99999 44555555544321 112366778899999999999999
Q ss_pred hhcceeccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhh-----cCCCCCcchHHHH
Q 003644 526 HEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLL-----QGRQTRAIDLFSL 600 (805)
Q Consensus 526 H~~~IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~-----~~~~t~~sDVwSl 600 (805)
|+.+|+||||||+||++++++. ++|+|||++....... .......|+..|+|||++. ...++.++|||||
T Consensus 128 H~~~ivh~dl~~~nili~~~~~--~~l~Dfg~~~~~~~~~---~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~sl 202 (272)
T cd06637 128 HQHKVIHRDIKGQNVLLTENAE--VKLVDFGVSAQLDRTV---GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSL 202 (272)
T ss_pred HHCCCccCCCCHHHEEECCCCC--EEEccCCCceeccccc---ccCCcccccccccCHhHhccccCcCCCCCchhhHHHH
Confidence 9999999999999999988765 8999999988654321 1223456899999999986 3457889999999
Q ss_pred HHHHHHHHhCCCCCCCCchHHHH-HHHhhc--cccccccCChHHHHHHHHhcCCCCCCCCChhhhhcCccc
Q 003644 601 GCILFFCITGGKHPYGESFERDA-NIVKDR--KDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 668 (805)
Q Consensus 601 Gvil~elltG~~~Pf~~~~~~~~-~~~~~~--~~~~~~~~~~~~~dLi~~~L~~dP~~Rps~~ell~Hpff 668 (805)
||++|||++| ..||........ ...... ........+.++.+|+.+||+.||.+||++.++++||||
T Consensus 203 Gv~l~el~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 203 GITAIEMAEG-APPLCDMHPMRALFLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred HHHHHHHHhC-CCCccccCHHHHHHHHhcCCCCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence 9999999997 567754332221 111111 111222345789999999999999999999999999997
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=330.10 Aligned_cols=255 Identities=27% Similarity=0.398 Sum_probs=209.5
Q ss_pred ceEEEeEeeccCCceEEEEEE-eeCCcEEEEEEeecCC------chHHHHHHHHHHHhCCCCCeeeecccccCCceEEEe
Q 003644 376 KLVVFNKEIAKGSNGTVVLEG-NYEGRSVAVKRLVKTH------HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLS 448 (805)
Q Consensus 376 ~~~~~~~~LG~GsfGtVy~a~-~~~g~~VAVK~l~~~~------~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV 448 (805)
+.|..-++||+|+||.||-.. ..+|+.+|.|++.+.. ...++.|- .++.+++.+.||.+-..|+..+.++||
T Consensus 185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk-~iL~kV~s~FiVslaYAfeTkd~LClV 263 (591)
T KOG0986|consen 185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEK-QILEKVSSPFIVSLAYAFETKDALCLV 263 (591)
T ss_pred cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHH-HHHHHhccCcEEEEeeeecCCCceEEE
Confidence 446777899999999999764 4579999999885432 23344454 477888999999999999999999999
Q ss_pred cccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhc
Q 003644 449 LERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI 528 (805)
Q Consensus 449 ~E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~ 528 (805)
+. .|.+|+|.-+|.. ....++++..++.++.+|+.||++||..
T Consensus 264 Lt----------lMNGGDLkfHiyn---------------------------~g~~gF~e~ra~FYAAEi~cGLehlH~~ 306 (591)
T KOG0986|consen 264 LT----------LMNGGDLKFHIYN---------------------------HGNPGFDEQRARFYAAEIICGLEHLHRR 306 (591)
T ss_pred EE----------eecCCceeEEeec---------------------------cCCCCCchHHHHHHHHHHHhhHHHHHhc
Confidence 99 7777777655422 2235789999999999999999999999
Q ss_pred ceeccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHHHHH
Q 003644 529 GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCI 608 (805)
Q Consensus 529 ~IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~ell 608 (805)
+||.|||||+|||||+.|+ ++|+|+|||..+... ......+||.+|||||++.++.|+...|+|||||++|||+
T Consensus 307 ~iVYRDLKPeNILLDd~Gh--vRISDLGLAvei~~g----~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi 380 (591)
T KOG0986|consen 307 RIVYRDLKPENILLDDHGH--VRISDLGLAVEIPEG----KPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMI 380 (591)
T ss_pred ceeeccCChhheeeccCCC--eEeeccceEEecCCC----CccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHH
Confidence 9999999999999999988 789999999988754 3344558999999999999999999999999999999999
Q ss_pred hCCCCCCCCchHHH-----HHHHhhccccccccCChHHHHHHHHhcCCCCCCCCC-----hhhhhcCccccccccch
Q 003644 609 TGGKHPYGESFERD-----ANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPK-----AQNVLNHPFFWTADTRL 675 (805)
Q Consensus 609 tG~~~Pf~~~~~~~-----~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dP~~Rps-----~~ell~Hpff~~~~~~~ 675 (805)
.| ..||....+.. .+.+......++...+++++++.+.+|++||.+|.. ++++.+||||++.+++.
T Consensus 381 ~G-~sPFr~~KeKvk~eEvdrr~~~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw~r 456 (591)
T KOG0986|consen 381 AG-HSPFRQRKEKVKREEVDRRTLEDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNWRR 456 (591)
T ss_pred cc-cCchhhhhhhhhHHHHHHHHhcchhhcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccCCHhH
Confidence 97 77886543322 233444455667788999999999999999999975 67899999998877664
|
|
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=320.55 Aligned_cols=253 Identities=28% Similarity=0.379 Sum_probs=194.3
Q ss_pred eEEEeEeeccCCceEEEEEEe-eCCcEEEEEEeecCC----chHHHHHHHHHHHhCCCCCeeeecccccCCceEEEeccc
Q 003644 377 LVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH----HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLER 451 (805)
Q Consensus 377 ~~~~~~~LG~GsfGtVy~a~~-~~g~~VAVK~l~~~~----~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~E~ 451 (805)
.|.+.+.||+|+||.||++.. .+|+.||+|++.... ....+.|+..+++..+||||+++++++.+++..|++|||
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~ 81 (283)
T cd06617 2 DLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEV 81 (283)
T ss_pred CceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhh
Confidence 467889999999999999855 469999999986542 224455666667788999999999999999999999996
Q ss_pred ccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhc-ce
Q 003644 452 CTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI-GL 530 (805)
Q Consensus 452 ~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~-~I 530 (805)
++++|.+++ .... -....+++..++.++.||+.||+|||+. ++
T Consensus 82 ~~~~l~~~l-----------~~~~-------------------------~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i 125 (283)
T cd06617 82 MDTSLDKFY-----------KKVY-------------------------DKGLTIPEDILGKIAVSIVKALEYLHSKLSV 125 (283)
T ss_pred hcccHHHHH-----------HHhc-------------------------cCCCCCCHHHHHHHHHHHHHHHHHHhhcCCe
Confidence 655554443 2110 0113467888999999999999999997 99
Q ss_pred eccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhc----CCCCCcchHHHHHHHHHH
Q 003644 531 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ----GRQTRAIDLFSLGCILFF 606 (805)
Q Consensus 531 vHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~----~~~t~~sDVwSlGvil~e 606 (805)
+||||||+||+++.++. +||+|||++....... ......|+..|+|||++.+ ..++.++|+|||||++|+
T Consensus 126 ~h~dlkp~nil~~~~~~--~kl~dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~ 199 (283)
T cd06617 126 IHRDVKPSNVLINRNGQ--VKLCDFGISGYLVDSV----AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIE 199 (283)
T ss_pred ecCCCCHHHEEECCCCC--EEEeeccccccccccc----ccccccCCccccChhhcCCcccccccCccccchhhHHHHHH
Confidence 99999999999988775 8999999988664321 1122458899999998865 446889999999999999
Q ss_pred HHhCCCCCCCCch---HHHHHHHhhcccccc-ccCChHHHHHHHHhcCCCCCCCCChhhhhcCccccccc
Q 003644 607 CITGGKHPYGESF---ERDANIVKDRKDLFL-VEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTAD 672 (805)
Q Consensus 607 lltG~~~Pf~~~~---~~~~~~~~~~~~~~~-~~~~~~~~dLi~~~L~~dP~~Rps~~ell~Hpff~~~~ 672 (805)
|++| ..||.... +.............+ ...++++.++|.+||..+|.+||++.++++||||....
T Consensus 200 l~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 268 (283)
T cd06617 200 LATG-RFPYDSWKTPFQQLKQVVEEPSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHL 268 (283)
T ss_pred HHhC-CCCCCccccCHHHHHHHHhcCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhcc
Confidence 9997 67876422 222222222222222 23467899999999999999999999999999996644
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=337.49 Aligned_cols=232 Identities=27% Similarity=0.422 Sum_probs=185.7
Q ss_pred eeccCCceEEEEEEeeCCcEEEEEEeecCCchHHHHHHHHHHHhCCCCCeeeecccccCCceEEEecccccCChhhHHHH
Q 003644 383 EIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYV 462 (805)
Q Consensus 383 ~LG~GsfGtVy~a~~~~g~~VAVK~l~~~~~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~E~~~~sL~d~iy~ 462 (805)
=||.|+.|.|+++. ..++.||||+++.. ...+|. .++.++||||+.+.|+|...-.+|||||||
T Consensus 131 WlGSGaQGAVF~Gr-l~netVAVKKV~el----kETdIK-HLRkLkH~NII~FkGVCtqsPcyCIiMEfC---------- 194 (904)
T KOG4721|consen 131 WLGSGAQGAVFLGR-LHNETVAVKKVREL----KETDIK-HLRKLKHPNIITFKGVCTQSPCYCIIMEFC---------- 194 (904)
T ss_pred hhccCcccceeeee-ccCceehhHHHhhh----hhhhHH-HHHhccCcceeeEeeeecCCceeEEeeecc----------
Confidence 49999999999954 45689999987532 223444 568899999999999999999999999955
Q ss_pred hcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCCCceEEe
Q 003644 463 LSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLI 542 (805)
Q Consensus 463 ~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~IvHrDLKp~NILl 542 (805)
..|.|++.|... +.+....+..+..+||.|+.|||.+.|||||||+-||||
T Consensus 195 a~GqL~~VLka~-----------------------------~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLI 245 (904)
T KOG4721|consen 195 AQGQLYEVLKAG-----------------------------RPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILI 245 (904)
T ss_pred ccccHHHHHhcc-----------------------------CccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEe
Confidence 566777766432 335556778999999999999999999999999999999
Q ss_pred cCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH
Q 003644 543 SKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERD 622 (805)
Q Consensus 543 ~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~elltG~~~Pf~~~~~~~ 622 (805)
+.+.. +||+|||-++.+... .....++||..|||||++.+.+.+.|+|||||||+||||||| ..||.+-....
T Consensus 246 s~~d~--VKIsDFGTS~e~~~~----STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~-EiPYkdVdssA 318 (904)
T KOG4721|consen 246 SYDDV--VKISDFGTSKELSDK----STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTG-EIPYKDVDSSA 318 (904)
T ss_pred eccce--EEeccccchHhhhhh----hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhc-CCCccccchhe
Confidence 87765 999999999877643 333557899999999999999999999999999999999997 88997643321
Q ss_pred HH--HHhhc-cccccccCChHHHHHHHHhcCCCCCCCCChhhhhcCc
Q 003644 623 AN--IVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHP 666 (805)
Q Consensus 623 ~~--~~~~~-~~~~~~~~~~~~~dLi~~~L~~dP~~Rps~~ell~Hp 666 (805)
.- +-.+. ....+..++.-++=||++||+..|..||++.+++.|-
T Consensus 319 IIwGVGsNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~Hl 365 (904)
T KOG4721|consen 319 IIWGVGSNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHL 365 (904)
T ss_pred eEEeccCCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHH
Confidence 10 00011 1223445556788899999999999999999999984
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=321.96 Aligned_cols=247 Identities=25% Similarity=0.401 Sum_probs=201.9
Q ss_pred EeEeeccCCceEEEEE-EeeCCcEEEEEEeecC-CchHHHHHHHHHHHhCCCCCeeeecccccCCceEEEeccccc-CCh
Q 003644 380 FNKEIAKGSNGTVVLE-GNYEGRSVAVKRLVKT-HHDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCT-CSL 456 (805)
Q Consensus 380 ~~~~LG~GsfGtVy~a-~~~~g~~VAVK~l~~~-~~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~E~~~-~sL 456 (805)
+.++||+|+||.||+| +...|..||||.+.-. .-.+..+|+. ++...+.|++|++||.+.....+|+|||||. |+.
T Consensus 37 i~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~sDLQEIIKEIS-IMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAGSi 115 (502)
T KOG0574|consen 37 IVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDTDLQEIIKEIS-IMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAGSI 115 (502)
T ss_pred HHHHhcCCcchHHHHHHHhccCcEEEEEecCccchHHHHHHHHH-HHHHcCCchhhhhhhhhccCCceEeehhhcCCCcH
Confidence 4467999999999998 5668999999998643 3345667776 5677889999999999999999999999887 566
Q ss_pred hhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCC
Q 003644 457 NDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLK 536 (805)
Q Consensus 457 ~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~IvHrDLK 536 (805)
.|++..+ ..++.+.++..+++..+.||+|||...-||||||
T Consensus 116 SDI~R~R---------------------------------------~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIK 156 (502)
T KOG0574|consen 116 SDIMRAR---------------------------------------RKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIK 156 (502)
T ss_pred HHHHHHh---------------------------------------cCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcc
Confidence 6666433 3446667888999999999999999999999999
Q ss_pred CceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q 003644 537 PQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYG 616 (805)
Q Consensus 537 p~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~elltG~~~Pf~ 616 (805)
..||||+.+|. +||+|||.|-.+.+. .....+..|||.|||||++..-.|+.++||||||+...||..| +|||.
T Consensus 157 AGNILLNT~G~--AKLADFGVAGQLTDT---MAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG-~PPYs 230 (502)
T KOG0574|consen 157 AGNILLNTDGI--AKLADFGVAGQLTDT---MAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEG-RPPYS 230 (502)
T ss_pred cccEEEcccch--hhhhhccccchhhhh---HHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcC-CCCcc
Confidence 99999999887 899999999877643 3445677899999999999999999999999999999999996 88998
Q ss_pred CchHHHH-HHHhhccc-c--ccccCChHHHHHHHHhcCCCCCCCCChhhhhcCccccccc
Q 003644 617 ESFERDA-NIVKDRKD-L--FLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTAD 672 (805)
Q Consensus 617 ~~~~~~~-~~~~~~~~-~--~~~~~~~~~~dLi~~~L~~dP~~Rps~~ell~Hpff~~~~ 672 (805)
+-.+-.+ .++...+. . .+...+.++-|+|++||.+.|++|-|+.++++|||.+++.
T Consensus 231 DIHPMRAIFMIPT~PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~FiknA~ 290 (502)
T KOG0574|consen 231 DIHPMRAIFMIPTKPPPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEHTFIKNAP 290 (502)
T ss_pred cccccceeEeccCCCCCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhhhhcCCC
Confidence 7543221 22222111 1 1334567889999999999999999999999999998764
|
|
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=321.69 Aligned_cols=250 Identities=26% Similarity=0.408 Sum_probs=194.9
Q ss_pred EEEeEeeccCCceEEEEEEe-eCCcEEEEEEeecCCc------hHHHHHHHHHHHhCCCCCeeeecccccCCceEEEecc
Q 003644 378 VVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH------DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 450 (805)
Q Consensus 378 ~~~~~~LG~GsfGtVy~a~~-~~g~~VAVK~l~~~~~------~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~E 450 (805)
|...+.||+|+||+||++.. .+++.||||.+..... ....+|+. ++..++|+||+++++++.+++..|+|||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~-il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQ-ILEKVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHH-HHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence 45668899999999999754 4689999999864321 12345654 6778899999999999999999999999
Q ss_pred cccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcce
Q 003644 451 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 530 (805)
Q Consensus 451 ~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~I 530 (805)
|+.+++|..++... ...++++..+..++.|++.||+|||+.+|
T Consensus 81 ----------~~~~~~L~~~~~~~---------------------------~~~~~~~~~~~~~~~ql~~~l~~lH~~~i 123 (285)
T cd05632 81 ----------IMNGGDLKFHIYNM---------------------------GNPGFEEERALFYAAEILCGLEDLHRENT 123 (285)
T ss_pred ----------eccCccHHHHHHHh---------------------------cCCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 55555555544221 12357888899999999999999999999
Q ss_pred eccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHHHHHhC
Q 003644 531 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG 610 (805)
Q Consensus 531 vHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~elltG 610 (805)
+||||||+||+++.++. +||+|||++...... .......|+..|+|||++.+..++.++|+|||||++|||++|
T Consensus 124 iH~dikp~Nili~~~~~--~kl~Dfg~~~~~~~~----~~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g 197 (285)
T cd05632 124 VYRDLKPENILLDDYGH--IRISDLGLAVKIPEG----ESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEG 197 (285)
T ss_pred eecCCCHHHEEECCCCC--EEEecCCcceecCCC----CcccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhC
Confidence 99999999999987765 899999998765422 112334689999999999988899999999999999999997
Q ss_pred CCCCCCCchHHH--HHH---HhhccccccccCChHHHHHHHHhcCCCCCCCCC-----hhhhhcCccccccc
Q 003644 611 GKHPYGESFERD--ANI---VKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPK-----AQNVLNHPFFWTAD 672 (805)
Q Consensus 611 ~~~Pf~~~~~~~--~~~---~~~~~~~~~~~~~~~~~dLi~~~L~~dP~~Rps-----~~ell~Hpff~~~~ 672 (805)
.+||....... ..+ +............+++.+|+.+||+.||++||+ +.++++||||....
T Consensus 198 -~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~ 268 (285)
T cd05632 198 -QSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMN 268 (285)
T ss_pred -CCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcChhhhcCC
Confidence 77886543221 111 111122334456678999999999999999999 88999999997653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=330.99 Aligned_cols=253 Identities=23% Similarity=0.361 Sum_probs=192.0
Q ss_pred eEEEeEeeccCCceEEEEEEe-eCCcEEEEEEeecCC-----chHHHHHHHHHHHhCCCCCeeeecccccCCceEEEecc
Q 003644 377 LVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 450 (805)
Q Consensus 377 ~~~~~~~LG~GsfGtVy~a~~-~~g~~VAVK~l~~~~-----~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~E 450 (805)
.|.+.+.||+|+||+||++.. .+++.||||++.+.. ....++++..++...+|+||+++++++.+++..|+|||
T Consensus 2 ~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~E 81 (331)
T cd05624 2 DFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMD 81 (331)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEe
Confidence 477889999999999999854 468899999986421 12234444567788899999999999999999999999
Q ss_pred cccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcce
Q 003644 451 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 530 (805)
Q Consensus 451 ~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~I 530 (805)
|+.+|+|.+++... ...+++..+..++.|++.||+|||+.+|
T Consensus 82 ----------y~~gg~L~~~l~~~----------------------------~~~l~~~~~~~~~~qi~~~L~~lH~~~i 123 (331)
T cd05624 82 ----------YYVGGDLLTLLSKF----------------------------EDRLPEDMARFYIAEMVLAIHSIHQLHY 123 (331)
T ss_pred ----------CCCCCcHHHHHHHh----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 55566666655321 1235677788999999999999999999
Q ss_pred eccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhc-----CCCCCcchHHHHHHHHH
Q 003644 531 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ-----GRQTRAIDLFSLGCILF 605 (805)
Q Consensus 531 vHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~-----~~~t~~sDVwSlGvil~ 605 (805)
+||||||+|||++.++. +||+|||+++........ .....+||+.|+|||++.+ +.++.++|||||||++|
T Consensus 124 iHrDlkp~Nill~~~~~--~kl~DfG~a~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ 199 (331)
T cd05624 124 VHRDIKPDNVLLDMNGH--IRLADFGSCLKMNQDGTV--QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMY 199 (331)
T ss_pred eeccCchHHEEEcCCCC--EEEEeccceeeccCCCce--eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhh
Confidence 99999999999987776 899999999876543211 1223469999999999875 46789999999999999
Q ss_pred HHHhCCCCCCCCchHH-HH-HHHhhcc-ccc---cccCChHHHHHHHHhcCCCCCC--CCChhhhhcCccccccc
Q 003644 606 FCITGGKHPYGESFER-DA-NIVKDRK-DLF---LVEHIPEAVDLFTRLLDPNPDL--RPKAQNVLNHPFFWTAD 672 (805)
Q Consensus 606 elltG~~~Pf~~~~~~-~~-~~~~~~~-~~~---~~~~~~~~~dLi~~~L~~dP~~--Rps~~ell~Hpff~~~~ 672 (805)
||++| +.||...... .. .+..... ... ....+++++++|.+||..++.+ |++++++++||||...+
T Consensus 200 ell~g-~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~~ 273 (331)
T cd05624 200 EMLYG-ETPFYAESLVETYGKIMNHEERFQFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGID 273 (331)
T ss_pred hhhhC-CCCccCCCHHHHHHHHHcCCCcccCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCCCC
Confidence 99997 6777553322 22 2222111 111 1234679999999999876654 57899999999996543
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=336.00 Aligned_cols=249 Identities=25% Similarity=0.391 Sum_probs=204.7
Q ss_pred eEEEeEeeccCCceEEEEE-EeeCCcEEEEEEeecCC-----chHHHHHHHHHHHhCCCCCeeeecccccCCce-EEEec
Q 003644 377 LVVFNKEIAKGSNGTVVLE-GNYEGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQDF-VYLSL 449 (805)
Q Consensus 377 ~~~~~~~LG~GsfGtVy~a-~~~~g~~VAVK~l~~~~-----~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~-l~LV~ 449 (805)
.|...+.+|+|+||.+++. +..+++.+++|.+.-.. ...+.+|+. +++++.|||||.+++.|.+++. ++|||
T Consensus 5 ~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~-lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 5 NYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMD-LLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred hhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHH-HHHhccCCCeeeeccchhcCCceEEEEE
Confidence 4566788999999999875 56678899999885332 235667775 7888999999999999999988 99999
Q ss_pred ccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcc
Q 003644 450 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG 529 (805)
Q Consensus 450 E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~ 529 (805)
+||+ +|++.+.+.. .+..-++++.+..++.||+.|++|||+..
T Consensus 84 ~Y~e----------Gg~l~~~i~~---------------------------~k~~~f~E~~i~~~~~Q~~~av~ylH~~~ 126 (426)
T KOG0589|consen 84 EYCE----------GGDLAQLIKE---------------------------QKGVLFPEERILKWFVQILLAVNYLHENR 126 (426)
T ss_pred eecC----------CCCHHHHHHH---------------------------HhhccccHHHHHHHHHHHHHHHHHHHhhh
Confidence 9665 4455444332 22234688889999999999999999999
Q ss_pred eeccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHHHHHh
Q 003644 530 LIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCIT 609 (805)
Q Consensus 530 IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~ellt 609 (805)
|+|||||+.||+++.++. +||+|||+|+.+.... ....+.+||+.||.||.+.+.+|..|+|||||||++|||++
T Consensus 127 iLHRDlK~~Nifltk~~~--VkLgDfGlaK~l~~~~---~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~ 201 (426)
T KOG0589|consen 127 VLHRDLKCANIFLTKDKK--VKLGDFGLAKILNPED---SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCT 201 (426)
T ss_pred hhcccchhhhhhccccCc--eeecchhhhhhcCCch---hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHh
Confidence 999999999999999987 6999999999988653 23456789999999999999999999999999999999999
Q ss_pred CCCCCCCCchHHH--HHHHhhccccccccCChHHHHHHHHhcCCCCCCCCChhhhhcCcccc
Q 003644 610 GGKHPYGESFERD--ANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFW 669 (805)
Q Consensus 610 G~~~Pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dP~~Rps~~ell~Hpff~ 669 (805)
- +++|....-.. ..+........+...+.+++.+|+.||..+|..||++.++|.+|...
T Consensus 202 l-k~aF~a~~m~~Li~ki~~~~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P~l~ 262 (426)
T KOG0589|consen 202 L-KPAFKASNMSELILKINRGLYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRRPHLL 262 (426)
T ss_pred c-ccccCccchHHHHHHHhhccCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhChhhh
Confidence 5 77887654322 34444444555667788999999999999999999999999998764
|
|
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=315.91 Aligned_cols=248 Identities=28% Similarity=0.392 Sum_probs=191.4
Q ss_pred EEEeEeeccCCceEEEEEEeeCCcEEEEEEeecCCc---------hHHHHHHHHHHHhCCCCCeeeecccccCCceEEEe
Q 003644 378 VVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHH---------DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLS 448 (805)
Q Consensus 378 ~~~~~~LG~GsfGtVy~a~~~~g~~VAVK~l~~~~~---------~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV 448 (805)
|...+.||+|+||+||++...+|+.||||.+..... ....+|+ ..++.++|+||+++++++.+.+..|++
T Consensus 2 ~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~-~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 2 WTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEV-DLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred ccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHH-HHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 456688999999999998777899999998864321 1223344 477888999999999999999999999
Q ss_pred cccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhc
Q 003644 449 LERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI 528 (805)
Q Consensus 449 ~E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~ 528 (805)
+| |..+++|.+++.. ...+++..+..++.|++.||+|||+.
T Consensus 81 ~e----------~~~~~~L~~~l~~-----------------------------~~~~~~~~~~~~~~qi~~~l~~lH~~ 121 (265)
T cd06631 81 ME----------FVPGGSISSILNR-----------------------------FGPLPEPVFCKYTKQILDGVAYLHNN 121 (265)
T ss_pred Ee----------cCCCCcHHHHHHh-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 99 5555566555422 12356778889999999999999999
Q ss_pred ceeccCCCCceEEecCCCCceEEEeccCccccccCCCc---cccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHH
Q 003644 529 GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMS---CLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILF 605 (805)
Q Consensus 529 ~IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~---~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~ 605 (805)
+|+|+||+|+||+++.++. ++|+|||++........ .........|+..|+|||++.+..++.++|||||||++|
T Consensus 122 ~i~H~dl~p~nil~~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~ 199 (265)
T cd06631 122 CVVHRDIKGNNVMLMPNGI--IKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVF 199 (265)
T ss_pred CcccCCcCHHhEEECCCCe--EEeccchhhHhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHH
Confidence 9999999999999987765 89999999886532111 011122345899999999999888999999999999999
Q ss_pred HHHhCCCCCCCCchHHHH--HHHhh--ccccccccCChHHHHHHHHhcCCCCCCCCChhhhhcCccc
Q 003644 606 FCITGGKHPYGESFERDA--NIVKD--RKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 668 (805)
Q Consensus 606 elltG~~~Pf~~~~~~~~--~~~~~--~~~~~~~~~~~~~~dLi~~~L~~dP~~Rps~~ell~Hpff 668 (805)
+|++| ..||........ .+... .....+.....++.++|.+||+.+|.+||++.++++||||
T Consensus 200 ~l~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 200 EMATG-KPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL 265 (265)
T ss_pred HHHhC-CCccccCChHHHHHHhhhccCCCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 99997 778865332221 11111 1122333456789999999999999999999999999997
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=328.18 Aligned_cols=242 Identities=25% Similarity=0.339 Sum_probs=182.9
Q ss_pred eEEEeEeeccCCceEEEEEEeeCCcEEEEEEeecCC----chHHHHHHHHHHHhCCCCCeeeecccccCCceEEEecccc
Q 003644 377 LVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTH----HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERC 452 (805)
Q Consensus 377 ~~~~~~~LG~GsfGtVy~a~~~~g~~VAVK~l~~~~----~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~E~~ 452 (805)
.+.+.+.||+|+||+||+|.... .||||.+.... .-++|+.+...++.-+|.||+=+.|||..... .||..+|
T Consensus 393 ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTqwC 469 (678)
T KOG0193|consen 393 EVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIITQWC 469 (678)
T ss_pred Hhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeeehhc
Confidence 34567889999999999976654 49999996543 23445544457788999999999999998877 9999977
Q ss_pred cCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcceec
Q 003644 453 TCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIH 532 (805)
Q Consensus 453 ~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~IvH 532 (805)
+| .+|+.+||..+. .+.+...+.|++|||+|+.|||.++|||
T Consensus 470 eG----------sSLY~hlHv~et----------------------------kfdm~~~idIAqQiaqGM~YLHAK~IIH 511 (678)
T KOG0193|consen 470 EG----------SSLYTHLHVQET----------------------------KFDMNTTIDIAQQIAQGMDYLHAKNIIH 511 (678)
T ss_pred cC----------chhhhhccchhh----------------------------hhhHHHHHHHHHHHHHhhhhhhhhhhhh
Confidence 65 345555554332 2455677999999999999999999999
Q ss_pred cCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhc---CCCCCcchHHHHHHHHHHHHh
Q 003644 533 RDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ---GRQTRAIDLFSLGCILFFCIT 609 (805)
Q Consensus 533 rDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~---~~~t~~sDVwSlGvil~ellt 609 (805)
||||..||+|.+++. +||+||||+..-... ....+.....|...|||||+++. .+|++.+|||||||++|||++
T Consensus 512 rDLKSnNIFl~~~~k--VkIgDFGLatvk~~w-~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELlt 588 (678)
T KOG0193|consen 512 RDLKSNNIFLHEDLK--VKIGDFGLATVKTRW-SGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLT 588 (678)
T ss_pred hhccccceEEccCCc--EEEecccceeeeeee-ccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHh
Confidence 999999999988765 999999998643322 22233344458899999999975 468999999999999999999
Q ss_pred CCCCCCCCchHHHHHHH-hhcccc------ccccCChHHHHHHHHhcCCCCCCCCChhhhhc
Q 003644 610 GGKHPYGESFERDANIV-KDRKDL------FLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 664 (805)
Q Consensus 610 G~~~Pf~~~~~~~~~~~-~~~~~~------~~~~~~~~~~dLi~~~L~~dP~~Rps~~ell~ 664 (805)
| ..||... .++.-+. .++... .......++++|+..||..++++||...+||.
T Consensus 589 g-~lPysi~-~~dqIifmVGrG~l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 589 G-ELPYSIQ-NRDQIIFMVGRGYLMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLS 648 (678)
T ss_pred C-cCCcCCC-ChhheEEEecccccCccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence 7 8899833 3332111 111111 11122348999999999999999999999874
|
|
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=329.07 Aligned_cols=250 Identities=22% Similarity=0.297 Sum_probs=183.7
Q ss_pred eEeeccC--CceEEEEEE-eeCCcEEEEEEeecCCc----hHHHHHHHHHHHhCCCCCeeeecccccCCceEEEeccccc
Q 003644 381 NKEIAKG--SNGTVVLEG-NYEGRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCT 453 (805)
Q Consensus 381 ~~~LG~G--sfGtVy~a~-~~~g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~E~~~ 453 (805)
.++||+| +||+||++. ..+|+.||||++..... ...++++..+++.++||||+++++++.+++..|+|||
T Consensus 3 ~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e--- 79 (327)
T cd08227 3 LTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTS--- 79 (327)
T ss_pred hhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEe---
Confidence 4679999 788999974 46789999999865421 1233333457788899999999999999999999999
Q ss_pred CChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcceecc
Q 003644 454 CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHR 533 (805)
Q Consensus 454 ~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~IvHr 533 (805)
|+.+|++.+++... ...++++..++.++.|++.||+|||+.+|+||
T Consensus 80 -------~~~~~~l~~~~~~~---------------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~ 125 (327)
T cd08227 80 -------FMAYGSAKDLICTH---------------------------FMDGMSELAIAYILQGVLKALDYIHHMGYVHR 125 (327)
T ss_pred -------ccCCCcHHHHHHhh---------------------------ccCCCCHHHHHHHHHHHHHHHHHHHHCCEecC
Confidence 55566665554221 11346778889999999999999999999999
Q ss_pred CCCCceEEecCCCCceEEEeccCccccccCCCccc----cccccccCCCCCCChhhhhc--CCCCCcchHHHHHHHHHHH
Q 003644 534 DLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCL----TQNATGYGSSGWQAPEQLLQ--GRQTRAIDLFSLGCILFFC 607 (805)
Q Consensus 534 DLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~----~~~~~~~gt~~y~APE~l~~--~~~t~~sDVwSlGvil~el 607 (805)
||||+|||++.++. ++++|||.+.......... .......++..|+|||++.+ ..++.++|||||||++|||
T Consensus 126 dlkp~Nil~~~~~~--~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el 203 (327)
T cd08227 126 SVKASHILISVDGK--VYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACEL 203 (327)
T ss_pred CCChhhEEEecCCc--EEEcccchhhccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHH
Confidence 99999999988776 7899998755432211100 01122346788999999976 4588999999999999999
Q ss_pred HhCCCCCCCCchHHHHH--HHhhcc---------------------------------------------ccccccCChH
Q 003644 608 ITGGKHPYGESFERDAN--IVKDRK---------------------------------------------DLFLVEHIPE 640 (805)
Q Consensus 608 ltG~~~Pf~~~~~~~~~--~~~~~~---------------------------------------------~~~~~~~~~~ 640 (805)
++| ..||......... ...... .......+++
T Consensus 204 ~~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (327)
T cd08227 204 ANG-HVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPH 282 (327)
T ss_pred HHC-CCCCCCcchhHHHHHHhcCCccccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHH
Confidence 997 7788643221110 000000 0001123467
Q ss_pred HHHHHHHhcCCCCCCCCChhhhhcCccccc
Q 003644 641 AVDLFTRLLDPNPDLRPKAQNVLNHPFFWT 670 (805)
Q Consensus 641 ~~dLi~~~L~~dP~~Rps~~ell~Hpff~~ 670 (805)
+.++|.+||+.||++|||++|+++||||..
T Consensus 283 ~~~li~~~l~~dP~~Rpt~~ell~~p~f~~ 312 (327)
T cd08227 283 FHHFVEQCLQRNPDARPSASTLLNHSFFKQ 312 (327)
T ss_pred HHHHHHHHHhhCchhcCCHHHHhcChhhhh
Confidence 899999999999999999999999999954
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-36 Score=319.08 Aligned_cols=244 Identities=23% Similarity=0.384 Sum_probs=189.2
Q ss_pred eEEEeEeeccCCceEEEEEE-eeCCcEEEEEEeecCCch----HHHHHHHHHHHhCCCCCeeeecccccCCceEEEeccc
Q 003644 377 LVVFNKEIAKGSNGTVVLEG-NYEGRSVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLER 451 (805)
Q Consensus 377 ~~~~~~~LG~GsfGtVy~a~-~~~g~~VAVK~l~~~~~~----~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~E~ 451 (805)
.|.+.+.||+|+||+||++. ..+++.||||++...... ...+|+. ++..++||||+++++++.+.+..++|||
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~-~l~~l~h~~iv~~~~~~~~~~~~~lv~e- 79 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELE-ILYKCDSPYIIGFYGAFFVENRISICTE- 79 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHH-HHHhCCCCCeeeEEEEEEECCEEEEEEe-
Confidence 35677899999999999985 457899999998654222 2334544 6778899999999999999999999999
Q ss_pred ccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhccee
Q 003644 452 CTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLI 531 (805)
Q Consensus 452 ~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~Iv 531 (805)
|+.+|++..+ ..+++..+..++.|++.||+|||+.+|+
T Consensus 80 ---------~~~~~~l~~~---------------------------------~~~~~~~~~~~~~qi~~~l~~lH~~~i~ 117 (279)
T cd06619 80 ---------FMDGGSLDVY---------------------------------RKIPEHVLGRIAVAVVKGLTYLWSLKIL 117 (279)
T ss_pred ---------cCCCCChHHh---------------------------------hcCCHHHHHHHHHHHHHHHHHHHHCCEe
Confidence 4455555332 1245566789999999999999999999
Q ss_pred ccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHHHHHhCC
Q 003644 532 HRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGG 611 (805)
Q Consensus 532 HrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~elltG~ 611 (805)
|+||||+|||++.++. ++|+|||++...... ......||..|+|||++.+..++.++|+|||||++|+|++|
T Consensus 118 H~dlkp~Nill~~~~~--~~l~dfg~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g- 189 (279)
T cd06619 118 HRDVKPSNMLVNTRGQ--VKLCDFGVSTQLVNS-----IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALG- 189 (279)
T ss_pred eCCCCHHHEEECCCCC--EEEeeCCcceecccc-----cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhC-
Confidence 9999999999988876 899999999866432 12334689999999999988899999999999999999997
Q ss_pred CCCCCCchHH--------HHHHHh-hc-cccccccCChHHHHHHHHhcCCCCCCCCChhhhhcCccccccc
Q 003644 612 KHPYGESFER--------DANIVK-DR-KDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTAD 672 (805)
Q Consensus 612 ~~Pf~~~~~~--------~~~~~~-~~-~~~~~~~~~~~~~dLi~~~L~~dP~~Rps~~ell~Hpff~~~~ 672 (805)
.+||...... ....+. .. ........++++.++|.+||+.||++||+++|+++||||...+
T Consensus 190 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~~~ 260 (279)
T cd06619 190 RFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQYN 260 (279)
T ss_pred CCCchhhcccccccchHHHHHHHhccCCCCCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCccccccc
Confidence 7777542211 011111 11 1111223567899999999999999999999999999996543
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-36 Score=325.43 Aligned_cols=248 Identities=26% Similarity=0.362 Sum_probs=194.9
Q ss_pred ceEEEeEeeccCCceEEEEEEeeCCcEEEEEEeecCCc----hHHHHHHHHHHHhCCCCCeeeecccccCCceEEEeccc
Q 003644 376 KLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLER 451 (805)
Q Consensus 376 ~~~~~~~~LG~GsfGtVy~a~~~~g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~E~ 451 (805)
+...+.++||+|-||.|.+.....+..||||.++.... ..+.+|+. .+.+++|||||+|+|+|..++.+++++|
T Consensus 538 s~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIk-iLsqLkhPNIveLvGVC~~DePicmI~E- 615 (807)
T KOG1094|consen 538 SRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIK-ILSRLKHPNIVELLGVCVQDDPLCMITE- 615 (807)
T ss_pred hheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHH-HHhccCCCCeeEEEeeeecCCchHHHHH-
Confidence 44678899999999999998888889999999976543 34567776 5677799999999999999999999999
Q ss_pred ccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhccee
Q 003644 452 CTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLI 531 (805)
Q Consensus 452 ~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~Iv 531 (805)
||++|+|.++|..+.... .......+|+.||+.|++||.+.++|
T Consensus 616 ---------YmEnGDLnqFl~aheapt---------------------------~~t~~~vsi~tqiasgmaYLes~nfV 659 (807)
T KOG1094|consen 616 ---------YMENGDLNQFLSAHELPT---------------------------AETAPGVSICTQIASGMAYLESLNFV 659 (807)
T ss_pred ---------HHhcCcHHHHHHhccCcc---------------------------cccchhHHHHHHHHHHHHHHHhhchh
Confidence 999999999987654321 11233477999999999999999999
Q ss_pred ccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHHHHHhC-
Q 003644 532 HRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG- 610 (805)
Q Consensus 532 HrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~elltG- 610 (805)
||||.+.|+|+ ++++++||+|||+++.+....... .....+-..+|||+|.+..++++.++|||+||+.+||+++-
T Consensus 660 Hrd~a~rNcLv--~~e~~iKiadfgmsR~lysg~yy~-vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C 736 (807)
T KOG1094|consen 660 HRDLATRNCLV--DGEFTIKIADFGMSRNLYSGDYYR-VQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLC 736 (807)
T ss_pred hccccccceee--cCcccEEecCcccccccccCCcee-eecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHH
Confidence 99999999999 555669999999999776543322 22233457899999999999999999999999999997653
Q ss_pred CCCCCCCchHHHHH-----HHhhcc----ccccccCChHHHHHHHHhcCCCCCCCCChhhhhc
Q 003644 611 GKHPYGESFERDAN-----IVKDRK----DLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 664 (805)
Q Consensus 611 ~~~Pf~~~~~~~~~-----~~~~~~----~~~~~~~~~~~~dLi~~~L~~dP~~Rps~~ell~ 664 (805)
...||.+-..++.. ....+. ...+.-+...+.+++.+||..|-++||+.+++..
T Consensus 737 ~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~ 799 (807)
T KOG1094|consen 737 REQPYSQLTDEQVVENAGEFFRDQGRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHL 799 (807)
T ss_pred hhCchhhhhHHHHHHhhhhhcCCCCcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHH
Confidence 46688765443321 111111 1123334568889999999999999999999853
|
|
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-37 Score=333.62 Aligned_cols=240 Identities=26% Similarity=0.389 Sum_probs=196.3
Q ss_pred eEeeccCCceEEEEEE-eeCCcEEEEEEeecCC------chHHHHHHHHHHHhCCCCCeeeecccccCCceEEEeccccc
Q 003644 381 NKEIAKGSNGTVVLEG-NYEGRSVAVKRLVKTH------HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCT 453 (805)
Q Consensus 381 ~~~LG~GsfGtVy~a~-~~~g~~VAVK~l~~~~------~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~E~~~ 453 (805)
.+.||.|+||.||+|. ..+...||||++.-.. ..+.++|+. .+..++|||+|.+.|+|-.+...|||||||-
T Consensus 31 LrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVr-FL~~l~HPntieYkgCyLre~TaWLVMEYCl 109 (948)
T KOG0577|consen 31 LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVR-FLRQLRHPNTIEYKGCYLREHTAWLVMEYCL 109 (948)
T ss_pred HHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHH-HHHhccCCCcccccceeeccchHHHHHHHHh
Confidence 3579999999999985 4578899999985322 235677876 7788999999999999999999999999999
Q ss_pred CChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcceecc
Q 003644 454 CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHR 533 (805)
Q Consensus 454 ~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~IvHr 533 (805)
|+-.|++-+.. .++.+.++..|+.+.+.||+|||+++.|||
T Consensus 110 GSAsDlleVhk---------------------------------------KplqEvEIAAi~~gaL~gLaYLHS~~~IHR 150 (948)
T KOG0577|consen 110 GSASDLLEVHK---------------------------------------KPLQEVEIAAITHGALQGLAYLHSHNRIHR 150 (948)
T ss_pred ccHHHHHHHHh---------------------------------------ccchHHHHHHHHHHHHHHHHHHHHhhHHhh
Confidence 98888774433 334556778999999999999999999999
Q ss_pred CCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhh---cCCCCCcchHHHHHHHHHHHHhC
Q 003644 534 DLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLL---QGRQTRAIDLFSLGCILFFCITG 610 (805)
Q Consensus 534 DLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~---~~~~t~~sDVwSlGvil~elltG 610 (805)
|||..||||++.|- +||+|||.|.... +..+++|||.|||||++. .+.|+-++||||||++..||...
T Consensus 151 DiKAGNILLse~g~--VKLaDFGSAsi~~-------PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAER 221 (948)
T KOG0577|consen 151 DIKAGNILLSEPGL--VKLADFGSASIMA-------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAER 221 (948)
T ss_pred hccccceEecCCCe--eeeccccchhhcC-------chhcccCCccccchhHheeccccccCCccceeeccchhhhhhhc
Confidence 99999999998875 9999999987654 346688999999999986 47899999999999999999995
Q ss_pred CCCCCCCch--HHHHHHHhhccc-cccccCChHHHHHHHHhcCCCCCCCCChhhhhcCccccc
Q 003644 611 GKHPYGESF--ERDANIVKDRKD-LFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWT 670 (805)
Q Consensus 611 ~~~Pf~~~~--~~~~~~~~~~~~-~~~~~~~~~~~dLi~~~L~~dP~~Rps~~ell~Hpff~~ 670 (805)
+||+..-. .....|..+... +...+++..++.|+..||++-|..|||.+++++|+|...
T Consensus 222 -kPPlFnMNAMSALYHIAQNesPtLqs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~fv~R 283 (948)
T KOG0577|consen 222 -KPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVDSCLQKIPQERPTSEELLKHRFVLR 283 (948)
T ss_pred -CCCccCchHHHHHHHHHhcCCCCCCCchhHHHHHHHHHHHHhhCcccCCcHHHHhhcchhcc
Confidence 66665432 222344444333 334455678899999999999999999999999999854
|
|
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=309.29 Aligned_cols=247 Identities=26% Similarity=0.450 Sum_probs=190.6
Q ss_pred EEEeEeeccCCceEEEEEEe-eCCcEEEEEEeecCCc-----hHHHHHHHHHHHhCCCCCeeeecccccC-CceEEEecc
Q 003644 378 VVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH-----DVALKEIQNLIASDQHPNIVRWYGVESD-QDFVYLSLE 450 (805)
Q Consensus 378 ~~~~~~LG~GsfGtVy~a~~-~~g~~VAVK~l~~~~~-----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~-~~~l~LV~E 450 (805)
|.+.+.||+|++|.||++.. .+++.||||++..... +...+|+ .+++.++||||+++++.+.. +..+|++||
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~-~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 2 YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEA-QLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred ceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHH-HHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 67889999999999999854 4578999999864321 1233344 47788899999999998764 456899999
Q ss_pred cccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcce
Q 003644 451 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 530 (805)
Q Consensus 451 ~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~I 530 (805)
|.++++|.+++... ....+++.+++.++.|++.||+|||+.+|
T Consensus 81 ----------~~~~~~l~~~l~~~---------------------------~~~~l~~~~~~~~~~~l~~~l~~lH~~~i 123 (257)
T cd08223 81 ----------FCEGGDLYHKLKEQ---------------------------KGKLLPENQVVEWFVQIAMALQYLHEKHI 123 (257)
T ss_pred ----------ccCCCcHHHHHHHh---------------------------cCCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 44555555544321 11346778889999999999999999999
Q ss_pred eccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHHHHHhC
Q 003644 531 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG 610 (805)
Q Consensus 531 vHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~elltG 610 (805)
+||||||+||+++.++. ++|+|||++....... .......|++.|+|||++.+..++.++|||||||++|++++|
T Consensus 124 ~H~di~p~nil~~~~~~--~~l~df~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g 198 (257)
T cd08223 124 LHRDLKTQNVFLTRTNI--IKVGDLGIARVLENQC---DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATL 198 (257)
T ss_pred eccCCCchhEEEecCCc--EEEecccceEEecccC---CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcC
Confidence 99999999999987765 8999999998764321 122344589999999999998899999999999999999997
Q ss_pred CCCCCCCchHHH-H-HHHhhccccccccCChHHHHHHHHhcCCCCCCCCChhhhhcCccc
Q 003644 611 GKHPYGESFERD-A-NIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 668 (805)
Q Consensus 611 ~~~Pf~~~~~~~-~-~~~~~~~~~~~~~~~~~~~dLi~~~L~~dP~~Rps~~ell~Hpff 668 (805)
..||....... . .+........+...++++.+++.+||+.||++||++.++++||||
T Consensus 199 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 199 -KHAFNAKDMNSLVYRIIEGKLPPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQPYI 257 (257)
T ss_pred -CCCCCCCCHHHHHHHHHhcCCCCCccccCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 56775533222 2 222222222334566899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=322.02 Aligned_cols=252 Identities=25% Similarity=0.402 Sum_probs=189.8
Q ss_pred EEEeEeeccCCceEEEEEEee---CCcEEEEEEeecCC------chHHHHHHHHHHHhCCCCCeeeecccccCC--ceEE
Q 003644 378 VVFNKEIAKGSNGTVVLEGNY---EGRSVAVKRLVKTH------HDVALKEIQNLIASDQHPNIVRWYGVESDQ--DFVY 446 (805)
Q Consensus 378 ~~~~~~LG~GsfGtVy~a~~~---~g~~VAVK~l~~~~------~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~--~~l~ 446 (805)
|.+.+.||+|+||.||++... +++.||||.+.... .....+|+. ++..++||||+++++++.+. +.+|
T Consensus 2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIA-LLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred ceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHH-HHHhcCCCCccceEEEEeCCCCceEE
Confidence 567788999999999998654 58999999997622 234456665 67889999999999999988 8899
Q ss_pred EecccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhh
Q 003644 447 LSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH 526 (805)
Q Consensus 447 LV~E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH 526 (805)
+|||+|.++|.+++..... .....+++..++.++.||+.||+|||
T Consensus 81 lv~e~~~~~l~~~~~~~~~-----------------------------------~~~~~~~~~~~~~i~~qi~~~l~~lH 125 (316)
T cd07842 81 LLFDYAEHDLWQIIKFHRQ-----------------------------------AKRVSIPPSMVKSLLWQILNGVHYLH 125 (316)
T ss_pred EEEeCCCcCHHHHHHhhcc-----------------------------------CCCcCcCHHHHHHHHHHHHHHHHHHH
Confidence 9999887766655421100 00124677888999999999999999
Q ss_pred hcceeccCCCCceEEecC----CCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcC-CCCCcchHHHHH
Q 003644 527 EIGLIHRDLKPQNVLISK----DKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG-RQTRAIDLFSLG 601 (805)
Q Consensus 527 ~~~IvHrDLKp~NILl~~----~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~t~~sDVwSlG 601 (805)
+.+|+||||||+||+++. ++ .+||+|||+++................++..|+|||++.+. .++.++||||||
T Consensus 126 ~~~i~h~dlkp~Nil~~~~~~~~~--~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG 203 (316)
T cd07842 126 SNWVLHRDLKPANILVMGEGPERG--VVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIG 203 (316)
T ss_pred hCCEeeCCCCHHHEEEcCCCCccc--eEEECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHH
Confidence 999999999999999987 54 48999999998765432212222344688999999988764 578999999999
Q ss_pred HHHHHHHhCCCCCCCCchHHH-----------HHHHh------------------------h-cccccc-----------
Q 003644 602 CILFFCITGGKHPYGESFERD-----------ANIVK------------------------D-RKDLFL----------- 634 (805)
Q Consensus 602 vil~elltG~~~Pf~~~~~~~-----------~~~~~------------------------~-~~~~~~----------- 634 (805)
|++|+|++| .+||....... ..+.. . ....+.
T Consensus 204 ~~l~~l~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (316)
T cd07842 204 CIFAELLTL-EPIFKGREAKIKKSNPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKH 282 (316)
T ss_pred HHHHHHHhc-CCCCcCCcccccccchhHHHHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhc
Confidence 999999997 77875432211 00000 0 000000
Q ss_pred ccCChHHHHHHHHhcCCCCCCCCChhhhhcCccc
Q 003644 635 VEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 668 (805)
Q Consensus 635 ~~~~~~~~dLi~~~L~~dP~~Rps~~ell~Hpff 668 (805)
....+++.+++.+||+.||++|||+.|+++||||
T Consensus 283 ~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f 316 (316)
T cd07842 283 KKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF 316 (316)
T ss_pred cCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence 0344678999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=310.01 Aligned_cols=247 Identities=24% Similarity=0.391 Sum_probs=194.0
Q ss_pred EEEeEeeccCCceEEEEEEe-eCCcEEEEEEeecCC-----chHHHHHHHHHHHhCCCCCeeeecccccCCceEEEeccc
Q 003644 378 VVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLER 451 (805)
Q Consensus 378 ~~~~~~LG~GsfGtVy~a~~-~~g~~VAVK~l~~~~-----~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~E~ 451 (805)
|.+.+.||+|++|.||++.. .+|+.||+|.+.... .....+|+. +++.++||||+++++++.+++..|+|||
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~lv~e- 79 (256)
T cd08529 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEAR-VLAKLDSSYIIRYYESFLDKGKLNIVME- 79 (256)
T ss_pred ceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHH-HHHhcCCCCeehheeeeccCCEEEEEEE-
Confidence 56778999999999999855 468999999986432 123345554 6788899999999999999999999999
Q ss_pred ccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhccee
Q 003644 452 CTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLI 531 (805)
Q Consensus 452 ~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~Iv 531 (805)
|+.+++|.++++... ...+++..+..++.|++.||+|||+.+|+
T Consensus 80 ---------~~~~~~L~~~l~~~~---------------------------~~~~~~~~~~~i~~~l~~al~~lH~~~i~ 123 (256)
T cd08529 80 ---------YAENGDLHKLLKMQR---------------------------GRPLPEDQVWRFFIQILLGLAHLHSKKIL 123 (256)
T ss_pred ---------eCCCCcHHHHHHHhc---------------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 555566666554321 13456778889999999999999999999
Q ss_pred ccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHHHHHhCC
Q 003644 532 HRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGG 611 (805)
Q Consensus 532 HrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~elltG~ 611 (805)
||||||+||+++.++. ++|+|||+++....... ......|++.|+|||++.+..++.++|+|||||++|+|++|
T Consensus 124 h~dl~~~nili~~~~~--~~l~df~~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g- 197 (256)
T cd08529 124 HRDIKSLNLFLDAYDN--VKIGDLGVAKLLSDNTN---FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTG- 197 (256)
T ss_pred cCCCCcceEEEeCCCC--EEEcccccceeccCccc---hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhC-
Confidence 9999999999988776 89999999887654321 12234588999999999998899999999999999999996
Q ss_pred CCCCCCchHHHH--HHHhhccccccccCChHHHHHHHHhcCCCCCCCCChhhhhcCccc
Q 003644 612 KHPYGESFERDA--NIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 668 (805)
Q Consensus 612 ~~Pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~dLi~~~L~~dP~~Rps~~ell~Hpff 668 (805)
..||........ .+.............+++.+++.+||+.+|++||++.++++|||.
T Consensus 198 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 198 KHPFDANNQGALILKIIRGVFPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRNPSL 256 (256)
T ss_pred CCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHHHHHHccCCcccCcCHHHHhhCCCC
Confidence 778865543221 122222222233456789999999999999999999999999984
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-36 Score=333.57 Aligned_cols=276 Identities=23% Similarity=0.315 Sum_probs=191.9
Q ss_pred ceEEEeEeeccCCceEEEEEEe------eCCcEEEEEEeecCCc----hHHHHHHHHHHHhC-CCCCeeeecccccCCce
Q 003644 376 KLVVFNKEIAKGSNGTVVLEGN------YEGRSVAVKRLVKTHH----DVALKEIQNLIASD-QHPNIVRWYGVESDQDF 444 (805)
Q Consensus 376 ~~~~~~~~LG~GsfGtVy~a~~------~~g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l-~HpNIV~l~g~~~~~~~ 444 (805)
++|.+.+.||+|+||+||++.. .++..||||+++.... ....+|+. ++..+ +|||||+++++|.+.+.
T Consensus 35 ~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~-il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELK-VLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred HHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHH-HHHHhcCCcceeeeeeeeccCCc
Confidence 3578889999999999999743 2466899999864322 23456776 44555 89999999999999999
Q ss_pred EEEecccccCChhhHHHHhcCCHHHHHhhhhccc-------------------------hhhHHHHhh------------
Q 003644 445 VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDS-------------------------NLLNEVRIR------------ 487 (805)
Q Consensus 445 l~LV~E~~~~sL~d~iy~~~GsL~~~L~~~~~~~-------------------------~~l~~~~~~------------ 487 (805)
.|+|||||. +|+|.+++....... ..+......
T Consensus 114 ~~lv~E~~~----------~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 183 (375)
T cd05104 114 TLVITEYCC----------YGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKA 183 (375)
T ss_pred ceeeehhcc----------CCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccc
Confidence 999999554 444444443221100 000000000
Q ss_pred ---------hcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCCCceEEecCCCCceEEEeccCcc
Q 003644 488 ---------LLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGIS 558 (805)
Q Consensus 488 ---------~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~IvHrDLKp~NILl~~~~~~~~kL~DFGla 558 (805)
.............+....+++..++.++.||+.||+|||+.+|+||||||+|||++.++. +||+|||++
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~--~kl~DfG~a 261 (375)
T cd05104 184 DKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRI--TKICDFGLA 261 (375)
T ss_pred ccccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCc--EEEecCccc
Confidence 000000001111223346788999999999999999999999999999999999987654 899999999
Q ss_pred ccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHH--HHHHHhhc-cccccc
Q 003644 559 KRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFER--DANIVKDR-KDLFLV 635 (805)
Q Consensus 559 ~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~elltG~~~Pf~~~~~~--~~~~~~~~-~~~~~~ 635 (805)
+........ .......++..|+|||++.+..++.++|||||||++|||++++.+||...... ....+... ....+.
T Consensus 262 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 340 (375)
T cd05104 262 RDIRNDSNY-VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPE 340 (375)
T ss_pred eeccCcccc-cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCCCCC
Confidence 876543221 11122335678999999999999999999999999999999668888654322 12222222 112223
Q ss_pred cCChHHHHHHHHhcCCCCCCCCChhhhhcC
Q 003644 636 EHIPEAVDLFTRLLDPNPDLRPKAQNVLNH 665 (805)
Q Consensus 636 ~~~~~~~dLi~~~L~~dP~~Rps~~ell~H 665 (805)
..+.++.+++.+||+.||++||++.|+++.
T Consensus 341 ~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 370 (375)
T cd05104 341 CAPSEMYDIMKSCWDADPLKRPTFKQIVQL 370 (375)
T ss_pred CCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 345789999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=317.70 Aligned_cols=249 Identities=27% Similarity=0.418 Sum_probs=192.7
Q ss_pred ccccceEEEeEeeccCCceEEEEEEeeCCcEEEEEEeecCCchHHHHHHHHHHH-hCCCCCeeeecccccCC----ceEE
Q 003644 372 RRIGKLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQNLIA-SDQHPNIVRWYGVESDQ----DFVY 446 (805)
Q Consensus 372 ~~i~~~~~~~~~LG~GsfGtVy~a~~~~g~~VAVK~l~~~~~~~~~~Ei~~ll~-~l~HpNIV~l~g~~~~~----~~l~ 446 (805)
+.+.+++.+.+.||+|.||.||+ +.+-|..||||++...++..+++|-+.... .++|+||+.+++.-..+ ..+|
T Consensus 207 RTiarqI~L~e~IGkGRyGEVwr-G~wrGe~VAVKiF~srdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLw 285 (513)
T KOG2052|consen 207 RTIARQIVLQEIIGKGRFGEVWR-GRWRGEDVAVKIFSSRDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLW 285 (513)
T ss_pred HhhhheeEEEEEecCccccceee-ccccCCceEEEEecccchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEE
Confidence 67788999999999999999998 677889999999998888899998876544 47999999999975443 4689
Q ss_pred EecccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhh
Q 003644 447 LSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH 526 (805)
Q Consensus 447 LV~E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH 526 (805)
||.+ |+++|||+++|.. ..++....++++..+|.||+|||
T Consensus 286 LvTd----------YHe~GSL~DyL~r------------------------------~tv~~~~ml~LalS~AsGLaHLH 325 (513)
T KOG2052|consen 286 LVTD----------YHEHGSLYDYLNR------------------------------NTVTTEGMLKLALSIASGLAHLH 325 (513)
T ss_pred Eeee----------cccCCcHHHHHhh------------------------------ccCCHHHHHHHHHHHhhhHHHHH
Confidence 9999 9999999999754 34566778999999999999999
Q ss_pred hc--------ceeccCCCCceEEecCCCCceEEEeccCccccccCCCc-cccccccccCCCCCCChhhhhcCCC------
Q 003644 527 EI--------GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMS-CLTQNATGYGSSGWQAPEQLLQGRQ------ 591 (805)
Q Consensus 527 ~~--------~IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~-~~~~~~~~~gt~~y~APE~l~~~~~------ 591 (805)
.. .|.|||||+.|||+.+++. +.|+|+|||........ -....+..+||.+|||||++...-.
T Consensus 326 ~eI~GTqgKPaIAHRDlKSKNILVKkn~~--C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fes 403 (513)
T KOG2052|consen 326 MEIVGTQGKPAIAHRDLKSKNILVKKNGT--CCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFES 403 (513)
T ss_pred HHHhcCCCCchhhccccccccEEEccCCc--EEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhh
Confidence 65 5999999999999988887 66999999988776532 2345567889999999999976422
Q ss_pred CCcchHHHHHHHHHHHHh----CC-----CCCCCCchHHHH------HHH--hhccccccc-cCC-h---HHHHHHHHhc
Q 003644 592 TRAIDLFSLGCILFFCIT----GG-----KHPYGESFERDA------NIV--KDRKDLFLV-EHI-P---EAVDLFTRLL 649 (805)
Q Consensus 592 t~~sDVwSlGvil~ellt----G~-----~~Pf~~~~~~~~------~~~--~~~~~~~~~-~~~-~---~~~dLi~~~L 649 (805)
-..+||||||.++||++- || .+||.+-.+.+. .++ +......+. +.+ + .+..+++.||
T Consensus 404 yk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW 483 (513)
T KOG2052|consen 404 YKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECW 483 (513)
T ss_pred hhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhh
Confidence 247999999999999764 32 467765333222 111 111111111 112 2 4557899999
Q ss_pred CCCCCCCCChhhhh
Q 003644 650 DPNPDLRPKAQNVL 663 (805)
Q Consensus 650 ~~dP~~Rps~~ell 663 (805)
..+|..|.|+-.+.
T Consensus 484 ~~Np~aRltALriK 497 (513)
T KOG2052|consen 484 YANPAARLTALRIK 497 (513)
T ss_pred cCCchhhhHHHHHH
Confidence 99999999886654
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=321.24 Aligned_cols=240 Identities=25% Similarity=0.346 Sum_probs=179.2
Q ss_pred EeEeeccCCceEEEEEEeeCCcEEEEEEeecCCchHHHHHHHH-HHHhCCCCCeeeecccccCCc----eEEEecccccC
Q 003644 380 FNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQN-LIASDQHPNIVRWYGVESDQD----FVYLSLERCTC 454 (805)
Q Consensus 380 ~~~~LG~GsfGtVy~a~~~~g~~VAVK~l~~~~~~~~~~Ei~~-ll~~l~HpNIV~l~g~~~~~~----~l~LV~E~~~~ 454 (805)
+.+.||+|.||.||+|.+ +++.||||++...+...+..|-.. -+-.+.|+||++++++..... ..+||+|
T Consensus 214 l~eli~~Grfg~V~KaqL-~~~~VAVKifp~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~---- 288 (534)
T KOG3653|consen 214 LLELIGRGRFGCVWKAQL-DNRLVAVKIFPEQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTE---- 288 (534)
T ss_pred hHHHhhcCccceeehhhc-cCceeEEEecCHHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEee----
Confidence 446799999999999654 559999999976554444444331 123579999999999987666 7899999
Q ss_pred ChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhc------
Q 003644 455 SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI------ 528 (805)
Q Consensus 455 sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~------ 528 (805)
|.++|+|.++|.. ..++|....+|+..+++||+|||+.
T Consensus 289 ------fh~kGsL~dyL~~------------------------------ntisw~~~cria~SmarGLa~LHee~p~~d~ 332 (534)
T KOG3653|consen 289 ------FHPKGSLCDYLKA------------------------------NTISWNSLCRIAESMARGLAHLHEELPRGDH 332 (534)
T ss_pred ------eccCCcHHHHHHh------------------------------ccccHHHHHHHHHHHHHHHHHhcccCCcCCC
Confidence 9999999998743 4578889999999999999999975
Q ss_pred ---ceeccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCC------CCcchHHH
Q 003644 529 ---GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ------TRAIDLFS 599 (805)
Q Consensus 529 ---~IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~------t~~sDVwS 599 (805)
+|+|||||++||||..|+. +.|+|||||..+....... .....+||.+|||||++.+... -.+.||||
T Consensus 333 ~Kp~IaHRDlkSkNVLvK~DlT--ccIaDFGLAl~~~p~~~~~-d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYa 409 (534)
T KOG3653|consen 333 HKPPIAHRDLKSKNVLVKNDLT--CCIADFGLALRLEPGKPQG-DTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYA 409 (534)
T ss_pred CCCccccccccccceEEccCCc--EEeeccceeEEecCCCCCc-chhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHH
Confidence 6999999999999988876 7799999999987654433 3344789999999999986432 24789999
Q ss_pred HHHHHHHHHhCCC-------CCCCCchH----------HHHH-HHhhc-ccccccc-----CChHHHHHHHHhcCCCCCC
Q 003644 600 LGCILFFCITGGK-------HPYGESFE----------RDAN-IVKDR-KDLFLVE-----HIPEAVDLFTRLLDPNPDL 655 (805)
Q Consensus 600 lGvil~elltG~~-------~Pf~~~~~----------~~~~-~~~~~-~~~~~~~-----~~~~~~dLi~~~L~~dP~~ 655 (805)
+|.+||||++... ++|.-.++ +... .+..+ ...++.. ....+++.+..||+.||+.
T Consensus 410 mgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeA 489 (534)
T KOG3653|consen 410 MGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEA 489 (534)
T ss_pred HHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhh
Confidence 9999999998522 22222222 1111 22211 2222211 1246789999999999999
Q ss_pred CCChhhhh
Q 003644 656 RPKAQNVL 663 (805)
Q Consensus 656 Rps~~ell 663 (805)
|.|+.-+.
T Consensus 490 RLTA~Cv~ 497 (534)
T KOG3653|consen 490 RLTAGCVE 497 (534)
T ss_pred hhhhHHHH
Confidence 99987553
|
|
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=313.31 Aligned_cols=248 Identities=33% Similarity=0.516 Sum_probs=191.0
Q ss_pred EEEeEeeccCCceEEEEEEe-eCCcEEEEEEeecCCc------------hHHHHHHHHHHHhCCCCCeeeecccccCCce
Q 003644 378 VVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH------------DVALKEIQNLIASDQHPNIVRWYGVESDQDF 444 (805)
Q Consensus 378 ~~~~~~LG~GsfGtVy~a~~-~~g~~VAVK~l~~~~~------------~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~ 444 (805)
|.+...||+|++|.||+|.. .+++.||||.+..... ....+|+ .+++.++||||+++++++.+.+.
T Consensus 2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~-~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREI-ALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHH-HHHHhcCCCCeeeEEEEEEeCCc
Confidence 45667899999999999854 4688999998854321 1122344 46788899999999999999999
Q ss_pred EEEecccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHH
Q 003644 445 VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSH 524 (805)
Q Consensus 445 l~LV~E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~y 524 (805)
.++||| |.++++|.+++... ..+++..+..++.|++.||+|
T Consensus 81 ~~lv~e----------~~~~~~L~~~l~~~-----------------------------~~l~~~~~~~~~~~l~~~l~~ 121 (267)
T cd06628 81 LNIFLE----------YVPGGSVAALLNNY-----------------------------GAFEETLVRNFVRQILKGLNY 121 (267)
T ss_pred cEEEEE----------ecCCCCHHHHHHhc-----------------------------cCccHHHHHHHHHHHHHHHHH
Confidence 999999 44555555554221 235667788999999999999
Q ss_pred hhhcceeccCCCCceEEecCCCCceEEEeccCccccccCCCccc---cccccccCCCCCCChhhhhcCCCCCcchHHHHH
Q 003644 525 LHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCL---TQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLG 601 (805)
Q Consensus 525 LH~~~IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~---~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlG 601 (805)
||+.+++||||+|+||+++.++. ++|+|||+++......... .......|+..|+|||.+.+..++.++|+||||
T Consensus 122 lH~~~ivH~di~p~nil~~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG 199 (267)
T cd06628 122 LHNRGIIHRDIKGANILVDNKGG--IKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLG 199 (267)
T ss_pred HHhcCcccccCCHHHEEEcCCCC--EEecccCCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHH
Confidence 99999999999999999987765 8999999998775322111 111223588999999999988899999999999
Q ss_pred HHHHHHHhCCCCCCCCchHHH--HHHHhhccccccccCChHHHHHHHHhcCCCCCCCCChhhhhcCccc
Q 003644 602 CILFFCITGGKHPYGESFERD--ANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 668 (805)
Q Consensus 602 vil~elltG~~~Pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dP~~Rps~~ell~Hpff 668 (805)
|++|+|++| ..||....... ..+........+.....++.++|++||+.||.+||++.++++||||
T Consensus 200 ~il~~l~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 200 CLVVEMLTG-KHPFPDCTQLQAIFKIGENASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267 (267)
T ss_pred HHHHHHhhC-CCCCCCccHHHHHHHHhccCCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence 999999996 77886543222 1222222223344556789999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=321.00 Aligned_cols=247 Identities=24% Similarity=0.340 Sum_probs=190.2
Q ss_pred eEEEeEeeccCCceEEEEEEe-eCCcEEEEEEeecCCc----hHHHHHHHHHHHhCCCCCeeeecccccCCceEEEeccc
Q 003644 377 LVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLER 451 (805)
Q Consensus 377 ~~~~~~~LG~GsfGtVy~a~~-~~g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~E~ 451 (805)
.|.+.+.||+|+||.||++.. .+|..||+|.+..... ....+|++ ++..++||||+++++++.+++..|+|||
T Consensus 2 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~-~l~~l~h~~iv~~~~~~~~~~~~~lv~e- 79 (308)
T cd06615 2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELK-VLHECNSPYIVGFYGAFYSDGEISICME- 79 (308)
T ss_pred CceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHH-HHHhCCCCCCCeEEEEEeeCCEEEEEee-
Confidence 477889999999999999854 4688999998864322 23445655 6677899999999999999999999999
Q ss_pred ccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhh-cce
Q 003644 452 CTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE-IGL 530 (805)
Q Consensus 452 ~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~-~~I 530 (805)
|..+++|.+++.. ...+++..+..++.|++.||+|||+ .++
T Consensus 80 ---------y~~~~~L~~~l~~-----------------------------~~~~~~~~~~~~~~~i~~~l~~lH~~~~i 121 (308)
T cd06615 80 ---------HMDGGSLDQVLKK-----------------------------AGRIPENILGKISIAVLRGLTYLREKHKI 121 (308)
T ss_pred ---------ccCCCcHHHHHHh-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHhhCCE
Confidence 5566666665532 1336677889999999999999998 589
Q ss_pred eccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHHHHHhC
Q 003644 531 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG 610 (805)
Q Consensus 531 vHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~elltG 610 (805)
+||||||+|||++.++. +||+|||++...... ......|+..|+|||++.+..++.++|+|||||++|+|++|
T Consensus 122 ~H~dl~p~nil~~~~~~--~~l~dfg~~~~~~~~-----~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g 194 (308)
T cd06615 122 MHRDVKPSNILVNSRGE--IKLCDFGVSGQLIDS-----MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIG 194 (308)
T ss_pred EECCCChHHEEEecCCc--EEEccCCCccccccc-----ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhC
Confidence 99999999999987765 899999998765432 12335689999999999888899999999999999999997
Q ss_pred CCCCCCCchHHHH-HHHhhc-------------------------------------ccc-ccccCChHHHHHHHHhcCC
Q 003644 611 GKHPYGESFERDA-NIVKDR-------------------------------------KDL-FLVEHIPEAVDLFTRLLDP 651 (805)
Q Consensus 611 ~~~Pf~~~~~~~~-~~~~~~-------------------------------------~~~-~~~~~~~~~~dLi~~~L~~ 651 (805)
..||........ ...... ... .....++++.+++.+||..
T Consensus 195 -~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 273 (308)
T cd06615 195 -RYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKK 273 (308)
T ss_pred -CCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccC
Confidence 566643221111 111100 000 0012356799999999999
Q ss_pred CCCCCCChhhhhcCcccccc
Q 003644 652 NPDLRPKAQNVLNHPFFWTA 671 (805)
Q Consensus 652 dP~~Rps~~ell~Hpff~~~ 671 (805)
||++||++.++++||||...
T Consensus 274 ~P~~Rpt~~~ll~~~~~~~~ 293 (308)
T cd06615 274 NPKERADLKELTKHPFIKRA 293 (308)
T ss_pred ChhhCcCHHHHhcChhhhhc
Confidence 99999999999999999653
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=320.38 Aligned_cols=264 Identities=24% Similarity=0.321 Sum_probs=187.4
Q ss_pred ceEEEeEeeccCCceEEEEEEee-----------------CCcEEEEEEeecCCch----HHHHHHHHHHHhCCCCCeee
Q 003644 376 KLVVFNKEIAKGSNGTVVLEGNY-----------------EGRSVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVR 434 (805)
Q Consensus 376 ~~~~~~~~LG~GsfGtVy~a~~~-----------------~g~~VAVK~l~~~~~~----~~~~Ei~~ll~~l~HpNIV~ 434 (805)
.+|.+.+.||+|+||.||++... .+..||||.+...... ...+|+. ++..++||||++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~-~l~~l~h~niv~ 83 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVK-ILSRLKDPNIIR 83 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHH-HHhhcCCCCeeE
Confidence 45778899999999999997542 2347999998754322 3445665 677889999999
Q ss_pred ecccccCCceEEEecccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHH
Q 003644 435 WYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKV 514 (805)
Q Consensus 435 l~g~~~~~~~l~LV~E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i 514 (805)
+++++.+.+..++||||| .+|+|.+++............ +...........+++..++.+
T Consensus 84 ~~~~~~~~~~~~lv~e~~----------~~~~L~~~l~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~i 143 (304)
T cd05096 84 LLGVCVDEDPLCMITEYM----------ENGDLNQFLSSHHLDDKEENG----------NDAVPPAHCLPAISYSSLLHV 143 (304)
T ss_pred EEEEEecCCceEEEEecC----------CCCcHHHHHHhcccccccccc----------ccccccccccccccHHHHHHH
Confidence 999999999999999954 455555554332110000000 000000011234677888999
Q ss_pred HHHHHHHHHHhhhcceeccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCc
Q 003644 515 TRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRA 594 (805)
Q Consensus 515 ~~qIa~gL~yLH~~~IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~ 594 (805)
+.||+.||+|||+.+|+||||||+|||++.++. +||+|||+++.+..... ........++..|+|||++..+.++.+
T Consensus 144 ~~~i~~al~~lH~~~ivH~dlkp~Nill~~~~~--~kl~DfG~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~ 220 (304)
T cd05096 144 ALQIASGMKYLSSLNFVHRDLATRNCLVGENLT--IKIADFGMSRNLYAGDY-YRIQGRAVLPIRWMAWECILMGKFTTA 220 (304)
T ss_pred HHHHHHHHHHHHHCCccccCcchhheEEcCCcc--EEECCCccceecccCce-eEecCcCCCCccccCHHHHhcCCCCch
Confidence 999999999999999999999999999987765 89999999986643221 111223346789999999998899999
Q ss_pred chHHHHHHHHHHHHhC-CCCCCCCchHHHH-HHH----hhc----cccccccCChHHHHHHHHhcCCCCCCCCChhhhh
Q 003644 595 IDLFSLGCILFFCITG-GKHPYGESFERDA-NIV----KDR----KDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVL 663 (805)
Q Consensus 595 sDVwSlGvil~elltG-~~~Pf~~~~~~~~-~~~----~~~----~~~~~~~~~~~~~dLi~~~L~~dP~~Rps~~ell 663 (805)
+|||||||++|||+++ +..||........ ... ... ....+...++.+.+++.+||+.||++|||++++.
T Consensus 221 ~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~ 299 (304)
T cd05096 221 SDVWAFGVTLWEILMLCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIH 299 (304)
T ss_pred hhhHHHHHHHHHHHHccCCCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHH
Confidence 9999999999999875 4567765332211 111 000 1112234457899999999999999999999994
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=309.52 Aligned_cols=253 Identities=23% Similarity=0.342 Sum_probs=203.0
Q ss_pred cceEEEe-EeeccCCceEEEEE-EeeCCcEEEEEEeecCCchHHHHHHHHHHHhCCCCCeeeecccccC----CceEEEe
Q 003644 375 GKLVVFN-KEIAKGSNGTVVLE-GNYEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYGVESD----QDFVYLS 448 (805)
Q Consensus 375 ~~~~~~~-~~LG~GsfGtVy~a-~~~~g~~VAVK~l~~~~~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~----~~~l~LV 448 (805)
.++|.+. ++||-|-.|.|... ...+|+.+|+|++... ..+.+|++.......|||||++++++.. ..++++|
T Consensus 60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds--~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiV 137 (400)
T KOG0604|consen 60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS--PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIV 137 (400)
T ss_pred hhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC--HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEee
Confidence 3344433 57999999999765 5567999999998754 6778888765666789999999998754 5789999
Q ss_pred cccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhc
Q 003644 449 LERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI 528 (805)
Q Consensus 449 ~E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~ 528 (805)
|| .|.+|.|+..+..+. ...+++.++..|++||+.|+.|||+.
T Consensus 138 mE----------~meGGeLfsriq~~g---------------------------~~afTErea~eI~~qI~~Av~~lH~~ 180 (400)
T KOG0604|consen 138 ME----------CMEGGELFSRIQDRG---------------------------DQAFTEREASEIMKQIGLAVRYLHSM 180 (400)
T ss_pred ee----------cccchHHHHHHHHcc---------------------------cccchHHHHHHHHHHHHHHHHHHHhc
Confidence 99 889999988775543 24477889999999999999999999
Q ss_pred ceeccCCCCceEEecCC-CCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHHHH
Q 003644 529 GLIHRDLKPQNVLISKD-KSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFC 607 (805)
Q Consensus 529 ~IvHrDLKp~NILl~~~-~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~el 607 (805)
+|.||||||+|+|.+.. .+..+||+|||+|+..... ....+.|-||.|.|||++-..+|+..+|+||+||++|-|
T Consensus 181 nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~~----~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIl 256 (400)
T KOG0604|consen 181 NIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQEP----GDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYIL 256 (400)
T ss_pred chhhccCChhheeeecCCCCcceEecccccccccCCC----ccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHh
Confidence 99999999999999643 3456899999999976642 234566789999999999999999999999999999999
Q ss_pred HhCCCCCCCCchH-----HHHHHHhhccccccccC----ChHHHHHHHHhcCCCCCCCCChhhhhcCcccccc
Q 003644 608 ITGGKHPYGESFE-----RDANIVKDRKDLFLVEH----IPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTA 671 (805)
Q Consensus 608 ltG~~~Pf~~~~~-----~~~~~~~~~~~~~~~~~----~~~~~dLi~~~L~~dP~~Rps~~ell~Hpff~~~ 671 (805)
++| .|||-+... .....+......|+... +.+++|+|+++|..+|++|.|.++++.|||....
T Consensus 257 LCG-yPPFYS~hg~aispgMk~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~ 328 (400)
T KOG0604|consen 257 LCG-YPPFYSNHGLAISPGMKRRIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQY 328 (400)
T ss_pred hcC-CCcccccCCccCChhHHhHhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhccc
Confidence 997 677755332 22334444444454433 4688999999999999999999999999998654
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=311.14 Aligned_cols=259 Identities=26% Similarity=0.369 Sum_probs=198.3
Q ss_pred EEEeEeeccCCceEEEEEEeeC-----CcEEEEEEeecCC-----chHHHHHHHHHHHhCCCCCeeeecccccC-CceEE
Q 003644 378 VVFNKEIAKGSNGTVVLEGNYE-----GRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESD-QDFVY 446 (805)
Q Consensus 378 ~~~~~~LG~GsfGtVy~a~~~~-----g~~VAVK~l~~~~-----~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~-~~~l~ 446 (805)
|...+.||+|.||.||+|...+ .+.+|+|+++... ...+.+|+. +++.++||||+.|..++.. +..++
T Consensus 26 ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREia-L~REl~h~nvi~Lv~Vfl~~d~~v~ 104 (438)
T KOG0666|consen 26 YEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIA-LLRELKHPNVISLVKVFLSHDKKVW 104 (438)
T ss_pred hhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHH-HHHHhcCCcchhHHHHHhccCceEE
Confidence 5566889999999999983322 2379999997542 357889997 8888999999999999887 78899
Q ss_pred EecccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhh
Q 003644 447 LSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH 526 (805)
Q Consensus 447 LV~E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH 526 (805)
|++||.+-+|.+.|..+..+ +.+.+|...+..|+.||+.|+.|||
T Consensus 105 l~fdYAEhDL~~II~fHr~~-----------------------------------~~~~lp~~mvKsilwQil~Gv~YLH 149 (438)
T KOG0666|consen 105 LLFDYAEHDLWHIIKFHRAS-----------------------------------KAKQLPRSMVKSILWQILDGVHYLH 149 (438)
T ss_pred EEehhhhhhHHHHHHHhccc-----------------------------------hhccCCHHHHHHHHHHHHhhhHHHh
Confidence 99999988888888554322 1234677888999999999999999
Q ss_pred hcceeccCCCCceEEecCCCC--ceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcC-CCCCcchHHHHHHH
Q 003644 527 EIGLIHRDLKPQNVLISKDKS--FCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG-RQTRAIDLFSLGCI 603 (805)
Q Consensus 527 ~~~IvHrDLKp~NILl~~~~~--~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~t~~sDVwSlGvi 603 (805)
+.-|+||||||.|||+..+|. -++||+|||+++.+...-.........+-|.+|.|||.+.+. .||.++||||.|||
T Consensus 150 ~NWvlHRDLKPaNIlvmgdgperG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCI 229 (438)
T KOG0666|consen 150 SNWVLHRDLKPANILVMGDGPERGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCI 229 (438)
T ss_pred hhheeeccCCcceEEEeccCCccCeeEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHH
Confidence 999999999999999976621 359999999999987665444445566789999999999985 58999999999999
Q ss_pred HHHHHhCCCCCCCCch-------------HHHHH---------------------HHhhcccccc------------ccC
Q 003644 604 LFFCITGGKHPYGESF-------------ERDAN---------------------IVKDRKDLFL------------VEH 637 (805)
Q Consensus 604 l~elltG~~~Pf~~~~-------------~~~~~---------------------~~~~~~~~~~------------~~~ 637 (805)
+.||+|-...+++... .+... .+......+. ...
T Consensus 230 faElLtl~PlF~g~E~k~~~~~Pfq~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k 309 (438)
T KOG0666|consen 230 FAELLTLEPLFKGREEKIKTKNPFQHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVK 309 (438)
T ss_pred HHHHHccCccccchhhhcccCCCchHHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCC
Confidence 9999996333322110 00000 0000000000 012
Q ss_pred ChHHHHHHHHhcCCCCCCCCChhhhhcCccccccc
Q 003644 638 IPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTAD 672 (805)
Q Consensus 638 ~~~~~dLi~~~L~~dP~~Rps~~ell~Hpff~~~~ 672 (805)
++.+.+|+.+||+.||.+|.|++++|+|+||...+
T Consensus 310 ~~~a~~LL~klL~yDP~kRIta~qAleh~yF~~d~ 344 (438)
T KOG0666|consen 310 DPSALDLLQKLLTYDPIKRITAEQALEHPYFTEDP 344 (438)
T ss_pred CchHHHHHHHHhccCchhhccHHHHhcccccccCC
Confidence 34588999999999999999999999999997664
|
|
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=310.16 Aligned_cols=247 Identities=27% Similarity=0.433 Sum_probs=192.1
Q ss_pred eEEEeEeeccCCceEEEEEEeeC-CcEEEEEEeecCCc-hHHHHHHHHHHHhCCCCCeeeecccccCCceEEEecccccC
Q 003644 377 LVVFNKEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHH-DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTC 454 (805)
Q Consensus 377 ~~~~~~~LG~GsfGtVy~a~~~~-g~~VAVK~l~~~~~-~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~E~~~~ 454 (805)
.|.+.+.||+|+||.||++...+ ++.||+|.+..... ....+|+. +++.++||||+++++++.++...|+++|++
T Consensus 4 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~e~~-~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~-- 80 (256)
T cd06612 4 VFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEIS-ILKQCDSPYIVKYYGSYFKNTDLWIVMEYC-- 80 (256)
T ss_pred cchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHHHHHHHHHHH-HHHhCCCCcEeeeeeeeecCCcEEEEEecC--
Confidence 46677889999999999986654 89999999865432 33445554 677789999999999999999999999954
Q ss_pred ChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcceeccC
Q 003644 455 SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRD 534 (805)
Q Consensus 455 sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~IvHrD 534 (805)
.+++|.+++... ...+++..+..++.|++.||+|||+.+++|||
T Consensus 81 --------~~~~L~~~l~~~----------------------------~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~d 124 (256)
T cd06612 81 --------GAGSVSDIMKIT----------------------------NKTLTEEEIAAILYQTLKGLEYLHSNKKIHRD 124 (256)
T ss_pred --------CCCcHHHHHHhC----------------------------ccCCCHHHHHHHHHHHHHHHHHHHHCCcccCC
Confidence 455555544211 13467788899999999999999999999999
Q ss_pred CCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCC
Q 003644 535 LKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP 614 (805)
Q Consensus 535 LKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~elltG~~~P 614 (805)
|+|+||+++.++. ++|+|||++........ ......|+..|+|||++.+..++.++|||||||++|+|++| .+|
T Consensus 125 l~~~ni~~~~~~~--~~l~dfg~~~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g-~~p 198 (256)
T cd06612 125 IKAGNILLNEEGQ--AKLADFGVSGQLTDTMA---KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEG-KPP 198 (256)
T ss_pred CCcceEEECCCCc--EEEcccccchhcccCcc---ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhC-CCC
Confidence 9999999988776 89999999987654321 12234478999999999988899999999999999999997 778
Q ss_pred CCCchHHHHHHHhhc--cc--cccccCChHHHHHHHHhcCCCCCCCCChhhhhcCccc
Q 003644 615 YGESFERDANIVKDR--KD--LFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 668 (805)
Q Consensus 615 f~~~~~~~~~~~~~~--~~--~~~~~~~~~~~dLi~~~L~~dP~~Rps~~ell~Hpff 668 (805)
|.............. .. ..+.....++.++|.+||+.||++||++.|+++||||
T Consensus 199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~~~~ 256 (256)
T cd06612 199 YSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI 256 (256)
T ss_pred CCCcchhhhhhhhccCCCCCCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcCCCC
Confidence 765433322111111 10 1112334689999999999999999999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=316.16 Aligned_cols=247 Identities=29% Similarity=0.445 Sum_probs=196.0
Q ss_pred eEEEeEeeccCCceEEEEEEee-CCcEEEEEEeecCC------chHHHHHHHHHHHhCCCCCeeeecccccCCceEEEec
Q 003644 377 LVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH------HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSL 449 (805)
Q Consensus 377 ~~~~~~~LG~GsfGtVy~a~~~-~g~~VAVK~l~~~~------~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~ 449 (805)
.|.+.+.||+|+||.||++... +++.||||.+.+.. .+...+|+. ++..++||||+++++++.+++..|+||
T Consensus 2 ~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 2 DFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKR-ILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred ceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHH-HHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 4778899999999999998554 68999999986432 123344554 678889999999999999999999999
Q ss_pred ccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcc
Q 003644 450 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG 529 (805)
Q Consensus 450 E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~ 529 (805)
|+| .+++|.+++.. ...+++..+..++.||+.||+|||+.+
T Consensus 81 e~~----------~~~~L~~~~~~-----------------------------~~~l~~~~~~~~~~qil~~l~~lH~~~ 121 (290)
T cd05580 81 EYV----------PGGELFSHLRK-----------------------------SGRFPEPVARFYAAQVVLALEYLHSLD 121 (290)
T ss_pred ecC----------CCCCHHHHHHH-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 955 44555444321 134667788899999999999999999
Q ss_pred eeccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHHHHHh
Q 003644 530 LIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCIT 609 (805)
Q Consensus 530 IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~ellt 609 (805)
|+||||+|+|||++.++. +||+|||+++..... .....|++.|+|||.+.+...+.++||||||+++|+|++
T Consensus 122 i~H~dl~p~nili~~~~~--~kl~dfg~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~ 193 (290)
T cd05580 122 IVYRDLKPENLLLDSDGY--IKITDFGFAKRVKGR------TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLA 193 (290)
T ss_pred EecCCCCHHHEEECCCCC--EEEeeCCCccccCCC------CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHh
Confidence 999999999999988775 899999999876533 233468999999999988888999999999999999999
Q ss_pred CCCCCCCCchHHH-HHHHhhccccccccCChHHHHHHHHhcCCCCCCCC-----ChhhhhcCccccccc
Q 003644 610 GGKHPYGESFERD-ANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRP-----KAQNVLNHPFFWTAD 672 (805)
Q Consensus 610 G~~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dP~~Rp-----s~~ell~Hpff~~~~ 672 (805)
| ..||....... ...+.......+....+.++++|.+||+.||.+|+ +++|+++||||...+
T Consensus 194 g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~ 261 (290)
T cd05580 194 G-YPPFFDDNPIQIYEKILEGKVRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGID 261 (290)
T ss_pred C-CCCCCCCCHHHHHHHHhcCCccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCcccccCC
Confidence 7 77876544322 22222223334445578999999999999999999 899999999996644
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=316.98 Aligned_cols=252 Identities=26% Similarity=0.413 Sum_probs=196.0
Q ss_pred cccceEEEeEeeccCCceEEEEEEe-eCCcEEEEEEeecCCc---hHHHHHHHHHHHhCCCCCeeeecccccCCceEEEe
Q 003644 373 RIGKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH---DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLS 448 (805)
Q Consensus 373 ~i~~~~~~~~~LG~GsfGtVy~a~~-~~g~~VAVK~l~~~~~---~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV 448 (805)
...+.|...+.||+|+||+||++.. .+++.||+|.+..... ....+|+. ++..+.||||+++++++.+++..|+|
T Consensus 17 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~-~l~~~~h~~v~~~~~~~~~~~~~~lv 95 (296)
T cd06654 17 DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEIL-VMRENKNPNIVNYLDSYLVGDELWVV 95 (296)
T ss_pred CcccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHH-HHHhCCCCCEeeEEEEEEeCCEEEEe
Confidence 3446788889999999999999854 5789999999865432 23344554 66788999999999999999999999
Q ss_pred cccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhc
Q 003644 449 LERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI 528 (805)
Q Consensus 449 ~E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~ 528 (805)
|| |+.+++|.+++.. ..+++.++..++.|++.||+|||+.
T Consensus 96 ~e----------~~~~~~L~~~~~~------------------------------~~~~~~~~~~i~~ql~~aL~~LH~~ 135 (296)
T cd06654 96 ME----------YLAGGSLTDVVTE------------------------------TCMDEGQIAAVCRECLQALEFLHSN 135 (296)
T ss_pred ec----------ccCCCCHHHHHHh------------------------------cCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 99 6666666665421 1245667789999999999999999
Q ss_pred ceeccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHHHHH
Q 003644 529 GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCI 608 (805)
Q Consensus 529 ~IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~ell 608 (805)
||+||||||+||+++.++. +||+|||++........ ......|++.|+|||.+.+..++.++|||||||++|+|+
T Consensus 136 gi~H~dLkp~Nill~~~~~--~kl~dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~ 210 (296)
T cd06654 136 QVIHRDIKSDNILLGMDGS--VKLTDFGFCAQITPEQS---KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMI 210 (296)
T ss_pred CcccCCCCHHHEEEcCCCC--EEECccccchhcccccc---ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHH
Confidence 9999999999999987765 89999999886543211 122345889999999999888999999999999999999
Q ss_pred hCCCCCCCCchHHHH--HHHhhcc-c-cccccCChHHHHHHHHhcCCCCCCCCChhhhhcCcccccc
Q 003644 609 TGGKHPYGESFERDA--NIVKDRK-D-LFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTA 671 (805)
Q Consensus 609 tG~~~Pf~~~~~~~~--~~~~~~~-~-~~~~~~~~~~~dLi~~~L~~dP~~Rps~~ell~Hpff~~~ 671 (805)
+| .+||........ ....... . ..+....+.+.++|.+||..||++||++.++++||||...
T Consensus 211 ~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~~~~~ 276 (296)
T cd06654 211 EG-EPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIA 276 (296)
T ss_pred hC-CCCCCCCCHHHhHHHHhcCCCCCCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhChhhhcc
Confidence 97 667765433221 1111111 1 1223455789999999999999999999999999999643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=330.24 Aligned_cols=275 Identities=22% Similarity=0.304 Sum_probs=189.8
Q ss_pred ceEEEeEeeccCCceEEEEEEe------eCCcEEEEEEeecCCc----hHHHHHHHHHHHhC-CCCCeeeecccccCCce
Q 003644 376 KLVVFNKEIAKGSNGTVVLEGN------YEGRSVAVKRLVKTHH----DVALKEIQNLIASD-QHPNIVRWYGVESDQDF 444 (805)
Q Consensus 376 ~~~~~~~~LG~GsfGtVy~a~~------~~g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l-~HpNIV~l~g~~~~~~~ 444 (805)
+.|.+.+.||+|+||.||++.. .++..||||++..... ....+|+. +++.+ +|||||+++++|.+.+.
T Consensus 38 ~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~-il~~l~~h~nIv~~~~~~~~~~~ 116 (374)
T cd05106 38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELK-ILSHLGQHKNIVNLLGACTHGGP 116 (374)
T ss_pred HHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHH-HHHhhccCCceeeEeeEecCCCC
Confidence 4578889999999999998742 2346899999975432 23445665 45555 89999999999999999
Q ss_pred EEEecccccCChhhHHHHhcCCHHHHHhhhhccchhhHH-----------HH----------------------------
Q 003644 445 VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNE-----------VR---------------------------- 485 (805)
Q Consensus 445 l~LV~E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~-----------~~---------------------------- 485 (805)
.|+||||| .+|+|.++++........... +.
T Consensus 117 ~~lv~ey~----------~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 186 (374)
T cd05106 117 VLVITEYC----------CYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRP 186 (374)
T ss_pred eEEeHhhc----------cCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCC
Confidence 99999955 445555544332110000000 00
Q ss_pred --hhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCCCceEEecCCCCceEEEeccCccccccC
Q 003644 486 --IRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQG 563 (805)
Q Consensus 486 --~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~ 563 (805)
....................+++..+++++.||+.||+|||+.+|+||||||+|||++.++. +||+|||+++....
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~--~kL~DfGla~~~~~ 264 (374)
T cd05106 187 VSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRV--AKICDFGLARDIMN 264 (374)
T ss_pred ccccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCe--EEEeeceeeeeccC
Confidence 00000000000011112345788899999999999999999999999999999999987654 89999999987643
Q ss_pred CCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH--HHHHhhc-cccccccCChH
Q 003644 564 DMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERD--ANIVKDR-KDLFLVEHIPE 640 (805)
Q Consensus 564 ~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~elltG~~~Pf~~~~~~~--~~~~~~~-~~~~~~~~~~~ 640 (805)
.... .......++..|+|||++.+..++.++|||||||++|||++.|++||....... ....... ....+...+++
T Consensus 265 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 343 (374)
T cd05106 265 DSNY-VVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRPDFAPPE 343 (374)
T ss_pred Ccce-eeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccCCCCCCHH
Confidence 3211 111223356789999999988999999999999999999984488886543221 1222222 12223334689
Q ss_pred HHHHHHHhcCCCCCCCCChhhhhc
Q 003644 641 AVDLFTRLLDPNPDLRPKAQNVLN 664 (805)
Q Consensus 641 ~~dLi~~~L~~dP~~Rps~~ell~ 664 (805)
+.+++.+||+.||.+||++.++++
T Consensus 344 l~~li~~cl~~dp~~RPs~~~l~~ 367 (374)
T cd05106 344 IYSIMKMCWNLEPTERPTFSQISQ 367 (374)
T ss_pred HHHHHHHHcCCChhhCcCHHHHHH
Confidence 999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=312.81 Aligned_cols=246 Identities=21% Similarity=0.289 Sum_probs=187.0
Q ss_pred ceEEEeEeeccCCceEEEEEEee----CCcEEEEEEeecCCch----HHHHHHHHHHHhCCCCCeeeecccccCCceEEE
Q 003644 376 KLVVFNKEIAKGSNGTVVLEGNY----EGRSVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVRWYGVESDQDFVYL 447 (805)
Q Consensus 376 ~~~~~~~~LG~GsfGtVy~a~~~----~g~~VAVK~l~~~~~~----~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~L 447 (805)
+.|.+.+.||+|+||.||++... .+..||+|.++..... ...+|+. .+..++||||+++++++.+++..|+
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~-~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEAL-TLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHH-HHhcCCCCCcCeEEEEEecCCCcEE
Confidence 45788899999999999997542 4678999998754322 2344554 6677899999999999999999999
Q ss_pred ecccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhh
Q 003644 448 SLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE 527 (805)
Q Consensus 448 V~E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~ 527 (805)
||| |+.+|+|.+++... ...+++..++.++.||+.||+|||+
T Consensus 84 v~e----------~~~~~~L~~~l~~~----------------------------~~~l~~~~~~~~~~~i~~al~~lH~ 125 (266)
T cd05064 84 VTE----------YMSNGALDSFLRKH----------------------------EGQLVAGQLMGMLPGLASGMKYLSE 125 (266)
T ss_pred EEE----------eCCCCcHHHHHHhC----------------------------CCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 999 55566666554321 1236777889999999999999999
Q ss_pred cceeccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHHHH
Q 003644 528 IGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFC 607 (805)
Q Consensus 528 ~~IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~el 607 (805)
.+++||||||+|||++.++. ++++|||.+........ .......++..|+|||++.+..++.++|||||||++||+
T Consensus 126 ~~iiH~dikp~nili~~~~~--~~l~dfg~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el 201 (266)
T cd05064 126 MGYVHKGLAAHKVLVNSDLV--CKISGFRRLQEDKSEAI--YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEV 201 (266)
T ss_pred CCEeeccccHhhEEEcCCCc--EEECCCcccccccccch--hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHH
Confidence 99999999999999987765 89999998765432211 111223456789999999999999999999999999998
Q ss_pred HhCCCCCCCCchHH-HHHHHhhc-cccccccCChHHHHHHHHhcCCCCCCCCChhhhhc
Q 003644 608 ITGGKHPYGESFER-DANIVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 664 (805)
Q Consensus 608 ltG~~~Pf~~~~~~-~~~~~~~~-~~~~~~~~~~~~~dLi~~~L~~dP~~Rps~~ell~ 664 (805)
++.|..||...... ....+... ....+...+..+.+++.+||+.+|.+||+++++++
T Consensus 202 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 202 MSYGERPYWDMSGQDVIKAVEDGFRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHS 260 (266)
T ss_pred hcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHH
Confidence 86457788654332 22222222 22233445678999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=316.64 Aligned_cols=249 Identities=27% Similarity=0.414 Sum_probs=195.8
Q ss_pred cceEEEeEeeccCCceEEEEEE-eeCCcEEEEEEeecCCc---hHHHHHHHHHHHhCCCCCeeeecccccCCceEEEecc
Q 003644 375 GKLVVFNKEIAKGSNGTVVLEG-NYEGRSVAVKRLVKTHH---DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 450 (805)
Q Consensus 375 ~~~~~~~~~LG~GsfGtVy~a~-~~~g~~VAVK~l~~~~~---~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~E 450 (805)
.+.|.+.+.||.|++|+||++. ..+|+.||||.+..... ....+|+. +++.++||||+++++++.+.+..|+|+|
T Consensus 18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~-~l~~l~h~~iv~~~~~~~~~~~~~lv~e 96 (296)
T cd06655 18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEIL-VMKELKNPNIVNFLDSFLVGDELFVVME 96 (296)
T ss_pred cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHH-HHHhcCCCceeeeeeeEecCceEEEEEE
Confidence 4568899999999999999975 46789999998864322 23334544 6788899999999999999999999999
Q ss_pred cccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcce
Q 003644 451 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 530 (805)
Q Consensus 451 ~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~I 530 (805)
|..+++|..++. ...+++.+++.++.|++.||+|||+.|+
T Consensus 97 ----------~~~~~~L~~~~~------------------------------~~~l~~~~~~~i~~~l~~al~~LH~~~i 136 (296)
T cd06655 97 ----------YLAGGSLTDVVT------------------------------ETCMDEAQIAAVCRECLQALEFLHANQV 136 (296)
T ss_pred ----------ecCCCcHHHHHH------------------------------hcCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence 555666655432 1236778889999999999999999999
Q ss_pred eccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHHHHHhC
Q 003644 531 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG 610 (805)
Q Consensus 531 vHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~elltG 610 (805)
+||||||+||+++.++. +||+|||++........ ......|+..|+|||.+.+..++.++|||||||++|+|++|
T Consensus 137 ~H~dL~p~Nili~~~~~--~kl~dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg 211 (296)
T cd06655 137 IHRDIKSDNVLLGMDGS--VKLTDFGFCAQITPEQS---KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEG 211 (296)
T ss_pred ccCCCCHHHEEECCCCC--EEEccCccchhcccccc---cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhC
Confidence 99999999999988775 89999999887654321 11234588999999999988899999999999999999997
Q ss_pred CCCCCCCchHHH-HHHHh-hcc--ccccccCChHHHHHHHHhcCCCCCCCCChhhhhcCccccc
Q 003644 611 GKHPYGESFERD-ANIVK-DRK--DLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWT 670 (805)
Q Consensus 611 ~~~Pf~~~~~~~-~~~~~-~~~--~~~~~~~~~~~~dLi~~~L~~dP~~Rps~~ell~Hpff~~ 670 (805)
.+||....... ...+. ... ...+...++.+.++|.+||..||.+||++.++++||||..
T Consensus 212 -~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~ 274 (296)
T cd06655 212 -EPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKL 274 (296)
T ss_pred -CCCCCCCCHHHHHHHHHhcCCcccCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhChHhhh
Confidence 66776543322 21111 111 1123345678999999999999999999999999999954
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=316.07 Aligned_cols=233 Identities=20% Similarity=0.264 Sum_probs=181.8
Q ss_pred EeeccCCceEEEEEEeeCCcEEEEEEeecCCc------hHHHHHHHHHHHhCCCCCeeeecccccC----CceEEEeccc
Q 003644 382 KEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHH------DVALKEIQNLIASDQHPNIVRWYGVESD----QDFVYLSLER 451 (805)
Q Consensus 382 ~~LG~GsfGtVy~a~~~~g~~VAVK~l~~~~~------~~~~~Ei~~ll~~l~HpNIV~l~g~~~~----~~~l~LV~E~ 451 (805)
..||+|++|.||++. .+|+.||||++..... +...+|+. ++..++|||||+++|++.+ ....++|||
T Consensus 26 ~~i~~g~~~~v~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~-~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~E- 102 (283)
T PHA02988 26 VLIKENDQNSIYKGI-FNNKEVIIRTFKKFHKGHKVLIDITENEIK-NLRRIDSNNILKIYGFIIDIVDDLPRLSLILE- 102 (283)
T ss_pred eEEeeCCceEEEEEE-ECCEEEEEEeccccccccHHHHHHHHHHHH-HHHhcCCCCEEEEeeeEEecccCCCceEEEEE-
Confidence 459999999999964 5899999999965421 22235554 7788999999999999876 457899999
Q ss_pred ccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhc-ce
Q 003644 452 CTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI-GL 530 (805)
Q Consensus 452 ~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~-~I 530 (805)
|+.+|+|.+++... ..+++...+.++.|++.||+|||+. ++
T Consensus 103 ---------y~~~g~L~~~l~~~-----------------------------~~~~~~~~~~i~~~i~~~l~~lH~~~~~ 144 (283)
T PHA02988 103 ---------YCTRGYLREVLDKE-----------------------------KDLSFKTKLDMAIDCCKGLYNLYKYTNK 144 (283)
T ss_pred ---------eCCCCcHHHHHhhC-----------------------------CCCChhHHHHHHHHHHHHHHHHHhcCCC
Confidence 55666666665321 2355667789999999999999984 99
Q ss_pred eccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhc--CCCCCcchHHHHHHHHHHHH
Q 003644 531 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ--GRQTRAIDLFSLGCILFFCI 608 (805)
Q Consensus 531 vHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~--~~~t~~sDVwSlGvil~ell 608 (805)
+||||||+|||++.++. +||+|||+++..... .....||..|+|||++.+ ..++.++|||||||++|||+
T Consensus 145 ~Hrdlkp~nill~~~~~--~kl~dfg~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~ 216 (283)
T PHA02988 145 PYKNLTSVSFLVTENYK--LKIICHGLEKILSSP------PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIF 216 (283)
T ss_pred CCCcCChhhEEECCCCc--EEEcccchHhhhccc------cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHH
Confidence 99999999999988765 899999999865432 123458899999999976 67899999999999999999
Q ss_pred hCCCCCCCCchHHHH-H-HHhhc-cccccccCChHHHHHHHHhcCCCCCCCCChhhhhc
Q 003644 609 TGGKHPYGESFERDA-N-IVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 664 (805)
Q Consensus 609 tG~~~Pf~~~~~~~~-~-~~~~~-~~~~~~~~~~~~~dLi~~~L~~dP~~Rps~~ell~ 664 (805)
+| ..||......+. . +.... ....+...++++++++.+||+.||++|||++|+++
T Consensus 217 ~g-~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 274 (283)
T PHA02988 217 TG-KIPFENLTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILY 274 (283)
T ss_pred HC-CCCCCCCCHHHHHHHHHhcCCCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 96 778876543322 2 22222 22233356789999999999999999999999984
|
|
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=327.40 Aligned_cols=254 Identities=26% Similarity=0.406 Sum_probs=196.9
Q ss_pred cccceEEEeEeeccCCceEEEEEEeeCCcEEEEEEeecCCc-----hHHHHHHHHHHHhCCCCCeeeecccccCCceEEE
Q 003644 373 RIGKLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHH-----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYL 447 (805)
Q Consensus 373 ~i~~~~~~~~~LG~GsfGtVy~a~~~~g~~VAVK~l~~~~~-----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~L 447 (805)
.-++.|...+.||+|+...||++...+.+.+|+|++..... +....|+..|-+.-.|.+||+||+|...++++||
T Consensus 358 Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYm 437 (677)
T KOG0596|consen 358 VKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYM 437 (677)
T ss_pred ECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEE
Confidence 34566888899999999999998888888899998753322 2345677755555679999999999999999999
Q ss_pred ecccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhh
Q 003644 448 SLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE 527 (805)
Q Consensus 448 V~E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~ 527 (805)
|||+-+++|..++.-..+...+ -.++.+..|++.|+.+.|+
T Consensus 438 vmE~Gd~DL~kiL~k~~~~~~~---------------------------------------~~lk~ywkqML~aV~~IH~ 478 (677)
T KOG0596|consen 438 VMECGDIDLNKILKKKKSIDPD---------------------------------------WFLKFYWKQMLLAVKTIHQ 478 (677)
T ss_pred EeecccccHHHHHHhccCCCch---------------------------------------HHHHHHHHHHHHHHHHHHH
Confidence 9998888888777433332221 1457889999999999999
Q ss_pred cceeccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCC-----------CCCcch
Q 003644 528 IGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGR-----------QTRAID 596 (805)
Q Consensus 528 ~~IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~-----------~t~~sD 596 (805)
+||||.||||.|.|+-.. .+||+|||+|..+..+.... .....+||+.||+||.+.... .++++|
T Consensus 479 ~gIVHSDLKPANFLlVkG---~LKLIDFGIA~aI~~DTTsI-~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SD 554 (677)
T KOG0596|consen 479 HGIVHSDLKPANFLLVKG---RLKLIDFGIANAIQPDTTSI-VKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSD 554 (677)
T ss_pred hceeecCCCcccEEEEee---eEEeeeechhcccCccccce-eeccccCcccccCHHHHhhccccccCCCcceeecCccc
Confidence 999999999999998543 38999999999888765433 335568999999999987532 457999
Q ss_pred HHHHHHHHHHHHhCCCCCCCCchHHHHH---HHhhccccccccCC--hHHHHHHHHhcCCCCCCCCChhhhhcCccccc
Q 003644 597 LFSLGCILFFCITGGKHPYGESFERDAN---IVKDRKDLFLVEHI--PEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWT 670 (805)
Q Consensus 597 VwSlGvil~elltG~~~Pf~~~~~~~~~---~~~~~~~~~~~~~~--~~~~dLi~~~L~~dP~~Rps~~ell~Hpff~~ 670 (805)
|||||||||+|+.| ++||+.-...... +..........+.+ .++.++++.||..||.+||++.|+|+|||..-
T Consensus 555 vWSLGCILYqMvYg-ktPf~~~~n~~aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~ 632 (677)
T KOG0596|consen 555 VWSLGCILYQMVYG-KTPFGQIINQIAKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQHPFLQI 632 (677)
T ss_pred hhhhhhHHHHHHhc-CCchHHHHHHHHHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcCccccc
Confidence 99999999999996 8899875433322 22221211122222 24999999999999999999999999999854
|
|
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=308.05 Aligned_cols=247 Identities=26% Similarity=0.456 Sum_probs=193.1
Q ss_pred EEEeEeeccCCceEEEEEEe-eCCcEEEEEEeecCC-----chHHHHHHHHHHHhCCCCCeeeecccccCCceEEEeccc
Q 003644 378 VVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLER 451 (805)
Q Consensus 378 ~~~~~~LG~GsfGtVy~a~~-~~g~~VAVK~l~~~~-----~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~E~ 451 (805)
|.+.+.||+|+||+||++.. .+|+.||+|++.... .....+|+. .++.++||||+++++++.+.+..|+|+|
T Consensus 2 y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~-~l~~l~~~~i~~~~~~~~~~~~~~lv~e- 79 (256)
T cd08218 2 YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVA-VLSNMKHPNIVQYQESFEENGNLYIVMD- 79 (256)
T ss_pred ceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHH-HHHhCCCCCeeeeEeeecCCCeEEEEEe-
Confidence 66789999999999999754 468999999986421 123445554 6788999999999999999999999999
Q ss_pred ccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhccee
Q 003644 452 CTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLI 531 (805)
Q Consensus 452 ~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~Iv 531 (805)
|+.+++|.+++... ....+++.+++.++.|++.||+|||+.+++
T Consensus 80 ---------~~~~~~l~~~~~~~---------------------------~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~ 123 (256)
T cd08218 80 ---------YCEGGDLYKKINAQ---------------------------RGVLFPEDQILDWFVQICLALKHVHDRKIL 123 (256)
T ss_pred ---------cCCCCcHHHHHHhc---------------------------cCCCCCHHHHHHHHHHHHHHHHHHHhCCEe
Confidence 44555555544321 112356778899999999999999999999
Q ss_pred ccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHHHHHhCC
Q 003644 532 HRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGG 611 (805)
Q Consensus 532 HrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~elltG~ 611 (805)
|+||+|+||+++.++. ++|+|||++........ ......|++.|+|||++.+..++.++|+|||||++|+|++|
T Consensus 124 h~~l~~~nil~~~~~~--~~l~d~~~~~~~~~~~~---~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g- 197 (256)
T cd08218 124 HRDIKSQNIFLTKDGT--IKLGDFGIARVLNSTVE---LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTL- 197 (256)
T ss_pred cCCCCHHHEEEcCCCC--EEEeeccceeecCcchh---hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcC-
Confidence 9999999999987765 89999999986643211 11234588999999999988899999999999999999997
Q ss_pred CCCCCCchHHH--HHHHhhccccccccCChHHHHHHHHhcCCCCCCCCChhhhhcCccc
Q 003644 612 KHPYGESFERD--ANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 668 (805)
Q Consensus 612 ~~Pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dP~~Rps~~ell~Hpff 668 (805)
..||....... ..+........+....+++.++|.+||+.+|.+||++.++++||||
T Consensus 198 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 198 KHAFEAGNMKNLVLKIIRGSYPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEKNFI 256 (256)
T ss_pred CCCccCCCHHHHHHHHhcCCCCCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhCcCC
Confidence 66775443222 1223333333444567789999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=313.94 Aligned_cols=247 Identities=24% Similarity=0.361 Sum_probs=186.7
Q ss_pred ceEEEeEeeccCCceEEEEEEee-CCcEEEEEEeecCC----chHHHHHHHHHHHhCCCCCeeeecccccCCceEEEecc
Q 003644 376 KLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH----HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 450 (805)
Q Consensus 376 ~~~~~~~~LG~GsfGtVy~a~~~-~g~~VAVK~l~~~~----~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~E 450 (805)
+.|.+.+.||+|++|+||++... +++.||||.+.... .....+|+. +++.++||||+++++++.+++..|+|||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~-~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREAS-LLKDLKHANIVTLHDIIHTKKTLTLVFE 83 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHH-HHhhCCCcceeeEEEEEecCCeEEEEEe
Confidence 45788899999999999998654 68999999986432 123455665 6788899999999999999999999999
Q ss_pred cccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcce
Q 003644 451 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 530 (805)
Q Consensus 451 ~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~I 530 (805)
|+.++|.+++... ...+++..++.++.|++.||+|||+.+|
T Consensus 84 ~~~~~L~~~~~~~---------------------------------------~~~~~~~~~~~~~~ql~~al~~lH~~~i 124 (291)
T cd07844 84 YLDTDLKQYMDDC---------------------------------------GGGLSMHNVRLFLFQLLRGLAYCHQRRV 124 (291)
T ss_pred cCCCCHHHHHHhC---------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 7766655544211 1235667789999999999999999999
Q ss_pred eccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhc-CCCCCcchHHHHHHHHHHHHh
Q 003644 531 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ-GRQTRAIDLFSLGCILFFCIT 609 (805)
Q Consensus 531 vHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~t~~sDVwSlGvil~ellt 609 (805)
+||||||+||+++.++. +||+|||+++....... ......++..|+|||++.+ ..++.++||||+||++|+|++
T Consensus 125 ~H~dl~p~nil~~~~~~--~kl~dfg~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~ 199 (291)
T cd07844 125 LHRDLKPQNLLISERGE--LKLADFGLARAKSVPSK---TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMAT 199 (291)
T ss_pred ecccCCHHHEEEcCCCC--EEECccccccccCCCCc---cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHh
Confidence 99999999999988776 89999999875432111 1122346889999999875 457899999999999999999
Q ss_pred CCCCCCCCchHH--HHH-HHhhc---------------------c-----c-----cccccCChHHHHHHHHhcCCCCCC
Q 003644 610 GGKHPYGESFER--DAN-IVKDR---------------------K-----D-----LFLVEHIPEAVDLFTRLLDPNPDL 655 (805)
Q Consensus 610 G~~~Pf~~~~~~--~~~-~~~~~---------------------~-----~-----~~~~~~~~~~~dLi~~~L~~dP~~ 655 (805)
| .+||...... ... +.... . . .......+++.+++.+||+.||++
T Consensus 200 g-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~ 278 (291)
T cd07844 200 G-RPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKK 278 (291)
T ss_pred C-CCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCccc
Confidence 7 7788544311 100 00000 0 0 000111267889999999999999
Q ss_pred CCChhhhhcCccc
Q 003644 656 RPKAQNVLNHPFF 668 (805)
Q Consensus 656 Rps~~ell~Hpff 668 (805)
|||+.|+++||||
T Consensus 279 Rps~~e~l~~~~f 291 (291)
T cd07844 279 RISAAEAMKHPYF 291 (291)
T ss_pred ccCHHHHhcCCCC
Confidence 9999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=311.71 Aligned_cols=248 Identities=30% Similarity=0.387 Sum_probs=185.0
Q ss_pred EEEeEeeccCCceEEEEEEe-eCCcEEEEEEeecCCc--------hHHHHHHHHHHHhCCCCCeeeecccccC--CceEE
Q 003644 378 VVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH--------DVALKEIQNLIASDQHPNIVRWYGVESD--QDFVY 446 (805)
Q Consensus 378 ~~~~~~LG~GsfGtVy~a~~-~~g~~VAVK~l~~~~~--------~~~~~Ei~~ll~~l~HpNIV~l~g~~~~--~~~l~ 446 (805)
|...+.||+|+||.||++.. .+++.||+|++..... ....+|+. +++.++||||+++++++.+ .+..+
T Consensus 4 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (266)
T cd06651 4 WRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQ-LLKNLQHERIVQYYGCLRDRAEKTLT 82 (266)
T ss_pred ccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHH-HHHHcCCCCeeeEEEEEEcCCCCEEE
Confidence 55678899999999999855 4689999998854311 12334554 7788899999999998765 46789
Q ss_pred EecccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhh
Q 003644 447 LSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH 526 (805)
Q Consensus 447 LV~E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH 526 (805)
+++|+ ..+++|.+++... ..+++...+.++.|++.||+|||
T Consensus 83 l~~e~----------~~~~~L~~~l~~~-----------------------------~~l~~~~~~~~~~qi~~~l~~LH 123 (266)
T cd06651 83 IFMEY----------MPGGSVKDQLKAY-----------------------------GALTESVTRKYTRQILEGMSYLH 123 (266)
T ss_pred EEEeC----------CCCCcHHHHHHHc-----------------------------CCCCHHHHHHHHHHHHHHHHHHH
Confidence 99994 4455555544221 22556677899999999999999
Q ss_pred hcceeccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHHH
Q 003644 527 EIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFF 606 (805)
Q Consensus 527 ~~~IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~e 606 (805)
+.+|+||||||+||+++.++. +||+|||+++................++..|+|||++.+..++.++|||||||++||
T Consensus 124 ~~~i~H~~l~p~nil~~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~e 201 (266)
T cd06651 124 SNMIVHRDIKGANILRDSAGN--VKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVE 201 (266)
T ss_pred hCCeeeCCCCHHHEEECCCCC--EEEccCCCccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHH
Confidence 999999999999999987765 899999999866432111111223458899999999998889999999999999999
Q ss_pred HHhCCCCCCCCchHHHH--HHHhhc-cccccccCChHHHHHHHHhcCCCCCCCCChhhhhcCcccc
Q 003644 607 CITGGKHPYGESFERDA--NIVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFW 669 (805)
Q Consensus 607 lltG~~~Pf~~~~~~~~--~~~~~~-~~~~~~~~~~~~~dLi~~~L~~dP~~Rps~~ell~Hpff~ 669 (805)
|++| .+||........ ...... ....+....+.+.+++ +||..+|++||+++|+++||||.
T Consensus 202 l~~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 202 MLTE-KPPWAEYEAMAAIFKIATQPTNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLRHPFAQ 265 (266)
T ss_pred HHHC-CCCccccchHHHHHHHhcCCCCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence 9997 778875432221 111111 1122333456788888 67778999999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=314.22 Aligned_cols=247 Identities=24% Similarity=0.340 Sum_probs=186.9
Q ss_pred ceEEEeEeeccCCceEEEEEEe-eCCcEEEEEEeecCCc----hHHHHHHHHHHHhCCCCCeeeecccccCCceEEEecc
Q 003644 376 KLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 450 (805)
Q Consensus 376 ~~~~~~~~LG~GsfGtVy~a~~-~~g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~E 450 (805)
+.|.+.+.||+|+||.||++.. .+|+.||||++..... ....+|+. ++..++|+||+++++++.+++..|+|+|
T Consensus 5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~-~l~~l~h~ni~~~~~~~~~~~~~~lv~e 83 (291)
T cd07870 5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREAS-LLKGLKHANIVLLHDIIHTKETLTFVFE 83 (291)
T ss_pred ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHH-HHHhcCCCCEeEEEEEEecCCeEEEEEe
Confidence 5688889999999999999854 5689999999864321 23455664 6778899999999999999999999999
Q ss_pred cccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcce
Q 003644 451 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 530 (805)
Q Consensus 451 ~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~I 530 (805)
++.++|.+++... ...+++..+..++.|++.||+|||+.+|
T Consensus 84 ~~~~~l~~~~~~~---------------------------------------~~~~~~~~~~~~~~qi~~~L~~lH~~~i 124 (291)
T cd07870 84 YMHTDLAQYMIQH---------------------------------------PGGLHPYNVRLFMFQLLRGLAYIHGQHI 124 (291)
T ss_pred cccCCHHHHHHhC---------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCc
Confidence 7766655443211 1234556678899999999999999999
Q ss_pred eccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcC-CCCCcchHHHHHHHHHHHHh
Q 003644 531 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG-RQTRAIDLFSLGCILFFCIT 609 (805)
Q Consensus 531 vHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~t~~sDVwSlGvil~ellt 609 (805)
+||||||+|||++.++. +||+|||+++....... ......+++.|+|||++.+. .++.++|||||||++|||++
T Consensus 125 ~H~dlkp~Nil~~~~~~--~~l~Dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~ 199 (291)
T cd07870 125 LHRDLKPQNLLISYLGE--LKLADFGLARAKSIPSQ---TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQ 199 (291)
T ss_pred ccCCCChHHEEEcCCCc--EEEeccccccccCCCCC---CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHh
Confidence 99999999999988776 89999999876532211 11233578999999998754 47889999999999999999
Q ss_pred CCCCCCCCchHHHHHHHhh-----------------cc----ccc-------------cccCChHHHHHHHHhcCCCCCC
Q 003644 610 GGKHPYGESFERDANIVKD-----------------RK----DLF-------------LVEHIPEAVDLFTRLLDPNPDL 655 (805)
Q Consensus 610 G~~~Pf~~~~~~~~~~~~~-----------------~~----~~~-------------~~~~~~~~~dLi~~~L~~dP~~ 655 (805)
| .+||.........+... .. ... .....+++.+++.+|++.||.+
T Consensus 200 g-~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~ 278 (291)
T cd07870 200 G-QPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKD 278 (291)
T ss_pred C-CCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCccc
Confidence 7 67886533211111000 00 000 0012457889999999999999
Q ss_pred CCChhhhhcCccc
Q 003644 656 RPKAQNVLNHPFF 668 (805)
Q Consensus 656 Rps~~ell~Hpff 668 (805)
|||++|++.||||
T Consensus 279 R~t~~~~l~h~~~ 291 (291)
T cd07870 279 RISAQDALLHPYF 291 (291)
T ss_pred CcCHHHHhcCCCC
Confidence 9999999999997
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=314.56 Aligned_cols=245 Identities=27% Similarity=0.382 Sum_probs=185.6
Q ss_pred eeccCCceEEEEEEe-eCCcEEEEEEeecCCc-----hH-HHHHH--HHHHHhCCCCCeeeecccccCCceEEEeccccc
Q 003644 383 EIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH-----DV-ALKEI--QNLIASDQHPNIVRWYGVESDQDFVYLSLERCT 453 (805)
Q Consensus 383 ~LG~GsfGtVy~a~~-~~g~~VAVK~l~~~~~-----~~-~~~Ei--~~ll~~l~HpNIV~l~g~~~~~~~l~LV~E~~~ 453 (805)
.||+|+||.||++.. .+|+.||||.+.+... .. ..+|. ..++...+||||+.+++++.+++..|+|||
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e--- 77 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILD--- 77 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEe---
Confidence 389999999999865 4689999998864321 11 22222 234445689999999999999999999999
Q ss_pred CChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcceecc
Q 003644 454 CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHR 533 (805)
Q Consensus 454 ~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~IvHr 533 (805)
|+.+|+|.+++.. ...+++..+..++.|++.||+|||+.+|+||
T Consensus 78 -------~~~~~~L~~~i~~-----------------------------~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~ 121 (279)
T cd05633 78 -------LMNGGDLHYHLSQ-----------------------------HGVFSEKEMRFYATEIILGLEHMHNRFVVYR 121 (279)
T ss_pred -------cCCCCCHHHHHHh-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCcCCC
Confidence 5556666555422 1346778889999999999999999999999
Q ss_pred CCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhc-CCCCCcchHHHHHHHHHHHHhCCC
Q 003644 534 DLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ-GRQTRAIDLFSLGCILFFCITGGK 612 (805)
Q Consensus 534 DLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~t~~sDVwSlGvil~elltG~~ 612 (805)
||||+|||++.++. ++|+|||++....... .....||..|+|||.+.. ..++.++|+|||||++|||++| .
T Consensus 122 dikp~Nil~~~~~~--~~l~dfg~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g-~ 193 (279)
T cd05633 122 DLKPANILLDEHGH--VRISDLGLACDFSKKK-----PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRG-H 193 (279)
T ss_pred CCCHHHEEECCCCC--EEEccCCcceeccccC-----ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhC-C
Confidence 99999999987765 8999999987554221 123458999999999864 5578999999999999999997 6
Q ss_pred CCCCCchHHH----HHHHhhccccccccCChHHHHHHHHhcCCCCCCCC-----ChhhhhcCccccccccc
Q 003644 613 HPYGESFERD----ANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRP-----KAQNVLNHPFFWTADTR 674 (805)
Q Consensus 613 ~Pf~~~~~~~----~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dP~~Rp-----s~~ell~Hpff~~~~~~ 674 (805)
.||....... ...........+...++++.++|.+||+.||.+|| +++|+++||||...+..
T Consensus 194 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~~~~~ 264 (279)
T cd05633 194 SPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGIDWQ 264 (279)
T ss_pred CCcCCCCCcCHHHHHHHhhcCCcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccccCCCHh
Confidence 6775432111 11111112223445678999999999999999999 69999999999775543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=308.98 Aligned_cols=251 Identities=26% Similarity=0.397 Sum_probs=201.4
Q ss_pred EeeccCCceEEEEE-EeeCCcEEEEEEeecCC---chHHHHHHHHHHHhCCCCCeeeecccccCCceEEEecccccCChh
Q 003644 382 KEIAKGSNGTVVLE-GNYEGRSVAVKRLVKTH---HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCSLN 457 (805)
Q Consensus 382 ~~LG~GsfGtVy~a-~~~~g~~VAVK~l~~~~---~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~E~~~~sL~ 457 (805)
+.||+|+||.|--+ ...+|.++|||++.+.. ....++|++.+...-.|+||+.|+.+|+|++.+|||||
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfE------- 156 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFE------- 156 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEe-------
Confidence 56999999999654 67889999999997653 35678999988888899999999999999999999999
Q ss_pred hHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCCC
Q 003644 458 DLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKP 537 (805)
Q Consensus 458 d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~IvHrDLKp 537 (805)
.|.+|.|-.+++.+ ..+.+.++.++.++|+.||.|||.+||.||||||
T Consensus 157 ---Km~GGplLshI~~~-----------------------------~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKP 204 (463)
T KOG0607|consen 157 ---KMRGGPLLSHIQKR-----------------------------KHFNEREASRVVKDIASALDFLHTKGIAHRDLKP 204 (463)
T ss_pred ---cccCchHHHHHHHh-----------------------------hhccHHHHHHHHHHHHHHHHHHhhcCcccccCCc
Confidence 99999998877443 4467788999999999999999999999999999
Q ss_pred ceEEecCCCCc-eEEEeccCccccccCCCcc----ccccccccCCCCCCChhhhhc-----CCCCCcchHHHHHHHHHHH
Q 003644 538 QNVLISKDKSF-CAKLSDMGISKRLQGDMSC----LTQNATGYGSSGWQAPEQLLQ-----GRQTRAIDLFSLGCILFFC 607 (805)
Q Consensus 538 ~NILl~~~~~~-~~kL~DFGla~~~~~~~~~----~~~~~~~~gt~~y~APE~l~~-----~~~t~~sDVwSlGvil~el 607 (805)
+|||-....++ -+|||||.|...+.-.... .....+.+|+..|||||+..- ..|+.++|.||||||+|-|
T Consensus 205 ENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYIm 284 (463)
T KOG0607|consen 205 ENILCESPNKVSPVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIM 284 (463)
T ss_pred cceeecCCCCcCceeeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHH
Confidence 99998655443 4899999887554322111 123355689999999998742 3588999999999999999
Q ss_pred HhCCCCCCCCchH----------------HHHHHHhhccccccccC----ChHHHHHHHHhcCCCCCCCCChhhhhcCcc
Q 003644 608 ITGGKHPYGESFE----------------RDANIVKDRKDLFLVEH----IPEAVDLFTRLLDPNPDLRPKAQNVLNHPF 667 (805)
Q Consensus 608 ltG~~~Pf~~~~~----------------~~~~~~~~~~~~~~~~~----~~~~~dLi~~~L~~dP~~Rps~~ell~Hpf 667 (805)
|+| .+||...-. ....-++..+..++... +.+++|+|..+|..|+..|.++.++++|||
T Consensus 285 LsG-YpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw 363 (463)
T KOG0607|consen 285 LSG-YPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPW 363 (463)
T ss_pred HhC-CCCccCccCCcCCccCCCccHHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCcc
Confidence 997 778843211 11233455555565543 468999999999999999999999999999
Q ss_pred ccccc
Q 003644 668 FWTAD 672 (805)
Q Consensus 668 f~~~~ 672 (805)
+....
T Consensus 364 ~~~~~ 368 (463)
T KOG0607|consen 364 VQRCA 368 (463)
T ss_pred ccccc
Confidence 96543
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=308.90 Aligned_cols=248 Identities=25% Similarity=0.369 Sum_probs=190.5
Q ss_pred ceEEEeEeeccCCceEEEEEEeeCCcEEEEEEeecCCc-hHHHHHHHHHHHhCCCCCeeeecccccCCceEEEecccccC
Q 003644 376 KLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHH-DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTC 454 (805)
Q Consensus 376 ~~~~~~~~LG~GsfGtVy~a~~~~g~~VAVK~l~~~~~-~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~E~~~~ 454 (805)
+.|.+.++||+|+||+||++...++..||+|.+..... ...+.+...+++.++||||+++++++.+.+..|++||
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e---- 81 (261)
T cd05072 6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITE---- 81 (261)
T ss_pred HHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCchhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEe----
Confidence 45788899999999999999877888999999865332 2233333347788999999999999999999999999
Q ss_pred ChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcceeccC
Q 003644 455 SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRD 534 (805)
Q Consensus 455 sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~IvHrD 534 (805)
|+.+|+|.++++... ...+++..++.++.|++.||+|||+.+++|||
T Consensus 82 ------~~~~~~L~~~l~~~~---------------------------~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~d 128 (261)
T cd05072 82 ------YMAKGSLLDFLKSDE---------------------------GGKVLLPKLIDFSAQIAEGMAYIERKNYIHRD 128 (261)
T ss_pred ------cCCCCcHHHHHHHhc---------------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCeeccc
Confidence 555666666554321 12355667789999999999999999999999
Q ss_pred CCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCC
Q 003644 535 LKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP 614 (805)
Q Consensus 535 LKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~elltG~~~P 614 (805)
|||+||+++.++. ++|+|||+++....... .......++..|+|||++....++.++|||||||++|+|++++.+|
T Consensus 129 l~p~nili~~~~~--~~l~dfg~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p 204 (261)
T cd05072 129 LRAANVLVSESLM--CKIADFGLARVIEDNEY--TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIP 204 (261)
T ss_pred cchhhEEecCCCc--EEECCCccceecCCCce--eccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCC
Confidence 9999999987765 89999999987653211 1112233567899999998888999999999999999999956889
Q ss_pred CCCchHHH-HHHHhhc-cccccccCChHHHHHHHHhcCCCCCCCCChhhhhc
Q 003644 615 YGESFERD-ANIVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 664 (805)
Q Consensus 615 f~~~~~~~-~~~~~~~-~~~~~~~~~~~~~dLi~~~L~~dP~~Rps~~ell~ 664 (805)
|....... ...+... ........+.++.+++.+||..+|++||+++++++
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 256 (261)
T cd05072 205 YPGMSNSDVMSALQRGYRMPRMENCPDELYDIMKTCWKEKAEERPTFDYLQS 256 (261)
T ss_pred CCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 86543322 2222211 22222345678999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-35 Score=311.63 Aligned_cols=246 Identities=26% Similarity=0.424 Sum_probs=187.7
Q ss_pred eEEEeEeeccCCceEEEEEEee-CCcEEEEEEeecCCc-----hHHHHHHHHHHHhCCCCCeeeecccccCCceEEEecc
Q 003644 377 LVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHH-----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 450 (805)
Q Consensus 377 ~~~~~~~LG~GsfGtVy~a~~~-~g~~VAVK~l~~~~~-----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~E 450 (805)
.|.+.+.||+|++|.||++... +|+.||+|++..... ....+|+. +++.++||||+++++++.+.+..++|||
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~-~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 2 KYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIR-MLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred ceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHH-HHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 4778889999999999998654 689999999864321 23345554 7788899999999999999999999999
Q ss_pred cccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcce
Q 003644 451 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 530 (805)
Q Consensus 451 ~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~I 530 (805)
|+.+ +.+..++. ....+++..++.++.||+.||+|||+.+|
T Consensus 81 ~~~~----------~~l~~~~~-----------------------------~~~~~~~~~~~~~~~ql~~~l~~LH~~~i 121 (286)
T cd07847 81 YCDH----------TVLNELEK-----------------------------NPRGVPEHLIKKIIWQTLQAVNFCHKHNC 121 (286)
T ss_pred ccCc----------cHHHHHHh-----------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence 5554 33333221 11236778889999999999999999999
Q ss_pred eccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhc-CCCCCcchHHHHHHHHHHHHh
Q 003644 531 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ-GRQTRAIDLFSLGCILFFCIT 609 (805)
Q Consensus 531 vHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~t~~sDVwSlGvil~ellt 609 (805)
+||||||+||+++.++. ++|+|||++........ ......++..|+|||++.+ ..++.++|||||||++|||++
T Consensus 122 ~H~dl~p~nil~~~~~~--~~l~dfg~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~ 196 (286)
T cd07847 122 IHRDVKPENILITKQGQ--IKLCDFGFARILTGPGD---DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLT 196 (286)
T ss_pred eecCCChhhEEEcCCCc--EEECccccceecCCCcc---cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHh
Confidence 99999999999988775 89999999987654321 1123357889999999876 457899999999999999999
Q ss_pred CCCCCCCCchHHHH--HHHhhc----------------------cc--------cccccCChHHHHHHHHhcCCCCCCCC
Q 003644 610 GGKHPYGESFERDA--NIVKDR----------------------KD--------LFLVEHIPEAVDLFTRLLDPNPDLRP 657 (805)
Q Consensus 610 G~~~Pf~~~~~~~~--~~~~~~----------------------~~--------~~~~~~~~~~~dLi~~~L~~dP~~Rp 657 (805)
| .+||......+. .+.... .. ......++++.+++.+||+.||++||
T Consensus 197 g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 275 (286)
T cd07847 197 G-QPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERL 275 (286)
T ss_pred C-CCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccC
Confidence 7 778865332211 111000 00 00112356789999999999999999
Q ss_pred ChhhhhcCccc
Q 003644 658 KAQNVLNHPFF 668 (805)
Q Consensus 658 s~~ell~Hpff 668 (805)
++.|++.||||
T Consensus 276 ~~~eil~~~~f 286 (286)
T cd07847 276 SCEELLEHPYF 286 (286)
T ss_pred CHHHHhcCCCC
Confidence 99999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=307.91 Aligned_cols=245 Identities=22% Similarity=0.373 Sum_probs=189.3
Q ss_pred eEEEeEeeccCCceEEEEEEeeCCcEEEEEEeecCC--chHHHHHHHHHHHhCCCCCeeeecccccCCceEEEecccccC
Q 003644 377 LVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTH--HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTC 454 (805)
Q Consensus 377 ~~~~~~~LG~GsfGtVy~a~~~~g~~VAVK~l~~~~--~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~E~~~~ 454 (805)
.|.+.+.||+|+||.||++...++..+|+|.+.... .....+|+. ++..++||||+++++++.+.+..++|||
T Consensus 5 ~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~iv~e---- 79 (256)
T cd05114 5 ELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAK-VMMKLSHPKLVQLYGVCTQQKPLYIVTE---- 79 (256)
T ss_pred HcEEeeEecCCcCceEEEEEeccCceEEEEecccCCccHHHHHHHHH-HHHHCCCCCceeEEEEEccCCCEEEEEE----
Confidence 467788999999999999988788899999886543 234455655 7788999999999999999999999999
Q ss_pred ChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcceeccC
Q 003644 455 SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRD 534 (805)
Q Consensus 455 sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~IvHrD 534 (805)
|.++|+|.++++... ..+++..++.++.|++.||+|||+.+|+|||
T Consensus 80 ------~~~~~~L~~~~~~~~----------------------------~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~d 125 (256)
T cd05114 80 ------FMENGCLLNYLRQRQ----------------------------GKLSKDMLLSMCQDVCEGMEYLERNSFIHRD 125 (256)
T ss_pred ------cCCCCcHHHHHHhCc----------------------------cCCCHHHHHHHHHHHHHHHHHHHHCCccccc
Confidence 555556655543211 1256677899999999999999999999999
Q ss_pred CCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCC
Q 003644 535 LKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP 614 (805)
Q Consensus 535 LKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~elltG~~~P 614 (805)
|||+||+++.++. +||+|||+++....... .......++..|+|||++....++.++|||||||++|||++++++|
T Consensus 126 l~p~ni~i~~~~~--~kl~d~g~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p 201 (256)
T cd05114 126 LAARNCLVSSTGV--VKVSDFGMTRYVLDDEY--TSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMP 201 (256)
T ss_pred cCcceEEEcCCCe--EEECCCCCccccCCCce--eccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCC
Confidence 9999999977664 89999999886543211 1111223566899999998888999999999999999999955888
Q ss_pred CCCchHHH-HHHHh-hccccccccCChHHHHHHHHhcCCCCCCCCChhhhhc
Q 003644 615 YGESFERD-ANIVK-DRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 664 (805)
Q Consensus 615 f~~~~~~~-~~~~~-~~~~~~~~~~~~~~~dLi~~~L~~dP~~Rps~~ell~ 664 (805)
|....... ...+. ......+....+++.+++.+||+.||.+||+++++++
T Consensus 202 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~ 253 (256)
T cd05114 202 FEKKSNYEVVEMISRGFRLYRPKLASMTVYEVMYSCWHEKPEGRPTFAELLR 253 (256)
T ss_pred CCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 87644322 22222 2222223345678999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=312.28 Aligned_cols=246 Identities=23% Similarity=0.365 Sum_probs=187.1
Q ss_pred ceEEEeEeeccCCceEEEEEEe-eCCcEEEEEEeecCCc---hHHHHHHHHHHHhCCCCCeeeecccccCCceEEEeccc
Q 003644 376 KLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH---DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLER 451 (805)
Q Consensus 376 ~~~~~~~~LG~GsfGtVy~a~~-~~g~~VAVK~l~~~~~---~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~E~ 451 (805)
+.|.+.+.||+|+||.||++.. .+|+.||+|++..... ....+|+. ++..++||||+++++++.+++..|+|||
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~-~l~~~~h~~ii~~~~~~~~~~~~~iv~e- 86 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIF-MVKECKHCNIVAYFGSYLSREKLWICME- 86 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHH-HHHhcCCCCeeeeeEEEEeCCEEEEEEe-
Confidence 4577889999999999999864 5789999999864321 22334554 6788999999999999999999999999
Q ss_pred ccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhccee
Q 003644 452 CTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLI 531 (805)
Q Consensus 452 ~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~Iv 531 (805)
|+.+|+|.++++. ...+++..+..++.|++.||+|||+.+|+
T Consensus 87 ---------~~~~~~L~~~~~~-----------------------------~~~~~~~~~~~~~~qi~~~l~~lH~~~i~ 128 (267)
T cd06646 87 ---------YCGGGSLQDIYHV-----------------------------TGPLSELQIAYVCRETLQGLAYLHSKGKM 128 (267)
T ss_pred ---------CCCCCcHHHHHHh-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 5555666655432 12356778899999999999999999999
Q ss_pred ccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhh---cCCCCCcchHHHHHHHHHHHH
Q 003644 532 HRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLL---QGRQTRAIDLFSLGCILFFCI 608 (805)
Q Consensus 532 HrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~---~~~~t~~sDVwSlGvil~ell 608 (805)
||||||+||+++.++. ++|+|||+++...... .......|+..|+|||.+. ...++.++|||||||++|||+
T Consensus 129 H~dl~p~nill~~~~~--~~l~dfg~~~~~~~~~---~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~ 203 (267)
T cd06646 129 HRDIKGANILLTDNGD--VKLADFGVAAKITATI---AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELA 203 (267)
T ss_pred ccCCCHHHEEECCCCC--EEECcCccceeecccc---cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHH
Confidence 9999999999987765 8999999998764321 1122345889999999985 345788999999999999999
Q ss_pred hCCCCCCCCchHHHH--HHHhhccc----cccccCChHHHHHHHHhcCCCCCCCCChhhhhcCcc
Q 003644 609 TGGKHPYGESFERDA--NIVKDRKD----LFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPF 667 (805)
Q Consensus 609 tG~~~Pf~~~~~~~~--~~~~~~~~----~~~~~~~~~~~dLi~~~L~~dP~~Rps~~ell~Hpf 667 (805)
+| .+||........ .+...... ......+.++.++|.+||+.||++||+++++++|+|
T Consensus 204 ~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 204 EL-QPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred hC-CCCccccchhhhheeeecCCCCCCCCccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence 97 556643322111 11111000 011234578999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=317.19 Aligned_cols=251 Identities=27% Similarity=0.424 Sum_probs=195.7
Q ss_pred ccceEEEeEeeccCCceEEEEEEe-eCCcEEEEEEeecCCc---hHHHHHHHHHHHhCCCCCeeeecccccCCceEEEec
Q 003644 374 IGKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH---DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSL 449 (805)
Q Consensus 374 i~~~~~~~~~LG~GsfGtVy~a~~-~~g~~VAVK~l~~~~~---~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~ 449 (805)
..+.|.+.+.||+|+||.||++.. .+++.||+|.+..... +...+|+. +++.++||||+++++++.+++..|+||
T Consensus 17 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~-~l~~~~h~~i~~~~~~~~~~~~~~lv~ 95 (297)
T cd06656 17 PKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEIL-VMRENKNPNIVNYLDSYLVGDELWVVM 95 (297)
T ss_pred hhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHH-HHHhCCCCCEeeEEEEEecCCEEEEee
Confidence 346688889999999999999864 5799999999865332 22334544 678899999999999999999999999
Q ss_pred ccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcc
Q 003644 450 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG 529 (805)
Q Consensus 450 E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~ 529 (805)
| |+++++|.+++.. ..+++.++..++.|++.||+|||+.+
T Consensus 96 e----------~~~~~~L~~~~~~------------------------------~~~~~~~~~~~~~~l~~~L~~LH~~~ 135 (297)
T cd06656 96 E----------YLAGGSLTDVVTE------------------------------TCMDEGQIAAVCRECLQALDFLHSNQ 135 (297)
T ss_pred c----------ccCCCCHHHHHHh------------------------------CCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 9 6666666665421 23566678899999999999999999
Q ss_pred eeccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHHHHHh
Q 003644 530 LIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCIT 609 (805)
Q Consensus 530 IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~ellt 609 (805)
|+||||||+|||++.++. ++|+|||++........ ......+++.|+|||.+.+..++.++|+|||||++|++++
T Consensus 136 i~H~dL~p~Nili~~~~~--~~l~Dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~t 210 (297)
T cd06656 136 VIHRDIKSDNILLGMDGS--VKLTDFGFCAQITPEQS---KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVE 210 (297)
T ss_pred cccCCCCHHHEEECCCCC--EEECcCccceEccCCcc---CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHh
Confidence 999999999999988776 89999999876643321 1223458899999999998889999999999999999999
Q ss_pred CCCCCCCCchHHHH-H-HHhhcc-c-cccccCChHHHHHHHHhcCCCCCCCCChhhhhcCcccccc
Q 003644 610 GGKHPYGESFERDA-N-IVKDRK-D-LFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTA 671 (805)
Q Consensus 610 G~~~Pf~~~~~~~~-~-~~~~~~-~-~~~~~~~~~~~dLi~~~L~~dP~~Rps~~ell~Hpff~~~ 671 (805)
| .+||........ . +..... . ..+....+.+.+++.+||+.||++||+++++++||||...
T Consensus 211 g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 275 (297)
T cd06656 211 G-EPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLA 275 (297)
T ss_pred C-CCCCCCCCcchheeeeccCCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhccc
Confidence 7 677754332211 1 111111 1 1223445688999999999999999999999999999643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=332.62 Aligned_cols=250 Identities=26% Similarity=0.341 Sum_probs=195.4
Q ss_pred EeEeeccCCceEEEEEEeeC-CcEEEEEEeecCCc---hHHHHHHHHHHHhCCCCCeeeecccccCCceEEEecccccCC
Q 003644 380 FNKEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHH---DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCS 455 (805)
Q Consensus 380 ~~~~LG~GsfGtVy~a~~~~-g~~VAVK~l~~~~~---~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~E~~~~s 455 (805)
+...||.|+||+||+|...+ +-..|-|.+..... ++..-||. +++..+||+||+|++.|..++.+||..|+|+|.
T Consensus 36 IiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIe-ILa~CdHP~ivkLl~ayy~enkLwiliEFC~GG 114 (1187)
T KOG0579|consen 36 IIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIE-ILAECDHPVIVKLLSAYYFENKLWILIEFCGGG 114 (1187)
T ss_pred HHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhh-hhhcCCChHHHHHHHHHhccCceEEEEeecCCc
Confidence 44679999999999986554 44556677643322 23445665 678889999999999999999999999998875
Q ss_pred hhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcceeccCC
Q 003644 456 LNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDL 535 (805)
Q Consensus 456 L~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~IvHrDL 535 (805)
--|-|... -.+++.+.++..+++|++.||.|||+.+||||||
T Consensus 115 AVDaimlE--------------------------------------L~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDL 156 (1187)
T KOG0579|consen 115 AVDAIMLE--------------------------------------LGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDL 156 (1187)
T ss_pred hHhHHHHH--------------------------------------hccccchHHHHHHHHHHHHHHHHHhhcchhhhhc
Confidence 44444221 1356788899999999999999999999999999
Q ss_pred CCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhh-----cCCCCCcchHHHHHHHHHHHHhC
Q 003644 536 KPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLL-----QGRQTRAIDLFSLGCILFFCITG 610 (805)
Q Consensus 536 Kp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~-----~~~~t~~sDVwSlGvil~elltG 610 (805)
|..|||++.||. ++|+|||.+...... .....+++|||.|||||++. ..+|+.++||||||+.|.||..+
T Consensus 157 KAGNiL~TldGd--irLADFGVSAKn~~t---~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqi 231 (1187)
T KOG0579|consen 157 KAGNILLTLDGD--IRLADFGVSAKNKST---RQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQI 231 (1187)
T ss_pred cccceEEEecCc--EeeecccccccchhH---HhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhcc
Confidence 999999999998 889999998765432 33456788999999999875 46899999999999999999996
Q ss_pred CCCCCCCchHH--HHHHHhhccc--cccccCChHHHHHHHHhcCCCCCCCCChhhhhcCccccccccc
Q 003644 611 GKHPYGESFER--DANIVKDRKD--LFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTADTR 674 (805)
Q Consensus 611 ~~~Pf~~~~~~--~~~~~~~~~~--~~~~~~~~~~~dLi~~~L~~dP~~Rps~~ell~Hpff~~~~~~ 674 (805)
.||..+...- ...+.+..+. ..+..++..+.|++++||.+||..||+++++++||||.+....
T Consensus 232 -EPPHhelnpMRVllKiaKSePPTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~~Sn 298 (1187)
T KOG0579|consen 232 -EPPHHELNPMRVLLKIAKSEPPTLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQNAPSN 298 (1187)
T ss_pred -CCCccccchHHHHHHHhhcCCCcccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhCcccccCCcc
Confidence 7787654322 1222222221 2344556789999999999999999999999999999866543
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=321.37 Aligned_cols=253 Identities=25% Similarity=0.384 Sum_probs=189.5
Q ss_pred ccceEEEeEeeccCCceEEEEEE-eeCCcEEEEEEeecCCc----hHHHHHHHHHHHhCCCCCeeeecccccCC-----c
Q 003644 374 IGKLVVFNKEIAKGSNGTVVLEG-NYEGRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQ-----D 443 (805)
Q Consensus 374 i~~~~~~~~~LG~GsfGtVy~a~-~~~g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~-----~ 443 (805)
+++.|.+.+.||+|+||+||++. ..+|+.||||++..... ....+|+. ++..++||||+++++++... .
T Consensus 3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~~~ 81 (336)
T cd07849 3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIK-ILRRFKHENIIGILDIIRPPSFESFN 81 (336)
T ss_pred cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHH-HHHhCCCCCcCchhheeecccccccc
Confidence 45678999999999999999984 45789999999864221 23345554 77888999999999986544 3
Q ss_pred eEEEecccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHH
Q 003644 444 FVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLS 523 (805)
Q Consensus 444 ~l~LV~E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~ 523 (805)
..|+++|++.++|.+++ ....+++..+..++.|++.||+
T Consensus 82 ~~~lv~e~~~~~l~~~~-----------------------------------------~~~~l~~~~~~~i~~ql~~aL~ 120 (336)
T cd07849 82 DVYIVQELMETDLYKLI-----------------------------------------KTQHLSNDHIQYFLYQILRGLK 120 (336)
T ss_pred eEEEEehhcccCHHHHH-----------------------------------------hcCCCCHHHHHHHHHHHHHHHH
Confidence 58999997665544332 1234667788999999999999
Q ss_pred HhhhcceeccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhc-CCCCCcchHHHHHH
Q 003644 524 HLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ-GRQTRAIDLFSLGC 602 (805)
Q Consensus 524 yLH~~~IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~t~~sDVwSlGv 602 (805)
|||+.+|+||||||+|||++.++. +||+|||+++................||+.|+|||++.+ ..++.++|||||||
T Consensus 121 ~LH~~~ivH~dlkp~Nill~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv 198 (336)
T cd07849 121 YIHSANVLHRDLKPSNLLLNTNCD--LKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGC 198 (336)
T ss_pred HHHhCCeeccCCCHHHEEECCCCC--EEECcccceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHH
Confidence 999999999999999999988766 899999999876533222222233468999999998765 46889999999999
Q ss_pred HHHHHHhCCCCCCCCchHHH-HH----------------HHhh--------c---cc----cccccCChHHHHHHHHhcC
Q 003644 603 ILFFCITGGKHPYGESFERD-AN----------------IVKD--------R---KD----LFLVEHIPEAVDLFTRLLD 650 (805)
Q Consensus 603 il~elltG~~~Pf~~~~~~~-~~----------------~~~~--------~---~~----~~~~~~~~~~~dLi~~~L~ 650 (805)
++|+|++| ++||....... .. +... . .. ......++++.++|.+||+
T Consensus 199 il~el~~G-~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 277 (336)
T cd07849 199 ILAEMLSN-RPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLT 277 (336)
T ss_pred HHHHHHhC-CCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcC
Confidence 99999997 77875432110 00 0000 0 00 0012345688999999999
Q ss_pred CCCCCCCChhhhhcCcccccc
Q 003644 651 PNPDLRPKAQNVLNHPFFWTA 671 (805)
Q Consensus 651 ~dP~~Rps~~ell~Hpff~~~ 671 (805)
.||++||++.|+++||||...
T Consensus 278 ~dP~~Rpt~~e~l~hp~~~~~ 298 (336)
T cd07849 278 FNPHKRITVEEALAHPYLEQY 298 (336)
T ss_pred CChhhCcCHHHHhcCcccccc
Confidence 999999999999999999754
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-35 Score=317.29 Aligned_cols=256 Identities=24% Similarity=0.350 Sum_probs=194.8
Q ss_pred eEEEeEeeccCCceEEEEEEee-CCcEEEEEEeecCCch------HHHHHHHHHHHhCCCCCeeeecccccCCceEEEec
Q 003644 377 LVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHHD------VALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSL 449 (805)
Q Consensus 377 ~~~~~~~LG~GsfGtVy~a~~~-~g~~VAVK~l~~~~~~------~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~ 449 (805)
.|...+.||+|++|+||++... +++.||+|.+...... ....|+ .++..++||||+++++++.+.+..|+||
T Consensus 2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~-~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQ-EILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHH-HHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 4778899999999999998654 5899999999754322 233444 4778889999999999999999999999
Q ss_pred ccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcc
Q 003644 450 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG 529 (805)
Q Consensus 450 E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~ 529 (805)
|+| .+++|.+++... ....+++..++.++.|++.||+|||+.+
T Consensus 81 e~~----------~~~~L~~~~~~~---------------------------~~~~l~~~~~~~~~~qi~~~l~~lH~~~ 123 (316)
T cd05574 81 DYC----------PGGELFRLLQRQ---------------------------PGKCLSEEVARFYAAEVLLALEYLHLLG 123 (316)
T ss_pred Eec----------CCCCHHHHHHhC---------------------------CCCccCHHHHHHHHHHHHHHHHHHHHCC
Confidence 954 455555544321 1124677788899999999999999999
Q ss_pred eeccCCCCceEEecCCCCceEEEeccCccccccCCCccc--------------------------cccccccCCCCCCCh
Q 003644 530 LIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCL--------------------------TQNATGYGSSGWQAP 583 (805)
Q Consensus 530 IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~--------------------------~~~~~~~gt~~y~AP 583 (805)
++||||||+||+++.++. ++|+|||++.......... .......||..|+||
T Consensus 124 i~H~dlkp~Nili~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aP 201 (316)
T cd05574 124 IVYRDLKPENILLHESGH--IMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAP 201 (316)
T ss_pred eeccCCChHHeEEcCCCC--EEEeecchhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCH
Confidence 999999999999988776 8999999987653221100 011234688999999
Q ss_pred hhhhcCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH-HHHHhhcccccccc--CChHHHHHHHHhcCCCCCCCCC--
Q 003644 584 EQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERD-ANIVKDRKDLFLVE--HIPEAVDLFTRLLDPNPDLRPK-- 658 (805)
Q Consensus 584 E~l~~~~~t~~sDVwSlGvil~elltG~~~Pf~~~~~~~-~~~~~~~~~~~~~~--~~~~~~dLi~~~L~~dP~~Rps-- 658 (805)
|++.+..++.++|||||||++|+|++| ..||....... ...+.......+.. .++++.++|.+||+.||++||+
T Consensus 202 E~~~~~~~~~~~Di~slG~ll~~l~~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~ 280 (316)
T cd05574 202 EVISGDGHGSAVDWWTLGILLYEMLYG-TTPFKGSNRDETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSK 280 (316)
T ss_pred HHHcCCCCCchHHHHHHHHHHHHHhhC-CCCCCCCchHHHHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCch
Confidence 999988899999999999999999997 67775543322 11111111112222 4678999999999999999999
Q ss_pred --hhhhhcCcccccccc
Q 003644 659 --AQNVLNHPFFWTADT 673 (805)
Q Consensus 659 --~~ell~Hpff~~~~~ 673 (805)
++|+++||||.+..+
T Consensus 281 ~~~~~ll~~~~~~~~~~ 297 (316)
T cd05574 281 RGAAEIKQHPFFRGVNW 297 (316)
T ss_pred hhHHHHHcCchhhcCCh
Confidence 999999999976543
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=351.83 Aligned_cols=257 Identities=23% Similarity=0.344 Sum_probs=193.5
Q ss_pred cccceEEEeEeeccCCceEEEEEEe-eCCcEEEEEEeecCC-----chHHHHHHHHHHHhCCCCCeeeecccccC--Cce
Q 003644 373 RIGKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESD--QDF 444 (805)
Q Consensus 373 ~i~~~~~~~~~LG~GsfGtVy~a~~-~~g~~VAVK~l~~~~-----~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~--~~~ 444 (805)
..-..|.+.+.||+|+||+||++.. .++..||+|.+.... ......|+. ++..++|||||+++++|.+ ...
T Consensus 10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~-IL~~L~HPNIVrl~d~f~de~~~~ 88 (1021)
T PTZ00266 10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVN-VMRELKHKNIVRYIDRFLNKANQK 88 (1021)
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHH-HHHHcCCCCcCeEEEEEEecCCCE
Confidence 3445688999999999999999854 457889999886432 123445654 7788999999999998754 467
Q ss_pred EEEecccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHH
Q 003644 445 VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSH 524 (805)
Q Consensus 445 l~LV~E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~y 524 (805)
+||||||| .+|+|.++|..... ....+++..++.|+.||+.||+|
T Consensus 89 lyIVMEY~----------~gGSL~~lL~k~~~-------------------------~~g~L~E~~Il~Ia~QIL~ALaY 133 (1021)
T PTZ00266 89 LYILMEFC----------DAGDLSRNIQKCYK-------------------------MFGKIEEHAIVDITRQLLHALAY 133 (1021)
T ss_pred EEEEEeCC----------CCCcHHHHHHHHhh-------------------------ccCCCCHHHHHHHHHHHHHHHHH
Confidence 99999955 44555554432110 11347888899999999999999
Q ss_pred hhhc-------ceeccCCCCceEEecCC---------------CCceEEEeccCccccccCCCccccccccccCCCCCCC
Q 003644 525 LHEI-------GLIHRDLKPQNVLISKD---------------KSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQA 582 (805)
Q Consensus 525 LH~~-------~IvHrDLKp~NILl~~~---------------~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~A 582 (805)
||+. +||||||||+||||+.+ +...+||+|||++..+... .......||+.|+|
T Consensus 134 LHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~----s~~~s~vGTp~YmA 209 (1021)
T PTZ00266 134 CHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIE----SMAHSCVGTPYYWS 209 (1021)
T ss_pred HHhcccccccCCceeccCcHHHeEeecCccccccccccccccCCCCceEEccCCcccccccc----ccccccCCCccccC
Confidence 9984 49999999999999642 2335899999999866432 11234469999999
Q ss_pred hhhhhc--CCCCCcchHHHHHHHHHHHHhCCCCCCCCchH--HHHHHHhhccccccccCChHHHHHHHHhcCCCCCCCCC
Q 003644 583 PEQLLQ--GRQTRAIDLFSLGCILFFCITGGKHPYGESFE--RDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPK 658 (805)
Q Consensus 583 PE~l~~--~~~t~~sDVwSlGvil~elltG~~~Pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dP~~Rps 658 (805)
||++.+ ..++.++||||||||||||++| .+||..... .....+...........++++.+||.+||+.+|.+||+
T Consensus 210 PEvL~ge~~~~s~KSDVWSLG~ILYELLTG-k~PF~~~~~~~qli~~lk~~p~lpi~~~S~eL~dLI~~~L~~dPeeRPS 288 (1021)
T PTZ00266 210 PELLLHETKSYDDKSDMWALGCIIYELCSG-KTPFHKANNFSQLISELKRGPDLPIKGKSKELNILIKNLLNLSAKERPS 288 (1021)
T ss_pred HHHHhccCCCCCchhHHHHHHHHHHHHHHC-CCCCCcCCcHHHHHHHHhcCCCCCcCCCCHHHHHHHHHHhcCChhHCcC
Confidence 999865 4578999999999999999997 778864322 22223333333333445689999999999999999999
Q ss_pred hhhhhcCccccc
Q 003644 659 AQNVLNHPFFWT 670 (805)
Q Consensus 659 ~~ell~Hpff~~ 670 (805)
+.++|.|||+..
T Consensus 289 a~QlL~h~~ik~ 300 (1021)
T PTZ00266 289 ALQCLGYQIIKN 300 (1021)
T ss_pred HHHHhccHHHhh
Confidence 999999999964
|
|
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=312.66 Aligned_cols=245 Identities=24% Similarity=0.402 Sum_probs=185.2
Q ss_pred eEEEeEeeccCCceEEEEEEe-eCCcEEEEEEeecCCch---HHHHHHHHHHHhCCCCCeeeecccccCCceEEEecccc
Q 003644 377 LVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHHD---VALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERC 452 (805)
Q Consensus 377 ~~~~~~~LG~GsfGtVy~a~~-~~g~~VAVK~l~~~~~~---~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~E~~ 452 (805)
.|.+.+.||+|+||.||++.. .+++.||+|.++..... ...+|+ .++..++||||+++++++.+.+..|+|||||
T Consensus 10 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~-~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 10 DFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEI-IMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHH-HHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 455667899999999999854 46899999998654322 233454 4778889999999999999999999999955
Q ss_pred cCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcceec
Q 003644 453 TCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIH 532 (805)
Q Consensus 453 ~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~IvH 532 (805)
. +++|.+++.. ...+++.+++.++.|++.||+|||+.||+|
T Consensus 89 ~----------~~~L~~~~~~-----------------------------~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H 129 (267)
T cd06645 89 G----------GGSLQDIYHV-----------------------------TGPLSESQIAYVSRETLQGLYYLHSKGKMH 129 (267)
T ss_pred C----------CCcHHHHHHh-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCeec
Confidence 4 4455444321 134677788999999999999999999999
Q ss_pred cCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhh---cCCCCCcchHHHHHHHHHHHHh
Q 003644 533 RDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLL---QGRQTRAIDLFSLGCILFFCIT 609 (805)
Q Consensus 533 rDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~---~~~~t~~sDVwSlGvil~ellt 609 (805)
+||||+||+++.++. ++|+|||++....... .......|+..|+|||++. ...++.++|+|||||++|+|++
T Consensus 130 ~dlkp~nili~~~~~--~~l~dfg~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~ 204 (267)
T cd06645 130 RDIKGANILLTDNGH--VKLADFGVSAQITATI---AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAE 204 (267)
T ss_pred CCCCHHHEEECCCCC--EEECcceeeeEccCcc---cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhc
Confidence 999999999987765 8999999987664321 1223346899999999985 4557899999999999999999
Q ss_pred CCCCCCCCchHH-HHHHH-hhccc-c---ccccCChHHHHHHHHhcCCCCCCCCChhhhhcCcc
Q 003644 610 GGKHPYGESFER-DANIV-KDRKD-L---FLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPF 667 (805)
Q Consensus 610 G~~~Pf~~~~~~-~~~~~-~~~~~-~---~~~~~~~~~~dLi~~~L~~dP~~Rps~~ell~Hpf 667 (805)
| .+||...... ..... ..... . .....+..+.++|.+||+.||++||+++++++|||
T Consensus 205 ~-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 205 L-QPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred C-CCCcccccchhhHHhhhccCCCCCcccccCCCCHHHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence 7 5566433221 11111 11110 0 11134567899999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=353.19 Aligned_cols=260 Identities=27% Similarity=0.412 Sum_probs=213.6
Q ss_pred ccccccceEEEeEeeccCCceEEEEEE-eeCCcEEEEEEeec-----CCchHHHHHHHHHHHhCCCCCeeeecccccCCc
Q 003644 370 DGRRIGKLVVFNKEIAKGSNGTVVLEG-NYEGRSVAVKRLVK-----THHDVALKEIQNLIASDQHPNIVRWYGVESDQD 443 (805)
Q Consensus 370 ~~~~i~~~~~~~~~LG~GsfGtVy~a~-~~~g~~VAVK~l~~-----~~~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~ 443 (805)
..+.-.++|.+.+.||+|+||.|.+.. ..+++.+|+|++.+ ......|+|...++...+.+-||+|+..|+|++
T Consensus 69 ~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~ 148 (1317)
T KOG0612|consen 69 ELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDER 148 (1317)
T ss_pred HHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCcc
Confidence 335556778889999999999998874 45789999999975 334567899998999889999999999999999
Q ss_pred eEEEecccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHH
Q 003644 444 FVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLS 523 (805)
Q Consensus 444 ~l~LV~E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~ 523 (805)
++|+||| ||+||+|-..|... ..+|+..++.++..|+.||.
T Consensus 149 ~LYlVMd----------Y~pGGDlltLlSk~-----------------------------~~~pE~~ArFY~aEiVlAld 189 (1317)
T KOG0612|consen 149 YLYLVMD----------YMPGGDLLTLLSKF-----------------------------DRLPEDWARFYTAEIVLALD 189 (1317)
T ss_pred ceEEEEe----------cccCchHHHHHhhc-----------------------------CCChHHHHHHHHHHHHHHHH
Confidence 9999999 99999998876432 24788888999999999999
Q ss_pred HhhhcceeccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhc-----CCCCCcchHH
Q 003644 524 HLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ-----GRQTRAIDLF 598 (805)
Q Consensus 524 yLH~~~IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~-----~~~t~~sDVw 598 (805)
-||+.|+|||||||+||||+..|+ +||+|||.|-.+..+.. -.....+|||.|++||++.. +.|++.+|+|
T Consensus 190 slH~mgyVHRDiKPDNvLld~~GH--ikLADFGsClkm~~dG~--V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwW 265 (1317)
T KOG0612|consen 190 SLHSMGYVHRDIKPDNVLLDKSGH--IKLADFGSCLKMDADGT--VRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWW 265 (1317)
T ss_pred HHHhccceeccCCcceeEecccCc--EeeccchhHHhcCCCCc--EEeccccCCCCccCHHHHHhhcCCccccCCccchh
Confidence 999999999999999999999988 89999999988875432 33455689999999999973 5689999999
Q ss_pred HHHHHHHHHHhCCCCCCCCchHHH-HHHHhhcc-cccc--ccCChHHHHHHHHhcCCCCCCCCC---hhhhhcCcccccc
Q 003644 599 SLGCILFFCITGGKHPYGESFERD-ANIVKDRK-DLFL--VEHIPEAVDLFTRLLDPNPDLRPK---AQNVLNHPFFWTA 671 (805)
Q Consensus 599 SlGvil~elltG~~~Pf~~~~~~~-~~~~~~~~-~~~~--~~~~~~~~dLi~~~L~~dP~~Rps---~~ell~Hpff~~~ 671 (805)
|+||++|||+.|..|+|.++.-.. ..|+.... -.+| ...++++++||.+++. +|+.|.. ++++..||||.+.
T Consensus 266 SlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~ 344 (1317)
T KOG0612|consen 266 SLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGI 344 (1317)
T ss_pred hhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCC
Confidence 999999999998666666554333 33433321 2233 3467899999999876 7888888 9999999999766
Q ss_pred cc
Q 003644 672 DT 673 (805)
Q Consensus 672 ~~ 673 (805)
+|
T Consensus 345 ~W 346 (1317)
T KOG0612|consen 345 DW 346 (1317)
T ss_pred Ch
Confidence 55
|
|
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=311.96 Aligned_cols=259 Identities=19% Similarity=0.282 Sum_probs=192.6
Q ss_pred ccceEEEeEeeccCCceEEEEEEe------eCCcEEEEEEeecCCc----hHHHHHHHHHHHhCCCCCeeeecccccCCc
Q 003644 374 IGKLVVFNKEIAKGSNGTVVLEGN------YEGRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQD 443 (805)
Q Consensus 374 i~~~~~~~~~LG~GsfGtVy~a~~------~~g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~ 443 (805)
..++|.+.+.||+|+||+||++.. .++..||||++..... ....+|+. ++..++||||+++++++.+++
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~-~l~~l~~~~iv~~~~~~~~~~ 82 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS-VMKEFNCHHVVRLLGVVSQGQ 82 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHH-HHHhCCCCCeeeEEEEEcCCC
Confidence 356688899999999999998743 2357899999864322 12345554 677889999999999999999
Q ss_pred eEEEecccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHH
Q 003644 444 FVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLS 523 (805)
Q Consensus 444 ~l~LV~E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~ 523 (805)
..++||| |+.+|+|.+++......... ......+++..++.++.|++.||+
T Consensus 83 ~~~lv~e----------~~~~~~L~~~~~~~~~~~~~-------------------~~~~~~~~~~~~~~~~~~l~~~l~ 133 (277)
T cd05062 83 PTLVIME----------LMTRGDLKSYLRSLRPEMEN-------------------NPVQAPPSLKKMIQMAGEIADGMA 133 (277)
T ss_pred CeEEEEe----------cCCCCCHHHHHHHcCccccc-------------------cccccCCCHHHHHHHHHHHHHHHH
Confidence 9999999 55556666555432111000 011223566778999999999999
Q ss_pred HhhhcceeccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHH
Q 003644 524 HLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCI 603 (805)
Q Consensus 524 yLH~~~IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvi 603 (805)
|||+.+++||||||+||+++.++. ++|+|||+++........ .......+++.|+|||++.+..++.++|||||||+
T Consensus 134 ~lH~~~~vH~dlkp~Nil~~~~~~--~~l~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~ 210 (277)
T cd05062 134 YLNANKFVHRDLAARNCMVAEDFT--VKIGDFGMTRDIYETDYY-RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVV 210 (277)
T ss_pred HHHHCCcccCCcchheEEEcCCCC--EEECCCCCccccCCccee-ecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHH
Confidence 999999999999999999987765 899999998866432211 11122346788999999998889999999999999
Q ss_pred HHHHHhCCCCCCCCchHHHH-H-HHhhccccccccCChHHHHHHHHhcCCCCCCCCChhhhhcC
Q 003644 604 LFFCITGGKHPYGESFERDA-N-IVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNH 665 (805)
Q Consensus 604 l~elltG~~~Pf~~~~~~~~-~-~~~~~~~~~~~~~~~~~~dLi~~~L~~dP~~Rps~~ell~H 665 (805)
+|||++++.+||........ . +........+...++.+.+++.+||+.||++||++.|++++
T Consensus 211 l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 274 (277)
T cd05062 211 LWEIATLAEQPYQGMSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 274 (277)
T ss_pred HHHHHcCCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 99999976888866443322 1 22222223344556789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=306.75 Aligned_cols=244 Identities=32% Similarity=0.461 Sum_probs=190.7
Q ss_pred EEEeEeeccCCceEEEEEEee-CCcEEEEEEeecCC--------chHHHHHHHHHHHhCCCCCeeeecccccCCceEEEe
Q 003644 378 VVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH--------HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLS 448 (805)
Q Consensus 378 ~~~~~~LG~GsfGtVy~a~~~-~g~~VAVK~l~~~~--------~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV 448 (805)
|...+.||+|++|+||++... +++.||+|.+.... .....+|+. +++.++||||+++++++.+++..|++
T Consensus 2 ~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~-~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 2 WRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIA-LLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred ccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHH-HHHhcCCCCchheeeeEecCCeEEEE
Confidence 445678999999999998665 78999999986432 123344554 77888999999999999999999999
Q ss_pred cccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhc
Q 003644 449 LERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI 528 (805)
Q Consensus 449 ~E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~ 528 (805)
+| |..+++|.+++... ..+++..+..++.||+.||+|||+.
T Consensus 81 ~e----------~~~~~~L~~~~~~~-----------------------------~~~~~~~~~~~~~~i~~~l~~lH~~ 121 (258)
T cd06632 81 LE----------LVPGGSLAKLLKKY-----------------------------GSFPEPVIRLYTRQILLGLEYLHDR 121 (258)
T ss_pred EE----------ecCCCcHHHHHHhc-----------------------------CCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 99 55555555544221 2356677789999999999999999
Q ss_pred ceeccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCC-CCCcchHHHHHHHHHHH
Q 003644 529 GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGR-QTRAIDLFSLGCILFFC 607 (805)
Q Consensus 529 ~IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~-~t~~sDVwSlGvil~el 607 (805)
+|+|+||+|+||+++.++. +||+|||++....... ......|+..|+|||.+.... ++.++|+|||||++|+|
T Consensus 122 ~i~H~dl~~~ni~~~~~~~--~kl~d~~~~~~~~~~~----~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l 195 (258)
T cd06632 122 NTVHRDIKGANILVDTNGV--VKLADFGMAKQVVEFS----FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEM 195 (258)
T ss_pred CcccCCCCHHHEEECCCCC--EEEccCccceeccccc----cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHH
Confidence 9999999999999988765 8999999988764322 123345889999999998776 89999999999999999
Q ss_pred HhCCCCCCCCchHHHHH--HHh-hccccccccCChHHHHHHHHhcCCCCCCCCChhhhhcCccc
Q 003644 608 ITGGKHPYGESFERDAN--IVK-DRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 668 (805)
Q Consensus 608 ltG~~~Pf~~~~~~~~~--~~~-~~~~~~~~~~~~~~~dLi~~~L~~dP~~Rps~~ell~Hpff 668 (805)
++| .+||......... +.. ......+....+++.+++.+||+.+|.+||++.+++.|||+
T Consensus 196 ~~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 196 ATG-KPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEHPFV 258 (258)
T ss_pred HhC-CCCcccCcHHHHHHHHHhcccCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcCCCC
Confidence 997 7788765432221 111 11222333456789999999999999999999999999996
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=315.59 Aligned_cols=250 Identities=28% Similarity=0.391 Sum_probs=188.4
Q ss_pred EeEeeccCCceEEEEEEe-eCCcEEEEEEeecCCc----hHHHHHHHHHHHhCCCCCeeeecccccCCceEEEecccccC
Q 003644 380 FNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTC 454 (805)
Q Consensus 380 ~~~~LG~GsfGtVy~a~~-~~g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~E~~~~ 454 (805)
..+.||+|+||.||++.. .+|+.||||.+..... ....+|+..+.+...||||+++++++.+++..+++||++..
T Consensus 8 ~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~~~ 87 (288)
T cd06616 8 DLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMDI 87 (288)
T ss_pred HHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEecccC
Confidence 446799999999999754 4689999999865321 23455665444444699999999999999999999998877
Q ss_pred ChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhc-ceecc
Q 003644 455 SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI-GLIHR 533 (805)
Q Consensus 455 sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~-~IvHr 533 (805)
++.++... +.. .....+++..+..++.|++.||+|||+. +|+||
T Consensus 88 ~l~~l~~~--------~~~---------------------------~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~ 132 (288)
T cd06616 88 SLDKFYKY--------VYE---------------------------VLKSVIPEEILGKIAVATVKALNYLKEELKIIHR 132 (288)
T ss_pred CHHHHHHH--------HHH---------------------------hhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeecc
Confidence 66554311 000 1123477788899999999999999975 99999
Q ss_pred CCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcC---CCCCcchHHHHHHHHHHHHhC
Q 003644 534 DLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG---RQTRAIDLFSLGCILFFCITG 610 (805)
Q Consensus 534 DLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~---~~t~~sDVwSlGvil~elltG 610 (805)
||||+||+++.++. +||+|||+++....... .....|+..|+|||++... .++.++|||||||++|||++|
T Consensus 133 dlkp~Nil~~~~~~--~kl~dfg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g 206 (288)
T cd06616 133 DVKPSNILLDRNGN--IKLCDFGISGQLVDSIA----KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATG 206 (288)
T ss_pred CCCHHHEEEccCCc--EEEeecchhHHhccCCc----cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhC
Confidence 99999999987765 89999999986653211 1223588999999999876 688999999999999999996
Q ss_pred CCCCCCCchHHHHH---HHhhccccc----cccCChHHHHHHHHhcCCCCCCCCChhhhhcCcccccc
Q 003644 611 GKHPYGESFERDAN---IVKDRKDLF----LVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTA 671 (805)
Q Consensus 611 ~~~Pf~~~~~~~~~---~~~~~~~~~----~~~~~~~~~dLi~~~L~~dP~~Rps~~ell~Hpff~~~ 671 (805)
.+||......... ......... ....++++.+||.+||+.||++||+++++++||||...
T Consensus 207 -~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~ 273 (288)
T cd06616 207 -KFPYPKWNSVFDQLTQVVKGDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDY 273 (288)
T ss_pred -CCCchhcchHHHHHhhhcCCCCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhch
Confidence 7788654321111 111111111 12356789999999999999999999999999999653
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=309.23 Aligned_cols=250 Identities=26% Similarity=0.416 Sum_probs=191.2
Q ss_pred EEEeEeeccCCceEEEEEE-eeCCcEEEEEEeecCC---------chHHHHHHHHHHHhCCCCCeeeecccccCCceEEE
Q 003644 378 VVFNKEIAKGSNGTVVLEG-NYEGRSVAVKRLVKTH---------HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYL 447 (805)
Q Consensus 378 ~~~~~~LG~GsfGtVy~a~-~~~g~~VAVK~l~~~~---------~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~L 447 (805)
|...+.||+|++|.||++. ..+++.||+|.+.... .....+|+. +++.++||||+++++++.+.+..++
T Consensus 2 ~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~-~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 2 WLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIR-LMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred ccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHH-HHHHcCCCceehhhceeccCCeEEE
Confidence 4456789999999999975 4678999999986432 123344554 6778999999999999999999999
Q ss_pred ecccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhh
Q 003644 448 SLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE 527 (805)
Q Consensus 448 V~E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~ 527 (805)
|+| |+.+++|.+++.. ...+++..+..++.||+.||+|||+
T Consensus 81 v~e----------~~~~~~L~~~l~~-----------------------------~~~~~~~~~~~~~~ql~~al~~LH~ 121 (268)
T cd06630 81 FVE----------WMAGGSVSHLLSK-----------------------------YGAFKEAVIINYTEQLLRGLSYLHE 121 (268)
T ss_pred EEe----------ccCCCcHHHHHHH-----------------------------hCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 999 5555666555422 1245677889999999999999999
Q ss_pred cceeccCCCCceEEecCCCCceEEEeccCccccccCCCccc-cccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHHH
Q 003644 528 IGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCL-TQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFF 606 (805)
Q Consensus 528 ~~IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~e 606 (805)
.|++||||||+||+++.++. .+||+|||++.......... .......|+..|+|||.+.+..++.++|+||+||++|+
T Consensus 122 ~~i~H~~i~~~nil~~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~ 200 (268)
T cd06630 122 NQIIHRDVKGANLLIDSTGQ-RLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIE 200 (268)
T ss_pred CCeecCCCCHHHEEEcCCCC-EEEEcccccccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHH
Confidence 99999999999999976654 48999999998775431111 11123458899999999988889999999999999999
Q ss_pred HHhCCCCCCCCchH-HHHHHH-h----hccccccccCChHHHHHHHHhcCCCCCCCCChhhhhcCcccc
Q 003644 607 CITGGKHPYGESFE-RDANIV-K----DRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFW 669 (805)
Q Consensus 607 lltG~~~Pf~~~~~-~~~~~~-~----~~~~~~~~~~~~~~~dLi~~~L~~dP~~Rps~~ell~Hpff~ 669 (805)
|++| ..||..... ...... . ......+....+++.+++.+||+.+|.+||++.++++||||.
T Consensus 201 l~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 201 MATA-KPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHPVFR 268 (268)
T ss_pred HHhC-CCCCCCCCCcchHHHHHHHhccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence 9997 667754321 111111 1 111223334567899999999999999999999999999983
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-35 Score=312.81 Aligned_cols=264 Identities=21% Similarity=0.319 Sum_probs=194.9
Q ss_pred cceEEEeEeeccCCceEEEEEEee------CCcEEEEEEeecCCch----HHHHHHHHHHHhCCCCCeeeecccccCCce
Q 003644 375 GKLVVFNKEIAKGSNGTVVLEGNY------EGRSVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVRWYGVESDQDF 444 (805)
Q Consensus 375 ~~~~~~~~~LG~GsfGtVy~a~~~------~g~~VAVK~l~~~~~~----~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~ 444 (805)
.++|.+.+.||+|+||.||++... .+..||||.+...... ...+|+ ..++.++||||+++++++.+.+.
T Consensus 5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~-~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEA-SVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred HHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHH-HHHHhCCCCCeeeEEEEEcCCCC
Confidence 456888899999999999997432 3568999988644321 223343 46788899999999999999999
Q ss_pred EEEecccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHH
Q 003644 445 VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSH 524 (805)
Q Consensus 445 l~LV~E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~y 524 (805)
.|+||| |+.+|+|.+++......... . -.....+...+..++.|++.||+|
T Consensus 84 ~~lv~e----------~~~~g~L~~~l~~~~~~~~~---~----------------~~~~~~~~~~~~~~~~~l~~~l~~ 134 (288)
T cd05061 84 TLVVME----------LMAHGDLKSYLRSLRPEAEN---N----------------PGRPPPTLQEMIQMAAEIADGMAY 134 (288)
T ss_pred cEEEEe----------CCCCCCHHHHHHHhcccccc---C----------------CCCCCCCHHHHHHHHHHHHHHHHH
Confidence 999999 55566666665432211000 0 001223556778999999999999
Q ss_pred hhhcceeccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHH
Q 003644 525 LHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCIL 604 (805)
Q Consensus 525 LH~~~IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil 604 (805)
||+.+|+||||||+|||++.++. ++|+|||+++........ .......++..|+|||.+.++.++.++|+|||||++
T Consensus 135 lH~~~i~H~dikp~nili~~~~~--~~L~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l 211 (288)
T cd05061 135 LNAKKFVHRDLAARNCMVAHDFT--VKIGDFGMTRDIYETDYY-RKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVL 211 (288)
T ss_pred HHhCCCcCCCCChheEEEcCCCc--EEECcCCccccccccccc-cccCCCcccccccCHHHhccCCCChHhHHHHHHHHH
Confidence 99999999999999999987765 899999999866432211 112223457789999999988999999999999999
Q ss_pred HHHHhCCCCCCCCchHHHH-H-HHhhccccccccCChHHHHHHHHhcCCCCCCCCChhhhhc------Ccccccc
Q 003644 605 FFCITGGKHPYGESFERDA-N-IVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN------HPFFWTA 671 (805)
Q Consensus 605 ~elltG~~~Pf~~~~~~~~-~-~~~~~~~~~~~~~~~~~~dLi~~~L~~dP~~Rps~~ell~------Hpff~~~ 671 (805)
|||++++.+||........ . +........+....+++.+++.+||+.||.+||++.++++ ||||...
T Consensus 212 ~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~ 286 (288)
T cd05061 212 WEITSLAEQPYQGLSNEQVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEV 286 (288)
T ss_pred HHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCCC
Confidence 9999977888866443332 1 2222222233445678999999999999999999999985 8998654
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=345.08 Aligned_cols=260 Identities=18% Similarity=0.262 Sum_probs=186.9
Q ss_pred cccceEEEeEeeccCCceEEEEEEee--CCcEEEEE------------------EeecCC--chHHHHHHHHHHHhCCCC
Q 003644 373 RIGKLVVFNKEIAKGSNGTVVLEGNY--EGRSVAVK------------------RLVKTH--HDVALKEIQNLIASDQHP 430 (805)
Q Consensus 373 ~i~~~~~~~~~LG~GsfGtVy~a~~~--~g~~VAVK------------------~l~~~~--~~~~~~Ei~~ll~~l~Hp 430 (805)
.+...|.+.+.||+|+||+||++... .+..+++| .+.... .....+|+. ++..++||
T Consensus 145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~-il~~l~Hp 223 (501)
T PHA03210 145 EFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEIL-ALGRLNHE 223 (501)
T ss_pred hhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHH-HHHhCCCC
Confidence 34567899999999999999986432 22222222 111111 112345554 67889999
Q ss_pred CeeeecccccCCceEEEecccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHH
Q 003644 431 NIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQ 510 (805)
Q Consensus 431 NIV~l~g~~~~~~~l~LV~E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 510 (805)
|||++++++.+.+..|+|+|++.++|.++++.. .+. |.. ......
T Consensus 224 nIv~l~~~~~~~~~~~lv~e~~~~~l~~~l~~~--~~~--------------------------------~~~-~~~~~~ 268 (501)
T PHA03210 224 NILKIEEILRSEANTYMITQKYDFDLYSFMYDE--AFD--------------------------------WKD-RPLLKQ 268 (501)
T ss_pred CcCcEeEEEEECCeeEEEEeccccCHHHHHhhc--ccc--------------------------------ccc-cccHHH
Confidence 999999999999999999998887776665321 110 111 122345
Q ss_pred HHHHHHHHHHHHHHhhhcceeccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCC
Q 003644 511 LLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGR 590 (805)
Q Consensus 511 ~~~i~~qIa~gL~yLH~~~IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~ 590 (805)
++.|+.||+.||+|||+.+||||||||+|||++.++. +||+|||+++.+..... .......||..|+|||++.+..
T Consensus 269 ~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~~--vkL~DFGla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~ 344 (501)
T PHA03210 269 TRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGK--IVLGDFGTAMPFEKERE--AFDYGWVGTVATNSPEILAGDG 344 (501)
T ss_pred HHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC--EEEEeCCCceecCcccc--cccccccCCcCCCCchhhcCCC
Confidence 6789999999999999999999999999999988776 89999999987654321 1123356999999999999999
Q ss_pred CCCcchHHHHHHHHHHHHhCCCCCCCCchH----HHHHHHhhcc---cc----------------------------ccc
Q 003644 591 QTRAIDLFSLGCILFFCITGGKHPYGESFE----RDANIVKDRK---DL----------------------------FLV 635 (805)
Q Consensus 591 ~t~~sDVwSlGvil~elltG~~~Pf~~~~~----~~~~~~~~~~---~~----------------------------~~~ 635 (805)
++.++|||||||++|||++|+.+|+..... ....++.... .. ...
T Consensus 345 ~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 424 (501)
T PHA03210 345 YCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNL 424 (501)
T ss_pred CCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhc
Confidence 999999999999999999987777754321 1111111000 00 001
Q ss_pred cCChHHHHHHHHhcCCCCCCCCChhhhhcCccccccc
Q 003644 636 EHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTAD 672 (805)
Q Consensus 636 ~~~~~~~dLi~~~L~~dP~~Rps~~ell~Hpff~~~~ 672 (805)
....++.++|.+||+.||.+|||+.|+|.||||....
T Consensus 425 ~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~~~ 461 (501)
T PHA03210 425 GLPADFEYPLVKMLTFDWHLRPGAAELLALPLFSAEE 461 (501)
T ss_pred CCChHHHHHHHHHhccCcccCcCHHHHhhChhhhcCC
Confidence 1234677889999999999999999999999996543
|
|
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=306.51 Aligned_cols=252 Identities=26% Similarity=0.359 Sum_probs=193.2
Q ss_pred eEEEeEeeccCCceEEEEEEe-eCCcEEEEEEeecCCc----hHHHHHHHHHHHhCCCCCeeeecccccCCceEEEeccc
Q 003644 377 LVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLER 451 (805)
Q Consensus 377 ~~~~~~~LG~GsfGtVy~a~~-~~g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~E~ 451 (805)
.|.+.+.||.|+||+||++.. .++..||+|++..... ....+|+. .++.++|+||+++++.+.+++..|+|+|+
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~-~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 2 DYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQ-AMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred cceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHH-HHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 477889999999999999864 4688999999864331 23345554 67788999999999999999999999995
Q ss_pred ccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhccee
Q 003644 452 CTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLI 531 (805)
Q Consensus 452 ~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~Iv 531 (805)
| .+++|.+++.... ....+++..+..++.|++.||+|||+.||+
T Consensus 81 ~----------~~~~l~~~~~~~~--------------------------~~~~~~~~~~~~~~~ql~~al~~lh~~~i~ 124 (267)
T cd06610 81 L----------SGGSLLDIMKSSY--------------------------PRGGLDEAIIATVLKEVLKGLEYLHSNGQI 124 (267)
T ss_pred c----------CCCcHHHHHHHhc--------------------------ccCCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence 5 4555555443211 113467778899999999999999999999
Q ss_pred ccCCCCceEEecCCCCceEEEeccCccccccCCCccc-cccccccCCCCCCChhhhhcC-CCCCcchHHHHHHHHHHHHh
Q 003644 532 HRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCL-TQNATGYGSSGWQAPEQLLQG-RQTRAIDLFSLGCILFFCIT 609 (805)
Q Consensus 532 HrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~-~~~~~~~gt~~y~APE~l~~~-~~t~~sDVwSlGvil~ellt 609 (805)
||||||+||++++++. ++|+|||++.......... .......|+..|+|||++... .++.++|+|||||++|+|++
T Consensus 125 h~~l~p~ni~~~~~~~--~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~ 202 (267)
T cd06610 125 HRDIKAGNILLGEDGS--VKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELAT 202 (267)
T ss_pred cCCCCHHhEEEcCCCC--EEEcccchHHHhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHh
Confidence 9999999999988765 8999999998776432221 112334689999999999877 78999999999999999999
Q ss_pred CCCCCCCCchHHH--HHHHhhcccccc-----ccCChHHHHHHHHhcCCCCCCCCChhhhhcCccc
Q 003644 610 GGKHPYGESFERD--ANIVKDRKDLFL-----VEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 668 (805)
Q Consensus 610 G~~~Pf~~~~~~~--~~~~~~~~~~~~-----~~~~~~~~dLi~~~L~~dP~~Rps~~ell~Hpff 668 (805)
| ..||....... ............ ...++++.+++.+||+.||++||+++++++||||
T Consensus 203 g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 203 G-AAPYSKYPPMKVLMLTLQNDPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred C-CCCccccChhhhHHHHhcCCCCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence 7 77886543221 112222111111 1345788999999999999999999999999998
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=314.25 Aligned_cols=250 Identities=26% Similarity=0.358 Sum_probs=185.7
Q ss_pred ceEEEeEeeccCCceEEEEEEe-eCCcEEEEEEeecCC-----chHHHHHHHHHHHhCCCCCeeeecccccCCc------
Q 003644 376 KLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQD------ 443 (805)
Q Consensus 376 ~~~~~~~~LG~GsfGtVy~a~~-~~g~~VAVK~l~~~~-----~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~------ 443 (805)
+.|...+.||+|+||.||++.. .+++.||||++.... .....+|+. +++.++||||++++++|.+.+
T Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~-~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIK-ILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHH-HHHhCCCCCccceEEEEecccccccCC
Confidence 4578889999999999999855 468999999885432 123345665 778889999999999876543
Q ss_pred --eEEEecccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHH
Q 003644 444 --FVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSG 521 (805)
Q Consensus 444 --~l~LV~E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~g 521 (805)
..|+|||+|.++|.+++... ...+++.+++.++.||+.|
T Consensus 91 ~~~~~lv~e~~~~~l~~~l~~~---------------------------------------~~~~~~~~~~~i~~qi~~a 131 (310)
T cd07865 91 KGSFYLVFEFCEHDLAGLLSNK---------------------------------------NVKFTLSEIKKVMKMLLNG 131 (310)
T ss_pred CceEEEEEcCCCcCHHHHHHhc---------------------------------------ccCCCHHHHHHHHHHHHHH
Confidence 45999998876665544110 1236778889999999999
Q ss_pred HHHhhhcceeccCCCCceEEecCCCCceEEEeccCccccccCCCccc-cccccccCCCCCCChhhhhcCC-CCCcchHHH
Q 003644 522 LSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCL-TQNATGYGSSGWQAPEQLLQGR-QTRAIDLFS 599 (805)
Q Consensus 522 L~yLH~~~IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~-~t~~sDVwS 599 (805)
|+|||+.+++|+||||+||+++.++. +||+|||++.......... .......++..|+|||.+.+.. ++.++||||
T Consensus 132 l~~lH~~~i~H~dl~p~nil~~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s 209 (310)
T cd07865 132 LYYIHRNKILHRDMKAANILITKDGI--LKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWG 209 (310)
T ss_pred HHHHHHCCeeccCCCHHHEEECCCCc--EEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHH
Confidence 99999999999999999999987765 8999999998764322111 1112345788999999987643 688999999
Q ss_pred HHHHHHHHHhCCCCCCCCchHHH-HHHHhhccc-------------------c-------------ccccCChHHHHHHH
Q 003644 600 LGCILFFCITGGKHPYGESFERD-ANIVKDRKD-------------------L-------------FLVEHIPEAVDLFT 646 (805)
Q Consensus 600 lGvil~elltG~~~Pf~~~~~~~-~~~~~~~~~-------------------~-------------~~~~~~~~~~dLi~ 646 (805)
|||++|||++| .+||....... ...+..... . ......+.+.++|.
T Consensus 210 lG~~l~el~t~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~ 288 (310)
T cd07865 210 AGCIMAEMWTR-SPIMQGNTEQHQLTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLID 288 (310)
T ss_pred HHHHHHHHHhC-CCCCCCCCHHHHHHHHHHHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHH
Confidence 99999999996 67775433211 111000000 0 00012356789999
Q ss_pred HhcCCCCCCCCChhhhhcCccc
Q 003644 647 RLLDPNPDLRPKAQNVLNHPFF 668 (805)
Q Consensus 647 ~~L~~dP~~Rps~~ell~Hpff 668 (805)
+||..||.+|||++|+++||||
T Consensus 289 ~~l~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 289 KLLVLDPAKRIDADTALNHDFF 310 (310)
T ss_pred HHhcCChhhccCHHHHhcCCCC
Confidence 9999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=306.89 Aligned_cols=247 Identities=23% Similarity=0.357 Sum_probs=189.9
Q ss_pred ceEEEeEeeccCCceEEEEEEeeCCcEEEEEEeecCC--chHHHHHHHHHHHhCCCCCeeeecccccCCceEEEeccccc
Q 003644 376 KLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTH--HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCT 453 (805)
Q Consensus 376 ~~~~~~~~LG~GsfGtVy~a~~~~g~~VAVK~l~~~~--~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~E~~~ 453 (805)
+.|.+.+.||+|+||+||++...++..||||.+.... .+...+|+. ++..++||||+++++++.+.+..|++||+|
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~- 81 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAK-VMMKLSHEKLVQLYGVCTKQRPIYIVTEYM- 81 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcccHHHHHHHHH-HHhcCCCCCeeeEEEEEccCCCcEEEEEcC-
Confidence 3477889999999999999876666779999887543 233455655 678889999999999999999999999954
Q ss_pred CChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcceecc
Q 003644 454 CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHR 533 (805)
Q Consensus 454 ~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~IvHr 533 (805)
.+|+|.+++... ...+++..++.++.||+.||+|||+.+++|+
T Consensus 82 ---------~~~~l~~~i~~~----------------------------~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~ 124 (256)
T cd05113 82 ---------SNGCLLNYLREH----------------------------GKRFQPSQLLEMCKDVCEGMAYLESKQFIHR 124 (256)
T ss_pred ---------CCCcHHHHHHhc----------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCeecc
Confidence 455555544221 1135677889999999999999999999999
Q ss_pred CCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHHHHHhCCCC
Q 003644 534 DLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKH 613 (805)
Q Consensus 534 DLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~elltG~~~ 613 (805)
||||+||+++.++. +||+|||+++....... .......++..|+|||++....++.++|||||||++|||++.+..
T Consensus 125 dl~p~nili~~~~~--~kl~d~g~~~~~~~~~~--~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~ 200 (256)
T cd05113 125 DLAARNCLVDDQGC--VKVSDFGLSRYVLDDEY--TSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKM 200 (256)
T ss_pred ccCcceEEEcCCCC--EEECCCccceecCCCce--eecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCC
Confidence 99999999987765 89999999886643211 111122356789999999888899999999999999999995578
Q ss_pred CCCCchHHH--HHHHhhccccccccCChHHHHHHHHhcCCCCCCCCChhhhhcC
Q 003644 614 PYGESFERD--ANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNH 665 (805)
Q Consensus 614 Pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dP~~Rps~~ell~H 665 (805)
||....... ..+........+...++.+.+++.+||+.||++||++.+++++
T Consensus 201 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~ 254 (256)
T cd05113 201 PYERFNNSETVEKVSQGLRLYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSS 254 (256)
T ss_pred CcCcCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHh
Confidence 886543322 2222222222233456789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=311.45 Aligned_cols=245 Identities=28% Similarity=0.446 Sum_probs=184.5
Q ss_pred EEeEeeccCCceEEEEEEee-----CCcEEEEEEeecCCc----hHHHHHHHHHHHhCCCCCeeeecccccCCceEEEec
Q 003644 379 VFNKEIAKGSNGTVVLEGNY-----EGRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSL 449 (805)
Q Consensus 379 ~~~~~LG~GsfGtVy~a~~~-----~g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~ 449 (805)
.+.+.||.|+||.||+|... .+..||||.+..... +...+|+. .+..++||||++++|+|.+.+..++|+
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~-~l~~l~h~ni~~~~g~~~~~~~~~lv~ 80 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQ-ILRKLRHPNIVKLYGFCIENEPLFLVM 80 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHH-HHHTHSBTTBE-EEEEEESSSSEEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccc-ccccccccccccccccccccccccccc
Confidence 45688999999999998766 367899999965432 23445554 667779999999999999888899999
Q ss_pred ccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcc
Q 003644 450 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG 529 (805)
Q Consensus 450 E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~ 529 (805)
| |+++|+|.++|+... ...+++..+..|+.||+.||+|||+.+
T Consensus 81 e----------~~~~g~L~~~L~~~~---------------------------~~~~~~~~~~~i~~~i~~~l~~Lh~~~ 123 (259)
T PF07714_consen 81 E----------YCPGGSLDDYLKSKN---------------------------KEPLSEQQRLSIAIQIAEALSYLHSNN 123 (259)
T ss_dssp E------------TTEBHHHHHHHTC---------------------------TTTSBHHHHHHHHHHHHHHHHHHHHTT
T ss_pred c----------ccccccccccccccc---------------------------ccccccccccccccccccccccccccc
Confidence 9 556666666665431 123567788999999999999999999
Q ss_pred eeccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHHHHHh
Q 003644 530 LIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCIT 609 (805)
Q Consensus 530 IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~ellt 609 (805)
++|+||+++|||++.++ .+||+|||++........ ........+...|+|||.+....++.++||||||+++||+++
T Consensus 124 iiH~~l~~~nill~~~~--~~Kl~~f~~~~~~~~~~~-~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~ 200 (259)
T PF07714_consen 124 IIHGNLSPSNILLDSNG--QVKLSDFGLSRPISEKSK-YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILT 200 (259)
T ss_dssp EEEST-SGGGEEEETTT--EEEEESTTTGEETTTSSS-EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHT
T ss_pred ccccccccccccccccc--cccccccccccccccccc-cccccccccccccccccccccccccccccccccccccccccc
Confidence 99999999999998776 499999999987732211 122233346778999999999999999999999999999999
Q ss_pred CCCCCCCCchHHH--HHHHhhccccccccCChHHHHHHHHhcCCCCCCCCChhhhhc
Q 003644 610 GGKHPYGESFERD--ANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 664 (805)
Q Consensus 610 G~~~Pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dP~~Rps~~ell~ 664 (805)
++..||.+..... ..+........+...+..+.++|.+||..||++||+++++++
T Consensus 201 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 201 LGKFPFSDYDNEEIIEKLKQGQRLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp TSSGTTTTSCHHHHHHHHHTTEETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred cccccccccccccccccccccccceeccchhHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 7678887654333 233333333334456778999999999999999999999874
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=311.68 Aligned_cols=255 Identities=25% Similarity=0.336 Sum_probs=190.4
Q ss_pred ccceEEEeEeeccCCceEEEEEEe-eCCcEEEEEEeecCCc--hHHHHHHHHHHHhCCCCCeeeecccccCC-----ceE
Q 003644 374 IGKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH--DVALKEIQNLIASDQHPNIVRWYGVESDQ-----DFV 445 (805)
Q Consensus 374 i~~~~~~~~~LG~GsfGtVy~a~~-~~g~~VAVK~l~~~~~--~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~-----~~l 445 (805)
....|.+.+.||+|+||.||++.. .+++.+|+|++..... ....+|+..+....+||||+++++++... +..
T Consensus 20 ~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~ 99 (291)
T cd06639 20 PTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQL 99 (291)
T ss_pred CCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCee
Confidence 456688999999999999999865 4688999999865432 33345665444444899999999998643 468
Q ss_pred EEecccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHh
Q 003644 446 YLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHL 525 (805)
Q Consensus 446 ~LV~E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yL 525 (805)
|+||| |+.+|+|.++++... -....+++..++.++.|++.||+||
T Consensus 100 ~lv~e----------y~~~~sL~~~~~~~~-------------------------~~~~~~~~~~~~~~~~qi~~al~~l 144 (291)
T cd06639 100 WLVLE----------LCNGGSVTELVKGLL-------------------------ICGQRLDEAMISYILYGALLGLQHL 144 (291)
T ss_pred EEEEE----------ECCCCcHHHHHHHhh-------------------------hcCCCCCHHHHHHHHHHHHHHHHHH
Confidence 99999 555666665543211 1123467788899999999999999
Q ss_pred hhcceeccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcC-----CCCCcchHHHH
Q 003644 526 HEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG-----RQTRAIDLFSL 600 (805)
Q Consensus 526 H~~~IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-----~~t~~sDVwSl 600 (805)
|+.+|+||||||+||+++.++. +||+|||++........ ......|+..|+|||++... .++.++|||||
T Consensus 145 H~~~ivH~dlkp~nili~~~~~--~kl~dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~sl 219 (291)
T cd06639 145 HNNRIIHRDVKGNNILLTTEGG--VKLVDFGVSAQLTSTRL---RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSL 219 (291)
T ss_pred HhCCeeccCCCHHHEEEcCCCC--EEEeecccchhcccccc---cccCccCCccccChhhhcCCCCcccccCCccchHHH
Confidence 9999999999999999988776 89999999887653211 11234588999999998643 26889999999
Q ss_pred HHHHHHHHhCCCCCCCCchHHH-H-HHHhhccc--cccccCChHHHHHHHHhcCCCCCCCCChhhhhcCcccc
Q 003644 601 GCILFFCITGGKHPYGESFERD-A-NIVKDRKD--LFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFW 669 (805)
Q Consensus 601 Gvil~elltG~~~Pf~~~~~~~-~-~~~~~~~~--~~~~~~~~~~~dLi~~~L~~dP~~Rps~~ell~Hpff~ 669 (805)
||++|||++| ++||....... . .+...... ..+.....++.++|.+||+.||++||++.|+++||||.
T Consensus 220 Gvi~~el~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~ 291 (291)
T cd06639 220 GITAIELGDG-DPPLFDMHPVKTLFKIPRNPPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291 (291)
T ss_pred HHHHHHHhhC-CCCCCCCcHHHHHHHHhcCCCCCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence 9999999997 77876543221 1 11111111 11233456899999999999999999999999999983
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=335.66 Aligned_cols=249 Identities=25% Similarity=0.383 Sum_probs=201.3
Q ss_pred ceEEEeEeeccCCceEEEEEEeeC----CcEEEEEEeecCCchH----HHHHHHHHHHhCCCCCeeeecccccCCceEEE
Q 003644 376 KLVVFNKEIAKGSNGTVVLEGNYE----GRSVAVKRLVKTHHDV----ALKEIQNLIASDQHPNIVRWYGVESDQDFVYL 447 (805)
Q Consensus 376 ~~~~~~~~LG~GsfGtVy~a~~~~----g~~VAVK~l~~~~~~~----~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~L 447 (805)
..+.+.++||.|.||.|+++++.. ...||||.|+....+. ++.|. .+|...+||||++|-|+......++|
T Consensus 629 s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EA-sIMGQFdHPNIIrLEGVVTks~PvMI 707 (996)
T KOG0196|consen 629 SCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEA-SIMGQFDHPNIIRLEGVVTKSKPVMI 707 (996)
T ss_pred hheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhh-hhcccCCCCcEEEEEEEEecCceeEE
Confidence 346788899999999999987653 3579999998654443 34444 37788999999999999999999999
Q ss_pred ecccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhh
Q 003644 448 SLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE 527 (805)
Q Consensus 448 V~E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~ 527 (805)
|.| ||+||+|+.+|+..+.. +..-++.-++++||.|+.||-+
T Consensus 708 iTE----------yMENGsLDsFLR~~DGq----------------------------ftviQLVgMLrGIAsGMkYLsd 749 (996)
T KOG0196|consen 708 ITE----------YMENGSLDSFLRQNDGQ----------------------------FTVIQLVGMLRGIASGMKYLSD 749 (996)
T ss_pred Ehh----------hhhCCcHHHHHhhcCCc----------------------------eEeehHHHHHHHHHHHhHHHhh
Confidence 999 99999999999876542 4455678899999999999999
Q ss_pred cceeccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHHHH
Q 003644 528 IGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFC 607 (805)
Q Consensus 528 ~~IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~el 607 (805)
.++|||||..+|||+ +.++.+|++||||++.+.++...........-..+|.|||.+..+++|.++||||+|++|||.
T Consensus 750 m~YVHRDLAARNILV--NsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEV 827 (996)
T KOG0196|consen 750 MNYVHRDLAARNILV--NSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEV 827 (996)
T ss_pred cCchhhhhhhhheee--ccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEe
Confidence 999999999999999 555889999999999887665333333323345789999999999999999999999999998
Q ss_pred HhCCCCCCCC-chHHHHHHHhhc-cccccccCChHHHHHHHHhcCCCCCCCCChhhhhcC
Q 003644 608 ITGGKHPYGE-SFERDANIVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNH 665 (805)
Q Consensus 608 ltG~~~Pf~~-~~~~~~~~~~~~-~~~~~~~~~~~~~dLi~~~L~~dP~~Rps~~ell~H 665 (805)
++-|.-||-+ +.+.-.+.+... ....+.+++..+.+|+..||++|-.+||...+++.+
T Consensus 828 mSyGERPYWdmSNQdVIkaIe~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~ 887 (996)
T KOG0196|consen 828 MSYGERPYWDMSNQDVIKAIEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVST 887 (996)
T ss_pred cccCCCcccccchHHHHHHHHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHH
Confidence 8766666654 333334444444 444556677788899999999999999999998854
|
|
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-35 Score=311.69 Aligned_cols=250 Identities=27% Similarity=0.412 Sum_probs=185.5
Q ss_pred ceEEEeEeeccCCceEEEEEEe-eCCcEEEEEEeecCCc--hHHHHHHHHHHHhCCCCCeeeecccccC------CceEE
Q 003644 376 KLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH--DVALKEIQNLIASDQHPNIVRWYGVESD------QDFVY 446 (805)
Q Consensus 376 ~~~~~~~~LG~GsfGtVy~a~~-~~g~~VAVK~l~~~~~--~~~~~Ei~~ll~~l~HpNIV~l~g~~~~------~~~l~ 446 (805)
..|.+.+.||+|+||+||++.. .+++.||+|.+..... .....|+..+....+||||+++++++.. .+..|
T Consensus 16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~ 95 (282)
T cd06636 16 GIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLW 95 (282)
T ss_pred hhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEE
Confidence 4567778999999999999865 4688999999865422 2334555544444589999999999853 46789
Q ss_pred EecccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhh
Q 003644 447 LSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH 526 (805)
Q Consensus 447 LV~E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH 526 (805)
++||||. +|+|.+++... +...+++..++.++.||+.||+|||
T Consensus 96 iv~e~~~----------~~~L~~~~~~~---------------------------~~~~~~~~~~~~~~~qi~~al~~LH 138 (282)
T cd06636 96 LVMEFCG----------AGSVTDLVKNT---------------------------KGNALKEDWIAYICREILRGLAHLH 138 (282)
T ss_pred EEEEeCC----------CCcHHHHHHHc---------------------------cCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 9999554 44444433211 1123566677899999999999999
Q ss_pred hcceeccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhh-----cCCCCCcchHHHHH
Q 003644 527 EIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLL-----QGRQTRAIDLFSLG 601 (805)
Q Consensus 527 ~~~IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~-----~~~~t~~sDVwSlG 601 (805)
+.+|+||||||+||+++.++. ++|+|||++....... .......|++.|+|||++. ...++.++||||||
T Consensus 139 ~~~ivH~dl~~~nili~~~~~--~~l~dfg~~~~~~~~~---~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG 213 (282)
T cd06636 139 AHKVIHRDIKGQNVLLTENAE--VKLVDFGVSAQLDRTV---GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLG 213 (282)
T ss_pred HCCcccCCCCHHHEEECCCCC--EEEeeCcchhhhhccc---cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHH
Confidence 999999999999999988876 8999999987654221 1223356899999999986 34578899999999
Q ss_pred HHHHHHHhCCCCCCCCchHHH-HHHHhhc-c-ccccccCChHHHHHHHHhcCCCCCCCCChhhhhcCccc
Q 003644 602 CILFFCITGGKHPYGESFERD-ANIVKDR-K-DLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 668 (805)
Q Consensus 602 vil~elltG~~~Pf~~~~~~~-~~~~~~~-~-~~~~~~~~~~~~dLi~~~L~~dP~~Rps~~ell~Hpff 668 (805)
|++|||++| .+||....... ....... . .......++++.++|.+||+.||.+||++.|+++||||
T Consensus 214 ~~l~el~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 214 ITAIEMAEG-APPLCDMHPMRALFLIPRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred HHHHHHHhC-CCCccccCHHhhhhhHhhCCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence 999999997 66775433222 1111111 1 11122356789999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=310.70 Aligned_cols=253 Identities=25% Similarity=0.360 Sum_probs=187.6
Q ss_pred ccceEEEeEeeccCCceEEEEEEe-eCCcEEEEEEeecCCc--hHHHHHHHHHHHhC-CCCCeeeeccccc-----CCce
Q 003644 374 IGKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH--DVALKEIQNLIASD-QHPNIVRWYGVES-----DQDF 444 (805)
Q Consensus 374 i~~~~~~~~~LG~GsfGtVy~a~~-~~g~~VAVK~l~~~~~--~~~~~Ei~~ll~~l-~HpNIV~l~g~~~-----~~~~ 444 (805)
..+.|.+.+.||+|+||+||++.. .+++.||+|.+..... .....|+. ++..+ +||||+++++++. +++.
T Consensus 16 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~-~l~~l~~h~~i~~~~~~~~~~~~~~~~~ 94 (286)
T cd06638 16 PSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYN-ILKALSDHPNVVKFYGMYYKKDVKNGDQ 94 (286)
T ss_pred cccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHH-HHHHHhcCCCeeeeeeeeeecccCCCCe
Confidence 446688889999999999999754 4688999998865332 23445655 44555 7999999999873 4567
Q ss_pred EEEecccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHH
Q 003644 445 VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSH 524 (805)
Q Consensus 445 l~LV~E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~y 524 (805)
.|+||| |+.+|+|.++++.... ....+++..+..++.|++.||.|
T Consensus 95 ~~lv~e----------~~~~~~L~~~l~~~~~-------------------------~~~~~~~~~~~~~~~~i~~~l~~ 139 (286)
T cd06638 95 LWLVLE----------LCNGGSVTDLVKGFLK-------------------------RGERMEEPIIAYILHEALMGLQH 139 (286)
T ss_pred EEEEEe----------ecCCCCHHHHHHHhhc-------------------------cCccccHHHHHHHHHHHHHHHHH
Confidence 999999 5555666555432111 11346777889999999999999
Q ss_pred hhhcceeccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhc-----CCCCCcchHHH
Q 003644 525 LHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ-----GRQTRAIDLFS 599 (805)
Q Consensus 525 LH~~~IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~-----~~~t~~sDVwS 599 (805)
||+.+|+||||||+||+++.++. +||+|||+++...... .......|++.|+|||++.. ..++.++||||
T Consensus 140 lH~~~i~H~dlkp~nili~~~~~--~kl~dfg~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~s 214 (286)
T cd06638 140 LHVNKTIHRDVKGNNILLTTEGG--VKLVDFGVSAQLTSTR---LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWS 214 (286)
T ss_pred HHhCCccccCCCHHhEEECCCCC--EEEccCCceeecccCC---CccccccCCCcccChhhhchhhhccccccchhhhhh
Confidence 99999999999999999988876 8999999988764321 11223458999999999853 44788999999
Q ss_pred HHHHHHHHHhCCCCCCCCchHHH-HHHH-hhcccc--ccccCChHHHHHHHHhcCCCCCCCCChhhhhcCccc
Q 003644 600 LGCILFFCITGGKHPYGESFERD-ANIV-KDRKDL--FLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 668 (805)
Q Consensus 600 lGvil~elltG~~~Pf~~~~~~~-~~~~-~~~~~~--~~~~~~~~~~dLi~~~L~~dP~~Rps~~ell~Hpff 668 (805)
|||++|||++| ..||....... .... ...... .+.....++.++|.+||+.||++||++.|+++||||
T Consensus 215 lGvi~~el~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 215 LGITAIELGDG-DPPLADLHPMRALFKIPRNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred HHHHHHHHhcC-CCCCCCCchhHHHhhccccCCCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence 99999999997 66765543221 1111 111110 112234679999999999999999999999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-35 Score=311.02 Aligned_cols=246 Identities=28% Similarity=0.453 Sum_probs=186.4
Q ss_pred EEEeEeeccCCceEEEEEEe-eCCcEEEEEEeecCCc-----hHHHHHHHHHHHhCCCCCeeeecccccCCceEEEeccc
Q 003644 378 VVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH-----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLER 451 (805)
Q Consensus 378 ~~~~~~LG~GsfGtVy~a~~-~~g~~VAVK~l~~~~~-----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~E~ 451 (805)
|...+.||+|++|+||++.. .+|+.||||++..... ....+|+. +++.++||||+++++++.+++..|+||||
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~-~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREIS-LLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred ceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHH-HHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 56678999999999999855 4689999998864321 23455665 77888999999999999999999999996
Q ss_pred ccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhccee
Q 003644 452 CTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLI 531 (805)
Q Consensus 452 ~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~Iv 531 (805)
+.++|.+++ ... ....+++..++.++.|++.||+|||+.+++
T Consensus 81 ~~~~l~~~~-----------~~~---------------------------~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~ 122 (284)
T cd07860 81 LHQDLKKFM-----------DAS---------------------------PLSGIPLPLIKSYLFQLLQGLAFCHSHRVL 122 (284)
T ss_pred cccCHHHHH-----------HhC---------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence 655444433 211 113366778899999999999999999999
Q ss_pred ccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCC-CCCcchHHHHHHHHHHHHhC
Q 003644 532 HRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGR-QTRAIDLFSLGCILFFCITG 610 (805)
Q Consensus 532 HrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~-~t~~sDVwSlGvil~elltG 610 (805)
||||+|+||+++.++. +||+|||++....... .......+++.|+|||++.+.. ++.++|||||||++|||+||
T Consensus 123 H~~l~p~nill~~~~~--~~l~dfg~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg 197 (284)
T cd07860 123 HRDLKPQNLLINTEGA--IKLADFGLARAFGVPV---RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR 197 (284)
T ss_pred cCCCCHHHEEECCCCC--EEEeeccchhhcccCc---cccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHC
Confidence 9999999999988876 8999999987654321 1112334788999999887644 58899999999999999997
Q ss_pred CCCCCCCchHHH--HHHHhhcc----------------------------ccccccCChHHHHHHHHhcCCCCCCCCChh
Q 003644 611 GKHPYGESFERD--ANIVKDRK----------------------------DLFLVEHIPEAVDLFTRLLDPNPDLRPKAQ 660 (805)
Q Consensus 611 ~~~Pf~~~~~~~--~~~~~~~~----------------------------~~~~~~~~~~~~dLi~~~L~~dP~~Rps~~ 660 (805)
..||....... ..+..... ........++++++|.+||+.||.+||+++
T Consensus 198 -~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~ 276 (284)
T cd07860 198 -RALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAK 276 (284)
T ss_pred -CCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHH
Confidence 66775432211 11111000 000122456889999999999999999999
Q ss_pred hhhcCccc
Q 003644 661 NVLNHPFF 668 (805)
Q Consensus 661 ell~Hpff 668 (805)
++++||||
T Consensus 277 ~~l~~~~f 284 (284)
T cd07860 277 AALAHPFF 284 (284)
T ss_pred HHhcCCCC
Confidence 99999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=316.96 Aligned_cols=256 Identities=26% Similarity=0.377 Sum_probs=195.3
Q ss_pred EEeEeeccCCceEEEEEEe-eCCcEEEEEEeecCCch----HHHHHHHHHHHhCCCCCeeeecccccCCceEEEeccccc
Q 003644 379 VFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCT 453 (805)
Q Consensus 379 ~~~~~LG~GsfGtVy~a~~-~~g~~VAVK~l~~~~~~----~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~E~~~ 453 (805)
...+.||+|+||.||++.. .+++.||||.+...... ...+|+. +++.++||||+++++++.+++..|+|||
T Consensus 7 ~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~lv~e--- 82 (277)
T cd06642 7 TKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEIT-VLSQCDSPYITRYYGSYLKGTKLWIIME--- 82 (277)
T ss_pred HHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHH-HHHcCCCCccHhhhcccccCCceEEEEE---
Confidence 3346799999999999854 46889999988644321 2334554 6788899999999999999999999999
Q ss_pred CChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcceecc
Q 003644 454 CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHR 533 (805)
Q Consensus 454 ~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~IvHr 533 (805)
|+.+++|.+++.. ..+++..+..++.|++.||+|||+.+++|+
T Consensus 83 -------~~~~~~L~~~~~~------------------------------~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~ 125 (277)
T cd06642 83 -------YLGGGSALDLLKP------------------------------GPLEETYIATILREILKGLDYLHSERKIHR 125 (277)
T ss_pred -------ccCCCcHHHHhhc------------------------------CCCCHHHHHHHHHHHHHHHHHHhcCCeecc
Confidence 5555565554321 235567778999999999999999999999
Q ss_pred CCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHHHHHhCCCC
Q 003644 534 DLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKH 613 (805)
Q Consensus 534 DLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~elltG~~~ 613 (805)
||+|+||+++.++. ++|+|||++..+..... ......|+..|+|||++.+..++.++|||||||++|||++| ..
T Consensus 126 dl~p~ni~i~~~~~--~~l~dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg-~~ 199 (277)
T cd06642 126 DIKAANVLLSEQGD--VKLADFGVAGQLTDTQI---KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKG-EP 199 (277)
T ss_pred CCChheEEEeCCCC--EEEccccccccccCcch---hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhC-CC
Confidence 99999999988776 89999999876653211 11234578899999999988899999999999999999997 67
Q ss_pred CCCCchHHHH-HHH-hhccccccccCChHHHHHHHHhcCCCCCCCCChhhhhcCccccccccchhhhhhc
Q 003644 614 PYGESFERDA-NIV-KDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTADTRLSFLRDV 681 (805)
Q Consensus 614 Pf~~~~~~~~-~~~-~~~~~~~~~~~~~~~~dLi~~~L~~dP~~Rps~~ell~Hpff~~~~~~~~~l~~~ 681 (805)
||........ ..+ .............++.++|.+||+.+|++||++.++++||||........++.+.
T Consensus 200 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~~~~~~~~ 269 (277)
T cd06642 200 PNSDLHPMRVLFLIPKNSPPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKFITRYTKKTSFLTEL 269 (277)
T ss_pred CCcccchhhHHhhhhcCCCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHhHHHHHHhhhHHHHHHH
Confidence 7765332221 111 1111222223456899999999999999999999999999997666665555443
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=310.92 Aligned_cols=236 Identities=22% Similarity=0.362 Sum_probs=182.5
Q ss_pred eccCCceEEEEEEe-eCCcEEEEEEeecCCchHHHHHHHHHHHhCCCCCeeeecccccCCceEEEecccccCChhhHHHH
Q 003644 384 IAKGSNGTVVLEGN-YEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYV 462 (805)
Q Consensus 384 LG~GsfGtVy~a~~-~~g~~VAVK~l~~~~~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~E~~~~sL~d~iy~ 462 (805)
||+|+||+||++.. .+++.+|+|.+........ |+.......+||||+++++++.+.+..|+||| |+
T Consensus 24 lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~--e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e----------~~ 91 (267)
T PHA03390 24 LIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI--EPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMD----------YI 91 (267)
T ss_pred ecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh--hHHHHHHhhcCCCEEEEEEEEecCCeeEEEEE----------cC
Confidence 69999999999754 5688999999875432221 22111112379999999999999999999999 55
Q ss_pred hcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCCCceEEe
Q 003644 463 LSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLI 542 (805)
Q Consensus 463 ~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~IvHrDLKp~NILl 542 (805)
++|+|.+++... ..+++.+++.++.||++||+|||+.+++||||||+||++
T Consensus 92 ~~~~L~~~l~~~-----------------------------~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~ 142 (267)
T PHA03390 92 KDGDLFDLLKKE-----------------------------GKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLY 142 (267)
T ss_pred CCCcHHHHHHhc-----------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEE
Confidence 566666654321 246778889999999999999999999999999999999
Q ss_pred cCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH
Q 003644 543 SKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERD 622 (805)
Q Consensus 543 ~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~elltG~~~Pf~~~~~~~ 622 (805)
+.++. .++|+|||+++..... ....|+..|+|||++.+..++.++|||||||++|||++| ..||.......
T Consensus 143 ~~~~~-~~~l~dfg~~~~~~~~-------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g-~~p~~~~~~~~ 213 (267)
T PHA03390 143 DRAKD-RIYLCDYGLCKIIGTP-------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTG-KHPFKEDEDEE 213 (267)
T ss_pred eCCCC-eEEEecCccceecCCC-------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHC-CCCCCCCCcch
Confidence 87762 4899999998765432 223588999999999988899999999999999999997 67886443221
Q ss_pred H---HH--HhhccccccccCChHHHHHHHHhcCCCCCCCCC-hhhhhcCcccc
Q 003644 623 A---NI--VKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPK-AQNVLNHPFFW 669 (805)
Q Consensus 623 ~---~~--~~~~~~~~~~~~~~~~~dLi~~~L~~dP~~Rps-~~ell~Hpff~ 669 (805)
. .. ............++.+.++|.+||+.||.+||+ ++++++||||.
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~~~ 266 (267)
T PHA03390 214 LDLESLLKRQQKKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFLK 266 (267)
T ss_pred hhHHHHHHhhcccCCcccccCHHHHHHHHHHhccChhhCCchHHHHhcCCccc
Confidence 1 11 111112223346789999999999999999996 69999999995
|
|
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=307.20 Aligned_cols=246 Identities=30% Similarity=0.433 Sum_probs=185.3
Q ss_pred eEeeccCCceEEEEEEe-eCCcEEEEEEeecCCch---HHHHHHHHHHHhCCCCCeeeecccccCCceEEEecccccCCh
Q 003644 381 NKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHHD---VALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCSL 456 (805)
Q Consensus 381 ~~~LG~GsfGtVy~a~~-~~g~~VAVK~l~~~~~~---~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~E~~~~sL 456 (805)
...||+|+||.||++.. .++..||||.+...... ...+|+ .+++.++||||+++++++.+++..++|+|
T Consensus 13 ~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~-~~l~~l~h~~iv~~~~~~~~~~~~~lv~e------ 85 (268)
T cd06624 13 RVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEI-ALHSYLKHRNIVQYLGSDSENGFFKIFME------ 85 (268)
T ss_pred eEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHH-HHHHhcCCCCeeeeeeeeccCCEEEEEEe------
Confidence 35799999999999864 46788999988654322 233454 47788999999999999999999999999
Q ss_pred hhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCC
Q 003644 457 NDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLK 536 (805)
Q Consensus 457 ~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~IvHrDLK 536 (805)
|..+++|.+++..... ....++..+..++.||+.||+|||+.+|+|||||
T Consensus 86 ----~~~~~~L~~~l~~~~~--------------------------~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~ 135 (268)
T cd06624 86 ----QVPGGSLSALLRSKWG--------------------------PLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIK 135 (268)
T ss_pred ----cCCCCCHHHHHHHhcc--------------------------cCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCC
Confidence 5555666665532210 0012556778899999999999999999999999
Q ss_pred CceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCC--CCCcchHHHHHHHHHHHHhCCCCC
Q 003644 537 PQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGR--QTRAIDLFSLGCILFFCITGGKHP 614 (805)
Q Consensus 537 p~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~--~t~~sDVwSlGvil~elltG~~~P 614 (805)
|+||+++.+.. .++|+|||++........ ......|++.|+|||++.... ++.++|||||||++|+|++| .+|
T Consensus 136 p~nil~~~~~~-~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g-~~p 210 (268)
T cd06624 136 GDNVLVNTYSG-VVKISDFGTSKRLAGINP---CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATG-KPP 210 (268)
T ss_pred HHHEEEcCCCC-eEEEecchhheecccCCC---ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhC-CCC
Confidence 99999976432 489999999876643211 112234789999999986643 78899999999999999996 678
Q ss_pred CCCchHHHHHHH----hhccccccccCChHHHHHHHHhcCCCCCCCCChhhhhcCccc
Q 003644 615 YGESFERDANIV----KDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 668 (805)
Q Consensus 615 f~~~~~~~~~~~----~~~~~~~~~~~~~~~~dLi~~~L~~dP~~Rps~~ell~Hpff 668 (805)
|........... .......+....+++.+++.+||+.+|.+||++.|++.||||
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 211 FIELGEPQAAMFKVGMFKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQDPFL 268 (268)
T ss_pred CccccChhhhHhhhhhhccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhCCCC
Confidence 765332211111 111222334456789999999999999999999999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=303.97 Aligned_cols=247 Identities=23% Similarity=0.362 Sum_probs=192.8
Q ss_pred EEEeEeeccCCceEEEEEEe-eCCcEEEEEEeecCCc-----hHHHHHHHHHHHhCCCCCeeeecccccCCceEEEeccc
Q 003644 378 VVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH-----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLER 451 (805)
Q Consensus 378 ~~~~~~LG~GsfGtVy~a~~-~~g~~VAVK~l~~~~~-----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~E~ 451 (805)
|.+.+.||+|+||.||++.. .+++.||||++..... ....+|+ .+++.++||||+++++.+.+++..++|||
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~-~~l~~~~~~~i~~~~~~~~~~~~~~lv~e- 79 (256)
T cd08220 2 YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNEC-QVLKLLSHPNIIEYYENFLEDKALMIVME- 79 (256)
T ss_pred ceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHH-HHHhhCCCCchhheeeeEecCCEEEEEEe-
Confidence 67788999999999999754 5788999999865321 1233444 47788899999999999999999999999
Q ss_pred ccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhccee
Q 003644 452 CTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLI 531 (805)
Q Consensus 452 ~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~Iv 531 (805)
|..+++|.+++.... ...+++..++.++.|++.||+|||+.+|+
T Consensus 80 ---------~~~~~~L~~~~~~~~---------------------------~~~~~~~~~~~~~~~i~~~l~~lh~~~i~ 123 (256)
T cd08220 80 ---------YAPGGTLAEYIQKRC---------------------------NSLLDEDTILHFFVQILLALHHVHTKLIL 123 (256)
T ss_pred ---------cCCCCCHHHHHHHhc---------------------------ccCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence 555666666553321 12357778899999999999999999999
Q ss_pred ccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHHHHHhCC
Q 003644 532 HRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGG 611 (805)
Q Consensus 532 HrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~elltG~ 611 (805)
||||||+||+++.++. .+||+|||++....... ......|+..|+|||.+.+..++.++|||||||++|+|++|
T Consensus 124 h~dl~~~nil~~~~~~-~~~l~d~~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~- 197 (256)
T cd08220 124 HRDLKTQNILLDKHKM-VVKIGDFGISKILSSKS----KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASL- 197 (256)
T ss_pred cCCCCHHHEEEcCCCC-EEEEccCCCceecCCCc----cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhC-
Confidence 9999999999976654 48999999998765321 12234588999999999988889999999999999999997
Q ss_pred CCCCCCchHHH-H-HHHhhccccccccCChHHHHHHHHhcCCCCCCCCChhhhhcCccc
Q 003644 612 KHPYGESFERD-A-NIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 668 (805)
Q Consensus 612 ~~Pf~~~~~~~-~-~~~~~~~~~~~~~~~~~~~dLi~~~L~~dP~~Rps~~ell~Hpff 668 (805)
..||....... . .+........+...++++.+++.+||+.||.+|||+.|+++||||
T Consensus 198 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 198 KRAFEAANLPALVLKIMSGTFAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQPIC 256 (256)
T ss_pred CCCcccCchHHHHHHHHhcCCCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhCCCC
Confidence 66776543222 1 122222222334456889999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=311.90 Aligned_cols=262 Identities=23% Similarity=0.331 Sum_probs=191.5
Q ss_pred eEEEeEeeccCCceEEEEEEeeC------CcEEEEEEeecCCch----HHHHHHHHHHHhCCCCCeeeecccccCCceEE
Q 003644 377 LVVFNKEIAKGSNGTVVLEGNYE------GRSVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVRWYGVESDQDFVY 446 (805)
Q Consensus 377 ~~~~~~~LG~GsfGtVy~a~~~~------g~~VAVK~l~~~~~~----~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~ 446 (805)
.|.+.+.||+|+||.||++.... ...||+|.+...... ...+|+. .+..++||||+++++++.+.+..|
T Consensus 6 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~-~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 6 AVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAE-LMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHH-HHHhcCCcccceEEEEEcCCCceE
Confidence 46677899999999999986533 367999998654322 2334554 677889999999999999999999
Q ss_pred EecccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhh
Q 003644 447 LSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH 526 (805)
Q Consensus 447 LV~E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH 526 (805)
++||+ +.+|+|.+++........... ..........+++..++.++.|++.||+|||
T Consensus 85 ~~~e~----------~~~~~L~~~l~~~~~~~~~~~-------------~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH 141 (283)
T cd05048 85 MLFEY----------LAHGDLHEFLVRNSPHSDVGA-------------ESGDETVKSSLDCSDFLHIAIQIAAGMEYLS 141 (283)
T ss_pred EEEec----------CCCCcHHHHHHhcCCCccccc-------------ccccccccCCCCHHHHHHHHHHHHHHHHHHH
Confidence 99994 455555555543211100000 0000011245778889999999999999999
Q ss_pred hcceeccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHHH
Q 003644 527 EIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFF 606 (805)
Q Consensus 527 ~~~IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~e 606 (805)
+.+++||||||+||+++.++. ++|+|||+++....... ........+++.|+|||.+.+..++.++|||||||++||
T Consensus 142 ~~~i~H~dlkp~Nil~~~~~~--~~L~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~e 218 (283)
T cd05048 142 SHHFVHRDLAARNCLVGEGLT--VKISDFGLSRDIYSADY-YRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWE 218 (283)
T ss_pred hCCeeccccccceEEEcCCCc--EEECCCcceeecccccc-ccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHH
Confidence 999999999999999987765 89999999986543211 112233457889999999998899999999999999999
Q ss_pred HHhCCCCCCCC-chHHHHHHHh-hccccccccCChHHHHHHHHhcCCCCCCCCChhhhhcC
Q 003644 607 CITGGKHPYGE-SFERDANIVK-DRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNH 665 (805)
Q Consensus 607 lltG~~~Pf~~-~~~~~~~~~~-~~~~~~~~~~~~~~~dLi~~~L~~dP~~Rps~~ell~H 665 (805)
|++.+..||.. ........+. ......+...++++.+|+.+||+.||.+||+++|+++|
T Consensus 219 l~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~ 279 (283)
T cd05048 219 IFSYGLQPYYGFSNQEVIEMIRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTR 279 (283)
T ss_pred HHcCCCCCCCCCCHHHHHHHHHcCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 99833666654 3333333332 22223344567899999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=311.14 Aligned_cols=249 Identities=28% Similarity=0.404 Sum_probs=195.0
Q ss_pred eEEEeEeeccCCceEEEEEEee-CCcEEEEEEeecCCc----hHHHHHHHHHHHhCCCCCeeeecccccCCceEEEeccc
Q 003644 377 LVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLER 451 (805)
Q Consensus 377 ~~~~~~~LG~GsfGtVy~a~~~-~g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~E~ 451 (805)
+|.+.+.||.|++|.||++... +++.||+|.+..... ....+|+. +++.++||||+++++++.++...|+|+|
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~~v~e- 79 (274)
T cd06609 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQ-FLSQCRSPYITKYYGSFLKGSKLWIIME- 79 (274)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHH-HHHHcCCCCeeeeeEEEEECCeEEEEEE-
Confidence 3556688999999999998654 689999999865431 22344554 6788899999999999999999999999
Q ss_pred ccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhccee
Q 003644 452 CTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLI 531 (805)
Q Consensus 452 ~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~Iv 531 (805)
|..+++|.+++.. ..+++..+..++.|++.||+|||+.+++
T Consensus 80 ---------~~~~~~L~~~~~~------------------------------~~~~~~~~~~~~~ql~~~l~~lh~~~i~ 120 (274)
T cd06609 80 ---------YCGGGSCLDLLKP------------------------------GKLDETYIAFILREVLLGLEYLHEEGKI 120 (274)
T ss_pred ---------eeCCCcHHHHHhh------------------------------cCCCHHHHHHHHHHHHHHHHHHHhCCcc
Confidence 5555666554421 1356778899999999999999999999
Q ss_pred ccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHHHHHhCC
Q 003644 532 HRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGG 611 (805)
Q Consensus 532 HrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~elltG~ 611 (805)
||||+|+||+++.++. ++|+|||+++...... .......|++.|+|||++.+..++.++|||||||++|+|++|
T Consensus 121 h~dl~p~ni~i~~~~~--~~l~d~g~~~~~~~~~---~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg- 194 (274)
T cd06609 121 HRDIKAANILLSEEGD--VKLADFGVSGQLTSTM---SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKG- 194 (274)
T ss_pred cCCCCHHHEEECCCCC--EEEcccccceeecccc---cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhC-
Confidence 9999999999988776 8999999998776432 122334588899999999988899999999999999999996
Q ss_pred CCCCCCchHHHH--HHHhhcccccccc-CChHHHHHHHHhcCCCCCCCCChhhhhcCccccccc
Q 003644 612 KHPYGESFERDA--NIVKDRKDLFLVE-HIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTAD 672 (805)
Q Consensus 612 ~~Pf~~~~~~~~--~~~~~~~~~~~~~-~~~~~~dLi~~~L~~dP~~Rps~~ell~Hpff~~~~ 672 (805)
.+||........ .+........... .++++.+++.+||..||++||+++++++||||....
T Consensus 195 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~~~~~~ 258 (274)
T cd06609 195 EPPLSDLHPMRVLFLIPKNNPPSLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLKHKFIKKAK 258 (274)
T ss_pred CCCcccCchHHHHHHhhhcCCCCCcccccCHHHHHHHHHHhhCChhhCcCHHHHhhChhhcCCC
Confidence 778865432221 1112222222222 567899999999999999999999999999996643
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-35 Score=310.38 Aligned_cols=244 Identities=28% Similarity=0.432 Sum_probs=183.7
Q ss_pred EEEeEeeccCCceEEEEEEe-eCCcEEEEEEeecCCc----hHHHHHHHHHHHhCCCCCeeeecccccCC--ceEEEecc
Q 003644 378 VVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQ--DFVYLSLE 450 (805)
Q Consensus 378 ~~~~~~LG~GsfGtVy~a~~-~~g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~--~~l~LV~E 450 (805)
|.+.+.||+|+||.||++.. .+++.||||++++... ...++|+..+....+||||+++++++.+. +..++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 34678899999999999854 4689999999865321 23356766555555699999999999987 89999999
Q ss_pred cccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcce
Q 003644 451 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 530 (805)
Q Consensus 451 ~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~I 530 (805)
++.++|.+.+ .. ....+++.+++.++.|++.||+|||+.++
T Consensus 81 ~~~~~l~~~l-----------~~----------------------------~~~~~~~~~~~~~~~qi~~~L~~LH~~~i 121 (282)
T cd07831 81 LMDMNLYELI-----------KG----------------------------RKRPLPEKRVKSYMYQLLKSLDHMHRNGI 121 (282)
T ss_pred cCCccHHHHH-----------Hh----------------------------ccCCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence 7665554433 11 01246778889999999999999999999
Q ss_pred eccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhc-CCCCCcchHHHHHHHHHHHHh
Q 003644 531 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ-GRQTRAIDLFSLGCILFFCIT 609 (805)
Q Consensus 531 vHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~t~~sDVwSlGvil~ellt 609 (805)
+||||||+||+++. +. +||+|||+++....... .....++..|+|||++.. ..++.++|||||||++|||++
T Consensus 122 ~H~dl~p~ni~l~~-~~--~kl~dfg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~ 194 (282)
T cd07831 122 FHRDIKPENILIKD-DI--LKLADFGSCRGIYSKPP----YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILS 194 (282)
T ss_pred eecccCHHHEEEcC-CC--eEEEecccccccccCCC----cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHc
Confidence 99999999999987 54 89999999987653321 122457899999998754 457899999999999999999
Q ss_pred CCCCCCCCchHHHH--HHHh-----------h------cccc-----------ccccCChHHHHHHHHhcCCCCCCCCCh
Q 003644 610 GGKHPYGESFERDA--NIVK-----------D------RKDL-----------FLVEHIPEAVDLFTRLLDPNPDLRPKA 659 (805)
Q Consensus 610 G~~~Pf~~~~~~~~--~~~~-----------~------~~~~-----------~~~~~~~~~~dLi~~~L~~dP~~Rps~ 659 (805)
| .+||......+. .+.. . .... .....+.++.++|.+||+.||++||++
T Consensus 195 ~-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~ 273 (282)
T cd07831 195 L-FPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITA 273 (282)
T ss_pred C-CcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCH
Confidence 6 778865332110 0000 0 0000 011335789999999999999999999
Q ss_pred hhhhcCccc
Q 003644 660 QNVLNHPFF 668 (805)
Q Consensus 660 ~ell~Hpff 668 (805)
+++++||||
T Consensus 274 ~~~l~~~~~ 282 (282)
T cd07831 274 KQALRHPYF 282 (282)
T ss_pred HHHhhCCCC
Confidence 999999997
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=310.33 Aligned_cols=246 Identities=27% Similarity=0.456 Sum_probs=187.9
Q ss_pred EEEeEeeccCCceEEEEEEe-eCCcEEEEEEeecCC-----chHHHHHHHHHHHhCCCCCeeeecccccCCceEEEeccc
Q 003644 378 VVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLER 451 (805)
Q Consensus 378 ~~~~~~LG~GsfGtVy~a~~-~~g~~VAVK~l~~~~-----~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~E~ 451 (805)
|.+.+.||+|+||.||++.. .+|+.||||++.... .....+|+. +++.++||||+++++++.+++..|+|+|+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~-~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 2 YKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIK-ALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred ceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHH-HHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 67788999999999999865 468999999986543 123445554 67788999999999999999999999995
Q ss_pred ccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhccee
Q 003644 452 CTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLI 531 (805)
Q Consensus 452 ~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~Iv 531 (805)
+ +++|.+++... ...+++.+++.++.||+.||+|||+.+++
T Consensus 81 ~-----------~~~L~~~~~~~----------------------------~~~~~~~~~~~~~~~i~~~l~~lH~~~i~ 121 (286)
T cd07832 81 M-----------PSDLSEVLRDE----------------------------ERPLPEAQVKSYMRMLLKGVAYMHANGIM 121 (286)
T ss_pred c-----------CCCHHHHHHhc----------------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence 5 44444443211 13467778899999999999999999999
Q ss_pred ccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcC-CCCCcchHHHHHHHHHHHHhC
Q 003644 532 HRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG-RQTRAIDLFSLGCILFFCITG 610 (805)
Q Consensus 532 HrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~t~~sDVwSlGvil~elltG 610 (805)
|+||||+||+++.++. ++|+|||++........ .......|+..|+|||++.+. .++.++||||+||++|||++|
T Consensus 122 H~dl~p~ni~~~~~~~--~~l~dfg~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg 197 (286)
T cd07832 122 HRDLKPANLLISADGV--LKIADFGLARLFSEEEP--RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNG 197 (286)
T ss_pred cCCcCHHHEEEcCCCc--EEEeeeeecccccCCCC--CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcC
Confidence 9999999999988765 89999999987654321 112334689999999998654 468999999999999999998
Q ss_pred CCCCCCCchHHH-H-HHHhhc------------------c-----------ccccccCChHHHHHHHHhcCCCCCCCCCh
Q 003644 611 GKHPYGESFERD-A-NIVKDR------------------K-----------DLFLVEHIPEAVDLFTRLLDPNPDLRPKA 659 (805)
Q Consensus 611 ~~~Pf~~~~~~~-~-~~~~~~------------------~-----------~~~~~~~~~~~~dLi~~~L~~dP~~Rps~ 659 (805)
.+||....... . .+.... . .........++.++|++||+.||++||++
T Consensus 198 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~ 276 (286)
T cd07832 198 -SPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSA 276 (286)
T ss_pred -CcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCH
Confidence 77775433211 0 111000 0 00011334788999999999999999999
Q ss_pred hhhhcCccc
Q 003644 660 QNVLNHPFF 668 (805)
Q Consensus 660 ~ell~Hpff 668 (805)
+++++||||
T Consensus 277 ~~~l~h~~~ 285 (286)
T cd07832 277 AEALRHPYF 285 (286)
T ss_pred HHHhhCcCc
Confidence 999999998
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=306.78 Aligned_cols=247 Identities=24% Similarity=0.329 Sum_probs=190.4
Q ss_pred ceEEEeEeeccCCceEEEEEEee-CCcEEEEEEeecCCc--hHHHHHHHHHHHhCCCCCeeeecccccCCceEEEecccc
Q 003644 376 KLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHH--DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERC 452 (805)
Q Consensus 376 ~~~~~~~~LG~GsfGtVy~a~~~-~g~~VAVK~l~~~~~--~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~E~~ 452 (805)
..|.+.+.||+|+||.||++... .++.||+|++..... ....+|+. ++..++||||+++++++.+++..+++||
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~lv~e-- 82 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAA-VMKEIKHPNLVQLLGVCTREPPFYIITE-- 82 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHH-HHHhCCCCChhheEEEEcCCCCcEEEEE--
Confidence 34778899999999999998544 588999999875432 23455665 6677899999999999999999999999
Q ss_pred cCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcceec
Q 003644 453 TCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIH 532 (805)
Q Consensus 453 ~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~IvH 532 (805)
|+.+++|.+++.... ...+++..++.++.|++.||+|||+.+++|
T Consensus 83 --------~~~~~~L~~~~~~~~---------------------------~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H 127 (263)
T cd05052 83 --------FMTYGNLLDYLRECN---------------------------RQEVNAVVLLYMATQISSAMEYLEKKNFIH 127 (263)
T ss_pred --------eCCCCcHHHHHHhCC---------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCEee
Confidence 556666666553211 123567788999999999999999999999
Q ss_pred cCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHHHHHhCCC
Q 003644 533 RDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGK 612 (805)
Q Consensus 533 rDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~elltG~~ 612 (805)
|||||+|||+++++. +||+|||++........ .......++..|+|||.+.+..++.++|||||||++|||++++.
T Consensus 128 ~dlkp~nil~~~~~~--~kl~df~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~ 203 (263)
T cd05052 128 RDLAARNCLVGENHL--VKVADFGLSRLMTGDTY--TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGM 203 (263)
T ss_pred cccCcceEEEcCCCc--EEeCCCcccccccccee--eccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCC
Confidence 999999999987765 89999999987653211 11112234678999999998899999999999999999999557
Q ss_pred CCCCCchHH-HHHHHhh-ccccccccCChHHHHHHHHhcCCCCCCCCChhhhhc
Q 003644 613 HPYGESFER-DANIVKD-RKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 664 (805)
Q Consensus 613 ~Pf~~~~~~-~~~~~~~-~~~~~~~~~~~~~~dLi~~~L~~dP~~Rps~~ell~ 664 (805)
.||...... ....+.. .....+...++++.++|.+||+.||++||++.++++
T Consensus 204 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 257 (263)
T cd05052 204 SPYPGIDLSQVYELLEKGYRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQ 257 (263)
T ss_pred CCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 787653322 2222222 122334455689999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=322.06 Aligned_cols=246 Identities=27% Similarity=0.429 Sum_probs=187.6
Q ss_pred ccceEEEeEeeccCCceEEEEEEe-eCCcEEEEEEeecCC-----chHHHHHHHHHHHhCCCCCeeeecccccCC-----
Q 003644 374 IGKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQ----- 442 (805)
Q Consensus 374 i~~~~~~~~~LG~GsfGtVy~a~~-~~g~~VAVK~l~~~~-----~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~----- 442 (805)
+.+.|...+.||+|+||+||++.. .+|+.||||++.+.. .....+|+. ++..++||||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~-~l~~l~h~~iv~~~~~~~~~~~~~~ 92 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELV-LMKLVNHKNIIGLLNVFTPQKSLEE 92 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHH-HHHhcCCCCCcceeeeeccCCCccc
Confidence 456788889999999999999854 478999999986432 123445665 67889999999999987644
Q ss_pred -ceEEEecccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHH
Q 003644 443 -DFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSG 521 (805)
Q Consensus 443 -~~l~LV~E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~g 521 (805)
...|+|||+|.++|.+++.. .+++..+..++.|++.|
T Consensus 93 ~~~~~lv~e~~~~~l~~~~~~------------------------------------------~l~~~~~~~~~~ql~~a 130 (353)
T cd07850 93 FQDVYLVMELMDANLCQVIQM------------------------------------------DLDHERMSYLLYQMLCG 130 (353)
T ss_pred cCcEEEEEeccCCCHHHHHhh------------------------------------------cCCHHHHHHHHHHHHHH
Confidence 35799999887766554411 14556678899999999
Q ss_pred HHHhhhcceeccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHH
Q 003644 522 LSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLG 601 (805)
Q Consensus 522 L~yLH~~~IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlG 601 (805)
|+|||+.||+||||||+||+++.++. +||+|||+++...... ......++..|+|||++.+..++.++||||||
T Consensus 131 L~~LH~~gi~H~dlkp~Nil~~~~~~--~kL~Dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG 204 (353)
T cd07850 131 IKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSF----MMTPYVVTRYYRAPEVILGMGYKENVDIWSVG 204 (353)
T ss_pred HHHHHhCCeeeCCCCHHHEEECCCCC--EEEccCccceeCCCCC----CCCCCcccccccCHHHHhCCCCCCchhhHhHH
Confidence 99999999999999999999988876 8999999998765321 12334588999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCCchHHH-H-HHHh----------------------hccc-------------cc-------cccC
Q 003644 602 CILFFCITGGKHPYGESFERD-A-NIVK----------------------DRKD-------------LF-------LVEH 637 (805)
Q Consensus 602 vil~elltG~~~Pf~~~~~~~-~-~~~~----------------------~~~~-------------~~-------~~~~ 637 (805)
|++|+|++| +.||....... . .+.. .... .+ ....
T Consensus 205 ~~l~~l~~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (353)
T cd07850 205 CIMGEMIRG-TVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLK 283 (353)
T ss_pred HHHHHHHHC-CCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccc
Confidence 999999997 66775432111 0 0000 0000 00 0012
Q ss_pred ChHHHHHHHHhcCCCCCCCCChhhhhcCcccc
Q 003644 638 IPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFW 669 (805)
Q Consensus 638 ~~~~~dLi~~~L~~dP~~Rps~~ell~Hpff~ 669 (805)
.+++.++|.+||+.||.+|||+.|+|+||||.
T Consensus 284 ~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~ 315 (353)
T cd07850 284 ASQARDLLSKMLVIDPEKRISVDDALQHPYIN 315 (353)
T ss_pred hhHHHHHHHHHcCCChhhCcCHHHHhcChhHh
Confidence 34688999999999999999999999999984
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=347.77 Aligned_cols=253 Identities=24% Similarity=0.358 Sum_probs=203.3
Q ss_pred ceEEEeEeeccCCceEEEEEEeeC--Cc----EEEEEEeecCCch----HHHHHHHHHHHhCCCCCeeeecccccCCceE
Q 003644 376 KLVVFNKEIAKGSNGTVVLEGNYE--GR----SVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVRWYGVESDQDFV 445 (805)
Q Consensus 376 ~~~~~~~~LG~GsfGtVy~a~~~~--g~----~VAVK~l~~~~~~----~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l 445 (805)
+...+...||+|+||.||.|...+ |. .||||.+.+.... ++.+|. .+|+..+|||||+++|+|.+....
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea-~~m~~f~HpNiv~liGv~l~~~~~ 770 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEA-LLMSKFDHPNIVSLIGVCLDSGPP 770 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHH-HHHhcCCCcceeeEEEeecCCCCc
Confidence 346678899999999999985543 43 4999999765433 233444 488999999999999999999999
Q ss_pred EEecccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHh
Q 003644 446 YLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHL 525 (805)
Q Consensus 446 ~LV~E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yL 525 (805)
+|++| ||.+|+|..+|...+... .....+...+++.++.|||+|+.||
T Consensus 771 ~i~le----------yM~gGDL~sflr~~r~~~----------------------~~~~~L~~~dLl~~a~dvA~G~~YL 818 (1025)
T KOG1095|consen 771 LILLE----------YMEGGDLLSFLRESRPAP----------------------FQPSNLSMRDLLAFALDVAKGMNYL 818 (1025)
T ss_pred EEEeh----------hcccCcHHHHHHhccccc----------------------CCCCCCCHHHHHHHHHHHhhhhHHH
Confidence 99999 999999999987653321 2245678889999999999999999
Q ss_pred hhcceeccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHH
Q 003644 526 HEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILF 605 (805)
Q Consensus 526 H~~~IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~ 605 (805)
+++++|||||..+|+||+.. ..+||+|||+|+.+..... +.......-...|||||.+..+.++.|+|||||||++|
T Consensus 819 e~~~fvHRDLAaRNCLL~~~--r~VKIaDFGlArDiy~~~y-yr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllW 895 (1025)
T KOG1095|consen 819 ESKHFVHRDLAARNCLLDER--RVVKIADFGLARDIYDKDY-YRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLW 895 (1025)
T ss_pred HhCCCcCcchhhhheeeccc--CcEEEcccchhHhhhhchh-eeccCccccceecCCHHHHhhcccccccchhhhHHHHH
Confidence 99999999999999999776 4599999999996543321 22222223457899999999999999999999999999
Q ss_pred HHHhCCCCCCCCchHHHH--HHHhhccccccccCChHHHHHHHHhcCCCCCCCCChhhhhc
Q 003644 606 FCITGGKHPYGESFERDA--NIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 664 (805)
Q Consensus 606 elltG~~~Pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~dLi~~~L~~dP~~Rps~~ell~ 664 (805)
|++|.|..||.+....+. .......-..+..++..+.++|.+||+.+|+.||+...+++
T Consensus 896 EifslG~~PY~~~~n~~v~~~~~~ggRL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 896 EIFSLGATPYPSRSNFEVLLDVLEGGRLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred HHHhCCCCCCCCcchHHHHHHHHhCCccCCCCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence 999999999998665543 23444444455556667889999999999999999999986
|
|
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=312.54 Aligned_cols=257 Identities=25% Similarity=0.393 Sum_probs=196.2
Q ss_pred EEEeEeeccCCceEEEEEEe-eCCcEEEEEEeecCCch----HHHHHHHHHHHhCCCCCeeeecccccCCceEEEecccc
Q 003644 378 VVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERC 452 (805)
Q Consensus 378 ~~~~~~LG~GsfGtVy~a~~-~~g~~VAVK~l~~~~~~----~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~E~~ 452 (805)
|...+.||.|+||.||++.. .++..||||.+...... ...+|+. +++.++||||+++++++.+++..|+|||
T Consensus 6 y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~lv~e-- 82 (277)
T cd06640 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIT-VLSQCDSPYVTKYYGSYLKGTKLWIIME-- 82 (277)
T ss_pred hhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHH-HHHhCCCCCEeeEEEEEEECCEEEEEEe--
Confidence 45567899999999999865 46889999998754322 2334444 6778899999999999999999999999
Q ss_pred cCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcceec
Q 003644 453 TCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIH 532 (805)
Q Consensus 453 ~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~IvH 532 (805)
|..+|+|.+++.. ..+++.++..++.|++.||+|||+.+++|
T Consensus 83 --------~~~~~~L~~~i~~------------------------------~~l~~~~~~~~~~~l~~~l~~lh~~~ivH 124 (277)
T cd06640 83 --------YLGGGSALDLLRA------------------------------GPFDEFQIATMLKEILKGLDYLHSEKKIH 124 (277)
T ss_pred --------cCCCCcHHHHHhc------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCccC
Confidence 5556666554421 23456677889999999999999999999
Q ss_pred cCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHHHHHhCCC
Q 003644 533 RDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGK 612 (805)
Q Consensus 533 rDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~elltG~~ 612 (805)
+||+|+||+++.++. ++|+|||++........ ......++..|+|||++.+..++.++|+|||||++|||++| .
T Consensus 125 ~dl~p~Nil~~~~~~--~~l~dfg~~~~~~~~~~---~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg-~ 198 (277)
T cd06640 125 RDIKAANVLLSEQGD--VKLADFGVAGQLTDTQI---KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKG-E 198 (277)
T ss_pred cCCChhhEEEcCCCC--EEEcccccceeccCCcc---ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHC-C
Confidence 999999999988776 89999999977653321 12233578899999999888899999999999999999997 6
Q ss_pred CCCCCchHHHH-HHH-hhccccccccCChHHHHHHHHhcCCCCCCCCChhhhhcCccccccccchhhhhhc
Q 003644 613 HPYGESFERDA-NIV-KDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTADTRLSFLRDV 681 (805)
Q Consensus 613 ~Pf~~~~~~~~-~~~-~~~~~~~~~~~~~~~~dLi~~~L~~dP~~Rps~~ell~Hpff~~~~~~~~~l~~~ 681 (805)
+||........ ..+ ...........+.++.+++.+||+.+|++||++.++++||||.....+...+..+
T Consensus 199 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~~~~~~~~ 269 (277)
T cd06640 199 PPNSDMHPMRVLFLIPKNNPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFIVKNAKKTSYLTEL 269 (277)
T ss_pred CCCCCcChHhHhhhhhcCCCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhChHhhhcchhhhHHHHH
Confidence 77765432221 111 1112222223456889999999999999999999999999997665554444443
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=313.48 Aligned_cols=250 Identities=28% Similarity=0.447 Sum_probs=191.6
Q ss_pred EEEeEeeccCCceEEEEEEee-CCcEEEEEEeecCCc----hHHHHHHHHHHHhCCCCCeeeecccccCCceEEEecccc
Q 003644 378 VVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERC 452 (805)
Q Consensus 378 ~~~~~~LG~GsfGtVy~a~~~-~g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~E~~ 452 (805)
|.+.+.||+|+||+||++... +|+.||+|.+..... ....+|+. ++..++||||+++++++...+..|+|||
T Consensus 3 ~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~-~l~~~~~~~i~~~~~~~~~~~~~~lv~e-- 79 (286)
T cd06622 3 IEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELD-ILHKAVSPYIVDFYGAFFIEGAVYMCME-- 79 (286)
T ss_pred hhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHH-HHHhcCCCcHHhhhhheecCCeEEEEEe--
Confidence 556788999999999998654 789999998865322 23445554 6677899999999999999999999999
Q ss_pred cCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhh-ccee
Q 003644 453 TCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE-IGLI 531 (805)
Q Consensus 453 ~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~-~~Iv 531 (805)
|+++++|..++.... ....+++..+..++.||+.||+|||+ .+|+
T Consensus 80 --------~~~~~~l~~~~~~~~--------------------------~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~ 125 (286)
T cd06622 80 --------YMDAGSLDKLYAGGV--------------------------ATEGIPEDVLRRITYAVVKGLKFLKEEHNII 125 (286)
T ss_pred --------ecCCCCHHHHHHhcc--------------------------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCEe
Confidence 445555555443210 01246778889999999999999997 5999
Q ss_pred ccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcC------CCCCcchHHHHHHHHH
Q 003644 532 HRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG------RQTRAIDLFSLGCILF 605 (805)
Q Consensus 532 HrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~------~~t~~sDVwSlGvil~ 605 (805)
||||||+||+++.++. +||+|||++...... ......+++.|+|||++.+. .++.++|+|||||++|
T Consensus 126 H~dl~p~nil~~~~~~--~~l~dfg~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~ 198 (286)
T cd06622 126 HRDVKPTNVLVNGNGQ--VKLCDFGVSGNLVAS-----LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSIL 198 (286)
T ss_pred eCCCCHHHEEECCCCC--EEEeecCCcccccCC-----ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHH
Confidence 9999999999988765 899999998765422 12234588899999998553 3478999999999999
Q ss_pred HHHhCCCCCCCCchHHH-H----HHHhhccccccccCChHHHHHHHHhcCCCCCCCCChhhhhcCccccccc
Q 003644 606 FCITGGKHPYGESFERD-A----NIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTAD 672 (805)
Q Consensus 606 elltG~~~Pf~~~~~~~-~----~~~~~~~~~~~~~~~~~~~dLi~~~L~~dP~~Rps~~ell~Hpff~~~~ 672 (805)
+|++| ..||....... . .+........+...++++.++|.+||+.+|.+||+++++++||||+...
T Consensus 199 ~l~~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~ 269 (286)
T cd06622 199 EMALG-RYPYPPETYANIFAQLSAIVDGDPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYK 269 (286)
T ss_pred HHHhC-CCCCCCcchhhHHHHHHHHhhcCCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhcc
Confidence 99997 67885432211 1 1222222333445678999999999999999999999999999996644
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=309.42 Aligned_cols=257 Identities=22% Similarity=0.299 Sum_probs=192.5
Q ss_pred cceEEEeEeeccCCceEEEEEEee------CCcEEEEEEeecCCc----hHHHHHHHHHHHhCCCCCeeeecccccCCce
Q 003644 375 GKLVVFNKEIAKGSNGTVVLEGNY------EGRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQDF 444 (805)
Q Consensus 375 ~~~~~~~~~LG~GsfGtVy~a~~~------~g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~ 444 (805)
++.|.+.+.||+|++|.||++... .+..||+|.+..... ....+|+. +++.++||||+++++++.+.+.
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~-~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEAL-IMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHH-HHHhCCCCCEeeEEEEEccCCC
Confidence 345778899999999999998654 467899998864332 23445554 6788899999999999999999
Q ss_pred EEEecccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHH
Q 003644 445 VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSH 524 (805)
Q Consensus 445 l~LV~E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~y 524 (805)
.|+||| |+.+|+|.++++...... -....+++..++.++.||+.||+|
T Consensus 84 ~~lv~e----------~~~g~~L~~~i~~~~~~~----------------------~~~~~~~~~~~~~~~~qi~~~l~~ 131 (277)
T cd05036 84 RFILLE----------LMAGGDLKSFLRENRPRP----------------------ERPSSLTMKDLLFCARDVAKGCKY 131 (277)
T ss_pred cEEEEe----------cCCCCCHHHHHHHhCCCC----------------------CCCCCCCHHHHHHHHHHHHHHHHH
Confidence 999999 555556665554322100 011246778889999999999999
Q ss_pred hhhcceeccCCCCceEEecCCC-CceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHH
Q 003644 525 LHEIGLIHRDLKPQNVLISKDK-SFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCI 603 (805)
Q Consensus 525 LH~~~IvHrDLKp~NILl~~~~-~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvi 603 (805)
||+.+++||||||+|||++.++ ...+||+|||+++.+...... ........+..|+|||++.+..++.++|||||||+
T Consensus 132 LH~~~ivH~dlkp~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~i 210 (277)
T cd05036 132 LEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYY-RKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVL 210 (277)
T ss_pred HHHCCEeecccchheEEEeccCCCcceEeccCccccccCCccce-ecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHH
Confidence 9999999999999999997654 235899999999876432111 11112234568999999998899999999999999
Q ss_pred HHHHHhCCCCCCCCchHH-HHHHHh-hccccccccCChHHHHHHHHhcCCCCCCCCChhhhhcC
Q 003644 604 LFFCITGGKHPYGESFER-DANIVK-DRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNH 665 (805)
Q Consensus 604 l~elltG~~~Pf~~~~~~-~~~~~~-~~~~~~~~~~~~~~~dLi~~~L~~dP~~Rps~~ell~H 665 (805)
+|||++++..||...... ....+. ......+...++++.+++.+||+.||++||++.++++|
T Consensus 211 l~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 211 LWEIFSLGYMPYPGRTNQEVMEFVTGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER 274 (277)
T ss_pred HHHHHcCCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 999998668888764322 222222 22223345566789999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=309.76 Aligned_cols=246 Identities=27% Similarity=0.418 Sum_probs=187.8
Q ss_pred eeccCCceEEEEEEe-eCCcEEEEEEeecCCc-----h-HHHHHH--HHHHHhCCCCCeeeecccccCCceEEEeccccc
Q 003644 383 EIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH-----D-VALKEI--QNLIASDQHPNIVRWYGVESDQDFVYLSLERCT 453 (805)
Q Consensus 383 ~LG~GsfGtVy~a~~-~~g~~VAVK~l~~~~~-----~-~~~~Ei--~~ll~~l~HpNIV~l~g~~~~~~~l~LV~E~~~ 453 (805)
.||+|+||+||++.. .+|+.||+|.+.+... . ....|. ..++....||||+++++++.+.+..|+|||
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e--- 77 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILD--- 77 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEe---
Confidence 389999999999854 4689999998865321 1 122222 224455689999999999999999999999
Q ss_pred CChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcceecc
Q 003644 454 CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHR 533 (805)
Q Consensus 454 ~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~IvHr 533 (805)
|+.+|+|..++.. ...+++..++.++.|++.||+|||+.+|+||
T Consensus 78 -------~~~g~~L~~~l~~-----------------------------~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~ 121 (278)
T cd05606 78 -------LMNGGDLHYHLSQ-----------------------------HGVFSEAEMRFYAAEIILGLEHMHNRFVVYR 121 (278)
T ss_pred -------cCCCCcHHHHHHh-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCEEcC
Confidence 5556666554421 2346788899999999999999999999999
Q ss_pred CCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcC-CCCCcchHHHHHHHHHHHHhCCC
Q 003644 534 DLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG-RQTRAIDLFSLGCILFFCITGGK 612 (805)
Q Consensus 534 DLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~t~~sDVwSlGvil~elltG~~ 612 (805)
||||+||+++.++. +||+|||++...... ......|+..|+|||++.++ .++.++||||+||++|||++| .
T Consensus 122 di~p~nili~~~~~--~kl~dfg~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g-~ 193 (278)
T cd05606 122 DLKPANILLDEHGH--VRISDLGLACDFSKK-----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG-H 193 (278)
T ss_pred CCCHHHEEECCCCC--EEEccCcCccccCcc-----CCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhC-C
Confidence 99999999987765 899999998765432 12234689999999999754 589999999999999999997 6
Q ss_pred CCCCCchHH---H-HHHHhhccccccccCChHHHHHHHHhcCCCCCCCC-----ChhhhhcCccccccccch
Q 003644 613 HPYGESFER---D-ANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRP-----KAQNVLNHPFFWTADTRL 675 (805)
Q Consensus 613 ~Pf~~~~~~---~-~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dP~~Rp-----s~~ell~Hpff~~~~~~~ 675 (805)
.||...... . ...........+...++++.+++.+||..||.+|| ++.++++||||....+..
T Consensus 194 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~~~~~ 265 (278)
T cd05606 194 SPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLDWQM 265 (278)
T ss_pred CCCCCCCccchHHHHHHhhccCCCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCccccCCCchH
Confidence 787654211 1 11122222223334578999999999999999999 999999999997765443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-35 Score=312.04 Aligned_cols=249 Identities=25% Similarity=0.340 Sum_probs=189.2
Q ss_pred EEEeEeeccCCceEEEEEEee-CCcEEEEEEeecCCch---HHHHHHHHHHHhCCCCCeeeecccccCCceEEEeccccc
Q 003644 378 VVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHHD---VALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCT 453 (805)
Q Consensus 378 ~~~~~~LG~GsfGtVy~a~~~-~g~~VAVK~l~~~~~~---~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~E~~~ 453 (805)
|.+.+.||+|+||+||++... ++..+|+|.+...... ...+|+. ++..++||||+++++++.+++..|+|+|
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~-~l~~l~h~~ii~~~~~~~~~~~~~~v~e--- 82 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEID-ILASCDHPNIVKLLDAFYYENNLWILIE--- 82 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHH-HHHHCCCCCeeeEEEEEeeCCEEEEEEE---
Confidence 345577999999999998654 5788999998654322 2344554 6778899999999999999999999999
Q ss_pred CChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcceecc
Q 003644 454 CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHR 533 (805)
Q Consensus 454 ~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~IvHr 533 (805)
|..+|++..+++.. ...+++..+..++.|++.||+|||+.+|+||
T Consensus 83 -------~~~~~~l~~~~~~~----------------------------~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~ 127 (282)
T cd06643 83 -------FCAGGAVDAVMLEL----------------------------ERPLTEPQIRVVCKQTLEALNYLHENKIIHR 127 (282)
T ss_pred -------ecCCCcHHHHHHhc----------------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCeeec
Confidence 44555555443221 1346777889999999999999999999999
Q ss_pred CCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhh-----cCCCCCcchHHHHHHHHHHHH
Q 003644 534 DLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLL-----QGRQTRAIDLFSLGCILFFCI 608 (805)
Q Consensus 534 DLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~-----~~~~t~~sDVwSlGvil~ell 608 (805)
||||+|||++.++. +||+|||++....... .......++..|+|||++. ...++.++|||||||++|||+
T Consensus 128 dlkp~nili~~~~~--~kl~dfg~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~ 202 (282)
T cd06643 128 DLKAGNILFTLDGD--IKLADFGVSAKNTRTI---QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMA 202 (282)
T ss_pred CCCcccEEEccCCC--EEEccccccccccccc---cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHc
Confidence 99999999987776 8999999987654321 1123345899999999984 345778999999999999999
Q ss_pred hCCCCCCCCchHHH--HHHHhhccc--cccccCChHHHHHHHHhcCCCCCCCCChhhhhcCcccccc
Q 003644 609 TGGKHPYGESFERD--ANIVKDRKD--LFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTA 671 (805)
Q Consensus 609 tG~~~Pf~~~~~~~--~~~~~~~~~--~~~~~~~~~~~dLi~~~L~~dP~~Rps~~ell~Hpff~~~ 671 (805)
+| .+||....... ..+...... ..+...+.++.++|.+||+.||.+||+++++++||||...
T Consensus 203 ~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 268 (282)
T cd06643 203 QI-EPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTVN 268 (282)
T ss_pred cC-CCCccccCHHHHHHHHhhcCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCCCEecc
Confidence 97 67776533222 122221111 1223456789999999999999999999999999999653
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=312.34 Aligned_cols=258 Identities=25% Similarity=0.382 Sum_probs=191.4
Q ss_pred ceEEEeEeeccCCceEEEEEEe------eCCcEEEEEEeecCCc---hHHHHHHHHHHHhCCCCCeeeecccccCCceEE
Q 003644 376 KLVVFNKEIAKGSNGTVVLEGN------YEGRSVAVKRLVKTHH---DVALKEIQNLIASDQHPNIVRWYGVESDQDFVY 446 (805)
Q Consensus 376 ~~~~~~~~LG~GsfGtVy~a~~------~~g~~VAVK~l~~~~~---~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~ 446 (805)
..|.+.+.||+|+||+||++.. .++..||||.+..... ....+|+. ++..++||||+++++++.+.+..|
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~ 83 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAE-LLTNLQHEHIVKFYGVCVEGDPLI 83 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHH-HHHhCCCCCcceEEEEEecCCccE
Confidence 4578889999999999999854 2356799999865432 23445554 677889999999999999999999
Q ss_pred EecccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhh
Q 003644 447 LSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH 526 (805)
Q Consensus 447 LV~E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH 526 (805)
+||| |+.+|+|.+++...........+ .-....+++..++.++.|++.||+|||
T Consensus 84 lv~e----------~~~~~~L~~~i~~~~~~~~~~~~----------------~~~~~~l~~~~~~~~~~ql~~aL~~lH 137 (288)
T cd05093 84 MVFE----------YMKHGDLNKFLRAHGPDAVLMAE----------------GNRPAELTQSQMLHIAQQIAAGMVYLA 137 (288)
T ss_pred EEEE----------cCCCCCHHHHHHHcCCccccccc----------------cCCCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 9999 55555555555432211000000 011234788899999999999999999
Q ss_pred hcceeccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHHH
Q 003644 527 EIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFF 606 (805)
Q Consensus 527 ~~~IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~e 606 (805)
+.|++||||||+|||++.++. +||+|||+++....... ........++..|+|||++.+..++.++|||||||++|+
T Consensus 138 ~~~i~H~dlkp~Nili~~~~~--~kl~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~ 214 (288)
T cd05093 138 SQHFVHRDLATRNCLVGENLL--VKIGDFGMSRDVYSTDY-YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWE 214 (288)
T ss_pred hCCeeecccCcceEEEccCCc--EEeccCCccccccCCce-eecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHH
Confidence 999999999999999987765 89999999986643221 111223346788999999998889999999999999999
Q ss_pred HHhCCCCCCCCchHHH--HHHHhhccccccccCChHHHHHHHHhcCCCCCCCCChhhhh
Q 003644 607 CITGGKHPYGESFERD--ANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVL 663 (805)
Q Consensus 607 lltG~~~Pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dP~~Rps~~ell 663 (805)
|++++.+||....... ..+........+...++++.+++.+||+.||.+|||+.+++
T Consensus 215 l~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~ 273 (288)
T cd05093 215 IFTYGKQPWYQLSNNEVIECITQGRVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIH 273 (288)
T ss_pred HHhCCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHH
Confidence 9996688886644322 12222222222334567999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=311.74 Aligned_cols=251 Identities=26% Similarity=0.396 Sum_probs=185.6
Q ss_pred eEEEeEeeccCCceEEEEEEe-eCCcEEEEEEeecCC-----chHHHHHHHHHHHhCCCCCeeeecccccCCce-----E
Q 003644 377 LVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQDF-----V 445 (805)
Q Consensus 377 ~~~~~~~LG~GsfGtVy~a~~-~~g~~VAVK~l~~~~-----~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~-----l 445 (805)
.|...+.||+|+||+||++.. .+|+.||||++.... .....+|+..+....+||||+++++++...+. .
T Consensus 2 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~ 81 (295)
T cd07837 2 AYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSL 81 (295)
T ss_pred CceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceE
Confidence 467788999999999999865 468999999875432 13456677644444467999999999887665 8
Q ss_pred EEecccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHh
Q 003644 446 YLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHL 525 (805)
Q Consensus 446 ~LV~E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yL 525 (805)
|+|||||.++|.+++.... . .....+++..++.++.||+.||+||
T Consensus 82 ~lv~e~~~~~l~~~~~~~~-----------~------------------------~~~~~~~~~~~~~~~~qi~~~L~~L 126 (295)
T cd07837 82 YLVFEYLDSDLKKFMDSNG-----------R------------------------GPGRPLPAKTIKSFMYQLLKGVAHC 126 (295)
T ss_pred EEEeeccCcCHHHHHHHhc-----------c------------------------cCCCCCCHHHHHHHHHHHHHHHHHH
Confidence 9999977766665552110 0 0113467788899999999999999
Q ss_pred hhcceeccCCCCceEEecC-CCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhc-CCCCCcchHHHHHHH
Q 003644 526 HEIGLIHRDLKPQNVLISK-DKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ-GRQTRAIDLFSLGCI 603 (805)
Q Consensus 526 H~~~IvHrDLKp~NILl~~-~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~t~~sDVwSlGvi 603 (805)
|+.+|+||||||+||+++. ++ .+||+|||+++....... ......+++.|+|||++.+ ..++.++|+|||||+
T Consensus 127 H~~~i~H~dl~~~nil~~~~~~--~~kl~dfg~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~ 201 (295)
T cd07837 127 HKHGVMHRDLKPQNLLVDKQKG--LLKIADLGLGRAFSIPVK---SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCI 201 (295)
T ss_pred HHCCeeecCCChHHEEEecCCC--eEEEeecccceecCCCcc---ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHH
Confidence 9999999999999999987 44 489999999886543211 1122346889999999865 457899999999999
Q ss_pred HHHHHhCCCCCCCCchHHH--HHHHhhc-----------------------c----ccccccCChHHHHHHHHhcCCCCC
Q 003644 604 LFFCITGGKHPYGESFERD--ANIVKDR-----------------------K----DLFLVEHIPEAVDLFTRLLDPNPD 654 (805)
Q Consensus 604 l~elltG~~~Pf~~~~~~~--~~~~~~~-----------------------~----~~~~~~~~~~~~dLi~~~L~~dP~ 654 (805)
+|+|++| .+||....... ..+.... . .......++++.++|.+||+.||.
T Consensus 202 l~~l~~g-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~ 280 (295)
T cd07837 202 FAEMSRK-QPLFPGDSELQQLLHIFKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPA 280 (295)
T ss_pred HHHHHcC-CCCCCCCCHHHHHHHHHHHhCCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChh
Confidence 9999997 66775432111 1111100 0 000123467899999999999999
Q ss_pred CCCChhhhhcCccc
Q 003644 655 LRPKAQNVLNHPFF 668 (805)
Q Consensus 655 ~Rps~~ell~Hpff 668 (805)
+||++.|++.||||
T Consensus 281 ~R~~~~eil~~~~~ 294 (295)
T cd07837 281 KRISAKAALTHPYF 294 (295)
T ss_pred hcCCHHHHhcCCCc
Confidence 99999999999998
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=312.83 Aligned_cols=249 Identities=27% Similarity=0.386 Sum_probs=187.6
Q ss_pred EEEeEeeccCCceEEEEEEe-eCCcEEEEEEeecCCch--------HHHHHHHHHHHhCCCCCeeeecccccCCceEEEe
Q 003644 378 VVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHHD--------VALKEIQNLIASDQHPNIVRWYGVESDQDFVYLS 448 (805)
Q Consensus 378 ~~~~~~LG~GsfGtVy~a~~-~~g~~VAVK~l~~~~~~--------~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV 448 (805)
|.+.+.||+|+||.||++.. .+|+.||||++...... ....|+. ++..++||||+++++++.+++..|+|
T Consensus 2 y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~-~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIK-LLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred ceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHH-HHhhcCCCCChhhhheeecCCEEEEE
Confidence 56678899999999999865 46899999999654321 2234554 67788999999999999999999999
Q ss_pred cccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhc
Q 003644 449 LERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI 528 (805)
Q Consensus 449 ~E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~ 528 (805)
||++ +|+|.+++.... ..+++..++.++.||++||+|||+.
T Consensus 81 ~e~~-----------~~~L~~~i~~~~----------------------------~~~~~~~~~~~~~qi~~al~~lH~~ 121 (298)
T cd07841 81 FEFM-----------ETDLEKVIKDKS----------------------------IVLTPADIKSYMLMTLRGLEYLHSN 121 (298)
T ss_pred Eccc-----------CCCHHHHHhccC----------------------------CCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 9954 444544432110 1366778899999999999999999
Q ss_pred ceeccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhc-CCCCCcchHHHHHHHHHHH
Q 003644 529 GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ-GRQTRAIDLFSLGCILFFC 607 (805)
Q Consensus 529 ~IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~t~~sDVwSlGvil~el 607 (805)
+|+||||||+||+++.++. ++|+|||+++....... ......+++.|+|||.+.+ ..++.++|||||||++|||
T Consensus 122 ~i~H~dl~p~nill~~~~~--~~l~dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~ 196 (298)
T cd07841 122 WILHRDLKPNNLLIASDGV--LKLADFGLARSFGSPNR---KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAEL 196 (298)
T ss_pred CeeecCCChhhEEEcCCCC--EEEccceeeeeccCCCc---cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHH
Confidence 9999999999999988776 89999999987654321 1122346788999999865 4578999999999999999
Q ss_pred HhCCCCCCCCchHHH--HHHHhhcc---------------------------ccccccCChHHHHHHHHhcCCCCCCCCC
Q 003644 608 ITGGKHPYGESFERD--ANIVKDRK---------------------------DLFLVEHIPEAVDLFTRLLDPNPDLRPK 658 (805)
Q Consensus 608 ltG~~~Pf~~~~~~~--~~~~~~~~---------------------------~~~~~~~~~~~~dLi~~~L~~dP~~Rps 658 (805)
++| .+||....... ..+..... .......+.++.++|.+||+.||++|||
T Consensus 197 ~~g-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s 275 (298)
T cd07841 197 LLR-VPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRIT 275 (298)
T ss_pred HcC-CccccCCccHHHHHHHHHHcCCCchhhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcC
Confidence 997 76765432211 11110000 0001123467889999999999999999
Q ss_pred hhhhhcCccccccc
Q 003644 659 AQNVLNHPFFWTAD 672 (805)
Q Consensus 659 ~~ell~Hpff~~~~ 672 (805)
++|+++||||.+..
T Consensus 276 ~~e~l~~~~~~~~~ 289 (298)
T cd07841 276 ARQALEHPYFSNDP 289 (298)
T ss_pred HHHHhhCccccCCC
Confidence 99999999997643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=312.12 Aligned_cols=251 Identities=26% Similarity=0.371 Sum_probs=190.0
Q ss_pred cceEEEeEeeccCCceEEEEEEee-CCcEEEEEEeecCCch---HHHHHHHHHHHhCCCCCeeeecccccCCceEEEecc
Q 003644 375 GKLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHHD---VALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 450 (805)
Q Consensus 375 ~~~~~~~~~LG~GsfGtVy~a~~~-~g~~VAVK~l~~~~~~---~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~E 450 (805)
.+.|.+.+.||+|+||.||++... +++.||+|.+...... ...+|+. +++.++||||+++++++..++..|+|||
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~lv~e 89 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIE-ILATCNHPYIVKLLGAFYWDGKLWIMIE 89 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHH-HHHhCCCCcEeeeEEEEEeCCeEEEEEe
Confidence 355778889999999999998654 5899999998654322 2334544 6788899999999999999999999999
Q ss_pred cccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcce
Q 003644 451 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 530 (805)
Q Consensus 451 ~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~I 530 (805)
| ..++++..++... ...+++..++.++.|++.||+|||+.++
T Consensus 90 ~----------~~~~~l~~~~~~~----------------------------~~~l~~~~~~~~~~ql~~~l~~lH~~~i 131 (292)
T cd06644 90 F----------CPGGAVDAIMLEL----------------------------DRGLTEPQIQVICRQMLEALQYLHSMKI 131 (292)
T ss_pred c----------CCCCcHHHHHHhh----------------------------cCCCCHHHHHHHHHHHHHHHHHHhcCCe
Confidence 4 4555554433211 1246677889999999999999999999
Q ss_pred eccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhh-----cCCCCCcchHHHHHHHHH
Q 003644 531 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLL-----QGRQTRAIDLFSLGCILF 605 (805)
Q Consensus 531 vHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~-----~~~~t~~sDVwSlGvil~ 605 (805)
+||||||+||+++.++. +||+|||++....... .......+++.|+|||++. ...++.++|||||||++|
T Consensus 132 ~H~dlkp~Nili~~~~~--~kl~dfg~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~ 206 (292)
T cd06644 132 IHRDLKAGNVLLTLDGD--IKLADFGVSAKNVKTL---QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLI 206 (292)
T ss_pred eecCCCcceEEEcCCCC--EEEccCccceeccccc---cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHH
Confidence 99999999999987766 8999999987643221 1122345789999999985 345688999999999999
Q ss_pred HHHhCCCCCCCCchHHH-H-HHHhhccc--cccccCChHHHHHHHHhcCCCCCCCCChhhhhcCccccc
Q 003644 606 FCITGGKHPYGESFERD-A-NIVKDRKD--LFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWT 670 (805)
Q Consensus 606 elltG~~~Pf~~~~~~~-~-~~~~~~~~--~~~~~~~~~~~dLi~~~L~~dP~~Rps~~ell~Hpff~~ 670 (805)
||++| .+||....... . .+...... ..+...+.++.++|.+||+.||++||+++++++||||..
T Consensus 207 el~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 274 (292)
T cd06644 207 EMAQI-EPPHHELNPMRVLLKIAKSEPPTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSS 274 (292)
T ss_pred HHhcC-CCCCccccHHHHHHHHhcCCCccCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence 99997 66775533221 1 11111111 112334578999999999999999999999999999964
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=313.90 Aligned_cols=250 Identities=26% Similarity=0.357 Sum_probs=190.1
Q ss_pred ceEEEeEeeccCCceEEEEEEe-eCCcEEEEEEeecCCc-----hHHHHHHHHHHHhCCCCCeeeecccccCC--ceEEE
Q 003644 376 KLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH-----DVALKEIQNLIASDQHPNIVRWYGVESDQ--DFVYL 447 (805)
Q Consensus 376 ~~~~~~~~LG~GsfGtVy~a~~-~~g~~VAVK~l~~~~~-----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~--~~l~L 447 (805)
+.|.+.+.||+|+||.||++.. .+|+.||+|++..... ....+|+. ++..++|+||+++++++.+. +..|+
T Consensus 7 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~-~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 7 TEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREIT-LLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred cceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHH-HHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 4578889999999999999865 4689999999864321 13345665 67788999999999998655 56899
Q ss_pred ecccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhh
Q 003644 448 SLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE 527 (805)
Q Consensus 448 V~E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~ 527 (805)
|||+|.++|.+++... ...+++.++..++.||+.||+|||+
T Consensus 86 v~e~~~~~l~~~l~~~---------------------------------------~~~l~~~~~~~~~~qi~~~l~~lH~ 126 (309)
T cd07845 86 VMEYCEQDLASLLDNM---------------------------------------PTPFSESQVKCLMLQLLRGLQYLHE 126 (309)
T ss_pred EEecCCCCHHHHHHhc---------------------------------------ccCCCHHHHHHHHHHHHHHHHHHHh
Confidence 9998877766655221 1235677889999999999999999
Q ss_pred cceeccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhc-CCCCCcchHHHHHHHHHH
Q 003644 528 IGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ-GRQTRAIDLFSLGCILFF 606 (805)
Q Consensus 528 ~~IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~t~~sDVwSlGvil~e 606 (805)
.+++||||||+||+++.++. +||+|||++........ ......+++.|+|||++.+ ..++.++|||||||++||
T Consensus 127 ~~i~H~dl~p~nil~~~~~~--~kL~dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~e 201 (309)
T cd07845 127 NFIIHRDLKVSNLLLTDKGC--LKIADFGLARTYGLPAK---PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAE 201 (309)
T ss_pred CCeecCCCCHHHEEECCCCC--EEECccceeeecCCccC---CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHH
Confidence 99999999999999988775 89999999987653321 1122346788999999875 457899999999999999
Q ss_pred HHhCCCCCCCCchHHHH-H-HHhhcc-------------------cc----------ccccCChHHHHHHHHhcCCCCCC
Q 003644 607 CITGGKHPYGESFERDA-N-IVKDRK-------------------DL----------FLVEHIPEAVDLFTRLLDPNPDL 655 (805)
Q Consensus 607 lltG~~~Pf~~~~~~~~-~-~~~~~~-------------------~~----------~~~~~~~~~~dLi~~~L~~dP~~ 655 (805)
|++| .+||........ . +..... .. .....++++.++|.+||+.||++
T Consensus 202 l~~g-~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~ 280 (309)
T cd07845 202 LLAH-KPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKK 280 (309)
T ss_pred HHhC-CCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhh
Confidence 9997 677765432221 1 111000 00 00123578899999999999999
Q ss_pred CCChhhhhcCcccccc
Q 003644 656 RPKAQNVLNHPFFWTA 671 (805)
Q Consensus 656 Rps~~ell~Hpff~~~ 671 (805)
|||+++++.||||...
T Consensus 281 R~t~~~il~h~~f~~~ 296 (309)
T cd07845 281 RATAEEALESSYFKEK 296 (309)
T ss_pred CcCHHHHhcChhhccC
Confidence 9999999999999653
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=313.58 Aligned_cols=246 Identities=24% Similarity=0.374 Sum_probs=190.0
Q ss_pred cceEEEeEeeccCCceEEEEEEee-CCcEEEEEEeecCCc------hHHHHHHHHHHHhCCCCCeeeecccccCCceEEE
Q 003644 375 GKLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHH------DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYL 447 (805)
Q Consensus 375 ~~~~~~~~~LG~GsfGtVy~a~~~-~g~~VAVK~l~~~~~------~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~L 447 (805)
.+.|...+.||+|+||+||++... +|+.||+|.+..... ....+|+. ++..++||||++++++|.+.+..|+
T Consensus 14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~-~l~~l~h~niv~~~~~~~~~~~~~l 92 (307)
T cd06607 14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVR-FLQQLRHPNTIEYKGCYLREHTAWL 92 (307)
T ss_pred chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHH-HHHhCCCCCEEEEEEEEEeCCeEEE
Confidence 455778899999999999998654 689999999864321 23345554 6788899999999999999999999
Q ss_pred ecccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhh
Q 003644 448 SLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE 527 (805)
Q Consensus 448 V~E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~ 527 (805)
|+|||.+++.+++... ...+++..+..++.|++.||.|||+
T Consensus 93 v~e~~~g~l~~~~~~~---------------------------------------~~~l~~~~~~~~~~ql~~~L~~LH~ 133 (307)
T cd06607 93 VMEYCLGSASDILEVH---------------------------------------KKPLQEVEIAAICHGALQGLAYLHS 133 (307)
T ss_pred EHHhhCCCHHHHHHHc---------------------------------------ccCCCHHHHHHHHHHHHHHHHHHHH
Confidence 9997766655443211 1235677889999999999999999
Q ss_pred cceeccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhh---cCCCCCcchHHHHHHHH
Q 003644 528 IGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLL---QGRQTRAIDLFSLGCIL 604 (805)
Q Consensus 528 ~~IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~---~~~~t~~sDVwSlGvil 604 (805)
.+|+||||+|+||+++.++. ++|+|||++...... ....++..|+|||++. ...++.++|||||||++
T Consensus 134 ~~i~H~dl~p~nIl~~~~~~--~kL~dfg~~~~~~~~-------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il 204 (307)
T cd06607 134 HERIHRDIKAGNILLTEPGT--VKLADFGSASLVSPA-------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITC 204 (307)
T ss_pred CCceecCCCcccEEECCCCC--EEEeecCcceecCCC-------CCccCCccccCceeeeccCCCCCCcccchHHHHHHH
Confidence 99999999999999988776 899999998765422 2345788999999874 35688999999999999
Q ss_pred HHHHhCCCCCCCCchHHH-HHHHh-hc-cccccccCChHHHHHHHHhcCCCCCCCCChhhhhcCccccc
Q 003644 605 FFCITGGKHPYGESFERD-ANIVK-DR-KDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWT 670 (805)
Q Consensus 605 ~elltG~~~Pf~~~~~~~-~~~~~-~~-~~~~~~~~~~~~~dLi~~~L~~dP~~Rps~~ell~Hpff~~ 670 (805)
|||++| .+||....... ...+. .. ........+.++.++|.+||+.||++||++.+++.||||..
T Consensus 205 ~el~tg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 272 (307)
T cd06607 205 IELAER-KPPLFNMNAMSALYHIAQNDSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLR 272 (307)
T ss_pred HHHHcC-CCCCCCccHHHHHHHHhcCCCCCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhcc
Confidence 999997 66765432222 11111 11 11112234568999999999999999999999999999964
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=307.95 Aligned_cols=238 Identities=22% Similarity=0.306 Sum_probs=178.6
Q ss_pred eeccCCceEEEEEEee-------------CCcEEEEEEeecCCch--HHHHHHHHHHHhCCCCCeeeecccccCCceEEE
Q 003644 383 EIAKGSNGTVVLEGNY-------------EGRSVAVKRLVKTHHD--VALKEIQNLIASDQHPNIVRWYGVESDQDFVYL 447 (805)
Q Consensus 383 ~LG~GsfGtVy~a~~~-------------~g~~VAVK~l~~~~~~--~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~L 447 (805)
.||+|+||+||++... ....||||.+...... ..+.|+..++..++||||+++++++.++...++
T Consensus 2 ~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~l 81 (262)
T cd05077 2 HLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIM 81 (262)
T ss_pred ccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCEE
Confidence 5899999999997532 1236899987654322 234454557888999999999999999999999
Q ss_pred ecccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhh
Q 003644 448 SLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE 527 (805)
Q Consensus 448 V~E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~ 527 (805)
||| |+.+|+|..+++.. ...+++..++.++.||+.||+|||+
T Consensus 82 v~e----------~~~~~~l~~~~~~~----------------------------~~~~~~~~~~~i~~qi~~~l~~lH~ 123 (262)
T cd05077 82 VEE----------FVEFGPLDLFMHRK----------------------------SDVLTTPWKFKVAKQLASALSYLED 123 (262)
T ss_pred EEe----------cccCCCHHHHHHhc----------------------------CCCCCHHHHHHHHHHHHHHHHHhhh
Confidence 999 44555555443221 1235667789999999999999999
Q ss_pred cceeccCCCCceEEecCCCC-----ceEEEeccCccccccCCCccccccccccCCCCCCChhhhh-cCCCCCcchHHHHH
Q 003644 528 IGLIHRDLKPQNVLISKDKS-----FCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLL-QGRQTRAIDLFSLG 601 (805)
Q Consensus 528 ~~IvHrDLKp~NILl~~~~~-----~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~-~~~~t~~sDVwSlG 601 (805)
.+|+||||||+|||++.++. ..++++|||++...... ....++..|+|||++. ...++.++||||||
T Consensus 124 ~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~~~~~~~~-------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG 196 (262)
T cd05077 124 KDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSR-------QECVERIPWIAPECVEDSKNLSIAADKWSFG 196 (262)
T ss_pred CCeECCCCCcccEEEecCCccCCCCceeEeCCCCCCccccCc-------ccccccccccChhhhcCCCCCCchhHHHHHH
Confidence 99999999999999975542 23799999998755321 2245788999999987 46689999999999
Q ss_pred HHHHHHHhCCCCCCCCchHHHHHHHhhccccccccCChHHHHHHHHhcCCCCCCCCChhhhhcC
Q 003644 602 CILFFCITGGKHPYGESFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNH 665 (805)
Q Consensus 602 vil~elltG~~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dP~~Rps~~ell~H 665 (805)
|++|||++++..||.......................+++.++|.+||+.||.+||++.+++++
T Consensus 197 ~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 197 TTLWEICYNGEIPLKDKTLAEKERFYEGQCMLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRD 260 (262)
T ss_pred HHHHHHHhCCCCCCCCcchhHHHHHHhcCccCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence 9999999766888876443322222122112222345689999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=304.44 Aligned_cols=248 Identities=29% Similarity=0.400 Sum_probs=185.7
Q ss_pred eEEEeEeeccCCceEEEEEEe-eCCcEEEEEEeecCC----c----hHHHHHHHHHHHhCCCCCeeeecccccCC--ceE
Q 003644 377 LVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH----H----DVALKEIQNLIASDQHPNIVRWYGVESDQ--DFV 445 (805)
Q Consensus 377 ~~~~~~~LG~GsfGtVy~a~~-~~g~~VAVK~l~~~~----~----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~--~~l 445 (805)
.|...+.||+|+||.||.+.. .+|+.||||.+.... . ....+|+. ++..++||||+++++++.+. ..+
T Consensus 3 ~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~-~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQ-LLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred cceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHH-HHHhcCCCCeeeEEeEeccCCCceE
Confidence 467789999999999999854 468999999885321 1 12334554 67888999999999988763 568
Q ss_pred EEecccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHh
Q 003644 446 YLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHL 525 (805)
Q Consensus 446 ~LV~E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yL 525 (805)
|++|| |.++|+|.+++... ..+++..+++++.|++.||+||
T Consensus 82 ~~v~e----------~~~~~~L~~~l~~~-----------------------------~~~~~~~~~~~~~~l~~~l~~l 122 (265)
T cd06652 82 SIFME----------HMPGGSIKDQLKSY-----------------------------GALTENVTRKYTRQILEGVSYL 122 (265)
T ss_pred EEEEE----------ecCCCcHHHHHHHc-----------------------------CCCCHHHHHHHHHHHHHHHHHH
Confidence 99999 55555555544221 2245667789999999999999
Q ss_pred hhcceeccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHH
Q 003644 526 HEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILF 605 (805)
Q Consensus 526 H~~~IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~ 605 (805)
|+.+|+|+||||+||+++.++. ++|+|||+++................|+..|+|||++.+..++.++|||||||++|
T Consensus 123 H~~~i~H~dl~p~nil~~~~~~--~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ 200 (265)
T cd06652 123 HSNMIVHRDIKGANILRDSVGN--VKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVV 200 (265)
T ss_pred HhCCEecCCCCHHHEEecCCCC--EEECcCccccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHH
Confidence 9999999999999999987765 89999999886543211111223345889999999998888999999999999999
Q ss_pred HHHhCCCCCCCCchHHHH--HHHhh-ccccccccCChHHHHHHHHhcCCCCCCCCChhhhhcCccc
Q 003644 606 FCITGGKHPYGESFERDA--NIVKD-RKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 668 (805)
Q Consensus 606 elltG~~~Pf~~~~~~~~--~~~~~-~~~~~~~~~~~~~~dLi~~~L~~dP~~Rps~~ell~Hpff 668 (805)
||++| .+||........ ..... .....+......+.++|.+|+. +|++||+++++++|||+
T Consensus 201 el~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~~~ 264 (265)
T cd06652 201 EMLTE-KPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRHTFV 264 (265)
T ss_pred HHhhC-CCCCCccchHHHHHHHhcCCCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcCccc
Confidence 99997 677765322211 11111 1122233445678999999995 99999999999999997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-35 Score=310.52 Aligned_cols=259 Identities=25% Similarity=0.371 Sum_probs=190.9
Q ss_pred eEEEeEeeccCCceEEEEEEee------CCcEEEEEEeecCCch----HHHHHHHHHHHhCCCCCeeeecccccCCceEE
Q 003644 377 LVVFNKEIAKGSNGTVVLEGNY------EGRSVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVRWYGVESDQDFVY 446 (805)
Q Consensus 377 ~~~~~~~LG~GsfGtVy~a~~~------~g~~VAVK~l~~~~~~----~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~ 446 (805)
.|.+.+.||+|+||.||++... +++.||||.+...... ...+|+. ++..++||||+++++++.+.+..|
T Consensus 6 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~-~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 6 TIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAE-LLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHH-HHHhcCCCCchheeeEEecCCCeE
Confidence 3666788999999999998653 3578999998754332 3345554 778899999999999999999999
Q ss_pred EecccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhh
Q 003644 447 LSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH 526 (805)
Q Consensus 447 LV~E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH 526 (805)
+||| |+.+|+|.+++.........+. ...-....+++.++..++.||+.||+|||
T Consensus 85 lv~e----------~~~~~~L~~~i~~~~~~~~~~~---------------~~~~~~~~l~~~~~~~~~~~i~~~l~~lH 139 (280)
T cd05049 85 MVFE----------YMEHGDLNKFLRSHGPDAAFLK---------------SPDSPMGELTLSQLLQIAVQIASGMVYLA 139 (280)
T ss_pred EEEe----------cCCCCCHHHHHHhcCCchhhhc---------------ccccccccccHHHHHHHHHHHHHHHHHHh
Confidence 9999 5555555555543321110000 00011244678889999999999999999
Q ss_pred hcceeccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHHH
Q 003644 527 EIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFF 606 (805)
Q Consensus 527 ~~~IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~e 606 (805)
+.+++||||||+||+++.++. +||+|||+++........ .......+++.|+|||++.+..++.++|||||||++||
T Consensus 140 ~~~i~h~dlkp~nili~~~~~--~kl~d~g~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e 216 (280)
T cd05049 140 SQHFVHRDLATRNCLVGYDLV--VKIGDFGMSRDVYTTDYY-RVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWE 216 (280)
T ss_pred hCCeeccccccceEEEcCCCe--EEECCcccceecccCcce-ecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHH
Confidence 999999999999999988765 899999999765432111 11123346788999999999999999999999999999
Q ss_pred HHhCCCCCCCCch-HHHHHHHh-hccccccccCChHHHHHHHHhcCCCCCCCCChhhhhc
Q 003644 607 CITGGKHPYGESF-ERDANIVK-DRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 664 (805)
Q Consensus 607 lltG~~~Pf~~~~-~~~~~~~~-~~~~~~~~~~~~~~~dLi~~~L~~dP~~Rps~~ell~ 664 (805)
|++.+..||.... ......+. ......+...+.++.+++.+||+.||++||++.|+++
T Consensus 217 ~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 217 IFTYGKQPWYGLSNEEVIECITQGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276 (280)
T ss_pred HHhcCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 9984467765433 22222222 2222233445679999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=312.99 Aligned_cols=261 Identities=21% Similarity=0.340 Sum_probs=189.8
Q ss_pred EEEeEeeccCCceEEEEEEee------CCcEEEEEEeecCCch---HHHHHHHHHHHhCCCCCeeeecccccCCceEEEe
Q 003644 378 VVFNKEIAKGSNGTVVLEGNY------EGRSVAVKRLVKTHHD---VALKEIQNLIASDQHPNIVRWYGVESDQDFVYLS 448 (805)
Q Consensus 378 ~~~~~~LG~GsfGtVy~a~~~------~g~~VAVK~l~~~~~~---~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV 448 (805)
|.+.+.||+|+||+||++... +++.||||++...... ..+.++..++..++||||+++++++.+.+..+++
T Consensus 7 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~ 86 (283)
T cd05091 7 VRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMI 86 (283)
T ss_pred HHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEEE
Confidence 445578999999999998653 3578999999754322 2233333577889999999999999999999999
Q ss_pred ccccc-CChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhh
Q 003644 449 LERCT-CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE 527 (805)
Q Consensus 449 ~E~~~-~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~ 527 (805)
+|++. ++|.+++.+.... ... ..... ..-....+++..++.++.|++.||+|||+
T Consensus 87 ~e~~~~~~l~~~l~~~~~~-----------~~~------------~~~~~-~~~~~~~~~~~~~~~~~~ql~~aL~~lH~ 142 (283)
T cd05091 87 FSYCSHSDLHEFLVMRSPH-----------SDV------------GSTDD-DKTVKSTLEPADFVHIVTQIAAGMEFLSS 142 (283)
T ss_pred EEcCCCCcHHHHHHhcCCC-----------ccc------------ccccc-ccccccccCHHHHHHHHHHHHHHHHHHHH
Confidence 99655 3455544322110 000 00000 00112347788889999999999999999
Q ss_pred cceeccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHHHH
Q 003644 528 IGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFC 607 (805)
Q Consensus 528 ~~IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~el 607 (805)
.+|+||||||+|||+++++. +||+|||+++....... ........+++.|+|||++....++.++|||||||++|||
T Consensus 143 ~gi~H~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el 219 (283)
T cd05091 143 HHVVHKDLATRNVLVFDKLN--VKISDLGLFREVYAADY-YKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEV 219 (283)
T ss_pred cCccccccchhheEecCCCc--eEecccccccccccchh-eeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHH
Confidence 99999999999999987765 89999999887643211 1122333467899999999988899999999999999999
Q ss_pred HhCCCCCCCCchHHH-HHHH-hhccccccccCChHHHHHHHHhcCCCCCCCCChhhhhcC
Q 003644 608 ITGGKHPYGESFERD-ANIV-KDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNH 665 (805)
Q Consensus 608 ltG~~~Pf~~~~~~~-~~~~-~~~~~~~~~~~~~~~~dLi~~~L~~dP~~Rps~~ell~H 665 (805)
++++.+||....... ...+ .......+...++++.+++.+||+.+|.+||++++++..
T Consensus 220 ~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~ 279 (283)
T cd05091 220 FSYGLQPYCGYSNQDVIEMIRNRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR 279 (283)
T ss_pred HcCCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence 996688886543322 2222 222223345567789999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=305.09 Aligned_cols=242 Identities=30% Similarity=0.438 Sum_probs=191.2
Q ss_pred eccCCceEEEEEEee-CCcEEEEEEeecCCc------hHHHHHHHHHHHhCCCCCeeeecccccCCceEEEecccccCCh
Q 003644 384 IAKGSNGTVVLEGNY-EGRSVAVKRLVKTHH------DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCSL 456 (805)
Q Consensus 384 LG~GsfGtVy~a~~~-~g~~VAVK~l~~~~~------~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~E~~~~sL 456 (805)
||.|++|+||++... +++.||||.+.+... ....+|+. ++..++||||+++++++.+++..|+++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~lv~e------ 73 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKE-ILEECNHPFIVKLYRTFKDKKYIYMLME------ 73 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHH-HHHhCCCCCEeeeeeeEEcCCccEEEEe------
Confidence 699999999998654 489999999865321 22344544 6788899999999999999999999999
Q ss_pred hhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCC
Q 003644 457 NDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLK 536 (805)
Q Consensus 457 ~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~IvHrDLK 536 (805)
|+.+++|.+++... ..+++..+..++.||+.||+|||+.+++|+||+
T Consensus 74 ----~~~~~~L~~~l~~~-----------------------------~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~ 120 (262)
T cd05572 74 ----YCLGGELWTILRDR-----------------------------GLFDEYTARFYIACVVLAFEYLHNRGIIYRDLK 120 (262)
T ss_pred ----cCCCCcHHHHHhhc-----------------------------CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCC
Confidence 66677777665332 235667788999999999999999999999999
Q ss_pred CceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q 003644 537 PQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYG 616 (805)
Q Consensus 537 p~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~elltG~~~Pf~ 616 (805)
|+||+++.++. ++|+|||+++...... ......|++.|+|||.+....++.++|+|||||++|+|++| .+||.
T Consensus 121 ~~nilv~~~~~--~~l~df~~~~~~~~~~----~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g-~~p~~ 193 (262)
T cd05572 121 PENLLLDSNGY--VKLVDFGFAKKLKSGQ----KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTG-RPPFG 193 (262)
T ss_pred HHHEEEcCCCC--EEEeeCCcccccCccc----ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhC-CCCcC
Confidence 99999988775 8999999998765431 12234588999999999888899999999999999999997 77876
Q ss_pred CchH--H-HH-HHHh-hccccccccCChHHHHHHHHhcCCCCCCCCC-----hhhhhcCccccccc
Q 003644 617 ESFE--R-DA-NIVK-DRKDLFLVEHIPEAVDLFTRLLDPNPDLRPK-----AQNVLNHPFFWTAD 672 (805)
Q Consensus 617 ~~~~--~-~~-~~~~-~~~~~~~~~~~~~~~dLi~~~L~~dP~~Rps-----~~ell~Hpff~~~~ 672 (805)
.... . .. .+.. .....++....+++.++|.+||+.||++||+ ++|+++||||.+..
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~ 259 (262)
T cd05572 194 EDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFNGFD 259 (262)
T ss_pred CCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcChhhhCCC
Confidence 5441 1 11 1221 2222334444679999999999999999999 99999999997543
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=302.93 Aligned_cols=248 Identities=27% Similarity=0.455 Sum_probs=191.6
Q ss_pred EEEeEeeccCCceEEEEEEe-eCCcEEEEEEeecC-----CchHHHHHHHHHHHhCCCCCeeeecccccCCceEEEeccc
Q 003644 378 VVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKT-----HHDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLER 451 (805)
Q Consensus 378 ~~~~~~LG~GsfGtVy~a~~-~~g~~VAVK~l~~~-----~~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~E~ 451 (805)
|.+.+.||+|+||.||++.. .+|..||+|.+... ..+...+|+. +++.++||||+++++.+.+.+..|+|+|
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~-~l~~~~h~~i~~~~~~~~~~~~~~lv~e- 79 (257)
T cd08225 2 YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVI-LLAKMKHPNIVTFFASFQENGRLFIVME- 79 (257)
T ss_pred ceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHH-HHHhCCCCChhhhhheeccCCeEEEEEe-
Confidence 66788999999999999855 46899999998643 2233445654 6788899999999999999999999999
Q ss_pred ccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhccee
Q 003644 452 CTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLI 531 (805)
Q Consensus 452 ~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~Iv 531 (805)
|+.+++|.+++.... ...+++..++.++.|++.||+|||+.+++
T Consensus 80 ---------~~~~~~L~~~~~~~~---------------------------~~~~~~~~~~~~~~~l~~~l~~lh~~~i~ 123 (257)
T cd08225 80 ---------YCDGGDLMKRINRQR---------------------------GVLFSEDQILSWFVQISLGLKHIHDRKIL 123 (257)
T ss_pred ---------cCCCCcHHHHHHhcc---------------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 445555555443211 12356778899999999999999999999
Q ss_pred ccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHHHHHhCC
Q 003644 532 HRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGG 611 (805)
Q Consensus 532 HrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~elltG~ 611 (805)
|+||||+||+++.++. .+||+|||.+........ ......|++.|+|||++....++.++|+|||||++|||++|
T Consensus 124 H~dl~~~nil~~~~~~-~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g- 198 (257)
T cd08225 124 HRDIKSQNIFLSKNGM-VAKLGDFGIARQLNDSME---LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTL- 198 (257)
T ss_pred cccCCHHHEEEcCCCC-eEEecccccchhccCCcc---cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhC-
Confidence 9999999999987754 479999999887653321 11234589999999999888899999999999999999997
Q ss_pred CCCCCCchHHHH--HHHhhccccccccCChHHHHHHHHhcCCCCCCCCChhhhhcCccc
Q 003644 612 KHPYGESFERDA--NIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 668 (805)
Q Consensus 612 ~~Pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~dLi~~~L~~dP~~Rps~~ell~Hpff 668 (805)
..||........ .+..............++.++|.+||..+|++|||+.++++||||
T Consensus 199 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 199 KHPFEGNNLHQLVLKICQGYFAPISPNFSRDLRSLISQLFKVSPRDRPSITSILKRPFL 257 (257)
T ss_pred CCCCCCccHHHHHHHHhcccCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhCCCC
Confidence 667765332221 122222222223445689999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=309.34 Aligned_cols=264 Identities=22% Similarity=0.329 Sum_probs=191.9
Q ss_pred eEEEeEeeccCCceEEEEEEe-----eCCcEEEEEEeecCCch----HHHHHHHHHHHhCCCCCeeeecccccCCceEEE
Q 003644 377 LVVFNKEIAKGSNGTVVLEGN-----YEGRSVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVRWYGVESDQDFVYL 447 (805)
Q Consensus 377 ~~~~~~~LG~GsfGtVy~a~~-----~~g~~VAVK~l~~~~~~----~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~L 447 (805)
.|.+.+.||+|+||+||+|.. .+++.||+|.+...... ...+|+. +++.++||||+++++++.+++..|+
T Consensus 6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 6 AVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEAS-LMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHH-HHhhCCCCCeeeEEEEEecCCceEE
Confidence 467789999999999999853 35689999999754322 2334554 7788899999999999999999999
Q ss_pred ecccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhh
Q 003644 448 SLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE 527 (805)
Q Consensus 448 V~E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~ 527 (805)
||||+ .+|+|.+++......... .............+++.+++.++.|++.||+|||+
T Consensus 85 v~e~~----------~~~~L~~~l~~~~~~~~~------------~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~ 142 (283)
T cd05090 85 LFEYL----------NQGDLHEFLIMRSPHSDV------------GCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSS 142 (283)
T ss_pred EEEcC----------CCCcHHHHHHhcCCCCcc------------ccccccccccccccCHHHHHHHHHHHHHHHHHHHh
Confidence 99955 445555544322110000 00000000112346788889999999999999999
Q ss_pred cceeccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHHHH
Q 003644 528 IGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFC 607 (805)
Q Consensus 528 ~~IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~el 607 (805)
.+|+||||||+|||++.++. +||+|||+++........ .......++..|+|||++.+..++.++|||||||++|||
T Consensus 143 ~~i~H~dlkp~nili~~~~~--~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el 219 (283)
T cd05090 143 HFFVHKDLAARNILIGEQLH--VKISDLGLSREIYSADYY-RVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEI 219 (283)
T ss_pred cCeehhccccceEEEcCCCc--EEeccccccccccCCcce-ecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHH
Confidence 99999999999999987765 899999999876433211 112233467789999999888899999999999999999
Q ss_pred HhCCCCCCCCch-HHHHHHHhhc-cccccccCChHHHHHHHHhcCCCCCCCCChhhhhcCc
Q 003644 608 ITGGKHPYGESF-ERDANIVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHP 666 (805)
Q Consensus 608 ltG~~~Pf~~~~-~~~~~~~~~~-~~~~~~~~~~~~~dLi~~~L~~dP~~Rps~~ell~Hp 666 (805)
++++.+||.... ......+... ....+...++++.+++.+||+.||++||++.+++++-
T Consensus 220 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l 280 (283)
T cd05090 220 FSFGLQPYYGFSNQEVIEMVRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRL 280 (283)
T ss_pred HcCCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHh
Confidence 995577875533 2222222222 2223344568899999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=309.26 Aligned_cols=246 Identities=28% Similarity=0.458 Sum_probs=190.1
Q ss_pred eccCCceEEEEEEe-eCCcEEEEEEeecCC------chHHHHHHHHHHHhCCCCCeeeecccccCCceEEEecccccCCh
Q 003644 384 IAKGSNGTVVLEGN-YEGRSVAVKRLVKTH------HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCSL 456 (805)
Q Consensus 384 LG~GsfGtVy~a~~-~~g~~VAVK~l~~~~------~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~E~~~~sL 456 (805)
||+|+||+||++.. .+|+.||+|.+.... ......|+ .++..++||||+++++++.+.+..|+|||
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~-~~l~~l~~~~i~~~~~~~~~~~~~~lv~e------ 73 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEK-KILEKVSSRFIVSLAYAFETKDDLCLVMT------ 73 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHH-HHHHhCCCCCEeeeeeEEecCCeEEEEEe------
Confidence 69999999999854 468999999986432 11223455 46788899999999999999999999999
Q ss_pred hhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCC
Q 003644 457 NDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLK 536 (805)
Q Consensus 457 ~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~IvHrDLK 536 (805)
|..+++|.+++.... ...+++..++.++.|++.||.|||+.+++||||+
T Consensus 74 ----~~~~~~L~~~l~~~~---------------------------~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~ 122 (277)
T cd05577 74 ----LMNGGDLKYHIYNVG---------------------------EPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLK 122 (277)
T ss_pred ----cCCCCcHHHHHHHcC---------------------------cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCC
Confidence 555666665543221 1246778889999999999999999999999999
Q ss_pred CceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q 003644 537 PQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYG 616 (805)
Q Consensus 537 p~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~elltG~~~Pf~ 616 (805)
|+||+++.++. ++|+|||++...... .......++..|+|||++.+..++.++|||||||++|+|++| ..||.
T Consensus 123 p~Nil~~~~~~--~~l~dfg~~~~~~~~----~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g-~~p~~ 195 (277)
T cd05577 123 PENVLLDDHGN--VRISDLGLAVELKGG----KKIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAG-RSPFR 195 (277)
T ss_pred HHHEEECCCCC--EEEccCcchhhhccC----CccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhC-CCCCC
Confidence 99999988775 899999998765432 112234578899999999888899999999999999999996 77886
Q ss_pred CchHH--HHHH---HhhccccccccCChHHHHHHHHhcCCCCCCCC-----ChhhhhcCccccccccc
Q 003644 617 ESFER--DANI---VKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRP-----KAQNVLNHPFFWTADTR 674 (805)
Q Consensus 617 ~~~~~--~~~~---~~~~~~~~~~~~~~~~~dLi~~~L~~dP~~Rp-----s~~ell~Hpff~~~~~~ 674 (805)
..... ...+ ........+...++++.++|.+||+.||.+|| ++.++++||||+..+++
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~~~~~~~ 263 (277)
T cd05577 196 QRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDLNWR 263 (277)
T ss_pred CCcccccHHHHHhccccccccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhChhhhcCChh
Confidence 54321 1111 11122223344578999999999999999999 88889999999765543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-35 Score=321.34 Aligned_cols=277 Identities=21% Similarity=0.319 Sum_probs=191.5
Q ss_pred ceEEEeEeeccCCceEEEEEEe------eCCcEEEEEEeecCCc----hHHHHHHHHHHHhCCCCCeeeecccccC-Cce
Q 003644 376 KLVVFNKEIAKGSNGTVVLEGN------YEGRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESD-QDF 444 (805)
Q Consensus 376 ~~~~~~~~LG~GsfGtVy~a~~------~~g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~-~~~ 444 (805)
++|.+.+.||+|+||.||++.. .+++.||||++..... ....+|+..+.+..+||||++++++|.. +..
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~ 86 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGP 86 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCC
Confidence 4678889999999999999743 2357899999864322 2345677644444489999999998764 467
Q ss_pred EEEecccccCChhhHHHHhcCCHHHHHhhhhccchhhHH------H-------Hh-------------------hhcccc
Q 003644 445 VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNE------V-------RI-------------------RLLPVM 492 (805)
Q Consensus 445 l~LV~E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~------~-------~~-------------------~~~~~~ 492 (805)
++++|||+. +|+|.+++............ . .. ......
T Consensus 87 ~~~v~ey~~----------~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (337)
T cd05054 87 LMVIVEYCK----------FGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDV 156 (337)
T ss_pred EEEEEecCC----------CCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhc
Confidence 899999554 44444444322110000000 0 00 000000
Q ss_pred cchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCCCceEEecCCCCceEEEeccCccccccCCCccccccc
Q 003644 493 ENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNA 572 (805)
Q Consensus 493 ~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~ 572 (805)
++......+....+++..+..++.||+.||+|||+.+|+||||||+|||++.++. +||+|||+++.+...... ....
T Consensus 157 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~--vkL~DfG~a~~~~~~~~~-~~~~ 233 (337)
T cd05054 157 EEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNV--VKICDFGLARDIYKDPDY-VRKG 233 (337)
T ss_pred ccchhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCc--EEEeccccchhcccCcch-hhcc
Confidence 0111112233457899999999999999999999999999999999999987765 899999999876533221 1222
Q ss_pred cccCCCCCCChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHH--HHHHHhh-ccccccccCChHHHHHHHHhc
Q 003644 573 TGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFER--DANIVKD-RKDLFLVEHIPEAVDLFTRLL 649 (805)
Q Consensus 573 ~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~elltG~~~Pf~~~~~~--~~~~~~~-~~~~~~~~~~~~~~dLi~~~L 649 (805)
...++..|+|||++.+..++.++|||||||++|||++.+..||...... ....+.. .....+....+++.+++.+||
T Consensus 234 ~~~~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl 313 (337)
T cd05054 234 DARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYSIMLDCW 313 (337)
T ss_pred CCCCCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCCccCCHHHHHHHHHHc
Confidence 3446778999999999999999999999999999998447888653221 1112221 122223445678999999999
Q ss_pred CCCCCCCCChhhhhcC
Q 003644 650 DPNPDLRPKAQNVLNH 665 (805)
Q Consensus 650 ~~dP~~Rps~~ell~H 665 (805)
+.+|++||++.|+++|
T Consensus 314 ~~~p~~RPs~~ell~~ 329 (337)
T cd05054 314 HNNPEDRPTFSELVEI 329 (337)
T ss_pred cCChhhCcCHHHHHHH
Confidence 9999999999999875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=305.24 Aligned_cols=239 Identities=26% Similarity=0.364 Sum_probs=181.3
Q ss_pred eeccCCceEEEEEEe---eCCcEEEEEEeecCCc-----hHHHHHHHHHHHhCCCCCeeeecccccCCceEEEecccccC
Q 003644 383 EIAKGSNGTVVLEGN---YEGRSVAVKRLVKTHH-----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTC 454 (805)
Q Consensus 383 ~LG~GsfGtVy~a~~---~~g~~VAVK~l~~~~~-----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~E~~~~ 454 (805)
+||+|+||+||++.. .+++.||||+++.... +...+|+ .+++.++||||+++++++.+ +..++|||
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~-~~l~~l~h~~i~~~~~~~~~-~~~~lv~e---- 75 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREA-NVMQQLDNPYIVRMIGICEA-ESWMLVME---- 75 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHH-HHHHhCCCCCcceEEEEEcC-CCcEEEEe----
Confidence 589999999999743 4678999999864432 1233444 47788999999999998864 56789999
Q ss_pred ChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcceeccC
Q 003644 455 SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRD 534 (805)
Q Consensus 455 sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~IvHrD 534 (805)
|..+|+|.+++... ..+++..+..++.|++.||+|||+.+|+|||
T Consensus 76 ------~~~~~~L~~~l~~~-----------------------------~~~~~~~~~~i~~qi~~al~~lH~~~i~H~d 120 (257)
T cd05116 76 ------LAELGPLNKFLQKN-----------------------------KHVTEKNITELVHQVSMGMKYLEETNFVHRD 120 (257)
T ss_pred ------cCCCCcHHHHHHhc-----------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCEeecc
Confidence 55556665554221 2356778899999999999999999999999
Q ss_pred CCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCC
Q 003644 535 LKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP 614 (805)
Q Consensus 535 LKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~elltG~~~P 614 (805)
|||+||+++.++. +||+|||+++................++..|+|||.+....++.++|+|||||++|||++.+.+|
T Consensus 121 lkp~nill~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p 198 (257)
T cd05116 121 LAARNVLLVTQHY--AKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKP 198 (257)
T ss_pred cchhhEEEcCCCe--EEECCCccccccCCCCCeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCC
Confidence 9999999987754 89999999987654332222222334567899999998888999999999999999999844788
Q ss_pred CCCchHHH-HHHHhh-ccccccccCChHHHHHHHHhcCCCCCCCCChhhhhc
Q 003644 615 YGESFERD-ANIVKD-RKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 664 (805)
Q Consensus 615 f~~~~~~~-~~~~~~-~~~~~~~~~~~~~~dLi~~~L~~dP~~Rps~~ell~ 664 (805)
|....... ...+.. .....+...++++.++|.+||+.||+.||++++|.+
T Consensus 199 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~ 250 (257)
T cd05116 199 YKGMKGNEVTQMIESGERMECPQRCPPEMYDLMKLCWTYGVDERPGFAVVEL 250 (257)
T ss_pred CCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHH
Confidence 87643322 222222 222334456789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=304.19 Aligned_cols=248 Identities=24% Similarity=0.331 Sum_probs=190.5
Q ss_pred cceEEEeEeeccCCceEEEEEEeeCCcEEEEEEeecCCc--hHHHHHHHHHHHhCCCCCeeeecccccCCceEEEecccc
Q 003644 375 GKLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHH--DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERC 452 (805)
Q Consensus 375 ~~~~~~~~~LG~GsfGtVy~a~~~~g~~VAVK~l~~~~~--~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~E~~ 452 (805)
.+.|.+.+.||+|++|.||++...+++.||||.++.... ....+|+. +++.++||||+++++++.+.+..|++||++
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQ-IMKKLRHPKLIQLYAVCTLEEPIYIVTELM 83 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcccHHHHHHHHH-HHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence 355888899999999999998777788999999875432 33445554 778889999999999999999999999954
Q ss_pred cCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcceec
Q 003644 453 TCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIH 532 (805)
Q Consensus 453 ~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~IvH 532 (805)
.+++|.+++.... ...+++..+..++.|++.||+|||+.+|+|
T Consensus 84 ----------~~~~L~~~~~~~~---------------------------~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H 126 (261)
T cd05068 84 ----------KYGSLLEYLQGGA---------------------------GRALKLPQLIDMAAQVASGMAYLEAQNYIH 126 (261)
T ss_pred ----------cCCcHHHHHhccC---------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCeee
Confidence 4455555442211 123567788999999999999999999999
Q ss_pred cCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHHHHHhCCC
Q 003644 533 RDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGK 612 (805)
Q Consensus 533 rDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~elltG~~ 612 (805)
|||||+||+++.++. +||+|||+++....... ........+..|+|||++....++.++|||||||++|||++++.
T Consensus 127 ~dl~p~Nil~~~~~~--~~l~dfg~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~ 202 (261)
T cd05068 127 RDLAARNVLVGENNI--CKVADFGLARVIKEDIY--EAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGR 202 (261)
T ss_pred ccCCcceEEEcCCCC--EEECCcceEEEccCCcc--cccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCC
Confidence 999999999988876 89999999987753211 11111123457999999998889999999999999999999668
Q ss_pred CCCCCchHHH-HHHHhhc-cccccccCChHHHHHHHHhcCCCCCCCCChhhhhc
Q 003644 613 HPYGESFERD-ANIVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 664 (805)
Q Consensus 613 ~Pf~~~~~~~-~~~~~~~-~~~~~~~~~~~~~dLi~~~L~~dP~~Rps~~ell~ 664 (805)
+||....... ...+... ....+...+..+.+++.+||+.||.+||++.++++
T Consensus 203 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 203 MPYPGMTNAEVLQQVDQGYRMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQW 256 (261)
T ss_pred CCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 8887643322 2222222 22233445678999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-35 Score=308.17 Aligned_cols=247 Identities=28% Similarity=0.433 Sum_probs=190.2
Q ss_pred EEEeEeeccCCceEEEEEEee-CCcEEEEEEeecCCc----hHHHHHHHHHHHhCCCCCeeeecccccCCceEEEecccc
Q 003644 378 VVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERC 452 (805)
Q Consensus 378 ~~~~~~LG~GsfGtVy~a~~~-~g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~E~~ 452 (805)
|.+.+.||+|++|.||++... +++.||+|++..... ....+|+. +++.++||||+++++++.+++..|+++|+|
T Consensus 3 ~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~-~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (265)
T cd06605 3 LEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELD-ILHKCNSPYIVGFYGAFYNNGDISICMEYM 81 (265)
T ss_pred chHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHH-HHHHCCCCchhhhheeeecCCEEEEEEEec
Confidence 456678999999999998655 689999999875532 23445554 567788999999999999999999999965
Q ss_pred cCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhh-ccee
Q 003644 453 TCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE-IGLI 531 (805)
Q Consensus 453 ~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~-~~Iv 531 (805)
. +++|.+++... ...+++..+..++.|++.||+|||+ .+++
T Consensus 82 ~----------~~~L~~~~~~~----------------------------~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~ 123 (265)
T cd06605 82 D----------GGSLDKILKEV----------------------------QGRIPERILGKIAVAVLKGLTYLHEKHKII 123 (265)
T ss_pred C----------CCcHHHHHHHc----------------------------cCCCCHHHHHHHHHHHHHHHHHHcCCCCee
Confidence 5 44444433211 0345667788999999999999999 9999
Q ss_pred ccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHHHHHhCC
Q 003644 532 HRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGG 611 (805)
Q Consensus 532 HrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~elltG~ 611 (805)
||||||+||+++.++. ++|+|||.+........ ....++..|+|||.+.+..++.++|||||||++|+|++|
T Consensus 124 H~dl~~~ni~~~~~~~--~~l~d~g~~~~~~~~~~-----~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g- 195 (265)
T cd06605 124 HRDVKPSNILVNSRGQ--IKLCDFGVSGQLVNSLA-----KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATG- 195 (265)
T ss_pred cCCCCHHHEEECCCCC--EEEeecccchhhHHHHh-----hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhC-
Confidence 9999999999988765 89999999876643211 125688999999999988999999999999999999997
Q ss_pred CCCCCCch---H---HH-HHHHhhcccccccc-CChHHHHHHHHhcCCCCCCCCChhhhhcCcccccc
Q 003644 612 KHPYGESF---E---RD-ANIVKDRKDLFLVE-HIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTA 671 (805)
Q Consensus 612 ~~Pf~~~~---~---~~-~~~~~~~~~~~~~~-~~~~~~dLi~~~L~~dP~~Rps~~ell~Hpff~~~ 671 (805)
..||.... . .. ..+........+.. .++++.++|.+||..||++||++.+++.||||...
T Consensus 196 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~~ 263 (265)
T cd06605 196 RFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIKKY 263 (265)
T ss_pred CCCCCccccccccHHHHHHHHhcCCCCCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhCchhhcc
Confidence 66765431 1 11 11122222122222 56789999999999999999999999999999654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=302.04 Aligned_cols=247 Identities=27% Similarity=0.423 Sum_probs=193.4
Q ss_pred EEEeEeeccCCceEEEEEE-eeCCcEEEEEEeecCC-----chHHHHHHHHHHHhCCCCCeeeecccccCCceEEEeccc
Q 003644 378 VVFNKEIAKGSNGTVVLEG-NYEGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLER 451 (805)
Q Consensus 378 ~~~~~~LG~GsfGtVy~a~-~~~g~~VAVK~l~~~~-----~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~E~ 451 (805)
|.+.+.||.|+||.||.+. ..+++.||+|++.... .....+|+. +++.++|+||+++++++.+.+..+++||
T Consensus 2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~-~l~~~~h~~i~~~~~~~~~~~~~~~~~e- 79 (256)
T cd08221 2 YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIV-ILSLLQHPNIIAYYNHFMDDNTLLIEME- 79 (256)
T ss_pred ceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHH-HHHhCCCCCeeEEEeEEecCCeEEEEEE-
Confidence 6778999999999998864 4568999999875432 123456665 6778899999999999999999999999
Q ss_pred ccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhccee
Q 003644 452 CTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLI 531 (805)
Q Consensus 452 ~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~Iv 531 (805)
|+.+|+|.+++.... ...+++..+..++.|++.||+|||+.+++
T Consensus 80 ---------~~~~~~L~~~~~~~~---------------------------~~~~~~~~~~~~~~~l~~~l~~lh~~~i~ 123 (256)
T cd08221 80 ---------YANGGTLYDKIVRQK---------------------------GQLFEEEMVLWYLFQIVSAVSYIHKAGIL 123 (256)
T ss_pred ---------ecCCCcHHHHHHhcc---------------------------ccCCCHHHHHHHHHHHHHHHHHHHhCCcc
Confidence 555556655543211 12356778899999999999999999999
Q ss_pred ccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHHHHHhCC
Q 003644 532 HRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGG 611 (805)
Q Consensus 532 HrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~elltG~ 611 (805)
||||+|+||+++.++. +||+|||++........ ......|++.|+|||++.+..++.++|||||||++|||++|
T Consensus 124 h~dl~p~ni~~~~~~~--~kl~d~~~~~~~~~~~~---~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g- 197 (256)
T cd08221 124 HRDIKTLNIFLTKAGL--IKLGDFGISKILGSEYS---MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTL- 197 (256)
T ss_pred ccCCChHhEEEeCCCC--EEECcCcceEEcccccc---cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHC-
Confidence 9999999999988775 89999999987654321 22334589999999999888889999999999999999997
Q ss_pred CCCCCCchHHH-H-HHHhhccccccccCChHHHHHHHHhcCCCCCCCCChhhhhcCccc
Q 003644 612 KHPYGESFERD-A-NIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 668 (805)
Q Consensus 612 ~~Pf~~~~~~~-~-~~~~~~~~~~~~~~~~~~~dLi~~~L~~dP~~Rps~~ell~Hpff 668 (805)
..||....... . .+............+.++.+++.+||..+|.+||++.++++|||+
T Consensus 198 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~~l 256 (256)
T cd08221 198 KRTFDATNPLNLVVKIVQGNYTPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQPLL 256 (256)
T ss_pred CCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHHHHHHcccCcccCCCHHHHhhCcCC
Confidence 56775533222 2 222222222334456789999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=304.48 Aligned_cols=244 Identities=27% Similarity=0.465 Sum_probs=194.0
Q ss_pred EEEeEeeccCCceEEEEEEee-CCcEEEEEEeecCC------chHHHHHHHHHHHhCCCCCeeeecccccCCceEEEecc
Q 003644 378 VVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH------HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 450 (805)
Q Consensus 378 ~~~~~~LG~GsfGtVy~a~~~-~g~~VAVK~l~~~~------~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~E 450 (805)
|.+.+.||.|+||.||++... +++.||+|.+.+.. .....+|++ .++.++||||+++++++.+++..|+|+|
T Consensus 2 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERR-ILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred ceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHH-HHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 678899999999999998654 68999999986532 123344554 6788999999999999999999999999
Q ss_pred cccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcce
Q 003644 451 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 530 (805)
Q Consensus 451 ~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~I 530 (805)
|+.+++|.+++... ..+++..+..++.||+.||+|||+.++
T Consensus 81 ----------~~~~~~L~~~l~~~-----------------------------~~l~~~~~~~~~~~i~~~l~~lh~~~i 121 (258)
T cd05578 81 ----------LLLGGDLRYHLSQK-----------------------------VKFSEEQVKFWICEIVLALEYLHSKGI 121 (258)
T ss_pred ----------CCCCCCHHHHHHhc-----------------------------CCcCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 45555665544221 245677889999999999999999999
Q ss_pred eccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHHHHHhC
Q 003644 531 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG 610 (805)
Q Consensus 531 vHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~elltG 610 (805)
+|+||+|+||+++.++. ++|+|||++....... ......|+..|+|||.+....++.++|+|||||++|+|++|
T Consensus 122 ~h~dl~~~nil~~~~~~--~~l~d~~~~~~~~~~~----~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g 195 (258)
T cd05578 122 IHRDIKPDNILLDEQGH--VHITDFNIATKVTPDT----LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRG 195 (258)
T ss_pred eccCCCHHHeEEcCCCC--EEEeecccccccCCCc----cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhC
Confidence 99999999999988876 8999999988765331 12334588899999999988899999999999999999997
Q ss_pred CCCCCCCchH---HH-HHHHhhccccccccCChHHHHHHHHhcCCCCCCCCCh--hhhhcCccc
Q 003644 611 GKHPYGESFE---RD-ANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKA--QNVLNHPFF 668 (805)
Q Consensus 611 ~~~Pf~~~~~---~~-~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dP~~Rps~--~ell~Hpff 668 (805)
..||..... .. ...........+...++++.++|.+||+.||.+||++ +|+++||||
T Consensus 196 -~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 196 -KRPYRGHSRTIRDQIRAKQETADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred -CCCCCCCCccHHHHHHHHhccccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhcCCCC
Confidence 667765432 11 1222212333445566799999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=302.80 Aligned_cols=248 Identities=30% Similarity=0.523 Sum_probs=190.0
Q ss_pred EEEeEeeccCCceEEEEEEe-eCCcEEEEEEeecCCch-----HHHHHHHHHHHhCCCCCeeeecccccCCceEEEeccc
Q 003644 378 VVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHHD-----VALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLER 451 (805)
Q Consensus 378 ~~~~~~LG~GsfGtVy~a~~-~~g~~VAVK~l~~~~~~-----~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~E~ 451 (805)
|...+.||+|+||.||++.. .+++.||||.+...... ....|+ ..+..++|+||+++++++.+.+..++|+|
T Consensus 2 y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~-~~~~~l~~~~i~~~~~~~~~~~~~~lv~e- 79 (264)
T cd06626 2 WQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEM-KVLELLKHPNLVKYYGVEVHREKVYIFME- 79 (264)
T ss_pred ceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHH-HHHHhCCCCChhheeeeEecCCEEEEEEe-
Confidence 56778999999999999864 47899999998754332 233444 47788899999999999999999999999
Q ss_pred ccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhccee
Q 003644 452 CTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLI 531 (805)
Q Consensus 452 ~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~Iv 531 (805)
|..+++|.+++... ..+++..+..++.|++.||+|||+.+|+
T Consensus 80 ---------~~~~~~L~~~~~~~-----------------------------~~~~~~~~~~i~~~i~~~l~~lh~~~i~ 121 (264)
T cd06626 80 ---------YCSGGTLEELLEHG-----------------------------RILDEHVIRVYTLQLLEGLAYLHSHGIV 121 (264)
T ss_pred ---------cCCCCcHHHHHhhc-----------------------------CCCChHHHHHHHHHHHHHHHHHHHCCcc
Confidence 44555555544221 2245667789999999999999999999
Q ss_pred ccCCCCceEEecCCCCceEEEeccCccccccCCCccccc-cccccCCCCCCChhhhhcCC---CCCcchHHHHHHHHHHH
Q 003644 532 HRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQ-NATGYGSSGWQAPEQLLQGR---QTRAIDLFSLGCILFFC 607 (805)
Q Consensus 532 HrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~-~~~~~gt~~y~APE~l~~~~---~t~~sDVwSlGvil~el 607 (805)
|+||+|+||+++.++. +||+|||++............ .....++..|+|||++.... ++.++|||||||++|++
T Consensus 122 H~dl~~~nil~~~~~~--~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l 199 (264)
T cd06626 122 HRDIKPANIFLDHNGV--IKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEM 199 (264)
T ss_pred cCCCCHHHEEECCCCC--EEEcccccccccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHH
Confidence 9999999999988765 899999999877543221111 22345789999999998766 78999999999999999
Q ss_pred HhCCCCCCCCchHHH--H-HHHhhccccccccC--ChHHHHHHHHhcCCCCCCCCChhhhhcCccc
Q 003644 608 ITGGKHPYGESFERD--A-NIVKDRKDLFLVEH--IPEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 668 (805)
Q Consensus 608 ltG~~~Pf~~~~~~~--~-~~~~~~~~~~~~~~--~~~~~dLi~~~L~~dP~~Rps~~ell~Hpff 668 (805)
++| ..||....... . .+........+... .+.+.++|.+||+.||.+||++.+++.|||+
T Consensus 200 ~~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 200 ATG-KRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQHPFV 264 (264)
T ss_pred HhC-CCCccCCcchHHHHHHHhcCCCCCCCcccccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 997 77886432211 1 11111122222222 6788999999999999999999999999995
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=305.83 Aligned_cols=250 Identities=22% Similarity=0.298 Sum_probs=188.3
Q ss_pred EEeEeeccCCceEEEEEEeeC----CcEEEEEEeecCCc-----hHHHHHHHHHHHhCCCCCeeeecccccCCce-----
Q 003644 379 VFNKEIAKGSNGTVVLEGNYE----GRSVAVKRLVKTHH-----DVALKEIQNLIASDQHPNIVRWYGVESDQDF----- 444 (805)
Q Consensus 379 ~~~~~LG~GsfGtVy~a~~~~----g~~VAVK~l~~~~~-----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~----- 444 (805)
.+.+.||+|+||.||++.... +..||||+++.... ....+|+. .++.++||||+++++++.+.+.
T Consensus 2 ~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~-~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 2 KLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAA-CMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred ccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHH-HHHhCCCCCeeeEEeeeccCCccccCc
Confidence 456789999999999986542 47899999864321 23445654 6778899999999998766554
Q ss_pred -EEEecccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHH
Q 003644 445 -VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLS 523 (805)
Q Consensus 445 -l~LV~E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~ 523 (805)
.++++| |+.+|+|..++....... ....+++..++.++.|++.||+
T Consensus 81 ~~~~v~e----------~~~~~~l~~~l~~~~~~~-----------------------~~~~~~~~~~~~~~~~i~~aL~ 127 (273)
T cd05035 81 KPMVILP----------FMKHGDLHSFLLYSRLGG-----------------------LPEKLPLQTLLKFMVDIALGME 127 (273)
T ss_pred ccEEEEe----------ccCCCCHHHHHHHhhccC-----------------------CcccCCHHHHHHHHHHHHHHHH
Confidence 799999 666677766654322110 1124677888999999999999
Q ss_pred HhhhcceeccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHH
Q 003644 524 HLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCI 603 (805)
Q Consensus 524 yLH~~~IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvi 603 (805)
|||+.+|+||||||+||++++++. +||+|||+++......... ......++..|+|||++....++.++|||||||+
T Consensus 128 ~lH~~~i~H~dlkp~Nil~~~~~~--~kl~dfg~~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~i 204 (273)
T cd05035 128 YLSNRNFIHRDLAARNCMLREDMT--VCVADFGLSKKIYSGDYYR-QGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVT 204 (273)
T ss_pred HHHhCCeeccccchheEEECCCCe--EEECCccceeecccccccc-ccccccCCccccCHhhcccCCCCcccchHHHHHH
Confidence 999999999999999999987765 8999999998765432211 1122235678999999988889999999999999
Q ss_pred HHHHHhCCCCCCCCchHHHH--HHHhhccccccccCChHHHHHHHHhcCCCCCCCCChhhhhcC
Q 003644 604 LFFCITGGKHPYGESFERDA--NIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNH 665 (805)
Q Consensus 604 l~elltG~~~Pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~dLi~~~L~~dP~~Rps~~ell~H 665 (805)
+|||++++.+||........ .+........+...++++.+++.+||+.||.+||++.|++++
T Consensus 205 l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~ 268 (273)
T cd05035 205 MWEIATRGQTPYPGVENHEIYDYLRHGNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREV 268 (273)
T ss_pred HHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 99999966888866433221 222222233344567899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=309.03 Aligned_cols=246 Identities=26% Similarity=0.412 Sum_probs=186.5
Q ss_pred eEEEeEeeccCCceEEEEEEee-CCcEEEEEEeecCCc-----hHHHHHHHHHHHhCCCCCeeeecccccCCceEEEecc
Q 003644 377 LVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHH-----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 450 (805)
Q Consensus 377 ~~~~~~~LG~GsfGtVy~a~~~-~g~~VAVK~l~~~~~-----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~E 450 (805)
.|.+.+.||+|+||.||++... +++.||+|++.+... ....+|+. ++..++||||+++++++.+++..|+|+|
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIR-MLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred ceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHH-HHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 4677899999999999998654 589999998854322 23345554 7788899999999999999999999999
Q ss_pred cccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcce
Q 003644 451 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 530 (805)
Q Consensus 451 ~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~I 530 (805)
|+. ++.+..+.. ....+++.+++.++.||+.||+|||+.+|
T Consensus 81 ~~~----------~~~l~~~~~-----------------------------~~~~~~~~~~~~~~~~i~~~l~~LH~~~i 121 (286)
T cd07846 81 FVD----------HTVLDDLEK-----------------------------YPNGLDESRVRKYLFQILRGIEFCHSHNI 121 (286)
T ss_pred cCC----------ccHHHHHHh-----------------------------ccCCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence 555 344433221 11236677889999999999999999999
Q ss_pred eccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhc-CCCCCcchHHHHHHHHHHHHh
Q 003644 531 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ-GRQTRAIDLFSLGCILFFCIT 609 (805)
Q Consensus 531 vHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~t~~sDVwSlGvil~ellt 609 (805)
+||||+|+||++++++. ++|+|||++........ ......++..|+|||++.+ ..++.++|||||||++|||++
T Consensus 122 ~h~~l~p~ni~~~~~~~--~~l~dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~ 196 (286)
T cd07846 122 IHRDIKPENILVSQSGV--VKLCDFGFARTLAAPGE---VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLT 196 (286)
T ss_pred cccCCCHHHEEECCCCc--EEEEeeeeeeeccCCcc---ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHc
Confidence 99999999999988775 89999999887643321 1123457899999999875 347889999999999999999
Q ss_pred CCCCCCCCchHHH--HHHHhh--------------------ccc----------cccccCChHHHHHHHHhcCCCCCCCC
Q 003644 610 GGKHPYGESFERD--ANIVKD--------------------RKD----------LFLVEHIPEAVDLFTRLLDPNPDLRP 657 (805)
Q Consensus 610 G~~~Pf~~~~~~~--~~~~~~--------------------~~~----------~~~~~~~~~~~dLi~~~L~~dP~~Rp 657 (805)
| .+||....... ..+... ... ......+..+.+++.+||+.||++||
T Consensus 197 g-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp 275 (286)
T cd07846 197 G-EPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRP 275 (286)
T ss_pred C-CCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccch
Confidence 7 66775432211 011000 000 00123456799999999999999999
Q ss_pred ChhhhhcCccc
Q 003644 658 KAQNVLNHPFF 668 (805)
Q Consensus 658 s~~ell~Hpff 668 (805)
++.++++||||
T Consensus 276 ~~~~il~~~~~ 286 (286)
T cd07846 276 SSSQLLHHEFF 286 (286)
T ss_pred hHHHHhcCCCC
Confidence 99999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=309.67 Aligned_cols=250 Identities=26% Similarity=0.361 Sum_probs=192.0
Q ss_pred eEEEeEeeccCCceEEEEEEe-eCCcEEEEEEeecCCch---HHHHHHHHHHHhCCCCCeeeecccccCCceEEEecccc
Q 003644 377 LVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHHD---VALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERC 452 (805)
Q Consensus 377 ~~~~~~~LG~GsfGtVy~a~~-~~g~~VAVK~l~~~~~~---~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~E~~ 452 (805)
.|.+.+.||.|+||+||++.. .++..||+|.+...... ...+|+. +++.++||||+++++++.+++..|+|||
T Consensus 6 ~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~lv~e-- 82 (280)
T cd06611 6 IWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEID-ILSECKHPNIVGLYEAYFYENKLWILIE-- 82 (280)
T ss_pred HHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHH-HHHhCCCCceeEEEEEEecCCeEEEEee--
Confidence 356678899999999999865 46899999998654322 3345554 7788899999999999999999999999
Q ss_pred cCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcceec
Q 003644 453 TCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIH 532 (805)
Q Consensus 453 ~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~IvH 532 (805)
|+.+++|.+++... ...+++..++.++.|++.||+|||+.+|+|
T Consensus 83 --------~~~~~~L~~~~~~~----------------------------~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h 126 (280)
T cd06611 83 --------FCDGGALDSIMLEL----------------------------ERGLTEPQIRYVCRQMLEALNFLHSHKVIH 126 (280)
T ss_pred --------ccCCCcHHHHHHHh----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCccc
Confidence 55566666554321 124677888999999999999999999999
Q ss_pred cCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhc-----CCCCCcchHHHHHHHHHHH
Q 003644 533 RDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ-----GRQTRAIDLFSLGCILFFC 607 (805)
Q Consensus 533 rDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~-----~~~t~~sDVwSlGvil~el 607 (805)
|||||+||+++.++. ++|+|||++....... .......|++.|+|||++.. ..++.++|+|||||++|||
T Consensus 127 ~dl~p~nili~~~~~--~~l~d~g~~~~~~~~~---~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l 201 (280)
T cd06611 127 RDLKAGNILLTLDGD--VKLADFGVSAKNKSTL---QKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIEL 201 (280)
T ss_pred CCCChhhEEECCCCC--EEEccCccchhhcccc---cccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHH
Confidence 999999999988776 8999999987654321 11223458999999999853 3467899999999999999
Q ss_pred HhCCCCCCCCchHHH-H-HHHhhccc--cccccCChHHHHHHHHhcCCCCCCCCChhhhhcCcccccc
Q 003644 608 ITGGKHPYGESFERD-A-NIVKDRKD--LFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTA 671 (805)
Q Consensus 608 ltG~~~Pf~~~~~~~-~-~~~~~~~~--~~~~~~~~~~~dLi~~~L~~dP~~Rps~~ell~Hpff~~~ 671 (805)
++| .+||....... . .+...... ..+...+.++.++|.+||+.||.+||++.++++||||.+.
T Consensus 202 ~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 268 (280)
T cd06611 202 AQM-EPPHHELNPMRVLLKILKSEPPTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQ 268 (280)
T ss_pred HhC-CCCcccCCHHHHHHHHhcCCCCCcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcChhhccc
Confidence 997 67776543221 1 12111111 1123456789999999999999999999999999999654
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=325.02 Aligned_cols=286 Identities=23% Similarity=0.354 Sum_probs=190.4
Q ss_pred cceEEEeEeeccCCceEEEEEEee------CCcEEEEEEeecCCc----hHHHHHHHHHHHhC-CCCCeeeecccccCCc
Q 003644 375 GKLVVFNKEIAKGSNGTVVLEGNY------EGRSVAVKRLVKTHH----DVALKEIQNLIASD-QHPNIVRWYGVESDQD 443 (805)
Q Consensus 375 ~~~~~~~~~LG~GsfGtVy~a~~~------~g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l-~HpNIV~l~g~~~~~~ 443 (805)
.+.|.+.+.||+|+||+||++... .+..||||++..... +...+|+. ++..+ .|||||+++++|.+.+
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~-~l~~l~~HpnIv~l~~~~~~~~ 114 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELK-IMTHLGPHLNIVNLLGACTKSG 114 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHH-HHHhcCCCCCeeeEEEEEccCC
Confidence 356788899999999999997543 235799999965432 23456766 45666 5999999999999999
Q ss_pred eEEEeccccc-CChhhHHHHhcCCHHHHHhhhhccc------hhhHH----HHh--------------------------
Q 003644 444 FVYLSLERCT-CSLNDLIYVLSGSFEEQLNAKEQDS------NLLNE----VRI-------------------------- 486 (805)
Q Consensus 444 ~l~LV~E~~~-~sL~d~iy~~~GsL~~~L~~~~~~~------~~l~~----~~~-------------------------- 486 (805)
..|||||||. ++|.+++......+........... ....+ +..
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (400)
T cd05105 115 PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEI 194 (400)
T ss_pred ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhh
Confidence 9999999664 3555544322111100000000000 00000 000
Q ss_pred -------------hhccc---ccchhhHHHH----hhCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCCCceEEecCCC
Q 003644 487 -------------RLLPV---MENTKDIELW----KANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDK 546 (805)
Q Consensus 487 -------------~~~~~---~~~~~~~~~~----~~~~l~~~~~~~i~~qIa~gL~yLH~~~IvHrDLKp~NILl~~~~ 546 (805)
...+. ..+......+ ....+++..++.++.||+.||+|||+.+|+||||||+|||++.++
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~~~~ 274 (400)
T cd05105 195 KEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGK 274 (400)
T ss_pred hhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEeCCC
Confidence 00000 0000000011 124588899999999999999999999999999999999997765
Q ss_pred CceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH--HH
Q 003644 547 SFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERD--AN 624 (805)
Q Consensus 547 ~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~elltG~~~Pf~~~~~~~--~~ 624 (805)
. +||+|||+++........ .......++..|+|||++.+..++.++|||||||++|||++.+..||....... ..
T Consensus 275 ~--~kL~DfGla~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~ 351 (400)
T cd05105 275 I--VKICDFGLARDIMHDSNY-VSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYN 351 (400)
T ss_pred E--EEEEeCCcceeccccccc-cccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHH
Confidence 4 899999999876433221 122233577889999999988899999999999999999985567776532211 12
Q ss_pred HHhhc-cccccccCChHHHHHHHHhcCCCCCCCCChhhhhc
Q 003644 625 IVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 664 (805)
Q Consensus 625 ~~~~~-~~~~~~~~~~~~~dLi~~~L~~dP~~Rps~~ell~ 664 (805)
.+... ....+...++++.+++.+||+.||++||++.++.+
T Consensus 352 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~ 392 (400)
T cd05105 352 KIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD 392 (400)
T ss_pred HHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence 22222 22223445678999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=304.33 Aligned_cols=241 Identities=31% Similarity=0.502 Sum_probs=186.2
Q ss_pred EeeccCCceEEEEEEe-eCCcEEEEEEeecCCc------hHHHHHHHHHHHhCCCCCeeeecccccCCceEEEecccccC
Q 003644 382 KEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH------DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTC 454 (805)
Q Consensus 382 ~~LG~GsfGtVy~a~~-~~g~~VAVK~l~~~~~------~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~E~~~~ 454 (805)
+.||+|+||.||+|.. .+|+.||||.+.+... .....|...+....+||||+++++++.+++..|+|+|
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e---- 77 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVME---- 77 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEe----
Confidence 4699999999999855 4689999999865421 1123344445556789999999999999999999999
Q ss_pred ChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcceeccC
Q 003644 455 SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRD 534 (805)
Q Consensus 455 sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~IvHrD 534 (805)
|+.+++|.+++.. ...+++..+..++.|++.||.|||+.+++|||
T Consensus 78 ------~~~~~~L~~~l~~-----------------------------~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~d 122 (260)
T cd05611 78 ------YLNGGDCASLIKT-----------------------------LGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRD 122 (260)
T ss_pred ------ccCCCCHHHHHHH-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCC
Confidence 5566666655422 12367778899999999999999999999999
Q ss_pred CCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCC
Q 003644 535 LKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP 614 (805)
Q Consensus 535 LKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~elltG~~~P 614 (805)
|+|+||+++.++. +||+|||+++.... .....|+..|+|||.+.+..++.++||||||+++|||++| .+|
T Consensus 123 l~p~nil~~~~~~--~~l~dfg~~~~~~~-------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g-~~p 192 (260)
T cd05611 123 IKPENLLIDQTGH--LKLTDFGLSRNGLE-------NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFG-YPP 192 (260)
T ss_pred CCHHHeEECCCCc--EEEeecccceeccc-------cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHC-CCC
Confidence 9999999988765 89999999875432 1234588999999999888889999999999999999996 778
Q ss_pred CCCchHHHH-HHHhhcc----ccccccCChHHHHHHHHhcCCCCCCCCCh---hhhhcCcccccc
Q 003644 615 YGESFERDA-NIVKDRK----DLFLVEHIPEAVDLFTRLLDPNPDLRPKA---QNVLNHPFFWTA 671 (805)
Q Consensus 615 f~~~~~~~~-~~~~~~~----~~~~~~~~~~~~dLi~~~L~~dP~~Rps~---~ell~Hpff~~~ 671 (805)
|........ ....... .......++++.++|.+||+.||++||++ +|+++||||.+.
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~~~~ 257 (260)
T cd05611 193 FHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKSI 257 (260)
T ss_pred CCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcChHhhcC
Confidence 865433221 1111111 11122356799999999999999999955 799999999654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=309.30 Aligned_cols=251 Identities=25% Similarity=0.387 Sum_probs=187.7
Q ss_pred eEEEeEeeccCCceEEEEEEe-eCCcEEEEEEeecCCc-----hHHHHHHHHHHHhCCCCCeeeecccccCCceEEEecc
Q 003644 377 LVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH-----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 450 (805)
Q Consensus 377 ~~~~~~~LG~GsfGtVy~a~~-~~g~~VAVK~l~~~~~-----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~E 450 (805)
.|.+.+.||+|++|+||++.. .+|+.||||++..... ....+|+. +++.++||||+++++++.+++..|+|||
T Consensus 3 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 3 QYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREIS-LLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred ceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHH-HHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 477889999999999999865 4789999998864321 23445554 6778899999999999999999999999
Q ss_pred cccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcce
Q 003644 451 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 530 (805)
Q Consensus 451 ~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~I 530 (805)
|+.++|.+++ ... ....+++..+..++.||+.||+|||+.++
T Consensus 82 ~~~~~l~~~~-----------~~~---------------------------~~~~~~~~~~~~~~~qi~~aL~~LH~~~i 123 (294)
T PLN00009 82 YLDLDLKKHM-----------DSS---------------------------PDFAKNPRLIKTYLYQILRGIAYCHSHRV 123 (294)
T ss_pred cccccHHHHH-----------HhC---------------------------CCCCcCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 6655544433 110 01123556778999999999999999999
Q ss_pred eccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcC-CCCCcchHHHHHHHHHHHHh
Q 003644 531 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG-RQTRAIDLFSLGCILFFCIT 609 (805)
Q Consensus 531 vHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~t~~sDVwSlGvil~ellt 609 (805)
+||||+|+||+++.++. .+||+|||++........ ......+++.|+|||++.+. .++.++|||||||++|+|++
T Consensus 124 ~H~dl~p~nill~~~~~-~~kl~dfg~~~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~t 199 (294)
T PLN00009 124 LHRDLKPQNLLIDRRTN-ALKLADFGLARAFGIPVR---TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVN 199 (294)
T ss_pred eCCCCCcceEEEECCCC-EEEEcccccccccCCCcc---ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHh
Confidence 99999999999975443 489999999976543211 11223578899999998764 57899999999999999999
Q ss_pred CCCCCCCCchHHHH--HHHhhcc--------------------c--------cccccCChHHHHHHHHhcCCCCCCCCCh
Q 003644 610 GGKHPYGESFERDA--NIVKDRK--------------------D--------LFLVEHIPEAVDLFTRLLDPNPDLRPKA 659 (805)
Q Consensus 610 G~~~Pf~~~~~~~~--~~~~~~~--------------------~--------~~~~~~~~~~~dLi~~~L~~dP~~Rps~ 659 (805)
| .+||........ .+..... . ......++++.+++.+||+.||++||++
T Consensus 200 g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~ 278 (294)
T PLN00009 200 Q-KPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITA 278 (294)
T ss_pred C-CCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCH
Confidence 7 778865332211 1110000 0 0112345788999999999999999999
Q ss_pred hhhhcCcccccc
Q 003644 660 QNVLNHPFFWTA 671 (805)
Q Consensus 660 ~ell~Hpff~~~ 671 (805)
.++++||||...
T Consensus 279 ~~~l~~~~~~~~ 290 (294)
T PLN00009 279 RAALEHEYFKDL 290 (294)
T ss_pred HHHhcCchHhHH
Confidence 999999999653
|
|
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=310.94 Aligned_cols=254 Identities=26% Similarity=0.333 Sum_probs=190.5
Q ss_pred eEEEeEeeccCCceEEEEEEe-eCCcEEEEEEeecCCc------hHHHHHHHHHHHhCCCCCeeeecccccCCceEEEec
Q 003644 377 LVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH------DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSL 449 (805)
Q Consensus 377 ~~~~~~~LG~GsfGtVy~a~~-~~g~~VAVK~l~~~~~------~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~ 449 (805)
.|.+.+.||+|+||.||++.. .+++.||||.+..... ....+|+ .++..++||||+++++++.+++..|+||
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~-~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVER-DILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHH-HHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 367789999999999999854 4578999999865421 1223444 4678889999999999999999999999
Q ss_pred ccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcc
Q 003644 450 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG 529 (805)
Q Consensus 450 E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~ 529 (805)
| |+.+++|.+++.. ...+++..+..++.|++.||+|||+.+
T Consensus 81 e----------~~~g~~L~~~l~~-----------------------------~~~~~~~~~~~~~~~i~~~l~~lH~~~ 121 (305)
T cd05609 81 E----------YVEGGDCATLLKN-----------------------------IGALPVDMARMYFAETVLALEYLHNYG 121 (305)
T ss_pred e----------cCCCCcHHHHHHH-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 9 5566666665532 123567778899999999999999999
Q ss_pred eeccCCCCceEEecCCCCceEEEeccCccccccCCCcc------------ccccccccCCCCCCChhhhhcCCCCCcchH
Q 003644 530 LIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSC------------LTQNATGYGSSGWQAPEQLLQGRQTRAIDL 597 (805)
Q Consensus 530 IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~------------~~~~~~~~gt~~y~APE~l~~~~~t~~sDV 597 (805)
++||||||+||+++.++. +||+|||+++........ ........|+..|+|||.+.+..++.++|+
T Consensus 122 i~H~dl~p~NIll~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di 199 (305)
T cd05609 122 IVHRDLKPDNLLITSMGH--IKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDW 199 (305)
T ss_pred ccccCCchHHEEECCCCC--EEEeeCCCccccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhH
Confidence 999999999999988776 899999998742111000 001112357889999999988889999999
Q ss_pred HHHHHHHHHHHhCCCCCCCCch-HHHHHHHhhccccc---cccCChHHHHHHHHhcCCCCCCCCC---hhhhhcCccccc
Q 003644 598 FSLGCILFFCITGGKHPYGESF-ERDANIVKDRKDLF---LVEHIPEAVDLFTRLLDPNPDLRPK---AQNVLNHPFFWT 670 (805)
Q Consensus 598 wSlGvil~elltG~~~Pf~~~~-~~~~~~~~~~~~~~---~~~~~~~~~dLi~~~L~~dP~~Rps---~~ell~Hpff~~ 670 (805)
|||||++|||++| ..||.... .............. ....++++.++|.+||+.||++||+ +.++++||||..
T Consensus 200 ~slG~vl~el~~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~ 278 (305)
T cd05609 200 WAMGIILYEFLVG-CVPFFGDTPEELFGQVISDDIEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLG 278 (305)
T ss_pred HHHHHHHHHHHhC-CCCCCCCCHHHHHHHHHhcccCCCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccC
Confidence 9999999999997 55665432 22222221111111 1134678999999999999999998 789999999965
Q ss_pred ccc
Q 003644 671 ADT 673 (805)
Q Consensus 671 ~~~ 673 (805)
.+.
T Consensus 279 ~~~ 281 (305)
T cd05609 279 LDW 281 (305)
T ss_pred CCH
Confidence 443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=314.90 Aligned_cols=247 Identities=24% Similarity=0.307 Sum_probs=187.1
Q ss_pred ceEEEeEeeccCCceEEEEEEee-CCc----EEEEEEeecCCc----hHHHHHHHHHHHhCCCCCeeeecccccCCceEE
Q 003644 376 KLVVFNKEIAKGSNGTVVLEGNY-EGR----SVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVY 446 (805)
Q Consensus 376 ~~~~~~~~LG~GsfGtVy~a~~~-~g~----~VAVK~l~~~~~----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~ 446 (805)
..|...+.||+|+||+||++... +|. .||||++..... ....+|+ .+++.++||||++++|+|... ..+
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~-~~l~~l~h~niv~~~g~~~~~-~~~ 84 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEA-YVMASVDNPHVCRLLGICLTS-TVQ 84 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHH-HHHHhCCCCCCCeEEEEEcCC-Cce
Confidence 34778899999999999998643 343 489999864432 2233344 477889999999999999875 567
Q ss_pred EecccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhh
Q 003644 447 LSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH 526 (805)
Q Consensus 447 LV~E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH 526 (805)
+++| |+.+|+|.+++.... ..+++..++.++.||+.||+|||
T Consensus 85 ~v~e----------~~~~g~l~~~l~~~~----------------------------~~~~~~~~~~~~~qi~~~L~~LH 126 (316)
T cd05108 85 LITQ----------LMPFGCLLDYVREHK----------------------------DNIGSQYLLNWCVQIAKGMNYLE 126 (316)
T ss_pred eeee----------cCCCCCHHHHHHhcc----------------------------ccCCHHHHHHHHHHHHHHHHHHH
Confidence 8999 666777777654321 23566778899999999999999
Q ss_pred hcceeccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHHH
Q 003644 527 EIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFF 606 (805)
Q Consensus 527 ~~~IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~e 606 (805)
+.+|+||||||+|||++.++. +||+|||+++.......... .....++..|+|||++.+..++.++|||||||++||
T Consensus 127 ~~~iiH~dlkp~Nill~~~~~--~kl~DfG~a~~~~~~~~~~~-~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~e 203 (316)
T cd05108 127 ERRLVHRDLAARNVLVKTPQH--VKITDFGLAKLLGADEKEYH-AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWE 203 (316)
T ss_pred hcCeeccccchhheEecCCCc--EEEccccccccccCCCccee-ccCCccceeecChHHhccCCCCchhhhHHHHHHHHH
Confidence 999999999999999987765 89999999987754322111 122234678999999999999999999999999999
Q ss_pred HHhCCCCCCCCchHHH-HHHHhhc-cccccccCChHHHHHHHHhcCCCCCCCCChhhhhcC
Q 003644 607 CITGGKHPYGESFERD-ANIVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNH 665 (805)
Q Consensus 607 lltG~~~Pf~~~~~~~-~~~~~~~-~~~~~~~~~~~~~dLi~~~L~~dP~~Rps~~ell~H 665 (805)
|++.+..||....... ..+.... ....+.....++.+++.+||..||++||++.+++.+
T Consensus 204 l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~ 264 (316)
T cd05108 204 LMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 264 (316)
T ss_pred HHcCCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 9984578887643322 2232222 112233456789999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=302.64 Aligned_cols=247 Identities=26% Similarity=0.421 Sum_probs=189.4
Q ss_pred ceEEEeEeeccCCceEEEEEEe-eCCcEEEEEEeecCCc---hHHHHHHHHHHHhCCCCCeeeecccccCCceEEEeccc
Q 003644 376 KLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH---DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLER 451 (805)
Q Consensus 376 ~~~~~~~~LG~GsfGtVy~a~~-~~g~~VAVK~l~~~~~---~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~E~ 451 (805)
+.|.+.+.||+|+||.||++.. .+++.+|+|.+..... ....+|+. +++.++||||+++++++.+++.+|++||+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~-~l~~~~h~~i~~~~~~~~~~~~~~l~~e~ 81 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEIS-MLKECRHPNIVAYFGSYLRRDKLWIVMEY 81 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHH-HHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence 4578889999999999999865 4578999999875432 23445554 77889999999999999999999999995
Q ss_pred ccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhccee
Q 003644 452 CTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLI 531 (805)
Q Consensus 452 ~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~Iv 531 (805)
+. +++|.+++... ...+++.++..++.|++.||+|||+.+|+
T Consensus 82 ~~----------~~~l~~~~~~~----------------------------~~~l~~~~~~~~~~ql~~~l~~lh~~~i~ 123 (262)
T cd06613 82 CG----------GGSLQDIYQVT----------------------------RGPLSELQIAYVCRETLKGLAYLHETGKI 123 (262)
T ss_pred CC----------CCcHHHHHHhh----------------------------ccCCCHHHHHHHHHHHHHHHHHHHhCCce
Confidence 54 44444433211 12466778899999999999999999999
Q ss_pred ccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcC---CCCCcchHHHHHHHHHHHH
Q 003644 532 HRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG---RQTRAIDLFSLGCILFFCI 608 (805)
Q Consensus 532 HrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~---~~t~~sDVwSlGvil~ell 608 (805)
|+||||+||+++.++. +||+|||++....... .......++..|+|||.+... .++.++|+|||||++|||+
T Consensus 124 h~dl~p~ni~i~~~~~--~~l~d~g~~~~~~~~~---~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~ 198 (262)
T cd06613 124 HRDIKGANILLTEDGD--VKLADFGVSAQLTATI---AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELA 198 (262)
T ss_pred ecCCChhhEEECCCCC--EEECccccchhhhhhh---hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHH
Confidence 9999999999988776 8999999988765321 112234588899999999776 7899999999999999999
Q ss_pred hCCCCCCCCchHHH-HHHHhhc--cc---cccccCChHHHHHHHHhcCCCCCCCCChhhhhcCcc
Q 003644 609 TGGKHPYGESFERD-ANIVKDR--KD---LFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPF 667 (805)
Q Consensus 609 tG~~~Pf~~~~~~~-~~~~~~~--~~---~~~~~~~~~~~dLi~~~L~~dP~~Rps~~ell~Hpf 667 (805)
+| .+||....... ....... .. ......+.++.+++.+||..||..||++++++.|||
T Consensus 199 tg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 199 EL-QPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQHPF 262 (262)
T ss_pred hC-CCCCCCCCHHHHHHHHHhccCCCccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence 97 66775533222 2111111 00 011223467899999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=304.97 Aligned_cols=247 Identities=32% Similarity=0.501 Sum_probs=187.5
Q ss_pred EEEeEeeccCCceEEEEEEe-eCCcEEEEEEeecCCc-------------hHHHHHHHHHHHhCCCCCeeeecccccCCc
Q 003644 378 VVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH-------------DVALKEIQNLIASDQHPNIVRWYGVESDQD 443 (805)
Q Consensus 378 ~~~~~~LG~GsfGtVy~a~~-~~g~~VAVK~l~~~~~-------------~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~ 443 (805)
|...+.||+|+||+||++.. .+|+.||||.+..... +...+|+. ++..++||||+++++++.+.+
T Consensus 3 ~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 3 WVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIE-TLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred eeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHH-HHHhcCCCCcceEEEEeccCC
Confidence 56678899999999999854 4689999998753210 11234544 678889999999999999999
Q ss_pred eEEEecccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHH
Q 003644 444 FVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLS 523 (805)
Q Consensus 444 ~l~LV~E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~ 523 (805)
..++||| |..+|+|.+++... ..+++..+..++.||+.||.
T Consensus 82 ~~~lv~e----------~~~~~~L~~~l~~~-----------------------------~~l~~~~~~~~~~qi~~~l~ 122 (272)
T cd06629 82 YLSIFLE----------YVPGGSIGSCLRTY-----------------------------GRFEEQLVRFFTEQVLEGLA 122 (272)
T ss_pred ceEEEEe----------cCCCCcHHHHHhhc-----------------------------cCCCHHHHHHHHHHHHHHHH
Confidence 9999999 55566666554321 23566778899999999999
Q ss_pred HhhhcceeccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCC--CCCcchHHHHH
Q 003644 524 HLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGR--QTRAIDLFSLG 601 (805)
Q Consensus 524 yLH~~~IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~--~t~~sDVwSlG 601 (805)
|||+.+++||||+|+||+++.++. ++|+|||+++........ .......|+..|+|||.+.... ++.++|+||||
T Consensus 123 ~lH~~~i~H~dl~~~nil~~~~~~--~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG 199 (272)
T cd06629 123 YLHSKGILHRDLKADNLLVDADGI--CKISDFGISKKSDDIYDN-DQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLG 199 (272)
T ss_pred HHhhCCeeecCCChhhEEEcCCCe--EEEeeccccccccccccc-cccccccCCccccCHHHhccccCCCCccchhHHHH
Confidence 999999999999999999987765 899999998765432111 1122345889999999987654 78999999999
Q ss_pred HHHHHHHhCCCCCCCCchHHHH--HHHhhc-ccccc----ccCChHHHHHHHHhcCCCCCCCCChhhhhcCccc
Q 003644 602 CILFFCITGGKHPYGESFERDA--NIVKDR-KDLFL----VEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 668 (805)
Q Consensus 602 vil~elltG~~~Pf~~~~~~~~--~~~~~~-~~~~~----~~~~~~~~dLi~~~L~~dP~~Rps~~ell~Hpff 668 (805)
+++|++++| ..||........ .+.... ....+ ...+.++.++|.+||..||.+||++.++++||||
T Consensus 200 ~~l~~l~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 200 CVVLEMFAG-RRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPFI 272 (272)
T ss_pred HHHHHHHhC-CCCCcCcchHHHHHHhhccccCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence 999999997 678764332211 111111 11111 2335789999999999999999999999999996
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=304.11 Aligned_cols=246 Identities=24% Similarity=0.384 Sum_probs=189.2
Q ss_pred eEEEeEeeccCCceEEEEEEeeCCcEEEEEEeecCC--chHHHHHHHHHHHhCCCCCeeeecccccCCceEEEecccccC
Q 003644 377 LVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTH--HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTC 454 (805)
Q Consensus 377 ~~~~~~~LG~GsfGtVy~a~~~~g~~VAVK~l~~~~--~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~E~~~~ 454 (805)
.|.+.+.||+|+||.||++...++..+|||.+.+.. .+...+|+. ++..++||||+++++++.+.+..|+|||
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~-~l~~l~~~~i~~~~~~~~~~~~~~lv~e---- 79 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAK-VMMKLSHPNLVQLYGVCTKQRPIFIVTE---- 79 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCCccEEEEEeccCCCCHHHHHHHHH-HHHhCCCCCEEEEEEEEcCCCceEEEEe----
Confidence 366778899999999999877677789999986543 234456665 6778899999999999999999999999
Q ss_pred ChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcceeccC
Q 003644 455 SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRD 534 (805)
Q Consensus 455 sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~IvHrD 534 (805)
|+++++|.+++.... ..+++..++.++.|++.||+|||+.+|+|||
T Consensus 80 ------~~~~~~L~~~l~~~~----------------------------~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~d 125 (256)
T cd05059 80 ------YMANGCLLNYLRERK----------------------------GKLGTEWLLDMCSDVCEAMEYLESNGFIHRD 125 (256)
T ss_pred ------cCCCCCHHHHHHhcc----------------------------cCCCHHHHHHHHHHHHHHHHHHHHCCccccc
Confidence 555566665543211 1356778899999999999999999999999
Q ss_pred CCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCC
Q 003644 535 LKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP 614 (805)
Q Consensus 535 LKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~elltG~~~P 614 (805)
|||+||+++.++. +||+|||+++....... .......++..|+|||.+.+..++.++|||||||++|||++++.+|
T Consensus 126 l~p~ni~i~~~~~--~kl~dfg~~~~~~~~~~--~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p 201 (256)
T cd05059 126 LAARNCLVGEDNV--VKVSDFGLARYVLDDQY--TSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMP 201 (256)
T ss_pred ccHhhEEECCCCc--EEECCcccceecccccc--cccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCC
Confidence 9999999988776 89999999886643211 1111112345799999999889999999999999999999966888
Q ss_pred CCCchHHH-HHHHh-hccccccccCChHHHHHHHHhcCCCCCCCCChhhhhcC
Q 003644 615 YGESFERD-ANIVK-DRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNH 665 (805)
Q Consensus 615 f~~~~~~~-~~~~~-~~~~~~~~~~~~~~~dLi~~~L~~dP~~Rps~~ell~H 665 (805)
|....... ...+. ......+...++++.+++.+||..+|++||++.|+++.
T Consensus 202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~ 254 (256)
T cd05059 202 YERFSNSEVVESVSAGYRLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQ 254 (256)
T ss_pred CCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 86543222 11121 11222233456789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=310.06 Aligned_cols=251 Identities=28% Similarity=0.400 Sum_probs=190.2
Q ss_pred ceEEEeEeeccCCceEEEEEEeeC-CcEEEEEEeecCCc----hHHHHHHHHHHHhCCCCCeeeecccccCCceEEEecc
Q 003644 376 KLVVFNKEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 450 (805)
Q Consensus 376 ~~~~~~~~LG~GsfGtVy~a~~~~-g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~E 450 (805)
+.|.+.+.||+|+||+||++.... ++.||||++..... ....+|+..+.....||||+++++++.++...|+|||
T Consensus 15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e 94 (296)
T cd06618 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICME 94 (296)
T ss_pred chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEee
Confidence 446778999999999999986654 89999999975432 2234555545555679999999999999999999999
Q ss_pred cccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhh-cc
Q 003644 451 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE-IG 529 (805)
Q Consensus 451 ~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~-~~ 529 (805)
++.++|.+++.. ....+++..+..++.||+.||+|||+ .+
T Consensus 95 ~~~~~l~~l~~~---------------------------------------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~ 135 (296)
T cd06618 95 LMSTCLDKLLKR---------------------------------------IQGPIPEDILGKMTVAIVKALHYLKEKHG 135 (296)
T ss_pred ccCcCHHHHHHH---------------------------------------hcCCCCHHHHHHHHHHHHHHHHHHHhhCC
Confidence 766555444321 11246677788999999999999997 59
Q ss_pred eeccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCC----CCCcchHHHHHHHHH
Q 003644 530 LIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGR----QTRAIDLFSLGCILF 605 (805)
Q Consensus 530 IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~----~t~~sDVwSlGvil~ 605 (805)
|+||||+|+||+++.++. +||+|||++..+..... .....++..|+|||.+.... ++.++|||||||++|
T Consensus 136 i~H~dl~p~nill~~~~~--~kL~dfg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~ 209 (296)
T cd06618 136 VIHRDVKPSNILLDASGN--VKLCDFGISGRLVDSKA----KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLV 209 (296)
T ss_pred EecCCCcHHHEEEcCCCC--EEECccccchhccCCCc----ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHH
Confidence 999999999999987765 89999999876643211 12234788999999987553 788999999999999
Q ss_pred HHHhCCCCCCCCchHH---HHHHHhhcccccc--ccCChHHHHHHHHhcCCCCCCCCChhhhhcCccccccc
Q 003644 606 FCITGGKHPYGESFER---DANIVKDRKDLFL--VEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTAD 672 (805)
Q Consensus 606 elltG~~~Pf~~~~~~---~~~~~~~~~~~~~--~~~~~~~~dLi~~~L~~dP~~Rps~~ell~Hpff~~~~ 672 (805)
+|++| +.||...... ...+......... ....+++.+++.+||+.||.+||++.++++||||....
T Consensus 210 el~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 280 (296)
T cd06618 210 ELATG-QFPYKNCKTEFEVLTKILQEEPPSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYE 280 (296)
T ss_pred HHHhC-CCCCCcchhHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhccc
Confidence 99996 7787653221 1122222111111 12467899999999999999999999999999996543
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=328.18 Aligned_cols=254 Identities=24% Similarity=0.371 Sum_probs=196.1
Q ss_pred ccccccceEEEeEeeccCCceEEEEE-EeeCCcEEEEEEe------ecCCchHHHHHHHHHHHhCCCCCeeeecccccCC
Q 003644 370 DGRRIGKLVVFNKEIAKGSNGTVVLE-GNYEGRSVAVKRL------VKTHHDVALKEIQNLIASDQHPNIVRWYGVESDQ 442 (805)
Q Consensus 370 ~~~~i~~~~~~~~~LG~GsfGtVy~a-~~~~g~~VAVK~l------~~~~~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~ 442 (805)
+....++..++..+||+|+|-+||+| ...+|.+||=-.+ +.....+.+.++..|++.++|||||++|.+|.+.
T Consensus 34 e~~p~gRy~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~ 113 (632)
T KOG0584|consen 34 EKDPTGRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDT 113 (632)
T ss_pred ccCCCCceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecC
Confidence 33455677788899999999999998 4456777764222 1222224555556699999999999999999886
Q ss_pred ce--EEEecccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHH
Q 003644 443 DF--VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVS 520 (805)
Q Consensus 443 ~~--l~LV~E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~ 520 (805)
.. +-+|+| .+..|+|..++.. .+......++.|++||++
T Consensus 114 ~n~~in~iTE----------L~TSGtLr~Y~kk-----------------------------~~~vn~kaik~W~RQILk 154 (632)
T KOG0584|consen 114 DNKTINFITE----------LFTSGTLREYRKK-----------------------------HRRVNIKAIKSWCRQILK 154 (632)
T ss_pred CCceeeeeee----------cccCCcHHHHHHH-----------------------------hccCCHHHHHHHHHHHHH
Confidence 55 788899 6667777776532 234566788999999999
Q ss_pred HHHHhhhc--ceeccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHH
Q 003644 521 GLSHLHEI--GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLF 598 (805)
Q Consensus 521 gL~yLH~~--~IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVw 598 (805)
||.|||++ .|||||||-+||+|+.+.. .+||+|+|||+..... .....+|||.|||||+.. ..|+..+|||
T Consensus 155 GL~yLHs~~PPIIHRDLKCDNIFinG~~G-~VKIGDLGLAtl~r~s-----~aksvIGTPEFMAPEmYE-E~YnE~VDVY 227 (632)
T KOG0584|consen 155 GLVYLHSQDPPIIHRDLKCDNIFVNGNLG-EVKIGDLGLATLLRKS-----HAKSVIGTPEFMAPEMYE-ENYNELVDVY 227 (632)
T ss_pred HhhhhhcCCCCccccccccceEEEcCCcC-ceeecchhHHHHhhcc-----ccceeccCccccChHHHh-hhcchhhhhh
Confidence 99999998 6999999999999965432 5999999999987643 223467999999999987 7899999999
Q ss_pred HHHHHHHHHHhCCCCCCCCchHHH---HHHHhhcccc-ccccCChHHHHHHHHhcCCCCCCCCChhhhhcCcccccc
Q 003644 599 SLGCILFFCITGGKHPYGESFERD---ANIVKDRKDL-FLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTA 671 (805)
Q Consensus 599 SlGvil~elltG~~~Pf~~~~~~~---~~~~~~~~~~-~~~~~~~~~~dLi~~~L~~dP~~Rps~~ell~Hpff~~~ 671 (805)
|||+.++||+|+ ..||.+..... ..++.+.+.. +..-..|+++++|.+||.. ...|||+.|+|+||||...
T Consensus 228 aFGMCmLEMvT~-eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d 302 (632)
T KOG0584|consen 228 AFGMCMLEMVTS-EYPYSECTNPAQIYKKVTSGIKPAALSKVKDPEVREFIEKCLAT-KSERLSAKELLKDPFFDED 302 (632)
T ss_pred hhhHHHHHHHhc-cCChhhhCCHHHHHHHHHcCCCHHHhhccCCHHHHHHHHHHhcC-chhccCHHHHhhChhhccc
Confidence 999999999997 78997754322 1233332221 2222358999999999999 8999999999999999765
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=328.71 Aligned_cols=246 Identities=28% Similarity=0.360 Sum_probs=196.6
Q ss_pred cccceEEEeEeeccCCceEEEEE-EeeCCcEEEEEEeecCCchHHHHHHHHHHHhCCCCCeeeecccccCCceEEEeccc
Q 003644 373 RIGKLVVFNKEIAKGSNGTVVLE-GNYEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLER 451 (805)
Q Consensus 373 ~i~~~~~~~~~LG~GsfGtVy~a-~~~~g~~VAVK~l~~~~~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~E~ 451 (805)
...+.|.+...+|.|+|+.|-+. ...+++..|||++.+. ..+..+|+..++...+||||+++++++.++.+.|+|||
T Consensus 319 ~~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~-~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e- 396 (612)
T KOG0603|consen 319 PFTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR-ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME- 396 (612)
T ss_pred CcchhhccccccCCCCccceeeeeccccccchhheecccc-ccccccccchhhhhcCCCcceeecceecCCceeeeeeh-
Confidence 35667888889999999999665 5567899999999765 23445666667777899999999999999999999999
Q ss_pred ccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhccee
Q 003644 452 CTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLI 531 (805)
Q Consensus 452 ~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~Iv 531 (805)
.+.+|-+.+.+. ...... .++..|+.+|+.|+.|||++|+|
T Consensus 397 ---------~l~g~ell~ri~-----------------------------~~~~~~-~e~~~w~~~lv~Av~~LH~~gvv 437 (612)
T KOG0603|consen 397 ---------LLDGGELLRRIR-----------------------------SKPEFC-SEASQWAAELVSAVDYLHEQGVV 437 (612)
T ss_pred ---------hccccHHHHHHH-----------------------------hcchhH-HHHHHHHHHHHHHHHHHHhcCee
Confidence 555554444321 111122 56678999999999999999999
Q ss_pred ccCCCCceEEe-cCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHHHHHhC
Q 003644 532 HRDLKPQNVLI-SKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG 610 (805)
Q Consensus 532 HrDLKp~NILl-~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~elltG 610 (805)
||||||+|||+ +.+++ ++|+|||.++..... ..+.+-|..|.|||++....|++++||||||++||+||+|
T Consensus 438 hRDLkp~NIL~~~~~g~--lrltyFG~a~~~~~~------~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G 509 (612)
T KOG0603|consen 438 HRDLKPGNILLDGSAGH--LRLTYFGFWSELERS------CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTG 509 (612)
T ss_pred ecCCChhheeecCCCCc--EEEEEechhhhCchh------hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhC
Confidence 99999999999 46766 889999999887643 3345678999999999999999999999999999999997
Q ss_pred CCCCCCCchHHHHHHHhhccccccccCChHHHHHHHHhcCCCCCCCCChhhhhcCccc
Q 003644 611 GKHPYGESFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 668 (805)
Q Consensus 611 ~~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dP~~Rps~~ell~Hpff 668 (805)
..||........-...-....+....+.+++|||++||+.||.+||++.+++.||||
T Consensus 510 -~tp~~~~P~~~ei~~~i~~~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 510 -RTLFAAHPAGIEIHTRIQMPKFSECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred -CCccccCCchHHHHHhhcCCccccccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence 677765443322112222333346678899999999999999999999999999999
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=317.19 Aligned_cols=253 Identities=25% Similarity=0.380 Sum_probs=189.4
Q ss_pred EEeEeeccCCceEEEEEEe-eCCcEEEEEEeecCCch-----------------HHHHHHHHHHHhCCCCCeeeeccccc
Q 003644 379 VFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHHD-----------------VALKEIQNLIASDQHPNIVRWYGVES 440 (805)
Q Consensus 379 ~~~~~LG~GsfGtVy~a~~-~~g~~VAVK~l~~~~~~-----------------~~~~Ei~~ll~~l~HpNIV~l~g~~~ 440 (805)
.+.+.||+|+||+||++.. .+++.||||.+...... ...+|+. ++..++||||+++++++.
T Consensus 12 ~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~-~l~~l~h~~iv~~~~~~~ 90 (335)
T PTZ00024 12 QKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELK-IMNEIKHENIMGLVDVYV 90 (335)
T ss_pred hhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHH-HHHhCCCcceeeeeEEEe
Confidence 3567799999999999864 46899999998643221 2445655 678889999999999999
Q ss_pred CCceEEEecccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHH
Q 003644 441 DQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVS 520 (805)
Q Consensus 441 ~~~~l~LV~E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~ 520 (805)
.++..|+|||++.++|.+++ .. ...+++..+..++.|++.
T Consensus 91 ~~~~~~lv~e~~~~~l~~~l-----------~~-----------------------------~~~~~~~~~~~~~~ql~~ 130 (335)
T PTZ00024 91 EGDFINLVMDIMASDLKKVV-----------DR-----------------------------KIRLTESQVKCILLQILN 130 (335)
T ss_pred cCCcEEEEEeccccCHHHHH-----------Hh-----------------------------cCCCCHHHHHHHHHHHHH
Confidence 99999999997666554443 11 123566778999999999
Q ss_pred HHHHhhhcceeccCCCCceEEecCCCCceEEEeccCccccccCCCc-----------cccccccccCCCCCCChhhhhcC
Q 003644 521 GLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMS-----------CLTQNATGYGSSGWQAPEQLLQG 589 (805)
Q Consensus 521 gL~yLH~~~IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~-----------~~~~~~~~~gt~~y~APE~l~~~ 589 (805)
||+|||+.+|+||||||+||+++.++. ++|+|||+++....... .........+++.|+|||.+.+.
T Consensus 131 aL~~LH~~~i~H~dl~~~nill~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 208 (335)
T PTZ00024 131 GLNVLHKWYFMHRDLSPANIFINSKGI--CKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGA 208 (335)
T ss_pred HHHHHHhCCeecccccHHHeEECCCCC--EEECCccceeecccccccccccccccccccccccccccccCCCCChhcccC
Confidence 999999999999999999999988775 89999999976651110 01111223468899999998764
Q ss_pred -CCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHH--HHHhhcc---c------------------------cccccCCh
Q 003644 590 -RQTRAIDLFSLGCILFFCITGGKHPYGESFERDA--NIVKDRK---D------------------------LFLVEHIP 639 (805)
Q Consensus 590 -~~t~~sDVwSlGvil~elltG~~~Pf~~~~~~~~--~~~~~~~---~------------------------~~~~~~~~ 639 (805)
.++.++|||||||++|||++| .+||........ .+..... . ......++
T Consensus 209 ~~~~~~~Dv~slG~~l~el~tg-~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (335)
T PTZ00024 209 EKYHFAVDMWSVGCIFAELLTG-KPLFPGENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASD 287 (335)
T ss_pred CCCCcHHHHHHHHHHHHHHHhC-CCCCCCCCHHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCCh
Confidence 468999999999999999996 778765432211 1111000 0 00112356
Q ss_pred HHHHHHHHhcCCCCCCCCChhhhhcCccccccccch
Q 003644 640 EAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTADTRL 675 (805)
Q Consensus 640 ~~~dLi~~~L~~dP~~Rps~~ell~Hpff~~~~~~~ 675 (805)
++.++|.+||+.||++||+++|++.||||+......
T Consensus 288 ~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~~~~~ 323 (335)
T PTZ00024 288 DAIDLLQSLLKLNPLERISAKEALKHEYFKSDPLPC 323 (335)
T ss_pred HHHHHHHHHcCCCchhccCHHHHhcCcccCCCCCCC
Confidence 789999999999999999999999999998765543
|
|
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=303.73 Aligned_cols=246 Identities=24% Similarity=0.382 Sum_probs=188.5
Q ss_pred ceEEEeEeeccCCceEEEEEEeeCCcEEEEEEeecCCc--hHHHHHHHHHHHhCCCCCeeeecccccCCceEEEeccccc
Q 003644 376 KLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHH--DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCT 453 (805)
Q Consensus 376 ~~~~~~~~LG~GsfGtVy~a~~~~g~~VAVK~l~~~~~--~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~E~~~ 453 (805)
.+|.+.++||+|+||+||++...+...||||++..... ....+|+. ++..++||||+++++++.+ +..|+|||
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~~~~~~~~E~~-~l~~l~~~~i~~~~~~~~~-~~~~lv~e--- 80 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQ-VMKKLRHEKLVQLYAVVSE-EPIYIVTE--- 80 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCccCHHHHHHHHH-HHHhCCCCCcceEEEEECC-CCcEEEEE---
Confidence 45889999999999999998776667899999975332 33455655 6777899999999998754 56899999
Q ss_pred CChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcceecc
Q 003644 454 CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHR 533 (805)
Q Consensus 454 ~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~IvHr 533 (805)
|+.+|+|.+++.... ...+++..++.++.|++.||+|||+.+|+||
T Consensus 81 -------~~~~~~L~~~~~~~~---------------------------~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~ 126 (262)
T cd05071 81 -------YMSKGSLLDFLKGEM---------------------------GKYLRLPQLVDMAAQIASGMAYVERMNYVHR 126 (262)
T ss_pred -------cCCCCcHHHHHhhcc---------------------------ccCCCHHHHHHHHHHHHHHHHHHHHCCcccc
Confidence 555566655543211 1235677889999999999999999999999
Q ss_pred CCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHHHHHhCCCC
Q 003644 534 DLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKH 613 (805)
Q Consensus 534 DLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~elltG~~~ 613 (805)
||||+||+++.++. ++|+|||+++....... .......++..|+|||++.+..++.++|||||||++|||++|+.+
T Consensus 127 dl~p~Nill~~~~~--~~L~dfg~~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~ 202 (262)
T cd05071 127 DLRAANILVGENLV--CKVADFGLARLIEDNEY--TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRV 202 (262)
T ss_pred ccCcccEEEcCCCc--EEeccCCceeecccccc--ccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCC
Confidence 99999999988765 89999999986653221 111223367789999999888899999999999999999997788
Q ss_pred CCCCchHHHH-HHHh-hccccccccCChHHHHHHHHhcCCCCCCCCChhhhhc
Q 003644 614 PYGESFERDA-NIVK-DRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 664 (805)
Q Consensus 614 Pf~~~~~~~~-~~~~-~~~~~~~~~~~~~~~dLi~~~L~~dP~~Rps~~ell~ 664 (805)
||........ ..+. ..........+..+.+++.+||+.||++||+++++++
T Consensus 203 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~ 255 (262)
T cd05071 203 PYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQA 255 (262)
T ss_pred CCCCCChHHHHHHHhcCCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 9876543321 1111 1112223445678999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=307.54 Aligned_cols=254 Identities=25% Similarity=0.366 Sum_probs=194.0
Q ss_pred EEEeEeeccCCceEEEEEEe-eCCcEEEEEEeecCCc----hHHHHHHHHHHHhCCCCCeeeecccccCCceEEEecccc
Q 003644 378 VVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERC 452 (805)
Q Consensus 378 ~~~~~~LG~GsfGtVy~a~~-~~g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~E~~ 452 (805)
|...+.||+|+||.||++.. .+++.||||.+..... ....+|+ ..+..++||||+++++++.+++..|+|||||
T Consensus 6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~-~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEI-TVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHH-HHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 55668899999999999854 5689999998864332 1223344 4678889999999999999999999999955
Q ss_pred cCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcceec
Q 003644 453 TCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIH 532 (805)
Q Consensus 453 ~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~IvH 532 (805)
.+++|.+++.. ..+++..+..++.|++.|++|||+.+++|
T Consensus 85 ----------~~~~l~~~i~~------------------------------~~~~~~~~~~~~~~l~~~l~~lh~~~i~h 124 (277)
T cd06641 85 ----------GGGSALDLLEP------------------------------GPLDETQIATILREILKGLDYLHSEKKIH 124 (277)
T ss_pred ----------CCCcHHHHHhc------------------------------CCCCHHHHHHHHHHHHHHHHHHccCCeec
Confidence 44555444321 23566778999999999999999999999
Q ss_pred cCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHHHHHhCCC
Q 003644 533 RDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGK 612 (805)
Q Consensus 533 rDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~elltG~~ 612 (805)
+||||+||+++.++. ++|+|||++........ ......++..|+|||.+.....+.++|+|||||++|+|++| .
T Consensus 125 ~dl~p~Ni~i~~~~~--~~l~dfg~~~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g-~ 198 (277)
T cd06641 125 RDIKAANVLLSEHGE--VKLADFGVAGQLTDTQI---KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKG-E 198 (277)
T ss_pred CCCCHHhEEECCCCC--EEEeecccceecccchh---hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcC-C
Confidence 999999999987765 89999999876643211 11234578899999999888889999999999999999997 7
Q ss_pred CCCCCchHHHH-HHHh-hccccccccCChHHHHHHHHhcCCCCCCCCChhhhhcCccccccccchhhh
Q 003644 613 HPYGESFERDA-NIVK-DRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTADTRLSFL 678 (805)
Q Consensus 613 ~Pf~~~~~~~~-~~~~-~~~~~~~~~~~~~~~dLi~~~L~~dP~~Rps~~ell~Hpff~~~~~~~~~l 678 (805)
.||........ ..+. ..........+.++.+++.+||+.+|.+||++.++++||||.....+..++
T Consensus 199 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~~~~~~~~~~~ 266 (277)
T cd06641 199 PPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIVRFAKKTSYL 266 (277)
T ss_pred CCCCccchHHHHHHHhcCCCCCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhhhhhccchH
Confidence 78865433221 1111 112223334567899999999999999999999999999996654433333
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=303.41 Aligned_cols=248 Identities=26% Similarity=0.397 Sum_probs=189.5
Q ss_pred ceEEEeEeeccCCceEEEEEEee----CCcEEEEEEeecCCch----HHHHHHHHHHHhCCCCCeeeecccccCCceEEE
Q 003644 376 KLVVFNKEIAKGSNGTVVLEGNY----EGRSVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVRWYGVESDQDFVYL 447 (805)
Q Consensus 376 ~~~~~~~~LG~GsfGtVy~a~~~----~g~~VAVK~l~~~~~~----~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~L 447 (805)
+.|.+.+.||+|+||+||+|... +...||||.+...... ...+|+. .+..++||||+++++++.+++..|+
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~i 82 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEAS-IMGQFDHPNIIRLEGVVTKSRPVMI 82 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHH-HHHhCCCCCcceEeEEEecCCceEE
Confidence 34778899999999999998653 2458999998654322 2344554 6788899999999999999999999
Q ss_pred ecccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhh
Q 003644 448 SLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE 527 (805)
Q Consensus 448 V~E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~ 527 (805)
+|| |..+|+|.+++.... ..+++..++.++.|++.||+|||+
T Consensus 83 v~e----------~~~~~~L~~~~~~~~----------------------------~~~~~~~~~~~~~~l~~~l~~Lh~ 124 (266)
T cd05033 83 ITE----------YMENGSLDKFLREND----------------------------GKFTVGQLVGMLRGIASGMKYLSE 124 (266)
T ss_pred EEE----------cCCCCCHHHHHHhcc----------------------------CCCCHHHHHHHHHHHHHHHHHHHh
Confidence 999 555566665543211 235677889999999999999999
Q ss_pred cceeccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHHHH
Q 003644 528 IGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFC 607 (805)
Q Consensus 528 ~~IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~el 607 (805)
.+|+||||||+|||++.++. ++|+|||+++.......... .....++..|+|||.+.+..++.++|||||||++|||
T Consensus 125 ~~i~H~di~p~nili~~~~~--~~l~dfg~~~~~~~~~~~~~-~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l 201 (266)
T cd05033 125 MNYVHRDLAARNILVNSNLV--CKVSDFGLSRRLEDSEATYT-TKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEV 201 (266)
T ss_pred CCcccCCCCcceEEEcCCCC--EEECccchhhccccccccee-ccCCCCCccccChhhhccCCCccccchHHHHHHHHHH
Confidence 99999999999999987765 89999999988752221111 1223356789999999988899999999999999999
Q ss_pred HhCCCCCCCCchHH-HHHHHh-hccccccccCChHHHHHHHHhcCCCCCCCCChhhhhcC
Q 003644 608 ITGGKHPYGESFER-DANIVK-DRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNH 665 (805)
Q Consensus 608 ltG~~~Pf~~~~~~-~~~~~~-~~~~~~~~~~~~~~~dLi~~~L~~dP~~Rps~~ell~H 665 (805)
++.+..||.+.... ....+. ......+...++.+.+++.+||+.+|++||++++++++
T Consensus 202 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~ 261 (266)
T cd05033 202 MSYGERPYWDMSNQDVIKAVEDGYRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVST 261 (266)
T ss_pred HccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 98447787654322 222222 21222334556789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=308.96 Aligned_cols=238 Identities=22% Similarity=0.272 Sum_probs=178.6
Q ss_pred eeccCCceEEEEEEeeC-------------------------CcEEEEEEeecCCch--HHHHHHHHHHHhCCCCCeeee
Q 003644 383 EIAKGSNGTVVLEGNYE-------------------------GRSVAVKRLVKTHHD--VALKEIQNLIASDQHPNIVRW 435 (805)
Q Consensus 383 ~LG~GsfGtVy~a~~~~-------------------------g~~VAVK~l~~~~~~--~~~~Ei~~ll~~l~HpNIV~l 435 (805)
.||+|+||.||++.... ...||||++...... ..+.|...+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 59999999999875321 246899988654322 234444567888999999999
Q ss_pred cccccCCceEEEecccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHH
Q 003644 436 YGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVT 515 (805)
Q Consensus 436 ~g~~~~~~~l~LV~E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~ 515 (805)
+++|.+++..|+||| |+.+|+|..++... ...+++..++.++
T Consensus 82 ~~~~~~~~~~~lv~e----------y~~~g~L~~~l~~~----------------------------~~~~~~~~~~~i~ 123 (274)
T cd05076 82 HGVCVRGSENIMVEE----------FVEHGPLDVCLRKE----------------------------KGRVPVAWKITVA 123 (274)
T ss_pred EEEEEeCCceEEEEe----------cCCCCcHHHHHHhc----------------------------CCCCCHHHHHHHH
Confidence 999999999999999 55566665554321 1235677789999
Q ss_pred HHHHHHHHHhhhcceeccCCCCceEEecCCCC-----ceEEEeccCccccccCCCccccccccccCCCCCCChhhhhc-C
Q 003644 516 RDIVSGLSHLHEIGLIHRDLKPQNVLISKDKS-----FCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ-G 589 (805)
Q Consensus 516 ~qIa~gL~yLH~~~IvHrDLKp~NILl~~~~~-----~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~-~ 589 (805)
.||++||+|||+.+|+||||||+|||++.++. ..+|++|||++...... ....++..|+|||.+.+ .
T Consensus 124 ~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~~-------~~~~~~~~~~aPe~~~~~~ 196 (274)
T cd05076 124 QQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSR-------EERVERIPWIAPECVPGGN 196 (274)
T ss_pred HHHHHHHHHHHcCCccCCCCCcccEEEeccCcccCccceeeecCCccccccccc-------cccccCCcccCchhhcCCC
Confidence 99999999999999999999999999975432 24799999987654321 22347888999998875 4
Q ss_pred CCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhccccccccCChHHHHHHHHhcCCCCCCCCChhhhhcC
Q 003644 590 RQTRAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNH 665 (805)
Q Consensus 590 ~~t~~sDVwSlGvil~elltG~~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dP~~Rps~~ell~H 665 (805)
.++.++|||||||++||+++++.+||..................+....+++.++|.+||+.+|++||++.+++++
T Consensus 197 ~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~ 272 (274)
T cd05076 197 SLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERFYEKKHRLPEPSCKELATLISQCLTYEPTQRPSFRTILRD 272 (274)
T ss_pred CCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHHHHHhccCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence 5799999999999999997656888865433322111111222333445789999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=300.38 Aligned_cols=250 Identities=26% Similarity=0.346 Sum_probs=190.9
Q ss_pred EeeccCCceEEEEEEeeC----CcEEEEEEeecCCch----HHHHHHHHHHHhCCCCCeeeecccccCCceEEEeccccc
Q 003644 382 KEIAKGSNGTVVLEGNYE----GRSVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCT 453 (805)
Q Consensus 382 ~~LG~GsfGtVy~a~~~~----g~~VAVK~l~~~~~~----~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~E~~~ 453 (805)
+.||+|+||.||++.... +..||||.+...... ...+|+. ++..++|+||+++++++.++...+++||+|
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~-~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~- 78 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEAR-VMKKLGHPNVVRLLGVCTEEEPLYLVLEYM- 78 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHH-HHhhcCCCChheeeeeecCCCceEEEEEec-
Confidence 369999999999986654 889999999765432 3334554 667788999999999999999999999954
Q ss_pred CChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcceecc
Q 003644 454 CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHR 533 (805)
Q Consensus 454 ~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~IvHr 533 (805)
.+++|.+++........ ......+++..+..++.|++.||+|||+.+|+||
T Consensus 79 ---------~~~~L~~~l~~~~~~~~--------------------~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~ 129 (262)
T cd00192 79 ---------EGGDLLDYLRKSRPVFP--------------------SPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHR 129 (262)
T ss_pred ---------cCCcHHHHHhhcccccc--------------------ccccccCCHHHHHHHHHHHHHHHHHHHcCCcccC
Confidence 45555555433210000 0012457888899999999999999999999999
Q ss_pred CCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHHHHHhCCCC
Q 003644 534 DLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKH 613 (805)
Q Consensus 534 DLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~elltG~~~ 613 (805)
||||+||+++.++. +||+|||.+........ ........++..|+|||.+....++.++|||||||++|||++++..
T Consensus 130 di~p~nili~~~~~--~~l~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~ 206 (262)
T cd00192 130 DLAARNCLVGEDLV--VKISDFGLSRDVYDDDY-YRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGAT 206 (262)
T ss_pred ccCcceEEECCCCc--EEEcccccccccccccc-cccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCC
Confidence 99999999988765 89999999987764322 1222334578899999999888899999999999999999997788
Q ss_pred CCCCchHHH-HHHHh-hccccccccCChHHHHHHHHhcCCCCCCCCChhhhhcC
Q 003644 614 PYGESFERD-ANIVK-DRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNH 665 (805)
Q Consensus 614 Pf~~~~~~~-~~~~~-~~~~~~~~~~~~~~~dLi~~~L~~dP~~Rps~~ell~H 665 (805)
||....... ...+. ......+...++++.+++.+||..||.+||++.++++|
T Consensus 207 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 207 PYPGLSNEEVLEYLRKGYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVER 260 (262)
T ss_pred CCCCCCHHHHHHHHHcCCCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 987654322 22222 22223344556899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=301.63 Aligned_cols=241 Identities=25% Similarity=0.381 Sum_probs=183.4
Q ss_pred EeeccCCceEEEEEEe-eCCcEEEEEEeecCCc----hHHHHHHHHHHHhCCCCCeeeecccccCCceEEEecccccCCh
Q 003644 382 KEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCSL 456 (805)
Q Consensus 382 ~~LG~GsfGtVy~a~~-~~g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~E~~~~sL 456 (805)
+.||+|+||+||++.. .+++.||+|.+..... ....+|+. ++..++||||+++++++.+.+..|+|||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~lv~e------ 73 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEAR-ILKQYSHPNIVRLIGVCTQKQPIYIVME------ 73 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHH-HHHhCCCCCcceEEEEEcCCCCeEEEEe------
Confidence 3599999999999865 4789999998764432 23445554 6788899999999999999999999999
Q ss_pred hhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCC
Q 003644 457 NDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLK 536 (805)
Q Consensus 457 ~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~IvHrDLK 536 (805)
|..+++|.+++... ...+++.+++.++.|++.||+|||+.+|+|||||
T Consensus 74 ----~~~~~~L~~~~~~~----------------------------~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~ 121 (252)
T cd05084 74 ----LVQGGDFLTFLRTE----------------------------GPRLKVKELIQMVENAAAGMEYLESKHCIHRDLA 121 (252)
T ss_pred ----eccCCcHHHHHHhC----------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCccccccc
Confidence 55566666654321 1235677889999999999999999999999999
Q ss_pred CceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q 003644 537 PQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYG 616 (805)
Q Consensus 537 p~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~elltG~~~Pf~ 616 (805)
|+||+++.++. +||+|||++........ ........++..|+|||.+..+.++.++|||||||++|||++++.+||.
T Consensus 122 p~nil~~~~~~--~kl~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~ 198 (252)
T cd05084 122 ARNCLVTEKNV--LKISDFGMSREEEDGVY-ASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYA 198 (252)
T ss_pred hheEEEcCCCc--EEECccccCcccccccc-cccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcc
Confidence 99999987765 89999999876543211 0111111234579999999988899999999999999999986688886
Q ss_pred CchHHH-HHHH-hhccccccccCChHHHHHHHHhcCCCCCCCCChhhhhc
Q 003644 617 ESFERD-ANIV-KDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 664 (805)
Q Consensus 617 ~~~~~~-~~~~-~~~~~~~~~~~~~~~~dLi~~~L~~dP~~Rps~~ell~ 664 (805)
...... ...+ .......+...+..+.+++.+||+.||++||++.++++
T Consensus 199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 248 (252)
T cd05084 199 NLSNQQTREAIEQGVRLPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQ 248 (252)
T ss_pred ccCHHHHHHHHHcCCCCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 543322 2222 22222334445678999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-34 Score=305.11 Aligned_cols=251 Identities=25% Similarity=0.414 Sum_probs=188.9
Q ss_pred eEEEeEeeccCCceEEEEEEe-eCCcEEEEEEeecCCc----hHHHHHHHHHHHhCCCCCeeeecccccC--CceEEEec
Q 003644 377 LVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESD--QDFVYLSL 449 (805)
Q Consensus 377 ~~~~~~~LG~GsfGtVy~a~~-~~g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~--~~~l~LV~ 449 (805)
.|...+.||.|++|.||++.. .+++.||+|.+..... ....+|++ +++.++||||+++++++.+ .+.+|+||
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~-~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELE-INKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred ceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHH-HHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 467788999999999999865 4689999999875432 34456665 6788899999999998754 45789999
Q ss_pred ccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcc
Q 003644 450 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG 529 (805)
Q Consensus 450 E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~ 529 (805)
||| .+++|.+++..... ....+++..+..++.||+.||+|||+.+
T Consensus 81 e~~----------~~~~L~~~l~~~~~-------------------------~~~~l~~~~~~~i~~~i~~~L~~lH~~~ 125 (287)
T cd06621 81 EYC----------EGGSLDSIYKKVKK-------------------------RGGRIGEKVLGKIAESVLKGLSYLHSRK 125 (287)
T ss_pred Eec----------CCCCHHHHHHHHHh-------------------------cCCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 954 45555554432110 1234667788999999999999999999
Q ss_pred eeccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHHHHHh
Q 003644 530 LIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCIT 609 (805)
Q Consensus 530 IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~ellt 609 (805)
++|+||+|+||+++.++. ++|+|||++....... .....++..|+|||.+.+..++.++|||||||++|+|++
T Consensus 126 i~H~dl~~~nil~~~~~~--~~l~dfg~~~~~~~~~-----~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~ 198 (287)
T cd06621 126 IIHRDIKPSNILLTRKGQ--VKLCDFGVSGELVNSL-----AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQ 198 (287)
T ss_pred cccCCCCHHHEEEecCCe--EEEeeccccccccccc-----cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHh
Confidence 999999999999987765 8999999987654221 123347889999999998899999999999999999999
Q ss_pred CCCCCCCCchH------HHHHHHhhcccccc-------ccCChHHHHHHHHhcCCCCCCCCChhhhhcCcccccc
Q 003644 610 GGKHPYGESFE------RDANIVKDRKDLFL-------VEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTA 671 (805)
Q Consensus 610 G~~~Pf~~~~~------~~~~~~~~~~~~~~-------~~~~~~~~dLi~~~L~~dP~~Rps~~ell~Hpff~~~ 671 (805)
| ..||..... .....+........ ...++++.++|.+||+.||.+|||+.|+++||||...
T Consensus 199 g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~ 272 (287)
T cd06621 199 N-RFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQ 272 (287)
T ss_pred C-CCCCCcccCCCCChHHHHHHHhcCCchhhccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCcccccc
Confidence 7 677765411 11111111111111 1123578999999999999999999999999999543
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-34 Score=314.14 Aligned_cols=252 Identities=29% Similarity=0.429 Sum_probs=186.7
Q ss_pred cceEEEeEeeccCCceEEEEEEe-eCCcEEEEEEeecCCc---hHHHHHHHHHHHhCCCCCeeeecccccCC--------
Q 003644 375 GKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH---DVALKEIQNLIASDQHPNIVRWYGVESDQ-------- 442 (805)
Q Consensus 375 ~~~~~~~~~LG~GsfGtVy~a~~-~~g~~VAVK~l~~~~~---~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~-------- 442 (805)
+.+|.+.+.||.|+||+||++.. .+|+.||+|.+..... ....+|+. ++..++||||+++++++.+.
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~-~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIK-IIRRLDHDNIVKVYEVLGPSGSDLTEDV 82 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHH-HHHhcCCCcchhhHhhhccccccccccc
Confidence 56788999999999999999854 4689999999865432 23445655 67788999999999876554
Q ss_pred ------ceEEEecccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHH
Q 003644 443 ------DFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTR 516 (805)
Q Consensus 443 ------~~l~LV~E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~ 516 (805)
...|+||||+.++|.+++ ....+++..++.++.
T Consensus 83 ~~~~~~~~~~lv~e~~~~~L~~~~-----------------------------------------~~~~l~~~~~~~~~~ 121 (342)
T cd07854 83 GSLTELNSVYIVQEYMETDLANVL-----------------------------------------EQGPLSEEHARLFMY 121 (342)
T ss_pred ccccccceEEEEeecccccHHHHH-----------------------------------------HcCCCCHHHHHHHHH
Confidence 457999997665544332 112356778899999
Q ss_pred HHHHHHHHhhhcceeccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhc-CCCCCcc
Q 003644 517 DIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ-GRQTRAI 595 (805)
Q Consensus 517 qIa~gL~yLH~~~IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~t~~s 595 (805)
||+.||+|||+.||+||||||+||+++.++. .+||+|||+++................++..|+|||.+.. ..++.++
T Consensus 122 qi~~aL~~LH~~givH~dikp~Nili~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~ 200 (342)
T cd07854 122 QLLRGLKYIHSANVLHRDLKPANVFINTEDL-VLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAI 200 (342)
T ss_pred HHHHHHHHHHhCCcccCCCCHHHEEEcCCCc-eEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchh
Confidence 9999999999999999999999999975543 4899999999866432221111122357889999998765 4578899
Q ss_pred hHHHHHHHHHHHHhCCCCCCCCchHHHH--HHHhh-----------------------c-c-----ccccccCChHHHHH
Q 003644 596 DLFSLGCILFFCITGGKHPYGESFERDA--NIVKD-----------------------R-K-----DLFLVEHIPEAVDL 644 (805)
Q Consensus 596 DVwSlGvil~elltG~~~Pf~~~~~~~~--~~~~~-----------------------~-~-----~~~~~~~~~~~~dL 644 (805)
|||||||++|+|++| ..||........ ..... . . .........++.++
T Consensus 201 DiwSlGvil~el~~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 279 (342)
T cd07854 201 DMWAAGCIFAEMLTG-KPLFAGAHELEQMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDF 279 (342)
T ss_pred hHHHHHHHHHHHHhC-CCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHH
Confidence 999999999999997 667754322111 01000 0 0 00112345688999
Q ss_pred HHHhcCCCCCCCCChhhhhcCccccc
Q 003644 645 FTRLLDPNPDLRPKAQNVLNHPFFWT 670 (805)
Q Consensus 645 i~~~L~~dP~~Rps~~ell~Hpff~~ 670 (805)
|.+||+.||.+||+++++++||||..
T Consensus 280 i~~~L~~dP~~R~t~~ell~h~~~~~ 305 (342)
T cd07854 280 LEQILTFNPMDRLTAEEALMHPYMSC 305 (342)
T ss_pred HHHHhCCCchhccCHHHHhCCCcccc
Confidence 99999999999999999999999964
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-34 Score=298.95 Aligned_cols=249 Identities=25% Similarity=0.413 Sum_probs=192.2
Q ss_pred EEEeEeeccCCceEEEEEE-eeCCcEEEEEEeecCCc-----hHHHHHHHHHHHhCCCCCeeeecccccC--CceEEEec
Q 003644 378 VVFNKEIAKGSNGTVVLEG-NYEGRSVAVKRLVKTHH-----DVALKEIQNLIASDQHPNIVRWYGVESD--QDFVYLSL 449 (805)
Q Consensus 378 ~~~~~~LG~GsfGtVy~a~-~~~g~~VAVK~l~~~~~-----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~--~~~l~LV~ 449 (805)
|.+.+.||.|+||+||++. ..+|+.||+|++..... .....|+ .+++.++||||+++++++.+ +...|++|
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~-~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 2 YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEV-NILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred ceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHH-HHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 5677899999999999984 45789999999864321 1223344 46788999999999997753 46689999
Q ss_pred ccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhh---
Q 003644 450 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH--- 526 (805)
Q Consensus 450 E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH--- 526 (805)
| |..+++|.+++..... ....+++..++.++.||+.||+|||
T Consensus 81 e----------~~~~~~L~~~l~~~~~-------------------------~~~~l~~~~~~~~~~~i~~~l~~lH~~~ 125 (265)
T cd08217 81 E----------YCEGGDLAQLIQKCKK-------------------------ERKYIEEEFIWRILTQLLLALYECHNRS 125 (265)
T ss_pred h----------hccCCCHHHHHHHHhh-------------------------cccCCCHHHHHHHHHHHHHHHHHHhcCc
Confidence 9 5566666665533211 1234677888999999999999999
Q ss_pred --hcceeccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHH
Q 003644 527 --EIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCIL 604 (805)
Q Consensus 527 --~~~IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil 604 (805)
+.+++|+||||+||+++.++. +||+|||++........ ......|++.|+|||++....++.++|+||||+++
T Consensus 126 ~~~~~i~h~dl~p~nili~~~~~--~kl~d~g~~~~~~~~~~---~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il 200 (265)
T cd08217 126 DPGNTVLHRDLKPANIFLDANNN--VKLGDFGLAKILGHDSS---FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLI 200 (265)
T ss_pred cccCcceecCCCHHHEEEecCCC--EEEecccccccccCCcc---cccccccCCCccChhhhcCCCCCchhHHHHHHHHH
Confidence 889999999999999987765 89999999987754321 12234589999999999988899999999999999
Q ss_pred HHHHhCCCCCCCCchHHH-HH-HHhhccccccccCChHHHHHHHHhcCCCCCCCCChhhhhcCccc
Q 003644 605 FFCITGGKHPYGESFERD-AN-IVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 668 (805)
Q Consensus 605 ~elltG~~~Pf~~~~~~~-~~-~~~~~~~~~~~~~~~~~~dLi~~~L~~dP~~Rps~~ell~Hpff 668 (805)
|+|++| ..||....... .. +........+...++++.+++.+||+.+|.+||++.++++|||+
T Consensus 201 ~~l~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 201 YELCAL-SPPFTARNQLQLASKIKEGKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI 265 (265)
T ss_pred HHHHHC-CCcccCcCHHHHHHHHhcCCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence 999997 77886643222 12 22222223344556889999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=308.80 Aligned_cols=246 Identities=28% Similarity=0.424 Sum_probs=186.3
Q ss_pred eEEEeEeeccCCceEEEEEEee-CCcEEEEEEeecCCc-----hHHHHHHHHHHHhCCCCCeeeecccccCC--ceEEEe
Q 003644 377 LVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHH-----DVALKEIQNLIASDQHPNIVRWYGVESDQ--DFVYLS 448 (805)
Q Consensus 377 ~~~~~~~LG~GsfGtVy~a~~~-~g~~VAVK~l~~~~~-----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~--~~l~LV 448 (805)
.|.+.+.||+|+||.||++... +++.||||.++.... ....+|+. ++..++||||+++++++.+. +..|+|
T Consensus 6 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~-~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 6 EYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREIN-ILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHH-HHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 4666788999999999998654 588999999864321 13345665 66778899999999998877 899999
Q ss_pred cccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhc
Q 003644 449 LERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI 528 (805)
Q Consensus 449 ~E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~ 528 (805)
||+|.++|.+++... ...+++..++.++.||+.||+|||+.
T Consensus 85 ~e~~~~~L~~~~~~~---------------------------------------~~~l~~~~~~~i~~qi~~aL~~LH~~ 125 (293)
T cd07843 85 MEYVEHDLKSLMETM---------------------------------------KQPFLQSEVKCLMLQLLSGVAHLHDN 125 (293)
T ss_pred ehhcCcCHHHHHHhc---------------------------------------cCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 997765555444210 12366778899999999999999999
Q ss_pred ceeccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCC-CCCcchHHHHHHHHHHH
Q 003644 529 GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGR-QTRAIDLFSLGCILFFC 607 (805)
Q Consensus 529 ~IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~-~t~~sDVwSlGvil~el 607 (805)
+++||||||+||+++.++. +||+|||++........ ......+++.|+|||.+.+.. ++.++|+|||||++|+|
T Consensus 126 ~i~H~dl~p~nili~~~~~--~~l~d~g~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l 200 (293)
T cd07843 126 WILHRDLKTSNLLLNNRGI--LKICDFGLAREYGSPLK---PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAEL 200 (293)
T ss_pred CeeeccCCHHHEEECCCCc--EEEeecCceeeccCCcc---ccccccccccccCchhhcCCccccchhhHHHHHHHHHHH
Confidence 9999999999999987765 89999999987654311 112345788999999987644 68999999999999999
Q ss_pred HhCCCCCCCCchHHHH--HHHhh------------------------------cccccccc-CChHHHHHHHHhcCCCCC
Q 003644 608 ITGGKHPYGESFERDA--NIVKD------------------------------RKDLFLVE-HIPEAVDLFTRLLDPNPD 654 (805)
Q Consensus 608 ltG~~~Pf~~~~~~~~--~~~~~------------------------------~~~~~~~~-~~~~~~dLi~~~L~~dP~ 654 (805)
++| .+||........ .+... ....++.. .++.+.++|++||+.||+
T Consensus 201 ~~g-~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~ 279 (293)
T cd07843 201 LTK-KPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPA 279 (293)
T ss_pred HhC-CCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCcc
Confidence 997 777754322110 00000 00001111 356789999999999999
Q ss_pred CCCChhhhhcCccc
Q 003644 655 LRPKAQNVLNHPFF 668 (805)
Q Consensus 655 ~Rps~~ell~Hpff 668 (805)
+|||+.|+++||||
T Consensus 280 ~R~t~~ell~~~~f 293 (293)
T cd07843 280 KRISAEDALKHPYF 293 (293)
T ss_pred ccCCHHHHhcCCCC
Confidence 99999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=311.94 Aligned_cols=245 Identities=26% Similarity=0.457 Sum_probs=188.9
Q ss_pred EeEeeccCCceEEEEEEe-eCCcEEEEEEeecCC---chHHHHHHHHHHHhCCCCCeeeecccccCCceEEEecccccCC
Q 003644 380 FNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH---HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCS 455 (805)
Q Consensus 380 ~~~~LG~GsfGtVy~a~~-~~g~~VAVK~l~~~~---~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~E~~~~s 455 (805)
....||+|+||.||++.. .+++.||||.+.... .....+|+. .+..++||||+++++++..++..|+|+|
T Consensus 25 ~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~-~l~~l~hp~i~~~~~~~~~~~~~~iv~e----- 98 (297)
T cd06659 25 NYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVV-IMRDYQHQNVVEMYKSYLVGEELWVLME----- 98 (297)
T ss_pred hhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHH-HHHhCCCCchhhhhhheeeCCeEEEEEe-----
Confidence 345799999999999854 478999999985432 233445554 6677899999999999999999999999
Q ss_pred hhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcceeccCC
Q 003644 456 LNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDL 535 (805)
Q Consensus 456 L~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~IvHrDL 535 (805)
|+++++|..++. ...+++..++.++.|++.||+|||+.+|+||||
T Consensus 99 -----~~~~~~L~~~~~------------------------------~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl 143 (297)
T cd06659 99 -----FLQGGALTDIVS------------------------------QTRLNEEQIATVCESVLQALCYLHSQGVIHRDI 143 (297)
T ss_pred -----cCCCCCHHHHHh------------------------------hcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCC
Confidence 555555554331 123566778999999999999999999999999
Q ss_pred CCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCCC
Q 003644 536 KPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY 615 (805)
Q Consensus 536 Kp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~elltG~~~Pf 615 (805)
||+||+++.++. +||+|||++....... .......|+..|+|||++.+..++.++|||||||++|||++| ..||
T Consensus 144 ~p~Nill~~~~~--~kL~dfg~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g-~~p~ 217 (297)
T cd06659 144 KSDSILLTLDGR--VKLSDFGFCAQISKDV---PKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDG-EPPY 217 (297)
T ss_pred CHHHeEEccCCc--EEEeechhHhhccccc---ccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhC-CCCC
Confidence 999999988876 8999999987654321 112334689999999999988899999999999999999997 6666
Q ss_pred CCchH-HHHHHHhhccc---cccccCChHHHHHHHHhcCCCCCCCCChhhhhcCcccccc
Q 003644 616 GESFE-RDANIVKDRKD---LFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTA 671 (805)
Q Consensus 616 ~~~~~-~~~~~~~~~~~---~~~~~~~~~~~dLi~~~L~~dP~~Rps~~ell~Hpff~~~ 671 (805)
..... .....+..... .......+++.++|.+||+.+|.+||+++++++||||...
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~~~ 277 (297)
T cd06659 218 FSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLERMLTREPQERATAQELLDHPFLLQT 277 (297)
T ss_pred CCCCHHHHHHHHhccCCCCccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhChhhccC
Confidence 54322 22222221111 1122345689999999999999999999999999999654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=315.12 Aligned_cols=253 Identities=24% Similarity=0.400 Sum_probs=189.3
Q ss_pred cceEEEeEeeccCCceEEEEEEe-eCCcEEEEEEeecCC-----chHHHHHHHHHHHhCCCCCeeeeccccc----CCce
Q 003644 375 GKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVES----DQDF 444 (805)
Q Consensus 375 ~~~~~~~~~LG~GsfGtVy~a~~-~~g~~VAVK~l~~~~-----~~~~~~Ei~~ll~~l~HpNIV~l~g~~~----~~~~ 444 (805)
+..|.+.+.||+|+||.||++.. .+|+.||+|++.... .....+|+. ++..++||||+++++++. +...
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~-~l~~l~h~~iv~~~~~~~~~~~~~~~ 82 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELK-ILRHFKHDNIIAIRDILRPPGADFKD 82 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHH-HHHhcCCCCccCHHHhccccCCCCce
Confidence 46688889999999999999854 469999999986532 123455664 678889999999999875 3457
Q ss_pred EEEecccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHH
Q 003644 445 VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSH 524 (805)
Q Consensus 445 l~LV~E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~y 524 (805)
.|+||||+.++|.+++ .. ...+++..+..++.||+.||+|
T Consensus 83 ~~lv~e~~~~~l~~~~-----------~~-----------------------------~~~~~~~~~~~i~~qi~~aL~~ 122 (334)
T cd07855 83 VYVVMDLMESDLHHII-----------HS-----------------------------DQPLTEEHIRYFLYQLLRGLKY 122 (334)
T ss_pred EEEEEehhhhhHHHHh-----------cc-----------------------------CCCCCHHHHHHHHHHHHHHHHH
Confidence 8999996554443333 11 1236777889999999999999
Q ss_pred hhhcceeccCCCCceEEecCCCCceEEEeccCccccccCCCcc-ccccccccCCCCCCChhhhhc-CCCCCcchHHHHHH
Q 003644 525 LHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSC-LTQNATGYGSSGWQAPEQLLQ-GRQTRAIDLFSLGC 602 (805)
Q Consensus 525 LH~~~IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~-~~~~~~~~gt~~y~APE~l~~-~~~t~~sDVwSlGv 602 (805)
||+.+|+||||||+||+++.++. +||+|||+++........ ........|+..|+|||.+.. ..++.++|||||||
T Consensus 123 LH~~~ivH~dlkp~Nil~~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ 200 (334)
T cd07855 123 IHSANVIHRDLKPSNLLVNEDCE--LRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGC 200 (334)
T ss_pred HHHCCeecCCCCHHHEEEcCCCc--EEecccccceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHH
Confidence 99999999999999999988876 899999999776432211 111123468999999999866 45889999999999
Q ss_pred HHHHHHhCCCCCCCCchHHH-HH------------------------HHhhcc--cc-----ccccCChHHHHHHHHhcC
Q 003644 603 ILFFCITGGKHPYGESFERD-AN------------------------IVKDRK--DL-----FLVEHIPEAVDLFTRLLD 650 (805)
Q Consensus 603 il~elltG~~~Pf~~~~~~~-~~------------------------~~~~~~--~~-----~~~~~~~~~~dLi~~~L~ 650 (805)
++|||++| ++||....... .. ...... .. .....++++.++|++||+
T Consensus 201 ~l~el~~g-~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 279 (334)
T cd07855 201 IFAEMLGR-RQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQ 279 (334)
T ss_pred HHHHHHcC-CCccCCCChHHHHHHHHHHhCCChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHcc
Confidence 99999996 77885432110 00 000000 00 112346789999999999
Q ss_pred CCCCCCCChhhhhcCcccccc
Q 003644 651 PNPDLRPKAQNVLNHPFFWTA 671 (805)
Q Consensus 651 ~dP~~Rps~~ell~Hpff~~~ 671 (805)
.||.+||++++++.||||...
T Consensus 280 ~~P~~Rpt~~~~l~~~~~~~~ 300 (334)
T cd07855 280 FDPEERITVEQALQHPFLAQY 300 (334)
T ss_pred CChhhCcCHHHHHhChhhhhc
Confidence 999999999999999999643
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-34 Score=304.56 Aligned_cols=247 Identities=28% Similarity=0.431 Sum_probs=188.4
Q ss_pred EEEeEeeccCCceEEEEEEee-CCcEEEEEEeecCC----chHHHHHHHHHHHhCCCCCeeeecccccCCceEEEecccc
Q 003644 378 VVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH----HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERC 452 (805)
Q Consensus 378 ~~~~~~LG~GsfGtVy~a~~~-~g~~VAVK~l~~~~----~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~E~~ 452 (805)
|.+.+.||.|++|+||++... +|+.||||++.... .....+|+. +++.++||||+++++++.+.+..++|||++
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~-~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREIS-LMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred ceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHH-HHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 667889999999999998654 68999999986432 234456655 677889999999999999999999999977
Q ss_pred cCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcceec
Q 003644 453 TCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIH 532 (805)
Q Consensus 453 ~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~IvH 532 (805)
.++|.+++. .. .....+++..+..++.||+.||+|||+.+++|
T Consensus 81 ~~~l~~~~~-----------~~--------------------------~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h 123 (284)
T cd07836 81 DKDLKKYMD-----------TH--------------------------GVRGALDPNTVKSFTYQLLKGIAFCHENRVLH 123 (284)
T ss_pred CccHHHHHH-----------hc--------------------------CCCCCcCHHHHHHHHHHHHHHHHHHHHCCeee
Confidence 665555441 11 01124677888999999999999999999999
Q ss_pred cCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcC-CCCCcchHHHHHHHHHHHHhCC
Q 003644 533 RDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG-RQTRAIDLFSLGCILFFCITGG 611 (805)
Q Consensus 533 rDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~t~~sDVwSlGvil~elltG~ 611 (805)
|||||+||+++.++. ++|+|||++........ ......++..|++||++.+. .++.++|||||||++|+|++|
T Consensus 124 ~dl~p~ni~~~~~~~--~~l~d~g~~~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g- 197 (284)
T cd07836 124 RDLKPQNLLINKRGE--LKLADFGLARAFGIPVN---TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITG- 197 (284)
T ss_pred CCCCHHHEEECCCCc--EEEeecchhhhhcCCcc---ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhC-
Confidence 999999999987766 89999999976543211 11234578899999998664 468899999999999999997
Q ss_pred CCCCCCchHHHH--HHHhh--------------cc--------------ccccccCChHHHHHHHHhcCCCCCCCCChhh
Q 003644 612 KHPYGESFERDA--NIVKD--------------RK--------------DLFLVEHIPEAVDLFTRLLDPNPDLRPKAQN 661 (805)
Q Consensus 612 ~~Pf~~~~~~~~--~~~~~--------------~~--------------~~~~~~~~~~~~dLi~~~L~~dP~~Rps~~e 661 (805)
.+||........ .+... .. .......++++.++|.+||+.||.+||++++
T Consensus 198 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ 277 (284)
T cd07836 198 RPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHD 277 (284)
T ss_pred CCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHH
Confidence 777764332110 11000 00 0001123568899999999999999999999
Q ss_pred hhcCccc
Q 003644 662 VLNHPFF 668 (805)
Q Consensus 662 ll~Hpff 668 (805)
+++||||
T Consensus 278 ~l~~~~f 284 (284)
T cd07836 278 ALQHPWF 284 (284)
T ss_pred HhcCCCC
Confidence 9999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=300.95 Aligned_cols=245 Identities=31% Similarity=0.480 Sum_probs=188.4
Q ss_pred eccCCceEEEEEEee-CCcEEEEEEeecCCc------hHHHHHHHHHHHhCCCCCeeeecccccCCceEEEecccccCCh
Q 003644 384 IAKGSNGTVVLEGNY-EGRSVAVKRLVKTHH------DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCSL 456 (805)
Q Consensus 384 LG~GsfGtVy~a~~~-~g~~VAVK~l~~~~~------~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~E~~~~sL 456 (805)
||+|+||+||++... +|+.||+|++..... ....+|+ .++..++||||+++++.+.+++..|+++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~-~~l~~~~h~~i~~~~~~~~~~~~~~lv~e------ 73 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTER-DILSQAQSPYVVKLYYSFQGKKNLYLVME------ 73 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHH-HHHHhCCCcchhHHHHheecCcEEEEEEe------
Confidence 689999999998665 499999999865422 1233344 46778899999999999999999999999
Q ss_pred hhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCC
Q 003644 457 NDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLK 536 (805)
Q Consensus 457 ~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~IvHrDLK 536 (805)
|+.+++|.+++... ..+++..+..++.||+.||+|||+.+++||||+
T Consensus 74 ----~~~~~~L~~~l~~~-----------------------------~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~ 120 (265)
T cd05579 74 ----YLPGGDLASLLENV-----------------------------GSLDEDVARIYIAEIVLALEYLHSNGIIHRDLK 120 (265)
T ss_pred ----cCCCCcHHHHHHHc-----------------------------CCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCC
Confidence 55555665554321 246777889999999999999999999999999
Q ss_pred CceEEecCCCCceEEEeccCccccccCCCcc-----ccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHHHHHhCC
Q 003644 537 PQNVLISKDKSFCAKLSDMGISKRLQGDMSC-----LTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGG 611 (805)
Q Consensus 537 p~NILl~~~~~~~~kL~DFGla~~~~~~~~~-----~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~elltG~ 611 (805)
|+||+++.++. ++|+|||++......... ........++..|+|||.+....++.++|||||||++|++++|
T Consensus 121 ~~nil~~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g- 197 (265)
T cd05579 121 PDNILIDSNGH--LKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVG- 197 (265)
T ss_pred HHHeEEcCCCC--EEEEecccchhcccCcccccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhC-
Confidence 99999988876 899999998765432110 0112234578899999999888899999999999999999997
Q ss_pred CCCCCCchHHH-HHHHhhccccccccC--ChHHHHHHHHhcCCCCCCCCCh---hhhhcCcccccc
Q 003644 612 KHPYGESFERD-ANIVKDRKDLFLVEH--IPEAVDLFTRLLDPNPDLRPKA---QNVLNHPFFWTA 671 (805)
Q Consensus 612 ~~Pf~~~~~~~-~~~~~~~~~~~~~~~--~~~~~dLi~~~L~~dP~~Rps~---~ell~Hpff~~~ 671 (805)
..||....... ...........+... ++++.+++.+||+.+|.+||++ .++++||||.+.
T Consensus 198 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~~ 263 (265)
T cd05579 198 IPPFHGETPEEIFQNILNGKIEWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKGI 263 (265)
T ss_pred CCCCCCCCHHHHHHHHhcCCcCCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCccccCC
Confidence 77876544332 222222222222222 6789999999999999999999 999999999653
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=327.62 Aligned_cols=245 Identities=26% Similarity=0.391 Sum_probs=187.1
Q ss_pred ceEEEeEeeccCCceEEEEEEeeCC----cE-EEEEEeecCC--c----hHHHHHHHHHHHhCCCCCeeeecccccCCce
Q 003644 376 KLVVFNKEIAKGSNGTVVLEGNYEG----RS-VAVKRLVKTH--H----DVALKEIQNLIASDQHPNIVRWYGVESDQDF 444 (805)
Q Consensus 376 ~~~~~~~~LG~GsfGtVy~a~~~~g----~~-VAVK~l~~~~--~----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~ 444 (805)
.+..+.++||+|+||.||+|.+..+ .. ||||..+... . ....+|. +++..++|||||++||++.++..
T Consensus 157 ~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EA-rvMr~l~H~NVVr~yGVa~~~~P 235 (474)
T KOG0194|consen 157 SDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEA-RVMRQLNHPNVVRFYGVAVLEEP 235 (474)
T ss_pred cCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHH-HHHHhCCCCCEEEEEEEEcCCCc
Confidence 4456678999999999999865532 23 8999887422 1 2334454 47777999999999999999999
Q ss_pred EEEecccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHH
Q 003644 445 VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSH 524 (805)
Q Consensus 445 l~LV~E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~y 524 (805)
+|||||+| .+|+|.++|.... ..++..+.+.++.+.|+||+|
T Consensus 236 l~ivmEl~----------~gGsL~~~L~k~~----------------------------~~v~~~ek~~~~~~AA~Gl~Y 277 (474)
T KOG0194|consen 236 LMLVMELC----------NGGSLDDYLKKNK----------------------------KSLPTLEKLRFCYDAARGLEY 277 (474)
T ss_pred cEEEEEec----------CCCcHHHHHHhCC----------------------------CCCCHHHHHHHHHHHHhHHHH
Confidence 99999954 5566666654321 136677889999999999999
Q ss_pred hhhcceeccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHH
Q 003644 525 LHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCIL 604 (805)
Q Consensus 525 LH~~~IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil 604 (805)
||++++|||||..+|+|++.++. +||+||||++..... ........-...|+|||.+....|+.++|||||||++
T Consensus 278 Lh~k~~IHRDIAARNcL~~~~~~--vKISDFGLs~~~~~~---~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~ 352 (474)
T KOG0194|consen 278 LHSKNCIHRDIAARNCLYSKKGV--VKISDFGLSRAGSQY---VMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLL 352 (474)
T ss_pred HHHCCCcchhHhHHHheecCCCe--EEeCccccccCCcce---eeccccccCcceecChhhhccCccccccchhheeeeE
Confidence 99999999999999999987654 899999998765411 1111111246789999999999999999999999999
Q ss_pred HHHHhCCCCCCCCchHHHH--HHHhhc-cccccccCChHHHHHHHHhcCCCCCCCCChhhhhc
Q 003644 605 FFCITGGKHPYGESFERDA--NIVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 664 (805)
Q Consensus 605 ~elltG~~~Pf~~~~~~~~--~~~~~~-~~~~~~~~~~~~~dLi~~~L~~dP~~Rps~~ell~ 664 (805)
||+++-+..||......+. .+.... ....+...+.++..++.+||..||+.||+|.++.+
T Consensus 353 ~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~ 415 (474)
T KOG0194|consen 353 WEIFENGAEPYPGMKNYEVKAKIVKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKK 415 (474)
T ss_pred EeeeccCCCCCCCCCHHHHHHHHHhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHH
Confidence 9999966778877554433 332333 33334455568889999999999999999999863
|
|
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=308.41 Aligned_cols=246 Identities=25% Similarity=0.376 Sum_probs=189.8
Q ss_pred eEEEeEeeccCCceEEEEEEe-eCCcEEEEEEeecCCc----hHHHHHHHHHHHhCCCCCeeeecccccCCceEEEeccc
Q 003644 377 LVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLER 451 (805)
Q Consensus 377 ~~~~~~~LG~GsfGtVy~a~~-~~g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~E~ 451 (805)
.|.+.+.||+|+||+||++.. .+|+.||+|++..... ....+|++ ++..++||||+++++++.+.+..|+|||
T Consensus 6 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~-~l~~l~h~~i~~~~~~~~~~~~~~lv~e- 83 (284)
T cd06620 6 DLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQ-IMHECRSPYIVSFYGAFLNENNICMCME- 83 (284)
T ss_pred HHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHH-HHHHcCCCCcceEeeeEecCCEEEEEEe-
Confidence 355668899999999999854 4689999998864322 23445654 6677899999999999999999999999
Q ss_pred ccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhh-cce
Q 003644 452 CTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE-IGL 530 (805)
Q Consensus 452 ~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~-~~I 530 (805)
|+++|+|..++.. ...+++..+..++.+++.||.|||+ .++
T Consensus 84 ---------~~~~~~L~~~~~~-----------------------------~~~~~~~~~~~~~~~i~~~l~~LH~~~~i 125 (284)
T cd06620 84 ---------FMDCGSLDRIYKK-----------------------------GGPIPVEILGKIAVAVVEGLTYLYNVHRI 125 (284)
T ss_pred ---------cCCCCCHHHHHHh-----------------------------ccCCCHHHHHHHHHHHHHHHHHHHHhcCe
Confidence 5566666554422 1246677889999999999999997 589
Q ss_pred eccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHHHHHhC
Q 003644 531 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG 610 (805)
Q Consensus 531 vHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~elltG 610 (805)
+||||||+||+++.++. ++|+|||++...... ......|+..|+|||++.+..++.++|+|||||++|++++|
T Consensus 126 ~H~dl~p~nil~~~~~~--~~l~d~gl~~~~~~~-----~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg 198 (284)
T cd06620 126 MHRDIKPSNILVNSRGQ--IKLCDFGVSGELINS-----IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALG 198 (284)
T ss_pred eccCCCHHHEEECCCCc--EEEccCCcccchhhh-----ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhC
Confidence 99999999999987765 899999998755322 11234689999999999888899999999999999999997
Q ss_pred CCCCCCCchHH-------------HHHHHhhcccccc-ccCChHHHHHHHHhcCCCCCCCCChhhhhcCccccc
Q 003644 611 GKHPYGESFER-------------DANIVKDRKDLFL-VEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWT 670 (805)
Q Consensus 611 ~~~Pf~~~~~~-------------~~~~~~~~~~~~~-~~~~~~~~dLi~~~L~~dP~~Rps~~ell~Hpff~~ 670 (805)
..||...... ...+........+ ...+.++.+|+.+||+.||++||++.|+++||||..
T Consensus 199 -~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~ 271 (284)
T cd06620 199 -KFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQ 271 (284)
T ss_pred -CCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence 6787643321 0111111111111 124568999999999999999999999999999854
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=301.05 Aligned_cols=242 Identities=28% Similarity=0.400 Sum_probs=185.2
Q ss_pred ceEEEeEeeccCCceEEEEEEeeCCcEEEEEEeecCCchH-HHHHHHHHHHhCCCCCeeeecccc-cCCceEEEeccccc
Q 003644 376 KLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDV-ALKEIQNLIASDQHPNIVRWYGVE-SDQDFVYLSLERCT 453 (805)
Q Consensus 376 ~~~~~~~~LG~GsfGtVy~a~~~~g~~VAVK~l~~~~~~~-~~~Ei~~ll~~l~HpNIV~l~g~~-~~~~~l~LV~E~~~ 453 (805)
+.|.+.+.||+|+||.||++. ..|..||+|.+....... ..+|+. +++.++|+||+++++++ .+++..|++||
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~-~~~~~~~~k~~~~~~~~~~~~~e~~-~l~~l~~~~i~~~~~~~~~~~~~~~lv~e--- 80 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGD-YRGNKVAVKCIKNDATAQAFLAEAS-VMTQLRHSNLVQLLGVIVEEKGGLYIVTE--- 80 (256)
T ss_pred HhCeeeeeecccCCCeEEEEE-EcCCcEEEEEeCCCchHHHHHHHHH-HHHhCCCCCeeeEEEEEEcCCCceEEEEE---
Confidence 346778999999999999964 458899999987554333 345554 77889999999999975 45677899999
Q ss_pred CChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcceecc
Q 003644 454 CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHR 533 (805)
Q Consensus 454 ~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~IvHr 533 (805)
|+.+|+|.+++.... ...+++..++.++.|++.||+|||+.||+||
T Consensus 81 -------~~~~~~L~~~~~~~~---------------------------~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~ 126 (256)
T cd05082 81 -------YMAKGSLVDYLRSRG---------------------------RSVLGGDCLLKFSLDVCEAMEYLEANNFVHR 126 (256)
T ss_pred -------CCCCCcHHHHHHhcC---------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCEecc
Confidence 555556655543211 1235677889999999999999999999999
Q ss_pred CCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHHHHHhCCCC
Q 003644 534 DLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKH 613 (805)
Q Consensus 534 DLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~elltG~~~ 613 (805)
||||+||+++.++. +||+|||+++...... ....++..|+|||++....++.++|||||||++|||++.+.+
T Consensus 127 dlkp~nil~~~~~~--~kl~dfg~~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~ 198 (256)
T cd05082 127 DLAARNVLVSEDNV--AKVSDFGLTKEASSTQ------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRV 198 (256)
T ss_pred ccchheEEEcCCCc--EEecCCccceeccccC------CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCC
Confidence 99999999988775 8999999988654321 122356789999999888899999999999999999985578
Q ss_pred CCCCchHHH-HHHH-hhccccccccCChHHHHHHHHhcCCCCCCCCChhhhhc
Q 003644 614 PYGESFERD-ANIV-KDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 664 (805)
Q Consensus 614 Pf~~~~~~~-~~~~-~~~~~~~~~~~~~~~~dLi~~~L~~dP~~Rps~~ell~ 664 (805)
||....... ...+ ...........++.+.+++.+||+.||++|||++++++
T Consensus 199 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 251 (256)
T cd05082 199 PYPRIPLKDVVPRVEKGYKMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLRE 251 (256)
T ss_pred CCCCCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 886543322 1222 22122223445678999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=303.73 Aligned_cols=249 Identities=30% Similarity=0.431 Sum_probs=194.3
Q ss_pred eEEEeEeeccCCceEEEEEEee-CCcEEEEEEeecCC------chHHHHHHHHHHHhCC-CCCeeeecccccCCceEEEe
Q 003644 377 LVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH------HDVALKEIQNLIASDQ-HPNIVRWYGVESDQDFVYLS 448 (805)
Q Consensus 377 ~~~~~~~LG~GsfGtVy~a~~~-~g~~VAVK~l~~~~------~~~~~~Ei~~ll~~l~-HpNIV~l~g~~~~~~~l~LV 448 (805)
.|.+.+.||+|+||.||++... +|+.||+|++.+.. .....+|. .++..++ ||||+++++++.+++..++|
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~-~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 2 DFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEK-EVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHH-HHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 4778899999999999998654 78999999986521 12233444 4566677 99999999999999999999
Q ss_pred cccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhc
Q 003644 449 LERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI 528 (805)
Q Consensus 449 ~E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~ 528 (805)
||++ .+++|.+++.. ...+++..++.++.|++.||+|||+.
T Consensus 81 ~e~~----------~~~~L~~~l~~-----------------------------~~~l~~~~~~~i~~ql~~~l~~Lh~~ 121 (280)
T cd05581 81 LEYA----------PNGELLQYIRK-----------------------------YGSLDEKCTRFYAAEILLALEYLHSK 121 (280)
T ss_pred EcCC----------CCCcHHHHHHH-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 9955 44455444321 12467788899999999999999999
Q ss_pred ceeccCCCCceEEecCCCCceEEEeccCccccccCCCcc-----------------ccccccccCCCCCCChhhhhcCCC
Q 003644 529 GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSC-----------------LTQNATGYGSSGWQAPEQLLQGRQ 591 (805)
Q Consensus 529 ~IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~-----------------~~~~~~~~gt~~y~APE~l~~~~~ 591 (805)
+++|+||+|+||+++.++. ++|+|||++......... ........++..|+|||++....+
T Consensus 122 ~~~H~dl~~~ni~i~~~~~--~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~ 199 (280)
T cd05581 122 GIIHRDLKPENILLDKDMH--IKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPA 199 (280)
T ss_pred CeeecCCCHHHeEECCCCC--EEecCCccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCC
Confidence 9999999999999988876 899999999876543211 012233457899999999988889
Q ss_pred CCcchHHHHHHHHHHHHhCCCCCCCCchHHH-HHHHhhccccccccCChHHHHHHHHhcCCCCCCCCCh----hhhhcCc
Q 003644 592 TRAIDLFSLGCILFFCITGGKHPYGESFERD-ANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKA----QNVLNHP 666 (805)
Q Consensus 592 t~~sDVwSlGvil~elltG~~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dP~~Rps~----~ell~Hp 666 (805)
+.++|+|||||+++++++| ..||....... ...........+...++.+.++|.+||+.||.+||++ +++++||
T Consensus 200 ~~~~Di~slG~~l~~l~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~ 278 (280)
T cd05581 200 GKSSDLWALGCIIYQMLTG-KPPFRGSNEYLTFQKILKLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHP 278 (280)
T ss_pred ChhhhHHHHHHHHHHHHhC-CCCCCCccHHHHHHHHHhcCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCC
Confidence 9999999999999999996 77887644322 1222222333445567899999999999999999999 9999999
Q ss_pred cc
Q 003644 667 FF 668 (805)
Q Consensus 667 ff 668 (805)
||
T Consensus 279 ~~ 280 (280)
T cd05581 279 FF 280 (280)
T ss_pred CC
Confidence 97
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=310.32 Aligned_cols=244 Identities=25% Similarity=0.406 Sum_probs=187.2
Q ss_pred eEeeccCCceEEEEEEe-eCCcEEEEEEeecCCc---hHHHHHHHHHHHhCCCCCeeeecccccCCceEEEecccccCCh
Q 003644 381 NKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH---DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCSL 456 (805)
Q Consensus 381 ~~~LG~GsfGtVy~a~~-~~g~~VAVK~l~~~~~---~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~E~~~~sL 456 (805)
...||+|+||.||++.. .++..||||.+..... +...+|+. .+..++||||+++++.+.+.+..|+|||+|
T Consensus 27 ~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~-~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~---- 101 (292)
T cd06658 27 FIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVV-IMRDYHHENVVDMYNSYLVGDELWVVMEFL---- 101 (292)
T ss_pred hhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHH-HHHhCCCCcHHHHHHheecCCeEEEEEeCC----
Confidence 35699999999999854 4689999999864332 23445655 667789999999999999999999999954
Q ss_pred hhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCC
Q 003644 457 NDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLK 536 (805)
Q Consensus 457 ~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~IvHrDLK 536 (805)
.+++|.+++.. ..+++.++..++.||+.||+|||+.+|+|||||
T Consensus 102 ------~~~~L~~~~~~------------------------------~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlk 145 (292)
T cd06658 102 ------EGGALTDIVTH------------------------------TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIK 145 (292)
T ss_pred ------CCCcHHHHHhc------------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCC
Confidence 45555544311 124566788999999999999999999999999
Q ss_pred CceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q 003644 537 PQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYG 616 (805)
Q Consensus 537 p~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~elltG~~~Pf~ 616 (805)
|+||+++.++. ++|+|||++........ ......|+..|+|||.+.+..++.++|||||||++|||++| ..||.
T Consensus 146 p~Nill~~~~~--~kL~dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g-~~p~~ 219 (292)
T cd06658 146 SDSILLTSDGR--IKLSDFGFCAQVSKEVP---KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDG-EPPYF 219 (292)
T ss_pred HHHEEEcCCCC--EEEccCcchhhcccccc---cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhC-CCCCC
Confidence 99999987765 89999999876543221 12334589999999999888899999999999999999997 66765
Q ss_pred CchH-HHHHHHhhcc-cc--ccccCChHHHHHHHHhcCCCCCCCCChhhhhcCcccccc
Q 003644 617 ESFE-RDANIVKDRK-DL--FLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTA 671 (805)
Q Consensus 617 ~~~~-~~~~~~~~~~-~~--~~~~~~~~~~dLi~~~L~~dP~~Rps~~ell~Hpff~~~ 671 (805)
.... .....+.... .. .....++.+.+++.+||..||.+|||++++++||||...
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~~~~ 278 (292)
T cd06658 220 NEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLDLMLVREPSQRATAQELLQHPFLKLA 278 (292)
T ss_pred CCCHHHHHHHHHhcCCCccccccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhhcc
Confidence 4332 2222221111 11 112345689999999999999999999999999999643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=302.83 Aligned_cols=252 Identities=26% Similarity=0.396 Sum_probs=187.6
Q ss_pred cceEEEeEeeccCCceEEEEEEe-eCCcEEEEEEeecCCc--hHHHHHHHHHHHhC-CCCCeeeecccccCC------ce
Q 003644 375 GKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH--DVALKEIQNLIASD-QHPNIVRWYGVESDQ------DF 444 (805)
Q Consensus 375 ~~~~~~~~~LG~GsfGtVy~a~~-~~g~~VAVK~l~~~~~--~~~~~Ei~~ll~~l-~HpNIV~l~g~~~~~------~~ 444 (805)
.+.|.+.+.||+|++|+||++.. .+++.||+|++..... +...+|+. ++..+ .||||+++++++.+. +.
T Consensus 5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~-~l~~~~~h~~i~~~~~~~~~~~~~~~~~~ 83 (275)
T cd06608 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYN-ILRKYSNHPNIATFYGAFIKKNPPGNDDQ 83 (275)
T ss_pred hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHH-HHHHhcCCCChheEEEEEEecCCCCcceE
Confidence 45688889999999999999865 4678999999875432 33445665 44554 799999999998654 45
Q ss_pred EEEecccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHH
Q 003644 445 VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSH 524 (805)
Q Consensus 445 l~LV~E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~y 524 (805)
.|+|||+| .+++|.+++.... -+...+++..+..++.|++.||+|
T Consensus 84 ~~lv~e~~----------~~~~L~~~~~~~~-------------------------~~~~~~~~~~~~~~~~ql~~al~~ 128 (275)
T cd06608 84 LWLVMELC----------GGGSVTDLVKGLR-------------------------KKGKRLKEEWIAYILRETLRGLAY 128 (275)
T ss_pred EEEEEEcC----------CCCcHHHHHHHHh-------------------------hcCCCCCHHHHHHHHHHHHHHHHH
Confidence 89999954 4555555443211 012346778889999999999999
Q ss_pred hhhcceeccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhc-----CCCCCcchHHH
Q 003644 525 LHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ-----GRQTRAIDLFS 599 (805)
Q Consensus 525 LH~~~IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~-----~~~t~~sDVwS 599 (805)
||+.+++|+||+|+||+++.++. ++|+|||++....... .......|+..|+|||++.. ..++.++||||
T Consensus 129 lH~~~i~H~~l~p~ni~~~~~~~--~~l~d~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~s 203 (275)
T cd06608 129 LHENKVIHRDIKGQNILLTKNAE--VKLVDFGVSAQLDSTL---GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWS 203 (275)
T ss_pred HhcCCcccCCCCHHHEEEccCCe--EEECCCccceecccch---hhhcCccccccccCHhHhcccccccCCccccccHHH
Confidence 99999999999999999987765 8999999987654321 12233458999999999854 34678999999
Q ss_pred HHHHHHHHHhCCCCCCCCchHHH--HHHHhhcccc--ccccCChHHHHHHHHhcCCCCCCCCChhhhhcCccc
Q 003644 600 LGCILFFCITGGKHPYGESFERD--ANIVKDRKDL--FLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 668 (805)
Q Consensus 600 lGvil~elltG~~~Pf~~~~~~~--~~~~~~~~~~--~~~~~~~~~~dLi~~~L~~dP~~Rps~~ell~Hpff 668 (805)
|||++|+|++| .+||....... ..+....... .....++++.++|.+||..||++|||+.++++|||+
T Consensus 204 lG~il~~l~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 204 LGITAIELADG-KPPLCDMHPMRALFKIPRNPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred hHHHHHHHHhC-CCCccccchHHHHHHhhccCCCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence 99999999997 77886432211 1222111111 112245689999999999999999999999999995
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=307.11 Aligned_cols=261 Identities=24% Similarity=0.350 Sum_probs=191.1
Q ss_pred ceEEEeEeeccCCceEEEEEEe------eCCcEEEEEEeecCCc---hHHHHHHHHHHHhCCCCCeeeecccccCCceEE
Q 003644 376 KLVVFNKEIAKGSNGTVVLEGN------YEGRSVAVKRLVKTHH---DVALKEIQNLIASDQHPNIVRWYGVESDQDFVY 446 (805)
Q Consensus 376 ~~~~~~~~LG~GsfGtVy~a~~------~~g~~VAVK~l~~~~~---~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~ 446 (805)
+++.+.++||+|+||+||++.. .++..||+|.+..... ....+|+. ++..++||||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~ 83 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAE-LLTVLQHQHIVRFYGVCTEGRPLL 83 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHH-HHhcCCCCCCceEEEEEecCCceE
Confidence 3467788999999999999753 2467899998865432 23445554 778889999999999999999999
Q ss_pred EecccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhh
Q 003644 447 LSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH 526 (805)
Q Consensus 447 LV~E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH 526 (805)
++||++ .+|+|.++++........... ........+++..++.++.||+.||+|||
T Consensus 84 lv~e~~----------~~~~L~~~i~~~~~~~~~~~~--------------~~~~~~~~l~~~~~~~~~~qi~~al~~LH 139 (280)
T cd05092 84 MVFEYM----------RHGDLNRFLRSHGPDAKILAG--------------GEDVAPGQLTLGQMLAIASQIASGMVYLA 139 (280)
T ss_pred EEEecC----------CCCCHHHHHHhcCcchhhhcc--------------cccCCccccCHHHHHHHHHHHHHHHHHHH
Confidence 999944 455555554432211100000 00011234678889999999999999999
Q ss_pred hcceeccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHHH
Q 003644 527 EIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFF 606 (805)
Q Consensus 527 ~~~IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~e 606 (805)
+.+|+||||||+|||+++++. +||+|||+++....... ........+++.|+|||++.+..++.++|||||||++||
T Consensus 140 ~~~i~H~dlkp~nil~~~~~~--~kL~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e 216 (280)
T cd05092 140 SLHFVHRDLATRNCLVGQGLV--VKIGDFGMSRDIYSTDY-YRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWE 216 (280)
T ss_pred HCCeecccccHhhEEEcCCCC--EEECCCCceeEcCCCce-eecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHH
Confidence 999999999999999987765 89999999876543211 111122335788999999999899999999999999999
Q ss_pred HHhCCCCCCCCchHHH-H-HHHhhccccccccCChHHHHHHHHhcCCCCCCCCChhhhhc
Q 003644 607 CITGGKHPYGESFERD-A-NIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 664 (805)
Q Consensus 607 lltG~~~Pf~~~~~~~-~-~~~~~~~~~~~~~~~~~~~dLi~~~L~~dP~~Rps~~ell~ 664 (805)
|++++.+||.+..... . .+........+...++.+.++|.+||+.||.+||++.++++
T Consensus 217 l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 217 IFTYGKQPWYQLSNTEAIECITQGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS 276 (280)
T ss_pred HHcCCCCCCccCCHHHHHHHHHcCccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 9996688886543322 2 22222222334456688999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=301.40 Aligned_cols=245 Identities=24% Similarity=0.384 Sum_probs=187.4
Q ss_pred ceEEEeEeeccCCceEEEEEEeeCCcEEEEEEeecCCc--hHHHHHHHHHHHhCCCCCeeeecccccCCceEEEeccccc
Q 003644 376 KLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHH--DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCT 453 (805)
Q Consensus 376 ~~~~~~~~LG~GsfGtVy~a~~~~g~~VAVK~l~~~~~--~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~E~~~ 453 (805)
++|.+.+.||+|+||+||++...++..||+|.+..... +...+|+. +++.++||||+++++++.+ +..|++||
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~E~~-~l~~l~~~~i~~~~~~~~~-~~~~lv~e--- 80 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQ-IMKKLRHDKLVQLYAVVSE-EPIYIVTE--- 80 (260)
T ss_pred HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCCCHHHHHHHHH-HHHhcCCCceEEEEeEECC-CCcEEEEE---
Confidence 45677889999999999999877888999999875332 33445654 6788899999999998754 56899999
Q ss_pred CChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcceecc
Q 003644 454 CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHR 533 (805)
Q Consensus 454 ~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~IvHr 533 (805)
|+.+++|.++++... ...+++..++.++.|++.||+|||+.+|+||
T Consensus 81 -------~~~~~~L~~~~~~~~---------------------------~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~ 126 (260)
T cd05070 81 -------YMSKGSLLDFLKDGE---------------------------GRALKLPNLVDMAAQVAAGMAYIERMNYIHR 126 (260)
T ss_pred -------ecCCCcHHHHHHhcC---------------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccC
Confidence 555666666553211 1235677889999999999999999999999
Q ss_pred CCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHHHHHhCCCC
Q 003644 534 DLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKH 613 (805)
Q Consensus 534 DLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~elltG~~~ 613 (805)
||||+||+++.++. ++|+|||++........ .......++..|+|||++....++.++|+|||||++|||++++.+
T Consensus 127 di~p~Nili~~~~~--~~l~dfg~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~ 202 (260)
T cd05070 127 DLRSANILVGDGLV--CKIADFGLARLIEDNEY--TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRV 202 (260)
T ss_pred CCccceEEEeCCce--EEeCCceeeeeccCccc--ccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCC
Confidence 99999999987754 89999999987643211 111122356789999999888899999999999999999996688
Q ss_pred CCCCchHHH-HHHHh-hccccccccCChHHHHHHHHhcCCCCCCCCChhhhh
Q 003644 614 PYGESFERD-ANIVK-DRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVL 663 (805)
Q Consensus 614 Pf~~~~~~~-~~~~~-~~~~~~~~~~~~~~~dLi~~~L~~dP~~Rps~~ell 663 (805)
||....... ...+. ......+...+.++.+++.+||..||.+|||+.++.
T Consensus 203 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~ 254 (260)
T cd05070 203 PYPGMNNREVLEQVERGYRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQ 254 (260)
T ss_pred CCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHH
Confidence 886543322 22222 112223344567899999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-34 Score=301.38 Aligned_cols=248 Identities=21% Similarity=0.334 Sum_probs=187.0
Q ss_pred ceEEEeEeeccCCceEEEEEEe-eCCcEEEEEEeecCC---c---hHHHHHHHHHHHhCCCCCeeeecccccCCceEEEe
Q 003644 376 KLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH---H---DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLS 448 (805)
Q Consensus 376 ~~~~~~~~LG~GsfGtVy~a~~-~~g~~VAVK~l~~~~---~---~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV 448 (805)
..|.+.+.||+|+||.||++.. .+++.||||.+.... . ....+|+. +++.++||||+++++++.+.+..|++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~~v 80 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEID-LLKQLNHPNVIKYLDSFIEDNELNIV 80 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHH-HHHhCCCcceeeeeeeEEECCeEEEE
Confidence 3577889999999999999854 478999999875421 1 12344554 77888999999999999999999999
Q ss_pred cccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhc
Q 003644 449 LERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI 528 (805)
Q Consensus 449 ~E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~ 528 (805)
+| |..+|+|.+++.... .+...+++..+..++.||+.||+|||+.
T Consensus 81 ~e----------~~~~~~L~~~~~~~~-------------------------~~~~~~~~~~~~~~~~~i~~~l~~LH~~ 125 (267)
T cd08228 81 LE----------LADAGDLSQMIKYFK-------------------------KQKRLIPERTVWKYFVQLCSAVEHMHSR 125 (267)
T ss_pred EE----------ecCCCcHHHHHHHhh-------------------------hccCCCCHHHHHHHHHHHHHHHHHHhhC
Confidence 99 555555555442211 1123367778899999999999999999
Q ss_pred ceeccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHHHHH
Q 003644 529 GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCI 608 (805)
Q Consensus 529 ~IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~ell 608 (805)
+++||||||+||+++.++. ++|+|||++........ ......|++.|+|||.+.+..++.++|+|||||++|||+
T Consensus 126 ~i~H~dl~~~nil~~~~~~--~~l~d~g~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~ 200 (267)
T cd08228 126 RVMHRDIKPANVFITATGV--VKLGDLGLGRFFSSKTT---AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMA 200 (267)
T ss_pred CeeCCCCCHHHEEEcCCCC--EEECccccceeccchhH---HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHh
Confidence 9999999999999988776 89999999887653211 112345889999999998888999999999999999999
Q ss_pred hCCCCCCCCchHH---HHHHHhh-cc-ccccccCChHHHHHHHHhcCCCCCCCCChhhhhcC
Q 003644 609 TGGKHPYGESFER---DANIVKD-RK-DLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNH 665 (805)
Q Consensus 609 tG~~~Pf~~~~~~---~~~~~~~-~~-~~~~~~~~~~~~dLi~~~L~~dP~~Rps~~ell~H 665 (805)
+|+ .||...... ....+.. .. .......+.++.+++.+||+.+|++||++.++++.
T Consensus 201 ~g~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~ 261 (267)
T cd08228 201 ALQ-SPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQI 261 (267)
T ss_pred cCC-CCCccccccHHHHHHHHhcCCCCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHH
Confidence 974 455432211 1112111 11 11122345689999999999999999999999854
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=309.93 Aligned_cols=263 Identities=22% Similarity=0.320 Sum_probs=190.4
Q ss_pred ceEEEeEeeccCCceEEEEEEee--------CCcEEEEEEeecCCc----hHHHHHHHHHHHhC-CCCCeeeecccccCC
Q 003644 376 KLVVFNKEIAKGSNGTVVLEGNY--------EGRSVAVKRLVKTHH----DVALKEIQNLIASD-QHPNIVRWYGVESDQ 442 (805)
Q Consensus 376 ~~~~~~~~LG~GsfGtVy~a~~~--------~g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l-~HpNIV~l~g~~~~~ 442 (805)
+.|.+.+.||+|+||.||++... ++..||+|.+..... ....+|+. ++..+ +||||+++++++.++
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~-~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEME-MMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHH-HHHHhcCCCCEeeEEEEEecC
Confidence 56889999999999999987532 235799999975422 23445655 44555 899999999999999
Q ss_pred ceEEEecccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHH
Q 003644 443 DFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGL 522 (805)
Q Consensus 443 ~~l~LV~E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL 522 (805)
+..|+|||| ..+|+|.+++......... ............+++.+++.++.|++.||
T Consensus 97 ~~~~lv~e~----------~~~~~L~~~i~~~~~~~~~-------------~~~~~~~~~~~~l~~~~~~~~~~qi~~aL 153 (307)
T cd05098 97 GPLYVIVEY----------ASKGNLREYLRARRPPGME-------------YCYNPTQVPEEQLSFKDLVSCAYQVARGM 153 (307)
T ss_pred CceEEEEec----------CCCCcHHHHHHhcCCcccc-------------cccccccCccccCCHHHHHHHHHHHHHHH
Confidence 999999994 4555555555432211000 00000001123477888999999999999
Q ss_pred HHhhhcceeccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHH
Q 003644 523 SHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGC 602 (805)
Q Consensus 523 ~yLH~~~IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGv 602 (805)
+|||+.|++||||||+|||++.++. +||+|||+++....... ........++..|+|||++.+..++.++|||||||
T Consensus 154 ~~lH~~gi~H~dlkp~Nill~~~~~--~kL~dfg~a~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~ 230 (307)
T cd05098 154 EYLASKKCIHRDLAARNVLVTEDNV--MKIADFGLARDIHHIDY-YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGV 230 (307)
T ss_pred HHHHHCCcccccccHHheEEcCCCc--EEECCCcccccccccch-hhccccCCCccceeChHHhccCCCCcHHHHHHHHH
Confidence 9999999999999999999988765 89999999876643211 11112223457899999999888999999999999
Q ss_pred HHHHHHhCCCCCCCCchHHH-HHHHhhc-cccccccCChHHHHHHHHhcCCCCCCCCChhhhhcC
Q 003644 603 ILFFCITGGKHPYGESFERD-ANIVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNH 665 (805)
Q Consensus 603 il~elltG~~~Pf~~~~~~~-~~~~~~~-~~~~~~~~~~~~~dLi~~~L~~dP~~Rps~~ell~H 665 (805)
++|||++++.+||....... ...+... ....+...++++.+++.+||..+|.+||++.+++++
T Consensus 231 ~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~ 295 (307)
T cd05098 231 LLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 295 (307)
T ss_pred HHHHHHcCCCCCCCcCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 99999996688887654332 2222222 222334556799999999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-35 Score=307.38 Aligned_cols=238 Identities=23% Similarity=0.321 Sum_probs=181.2
Q ss_pred eeccCCceEEEEEEee--------CCcEEEEEEeecCCc--hHHHHHHHHHHHhCCCCCeeeecccccCCceEEEecccc
Q 003644 383 EIAKGSNGTVVLEGNY--------EGRSVAVKRLVKTHH--DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERC 452 (805)
Q Consensus 383 ~LG~GsfGtVy~a~~~--------~g~~VAVK~l~~~~~--~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~E~~ 452 (805)
.||+|+||+||++... ....||+|.+..... ...+.++..++..+.||||+++++++.+++..++|||
T Consensus 2 ~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e-- 79 (258)
T cd05078 2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQE-- 79 (258)
T ss_pred CCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEe--
Confidence 5999999999997542 234589998865432 2334444557888999999999999999999999999
Q ss_pred cCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcceec
Q 003644 453 TCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIH 532 (805)
Q Consensus 453 ~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~IvH 532 (805)
|+.+|+|..+++... ..+++..++.++.||+.||+|||+.+|+|
T Consensus 80 --------~~~~g~L~~~l~~~~----------------------------~~~~~~~~~~~~~qi~~~l~~lH~~~iiH 123 (258)
T cd05078 80 --------YVKFGSLDTYLKKNK----------------------------NLINISWKLEVAKQLAWALHFLEDKGLTH 123 (258)
T ss_pred --------cCCCCcHHHHHhcCC----------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCeec
Confidence 555566655553221 12456677899999999999999999999
Q ss_pred cCCCCceEEecCCCCc------eEEEeccCccccccCCCccccccccccCCCCCCChhhhhc-CCCCCcchHHHHHHHHH
Q 003644 533 RDLKPQNVLISKDKSF------CAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ-GRQTRAIDLFSLGCILF 605 (805)
Q Consensus 533 rDLKp~NILl~~~~~~------~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~t~~sDVwSlGvil~ 605 (805)
|||||+|||++.++.. .++++|||++...... ....++..|+|||++.+ ..++.++|||||||++|
T Consensus 124 ~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~~~~-------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~ 196 (258)
T cd05078 124 GNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPK-------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLW 196 (258)
T ss_pred CCCccceEEEecccccccCCCceEEecccccccccCCc-------hhccccCCccCchhccCCCCCCchhhHHHHHHHHH
Confidence 9999999999876542 3789999988654321 22457889999999986 45799999999999999
Q ss_pred HHHhCCCCCCCCchHHHHHHHhhccccccccCChHHHHHHHHhcCCCCCCCCChhhhhcC
Q 003644 606 FCITGGKHPYGESFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNH 665 (805)
Q Consensus 606 elltG~~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dP~~Rps~~ell~H 665 (805)
||++|+.+||..................+....+++.+++.+||+.||++|||++++++.
T Consensus 197 ~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 256 (258)
T cd05078 197 EIFSGGDKPLSALDSQKKLQFYEDRHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRD 256 (258)
T ss_pred HHHcCCCCChhhccHHHHHHHHHccccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence 999987778766443332222222233344455789999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=275.84 Aligned_cols=244 Identities=28% Similarity=0.448 Sum_probs=194.5
Q ss_pred EeeccCCceEEEEEEee-CCcEEEEEEeecCC-----chHHHHHHHHHHHhCCCCCeeeecccccCCceEEEecccccCC
Q 003644 382 KEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCS 455 (805)
Q Consensus 382 ~~LG~GsfGtVy~a~~~-~g~~VAVK~l~~~~-----~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~E~~~~s 455 (805)
++||+|.||+|++++.. +++.||+|+++-.. ...+++|+- +++.+.|.|||+++++...++.+-+|+|+|+.+
T Consensus 8 ekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreic-llkelkhknivrl~dvlhsdkkltlvfe~cdqd 86 (292)
T KOG0662|consen 8 EKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREIC-LLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQD 86 (292)
T ss_pred HhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHH-HHHHhhhcceeehhhhhccCceeEEeHHHhhHH
Confidence 67999999999998665 57899999986443 246889985 888999999999999999999999999999998
Q ss_pred hhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcceeccCC
Q 003644 456 LNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDL 535 (805)
Q Consensus 456 L~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~IvHrDL 535 (805)
|..++-.-+|.+ +.+.++.++.|+++||.++|++++.||||
T Consensus 87 lkkyfdslng~~---------------------------------------d~~~~rsfmlqllrgl~fchshnvlhrdl 127 (292)
T KOG0662|consen 87 LKKYFDSLNGDL---------------------------------------DPEIVRSFMLQLLRGLGFCHSHNVLHRDL 127 (292)
T ss_pred HHHHHHhcCCcC---------------------------------------CHHHHHHHHHHHHhhhhhhhhhhhhhccC
Confidence 888875555543 44566899999999999999999999999
Q ss_pred CCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCC-CCCcchHHHHHHHHHHHHhCCCCC
Q 003644 536 KPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGR-QTRAIDLFSLGCILFFCITGGKHP 614 (805)
Q Consensus 536 Kp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~-~t~~sDVwSlGvil~elltG~~~P 614 (805)
||+|.||+.+|+ +|++|||+++.+.-...+. ...+-|..|.+|.++.+.+ |+...|+||.|||+.|+...|+|-
T Consensus 128 kpqnllin~nge--lkladfglarafgipvrcy---saevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrpl 202 (292)
T KOG0662|consen 128 KPQNLLINRNGE--LKLADFGLARAFGIPVRCY---SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 202 (292)
T ss_pred CcceEEeccCCc--EEecccchhhhcCCceEee---eceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCC
Confidence 999999999887 8999999999876443232 2234689999999999865 799999999999999999888887
Q ss_pred CCCchHHHH--HHHhh--cc-----------------ccccc---------cCChHHHHHHHHhcCCCCCCCCChhhhhc
Q 003644 615 YGESFERDA--NIVKD--RK-----------------DLFLV---------EHIPEAVDLFTRLLDPNPDLRPKAQNVLN 664 (805)
Q Consensus 615 f~~~~~~~~--~~~~~--~~-----------------~~~~~---------~~~~~~~dLi~~~L~~dP~~Rps~~ell~ 664 (805)
|....-.+. .+... .. ..++. .....-+|+++++|.-+|.+|.++++.++
T Consensus 203 fpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq 282 (292)
T KOG0662|consen 203 FPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ 282 (292)
T ss_pred CCCCcHHHHHHHHHHHhCCCccccCCccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence 765443221 11110 00 00000 01123579999999999999999999999
Q ss_pred Cccccc
Q 003644 665 HPFFWT 670 (805)
Q Consensus 665 Hpff~~ 670 (805)
||||..
T Consensus 283 hpyf~d 288 (292)
T KOG0662|consen 283 HPYFSD 288 (292)
T ss_pred Cccccc
Confidence 999965
|
|
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-34 Score=300.17 Aligned_cols=247 Identities=25% Similarity=0.370 Sum_probs=189.5
Q ss_pred cceEEEeEeeccCCceEEEEEEeeCCcEEEEEEeecCCc--hHHHHHHHHHHHhCCCCCeeeecccccCCceEEEecccc
Q 003644 375 GKLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHH--DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERC 452 (805)
Q Consensus 375 ~~~~~~~~~LG~GsfGtVy~a~~~~g~~VAVK~l~~~~~--~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~E~~ 452 (805)
.+.|.+.++||+|+||+||++...+++.||||.+..... ....+|+ .+++.++||||+++++++. .+..|++||
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~-~~l~~l~h~~i~~~~~~~~-~~~~~~v~e-- 80 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEA-NLMKQLQHPRLVRLYAVVT-QEPIYIITE-- 80 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCCcHHHHHHHH-HHHHhcCCcCeeeEEEEEc-cCCcEEEEE--
Confidence 456788899999999999999888899999999875432 3445555 4778889999999999874 457899999
Q ss_pred cCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcceec
Q 003644 453 TCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIH 532 (805)
Q Consensus 453 ~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~IvH 532 (805)
|+.+|+|.+++.... ...+++.+++.++.|++.||+|||+.+++|
T Consensus 81 --------~~~~~~L~~~~~~~~---------------------------~~~~~~~~~~~i~~~i~~al~~LH~~~i~H 125 (260)
T cd05067 81 --------YMENGSLVDFLKTPE---------------------------GIKLTINKLIDMAAQIAEGMAFIERKNYIH 125 (260)
T ss_pred --------cCCCCCHHHHHHhcC---------------------------CCCCCHHHHHHHHHHHHHHHHHHhcCCeec
Confidence 555566655543211 123567788999999999999999999999
Q ss_pred cCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHHHHHhCCC
Q 003644 533 RDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGK 612 (805)
Q Consensus 533 rDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~elltG~~ 612 (805)
|||||+||+++.++. ++|+|||++........ .......++..|+|||++....++.++|||||||++||+++++.
T Consensus 126 ~dl~p~ni~i~~~~~--~~l~dfg~~~~~~~~~~--~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~ 201 (260)
T cd05067 126 RDLRAANILVSETLC--CKIADFGLARLIEDNEY--TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGR 201 (260)
T ss_pred ccccHHhEEEcCCCC--EEEccCcceeecCCCCc--ccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCC
Confidence 999999999988765 89999999977652211 11122335678999999988889999999999999999999558
Q ss_pred CCCCCchHHH-HHHHhhc-cccccccCChHHHHHHHHhcCCCCCCCCChhhhhc
Q 003644 613 HPYGESFERD-ANIVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 664 (805)
Q Consensus 613 ~Pf~~~~~~~-~~~~~~~-~~~~~~~~~~~~~dLi~~~L~~dP~~Rps~~ell~ 664 (805)
+||....... ...+... ....+...+.++.+++.+||..+|++||+++++++
T Consensus 202 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05067 202 IPYPGMTNPEVIQNLERGYRMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRS 255 (260)
T ss_pred CCCCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 8986543322 2222222 22223344578999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-34 Score=302.13 Aligned_cols=256 Identities=20% Similarity=0.307 Sum_probs=191.4
Q ss_pred ceEEEeEeeccCCceEEEEEEee------CCcEEEEEEeecCCch----HHHHHHHHHHHhCCCCCeeeecccccCCceE
Q 003644 376 KLVVFNKEIAKGSNGTVVLEGNY------EGRSVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVRWYGVESDQDFV 445 (805)
Q Consensus 376 ~~~~~~~~LG~GsfGtVy~a~~~------~g~~VAVK~l~~~~~~----~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l 445 (805)
+.|.+.+.||+|+||.||++... ++..||+|.+...... ...+|+. ++..++||||+++++++.+....
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~-~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEAS-VMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred HHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHH-HHHhCCCCceeEEEEEEcCCCCc
Confidence 45778899999999999997543 3478999998654321 2334444 66788999999999999999999
Q ss_pred EEecccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHh
Q 003644 446 YLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHL 525 (805)
Q Consensus 446 ~LV~E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yL 525 (805)
|+|||++ .+|+|.+++......... .-....+++..++.++.||+.||+||
T Consensus 85 ~~v~e~~----------~~~~L~~~l~~~~~~~~~-------------------~~~~~~~~~~~~~~~~~~i~~~l~~l 135 (277)
T cd05032 85 LVVMELM----------AKGDLKSYLRSRRPEAEN-------------------NPGLGPPTLQKFIQMAAEIADGMAYL 135 (277)
T ss_pred EEEEecC----------CCCCHHHHHHhcccchhh-------------------ccCCCCCCHHHHHHHHHHHHHHHHHH
Confidence 9999955 445555544322110000 01123467788899999999999999
Q ss_pred hhcceeccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHH
Q 003644 526 HEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILF 605 (805)
Q Consensus 526 H~~~IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~ 605 (805)
|+.+|+||||||+|||++.++. +||+|||+++.+..... ........++..|+|||.+....++.++|||||||++|
T Consensus 136 H~~~i~H~di~p~nill~~~~~--~kl~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ 212 (277)
T cd05032 136 AAKKFVHRDLAARNCMVAEDLT--VKIGDFGMTRDIYETDY-YRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLW 212 (277)
T ss_pred HhCCccccccChheEEEcCCCC--EEECCcccchhhccCcc-cccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHH
Confidence 9999999999999999988876 89999999987653321 12223345788999999998888999999999999999
Q ss_pred HHHhCCCCCCCCchHHH-HHHHh-hccccccccCChHHHHHHHHhcCCCCCCCCChhhhhc
Q 003644 606 FCITGGKHPYGESFERD-ANIVK-DRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 664 (805)
Q Consensus 606 elltG~~~Pf~~~~~~~-~~~~~-~~~~~~~~~~~~~~~dLi~~~L~~dP~~Rps~~ell~ 664 (805)
|+++++.+||....... ..... ......+...+.++.+++.+||+.+|++|||+.++++
T Consensus 213 el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 273 (277)
T cd05032 213 EMATLAEQPYQGLSNEEVLKFVIDGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVS 273 (277)
T ss_pred HhhccCCCCCccCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 99995588886543322 22222 2222334455688999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=305.45 Aligned_cols=247 Identities=23% Similarity=0.396 Sum_probs=189.3
Q ss_pred eEEEeEeeccCCceEEEEEEee-CCcEEEEEEeecCC-----chHHHHHHHHHHHhCCCCCeeeecccccCCceEEEecc
Q 003644 377 LVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 450 (805)
Q Consensus 377 ~~~~~~~LG~GsfGtVy~a~~~-~g~~VAVK~l~~~~-----~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~E 450 (805)
.|.+.+.||+|+||.||++... +++.||||++.... .....+|+. +++.++||||+++++++.+++..|+|||
T Consensus 2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~-~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVK-VLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHH-HHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 4778899999999999998654 58899999886432 133445654 6788899999999999999999999999
Q ss_pred cccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcce
Q 003644 451 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 530 (805)
Q Consensus 451 ~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~I 530 (805)
+|.+++.+.+ . .+...+++.++..++.||+.||+|||+.++
T Consensus 81 ~~~~~~l~~~----------~-----------------------------~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i 121 (288)
T cd07833 81 YVERTLLELL----------E-----------------------------ASPGGLPPDAVRSYIWQLLQAIAYCHSHNI 121 (288)
T ss_pred cCCCCHHHHH----------H-----------------------------hcCCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 7665443322 1 111335677889999999999999999999
Q ss_pred eccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcC-CCCCcchHHHHHHHHHHHHh
Q 003644 531 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG-RQTRAIDLFSLGCILFFCIT 609 (805)
Q Consensus 531 vHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~t~~sDVwSlGvil~ellt 609 (805)
+||||+|+||+++.++. +||+|||++........ .......++..|+|||++... .++.++|||||||++|+|++
T Consensus 122 ~H~dl~~~ni~~~~~~~--~kl~d~g~~~~~~~~~~--~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~ 197 (288)
T cd07833 122 IHRDIKPENILVSESGV--LKLCDFGFARALRARPA--SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLD 197 (288)
T ss_pred ecCCCCHHHeEECCCCC--EEEEeeecccccCCCcc--ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHh
Confidence 99999999999987765 89999999887654321 112234578999999999888 78999999999999999999
Q ss_pred CCCCCCCCchHHHH--HHHhh--------------c-----------------cccccccCChHHHHHHHHhcCCCCCCC
Q 003644 610 GGKHPYGESFERDA--NIVKD--------------R-----------------KDLFLVEHIPEAVDLFTRLLDPNPDLR 656 (805)
Q Consensus 610 G~~~Pf~~~~~~~~--~~~~~--------------~-----------------~~~~~~~~~~~~~dLi~~~L~~dP~~R 656 (805)
| .+||......+. .+... . ...++...++++.++|++||..||++|
T Consensus 198 g-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 276 (288)
T cd07833 198 G-EPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKER 276 (288)
T ss_pred C-CCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhc
Confidence 7 677764322111 00000 0 001112235789999999999999999
Q ss_pred CChhhhhcCccc
Q 003644 657 PKAQNVLNHPFF 668 (805)
Q Consensus 657 ps~~ell~Hpff 668 (805)
|+++++++||||
T Consensus 277 ps~~~il~~~~f 288 (288)
T cd07833 277 LTCDELLQHPYF 288 (288)
T ss_pred ccHHHHhcCCCC
Confidence 999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=318.40 Aligned_cols=247 Identities=26% Similarity=0.405 Sum_probs=198.0
Q ss_pred EeEeeccCCceEEEEE-EeeCCcEEEEEEeecC-----CchHHHHHHHHHHHhCCCCCeeeecccccCCceEEEeccccc
Q 003644 380 FNKEIAKGSNGTVVLE-GNYEGRSVAVKRLVKT-----HHDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCT 453 (805)
Q Consensus 380 ~~~~LG~GsfGtVy~a-~~~~g~~VAVK~l~~~-----~~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~E~~~ 453 (805)
-.+.||+|.||+||-+ ...+|+.||||++.+. ..++...|+ .++..+.||.||.|-..|+..+.+++|||-+.
T Consensus 568 ~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EV-aILq~l~HPGiV~le~M~ET~ervFVVMEKl~ 646 (888)
T KOG4236|consen 568 ADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEV-AILQNLHHPGIVNLECMFETPERVFVVMEKLH 646 (888)
T ss_pred hHhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHH-HHHHhcCCCCeeEEEEeecCCceEEEEehhhc
Confidence 3467999999999986 4568999999998653 223444455 47889999999999999999999999999665
Q ss_pred CChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcceecc
Q 003644 454 CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHR 533 (805)
Q Consensus 454 ~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~IvHr 533 (805)
|++.++| |.. ..+.+++.....+..||+.||.|||.++|+|.
T Consensus 647 GDMLEMI----------LSs----------------------------EkgRL~er~TkFlvtQIL~ALr~LH~knIvHC 688 (888)
T KOG4236|consen 647 GDMLEMI----------LSS----------------------------EKGRLPERITKFLVTQILVALRYLHFKNIVHC 688 (888)
T ss_pred chHHHHH----------HHh----------------------------hcccchHHHHHHHHHHHHHHHHHhhhcceeec
Confidence 5554444 211 12346677778899999999999999999999
Q ss_pred CCCCceEEecCCCC-ceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHHHHHhCCC
Q 003644 534 DLKPQNVLISKDKS-FCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGK 612 (805)
Q Consensus 534 DLKp~NILl~~~~~-~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~elltG~~ 612 (805)
||||+||||..... .++||||||+|+.+... ....+.+|||.|+|||++..+.|.+.-|+||.|||+|--++| .
T Consensus 689 DLKPENVLLas~~~FPQvKlCDFGfARiIgEk----sFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSG-T 763 (888)
T KOG4236|consen 689 DLKPENVLLASASPFPQVKLCDFGFARIIGEK----SFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSG-T 763 (888)
T ss_pred cCCchheeeccCCCCCceeeccccceeecchh----hhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecc-c
Confidence 99999999975433 36999999999998753 334567899999999999999999999999999999999997 7
Q ss_pred CCCCCchHHHHHHHhhcccc----ccccCChHHHHHHHHhcCCCCCCCCChhhhhcCcccccc
Q 003644 613 HPYGESFERDANIVKDRKDL----FLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTA 671 (805)
Q Consensus 613 ~Pf~~~~~~~~~~~~~~~~~----~~~~~~~~~~dLi~~~L~~dP~~Rps~~ell~Hpff~~~ 671 (805)
.||.++.+-..++ ++..-. ...+.++++.|||..+|+..-.+|.+....+.|||.++.
T Consensus 764 FPFNEdEdIndQI-QNAaFMyPp~PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~y 825 (888)
T KOG4236|consen 764 FPFNEDEDINDQI-QNAAFMYPPNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQDY 825 (888)
T ss_pred ccCCCccchhHHh-hccccccCCCchhhcCHHHHHHHHHHHHHHHHHhcchHhhccchhhhcc
Confidence 8887755433333 222222 233557899999999999999999999999999998653
|
|
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=300.20 Aligned_cols=244 Identities=24% Similarity=0.395 Sum_probs=188.8
Q ss_pred EEEeEeeccCCceEEEEEEe-eCCcEEEEEEeecCCc----hHHHHHHHHHHHhCCCCCeeeecccccCCceEEEecccc
Q 003644 378 VVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERC 452 (805)
Q Consensus 378 ~~~~~~LG~GsfGtVy~a~~-~~g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~E~~ 452 (805)
|.+.+.||+|+||.||++.. .+++.||+|.+..... +...+|+. +++.++||||+++++++.+++.+|++||
T Consensus 2 y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~lv~e-- 78 (255)
T cd08219 2 YNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAV-LLAKMKHPNIVAFKESFEADGHLYIVME-- 78 (255)
T ss_pred ceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHH-HHHhCCCCCcceEEEEEEECCEEEEEEe--
Confidence 56789999999999999854 4689999998854321 23344544 6788899999999999999999999999
Q ss_pred cCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcceec
Q 003644 453 TCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIH 532 (805)
Q Consensus 453 ~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~IvH 532 (805)
|.++|++.+++... +...+++..++.++.||+.||+|||+.+|+|
T Consensus 79 --------~~~~~~l~~~~~~~---------------------------~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H 123 (255)
T cd08219 79 --------YCDGGDLMQKIKLQ---------------------------RGKLFPEDTILQWFVQMCLGVQHIHEKRVLH 123 (255)
T ss_pred --------eCCCCcHHHHHHhc---------------------------cCCCCCHHHHHHHHHHHHHHHHHHhhCCccc
Confidence 55555655544221 1123567788999999999999999999999
Q ss_pred cCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHHHHHhCCC
Q 003644 533 RDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGK 612 (805)
Q Consensus 533 rDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~elltG~~ 612 (805)
+||||+||+++.++. ++++|||++........ ......|++.|+|||++.+..++.++|+||||+++|+|++| .
T Consensus 124 ~dl~p~nili~~~~~--~~l~dfg~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g-~ 197 (255)
T cd08219 124 RDIKSKNIFLTQNGK--VKLGDFGSARLLTSPGA---YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTL-K 197 (255)
T ss_pred CCCCcceEEECCCCc--EEEcccCcceeeccccc---ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhc-c
Confidence 999999999988776 89999999876643211 11234588999999999888899999999999999999997 6
Q ss_pred CCCCCchHHH-H-HHHhhccccccccCChHHHHHHHHhcCCCCCCCCChhhhhcC
Q 003644 613 HPYGESFERD-A-NIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNH 665 (805)
Q Consensus 613 ~Pf~~~~~~~-~-~~~~~~~~~~~~~~~~~~~dLi~~~L~~dP~~Rps~~ell~H 665 (805)
+||....... . .+........+...+.++.++|.+||+.||++||++.+++.-
T Consensus 198 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 198 HPFQANSWKNLILKVCQGSYKPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred CCCCCCCHHHHHHHHhcCCCCCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 6776543322 1 222222222334456789999999999999999999999853
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-34 Score=304.15 Aligned_cols=245 Identities=26% Similarity=0.435 Sum_probs=184.9
Q ss_pred EEeEeeccCCceEEEEEEe-eCCcEEEEEEeecCC-----chHHHHHHHHHHHhCCCCCeeeecccccCCceEEEecccc
Q 003644 379 VFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERC 452 (805)
Q Consensus 379 ~~~~~LG~GsfGtVy~a~~-~~g~~VAVK~l~~~~-----~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~E~~ 452 (805)
...+.||.|++|+||++.. .+|+.||||++.... .....+|+. .++.++||||+++++++.+++..|++|||+
T Consensus 2 ~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~-~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 2 QKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREIS-LLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred chheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHH-HHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 3457899999999999854 479999999986432 123456665 678889999999999999999999999966
Q ss_pred cCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcceec
Q 003644 453 TCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIH 532 (805)
Q Consensus 453 ~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~IvH 532 (805)
..+|.+++ .... ...+++..++.++.|++.||+|||+.+++|
T Consensus 81 ~~~l~~~~-----------~~~~---------------------------~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H 122 (283)
T cd07835 81 DLDLKKYM-----------DSSP---------------------------LTGLDPPLIKSYLYQLLQGIAYCHSHRVLH 122 (283)
T ss_pred CcCHHHHH-----------hhCC---------------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCeeC
Confidence 54444433 2110 023677888999999999999999999999
Q ss_pred cCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcC-CCCCcchHHHHHHHHHHHHhCC
Q 003644 533 RDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG-RQTRAIDLFSLGCILFFCITGG 611 (805)
Q Consensus 533 rDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~t~~sDVwSlGvil~elltG~ 611 (805)
|||+|+||+++.++. ++|+|||++........ ......++..|+|||++.+. .++.++|||||||++|+|++|
T Consensus 123 ~dl~p~nil~~~~~~--~~l~df~~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g- 196 (283)
T cd07835 123 RDLKPQNLLIDREGA--LKLADFGLARAFGVPVR---TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNR- 196 (283)
T ss_pred CCCCHHHEEEcCCCc--EEEeecccccccCCCcc---ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhC-
Confidence 999999999988765 89999999876542211 11223468899999988664 468899999999999999997
Q ss_pred CCCCCCchHHH--HHHHhhc----------------------------cccccccCChHHHHHHHHhcCCCCCCCCChhh
Q 003644 612 KHPYGESFERD--ANIVKDR----------------------------KDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQN 661 (805)
Q Consensus 612 ~~Pf~~~~~~~--~~~~~~~----------------------------~~~~~~~~~~~~~dLi~~~L~~dP~~Rps~~e 661 (805)
.+||....... ..+.... ........++++.++|.+||+.||.+||+++|
T Consensus 197 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ 276 (283)
T cd07835 197 RPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKA 276 (283)
T ss_pred CCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHH
Confidence 67775432211 1111100 00011233468899999999999999999999
Q ss_pred hhcCccc
Q 003644 662 VLNHPFF 668 (805)
Q Consensus 662 ll~Hpff 668 (805)
+++||||
T Consensus 277 il~~~~~ 283 (283)
T cd07835 277 ALQHPYF 283 (283)
T ss_pred HhcCCCC
Confidence 9999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-34 Score=312.98 Aligned_cols=250 Identities=24% Similarity=0.374 Sum_probs=189.0
Q ss_pred ccceEEEeEeeccCCceEEEEEEe-eCCcEEEEEEeecCC-----chHHHHHHHHHHHhCCCCCeeeecccccCC-----
Q 003644 374 IGKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQ----- 442 (805)
Q Consensus 374 i~~~~~~~~~LG~GsfGtVy~a~~-~~g~~VAVK~l~~~~-----~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~----- 442 (805)
+.+.|...+.||+|+||+||++.. .+|+.||||.+.... .....+|+. ++..++||||+++++++...
T Consensus 3 ~~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~-~l~~l~h~ni~~~~~~~~~~~~~~~ 81 (337)
T cd07858 3 VDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIK-LLRHLDHENVIAIKDIMPPPHREAF 81 (337)
T ss_pred cccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHH-HHHhcCCCCccchHHheeccccccc
Confidence 345688889999999999999854 568999999986431 123445664 67778999999999988654
Q ss_pred ceEEEecccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHH
Q 003644 443 DFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGL 522 (805)
Q Consensus 443 ~~l~LV~E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL 522 (805)
...|+|+||+.++|.+++. ....+++..+..++.|++.||
T Consensus 82 ~~~~lv~e~~~~~L~~~~~----------------------------------------~~~~l~~~~~~~i~~qi~~aL 121 (337)
T cd07858 82 NDVYIVYELMDTDLHQIIR----------------------------------------SSQTLSDDHCQYFLYQLLRGL 121 (337)
T ss_pred CcEEEEEeCCCCCHHHHHh----------------------------------------cCCCCCHHHHHHHHHHHHHHH
Confidence 3589999977766554431 112366778899999999999
Q ss_pred HHhhhcceeccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhc-CCCCCcchHHHHH
Q 003644 523 SHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ-GRQTRAIDLFSLG 601 (805)
Q Consensus 523 ~yLH~~~IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~t~~sDVwSlG 601 (805)
+|||+.+++||||||+||+++.++. +||+|||+++...... .......++..|+|||.+.. ..++.++||||||
T Consensus 122 ~~LH~~~i~H~dlkp~Nil~~~~~~--~kL~Dfg~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG 196 (337)
T cd07858 122 KYIHSANVLHRDLKPSNLLLNANCD--LKICDFGLARTTSEKG---DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVG 196 (337)
T ss_pred HHHHhCCEecCCCCHHHEEEcCCCC--EEECcCccccccCCCc---ccccccccccCccChHHHhcCCCCCCcccHHHHH
Confidence 9999999999999999999988765 8999999998764321 11223457889999999875 4688999999999
Q ss_pred HHHHHHHhCCCCCCCCchHHH-HH-H-----------------------Hhhc---c----ccccccCChHHHHHHHHhc
Q 003644 602 CILFFCITGGKHPYGESFERD-AN-I-----------------------VKDR---K----DLFLVEHIPEAVDLFTRLL 649 (805)
Q Consensus 602 vil~elltG~~~Pf~~~~~~~-~~-~-----------------------~~~~---~----~~~~~~~~~~~~dLi~~~L 649 (805)
|++|+|++| .+||....... .. + .... . .......++++.++|++||
T Consensus 197 ~il~~l~~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 275 (337)
T cd07858 197 CIFAELLGR-KPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKML 275 (337)
T ss_pred HHHHHHHcC-CCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHh
Confidence 999999997 77775432110 00 0 0000 0 0011245678999999999
Q ss_pred CCCCCCCCChhhhhcCccccc
Q 003644 650 DPNPDLRPKAQNVLNHPFFWT 670 (805)
Q Consensus 650 ~~dP~~Rps~~ell~Hpff~~ 670 (805)
+.||++|||++++++||||..
T Consensus 276 ~~~P~~Rps~~ell~h~~~~~ 296 (337)
T cd07858 276 VFDPSKRITVEEALAHPYLAS 296 (337)
T ss_pred cCChhhccCHHHHHcCcchhh
Confidence 999999999999999999954
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-34 Score=306.21 Aligned_cols=262 Identities=24% Similarity=0.366 Sum_probs=190.4
Q ss_pred ceEEEeEeeccCCceEEEEEEee------CCcEEEEEEeecCCc---hHHHHHHHHHHHhCCCCCeeeecccccCCceEE
Q 003644 376 KLVVFNKEIAKGSNGTVVLEGNY------EGRSVAVKRLVKTHH---DVALKEIQNLIASDQHPNIVRWYGVESDQDFVY 446 (805)
Q Consensus 376 ~~~~~~~~LG~GsfGtVy~a~~~------~g~~VAVK~l~~~~~---~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~ 446 (805)
+.|.+.+.||+|+||.||++... ++..||+|.+..... ....+|+. .++.++||||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~ 83 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAE-LLTNLQHEHIVKFYGVCGDGDPLI 83 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHH-HHhcCCCCCcceEEEEEccCCceE
Confidence 44778899999999999997532 456799999865432 23445554 778899999999999999999999
Q ss_pred EecccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhh
Q 003644 447 LSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH 526 (805)
Q Consensus 447 LV~E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH 526 (805)
+||| |+.+++|.+++.........+.. .........+++..++.++.||+.||+|||
T Consensus 84 lv~e----------~~~~~~L~~~i~~~~~~~~~~~~-------------~~~~~~~~~~~~~~~~~i~~~i~~al~~lH 140 (291)
T cd05094 84 MVFE----------YMKHGDLNKFLRAHGPDAMILVD-------------GQPRQAKGELGLSQMLHIASQIASGMVYLA 140 (291)
T ss_pred EEEe----------cCCCCcHHHHHHhcCcccccccc-------------cccccCcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 9999 44555555555432110000000 000011134678889999999999999999
Q ss_pred hcceeccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHHH
Q 003644 527 EIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFF 606 (805)
Q Consensus 527 ~~~IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~e 606 (805)
+.+|+||||||+|||++.++. ++|+|||+++....... ........++..|+|||++.+..++.++|||||||++||
T Consensus 141 ~~~i~H~dlkp~Nil~~~~~~--~~l~dfg~a~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e 217 (291)
T cd05094 141 SQHFVHRDLATRNCLVGANLL--VKIGDFGMSRDVYSTDY-YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWE 217 (291)
T ss_pred hCCeeecccCcceEEEccCCc--EEECCCCcccccCCCce-eecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHH
Confidence 999999999999999987765 89999999976543211 111223446888999999999899999999999999999
Q ss_pred HHhCCCCCCCCchHHH-HHHHhh-ccccccccCChHHHHHHHHhcCCCCCCCCChhhhhc
Q 003644 607 CITGGKHPYGESFERD-ANIVKD-RKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 664 (805)
Q Consensus 607 lltG~~~Pf~~~~~~~-~~~~~~-~~~~~~~~~~~~~~dLi~~~L~~dP~~Rps~~ell~ 664 (805)
|++++.+||....... ...+.. .........+.++.+++.+||+.||++||++.++++
T Consensus 218 l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~ 277 (291)
T cd05094 218 IFTYGKQPWFQLSNTEVIECITQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK 277 (291)
T ss_pred HHhCCCCCCCCCCHHHHHHHHhCCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 9995578876543322 222222 122223334678999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-34 Score=299.10 Aligned_cols=249 Identities=29% Similarity=0.437 Sum_probs=194.0
Q ss_pred eEEEeEeeccCCceEEEEEEee-CCcEEEEEEeecCCc----hHHHHHHHHHHHhCCCCCeeeecccccCCceEEEeccc
Q 003644 377 LVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLER 451 (805)
Q Consensus 377 ~~~~~~~LG~GsfGtVy~a~~~-~g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~E~ 451 (805)
.|.+.+.||+|++|.||++... +++.||||++..... ....+|+. .+..++||||+++++++.+.+..|+|||+
T Consensus 2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~-~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELK-TLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHH-HHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 3667789999999999998665 599999999876532 23444554 56778899999999999999999999994
Q ss_pred ccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhh-cce
Q 003644 452 CTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE-IGL 530 (805)
Q Consensus 452 ~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~-~~I 530 (805)
+.+++|.+++... ..+++..++.++.|++.||+|||+ .++
T Consensus 81 ----------~~~~~L~~~l~~~-----------------------------~~l~~~~~~~~~~~l~~~l~~lh~~~~~ 121 (264)
T cd06623 81 ----------MDGGSLADLLKKV-----------------------------GKIPEPVLAYIARQILKGLDYLHTKRHI 121 (264)
T ss_pred ----------cCCCcHHHHHHHc-----------------------------CCCCHHHHHHHHHHHHHHHHHHhccCCC
Confidence 4555555544221 346677889999999999999999 999
Q ss_pred eccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHHHHHhC
Q 003644 531 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG 610 (805)
Q Consensus 531 vHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~elltG 610 (805)
+||||+|+||+++.++. ++|+|||++......... .....++..|+|||.+....++.++|+||||+++|+|++|
T Consensus 122 ~H~~l~~~ni~~~~~~~--~~l~df~~~~~~~~~~~~---~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg 196 (264)
T cd06623 122 IHRDIKPSNLLINSKGE--VKIADFGISKVLENTLDQ---CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALG 196 (264)
T ss_pred ccCCCCHHHEEECCCCC--EEEccCccceecccCCCc---ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhC
Confidence 99999999999988765 899999998876543221 1234578899999999988899999999999999999996
Q ss_pred CCCCCCCch--HH---HHHHHhhcccccccc-CChHHHHHHHHhcCCCCCCCCChhhhhcCcccccc
Q 003644 611 GKHPYGESF--ER---DANIVKDRKDLFLVE-HIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTA 671 (805)
Q Consensus 611 ~~~Pf~~~~--~~---~~~~~~~~~~~~~~~-~~~~~~dLi~~~L~~dP~~Rps~~ell~Hpff~~~ 671 (805)
.+||.... .. ...+........... .+..+.++|.+||..+|++||++.++++||||...
T Consensus 197 -~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~~~~~~~ 262 (264)
T cd06623 197 -KFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQHPFIKKA 262 (264)
T ss_pred -CCCCccccccCHHHHHHHHhcCCCCCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhCHHHHhc
Confidence 77876553 11 112222222222233 56789999999999999999999999999998543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=303.37 Aligned_cols=249 Identities=22% Similarity=0.287 Sum_probs=182.8
Q ss_pred EeEeeccCCceEEEEEEeeC-Cc--EEEEEEeecCC-----chHHHHHHHHHHHhCCCCCeeeecccccCC------ceE
Q 003644 380 FNKEIAKGSNGTVVLEGNYE-GR--SVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQ------DFV 445 (805)
Q Consensus 380 ~~~~LG~GsfGtVy~a~~~~-g~--~VAVK~l~~~~-----~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~------~~l 445 (805)
+.+.||+|+||.||++.... +. .||||.++... .....+|.. .+..++||||+++++++... ...
T Consensus 3 i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~-~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 81 (272)
T cd05075 3 LGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAV-CMKEFDHPNVMRLIGVCLQTVESEGYPSP 81 (272)
T ss_pred cccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHH-HHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence 45789999999999986544 32 69999886432 122334544 66788999999999986432 346
Q ss_pred EEecccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHh
Q 003644 446 YLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHL 525 (805)
Q Consensus 446 ~LV~E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yL 525 (805)
+++|| |+.+|+|.+++...... .+...+++..+..++.||+.||+||
T Consensus 82 ~~v~e----------~~~~~~l~~~~~~~~~~-----------------------~~~~~~~~~~~~~~~~~i~~~l~~l 128 (272)
T cd05075 82 VVILP----------FMKHGDLHSFLLYSRLG-----------------------DCPQYLPTQMLVKFMTDIASGMEYL 128 (272)
T ss_pred EEEEE----------eCCCCcHHHHHHHhccc-----------------------CCcccCCHHHHHHHHHHHHHHHHHH
Confidence 89999 55666666554321100 1123467888899999999999999
Q ss_pred hhcceeccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHH
Q 003644 526 HEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILF 605 (805)
Q Consensus 526 H~~~IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~ 605 (805)
|+.+|+||||||+|||++.++. +||+|||+++........ .......+++.|+|||++.+..++.++|||||||++|
T Consensus 129 H~~~i~H~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~ 205 (272)
T cd05075 129 SSKSFIHRDLAARNCMLNENMN--VCVADFGLSKKIYNGDYY-RQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMW 205 (272)
T ss_pred HHCCeeccccchhheEEcCCCC--EEECCCCcccccCcccce-ecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHH
Confidence 9999999999999999987765 899999999876533211 1112234677899999999888999999999999999
Q ss_pred HHHhCCCCCCCCchHHH-HHHHh-hccccccccCChHHHHHHHHhcCCCCCCCCChhhhhcC
Q 003644 606 FCITGGKHPYGESFERD-ANIVK-DRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNH 665 (805)
Q Consensus 606 elltG~~~Pf~~~~~~~-~~~~~-~~~~~~~~~~~~~~~dLi~~~L~~dP~~Rps~~ell~H 665 (805)
||++++.+||....... ...+. .............+.++|.+||+.||++|||+.+++++
T Consensus 206 el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 267 (272)
T cd05075 206 EIATRGQTPYPGVENSEIYDYLRQGNRLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCE 267 (272)
T ss_pred HHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 99996688886543322 12222 22222334456789999999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=303.05 Aligned_cols=245 Identities=23% Similarity=0.330 Sum_probs=191.0
Q ss_pred eEEEeEeeccCCceEEEEEEeeCCcEEEEEEeecCCc---hHHHHHHHHHHHhCCCCCeeeecccccCCceEEEeccccc
Q 003644 377 LVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHH---DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCT 453 (805)
Q Consensus 377 ~~~~~~~LG~GsfGtVy~a~~~~g~~VAVK~l~~~~~---~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~E~~~ 453 (805)
.|.+.+.||.|+||+||++...+++.||+|.+..... ....+|+. ++..++||||+++++++.+.+..|+|||
T Consensus 7 ~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~-~l~~l~~~~i~~~~~~~~~~~~~~lv~e--- 82 (261)
T cd05148 7 EFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQ-ALKRLRHKHLISLFAVCSVGEPVYIITE--- 82 (261)
T ss_pred HHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHH-HHhcCCCcchhheeeeEecCCCeEEEEe---
Confidence 3667788999999999999877799999999875543 23445554 6788899999999999999999999999
Q ss_pred CChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcceecc
Q 003644 454 CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHR 533 (805)
Q Consensus 454 ~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~IvHr 533 (805)
|+.+|+|.+++.... ...+++..++.++.||+.||+|||+.+|+||
T Consensus 83 -------~~~~~~L~~~~~~~~---------------------------~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~ 128 (261)
T cd05148 83 -------LMEKGSLLAFLRSPE---------------------------GQVLPVASLIDMACQVAEGMAYLEEQNSIHR 128 (261)
T ss_pred -------ecccCCHHHHHhcCC---------------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCeecc
Confidence 555555555543211 1235667789999999999999999999999
Q ss_pred CCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHHHHHhCCCC
Q 003644 534 DLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKH 613 (805)
Q Consensus 534 DLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~elltG~~~ 613 (805)
||||+||+++.++. +||+|||++......... .....++..|+|||++....++.++|||||||++|+|++++.+
T Consensus 129 dl~~~nilv~~~~~--~kl~d~g~~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~ 203 (261)
T cd05148 129 DLAARNILVGEDLV--CKVADFGLARLIKEDVYL---SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQV 203 (261)
T ss_pred ccCcceEEEcCCce--EEEccccchhhcCCcccc---ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCC
Confidence 99999999987765 899999999876533211 1233467789999999888899999999999999999996688
Q ss_pred CCCCchHHH-HH-HHhhccccccccCChHHHHHHHHhcCCCCCCCCChhhhhc
Q 003644 614 PYGESFERD-AN-IVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 664 (805)
Q Consensus 614 Pf~~~~~~~-~~-~~~~~~~~~~~~~~~~~~dLi~~~L~~dP~~Rps~~ell~ 664 (805)
||....... .. +........+...++++.++|.+||+.||.+|||+.++++
T Consensus 204 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~ 256 (261)
T cd05148 204 PYPGMNNHEVYDQITAGYRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALRE 256 (261)
T ss_pred CCCcCCHHHHHHHHHhCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 986543322 22 2222222233456688999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-34 Score=299.94 Aligned_cols=240 Identities=24% Similarity=0.345 Sum_probs=180.7
Q ss_pred eeccCCceEEEEEEee---CCcEEEEEEeecCCch----HHHHHHHHHHHhCCCCCeeeecccccCCceEEEecccccCC
Q 003644 383 EIAKGSNGTVVLEGNY---EGRSVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCS 455 (805)
Q Consensus 383 ~LG~GsfGtVy~a~~~---~g~~VAVK~l~~~~~~----~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~E~~~~s 455 (805)
.||+|+||.||++... .+..||||++...... ...+|+. +++.++||||+++++++.. +..++|||
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~-~l~~l~h~~ii~~~~~~~~-~~~~lv~e----- 74 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAE-IMHQLDNPYIVRMIGVCEA-EALMLVME----- 74 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHH-HHHhcCCCCeEEEEEEEcC-CCeEEEEE-----
Confidence 3899999999997543 4567999998654322 2335554 7788999999999998864 57899999
Q ss_pred hhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcceeccCC
Q 003644 456 LNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDL 535 (805)
Q Consensus 456 L~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~IvHrDL 535 (805)
|.++|+|.+++... ...+++..++.++.||+.||+|||+.+++||||
T Consensus 75 -----~~~~~~L~~~l~~~----------------------------~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl 121 (257)
T cd05115 75 -----MASGGPLNKFLSGK----------------------------KDEITVSNVVELMHQVSMGMKYLEGKNFVHRDL 121 (257)
T ss_pred -----eCCCCCHHHHHHhC----------------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccc
Confidence 55556666554321 124677888999999999999999999999999
Q ss_pred CCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCCC
Q 003644 536 KPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY 615 (805)
Q Consensus 536 Kp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~elltG~~~Pf 615 (805)
||+|||++.++. +||+|||+++................++..|+|||++....++.++|||||||++||+++.+.+||
T Consensus 122 kp~nil~~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~ 199 (257)
T cd05115 122 AARNVLLVNQHY--AKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPY 199 (257)
T ss_pred chheEEEcCCCc--EEeccCCccccccCCccceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCc
Confidence 999999987765 899999999866433222111122234678999999988889999999999999999997447788
Q ss_pred CCchHHHH-H-HHhhccccccccCChHHHHHHHHhcCCCCCCCCChhhhhc
Q 003644 616 GESFERDA-N-IVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 664 (805)
Q Consensus 616 ~~~~~~~~-~-~~~~~~~~~~~~~~~~~~dLi~~~L~~dP~~Rps~~ell~ 664 (805)
........ . +........+...++++.++|.+||+.||++||++.++.+
T Consensus 200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~ 250 (257)
T cd05115 200 KKMKGPEVMSFIEQGKRLDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEE 250 (257)
T ss_pred CcCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 66443322 2 2222223334455789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=298.21 Aligned_cols=247 Identities=26% Similarity=0.389 Sum_probs=191.4
Q ss_pred cceEEEeEeeccCCceEEEEEEeeCCcEEEEEEeecCCc--hHHHHHHHHHHHhCCCCCeeeecccccCCceEEEecccc
Q 003644 375 GKLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHH--DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERC 452 (805)
Q Consensus 375 ~~~~~~~~~LG~GsfGtVy~a~~~~g~~VAVK~l~~~~~--~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~E~~ 452 (805)
.+.|.+.+.||+|+||+||++...+++.||||.+..... ....+|+. +++.++||||+++++++.+....++|||
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~~v~e-- 81 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQ-IMKKLRHDKLVQLYAVCSEEEPIYIVTE-- 81 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCccCHHHHHHHHH-HHhhCCCCCEeeeeeeeecCCceEEEEe--
Confidence 456888999999999999998877788999999875432 33445554 7788999999999999999899999999
Q ss_pred cCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcceec
Q 003644 453 TCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIH 532 (805)
Q Consensus 453 ~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~IvH 532 (805)
|+.+++|.+++.... ...+++..++.++.|++.||+|||+.+++|
T Consensus 82 --------~~~~~~L~~~i~~~~---------------------------~~~~~~~~~~~~~~~i~~al~~lh~~~i~h 126 (261)
T cd05034 82 --------YMSKGSLLDFLKSGE---------------------------GKKLRLPQLVDMAAQIAEGMAYLESRNYIH 126 (261)
T ss_pred --------ccCCCCHHHHHhccc---------------------------cCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence 555566665553321 123567788999999999999999999999
Q ss_pred cCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHHHHHhCCC
Q 003644 533 RDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGK 612 (805)
Q Consensus 533 rDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~elltG~~ 612 (805)
+||||+||+++.++. +||+|||++....... ........++..|+|||.+.+..++.++|+|||||++||++++++
T Consensus 127 ~di~p~nili~~~~~--~~l~d~g~~~~~~~~~--~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~ 202 (261)
T cd05034 127 RDLAARNILVGENLV--CKIADFGLARLIEDDE--YTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGR 202 (261)
T ss_pred CCcchheEEEcCCCC--EEECccccceeccchh--hhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCC
Confidence 999999999988865 8999999988765321 111112235678999999998889999999999999999999668
Q ss_pred CCCCCchHHH-HH-HHhhccccccccCChHHHHHHHHhcCCCCCCCCChhhhh
Q 003644 613 HPYGESFERD-AN-IVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVL 663 (805)
Q Consensus 613 ~Pf~~~~~~~-~~-~~~~~~~~~~~~~~~~~~dLi~~~L~~dP~~Rps~~ell 663 (805)
+||....... .. +........+...++++.+++.+||+.+|.+||+++++.
T Consensus 203 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~ 255 (261)
T cd05034 203 VPYPGMTNREVLEQVERGYRMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQ 255 (261)
T ss_pred CCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHH
Confidence 8986543322 12 221112223344567899999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=302.56 Aligned_cols=247 Identities=23% Similarity=0.316 Sum_probs=187.2
Q ss_pred cceEEEeEeeccCCceEEEEEEe-eCCc----EEEEEEeecCCch----HHHHHHHHHHHhCCCCCeeeecccccCCceE
Q 003644 375 GKLVVFNKEIAKGSNGTVVLEGN-YEGR----SVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVRWYGVESDQDFV 445 (805)
Q Consensus 375 ~~~~~~~~~LG~GsfGtVy~a~~-~~g~----~VAVK~l~~~~~~----~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l 445 (805)
..+|.+.+.||+|+||+||++.. .+|+ .||||.+...... ...+|+ ..+..+.||||+++++++... ..
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~-~~l~~~~~~~i~~~~~~~~~~-~~ 83 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEA-YVMAGVGSPYVCRLLGICLTS-TV 83 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHH-HHHHhcCCCCCceEEEEEcCC-Cc
Confidence 34577889999999999999853 3454 4899998654322 223344 366788999999999998764 57
Q ss_pred EEecccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHh
Q 003644 446 YLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHL 525 (805)
Q Consensus 446 ~LV~E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yL 525 (805)
++++| |+++|+|.++++.. ...+++..++.++.||+.||+||
T Consensus 84 ~l~~~----------~~~~g~l~~~l~~~----------------------------~~~~~~~~~~~~~~qi~~~L~~l 125 (279)
T cd05109 84 QLVTQ----------LMPYGCLLDYVREN----------------------------KDRIGSQDLLNWCVQIAKGMSYL 125 (279)
T ss_pred EEEEE----------cCCCCCHHHHHhhc----------------------------cCCCCHHHHHHHHHHHHHHHHHH
Confidence 88999 66777777665421 12367788899999999999999
Q ss_pred hhcceeccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHH
Q 003644 526 HEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILF 605 (805)
Q Consensus 526 H~~~IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~ 605 (805)
|+.+|+||||||+|||++.++. +||+|||+++......... ......++..|+|||.+.+..++.++|||||||++|
T Consensus 126 H~~~iiH~dlkp~Nil~~~~~~--~kL~dfG~~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~ 202 (279)
T cd05109 126 EEVRLVHRDLAARNVLVKSPNH--VKITDFGLARLLDIDETEY-HADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVW 202 (279)
T ss_pred HHCCeeccccccceEEEcCCCc--EEECCCCceeeccccccee-ecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHH
Confidence 9999999999999999987765 8999999998775322111 111223567899999999888999999999999999
Q ss_pred HHHhCCCCCCCCchHHH-HHHHhh-ccccccccCChHHHHHHHHhcCCCCCCCCChhhhhc
Q 003644 606 FCITGGKHPYGESFERD-ANIVKD-RKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 664 (805)
Q Consensus 606 elltG~~~Pf~~~~~~~-~~~~~~-~~~~~~~~~~~~~~dLi~~~L~~dP~~Rps~~ell~ 664 (805)
||++.+.+||....... ...+.. .....+...++++.+++.+||+.||+.||++.++++
T Consensus 203 el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~ 263 (279)
T cd05109 203 ELMTFGAKPYDGIPAREIPDLLEKGERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVD 263 (279)
T ss_pred HHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 99995588887644322 222222 222233445678999999999999999999999984
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=306.67 Aligned_cols=263 Identities=23% Similarity=0.349 Sum_probs=190.9
Q ss_pred ceEEEeEeeccCCceEEEEEEee------CCcEEEEEEeecCCch----HHHHHHHHHHHhC-CCCCeeeecccccCCce
Q 003644 376 KLVVFNKEIAKGSNGTVVLEGNY------EGRSVAVKRLVKTHHD----VALKEIQNLIASD-QHPNIVRWYGVESDQDF 444 (805)
Q Consensus 376 ~~~~~~~~LG~GsfGtVy~a~~~------~g~~VAVK~l~~~~~~----~~~~Ei~~ll~~l-~HpNIV~l~g~~~~~~~ 444 (805)
..|.+.+.||+|+||.||++... ....||+|++...... ...+|+. ++..+ +||||+++++++.+++.
T Consensus 12 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~-~l~~l~~h~~i~~~~~~~~~~~~ 90 (293)
T cd05053 12 DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEME-MMKMIGKHKNIINLLGVCTQEGP 90 (293)
T ss_pred hHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHH-HHHhhcCCCCeeeEEEEEcCCCC
Confidence 45778899999999999997543 2468999998754322 2445665 45555 89999999999999999
Q ss_pred EEEecccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHH
Q 003644 445 VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSH 524 (805)
Q Consensus 445 l~LV~E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~y 524 (805)
.|++|| |..+|+|..+++.......... .....-....+++..++.++.||+.||+|
T Consensus 91 ~~li~e----------~~~~~~L~~~l~~~~~~~~~~~-------------~~~~~~~~~~l~~~~~~~i~~qi~~al~~ 147 (293)
T cd05053 91 LYVVVE----------YAAHGNLRDFLRARRPPGEYAS-------------PDDPRPPEETLTQKDLVSFAYQVARGMEF 147 (293)
T ss_pred eEEEEE----------eCCCCcHHHHHHhcCCCccccc-------------cccccccccccCHHHHHHHHHHHHHHHHH
Confidence 999999 4455555555543211100000 00000112457788999999999999999
Q ss_pred hhhcceeccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHH
Q 003644 525 LHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCIL 604 (805)
Q Consensus 525 LH~~~IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil 604 (805)
||+.+|+||||||+|||++.++. +||+|||+++.+..... ........++..|+|||++.+..++.++|||||||++
T Consensus 148 LH~~~ivH~dlkp~Nil~~~~~~--~kL~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il 224 (293)
T cd05053 148 LASKKCIHRDLAARNVLVTEDHV--MKIADFGLARDIHHIDY-YRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLL 224 (293)
T ss_pred HHHCCccccccceeeEEEcCCCe--EEeCccccccccccccc-eeccCCCCCCccccCHHHhccCCcCcccceeehhhHH
Confidence 99999999999999999987765 89999999987653221 1112223356789999999888999999999999999
Q ss_pred HHHHhCCCCCCCCchHH-HHHHHhhc-cccccccCChHHHHHHHHhcCCCCCCCCChhhhhcC
Q 003644 605 FFCITGGKHPYGESFER-DANIVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNH 665 (805)
Q Consensus 605 ~elltG~~~Pf~~~~~~-~~~~~~~~-~~~~~~~~~~~~~dLi~~~L~~dP~~Rps~~ell~H 665 (805)
||+++.+..||...... ....+... ....+....+++.+|+.+||..||++|||+.|++++
T Consensus 225 ~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~ 287 (293)
T cd05053 225 WEIFTLGGSPYPGIPVEELFKLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED 287 (293)
T ss_pred HHHhcCCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 99998557787654322 22222222 222334556789999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=315.76 Aligned_cols=287 Identities=21% Similarity=0.296 Sum_probs=192.1
Q ss_pred ceEEEeEeeccCCceEEEEEE------eeCCcEEEEEEeecCCc----hHHHHHHHHHHHhCCCCCeeeecccccC-Cce
Q 003644 376 KLVVFNKEIAKGSNGTVVLEG------NYEGRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESD-QDF 444 (805)
Q Consensus 376 ~~~~~~~~LG~GsfGtVy~a~------~~~g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~-~~~ 444 (805)
++|.+.+.||+|+||+||++. ..+++.||||+++.... ....+|+..+....+||||++++++|.. +..
T Consensus 7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 86 (343)
T cd05103 7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 86 (343)
T ss_pred hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCc
Confidence 457888999999999999984 24578999999965322 2355677755444589999999998765 456
Q ss_pred EEEeccccc-CChhhHHHHhcCC--------------------HHHHHhhhhccchhhHHH-------Hhhhcccccchh
Q 003644 445 VYLSLERCT-CSLNDLIYVLSGS--------------------FEEQLNAKEQDSNLLNEV-------RIRLLPVMENTK 496 (805)
Q Consensus 445 l~LV~E~~~-~sL~d~iy~~~Gs--------------------L~~~L~~~~~~~~~l~~~-------~~~~~~~~~~~~ 496 (805)
.+++||||. ++|.+++....+. +.+.+............. ............
T Consensus 87 ~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (343)
T cd05103 87 LMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA 166 (343)
T ss_pred eEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhh
Confidence 899999776 3666665432211 111100000000000000 000000000000
Q ss_pred hHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccC
Q 003644 497 DIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYG 576 (805)
Q Consensus 497 ~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~g 576 (805)
....+....+++..+..++.||+.||+|||+.+|+||||||+|||++.++. +||+|||+++........ .......+
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~--~kl~dfg~~~~~~~~~~~-~~~~~~~~ 243 (343)
T cd05103 167 EQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNV--VKICDFGLARDIYKDPDY-VRKGDARL 243 (343)
T ss_pred hhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCc--EEEEecccccccccCcch-hhcCCCCC
Confidence 111123345788999999999999999999999999999999999987765 899999999876432211 11122335
Q ss_pred CCCCCChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHH--HHHHH-hhccccccccCChHHHHHHHHhcCCCC
Q 003644 577 SSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFER--DANIV-KDRKDLFLVEHIPEAVDLFTRLLDPNP 653 (805)
Q Consensus 577 t~~y~APE~l~~~~~t~~sDVwSlGvil~elltG~~~Pf~~~~~~--~~~~~-~~~~~~~~~~~~~~~~dLi~~~L~~dP 653 (805)
+..|+|||++.+..++.++|||||||++|+|++++..||...... ....+ .......+...++++.+++.+||+.||
T Consensus 244 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~~p 323 (343)
T cd05103 244 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEP 323 (343)
T ss_pred CcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCCCCCCHHHHHHHHHHccCCh
Confidence 678999999998889999999999999999998567888653211 11112 112222233356789999999999999
Q ss_pred CCCCChhhhhcC
Q 003644 654 DLRPKAQNVLNH 665 (805)
Q Consensus 654 ~~Rps~~ell~H 665 (805)
++||++.|+++|
T Consensus 324 ~~Rps~~eil~~ 335 (343)
T cd05103 324 SQRPTFSELVEH 335 (343)
T ss_pred hhCcCHHHHHHH
Confidence 999999999976
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-34 Score=304.69 Aligned_cols=244 Identities=25% Similarity=0.329 Sum_probs=181.8
Q ss_pred eEEEeEeeccCCceEEEEEE-----eeCCcEEEEEEeecCCc----hHHHHHHHHHHHhCCCCCeeeecccccC--CceE
Q 003644 377 LVVFNKEIAKGSNGTVVLEG-----NYEGRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESD--QDFV 445 (805)
Q Consensus 377 ~~~~~~~LG~GsfGtVy~a~-----~~~g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~--~~~l 445 (805)
.+.+.+.||+|+||+||++. ..+++.||+|.+..... ....+|+. ++..++||||+++++++.+ ....
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~-~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (283)
T cd05080 5 YLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEIN-ILKTLYHENIVKYKGCCSEQGGKGL 83 (283)
T ss_pred hceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHH-HHHhCCCCCEeeEEEEEecCCCceE
Confidence 34778999999999998743 24678999999875432 23345654 7788899999999998765 3468
Q ss_pred EEecccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHh
Q 003644 446 YLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHL 525 (805)
Q Consensus 446 ~LV~E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yL 525 (805)
|+||| |..+|+|.+++.. ..+++.+++.++.|++.||+||
T Consensus 84 ~lv~e----------~~~~~~l~~~~~~------------------------------~~l~~~~~~~i~~~l~~~l~~l 123 (283)
T cd05080 84 QLIME----------YVPLGSLRDYLPK------------------------------HKLNLAQLLLFAQQICEGMAYL 123 (283)
T ss_pred EEEec----------CCCCCCHHHHHHH------------------------------cCCCHHHHHHHHHHHHHHHHHH
Confidence 99999 5555666555421 2367778899999999999999
Q ss_pred hhcceeccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHH
Q 003644 526 HEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILF 605 (805)
Q Consensus 526 H~~~IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~ 605 (805)
|+.+|+||||||+|||++.++. +||+|||+++................++..|+|||++....++.++|||||||++|
T Consensus 124 H~~~i~H~dlkp~Nili~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~ 201 (283)
T cd05080 124 HSQHYIHRDLAARNVLLDNDRL--VKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLY 201 (283)
T ss_pred HHCCeeccccChheEEEcCCCc--EEEeecccccccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHH
Confidence 9999999999999999987765 89999999987654322111122234567799999998888999999999999999
Q ss_pred HHHhCCCCCCCCchHHHHH----------------HHhh-ccccccccCChHHHHHHHHhcCCCCCCCCChhhhhc
Q 003644 606 FCITGGKHPYGESFERDAN----------------IVKD-RKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 664 (805)
Q Consensus 606 elltG~~~Pf~~~~~~~~~----------------~~~~-~~~~~~~~~~~~~~dLi~~~L~~dP~~Rps~~ell~ 664 (805)
||++| ..||......... .... .....+...+.++.+++.+||+.||+.||+++++++
T Consensus 202 el~tg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~ 276 (283)
T cd05080 202 ELLTH-CDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276 (283)
T ss_pred HHHhC-CCCCCCCcchhhhhhcccccccchhhhhhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 99997 6676543211100 0000 111112334578999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-34 Score=303.45 Aligned_cols=246 Identities=22% Similarity=0.292 Sum_probs=182.6
Q ss_pred eEEEeEeeccCCceEEEEEEee-CCc----EEEEEEeecCCchHHHHHHH---HHHHhCCCCCeeeecccccCCceEEEe
Q 003644 377 LVVFNKEIAKGSNGTVVLEGNY-EGR----SVAVKRLVKTHHDVALKEIQ---NLIASDQHPNIVRWYGVESDQDFVYLS 448 (805)
Q Consensus 377 ~~~~~~~LG~GsfGtVy~a~~~-~g~----~VAVK~l~~~~~~~~~~Ei~---~ll~~l~HpNIV~l~g~~~~~~~l~LV 448 (805)
.|.+.+.||+|+||+||++... +|+ .||+|.+........+.++. ..++.++||||+++++++.. ...+++
T Consensus 8 ~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~i 86 (279)
T cd05111 8 ELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQLV 86 (279)
T ss_pred hceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEEE
Confidence 4566788999999999998543 454 47788775433333333322 25577899999999998764 457889
Q ss_pred cccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhc
Q 003644 449 LERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI 528 (805)
Q Consensus 449 ~E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~ 528 (805)
+| |+++|+|.++++.. ...+++..++.++.||+.||+|||+.
T Consensus 87 ~e----------~~~~gsL~~~l~~~----------------------------~~~~~~~~~~~i~~qi~~~l~~lH~~ 128 (279)
T cd05111 87 TQ----------LSPLGSLLDHVRQH----------------------------RDSLDPQRLLNWCVQIAKGMYYLEEH 128 (279)
T ss_pred EE----------eCCCCcHHHHHHhc----------------------------ccCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 99 66677777665432 12367778899999999999999999
Q ss_pred ceeccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHHHHH
Q 003644 529 GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCI 608 (805)
Q Consensus 529 ~IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~ell 608 (805)
+++||||||+|||++.++. +||+|||+++......... ......++..|+|||++.+..++.++|||||||++||++
T Consensus 129 ~iiH~dlkp~nili~~~~~--~kl~Dfg~~~~~~~~~~~~-~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~ 205 (279)
T cd05111 129 RMVHRNLAARNILLKSDSI--VQIADFGVADLLYPDDKKY-FYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMM 205 (279)
T ss_pred CEeccccCcceEEEcCCCc--EEEcCCccceeccCCCccc-ccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHH
Confidence 9999999999999987765 8999999998764332111 112334678899999999889999999999999999999
Q ss_pred hCCCCCCCCchHHH-HHHHhhccc-cccccCChHHHHHHHHhcCCCCCCCCChhhhhc
Q 003644 609 TGGKHPYGESFERD-ANIVKDRKD-LFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 664 (805)
Q Consensus 609 tG~~~Pf~~~~~~~-~~~~~~~~~-~~~~~~~~~~~dLi~~~L~~dP~~Rps~~ell~ 664 (805)
+.+..||....... ..++..... ..+.....++.+++.+||..||++||++.|+++
T Consensus 206 t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~ 263 (279)
T cd05111 206 SYGAEPYAGMRPHEVPDLLEKGERLAQPQICTIDVYMVMVKCWMIDENVRPTFKELAN 263 (279)
T ss_pred cCCCCCCCCCCHHHHHHHHHCCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 84477886643322 233332222 122234568899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=297.90 Aligned_cols=246 Identities=24% Similarity=0.376 Sum_probs=186.7
Q ss_pred ceEEEeEeeccCCceEEEEEEeeCCcEEEEEEeecCCc--hHHHHHHHHHHHhCCCCCeeeecccccCCceEEEeccccc
Q 003644 376 KLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHH--DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCT 453 (805)
Q Consensus 376 ~~~~~~~~LG~GsfGtVy~a~~~~g~~VAVK~l~~~~~--~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~E~~~ 453 (805)
+.|.+.+.||+|++|+||++....+..||+|++..... ....+|+. +++.++||||+++++++. .+..|++||
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~~~~~~~~E~~-~l~~l~h~~i~~~~~~~~-~~~~~~v~e--- 80 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQ-IMKKLRHDKLVPLYAVVS-EEPIYIVTE--- 80 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCccHHHHHHHHH-HHHhCCCCCeeeEEEEEc-CCCcEEEEE---
Confidence 45778899999999999998777777899998865432 23445554 778899999999999875 456899999
Q ss_pred CChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcceecc
Q 003644 454 CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHR 533 (805)
Q Consensus 454 ~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~IvHr 533 (805)
|+.+|+|.++++... ...+++..+..++.|++.||+|||+.+|+||
T Consensus 81 -------~~~~~~L~~~~~~~~---------------------------~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~ 126 (260)
T cd05069 81 -------FMGKGSLLDFLKEGD---------------------------GKYLKLPQLVDMAAQIADGMAYIERMNYIHR 126 (260)
T ss_pred -------cCCCCCHHHHHhhCC---------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCEeec
Confidence 555556655543211 1225667788999999999999999999999
Q ss_pred CCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHHHHHhCCCC
Q 003644 534 DLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKH 613 (805)
Q Consensus 534 DLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~elltG~~~ 613 (805)
||||+||++++++. ++|+|||+++....... .......++..|+|||.+.+..++.++|||||||++|||++++.+
T Consensus 127 dl~~~Nill~~~~~--~~l~dfg~~~~~~~~~~--~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~ 202 (260)
T cd05069 127 DLRAANILVGDNLV--CKIADFGLARLIEDNEY--TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRV 202 (260)
T ss_pred ccCcceEEEcCCCe--EEECCCccceEccCCcc--cccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCC
Confidence 99999999987765 89999999976643211 111222357789999999888899999999999999999996688
Q ss_pred CCCCchHHH-HHHHhhc-cccccccCChHHHHHHHHhcCCCCCCCCChhhhhc
Q 003644 614 PYGESFERD-ANIVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 664 (805)
Q Consensus 614 Pf~~~~~~~-~~~~~~~-~~~~~~~~~~~~~dLi~~~L~~dP~~Rps~~ell~ 664 (805)
||....... ...+... ....+...+..+.+++.+||..||++||+++++++
T Consensus 203 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 255 (260)
T cd05069 203 PYPGMVNREVLEQVERGYRMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQS 255 (260)
T ss_pred CCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 887643322 2222221 22223345678999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-34 Score=307.59 Aligned_cols=249 Identities=24% Similarity=0.364 Sum_probs=189.1
Q ss_pred cceEEEeEeeccCCceEEEEEEee------CCcEEEEEEeecCCch----HHHHHHHHHHHhC-CCCCeeeecccccCCc
Q 003644 375 GKLVVFNKEIAKGSNGTVVLEGNY------EGRSVAVKRLVKTHHD----VALKEIQNLIASD-QHPNIVRWYGVESDQD 443 (805)
Q Consensus 375 ~~~~~~~~~LG~GsfGtVy~a~~~------~g~~VAVK~l~~~~~~----~~~~Ei~~ll~~l-~HpNIV~l~g~~~~~~ 443 (805)
.+.|.+.+.||+|+||.||++... ++..||||+++..... ...+|+. +++.+ +||||+++++++.+.+
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~-~l~~l~~h~~iv~~~~~~~~~~ 112 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELK-IMSHLGNHENIVNLLGACTIGG 112 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHH-HHHhccCCCCcceEEEEEecCC
Confidence 356888999999999999997532 3568999998754322 2345655 55666 8999999999999999
Q ss_pred eEEEecccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHH
Q 003644 444 FVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLS 523 (805)
Q Consensus 444 ~l~LV~E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~ 523 (805)
..|+||| |+.+|+|.++++... ...+++.+++.++.|++.||+
T Consensus 113 ~~~lv~e----------~~~~~~L~~~i~~~~---------------------------~~~l~~~~~~~i~~~i~~~l~ 155 (302)
T cd05055 113 PILVITE----------YCCYGDLLNFLRRKR---------------------------ESFLTLEDLLSFSYQVAKGMA 155 (302)
T ss_pred ceEEEEE----------cCCCCcHHHHHHhCC---------------------------CCCCCHHHHHHHHHHHHHHHH
Confidence 9999999 666666666654321 122677888999999999999
Q ss_pred HhhhcceeccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHH
Q 003644 524 HLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCI 603 (805)
Q Consensus 524 yLH~~~IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvi 603 (805)
|||+.+|+|+||||+|||++.++. ++|+|||+++........ .......++..|+|||++....++.++|||||||+
T Consensus 156 ~lH~~~ivH~dlkp~Nil~~~~~~--~~l~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvi 232 (302)
T cd05055 156 FLASKNCIHRDLAARNVLLTHGKI--VKICDFGLARDIMNDSNY-VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIL 232 (302)
T ss_pred HHHHCCeehhhhccceEEEcCCCe--EEECCCcccccccCCCce-eecCCCCcccccCCHhhhccCCCCcHhHHHHHHHH
Confidence 999999999999999999976654 899999999866533211 11122346788999999998899999999999999
Q ss_pred HHHHHhCCCCCCCCchHHH--HHHHhhc-cccccccCChHHHHHHHHhcCCCCCCCCChhhhhc
Q 003644 604 LFFCITGGKHPYGESFERD--ANIVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 664 (805)
Q Consensus 604 l~elltG~~~Pf~~~~~~~--~~~~~~~-~~~~~~~~~~~~~dLi~~~L~~dP~~Rps~~ell~ 664 (805)
+|||++++.+||....... ....... ....+...++++.+++.+||+.+|++||++.|+++
T Consensus 233 l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~ 296 (302)
T cd05055 233 LWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ 296 (302)
T ss_pred HHHHHhCCCCCcCCCCchHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 9999985577876543221 1222211 11222344678999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=305.34 Aligned_cols=251 Identities=25% Similarity=0.380 Sum_probs=186.4
Q ss_pred cceEEEeEeeccCCceEEEEEEe-eCCcEEEEEEeecCC-----chHHHHHHHHHHHhCCCCCeeeecccccCC------
Q 003644 375 GKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQ------ 442 (805)
Q Consensus 375 ~~~~~~~~~LG~GsfGtVy~a~~-~~g~~VAVK~l~~~~-----~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~------ 442 (805)
.+.|.+.+.||+|+||.||++.. .+++.||||++.... .....+|+. ++..++||||+++++++.+.
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~~~ 85 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIK-ILKKLKHPNVVPLIDMAVERPDKSKR 85 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHH-HHHhcCCCCccchhhheecccccccc
Confidence 46688999999999999999864 468999999985432 123456765 67888999999999987543
Q ss_pred --ceEEEecccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHH
Q 003644 443 --DFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVS 520 (805)
Q Consensus 443 --~~l~LV~E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~ 520 (805)
..+|+|+||+..+|.+.+.. ....+++..+..++.|+++
T Consensus 86 ~~~~~~lv~~~~~~~l~~~~~~---------------------------------------~~~~~~~~~~~~i~~~l~~ 126 (311)
T cd07866 86 KRGSVYMVTPYMDHDLSGLLEN---------------------------------------PSVKLTESQIKCYMLQLLE 126 (311)
T ss_pred cCceEEEEEecCCcCHHHHHhc---------------------------------------cccCCCHHHHHHHHHHHHH
Confidence 35799999776554443311 1123677888999999999
Q ss_pred HHHHhhhcceeccCCCCceEEecCCCCceEEEeccCccccccCCCcccc--------ccccccCCCCCCChhhhhcC-CC
Q 003644 521 GLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLT--------QNATGYGSSGWQAPEQLLQG-RQ 591 (805)
Q Consensus 521 gL~yLH~~~IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~--------~~~~~~gt~~y~APE~l~~~-~~ 591 (805)
||+|||+.||+||||||+||+++.++. ++|+|||+++.......... ......+++.|+|||.+.+. .+
T Consensus 127 al~~lH~~~i~H~dl~p~nil~~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 204 (311)
T cd07866 127 GINYLHENHILHRDIKAANILIDNQGI--LKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRY 204 (311)
T ss_pred HHHHHHhCCeecCCCCHHHEEECCCCC--EEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCcc
Confidence 999999999999999999999988776 89999999987653321111 11223478889999988754 57
Q ss_pred CCcchHHHHHHHHHHHHhCCCCCCCCchHHHH--HHHhhcc--------------c---------------cccccCChH
Q 003644 592 TRAIDLFSLGCILFFCITGGKHPYGESFERDA--NIVKDRK--------------D---------------LFLVEHIPE 640 (805)
Q Consensus 592 t~~sDVwSlGvil~elltG~~~Pf~~~~~~~~--~~~~~~~--------------~---------------~~~~~~~~~ 640 (805)
+.++|||||||++|||++| .+||........ .+..... . .......++
T Consensus 205 ~~~~Dv~slG~il~el~~g-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (311)
T cd07866 205 TTAVDIWGIGCVFAEMFTR-RPILQGKSDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPE 283 (311)
T ss_pred CchhHhHHHHHHHHHHHhC-CCCCCCCCHHHHHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChh
Confidence 8999999999999999997 778764332211 1110000 0 000123367
Q ss_pred HHHHHHHhcCCCCCCCCChhhhhcCccc
Q 003644 641 AVDLFTRLLDPNPDLRPKAQNVLNHPFF 668 (805)
Q Consensus 641 ~~dLi~~~L~~dP~~Rps~~ell~Hpff 668 (805)
+.++|.+||+.||.+|||+.|++.||||
T Consensus 284 ~~~~i~~~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 284 GLDLLSKLLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred HHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence 8899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-34 Score=301.04 Aligned_cols=243 Identities=23% Similarity=0.334 Sum_probs=175.9
Q ss_pred eeccCCceEEEEEEeeC---CcEEEEEEeecCCch----HHHHHHHHHHHhCCCCCeeeecccccCCceEEEecccccCC
Q 003644 383 EIAKGSNGTVVLEGNYE---GRSVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCS 455 (805)
Q Consensus 383 ~LG~GsfGtVy~a~~~~---g~~VAVK~l~~~~~~----~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~E~~~~s 455 (805)
+||+|+||+||++.... ...||||.+...... ...+|+. .++.++||||+++++++.+.+..|+|||
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~-~~~~l~h~nii~~~~~~~~~~~~~lv~e----- 75 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQ-PYRELNHPNVLQCLGQCIESIPYLLVLE----- 75 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHH-HHHhCCCCCcceEEEEECCCCceEEEEE-----
Confidence 59999999999986544 357888987644322 2344554 5677899999999999999999999999
Q ss_pred hhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcceeccCC
Q 003644 456 LNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDL 535 (805)
Q Consensus 456 L~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~IvHrDL 535 (805)
|+.+|+|.+++...... .....++..++.++.||+.||+|||+.+|+||||
T Consensus 76 -----~~~~g~L~~~l~~~~~~------------------------~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dl 126 (269)
T cd05042 76 -----FCPLGDLKNYLRSNRGM------------------------VAQMAQKDVLQRMACEVASGLLWLHQADFIHSDL 126 (269)
T ss_pred -----eCCCCcHHHHHHhcccc------------------------ccccccHHHHHHHHHHHHHHHHHHHhcCEecccc
Confidence 55556666555432210 0112345677899999999999999999999999
Q ss_pred CCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhc-------CCCCCcchHHHHHHHHHHHH
Q 003644 536 KPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ-------GRQTRAIDLFSLGCILFFCI 608 (805)
Q Consensus 536 Kp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~-------~~~t~~sDVwSlGvil~ell 608 (805)
||+|||++.++. +||+|||++......... .......++..|+|||++.. ..++.++|||||||++|||+
T Consensus 127 kp~Nill~~~~~--~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~ 203 (269)
T cd05042 127 ALRNCQLTADLS--VKIGDYGLALEQYPEDYY-ITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELF 203 (269)
T ss_pred cHhheEecCCCc--EEEeccccccccccchhe-eccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHH
Confidence 999999988765 899999998754332111 11122346778999999753 34678999999999999999
Q ss_pred hCCCCCCCCchHHHH--HHHhhcc-----ccccccCChHHHHHHHHhcCCCCCCCCChhhhhc
Q 003644 609 TGGKHPYGESFERDA--NIVKDRK-----DLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 664 (805)
Q Consensus 609 tG~~~Pf~~~~~~~~--~~~~~~~-----~~~~~~~~~~~~dLi~~~L~~dP~~Rps~~ell~ 664 (805)
+++.+||......+. ..+.... ........+.+.+++..|+ .||++||++++|++
T Consensus 204 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~ 265 (269)
T cd05042 204 TAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHE 265 (269)
T ss_pred hCCCCCCCcCCHHHHHHHHhhccCccCCCCcccccCCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence 977888876543321 1122111 1112234567888999998 59999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-34 Score=299.37 Aligned_cols=236 Identities=23% Similarity=0.316 Sum_probs=178.8
Q ss_pred EeeccCCceEEEEEEeeCC-----------cEEEEEEeecCCc-hHHHHHHHHHHHhCCCCCeeeecccccCCceEEEec
Q 003644 382 KEIAKGSNGTVVLEGNYEG-----------RSVAVKRLVKTHH-DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSL 449 (805)
Q Consensus 382 ~~LG~GsfGtVy~a~~~~g-----------~~VAVK~l~~~~~-~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~ 449 (805)
+.||+|+||.||++...+. ..||+|.+..... ...+.+...+++.++||||+++++++.. +..++||
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~ 79 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVE 79 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEE
Confidence 3589999999999866543 2588888765433 3334444457888999999999999988 7789999
Q ss_pred ccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcc
Q 003644 450 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG 529 (805)
Q Consensus 450 E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~ 529 (805)
| |+.+|+|.+++.... ..+++..++.++.||+.||+|||+.+
T Consensus 80 e----------~~~~~~L~~~l~~~~----------------------------~~~~~~~~~~~~~~i~~~l~~LH~~~ 121 (259)
T cd05037 80 E----------YVKFGPLDVFLHREK----------------------------NNVSLHWKLDVAKQLASALHYLEDKK 121 (259)
T ss_pred E----------cCCCCcHHHHHHhhc----------------------------cCCCHHHHHHHHHHHHHHHHHHhhCC
Confidence 9 556666666553221 13567778999999999999999999
Q ss_pred eeccCCCCceEEecCCCC-----ceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcC--CCCCcchHHHHHH
Q 003644 530 LIHRDLKPQNVLISKDKS-----FCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG--RQTRAIDLFSLGC 602 (805)
Q Consensus 530 IvHrDLKp~NILl~~~~~-----~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~--~~t~~sDVwSlGv 602 (805)
|+||||||+|||++.++. ..+||+|||++..... .....++..|+|||++... .++.++|||||||
T Consensus 122 i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~ 194 (259)
T cd05037 122 LVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLS-------REERVERIPWIAPECIRNGQASLTIAADKWSFGT 194 (259)
T ss_pred eecccCccceEEEecCccccCCceeEEeCCCCccccccc-------ccccccCCCccChhhhcCCCCCcchhhHHHHHHH
Confidence 999999999999987652 1489999999886543 1223467789999999876 7899999999999
Q ss_pred HHHHHHhCCCCCCCCchHHHH-HHHhhccccccccCChHHHHHHHHhcCCCCCCCCChhhhhc
Q 003644 603 ILFFCITGGKHPYGESFERDA-NIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 664 (805)
Q Consensus 603 il~elltG~~~Pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~dLi~~~L~~dP~~Rps~~ell~ 664 (805)
++|||++|+..||........ .... .....+.....++.++|.+||..+|.+||++.++++
T Consensus 195 ~~~~l~~~~~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 256 (259)
T cd05037 195 TLLEICSNGEEPLSTLSSSEKERFYQ-DQHRLPMPDCAELANLINQCWTYDPTKRPSFRAILR 256 (259)
T ss_pred HHHHHHhCCCCCcccCCchhHHHHHh-cCCCCCCCCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence 999999977888866532221 1111 111122223378999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=303.64 Aligned_cols=250 Identities=25% Similarity=0.333 Sum_probs=187.8
Q ss_pred ccceEEEeEeeccCCceEEEEEEee-CCcEEEEEEeecCCc-----hHHHHHHHHHHHhCCCCCeeeecccccCCc----
Q 003644 374 IGKLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHH-----DVALKEIQNLIASDQHPNIVRWYGVESDQD---- 443 (805)
Q Consensus 374 i~~~~~~~~~LG~GsfGtVy~a~~~-~g~~VAVK~l~~~~~-----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~---- 443 (805)
..+.|.+.+.||+|+||+||++... +|+.||||++..... ....+|+. ++..++||||+++++++.+..
T Consensus 5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~-~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIK-ILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHH-HHHhCCCCCeeeeeheecCcchhhh
Confidence 3456778899999999999998654 589999999864321 23345554 677889999999999987655
Q ss_pred ------eEEEecccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHH
Q 003644 444 ------FVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRD 517 (805)
Q Consensus 444 ------~l~LV~E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~q 517 (805)
..|+|+|++++++.+++.. ....+++..++.++.|
T Consensus 84 ~~~~~~~~~lv~e~~~~~l~~~l~~---------------------------------------~~~~~~~~~~~~i~~q 124 (302)
T cd07864 84 FKKDKGAFYLVFEYMDHDLMGLLES---------------------------------------GLVHFSEDHIKSFMKQ 124 (302)
T ss_pred ccccCCcEEEEEcccCccHHHHHhc---------------------------------------CCCCCCHHHHHHHHHH
Confidence 7999999777655444311 1124677888999999
Q ss_pred HHHHHHHhhhcceeccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcC-CCCCcch
Q 003644 518 IVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG-RQTRAID 596 (805)
Q Consensus 518 Ia~gL~yLH~~~IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~t~~sD 596 (805)
|+.||+|||+.+|+||||||+||+++.++. +||+|||++........ .......++..|+|||.+.+. .++.++|
T Consensus 125 i~~aL~~LH~~~i~H~dl~p~nili~~~~~--~kl~dfg~~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~D 200 (302)
T cd07864 125 LLEGLNYCHKKNFLHRDIKCSNILLNNKGQ--IKLADFGLARLYNSEES--RPYTNKVITLWYRPPELLLGEERYGPAID 200 (302)
T ss_pred HHHHHHHHHhCCeecCCCCHHHEEECCCCc--EEeCcccccccccCCcc--cccccceeccCccChHHhcCCCCCCchhH
Confidence 999999999999999999999999987765 89999999987653321 111223467889999988653 5789999
Q ss_pred HHHHHHHHHHHHhCCCCCCCCchHHHH--HHHhh--ccc---------------------------cccccCChHHHHHH
Q 003644 597 LFSLGCILFFCITGGKHPYGESFERDA--NIVKD--RKD---------------------------LFLVEHIPEAVDLF 645 (805)
Q Consensus 597 VwSlGvil~elltG~~~Pf~~~~~~~~--~~~~~--~~~---------------------------~~~~~~~~~~~dLi 645 (805)
||||||++|||++| ++||........ .+... ... ......++.+.+++
T Consensus 201 i~slG~~~~el~~g-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 279 (302)
T cd07864 201 VWSCGCILGELFTK-KPIFQANQELAQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLL 279 (302)
T ss_pred HHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHHHhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHH
Confidence 99999999999997 778865332211 11110 000 00112357899999
Q ss_pred HHhcCCCCCCCCChhhhhcCccc
Q 003644 646 TRLLDPNPDLRPKAQNVLNHPFF 668 (805)
Q Consensus 646 ~~~L~~dP~~Rps~~ell~Hpff 668 (805)
.+||+.||.+||++.+++.||||
T Consensus 280 ~~~l~~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 280 DHMLTLDPSKRCTAEEALNSPWL 302 (302)
T ss_pred HHHccCChhhCCCHHHHhcCCCC
Confidence 99999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=296.79 Aligned_cols=240 Identities=27% Similarity=0.393 Sum_probs=181.1
Q ss_pred EeeccCCceEEEEEEee----CCcEEEEEEeecCCc----hHHHHHHHHHHHhCCCCCeeeecccccCCceEEEeccccc
Q 003644 382 KEIAKGSNGTVVLEGNY----EGRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCT 453 (805)
Q Consensus 382 ~~LG~GsfGtVy~a~~~----~g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~E~~~ 453 (805)
++||+|+||.||+|... .+..||+|.+..... ....+|+. +++.+.|||||++++++. .+..++|||
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~-~l~~l~h~~iv~~~~~~~-~~~~~~v~e--- 75 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREAS-VMAQLDHPCIVRLIGVCK-GEPLMLVME--- 75 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHH-HHHhcCCCCeeeEEEEEc-CCceEEEEE---
Confidence 36999999999997432 237899999875443 23344554 667889999999999876 456899999
Q ss_pred CChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcceecc
Q 003644 454 CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHR 533 (805)
Q Consensus 454 ~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~IvHr 533 (805)
|..+|+|.+++... ..+++..++.++.|++.||+|||+.+++||
T Consensus 76 -------~~~~~~L~~~l~~~-----------------------------~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~ 119 (257)
T cd05060 76 -------LAPLGPLLKYLKKR-----------------------------REIPVSDLKELAHQVAMGMAYLESKHFVHR 119 (257)
T ss_pred -------eCCCCcHHHHHHhC-----------------------------CCCCHHHHHHHHHHHHHHHHHHhhcCeecc
Confidence 55555555554321 135677889999999999999999999999
Q ss_pred CCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHHHHHhCCCC
Q 003644 534 DLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKH 613 (805)
Q Consensus 534 DLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~elltG~~~ 613 (805)
||||+|||++.++. +||+|||+++................++..|+|||.+....++.++|||||||++||+++++.+
T Consensus 120 di~p~nili~~~~~--~kl~df~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~ 197 (257)
T cd05060 120 DLAARNVLLVNRHQ--AKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAK 197 (257)
T ss_pred CcccceEEEcCCCc--EEeccccccceeecCCcccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCC
Confidence 99999999988776 8999999998775433222222222345689999999988899999999999999999985588
Q ss_pred CCCCchHHHH-HHH-hhccccccccCChHHHHHHHHhcCCCCCCCCChhhhhc
Q 003644 614 PYGESFERDA-NIV-KDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 664 (805)
Q Consensus 614 Pf~~~~~~~~-~~~-~~~~~~~~~~~~~~~~dLi~~~L~~dP~~Rps~~ell~ 664 (805)
||........ ..+ .......+...++.++++|.+||..||++||++.++++
T Consensus 198 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~ 250 (257)
T cd05060 198 PYGEMKGAEVIAMLESGERLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELES 250 (257)
T ss_pred CcccCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 9876543322 222 22222334455678999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=306.94 Aligned_cols=262 Identities=24% Similarity=0.367 Sum_probs=189.4
Q ss_pred ceEEEeEeeccCCceEEEEEEee--------CCcEEEEEEeecCCch----HHHHHHHHHHHhC-CCCCeeeecccccCC
Q 003644 376 KLVVFNKEIAKGSNGTVVLEGNY--------EGRSVAVKRLVKTHHD----VALKEIQNLIASD-QHPNIVRWYGVESDQ 442 (805)
Q Consensus 376 ~~~~~~~~LG~GsfGtVy~a~~~--------~g~~VAVK~l~~~~~~----~~~~Ei~~ll~~l-~HpNIV~l~g~~~~~ 442 (805)
.+|.+.+.||+|+||.||++... ....||+|.+...... ...+|+. ++..+ +||||+++++++.++
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~-~l~~l~~h~~iv~~~~~~~~~ 90 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEME-LMKLIGKHKNIINLLGVCTQE 90 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHH-HHHhccCCCCeeeEEEEEccC
Confidence 45778899999999999997532 3467999998754322 3345665 44555 799999999999999
Q ss_pred ceEEEecccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHH
Q 003644 443 DFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGL 522 (805)
Q Consensus 443 ~~l~LV~E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL 522 (805)
+..|++|| |+.+|+|.+++.......... ...........+++.+++.++.||+.||
T Consensus 91 ~~~~lv~e----------~~~~g~L~~~i~~~~~~~~~~-------------~~~~~~~~~~~l~~~~~~~~~~qi~~aL 147 (314)
T cd05099 91 GPLYVIVE----------YAAKGNLREFLRARRPPGPDY-------------TFDITKVPEEQLSFKDLVSCAYQVARGM 147 (314)
T ss_pred CceEEEEe----------cCCCCcHHHHHHhcCCCcccc-------------cccccCCcccccCHHHHHHHHHHHHHHH
Confidence 99999999 555666666554322100000 0000001123477888899999999999
Q ss_pred HHhhhcceeccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHH
Q 003644 523 SHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGC 602 (805)
Q Consensus 523 ~yLH~~~IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGv 602 (805)
+|||+.||+||||||+|||++.++. +||+|||+++........ .......++..|+|||++.+..++.++|||||||
T Consensus 148 ~~lH~~gi~H~dlkp~Nill~~~~~--~kL~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~ 224 (314)
T cd05099 148 EYLESRRCIHRDLAARNVLVTEDNV--MKIADFGLARGVHDIDYY-KKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGI 224 (314)
T ss_pred HHHHHCCeeeccccceeEEEcCCCc--EEEccccccccccccccc-cccccCCCCccccCHHHHccCCcCccchhhHHHH
Confidence 9999999999999999999987765 899999999876532111 1112223456899999999888999999999999
Q ss_pred HHHHHHhCCCCCCCCchHHH-HHHHhhc-cccccccCChHHHHHHHHhcCCCCCCCCChhhhhc
Q 003644 603 ILFFCITGGKHPYGESFERD-ANIVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 664 (805)
Q Consensus 603 il~elltG~~~Pf~~~~~~~-~~~~~~~-~~~~~~~~~~~~~dLi~~~L~~dP~~Rps~~ell~ 664 (805)
++|||++++..||....... ...+... ....+.....++.+++.+||+.||++||++.++++
T Consensus 225 ~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 288 (314)
T cd05099 225 LMWEIFTLGGSPYPGIPVEELFKLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE 288 (314)
T ss_pred HHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 99999996678886543322 2222222 12223445568999999999999999999999884
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-34 Score=307.52 Aligned_cols=264 Identities=22% Similarity=0.334 Sum_probs=191.8
Q ss_pred cceEEEeEeeccCCceEEEEEEe--------eCCcEEEEEEeecCCc----hHHHHHHHHHHHhC-CCCCeeeecccccC
Q 003644 375 GKLVVFNKEIAKGSNGTVVLEGN--------YEGRSVAVKRLVKTHH----DVALKEIQNLIASD-QHPNIVRWYGVESD 441 (805)
Q Consensus 375 ~~~~~~~~~LG~GsfGtVy~a~~--------~~g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l-~HpNIV~l~g~~~~ 441 (805)
...|.+.+.||+|+||.||++.. .++..||+|.+..... ....+|+. ++..+ +||||+++++++.+
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~-~l~~l~~h~~i~~~~~~~~~ 92 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEME-MMKMIGKHKNIINLLGACTQ 92 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHH-HHHhhccCCCchheeEEEec
Confidence 45577889999999999998753 2345899999865322 23445655 55566 89999999999999
Q ss_pred CceEEEecccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHH
Q 003644 442 QDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSG 521 (805)
Q Consensus 442 ~~~l~LV~E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~g 521 (805)
.+..|++|| |..+|+|.+++........... ..........+++..++.++.||+.|
T Consensus 93 ~~~~~lv~e----------~~~~~~L~~~l~~~~~~~~~~~-------------~~~~~~~~~~~~~~~~~~~~~qi~~a 149 (304)
T cd05101 93 DGPLYVIVE----------YASKGNLREYLRARRPPGMEYS-------------YDIARVPDEQMTFKDLVSCTYQVARG 149 (304)
T ss_pred CCceEEEEe----------cCCCCcHHHHHHhcCCcccccc-------------cccccCCcccccHHHHHHHHHHHHHH
Confidence 999999999 5555566555543321110000 00000112347788899999999999
Q ss_pred HHHhhhcceeccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHH
Q 003644 522 LSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLG 601 (805)
Q Consensus 522 L~yLH~~~IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlG 601 (805)
|+|||+.||+||||||+|||++.++. +||+|||+++........ .......++..|+|||++.+..++.++||||||
T Consensus 150 l~~LH~~givH~dlkp~Nili~~~~~--~kl~D~g~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG 226 (304)
T cd05101 150 MEYLASQKCIHRDLAARNVLVTENNV--MKIADFGLARDVNNIDYY-KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFG 226 (304)
T ss_pred HHHHHHCCeeecccccceEEEcCCCc--EEECCCccceeccccccc-ccccCCCCCceeeCchhhccCCCCchhhHHHHH
Confidence 99999999999999999999987765 899999999876532211 112233467789999999888899999999999
Q ss_pred HHHHHHHhCCCCCCCCchHH-HHHHHhhc-cccccccCChHHHHHHHHhcCCCCCCCCChhhhhcC
Q 003644 602 CILFFCITGGKHPYGESFER-DANIVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNH 665 (805)
Q Consensus 602 vil~elltG~~~Pf~~~~~~-~~~~~~~~-~~~~~~~~~~~~~dLi~~~L~~dP~~Rps~~ell~H 665 (805)
|++|||++++..||...... ....+... ....+...+.++.+++.+||+.+|.+||++.|+++.
T Consensus 227 ~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~ 292 (304)
T cd05101 227 VLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED 292 (304)
T ss_pred HHHHHHHcCCCCCcccCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence 99999999667777654322 22222222 222334456789999999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-35 Score=306.88 Aligned_cols=252 Identities=25% Similarity=0.344 Sum_probs=204.3
Q ss_pred ceEEEeEeeccCCceEEEEEEe-eCCcEEEEEEeecCCc----h--HHHHHHHHHHHh-CCCCCeeeecccccCCceEEE
Q 003644 376 KLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH----D--VALKEIQNLIAS-DQHPNIVRWYGVESDQDFVYL 447 (805)
Q Consensus 376 ~~~~~~~~LG~GsfGtVy~a~~-~~g~~VAVK~l~~~~~----~--~~~~Ei~~ll~~-l~HpNIV~l~g~~~~~~~l~L 447 (805)
.+|.|...||+|+||+|.++.. .+...+|||++++.-. + -...|-. +++. -+-|.++.++.+|+.-+.+|.
T Consensus 349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKr-vLAL~~kppFL~qlHScFQTmDRLyF 427 (683)
T KOG0696|consen 349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKR-VLALPGKPPFLVQLHSCFQTMDRLYF 427 (683)
T ss_pred cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhh-heecCCCCchHHHHHHHhhhhhheee
Confidence 4578899999999999999844 4577899999976521 1 1122322 3343 456889999999999999999
Q ss_pred ecccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhh
Q 003644 448 SLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE 527 (805)
Q Consensus 448 V~E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~ 527 (805)
||| |..+|+|.-++.. -+.+.++.+..++.+||-||-+||+
T Consensus 428 VME----------yvnGGDLMyhiQQ-----------------------------~GkFKEp~AvFYAaEiaigLFFLh~ 468 (683)
T KOG0696|consen 428 VME----------YVNGGDLMYHIQQ-----------------------------VGKFKEPVAVFYAAEIAIGLFFLHS 468 (683)
T ss_pred EEE----------EecCchhhhHHHH-----------------------------hcccCCchhhhhhHHHHHHhhhhhc
Confidence 999 6666776655532 2346677889999999999999999
Q ss_pred cceeccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHHHH
Q 003644 528 IGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFC 607 (805)
Q Consensus 528 ~~IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~el 607 (805)
+|||.||||.+||||+.+|+ +||+|||+++.--- ....+.+.||||.|+|||++..++|+.++|+||+||+||||
T Consensus 469 kgIiYRDLKLDNvmLd~eGH--iKi~DFGmcKEni~---~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEm 543 (683)
T KOG0696|consen 469 KGIIYRDLKLDNVMLDSEGH--IKIADFGMCKENIF---DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEM 543 (683)
T ss_pred CCeeeeeccccceEeccCCc--eEeeeccccccccc---CCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHH
Confidence 99999999999999998887 89999999986432 23455788999999999999999999999999999999999
Q ss_pred HhCCCCCCCCchHH-HHHHHhhccccccccCChHHHHHHHHhcCCCCCCCCCh-----hhhhcCcccccccc
Q 003644 608 ITGGKHPYGESFER-DANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKA-----QNVLNHPFFWTADT 673 (805)
Q Consensus 608 ltG~~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dP~~Rps~-----~ell~Hpff~~~~~ 673 (805)
+.| .+||+...+. ..+.+......++...+.|+.++.+.+|.+.|.+|..+ .++-.||||...++
T Consensus 544 laG-QpPFdGeDE~elF~aI~ehnvsyPKslSkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~iDW 614 (683)
T KOG0696|consen 544 LAG-QPPFDGEDEDELFQAIMEHNVSYPKSLSKEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRRIDW 614 (683)
T ss_pred HcC-CCCCCCCCHHHHHHHHHHccCcCcccccHHHHHHHHHHhhcCCccccCCCCccccchhhCcchhhccH
Confidence 997 7788665544 34556666677888899999999999999999999754 47999999976554
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=288.97 Aligned_cols=254 Identities=25% Similarity=0.354 Sum_probs=192.2
Q ss_pred cccceEEEeEeeccCCceEEEEE-EeeCCcEEEEEEeecCC---chHHHHHHHHHHHhCCCCCeeeecccccCCc-----
Q 003644 373 RIGKLVVFNKEIAKGSNGTVVLE-GNYEGRSVAVKRLVKTH---HDVALKEIQNLIASDQHPNIVRWYGVESDQD----- 443 (805)
Q Consensus 373 ~i~~~~~~~~~LG~GsfGtVy~a-~~~~g~~VAVK~l~~~~---~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~----- 443 (805)
..+++|.+.+.||+|+|.-||++ +..+++.+|+|++.-.. .+.+.+|+. +.++.+|||++++++++..+.
T Consensus 18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid-~~rkf~s~~vl~l~dh~l~~~~D~~~ 96 (302)
T KOG2345|consen 18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREID-NHRKFNSPNVLRLVDHQLREEKDGKH 96 (302)
T ss_pred EcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHH-HHHhhCCcchHHHHHHHHHhhccCce
Confidence 44678999999999999999997 57789999999985433 345677776 678899999999999876543
Q ss_pred eEEEecccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHH
Q 003644 444 FVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLS 523 (805)
Q Consensus 444 ~l~LV~E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~ 523 (805)
+.||+++ |...|+|.+.+.... .+...+++.+++.|+.+|++||+
T Consensus 97 ~~yll~P----------yy~~Gsl~d~i~~~k-------------------------~kg~~~sE~~iL~if~gic~gL~ 141 (302)
T KOG2345|consen 97 EAYLLLP----------YYKRGSLLDEIERLK-------------------------IKGNFVSEAQILWIFLGICRGLE 141 (302)
T ss_pred eEEEEee----------hhccccHHHHHHHHh-------------------------hcCCccCHHHHHHHHHHHHHHHH
Confidence 4899999 777888877664432 22345788899999999999999
Q ss_pred Hhhhcc--eeccCCCCceEEecCCCCceEEEeccCccccccCCCccccc------cccccCCCCCCChhhhhc---CCCC
Q 003644 524 HLHEIG--LIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQ------NATGYGSSGWQAPEQLLQ---GRQT 592 (805)
Q Consensus 524 yLH~~~--IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~------~~~~~gt~~y~APE~l~~---~~~t 592 (805)
+||+.. ++||||||.|||+++++. ++|.|||.+....-......+ -.....|..|.|||.+.- ...+
T Consensus 142 ~lH~~~~~yAH~DiKP~NILls~~~~--~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ 219 (302)
T KOG2345|consen 142 ALHEKEPPYAHRDIKPANILLSDSGL--PVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTIT 219 (302)
T ss_pred HHhccCCcccccCCCcceeEecCCCc--eEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccc
Confidence 999997 999999999999988665 899999998765321111110 111236889999998764 3458
Q ss_pred CcchHHHHHHHHHHHHhCCCCCCCCchHHHHH---HHhhcccccc--ccCChHHHHHHHHhcCCCCCCCCChhhhhcC
Q 003644 593 RAIDLFSLGCILFFCITGGKHPYGESFERDAN---IVKDRKDLFL--VEHIPEAVDLFTRLLDPNPDLRPKAQNVLNH 665 (805)
Q Consensus 593 ~~sDVwSlGvil~elltG~~~Pf~~~~~~~~~---~~~~~~~~~~--~~~~~~~~dLi~~~L~~dP~~Rps~~ell~H 665 (805)
.++|||||||++|+|+.| ..||....+.-.. .+......++ ...+..+.++|+.||+.||.+||++.+++.+
T Consensus 220 ertDIWSLGCtLYa~mf~-~sPfe~~~~~GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 220 ERTDIWSLGCTLYAMMFG-ESPFERIYQQGGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSK 296 (302)
T ss_pred cccchhhhhHHHHHHHHc-CCcchHHhhcCCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 999999999999999997 7788654432110 1111111111 1256788999999999999999999999864
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=303.08 Aligned_cols=250 Identities=25% Similarity=0.390 Sum_probs=190.5
Q ss_pred EEEeEeeccCCceEEEEEEe----eCCcEEEEEEeecCC-------chHHHHHHHHHHHhC-CCCCeeeecccccCCceE
Q 003644 378 VVFNKEIAKGSNGTVVLEGN----YEGRSVAVKRLVKTH-------HDVALKEIQNLIASD-QHPNIVRWYGVESDQDFV 445 (805)
Q Consensus 378 ~~~~~~LG~GsfGtVy~a~~----~~g~~VAVK~l~~~~-------~~~~~~Ei~~ll~~l-~HpNIV~l~g~~~~~~~l 445 (805)
|.+.+.||+|+||.||++.. .+|+.||+|++.... .+...+|+. ++..+ +||||+++++++..+...
T Consensus 2 y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~-~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQ-VLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred ceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHH-HHHhcccCCChhceeeEeecCCeE
Confidence 56778999999999999764 378999999986432 123344555 44555 799999999999999999
Q ss_pred EEecccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHh
Q 003644 446 YLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHL 525 (805)
Q Consensus 446 ~LV~E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yL 525 (805)
|+||| |+++++|.+++.. ...+++..+..++.|++.||+||
T Consensus 81 ~lv~e----------~~~~~~L~~~l~~-----------------------------~~~l~~~~~~~~~~qi~~al~~l 121 (290)
T cd05613 81 HLILD----------YINGGELFTHLSQ-----------------------------RERFKEQEVQIYSGEIVLALEHL 121 (290)
T ss_pred EEEEe----------cCCCCcHHHHHHH-----------------------------cCCCCHHHHHHHHHHHHHHHHHH
Confidence 99999 5556666665532 12356677889999999999999
Q ss_pred hhcceeccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcC--CCCCcchHHHHHHH
Q 003644 526 HEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG--RQTRAIDLFSLGCI 603 (805)
Q Consensus 526 H~~~IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~--~~t~~sDVwSlGvi 603 (805)
|+.+++||||||+|||++.++. +||+|||++........ .......|+..|+|||.+... .++.++|||||||+
T Consensus 122 H~~~i~H~dl~p~nil~~~~~~--~kl~dfg~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~ 197 (290)
T cd05613 122 HKLGIIYRDIKLENILLDSNGH--VVLTDFGLSKEFHEDEV--ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVL 197 (290)
T ss_pred HhCCeeccCCCHHHeEECCCCC--EEEeeCccceecccccc--cccccccCCcccCChhhccCCCCCCCccccHHHHHHH
Confidence 9999999999999999988765 89999999986643211 112234589999999998753 46789999999999
Q ss_pred HHHHHhCCCCCCCCch-----HHHHHHHhhccccccccCChHHHHHHHHhcCCCCCCCC-----ChhhhhcCccccccc
Q 003644 604 LFFCITGGKHPYGESF-----ERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRP-----KAQNVLNHPFFWTAD 672 (805)
Q Consensus 604 l~elltG~~~Pf~~~~-----~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dP~~Rp-----s~~ell~Hpff~~~~ 672 (805)
+|+|++| ..||.... ..............+....+.+.+++.+||+.||++|| ++.++++||||....
T Consensus 198 l~~ll~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~ 275 (290)
T cd05613 198 MYELLTG-ASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKIN 275 (290)
T ss_pred HHHHhcC-CCCCCcCCccccHHHHHHHhhccCCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCC
Confidence 9999997 67875321 11112222222334445678899999999999999997 889999999996543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=319.95 Aligned_cols=248 Identities=26% Similarity=0.384 Sum_probs=200.8
Q ss_pred cceEEEeEeeccCCceEEEEEE-eeCCcEEEEEEeecCCch-----HHHHHHHHHHHhCCCCCeeeecccccCCceEEEe
Q 003644 375 GKLVVFNKEIAKGSNGTVVLEG-NYEGRSVAVKRLVKTHHD-----VALKEIQNLIASDQHPNIVRWYGVESDQDFVYLS 448 (805)
Q Consensus 375 ~~~~~~~~~LG~GsfGtVy~a~-~~~g~~VAVK~l~~~~~~-----~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV 448 (805)
...|.+.+.||+|.|++|.++. ..+|..||||.+.++..+ ...+|+. ++..++|||||+++.+......+|+|
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~-imk~l~HPnIvkl~~v~~t~~~lylV 133 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVD-IMKSLNHPNIVKLFSVIETEATLYLV 133 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHH-HHHhcCCcceeeeeeeeeecceeEEE
Confidence 3457888999999999999984 557999999999876532 3467776 67889999999999999999999999
Q ss_pred cccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhc
Q 003644 449 LERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI 528 (805)
Q Consensus 449 ~E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~ 528 (805)
|| |..+|.++++|..... ..+..+..++.|+.+|++|||++
T Consensus 134 ~e----------ya~~ge~~~yl~~~gr-----------------------------~~e~~ar~~F~q~vsaveYcH~k 174 (596)
T KOG0586|consen 134 ME----------YASGGELFDYLVKHGR-----------------------------MKEKEARAKFRQIVSAVEYCHSK 174 (596)
T ss_pred EE----------eccCchhHHHHHhccc-----------------------------chhhhhhhhhHHHHHHHHHHhhc
Confidence 99 6666777776654332 22345678999999999999999
Q ss_pred ceeccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCC-CCcchHHHHHHHHHHH
Q 003644 529 GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ-TRAIDLFSLGCILFFC 607 (805)
Q Consensus 529 ~IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~-t~~sDVwSlGvil~el 607 (805)
+|||||||++||||+.+.+ +||+|||++..+... ....+.||++.|.|||+..+..| ++.+|+||+|+++|-|
T Consensus 175 ~ivHrdLk~eNilL~~~mn--ikIaDfgfS~~~~~~----~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~L 248 (596)
T KOG0586|consen 175 NIVHRDLKAENILLDENMN--IKIADFGFSTFFDYG----LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYAL 248 (596)
T ss_pred ceeccccchhhcccccccc--eeeeccccceeeccc----ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheee
Confidence 9999999999999977765 899999999988743 44567899999999999998877 6899999999999999
Q ss_pred HhCCCCCCCCchHHH--HHHHhhccccccccCChHHHHHHHHhcCCCCCCCCChhhhhcCccccc
Q 003644 608 ITGGKHPYGESFERD--ANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWT 670 (805)
Q Consensus 608 ltG~~~Pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dP~~Rps~~ell~Hpff~~ 670 (805)
+.| ..||+...-.. ...+.. ....+.-.+.++.++|+++|..+|.+|++++++++|+|...
T Consensus 249 V~G-sLPFDG~~lk~Lr~rvl~g-k~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~ 311 (596)
T KOG0586|consen 249 VEG-SLPFDGQNLKELRPRVLRG-KYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRND 311 (596)
T ss_pred eec-ccccCCcccccccchheee-eecccceeechhHHHHHHhhccCccccCCHHHhhhhcccch
Confidence 997 88887643221 111211 11223334569999999999999999999999999999744
|
|
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=291.31 Aligned_cols=244 Identities=30% Similarity=0.505 Sum_probs=189.9
Q ss_pred EEEeEeeccCCceEEEEEEee-CCcEEEEEEeecCCc---hHHHHHHHHHHHhCCCCCeeeecccccCCceEEEeccccc
Q 003644 378 VVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHH---DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCT 453 (805)
Q Consensus 378 ~~~~~~LG~GsfGtVy~a~~~-~g~~VAVK~l~~~~~---~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~E~~~ 453 (805)
|...+.||+|++|.||++... +++.||+|++..... ....+|+. +++.++||||+++++++.+++..++++|+++
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~-~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQ-ILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred ceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHH-HHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 566788999999999998654 689999999966542 33445554 7788899999999999999999999999554
Q ss_pred CChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcceecc
Q 003644 454 CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHR 533 (805)
Q Consensus 454 ~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~IvHr 533 (805)
+++|.+++... ...+++..+..++.|++.||+|||+.+++||
T Consensus 81 ----------~~~L~~~~~~~----------------------------~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~ 122 (253)
T cd05122 81 ----------GGSLKDLLKST----------------------------NQTLTESQIAYVCKELLKGLEYLHSNGIIHR 122 (253)
T ss_pred ----------CCcHHHHHhhc----------------------------CCCCCHHHHHHHHHHHHHHHHHhhcCCEecC
Confidence 44444433211 0346777889999999999999999999999
Q ss_pred CCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHHHHHhCCCC
Q 003644 534 DLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKH 613 (805)
Q Consensus 534 DLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~elltG~~~ 613 (805)
||+|+||+++.++. ++|+|||.+........ .....++..|+|||.+....++.++|+|||||++|+|++| .+
T Consensus 123 dl~p~ni~i~~~~~--~~l~d~~~~~~~~~~~~----~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g-~~ 195 (253)
T cd05122 123 DIKAANILLTSDGE--VKLIDFGLSAQLSDTKA----RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEG-KP 195 (253)
T ss_pred CCCHHHEEEccCCe--EEEeecccccccccccc----ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhC-CC
Confidence 99999999987765 89999999987764321 2344588999999999888899999999999999999997 66
Q ss_pred CCCCchHHH--HHHHhhcccccccc--CChHHHHHHHHhcCCCCCCCCChhhhhcCcc
Q 003644 614 PYGESFERD--ANIVKDRKDLFLVE--HIPEAVDLFTRLLDPNPDLRPKAQNVLNHPF 667 (805)
Q Consensus 614 Pf~~~~~~~--~~~~~~~~~~~~~~--~~~~~~dLi~~~L~~dP~~Rps~~ell~Hpf 667 (805)
||....... .............. .+.++.++|.+||+.||++|||+.++++|||
T Consensus 196 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 196 PYSELPPMKALFKIATNGPPGLRNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF 253 (253)
T ss_pred CCCCCchHHHHHHHHhcCCCCcCcccccCHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence 776542211 11111111111112 2578999999999999999999999999998
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=305.75 Aligned_cols=249 Identities=27% Similarity=0.429 Sum_probs=192.6
Q ss_pred ceEEEeEeeccCCceEEEEEEe-eCCcEEEEEEeecCCc---hHHHHHHHHHHHhCCCCCeeeecccccCCceEEEeccc
Q 003644 376 KLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH---DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLER 451 (805)
Q Consensus 376 ~~~~~~~~LG~GsfGtVy~a~~-~~g~~VAVK~l~~~~~---~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~E~ 451 (805)
+.|.+.+.||+|+||+||++.. .+++.||+|.+..... +...+|+. ++..++||||+++++++.+.+..|+|+|
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~-~l~~l~hp~i~~~~~~~~~~~~~~lv~e- 96 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEIL-VMRENKHPNIVNYLDSYLVGDELWVVME- 96 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHH-HHhhcCCCCeeehhheeeeCCcEEEEEe-
Confidence 4577889999999999999854 4688999999854322 23445554 6778899999999999999999999999
Q ss_pred ccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhccee
Q 003644 452 CTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLI 531 (805)
Q Consensus 452 ~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~Iv 531 (805)
|+.+++|.+++.. ..+++.++..++.|++.||+|||+.+++
T Consensus 97 ---------~~~~~~L~~~~~~------------------------------~~l~~~~~~~i~~~l~~al~~LH~~gi~ 137 (293)
T cd06647 97 ---------YLAGGSLTDVVTE------------------------------TCMDEGQIAAVCRECLQALEFLHSNQVI 137 (293)
T ss_pred ---------cCCCCcHHHHHhh------------------------------cCCCHHHHHHHHHHHHHHHHHHHhCCEe
Confidence 5556666655421 2345667789999999999999999999
Q ss_pred ccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHHHHHhCC
Q 003644 532 HRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGG 611 (805)
Q Consensus 532 HrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~elltG~ 611 (805)
||||||+||+++.++. ++|+|||++........ ......|++.|+|||.+....++.++|+|||||++|++++|
T Consensus 138 H~dL~p~Nili~~~~~--~kL~dfg~~~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g- 211 (293)
T cd06647 138 HRDIKSDNILLGMDGS--VKLTDFGFCAQITPEQS---KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEG- 211 (293)
T ss_pred eccCCHHHEEEcCCCC--EEEccCcceeccccccc---ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhC-
Confidence 9999999999988765 89999999876553321 11234588999999999888899999999999999999997
Q ss_pred CCCCCCchHHHH--HHHhhcccc--ccccCChHHHHHHHHhcCCCCCCCCChhhhhcCcccccc
Q 003644 612 KHPYGESFERDA--NIVKDRKDL--FLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTA 671 (805)
Q Consensus 612 ~~Pf~~~~~~~~--~~~~~~~~~--~~~~~~~~~~dLi~~~L~~dP~~Rps~~ell~Hpff~~~ 671 (805)
.+||........ .+....... ......+.+.++|.+||..+|++||++.+++.||||...
T Consensus 212 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~ 275 (293)
T cd06647 212 EPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIA 275 (293)
T ss_pred CCCCCCCChhhheeehhcCCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcC
Confidence 778865433221 111111111 112234679999999999999999999999999999654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=301.85 Aligned_cols=247 Identities=27% Similarity=0.469 Sum_probs=190.0
Q ss_pred EEEeEeeccCCceEEEEEEe-eCCcEEEEEEeecCCc---hHHHHHHHHHHHhCCCCCeeeecccccCCceEEEeccccc
Q 003644 378 VVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH---DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCT 453 (805)
Q Consensus 378 ~~~~~~LG~GsfGtVy~a~~-~~g~~VAVK~l~~~~~---~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~E~~~ 453 (805)
+..-+.||+|++|.||++.. .+++.||+|++..... ....+|+. ++..++||||+++++++...+..|+++|
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~-~l~~~~h~~vv~~~~~~~~~~~~~~v~e--- 96 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVV-IMRDYQHPNIVEMYSSYLVGDELWVVME--- 96 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHH-HHHHcCCCChheEEEEEEcCCeEEEEEe---
Confidence 33447899999999999854 5789999998854322 23445554 6778899999999999999999999999
Q ss_pred CChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcceecc
Q 003644 454 CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHR 533 (805)
Q Consensus 454 ~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~IvHr 533 (805)
|+.+++|.+++.. ..+++..+..++.|++.||+|||+.+|+||
T Consensus 97 -------~~~~~~L~~~~~~------------------------------~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~ 139 (285)
T cd06648 97 -------FLEGGALTDIVTH------------------------------TRMNEEQIATVCLAVLKALSFLHAQGVIHR 139 (285)
T ss_pred -------ccCCCCHHHHHHh------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence 5555666554422 235667788999999999999999999999
Q ss_pred CCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHHHHHhCCCC
Q 003644 534 DLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKH 613 (805)
Q Consensus 534 DLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~elltG~~~ 613 (805)
||+|+||+++.++. ++|+|||++........ ......|++.|+|||.+.+..++.++|||||||++|||++| .+
T Consensus 140 dl~p~Nil~~~~~~--~~l~d~g~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g-~~ 213 (285)
T cd06648 140 DIKSDSILLTSDGR--VKLSDFGFCAQVSKEVP---RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDG-EP 213 (285)
T ss_pred CCChhhEEEcCCCc--EEEcccccchhhccCCc---ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhC-CC
Confidence 99999999987765 89999998876543211 12234589999999999888899999999999999999997 56
Q ss_pred CCCCchH-HHHHHHhhccc-c--ccccCChHHHHHHHHhcCCCCCCCCChhhhhcCcccccc
Q 003644 614 PYGESFE-RDANIVKDRKD-L--FLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTA 671 (805)
Q Consensus 614 Pf~~~~~-~~~~~~~~~~~-~--~~~~~~~~~~dLi~~~L~~dP~~Rps~~ell~Hpff~~~ 671 (805)
||..... .....+..... . .....++.+.+++.+||+.+|++||++.++++||||...
T Consensus 214 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~ 275 (285)
T cd06648 214 PYFNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLAKA 275 (285)
T ss_pred CCcCCCHHHHHHHHHhcCCCCCcccccCCHHHHHHHHHHcccChhhCcCHHHHccCcccccC
Confidence 6654322 22222222111 1 112245789999999999999999999999999999654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=311.41 Aligned_cols=245 Identities=25% Similarity=0.431 Sum_probs=184.9
Q ss_pred cceEEEeEeeccCCceEEEEEEe-eCCcEEEEEEeecCCc-----hHHHHHHHHHHHhCCCCCeeeecccccCC------
Q 003644 375 GKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH-----DVALKEIQNLIASDQHPNIVRWYGVESDQ------ 442 (805)
Q Consensus 375 ~~~~~~~~~LG~GsfGtVy~a~~-~~g~~VAVK~l~~~~~-----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~------ 442 (805)
...|...+.||+|+||+||+|.. .+|+.||||++.+... ....+|+. ++..++||||+++++++...
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~~~ 92 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELT-LLKHMQHENVIGLLDVFTSAVSGDEF 92 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHH-HHHhcCCCCccchhheecccccCCCC
Confidence 45688889999999999999864 5789999999864321 23456665 67788999999999988654
Q ss_pred ceEEEecccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHH
Q 003644 443 DFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGL 522 (805)
Q Consensus 443 ~~l~LV~E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL 522 (805)
...|+|+|++..+|.++. ...+++..+..++.|++.||
T Consensus 93 ~~~~lv~e~~~~~l~~~~------------------------------------------~~~~~~~~~~~~~~qi~~aL 130 (342)
T cd07879 93 QDFYLVMPYMQTDLQKIM------------------------------------------GHPLSEDKVQYLVYQMLCGL 130 (342)
T ss_pred ceEEEEecccccCHHHHH------------------------------------------cCCCCHHHHHHHHHHHHHHH
Confidence 346999996543332211 12366778889999999999
Q ss_pred HHhhhcceeccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhc-CCCCCcchHHHHH
Q 003644 523 SHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ-GRQTRAIDLFSLG 601 (805)
Q Consensus 523 ~yLH~~~IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~t~~sDVwSlG 601 (805)
+|||+.+|+||||||+||+++.++. +||+|||+++..... .....++..|+|||++.+ ..++.++||||||
T Consensus 131 ~~LH~~~i~H~dlkp~NIll~~~~~--~kL~dfg~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG 202 (342)
T cd07879 131 KYIHSAGIIHRDLKPGNLAVNEDCE--LKILDFGLARHADAE------MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVG 202 (342)
T ss_pred HHHHHCCcccCCCCHHHEEECCCCC--EEEeeCCCCcCCCCC------CCCceeeecccChhhhcCccccCchHHHHHHH
Confidence 9999999999999999999988765 899999998765321 122357889999999876 4588999999999
Q ss_pred HHHHHHHhCCCCCCCCchH-HHHH-HHhh----------------------ccccc--------cccCChHHHHHHHHhc
Q 003644 602 CILFFCITGGKHPYGESFE-RDAN-IVKD----------------------RKDLF--------LVEHIPEAVDLFTRLL 649 (805)
Q Consensus 602 vil~elltG~~~Pf~~~~~-~~~~-~~~~----------------------~~~~~--------~~~~~~~~~dLi~~~L 649 (805)
|++|||++| +.||..... .... +... ..... .....+++.++|.+||
T Consensus 203 vil~el~~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 281 (342)
T cd07879 203 CIMAEMLTG-KTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKML 281 (342)
T ss_pred HHHHHHHhC-CCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHc
Confidence 999999997 667765321 1111 1000 00000 1124567899999999
Q ss_pred CCCCCCCCChhhhhcCcccccc
Q 003644 650 DPNPDLRPKAQNVLNHPFFWTA 671 (805)
Q Consensus 650 ~~dP~~Rps~~ell~Hpff~~~ 671 (805)
+.||++||++++++.||||...
T Consensus 282 ~~dP~~R~~~~e~l~h~~f~~~ 303 (342)
T cd07879 282 ELDVDKRLTATEALEHPYFDSF 303 (342)
T ss_pred CCChhhCcCHHHHhcCcchhhc
Confidence 9999999999999999999654
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=309.96 Aligned_cols=250 Identities=29% Similarity=0.416 Sum_probs=189.9
Q ss_pred EEEeEeeccCCceEEEEEEee-CCcEEEEEEeecCC-----chHHHHHHHHHHHhCCCCCeeeecccccCCc-----eEE
Q 003644 378 VVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQD-----FVY 446 (805)
Q Consensus 378 ~~~~~~LG~GsfGtVy~a~~~-~g~~VAVK~l~~~~-----~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~-----~l~ 446 (805)
|.+.+.||+|++|.||++... +|+.||||++.... .....+|+. .+..++||||+++++++.+.+ ..|
T Consensus 2 y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~-~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIK-LLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred ceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHH-HHHhcCCcchhhhhhhhcccCcccccceE
Confidence 677889999999999998654 48999999986532 123445554 667789999999999998875 789
Q ss_pred EecccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhh
Q 003644 447 LSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH 526 (805)
Q Consensus 447 LV~E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH 526 (805)
++||++.++|.+++ . ....+++..++.++.||+.||+|||
T Consensus 81 lv~e~~~~~l~~~l-----------~-----------------------------~~~~l~~~~~~~i~~~l~~~l~~LH 120 (330)
T cd07834 81 IVTELMETDLHKVI-----------K-----------------------------SPQPLTDDHIQYFLYQILRGLKYLH 120 (330)
T ss_pred EEecchhhhHHHHH-----------h-----------------------------CCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 99996654443333 1 1124677788999999999999999
Q ss_pred hcceeccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcC-CCCCcchHHHHHHHHH
Q 003644 527 EIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG-RQTRAIDLFSLGCILF 605 (805)
Q Consensus 527 ~~~IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~t~~sDVwSlGvil~ 605 (805)
+.||+||||||+|||++.++. ++|+|||++.................++..|+|||++.+. .++.++|+|||||++|
T Consensus 121 ~~gi~H~dlkp~nili~~~~~--~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~ 198 (330)
T cd07834 121 SANVIHRDLKPSNILVNSNCD--LKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFA 198 (330)
T ss_pred hCCeecCCCCHHHEEEcCCCC--EEEcccCceEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHH
Confidence 999999999999999988765 8999999998775432111122334578999999999887 7899999999999999
Q ss_pred HHHhCCCCCCCCchHHH-HH-HHhhc-----------------------c-------ccccccCChHHHHHHHHhcCCCC
Q 003644 606 FCITGGKHPYGESFERD-AN-IVKDR-----------------------K-------DLFLVEHIPEAVDLFTRLLDPNP 653 (805)
Q Consensus 606 elltG~~~Pf~~~~~~~-~~-~~~~~-----------------------~-------~~~~~~~~~~~~dLi~~~L~~dP 653 (805)
+|++| .+||....... .. +.... . .......++++.++|.+||+.||
T Consensus 199 ~l~~g-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P 277 (330)
T cd07834 199 ELLTR-KPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDP 277 (330)
T ss_pred HHHcC-CCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCCh
Confidence 99997 77775433211 00 00000 0 00012245688999999999999
Q ss_pred CCCCChhhhhcCcccccc
Q 003644 654 DLRPKAQNVLNHPFFWTA 671 (805)
Q Consensus 654 ~~Rps~~ell~Hpff~~~ 671 (805)
.+||++++++.||||...
T Consensus 278 ~~Rpt~~~ll~~~~~~~~ 295 (330)
T cd07834 278 KKRITADEALAHPYLAQL 295 (330)
T ss_pred hhCCCHHHHHhCccHHhh
Confidence 999999999999999653
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=297.78 Aligned_cols=243 Identities=21% Similarity=0.338 Sum_probs=179.0
Q ss_pred EeeccCCceEEEEEEee----CCcEEEEEEeecCCc----hHHHHHHHHHHHhCCCCCeeeeccccc-CCceEEEecccc
Q 003644 382 KEIAKGSNGTVVLEGNY----EGRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVES-DQDFVYLSLERC 452 (805)
Q Consensus 382 ~~LG~GsfGtVy~a~~~----~g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l~HpNIV~l~g~~~-~~~~l~LV~E~~ 452 (805)
+.||+|+||+||++... ++..||+|++..... ....+|+. +++.++||||+++++++. .++..|++||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~-~l~~l~h~~iv~~~~~~~~~~~~~~lv~e-- 77 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGI-IMKDFSHPNVLSLLGICLPSEGSPLVVLP-- 77 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHH-HHccCCCCCcceEEEEeecCCCCcEEEEe--
Confidence 35899999999998643 246799999854322 23334544 678899999999999765 4566899999
Q ss_pred cCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcceec
Q 003644 453 TCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIH 532 (805)
Q Consensus 453 ~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~IvH 532 (805)
|+.+|+|.+++.... ....+..++.++.||+.||+|||+.+++|
T Consensus 78 --------~~~~~~L~~~~~~~~----------------------------~~~~~~~~~~~~~~i~~~l~~lH~~~i~H 121 (262)
T cd05058 78 --------YMKHGDLRNFIRSET----------------------------HNPTVKDLIGFGLQVAKGMEYLASKKFVH 121 (262)
T ss_pred --------cCCCCCHHHHHHhcC----------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence 556666666553221 11334556889999999999999999999
Q ss_pred cCCCCceEEecCCCCceEEEeccCccccccCCCcc-ccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHHHHHhCC
Q 003644 533 RDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSC-LTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGG 611 (805)
Q Consensus 533 rDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~-~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~elltG~ 611 (805)
|||||+|||++.++. +||+|||+++........ ........++..|+|||.+....++.++|||||||++|||++|+
T Consensus 122 ~dlk~~nili~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~ 199 (262)
T cd05058 122 RDLAARNCMLDESFT--VKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRG 199 (262)
T ss_pred cccCcceEEEcCCCc--EEECCccccccccCCcceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCC
Confidence 999999999987765 899999999865432111 11112234677899999998888999999999999999999987
Q ss_pred CCCCCCchHHHH--HHHhhccccccccCChHHHHHHHHhcCCCCCCCCChhhhhcC
Q 003644 612 KHPYGESFERDA--NIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNH 665 (805)
Q Consensus 612 ~~Pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~dLi~~~L~~dP~~Rps~~ell~H 665 (805)
.+||........ .+........+...++.+.+++.+||+.+|++||++.++++.
T Consensus 200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~ 255 (262)
T cd05058 200 APPYPDVDSFDITVYLLQGRRLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSR 255 (262)
T ss_pred CCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 888865433221 122222222233345789999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=298.89 Aligned_cols=248 Identities=25% Similarity=0.381 Sum_probs=186.1
Q ss_pred ceEEEeEeeccCCceEEEEEEee----CCcEEEEEEeecCCc----hHHHHHHHHHHHhCCCCCeeeecccccCCceEEE
Q 003644 376 KLVVFNKEIAKGSNGTVVLEGNY----EGRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYL 447 (805)
Q Consensus 376 ~~~~~~~~LG~GsfGtVy~a~~~----~g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~L 447 (805)
.+|.+.+.||+|+||.||++... .+..||+|.++.... ....+|+. ++..++||||+++++++.+++..|+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~l 82 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEAS-IMGQFDHPNIIHLEGVVTKSKPVMI 82 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHH-HHHhCCCCCcceEEEEEecCCccEE
Confidence 45778899999999999998653 234799999865432 23344554 6678899999999999999999999
Q ss_pred ecccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhh
Q 003644 448 SLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE 527 (805)
Q Consensus 448 V~E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~ 527 (805)
||| |.++|+|.+++.... ..+++.+++.++.|++.||+|||+
T Consensus 83 v~e----------~~~~~~L~~~~~~~~----------------------------~~~~~~~~~~i~~~i~~~l~~lH~ 124 (267)
T cd05066 83 VTE----------YMENGSLDAFLRKHD----------------------------GQFTVIQLVGMLRGIASGMKYLSD 124 (267)
T ss_pred EEE----------cCCCCCHHHHHHhcC----------------------------CCCCHHHHHHHHHHHHHHHHHHHH
Confidence 999 555556655543211 235667789999999999999999
Q ss_pred cceeccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHHHH
Q 003644 528 IGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFC 607 (805)
Q Consensus 528 ~~IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~el 607 (805)
.+++||||||+|||++.++. ++|+|||++.................++..|+|||++.+..++.++|+|||||++||+
T Consensus 125 ~~i~h~dlkp~nili~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el 202 (267)
T cd05066 125 MGYVHRDLAARNILVNSNLV--CKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEV 202 (267)
T ss_pred CCEeehhhchhcEEECCCCe--EEeCCCCcccccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHH
Confidence 99999999999999987765 8999999998765432221111222345689999999988899999999999999998
Q ss_pred HhCCCCCCCCchHH-HHHHHhhc-cccccccCChHHHHHHHHhcCCCCCCCCChhhhhc
Q 003644 608 ITGGKHPYGESFER-DANIVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 664 (805)
Q Consensus 608 ltG~~~Pf~~~~~~-~~~~~~~~-~~~~~~~~~~~~~dLi~~~L~~dP~~Rps~~ell~ 664 (805)
++.+..||...... ....+... ........++.+.+++.+||+.+|.+||++.++++
T Consensus 203 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 203 MSYGERPYWEMSNQDVIKAIEEGYRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVS 261 (267)
T ss_pred hcCCCCCcccCCHHHHHHHHhCCCcCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHH
Confidence 87347787654322 22222221 11223345678999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=289.85 Aligned_cols=246 Identities=27% Similarity=0.409 Sum_probs=191.5
Q ss_pred eEeeccCCceEEEEEEe-eCCcEEEEEEeecCCchHHH----HHHHHHHHhCCCCCeeeecccccCCceEEEecccccCC
Q 003644 381 NKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHHDVAL----KEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCS 455 (805)
Q Consensus 381 ~~~LG~GsfGtVy~a~~-~~g~~VAVK~l~~~~~~~~~----~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~E~~~~s 455 (805)
...||.|+-|+|+++.. .+|..+|||.+.+....+.. ..+..++..-+.|.||+.+|||..+..++++||.+..-
T Consensus 97 l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs~C 176 (391)
T KOG0983|consen 97 LGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMSTC 176 (391)
T ss_pred HHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHHHH
Confidence 35699999999999854 46899999999876544433 33444555667899999999999999999999954322
Q ss_pred hhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhc-ceeccC
Q 003644 456 LNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI-GLIHRD 534 (805)
Q Consensus 456 L~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~-~IvHrD 534 (805)
++.++. .-..++|+..+-++...++.||.||.++ +|+|||
T Consensus 177 ~ekLlk---------------------------------------rik~piPE~ilGk~tva~v~AL~YLKeKH~viHRD 217 (391)
T KOG0983|consen 177 AEKLLK---------------------------------------RIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRD 217 (391)
T ss_pred HHHHHH---------------------------------------HhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecc
Confidence 222221 1234577778888999999999999976 899999
Q ss_pred CCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhc---CCCCCcchHHHHHHHHHHHHhCC
Q 003644 535 LKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ---GRQTRAIDLFSLGCILFFCITGG 611 (805)
Q Consensus 535 LKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~---~~~t~~sDVwSlGvil~elltG~ 611 (805)
+||+|||+++.|+ +|+||||++-++.+.. ......|.+.|||||.+.. ..|+.++||||||+.++||.||
T Consensus 218 vKPSNILlDe~Gn--iKlCDFGIsGrlvdSk----AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg- 290 (391)
T KOG0983|consen 218 VKPSNILLDERGN--IKLCDFGISGRLVDSK----AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATG- 290 (391)
T ss_pred cCccceEEccCCC--EEeecccccceeeccc----ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcc-
Confidence 9999999998887 8999999998876542 2234569999999999875 4688999999999999999997
Q ss_pred CCCCCCc---hHHHHHHHhhcccccc--ccCChHHHHHHHHhcCCCCCCCCChhhhhcCccccccc
Q 003644 612 KHPYGES---FERDANIVKDRKDLFL--VEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTAD 672 (805)
Q Consensus 612 ~~Pf~~~---~~~~~~~~~~~~~~~~--~~~~~~~~dLi~~~L~~dP~~Rps~~ell~Hpff~~~~ 672 (805)
..||... ++....++...+...+ ..+++++++++..||++|+.+||...++|+|||+...+
T Consensus 291 ~yPy~~c~tdFe~ltkvln~ePP~L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye 356 (391)
T KOG0983|consen 291 QYPYKGCKTDFEVLTKVLNEEPPLLPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKRYE 356 (391)
T ss_pred cCCCCCCCccHHHHHHHHhcCCCCCCcccCcCHHHHHHHHHHhhcCcccCcchHHHhcCcceeecc
Confidence 7788652 3333344443333222 23689999999999999999999999999999986544
|
|
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=306.56 Aligned_cols=247 Identities=25% Similarity=0.384 Sum_probs=190.0
Q ss_pred eEEEeEeeccCCceEEEEEEe-eCCcEEEEEEeecCCc------hHHHHHHHHHHHhCCCCCeeeecccccCCceEEEec
Q 003644 377 LVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH------DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSL 449 (805)
Q Consensus 377 ~~~~~~~LG~GsfGtVy~a~~-~~g~~VAVK~l~~~~~------~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~ 449 (805)
.|...+.||+|+||+||++.. .+|..||+|++..... ....+|+. .++.++|||++++++++.+++..|+||
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~-~l~~l~h~~iv~~~~~~~~~~~~~lv~ 104 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVK-FLQRIKHPNSIEYKGCYLREHTAWLVM 104 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHH-HHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence 356668899999999999864 4689999999864321 12345554 678889999999999999999999999
Q ss_pred ccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcc
Q 003644 450 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG 529 (805)
Q Consensus 450 E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~ 529 (805)
|||.++|.+++... ...+++.++..++.|++.||.|||+.+
T Consensus 105 e~~~g~l~~~~~~~---------------------------------------~~~l~~~~~~~i~~~i~~~l~~lH~~~ 145 (317)
T cd06635 105 EYCLGSASDLLEVH---------------------------------------KKPLQEVEIAAITHGALQGLAYLHSHN 145 (317)
T ss_pred eCCCCCHHHHHHHh---------------------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 98877665554211 123566778899999999999999999
Q ss_pred eeccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhh---cCCCCCcchHHHHHHHHHH
Q 003644 530 LIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLL---QGRQTRAIDLFSLGCILFF 606 (805)
Q Consensus 530 IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~---~~~~t~~sDVwSlGvil~e 606 (805)
|+||||+|+||+++.++. +||+|||++..... .....|+..|+|||++. .+.++.++|||||||++||
T Consensus 146 i~H~dL~p~Nil~~~~~~--~kl~dfg~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~e 216 (317)
T cd06635 146 MIHRDIKAGNILLTEPGQ--VKLADFGSASIASP-------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIE 216 (317)
T ss_pred cccCCCCcccEEECCCCC--EEEecCCCccccCC-------cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHH
Confidence 999999999999987766 89999999875432 12345889999999974 4568899999999999999
Q ss_pred HHhCCCCCCCCch-HHHH-HHHhhcc-ccccccCChHHHHHHHHhcCCCCCCCCChhhhhcCcccccccc
Q 003644 607 CITGGKHPYGESF-ERDA-NIVKDRK-DLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTADT 673 (805)
Q Consensus 607 lltG~~~Pf~~~~-~~~~-~~~~~~~-~~~~~~~~~~~~dLi~~~L~~dP~~Rps~~ell~Hpff~~~~~ 673 (805)
|++| .+||.... .... .+..... .......++.+.+++.+||+.+|.+||++.++++|||+.....
T Consensus 217 l~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~ 285 (317)
T cd06635 217 LAER-KPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRERP 285 (317)
T ss_pred HHhC-CCCCCCccHHHHHHHHHhccCCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccCc
Confidence 9997 55654432 2222 2222222 1122234578999999999999999999999999999965443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=301.56 Aligned_cols=247 Identities=25% Similarity=0.366 Sum_probs=182.6
Q ss_pred ceEEEeEeeccCCceEEEEEEe-----eCCcEEEEEEeecCCch---HHHHHHHHHHHhCCCCCeeeecccccC--CceE
Q 003644 376 KLVVFNKEIAKGSNGTVVLEGN-----YEGRSVAVKRLVKTHHD---VALKEIQNLIASDQHPNIVRWYGVESD--QDFV 445 (805)
Q Consensus 376 ~~~~~~~~LG~GsfGtVy~a~~-----~~g~~VAVK~l~~~~~~---~~~~Ei~~ll~~l~HpNIV~l~g~~~~--~~~l 445 (805)
+.|.+.+.||+|+||+||++.. .+++.||||++...... ...+|+. ++..++||||+++++++.. ....
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~-~l~~l~h~~iv~~~~~~~~~~~~~~ 82 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIE-ILKSLQHDNIVKYKGVCYSAGRRNL 82 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHH-HHHhCCCCCeeEEEEEEccCCCCce
Confidence 3577789999999999999753 35889999998654322 3345654 6778899999999997643 4578
Q ss_pred EEecccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHh
Q 003644 446 YLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHL 525 (805)
Q Consensus 446 ~LV~E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yL 525 (805)
++||| |+++|+|.+++... ...+++..++.++.|++.||+||
T Consensus 83 ~lv~e----------~~~~~~L~~~l~~~----------------------------~~~l~~~~~~~~~~~l~~aL~~L 124 (284)
T cd05081 83 RLVME----------YLPYGSLRDYLQKH----------------------------RERLDHRKLLLYASQICKGMEYL 124 (284)
T ss_pred EEEEE----------ecCCCCHHHHHHhc----------------------------CcCCCHHHHHHHHHHHHHHHHHH
Confidence 99999 66677777665321 12356778899999999999999
Q ss_pred hhcceeccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHH
Q 003644 526 HEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILF 605 (805)
Q Consensus 526 H~~~IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~ 605 (805)
|+.||+||||||+||+++.++. +||+|||+++................++..|+|||++.+..++.++|||||||++|
T Consensus 125 H~~~i~H~dlkp~nili~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ 202 (284)
T cd05081 125 GSKRYVHRDLATRNILVESENR--VKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLY 202 (284)
T ss_pred HHCCceeccCCHhhEEECCCCe--EEECCCcccccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHH
Confidence 9999999999999999987765 89999999987754322211112223445699999999888999999999999999
Q ss_pred HHHhCCCCCCCCchHHH-----------------HHHHhhc-cccccccCChHHHHHHHHhcCCCCCCCCChhhhhc
Q 003644 606 FCITGGKHPYGESFERD-----------------ANIVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 664 (805)
Q Consensus 606 elltG~~~Pf~~~~~~~-----------------~~~~~~~-~~~~~~~~~~~~~dLi~~~L~~dP~~Rps~~ell~ 664 (805)
||++|.. ++....... ...+... ........++++.+++.+||..+|++|||+.|+++
T Consensus 203 el~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05081 203 ELFTYSD-KSCSPPAEFMRMMGNDKQGQMIVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL 278 (284)
T ss_pred HHhhcCC-cCCCcchhhhhhcccccccccchHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 9999744 332221110 0111111 11122334578999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=297.12 Aligned_cols=248 Identities=24% Similarity=0.355 Sum_probs=185.7
Q ss_pred ceEEEeEeeccCCceEEEEEEee-CC---cEEEEEEeecCCc----hHHHHHHHHHHHhCCCCCeeeecccccCCceEEE
Q 003644 376 KLVVFNKEIAKGSNGTVVLEGNY-EG---RSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYL 447 (805)
Q Consensus 376 ~~~~~~~~LG~GsfGtVy~a~~~-~g---~~VAVK~l~~~~~----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~L 447 (805)
..|...+.||+|+||.||++... ++ ..||||.+..... .....|+ .++..++||||+++++++.+.+..|+
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~-~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEA-SIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHH-HHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 34667789999999999998654 33 3799999865432 2234455 46788899999999999999999999
Q ss_pred ecccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhh
Q 003644 448 SLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE 527 (805)
Q Consensus 448 V~E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~ 527 (805)
||| |..+++|.+++... ...+++.++..++.|++.||+|||+
T Consensus 84 v~e----------~~~~~~L~~~~~~~----------------------------~~~~~~~~~~~~~~~l~~al~~lH~ 125 (268)
T cd05063 84 ITE----------YMENGALDKYLRDH----------------------------DGEFSSYQLVGMLRGIAAGMKYLSD 125 (268)
T ss_pred EEE----------cCCCCCHHHHHHhc----------------------------CCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 999 55556665554321 1235677789999999999999999
Q ss_pred cceeccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHHHH
Q 003644 528 IGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFC 607 (805)
Q Consensus 528 ~~IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~el 607 (805)
.+++||||||+||+++.++. +||+|||++..................+..|+|||++....++.++|||||||++||+
T Consensus 126 ~~i~H~dlkp~Nili~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~el 203 (268)
T cd05063 126 MNYVHRDLAARNILVNSNLE--CKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEV 203 (268)
T ss_pred CCeeccccchhhEEEcCCCc--EEECCCccceecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHH
Confidence 99999999999999987765 8999999998765332111111112235679999999988899999999999999999
Q ss_pred HhCCCCCCCCchH-HHHHHHh-hccccccccCChHHHHHHHHhcCCCCCCCCChhhhhc
Q 003644 608 ITGGKHPYGESFE-RDANIVK-DRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 664 (805)
Q Consensus 608 ltG~~~Pf~~~~~-~~~~~~~-~~~~~~~~~~~~~~~dLi~~~L~~dP~~Rps~~ell~ 664 (805)
++.+..||..... .....+. ..........+.++.+++.+||+.||+.||++.++++
T Consensus 204 l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~ 262 (268)
T cd05063 204 MSFGERPYWDMSNHEVMKAINDGFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVN 262 (268)
T ss_pred HhCCCCCCCcCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 9844677754332 2222222 2222233345678999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=304.66 Aligned_cols=259 Identities=23% Similarity=0.317 Sum_probs=186.0
Q ss_pred eEEEeEeeccCCceEEEEEEee-CC--cEEEEEEeecCCc----hHHHHHHHHHHHhCCCCCeeeecccccCCceEEEec
Q 003644 377 LVVFNKEIAKGSNGTVVLEGNY-EG--RSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSL 449 (805)
Q Consensus 377 ~~~~~~~LG~GsfGtVy~a~~~-~g--~~VAVK~l~~~~~----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~ 449 (805)
.|.+.+.||+|+||.||++... ++ ..+|+|.++.... ....+|+..+.+..+||||+++++++.+.+..|+|+
T Consensus 3 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~ 82 (297)
T cd05089 3 DIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAI 82 (297)
T ss_pred cceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEE
Confidence 4778899999999999998654 33 3579988864322 234456654444448999999999999999999999
Q ss_pred ccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHH-hhCCCCHHHHHHHHHHHHHHHHHhhhc
Q 003644 450 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELW-KANGHPSAQLLKVTRDIVSGLSHLHEI 528 (805)
Q Consensus 450 E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~-~~~~l~~~~~~~i~~qIa~gL~yLH~~ 528 (805)
| |.++|+|.++++........ ......+ ....+++..++.++.||+.||+|||+.
T Consensus 83 e----------~~~~~~L~~~l~~~~~~~~~--------------~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~ 138 (297)
T cd05089 83 E----------YAPYGNLLDFLRKSRVLETD--------------PAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK 138 (297)
T ss_pred E----------ecCCCcHHHHHHhccccccc--------------cccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 9 55666666665432211000 0000001 123578889999999999999999999
Q ss_pred ceeccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHHHHH
Q 003644 529 GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCI 608 (805)
Q Consensus 529 ~IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~ell 608 (805)
||+||||||+|||++.++. +||+|||++...... ........+..|+|||++....++.++|||||||++|||+
T Consensus 139 ~ivH~dlkp~Nill~~~~~--~kl~dfg~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~ 212 (297)
T cd05089 139 QFIHRDLAARNVLVGENLA--SKIADFGLSRGEEVY----VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIV 212 (297)
T ss_pred CcccCcCCcceEEECCCCe--EEECCcCCCccccce----eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHH
Confidence 9999999999999987765 899999998643211 1111122356799999998888999999999999999999
Q ss_pred hCCCCCCCCchHHH-HHHHhhc-cccccccCChHHHHHHHHhcCCCCCCCCChhhhhcC
Q 003644 609 TGGKHPYGESFERD-ANIVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNH 665 (805)
Q Consensus 609 tG~~~Pf~~~~~~~-~~~~~~~-~~~~~~~~~~~~~dLi~~~L~~dP~~Rps~~ell~H 665 (805)
+.+.+||....... ...+... ....+...++++.+++.+||+.||.+||+++++++.
T Consensus 213 t~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 271 (297)
T cd05089 213 SLGGTPYCGMTCAELYEKLPQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ 271 (297)
T ss_pred cCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 84477886543332 2222211 122233456789999999999999999999999754
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=294.00 Aligned_cols=249 Identities=27% Similarity=0.447 Sum_probs=194.3
Q ss_pred EEEeEeeccCCceEEEEEEee-CCcEEEEEEeecCCc-----hHHHHHHHHHHHhCCCCCeeeecccccCCceEEEeccc
Q 003644 378 VVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHH-----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLER 451 (805)
Q Consensus 378 ~~~~~~LG~GsfGtVy~a~~~-~g~~VAVK~l~~~~~-----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~E~ 451 (805)
|.+.+.||+|+||.||++... +++.||+|++..... ....+|++ .++.++|||++++++.+.+++..++|+|+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~-~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 2 YEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVK-ILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred ceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHH-HHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 567789999999999998554 689999999875432 23344554 67788999999999999999999999995
Q ss_pred ccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhccee
Q 003644 452 CTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLI 531 (805)
Q Consensus 452 ~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~Iv 531 (805)
+ .+++|.+++.... .+...+++..+..++.+++.||+|||+.+++
T Consensus 81 ~----------~~~~L~~~l~~~~-------------------------~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~ 125 (258)
T cd08215 81 A----------DGGDLSQKIKKQK-------------------------KEGKPFPEEQILDWFVQLCLALKYLHSRKIL 125 (258)
T ss_pred c----------CCCcHHHHHHHhh-------------------------ccCCCcCHHHHHHHHHHHHHHHHHHHhCCEe
Confidence 4 4555555443221 1124577888999999999999999999999
Q ss_pred ccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHHHHHhCC
Q 003644 532 HRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGG 611 (805)
Q Consensus 532 HrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~elltG~ 611 (805)
|+||+|+||+++.++. ++|+|||++....... .......|++.|+|||.+....++.++|+||+|+++|+|++|
T Consensus 126 H~dl~~~nil~~~~~~--~~l~d~~~~~~~~~~~---~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g- 199 (258)
T cd08215 126 HRDIKPQNIFLTSNGL--VKLGDFGISKVLSSTV---DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTL- 199 (258)
T ss_pred cccCChHHeEEcCCCc--EEECCccceeecccCc---ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcC-
Confidence 9999999999987765 8999999998765432 122334688999999999888899999999999999999996
Q ss_pred CCCCCCchHHHH--HHHhhccccccccCChHHHHHHHHhcCCCCCCCCChhhhhcCccc
Q 003644 612 KHPYGESFERDA--NIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 668 (805)
Q Consensus 612 ~~Pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~dLi~~~L~~dP~~Rps~~ell~Hpff 668 (805)
..||........ ..........+.....++.+++.+||..+|++||++.++++||||
T Consensus 200 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 200 KHPFEGENLLELALKILKGQYPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQSPFI 258 (258)
T ss_pred CCCCCCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCCCC
Confidence 778765432221 222222222333456789999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=310.77 Aligned_cols=248 Identities=24% Similarity=0.305 Sum_probs=180.5
Q ss_pred eeccC--CceEEEEEEe-eCCcEEEEEEeecCCc----hHHHHHHHHHHHhCCCCCeeeecccccCCceEEEecccccCC
Q 003644 383 EIAKG--SNGTVVLEGN-YEGRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCS 455 (805)
Q Consensus 383 ~LG~G--sfGtVy~a~~-~~g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~E~~~~s 455 (805)
.||+| +||+||++.. .+|+.||||++..... ...++++..+++.++||||+++++++.+++..|+|+|
T Consensus 5 ~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e----- 79 (328)
T cd08226 5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISP----- 79 (328)
T ss_pred HhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEe-----
Confidence 46666 9999999854 5799999999864331 1233333457778999999999999999999999999
Q ss_pred hhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcceeccCC
Q 003644 456 LNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDL 535 (805)
Q Consensus 456 L~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~IvHrDL 535 (805)
|+.+|++.+++... ...++++..+..++.||+.||+|||+.+|+||||
T Consensus 80 -----~~~~~~l~~~l~~~---------------------------~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDl 127 (328)
T cd08226 80 -----FMAYGSANSLLKTY---------------------------FPEGMSEALIGNILFGALRGLNYLHQNGYIHRNI 127 (328)
T ss_pred -----cccCCCHHHHHHhh---------------------------cccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCC
Confidence 55556666554321 1134677888999999999999999999999999
Q ss_pred CCceEEecCCCCceEEEeccCccccccCCCccc----cccccccCCCCCCChhhhhcC--CCCCcchHHHHHHHHHHHHh
Q 003644 536 KPQNVLISKDKSFCAKLSDMGISKRLQGDMSCL----TQNATGYGSSGWQAPEQLLQG--RQTRAIDLFSLGCILFFCIT 609 (805)
Q Consensus 536 Kp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~----~~~~~~~gt~~y~APE~l~~~--~~t~~sDVwSlGvil~ellt 609 (805)
||+|||++.++. ++++||+.+.......... .......++..|+|||++.+. .++.++|||||||++|||++
T Consensus 128 kp~Nill~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~ 205 (328)
T cd08226 128 KASHILISGDGL--VSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELAT 205 (328)
T ss_pred CHHHEEEeCCCc--EEEechHHHhhhhccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHh
Confidence 999999987765 8999998654332211100 001112356779999999764 47899999999999999999
Q ss_pred CCCCCCCCchHHHH--HHHhhcc----------------------------------------------ccccccCChHH
Q 003644 610 GGKHPYGESFERDA--NIVKDRK----------------------------------------------DLFLVEHIPEA 641 (805)
Q Consensus 610 G~~~Pf~~~~~~~~--~~~~~~~----------------------------------------------~~~~~~~~~~~ 641 (805)
| .+||........ ....... ........+++
T Consensus 206 g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (328)
T cd08226 206 G-RVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAF 284 (328)
T ss_pred C-CCCCCCcChHHHHHHHhcCCCCCCccccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHH
Confidence 6 778865432211 1110000 00011234578
Q ss_pred HHHHHHhcCCCCCCCCChhhhhcCccccc
Q 003644 642 VDLFTRLLDPNPDLRPKAQNVLNHPFFWT 670 (805)
Q Consensus 642 ~dLi~~~L~~dP~~Rps~~ell~Hpff~~ 670 (805)
.+|+++||+.||++|||+.|+++||||..
T Consensus 285 ~~li~~~l~~dP~~Rpta~e~l~~~~~~~ 313 (328)
T cd08226 285 QNLVELCLQQDPEKRPSASSLLSHAFFKQ 313 (328)
T ss_pred HHHHHHHccCCcccCCCHHHHhhCHHHHH
Confidence 99999999999999999999999999954
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=301.77 Aligned_cols=254 Identities=28% Similarity=0.441 Sum_probs=197.0
Q ss_pred ccceEEEeEeeccCCceEEEEEEee-CCcEEEEEEeecCC--chHHHHHHHHHHHhCCCCCeeeecccccCCceEEEecc
Q 003644 374 IGKLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH--HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 450 (805)
Q Consensus 374 i~~~~~~~~~LG~GsfGtVy~a~~~-~g~~VAVK~l~~~~--~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~E 450 (805)
..+.|.+.+.||+|++|.||++... +++.||+|++.... .....+|+. ++..++|+||+++++++.+.+..|+++|
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~-~l~~l~~~~i~~~~~~~~~~~~~~lv~e 95 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEIL-IMKDCKHPNIVDYYDSYLVGDELWVVME 95 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHH-HHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence 4555777789999999999998655 68999999997654 234455665 7788899999999999999999999999
Q ss_pred cccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcce
Q 003644 451 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 530 (805)
Q Consensus 451 ~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~I 530 (805)
++ .+++|.+++.... ..+++..+..++.|++.||+|||+.||
T Consensus 96 ~~----------~~~~L~~~l~~~~----------------------------~~l~~~~~~~i~~~i~~~L~~lH~~gi 137 (286)
T cd06614 96 YM----------DGGSLTDIITQNF----------------------------VRMNEPQIAYVCREVLQGLEYLHSQNV 137 (286)
T ss_pred cc----------CCCcHHHHHHHhc----------------------------cCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 55 4455555443211 246777889999999999999999999
Q ss_pred eccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHHHHHhC
Q 003644 531 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG 610 (805)
Q Consensus 531 vHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~elltG 610 (805)
+|+||+|+||+++.++. ++|+|||++........ ......++..|+|||++.+..++.++|+|||||++|+|++|
T Consensus 138 ~H~dl~p~ni~i~~~~~--~~l~d~~~~~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g 212 (286)
T cd06614 138 IHRDIKSDNILLSKDGS--VKLADFGFAAQLTKEKS---KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEG 212 (286)
T ss_pred eeCCCChhhEEEcCCCC--EEECccchhhhhccchh---hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhC
Confidence 99999999999988776 89999999876543211 11233578899999999888899999999999999999997
Q ss_pred CCCCCCCchHHHH--HHHhhcccc--ccccCChHHHHHHHHhcCCCCCCCCChhhhhcCccccccc
Q 003644 611 GKHPYGESFERDA--NIVKDRKDL--FLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTAD 672 (805)
Q Consensus 611 ~~~Pf~~~~~~~~--~~~~~~~~~--~~~~~~~~~~dLi~~~L~~dP~~Rps~~ell~Hpff~~~~ 672 (805)
..||........ .+....... .......++.++|.+||+.+|.+||++.++++||||....
T Consensus 213 -~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~ 277 (286)
T cd06614 213 -EPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKKAC 277 (286)
T ss_pred -CCCCCCCCHHHHHHHHHhcCCCCCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhChHhhccC
Confidence 778765433221 111111111 1112457899999999999999999999999999997643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=305.04 Aligned_cols=244 Identities=26% Similarity=0.393 Sum_probs=187.1
Q ss_pred EEEeEeeccCCceEEEEEEe-eCCcEEEEEEeecCCc------hHHHHHHHHHHHhCCCCCeeeecccccCCceEEEecc
Q 003644 378 VVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH------DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 450 (805)
Q Consensus 378 ~~~~~~LG~GsfGtVy~a~~-~~g~~VAVK~l~~~~~------~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~E 450 (805)
|...+.||+|+||+||++.. .+|+.||+|++..... ....+|+. ++..++|||++++++++.+.+..|+|||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~-~l~~l~h~~iv~~~~~~~~~~~~~lv~e 101 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVK-FLQQLKHPNTIEYKGCYLKEHTAWLVME 101 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHH-HHHhCCCCCCccEEEEEEeCCEEEEEEe
Confidence 45567799999999999854 4689999999864321 12344554 6788899999999999999999999999
Q ss_pred cccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcce
Q 003644 451 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 530 (805)
Q Consensus 451 ~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~I 530 (805)
+|.++|.+++... ...+++.+++.++.||+.||+|||+.||
T Consensus 102 ~~~~~l~~~l~~~---------------------------------------~~~l~~~~~~~~~~qi~~al~~LH~~gi 142 (313)
T cd06633 102 YCLGSASDLLEVH---------------------------------------KKPLQEVEIAAITHGALQGLAYLHSHNM 142 (313)
T ss_pred cCCCCHHHHHHhc---------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 8877665554211 1235667788999999999999999999
Q ss_pred eccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhh---cCCCCCcchHHHHHHHHHHH
Q 003644 531 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLL---QGRQTRAIDLFSLGCILFFC 607 (805)
Q Consensus 531 vHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~---~~~~t~~sDVwSlGvil~el 607 (805)
+||||+|+||+++.++. +||+|||++..... .....|+..|+|||++. ...++.++|||||||++|+|
T Consensus 143 ~H~dl~p~nili~~~~~--~kL~dfg~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el 213 (313)
T cd06633 143 IHRDIKAGNILLTEPGQ--VKLADFGSASKSSP-------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 213 (313)
T ss_pred ecCCCChhhEEECCCCC--EEEeecCCCcccCC-------CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHH
Confidence 99999999999988776 89999998864321 22346889999999984 35678899999999999999
Q ss_pred HhCCCCCCCCch-HHHH-HHHhhcc-ccccccCChHHHHHHHHhcCCCCCCCCChhhhhcCcccccc
Q 003644 608 ITGGKHPYGESF-ERDA-NIVKDRK-DLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTA 671 (805)
Q Consensus 608 ltG~~~Pf~~~~-~~~~-~~~~~~~-~~~~~~~~~~~~dLi~~~L~~dP~~Rps~~ell~Hpff~~~ 671 (805)
++| .+||.... .... .+..... .......+..+++++.+||+.+|.+||++.+++.||||...
T Consensus 214 ~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~~ 279 (313)
T cd06633 214 AER-KPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRHDFVRRD 279 (313)
T ss_pred HhC-CCCCCCCChHHHHHHHHhcCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCC
Confidence 997 55664432 2222 2221111 11122344679999999999999999999999999999653
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=291.98 Aligned_cols=247 Identities=33% Similarity=0.503 Sum_probs=192.4
Q ss_pred EEEeEeeccCCceEEEEEEee-CCcEEEEEEeecCC-----chHHHHHHHHHHHhCCCCCeeeecccccCC--ceEEEec
Q 003644 378 VVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQ--DFVYLSL 449 (805)
Q Consensus 378 ~~~~~~LG~GsfGtVy~a~~~-~g~~VAVK~l~~~~-----~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~--~~l~LV~ 449 (805)
|...+.||+|++|.||++... +++.|++|++.... .+...+|+ ..++.++||||+++++.+.+. +..++++
T Consensus 2 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~-~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 2 WTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREI-RILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred ceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHH-HHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 556788999999999998655 68999999986554 22334444 477888999999999999988 8999999
Q ss_pred ccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcc
Q 003644 450 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG 529 (805)
Q Consensus 450 E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~ 529 (805)
|++ .+++|.+++... ..+++..+..++.|++.||+|||+.+
T Consensus 81 e~~----------~~~~L~~~~~~~-----------------------------~~~~~~~~~~~~~~l~~~l~~lh~~~ 121 (260)
T cd06606 81 EYV----------SGGSLSSLLKKF-----------------------------GKLPEPVIRKYTRQILEGLAYLHSNG 121 (260)
T ss_pred Eec----------CCCcHHHHHHHc-----------------------------CCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 954 455555544221 14677788999999999999999999
Q ss_pred eeccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHHHHHh
Q 003644 530 LIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCIT 609 (805)
Q Consensus 530 IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~ellt 609 (805)
++|+||+|+||+++.++. ++|+|||.+......... .......++..|+|||.+.....+.++||||||+++|+|++
T Consensus 122 ~~h~dl~p~ni~i~~~~~--~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~ 198 (260)
T cd06606 122 IVHRDIKGANILVDSDGV--VKLADFGCAKRLGDIETG-EGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMAT 198 (260)
T ss_pred ccccCCCHHHEEEcCCCC--EEEcccccEEeccccccc-ccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHh
Confidence 999999999999988765 899999999877643221 01233458899999999988889999999999999999999
Q ss_pred CCCCCCCCchHHHHHH--Hh--hccccccccCChHHHHHHHHhcCCCCCCCCChhhhhcCccc
Q 003644 610 GGKHPYGESFERDANI--VK--DRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 668 (805)
Q Consensus 610 G~~~Pf~~~~~~~~~~--~~--~~~~~~~~~~~~~~~dLi~~~L~~dP~~Rps~~ell~Hpff 668 (805)
| ..||.......... .. ......+...++++.++|.+||+.||.+||++.++++||||
T Consensus 199 g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 199 G-KPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQHPFL 260 (260)
T ss_pred C-CCCCCCCCchHHHHHhccccCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhCCCC
Confidence 6 67876644211111 11 11122333446789999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=299.79 Aligned_cols=246 Identities=29% Similarity=0.446 Sum_probs=185.6
Q ss_pred EEEeEeeccCCceEEEEEEee-CCcEEEEEEeecCC-----chHHHHHHHHHHHhCCCCCeeeecccccCC--ceEEEec
Q 003644 378 VVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQ--DFVYLSL 449 (805)
Q Consensus 378 ~~~~~~LG~GsfGtVy~a~~~-~g~~VAVK~l~~~~-----~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~--~~l~LV~ 449 (805)
|.+.+.||+|++|.||++... +|+.||||++.... .....+|+. ++..++||||+++++++.+. +..|+|+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~-~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 79 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIK-LLQKLRHPNIVRLKEIVTSKGKGSIYMVF 79 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHH-HHHhccCCCeeeheeeEecCCCCcEEEEe
Confidence 346688999999999998655 58999999997652 123445655 66788899999999999888 8999999
Q ss_pred ccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcc
Q 003644 450 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG 529 (805)
Q Consensus 450 E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~ 529 (805)
||+.++|.+++ ... ...+++..++.++.||+.||+|||+.+
T Consensus 80 e~~~~~l~~~~-----------~~~----------------------------~~~~~~~~~~~i~~~i~~al~~LH~~~ 120 (287)
T cd07840 80 EYMDHDLTGLL-----------DSP----------------------------EVKFTESQIKCYMKQLLEGLQYLHSNG 120 (287)
T ss_pred ccccccHHHHH-----------hcc----------------------------CCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 96655544433 110 123567788999999999999999999
Q ss_pred eeccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhc-CCCCCcchHHHHHHHHHHHH
Q 003644 530 LIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ-GRQTRAIDLFSLGCILFFCI 608 (805)
Q Consensus 530 IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~t~~sDVwSlGvil~ell 608 (805)
++|+||||+||++++++. +||+|||++........ .......++..|+|||.+.+ ..++.++|||||||++|||+
T Consensus 121 ~~h~dl~p~nil~~~~~~--~~l~d~g~~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~ 196 (287)
T cd07840 121 ILHRDIKGSNILINNDGV--LKLADFGLARPYTKRNS--ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELF 196 (287)
T ss_pred ceeccCcHHHeEEcCCCC--EEEccccceeeccCCCc--ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHH
Confidence 999999999999988766 89999999987754321 11122356888999998765 45789999999999999999
Q ss_pred hCCCCCCCCchHHHH--HHHhhcc-----------------------------cccccc-CChHHHHHHHHhcCCCCCCC
Q 003644 609 TGGKHPYGESFERDA--NIVKDRK-----------------------------DLFLVE-HIPEAVDLFTRLLDPNPDLR 656 (805)
Q Consensus 609 tG~~~Pf~~~~~~~~--~~~~~~~-----------------------------~~~~~~-~~~~~~dLi~~~L~~dP~~R 656 (805)
+| .+||........ .+..... ...... .++++.+++.+||+.||.+|
T Consensus 197 t~-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R 275 (287)
T cd07840 197 LG-KPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKR 275 (287)
T ss_pred hC-CCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhC
Confidence 97 677765332211 1100000 000011 26788999999999999999
Q ss_pred CChhhhhcCccc
Q 003644 657 PKAQNVLNHPFF 668 (805)
Q Consensus 657 ps~~ell~Hpff 668 (805)
|+++++++||||
T Consensus 276 p~~~~~l~~~~~ 287 (287)
T cd07840 276 ISADQALQHEYF 287 (287)
T ss_pred cCHHHHhhCcCC
Confidence 999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=309.51 Aligned_cols=249 Identities=25% Similarity=0.410 Sum_probs=190.8
Q ss_pred cccceEEEeEeeccCCceEEEEEEee-CCcEEEEEEeecCC-----chHHHHHHHHHHHhCCCCCeeeecccccCCce--
Q 003644 373 RIGKLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQDF-- 444 (805)
Q Consensus 373 ~i~~~~~~~~~LG~GsfGtVy~a~~~-~g~~VAVK~l~~~~-----~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~-- 444 (805)
.+++.|.+.+.||+|++|+||++... +++.||||++.... .....+|+. +++.++||||+++++++...+.
T Consensus 12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~-~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07851 12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELR-LLKHMDHENVIGLLDVFTPASSLE 90 (343)
T ss_pred cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHH-HHHhccCCCHHHHHHHhhcccccc
Confidence 34667888999999999999998654 68899999986432 123446665 6677899999999998876655
Q ss_pred ----EEEecccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHH
Q 003644 445 ----VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVS 520 (805)
Q Consensus 445 ----l~LV~E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~ 520 (805)
.|+|+|++.++|.+++. ...+++..+..++.|++.
T Consensus 91 ~~~~~~lv~e~~~~~L~~~~~-----------------------------------------~~~l~~~~~~~~~~ql~~ 129 (343)
T cd07851 91 DFQDVYLVTHLMGADLNNIVK-----------------------------------------CQKLSDDHIQFLVYQILR 129 (343)
T ss_pred ccccEEEEEecCCCCHHHHHh-----------------------------------------cCCCCHHHHHHHHHHHHH
Confidence 89999977666555441 123667788999999999
Q ss_pred HHHHhhhcceeccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcC-CCCCcchHHH
Q 003644 521 GLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG-RQTRAIDLFS 599 (805)
Q Consensus 521 gL~yLH~~~IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~t~~sDVwS 599 (805)
||+|||+.||+||||||+||+++.++. ++|+|||++...... .....++..|+|||.+.+. .++.++||||
T Consensus 130 aL~~LH~~gi~H~dlkp~Nill~~~~~--~kL~dfg~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~Dvws 201 (343)
T cd07851 130 GLKYIHSAGIIHRDLKPSNIAVNEDCE--LKILDFGLARHTDDE------MTGYVATRWYRAPEIMLNWMHYNQTVDIWS 201 (343)
T ss_pred HHHHHHHCCeecCCCCHHHeEECCCCC--EEEcccccccccccc------ccCCcccccccCHHHHhCCCCCCchHhHHH
Confidence 999999999999999999999988765 899999999866432 2234578899999998753 6789999999
Q ss_pred HHHHHHHHHhCCCCCCCCchHHH-H-HHHhhcc------------------------------ccccccCChHHHHHHHH
Q 003644 600 LGCILFFCITGGKHPYGESFERD-A-NIVKDRK------------------------------DLFLVEHIPEAVDLFTR 647 (805)
Q Consensus 600 lGvil~elltG~~~Pf~~~~~~~-~-~~~~~~~------------------------------~~~~~~~~~~~~dLi~~ 647 (805)
|||++|||++| .+||....... . .+..... .......++++.++|.+
T Consensus 202 lGv~l~elltg-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~ 280 (343)
T cd07851 202 VGCIMAELLTG-KTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEK 280 (343)
T ss_pred HHHHHHHHHhC-CCCCCCCChHHHHHHHHHhcCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHH
Confidence 99999999997 67775432211 1 1110000 00011246789999999
Q ss_pred hcCCCCCCCCChhhhhcCccccccc
Q 003644 648 LLDPNPDLRPKAQNVLNHPFFWTAD 672 (805)
Q Consensus 648 ~L~~dP~~Rps~~ell~Hpff~~~~ 672 (805)
||+.||++|||+.++++||||....
T Consensus 281 ~l~~~P~~Rpt~~ell~h~~~~~~~ 305 (343)
T cd07851 281 MLVLDPDKRITAAEALAHPYLAEYH 305 (343)
T ss_pred hCCCChhhCCCHHHHhcCCCccccC
Confidence 9999999999999999999996543
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=293.93 Aligned_cols=239 Identities=26% Similarity=0.387 Sum_probs=183.3
Q ss_pred eeccCCceEEEEEEeeCCcEEEEEEeecCCch----HHHHHHHHHHHhCCCCCeeeecccccCCceEEEecccccCChhh
Q 003644 383 EIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCSLND 458 (805)
Q Consensus 383 ~LG~GsfGtVy~a~~~~g~~VAVK~l~~~~~~----~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~E~~~~sL~d 458 (805)
.||+|+||.||++...+++.||+|.+...... ...+|+. +++.++||||+++++++.+.+..++||||+
T Consensus 2 ~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~------ 74 (250)
T cd05085 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEAR-ILKQYDHPNIVKLIGVCTQRQPIYIVMELV------ 74 (250)
T ss_pred ccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHH-HHHhCCCCCcCeEEEEEecCCccEEEEECC------
Confidence 58999999999998778899999998654322 2344554 677889999999999999999999999954
Q ss_pred HHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCCCc
Q 003644 459 LIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQ 538 (805)
Q Consensus 459 ~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~IvHrDLKp~ 538 (805)
.+|+|.+++... ...+++..++.++.|++.||.|||+.+++||||||+
T Consensus 75 ----~~~~L~~~~~~~----------------------------~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~ 122 (250)
T cd05085 75 ----PGGDFLSFLRKK----------------------------KDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAAR 122 (250)
T ss_pred ----CCCcHHHHHHhc----------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChh
Confidence 455555544221 122466778899999999999999999999999999
Q ss_pred eEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCCCCCc
Q 003644 539 NVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGES 618 (805)
Q Consensus 539 NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~elltG~~~Pf~~~ 618 (805)
||+++.++. +||+|||++........ .......++..|+|||++....++.++|||||||++|++++.+..||...
T Consensus 123 nili~~~~~--~~l~d~g~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~ 198 (250)
T cd05085 123 NCLVGENNV--LKISDFGMSRQEDDGIY--SSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGM 198 (250)
T ss_pred eEEEcCCCe--EEECCCccceecccccc--ccCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCC
Confidence 999987765 89999999876543211 11122235678999999988889999999999999999999557788654
Q ss_pred hHHHH-HHHh-hccccccccCChHHHHHHHHhcCCCCCCCCChhhhhc
Q 003644 619 FERDA-NIVK-DRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 664 (805)
Q Consensus 619 ~~~~~-~~~~-~~~~~~~~~~~~~~~dLi~~~L~~dP~~Rps~~ell~ 664 (805)
..... ..+. ......+...++++.+++.+||+.+|++||++.|+++
T Consensus 199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 246 (250)
T cd05085 199 TNQQAREQVEKGYRMSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQK 246 (250)
T ss_pred CHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 33221 1222 2122233445689999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=293.97 Aligned_cols=246 Identities=23% Similarity=0.391 Sum_probs=189.1
Q ss_pred eEEEeEeeccCCceEEEEEEeeCCcEEEEEEeecCC--chHHHHHHHHHHHhCCCCCeeeecccccCCceEEEecccccC
Q 003644 377 LVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTH--HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTC 454 (805)
Q Consensus 377 ~~~~~~~LG~GsfGtVy~a~~~~g~~VAVK~l~~~~--~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~E~~~~ 454 (805)
.|.+.+.||+|+||.||++...+++.+|||.+.... .....+|+. ++..++||||+++++++.+....++|||
T Consensus 5 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~-~l~~l~~~~i~~~~~~~~~~~~~~~v~e---- 79 (256)
T cd05112 5 ELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQ-VMMKLSHPKLVQLYGVCTERSPICLVFE---- 79 (256)
T ss_pred HeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCCHHHHHHHHH-HHHhCCCCCeeeEEEEEccCCceEEEEE----
Confidence 467789999999999999877778899999986543 234455665 7778899999999999999999999999
Q ss_pred ChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcceeccC
Q 003644 455 SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRD 534 (805)
Q Consensus 455 sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~IvHrD 534 (805)
|..+++|.+++... ...+++..++.++.|++.||+|||+.+++|||
T Consensus 80 ------~~~~~~L~~~~~~~----------------------------~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~d 125 (256)
T cd05112 80 ------FMEHGCLSDYLRAQ----------------------------RGKFSQETLLGMCLDVCEGMAYLESSNVIHRD 125 (256)
T ss_pred ------cCCCCcHHHHHHhC----------------------------ccCCCHHHHHHHHHHHHHHHHHHHHCCccccc
Confidence 55555555544321 12356677889999999999999999999999
Q ss_pred CCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCC
Q 003644 535 LKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP 614 (805)
Q Consensus 535 LKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~elltG~~~P 614 (805)
|||+||+++.++. ++|+|||+++....... .......++.+|+|||++.++.++.++|||||||++|||++++.+|
T Consensus 126 l~p~ni~i~~~~~--~~l~d~g~~~~~~~~~~--~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p 201 (256)
T cd05112 126 LAARNCLVGENQV--VKVSDFGMTRFVLDDQY--TSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTP 201 (256)
T ss_pred cccceEEEcCCCe--EEECCCcceeecccCcc--cccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCC
Confidence 9999999987664 89999999876643211 1112223567899999999888999999999999999999955888
Q ss_pred CCCchHHH-HHHHhh-ccccccccCChHHHHHHHHhcCCCCCCCCChhhhhcC
Q 003644 615 YGESFERD-ANIVKD-RKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNH 665 (805)
Q Consensus 615 f~~~~~~~-~~~~~~-~~~~~~~~~~~~~~dLi~~~L~~dP~~Rps~~ell~H 665 (805)
|....... ...+.. .....+...+.++.+++.+||+.+|++||++.+++++
T Consensus 202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~ 254 (256)
T cd05112 202 YENRSNSEVVETINAGFRLYKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQ 254 (256)
T ss_pred CCcCCHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHh
Confidence 87544322 222211 1212233356789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=299.40 Aligned_cols=255 Identities=21% Similarity=0.280 Sum_probs=189.0
Q ss_pred cceEEEeEeeccCCceEEEEEEeeC-----CcEEEEEEeecCCc----hHHHHHHHHHHHhCCCCCeeeecccccC-Cce
Q 003644 375 GKLVVFNKEIAKGSNGTVVLEGNYE-----GRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESD-QDF 444 (805)
Q Consensus 375 ~~~~~~~~~LG~GsfGtVy~a~~~~-----g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~-~~~ 444 (805)
++.|.+.+.||+|+||.||++.... +..||+|++..... ....+|+. .+..++||||+++++++.+ +..
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~-~l~~l~h~ni~~~~~~~~~~~~~ 83 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESC-LLYGLSHQNILPILHVCIEDGEP 83 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHH-HHHhCCCCCCCeEEEEEecCCCC
Confidence 4568888999999999999987655 78899999865432 22344554 6778899999999998766 577
Q ss_pred EEEecccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHH
Q 003644 445 VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSH 524 (805)
Q Consensus 445 l~LV~E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~y 524 (805)
.++++| |..+|+|.+++........ -....+++..++.++.|++.||+|
T Consensus 84 ~~~~~~----------~~~~~~L~~~l~~~~~~~~---------------------~~~~~l~~~~~~~i~~~i~~~l~~ 132 (280)
T cd05043 84 PFVLYP----------YMNWGNLKLFLQQCRLGEA---------------------NNPQALSTQQLVHMAIQIACGMSY 132 (280)
T ss_pred CEEEEE----------cCCCCcHHHHHHhcccccc---------------------ccccCCCHHHHHHHHHHHHHHHHH
Confidence 899999 4455555555433211000 011346788889999999999999
Q ss_pred hhhcceeccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHH
Q 003644 525 LHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCIL 604 (805)
Q Consensus 525 LH~~~IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil 604 (805)
||+.+++||||||+||+++.++. +||+|||+++.+...... .......++..|+|||++.+..++.++|||||||++
T Consensus 133 LH~~~i~H~di~p~nil~~~~~~--~kl~d~g~~~~~~~~~~~-~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l 209 (280)
T cd05043 133 LHKRGVIHKDIAARNCVIDEELQ--VKITDNALSRDLFPMDYH-CLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLL 209 (280)
T ss_pred HHHCCEeecccCHhhEEEcCCCc--EEECCCCCcccccCCceE-EeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHH
Confidence 99999999999999999987765 899999999866432211 111223357789999999988899999999999999
Q ss_pred HHHHhCCCCCCCCchHHHH-HHHhhc-cccccccCChHHHHHHHHhcCCCCCCCCChhhhhc
Q 003644 605 FFCITGGKHPYGESFERDA-NIVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 664 (805)
Q Consensus 605 ~elltG~~~Pf~~~~~~~~-~~~~~~-~~~~~~~~~~~~~dLi~~~L~~dP~~Rps~~ell~ 664 (805)
||+++.+++||........ ..+... ........++++.+++.+||..||++|||+.++++
T Consensus 210 ~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 271 (280)
T cd05043 210 WELMTLGQTPYVEIDPFEMAAYLKDGYRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQ 271 (280)
T ss_pred HHHhcCCCCCcCcCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 9999955888876433222 222222 11222344678999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=295.98 Aligned_cols=248 Identities=29% Similarity=0.386 Sum_probs=187.5
Q ss_pred eEEEeEeeccCCceEEEEEEe-eCCcEEEEEEeecCC----c----hHHHHHHHHHHHhCCCCCeeeecccccCC--ceE
Q 003644 377 LVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH----H----DVALKEIQNLIASDQHPNIVRWYGVESDQ--DFV 445 (805)
Q Consensus 377 ~~~~~~~LG~GsfGtVy~a~~-~~g~~VAVK~l~~~~----~----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~--~~l 445 (805)
.|.+.+.||+|+||.||++.. .+|+.||+|.+.... . ....+|+. +++.++||||+++++++.+. +.+
T Consensus 3 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~-~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQ-LLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred ceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHH-HHHHcCCCCcceEEEEEEcCCCCEE
Confidence 477889999999999999854 568999999874321 1 12334554 77888999999999998664 568
Q ss_pred EEecccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHh
Q 003644 446 YLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHL 525 (805)
Q Consensus 446 ~LV~E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yL 525 (805)
++++|++ ++++|.+++.. ...+++..++.++.|++.||+||
T Consensus 82 ~~v~e~~----------~~~~L~~~~~~-----------------------------~~~l~~~~~~~~~~~i~~al~~L 122 (264)
T cd06653 82 SIFVEYM----------PGGSIKDQLKA-----------------------------YGALTENVTRRYTRQILQGVSYL 122 (264)
T ss_pred EEEEEeC----------CCCcHHHHHHH-----------------------------cCCCCHHHHHHHHHHHHHHHHHH
Confidence 9999954 44555444321 12356677789999999999999
Q ss_pred hhcceeccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHH
Q 003644 526 HEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILF 605 (805)
Q Consensus 526 H~~~IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~ 605 (805)
|+.+++|+||||+||+++.++. ++|+|||+++................|+..|+|||++.+..++.++|+|||||++|
T Consensus 123 H~~~i~H~dl~p~ni~i~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ 200 (264)
T cd06653 123 HSNMIVHRDIKGANILRDSAGN--VKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVV 200 (264)
T ss_pred HhCCEecCCCCHHHEEEcCCCC--EEECccccccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHH
Confidence 9999999999999999987765 89999999987643211111112345889999999998888899999999999999
Q ss_pred HHHhCCCCCCCCchHHHH--HHHh-hccccccccCChHHHHHHHHhcCCCCCCCCChhhhhcCccc
Q 003644 606 FCITGGKHPYGESFERDA--NIVK-DRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 668 (805)
Q Consensus 606 elltG~~~Pf~~~~~~~~--~~~~-~~~~~~~~~~~~~~~dLi~~~L~~dP~~Rps~~ell~Hpff 668 (805)
++++| .+||.+...... .+.. ......+....+++.++|.+||+ +|.+||++.++++|||.
T Consensus 201 ~l~~g-~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~~~ 264 (264)
T cd06653 201 EMLTE-KPPWAEYEAMAAIFKIATQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRHPFV 264 (264)
T ss_pred HHHhC-CCCCCccCHHHHHHHHHcCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcCCCC
Confidence 99997 778876433221 1111 11223455566889999999999 57999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=294.99 Aligned_cols=242 Identities=29% Similarity=0.423 Sum_probs=188.4
Q ss_pred ceEEEeEeeccCCceEEEEEEeeCCcEEEEEEeecCCc--hHHHHHHHHHHHhCCCCCeeeecccccCCceEEEeccccc
Q 003644 376 KLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHH--DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCT 453 (805)
Q Consensus 376 ~~~~~~~~LG~GsfGtVy~a~~~~g~~VAVK~l~~~~~--~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~E~~~ 453 (805)
+.|.+.+.||+|+||.||++.. .|+.||||.+..... ....+|+. ++..++|+||+++++++.+.+..|+|||
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~-~~~~v~iK~~~~~~~~~~~~~~e~~-~l~~l~~~~i~~~~~~~~~~~~~~~v~e--- 80 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDY-RGQKVAVKCLKDDSTAAQAFLAEAS-VMTTLRHPNLVQLLGVVLQGNPLYIVTE--- 80 (256)
T ss_pred hhccceeeeecCCCceEEEEEe-cCcEEEEEEeccchhHHHHHHHHHH-HHHhcCCcceeeeEEEEcCCCCeEEEEE---
Confidence 4567789999999999999754 589999999976543 34455654 6788899999999999999999999999
Q ss_pred CChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcceecc
Q 003644 454 CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHR 533 (805)
Q Consensus 454 ~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~IvHr 533 (805)
|+.+++|.+++.... ...+++..+..++.|++.||+|||+.+++||
T Consensus 81 -------~~~~~~L~~~~~~~~---------------------------~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~ 126 (256)
T cd05039 81 -------YMAKGSLVDYLRSRG---------------------------RAVITLAQQLGFALDVCEGMEYLEEKNFVHR 126 (256)
T ss_pred -------ecCCCcHHHHHHhcC---------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCccch
Confidence 445555555443211 1236778889999999999999999999999
Q ss_pred CCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHHHHHhCCCC
Q 003644 534 DLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKH 613 (805)
Q Consensus 534 DLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~elltG~~~ 613 (805)
||||+||+++.++. +||+|||+++....... ...++..|+|||++....++.++|||||||++||+++.+..
T Consensus 127 di~p~Nili~~~~~--~~l~d~g~~~~~~~~~~------~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~ 198 (256)
T cd05039 127 DLAARNVLVSEDLV--AKVSDFGLAKEASQGQD------SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRV 198 (256)
T ss_pred hcccceEEEeCCCC--EEEcccccccccccccc------cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCC
Confidence 99999999987765 89999999987642211 22346689999999888899999999999999999984478
Q ss_pred CCCCchHHHH-HHHhhc-cccccccCChHHHHHHHHhcCCCCCCCCChhhhhc
Q 003644 614 PYGESFERDA-NIVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 664 (805)
Q Consensus 614 Pf~~~~~~~~-~~~~~~-~~~~~~~~~~~~~dLi~~~L~~dP~~Rps~~ell~ 664 (805)
||........ ..+... ....+...++++.++|.+||..+|++||++.++++
T Consensus 199 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 251 (256)
T cd05039 199 PYPRIPLKDVVPHVEKGYRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLRE 251 (256)
T ss_pred CCCCCCHHHHHHHHhcCCCCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 8876543332 222211 22233445688999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=294.87 Aligned_cols=247 Identities=22% Similarity=0.367 Sum_probs=188.4
Q ss_pred ccceEEEeEeeccCCceEEEEEEeeCCcEEEEEEeecCCc--hHHHHHHHHHHHhCCCCCeeeecccccCCceEEEeccc
Q 003644 374 IGKLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHH--DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLER 451 (805)
Q Consensus 374 i~~~~~~~~~LG~GsfGtVy~a~~~~g~~VAVK~l~~~~~--~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~E~ 451 (805)
..+.|.+.+.||+|+||.||++...++..||+|.+..... ....+|+. +++.++|+||+++++++.+ ...|++||
T Consensus 4 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~-~l~~l~~~~i~~~~~~~~~-~~~~~v~e- 80 (260)
T cd05073 4 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEAN-VMKTLQHDKLVKLHAVVTK-EPIYIITE- 80 (260)
T ss_pred cccceeEEeEecCccceEEEEEEecCCccEEEEecCCChhHHHHHHHHHH-HHHhcCCCCcceEEEEEcC-CCeEEEEE-
Confidence 3567889999999999999999877778899998865432 23445554 7788999999999999887 77899999
Q ss_pred ccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhccee
Q 003644 452 CTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLI 531 (805)
Q Consensus 452 ~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~Iv 531 (805)
|+.+|+|.+++.... ...+++..++.++.|++.||+|||+.+++
T Consensus 81 ---------~~~~~~L~~~~~~~~---------------------------~~~~~~~~~~~~~~~l~~aL~~lH~~~i~ 124 (260)
T cd05073 81 ---------FMAKGSLLDFLKSDE---------------------------GSKQPLPKLIDFSAQIAEGMAFIEQRNYI 124 (260)
T ss_pred ---------eCCCCcHHHHHHhCC---------------------------ccccCHHHHHHHHHHHHHHHHHHHhCCcc
Confidence 555555555543211 12245667789999999999999999999
Q ss_pred ccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHHHHHhCC
Q 003644 532 HRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGG 611 (805)
Q Consensus 532 HrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~elltG~ 611 (805)
||||||+||+++.++. +||+|||++........ .......++..|+|||++....++.++|+|||||++|++++++
T Consensus 125 H~dl~p~ni~i~~~~~--~~l~d~~~~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g 200 (260)
T cd05073 125 HRDLRAANILVSASLV--CKIADFGLARVIEDNEY--TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYG 200 (260)
T ss_pred ccccCcceEEEcCCCc--EEECCCcceeeccCCCc--ccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcC
Confidence 9999999999977765 89999999976643211 1111223567899999998888999999999999999999966
Q ss_pred CCCCCCchHHH-HHHHhhc-cccccccCChHHHHHHHHhcCCCCCCCCChhhhh
Q 003644 612 KHPYGESFERD-ANIVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVL 663 (805)
Q Consensus 612 ~~Pf~~~~~~~-~~~~~~~-~~~~~~~~~~~~~dLi~~~L~~dP~~Rps~~ell 663 (805)
.+||....... ...+... ........+.++.+++.+||+.+|++||++.+++
T Consensus 201 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~ 254 (260)
T cd05073 201 RIPYPGMSNPEVIRALERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQ 254 (260)
T ss_pred CCCCCCCCHHHHHHHHhCCCCCCCcccCCHHHHHHHHHHcccCcccCcCHHHHH
Confidence 88887643322 2222222 1122334567899999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=298.57 Aligned_cols=246 Identities=30% Similarity=0.447 Sum_probs=184.4
Q ss_pred EEEeEeeccCCceEEEEEEee-CCcEEEEEEeecCCc-----hHHHHHHHH--HHHhCCCCCeeeecccccCCce-----
Q 003644 378 VVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHH-----DVALKEIQN--LIASDQHPNIVRWYGVESDQDF----- 444 (805)
Q Consensus 378 ~~~~~~LG~GsfGtVy~a~~~-~g~~VAVK~l~~~~~-----~~~~~Ei~~--ll~~l~HpNIV~l~g~~~~~~~----- 444 (805)
|.+.+.||+|+||.||++... +++.||||++..... ....+|+.. .+..+.||||+++++++.+.+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 346788999999999998765 589999999964321 123345442 2344579999999999988776
Q ss_pred EEEecccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHH
Q 003644 445 VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSH 524 (805)
Q Consensus 445 l~LV~E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~y 524 (805)
.+++||++.++|.+++ ... ....+++..++.++.|++.||+|
T Consensus 81 ~~l~~e~~~~~l~~~l-----------~~~---------------------------~~~~l~~~~~~~~~~~i~~al~~ 122 (287)
T cd07838 81 LTLVFEHVDQDLATYL-----------SKC---------------------------PKPGLPPETIKDLMRQLLRGVDF 122 (287)
T ss_pred eEEEehhcccCHHHHH-----------HHc---------------------------cCCCCCHHHHHHHHHHHHHHHHH
Confidence 9999996665554433 111 01236778889999999999999
Q ss_pred hhhcceeccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHH
Q 003644 525 LHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCIL 604 (805)
Q Consensus 525 LH~~~IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil 604 (805)
||+.+++|+||+|+||+++.++. +||+|||++....... ......++..|+|||++.+..++.++|+|||||++
T Consensus 123 LH~~~i~h~~l~~~nili~~~~~--~~l~dfg~~~~~~~~~----~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l 196 (287)
T cd07838 123 LHSHRIVHRDLKPQNILVTSDGQ--VKIADFGLARIYSFEM----ALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIF 196 (287)
T ss_pred HHHCCeeeccCChhhEEEccCCC--EEEeccCcceeccCCc----ccccccccccccChHHhccCCCCCcchhhhHHHHH
Confidence 99999999999999999988765 8999999988764321 11223478899999999998899999999999999
Q ss_pred HHHHhCCCCCCCCchHHH--HHHHhhcc--------------------------ccccccCChHHHHHHHHhcCCCCCCC
Q 003644 605 FFCITGGKHPYGESFERD--ANIVKDRK--------------------------DLFLVEHIPEAVDLFTRLLDPNPDLR 656 (805)
Q Consensus 605 ~elltG~~~Pf~~~~~~~--~~~~~~~~--------------------------~~~~~~~~~~~~dLi~~~L~~dP~~R 656 (805)
|||++| .+||......+ ..+..... ........+++.++|.+||+.||.+|
T Consensus 197 ~~l~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R 275 (287)
T cd07838 197 AELFRR-RPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKR 275 (287)
T ss_pred HHHHhC-CCcccCCChHHHHHHHHHHcCCCChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccC
Confidence 999997 77776533221 11111000 00001224678899999999999999
Q ss_pred CChhhhhcCccc
Q 003644 657 PKAQNVLNHPFF 668 (805)
Q Consensus 657 ps~~ell~Hpff 668 (805)
|++.+++.||||
T Consensus 276 p~~~~il~~~~~ 287 (287)
T cd07838 276 ISAFEALQHPYF 287 (287)
T ss_pred CCHHHHhcCcCC
Confidence 999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=294.66 Aligned_cols=247 Identities=25% Similarity=0.389 Sum_probs=188.2
Q ss_pred ceEEEeEeeccCCceEEEEEEee-CCcEEEEEEeecCC------chHHHHHHHHHHHhCCCCCeeeecccccCCceEEEe
Q 003644 376 KLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH------HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLS 448 (805)
Q Consensus 376 ~~~~~~~~LG~GsfGtVy~a~~~-~g~~VAVK~l~~~~------~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV 448 (805)
+.|.+.+.||+|+||.||++... +|+.||+|.++... .....+|+. ++..++|+||+++++++.+++..++|
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~-~l~~~~~~~i~~~~~~~~~~~~~~lv 80 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEID-LLKQLDHPNVIKYLASFIENNELNIV 80 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHH-HHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 35788899999999999998665 79999999885321 223445654 67788999999999999999999999
Q ss_pred cccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhc
Q 003644 449 LERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI 528 (805)
Q Consensus 449 ~E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~ 528 (805)
|| |+.+|+|..++..... ....+++.+++.++.|++.||+|||+.
T Consensus 81 ~e----------~~~~~~L~~~l~~~~~-------------------------~~~~~~~~~~~~~~~~l~~~l~~lh~~ 125 (267)
T cd08224 81 LE----------LADAGDLSRMIKHFKK-------------------------QKRLIPERTIWKYFVQLCSALEHMHSK 125 (267)
T ss_pred Ee----------cCCCCCHHHHHHHhcc-------------------------cCCCcCHHHHHHHHHHHHHHHHHHHhC
Confidence 99 5555666555432110 113367788899999999999999999
Q ss_pred ceeccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHHHHH
Q 003644 529 GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCI 608 (805)
Q Consensus 529 ~IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~ell 608 (805)
||+||||||+||+++.++. ++|+|||++........ ......++..|+|||.+.+..++.++|+|||||++|+|+
T Consensus 126 ~i~h~dl~p~nil~~~~~~--~~l~d~~~~~~~~~~~~---~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~ 200 (267)
T cd08224 126 RIMHRDIKPANVFITATGV--VKLGDLGLGRFFSSKTT---AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMA 200 (267)
T ss_pred CEecCCcChhhEEECCCCc--EEEeccceeeeccCCCc---ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHH
Confidence 9999999999999988776 89999999876543211 112345889999999999888999999999999999999
Q ss_pred hCCCCCCCCchHHHH----HHHhhccccccc-cCChHHHHHHHHhcCCCCCCCCChhhhhc
Q 003644 609 TGGKHPYGESFERDA----NIVKDRKDLFLV-EHIPEAVDLFTRLLDPNPDLRPKAQNVLN 664 (805)
Q Consensus 609 tG~~~Pf~~~~~~~~----~~~~~~~~~~~~-~~~~~~~dLi~~~L~~dP~~Rps~~ell~ 664 (805)
+| ..||........ .+........+. ....++.++|.+||..+|++||++.++++
T Consensus 201 ~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~ 260 (267)
T cd08224 201 AL-QSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQ 260 (267)
T ss_pred HC-CCCcccCCccHHHHHhhhhcCCCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 97 567644322111 111111111222 45568999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-34 Score=309.00 Aligned_cols=248 Identities=22% Similarity=0.285 Sum_probs=179.6
Q ss_pred eEeeccCCceEEEEEEeeCCcEEEEEEeecCC-----chHHHHHHHHHHHhCCCCCeeeecccccCCceEEEecccccCC
Q 003644 381 NKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCS 455 (805)
Q Consensus 381 ~~~LG~GsfGtVy~a~~~~g~~VAVK~l~~~~-----~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~E~~~~s 455 (805)
.+.+|.|+++.||++ ..+++.||||++.... .....+|+. .++.++||||+++++++.+.+..|++|||
T Consensus 7 ~~~~~~~~~v~~~~~-~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~-~l~~l~h~~i~~~~~~~~~~~~~~~~~e~---- 80 (314)
T cd08216 7 GKCFEDLMIVHLAKH-KPTNTLVAVKKINLDSCSKEDLKLLQQEII-TSRQLQHPNILPYVTSFIVDSELYVVSPL---- 80 (314)
T ss_pred hHhhcCCceEEEEEe-cCCCCEEEEEEEeccccchhHHHHHHHHHH-HHHhcCCcchhhhhheeecCCeEEEEEec----
Confidence 344566666666653 4479999999986541 123445554 67788999999999999999999999994
Q ss_pred hhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcceeccCC
Q 003644 456 LNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDL 535 (805)
Q Consensus 456 L~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~IvHrDL 535 (805)
+.+|++.+++.... ...+++..+..++.|++.||+|||+.+|+||||
T Consensus 81 ------~~~~~l~~~l~~~~---------------------------~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dl 127 (314)
T cd08216 81 ------MAYGSCEDLLKTHF---------------------------PEGLPELAIAFILKDVLNALDYIHSKGFIHRSV 127 (314)
T ss_pred ------cCCCCHHHHHHHhc---------------------------ccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCC
Confidence 45555555543211 123567778899999999999999999999999
Q ss_pred CCceEEecCCCCceEEEeccCccccccCCCcc----ccccccccCCCCCCChhhhhcC--CCCCcchHHHHHHHHHHHHh
Q 003644 536 KPQNVLISKDKSFCAKLSDMGISKRLQGDMSC----LTQNATGYGSSGWQAPEQLLQG--RQTRAIDLFSLGCILFFCIT 609 (805)
Q Consensus 536 Kp~NILl~~~~~~~~kL~DFGla~~~~~~~~~----~~~~~~~~gt~~y~APE~l~~~--~~t~~sDVwSlGvil~ellt 609 (805)
||+||+++.++. +||+|||.+......... ........++..|+|||++... .++.++|+|||||++|||++
T Consensus 128 k~~Nili~~~~~--~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~ 205 (314)
T cd08216 128 KASHILLSGDGK--VVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELAN 205 (314)
T ss_pred CcceEEEecCCc--eEEecCccceeeccccccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHh
Confidence 999999987776 899999998766432110 0111233477889999998763 57899999999999999999
Q ss_pred CCCCCCCCchHHHHHH--Hhhc---------------------------------cccccccCChHHHHHHHHhcCCCCC
Q 003644 610 GGKHPYGESFERDANI--VKDR---------------------------------KDLFLVEHIPEAVDLFTRLLDPNPD 654 (805)
Q Consensus 610 G~~~Pf~~~~~~~~~~--~~~~---------------------------------~~~~~~~~~~~~~dLi~~~L~~dP~ 654 (805)
| ..||.......... .... ........++++.+++.+||+.||+
T Consensus 206 g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~ 284 (314)
T cd08216 206 G-HVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPE 284 (314)
T ss_pred C-CCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCC
Confidence 6 77886543221110 1000 0000001124688999999999999
Q ss_pred CCCChhhhhcCccccc
Q 003644 655 LRPKAQNVLNHPFFWT 670 (805)
Q Consensus 655 ~Rps~~ell~Hpff~~ 670 (805)
+|||++++++||||..
T Consensus 285 ~Rpt~~~ll~~p~~~~ 300 (314)
T cd08216 285 SRPSASQLLNHSFFKQ 300 (314)
T ss_pred cCcCHHHHhcCchHhh
Confidence 9999999999999954
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=302.45 Aligned_cols=257 Identities=23% Similarity=0.302 Sum_probs=187.1
Q ss_pred ceEEEeEeeccCCceEEEEEEee-----------------CCcEEEEEEeecCCch----HHHHHHHHHHHhCCCCCeee
Q 003644 376 KLVVFNKEIAKGSNGTVVLEGNY-----------------EGRSVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVR 434 (805)
Q Consensus 376 ~~~~~~~~LG~GsfGtVy~a~~~-----------------~g~~VAVK~l~~~~~~----~~~~Ei~~ll~~l~HpNIV~ 434 (805)
+.|.+.+.||+|+||.||++... .+..||+|.+...... ...+|+. ++..++||||++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~-~l~~l~~~~i~~ 83 (296)
T cd05051 5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVK-ILSRLSDPNIAR 83 (296)
T ss_pred hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHH-HHHhcCCCCEeE
Confidence 34677899999999999987543 2356899998755322 2334554 677889999999
Q ss_pred ecccccCCceEEEecccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHH
Q 003644 435 WYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKV 514 (805)
Q Consensus 435 l~g~~~~~~~l~LV~E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i 514 (805)
+++++.+++..+++||++ .+++|.+++.......... ......+++..++.+
T Consensus 84 ~~~~~~~~~~~~lv~e~~----------~~~~L~~~l~~~~~~~~~~------------------~~~~~~~~~~~~~~~ 135 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYM----------ENGDLNQFLQKHVAETSGL------------------ACNSKSLSFSTLLYM 135 (296)
T ss_pred EEEEEecCCCcEEEEecC----------CCCCHHHHHHhcccccccc------------------cccCCCCCHHHHHHH
Confidence 999999999999999944 4555555543322110000 012235788899999
Q ss_pred HHHHHHHHHHhhhcceeccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCc
Q 003644 515 TRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRA 594 (805)
Q Consensus 515 ~~qIa~gL~yLH~~~IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~ 594 (805)
+.|++.||+|||+.+|+||||||+||+++.++. ++|+|||+++....... ........++..|+|||++....++.+
T Consensus 136 ~~~i~~al~~LH~~~i~H~dlkp~Nili~~~~~--~~l~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~ 212 (296)
T cd05051 136 ATQIASGMRYLESLNFVHRDLATRNCLVGKNYT--IKIADFGMSRNLYSSDY-YRVQGRAPLPIRWMAWESVLLGKFTTK 212 (296)
T ss_pred HHHHHHHHHHHHHcCccccccchhceeecCCCc--eEEccccceeecccCcc-eeecCcCCCCceecCHHHhhcCCCCcc
Confidence 999999999999999999999999999987765 89999999986543221 111223346788999999998889999
Q ss_pred chHHHHHHHHHHHHhC-CCCCCCCchHHHH--HHHhh-----c--cccccccCChHHHHHHHHhcCCCCCCCCChhhhhc
Q 003644 595 IDLFSLGCILFFCITG-GKHPYGESFERDA--NIVKD-----R--KDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 664 (805)
Q Consensus 595 sDVwSlGvil~elltG-~~~Pf~~~~~~~~--~~~~~-----~--~~~~~~~~~~~~~dLi~~~L~~dP~~Rps~~ell~ 664 (805)
+|||||||++|||+++ +..||........ ..... . ....+...++++.+++.+||+.||++||++.|+++
T Consensus 213 ~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~ 292 (296)
T cd05051 213 SDVWAFGVTLWEILTLCREQPYEHLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL 292 (296)
T ss_pred chhhhhHHHHHHHHhcCCCCCCCCcChHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence 9999999999999984 4677765332221 11111 0 01112234578999999999999999999999964
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=291.79 Aligned_cols=245 Identities=31% Similarity=0.513 Sum_probs=192.4
Q ss_pred EEEeEeeccCCceEEEEEEee-CCcEEEEEEeecCCc-----hHHHHHHHHHHHhCCCCCeeeecccccCCceEEEeccc
Q 003644 378 VVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHH-----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLER 451 (805)
Q Consensus 378 ~~~~~~LG~GsfGtVy~a~~~-~g~~VAVK~l~~~~~-----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~E~ 451 (805)
|.+.+.||+|++|.||++... +++.||||.+..... ....+|+ .++..++|||++++++++.+++..|++||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~-~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 2 YQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEI-DLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred ceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHH-HHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 567789999999999998544 688999999865532 2233444 467788999999999999999999999994
Q ss_pred ccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhccee
Q 003644 452 CTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLI 531 (805)
Q Consensus 452 ~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~Iv 531 (805)
..+++|.+++.. ...+++..+..++.|++.||+|||+.||+
T Consensus 81 ----------~~~~~L~~~~~~-----------------------------~~~l~~~~~~~~~~~i~~~l~~lH~~~i~ 121 (254)
T cd06627 81 ----------AENGSLRQIIKK-----------------------------FGPFPESLVAVYVYQVLQGLAYLHEQGVI 121 (254)
T ss_pred ----------CCCCcHHHHHHh-----------------------------ccCCCHHHHHHHHHHHHHHHHHHhhCCcc
Confidence 445555554321 13467778899999999999999999999
Q ss_pred ccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHHHHHhCC
Q 003644 532 HRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGG 611 (805)
Q Consensus 532 HrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~elltG~ 611 (805)
||||||+||+++.++. ++|+|||++......... .....++..|+|||.+....++.++||||||+++|+|++|
T Consensus 122 H~dl~p~ni~i~~~~~--~~l~d~~~~~~~~~~~~~---~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g- 195 (254)
T cd06627 122 HRDIKAANILTTKDGV--VKLADFGVATKLNDVSKD---DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTG- 195 (254)
T ss_pred cCCCCHHHEEECCCCC--EEEeccccceecCCCccc---ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhC-
Confidence 9999999999987765 899999999877643221 2234588999999999888889999999999999999997
Q ss_pred CCCCCCchHHH--HHHHhhccccccccCChHHHHHHHHhcCCCCCCCCChhhhhcCccc
Q 003644 612 KHPYGESFERD--ANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 668 (805)
Q Consensus 612 ~~Pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dP~~Rps~~ell~Hpff 668 (805)
.+||....... ...........+....+++.+++.+||..+|++||++.+++.||||
T Consensus 196 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~~ 254 (254)
T cd06627 196 NPPYYDLNPMAALFRIVQDDHPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI 254 (254)
T ss_pred CCCCCCccHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcCCCC
Confidence 66776533222 1222222333344456789999999999999999999999999997
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=335.37 Aligned_cols=257 Identities=25% Similarity=0.324 Sum_probs=187.6
Q ss_pred ceEEEeEeeccCCceEEEEEEe-eCCcEEEEEEeecCCc------hHHHHHHHHHHHhCCCCCeeeecccccCCceEEEe
Q 003644 376 KLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH------DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLS 448 (805)
Q Consensus 376 ~~~~~~~~LG~GsfGtVy~a~~-~~g~~VAVK~l~~~~~------~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV 448 (805)
++|.+.+.||+|+||+||++.. .+|+.||||++..... ....+|+. +++.++||||+++++++.+++..|+|
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~-ILs~L~HPNIVkl~~v~~d~~~lyLV 80 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAK-IAADLIHPGIVPVYSICSDGDPVYYT 80 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHH-HHHhCCCcCcCeEEEEEeeCCEEEEE
Confidence 3578889999999999999854 4689999999864321 23345554 77889999999999999999999999
Q ss_pred cccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhc
Q 003644 449 LERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI 528 (805)
Q Consensus 449 ~E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~ 528 (805)
|| |+.+|+|.+++........ +. .-.....++..++.++.||+.||+|||+.
T Consensus 81 ME----------Y~eGGSL~~lL~s~~~~~~-l~-----------------e~~~~~lsv~~iL~I~~QIa~AL~yLHs~ 132 (932)
T PRK13184 81 MP----------YIEGYTLKSLLKSVWQKES-LS-----------------KELAEKTSVGAFLSIFHKICATIEYVHSK 132 (932)
T ss_pred EE----------cCCCCCHHHHHHHhhhccc-cc-----------------hhhhcccCHHHHHHHHHHHHHHHHHHHHC
Confidence 99 5555555555543211000 00 00123355677899999999999999999
Q ss_pred ceeccCCCCceEEecCCCCceEEEeccCccccccCCCc---------------cccccccccCCCCCCChhhhhcCCCCC
Q 003644 529 GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMS---------------CLTQNATGYGSSGWQAPEQLLQGRQTR 593 (805)
Q Consensus 529 ~IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~---------------~~~~~~~~~gt~~y~APE~l~~~~~t~ 593 (805)
||+||||||+|||++.++. +||+|||+++....... ........+||+.|+|||++.+..++.
T Consensus 133 GIIHRDLKPeNILLd~dg~--vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~ 210 (932)
T PRK13184 133 GVLHRDLKPDNILLGLFGE--VVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASE 210 (932)
T ss_pred CccccCCchheEEEcCCCC--EEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCc
Confidence 9999999999999988876 89999999987621110 011112346999999999999999999
Q ss_pred cchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHh---hc-cccccccCChHHHHHHHHhcCCCCCCCCChhhhhc
Q 003644 594 AIDLFSLGCILFFCITGGKHPYGESFERDANIVK---DR-KDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 664 (805)
Q Consensus 594 ~sDVwSlGvil~elltG~~~Pf~~~~~~~~~~~~---~~-~~~~~~~~~~~~~dLi~~~L~~dP~~Rps~~ell~ 664 (805)
++|||||||++|||+|| .+||............ .. ........++.+.+++.+||+.||++|++..+.+.
T Consensus 211 kSDIWSLGVILyELLTG-~~PF~~~~~~ki~~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl 284 (932)
T PRK13184 211 STDIYALGVILYQMLTL-SFPYRRKKGRKISYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELK 284 (932)
T ss_pred HhHHHHHHHHHHHHHHC-CCCCCCcchhhhhhhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 99999999999999997 6788653322211111 00 00112245678999999999999999987665543
|
|
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=304.92 Aligned_cols=260 Identities=24% Similarity=0.330 Sum_probs=185.1
Q ss_pred eEEEeEeeccCCceEEEEEEee-CCc--EEEEEEeecCCc----hHHHHHHHHHHHhCCCCCeeeecccccCCceEEEec
Q 003644 377 LVVFNKEIAKGSNGTVVLEGNY-EGR--SVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSL 449 (805)
Q Consensus 377 ~~~~~~~LG~GsfGtVy~a~~~-~g~--~VAVK~l~~~~~----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~ 449 (805)
.|.+.+.||+|+||+||++... ++. .+|+|++..... ....+|+..+....+||||+++++++.+++..|+||
T Consensus 8 ~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv~ 87 (303)
T cd05088 8 DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAI 87 (303)
T ss_pred hceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEEE
Confidence 4677899999999999998653 454 468887764322 233456654444448999999999999999999999
Q ss_pred ccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcc
Q 003644 450 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG 529 (805)
Q Consensus 450 E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~ 529 (805)
| |+.+|+|.++++.......... ..........+++..++.++.||+.||+|||+.|
T Consensus 88 e----------~~~~~~L~~~l~~~~~~~~~~~-------------~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g 144 (303)
T cd05088 88 E----------YAPHGNLLDFLRKSRVLETDPA-------------FAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ 144 (303)
T ss_pred E----------eCCCCcHHHHHHhccccccccc-------------ccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 9 5555556555543321100000 0000011234778889999999999999999999
Q ss_pred eeccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHHHHHh
Q 003644 530 LIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCIT 609 (805)
Q Consensus 530 IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~ellt 609 (805)
|+||||||+|||++.++. +||+|||+++..... .......++..|+|||++....++.++|||||||++|||+|
T Consensus 145 i~H~dlkp~Nili~~~~~--~kl~dfg~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt 218 (303)
T cd05088 145 FIHRDLAARNILVGENYV--AKIADFGLSRGQEVY----VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218 (303)
T ss_pred ccccccchheEEecCCCc--EEeCccccCcccchh----hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHh
Confidence 999999999999987765 899999998643211 11122234678999999988889999999999999999998
Q ss_pred CCCCCCCCchHHH-HHHHhhc-cccccccCChHHHHHHHHhcCCCCCCCCChhhhhcC
Q 003644 610 GGKHPYGESFERD-ANIVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNH 665 (805)
Q Consensus 610 G~~~Pf~~~~~~~-~~~~~~~-~~~~~~~~~~~~~dLi~~~L~~dP~~Rps~~ell~H 665 (805)
++.+||....... ....... ....+...++++.+++.+||+.+|++||++++++.+
T Consensus 219 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 276 (303)
T cd05088 219 LGGTPYCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 276 (303)
T ss_pred cCCCCcccCChHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 4477875433222 2222221 112233456789999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=307.87 Aligned_cols=247 Identities=26% Similarity=0.396 Sum_probs=188.7
Q ss_pred ccceEEEeEeeccCCceEEEEEE-eeCCcEEEEEEeecCCc-----hHHHHHHHHHHHhCCCCCeeeecccccCCc----
Q 003644 374 IGKLVVFNKEIAKGSNGTVVLEG-NYEGRSVAVKRLVKTHH-----DVALKEIQNLIASDQHPNIVRWYGVESDQD---- 443 (805)
Q Consensus 374 i~~~~~~~~~LG~GsfGtVy~a~-~~~g~~VAVK~l~~~~~-----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~---- 443 (805)
+++.|...+.||+|+||+||++. ..+|+.||||++..... ....+|+. ++..++||||+++++++..+.
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~-~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELR-LLKHMKHENVIGLLDVFTPDLSLDR 91 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHH-HHHhcCCCCccceeeeecCCccccc
Confidence 46678899999999999999985 45789999999854321 23445555 778889999999999887654
Q ss_pred --eEEEecccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHH
Q 003644 444 --FVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSG 521 (805)
Q Consensus 444 --~l~LV~E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~g 521 (805)
..++|||++.++|.+++. ...+++..++.++.||+.|
T Consensus 92 ~~~~~lv~e~~~~~l~~~~~-----------------------------------------~~~l~~~~~~~i~~qi~~a 130 (343)
T cd07880 92 FHDFYLVMPFMGTDLGKLMK-----------------------------------------HEKLSEDRIQFLVYQMLKG 130 (343)
T ss_pred cceEEEEEecCCCCHHHHHh-----------------------------------------cCCCCHHHHHHHHHHHHHH
Confidence 458999977655544431 1235677889999999999
Q ss_pred HHHhhhcceeccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhc-CCCCCcchHHHH
Q 003644 522 LSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ-GRQTRAIDLFSL 600 (805)
Q Consensus 522 L~yLH~~~IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~t~~sDVwSl 600 (805)
|+|||+.||+||||||+||+++.++. ++|+|||++...... .....+++.|+|||++.+ ..++.++|+|||
T Consensus 131 l~~LH~~gi~H~dlkp~Nill~~~~~--~kl~dfg~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~sl 202 (343)
T cd07880 131 LKYIHAAGIIHRDLKPGNLAVNEDCE--LKILDFGLARQTDSE------MTGYVVTRWYRAPEVILNWMHYTQTVDIWSV 202 (343)
T ss_pred HHHHHhCCeecCCCCHHHEEEcCCCC--EEEeecccccccccC------ccccccCCcccCHHHHhCCCCCCcHHHHHHH
Confidence 99999999999999999999987765 899999999865432 123357899999999876 457899999999
Q ss_pred HHHHHHHHhCCCCCCCCchHHH--HHHHhhc-----------------------c-------ccccccCChHHHHHHHHh
Q 003644 601 GCILFFCITGGKHPYGESFERD--ANIVKDR-----------------------K-------DLFLVEHIPEAVDLFTRL 648 (805)
Q Consensus 601 Gvil~elltG~~~Pf~~~~~~~--~~~~~~~-----------------------~-------~~~~~~~~~~~~dLi~~~ 648 (805)
||++|++++| .+||....... ..+.... . ........+++.++|.+|
T Consensus 203 G~ll~~l~~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 281 (343)
T cd07880 203 GCIMAEMLTG-KPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKM 281 (343)
T ss_pred HHHHHHHHhC-CCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHH
Confidence 9999999997 67886532211 0110000 0 001123456789999999
Q ss_pred cCCCCCCCCChhhhhcCcccccc
Q 003644 649 LDPNPDLRPKAQNVLNHPFFWTA 671 (805)
Q Consensus 649 L~~dP~~Rps~~ell~Hpff~~~ 671 (805)
|+.||.+|||+.+++.||||...
T Consensus 282 l~~dP~~R~t~~~~l~~~~~~~~ 304 (343)
T cd07880 282 LVLDAESRITAAEALAHPYFEEF 304 (343)
T ss_pred cCCChhhCCCHHHHhcCccHhhh
Confidence 99999999999999999999654
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=316.28 Aligned_cols=285 Identities=22% Similarity=0.340 Sum_probs=191.0
Q ss_pred ceEEEeEeeccCCceEEEEEEe------eCCcEEEEEEeecCCch----HHHHHHHHHHHhCC-CCCeeeecccccCCce
Q 003644 376 KLVVFNKEIAKGSNGTVVLEGN------YEGRSVAVKRLVKTHHD----VALKEIQNLIASDQ-HPNIVRWYGVESDQDF 444 (805)
Q Consensus 376 ~~~~~~~~LG~GsfGtVy~a~~------~~g~~VAVK~l~~~~~~----~~~~Ei~~ll~~l~-HpNIV~l~g~~~~~~~ 444 (805)
+.+.+.+.||+|+||.||++.. ..++.||||++...... ...+|+. ++..+. |||||+++++|.+.+.
T Consensus 37 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~-~l~~l~~H~niv~~~~~~~~~~~ 115 (401)
T cd05107 37 DNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELK-IMSHLGPHLNIVNLLGACTKGGP 115 (401)
T ss_pred HHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHH-HHHhcCCCCCeEEEEEEEccCCC
Confidence 4467788999999999999753 23568999999754322 3445665 555665 9999999999999999
Q ss_pred EEEeccccc-CChhhHHHHhcCCHHHHHhhhhccc-hhhHH---------------------------------------
Q 003644 445 VYLSLERCT-CSLNDLIYVLSGSFEEQLNAKEQDS-NLLNE--------------------------------------- 483 (805)
Q Consensus 445 l~LV~E~~~-~sL~d~iy~~~GsL~~~L~~~~~~~-~~l~~--------------------------------------- 483 (805)
.|+|||||. ++|.+++...+.....+........ .....
T Consensus 116 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (401)
T cd05107 116 IYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDM 195 (401)
T ss_pred cEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcc
Confidence 999999665 3555554322221111100000000 00000
Q ss_pred ----HHh---------------hhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCCCceEEecC
Q 003644 484 ----VRI---------------RLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISK 544 (805)
Q Consensus 484 ----~~~---------------~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~IvHrDLKp~NILl~~ 544 (805)
... ...+.... ..........+++..++.|+.||+.||+|||+.+|+||||||+|||++.
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl~~ 274 (401)
T cd05107 196 KGTVKYADIESSNYESPYDQYLPSAPERTR-RDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLICE 274 (401)
T ss_pred hhhhhhhhhhccCcCCchhhhhcccCCCcc-hhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEEeC
Confidence 000 00000000 0000012245678889999999999999999999999999999999977
Q ss_pred CCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH--
Q 003644 545 DKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERD-- 622 (805)
Q Consensus 545 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~elltG~~~Pf~~~~~~~-- 622 (805)
++ .+||+|||+++........ .......++..|+|||.+....++.++|||||||++|||++++.+||.......
T Consensus 275 ~~--~~kL~DfGla~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~ 351 (401)
T cd05107 275 GK--LVKICDFGLARDIMRDSNY-ISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQF 351 (401)
T ss_pred CC--EEEEEecCcceeccccccc-ccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHH
Confidence 65 4899999999865432211 112233578899999999988899999999999999999995577886533222
Q ss_pred HHHHhhc-cccccccCChHHHHHHHHhcCCCCCCCCChhhhhcC
Q 003644 623 ANIVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNH 665 (805)
Q Consensus 623 ~~~~~~~-~~~~~~~~~~~~~dLi~~~L~~dP~~Rps~~ell~H 665 (805)
...+... ....+...+.++.+++.+||+.+|.+||+++++++.
T Consensus 352 ~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 395 (401)
T cd05107 352 YNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL 395 (401)
T ss_pred HHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 1222222 122333456799999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=302.46 Aligned_cols=247 Identities=26% Similarity=0.357 Sum_probs=184.1
Q ss_pred eEEEeEeeccCCceEEEEEE-----eeCCcEEEEEEeecCCc----hHHHHHHHHHHHhCCCCCeeeecccccCC--ceE
Q 003644 377 LVVFNKEIAKGSNGTVVLEG-----NYEGRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQ--DFV 445 (805)
Q Consensus 377 ~~~~~~~LG~GsfGtVy~a~-----~~~g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~--~~l 445 (805)
.|...+.||+|+||.||++. ..+++.||+|.+..... ....+|+. +++.++||||+++++++.+. ...
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIE-ILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHH-HHHhCCCCCeeeeeeEEecCCCCce
Confidence 35667889999999999875 34688999999864422 23345555 77889999999999998775 678
Q ss_pred EEecccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHh
Q 003644 446 YLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHL 525 (805)
Q Consensus 446 ~LV~E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yL 525 (805)
++||| |.++++|.+++... ...+++..++.++.||+.||+||
T Consensus 84 ~lv~e----------~~~g~~L~~~l~~~----------------------------~~~~~~~~~~~i~~~i~~aL~~l 125 (284)
T cd05079 84 KLIME----------FLPSGSLKEYLPRN----------------------------KNKINLKQQLKYAVQICKGMDYL 125 (284)
T ss_pred EEEEE----------ccCCCCHHHHHHhc----------------------------cCCCCHHHHHHHHHHHHHHHHHH
Confidence 99999 55666666654321 12356778899999999999999
Q ss_pred hhcceeccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHH
Q 003644 526 HEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILF 605 (805)
Q Consensus 526 H~~~IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~ 605 (805)
|+.||+||||||+||+++.++. ++|+|||+++.+..............++..|+|||++.+..++.++|||||||++|
T Consensus 126 H~~gi~H~dlkp~Nil~~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ 203 (284)
T cd05079 126 GSRQYVHRDLAARNVLVESEHQ--VKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLY 203 (284)
T ss_pred HHCCeeecccchheEEEcCCCC--EEECCCccccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhh
Confidence 9999999999999999988776 89999999987654322212222345677899999998888999999999999999
Q ss_pred HHHhCCCCCCCCchH----------------HHHHHHh-hccccccccCChHHHHHHHHhcCCCCCCCCChhhhhcC
Q 003644 606 FCITGGKHPYGESFE----------------RDANIVK-DRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNH 665 (805)
Q Consensus 606 elltG~~~Pf~~~~~----------------~~~~~~~-~~~~~~~~~~~~~~~dLi~~~L~~dP~~Rps~~ell~H 665 (805)
||+++.. |+..... ....... ......+...++++.+|+.+||+.||.+||++++++++
T Consensus 204 ellt~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 279 (284)
T cd05079 204 ELLTYCD-SESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG 279 (284)
T ss_pred hhhcCCC-CCccccchhhhhcccccccccHHHHHHHHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 9999643 3321110 0111111 11111233456799999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=294.86 Aligned_cols=241 Identities=25% Similarity=0.375 Sum_probs=183.5
Q ss_pred ceEEEeEeeccCCceEEEEEEeeCCcEEEEEEeecCCch-HHHHHHHHHHHhCCCCCeeeecccccCCceEEEecccccC
Q 003644 376 KLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHD-VALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTC 454 (805)
Q Consensus 376 ~~~~~~~~LG~GsfGtVy~a~~~~g~~VAVK~l~~~~~~-~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~E~~~~ 454 (805)
+.|.+.+.||+|+||.||++ ..+++.||+|.+...... ...+|+. ++..++||||+++++++.++ ..|++||||
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~-~~~~~~~~iK~~~~~~~~~~~~~e~~-~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~-- 80 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQG-EYTGQKVAVKNIKCDVTAQAFLEETA-VMTKLHHKNLVRLLGVILHN-GLYIVMELM-- 80 (254)
T ss_pred HHceeeeeeccCCCCceEec-ccCCCceEEEeecCcchHHHHHHHHH-HHHhCCCCCcCeEEEEEcCC-CcEEEEECC--
Confidence 44778899999999999985 467889999998654333 3344554 77889999999999998765 479999954
Q ss_pred ChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcceeccC
Q 003644 455 SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRD 534 (805)
Q Consensus 455 sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~IvHrD 534 (805)
.+|+|.+++.... ...+++..++.++.|++.||+|||+.|++|||
T Consensus 81 --------~~~~L~~~l~~~~---------------------------~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~d 125 (254)
T cd05083 81 --------SKGNLVNFLRTRG---------------------------RALVSVIQLLQFSLDVAEGMEYLESKKLVHRD 125 (254)
T ss_pred --------CCCCHHHHHHhcC---------------------------cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccc
Confidence 4555555443211 12356777899999999999999999999999
Q ss_pred CCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCC
Q 003644 535 LKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP 614 (805)
Q Consensus 535 LKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~elltG~~~P 614 (805)
|||+||+++.++. +||+|||+++...... .....+..|+|||.+.+..++.++|+|||||++|||++++.+|
T Consensus 126 l~p~nili~~~~~--~kl~Dfg~~~~~~~~~------~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p 197 (254)
T cd05083 126 LAARNILVSEDGV--AKVSDFGLARVGSMGV------DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAP 197 (254)
T ss_pred cCcceEEEcCCCc--EEECCCccceeccccC------CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCC
Confidence 9999999987765 8999999987643211 1122456799999998888999999999999999999856888
Q ss_pred CCCchHHH-HHHHh-hccccccccCChHHHHHHHHhcCCCCCCCCChhhhhc
Q 003644 615 YGESFERD-ANIVK-DRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 664 (805)
Q Consensus 615 f~~~~~~~-~~~~~-~~~~~~~~~~~~~~~dLi~~~L~~dP~~Rps~~ell~ 664 (805)
|....... ...+. ..........++++.+++.+||+.+|+.||++++++.
T Consensus 198 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 249 (254)
T cd05083 198 YPKMSLKEVKECVEKGYRMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLRE 249 (254)
T ss_pred CccCCHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 86643322 12222 1112223345678999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=299.05 Aligned_cols=246 Identities=24% Similarity=0.395 Sum_probs=188.0
Q ss_pred EEEeEeeccCCceEEEEEEe-eCCcEEEEEEeecCCc----hHHHHHHHHHHHhCC---CCCeeeecccccCCceEEEec
Q 003644 378 VVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH----DVALKEIQNLIASDQ---HPNIVRWYGVESDQDFVYLSL 449 (805)
Q Consensus 378 ~~~~~~LG~GsfGtVy~a~~-~~g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l~---HpNIV~l~g~~~~~~~l~LV~ 449 (805)
|...+.||+|+||.||++.. .+++.||||.+..... ....+|+. +++.+. ||||+++++++.++...|+||
T Consensus 3 y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~-~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVA-LLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHH-HHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 45567899999999999864 5789999999864322 23445554 455554 999999999999999999999
Q ss_pred ccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcc
Q 003644 450 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG 529 (805)
Q Consensus 450 E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~ 529 (805)
| |..+++|.+++.. ..+++..++.++.|++.||+|||+.+
T Consensus 82 e----------~~~~~~L~~~~~~------------------------------~~l~~~~~~~i~~~i~~~l~~lh~~~ 121 (277)
T cd06917 82 E----------YAEGGSVRTLMKA------------------------------GPIAEKYISVIIREVLVALKYIHKVG 121 (277)
T ss_pred e----------cCCCCcHHHHHHc------------------------------cCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 9 4455555544321 23567788999999999999999999
Q ss_pred eeccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcC-CCCCcchHHHHHHHHHHHH
Q 003644 530 LIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG-RQTRAIDLFSLGCILFFCI 608 (805)
Q Consensus 530 IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~t~~sDVwSlGvil~ell 608 (805)
|+||||+|+||+++.++. ++|+|||++....... .......|+..|+|||.+..+ .++.++|+|||||++|+|+
T Consensus 122 i~H~dl~p~ni~i~~~~~--~~l~dfg~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll 196 (277)
T cd06917 122 VIHRDIKAANILVTNTGN--VKLCDFGVAALLNQNS---SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMA 196 (277)
T ss_pred cccCCcCHHHEEEcCCCC--EEEccCCceeecCCCc---cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHH
Confidence 999999999999988765 8999999998765432 112234588999999998754 4689999999999999999
Q ss_pred hCCCCCCCCchHHHHH-HHhh-ccccccc-cCChHHHHHHHHhcCCCCCCCCChhhhhcCccccc
Q 003644 609 TGGKHPYGESFERDAN-IVKD-RKDLFLV-EHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWT 670 (805)
Q Consensus 609 tG~~~Pf~~~~~~~~~-~~~~-~~~~~~~-~~~~~~~dLi~~~L~~dP~~Rps~~ell~Hpff~~ 670 (805)
+| .+||......... .... ....... ....++.+++.+||+.||++||++.++++||||..
T Consensus 197 ~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~~~ 260 (277)
T cd06917 197 TG-NPPYSDVDAFRAMMLIPKSKPPRLEDNGYSKLLREFVAACLDEEPKERLSAEELLKSKWIKA 260 (277)
T ss_pred hC-CCCCCCCChhhhhhccccCCCCCCCcccCCHHHHHHHHHHcCCCcccCcCHHHHhhChHhhc
Confidence 96 7788664332211 1111 1111112 25678999999999999999999999999999954
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=300.48 Aligned_cols=268 Identities=25% Similarity=0.355 Sum_probs=189.0
Q ss_pred EEEeEeeccCCceEEEEEEee------CCcEEEEEEeecCCc----hHHHHHHHHHHHhCCCCCeeeecccccCCceEEE
Q 003644 378 VVFNKEIAKGSNGTVVLEGNY------EGRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYL 447 (805)
Q Consensus 378 ~~~~~~LG~GsfGtVy~a~~~------~g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~L 447 (805)
|.+.+.||+|+||+||++... ....||+|.+..... ....+|+. +++.++||||+++++.+.+++..|+
T Consensus 2 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~-~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 2 LVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFN-LLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred ccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHH-HHhhCCCCCEeeEEEEEecCCCcEE
Confidence 456788999999999997542 235799998865432 23445655 6788899999999999999999999
Q ss_pred ecccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhh
Q 003644 448 SLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE 527 (805)
Q Consensus 448 V~E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~ 527 (805)
++|||. +|+|.+++............ .....+...........+++..++.++.|++.||+|||+
T Consensus 81 v~e~~~----------~~~L~~~l~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~ 145 (290)
T cd05045 81 IVEYAK----------YGSLRSFLRESRKVGPSYLG-----SDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAE 145 (290)
T ss_pred EEEecC----------CCCHHHHHHhcCCccccccc-----cccccccccccCccccccCHHHHHHHHHHHHHHHHHHHH
Confidence 999554 44444444321110000000 000000000000112457888999999999999999999
Q ss_pred cceeccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHHHH
Q 003644 528 IGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFC 607 (805)
Q Consensus 528 ~~IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~el 607 (805)
.+|+||||||+|||+++++. +||+|||+++......... ......++..|+|||++.+..++.++|||||||++|||
T Consensus 146 ~~ivH~dikp~nill~~~~~--~kl~dfg~~~~~~~~~~~~-~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el 222 (290)
T cd05045 146 MKLVHRDLAARNVLVAEGRK--MKISDFGLSRDVYEEDSYV-KRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEI 222 (290)
T ss_pred CCeehhhhhhheEEEcCCCc--EEeccccccccccCccchh-cccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHH
Confidence 99999999999999987765 8999999998664332211 11223467789999999888899999999999999999
Q ss_pred HhCCCCCCCCchHHH-HHHHhhc-cccccccCChHHHHHHHHhcCCCCCCCCChhhhhc
Q 003644 608 ITGGKHPYGESFERD-ANIVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 664 (805)
Q Consensus 608 ltG~~~Pf~~~~~~~-~~~~~~~-~~~~~~~~~~~~~dLi~~~L~~dP~~Rps~~ell~ 664 (805)
++++..||....... ....... ....+...+.++.+++.+||+.||++||++.++++
T Consensus 223 ~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~ 281 (290)
T cd05045 223 VTLGGNPYPGIAPERLFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISK 281 (290)
T ss_pred HhcCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 995578886544332 2222221 22223445679999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=345.49 Aligned_cols=256 Identities=27% Similarity=0.401 Sum_probs=198.9
Q ss_pred ccccceEEEeEeeccCCceEEEEEE-eeCCcEEEEEEeecCCch----HHHHHHHHHHHhCCCCCeeeecccccCCceEE
Q 003644 372 RRIGKLVVFNKEIAKGSNGTVVLEG-NYEGRSVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVRWYGVESDQDFVY 446 (805)
Q Consensus 372 ~~i~~~~~~~~~LG~GsfGtVy~a~-~~~g~~VAVK~l~~~~~~----~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~ 446 (805)
+.+.-++.-+..||.|.||.||-+. ..+|...|||-++-...+ ....|+..++..++|||+|++||+..+.+..|
T Consensus 1231 snV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~ 1310 (1509)
T KOG4645|consen 1231 SNVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVY 1310 (1509)
T ss_pred ccceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHH
Confidence 3444455556789999999999985 456899999987533211 22345556889999999999999999999999
Q ss_pred Eeccccc-CChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHh
Q 003644 447 LSLERCT-CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHL 525 (805)
Q Consensus 447 LV~E~~~-~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yL 525 (805)
|.||||. |+|.+++- +++ ..++.....+..|++.|++||
T Consensus 1311 IFMEyC~~GsLa~ll~-~gr---------------------------------------i~dE~vt~vyt~qll~gla~L 1350 (1509)
T KOG4645|consen 1311 IFMEYCEGGSLASLLE-HGR---------------------------------------IEDEMVTRVYTKQLLEGLAYL 1350 (1509)
T ss_pred HHHHHhccCcHHHHHH-hcc---------------------------------------hhhhhHHHHHHHHHHHHHHHH
Confidence 9999775 35555541 111 123344567899999999999
Q ss_pred hhcceeccCCCCceEEecCCCCceEEEeccCccccccCCCcc-ccccccccCCCCCCChhhhhcCC---CCCcchHHHHH
Q 003644 526 HEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSC-LTQNATGYGSSGWQAPEQLLQGR---QTRAIDLFSLG 601 (805)
Q Consensus 526 H~~~IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~-~~~~~~~~gt~~y~APE~l~~~~---~t~~sDVwSlG 601 (805)
|++|||||||||.||+|+.+|- +|++|||.|..+...... ........||+.|||||++.+.. ...+.||||||
T Consensus 1351 H~~gIVHRDIK~aNI~Ld~~g~--iK~~DFGsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslG 1428 (1509)
T KOG4645|consen 1351 HEHGIVHRDIKPANILLDFNGL--IKYGDFGSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLG 1428 (1509)
T ss_pred HhcCceecCCCccceeeecCCc--EEeecccceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhccc
Confidence 9999999999999999988874 899999999998765321 12234567999999999998643 56899999999
Q ss_pred HHHHHHHhCCCCCCCCchH---HHHHHHhhccccccccCChHHHHHHHHhcCCCCCCCCChhhhhcCccccc
Q 003644 602 CILFFCITGGKHPYGESFE---RDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWT 670 (805)
Q Consensus 602 vil~elltG~~~Pf~~~~~---~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dP~~Rps~~ell~Hpff~~ 670 (805)
|++.||+|| +-||.+-.. -..++-.+.....|...+++.+|+|.+||+.||++|.++.|+++|.|-..
T Consensus 1429 CVVlEM~tG-krPW~~~dne~aIMy~V~~gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~ 1499 (1509)
T KOG4645|consen 1429 CVVLEMATG-KRPWAELDNEWAIMYHVAAGHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEHAFGKS 1499 (1509)
T ss_pred ceEEEeecC-CCchhhccchhHHHhHHhccCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHhhcccc
Confidence 999999998 668865322 22344445556667778899999999999999999999999999998644
|
|
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=300.01 Aligned_cols=267 Identities=22% Similarity=0.283 Sum_probs=188.3
Q ss_pred ceEEEeEeeccCCceEEEEEEee------CCcEEEEEEeecCCch----HHHHHHHHHHHhCCCCCeeeecccccCCceE
Q 003644 376 KLVVFNKEIAKGSNGTVVLEGNY------EGRSVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVRWYGVESDQDFV 445 (805)
Q Consensus 376 ~~~~~~~~LG~GsfGtVy~a~~~------~g~~VAVK~l~~~~~~----~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l 445 (805)
++|.+.+.||+|+||.||++... ++..||+|++...... ...+|+. +++.++||||+++++++.+++..
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~-~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAA-LMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred HhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHH-HHHhcCCCchheEEEEEcCCCcc
Confidence 34677789999999999998642 5689999998754332 2334554 67888999999999999999999
Q ss_pred EEecccccCChhhHHHHhcCCHHHHHhhhhccch-hhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHH
Q 003644 446 YLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSN-LLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSH 524 (805)
Q Consensus 446 ~LV~E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~y 524 (805)
|++||+|. +|+|.+++........ ...... ............+++.+++.++.||+.||+|
T Consensus 84 ~lv~e~~~----------~~~L~~~l~~~~~~~~~~~~~~~--------~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~ 145 (288)
T cd05050 84 CLLFEYMA----------YGDLNEFLRHRSPRAQCSLSHST--------SSARKCGLNPLPLSCTEQLCIAKQVAAGMAY 145 (288)
T ss_pred EEEEecCC----------CCCHHHHHHHcCccccccccccc--------cccccccccccccCHHHHHHHHHHHHHHHHH
Confidence 99999554 4444444432111000 000000 0000000112347788899999999999999
Q ss_pred hhhcceeccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHH
Q 003644 525 LHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCIL 604 (805)
Q Consensus 525 LH~~~IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil 604 (805)
||+.+++||||||+||+++.++. ++|+|||++..+...... .......++..|+|||++.+..++.++|||||||++
T Consensus 146 lH~~~i~H~dl~p~nil~~~~~~--~~l~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il 222 (288)
T cd05050 146 LSERKFVHRDLATRNCLVGENMV--VKIADFGLSRNIYSADYY-KASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVL 222 (288)
T ss_pred HHhCCeecccccHhheEecCCCc--eEECccccceecccCccc-cccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHH
Confidence 99999999999999999987765 899999998765432211 111222356789999999988999999999999999
Q ss_pred HHHHhCCCCCCCCc-hHHHHHHHhhc-cccccccCChHHHHHHHHhcCCCCCCCCChhhhhc
Q 003644 605 FFCITGGKHPYGES-FERDANIVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 664 (805)
Q Consensus 605 ~elltG~~~Pf~~~-~~~~~~~~~~~-~~~~~~~~~~~~~dLi~~~L~~dP~~Rps~~ell~ 664 (805)
|||++.+..||... .......+... ....+...++++.+++.+||+.||.+||++.|+++
T Consensus 223 ~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 223 WEIFSYGMQPYYGMAHEEVIYYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINR 284 (288)
T ss_pred HHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 99998556676443 33222222222 11223345678999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=297.58 Aligned_cols=245 Identities=22% Similarity=0.363 Sum_probs=185.2
Q ss_pred EEEeEeeccCCceEEEEEEe-eCCcEEEEEEeecCCc------hHHHHHHHHHHHhCCCCCeeeecccccCCceEEEecc
Q 003644 378 VVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH------DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 450 (805)
Q Consensus 378 ~~~~~~LG~GsfGtVy~a~~-~~g~~VAVK~l~~~~~------~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~E 450 (805)
|.+.+.||+|+||.||++.. .+|+.||||.+..... ....+|+. ++..++||||+++++++.+++..+++||
T Consensus 4 y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~-~l~~~~h~~i~~~~~~~~~~~~~~~v~e 82 (267)
T cd08229 4 FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEID-LLKQLNHPNVIKYYASFIEDNELNIVLE 82 (267)
T ss_pred hhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHH-HHHHccCCchhhhhheeEeCCeEEEEEE
Confidence 55668899999999999864 5799999998864321 22334554 6778899999999999999999999999
Q ss_pred cccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcce
Q 003644 451 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 530 (805)
Q Consensus 451 ~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~I 530 (805)
|..+++|.+++.... .....+++..+..++.||+.||+|||+.++
T Consensus 83 ----------~~~~~~L~~~~~~~~-------------------------~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i 127 (267)
T cd08229 83 ----------LADAGDLSRMIKHFK-------------------------KQKRLIPEKTVWKYFVQLCSALEHMHSRRV 127 (267)
T ss_pred ----------ecCCCCHHHHHHHhh-------------------------ccCCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 555556655543211 012346788889999999999999999999
Q ss_pred eccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHHHHHhC
Q 003644 531 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG 610 (805)
Q Consensus 531 vHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~elltG 610 (805)
+|+||||+||+++.++. ++|+|||++........ ......|+..|+|||++.+..++.++|+||||+++|+|++|
T Consensus 128 ~H~dl~p~nili~~~~~--~~l~dfg~~~~~~~~~~---~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g 202 (267)
T cd08229 128 MHRDIKPANVFITATGV--VKLGDLGLGRFFSSKTT---AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAAL 202 (267)
T ss_pred ecCCCCHHHEEEcCCCC--EEECcchhhhccccCCc---ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhC
Confidence 99999999999987765 89999999876643221 11234588999999999888899999999999999999997
Q ss_pred CCCCCCCchHHHHH---HH-hhccc-cccccCChHHHHHHHHhcCCCCCCCCChhhhhc
Q 003644 611 GKHPYGESFERDAN---IV-KDRKD-LFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 664 (805)
Q Consensus 611 ~~~Pf~~~~~~~~~---~~-~~~~~-~~~~~~~~~~~dLi~~~L~~dP~~Rps~~ell~ 664 (805)
..||......... .+ ..... ......++++.+++.+||+.||++|||+.+|++
T Consensus 203 -~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 203 -QSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYD 260 (267)
T ss_pred -CCCcccccchHHHHhhhhhcCCCCCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHH
Confidence 5566433221111 11 11111 112234578999999999999999999998763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=297.74 Aligned_cols=245 Identities=29% Similarity=0.495 Sum_probs=184.0
Q ss_pred EEEeEeeccCCceEEEEEEee-CCcEEEEEEeecCCc----hHHHHHHHHHHHhCC-CCCeeeecccccCCceEEEeccc
Q 003644 378 VVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHH----DVALKEIQNLIASDQ-HPNIVRWYGVESDQDFVYLSLER 451 (805)
Q Consensus 378 ~~~~~~LG~GsfGtVy~a~~~-~g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l~-HpNIV~l~g~~~~~~~l~LV~E~ 451 (805)
|.+.+.||+|++|+||+|... +++.||||++..... ....+|+. .+..++ ||||+++++++.+++..|+|||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~-~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~ 79 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVK-SLRKLNEHPNIVKLKEVFRENDELYFVFEY 79 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHH-HHHhccCCCCchhHHHHhhcCCcEEEEEec
Confidence 356688999999999998664 578999999865422 23345665 445566 99999999999999999999996
Q ss_pred ccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhccee
Q 003644 452 CTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLI 531 (805)
Q Consensus 452 ~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~Iv 531 (805)
|.++|.+++ .... ...+++..++.++.|++.||+|||+.+++
T Consensus 80 ~~~~l~~~~-----------~~~~---------------------------~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~ 121 (283)
T cd07830 80 MEGNLYQLM-----------KDRK---------------------------GKPFSESVIRSIIYQILQGLAHIHKHGFF 121 (283)
T ss_pred CCCCHHHHH-----------Hhcc---------------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 655554443 2110 12467788899999999999999999999
Q ss_pred ccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhc-CCCCCcchHHHHHHHHHHHHhC
Q 003644 532 HRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ-GRQTRAIDLFSLGCILFFCITG 610 (805)
Q Consensus 532 HrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~t~~sDVwSlGvil~elltG 610 (805)
|+||+|+||+++.++. ++|+|||++....... ......++..|+|||++.. ..++.++|+||||+++|||++|
T Consensus 122 H~dl~~~ni~i~~~~~--~~l~d~~~~~~~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g 195 (283)
T cd07830 122 HRDLKPENLLVSGPEV--VKIADFGLAREIRSRP----PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTL 195 (283)
T ss_pred cCCCChhhEEEcCCCC--EEEeecccceeccCCC----CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhC
Confidence 9999999999987765 8999999998665321 1123457889999998854 4578999999999999999997
Q ss_pred CCCCCCCchHHH-H-HHHhh------------------c-----------cccccccCChHHHHHHHHhcCCCCCCCCCh
Q 003644 611 GKHPYGESFERD-A-NIVKD------------------R-----------KDLFLVEHIPEAVDLFTRLLDPNPDLRPKA 659 (805)
Q Consensus 611 ~~~Pf~~~~~~~-~-~~~~~------------------~-----------~~~~~~~~~~~~~dLi~~~L~~dP~~Rps~ 659 (805)
.+||....... . .+... . .........+++.++|.+||+.||++||++
T Consensus 196 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~ 274 (283)
T cd07830 196 -RPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTA 274 (283)
T ss_pred -CCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCH
Confidence 67775432111 0 00000 0 000011224689999999999999999999
Q ss_pred hhhhcCccc
Q 003644 660 QNVLNHPFF 668 (805)
Q Consensus 660 ~ell~Hpff 668 (805)
+|++.||||
T Consensus 275 ~ei~~~~~~ 283 (283)
T cd07830 275 SQALQHPYF 283 (283)
T ss_pred HHHhhCCCC
Confidence 999999997
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=292.33 Aligned_cols=241 Identities=27% Similarity=0.381 Sum_probs=184.6
Q ss_pred EeeccCCceEEEEEEeeCCcEEEEEEeecCCch----HHHHHHHHHHHhCCCCCeeeecccccCCceEEEecccccCChh
Q 003644 382 KEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCSLN 457 (805)
Q Consensus 382 ~~LG~GsfGtVy~a~~~~g~~VAVK~l~~~~~~----~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~E~~~~sL~ 457 (805)
+.||+|+||.||++...+++.||+|.+...... ...+|+ .+++.++||||+++++++.+.+..|+|||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~-~~l~~l~~~~i~~~~~~~~~~~~~~~v~e------- 72 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEA-EILKQYDHPNIVKLIGVCVQKQPIYIVME------- 72 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHH-HHHHhCCCCCeEEEEEEEecCCCeEEEEE-------
Confidence 369999999999987767999999988654332 233454 47788999999999999999999999999
Q ss_pred hHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCCC
Q 003644 458 DLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKP 537 (805)
Q Consensus 458 d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~IvHrDLKp 537 (805)
|+.+++|.+++... ...+++..++.++.+++.||+|||+.+++||||||
T Consensus 73 ---~~~~~~l~~~l~~~----------------------------~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p 121 (251)
T cd05041 73 ---LVPGGSLLTFLRKK----------------------------KNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAA 121 (251)
T ss_pred ---cCCCCcHHHHHHhc----------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCc
Confidence 55555555554321 12345667789999999999999999999999999
Q ss_pred ceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 003644 538 QNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGE 617 (805)
Q Consensus 538 ~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~elltG~~~Pf~~ 617 (805)
+|||++.++. +||+|||++......... .......++..|+|||.+.++.++.++|+|||||++|||++++..||..
T Consensus 122 ~nili~~~~~--~~l~d~g~~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~ 198 (251)
T cd05041 122 RNCLVGENNV--LKISDFGMSREEEGGIYT-VSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPG 198 (251)
T ss_pred ceEEEcCCCc--EEEeeccccccccCCcce-eccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCcc
Confidence 9999987765 899999998865422111 1111223466799999998888999999999999999999976888866
Q ss_pred chHHH-HHHHhhc-cccccccCChHHHHHHHHhcCCCCCCCCChhhhhc
Q 003644 618 SFERD-ANIVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 664 (805)
Q Consensus 618 ~~~~~-~~~~~~~-~~~~~~~~~~~~~dLi~~~L~~dP~~Rps~~ell~ 664 (805)
..... ...+... ....+...+.++.+++.+||+.+|.+||++.|+++
T Consensus 199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~ 247 (251)
T cd05041 199 MSNQQTRERIESGYRMPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYN 247 (251)
T ss_pred CCHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 44322 2222221 12223345678999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=326.03 Aligned_cols=247 Identities=27% Similarity=0.388 Sum_probs=186.5
Q ss_pred ceEEEeEeeccCCceEEEEEEeeCC-cEEEEEEeecCCc---hHHHHHHHHHHHhCCCCCeeeecccc-c---CC---ce
Q 003644 376 KLVVFNKEIAKGSNGTVVLEGNYEG-RSVAVKRLVKTHH---DVALKEIQNLIASDQHPNIVRWYGVE-S---DQ---DF 444 (805)
Q Consensus 376 ~~~~~~~~LG~GsfGtVy~a~~~~g-~~VAVK~l~~~~~---~~~~~Ei~~ll~~l~HpNIV~l~g~~-~---~~---~~ 444 (805)
-.+++.+.|.+|||+.||+|....+ ..||+|++...+. ....+|+..|.....|||||.|++.. . .+ -+
T Consensus 37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~E 116 (738)
T KOG1989|consen 37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWE 116 (738)
T ss_pred EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeE
Confidence 3467889999999999999987766 9999999965532 23456776554455699999999932 1 11 35
Q ss_pred EEEeccccc-CChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHH
Q 003644 445 VYLSLERCT-CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLS 523 (805)
Q Consensus 445 l~LV~E~~~-~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~ 523 (805)
++|.||||. ++|.|++ .. ....+|.+.++++|+.|+++|++
T Consensus 117 vllLmEyC~gg~Lvd~m-----------n~---------------------------Rlq~~lte~eVLkIf~dv~~AVa 158 (738)
T KOG1989|consen 117 VLLLMEYCKGGSLVDFM-----------NT---------------------------RLQTRLTEDEVLKIFYDVCEAVA 158 (738)
T ss_pred EEeehhhccCCcHHHHH-----------HH---------------------------HHhccCChHHHHHHHHHHHHHHH
Confidence 799999887 4666655 21 11244888999999999999999
Q ss_pred Hhhhcc--eeccCCCCceEEecCCCCceEEEeccCccccccCCCcc------ccccccccCCCCCCChhhhh---cCCCC
Q 003644 524 HLHEIG--LIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSC------LTQNATGYGSSGWQAPEQLL---QGRQT 592 (805)
Q Consensus 524 yLH~~~--IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~------~~~~~~~~gt~~y~APE~l~---~~~~t 592 (805)
+||... |||||||-+||||+.+|+ .||||||.+...-..... ....-...-|+.|+|||++. +...+
T Consensus 159 ~mH~~~pPiIHRDLKiENvLls~~g~--~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~ 236 (738)
T KOG1989|consen 159 AMHYLKPPIIHRDLKIENVLLSADGN--YKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIG 236 (738)
T ss_pred HHhcCCCccchhhhhhhheEEcCCCC--EEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCc
Confidence 999986 999999999999999987 899999998654322110 01111224699999999975 45689
Q ss_pred CcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhcccccc-ccCChHHHHHHHHhcCCCCCCCCChhhhhcC
Q 003644 593 RAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDRKDLFL-VEHIPEAVDLFTRLLDPNPDLRPKAQNVLNH 665 (805)
Q Consensus 593 ~~sDVwSlGvil~elltG~~~Pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~dLi~~~L~~dP~~Rps~~ell~H 665 (805)
+|+|||||||+||-|+.. .+||++.-. ..|+...+...+ ...+..+.+||+.||+.||.+||++.+++.+
T Consensus 237 eKsDIWALGclLYkLCy~-t~PFe~sg~--laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~ 307 (738)
T KOG1989|consen 237 EKSDIWALGCLLYKLCYF-TTPFEESGK--LAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEE 307 (738)
T ss_pred chhHHHHHHHHHHHHHHh-CCCcCcCcc--eeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHH
Confidence 999999999999999995 889987522 223333332222 3567799999999999999999999998855
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-33 Score=291.00 Aligned_cols=247 Identities=26% Similarity=0.410 Sum_probs=194.0
Q ss_pred EEEeEeeccCCceEEEEEE-eeCCcEEEEEEeecCCc-----hHHHHHHHHHHHhCCCCCeeeecccccCCceEEEeccc
Q 003644 378 VVFNKEIAKGSNGTVVLEG-NYEGRSVAVKRLVKTHH-----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLER 451 (805)
Q Consensus 378 ~~~~~~LG~GsfGtVy~a~-~~~g~~VAVK~l~~~~~-----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~E~ 451 (805)
|.+.+.||+|+||.||++. ..+++.+|||.+..... ....+|+. +++.++||||+++++++.++...|+|+|
T Consensus 2 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~-~l~~l~~~~i~~~~~~~~~~~~~~~v~e- 79 (256)
T cd08530 2 FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIR-ILASVNHPNIISYKEAFLDGNKLCIVME- 79 (256)
T ss_pred ceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHH-HHHhCCCCCchhhhhhhccCCEEEEEeh-
Confidence 6677899999999999974 45788999999865321 12334543 6678899999999999999999999999
Q ss_pred ccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhccee
Q 003644 452 CTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLI 531 (805)
Q Consensus 452 ~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~Iv 531 (805)
|.++++|.+++.... .....+++..+..++.|++.||+|||+.|++
T Consensus 80 ---------~~~~~~L~~~~~~~~-------------------------~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~ 125 (256)
T cd08530 80 ---------YAPFGDLSKAISKRK-------------------------KKRKLIPEQEIWRIFIQLLRGLQALHEQKIL 125 (256)
T ss_pred ---------hcCCCCHHHHHHHHH-------------------------hhcCCCCHHHHHHHHHHHHHHHHHHhhCCcc
Confidence 666667766654321 1123467788899999999999999999999
Q ss_pred ccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHHHHHhCC
Q 003644 532 HRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGG 611 (805)
Q Consensus 532 HrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~elltG~ 611 (805)
|+||+|+||+++.++. +||+|||++...... ......+++.|+|||.+.+..++.++|+||||+++|||++|
T Consensus 126 h~~l~~~ni~~~~~~~--~kl~d~g~~~~~~~~-----~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g- 197 (256)
T cd08530 126 HRDLKSANILLVANDL--VKIGDLGISKVLKKN-----MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATF- 197 (256)
T ss_pred cCCCCcceEEEecCCc--EEEeeccchhhhccC-----CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhC-
Confidence 9999999999988765 899999999877543 11234588999999999988899999999999999999996
Q ss_pred CCCCCCchHHHH--HHHhhccccccccCChHHHHHHHHhcCCCCCCCCChhhhhcCccc
Q 003644 612 KHPYGESFERDA--NIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 668 (805)
Q Consensus 612 ~~Pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~dLi~~~L~~dP~~Rps~~ell~Hpff 668 (805)
..||........ .+..............++.+++.+||+.+|++||++.++++||+.
T Consensus 198 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~p~~ 256 (256)
T cd08530 198 APPFEARSMQDLRYKVQRGKYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILASPAV 256 (256)
T ss_pred CCCCCCCCHHHHHHHHhcCCCCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcCCCC
Confidence 778866443221 122222222233456789999999999999999999999999973
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=307.38 Aligned_cols=264 Identities=22% Similarity=0.323 Sum_probs=190.2
Q ss_pred cceEEEeEeeccCCceEEEEEEee--------CCcEEEEEEeecCCc----hHHHHHHHHHHHhC-CCCCeeeecccccC
Q 003644 375 GKLVVFNKEIAKGSNGTVVLEGNY--------EGRSVAVKRLVKTHH----DVALKEIQNLIASD-QHPNIVRWYGVESD 441 (805)
Q Consensus 375 ~~~~~~~~~LG~GsfGtVy~a~~~--------~g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l-~HpNIV~l~g~~~~ 441 (805)
..+|.+.+.||+|+||.||++... .+..||+|.+..... ....+|+. ++..+ +||||++++++|.+
T Consensus 11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~-~l~~l~~h~~iv~~~~~~~~ 89 (334)
T cd05100 11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEME-MMKMIGKHKNIINLLGACTQ 89 (334)
T ss_pred HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHH-HHHhhcCCCCeeeeeEEEcc
Confidence 346888999999999999998532 234799998865332 23445665 45555 89999999999999
Q ss_pred CceEEEecccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHH
Q 003644 442 QDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSG 521 (805)
Q Consensus 442 ~~~l~LV~E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~g 521 (805)
++..|+++|| ..+|+|.+++.......... ...........+++.+++.++.||+.|
T Consensus 90 ~~~~~lv~e~----------~~~g~L~~~l~~~~~~~~~~-------------~~~~~~~~~~~l~~~~~~~~~~qi~~a 146 (334)
T cd05100 90 DGPLYVLVEY----------ASKGNLREYLRARRPPGMDY-------------SFDTCKLPEEQLTFKDLVSCAYQVARG 146 (334)
T ss_pred CCceEEEEec----------CCCCcHHHHHHhcCCccccc-------------ccccccCccccCCHHHHHHHHHHHHHH
Confidence 9999999994 45555555554321100000 000000112346778889999999999
Q ss_pred HHHhhhcceeccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHH
Q 003644 522 LSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLG 601 (805)
Q Consensus 522 L~yLH~~~IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlG 601 (805)
|+|||+.||+||||||+|||++.++. +||+|||+++........ .......++..|+|||++.+..++.++||||||
T Consensus 147 l~~LH~~givH~dlkp~Nill~~~~~--~kL~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG 223 (334)
T cd05100 147 MEYLASQKCIHRDLAARNVLVTEDNV--MKIADFGLARDVHNIDYY-KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFG 223 (334)
T ss_pred HHHHHHCCeeccccccceEEEcCCCc--EEECCcccceeccccccc-ccccCCCcCceEcCHHHhccCCcCchhhhHHHH
Confidence 99999999999999999999987765 899999999866432111 111223346789999999998999999999999
Q ss_pred HHHHHHHhCCCCCCCCchHHH-HHHHhh-ccccccccCChHHHHHHHHhcCCCCCCCCChhhhhcC
Q 003644 602 CILFFCITGGKHPYGESFERD-ANIVKD-RKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNH 665 (805)
Q Consensus 602 vil~elltG~~~Pf~~~~~~~-~~~~~~-~~~~~~~~~~~~~~dLi~~~L~~dP~~Rps~~ell~H 665 (805)
|++|||++++.+||....... ...+.. .....+.....++.+++.+||+.+|++||++.|++++
T Consensus 224 ~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~ 289 (334)
T cd05100 224 VLLWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVED 289 (334)
T ss_pred HHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 999999996677886543322 222222 2222334456789999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-33 Score=306.06 Aligned_cols=252 Identities=27% Similarity=0.392 Sum_probs=185.2
Q ss_pred EEEeEeeccCCceEEEEEEee-C--CcEEEEEEeecCC-----chHHHHHHHHHHHhCCCCCeeeecccccC----CceE
Q 003644 378 VVFNKEIAKGSNGTVVLEGNY-E--GRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESD----QDFV 445 (805)
Q Consensus 378 ~~~~~~LG~GsfGtVy~a~~~-~--g~~VAVK~l~~~~-----~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~----~~~l 445 (805)
|.+.+.||+|+||.||++... . +..||||++.... .....+|+..+.....||||+++++++.. ....
T Consensus 2 y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~ 81 (332)
T cd07857 2 YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNEL 81 (332)
T ss_pred ceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcE
Confidence 667889999999999998644 3 7899999986432 22445676644444479999999987532 2557
Q ss_pred EEecccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHh
Q 003644 446 YLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHL 525 (805)
Q Consensus 446 ~LV~E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yL 525 (805)
|+++|++.++|.+++. ....+++..++.++.||+.||+||
T Consensus 82 ~~~~e~~~~~L~~~l~----------------------------------------~~~~~~~~~~~~~~~qi~~aL~~L 121 (332)
T cd07857 82 YLYEELMEADLHQIIR----------------------------------------SGQPLTDAHFQSFIYQILCGLKYI 121 (332)
T ss_pred EEEEecccCCHHHHHh----------------------------------------cCCCCCHHHHHHHHHHHHHHHHHH
Confidence 8999976665554441 123466778899999999999999
Q ss_pred hhcceeccCCCCceEEecCCCCceEEEeccCccccccCCCcc-ccccccccCCCCCCChhhhhc-CCCCCcchHHHHHHH
Q 003644 526 HEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSC-LTQNATGYGSSGWQAPEQLLQ-GRQTRAIDLFSLGCI 603 (805)
Q Consensus 526 H~~~IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~-~~~~~~~~gt~~y~APE~l~~-~~~t~~sDVwSlGvi 603 (805)
|+.||+||||||+||+++.++. +||+|||+++.+...... ........||..|+|||++.+ ..++.++|+|||||+
T Consensus 122 H~~givH~dlkp~Nili~~~~~--~kl~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~ 199 (332)
T cd07857 122 HSANVLHRDLKPGNLLVNADCE--LKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCI 199 (332)
T ss_pred HhCCcccCCCCHHHeEEcCCCC--EEeCcCCCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHH
Confidence 9999999999999999988776 899999999876533211 111233468999999998866 468999999999999
Q ss_pred HHHHHhCCCCCCCCchHHHH--HHH-----------------------hhc----cc---cccccCChHHHHHHHHhcCC
Q 003644 604 LFFCITGGKHPYGESFERDA--NIV-----------------------KDR----KD---LFLVEHIPEAVDLFTRLLDP 651 (805)
Q Consensus 604 l~elltG~~~Pf~~~~~~~~--~~~-----------------------~~~----~~---~~~~~~~~~~~dLi~~~L~~ 651 (805)
+|+|++| .+||........ .++ ... .. .......+++.+++.+||+.
T Consensus 200 l~~l~~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 278 (332)
T cd07857 200 LAELLGR-KPVFKGKDYVDQLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAF 278 (332)
T ss_pred HHHHHhC-CcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccC
Confidence 9999996 778865321110 000 000 00 00112356899999999999
Q ss_pred CCCCCCChhhhhcCccccccc
Q 003644 652 NPDLRPKAQNVLNHPFFWTAD 672 (805)
Q Consensus 652 dP~~Rps~~ell~Hpff~~~~ 672 (805)
||.+|||+.+++.||||..+.
T Consensus 279 ~P~~R~t~~~ll~~~~~~~~~ 299 (332)
T cd07857 279 DPTKRISVEEALEHPYLAIWH 299 (332)
T ss_pred CcccCCCHHHHhcChhhhhhc
Confidence 999999999999999996543
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=297.59 Aligned_cols=243 Identities=28% Similarity=0.474 Sum_probs=186.2
Q ss_pred EeEeeccCCceEEEEEEe-eCCcEEEEEEeecCCc-----hHHHHHHHHHHHhCCCCCeeeecccccCCceEEEeccccc
Q 003644 380 FNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH-----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCT 453 (805)
Q Consensus 380 ~~~~LG~GsfGtVy~a~~-~~g~~VAVK~l~~~~~-----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~E~~~ 453 (805)
..+.||+|++|.||++.. .+|+.+|+|++..... ....+|+. +++.++||||+++++++.+++..|+|+||+.
T Consensus 3 ~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~-~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 81 (283)
T cd05118 3 KLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIK-LLKELNHPNIIKLLDVFRHKGDLYLVFEFMD 81 (283)
T ss_pred cceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHH-HHHHhcCCCcchHHHhhccCCCEEEEEeccC
Confidence 457899999999999855 4689999999865432 23445554 6677889999999999999999999999777
Q ss_pred CChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcceecc
Q 003644 454 CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHR 533 (805)
Q Consensus 454 ~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~IvHr 533 (805)
++|.+++... ...+++..++.++.||+.||+|||+.+|+|+
T Consensus 82 ~~l~~~l~~~---------------------------------------~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~ 122 (283)
T cd05118 82 TDLYKLIKDR---------------------------------------QRGLPESLIKSYLYQLLQGLAFCHSHGILHR 122 (283)
T ss_pred CCHHHHHHhh---------------------------------------cccCCHHHHHHHHHHHHHHHHHHHHCCeeec
Confidence 6665544211 1235677889999999999999999999999
Q ss_pred CCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcC-CCCCcchHHHHHHHHHHHHhCCC
Q 003644 534 DLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG-RQTRAIDLFSLGCILFFCITGGK 612 (805)
Q Consensus 534 DLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~t~~sDVwSlGvil~elltG~~ 612 (805)
||||+||+++.++. ++|+|||.+....... .......++..|+|||.+.+. .++.++|+|||||++|+|++| .
T Consensus 123 dl~p~nili~~~~~--~~l~df~~~~~~~~~~---~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg-~ 196 (283)
T cd05118 123 DLKPENLLINTEGV--LKLADFGLARSFGSPV---RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSR-R 196 (283)
T ss_pred CcCHHHEEECCCCc--EEEeeeeeeEecCCCc---ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhC-C
Confidence 99999999987765 8999999988775432 111223578899999999876 689999999999999999997 6
Q ss_pred CCCCCchHHHH--HHHhhcc-----------------------------ccccccCChHHHHHHHHhcCCCCCCCCChhh
Q 003644 613 HPYGESFERDA--NIVKDRK-----------------------------DLFLVEHIPEAVDLFTRLLDPNPDLRPKAQN 661 (805)
Q Consensus 613 ~Pf~~~~~~~~--~~~~~~~-----------------------------~~~~~~~~~~~~dLi~~~L~~dP~~Rps~~e 661 (805)
+||......+. .+..... .......+.++.++|.+||+.||.+||++.+
T Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ 276 (283)
T cd05118 197 PLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQ 276 (283)
T ss_pred CCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHH
Confidence 77754332111 0000000 0001123568899999999999999999999
Q ss_pred hhcCccc
Q 003644 662 VLNHPFF 668 (805)
Q Consensus 662 ll~Hpff 668 (805)
+++||||
T Consensus 277 ll~~~~~ 283 (283)
T cd05118 277 ALAHPYF 283 (283)
T ss_pred HhhCCCC
Confidence 9999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=308.12 Aligned_cols=248 Identities=24% Similarity=0.390 Sum_probs=186.4
Q ss_pred cccceEEEeEeeccCCceEEEEEEe-eCCcEEEEEEeecCCc-----hHHHHHHHHHHHhCCCCCeeeecccccCC----
Q 003644 373 RIGKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH-----DVALKEIQNLIASDQHPNIVRWYGVESDQ---- 442 (805)
Q Consensus 373 ~i~~~~~~~~~LG~GsfGtVy~a~~-~~g~~VAVK~l~~~~~-----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~---- 442 (805)
.+.++|...+.||+|+||.||++.. .+|+.||||++..... ....+|+. ++..++||||+++++++...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~-~l~~l~h~~iv~~~~~~~~~~~~~ 92 (345)
T cd07877 14 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR-LLKHMKHENVIGLLDVFTPARSLE 92 (345)
T ss_pred hccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHH-HHHHcCCCcccceeeeeeeccccc
Confidence 3457788999999999999999854 5789999999865321 23345554 77888999999999987543
Q ss_pred --ceEEEecccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHH
Q 003644 443 --DFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVS 520 (805)
Q Consensus 443 --~~l~LV~E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~ 520 (805)
+..|++++++.++|.+++. ...+++..+..++.|++.
T Consensus 93 ~~~~~~lv~~~~~~~L~~~~~-----------------------------------------~~~l~~~~~~~i~~qi~~ 131 (345)
T cd07877 93 EFNDVYLVTHLMGADLNNIVK-----------------------------------------CQKLTDDHVQFLIYQILR 131 (345)
T ss_pred ccccEEEEehhcccCHHHHHh-----------------------------------------cCCCCHHHHHHHHHHHHH
Confidence 4478888865554443321 123566778899999999
Q ss_pred HHHHhhhcceeccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhc-CCCCCcchHHH
Q 003644 521 GLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ-GRQTRAIDLFS 599 (805)
Q Consensus 521 gL~yLH~~~IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~t~~sDVwS 599 (805)
||+|||+.+|+||||||+||+++.++. +||+|||+++..... .....++..|+|||.+.+ ..++.++||||
T Consensus 132 aL~~LH~~~ivH~dlkp~NIll~~~~~--~kl~dfg~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~Dvws 203 (345)
T cd07877 132 GLKYIHSADIIHRDLKPSNLAVNEDCE--LKILDFGLARHTDDE------MTGYVATRWYRAPEIMLNWMHYNQTVDIWS 203 (345)
T ss_pred HHHHHHHCCeeecCCChHHEEEcCCCC--EEEeccccccccccc------ccccccCCCccCHHHHhCccCCCchhhHHH
Confidence 999999999999999999999988876 899999998765421 123457899999999876 46789999999
Q ss_pred HHHHHHHHHhCCCCCCCCchHHH--HHHHhh-----------------------ccc-------cccccCChHHHHHHHH
Q 003644 600 LGCILFFCITGGKHPYGESFERD--ANIVKD-----------------------RKD-------LFLVEHIPEAVDLFTR 647 (805)
Q Consensus 600 lGvil~elltG~~~Pf~~~~~~~--~~~~~~-----------------------~~~-------~~~~~~~~~~~dLi~~ 647 (805)
|||++|||++| .+||....... ..+... ... ......++++.++|.+
T Consensus 204 lG~il~el~~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 282 (345)
T cd07877 204 VGCIMAELLTG-RTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEK 282 (345)
T ss_pred HHHHHHHHHhC-CCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHH
Confidence 99999999997 66775432111 000000 000 0011235788999999
Q ss_pred hcCCCCCCCCChhhhhcCcccccc
Q 003644 648 LLDPNPDLRPKAQNVLNHPFFWTA 671 (805)
Q Consensus 648 ~L~~dP~~Rps~~ell~Hpff~~~ 671 (805)
||+.||.+||++.++++||||...
T Consensus 283 ~L~~dp~~R~t~~e~l~h~~f~~~ 306 (345)
T cd07877 283 MLVLDSDKRITAAQALAHAYFAQY 306 (345)
T ss_pred HcCCChhhcCCHHHHhcChhhhhc
Confidence 999999999999999999999653
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=296.16 Aligned_cols=248 Identities=25% Similarity=0.367 Sum_probs=185.2
Q ss_pred eeccCCceEEEEEEeeC-------CcEEEEEEeecCC----chHHHHHHHHHHHhCCCCCeeeecccccCCceEEEeccc
Q 003644 383 EIAKGSNGTVVLEGNYE-------GRSVAVKRLVKTH----HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLER 451 (805)
Q Consensus 383 ~LG~GsfGtVy~a~~~~-------g~~VAVK~l~~~~----~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~E~ 451 (805)
.||+|+||.||++...+ ++.||||.+.... .....+|+. .++.++||||+++++++.+.+..|+|||
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~~v~e- 79 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAH-LMSNFNHPNIVKLLGVCLLNEPQYIIME- 79 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHH-HHHhcCCCCeeeEeeeecCCCCeEEEEe-
Confidence 58999999999975432 3679999886532 123344544 7788999999999999999999999999
Q ss_pred ccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhccee
Q 003644 452 CTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLI 531 (805)
Q Consensus 452 ~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~Iv 531 (805)
|+++|+|.+++....... .....+++.+++.++.|++.||+|||+.+++
T Consensus 80 ---------~~~~~~L~~~l~~~~~~~----------------------~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~ 128 (269)
T cd05044 80 ---------LMEGGDLLSYLRDARVER----------------------FGPPLLTLKELLDICLDVAKGCVYLEQMHFI 128 (269)
T ss_pred ---------ccCCCcHHHHHHHhhhcc----------------------cCCccccHHHHHHHHHHHHHHHHHHHhCCcc
Confidence 666777777665422110 0123367788899999999999999999999
Q ss_pred ccCCCCceEEecCCC---CceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHHHHH
Q 003644 532 HRDLKPQNVLISKDK---SFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCI 608 (805)
Q Consensus 532 HrDLKp~NILl~~~~---~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~ell 608 (805)
|+||||+||+++.++ ...++|+|||+++....... ........++..|+|||++.+..++.++|||||||++|||+
T Consensus 129 H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ell 207 (269)
T cd05044 129 HRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDY-YRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEIL 207 (269)
T ss_pred cCCCChheEEEecCCCCCCcceEECCcccccccccccc-cccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHH
Confidence 999999999998655 22589999999986643211 11122334678899999999999999999999999999999
Q ss_pred hCCCCCCCCchHHHH-HHHh-hccccccccCChHHHHHHHHhcCCCCCCCCChhhhhc
Q 003644 609 TGGKHPYGESFERDA-NIVK-DRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 664 (805)
Q Consensus 609 tG~~~Pf~~~~~~~~-~~~~-~~~~~~~~~~~~~~~dLi~~~L~~dP~~Rps~~ell~ 664 (805)
+.+..||........ ..+. ......+...++.+.++|.+||..+|.+||++.++++
T Consensus 208 t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 208 TLGQQPYPALNNQEVLQHVTAGGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQE 265 (269)
T ss_pred HcCCCCCcccCHHHHHHHHhcCCccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 844778865433221 1111 1122233345678999999999999999999999874
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=308.93 Aligned_cols=254 Identities=28% Similarity=0.406 Sum_probs=188.1
Q ss_pred cccceEEEeEeeccCCceEEEEEEee-CCcEEEEEEeecCC-----chHHHHHHHHHHHhC-CCCCeeeecccccCC--c
Q 003644 373 RIGKLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH-----HDVALKEIQNLIASD-QHPNIVRWYGVESDQ--D 443 (805)
Q Consensus 373 ~i~~~~~~~~~LG~GsfGtVy~a~~~-~g~~VAVK~l~~~~-----~~~~~~Ei~~ll~~l-~HpNIV~l~g~~~~~--~ 443 (805)
.+.+.|.+.+.||+|+||.||++... +|+.||||++.+.. .....+|+. ++..+ +||||+++++++... .
T Consensus 4 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~-~l~~l~~h~ni~~~~~~~~~~~~~ 82 (337)
T cd07852 4 HILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIM-FLQELGDHPNIVKLLNVIKAENDK 82 (337)
T ss_pred hhhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHH-HHHHhcCCCCccceeeeeccCCCc
Confidence 45566778899999999999998654 68899999885421 223456665 66777 999999999988653 4
Q ss_pred eEEEecccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHH
Q 003644 444 FVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLS 523 (805)
Q Consensus 444 ~l~LV~E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~ 523 (805)
..|+|||+|.++|.+++. . ..+++..++.++.||+.||+
T Consensus 83 ~~~lv~e~~~~~L~~~~~-----------~------------------------------~~~~~~~~~~i~~qi~~~L~ 121 (337)
T cd07852 83 DIYLVFEYMETDLHAVIR-----------A------------------------------NILEDVHKRYIMYQLLKALK 121 (337)
T ss_pred eEEEEecccccCHHHHHh-----------c------------------------------CCCCHHHHHHHHHHHHHHHH
Confidence 689999977766554431 0 12445566789999999999
Q ss_pred HhhhcceeccCCCCceEEecCCCCceEEEeccCccccccCCCcc--ccccccccCCCCCCChhhhhc-CCCCCcchHHHH
Q 003644 524 HLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSC--LTQNATGYGSSGWQAPEQLLQ-GRQTRAIDLFSL 600 (805)
Q Consensus 524 yLH~~~IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~--~~~~~~~~gt~~y~APE~l~~-~~~t~~sDVwSl 600 (805)
|||+.||+||||||+||+++.++. +||+|||+++........ ........||..|+|||++.+ ..++.++|||||
T Consensus 122 ~LH~~~i~H~dl~p~nill~~~~~--~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~sl 199 (337)
T cd07852 122 YIHSGNVIHRDLKPSNILLNSDCR--VKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSV 199 (337)
T ss_pred HHHHCCeecCCCCHHHEEEcCCCc--EEEeeccchhccccccccccCcchhcccccccccCceeeeccccccccchHHHH
Confidence 999999999999999999988875 899999999876543211 011223458999999998765 457899999999
Q ss_pred HHHHHHHHhCCCCCCCCchHHHH--HHHhh--------------------------cc----ccccccCChHHHHHHHHh
Q 003644 601 GCILFFCITGGKHPYGESFERDA--NIVKD--------------------------RK----DLFLVEHIPEAVDLFTRL 648 (805)
Q Consensus 601 Gvil~elltG~~~Pf~~~~~~~~--~~~~~--------------------------~~----~~~~~~~~~~~~dLi~~~ 648 (805)
||++|+|++| ++||........ .+... .. .......+.++.++|.+|
T Consensus 200 G~~l~el~tg-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 278 (337)
T cd07852 200 GCILGEMLLG-KPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKL 278 (337)
T ss_pred HHHHHHHHhC-CCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHh
Confidence 9999999997 677754321110 00000 00 001122457889999999
Q ss_pred cCCCCCCCCChhhhhcCcccccc
Q 003644 649 LDPNPDLRPKAQNVLNHPFFWTA 671 (805)
Q Consensus 649 L~~dP~~Rps~~ell~Hpff~~~ 671 (805)
|+.||.+|||+.++++||||...
T Consensus 279 l~~~P~~Rps~~~il~~~~~~~~ 301 (337)
T cd07852 279 LVFNPNKRLTAEEALEHPYVAQF 301 (337)
T ss_pred ccCCcccccCHHHHhhChhhhhh
Confidence 99999999999999999999553
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-33 Score=300.40 Aligned_cols=257 Identities=24% Similarity=0.324 Sum_probs=186.6
Q ss_pred ceEEEeEeeccCCceEEEEEEee-----------------CCcEEEEEEeecCCc----hHHHHHHHHHHHhCCCCCeee
Q 003644 376 KLVVFNKEIAKGSNGTVVLEGNY-----------------EGRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVR 434 (805)
Q Consensus 376 ~~~~~~~~LG~GsfGtVy~a~~~-----------------~g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l~HpNIV~ 434 (805)
++|.+.+.||+|+||+||++... ++..||||++..... ....+|+. ++..++||||++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~-~l~~l~~~~i~~ 83 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIK-IMSRLKDPNIIR 83 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHH-HHHhCCCCCcce
Confidence 45788899999999999986322 245799999875432 23345655 677889999999
Q ss_pred ecccccCCceEEEecccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHH
Q 003644 435 WYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKV 514 (805)
Q Consensus 435 l~g~~~~~~~l~LV~E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i 514 (805)
+++++.+++..|+||| |+.+|+|.+++........ ...+....+++.++..+
T Consensus 84 ~~~~~~~~~~~~lv~e----------~~~~~~L~~~l~~~~~~~~------------------~~~~~~~~~~~~~~~~~ 135 (296)
T cd05095 84 LLAVCITSDPLCMITE----------YMENGDLNQFLSRHEPQEA------------------AEKADVVTISYSTLIFM 135 (296)
T ss_pred EEEEEecCCccEEEEE----------eCCCCcHHHHHHhcCcccc------------------cccccccccCHHHHHHH
Confidence 9999999999999999 4455555555543221100 00122344678889999
Q ss_pred HHHHHHHHHHhhhcceeccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCc
Q 003644 515 TRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRA 594 (805)
Q Consensus 515 ~~qIa~gL~yLH~~~IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~ 594 (805)
+.|++.||+|||+.+|+||||||+|||++.++. ++|+|||+++.+...... .......++..|+|||+...+.++.+
T Consensus 136 ~~~i~~al~~lH~~~i~H~dlkp~Nili~~~~~--~~l~dfg~~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~ 212 (296)
T cd05095 136 ATQIASGMKYLSSLNFVHRDLATRNCLVGKNYT--IKIADFGMSRNLYSGDYY-RIQGRAVLPIRWMSWESILLGKFTTA 212 (296)
T ss_pred HHHHHHHHHHHHHCCeecccCChheEEEcCCCC--EEeccCcccccccCCcce-eccCcCcCccccCCHHHHhcCCccch
Confidence 999999999999999999999999999987765 899999999866432211 11122235678999999988899999
Q ss_pred chHHHHHHHHHHHHhC-CCCCCCCchHHHH-HHH-h---h----ccccccccCChHHHHHHHHhcCCCCCCCCChhhhhc
Q 003644 595 IDLFSLGCILFFCITG-GKHPYGESFERDA-NIV-K---D----RKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 664 (805)
Q Consensus 595 sDVwSlGvil~elltG-~~~Pf~~~~~~~~-~~~-~---~----~~~~~~~~~~~~~~dLi~~~L~~dP~~Rps~~ell~ 664 (805)
+|||||||++|||+++ +..||........ ... . . .....+...++.+.+++.+||+.||.+||++.++++
T Consensus 213 ~DiwSlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 292 (296)
T cd05095 213 SDVWAFGVTLWEILTLCKEQPYSQLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA 292 (296)
T ss_pred hhhhHHHHHHHHHHHhCCCCCccccChHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 9999999999999984 4677754322111 100 0 0 011112334578999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-34 Score=333.00 Aligned_cols=157 Identities=32% Similarity=0.548 Sum_probs=126.7
Q ss_pred HHHHHHHHHHHHHHHHHhhhcceeccCCCCceEEecCCCCceEEEeccCcccccc----C---C--------Cccccccc
Q 003644 508 SAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQ----G---D--------MSCLTQNA 572 (805)
Q Consensus 508 ~~~~~~i~~qIa~gL~yLH~~~IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~----~---~--------~~~~~~~~ 572 (805)
...+++++++|++||+|+|+.|||||||||.||+|+++++ +||+|||+|+... . . ........
T Consensus 696 ~d~~wrLFreIlEGLaYIH~~giIHRDLKP~NIFLd~~~~--VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~T 773 (1351)
T KOG1035|consen 696 RDEAWRLFREILEGLAYIHDQGIIHRDLKPRNIFLDSRNS--VKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLT 773 (1351)
T ss_pred hHHHHHHHHHHHHHHHHHHhCceeeccCCcceeEEcCCCC--eeecccccchhhhhhhhhHhhccCccccccCCCCcccc
Confidence 5678999999999999999999999999999999998876 8999999998722 0 0 01111234
Q ss_pred cccCCCCCCChhhhhcCC---CCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhcccccc------ccCChHHHH
Q 003644 573 TGYGSSGWQAPEQLLQGR---QTRAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDRKDLFL------VEHIPEAVD 643 (805)
Q Consensus 573 ~~~gt~~y~APE~l~~~~---~t~~sDVwSlGvil~elltG~~~Pf~~~~~~~~~~~~~~~~~~~------~~~~~~~~d 643 (805)
..+||.-|+|||++.+.. |+.|+|+||||+|++||+. ||+...++...+..-+....+ ....+.-..
T Consensus 774 s~VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~y----PF~TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~s 849 (1351)
T KOG1035|consen 774 SQVGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEMLY----PFGTSMERASILTNLRKGSIPEPADFFDPEHPEEAS 849 (1351)
T ss_pred cccceeeeecHHHhcccccccccchhhhHHHHHHHHHHhc----cCCchHHHHHHHHhcccCCCCCCcccccccchHHHH
Confidence 567999999999998754 9999999999999999986 699988887654443332222 223467789
Q ss_pred HHHHhcCCCCCCCCChhhhhcCccccc
Q 003644 644 LFTRLLDPNPDLRPKAQNVLNHPFFWT 670 (805)
Q Consensus 644 Li~~~L~~dP~~Rps~~ell~Hpff~~ 670 (805)
+|++|++.||.+||||.|+|++-||-.
T Consensus 850 lI~~Ll~hdP~kRPtA~eLL~s~llpp 876 (1351)
T KOG1035|consen 850 LIRWLLSHDPSKRPTATELLNSELLPP 876 (1351)
T ss_pred HHHHHhcCCCccCCCHHHHhhccCCCc
Confidence 999999999999999999999999863
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-33 Score=297.82 Aligned_cols=251 Identities=27% Similarity=0.391 Sum_probs=188.2
Q ss_pred EEEeEeeccCCceEEEEEEe----eCCcEEEEEEeecCCc-------hHHHHHHHHHHHhC-CCCCeeeecccccCCceE
Q 003644 378 VVFNKEIAKGSNGTVVLEGN----YEGRSVAVKRLVKTHH-------DVALKEIQNLIASD-QHPNIVRWYGVESDQDFV 445 (805)
Q Consensus 378 ~~~~~~LG~GsfGtVy~a~~----~~g~~VAVK~l~~~~~-------~~~~~Ei~~ll~~l-~HpNIV~l~g~~~~~~~l 445 (805)
|.+.+.||+|++|+||++.. .+++.||||.+++... ....+|+. ++..+ +||||+++++.+.+++..
T Consensus 2 ~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~-~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQ-VLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred ceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHH-HHHhccCCcchhhhheeeecCCEE
Confidence 56778999999999998753 3578999999864321 22345555 44455 799999999999999999
Q ss_pred EEecccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHh
Q 003644 446 YLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHL 525 (805)
Q Consensus 446 ~LV~E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yL 525 (805)
|+||| |+.+|+|.+++.. ...+++..++.++.|++.||+||
T Consensus 81 ~lv~e----------~~~~~~L~~~~~~-----------------------------~~~~~~~~~~~~~~ql~~~l~~l 121 (288)
T cd05583 81 HLILD----------YVNGGELFTHLYQ-----------------------------REHFTESEVRVYIAEIVLALDHL 121 (288)
T ss_pred EEEEe----------cCCCCcHHHHHhh-----------------------------cCCcCHHHHHHHHHHHHHHHHHH
Confidence 99999 5555666555422 12356677889999999999999
Q ss_pred hhcceeccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCC--CCCcchHHHHHHH
Q 003644 526 HEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGR--QTRAIDLFSLGCI 603 (805)
Q Consensus 526 H~~~IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~--~t~~sDVwSlGvi 603 (805)
|+.+++||||||+||+++.++. ++|+|||+++........ ......|+..|+|||.+.+.. .+.++|+||||++
T Consensus 122 H~~~~~H~dl~p~nil~~~~~~--~~l~dfg~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~i 197 (288)
T cd05583 122 HQLGIIYRDIKLENILLDSEGH--VVLTDFGLSKEFLAEEEE--RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVL 197 (288)
T ss_pred HHCCeeccCCCHHHeEECCCCC--EEEEECcccccccccccc--ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHH
Confidence 9999999999999999987765 899999998776433211 112345889999999987655 6889999999999
Q ss_pred HHHHHhCCCCCCCCch-----HHHHHHHhhccccccccCChHHHHHHHHhcCCCCCCCCC---hhhhhcCcccccccc
Q 003644 604 LFFCITGGKHPYGESF-----ERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPK---AQNVLNHPFFWTADT 673 (805)
Q Consensus 604 l~elltG~~~Pf~~~~-----~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dP~~Rps---~~ell~Hpff~~~~~ 673 (805)
+|||++| ..||.... ..............+....+++.+++.+||+.||++||| +.++++||||...++
T Consensus 198 l~el~tg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~~ 274 (288)
T cd05583 198 TFELLTG-ASPFTVDGEQNSQSEISRRILKSKPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGIDW 274 (288)
T ss_pred HHHHHhC-CCCcccCcccchHHHHHHHHHccCCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccCCH
Confidence 9999996 77775321 111111111222233445678999999999999999998 467799999976543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-33 Score=299.70 Aligned_cols=249 Identities=18% Similarity=0.230 Sum_probs=175.4
Q ss_pred cccceEEEeEeeccCCceEEEEEEeeC----CcEEEEEEeecCCchH-----H------HHHHH--HHHHhCCCCCeeee
Q 003644 373 RIGKLVVFNKEIAKGSNGTVVLEGNYE----GRSVAVKRLVKTHHDV-----A------LKEIQ--NLIASDQHPNIVRW 435 (805)
Q Consensus 373 ~i~~~~~~~~~LG~GsfGtVy~a~~~~----g~~VAVK~l~~~~~~~-----~------~~Ei~--~ll~~l~HpNIV~l 435 (805)
..++.|.+.+.||+|+||+||++...+ +..+|+|......... . ..++. ..+..+.|+||+++
T Consensus 9 i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~ 88 (294)
T PHA02882 9 ITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKY 88 (294)
T ss_pred cCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcE
Confidence 445779999999999999999986544 4566777543221110 0 01111 12345789999999
Q ss_pred cccccCCc----eEEEecccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHH
Q 003644 436 YGVESDQD----FVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQL 511 (805)
Q Consensus 436 ~g~~~~~~----~l~LV~E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 511 (805)
++++.... ..++++|++..++.+++. .....++..+
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------------------------------------~~~~~~~~~~ 128 (294)
T PHA02882 89 YGCGSFKRCRMYYRFILLEKLVENTKEIFK----------------------------------------RIKCKNKKLI 128 (294)
T ss_pred EEeeeEecCCceEEEEEEehhccCHHHHHH----------------------------------------hhccCCHHHH
Confidence 98765543 457788865544433320 0012355677
Q ss_pred HHHHHHHHHHHHHhhhcceeccCCCCceEEecCCCCceEEEeccCccccccCCCccc----cccccccCCCCCCChhhhh
Q 003644 512 LKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCL----TQNATGYGSSGWQAPEQLL 587 (805)
Q Consensus 512 ~~i~~qIa~gL~yLH~~~IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~----~~~~~~~gt~~y~APE~l~ 587 (805)
+.|+.|++.||+|||+.+|+||||||+|||++.++. ++|+|||+++......... .......||+.|+|||+..
T Consensus 129 ~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~--~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~ 206 (294)
T PHA02882 129 KNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNR--GYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHN 206 (294)
T ss_pred HHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCc--EEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhC
Confidence 899999999999999999999999999999987765 8999999998764321111 1112346999999999999
Q ss_pred cCCCCCcchHHHHHHHHHHHHhCCCCCCCCchH--HHH-----HHHhh--ccccccccCChHHHHHHHHhcCCCCCCCCC
Q 003644 588 QGRQTRAIDLFSLGCILFFCITGGKHPYGESFE--RDA-----NIVKD--RKDLFLVEHIPEAVDLFTRLLDPNPDLRPK 658 (805)
Q Consensus 588 ~~~~t~~sDVwSlGvil~elltG~~~Pf~~~~~--~~~-----~~~~~--~~~~~~~~~~~~~~dLi~~~L~~dP~~Rps 658 (805)
+..++.++|||||||++|||++| .+||..... ... ..... ..........+++.++++.|+..+|++||+
T Consensus 207 ~~~~~~~~DiwSlG~~l~el~~g-~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~rp~ 285 (294)
T PHA02882 207 GACVTRRGDLESLGYCMLKWAGI-KLPWKGFGHNGNLIHAAKCDFIKRLHEGKIKIKNANKFIYDFIECVTKLSYEEKPD 285 (294)
T ss_pred CCCCCcHHHHHHHHHHHHHHHhC-CCCCCccccchHHHHHhHHHHHHHhhhhhhccCCCCHHHHHHHHHHHhCCCCCCCC
Confidence 99999999999999999999997 889865421 111 11111 011123344678999999999999999999
Q ss_pred hhhhhc
Q 003644 659 AQNVLN 664 (805)
Q Consensus 659 ~~ell~ 664 (805)
++++++
T Consensus 286 ~~~l~~ 291 (294)
T PHA02882 286 YDALIK 291 (294)
T ss_pred HHHHHH
Confidence 999874
|
|
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-33 Score=295.16 Aligned_cols=243 Identities=23% Similarity=0.309 Sum_probs=176.3
Q ss_pred eeccCCceEEEEEEee---CCcEEEEEEeecCCc----hHHHHHHHHHHHhCCCCCeeeecccccCCceEEEecccccCC
Q 003644 383 EIAKGSNGTVVLEGNY---EGRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCS 455 (805)
Q Consensus 383 ~LG~GsfGtVy~a~~~---~g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~E~~~~s 455 (805)
.||+|+||.||++... ++..+|+|++..... ....+|+ .++..++||||+++++++.+....++|||
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~-~~l~~l~h~~iv~~~~~~~~~~~~~lv~e----- 75 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEA-QPYRSLQHSNLLQCLGQCTEVTPYLLVME----- 75 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHH-HHHHhCCCCCEeeEEEEEcCCCCcEEEEE-----
Confidence 5899999999998543 346799999865432 1333454 47788999999999999999999999999
Q ss_pred hhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcceeccCC
Q 003644 456 LNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDL 535 (805)
Q Consensus 456 L~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~IvHrDL 535 (805)
|+.+|+|.++++..... .....++..++.++.|++.||+|||+.+++||||
T Consensus 76 -----~~~~g~L~~~l~~~~~~------------------------~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl 126 (269)
T cd05087 76 -----FCPLGDLKGYLRSCRKA------------------------ELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDL 126 (269)
T ss_pred -----CCCCCcHHHHHHHhhhc------------------------ccccccHHHHHHHHHHHHHHHHHHHHCCEecccc
Confidence 55666666665432210 0112345667889999999999999999999999
Q ss_pred CCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcC-------CCCCcchHHHHHHHHHHHH
Q 003644 536 KPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG-------RQTRAIDLFSLGCILFFCI 608 (805)
Q Consensus 536 Kp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-------~~t~~sDVwSlGvil~ell 608 (805)
||+||+++.++. +||+|||+++........ .......|+..|+|||++... .++.++|+|||||++|||+
T Consensus 127 kp~nil~~~~~~--~kL~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~ 203 (269)
T cd05087 127 ALRNCLLTADLT--VKIGDYGLSHNKYKEDYY-VTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELF 203 (269)
T ss_pred CcceEEEcCCCc--EEECCccccccccCccee-ecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHH
Confidence 999999987765 899999998754432111 112234578899999998642 3578999999999999999
Q ss_pred hCCCCCCCCchHHHH--HHHhhccc-----cccccCChHHHHHHHHhcCCCCCCCCChhhhhc
Q 003644 609 TGGKHPYGESFERDA--NIVKDRKD-----LFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 664 (805)
Q Consensus 609 tG~~~Pf~~~~~~~~--~~~~~~~~-----~~~~~~~~~~~dLi~~~L~~dP~~Rps~~ell~ 664 (805)
+.|.+||......+. ..+..... .......+.+.+++.+|+ .+|++|||++||+.
T Consensus 204 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~ 265 (269)
T cd05087 204 ELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHL 265 (269)
T ss_pred hCCCCCCCCCChHHHHHHHhhcccCCCCCCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence 734788865433322 11111111 111124567889999998 68999999999973
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=293.12 Aligned_cols=228 Identities=25% Similarity=0.268 Sum_probs=176.6
Q ss_pred CCceEEEEEE-eeCCcEEEEEEeecCCchHHHHHHHHHHHhCCCCCeeeecccccCCceEEEecccccCChhhHHHHhcC
Q 003644 387 GSNGTVVLEG-NYEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSG 465 (805)
Q Consensus 387 GsfGtVy~a~-~~~g~~VAVK~l~~~~~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~E~~~~sL~d~iy~~~G 465 (805)
|.+|+||++. ..+|+.||+|++.... ...+|.. .+....||||+++++++.+.+..|+||| |+.+|
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~--~~~~~~~-~~~~~~~~~i~~~~~~~~~~~~~~lv~e----------~~~~~ 70 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS--EYSRERL-TIIPHCVPNMVCLHKYIVSEDSVFLVLQ----------HAEGG 70 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh--hhhhHHH-HHHhcCCCceeehhhheecCCeEEEEEe----------cCCCC
Confidence 8999999985 4578999999997643 2223333 3344569999999999999999999999 55666
Q ss_pred CHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCCCceEEecCC
Q 003644 466 SFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKD 545 (805)
Q Consensus 466 sL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~IvHrDLKp~NILl~~~ 545 (805)
+|.+++.. ...+++..+..++.|++.||+|||+.+|+||||||+||+++.+
T Consensus 71 ~L~~~l~~-----------------------------~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~ 121 (237)
T cd05576 71 KLWSHISK-----------------------------FLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDR 121 (237)
T ss_pred CHHHHHHH-----------------------------hcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCC
Confidence 66665422 1236778889999999999999999999999999999999888
Q ss_pred CCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHH
Q 003644 546 KSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERDANI 625 (805)
Q Consensus 546 ~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~elltG~~~Pf~~~~~~~~~~ 625 (805)
+. ++++|||++...... .....++..|+|||.+....++.++|+||+||++|||++| ..|+.......
T Consensus 122 ~~--~~l~df~~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g-~~~~~~~~~~~--- 189 (237)
T cd05576 122 GH--IQLTYFSRWSEVEDS------CDGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTG-KTLVECHPSGI--- 189 (237)
T ss_pred CC--EEEecccchhccccc------cccCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHC-cchhhcCchhc---
Confidence 76 899999988765432 1223467789999999888899999999999999999997 55554322110
Q ss_pred HhhccccccccCChHHHHHHHHhcCCCCCCCCCh-----hhhhcCccc
Q 003644 626 VKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKA-----QNVLNHPFF 668 (805)
Q Consensus 626 ~~~~~~~~~~~~~~~~~dLi~~~L~~dP~~Rps~-----~ell~Hpff 668 (805)
........+...+++++++|.+||+.||++||++ +++++||||
T Consensus 190 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h~~~ 237 (237)
T cd05576 190 NTHTTLNIPEWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF 237 (237)
T ss_pred ccccccCCcccCCHHHHHHHHHHccCCHHHhcCCCccchHHHHcCCCC
Confidence 0001111233456789999999999999999996 899999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=294.30 Aligned_cols=248 Identities=24% Similarity=0.375 Sum_probs=186.8
Q ss_pred EEEeEeeccCCceEEEEEEee-CCcEEEEEEeecC--------CchHHHHHHHHHHHhCCCCCeeeecccccCCceEEEe
Q 003644 378 VVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKT--------HHDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLS 448 (805)
Q Consensus 378 ~~~~~~LG~GsfGtVy~a~~~-~g~~VAVK~l~~~--------~~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV 448 (805)
|.+.+.||+|+||+||++... .+..+++|.++.. ....+..|.. +++.++||||+++++++.+.+..++|
T Consensus 2 y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 2 YILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQ-LLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred ceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHH-HHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 677889999999999997544 3455666665421 1123344554 67888999999999999999999999
Q ss_pred cccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhc
Q 003644 449 LERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI 528 (805)
Q Consensus 449 ~E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~ 528 (805)
+| |+.+++|.+.+.... .....+++..++.++.|++.||+|||+.
T Consensus 81 ~e----------~~~~~~l~~~~~~~~-------------------------~~~~~~~~~~~~~~~~~l~~~l~~lH~~ 125 (260)
T cd08222 81 TE----------YCEGRDLDCKLEELK-------------------------HTGKTLSENQVCEWFIQLLLGVHYMHQR 125 (260)
T ss_pred EE----------eCCCCCHHHHHHHHh-------------------------hcccccCHHHHHHHHHHHHHHHHHHHHc
Confidence 99 555555555543211 1123477888999999999999999999
Q ss_pred ceeccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHHHHH
Q 003644 529 GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCI 608 (805)
Q Consensus 529 ~IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~ell 608 (805)
+++|+||||+||+++.+ .++|+|||+++....... ......|++.|+|||.+....++.++|+||||+++|+|+
T Consensus 126 ~i~h~~l~~~nili~~~---~~~l~d~g~~~~~~~~~~---~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~ 199 (260)
T cd08222 126 RILHRDLKAKNIFLKNN---LLKIGDFGVSRLLMGSCD---LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMC 199 (260)
T ss_pred CccccCCChhheEeecC---CEeecccCceeecCCCcc---cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHH
Confidence 99999999999999643 389999999887643321 122345788999999998888899999999999999999
Q ss_pred hCCCCCCCCchHHH--HHHHhhccccccccCChHHHHHHHHhcCCCCCCCCChhhhhcCccc
Q 003644 609 TGGKHPYGESFERD--ANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 668 (805)
Q Consensus 609 tG~~~Pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dP~~Rps~~ell~Hpff 668 (805)
+| ..||....... ..+........+...++++.++|.+||+.||++||++.|+++||||
T Consensus 200 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 200 CL-AHAFEGQNFLSVVLRIVEGPTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred hC-CCCCCCccHHHHHHHHHcCCCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence 97 66775432221 1222222222334456799999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-33 Score=292.43 Aligned_cols=242 Identities=24% Similarity=0.313 Sum_probs=182.9
Q ss_pred EeeccCCceEEEEEEeeC--C--cEEEEEEeecCCc----hHHHHHHHHHHHhCCCCCeeeecccccCCceEEEeccccc
Q 003644 382 KEIAKGSNGTVVLEGNYE--G--RSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCT 453 (805)
Q Consensus 382 ~~LG~GsfGtVy~a~~~~--g--~~VAVK~l~~~~~----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~E~~~ 453 (805)
+.||+|++|+||++...+ + ..||||.+..... ....+|+. .++.++||||+++++++.+ ...++|||
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~-~l~~l~h~~iv~~~~~~~~-~~~~~v~e--- 75 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAA-IMHSLDHENLIRLYGVVLT-HPLMMVTE--- 75 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHH-HHhhcCCCCccceeEEEcC-CeEEEEEE---
Confidence 358999999999986543 3 3699999976543 12334554 6788899999999999988 88999999
Q ss_pred CChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcceecc
Q 003644 454 CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHR 533 (805)
Q Consensus 454 ~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~IvHr 533 (805)
|..+|+|.+++.... ...+++..+..++.|++.||+|||+.+++||
T Consensus 76 -------~~~~~~L~~~l~~~~---------------------------~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~ 121 (257)
T cd05040 76 -------LAPLGSLLDRLRKDA---------------------------LGHFLISTLCDYAVQIANGMRYLESKRFIHR 121 (257)
T ss_pred -------ecCCCcHHHHHHhcc---------------------------cccCcHHHHHHHHHHHHHHHHHHHhCCcccc
Confidence 455556655543211 0235677889999999999999999999999
Q ss_pred CCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHHHHHhCCCC
Q 003644 534 DLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKH 613 (805)
Q Consensus 534 DLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~elltG~~~ 613 (805)
||||+||+++.++. +||+|||+++.+..............++..|+|||++....++.++|||||||++|||++.|..
T Consensus 122 di~p~nil~~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~ 199 (257)
T cd05040 122 DLAARNILLASDDK--VKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEE 199 (257)
T ss_pred ccCcccEEEecCCE--EEeccccccccccccccceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCC
Confidence 99999999988765 8999999998875432222222234578899999999988999999999999999999994477
Q ss_pred CCCCchHHH-HHHHh-hc-cccccccCChHHHHHHHHhcCCCCCCCCChhhhhc
Q 003644 614 PYGESFERD-ANIVK-DR-KDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 664 (805)
Q Consensus 614 Pf~~~~~~~-~~~~~-~~-~~~~~~~~~~~~~dLi~~~L~~dP~~Rps~~ell~ 664 (805)
||......+ ...+. .. ....+...+.++.+++.+||+.+|++||++.++++
T Consensus 200 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 253 (257)
T cd05040 200 PWAGLSGSQILKKIDKEGERLERPEACPQDIYNVMLQCWAHNPADRPTFAALRE 253 (257)
T ss_pred CCCCCCHHHHHHHHHhcCCcCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHH
Confidence 886433222 11111 11 11122344578999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-33 Score=295.16 Aligned_cols=242 Identities=23% Similarity=0.381 Sum_probs=174.7
Q ss_pred eeccCCceEEEEEEeeCCc---EEEEEEeecCCc----hHHHHHHHHHHHhCCCCCeeeecccccCCceEEEecccccCC
Q 003644 383 EIAKGSNGTVVLEGNYEGR---SVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCS 455 (805)
Q Consensus 383 ~LG~GsfGtVy~a~~~~g~---~VAVK~l~~~~~----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~E~~~~s 455 (805)
+||+|+||+||++...++. .+++|.+..... ....+|+ .++..++||||++++++|.+....|+|||
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~-~~~~~l~h~~iv~~~~~~~~~~~~~lv~e----- 75 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQG-DPYRILQHPNILQCLGQCVEAIPYLLVFE----- 75 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHH-HHHhccCCcchhheEEEecCCCccEEEEe-----
Confidence 5999999999998655543 456676654322 2334444 46678899999999999999999999999
Q ss_pred hhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcceeccCC
Q 003644 456 LNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDL 535 (805)
Q Consensus 456 L~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~IvHrDL 535 (805)
|+.+|+|.++++... +.....++..++.++.||+.||+|||+.+++||||
T Consensus 76 -----~~~~~~L~~~l~~~~-------------------------~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~di 125 (268)
T cd05086 76 -----YCELGDLKSYLSQEQ-------------------------WHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDL 125 (268)
T ss_pred -----cCCCCcHHHHHHhhh-------------------------cccccccHHHHHHHHHHHHHHHHHHHHCCeeccCC
Confidence 555666666654321 11122455667899999999999999999999999
Q ss_pred CCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhc-------CCCCCcchHHHHHHHHHHHH
Q 003644 536 KPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ-------GRQTRAIDLFSLGCILFFCI 608 (805)
Q Consensus 536 Kp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~-------~~~t~~sDVwSlGvil~ell 608 (805)
||+|||++.++. +||+|||++....... .........++..|+|||++.. ..++.++|||||||++|||+
T Consensus 126 kp~nil~~~~~~--~~l~Dfg~~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~ 202 (268)
T cd05086 126 ALRNCFLTSDLT--VKVGDYGIGPSRYKED-YIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELF 202 (268)
T ss_pred ccceEEEcCCcc--EEecccccccccCcch-hhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHH
Confidence 999999987765 8999999986432211 1112233468899999999853 23578999999999999999
Q ss_pred hCCCCCCCCchHHH--HHHHhhcc-----ccccccCChHHHHHHHHhcCCCCCCCCChhhhhc
Q 003644 609 TGGKHPYGESFERD--ANIVKDRK-----DLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 664 (805)
Q Consensus 609 tG~~~Pf~~~~~~~--~~~~~~~~-----~~~~~~~~~~~~dLi~~~L~~dP~~Rps~~ell~ 664 (805)
+++.+||....... ..+..... ........+.+.+++..|| .+|++||+++++++
T Consensus 203 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~ 264 (268)
T cd05086 203 ENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELPYSERWYEVLQFCW-LSPEKRATAEEVHR 264 (268)
T ss_pred hCCCCCCCCCCHHHHHHHHHhhcccccCCCccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence 98788886543322 12222211 1112234578889999999 67999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-33 Score=293.84 Aligned_cols=247 Identities=25% Similarity=0.357 Sum_probs=184.2
Q ss_pred eEEEeEeeccCCceEEEEEEee-CC---cEEEEEEeecCCch----HHHHHHHHHHHhCCCCCeeeecccccCCceEEEe
Q 003644 377 LVVFNKEIAKGSNGTVVLEGNY-EG---RSVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVRWYGVESDQDFVYLS 448 (805)
Q Consensus 377 ~~~~~~~LG~GsfGtVy~a~~~-~g---~~VAVK~l~~~~~~----~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV 448 (805)
.+.+.+.||+|+||.||+|... ++ ..||||.+...... ....|+. +++.++||||+++++++.+++..++|
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~-~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEAS-IMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHH-HHHhCCCcCcceEEEEECCCCceEEE
Confidence 4678899999999999998654 33 36999998754322 2334544 67788999999999999999999999
Q ss_pred cccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhc
Q 003644 449 LERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI 528 (805)
Q Consensus 449 ~E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~ 528 (805)
|| |..+|+|.+++... ...+++.+++.++.|++.||+|||+.
T Consensus 84 ~e----------~~~~~~L~~~l~~~----------------------------~~~~~~~~~~~i~~~l~~al~~lH~~ 125 (269)
T cd05065 84 TE----------FMENGALDSFLRQN----------------------------DGQFTVIQLVGMLRGIAAGMKYLSEM 125 (269)
T ss_pred Ee----------cCCCCcHHHHHhhC----------------------------CCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 99 55555665554321 12356778899999999999999999
Q ss_pred ceeccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccc--cCCCCCCChhhhhcCCCCCcchHHHHHHHHHH
Q 003644 529 GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATG--YGSSGWQAPEQLLQGRQTRAIDLFSLGCILFF 606 (805)
Q Consensus 529 ~IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~--~gt~~y~APE~l~~~~~t~~sDVwSlGvil~e 606 (805)
|++||||||+||+++.++. +||+|||++................ ..+..|+|||++....++.++|||||||++||
T Consensus 126 g~~H~dl~p~nili~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e 203 (269)
T cd05065 126 NYVHRDLAARNILVNSNLV--CKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWE 203 (269)
T ss_pred CEeecccChheEEEcCCCc--EEECCCccccccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHH
Confidence 9999999999999976654 8999999987665332211111111 12457999999998899999999999999999
Q ss_pred HHhCCCCCCCCchHH-HHHHHhh-ccccccccCChHHHHHHHHhcCCCCCCCCChhhhhc
Q 003644 607 CITGGKHPYGESFER-DANIVKD-RKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 664 (805)
Q Consensus 607 lltG~~~Pf~~~~~~-~~~~~~~-~~~~~~~~~~~~~~dLi~~~L~~dP~~Rps~~ell~ 664 (805)
+++.+.+||...... ....+.. .....+...++++.+++.+||+.+|.+||++.+++.
T Consensus 204 ~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 263 (269)
T cd05065 204 VMSYGERPYWDMSNQDVINAIEQDYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVS 263 (269)
T ss_pred HhcCCCCCCCCCCHHHHHHHHHcCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 987446777654332 2222221 122223445678999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-33 Score=290.56 Aligned_cols=244 Identities=26% Similarity=0.403 Sum_probs=187.7
Q ss_pred EEeEeeccCCceEEEEEEeeC-----CcEEEEEEeecCCc----hHHHHHHHHHHHhCCCCCeeeecccccCCceEEEec
Q 003644 379 VFNKEIAKGSNGTVVLEGNYE-----GRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSL 449 (805)
Q Consensus 379 ~~~~~LG~GsfGtVy~a~~~~-----g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~ 449 (805)
.+.+.||.|+||.||++.... +..||+|.+..... .....|+. ++..++||||+++++++.+.+..|++|
T Consensus 2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~-~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREAR-IMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHH-HHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 355789999999999986543 48899999975542 23344554 566779999999999999999999999
Q ss_pred ccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcc
Q 003644 450 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG 529 (805)
Q Consensus 450 E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~ 529 (805)
| |.++++|.+++..... ..+++..+..++.|++.||+|||+.+
T Consensus 81 e----------~~~~~~l~~~~~~~~~---------------------------~~~~~~~~~~~~~ql~~~l~~lh~~~ 123 (258)
T smart00219 81 E----------YMEGGDLLDYLRKNRP---------------------------KELSLSDLLSFALQIARGMEYLESKN 123 (258)
T ss_pred e----------ccCCCCHHHHHHhhhh---------------------------ccCCHHHHHHHHHHHHHHHHHHhcCC
Confidence 9 5555666655432211 11677888999999999999999999
Q ss_pred eeccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHHHHHh
Q 003644 530 LIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCIT 609 (805)
Q Consensus 530 IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~ellt 609 (805)
++||||||+||+++.++. ++|+|||+++.......... ....+++.|+|||.+....++.++|||||||++|+|++
T Consensus 124 ~~h~dl~~~nil~~~~~~--~~l~dfg~~~~~~~~~~~~~--~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~ 199 (258)
T smart00219 124 FIHRDLAARNCLVGENLV--VKISDFGLSRDLYDDDYYKK--KGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFT 199 (258)
T ss_pred eeecccccceEEEccCCe--EEEcccCCceeccccccccc--ccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHh
Confidence 999999999999988765 89999999987764322111 12237889999999988889999999999999999999
Q ss_pred CCCCCCCCchHHH-H-HHHhhccccccccCChHHHHHHHHhcCCCCCCCCChhhhhc
Q 003644 610 GGKHPYGESFERD-A-NIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 664 (805)
Q Consensus 610 G~~~Pf~~~~~~~-~-~~~~~~~~~~~~~~~~~~~dLi~~~L~~dP~~Rps~~ell~ 664 (805)
++.+||....... . .+........+...+.++.+++.+||..||++|||+.++++
T Consensus 200 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 200 LGESPYPGMSNEEVLEYLKKGYRLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVE 256 (258)
T ss_pred CCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHh
Confidence 7688887533222 2 22222222333445678999999999999999999999985
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-33 Score=300.45 Aligned_cols=258 Identities=24% Similarity=0.328 Sum_probs=185.7
Q ss_pred ceEEEeEeeccCCceEEEEEEeeC---------------CcEEEEEEeecCCc----hHHHHHHHHHHHhCCCCCeeeec
Q 003644 376 KLVVFNKEIAKGSNGTVVLEGNYE---------------GRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWY 436 (805)
Q Consensus 376 ~~~~~~~~LG~GsfGtVy~a~~~~---------------g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l~HpNIV~l~ 436 (805)
.+|.+.+.||+|+||.||++.... ...||||.+..... ....+|+. ++..++||||++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~-~l~~l~h~~i~~~~ 83 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIK-IMSRLKNPNIIRLL 83 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHH-HHHhCCCCCcCeEE
Confidence 357788999999999999864321 23589999865422 23345655 77889999999999
Q ss_pred ccccCCceEEEecccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHH
Q 003644 437 GVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTR 516 (805)
Q Consensus 437 g~~~~~~~l~LV~E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~ 516 (805)
+++...+..|+||| |+.+++|.+++........ .. .......+++..++.++.
T Consensus 84 ~~~~~~~~~~lv~e----------~~~~~~L~~~l~~~~~~~~-~~----------------~~~~~~~~~~~~~~~i~~ 136 (295)
T cd05097 84 GVCVSDDPLCMITE----------YMENGDLNQFLSQREIEST-FT----------------HANNIPSVSIANLLYMAV 136 (295)
T ss_pred EEEcCCCccEEEEe----------cCCCCcHHHHHHhcccccc-cc----------------ccccCCcccHHHHHHHHH
Confidence 99999999999999 5555666665543211000 00 001112357788899999
Q ss_pred HHHHHHHHhhhcceeccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcch
Q 003644 517 DIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAID 596 (805)
Q Consensus 517 qIa~gL~yLH~~~IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sD 596 (805)
|++.||+|||+.+++||||||+||+++.++. +||+|||++........ ........++..|+|||++..+.++.++|
T Consensus 137 ~i~~al~~lH~~~i~H~dlkp~Nill~~~~~--~kl~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~D 213 (295)
T cd05097 137 QIASGMKYLASLNFVHRDLATRNCLVGNHYT--IKIADFGMSRNLYSGDY-YRIQGRAVLPIRWMAWESILLGKFTTASD 213 (295)
T ss_pred HHHHHHHHHHhcCeeccccChhhEEEcCCCc--EEecccccccccccCcc-eeccCcCcCceeecChhhhccCCcCchhh
Confidence 9999999999999999999999999987765 89999999976543211 11122234577899999999889999999
Q ss_pred HHHHHHHHHHHHhC-CCCCCCCchHHH-H-HHHh---h--c--cccccccCChHHHHHHHHhcCCCCCCCCChhhhhc
Q 003644 597 LFSLGCILFFCITG-GKHPYGESFERD-A-NIVK---D--R--KDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 664 (805)
Q Consensus 597 VwSlGvil~elltG-~~~Pf~~~~~~~-~-~~~~---~--~--~~~~~~~~~~~~~dLi~~~L~~dP~~Rps~~ell~ 664 (805)
||||||++|+|+++ +..||....... . .... . . ........++.+.+++.+||+.||++||++.++++
T Consensus 214 vwSlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 291 (295)
T cd05097 214 VWAFGVTLWEMFTLCKEQPYSLLSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH 291 (295)
T ss_pred HHHHHHHHHHHHHcCCCCCCcccChHHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 99999999999984 356776533221 1 1111 0 0 11112234578999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-33 Score=294.42 Aligned_cols=244 Identities=30% Similarity=0.481 Sum_probs=186.7
Q ss_pred EEeEeeccCCceEEEEEEee-CCcEEEEEEeecCC-----chHHHHHHHHHHHhCCCCCeeeecccccCCceEEEecccc
Q 003644 379 VFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERC 452 (805)
Q Consensus 379 ~~~~~LG~GsfGtVy~a~~~-~g~~VAVK~l~~~~-----~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~E~~ 452 (805)
.+.+.||+|++|.||++... +++.||+|.+.... ......|+. .++.++||||+++++++.+.+..++|+|++
T Consensus 2 ~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~-~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 2 EKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREIS-LLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred eeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHH-HHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 45578999999999998655 58999999987542 123445654 667788999999999999999999999977
Q ss_pred cCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcceec
Q 003644 453 TCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIH 532 (805)
Q Consensus 453 ~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~IvH 532 (805)
.++|.+++... ...+++..+..++.|++.||+|||+.+|+|
T Consensus 81 ~~~l~~~i~~~---------------------------------------~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H 121 (282)
T cd07829 81 DMDLKKYLDKR---------------------------------------PGPLSPNLIKSIMYQLLRGLAYCHSHRILH 121 (282)
T ss_pred CcCHHHHHHhh---------------------------------------ccCCCHHHHHHHHHHHHHHHHHHHHCCccc
Confidence 76666555211 023567788999999999999999999999
Q ss_pred cCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcC-CCCCcchHHHHHHHHHHHHhCC
Q 003644 533 RDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG-RQTRAIDLFSLGCILFFCITGG 611 (805)
Q Consensus 533 rDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~t~~sDVwSlGvil~elltG~ 611 (805)
|||+|+||+++.++. ++|+|||+++....... ......++..|+|||.+... .++.++|||||||++||+++|
T Consensus 122 ~~l~~~ni~~~~~~~--~~l~d~g~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~- 195 (282)
T cd07829 122 RDLKPQNILINRDGV--LKLADFGLARAFGIPLR---TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITG- 195 (282)
T ss_pred CCCChheEEEcCCCC--EEEecCCcccccCCCcc---ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhC-
Confidence 999999999987765 89999999987653321 12223467889999998776 789999999999999999997
Q ss_pred CCCCCCchHHHH--HHHhh--------------c---c---c--------cccccCChHHHHHHHHhcCCCCCCCCChhh
Q 003644 612 KHPYGESFERDA--NIVKD--------------R---K---D--------LFLVEHIPEAVDLFTRLLDPNPDLRPKAQN 661 (805)
Q Consensus 612 ~~Pf~~~~~~~~--~~~~~--------------~---~---~--------~~~~~~~~~~~dLi~~~L~~dP~~Rps~~e 661 (805)
.+||........ .+... . . . .......+++.++|.+||+.||++||++++
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ 275 (282)
T cd07829 196 KPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKE 275 (282)
T ss_pred CCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHH
Confidence 778765432110 00000 0 0 0 001122467999999999999999999999
Q ss_pred hhcCccc
Q 003644 662 VLNHPFF 668 (805)
Q Consensus 662 ll~Hpff 668 (805)
+++||||
T Consensus 276 ~l~~p~~ 282 (282)
T cd07829 276 ALKHPYF 282 (282)
T ss_pred HhhCcCC
Confidence 9999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=288.13 Aligned_cols=251 Identities=25% Similarity=0.415 Sum_probs=189.3
Q ss_pred EeeccCCceEEEEEEe-eCCcEEEEEEeec-----CCchHHHHHHHHHHHhCCCCCeeeecccccCC--------ceEEE
Q 003644 382 KEIAKGSNGTVVLEGN-YEGRSVAVKRLVK-----THHDVALKEIQNLIASDQHPNIVRWYGVESDQ--------DFVYL 447 (805)
Q Consensus 382 ~~LG~GsfGtVy~a~~-~~g~~VAVK~l~~-----~~~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~--------~~l~L 447 (805)
.+||+|.||.|++|+. .+|+.||+|+..- .....+++|+. ++..+.|+|++.++..|... ..+||
T Consensus 23 ~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreik-iL~~lkHenv~nliEic~tk~Tp~~r~r~t~yl 101 (376)
T KOG0669|consen 23 AKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIK-ILQLLKHENVVNLIEICRTKATPTNRDRATFYL 101 (376)
T ss_pred HhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHH-HHHHhcchhHHHHHHHHhhccCCcccccceeee
Confidence 4699999999999854 4688899987632 23457888987 77889999999999988543 45899
Q ss_pred ecccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhh
Q 003644 448 SLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE 527 (805)
Q Consensus 448 V~E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~ 527 (805)
||++|+.+|.-++-. ....++..++.+++.++..||.|+|.
T Consensus 102 Vf~~cehDLaGlLsn---------------------------------------~~vr~sls~Ikk~Mk~Lm~GL~~iHr 142 (376)
T KOG0669|consen 102 VFDFCEHDLAGLLSN---------------------------------------RKVRFSLSEIKKVMKGLMNGLYYIHR 142 (376)
T ss_pred eHHHhhhhHHHHhcC---------------------------------------ccccccHHHHHHHHHHHHHHHHHHHH
Confidence 999999877665511 11235667889999999999999999
Q ss_pred cceeccCCCCceEEecCCCCceEEEeccCccccccCCCc-cccccccccCCCCCCChhhhhcC-CCCCcchHHHHHHHHH
Q 003644 528 IGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMS-CLTQNATGYGSSGWQAPEQLLQG-RQTRAIDLFSLGCILF 605 (805)
Q Consensus 528 ~~IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~-~~~~~~~~~gt~~y~APE~l~~~-~~t~~sDVwSlGvil~ 605 (805)
..|+|||+||+|+||+.+|. +||+|||+++.+..... ....-..++-|..|.+||.+.+. .|+.+.|||+.|||+.
T Consensus 143 ~kilHRDmKaaNvLIt~dgi--lklADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCima 220 (376)
T KOG0669|consen 143 NKILHRDMKAANVLITKDGI--LKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMA 220 (376)
T ss_pred hhHHhhcccHhhEEEcCCce--EEeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHH
Confidence 99999999999999988876 88999999976653222 11222334569999999999874 5899999999999999
Q ss_pred HHHhCCCCCCCC-chHHHHHHHhhcc-----c----------------c-c-------------cccCChHHHHHHHHhc
Q 003644 606 FCITGGKHPYGE-SFERDANIVKDRK-----D----------------L-F-------------LVEHIPEAVDLFTRLL 649 (805)
Q Consensus 606 elltG~~~Pf~~-~~~~~~~~~~~~~-----~----------------~-~-------------~~~~~~~~~dLi~~~L 649 (805)
||.|+ .|-+.. ....+...+...- . . . +--..+++.||+.+||
T Consensus 221 eMwtr-spimqgnteqqql~~Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll 299 (376)
T KOG0669|consen 221 EMWTR-SPIMQGNTEQQQLHLISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLL 299 (376)
T ss_pred HHHcc-CccccCChHHHHHHHHHHHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHh
Confidence 99997 444433 3222221111000 0 0 0 0001258999999999
Q ss_pred CCCCCCCCChhhhhcCccccccccch
Q 003644 650 DPNPDLRPKAQNVLNHPFFWTADTRL 675 (805)
Q Consensus 650 ~~dP~~Rps~~ell~Hpff~~~~~~~ 675 (805)
..||.+|++++++++|.|||......
T Consensus 300 ~~DP~kR~~ad~alnh~~F~kdp~pq 325 (376)
T KOG0669|consen 300 KLDPTKRIDADQALNHDFFWKDPMPQ 325 (376)
T ss_pred ccCcccCcchHhhhchhhhhcCCcch
Confidence 99999999999999999999866543
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-33 Score=301.49 Aligned_cols=243 Identities=26% Similarity=0.372 Sum_probs=186.1
Q ss_pred EEEeEeeccCCceEEEEEEe-eCCcEEEEEEeecCC--c----hHHHHHHHHHHHhCCCCCeeeecccccCCceEEEecc
Q 003644 378 VVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH--H----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 450 (805)
Q Consensus 378 ~~~~~~LG~GsfGtVy~a~~-~~g~~VAVK~l~~~~--~----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~E 450 (805)
|...+.||+|+||+||++.. .++..||||.+.... . ....+|+. +++.++|||++++++++.+.+..|+|||
T Consensus 17 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~lv~e 95 (308)
T cd06634 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVR-FLQKLRHPNTIQYRGCYLREHTAWLVME 95 (308)
T ss_pred HHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHH-HHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence 44557799999999999865 468899999986321 1 12345554 6788899999999999999999999999
Q ss_pred cccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcce
Q 003644 451 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 530 (805)
Q Consensus 451 ~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~I 530 (805)
||.++|.+++...+ ..+++..+..++.|++.||+|||+.++
T Consensus 96 ~~~~~l~~~~~~~~---------------------------------------~~l~~~~~~~~~~~l~~~l~~LH~~~i 136 (308)
T cd06634 96 YCLGSASDLLEVHK---------------------------------------KPLQEVEIAAVTHGALQGLAYLHSHNM 136 (308)
T ss_pred ccCCCHHHHHHHcC---------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCc
Confidence 87776655543211 224566778999999999999999999
Q ss_pred eccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhh---cCCCCCcchHHHHHHHHHHH
Q 003644 531 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLL---QGRQTRAIDLFSLGCILFFC 607 (805)
Q Consensus 531 vHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~---~~~~t~~sDVwSlGvil~el 607 (805)
+||||||+||+++.++. ++|+|||++...... ....|++.|+|||++. ...++.++|||||||++|+|
T Consensus 137 ~H~dl~p~nil~~~~~~--~kl~dfg~~~~~~~~-------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el 207 (308)
T cd06634 137 IHRDVKAGNILLSEPGL--VKLGDFGSASIMAPA-------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207 (308)
T ss_pred ccCCCCHHhEEECCCCc--EEECCcccceeecCc-------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHH
Confidence 99999999999987765 899999998765422 2345889999999985 34678899999999999999
Q ss_pred HhCCCCCCCCchHH-H-HHHHhhccc-cccccCChHHHHHHHHhcCCCCCCCCChhhhhcCccccc
Q 003644 608 ITGGKHPYGESFER-D-ANIVKDRKD-LFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWT 670 (805)
Q Consensus 608 ltG~~~Pf~~~~~~-~-~~~~~~~~~-~~~~~~~~~~~dLi~~~L~~dP~~Rps~~ell~Hpff~~ 670 (805)
++| ..||...... . ..+...... ......+..+.++|.+||+.+|.+||+++++++|||+..
T Consensus 208 ~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~ 272 (308)
T cd06634 208 AER-KPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 272 (308)
T ss_pred HcC-CCCCccccHHHHHHHHhhcCCCCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCccccc
Confidence 997 5566443221 1 122221111 112234568999999999999999999999999999854
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=301.21 Aligned_cols=247 Identities=24% Similarity=0.384 Sum_probs=187.1
Q ss_pred ccceEEEeEeeccCCceEEEEEE-eeCCcEEEEEEeecCC-----chHHHHHHHHHHHhCCCCCeeeecccccC-CceEE
Q 003644 374 IGKLVVFNKEIAKGSNGTVVLEG-NYEGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESD-QDFVY 446 (805)
Q Consensus 374 i~~~~~~~~~LG~GsfGtVy~a~-~~~g~~VAVK~l~~~~-----~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~-~~~l~ 446 (805)
+++.|.+.+.||+|+||.||++. ..+|+.||||++.+.. .....+|+. ++..++||||+++++++.. .+..|
T Consensus 8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~-~l~~l~hpniv~~~~~~~~~~~~~~ 86 (328)
T cd07856 8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELK-LLKHLRHENIISLSDIFISPLEDIY 86 (328)
T ss_pred cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHH-HHHhcCCCCeeeEeeeEecCCCcEE
Confidence 56778999999999999999985 4579999999885421 233445655 6788899999999998865 56789
Q ss_pred EecccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhh
Q 003644 447 LSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH 526 (805)
Q Consensus 447 LV~E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH 526 (805)
+++|++.++|.+++ . ...+++..+..++.|++.||+|||
T Consensus 87 lv~e~~~~~L~~~~-----------~------------------------------~~~~~~~~~~~~~~ql~~aL~~LH 125 (328)
T cd07856 87 FVTELLGTDLHRLL-----------T------------------------------SRPLEKQFIQYFLYQILRGLKYVH 125 (328)
T ss_pred EEeehhccCHHHHH-----------h------------------------------cCCCCHHHHHHHHHHHHHHHHHHH
Confidence 99996655444332 1 123556667889999999999999
Q ss_pred hcceeccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhc-CCCCCcchHHHHHHHHH
Q 003644 527 EIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ-GRQTRAIDLFSLGCILF 605 (805)
Q Consensus 527 ~~~IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~t~~sDVwSlGvil~ 605 (805)
+.+|+||||+|+||+++.++. ++|+|||++...... .....++..|+|||++.+ ..++.++|||||||++|
T Consensus 126 ~~~iiH~dl~p~Nili~~~~~--~~l~dfg~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~ 197 (328)
T cd07856 126 SAGVVHRDLKPSNILINENCD--LKICDFGLARIQDPQ------MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFA 197 (328)
T ss_pred hCCcccCCCCHHHEeECCCCC--EEeCccccccccCCC------cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHH
Confidence 999999999999999987765 899999998754321 123357889999998766 56899999999999999
Q ss_pred HHHhCCCCCCCCchHHHH-----H--------------------HHhhcc---c----cccccCChHHHHHHHHhcCCCC
Q 003644 606 FCITGGKHPYGESFERDA-----N--------------------IVKDRK---D----LFLVEHIPEAVDLFTRLLDPNP 653 (805)
Q Consensus 606 elltG~~~Pf~~~~~~~~-----~--------------------~~~~~~---~----~~~~~~~~~~~dLi~~~L~~dP 653 (805)
+|++| .+||........ . ...... . .......+++.++|.+||+.+|
T Consensus 198 el~tg-~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P 276 (328)
T cd07856 198 EMLEG-KPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDP 276 (328)
T ss_pred HHHhC-CCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCCh
Confidence 99997 778754322110 0 000000 0 0012245689999999999999
Q ss_pred CCCCChhhhhcCcccccc
Q 003644 654 DLRPKAQNVLNHPFFWTA 671 (805)
Q Consensus 654 ~~Rps~~ell~Hpff~~~ 671 (805)
++||++++++.||||...
T Consensus 277 ~~R~t~~ell~~~~~~~~ 294 (328)
T cd07856 277 QKRISAAEALAHPYLAPY 294 (328)
T ss_pred hhCCCHHHHhcCCccccc
Confidence 999999999999999543
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-33 Score=294.77 Aligned_cols=253 Identities=25% Similarity=0.334 Sum_probs=179.1
Q ss_pred eeccCCceEEEEEEeeC-Cc--EEEEEEeecCCc----hHHHHHHHHHHHhCCCCCeeeecccccCCceEEEecccccCC
Q 003644 383 EIAKGSNGTVVLEGNYE-GR--SVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCS 455 (805)
Q Consensus 383 ~LG~GsfGtVy~a~~~~-g~--~VAVK~l~~~~~----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~E~~~~s 455 (805)
.||+|+||.||++...+ +. .+|+|.++.... ....+|+..+.+..+||||+++++++...+..|+|||
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e----- 76 (270)
T cd05047 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIE----- 76 (270)
T ss_pred cCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEE-----
Confidence 58999999999986543 43 578898864322 2344566544343489999999999999999999999
Q ss_pred hhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcceeccCC
Q 003644 456 LNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDL 535 (805)
Q Consensus 456 L~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~IvHrDL 535 (805)
|.++|+|.++++.......... . ....-....+++..++.++.|++.||+|||+.+++||||
T Consensus 77 -----~~~~~~L~~~i~~~~~~~~~~~-~------------~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~di 138 (270)
T cd05047 77 -----YAPHGNLLDFLRKSRVLETDPA-F------------AIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDL 138 (270)
T ss_pred -----eCCCCcHHHHHHhccccccccc-c------------ccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccc
Confidence 5555566655543221000000 0 000011234778889999999999999999999999999
Q ss_pred CCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCCC
Q 003644 536 KPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY 615 (805)
Q Consensus 536 Kp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~elltG~~~Pf 615 (805)
||+|||++.++. +||+|||++...... ........+..|+|||++....++.++|||||||++|||++++.+||
T Consensus 139 kp~nili~~~~~--~kl~dfgl~~~~~~~----~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf 212 (270)
T cd05047 139 AARNILVGENYV--AKIADFGLSRGQEVY----VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPY 212 (270)
T ss_pred ccceEEEcCCCe--EEECCCCCccccchh----hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCc
Confidence 999999987764 899999998633211 11112234667999999988889999999999999999998457787
Q ss_pred CCchHHH-HHHHhhc-cccccccCChHHHHHHHHhcCCCCCCCCChhhhhc
Q 003644 616 GESFERD-ANIVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 664 (805)
Q Consensus 616 ~~~~~~~-~~~~~~~-~~~~~~~~~~~~~dLi~~~L~~dP~~Rps~~ell~ 664 (805)
....... ...+... ....+.....++.+++.+||..||.+||++.+++.
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (270)
T cd05047 213 CGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILV 263 (270)
T ss_pred cccCHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 5533222 2222221 11223345578999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-33 Score=298.13 Aligned_cols=243 Identities=26% Similarity=0.447 Sum_probs=187.1
Q ss_pred EeeccCCceEEEEEEe-eCCcEEEEEEeecCC---chHHHHHHHHHHHhCCCCCeeeecccccCCceEEEecccccCChh
Q 003644 382 KEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH---HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCSLN 457 (805)
Q Consensus 382 ~~LG~GsfGtVy~a~~-~~g~~VAVK~l~~~~---~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~E~~~~sL~ 457 (805)
..||+|+||.||++.. .+|+.||||++.... .....+|+. +++.++||||+++++++.+.+..|+||||+
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~-~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~----- 99 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVV-IMRDYQHENVVEMYNSYLVGDELWVVMEFL----- 99 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHH-HHHhcCCcchhheeeEEEeCCEEEEEEecC-----
Confidence 5699999999999855 578999999875322 123445665 678889999999999999999999999954
Q ss_pred hHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCCC
Q 003644 458 DLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKP 537 (805)
Q Consensus 458 d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~IvHrDLKp 537 (805)
.+++|.+++. ...+++..+..++.|++.||+|||+.|++||||+|
T Consensus 100 -----~~~~L~~~~~------------------------------~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p 144 (292)
T cd06657 100 -----EGGALTDIVT------------------------------HTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKS 144 (292)
T ss_pred -----CCCcHHHHHh------------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCH
Confidence 4455544321 12346677789999999999999999999999999
Q ss_pred ceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 003644 538 QNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGE 617 (805)
Q Consensus 538 ~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~elltG~~~Pf~~ 617 (805)
+||+++.++. ++|+|||++....... .......|++.|+|||.+....++.++|+||+||++|+|++| .+||..
T Consensus 145 ~Nilv~~~~~--~~l~dfg~~~~~~~~~---~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg-~~p~~~ 218 (292)
T cd06657 145 DSILLTHDGR--VKLSDFGFCAQVSKEV---PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDG-EPPYFN 218 (292)
T ss_pred HHEEECCCCC--EEEcccccceeccccc---ccccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhC-CCCCCC
Confidence 9999988776 8999999987654321 112234588999999999888889999999999999999997 667754
Q ss_pred chH-HHHHHHhhccc---cccccCChHHHHHHHHhcCCCCCCCCChhhhhcCcccccc
Q 003644 618 SFE-RDANIVKDRKD---LFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTA 671 (805)
Q Consensus 618 ~~~-~~~~~~~~~~~---~~~~~~~~~~~dLi~~~L~~dP~~Rps~~ell~Hpff~~~ 671 (805)
... ........... ......++++.+++.+||+.||.+||++.++++||||...
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~~~~~~~ 276 (292)
T cd06657 219 EPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKA 276 (292)
T ss_pred CCHHHHHHHHHhhCCcccCCcccCCHHHHHHHHHHHhCCcccCcCHHHHhcChHHhcc
Confidence 322 22222221111 1122346789999999999999999999999999999554
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=289.81 Aligned_cols=248 Identities=27% Similarity=0.381 Sum_probs=196.0
Q ss_pred EeeccCCceEEEEE-EeeCCcEEEEEEeecCCc----hHHHHHHHHHHHhCCCCCeeeecccccCCceEEEecccccCCh
Q 003644 382 KEIAKGSNGTVVLE-GNYEGRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCSL 456 (805)
Q Consensus 382 ~~LG~GsfGtVy~a-~~~~g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~E~~~~sL 456 (805)
..||.|+||+|++- ....|+..|||+++.... .+.+.|....++.-+.||||++||.+..++..|++||+++.||
T Consensus 70 g~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd~Sl 149 (361)
T KOG1006|consen 70 GEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMDISL 149 (361)
T ss_pred HHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHhhhH
Confidence 45999999999985 567899999999975433 3456777778888999999999999999999999999999887
Q ss_pred hhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhc-ceeccCC
Q 003644 457 NDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI-GLIHRDL 535 (805)
Q Consensus 457 ~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~-~IvHrDL 535 (805)
..+. +. .+ .-+...+|+..+-.|..-++.||.||-+. .|||||+
T Consensus 150 DklY-k~-------vy---------------------------~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDv 194 (361)
T KOG1006|consen 150 DKLY-KR-------VY---------------------------SVQKSRIPENILGHITVATVDALDYLKEELKIIHRDV 194 (361)
T ss_pred HHHH-HH-------HH---------------------------HHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccC
Confidence 6553 21 11 12334578888888999999999999965 8999999
Q ss_pred CCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcC--CCCCcchHHHHHHHHHHHHhCCCC
Q 003644 536 KPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG--RQTRAIDLFSLGCILFFCITGGKH 613 (805)
Q Consensus 536 Kp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~--~~t~~sDVwSlGvil~elltG~~~ 613 (805)
||+||||+..|. +||||||++-.+.+.. ......|...|||||.+... .|+.+|||||||+.|||+.|| ..
T Consensus 195 KPSNILldr~G~--vKLCDFGIcGqLv~Si----AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG-~f 267 (361)
T KOG1006|consen 195 KPSNILLDRHGD--VKLCDFGICGQLVDSI----AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATG-NF 267 (361)
T ss_pred ChhheEEecCCC--EeeecccchHhHHHHH----HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecC-CC
Confidence 999999987776 9999999998776431 12234588999999998753 489999999999999999997 78
Q ss_pred CCCCchHHH---HHHHhhcccc--cc---ccCChHHHHHHHHhcCCCCCCCCChhhhhcCcccccc
Q 003644 614 PYGESFERD---ANIVKDRKDL--FL---VEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTA 671 (805)
Q Consensus 614 Pf~~~~~~~---~~~~~~~~~~--~~---~~~~~~~~dLi~~~L~~dP~~Rps~~ell~Hpff~~~ 671 (805)
||......- ..++.+.+.. +. .+.+..++.+|..||.+|-..||...+++++||+...
T Consensus 268 Pyr~w~svfeql~~Vv~gdpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y 333 (361)
T KOG1006|consen 268 PYRKWDSVFEQLCQVVIGDPPILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMY 333 (361)
T ss_pred CcchHHHHHHHHHHHHcCCCCeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcCchhhhh
Confidence 887754432 2333332221 11 2356789999999999999999999999999998653
|
|
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=293.22 Aligned_cols=254 Identities=23% Similarity=0.320 Sum_probs=188.4
Q ss_pred eEEEeEeeccCCceEEEEEEee------CCcEEEEEEeecCCch----HHHHHHHHHHHhCCCCCeeeecccccCCceEE
Q 003644 377 LVVFNKEIAKGSNGTVVLEGNY------EGRSVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVRWYGVESDQDFVY 446 (805)
Q Consensus 377 ~~~~~~~LG~GsfGtVy~a~~~------~g~~VAVK~l~~~~~~----~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~ 446 (805)
.|...+.||+|+||+||++... +.+.||+|.+...... ...+|+. +++.++||||+++++++.+.+..|
T Consensus 6 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~-~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 6 NLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELD-MFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred hceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHH-HHHhcCCcceeeeEEEECCCCcce
Confidence 4667788999999999998643 3568999988654322 3445554 678889999999999999999999
Q ss_pred EecccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhh
Q 003644 447 LSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH 526 (805)
Q Consensus 447 LV~E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH 526 (805)
+|||+|. +|+|.+++......... -+...+++..+..++.|++.||+|||
T Consensus 85 lv~e~~~----------~~~L~~~i~~~~~~~~~--------------------~~~~~l~~~~~~~~~~~l~~~l~~LH 134 (275)
T cd05046 85 MILEYTD----------LGDLKQFLRATKSKDEK--------------------LKPPPLSTKQKVALCTQIALGMDHLS 134 (275)
T ss_pred EEEEecC----------CCcHHHHHHhccccccc--------------------ccccCCCHHHHHHHHHHHHHHHHHhh
Confidence 9999554 45555554322110000 01124678889999999999999999
Q ss_pred hcceeccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHHH
Q 003644 527 EIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFF 606 (805)
Q Consensus 527 ~~~IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~e 606 (805)
+.+|+||||||+||+++.++. ++++|||+++...... ........++..|+|||.+.+..++.++|||||||++|+
T Consensus 135 ~~~i~H~dlkp~Nili~~~~~--~~l~~~~~~~~~~~~~--~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~ 210 (275)
T cd05046 135 NARFVHRDLAARNCLVSSQRE--VKVSLLSLSKDVYNSE--YYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWE 210 (275)
T ss_pred hcCcccCcCccceEEEeCCCc--EEEcccccccccCccc--ccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHH
Confidence 999999999999999988776 8899999987543221 112223346778999999988888999999999999999
Q ss_pred HHhCCCCCCCCchHHH-HHHHhhcc--ccccccCChHHHHHHHHhcCCCCCCCCChhhhhcC
Q 003644 607 CITGGKHPYGESFERD-ANIVKDRK--DLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNH 665 (805)
Q Consensus 607 lltG~~~Pf~~~~~~~-~~~~~~~~--~~~~~~~~~~~~dLi~~~L~~dP~~Rps~~ell~H 665 (805)
+++++.+||....... ........ .......+..+.+++.+||+.||.+||++.+++.+
T Consensus 211 l~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~ 272 (275)
T cd05046 211 VFTQGELPFYGLSDEEVLNRLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA 272 (275)
T ss_pred HHhCCCCCccccchHHHHHHHHcCCcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 9997688886533222 22222111 11233455789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=287.84 Aligned_cols=239 Identities=32% Similarity=0.471 Sum_probs=186.8
Q ss_pred eccCCceEEEEEEee-CCcEEEEEEeecCCc------hHHHHHHHHHHHhCCCCCeeeecccccCCceEEEecccccCCh
Q 003644 384 IAKGSNGTVVLEGNY-EGRSVAVKRLVKTHH------DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCSL 456 (805)
Q Consensus 384 LG~GsfGtVy~a~~~-~g~~VAVK~l~~~~~------~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~E~~~~sL 456 (805)
||+|+||.||++... +++.||+|++.+... .....|+ .+++.++||||+++++.+.+++..|+|||++
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~-~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~---- 75 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTER-NILSRINHPFIVKLHYAFQTEEKLYLVLEYA---- 75 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHH-HHHHHcCCCcHHHHHHHeecCCeeEEEEecC----
Confidence 699999999998554 589999999865432 2334455 4778889999999999999999999999955
Q ss_pred hhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCC
Q 003644 457 NDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLK 536 (805)
Q Consensus 457 ~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~IvHrDLK 536 (805)
.+++|.+++.. ...+++..+..++.|++.||.|||+.+++|+||+
T Consensus 76 ------~~~~L~~~l~~-----------------------------~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~ 120 (250)
T cd05123 76 ------PGGELFSHLSK-----------------------------EGRFSEERARFYAAEIVLALEYLHSLGIIYRDLK 120 (250)
T ss_pred ------CCCcHHHHHHh-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCC
Confidence 34444444321 1235677889999999999999999999999999
Q ss_pred CceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q 003644 537 PQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYG 616 (805)
Q Consensus 537 p~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~elltG~~~Pf~ 616 (805)
|+||+++.++. ++|+|||++....... .......++..|+|||...+...+.++|+||||+++|++++| ..||.
T Consensus 121 p~ni~~~~~~~--~~l~d~~~~~~~~~~~---~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g-~~p~~ 194 (250)
T cd05123 121 PENILLDADGH--IKLTDFGLAKELSSEG---SRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTG-KPPFY 194 (250)
T ss_pred cceEEEcCCCc--EEEeecCcceecccCC---CcccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHC-CCCCC
Confidence 99999988775 8999999988765321 112334578899999999888889999999999999999996 77886
Q ss_pred CchHHH-HHHHhhccccccccCChHHHHHHHHhcCCCCCCCCCh---hhhhcCccc
Q 003644 617 ESFERD-ANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKA---QNVLNHPFF 668 (805)
Q Consensus 617 ~~~~~~-~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dP~~Rps~---~ell~Hpff 668 (805)
...... ...+.......+...+.++.+++++||..||+.||++ +++++||||
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~~~f 250 (250)
T cd05123 195 AEDRKEIYEKILKDPLRFPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF 250 (250)
T ss_pred CCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHhCCCC
Confidence 544322 2222222223344446789999999999999999999 899999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=290.62 Aligned_cols=246 Identities=23% Similarity=0.345 Sum_probs=184.5
Q ss_pred ceEEEeEeeccCCceEEEEEEeeC----CcEEEEEEeecCCc----hHHHHHHHHHHHhCCCCCeeeecccccCCceEEE
Q 003644 376 KLVVFNKEIAKGSNGTVVLEGNYE----GRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYL 447 (805)
Q Consensus 376 ~~~~~~~~LG~GsfGtVy~a~~~~----g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~L 447 (805)
+.|.+.+.||+|+||.||+|...+ ...||||....... +...+|+. ++..++||||+++++++.+ +..|+
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~-~l~~~~h~~i~~~~~~~~~-~~~~l 83 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAY-IMRQFDHPHIVKLIGVITE-NPVWI 83 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHH-HHHhCCCCchhceeEEEcC-CCcEE
Confidence 447788999999999999986543 24799998865432 12334544 7788899999999999876 45789
Q ss_pred ecccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhh
Q 003644 448 SLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE 527 (805)
Q Consensus 448 V~E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~ 527 (805)
|||+ .++|+|.+++... ...+++..++.++.|++.||+|||+
T Consensus 84 v~e~----------~~~~~L~~~l~~~----------------------------~~~~~~~~~~~~~~~l~~~l~~lH~ 125 (270)
T cd05056 84 VMEL----------APLGELRSYLQVN----------------------------KYSLDLASLILYSYQLSTALAYLES 125 (270)
T ss_pred EEEc----------CCCCcHHHHHHhC----------------------------CCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 9994 4555555554221 1235677889999999999999999
Q ss_pred cceeccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHHHH
Q 003644 528 IGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFC 607 (805)
Q Consensus 528 ~~IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~el 607 (805)
.+++||||||+||+++.++. +||+|||+++........ ......++..|+|||.+....++.++|||||||++||+
T Consensus 126 ~~~~H~dl~p~nili~~~~~--~~l~d~g~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el 201 (270)
T cd05056 126 KRFVHRDIAARNVLVSSPDC--VKLGDFGLSRYLEDESYY--KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEI 201 (270)
T ss_pred CCeeccccChheEEEecCCC--eEEccCceeeecccccce--ecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHH
Confidence 99999999999999987765 899999999876543211 11122345689999999888899999999999999999
Q ss_pred HhCCCCCCCCchHHHH--HHHhhccccccccCChHHHHHHHHhcCCCCCCCCChhhhhcC
Q 003644 608 ITGGKHPYGESFERDA--NIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNH 665 (805)
Q Consensus 608 ltG~~~Pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~dLi~~~L~~dP~~Rps~~ell~H 665 (805)
++.+.+||........ .+........+...++++.++|.+|+..+|.+|||+.+++.+
T Consensus 202 ~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~ 261 (270)
T cd05056 202 LMLGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQ 261 (270)
T ss_pred HHcCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 9744778866443221 222222223344566899999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-32 Score=291.66 Aligned_cols=245 Identities=24% Similarity=0.308 Sum_probs=185.8
Q ss_pred ceEEEeEeeccCCceEEEEEEee-CCc----EEEEEEeecCCch----HHHHHHHHHHHhCCCCCeeeecccccCCceEE
Q 003644 376 KLVVFNKEIAKGSNGTVVLEGNY-EGR----SVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVRWYGVESDQDFVY 446 (805)
Q Consensus 376 ~~~~~~~~LG~GsfGtVy~a~~~-~g~----~VAVK~l~~~~~~----~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~ 446 (805)
..|.+.+.||+|+||+||++... +|. .||+|.+...... ...+|+. .++.++||||+++++++.. ...+
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~-~~~~ 84 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAY-VMASVDHPHVVRLLGICLS-SQVQ 84 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHH-HHHhCCCCCcceEEEEEec-CceE
Confidence 45778899999999999998643 333 6999988655422 2334554 6778899999999999887 7899
Q ss_pred EecccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhh
Q 003644 447 LSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH 526 (805)
Q Consensus 447 LV~E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH 526 (805)
+||| |..+|+|.+++... ...+++..++.++.||+.||+|||
T Consensus 85 ~v~e----------~~~~g~L~~~l~~~----------------------------~~~~~~~~~~~~~~qi~~~l~~LH 126 (279)
T cd05057 85 LITQ----------LMPLGCLLDYVRNH----------------------------KDNIGSQYLLNWCVQIAKGMSYLE 126 (279)
T ss_pred EEEe----------cCCCCcHHHHHHhc----------------------------cCCCCHHHHHHHHHHHHHHHHHHH
Confidence 9999 55566666655321 123667788999999999999999
Q ss_pred hcceeccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHHH
Q 003644 527 EIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFF 606 (805)
Q Consensus 527 ~~~IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~e 606 (805)
+.+|+||||||+|||++.++. +||+|||+++.......... .....++..|+|||.+....++.++|+|||||++||
T Consensus 127 ~~~i~H~di~p~nil~~~~~~--~kL~dfg~~~~~~~~~~~~~-~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~e 203 (279)
T cd05057 127 EKRLVHRDLAARNVLVKTPQH--VKITDFGLAKLLDVDEKEYH-AEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWE 203 (279)
T ss_pred hCCEEecccCcceEEEcCCCe--EEECCCcccccccCccccee-cCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHH
Confidence 999999999999999987765 89999999987754322211 112224678999999988889999999999999999
Q ss_pred HHhCCCCCCCCchHHH-HHHHh-hccccccccCChHHHHHHHHhcCCCCCCCCChhhhh
Q 003644 607 CITGGKHPYGESFERD-ANIVK-DRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVL 663 (805)
Q Consensus 607 lltG~~~Pf~~~~~~~-~~~~~-~~~~~~~~~~~~~~~dLi~~~L~~dP~~Rps~~ell 663 (805)
+++.+.+||....... ...+. ......+.....++.+++.+||..||..||++.+++
T Consensus 204 l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~ 262 (279)
T cd05057 204 LMTFGAKPYEGIPAVEIPDLLEKGERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELI 262 (279)
T ss_pred HhcCCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHH
Confidence 9984477886644332 22222 222223334567899999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=293.42 Aligned_cols=246 Identities=27% Similarity=0.364 Sum_probs=183.1
Q ss_pred eEEEeEeeccCCceEEEEEEee-----CCcEEEEEEeecCCch----HHHHHHHHHHHhCCCCCeeeecccccC--CceE
Q 003644 377 LVVFNKEIAKGSNGTVVLEGNY-----EGRSVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVRWYGVESD--QDFV 445 (805)
Q Consensus 377 ~~~~~~~LG~GsfGtVy~a~~~-----~g~~VAVK~l~~~~~~----~~~~Ei~~ll~~l~HpNIV~l~g~~~~--~~~l 445 (805)
.|.+.+.||+|+||+||++... +++.||||.+...... ...+|+. .++.+.||||+++++++.+ ....
T Consensus 5 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~-~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 5 HLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIE-ILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHH-HHHhCCCCChheEEeeeecCCCCce
Confidence 4566789999999999998643 4789999999755432 3445554 6778899999999999877 6689
Q ss_pred EEecccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHh
Q 003644 446 YLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHL 525 (805)
Q Consensus 446 ~LV~E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yL 525 (805)
+++||+ .++++|.+++.... ..+++..++.++.|++.||+||
T Consensus 84 ~lv~e~----------~~~~~l~~~l~~~~----------------------------~~~~~~~~~~~~~~l~~aL~~l 125 (284)
T cd05038 84 RLIMEY----------LPSGSLRDYLQRHR----------------------------DQINLKRLLLFSSQICKGMDYL 125 (284)
T ss_pred EEEEec----------CCCCCHHHHHHhCc----------------------------cccCHHHHHHHHHHHHHHHHHH
Confidence 999994 44555555543211 1356678899999999999999
Q ss_pred hhcceeccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHH
Q 003644 526 HEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILF 605 (805)
Q Consensus 526 H~~~IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~ 605 (805)
|+.+|+||||||+||+++.++. ++|+|||++.................++..|+|||.+....++.++|||||||++|
T Consensus 126 H~~~i~H~dl~p~nil~~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~ 203 (284)
T cd05038 126 GSQRYIHRDLAARNILVESEDL--VKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLY 203 (284)
T ss_pred HhCCeecCCCCHHhEEEcCCCC--EEEcccccccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhh
Confidence 9999999999999999987765 89999999987764322222222234566799999998888999999999999999
Q ss_pred HHHhCCCCCCCCchHHH----------------HHHHhhc-cccccccCChHHHHHHHHhcCCCCCCCCChhhhhc
Q 003644 606 FCITGGKHPYGESFERD----------------ANIVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 664 (805)
Q Consensus 606 elltG~~~Pf~~~~~~~----------------~~~~~~~-~~~~~~~~~~~~~dLi~~~L~~dP~~Rps~~ell~ 664 (805)
||++|. .|+....... ...+... ....+.....++.+++.+||+.+|.+||++.|+++
T Consensus 204 el~tg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05038 204 ELFTYG-DPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL 278 (284)
T ss_pred eeeccC-CCcccccchhccccccccccccHHHHHHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 999974 4554321111 1111111 11112334568999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-32 Score=289.52 Aligned_cols=246 Identities=21% Similarity=0.351 Sum_probs=185.3
Q ss_pred EEEeEeeccCCceEEEEEEeeC--CcEEEEEEeecCC---------c----hHHHHHHHHHHHhCCCCCeeeecccccCC
Q 003644 378 VVFNKEIAKGSNGTVVLEGNYE--GRSVAVKRLVKTH---------H----DVALKEIQNLIASDQHPNIVRWYGVESDQ 442 (805)
Q Consensus 378 ~~~~~~LG~GsfGtVy~a~~~~--g~~VAVK~l~~~~---------~----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~ 442 (805)
|.+.+.||+|+||.||++.... ++.||||.+.... . ....+|+..+.+.++||||+++++++.++
T Consensus 2 y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 81 (269)
T cd08528 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLEN 81 (269)
T ss_pred chhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccC
Confidence 4566789999999999986554 7899999875321 1 12345555455568999999999999999
Q ss_pred ceEEEecccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHH
Q 003644 443 DFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGL 522 (805)
Q Consensus 443 ~~l~LV~E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL 522 (805)
+..+++||| +.+++|.+.+.... -....+++..++.++.|++.||
T Consensus 82 ~~~~lv~e~----------~~~~~l~~~l~~~~-------------------------~~~~~~~~~~~~~~~~~l~~~l 126 (269)
T cd08528 82 DRLYIVMDL----------IEGAPLGEHFNSLK-------------------------EKKQRFTEERIWNIFVQMVLAL 126 (269)
T ss_pred CeEEEEEec----------CCCCcHHHHHHHHH-------------------------hccCCCCHHHHHHHHHHHHHHH
Confidence 999999994 44555555442211 0113467778899999999999
Q ss_pred HHhhh-cceeccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHH
Q 003644 523 SHLHE-IGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLG 601 (805)
Q Consensus 523 ~yLH~-~~IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlG 601 (805)
+|||+ .+++|+||+|+||+++.++. +||+|||++....... ......|+..|+|||.+.+..++.++|+||||
T Consensus 127 ~~lh~~~~i~H~dl~~~nil~~~~~~--~~l~dfg~~~~~~~~~----~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG 200 (269)
T cd08528 127 RYLHKEKRIVHRDLTPNNIMLGEDDK--VTITDFGLAKQKQPES----KLTSVVGTILYSCPEIVKNEPYGEKADVWAFG 200 (269)
T ss_pred HHhccCCceeecCCCHHHEEECCCCc--EEEecccceeeccccc----ccccccCcccCcChhhhcCCCCchHHHHHHHH
Confidence 99996 68999999999999988765 8999999998765332 22334588999999999988899999999999
Q ss_pred HHHHHHHhCCCCCCCCchHHH-HHH-Hhhcccccc-ccCChHHHHHHHHhcCCCCCCCCChhhhhcC
Q 003644 602 CILFFCITGGKHPYGESFERD-ANI-VKDRKDLFL-VEHIPEAVDLFTRLLDPNPDLRPKAQNVLNH 665 (805)
Q Consensus 602 vil~elltG~~~Pf~~~~~~~-~~~-~~~~~~~~~-~~~~~~~~dLi~~~L~~dP~~Rps~~ell~H 665 (805)
|++|||++| .+||....... ... ......... ....+++.++|.+||+.||++||++.|+..+
T Consensus 201 ~ll~~l~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~ 266 (269)
T cd08528 201 CILYQMCTL-QPPFYSTNMLSLATKIVEAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAM 266 (269)
T ss_pred HHHHHHHhC-CCcccccCHHHHHHHHhhccCCcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence 999999997 77876543322 111 111111111 1346799999999999999999999998754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-32 Score=295.52 Aligned_cols=246 Identities=25% Similarity=0.306 Sum_probs=183.8
Q ss_pred eEEEeEeeccCCceEEEEEEee-CCc----EEEEEEeecCCch----HHHHHHHHHHHhCCCCCeeeecccccCCceEEE
Q 003644 377 LVVFNKEIAKGSNGTVVLEGNY-EGR----SVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVRWYGVESDQDFVYL 447 (805)
Q Consensus 377 ~~~~~~~LG~GsfGtVy~a~~~-~g~----~VAVK~l~~~~~~----~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~L 447 (805)
.|...+.||+|+||.||++... +|. .||+|.+...... ...+|+ .++..++||||++++++|... ..++
T Consensus 8 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~-~~~~~l~h~niv~~~~~~~~~-~~~~ 85 (303)
T cd05110 8 ELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEA-LIMASMDHPHLVRLLGVCLSP-TIQL 85 (303)
T ss_pred hceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHH-HHHHhCCCCCcccEEEEEcCC-Ccee
Confidence 3566788999999999998543 444 5799988654332 233444 477888999999999998764 4678
Q ss_pred ecccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhh
Q 003644 448 SLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE 527 (805)
Q Consensus 448 V~E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~ 527 (805)
++| |+++|+|.+++... ...+++..++.++.|++.||+|||+
T Consensus 86 v~e----------~~~~g~l~~~~~~~----------------------------~~~~~~~~~~~~~~qi~~~L~~LH~ 127 (303)
T cd05110 86 VTQ----------LMPHGCLLDYVHEH----------------------------KDNIGSQLLLNWCVQIAKGMMYLEE 127 (303)
T ss_pred eeh----------hcCCCCHHHHHHhc----------------------------ccCCCHHHHHHHHHHHHHHHHHHhh
Confidence 999 66666766655321 1235667789999999999999999
Q ss_pred cceeccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHHHH
Q 003644 528 IGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFC 607 (805)
Q Consensus 528 ~~IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~el 607 (805)
.+|+||||||+|||++.++. +||+|||+++......... ......++..|+|||++.+..++.++|||||||++||+
T Consensus 128 ~~ivH~dikp~Nill~~~~~--~kL~Dfg~~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el 204 (303)
T cd05110 128 RRLVHRDLAARNVLVKSPNH--VKITDFGLARLLEGDEKEY-NADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWEL 204 (303)
T ss_pred cCeeccccccceeeecCCCc--eEEccccccccccCccccc-ccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHH
Confidence 99999999999999987765 8999999998765432211 11223457789999999988899999999999999999
Q ss_pred HhCCCCCCCCchHH-HHHHHhhcc-ccccccCChHHHHHHHHhcCCCCCCCCChhhhhcC
Q 003644 608 ITGGKHPYGESFER-DANIVKDRK-DLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNH 665 (805)
Q Consensus 608 ltG~~~Pf~~~~~~-~~~~~~~~~-~~~~~~~~~~~~dLi~~~L~~dP~~Rps~~ell~H 665 (805)
++.+..||...... ....+.... ...+......+.+++.+||..||++||+++++++.
T Consensus 205 ~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~ 264 (303)
T cd05110 205 MTFGGKPYDGIPTREIPDLLEKGERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAE 264 (303)
T ss_pred HhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 98446787654322 233333222 11223345789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-32 Score=316.59 Aligned_cols=274 Identities=18% Similarity=0.207 Sum_probs=170.5
Q ss_pred cceEEEeEeeccCCceEEEEEEee-C----CcEEEEEEeecCCchHHHHHHHHHHHhCCCCCeeeeccc------ccCCc
Q 003644 375 GKLVVFNKEIAKGSNGTVVLEGNY-E----GRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYGV------ESDQD 443 (805)
Q Consensus 375 ~~~~~~~~~LG~GsfGtVy~a~~~-~----g~~VAVK~l~~~~~~~~~~Ei~~ll~~l~HpNIV~l~g~------~~~~~ 443 (805)
.+.|.+.+.||+|+||+||++... + +..||||++..........+. .+....+.+++.+... +.+++
T Consensus 131 ~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~~~ 208 (566)
T PLN03225 131 KDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEIWMNE--RVRRACPNSCADFVYGFLEPVSSKKED 208 (566)
T ss_pred cCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhHHHHHH--HHHhhchhhHHHHHHhhhcccccccCC
Confidence 456889999999999999998654 4 689999998654322221111 1222223333333222 24567
Q ss_pred eEEEecccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHH
Q 003644 444 FVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLS 523 (805)
Q Consensus 444 ~l~LV~E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~ 523 (805)
..+||+||+. +++|.++++....... ..++.. ...... ..........+..++.||+.||+
T Consensus 209 ~~~LV~ey~~----------~gsL~~~l~~~~~~~~-v~~~l~------~~~~~l--~~~~~r~~~~i~~i~~qll~aL~ 269 (566)
T PLN03225 209 EYWLVWRYEG----------ESTLADLMQSKEFPYN-VEPYLL------GKVQDL--PKGLERENKIIQTIMRQILFALD 269 (566)
T ss_pred ceEEEEEecC----------CCcHHHHHHhcCCchh-HHHHhc------cchhhc--cccchhhHHHHHHHHHHHHHHHH
Confidence 8999999554 4444444432211000 000000 000000 00011123456789999999999
Q ss_pred HhhhcceeccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcC--------------
Q 003644 524 HLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG-------------- 589 (805)
Q Consensus 524 yLH~~~IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-------------- 589 (805)
|||+.+|+||||||+|||++.+.. .+||+|||+++.+..... ......++|+.|+|||.+...
T Consensus 270 yLH~~gIiHRDLKP~NILl~~~~~-~~KL~DFGlA~~l~~~~~--~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~ 346 (566)
T PLN03225 270 GLHSTGIVHRDVKPQNIIFSEGSG-SFKIIDLGAAADLRVGIN--YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATA 346 (566)
T ss_pred HHHHCCEEeCcCCHHHEEEeCCCC-cEEEEeCCCccccccccc--cCCcccccCCCccChHHhhccCCCCCCcccccccc
Confidence 999999999999999999975422 489999999986643322 122345789999999976432
Q ss_pred --------CCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhc--------c---cccc----------ccCChH
Q 003644 590 --------RQTRAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDR--------K---DLFL----------VEHIPE 640 (805)
Q Consensus 590 --------~~t~~sDVwSlGvil~elltG~~~Pf~~~~~~~~~~~~~~--------~---~~~~----------~~~~~~ 640 (805)
.++.++|||||||++|||+++ ..++..........+... . .... .....+
T Consensus 347 ~sp~l~~~~~~~k~DVwSlGviL~el~~~-~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 425 (566)
T PLN03225 347 LSPVLWQLNLPDRFDIYSAGLIFLQMAFP-NLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGA 425 (566)
T ss_pred ccchhccccCCCCcccHHHHHHHHHHHhC-cCCCchHHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchH
Confidence 234567999999999999996 445443322111111100 0 0000 011224
Q ss_pred HHHHHHHhcCCCCCCCCChhhhhcCcccccccc
Q 003644 641 AVDLFTRLLDPNPDLRPKAQNVLNHPFFWTADT 673 (805)
Q Consensus 641 ~~dLi~~~L~~dP~~Rps~~ell~Hpff~~~~~ 673 (805)
..|||.+||+.||.+|||++++|+||||.....
T Consensus 426 ~~dLi~~mL~~dP~kR~ta~e~L~Hpff~~~~~ 458 (566)
T PLN03225 426 GWELLKSMMRFKGRQRISAKAALAHPYFDREGL 458 (566)
T ss_pred HHHHHHHHccCCcccCCCHHHHhCCcCcCCCCc
Confidence 568999999999999999999999999976554
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=291.15 Aligned_cols=250 Identities=22% Similarity=0.356 Sum_probs=184.0
Q ss_pred EEeEeeccCCceEEEEEEee----CCcEEEEEEeecCCc-----hHHHHHHHHHHHhCCCCCeeeecccccCCc------
Q 003644 379 VFNKEIAKGSNGTVVLEGNY----EGRSVAVKRLVKTHH-----DVALKEIQNLIASDQHPNIVRWYGVESDQD------ 443 (805)
Q Consensus 379 ~~~~~LG~GsfGtVy~a~~~----~g~~VAVK~l~~~~~-----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~------ 443 (805)
.+.+.||+|+||+||++... +++.||||++..... +...+|+. +++.++||||+++++++...+
T Consensus 2 ~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~-~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 2 TLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAA-CMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred cchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHH-HHhcCCCCCcceEEEEEccCCCCCccc
Confidence 45678999999999998543 468999999865321 23445664 778899999999999876532
Q ss_pred eEEEecccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHH
Q 003644 444 FVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLS 523 (805)
Q Consensus 444 ~l~LV~E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~ 523 (805)
..++++| |..+|++..++....... +...+++..++.++.||+.||+
T Consensus 81 ~~~~~~~----------~~~~~~l~~~~~~~~~~~-----------------------~~~~l~~~~~~~~~~~i~~~l~ 127 (273)
T cd05074 81 IPMVILP----------FMKHGDLHTFLLMSRIGE-----------------------EPFTLPLQTLVRFMIDIASGME 127 (273)
T ss_pred ceEEEEe----------cCCCCcHHHHHHHhcccC-----------------------CCCCCCHHHHHHHHHHHHHHHH
Confidence 2478888 555666655543221100 0123567788999999999999
Q ss_pred HhhhcceeccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHH
Q 003644 524 HLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCI 603 (805)
Q Consensus 524 yLH~~~IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvi 603 (805)
|||+.+|+||||||+||+++.++. +||+|||+++....... ........+++.|++||.+....++.++|||||||+
T Consensus 128 ~lH~~~i~H~dikp~nili~~~~~--~kl~dfg~~~~~~~~~~-~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~i 204 (273)
T cd05074 128 YLSSKNFIHRDLAARNCMLNENMT--VCVADFGLSKKIYSGDY-YRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVT 204 (273)
T ss_pred HHHhCCEeecccchhhEEEcCCCC--EEECcccccccccCCcc-eecCCCccCchhhcCHhHHhcCccchhhhhHHHHHH
Confidence 999999999999999999987765 89999999987643221 111122345678999999998889999999999999
Q ss_pred HHHHHhCCCCCCCCchHHHH-H-HHhhccccccccCChHHHHHHHHhcCCCCCCCCChhhhhcC
Q 003644 604 LFFCITGGKHPYGESFERDA-N-IVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNH 665 (805)
Q Consensus 604 l~elltG~~~Pf~~~~~~~~-~-~~~~~~~~~~~~~~~~~~dLi~~~L~~dP~~Rps~~ell~H 665 (805)
+|||++++.+||........ . +........+...++++.+++.+||+.+|+.||++.+++.+
T Consensus 205 l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~ 268 (273)
T cd05074 205 MWEIMTRGQTPYAGVENSEIYNYLIKGNRLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQ 268 (273)
T ss_pred HHHHhhCCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 99999966888876543321 1 22222222334456799999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-33 Score=303.31 Aligned_cols=256 Identities=27% Similarity=0.393 Sum_probs=198.9
Q ss_pred cceEEEeEeeccCCceEEEEEEee-CCcEEEEEEeecCCc-----hHHHHHHHHHHHhCCCCCeeeecccccCCceEEEe
Q 003644 375 GKLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHH-----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLS 448 (805)
Q Consensus 375 ~~~~~~~~~LG~GsfGtVy~a~~~-~g~~VAVK~l~~~~~-----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV 448 (805)
...|...+.||-|+||.|-++... +...+|+|.|.+... ..-.+.+..+++..+.+-||+||..|+|++.+|+|
T Consensus 628 KSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFV 707 (1034)
T KOG0608|consen 628 KSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFV 707 (1034)
T ss_pred ccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEE
Confidence 345777889999999999998554 467899999876421 11233444577888999999999999999999999
Q ss_pred cccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhc
Q 003644 449 LERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI 528 (805)
Q Consensus 449 ~E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~ 528 (805)
|| |+++|++..+|.. .+.+++..++.++.++..|+++.|..
T Consensus 708 Md----------YIPGGDmMSLLIr-----------------------------mgIFeE~LARFYIAEltcAiesVHkm 748 (1034)
T KOG0608|consen 708 MD----------YIPGGDMMSLLIR-----------------------------MGIFEEDLARFYIAELTCAIESVHKM 748 (1034)
T ss_pred Ee----------ccCCccHHHHHHH-----------------------------hccCHHHHHHHHHHHHHHHHHHHHhc
Confidence 99 8888888877632 34577788899999999999999999
Q ss_pred ceeccCCCCceEEecCCCCceEEEeccCccccccCCC--------c------------------ccc-------------
Q 003644 529 GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDM--------S------------------CLT------------- 569 (805)
Q Consensus 529 ~IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~--------~------------------~~~------------- 569 (805)
|+|||||||+||||+.||+ +||+|||||.-+.-.. + +..
T Consensus 749 GFIHRDiKPDNILIDrdGH--IKLTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~ 826 (1034)
T KOG0608|consen 749 GFIHRDIKPDNILIDRDGH--IKLTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRI 826 (1034)
T ss_pred cceecccCccceEEccCCc--eeeeeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhh
Confidence 9999999999999999998 8999999986542100 0 000
Q ss_pred ccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCCCCCchH--HHHHHHhhccc---cccccCChHHHHH
Q 003644 570 QNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFE--RDANIVKDRKD---LFLVEHIPEAVDL 644 (805)
Q Consensus 570 ~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~elltG~~~Pf~~~~~--~~~~~~~~~~~---~~~~~~~~~~~dL 644 (805)
.....+||+.|+|||++....|+..+|+||.|||||||+.| ++||..... .+..++.|... .+..+.++++.++
T Consensus 827 ~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~g-~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~l 905 (1034)
T KOG0608|consen 827 LAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLVG-QPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDL 905 (1034)
T ss_pred hhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhhC-CCCccCCCCCcceeeeeehhhccccccccccCHHHHHH
Confidence 01223699999999999999999999999999999999997 778865433 23344444433 2345667899999
Q ss_pred HHHhcCCCCCCCCC---hhhhhcCcccccccc
Q 003644 645 FTRLLDPNPDLRPK---AQNVLNHPFFWTADT 673 (805)
Q Consensus 645 i~~~L~~dP~~Rps---~~ell~Hpff~~~~~ 673 (805)
|.+++. +++.|.. +++|..||||+..+.
T Consensus 906 i~kLc~-sad~RLGkng~d~vKaHpfFkgIDf 936 (1034)
T KOG0608|consen 906 IQKLCC-SADSRLGKNGADQVKAHPFFKGIDF 936 (1034)
T ss_pred HHHHhc-ChhhhhcccchhhhhcCccccccch
Confidence 998654 5677764 678999999977653
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-32 Score=321.84 Aligned_cols=142 Identities=32% Similarity=0.442 Sum_probs=114.7
Q ss_pred ceEEEeEeeccCCceEEEEEEee-CCcEEEEEEeecCCc------hHHHHHHHHHHHhCCCCCeeeecccccCCceEEEe
Q 003644 376 KLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHH------DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLS 448 (805)
Q Consensus 376 ~~~~~~~~LG~GsfGtVy~a~~~-~g~~VAVK~l~~~~~------~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV 448 (805)
+.|.+.+.||+|+||+||++... +++.||||++..... ....+|+ .++..++||||+++++++.+.+..|||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~-~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAER-DALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHH-HHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 45788899999999999998654 689999999865321 2233343 467888999999999999999999999
Q ss_pred cccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhc
Q 003644 449 LERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI 528 (805)
Q Consensus 449 ~E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~ 528 (805)
||| +.+++|.+++.. ...+++..++.|+.||+.||+|||+.
T Consensus 83 mEy----------~~g~~L~~li~~-----------------------------~~~l~~~~~~~i~~qil~aL~yLH~~ 123 (669)
T cd05610 83 MEY----------LIGGDVKSLLHI-----------------------------YGYFDEEMAVKYISEVALALDYLHRH 123 (669)
T ss_pred EeC----------CCCCCHHHHHHh-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 994 445555554421 12356677899999999999999999
Q ss_pred ceeccCCCCceEEecCCCCceEEEeccCccc
Q 003644 529 GLIHRDLKPQNVLISKDKSFCAKLSDMGISK 559 (805)
Q Consensus 529 ~IvHrDLKp~NILl~~~~~~~~kL~DFGla~ 559 (805)
+|+||||||+|||++.++. +||+|||+++
T Consensus 124 gIiHrDLKP~NILl~~~g~--vkL~DFGls~ 152 (669)
T cd05610 124 GIIHRDLKPDNMLISNEGH--IKLTDFGLSK 152 (669)
T ss_pred CEEeCCccHHHEEEcCCCC--EEEEeCCCCc
Confidence 9999999999999987765 8999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.8e-33 Score=306.86 Aligned_cols=247 Identities=22% Similarity=0.296 Sum_probs=194.7
Q ss_pred EEEeEeeccCCceEEEEEEee--CCc--EEEEEEeecCC----chHHHHHHHHHHHhCCCCCeeeecccccCCceEEEec
Q 003644 378 VVFNKEIAKGSNGTVVLEGNY--EGR--SVAVKRLVKTH----HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSL 449 (805)
Q Consensus 378 ~~~~~~LG~GsfGtVy~a~~~--~g~--~VAVK~l~~~~----~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~ 449 (805)
+...++||+|+||.|++|... .|+ .||||.++... .+++++|.. .+.+++|||+|||||+..+ ....||+
T Consensus 112 i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas-~M~~L~H~hliRLyGvVl~-qp~mMV~ 189 (1039)
T KOG0199|consen 112 IKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREAS-HMLKLQHPHLIRLYGVVLD-QPAMMVF 189 (1039)
T ss_pred HHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHH-HHHhccCcceeEEeeeecc-chhhHHh
Confidence 345578999999999997443 354 58999996542 356677776 6678899999999999888 7889999
Q ss_pred ccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcc
Q 003644 450 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG 529 (805)
Q Consensus 450 E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~ 529 (805)
|+ .+.|+|.+.|+... ...+....+..++.|||.|++||.+++
T Consensus 190 EL----------aplGSLldrLrka~---------------------------~~~llv~~Lcdya~QiA~aM~YLeskr 232 (1039)
T KOG0199|consen 190 EL----------APLGSLLDRLRKAK---------------------------KAILLVSRLCDYAMQIAKAMQYLESKR 232 (1039)
T ss_pred hh----------cccchHHHHHhhcc---------------------------ccceeHHHHHHHHHHHHHHHHHHhhhh
Confidence 94 45677777766521 123455677899999999999999999
Q ss_pred eeccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHHHHHh
Q 003644 530 LIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCIT 609 (805)
Q Consensus 530 IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~ellt 609 (805)
+|||||..+|+||.... .+||+||||.+-+......+......--...|+|||.+....++.++|||+|||.||||+|
T Consensus 233 lvHRDLAARNlllaspr--tVKI~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFt 310 (1039)
T KOG0199|consen 233 LVHRDLAARNLLLASPR--TVKICDFGLMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFT 310 (1039)
T ss_pred hhhhhhhhhhheecccc--eeeeecccceeccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhc
Confidence 99999999999997654 4999999999998766554433333335678999999999999999999999999999999
Q ss_pred CCCCCCCCchHHHH-HHHh-hccccccccCChHHHHHHHHhcCCCCCCCCChhhhhcC
Q 003644 610 GGKHPYGESFERDA-NIVK-DRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNH 665 (805)
Q Consensus 610 G~~~Pf~~~~~~~~-~~~~-~~~~~~~~~~~~~~~dLi~~~L~~dP~~Rps~~ell~H 665 (805)
+|..||-.....+. +.+. .....-+..++.++.++++.||..+|+.||++..|.+.
T Consensus 311 yGEePW~G~~g~qIL~~iD~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~ 368 (1039)
T KOG0199|consen 311 YGEEPWVGCRGIQILKNIDAGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRED 368 (1039)
T ss_pred cCCCCCCCCCHHHHHHhccccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHh
Confidence 99999977554432 2222 23333455667789999999999999999999988644
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.1e-31 Score=305.05 Aligned_cols=277 Identities=20% Similarity=0.284 Sum_probs=180.7
Q ss_pred cccceEEEeEeeccCCceEEEEEEe-----------------eCCcEEEEEEeecCCc---hH--------------HHH
Q 003644 373 RIGKLVVFNKEIAKGSNGTVVLEGN-----------------YEGRSVAVKRLVKTHH---DV--------------ALK 418 (805)
Q Consensus 373 ~i~~~~~~~~~LG~GsfGtVy~a~~-----------------~~g~~VAVK~l~~~~~---~~--------------~~~ 418 (805)
...+.|.+.++||+|+||+||++.. ..++.||||++..... +. ...
T Consensus 142 ~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~v 221 (507)
T PLN03224 142 WSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMV 221 (507)
T ss_pred ccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHH
Confidence 3456788999999999999999742 2457899999864321 11 112
Q ss_pred HHHHHHHhCCCCC-----eeeecccccC--------CceEEEecccccCChhhHHHHhcCCHHHHHhhhhccc-hhhHHH
Q 003644 419 EIQNLIASDQHPN-----IVRWYGVESD--------QDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDS-NLLNEV 484 (805)
Q Consensus 419 Ei~~ll~~l~HpN-----IV~l~g~~~~--------~~~l~LV~E~~~~sL~d~iy~~~GsL~~~L~~~~~~~-~~l~~~ 484 (805)
|+. ++..++|.+ +++++++|.. ++..||||| |+.+|+|.++|+...... ..+.++
T Consensus 222 E~~-~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~E----------y~~~gsL~~~L~~~~~~~~~~L~e~ 290 (507)
T PLN03224 222 EAY-MCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWK----------FESDATLGDALDGKLGPFPGCLEEF 290 (507)
T ss_pred HHH-HHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEE----------cCCCCcHHHHHhhccCCCcchHHHH
Confidence 332 344555554 4678887753 356899999 555555655555322110 011111
Q ss_pred HhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCCCceEEecCCCCceEEEeccCccccccCC
Q 003644 485 RIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGD 564 (805)
Q Consensus 485 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~ 564 (805)
.. .............+++..++.++.|++.||+|||+.+|+||||||+|||++.++. +||+|||+++.....
T Consensus 291 l~------~g~~l~~~~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~--~kL~DFGla~~~~~~ 362 (507)
T PLN03224 291 MM------AGKKIPDNMPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQ--VKIIDFGAAVDMCTG 362 (507)
T ss_pred Hh------cCCchhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCc--EEEEeCcCccccccC
Confidence 00 0000001122234677889999999999999999999999999999999987765 899999999765432
Q ss_pred CccccccccccCCCCCCChhhhhcCC--------------------C--CCcchHHHHHHHHHHHHhCCCCCCCCchHHH
Q 003644 565 MSCLTQNATGYGSSGWQAPEQLLQGR--------------------Q--TRAIDLFSLGCILFFCITGGKHPYGESFERD 622 (805)
Q Consensus 565 ~~~~~~~~~~~gt~~y~APE~l~~~~--------------------~--t~~sDVwSlGvil~elltG~~~Pf~~~~~~~ 622 (805)
.. .......+|+.|+|||.+.... + ..+.||||+||++|+|++|...|+.......
T Consensus 363 ~~--~~~~~g~~tp~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~ 440 (507)
T PLN03224 363 IN--FNPLYGMLDPRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFN 440 (507)
T ss_pred Cc--cCccccCCCcceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhh
Confidence 11 1112234589999999986432 1 1347999999999999998655765321110
Q ss_pred ---------HH---HHhhccccc--cccCChHHHHHHHHhcCCCC---CCCCChhhhhcCccccc
Q 003644 623 ---------AN---IVKDRKDLF--LVEHIPEAVDLFTRLLDPNP---DLRPKAQNVLNHPFFWT 670 (805)
Q Consensus 623 ---------~~---~~~~~~~~~--~~~~~~~~~dLi~~~L~~dP---~~Rps~~ell~Hpff~~ 670 (805)
.. ........+ ....++.++||+.+||..+| .+|+|++|+|+||||..
T Consensus 441 ~~~~~~~~~~~~~r~~~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~ 505 (507)
T PLN03224 441 TELRQYDNDLNRWRMYKGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP 505 (507)
T ss_pred hHHhhccchHHHHHhhcccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence 00 011111111 22345789999999999876 68999999999999953
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.3e-32 Score=297.96 Aligned_cols=245 Identities=24% Similarity=0.339 Sum_probs=196.9
Q ss_pred eEEEeEeeccCCceEEEEEEee-CCcEEEEEEeecCCc--hHHHHHHHHHHHhCCCCCeeeecccccCCceEEEeccccc
Q 003644 377 LVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHH--DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCT 453 (805)
Q Consensus 377 ~~~~~~~LG~GsfGtVy~a~~~-~g~~VAVK~l~~~~~--~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~E~~~ 453 (805)
.+....+||-|.||.||.+... -.-.||||.++.... +++++|.. +++.+.|||+|+|+|+|..+-.+|||.|
T Consensus 268 dItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAA-vMKeikHpNLVqLLGVCT~EpPFYIiTE--- 343 (1157)
T KOG4278|consen 268 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAA-VMKEIKHPNLVQLLGVCTHEPPFYIITE--- 343 (1157)
T ss_pred heeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHH-HHHhhcCccHHHHhhhhccCCCeEEEEe---
Confidence 3567789999999999987443 356899999986543 34556655 7788999999999999999999999999
Q ss_pred CChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcceecc
Q 003644 454 CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHR 533 (805)
Q Consensus 454 ~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~IvHr 533 (805)
||..|+|-++|+..... -++.-.++.++.||..|++||..+++|||
T Consensus 344 -------fM~yGNLLdYLRecnr~---------------------------ev~avvLlyMAtQIsSaMeYLEkknFIHR 389 (1157)
T KOG4278|consen 344 -------FMCYGNLLDYLRECNRS---------------------------EVPAVVLLYMATQISSAMEYLEKKNFIHR 389 (1157)
T ss_pred -------cccCccHHHHHHHhchh---------------------------hcchhHHHHHHHHHHHHHHHHHHhhhhhh
Confidence 88888888888654432 13445678999999999999999999999
Q ss_pred CCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHHHHHhCCCC
Q 003644 534 DLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKH 613 (805)
Q Consensus 534 DLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~elltG~~~ 613 (805)
||..+|+|+.++. .+|++||||++.+.++.. +.....--...|.|||.+....++.++|||+|||+|||+.|-|-.
T Consensus 390 DLAARNCLVgEnh--iVKvADFGLsRlMtgDTY--TAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMs 465 (1157)
T KOG4278|consen 390 DLAARNCLVGENH--IVKVADFGLSRLMTGDTY--TAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMS 465 (1157)
T ss_pred hhhhhhccccccc--eEEeeccchhhhhcCCce--ecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCC
Confidence 9999999997664 499999999999986532 222222235679999999999999999999999999999998888
Q ss_pred CCCCchHHH-HHHHhhccc-cccccCChHHHHHHHHhcCCCCCCCCChhhhh
Q 003644 614 PYGESFERD-ANIVKDRKD-LFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVL 663 (805)
Q Consensus 614 Pf~~~~~~~-~~~~~~~~~-~~~~~~~~~~~dLi~~~L~~dP~~Rps~~ell 663 (805)
||..-...+ ..++..... ..+..+.+.+.+|++.||+..|..||++.|+-
T Consensus 466 PYPGidlSqVY~LLEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiH 517 (1157)
T KOG4278|consen 466 PYPGIDLSQVYGLLEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIH 517 (1157)
T ss_pred CCCCccHHHHHHHHhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHH
Confidence 997654333 234443332 34566778999999999999999999999874
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8e-32 Score=303.77 Aligned_cols=241 Identities=24% Similarity=0.301 Sum_probs=189.6
Q ss_pred eEeeccCCceEEEEEEeeC-C----cEEEEEEeecCCchH---HHHHHHHHHHhCCCCCeeeecccccCCceEEEecccc
Q 003644 381 NKEIAKGSNGTVVLEGNYE-G----RSVAVKRLVKTHHDV---ALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERC 452 (805)
Q Consensus 381 ~~~LG~GsfGtVy~a~~~~-g----~~VAVK~l~~~~~~~---~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~E~~ 452 (805)
.++||+|+||+||++.... | -+||+|++....... .+-|....+++++|||++||+|+|.... +.||++
T Consensus 701 ~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq-- 777 (1177)
T KOG1025|consen 701 DKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQ-- 777 (1177)
T ss_pred hceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHH--
Confidence 4679999999999986543 3 479999986544332 2333334778999999999999998876 888999
Q ss_pred cCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcceec
Q 003644 453 TCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIH 532 (805)
Q Consensus 453 ~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~IvH 532 (805)
+|+.|+|.++++.+. ..+.....+.|+.|||+|+.|||++.+||
T Consensus 778 --------~mP~G~LlDyvr~hr----------------------------~~igsq~lLnw~~QIAkgM~YLe~qrlVH 821 (1177)
T KOG1025|consen 778 --------LMPLGCLLDYVREHR----------------------------DNIGSQDLLNWCYQIAKGMKYLEEQRLVH 821 (1177)
T ss_pred --------hcccchHHHHHHHhh----------------------------ccccHHHHHHHHHHHHHHHHHHHhcchhh
Confidence 888888888775432 23455677999999999999999999999
Q ss_pred cCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHHHHHhCCC
Q 003644 533 RDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGK 612 (805)
Q Consensus 533 rDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~elltG~~ 612 (805)
|||..+|||+.+-.+ +||+|||+++.+..+........ ..-.+.|||-|.+....|+.++|||||||.+||++|-|.
T Consensus 822 rdLaaRNVLVksP~h--vkitdfgla~ll~~d~~ey~~~~-gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa 898 (1177)
T KOG1025|consen 822 RDLAARNVLVKSPNH--VKITDFGLAKLLAPDEKEYSAPG-GKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGA 898 (1177)
T ss_pred hhhhhhheeecCCCe--EEEEecchhhccCcccccccccc-cccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCC
Confidence 999999999987765 89999999999887654433222 223567999999999999999999999999999999777
Q ss_pred CCCCCchH-HHHHHHhhc-cccccccCChHHHHHHHHhcCCCCCCCCChhhhh
Q 003644 613 HPYGESFE-RDANIVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVL 663 (805)
Q Consensus 613 ~Pf~~~~~-~~~~~~~~~-~~~~~~~~~~~~~dLi~~~L~~dP~~Rps~~ell 663 (805)
-||..... ...+.++.. ....+.-.+.++..++.+||..|+..||+++++.
T Consensus 899 ~Py~gi~~~eI~dlle~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~ 951 (1177)
T KOG1025|consen 899 KPYDGIPAEEIPDLLEKGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELA 951 (1177)
T ss_pred CccCCCCHHHhhHHHhccccCCCCCCccHHHHHHHHHHhccCcccCccHHHHH
Confidence 77766443 333444433 3334455567899999999999999999999875
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.4e-33 Score=298.08 Aligned_cols=245 Identities=27% Similarity=0.384 Sum_probs=195.7
Q ss_pred EeeccCCceEEEEEEeeCCc-EEEEEEeecCCc------hHHHHHHHHHHHhCCCCCeeeecccccCCceEEEecccccC
Q 003644 382 KEIAKGSNGTVVLEGNYEGR-SVAVKRLVKTHH------DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTC 454 (805)
Q Consensus 382 ~~LG~GsfGtVy~a~~~~g~-~VAVK~l~~~~~------~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~E~~~~ 454 (805)
..||-|+||.|=+......+ .+|+|++++.+. +..+.|-. ++...+.|.||++|-.|.++.++|+.||-|-
T Consensus 426 aTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~-Im~~~~s~fIvrLYrTfrd~kyvYmLmEaCl- 503 (732)
T KOG0614|consen 426 ATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERN-IMMECRSDFIVRLYRTFRDSKYVYMLMEACL- 503 (732)
T ss_pred hhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHH-HHHhcCchHHHHHHHHhccchhhhhhHHhhc-
Confidence 45999999999875444433 489999876542 23344444 5556679999999999999999999999654
Q ss_pred ChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcceeccC
Q 003644 455 SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRD 534 (805)
Q Consensus 455 sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~IvHrD 534 (805)
+|.+-..|. +++.++...++.++..+++|++|||++|||.||
T Consensus 504 ---------GGElWTiLr-----------------------------dRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRD 545 (732)
T KOG0614|consen 504 ---------GGELWTILR-----------------------------DRGSFDDYTARFYVACVLEAFEYLHRKGIIYRD 545 (732)
T ss_pred ---------Cchhhhhhh-----------------------------hcCCcccchhhhhHHHHHHHHHHHHhcCceecc
Confidence 455444442 234566677889999999999999999999999
Q ss_pred CCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCC
Q 003644 535 LKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP 614 (805)
Q Consensus 535 LKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~elltG~~~P 614 (805)
|||+|++|+.+|. +||.|||+|+.+..+ ..+.++||||.|.|||++.++..+.++|.||||+++|||++| .||
T Consensus 546 LKPENllLd~~Gy--~KLVDFGFAKki~~g----~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G-~pP 618 (732)
T KOG0614|consen 546 LKPENLLLDNRGY--LKLVDFGFAKKIGSG----RKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTG-SPP 618 (732)
T ss_pred CChhheeeccCCc--eEEeehhhHHHhccC----CceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcC-CCC
Confidence 9999999998886 899999999999864 456789999999999999999999999999999999999997 889
Q ss_pred CCCchHHH--HHHHhhc-cccccccCChHHHHHHHHhcCCCCCCCCC-----hhhhhcCcccccccc
Q 003644 615 YGESFERD--ANIVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLRPK-----AQNVLNHPFFWTADT 673 (805)
Q Consensus 615 f~~~~~~~--~~~~~~~-~~~~~~~~~~~~~dLi~~~L~~dP~~Rps-----~~ell~Hpff~~~~~ 673 (805)
|....+-. ..++++. .-.+|......+.+||++++..+|.+|.. ..++.+|.||-+.++
T Consensus 619 Fs~~dpmktYn~ILkGid~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdw 685 (732)
T KOG0614|consen 619 FSGVDPMKTYNLILKGIDKIEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFDW 685 (732)
T ss_pred CCCCchHHHHHHHHhhhhhhhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCCh
Confidence 97755432 2333332 22345555678999999999999999976 789999999966554
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=303.72 Aligned_cols=250 Identities=28% Similarity=0.392 Sum_probs=196.1
Q ss_pred ceEEEeEeeccCCceEEEEE-EeeCCcEEEEEEeecCCch--HHHHHHHHHHHhCCCCCeeeecccccC-----CceEEE
Q 003644 376 KLVVFNKEIAKGSNGTVVLE-GNYEGRSVAVKRLVKTHHD--VALKEIQNLIASDQHPNIVRWYGVESD-----QDFVYL 447 (805)
Q Consensus 376 ~~~~~~~~LG~GsfGtVy~a-~~~~g~~VAVK~l~~~~~~--~~~~Ei~~ll~~l~HpNIV~l~g~~~~-----~~~l~L 447 (805)
+.+.+.+.||.|.+|.||++ +..+|+.+|||++...... +...|...++....|||++.+||++.- ++.+||
T Consensus 19 d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWL 98 (953)
T KOG0587|consen 19 DIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWL 98 (953)
T ss_pred CccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEE
Confidence 44778899999999999997 6678999999998655433 333333455666789999999998743 578999
Q ss_pred eccccc-CChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhh
Q 003644 448 SLERCT-CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH 526 (805)
Q Consensus 448 V~E~~~-~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH 526 (805)
|||+|. ||.-|++.- .+...+.|..+..|++.+++||.|||
T Consensus 99 VMEfC~gGSVTDLVKn--------------------------------------~~g~rl~E~~IaYI~re~lrgl~HLH 140 (953)
T KOG0587|consen 99 VMEFCGGGSVTDLVKN--------------------------------------TKGNRLKEEWIAYILREILRGLAHLH 140 (953)
T ss_pred EeeccCCccHHHHHhh--------------------------------------hcccchhhHHHHHHHHHHHHHHHHHh
Confidence 999886 366665521 11234567788999999999999999
Q ss_pred hcceeccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhc-----CCCCCcchHHHHH
Q 003644 527 EIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ-----GRQTRAIDLFSLG 601 (805)
Q Consensus 527 ~~~IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~-----~~~t~~sDVwSlG 601 (805)
...++|||||-.|||++.++. +||+|||++..+... .....+.+|||.|||||++.. ..|+..+|+||||
T Consensus 141 ~nkviHRDikG~NiLLT~e~~--VKLvDFGvSaQldsT---~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLG 215 (953)
T KOG0587|consen 141 NNKVIHRDIKGQNVLLTENAE--VKLVDFGVSAQLDST---VGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLG 215 (953)
T ss_pred hcceeeecccCceEEEeccCc--EEEeeeeeeeeeecc---cccccCcCCCcccccceeeecccCCCCCcccccchhhcc
Confidence 999999999999999998887 999999999887643 345567889999999999864 3467899999999
Q ss_pred HHHHHHHhCCCCCCCCchHHHHHHHhhccc----cccccCChHHHHHHHHhcCCCCCCCCChhhhhcCcccc
Q 003644 602 CILFFCITGGKHPYGESFERDANIVKDRKD----LFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFW 669 (805)
Q Consensus 602 vil~elltG~~~Pf~~~~~~~~~~~~~~~~----~~~~~~~~~~~dLi~~~L~~dP~~Rps~~ell~Hpff~ 669 (805)
++..||.-| .||+.+..+.-+-+...+.. ..+...+.++.|+|..||.+|-++||++.++|+|||..
T Consensus 216 ITaIEladG-~PPl~DmHPmraLF~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~ 286 (953)
T KOG0587|consen 216 ITAIEMAEG-APPLCDMHPMRALFLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFIT 286 (953)
T ss_pred ceeehhcCC-CCCccCcchhhhhccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccCCccc
Confidence 999999996 77887654433322221111 11234457899999999999999999999999999986
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.5e-32 Score=295.33 Aligned_cols=243 Identities=25% Similarity=0.388 Sum_probs=188.1
Q ss_pred eEEEeEeeccCCceEEEEEEee---CC--cEEEEEEeecCCc----hHHHHHHHHHHHhCCCCCeeeecccccCCceEEE
Q 003644 377 LVVFNKEIAKGSNGTVVLEGNY---EG--RSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYL 447 (805)
Q Consensus 377 ~~~~~~~LG~GsfGtVy~a~~~---~g--~~VAVK~l~~~~~----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~L 447 (805)
++...+.||.|-||.||.|... .| --||||..+.... +.+..|. .+++..+|||||+|+|+|.+. ..||
T Consensus 390 ~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa-~iMrnfdHphIikLIGv~~e~-P~Wi 467 (974)
T KOG4257|consen 390 LITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEA-SIMRNFDHPHIIKLIGVCVEQ-PMWI 467 (974)
T ss_pred hccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHH-HHHHhCCCcchhheeeeeecc-ceeE
Confidence 3456678999999999997432 23 3589999876432 3344454 478899999999999999864 7899
Q ss_pred ecccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhh
Q 003644 448 SLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE 527 (805)
Q Consensus 448 V~E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~ 527 (805)
|||+|. -|.|..+|... ...++...+..++.||+.||+|||+
T Consensus 468 vmEL~~----------~GELr~yLq~n----------------------------k~sL~l~tL~ly~~Qi~talaYLeS 509 (974)
T KOG4257|consen 468 VMELAP----------LGELREYLQQN----------------------------KDSLPLRTLTLYCYQICTALAYLES 509 (974)
T ss_pred EEeccc----------chhHHHHHHhc----------------------------cccchHHHHHHHHHHHHHHHHHHHh
Confidence 999665 44455544322 1224556678999999999999999
Q ss_pred cceeccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHHHH
Q 003644 528 IGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFC 607 (805)
Q Consensus 528 ~~IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~el 607 (805)
..+|||||..+|||+... -|+||+||||++.+..+.... .....-...|||||.+.-++++.++|||-|||.+||+
T Consensus 510 krfVHRDIAaRNiLVsSp--~CVKLaDFGLSR~~ed~~yYk--aS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEI 585 (974)
T KOG4257|consen 510 KRFVHRDIAARNILVSSP--QCVKLADFGLSRYLEDDAYYK--ASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEI 585 (974)
T ss_pred hchhhhhhhhhheeecCc--ceeeecccchhhhccccchhh--ccccccceeecCccccchhcccchhhHHHHHHHHHHH
Confidence 999999999999999765 469999999999887653322 2233356789999999999999999999999999999
Q ss_pred HhCCCCCCCCchHHH--HHHHhhccccccccCChHHHHHHHHhcCCCCCCCCChhhhh
Q 003644 608 ITGGKHPYGESFERD--ANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVL 663 (805)
Q Consensus 608 ltG~~~Pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dP~~Rps~~ell 663 (805)
+.-|..||..-...+ ..+..+.....+..++|.+..|+.+||..||.+||...|+.
T Consensus 586 l~lGvkPfqgvkNsDVI~~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~ 643 (974)
T KOG4257|consen 586 LSLGVKPFQGVKNSDVIGHIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIK 643 (974)
T ss_pred HHhcCCccccccccceEEEecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHH
Confidence 987788886643333 24455556667778889999999999999999999987754
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=274.66 Aligned_cols=255 Identities=22% Similarity=0.310 Sum_probs=202.0
Q ss_pred ceEEEeEeeccCCceEEEEEEe-eCCcEEEEEEeecCC-----chHHH-HHHHHHHHhCCCCCeeeecccccCCceEEEe
Q 003644 376 KLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH-----HDVAL-KEIQNLIASDQHPNIVRWYGVESDQDFVYLS 448 (805)
Q Consensus 376 ~~~~~~~~LG~GsfGtVy~a~~-~~g~~VAVK~l~~~~-----~~~~~-~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV 448 (805)
..|.+...||+|+|.+|.++.. .+.+.+|+|++++.- .-.+. .|-...-...+||.+|-|+.+|+.+..++.|
T Consensus 250 ~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffv 329 (593)
T KOG0695|consen 250 QDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFV 329 (593)
T ss_pred ccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEE
Confidence 3467778999999999998754 567899999987531 11222 2333344567899999999999999999999
Q ss_pred cccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhc
Q 003644 449 LERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI 528 (805)
Q Consensus 449 ~E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~ 528 (805)
.| |.++|+|.-++. +.+.+|++.++.+..+|+.||.|||+.
T Consensus 330 ie----------yv~ggdlmfhmq-----------------------------rqrklpeeharfys~ei~lal~flh~r 370 (593)
T KOG0695|consen 330 IE----------YVNGGDLMFHMQ-----------------------------RQRKLPEEHARFYSAEICLALNFLHER 370 (593)
T ss_pred EE----------EecCcceeeehh-----------------------------hhhcCcHHHhhhhhHHHHHHHHHHhhc
Confidence 99 778888765442 235689999999999999999999999
Q ss_pred ceeccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHHHHH
Q 003644 529 GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCI 608 (805)
Q Consensus 529 ~IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~ell 608 (805)
|||.||||-+|+||+..|+ +||+|+|+++.-... ...+.+.||||.|+|||++.+..|...+|+|+|||+++||+
T Consensus 371 giiyrdlkldnvlldaegh--ikltdygmcke~l~~---gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemm 445 (593)
T KOG0695|consen 371 GIIYRDLKLDNVLLDAEGH--IKLTDYGMCKEGLGP---GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMM 445 (593)
T ss_pred CeeeeeccccceEEccCCc--eeecccchhhcCCCC---CcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHH
Confidence 9999999999999998887 899999999865433 23456789999999999999999999999999999999999
Q ss_pred hCCCCCCCC-----c----hHHHHHHHhhccccccccCChHHHHHHHHhcCCCCCCCCC------hhhhhcCcccccccc
Q 003644 609 TGGKHPYGE-----S----FERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPK------AQNVLNHPFFWTADT 673 (805)
Q Consensus 609 tG~~~Pf~~-----~----~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dP~~Rps------~~ell~Hpff~~~~~ 673 (805)
.| +.||+- . .....+++-......+...+-.+..+++..|.+||.+|.. ..++..||||...++
T Consensus 446 ag-rspfdivgm~n~d~ntedylfqvilekqiriprslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~idw 524 (593)
T KOG0695|consen 446 AG-RSPFDIVGMDNPDMNTEDYLFQVILEKQIRIPRSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSIDW 524 (593)
T ss_pred cC-CCCcceecCCCcccchhHHHHHHHhhhcccccceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCCH
Confidence 97 668742 1 1112334433333445556667889999999999999964 578999999977665
Q ss_pred ch
Q 003644 674 RL 675 (805)
Q Consensus 674 ~~ 675 (805)
.+
T Consensus 525 d~ 526 (593)
T KOG0695|consen 525 DL 526 (593)
T ss_pred HH
Confidence 43
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.3e-31 Score=310.43 Aligned_cols=261 Identities=26% Similarity=0.377 Sum_probs=194.5
Q ss_pred EEEeEeeccCCceEEEEEEee--------CCcEEEEEEeecCCc----hHHHHHHHHHHHhCCCCCeeeecccccCCceE
Q 003644 378 VVFNKEIAKGSNGTVVLEGNY--------EGRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQDFV 445 (805)
Q Consensus 378 ~~~~~~LG~GsfGtVy~a~~~--------~g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l 445 (805)
..+.+.||+|.||+|++|... ....||||.++.... .....|+..|.....|||||.++|+|..++.+
T Consensus 298 l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~~ 377 (609)
T KOG0200|consen 298 LKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGPL 377 (609)
T ss_pred ccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCce
Confidence 355668999999999997433 145799999976543 34556777777788899999999999999999
Q ss_pred EEecccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcc-cccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHH
Q 003644 446 YLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLP-VMENTKDIELWKANGHPSAQLLKVTRDIVSGLSH 524 (805)
Q Consensus 446 ~LV~E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~y 524 (805)
++|+| |...|+|..+|+........ . .+ ..++. ...++..+++.++.|||.|++|
T Consensus 378 ~~v~E----------y~~~G~L~~~Lr~~r~~~~~-~------~~~~~~~~-------~~~L~~~dLlsfa~QIa~GMe~ 433 (609)
T KOG0200|consen 378 YVIVE----------YAEHGDLLEFLRKKRVTESI-D------GSGVFPNE-------RDALTTKDLLSFAYQIANGMEY 433 (609)
T ss_pred EEEEE----------eccCCcHHHHHHhccccccc-c------ccCCCccc-------cCCcCHHHHHHHHHHHHHHHHH
Confidence 99999 45556666665544300000 0 00 00000 0247888999999999999999
Q ss_pred hhhcceeccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHH
Q 003644 525 LHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCIL 604 (805)
Q Consensus 525 LH~~~IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil 604 (805)
|++.++|||||..+|||+..+. .+||+|||+|+................-...|||||.+....|+.++||||||++|
T Consensus 434 L~~~~~vHRDLAaRNVLi~~~~--~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L 511 (609)
T KOG0200|consen 434 LASVPCVHRDLAARNVLITKNK--VIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILL 511 (609)
T ss_pred HhhCCccchhhhhhhEEecCCC--EEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHH
Confidence 9999999999999999998774 48999999999765433222111110124459999999999999999999999999
Q ss_pred HHHHhCCCCCCCCch--HHHHHHHhhc-cccccccCChHHHHHHHHhcCCCCCCCCChhhhhc
Q 003644 605 FFCITGGKHPYGESF--ERDANIVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 664 (805)
Q Consensus 605 ~elltG~~~Pf~~~~--~~~~~~~~~~-~~~~~~~~~~~~~dLi~~~L~~dP~~Rps~~ell~ 664 (805)
||++|.|..||.... ......++.. ....+....+++.++++.||+.+|++||+..++.+
T Consensus 512 ~EifsLG~~PYp~~~~~~~l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~ 574 (609)
T KOG0200|consen 512 WEIFTLGGTPYPGIPPTEELLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVE 574 (609)
T ss_pred HHHhhCCCCCCCCCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 999999999998722 2223333333 33456666889999999999999999999999873
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-32 Score=286.43 Aligned_cols=255 Identities=22% Similarity=0.305 Sum_probs=187.5
Q ss_pred ccccceEEEeEeeccCCceEEEEE-EeeCCcEEEEEEeecCC--chHHHHHHHHHHHhCCC-C----CeeeecccccCCc
Q 003644 372 RRIGKLVVFNKEIAKGSNGTVVLE-GNYEGRSVAVKRLVKTH--HDVALKEIQNLIASDQH-P----NIVRWYGVESDQD 443 (805)
Q Consensus 372 ~~i~~~~~~~~~LG~GsfGtVy~a-~~~~g~~VAVK~l~~~~--~~~~~~Ei~~ll~~l~H-p----NIV~l~g~~~~~~ 443 (805)
..+..+|.+.+.+|+|.||.|... ....+..||||+++... .+.+.-|+..+.....+ | -+|.+.++|.-.+
T Consensus 85 D~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrg 164 (415)
T KOG0671|consen 85 DILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRG 164 (415)
T ss_pred cccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccC
Confidence 344677888899999999999875 23347899999986432 34556676644443233 2 3788888999999
Q ss_pred eEEEecccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHH
Q 003644 444 FVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLS 523 (805)
Q Consensus 444 ~l~LV~E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~ 523 (805)
+.+||+|.++.|+.|++. + .+..++|..+++.+++|++++++
T Consensus 165 hiCivfellG~S~~dFlk--~------------------------------------N~y~~fpi~~ir~m~~QL~~sv~ 206 (415)
T KOG0671|consen 165 HICIVFELLGLSTFDFLK--E------------------------------------NNYIPFPIDHIRHMGYQLLESVA 206 (415)
T ss_pred ceEEEEeccChhHHHHhc--c------------------------------------CCccccchHHHHHHHHHHHHHHH
Confidence 999999977766666551 1 11245788899999999999999
Q ss_pred HhhhcceeccCCCCceEEecCCC------------------CceEEEeccCccccccCCCccccccccccCCCCCCChhh
Q 003644 524 HLHEIGLIHRDLKPQNVLISKDK------------------SFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQ 585 (805)
Q Consensus 524 yLH~~~IvHrDLKp~NILl~~~~------------------~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~ 585 (805)
|||+.+++|-||||+|||+.+.. +..++|+|||.|+...... .+.+.|..|.|||+
T Consensus 207 fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h------s~iVsTRHYRAPEV 280 (415)
T KOG0671|consen 207 FLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH------STIVSTRHYRAPEV 280 (415)
T ss_pred HHHhcceeecCCChheEEEeccceEEEeccCCccceeccCCCcceEEEecCCcceeccCc------ceeeeccccCCchh
Confidence 99999999999999999985321 2358999999998765432 34567899999999
Q ss_pred hhcCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH----HH--------HHhhc--------------cc------c-
Q 003644 586 LLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERD----AN--------IVKDR--------------KD------L- 632 (805)
Q Consensus 586 l~~~~~t~~sDVwSlGvil~elltG~~~Pf~~~~~~~----~~--------~~~~~--------------~~------~- 632 (805)
+.+-.++..+||||+||||.|+.||...+......+. .. ++... .. .
T Consensus 281 iLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~ 360 (415)
T KOG0671|consen 281 ILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKY 360 (415)
T ss_pred eeccCcCCccCceeeeeEEEEeeccceecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchh
Confidence 9999999999999999999999998554443321111 00 01000 00 0
Q ss_pred ----------ccc---cCChHHHHHHHHhcCCCCCCCCChhhhhcCccccc
Q 003644 633 ----------FLV---EHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWT 670 (805)
Q Consensus 633 ----------~~~---~~~~~~~dLi~~~L~~dP~~Rps~~ell~Hpff~~ 670 (805)
+.. ....++.||+++||..||.+|+|+.|+|.||||..
T Consensus 361 v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl~EAL~HpFF~~ 411 (415)
T KOG0671|consen 361 VFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRITLREALSHPFFAR 411 (415)
T ss_pred hhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccccHHHHhcCHHhhc
Confidence 000 00125789999999999999999999999999964
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=300.66 Aligned_cols=196 Identities=33% Similarity=0.564 Sum_probs=163.6
Q ss_pred EEeEeeccCCceEEEEEE-eeCCcEEEEEEeecC----CchHHHHHHHHHHHhCCCCCeeeecccccCCc------eEEE
Q 003644 379 VFNKEIAKGSNGTVVLEG-NYEGRSVAVKRLVKT----HHDVALKEIQNLIASDQHPNIVRWYGVESDQD------FVYL 447 (805)
Q Consensus 379 ~~~~~LG~GsfGtVy~a~-~~~g~~VAVK~l~~~----~~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~------~l~L 447 (805)
...+.||+|+||.||+++ ..+|+.||||.+.+. ..+..-+|++ ++++++|||||+++++..+.. ...+
T Consensus 16 ~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~Eie-ilkKLnh~NIVk~f~iee~~~~~~~~~~~vl 94 (732)
T KOG4250|consen 16 EMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIE-ILKKLNHPNIVKLFDIEETKFLGLVTRLPVL 94 (732)
T ss_pred eehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHH-HHHHcCchhhhhhcccCCccccCcccccceE
Confidence 345679999999999997 678999999998763 2456678887 678889999999999977654 5689
Q ss_pred ecccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhh
Q 003644 448 SLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE 527 (805)
Q Consensus 448 V~E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~ 527 (805)
|||||. +|+|...|..- -+..|+|+.+++.++.+++.||.|||+
T Consensus 95 vmEyC~----------gGsL~~~L~~P--------------------------EN~~GLpE~e~l~lL~d~~~al~~LrE 138 (732)
T KOG4250|consen 95 VMEYCS----------GGSLRKVLNSP--------------------------ENAYGLPESEFLDLLSDLVSALRHLRE 138 (732)
T ss_pred EEeecC----------CCcHHHHhcCc--------------------------ccccCCCHHHHHHHHHHHHHHHHHHHH
Confidence 999664 55665555321 235789999999999999999999999
Q ss_pred cceeccCCCCceEEe--cCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhc-CCCCCcchHHHHHHHH
Q 003644 528 IGLIHRDLKPQNVLI--SKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ-GRQTRAIDLFSLGCIL 604 (805)
Q Consensus 528 ~~IvHrDLKp~NILl--~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~t~~sDVwSlGvil 604 (805)
+|||||||||.||++ ..+|...-||+|||.|+.+.++ +...+.+||+.|.+||.... +.|+..+|.|||||++
T Consensus 139 n~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel~d~----s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~Gvtl 214 (732)
T KOG4250|consen 139 NGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARELDDN----SLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTL 214 (732)
T ss_pred cCceeccCCCCcEEEeecCCCceEEeeecccccccCCCC----CeeeeecCchhhcChHHHhhccCcCceeehhhhhhHH
Confidence 999999999999998 4556777899999999988765 35567789999999999984 8899999999999999
Q ss_pred HHHHhCCCCCCC
Q 003644 605 FFCITGGKHPYG 616 (805)
Q Consensus 605 ~elltG~~~Pf~ 616 (805)
|+++|| ..||-
T Consensus 215 Y~caTG-~lPF~ 225 (732)
T KOG4250|consen 215 YECATG-ELPFI 225 (732)
T ss_pred HHHhcc-CCCCC
Confidence 999997 66664
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-29 Score=262.55 Aligned_cols=234 Identities=36% Similarity=0.559 Sum_probs=181.9
Q ss_pred CceEEEEEEee-CCcEEEEEEeecCCc----hHHHHHHHHHHHhCCCCCeeeecccccCCceEEEecccccCChhhHHHH
Q 003644 388 SNGTVVLEGNY-EGRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYV 462 (805)
Q Consensus 388 sfGtVy~a~~~-~g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~E~~~~sL~d~iy~ 462 (805)
+||.||++... +|+.||+|++..... +...+|++ .++.++|+||+++++++.+....++++|++
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~-~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~---------- 69 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREIS-ILKKLKHPNIVRLYDVFEDEDKLYLVMEYC---------- 69 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHH-HHHhCCCCcHHHHHhheeeCCEEEEEEeCC----------
Confidence 58999998665 489999999865432 34445554 667789999999999999999999999944
Q ss_pred hcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCCCceEEe
Q 003644 463 LSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLI 542 (805)
Q Consensus 463 ~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~IvHrDLKp~NILl 542 (805)
.+++|.+++... ..+++..+..++.+++.+++|||+.+++|+||+|+||++
T Consensus 70 ~~~~L~~~~~~~-----------------------------~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~ 120 (244)
T smart00220 70 DGGDLFDLLKKR-----------------------------GRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILL 120 (244)
T ss_pred CCCCHHHHHHhc-----------------------------cCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEE
Confidence 445555543221 115567788999999999999999999999999999999
Q ss_pred cCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCCCCC-c-hH
Q 003644 543 SKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGE-S-FE 620 (805)
Q Consensus 543 ~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~elltG~~~Pf~~-~-~~ 620 (805)
+.++. ++|+|||.+....... ......++..|++||.+....++.++|+||||+++|++++| ..||.. . ..
T Consensus 121 ~~~~~--~~l~d~~~~~~~~~~~----~~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~-~~p~~~~~~~~ 193 (244)
T smart00220 121 DEDGH--VKLADFGLARQLDPGG----LLTTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTG-KPPFPGDDQLL 193 (244)
T ss_pred CCCCc--EEEccccceeeecccc----ccccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhC-CCCCCCCCcHH
Confidence 87765 8999999998776431 22344588899999999888889999999999999999997 667765 2 22
Q ss_pred HHHHHHhhcccccccc---CChHHHHHHHHhcCCCCCCCCChhhhhcCccc
Q 003644 621 RDANIVKDRKDLFLVE---HIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 668 (805)
Q Consensus 621 ~~~~~~~~~~~~~~~~---~~~~~~dLi~~~L~~dP~~Rps~~ell~Hpff 668 (805)
................ ...++.+++.+||..+|++||++.++++||||
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~~~~~ 244 (244)
T smart00220 194 ELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 244 (244)
T ss_pred HHHHHHhccCCCCccccccCCHHHHHHHHHHccCCchhccCHHHHhhCCCC
Confidence 2222222222222111 55789999999999999999999999999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=283.11 Aligned_cols=258 Identities=26% Similarity=0.386 Sum_probs=194.1
Q ss_pred ccccceEEEeEeeccCCceEEEEE-EeeCCcEEEEEEee--cCC--------chHHHHHHHHHHHhCCCCCeeeeccccc
Q 003644 372 RRIGKLVVFNKEIAKGSNGTVVLE-GNYEGRSVAVKRLV--KTH--------HDVALKEIQNLIASDQHPNIVRWYGVES 440 (805)
Q Consensus 372 ~~i~~~~~~~~~LG~GsfGtVy~a-~~~~g~~VAVK~l~--~~~--------~~~~~~Ei~~ll~~l~HpNIV~l~g~~~ 440 (805)
+.+.++|-+...||+|+|..||+| .+...+.||||+-. +.. ...+.+|.. +.+.++||-||++|+|+.
T Consensus 459 ptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyr-IHKeLDHpRIVKlYDyfs 537 (775)
T KOG1151|consen 459 PTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYR-IHKELDHPRIVKLYDYFS 537 (775)
T ss_pred cchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHh-hhhccCcceeeeeeeeee
Confidence 344555666667999999999998 66778999999752 211 122344543 778899999999999986
Q ss_pred -CCceEEEecccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHH
Q 003644 441 -DQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIV 519 (805)
Q Consensus 441 -~~~~l~LV~E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa 519 (805)
|.+.+|-|+|||+|+-.|+. | ...+-+++++++.|+.||+
T Consensus 538 lDtdsFCTVLEYceGNDLDFY----------L-----------------------------KQhklmSEKEARSIiMQiV 578 (775)
T KOG1151|consen 538 LDTDSFCTVLEYCEGNDLDFY----------L-----------------------------KQHKLMSEKEARSIIMQIV 578 (775)
T ss_pred eccccceeeeeecCCCchhHH----------H-----------------------------HhhhhhhHHHHHHHHHHHH
Confidence 56778999999987533332 1 1112356778899999999
Q ss_pred HHHHHhhhc--ceeccCCCCceEEecCCCC-ceEEEeccCccccccCCCcc----ccccccccCCCCCCChhhhhcC---
Q 003644 520 SGLSHLHEI--GLIHRDLKPQNVLISKDKS-FCAKLSDMGISKRLQGDMSC----LTQNATGYGSSGWQAPEQLLQG--- 589 (805)
Q Consensus 520 ~gL~yLH~~--~IvHrDLKp~NILl~~~~~-~~~kL~DFGla~~~~~~~~~----~~~~~~~~gt~~y~APE~l~~~--- 589 (805)
.||.||.+. .|||-||||.||||..... ..+||+||||++.+.++... ..-+....||.+|++||.+.-+
T Consensus 579 nAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkeP 658 (775)
T KOG1151|consen 579 NALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEP 658 (775)
T ss_pred HHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCC
Confidence 999999987 6999999999999954321 23899999999998765322 1223445799999999987533
Q ss_pred -CCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHH-----HHHhhccccccc--cCChHHHHHHHHhcCCCCCCCCChhh
Q 003644 590 -RQTRAIDLFSLGCILFFCITGGKHPYGESFERDA-----NIVKDRKDLFLV--EHIPEAVDLFTRLLDPNPDLRPKAQN 661 (805)
Q Consensus 590 -~~t~~sDVwSlGvil~elltG~~~Pf~~~~~~~~-----~~~~~~~~~~~~--~~~~~~~dLi~~~L~~dP~~Rps~~e 661 (805)
+.+.++||||+|||+|.|+.| +.||+....... .+++.....++. ..+++++++|++||+.--+.|....+
T Consensus 659 PKIsnKVDVWSvGVIFyQClYG-rKPFGhnqsQQdILqeNTIlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~q 737 (775)
T KOG1151|consen 659 PKISNKVDVWSVGVIFYQCLYG-RKPFGHNQSQQDILQENTILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQ 737 (775)
T ss_pred CccccceeeEeeehhhhhhhcc-CCCCCCchhHHHHHhhhchhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHH
Confidence 468899999999999999997 669987654332 233333333332 34689999999999999999999999
Q ss_pred hhcCccccc
Q 003644 662 VLNHPFFWT 670 (805)
Q Consensus 662 ll~Hpff~~ 670 (805)
+..||||..
T Consensus 738 LA~dpyllP 746 (775)
T KOG1151|consen 738 LACDPYLLP 746 (775)
T ss_pred HccCccccc
Confidence 999999954
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.4e-31 Score=283.77 Aligned_cols=253 Identities=23% Similarity=0.331 Sum_probs=191.4
Q ss_pred cccccceEEEeEeeccCCceEEEEEEe-eCCcEEEEEEeecCC--chHHHHHHHHHHHhCC------CCCeeeecccccC
Q 003644 371 GRRIGKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH--HDVALKEIQNLIASDQ------HPNIVRWYGVESD 441 (805)
Q Consensus 371 ~~~i~~~~~~~~~LG~GsfGtVy~a~~-~~g~~VAVK~l~~~~--~~~~~~Ei~~ll~~l~------HpNIV~l~g~~~~ 441 (805)
++.+..+|.+....|+|-|++|+.|.. ..|..||||++.... +...++|++. +..++ --|+++|+..|..
T Consensus 427 gE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~Elei-LkKL~~AD~Edk~Hclrl~r~F~h 505 (752)
T KOG0670|consen 427 GELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEI-LKKLNDADPEDKFHCLRLFRHFKH 505 (752)
T ss_pred hhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHH-HHHhhccCchhhhHHHHHHHHhhh
Confidence 345567788888999999999999844 458899999997653 3455677764 44442 4579999999999
Q ss_pred CceEEEecccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHH
Q 003644 442 QDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSG 521 (805)
Q Consensus 442 ~~~l~LV~E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~g 521 (805)
.+++|||+|.+.-+|.+++.-.+. ..++....+..++.|+..|
T Consensus 506 knHLClVFE~LslNLRevLKKyG~-------------------------------------nvGL~ikaVRsYaqQLflA 548 (752)
T KOG0670|consen 506 KNHLCLVFEPLSLNLREVLKKYGR-------------------------------------NVGLHIKAVRSYAQQLFLA 548 (752)
T ss_pred cceeEEEehhhhchHHHHHHHhCc-------------------------------------ccceeehHHHHHHHHHHHH
Confidence 999999999877777777643332 2345566778999999999
Q ss_pred HHHhhhcceeccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHH
Q 003644 522 LSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLG 601 (805)
Q Consensus 522 L~yLH~~~IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlG 601 (805)
|..|-..||+|.||||.|||+++... .+||||||.|...... ......-+..|.|||++.+-+|+...|+||.|
T Consensus 549 LklLK~c~vlHaDIKPDNiLVNE~k~-iLKLCDfGSA~~~~en-----eitPYLVSRFYRaPEIiLG~~yd~~iD~WSvg 622 (752)
T KOG0670|consen 549 LKLLKKCGVLHADIKPDNILVNESKN-ILKLCDFGSASFASEN-----EITPYLVSRFYRAPEIILGLPYDYPIDTWSVG 622 (752)
T ss_pred HHHHHhcCeeecccCccceEeccCcc-eeeeccCccccccccc-----cccHHHHHHhccCcceeecCcccCCccceeec
Confidence 99999999999999999999987765 5899999999876542 11222346679999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCC-chHHHHHH------------H------------------------------------------
Q 003644 602 CILFFCITGGKHPYGE-SFERDANI------------V------------------------------------------ 626 (805)
Q Consensus 602 vil~elltG~~~Pf~~-~~~~~~~~------------~------------------------------------------ 626 (805)
|.||||.|| +.-|.. ........ +
T Consensus 623 ctLYElYtG-kIlFpG~TNN~MLrl~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl 701 (752)
T KOG0670|consen 623 CTLYELYTG-KILFPGRTNNQMLRLFMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDL 701 (752)
T ss_pred eeeEEeecc-ceecCCCCcHHHHHHHHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhH
Confidence 999999998 444432 21111000 0
Q ss_pred ----hhcccccccc---CChHHHHHHHHhcCCCCCCCCChhhhhcCcccc
Q 003644 627 ----KDRKDLFLVE---HIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFW 669 (805)
Q Consensus 627 ----~~~~~~~~~~---~~~~~~dLi~~~L~~dP~~Rps~~ell~Hpff~ 669 (805)
..... .+.+ ....+++|+.+||..||++|.|..++|.||||.
T Consensus 702 ~s~l~~~q~-~~deq~~~~~~~rdLLdkml~LdP~KRit~nqAL~HpFi~ 750 (752)
T KOG0670|consen 702 GSELIAVQR-LPDEQPKIVQQLRDLLDKMLILDPEKRITVNQALKHPFIT 750 (752)
T ss_pred HHHHhccCC-CCchhHHHHHHHHHHHHHHhccChhhcCCHHHHhcCCccc
Confidence 00000 0000 013678999999999999999999999999995
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.3e-31 Score=266.88 Aligned_cols=242 Identities=24% Similarity=0.395 Sum_probs=179.5
Q ss_pred EeeccCCceEEEEE-EeeCCcEEEEEEeecCC-----chHHHHHHHHHHHhCCCCCeeeecccccCC-----ceEEEecc
Q 003644 382 KEIAKGSNGTVVLE-GNYEGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQ-----DFVYLSLE 450 (805)
Q Consensus 382 ~~LG~GsfGtVy~a-~~~~g~~VAVK~l~~~~-----~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~-----~~l~LV~E 450 (805)
+.||.|+||.||-. .-.+|+.||.|++.... ....++|+. |+...+|.|++..++..+-. .++|+++|
T Consensus 59 RPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~k-mLcfFkHdNVLSaLDILQPph~dfFqEiYV~TE 137 (449)
T KOG0664|consen 59 RPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIK-MLSSFRHDNVLSLLDILQPANPSFFQELYVLTE 137 (449)
T ss_pred CcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHH-HHHhhccccHHHHHHhcCCCCchHHHHHHHHHH
Confidence 56999999999975 44579999999986543 245678886 78899999999998876544 34688888
Q ss_pred cccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcce
Q 003644 451 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 530 (805)
Q Consensus 451 ~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~I 530 (805)
++..+|..+|-. ...++...+.-+.+||++||.|||+.+|
T Consensus 138 LmQSDLHKIIVS----------------------------------------PQ~Ls~DHvKVFlYQILRGLKYLHsA~I 177 (449)
T KOG0664|consen 138 LMQSDLHKIIVS----------------------------------------PQALTPDHVKVFVYQILRGLKYLHTANI 177 (449)
T ss_pred HHHhhhhheecc----------------------------------------CCCCCcchhhhhHHHHHhhhHHHhhcch
Confidence 666666555421 1335556677899999999999999999
Q ss_pred eccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcC-CCCCcchHHHHHHHHHHHHh
Q 003644 531 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG-RQTRAIDLFSLGCILFFCIT 609 (805)
Q Consensus 531 vHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~t~~sDVwSlGvil~ellt 609 (805)
.||||||.|.|++.+ +.+||||||+++....+.. ......+-|..|.|||.+.+. .|+.++||||.|||+.|++.
T Consensus 178 LHRDIKPGNLLVNSN--CvLKICDFGLARvee~d~~--~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLg 253 (449)
T KOG0664|consen 178 LHRDIKPGNLLVNSN--CILKICDFGLARTWDQRDR--LNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQ 253 (449)
T ss_pred hhccCCCccEEeccC--ceEEecccccccccchhhh--hhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHh
Confidence 999999999999554 7799999999997654322 112233568899999999985 58999999999999999997
Q ss_pred CCCCCCCCchH-HHH------------------------HHHhhcccc------c----cccCChHHHHHHHHhcCCCCC
Q 003644 610 GGKHPYGESFE-RDA------------------------NIVKDRKDL------F----LVEHIPEAVDLFTRLLDPNPD 654 (805)
Q Consensus 610 G~~~Pf~~~~~-~~~------------------------~~~~~~~~~------~----~~~~~~~~~dLi~~~L~~dP~ 654 (805)
. +.-|....+ .+. .++...... + +.....++.+++.++|..||.
T Consensus 254 R-rILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~d 332 (449)
T KOG0664|consen 254 R-KILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPD 332 (449)
T ss_pred h-hhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCc
Confidence 4 655543211 111 111111100 0 011124788999999999999
Q ss_pred CCCChhhhhcCcccc
Q 003644 655 LRPKAQNVLNHPFFW 669 (805)
Q Consensus 655 ~Rps~~ell~Hpff~ 669 (805)
+|.+.++.+.|++.-
T Consensus 333 kris~~~A~~~~~~~ 347 (449)
T KOG0664|consen 333 KRISVEEALQHRYLE 347 (449)
T ss_pred ccccHhhhccccccc
Confidence 999999999999864
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.2e-30 Score=253.68 Aligned_cols=248 Identities=23% Similarity=0.338 Sum_probs=189.2
Q ss_pred ceEEEeEeeccCCceEEEEEE-eeCCcEEEEEEeecCCchHHHHHHHHHHHhCCCCCeeeecccccCC--ceEEEecccc
Q 003644 376 KLVVFNKEIAKGSNGTVVLEG-NYEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYGVESDQ--DFVYLSLERC 452 (805)
Q Consensus 376 ~~~~~~~~LG~GsfGtVy~a~-~~~g~~VAVK~l~~~~~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~--~~l~LV~E~~ 452 (805)
+.|.+.+++|+|.|+.|+-|. ..+...++||+++........+|+..+.....||||++|+++..|. ....|++|
T Consensus 38 ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE-- 115 (338)
T KOG0668|consen 38 DDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFE-- 115 (338)
T ss_pred chHHHHHHHcCccHhhHhcccccCCCceEEEeeechHHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhh--
Confidence 346667889999999999874 4567889999998877778889998776667799999999998875 45689999
Q ss_pred cCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcceec
Q 003644 453 TCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIH 532 (805)
Q Consensus 453 ~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~IvH 532 (805)
|..+-++...- ..++...++.++.+++.||.|||+.||.|
T Consensus 116 --------~v~n~Dfk~ly--------------------------------~tl~d~dIryY~~elLkALdyCHS~GImH 155 (338)
T KOG0668|consen 116 --------YVNNTDFKQLY--------------------------------PTLTDYDIRYYIYELLKALDYCHSMGIMH 155 (338)
T ss_pred --------hhccccHHHHh--------------------------------hhhchhhHHHHHHHHHHHHhHHHhcCccc
Confidence 55555443321 12445567899999999999999999999
Q ss_pred cCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhc-CCCCCcchHHHHHHHHHHHHhCC
Q 003644 533 RDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ-GRQTRAIDLFSLGCILFFCITGG 611 (805)
Q Consensus 533 rDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~t~~sDVwSlGvil~elltG~ 611 (805)
||+||.|++|+.... .++|+|+|||.+.....+. ...+.+..|--||.+.. +.|+.+-|+|||||++..|+...
T Consensus 156 RDVKPhNvmIdh~~r-kLrlIDWGLAEFYHp~~eY----nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrk 230 (338)
T KOG0668|consen 156 RDVKPHNVMIDHELR-KLRLIDWGLAEFYHPGKEY----NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRK 230 (338)
T ss_pred ccCCcceeeechhhc-eeeeeecchHhhcCCCcee----eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhcc
Confidence 999999999986543 5889999999988765433 33456777899999876 45899999999999999999976
Q ss_pred CCCCCCchHHH--HH---------------------------HHhhccc----cccc-----cCChHHHHHHHHhcCCCC
Q 003644 612 KHPYGESFERD--AN---------------------------IVKDRKD----LFLV-----EHIPEAVDLFTRLLDPNP 653 (805)
Q Consensus 612 ~~Pf~~~~~~~--~~---------------------------~~~~~~~----~~~~-----~~~~~~~dLi~~~L~~dP 653 (805)
.|+|......+ .. ++..... .+.. -.+|++.||+.++|..|.
T Consensus 231 epFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDH 310 (338)
T KOG0668|consen 231 EPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDH 310 (338)
T ss_pred CcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhcc
Confidence 66664432211 00 0000000 0000 014899999999999999
Q ss_pred CCCCChhhhhcCccccc
Q 003644 654 DLRPKAQNVLNHPFFWT 670 (805)
Q Consensus 654 ~~Rps~~ell~Hpff~~ 670 (805)
..|+|+.|++.||||..
T Consensus 311 qeRlTakEam~HpyF~~ 327 (338)
T KOG0668|consen 311 QERLTAKEAMAHPYFAP 327 (338)
T ss_pred ccccchHHHhcCchHHH
Confidence 99999999999999953
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-29 Score=264.53 Aligned_cols=252 Identities=22% Similarity=0.304 Sum_probs=188.5
Q ss_pred ceEEEeEeeccCCceEEEEEEe------eCCcEEEEEEeecCCch----HHHHHHHHHHHhCCCCCeeeecccccCC-ce
Q 003644 376 KLVVFNKEIAKGSNGTVVLEGN------YEGRSVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVRWYGVESDQ-DF 444 (805)
Q Consensus 376 ~~~~~~~~LG~GsfGtVy~a~~------~~g~~VAVK~l~~~~~~----~~~~Ei~~ll~~l~HpNIV~l~g~~~~~-~~ 444 (805)
.+++....+-+|.||.||+|.. .+.+.|-||.++..... ..+.|- .++-...|||+....|++.++ +.
T Consensus 284 ~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es-~lly~~sH~nll~V~~V~ie~~~~ 362 (563)
T KOG1024|consen 284 CRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQES-MLLYGASHPNLLSVLGVSIEDYAT 362 (563)
T ss_pred hheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHH-HHHhcCcCCCccceeEEEeeccCc
Confidence 4467777899999999999833 23456778877654322 223343 356667899999999998654 56
Q ss_pred EEEecccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHH
Q 003644 445 VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSH 524 (805)
Q Consensus 445 l~LV~E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~y 524 (805)
.++++. ++.-|+|..+|..-..... ...+.+...++..++.|++.|++|
T Consensus 363 P~V~y~----------~~~~gNLK~FL~~Cr~~~~---------------------~~aqtvtt~qlV~masQla~am~h 411 (563)
T KOG1024|consen 363 PFVLYP----------ATGVGNLKSFLQICRGDDP---------------------SYAQTVTTIQLVLMASQLAMAMEH 411 (563)
T ss_pred ceEEEe----------ccCcchHHHHHHHhccCCC---------------------ccccchhHHHHHHHHHHHHHHHHH
Confidence 688888 6667777777652221000 112334556788999999999999
Q ss_pred hhhcceeccCCCCceEEecCCCCceEEEeccCccccccCCC-ccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHH
Q 003644 525 LHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDM-SCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCI 603 (805)
Q Consensus 525 LH~~~IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~-~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvi 603 (805)
||..+|||.||..+|++|+ ..+++||+|=.+++.+-+.. .+... ..-....||+||.+.+..|+.++|||||||+
T Consensus 412 lh~~~ViHkDiAaRNCvId--d~LqVkltDsaLSRDLFP~DYhcLGD--nEnRPvkWMslEal~n~~yssasDvWsfGVl 487 (563)
T KOG1024|consen 412 LHNHGVIHKDIAARNCVID--DQLQVKLTDSALSRDLFPGDYHCLGD--NENRPVKWMSLEALQNSHYSSASDVWSFGVL 487 (563)
T ss_pred HHhcCcccchhhhhcceeh--hheeEEeccchhccccCcccccccCC--CCCCcccccCHHHHhhhhhcchhhhHHHHHH
Confidence 9999999999999999995 44889999999998764321 11111 1124678999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCchHHH-HHHHhhcc-ccccccCChHHHHHHHHhcCCCCCCCCChhhhh
Q 003644 604 LFFCITGGKHPYGESFERD-ANIVKDRK-DLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVL 663 (805)
Q Consensus 604 l~elltG~~~Pf~~~~~~~-~~~~~~~~-~~~~~~~~~~~~dLi~~~L~~dP~~Rps~~ell 663 (805)
+|||+|-|+.||.+-.+.+ ...++..+ -..+..+++++..++..||..+|++||+.+++.
T Consensus 488 lWELmtlg~~PyaeIDPfEm~~ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv 549 (563)
T KOG1024|consen 488 LWELMTLGKLPYAEIDPFEMEHYLKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLV 549 (563)
T ss_pred HHHHHhcCCCCccccCHHHHHHHHhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHH
Confidence 9999999999998865443 34444443 345667778999999999999999999999986
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=262.27 Aligned_cols=244 Identities=30% Similarity=0.444 Sum_probs=181.3
Q ss_pred ceEEEeEeeccCCceEEEEE-EeeCCcEEEEEEeecC-----CchHHHHHHHHHHHhCCCCCeeeecccccCC------c
Q 003644 376 KLVVFNKEIAKGSNGTVVLE-GNYEGRSVAVKRLVKT-----HHDVALKEIQNLIASDQHPNIVRWYGVESDQ------D 443 (805)
Q Consensus 376 ~~~~~~~~LG~GsfGtVy~a-~~~~g~~VAVK~l~~~-----~~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~------~ 443 (805)
.+|.-.+.+|.|.- .|.-+ ..-.++.||+|++... +...+.+|.. ++..+.|+||++++.++.-. .
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~-l~~~v~~~nii~l~n~ftP~~~l~~~~ 94 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELK-LMKCVNHKNIISLLNVFTPQKTLEEFQ 94 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhh-hhhhhcccceeeeeeccCccccHHHHH
Confidence 34555567888887 45444 4456899999988543 3456788886 77889999999999998754 3
Q ss_pred eEEEecccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHH
Q 003644 444 FVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLS 523 (805)
Q Consensus 444 ~l~LV~E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~ 523 (805)
..|+|||+++.+|.+.+.+. ++-..+..|+.|++.|++
T Consensus 95 e~y~v~e~m~~nl~~vi~~e------------------------------------------lDH~tis~i~yq~~~~ik 132 (369)
T KOG0665|consen 95 EVYLVMELMDANLCQVILME------------------------------------------LDHETISYILYQMLCGIK 132 (369)
T ss_pred hHHHHHHhhhhHHHHHHHHh------------------------------------------cchHHHHHHHHHHHHHHH
Confidence 57999998888777776432 122355789999999999
Q ss_pred HhhhcceeccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHH
Q 003644 524 HLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCI 603 (805)
Q Consensus 524 yLH~~~IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvi 603 (805)
|||+.||+||||||+||++..+.. +||.|||+|+....+ -.....+.|..|.|||++.+-.|...+||||+||+
T Consensus 133 ~lhs~~IihRdLkPsnivv~~~~~--lKi~dfg~ar~e~~~----~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci 206 (369)
T KOG0665|consen 133 HLHSAGIIHRDLKPSNIVVNSDCT--LKILDFGLARTEDTD----FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCI 206 (369)
T ss_pred HHHhcceeecccCcccceecchhh--eeeccchhhcccCcc----cccCchhheeeccCchheeccCCcccchhhhhhhH
Confidence 999999999999999999977754 899999999865532 12344568899999999999889999999999999
Q ss_pred HHHHHhCCCCCCCCchHHHH-----------------------HHHhhc--------cccccc-----------cCChHH
Q 003644 604 LFFCITGGKHPYGESFERDA-----------------------NIVKDR--------KDLFLV-----------EHIPEA 641 (805)
Q Consensus 604 l~elltG~~~Pf~~~~~~~~-----------------------~~~~~~--------~~~~~~-----------~~~~~~ 641 (805)
+.||++|.-.+-+.....+. ...... ...++. -.+..+
T Consensus 207 ~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~a 286 (369)
T KOG0665|consen 207 MGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLA 286 (369)
T ss_pred HHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHH
Confidence 99999974332222211110 000000 000110 112468
Q ss_pred HHHHHHhcCCCCCCCCChhhhhcCcccc
Q 003644 642 VDLFTRLLDPNPDLRPKAQNVLNHPFFW 669 (805)
Q Consensus 642 ~dLi~~~L~~dP~~Rps~~ell~Hpff~ 669 (805)
+|++.+||..||++|.+++++|+||||.
T Consensus 287 rdll~~MLvi~pe~Risv~daL~HPY~~ 314 (369)
T KOG0665|consen 287 RDLLSKMLVIDPEKRISVDDALRHPYIK 314 (369)
T ss_pred HHHHHHhhccChhhcccHHHHhcCCeee
Confidence 8999999999999999999999999995
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=265.96 Aligned_cols=131 Identities=27% Similarity=0.358 Sum_probs=106.2
Q ss_pred ceEEEeEeeccCCceEEEEE-EeeCCcEEEEEEeecCC--chHHHHHHHHHHHhCC-------CCCeeeecccccC----
Q 003644 376 KLVVFNKEIAKGSNGTVVLE-GNYEGRSVAVKRLVKTH--HDVALKEIQNLIASDQ-------HPNIVRWYGVESD---- 441 (805)
Q Consensus 376 ~~~~~~~~LG~GsfGtVy~a-~~~~g~~VAVK~l~~~~--~~~~~~Ei~~ll~~l~-------HpNIV~l~g~~~~---- 441 (805)
.+|.+.++||=|.|.|||++ .....+.||+|+.+..+ .+.+..||..+..... ..+||+|++.|..
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpN 157 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGPN 157 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCCC
Confidence 67889999999999999998 44567899999987644 3567888875443322 3479999999875
Q ss_pred CceEEEecccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHH
Q 003644 442 QDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSG 521 (805)
Q Consensus 442 ~~~l~LV~E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~g 521 (805)
+.+++||+|+.+.+|..+|.. ...+++|...+++|++||+.|
T Consensus 158 G~HVCMVfEvLGdnLLklI~~--------------------------------------s~YrGlpl~~VK~I~~qvL~G 199 (590)
T KOG1290|consen 158 GQHVCMVFEVLGDNLLKLIKY--------------------------------------SNYRGLPLSCVKEICRQVLTG 199 (590)
T ss_pred CcEEEEEehhhhhHHHHHHHH--------------------------------------hCCCCCcHHHHHHHHHHHHHH
Confidence 468999999888877776632 234789999999999999999
Q ss_pred HHHhhhc-ceeccCCCCceEEecC
Q 003644 522 LSHLHEI-GLIHRDLKPQNVLISK 544 (805)
Q Consensus 522 L~yLH~~-~IvHrDLKp~NILl~~ 544 (805)
|.|||.. ||||-||||+|||+..
T Consensus 200 LdYLH~ecgIIHTDlKPENvLl~~ 223 (590)
T KOG1290|consen 200 LDYLHRECGIIHTDLKPENVLLCS 223 (590)
T ss_pred HHHHHHhcCccccCCCcceeeeec
Confidence 9999975 9999999999999953
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.6e-29 Score=241.41 Aligned_cols=195 Identities=28% Similarity=0.399 Sum_probs=157.8
Q ss_pred eEeeccCCceEEEEE-EeeCCcEEEEEEeecCC----chHHHHHHHHHHHhCCCCCeeeecccccCCceEEEecccccCC
Q 003644 381 NKEIAKGSNGTVVLE-GNYEGRSVAVKRLVKTH----HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCS 455 (805)
Q Consensus 381 ~~~LG~GsfGtVy~a-~~~~g~~VAVK~l~~~~----~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~E~~~~s 455 (805)
...||+|++|.|=+- ...+|+..|||++...- +...++|+...+....+|.+|.+||...+....|+.||.++.|
T Consensus 51 i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M~tS 130 (282)
T KOG0984|consen 51 IEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELMDTS 130 (282)
T ss_pred hhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHhhhh
Confidence 356999999988443 66789999999996442 2345667776777889999999999999999999999988877
Q ss_pred hhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhc-ceeccC
Q 003644 456 LNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI-GLIHRD 534 (805)
Q Consensus 456 L~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~-~IvHrD 534 (805)
|..+... . ..+...+|+..+-+|+..+++||.|||++ .+||||
T Consensus 131 ldkfy~~-------v-----------------------------~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRD 174 (282)
T KOG0984|consen 131 LDKFYRK-------V-----------------------------LKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRD 174 (282)
T ss_pred HHHHHHH-------H-----------------------------HhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhcc
Confidence 7655310 0 12345678888999999999999999987 899999
Q ss_pred CCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhc----CCCCCcchHHHHHHHHHHHHhC
Q 003644 535 LKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ----GRQTRAIDLFSLGCILFFCITG 610 (805)
Q Consensus 535 LKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~----~~~t~~sDVwSlGvil~elltG 610 (805)
+||+||||+.+|+ +|+||||++-.+.+... .....|...|||||.+.. ..|+.++||||||+.+.||.++
T Consensus 175 vKPsNiLIn~~Gq--VKiCDFGIsG~L~dSiA----kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~l 248 (282)
T KOG0984|consen 175 VKPSNILINYDGQ--VKICDFGISGYLVDSIA----KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAIL 248 (282)
T ss_pred CCcceEEEccCCc--EEEcccccceeehhhhH----HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhc
Confidence 9999999999987 99999999988764321 111348889999998864 3689999999999999999997
Q ss_pred CCCCCCCc
Q 003644 611 GKHPYGES 618 (805)
Q Consensus 611 ~~~Pf~~~ 618 (805)
+.||...
T Consensus 249 -r~PY~~w 255 (282)
T KOG0984|consen 249 -RFPYESW 255 (282)
T ss_pred -ccccccc
Confidence 7888764
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.4e-28 Score=261.10 Aligned_cols=257 Identities=29% Similarity=0.419 Sum_probs=187.2
Q ss_pred ccccceEEEeEeeccCCceEEEEEEee----CCcEEEEEEeecCC-chHHHHHHHHHHHhCCCCCeeeecccccCCceEE
Q 003644 372 RRIGKLVVFNKEIAKGSNGTVVLEGNY----EGRSVAVKRLVKTH-HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVY 446 (805)
Q Consensus 372 ~~i~~~~~~~~~LG~GsfGtVy~a~~~----~g~~VAVK~l~~~~-~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~ 446 (805)
..+.+.|...++||+|+|++||++... ..+.||+|.+.... ......|++.+-....+.||+++.+++..++...
T Consensus 32 p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ 111 (418)
T KOG1167|consen 32 PFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVA 111 (418)
T ss_pred hhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCchHHHHHHHHHHHhccchhhhcchhhhccCCeeE
Confidence 445566778899999999999998544 46889999996554 3556678876767778999999999999999999
Q ss_pred EecccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhh
Q 003644 447 LSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH 526 (805)
Q Consensus 447 LV~E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH 526 (805)
+|+| |++.-...+++ ..++..+++.+++.++.||+++|
T Consensus 112 ivlp----------~~~H~~f~~l~--------------------------------~~l~~~~i~~Yl~~ll~Al~~~h 149 (418)
T KOG1167|consen 112 IVLP----------YFEHDRFRDLY--------------------------------RSLSLAEIRWYLRNLLKALAHLH 149 (418)
T ss_pred EEec----------ccCccCHHHHH--------------------------------hcCCHHHHHHHHHHHHHHhhhhh
Confidence 9999 54444444432 12445677899999999999999
Q ss_pred hcceeccCCCCceEEecCCCCceEEEeccCccccccCCC------c----------------------------------
Q 003644 527 EIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDM------S---------------------------------- 566 (805)
Q Consensus 527 ~~~IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~------~---------------------------------- 566 (805)
..|||||||||+|+|.+...+ .-.|.|||||....... .
T Consensus 150 ~~GIvHRDiKpsNFL~n~~t~-rg~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~ 228 (418)
T KOG1167|consen 150 KNGIVHRDIKPSNFLYNRRTQ-RGVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCND 228 (418)
T ss_pred ccCccccCCCccccccccccC-CceEEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCC
Confidence 999999999999999976543 35699999997321100 0
Q ss_pred -cccccccccCCCCCCChhhhhc-CCCCCcchHHHHHHHHHHHHhCCCCCCC-CchHHH----------------HHHH-
Q 003644 567 -CLTQNATGYGSSGWQAPEQLLQ-GRQTRAIDLFSLGCILFFCITGGKHPYG-ESFERD----------------ANIV- 626 (805)
Q Consensus 567 -~~~~~~~~~gt~~y~APE~l~~-~~~t~~sDVwSlGvil~elltG~~~Pf~-~~~~~~----------------~~~~- 626 (805)
.........||+||.|||++.. ...+.++||||.|||++-++++ +.||. ...+.+ ....
T Consensus 229 ~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~Lslls~-~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~ 307 (418)
T KOG1167|consen 229 GRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVILLSLLSR-RYPFFKAKDDADALAEIATIFGSAEMRKCAALP 307 (418)
T ss_pred CccceecccCCCCCCCchHHHhhccCcCCccceeeccceeehhhcc-ccccccCccccchHHHHHHHhChHHHHHHhhcC
Confidence 0001122359999999999976 4578999999999999999997 55553 221110 0000
Q ss_pred ----hhc----------------------cc-cc--------cccCChHHHHHHHHhcCCCCCCCCChhhhhcCcccccc
Q 003644 627 ----KDR----------------------KD-LF--------LVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTA 671 (805)
Q Consensus 627 ----~~~----------------------~~-~~--------~~~~~~~~~dLi~~~L~~dP~~Rps~~ell~Hpff~~~ 671 (805)
-+. .. .. ....+..+.||+.+||+.||.+|.|++++|+||||...
T Consensus 308 g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~~ 387 (418)
T KOG1167|consen 308 GRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDEA 387 (418)
T ss_pred CceeeeccccccccHHHHhchhccChhhcccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcch
Confidence 000 00 00 00012378899999999999999999999999999744
Q ss_pred c
Q 003644 672 D 672 (805)
Q Consensus 672 ~ 672 (805)
+
T Consensus 388 ~ 388 (418)
T KOG1167|consen 388 D 388 (418)
T ss_pred h
Confidence 3
|
|
| >PF06479 Ribonuc_2-5A: Ribonuclease 2-5A; InterPro: IPR010513 The proteins listed below share a common architecture with a protein kinase homology domain (see PDOC00100 from PROSITEDOC) followed by an ~135-residue globular kinase-extension nuclease (KEN) domain made of eight helices []: - Mammalian 2-5A-dependent RNase or RNase L (EC 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.1e-29 Score=231.30 Aligned_cols=129 Identities=53% Similarity=0.986 Sum_probs=113.8
Q ss_pred cchhhhhhccccchhccccchHHHHHHHHHHHHHhcCCcchHHHhHHHHhhhhhhcccCCCCHHHHHHHHhhcccccccC
Q 003644 673 TRLSFLRDVSDRVELEDRESDSKLLRALEGIALVALNGKWDEKMETKFIENIGRYRRYKYDNVRDLLRVIRNKSNHFREL 752 (805)
Q Consensus 673 ~~~~~l~~~~~~~e~~~~~~~~~l~~~le~~~~~~~~~~w~~~~~~~~~~~~~~~r~~~~~~~~dllr~irn~~~h~~e~ 752 (805)
+++.|++++||++|.+.+...+.++..||..+..+.+.+|++++|..++++++++|+|++++++||||+|||+.|||+|+
T Consensus 1 krl~Fl~dvSDr~E~~~~~~~s~~l~~Le~~~~~v~~~~W~~~ld~~l~~~l~~~R~Y~~~sv~DLLR~IRNk~~Hy~el 80 (129)
T PF06479_consen 1 KRLSFLQDVSDRIEKESRDPPSPLLQELESNAEDVLGGDWDKKLDPELLDDLGKYRKYDGDSVRDLLRAIRNKKHHYQEL 80 (129)
T ss_dssp HHHHHHHHHHHHCSSS-TTTTSHHHHHHHHCCCCCTTS-CGGCSBHHHHHCCTTTSS--TT-HHHHHHHHHHHHHTCCCS
T ss_pred ChhHHHHHhhhHhhhcccccchHHHHHHHhcCCCCCCccHhHHhCHHHHHHHHhccCCCccCHHHHHHHHHcchHhHHHC
Confidence 36789999999999999998899999999877777789999999999999999999999999999999999999999999
Q ss_pred ChhHHhhhCCCCccccccccccCCccHHHHHHHHHhhhcccchhhccccc
Q 003644 753 PQDIQELLGSHPEGFYNYFSCRFPKLLIEVYNVIFTYCKGEEVFHKYVTN 802 (805)
Q Consensus 753 ~~~~~~l~g~~p~~f~~yf~~~fp~ll~~~y~~~~~~~~~~~~~~~y~~~ 802 (805)
|+++++.+|++|+||..||+++||.||+|||.++. .|++|++|++||.+
T Consensus 81 ~~~~k~~lg~~p~gf~~YF~~rFP~Ll~~~Y~~~~-~~~~e~~F~~y~~~ 129 (129)
T PF06479_consen 81 PEEVKEILGSLPDGFLNYFTSRFPNLLIHVYNFVR-NCKNEPHFKKYFNP 129 (129)
T ss_dssp -HHHHHHC-STTHHHHHHHHTT-TTHHHHHHHHHH-HCTTSCCCHHHH--
T ss_pred CHHHHHHhCCCchHHHHHHHHHCcHHHHHHHHHHH-hcCccHHHHhhccC
Confidence 99999999999999999999999999999999998 99999999999974
|
1.26.-), an interferon- induced enzyme implicated in both the molecular mechanisms of interferon action and the fundamental control of RNA stability. 2-5A-dependent RNase is a unique enzyme in that it requires 2-5A, unusual oligoadenylates with 2',5'-phosphodiester linkages. RNase L is catalytically active only after binding to an unusual activator molecule containing a 5'-phosphorylated 2', 5'-linked oligoadenylate (2-5A), in the N-terminal half. RNase L consists of three domains, namely the N-terminal ankyrin repeat domain (see PDOC50088 from PROSITEDOC), the protein kinase homology domain, and the C-terminal KEN domain [, , ]. - Eukaryotic Ire1/Ern1, an ancient transmembrane sensor of endoplasmic reticulum (ER) stress with dual protein kinase and ribonuclease activities. In response to ER stress Ire1/Ern1 catalyzes the splicing of target mRNAs in a spliceosome-independent manner. Ire1/Ern1 is a type 1 transmembrane receptor consisting of an N-terminal ER luminal domain, a transmembrane segment and a cytoplasmic region. The cytoplasmic region encompasses a protein kinase domain followed by a C-terminal KEN domain [, ]. The dimerisation of the kinase domain activates the ribonuclease function of the KEN domain [].; GO: 0016891 endoribonuclease activity, producing 5'-phosphomonoesters, 0006397 mRNA processing; PDB: 3SDJ_D 3FBV_L 3LJ2_A 3SDM_A 3LJ0_A 2RIO_A 3LJ1_A 3P23_A. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.6e-28 Score=271.30 Aligned_cols=250 Identities=25% Similarity=0.382 Sum_probs=193.0
Q ss_pred ceEEEeEeeccCCceEEEEEE-eeCCcEEEEEEeecCCch---HHHHHHHHHHHhCCCCCeeeecccccCCceEEEeccc
Q 003644 376 KLVVFNKEIAKGSNGTVVLEG-NYEGRSVAVKRLVKTHHD---VALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLER 451 (805)
Q Consensus 376 ~~~~~~~~LG~GsfGtVy~a~-~~~g~~VAVK~l~~~~~~---~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~E~ 451 (805)
++|.....+|.|+||.||+++ ..+++..|||.++-.-.+ ...+|+. ++...+|||||.++|.+-..+.+|++|||
T Consensus 15 ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~-~~~dc~h~nivay~gsylr~dklwicMEy 93 (829)
T KOG0576|consen 15 DDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIG-MLRDCRHPNIVAYFGSYLRRDKLWICMEY 93 (829)
T ss_pred cchhheeeecCCcccchhhhcccccCchhhheeeeccCCcccccccccee-eeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence 457777899999999999985 457999999998754322 2345554 66788999999999999999999999999
Q ss_pred ccC-ChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcce
Q 003644 452 CTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 530 (805)
Q Consensus 452 ~~~-sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~I 530 (805)
|++ +|.|. |.-- +++.+.++...++..++||+|||+.|=
T Consensus 94 cgggslQdi-y~~T---------------------------------------gplselqiayvcRetl~gl~ylhs~gk 133 (829)
T KOG0576|consen 94 CGGGSLQDI-YHVT---------------------------------------GPLSELQIAYVCRETLQGLKYLHSQGK 133 (829)
T ss_pred cCCCcccce-eeec---------------------------------------ccchhHHHHHHHhhhhccchhhhcCCc
Confidence 874 55554 3222 334556778899999999999999999
Q ss_pred eccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhh---cCCCCCcchHHHHHHHHHHH
Q 003644 531 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLL---QGRQTRAIDLFSLGCILFFC 607 (805)
Q Consensus 531 vHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~---~~~~t~~sDVwSlGvil~el 607 (805)
+|||||-.|||+++.|. +|++|||.+..+... ......+.||+.|||||+.. .+.|...+|||++|+...|+
T Consensus 134 ~hRdiKGanilltd~gD--vklaDfgvsaqitat---i~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel 208 (829)
T KOG0576|consen 134 IHRDIKGANILLTDEGD--VKLADFGVSAQITAT---IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIEL 208 (829)
T ss_pred ccccccccceeecccCc--eeecccCchhhhhhh---hhhhhcccCCccccchhHHHHHhcccccccccccccccchhhh
Confidence 99999999999999888 899999998776532 34456678999999999863 46789999999999999998
Q ss_pred HhCCCCCCCCchHHHHHHHhhc-ccc----ccccCChHHHHHHHHhcCCCCCCCCChhhhhcCcccccc
Q 003644 608 ITGGKHPYGESFERDANIVKDR-KDL----FLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTA 671 (805)
Q Consensus 608 ltG~~~Pf~~~~~~~~~~~~~~-~~~----~~~~~~~~~~dLi~~~L~~dP~~Rps~~ell~Hpff~~~ 671 (805)
-....+-|+-...+...+.... ... ......+.+-+|++.+|.++|.+||+++.+|.|||....
T Consensus 209 ~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~ 277 (829)
T KOG0576|consen 209 GELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT 277 (829)
T ss_pred hhcCCcccccchHHHHHHhhccCCCCCcccCCccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc
Confidence 7753333433333332222211 111 112335678899999999999999999999999998654
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.3e-28 Score=293.91 Aligned_cols=204 Identities=19% Similarity=0.244 Sum_probs=144.6
Q ss_pred CC-CCeeeecccc-------cCCceEEEecccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHH
Q 003644 428 QH-PNIVRWYGVE-------SDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIE 499 (805)
Q Consensus 428 ~H-pNIV~l~g~~-------~~~~~l~LV~E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 499 (805)
.| +||++++++| .+.+.+++++|++..+|.+++. ..
T Consensus 30 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~L~~~l~-----------~~------------------------- 73 (793)
T PLN00181 30 SHIDYVRSLLGSHKEGNLDGLDDDSIVRALECEDVSLRQWLD-----------NP------------------------- 73 (793)
T ss_pred hHHHHHHHhhcccCCccccccccchhhhhhccCCccHHHHHh-----------cc-------------------------
Confidence 45 5788888877 3345678888866666655541 10
Q ss_pred HHhhCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCCCceEEecCCC-----------------CceEEEeccCcccccc
Q 003644 500 LWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDK-----------------SFCAKLSDMGISKRLQ 562 (805)
Q Consensus 500 ~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~IvHrDLKp~NILl~~~~-----------------~~~~kL~DFGla~~~~ 562 (805)
...+++.+++.|++||++||+|||++||+||||||+||||+..+ ...+|++|||+++...
T Consensus 74 ---~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~ 150 (793)
T PLN00181 74 ---DRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREE 150 (793)
T ss_pred ---cccccHHHHHHHHHHHHHHHHHHHhCCeeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccc
Confidence 13367778899999999999999999999999999999996422 2346788888876532
Q ss_pred CCCc-------------cccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhc
Q 003644 563 GDMS-------------CLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDR 629 (805)
Q Consensus 563 ~~~~-------------~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~elltG~~~Pf~~~~~~~~~~~~~~ 629 (805)
.... ........+||+.|||||++.+..++.++|||||||+||||++| .+|+.........+....
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~-~~~~~~~~~~~~~~~~~~ 229 (793)
T PLN00181 151 ILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNGSSSNCASDVYRLGVLLFELFCP-VSSREEKSRTMSSLRHRV 229 (793)
T ss_pred cccccchhhhhccccCCCcccccccCCCcceEChhhhccCCCCchhhhhhHHHHHHHHhhC-CCchhhHHHHHHHHHHhh
Confidence 1100 00011124589999999999999999999999999999999996 666654322211111111
Q ss_pred cccccccCChHHHHHHHHhcCCCCCCCCChhhhhcCcccccc
Q 003644 630 KDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTA 671 (805)
Q Consensus 630 ~~~~~~~~~~~~~dLi~~~L~~dP~~Rps~~ell~Hpff~~~ 671 (805)
.........++..+++.+||++||.+||++.|+++||||...
T Consensus 230 ~~~~~~~~~~~~~~~~~~~L~~~P~~Rps~~eil~h~~~~~~ 271 (793)
T PLN00181 230 LPPQILLNWPKEASFCLWLLHPEPSCRPSMSELLQSEFINEP 271 (793)
T ss_pred cChhhhhcCHHHHHHHHHhCCCChhhCcChHHHhhchhhhhh
Confidence 111112235677899999999999999999999999999764
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1e-25 Score=226.48 Aligned_cols=208 Identities=38% Similarity=0.661 Sum_probs=170.1
Q ss_pred eccCCceEEEEEEeeC-CcEEEEEEeecCCc----hHHHHHHHHHHHhCCCCCeeeecccccCCceEEEecccccCChhh
Q 003644 384 IAKGSNGTVVLEGNYE-GRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCSLND 458 (805)
Q Consensus 384 LG~GsfGtVy~a~~~~-g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~E~~~~sL~d 458 (805)
||+|++|.||++.... |+.++||++..... ....+|+. .+..+.|++|+++++++......++++|++.
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~-~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~----- 74 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIE-ILKKLNHPNIVKLYGVFEDENHLYLVMEYCE----- 74 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHH-HHHhcCCCCeeeEeeeeecCCeEEEEEecCC-----
Confidence 6899999999986654 89999999976644 34556665 6778899999999999999999999999655
Q ss_pred HHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCCCc
Q 003644 459 LIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQ 538 (805)
Q Consensus 459 ~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~IvHrDLKp~ 538 (805)
+++|.+++.... ..+++..+..++.+++++|+|||+.+++|+||+|.
T Consensus 75 -----~~~l~~~~~~~~----------------------------~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ 121 (215)
T cd00180 75 -----GGSLKDLLKENE----------------------------GKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPE 121 (215)
T ss_pred -----CCcHHHHHHhcc----------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHh
Confidence 344444332110 23566778999999999999999999999999999
Q ss_pred eEEecC-CCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcC-CCCCcchHHHHHHHHHHHHhCCCCCCC
Q 003644 539 NVLISK-DKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG-RQTRAIDLFSLGCILFFCITGGKHPYG 616 (805)
Q Consensus 539 NILl~~-~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~t~~sDVwSlGvil~elltG~~~Pf~ 616 (805)
||+++. ++. ++|+|||.+........ ......+...|++||.+... .++.+.|+|++|++++++
T Consensus 122 ni~~~~~~~~--~~l~d~~~~~~~~~~~~---~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l--------- 187 (215)
T cd00180 122 NILLDSDNGK--VKLADFGLSKLLTSDKS---LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL--------- 187 (215)
T ss_pred hEEEeCCCCc--EEEecCCceEEccCCcc---hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH---------
Confidence 999987 554 89999999987654321 12234478899999999877 788999999999999998
Q ss_pred CchHHHHHHHhhccccccccCChHHHHHHHHhcCCCCCCCCChhhhhcCc
Q 003644 617 ESFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHP 666 (805)
Q Consensus 617 ~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dP~~Rps~~ell~Hp 666 (805)
..+.+++.+|++.||.+||++.++++|+
T Consensus 188 ----------------------~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 ----------------------PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred ----------------------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 6789999999999999999999999885
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.3e-27 Score=257.04 Aligned_cols=190 Identities=26% Similarity=0.422 Sum_probs=153.5
Q ss_pred EEEeEeeccCCceEEEEEE-eeCCcEEEEEEeecCCc--hH---------HHHHHHHHHHhCC---CCCeeeecccccCC
Q 003644 378 VVFNKEIAKGSNGTVVLEG-NYEGRSVAVKRLVKTHH--DV---------ALKEIQNLIASDQ---HPNIVRWYGVESDQ 442 (805)
Q Consensus 378 ~~~~~~LG~GsfGtVy~a~-~~~g~~VAVK~l~~~~~--~~---------~~~Ei~~ll~~l~---HpNIV~l~g~~~~~ 442 (805)
|...+.||+|+||.|+++. ..+..+|+||.+.+... +. .-.||+ +++.++ |+||++++.+|+++
T Consensus 563 yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIq-Ila~l~~~sH~NIlKlLdfFEdd 641 (772)
T KOG1152|consen 563 YTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQ-ILATLNKHSHENILKLLDFFEDD 641 (772)
T ss_pred ceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHH-HHHHhhhcCccchhhhhheeecC
Confidence 7778899999999999984 44577899999876532 11 124776 455555 99999999999999
Q ss_pred ceEEEecccccC--ChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHH
Q 003644 443 DFVYLSLERCTC--SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVS 520 (805)
Q Consensus 443 ~~l~LV~E~~~~--sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~ 520 (805)
++.||+||.-.. +|.|+| .. ...+.+.++..|++|++.
T Consensus 642 d~yyl~te~hg~gIDLFd~I-----------E~-----------------------------kp~m~E~eAk~IFkQV~a 681 (772)
T KOG1152|consen 642 DYYYLETEVHGEGIDLFDFI-----------EF-----------------------------KPRMDEPEAKLIFKQVVA 681 (772)
T ss_pred CeeEEEecCCCCCcchhhhh-----------hc-----------------------------cCccchHHHHHHHHHHHh
Confidence 999999996542 444444 11 234677888999999999
Q ss_pred HHHHhhhcceeccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCC-CCcchHHH
Q 003644 521 GLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ-TRAIDLFS 599 (805)
Q Consensus 521 gL~yLH~~~IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~-t~~sDVwS 599 (805)
|+++||+.||||||||-+||.++.+| ++||+|||.+....++ +...++||.+|.|||++.+.+| +..-|||+
T Consensus 682 gi~hlh~~~ivhrdikdenvivd~~g--~~klidfgsaa~~ksg-----pfd~f~gtv~~aapevl~g~~y~gk~qdiwa 754 (772)
T KOG1152|consen 682 GIKHLHDQGIVHRDIKDENVIVDSNG--FVKLIDFGSAAYTKSG-----PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWA 754 (772)
T ss_pred ccccccccCceecccccccEEEecCC--eEEEeeccchhhhcCC-----CcceeeeeccccchhhhCCCccCCCcchhhh
Confidence 99999999999999999999996655 5999999999877643 4466789999999999999887 67899999
Q ss_pred HHHHHHHHHhCCCCCCC
Q 003644 600 LGCILFFCITGGKHPYG 616 (805)
Q Consensus 600 lGvil~elltG~~~Pf~ 616 (805)
+|++||-++.. ..||-
T Consensus 755 lgillytivyk-enpyy 770 (772)
T KOG1152|consen 755 LGILLYTIVYK-ENPYY 770 (772)
T ss_pred hhheeeEEEec-cCCCc
Confidence 99999998884 55653
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.4e-25 Score=225.06 Aligned_cols=246 Identities=22% Similarity=0.345 Sum_probs=180.0
Q ss_pred cceEEEeEeeccCCceEEEEEEe-eCCcEEEEEEeecCC--chHHHHHHHHHHHhCCCCCeeeeccc-ccCCceEEEecc
Q 003644 375 GKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH--HDVALKEIQNLIASDQHPNIVRWYGV-ESDQDFVYLSLE 450 (805)
Q Consensus 375 ~~~~~~~~~LG~GsfGtVy~a~~-~~g~~VAVK~l~~~~--~~~~~~Ei~~ll~~l~HpNIV~l~g~-~~~~~~l~LV~E 450 (805)
.+.|.+.+.||+|.||.+-++.. .+...+++|.+.+.. ..++.+|..--.....|.||+.-|.+ |+..+....++|
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE 102 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQE 102 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeec
Confidence 34577888999999999998754 457889999886543 34566777655556689999988875 777888889999
Q ss_pred cccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcce
Q 003644 451 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 530 (805)
Q Consensus 451 ~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~I 530 (805)
|.+.|+|...+.. .|+.+....+++.|+++|+.|+|++++
T Consensus 103 ----------~aP~gdL~snv~~------------------------------~GigE~~~K~v~~ql~SAi~fMHsknl 142 (378)
T KOG1345|consen 103 ----------FAPRGDLRSNVEA------------------------------AGIGEANTKKVFAQLLSAIEFMHSKNL 142 (378)
T ss_pred ----------cCccchhhhhcCc------------------------------ccccHHHHHHHHHHHHHHHHHhhccch
Confidence 6667777654321 345566678999999999999999999
Q ss_pred eccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcC---C--CCCcchHHHHHHHHH
Q 003644 531 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG---R--QTRAIDLFSLGCILF 605 (805)
Q Consensus 531 vHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~---~--~t~~sDVwSlGvil~ 605 (805)
||||||.+||||-...-.++||||||+++....... ..-.+..|.+||.+... . ..+.+|+|.||+|+|
T Consensus 143 VHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~tV~------~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f 216 (378)
T KOG1345|consen 143 VHRDLKAENILIFDADFYRVKLCDFGLTRKVGTTVK------YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFF 216 (378)
T ss_pred hhcccccceEEEecCCccEEEeeecccccccCceeh------hhhhhcccCCcHHHhhccccceEecccccchheeeeee
Confidence 999999999999654445899999999887653211 11245679999987542 2 367899999999999
Q ss_pred HHHhCCCCCCCCchH---HHHHHHhhcccc------ccccCChHHHHHHHHhcCCCCCCC---CChhhhhcCcc
Q 003644 606 FCITGGKHPYGESFE---RDANIVKDRKDL------FLVEHIPEAVDLFTRLLDPNPDLR---PKAQNVLNHPF 667 (805)
Q Consensus 606 elltG~~~Pf~~~~~---~~~~~~~~~~~~------~~~~~~~~~~dLi~~~L~~dP~~R---ps~~ell~Hpf 667 (805)
.++|| .+||..... ...+..++.... .....++.+..+.++-|.++|+.| -+++...+.-|
T Consensus 217 ~cltG-~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w 289 (378)
T KOG1345|consen 217 YCLTG-KFPWQKASIMDKPYWEWEQWLKRKNPALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLW 289 (378)
T ss_pred eeecC-CCcchhhhccCchHHHHHHHhcccCccCchhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHH
Confidence 99997 889975321 122222222211 123456789999999999999999 44444444433
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.1e-24 Score=212.63 Aligned_cols=147 Identities=21% Similarity=0.190 Sum_probs=114.6
Q ss_pred CCCCHHHHHHHHHHHHHHHHHhhhcceeccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCCh
Q 003644 504 NGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAP 583 (805)
Q Consensus 504 ~~l~~~~~~~i~~qIa~gL~yLH~~~IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~AP 583 (805)
.++++.+++.|+.||+.||+|||+.+ ||+|||++.++. +|+ ||+++..... ...||+.||||
T Consensus 12 ~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~--~~~--fG~~~~~~~~--------~~~g~~~y~aP 73 (176)
T smart00750 12 RPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGL--LKL--DGSVAFKTPE--------QSRVDPYFMAP 73 (176)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccc--eee--ccceEeeccc--------cCCCcccccCh
Confidence 35788999999999999999999998 999999987765 677 9998866532 12589999999
Q ss_pred hhhhcCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHH--H-HHHHhhccccc------cccCCh--HHHHHHHHhcCCC
Q 003644 584 EQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFER--D-ANIVKDRKDLF------LVEHIP--EAVDLFTRLLDPN 652 (805)
Q Consensus 584 E~l~~~~~t~~sDVwSlGvil~elltG~~~Pf~~~~~~--~-~~~~~~~~~~~------~~~~~~--~~~dLi~~~L~~d 652 (805)
|++.+..++.++|||||||++|||++| .+||...... . ..+........ ...... ++.++|.+||..|
T Consensus 74 E~~~~~~~~~~~DiwSlG~il~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~ 152 (176)
T smart00750 74 EVIQGQSYTEKADIYSLGITLYEALDY-ELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFMRVCASRL 152 (176)
T ss_pred HHhcCCCCcchhhHHHHHHHHHHHHhC-CCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHHHHHHhcc
Confidence 999999999999999999999999997 6677543221 1 11111111110 111112 5899999999999
Q ss_pred CCCCCChhhhhcCcccc
Q 003644 653 PDLRPKAQNVLNHPFFW 669 (805)
Q Consensus 653 P~~Rps~~ell~Hpff~ 669 (805)
|.+||++.|+++|+|+.
T Consensus 153 p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 153 PQRREAANHYLAHCRAL 169 (176)
T ss_pred cccccCHHHHHHHHHHH
Confidence 99999999999999863
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.9e-23 Score=212.81 Aligned_cols=194 Identities=35% Similarity=0.569 Sum_probs=153.3
Q ss_pred EEeEeeccCCceEEEEEEeeC-CcEEEEEEeecCC----chHHHHHHHHHHHhCCCCCeeeecccccCCceEEEeccccc
Q 003644 379 VFNKEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTH----HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCT 453 (805)
Q Consensus 379 ~~~~~LG~GsfGtVy~a~~~~-g~~VAVK~l~~~~----~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~E~~~ 453 (805)
.+.+.||+|++|+||++...+ ++.+|||.+.... .....+|+. .+..++|+|++++++++...+..++++|++.
T Consensus 2 ~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~-~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 2 ELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIR-ILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred ceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHH-HHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 456789999999999987664 8999999997653 234445555 6677799999999999999999999999554
Q ss_pred CChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCC-CCHHHHHHHHHHHHHHHHHhhhcceec
Q 003644 454 CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANG-HPSAQLLKVTRDIVSGLSHLHEIGLIH 532 (805)
Q Consensus 454 ~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~-l~~~~~~~i~~qIa~gL~yLH~~~IvH 532 (805)
+++|.+++... .. +++..+..++.+++.+|.|||+.+++|
T Consensus 81 ----------~~~L~~~~~~~-----------------------------~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h 121 (225)
T smart00221 81 ----------GGDLFDYLRKK-----------------------------GGKLSEEEARFYLRQILEALEYLHSLGIVH 121 (225)
T ss_pred ----------CCCHHHHHHhc-----------------------------ccCCCHHHHHHHHHHHHHHHHHHHhCCeec
Confidence 44554443221 11 456677899999999999999999999
Q ss_pred cCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhh-hcCCCCCcchHHHHHHHHHHHHhCC
Q 003644 533 RDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQL-LQGRQTRAIDLFSLGCILFFCITGG 611 (805)
Q Consensus 533 rDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l-~~~~~t~~sDVwSlGvil~elltG~ 611 (805)
+||+|.||+++.++. ++|+|||++........ .......++..|++||.+ ....++.++|+|+||++++||++|
T Consensus 122 ~di~~~ni~v~~~~~--~~l~d~g~~~~~~~~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g- 196 (225)
T smart00221 122 RDLKPENILLGMDGL--VKLADFGLARFIHRDLA--ALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWG- 196 (225)
T ss_pred CCCCHHHEEEcCCCC--EEEeeCceeeEecCccc--ccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHC-
Confidence 999999999987754 89999999987754320 022334578899999998 666778899999999999999996
Q ss_pred CCCCCC
Q 003644 612 KHPYGE 617 (805)
Q Consensus 612 ~~Pf~~ 617 (805)
+.||..
T Consensus 197 ~~pf~~ 202 (225)
T smart00221 197 PEPFSG 202 (225)
T ss_pred CCCccc
Confidence 788855
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.1e-22 Score=227.96 Aligned_cols=237 Identities=27% Similarity=0.387 Sum_probs=186.5
Q ss_pred eccCCceEEEEE----EeeCCcEEEEEEeecCCc----hHHHHHHHHHHHhCC-CCCeeeecccccCCceEEEecccccC
Q 003644 384 IAKGSNGTVVLE----GNYEGRSVAVKRLVKTHH----DVALKEIQNLIASDQ-HPNIVRWYGVESDQDFVYLSLERCTC 454 (805)
Q Consensus 384 LG~GsfGtVy~a----~~~~g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l~-HpNIV~l~g~~~~~~~l~LV~E~~~~ 454 (805)
+|+|+||.|++. +...|..+|.|.+++... ....+-+..++...+ ||.+|+++..++.+..+|++++
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld---- 77 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILD---- 77 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhh----
Confidence 799999999874 344578899998865421 111122223445544 9999999999999999999999
Q ss_pred ChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcceeccC
Q 003644 455 SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRD 534 (805)
Q Consensus 455 sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~IvHrD 534 (805)
+..+|.+...+... ..+.+.....+...++-+++++|+.+|+|||
T Consensus 78 ------~~rgg~lft~l~~~-----------------------------~~f~~~~~~~~~aelaLald~lh~l~iiyrd 122 (612)
T KOG0603|consen 78 ------FLRGGDLFTRLSKE-----------------------------VMFDELDVAFYLAELALALDHLHKLGIAYRD 122 (612)
T ss_pred ------hcccchhhhccccC-----------------------------CchHHHHHHHHHHHHHHHHhhcchhHHHHhc
Confidence 88888887765332 2234445577888999999999999999999
Q ss_pred CCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCC
Q 003644 535 LKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP 614 (805)
Q Consensus 535 LKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~elltG~~~P 614 (805)
+|++||+++.+|+ +++.|||+++...... ..|||..|||||++. ....++|.||||++++||+|| ..|
T Consensus 123 ~k~enilld~~Gh--i~~tdfglske~v~~~-------~~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg-~~p 190 (612)
T KOG0603|consen 123 YKLENVLLLLEGH--IKLTDFGLSKEAVKEK-------IACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTG-TLP 190 (612)
T ss_pred ccccceeecccCc--cccCCchhhhHhHhhh-------hcccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhC-CCC
Confidence 9999999999987 8899999998776431 128999999999997 678899999999999999997 677
Q ss_pred CCCchHHHHHHHhhccccccccCChHHHHHHHHhcCCCCCCCCCh-----hhhhcCccccccccc
Q 003644 615 YGESFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKA-----QNVLNHPFFWTADTR 674 (805)
Q Consensus 615 f~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dP~~Rps~-----~ell~Hpff~~~~~~ 674 (805)
|.. .....+.......+.+.++++++++..++..+|..|... .|+++|+|||..++.
T Consensus 191 f~~---~~~~~Il~~~~~~p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f~~~i~~~ 252 (612)
T KOG0603|consen 191 FGG---DTMKRILKAELEMPRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHEFFQSIDWN 252 (612)
T ss_pred Cch---HHHHHHhhhccCCchhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhccchheeeeHh
Confidence 776 233334444555677788999999999999999999754 689999999877654
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.85 E-value=4.4e-20 Score=196.43 Aligned_cols=251 Identities=31% Similarity=0.478 Sum_probs=183.5
Q ss_pred EEEeEeeccCCceEEEEEEeeCCcEEEEEEeecCCc------hHHHHHHHHHHHhCCCC-CeeeecccccCCceEEEecc
Q 003644 378 VVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHH------DVALKEIQNLIASDQHP-NIVRWYGVESDQDFVYLSLE 450 (805)
Q Consensus 378 ~~~~~~LG~GsfGtVy~a~~~~g~~VAVK~l~~~~~------~~~~~Ei~~ll~~l~Hp-NIV~l~g~~~~~~~l~LV~E 450 (805)
|...+.||.|+||.||++... ..+|+|.+..... ....+|.. +++.+.|+ +|++++.++......+++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~-~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 78 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQ-ILASLNHPPNIVKLYDFFQDEGSLYLVME 78 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHH-HHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence 456788999999999997665 7899999865432 23445554 66777777 79999999988788899999
Q ss_pred cccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcce
Q 003644 451 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 530 (805)
Q Consensus 451 ~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~I 530 (805)
++. ++++.+.+..... + ..++......++.|++.+++|+|+.++
T Consensus 79 ~~~----------~~~l~~~~~~~~~------------------------~--~~~~~~~~~~~~~~~~~~l~~~H~~~~ 122 (384)
T COG0515 79 YVD----------GGSLEDLLKKIGR------------------------K--GPLSESEALFILAQILSALEYLHSKGI 122 (384)
T ss_pred cCC----------CCcHHHHHHhccc------------------------c--cCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 554 4444432211100 0 245667789999999999999999999
Q ss_pred eccCCCCceEEecCCCCceEEEeccCccccccCCCcccc---ccccccCCCCCCChhhhhc---CCCCCcchHHHHHHHH
Q 003644 531 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLT---QNATGYGSSGWQAPEQLLQ---GRQTRAIDLFSLGCIL 604 (805)
Q Consensus 531 vHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~---~~~~~~gt~~y~APE~l~~---~~~t~~sDVwSlGvil 604 (805)
+|||+||+||+++..+. .++++|||+++.......... ......||..|+|||.+.. ..+....|+||+|+++
T Consensus 123 ~hrd~kp~nil~~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~ 201 (384)
T COG0515 123 IHRDIKPENILLDRDGR-VVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITL 201 (384)
T ss_pred eccCCCHHHeeecCCCC-eEEEeccCcceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHH
Confidence 99999999999987652 489999999986654332211 2355679999999999987 5788999999999999
Q ss_pred HHHHhCCCCCCCCchH-----HHHHHHhhcccc-c--cccCC------hHHHHHHHHhcCCCCCCCCChhhhhcCcccc
Q 003644 605 FFCITGGKHPYGESFE-----RDANIVKDRKDL-F--LVEHI------PEAVDLFTRLLDPNPDLRPKAQNVLNHPFFW 669 (805)
Q Consensus 605 ~elltG~~~Pf~~~~~-----~~~~~~~~~~~~-~--~~~~~------~~~~dLi~~~L~~dP~~Rps~~ell~Hpff~ 669 (805)
+++++| ..||..... .....+...... . ..... ..+.+++.+|+..+|..|.++.+...+++..
T Consensus 202 ~~~~~~-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~ 279 (384)
T COG0515 202 YELLTG-LPPFEGEKNSSATSQTLKIILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLA 279 (384)
T ss_pred HHHHhC-CCCCCCCCccccHHHHHHHHHhcCCcccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhh
Confidence 999997 556665432 222222222111 1 11111 3688999999999999999999998886653
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.8e-22 Score=233.57 Aligned_cols=251 Identities=22% Similarity=0.337 Sum_probs=176.6
Q ss_pred EEeEeeccCCceEEEEEEe-eCCcEEEEEEee----cCCchHH----HHHHHHHHHhCCCCCeeeecccccCCceEEEec
Q 003644 379 VFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLV----KTHHDVA----LKEIQNLIASDQHPNIVRWYGVESDQDFVYLSL 449 (805)
Q Consensus 379 ~~~~~LG~GsfGtVy~a~~-~~g~~VAVK~l~----~~~~~~~----~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~ 449 (805)
.....+|.|++|.|+.... ...+..+.|... ....... ..++..+-..+.|||++..+..+.+....+-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 3557899999997766432 334444554332 2221111 111122445689999999888888877777779
Q ss_pred ccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcc
Q 003644 450 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG 529 (805)
Q Consensus 450 E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~ 529 (805)
|||+.+|..++-. + ..+...++..+++|++.||+|||+.|
T Consensus 401 E~~~~Dlf~~~~~-~---------------------------------------~~~~~~e~~c~fKqL~~Gv~y~h~~G 440 (601)
T KOG0590|consen 401 EYCPYDLFSLVMS-N---------------------------------------GKLTPLEADCFFKQLLRGVKYLHSMG 440 (601)
T ss_pred hcccHHHHHHHhc-c---------------------------------------cccchhhhhHHHHHHHHHHHHHHhcC
Confidence 9887655544411 0 12334566899999999999999999
Q ss_pred eeccCCCCceEEecCCCCceEEEeccCccccccCCCcc-ccccccccCCCCCCChhhhhcCCCC-CcchHHHHHHHHHHH
Q 003644 530 LIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSC-LTQNATGYGSSGWQAPEQLLQGRQT-RAIDLFSLGCILFFC 607 (805)
Q Consensus 530 IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~-~~~~~~~~gt~~y~APE~l~~~~~t-~~sDVwSlGvil~el 607 (805)
|.|||||++|++++.+|. +||+|||.+....-..+. .......+|+..|+|||++.+..|. +.+||||.|++++.|
T Consensus 441 iahrdlK~enll~~~~g~--lki~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m 518 (601)
T KOG0590|consen 441 LAHRDLKLENLLVTENGI--LKIIDFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICM 518 (601)
T ss_pred ceeccCccccEEEecCCc--eEEeecCcceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEE
Confidence 999999999999998875 899999998766433221 1334556799999999999999886 579999999999999
Q ss_pred HhCCCCCCCCchHHHHHH----------HhhccccccccCChHHHHHHHHhcCCCCCCCCChhhhhcCccccccc
Q 003644 608 ITGGKHPYGESFERDANI----------VKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTAD 672 (805)
Q Consensus 608 ltG~~~Pf~~~~~~~~~~----------~~~~~~~~~~~~~~~~~dLi~~~L~~dP~~Rps~~ell~Hpff~~~~ 672 (805)
.+| +.||......+... +...+.........+.+.+|.+||++||.+|.|++++++.+||...+
T Consensus 519 ~~~-~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~ 592 (601)
T KOG0590|consen 519 ILG-RFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIE 592 (601)
T ss_pred ecC-CCccccccccccchhhhccccccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhcc
Confidence 997 88886543322110 00001111112234678899999999999999999999999997643
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.1e-20 Score=208.56 Aligned_cols=166 Identities=20% Similarity=0.157 Sum_probs=119.7
Q ss_pred ccccceEEEeEeeccCCceEEEEEEee--CCcEEEEEEeecCC--------chHHHHHHHHHHHhCCCCCeee-eccccc
Q 003644 372 RRIGKLVVFNKEIAKGSNGTVVLEGNY--EGRSVAVKRLVKTH--------HDVALKEIQNLIASDQHPNIVR-WYGVES 440 (805)
Q Consensus 372 ~~i~~~~~~~~~LG~GsfGtVy~a~~~--~g~~VAVK~l~~~~--------~~~~~~Ei~~ll~~l~HpNIV~-l~g~~~ 440 (805)
+.+...|.+.+.||+|+||+||+|... +++.||||++.... .....+|+. ++..++|+||++ ++.+
T Consensus 14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~-iL~~L~h~~iv~~l~~~-- 90 (365)
T PRK09188 14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIR-ALKTVRGIGVVPQLLAT-- 90 (365)
T ss_pred ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHH-HHHhccCCCCCcEEEEc--
Confidence 445667889999999999999998553 57888999875321 122345664 778899999984 5542
Q ss_pred CCceEEEecccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHH
Q 003644 441 DQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVS 520 (805)
Q Consensus 441 ~~~~l~LV~E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~ 520 (805)
+..|||||||. +++|... .. . ....++.|+++
T Consensus 91 --~~~~LVmE~~~----------G~~L~~~-~~--------------------------------~---~~~~~~~~i~~ 122 (365)
T PRK09188 91 --GKDGLVRGWTE----------GVPLHLA-RP--------------------------------H---GDPAWFRSAHR 122 (365)
T ss_pred --CCcEEEEEccC----------CCCHHHh-Cc--------------------------------c---chHHHHHHHHH
Confidence 45799999554 4444311 00 0 01357889999
Q ss_pred HHHHhhhcceeccCC-CCceEEecCCCCceEEEeccCccccccCCCcccc-----ccccccCCCCCCChhhhhcCC
Q 003644 521 GLSHLHEIGLIHRDL-KPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLT-----QNATGYGSSGWQAPEQLLQGR 590 (805)
Q Consensus 521 gL~yLH~~~IvHrDL-Kp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~-----~~~~~~gt~~y~APE~l~~~~ 590 (805)
||+|||+.||+|||| ||+|||++.++. +||+|||+|+.+........ ......+++.|+|||.+....
T Consensus 123 aL~~lH~~gIiHrDL~KP~NILv~~~~~--ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~ 196 (365)
T PRK09188 123 ALRDLHRAGITHNDLAKPQNWLMGPDGE--AAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRE 196 (365)
T ss_pred HHHHHHHCCCeeCCCCCcceEEEcCCCC--EEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChhh
Confidence 999999999999999 999999977765 89999999997754322111 113456889999999987643
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.5e-19 Score=198.46 Aligned_cols=248 Identities=23% Similarity=0.258 Sum_probs=173.4
Q ss_pred eEEEeEeeccCCceEEEEEEeeCC--cEEEEEEeecCC---chHHHHHHHHHHHhC---CCCCeeeecccc-cCCceEEE
Q 003644 377 LVVFNKEIAKGSNGTVVLEGNYEG--RSVAVKRLVKTH---HDVALKEIQNLIASD---QHPNIVRWYGVE-SDQDFVYL 447 (805)
Q Consensus 377 ~~~~~~~LG~GsfGtVy~a~~~~g--~~VAVK~l~~~~---~~~~~~Ei~~ll~~l---~HpNIV~l~g~~-~~~~~l~L 447 (805)
.|.+.+.||+|+||.||++..... ..+|+|...... ......|...+.... .-+++.+++... ..+.+.|+
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 688999999999999999865553 578999876432 113344554332222 235788888888 58889999
Q ss_pred ecccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhh
Q 003644 448 SLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE 527 (805)
Q Consensus 448 V~E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~ 527 (805)
||++++.+|.++..... .+.++..++++|+.|++.+|++||+
T Consensus 99 VM~l~G~sL~dl~~~~~--------------------------------------~~~fs~~T~l~ia~q~l~~l~~lH~ 140 (322)
T KOG1164|consen 99 VMSLLGPSLEDLRKRNP--------------------------------------PGRFSRKTVLRIAIQNLNALEDLHS 140 (322)
T ss_pred EEeccCccHHHHHHhCC--------------------------------------CCCcCHhHHHHHHHHHHHHHHHHHh
Confidence 99999999888653211 1346667889999999999999999
Q ss_pred cceeccCCCCceEEecCCC-C--ceEEEeccCccc--cccCCCcc----ccc-cccccCCCCCCChhhhhcCCCCCcchH
Q 003644 528 IGLIHRDLKPQNVLISKDK-S--FCAKLSDMGISK--RLQGDMSC----LTQ-NATGYGSSGWQAPEQLLQGRQTRAIDL 597 (805)
Q Consensus 528 ~~IvHrDLKp~NILl~~~~-~--~~~kL~DFGla~--~~~~~~~~----~~~-~~~~~gt~~y~APE~l~~~~~t~~sDV 597 (805)
.|++||||||+|+++.... . ..+.|.|||+++ ........ ... .....||..|+++.+..+...+++.|+
T Consensus 141 ~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDl 220 (322)
T KOG1164|consen 141 KGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDL 220 (322)
T ss_pred cCcccCCcCHHHeeecCCCCcccceEEEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhh
Confidence 9999999999999997653 1 358999999999 43322211 111 223459999999999999999999999
Q ss_pred HHHHHHHHHHHhCCCCCCCCchHH--HHHHHhhcccc----ccccCChHHHHHHHHhcCCCCCCCCChhhhh
Q 003644 598 FSLGCILFFCITGGKHPYGESFER--DANIVKDRKDL----FLVEHIPEAVDLFTRLLDPNPDLRPKAQNVL 663 (805)
Q Consensus 598 wSlGvil~elltG~~~Pf~~~~~~--~~~~~~~~~~~----~~~~~~~~~~dLi~~~L~~dP~~Rps~~ell 663 (805)
||++.++.|++.| ..||...... ........... .......++.++...+-..+...+|....+.
T Consensus 221 es~~Y~l~el~~g-~LPW~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~ 291 (322)
T KOG1164|consen 221 ESLFYMLLELLKG-SLPWEALEMTDLKSKFEKDPRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLA 291 (322)
T ss_pred hhHHHHHHHHhcC-CCCCccccccchHHHHHHHhhhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHH
Confidence 9999999999997 6898553321 11111111111 1111234556666666566777777766554
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.6e-20 Score=193.61 Aligned_cols=206 Identities=21% Similarity=0.318 Sum_probs=169.1
Q ss_pred ccccceEEEeEeeccCCceEEEEE-EeeCCcEEEEEEee-cCCchHHHHHHHHHHHhCCCCCeeeecccccCCceEEEec
Q 003644 372 RRIGKLVVFNKEIAKGSNGTVVLE-GNYEGRSVAVKRLV-KTHHDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSL 449 (805)
Q Consensus 372 ~~i~~~~~~~~~LG~GsfGtVy~a-~~~~g~~VAVK~l~-~~~~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~ 449 (805)
-.+|-.|.++++||+|+||..+.+ .+.+++.||||.-. ++...+...|.....-....+.|...|.+-.++-+-.||+
T Consensus 24 ~~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVi 103 (449)
T KOG1165|consen 24 LMVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVI 103 (449)
T ss_pred eEecccceeccccccCcceeeecccccccCceEEEEeccccCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhh
Confidence 356777999999999999999987 57889999999653 3334455556654333447899999999989999999999
Q ss_pred ccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcc
Q 003644 450 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG 529 (805)
Q Consensus 450 E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~ 529 (805)
|+..-||+|++- |..+.++.++++.|+.|++.-++|+|++.
T Consensus 104 dLLGPSLEDLFD---------------------------------------~CgR~FSvKTV~miA~Qmi~rie~vH~k~ 144 (449)
T KOG1165|consen 104 DLLGPSLEDLFD---------------------------------------LCGRRFSVKTVAMIAKQMITRIEYVHEKD 144 (449)
T ss_pred hhhCcCHHHHHH---------------------------------------HhcCcccHHhHHHHHHHHHHHHHHHHhcc
Confidence 999888888872 67778888999999999999999999999
Q ss_pred eeccCCCCceEEecCCCC---ceEEEeccCccccccCCCcc----ccccccccCCCCCCChhhhhcCCCCCcchHHHHHH
Q 003644 530 LIHRDLKPQNVLISKDKS---FCAKLSDMGISKRLQGDMSC----LTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGC 602 (805)
Q Consensus 530 IvHrDLKp~NILl~~~~~---~~~kL~DFGla~~~~~~~~~----~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGv 602 (805)
+|.|||||+|.||...++ -.+.|+|||+|+...+..+. ........||.+||+-....++..+++.|+-|||-
T Consensus 145 LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGH 224 (449)
T KOG1165|consen 145 LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGH 224 (449)
T ss_pred eeecccCccceeecCCCCCCCceEEEEeccchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhh
Confidence 999999999999964322 24789999999988654322 22334556999999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCC
Q 003644 603 ILFFCITGGKHPYGE 617 (805)
Q Consensus 603 il~elltG~~~Pf~~ 617 (805)
++.+.|-| ..||..
T Consensus 225 vFmYFLRG-sLPWQG 238 (449)
T KOG1165|consen 225 VFMYFLRG-SLPWQG 238 (449)
T ss_pred hhhhhccC-CCcccc
Confidence 99999996 889965
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=7.8e-20 Score=182.63 Aligned_cols=246 Identities=20% Similarity=0.242 Sum_probs=176.4
Q ss_pred cccceEEEeEeeccCCceEEEEE-EeeCCcEEEEEEeecC-CchHHHHHHHHHHHhCCCCCeeeecccccCCceEEEecc
Q 003644 373 RIGKLVVFNKEIAKGSNGTVVLE-GNYEGRSVAVKRLVKT-HHDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 450 (805)
Q Consensus 373 ~i~~~~~~~~~LG~GsfGtVy~a-~~~~g~~VAVK~l~~~-~~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~E 450 (805)
..+..|.+.++||.|+||.+|++ ...+|.+||||.-... .+.+...|-........-..|..++.|..++++-.||||
T Consensus 12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd 91 (341)
T KOG1163|consen 12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD 91 (341)
T ss_pred eeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCCcchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence 34566889999999999999998 5678999999986543 234444454422222234667778888899999999999
Q ss_pred cccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcce
Q 003644 451 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 530 (805)
Q Consensus 451 ~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~I 530 (805)
+..-||++++-+. .+.++..+++-++-|++.-++|+|.+++
T Consensus 92 LLGPsLEdLfnfC---------------------------------------~R~ftmkTvLMLaDQml~RiEyvH~r~f 132 (341)
T KOG1163|consen 92 LLGPSLEDLFNFC---------------------------------------SRRFTMKTVLMLADQMLSRIEYVHLRNF 132 (341)
T ss_pred ccCccHHHHHHHH---------------------------------------hhhhhHHhHHHHHHHHHHHHHHHHhhcc
Confidence 9999999887433 2345667889999999999999999999
Q ss_pred eccCCCCceEEecCCCCc-eEEEeccCccccccCCCcc----ccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHH
Q 003644 531 IHRDLKPQNVLISKDKSF-CAKLSDMGISKRLQGDMSC----LTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILF 605 (805)
Q Consensus 531 vHrDLKp~NILl~~~~~~-~~kL~DFGla~~~~~~~~~----~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~ 605 (805)
|||||||+|.|..-+.+. .+.++|||+|+...+..+. ........||..|.+-....+-..+.+.|+-|+|.+|.
T Consensus 133 iHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLm 212 (341)
T KOG1163|consen 133 IHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLM 212 (341)
T ss_pred ccccCCccceeeccccccceEEEEeccchhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceee
Confidence 999999999998544322 4779999999988653221 22233456999999988888878899999999999998
Q ss_pred HHHhCCCCCCCCchHHH-----HHHHhhcccc----ccccCChHHHHHHHHhcCCCCCCCCC
Q 003644 606 FCITGGKHPYGESFERD-----ANIVKDRKDL----FLVEHIPEAVDLFTRLLDPNPDLRPK 658 (805)
Q Consensus 606 elltG~~~Pf~~~~~~~-----~~~~~~~~~~----~~~~~~~~~~dLi~~~L~~dP~~Rps 658 (805)
+..-| ..||..-.... ..+....... .....+.|+.-.+.-|-..-=++-|.
T Consensus 213 YfnrG-~LPWQglka~tk~QKyEkI~EkK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pd 273 (341)
T KOG1163|consen 213 YFNRG-SLPWQGLKAATKKQKYEKISEKKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPD 273 (341)
T ss_pred eeecC-CCcccccchhhHHHHHHHHHHhhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCc
Confidence 87775 88997643221 1222221111 11233456777777775554444454
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=4.2e-20 Score=195.64 Aligned_cols=202 Identities=22% Similarity=0.315 Sum_probs=140.4
Q ss_pred CCCCCeeeecccccCC---------------------------ceEEEecccccCChhhHHHHhcCCHHHHHhhhhccch
Q 003644 427 DQHPNIVRWYGVESDQ---------------------------DFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSN 479 (805)
Q Consensus 427 l~HpNIV~l~g~~~~~---------------------------~~l~LV~E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~ 479 (805)
-+|||||++.++|.+. ..+|+||..+.++|.+|+....
T Consensus 273 a~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~tLr~yl~~~~--------------- 337 (598)
T KOG4158|consen 273 AKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQTLREYLWTRH--------------- 337 (598)
T ss_pred CCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchhhHHHHHhcCC---------------
Confidence 4699999999876543 3589999998888888774322
Q ss_pred hhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCCCceEEe--cCCCCceEEEeccCc
Q 003644 480 LLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLI--SKDKSFCAKLSDMGI 557 (805)
Q Consensus 480 ~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~IvHrDLKp~NILl--~~~~~~~~kL~DFGl 557 (805)
.+.....-++.|+++|+.|||.+||.|||+|++|||+ ++|+-..+.|+|||.
T Consensus 338 --------------------------~s~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGC 391 (598)
T KOG4158|consen 338 --------------------------RSYRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGC 391 (598)
T ss_pred --------------------------CchHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccce
Confidence 1222346789999999999999999999999999998 455555688999998
Q ss_pred cccccCC---CccccccccccCCCCCCChhhhhcCC------CCCcchHHHHHHHHHHHHhCCCCCCCCchHH---HHHH
Q 003644 558 SKRLQGD---MSCLTQNATGYGSSGWQAPEQLLQGR------QTRAIDLFSLGCILFFCITGGKHPYGESFER---DANI 625 (805)
Q Consensus 558 a~~~~~~---~~~~~~~~~~~gt~~y~APE~l~~~~------~t~~sDVwSlGvil~elltG~~~Pf~~~~~~---~~~~ 625 (805)
+---... ....+......|...-||||+....+ .-.++|.|+.|.+.||+++. ..||...-+- ....
T Consensus 392 cLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~-~NPFY~rGem~L~~r~Y 470 (598)
T KOG4158|consen 392 CLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGR-SNPFYKRGEMLLDTRTY 470 (598)
T ss_pred eeeccccccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhcc-CCcccccchheechhhh
Confidence 7432211 01111112234788899999986432 13589999999999999986 5555431111 1111
Q ss_pred HhhccccccccCChHHHHHHHHhcCCCCCCCCChh---hhhcCcccccc
Q 003644 626 VKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQ---NVLNHPFFWTA 671 (805)
Q Consensus 626 ~~~~~~~~~~~~~~~~~dLi~~~L~~dP~~Rps~~---ell~Hpff~~~ 671 (805)
.+.+-...+....+.+++++..+|+.||.+|++.. .++ |-+.|..
T Consensus 471 qe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~iAANvl-~LsLw~~ 518 (598)
T KOG4158|consen 471 QESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPNIAANVL-NLSLWRM 518 (598)
T ss_pred hhhhCCCCcccCChHHHHHHHHHhcCCccccCCccHHHhHH-HHHHhcC
Confidence 22233334556678999999999999999998853 444 4555543
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.7e-20 Score=218.94 Aligned_cols=244 Identities=23% Similarity=0.249 Sum_probs=170.5
Q ss_pred eEEEeEeeccCCceEEEEEEeeCCcEEEEEEeecCCc-------hHHHHHHHHHHHhCCCCCeeeecccccCCceEEEec
Q 003644 377 LVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHH-------DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSL 449 (805)
Q Consensus 377 ~~~~~~~LG~GsfGtVy~a~~~~g~~VAVK~l~~~~~-------~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~ 449 (805)
.+...+.||++.|=+|.++...+|. |+||++.+... .+.++|++ ....+|||.+++.-+...+...|||-
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik--~~l~~~pn~lPfqk~~~t~kAAylvR 100 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK--FALMKAPNCLPFQKVLVTDKAAYLVR 100 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH--HHhhcCCcccchHHHHHhhHHHHHHH
Confidence 3566788999999999998888886 99999976542 23444554 56779999999998877777788888
Q ss_pred ccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcc
Q 003644 450 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG 529 (805)
Q Consensus 450 E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~ 529 (805)
+|...+|.|-+ +...+| ..-+.+.|+.|++.||.-+|..|
T Consensus 101 qyvkhnLyDRl-----STRPFL-----------------------------------~~iEKkWiaFQLL~al~qcH~~g 140 (1431)
T KOG1240|consen 101 QYVKHNLYDRL-----STRPFL-----------------------------------VLIEKKWIAFQLLKALSQCHKLG 140 (1431)
T ss_pred HHHhhhhhhhh-----ccchHH-----------------------------------HHHHHHHHHHHHHHHHHHHHHcC
Confidence 85555544433 111111 12345789999999999999999
Q ss_pred eeccCCCCceEEecCCCCceEEEeccCcccccc--CC--CccccccccccCCCCCCChhhhhcC----------C-CCCc
Q 003644 530 LIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQ--GD--MSCLTQNATGYGSSGWQAPEQLLQG----------R-QTRA 594 (805)
Q Consensus 530 IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~--~~--~~~~~~~~~~~gt~~y~APE~l~~~----------~-~t~~ 594 (805)
|+|+|||.+||||+.-+- +.|+||..-+..- .+ .+...-..+...-..|+|||.+... . .+++
T Consensus 141 VcHGDIKsENILiTSWNW--~~LtDFAsFKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~pa 218 (1431)
T KOG1240|consen 141 VCHGDIKSENILITSWNW--LYLTDFASFKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPA 218 (1431)
T ss_pred ccccccccceEEEeeech--hhhhcccccCCccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChh
Confidence 999999999999988765 6699998655431 11 1111111222334579999987642 1 5678
Q ss_pred chHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhcccccccc--CChHHHHHHHHhcCCCCCCCCChhhhhcC
Q 003644 595 IDLFSLGCILFFCITGGKHPYGESFERDANIVKDRKDLFLVE--HIPEAVDLFTRLLDPNPDLRPKAQNVLNH 665 (805)
Q Consensus 595 sDVwSlGvil~elltG~~~Pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~dLi~~~L~~dP~~Rps~~ell~H 665 (805)
-||||+||++.|+++-|+|+|.-+.--..............+ ....++.+|..|++.||++|.+|++.|+.
T Consensus 219 MDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~~~~~~e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 219 MDIFSAGCVIAELFLEGRPLFTLSQLLAYRSGNADDPEQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred hhhhhhhHHHHHHHhcCCCcccHHHHHhHhccCccCHHHHHHhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 999999999999999889998643211110000000000000 12478999999999999999999999966
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=6.1e-19 Score=178.54 Aligned_cols=235 Identities=20% Similarity=0.290 Sum_probs=172.5
Q ss_pred EeEeeccCCceEEEEEEeeCCcEEEEEEeecCC----chHHHHHHHHHHHhCCCCCeeeecccccCCceEEEecccccCC
Q 003644 380 FNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTH----HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCS 455 (805)
Q Consensus 380 ~~~~LG~GsfGtVy~a~~~~g~~VAVK~l~~~~----~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~E~~~~s 455 (805)
+..+|.+...|..|+ +.+.|..+++|++.-.+ ....+.|+---++...||||+..+|.|....++.++..
T Consensus 194 l~tkl~e~hsgelwr-grwqgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq----- 267 (448)
T KOG0195|consen 194 LITKLAESHSGELWR-GRWQGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQ----- 267 (448)
T ss_pred hhhhhccCCCccccc-ccccCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeee-----
Confidence 345678888899998 45566678888875332 12334444335677889999999999999999999999
Q ss_pred hhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhc-cee-cc
Q 003644 456 LNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI-GLI-HR 533 (805)
Q Consensus 456 L~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~-~Iv-Hr 533 (805)
||+.|+|+..||..... -.+..++.+++.+|++|++|||+. .++ --
T Consensus 268 -----~mp~gslynvlhe~t~v---------------------------vvd~sqav~faldiargmaflhslep~ipr~ 315 (448)
T KOG0195|consen 268 -----YMPFGSLYNVLHEQTSV---------------------------VVDHSQAVRFALDIARGMAFLHSLEPMIPRF 315 (448)
T ss_pred -----eccchHHHHHHhcCccE---------------------------EEecchHHHHHHHHHhhHHHHhhcchhhhhh
Confidence 99999999999875421 123457899999999999999997 343 34
Q ss_pred CCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCC---CCcchHHHHHHHHHHHHhC
Q 003644 534 DLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ---TRAIDLFSLGCILFFCITG 610 (805)
Q Consensus 534 DLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~---t~~sDVwSlGvil~elltG 610 (805)
-|.+..++++++-...+-.+|--++- +.....-.|.||+||.+...+. -+++|+|||++++||+.|
T Consensus 316 ~lns~hvmidedltarismad~kfsf----------qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~t- 384 (448)
T KOG0195|consen 316 YLNSKHVMIDEDLTARISMADTKFSF----------QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNT- 384 (448)
T ss_pred hcccceEEecchhhhheecccceeee----------eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhc-
Confidence 68899999987754333333432221 1223346789999999987654 368999999999999999
Q ss_pred CCCCCCCchHHHHH---HHhhccccccccCChHHHHHHHHhcCCCCCCCCChhhhh
Q 003644 611 GKHPYGESFERDAN---IVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVL 663 (805)
Q Consensus 611 ~~~Pf~~~~~~~~~---~~~~~~~~~~~~~~~~~~dLi~~~L~~dP~~Rps~~ell 663 (805)
+..||.+...-+.. .+.+.....++..++....|+.-|+..||.+||....++
T Consensus 385 revpfadlspmecgmkialeglrv~ippgis~hm~klm~icmnedpgkrpkfdmiv 440 (448)
T KOG0195|consen 385 REVPFADLSPMECGMKIALEGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIV 440 (448)
T ss_pred cccccccCCchhhhhhhhhccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceeh
Confidence 48899875543321 233344455667778999999999999999999887664
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.6e-18 Score=202.85 Aligned_cols=154 Identities=32% Similarity=0.434 Sum_probs=121.0
Q ss_pred HHHHHHhhhcceeccCCCCceEEecCCCCceEEEeccCccccccCCCc------------cccccccccCCCCCCChhhh
Q 003644 519 VSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMS------------CLTQNATGYGSSGWQAPEQL 586 (805)
Q Consensus 519 a~gL~yLH~~~IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~------------~~~~~~~~~gt~~y~APE~l 586 (805)
+.+++|||+-||+|||+||+|.||+.-|+ +|++|||+++...-... ..-.....||||.|.|||++
T Consensus 153 vla~Eylh~ygivhrdlkpdnllIT~mGh--iKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVi 230 (1205)
T KOG0606|consen 153 VLAVEYLHSYGIVHRDLKPDNLLITSMGH--IKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVI 230 (1205)
T ss_pred hHHhHhhccCCeecCCCCCCcceeeeccc--ccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhhh
Confidence 78999999999999999999999998887 89999999876432110 01122345899999999999
Q ss_pred hcCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhccccc---cccCChHHHHHHHHhcCCCCCCCC---Chh
Q 003644 587 LQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDRKDLF---LVEHIPEAVDLFTRLLDPNPDLRP---KAQ 660 (805)
Q Consensus 587 ~~~~~t~~sDVwSlGvil~elltG~~~Pf~~~~~~~~~~~~~~~~~~---~~~~~~~~~dLi~~~L~~dP~~Rp---s~~ 660 (805)
..+.|+..+|+|++|+|+||.+.|..++|++..+.....+......+ .....+|++++|.++|+.+|..|. .+-
T Consensus 231 lrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~ 310 (1205)
T KOG0606|consen 231 LRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEEDEALPPEAQDLIEQLLRQNPLCRLGTGGAL 310 (1205)
T ss_pred hhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccccccCcCCCHHHHHHHHHHHHhChHhhcccchhh
Confidence 99999999999999999999999877677776665543333322222 334568999999999999999994 567
Q ss_pred hhhcCccccccccc
Q 003644 661 NVLNHPFFWTADTR 674 (805)
Q Consensus 661 ell~Hpff~~~~~~ 674 (805)
++.+|+||..-++.
T Consensus 311 evk~h~ff~~LDw~ 324 (1205)
T KOG0606|consen 311 EVKQHGFFQLLDWK 324 (1205)
T ss_pred hhhhccceeecccc
Confidence 89999999654443
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.74 E-value=3e-18 Score=173.68 Aligned_cols=136 Identities=17% Similarity=0.111 Sum_probs=94.0
Q ss_pred EeeccCCceEEEEEEeeCCcEEEEEEeecCCc---h--------------------------HHHHHHHHHHHhCCCCCe
Q 003644 382 KEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHH---D--------------------------VALKEIQNLIASDQHPNI 432 (805)
Q Consensus 382 ~~LG~GsfGtVy~a~~~~g~~VAVK~l~~~~~---~--------------------------~~~~Ei~~ll~~l~HpNI 432 (805)
+.||+|+||+||+|...+|+.||||+++.... . ...+|.. .+..+.|+++
T Consensus 3 ~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~-~l~~l~~~~v 81 (190)
T cd05147 3 GCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMR-NLKRLVTAGI 81 (190)
T ss_pred CccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHH-HHHHHHHCCC
Confidence 56999999999999777899999999965321 0 0112544 4455555554
Q ss_pred eeecccccCCceEEEecccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHH
Q 003644 433 VRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLL 512 (805)
Q Consensus 433 V~l~g~~~~~~~l~LV~E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 512 (805)
.....+.. ...+||||||+++ ++.... ....+++...+.
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~----------~l~~~~-----------------------------~~~~~~~~~~~~ 120 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDD----------GWAAPR-----------------------------LKDAPLSESKAR 120 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCC----------CCcchh-----------------------------hhcCCCCHHHHH
Confidence 32222211 1238999977653 221110 011346677889
Q ss_pred HHHHHHHHHHHHh-hhcceeccCCCCceEEecCCCCceEEEeccCcccccc
Q 003644 513 KVTRDIVSGLSHL-HEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQ 562 (805)
Q Consensus 513 ~i~~qIa~gL~yL-H~~~IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~ 562 (805)
.++.|++.+|+|| |+.||+||||||+|||++. +. ++|+|||+|....
T Consensus 121 ~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~~-~~--v~LiDFG~a~~~~ 168 (190)
T cd05147 121 ELYLQVIQIMRILYQDCRLVHADLSEYNLLYHD-GK--LYIIDVSQSVEHD 168 (190)
T ss_pred HHHHHHHHHHHHHHHhCCcccCCCCHHHEEEEC-Cc--EEEEEccccccCC
Confidence 9999999999999 6899999999999999973 43 8999999987543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.2e-17 Score=169.17 Aligned_cols=136 Identities=18% Similarity=0.153 Sum_probs=96.9
Q ss_pred EeeccCCceEEEEEEeeCCcEEEEEEeecCCch-----------------------------HHHHHHHHHHHhCCCCCe
Q 003644 382 KEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHD-----------------------------VALKEIQNLIASDQHPNI 432 (805)
Q Consensus 382 ~~LG~GsfGtVy~a~~~~g~~VAVK~l~~~~~~-----------------------------~~~~Ei~~ll~~l~HpNI 432 (805)
+.||+|++|+||+|...+|+.||||++...... ...+|.. .+..+.|++|
T Consensus 3 ~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~-~l~~l~~~~i 81 (190)
T cd05145 3 GCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFR-NLKRLYEAGV 81 (190)
T ss_pred ceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHH-HHHHHHhCCC
Confidence 579999999999997778999999998754210 0123443 5566778876
Q ss_pred eeecccccCCceEEEecccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHH
Q 003644 433 VRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLL 512 (805)
Q Consensus 433 V~l~g~~~~~~~l~LV~E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 512 (805)
.....+.... .|||||||++. ++.... .....++...+.
T Consensus 82 ~~p~~~~~~~--~~lVmE~~~g~----------~~~~~~-----------------------------l~~~~~~~~~~~ 120 (190)
T cd05145 82 PVPEPILLKK--NVLVMEFIGDD----------GSPAPR-----------------------------LKDVPLEEEEAE 120 (190)
T ss_pred CCceEEEecC--CEEEEEEecCC----------Cchhhh-----------------------------hhhccCCHHHHH
Confidence 4433332222 48999977653 111100 111234556778
Q ss_pred HHHHHHHHHHHHhhh-cceeccCCCCceEEecCCCCceEEEeccCcccccc
Q 003644 513 KVTRDIVSGLSHLHE-IGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQ 562 (805)
Q Consensus 513 ~i~~qIa~gL~yLH~-~~IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~ 562 (805)
.++.|++.+|.+||+ .||+||||||+|||++ ++. ++|+|||++....
T Consensus 121 ~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~--~~liDFG~a~~~~ 168 (190)
T cd05145 121 ELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGK--PYIIDVSQAVELD 168 (190)
T ss_pred HHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCC--EEEEEcccceecC
Confidence 999999999999999 9999999999999997 554 8999999998665
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.73 E-value=5e-18 Score=175.11 Aligned_cols=169 Identities=14% Similarity=0.091 Sum_probs=121.8
Q ss_pred cccceEEEeEeeccCCceEEEEEEeeCCcEEEEEEeecCCc--hH----------HHHHHHHHHHhCCCCCeeeeccccc
Q 003644 373 RIGKLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHH--DV----------ALKEIQNLIASDQHPNIVRWYGVES 440 (805)
Q Consensus 373 ~i~~~~~~~~~LG~GsfGtVy~a~~~~g~~VAVK~l~~~~~--~~----------~~~Ei~~ll~~l~HpNIV~l~g~~~ 440 (805)
-+..+|...+.||.|+||.||++.. ++..+|||.+..... +. ..+|+. .+.++.||+|.....++.
T Consensus 28 ~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~-~l~rL~~~GI~~~~d~~~ 105 (232)
T PRK10359 28 FLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIV-QTDRVRSEGLASLNDFYL 105 (232)
T ss_pred HhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHH-HHHHHHHCCCCcceEeee
Confidence 3456789999999999999999655 677899999964321 11 124443 567779999999988755
Q ss_pred CC--------ceEEEecccccC-ChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHH
Q 003644 441 DQ--------DFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQL 511 (805)
Q Consensus 441 ~~--------~~l~LV~E~~~~-sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 511 (805)
+. +..+|+|||++| +|.++. . ++
T Consensus 106 ~~~~~~~~~~~~~~lvmEyi~G~tL~~~~-----------~---------------------------------~~---- 137 (232)
T PRK10359 106 LAERKTLRYAHTYIMLIEYIEGVELNDMP-----------E---------------------------------IS---- 137 (232)
T ss_pred ecccccccccCCeEEEEEEECCccHHHhh-----------h---------------------------------cc----
Confidence 33 358999996664 343321 0 01
Q ss_pred HHHHHHHHHHHHHhhhcceeccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCC
Q 003644 512 LKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ 591 (805)
Q Consensus 512 ~~i~~qIa~gL~yLH~~~IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~ 591 (805)
.....+++.+|..||+.|++|||+||+||+++.++ ++|+|||..+....+.. ...++....+
T Consensus 138 ~~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g---i~liDfg~~~~~~e~~a---------------~d~~vler~y 199 (232)
T PRK10359 138 EDVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG---LRIIDLSGKRCTAQRKA---------------KDRIDLERHY 199 (232)
T ss_pred HHHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC---EEEEECCCcccccchhh---------------HHHHHHHhHh
Confidence 12456899999999999999999999999998776 78999998765532110 0114455667
Q ss_pred CCcchHHHHHHHHHHHHh
Q 003644 592 TRAIDLFSLGCILFFCIT 609 (805)
Q Consensus 592 t~~sDVwSlGvil~ellt 609 (805)
..++|+||||+.+.....
T Consensus 200 ~~~~di~~lg~~~~~~~~ 217 (232)
T PRK10359 200 GIKNEIKDLGYYLLIYKK 217 (232)
T ss_pred cccccccceeEeehHHHH
Confidence 789999999998776543
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.73 E-value=4.4e-17 Score=173.01 Aligned_cols=235 Identities=25% Similarity=0.261 Sum_probs=140.4
Q ss_pred eEEEeEeeccCCceEEEEEEe-eCCcEEEEEEeecCCc-----hHHHHHHHHHHHhCC----------C------CCeee
Q 003644 377 LVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH-----DVALKEIQNLIASDQ----------H------PNIVR 434 (805)
Q Consensus 377 ~~~~~~~LG~GsfGtVy~a~~-~~g~~VAVK~l~~~~~-----~~~~~Ei~~ll~~l~----------H------pNIV~ 434 (805)
.++....||.|+++.||.+.. .+|+.+|||++.-... -..++|......... | --+++
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 456678899999999999754 4689999999853321 112222221111111 1 11223
Q ss_pred eccc---ccCC---c-----eEEEecccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhh
Q 003644 435 WYGV---ESDQ---D-----FVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKA 503 (805)
Q Consensus 435 l~g~---~~~~---~-----~l~LV~E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 503 (805)
+-+- .... . ..+++|+...++|.+++-. |.........
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~dL~~~~~~--------l~~~~~~~~~----------------------- 141 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQGDLQDLVEA--------LFSRAQTHSP----------------------- 141 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE--SEEHHHHHHH--------HHHHTTTSHH-----------------------
T ss_pred EcCCCcceecCCCCccceeehhhhccchhhhcHHHHHHH--------Hhhcccccch-----------------------
Confidence 2221 1111 1 3477888888888776521 1111111000
Q ss_pred CCCCHHHHHHHHHHHHHHHHHhhhcceeccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCCh
Q 003644 504 NGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAP 583 (805)
Q Consensus 504 ~~l~~~~~~~i~~qIa~gL~yLH~~~IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~AP 583 (805)
+.....+.+..|+++.+++||+.|++|+||||+|++++.+|. +.|+||+.......... ....+..|.+|
T Consensus 142 --l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi~~~nfll~~~G~--v~Lg~F~~~~r~g~~~~------~~~~~~~~~PP 211 (288)
T PF14531_consen 142 --LAFAARLSLTVQMIRLVANLHSYGLVHGDIKPENFLLDQDGG--VFLGDFSSLVRAGTRYR------CSEFPVAFTPP 211 (288)
T ss_dssp --HHHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEE-TTS---EEE--GGGEEETTEEEE------GGGS-TTTS-H
T ss_pred --hHHHHHHHHHHHHHHHHHHHhhcceEecccceeeEEEcCCCC--EEEcChHHHeecCceee------ccCCCcccCCh
Confidence 011233677899999999999999999999999999999987 88999987766543211 12346789999
Q ss_pred hhhhcC--------CCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhccccccccCChHHHHHHHHhcCCCCCC
Q 003644 584 EQLLQG--------RQTRAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDL 655 (805)
Q Consensus 584 E~l~~~--------~~t~~sDVwSlGvil~elltG~~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dP~~ 655 (805)
|..... .++.+.|.|+||+++|.|.+| ..||+........ ........ +.++.+++||..+|+.||.+
T Consensus 212 e~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~-~lPf~~~~~~~~~--~~~f~~C~-~~Pe~v~~LI~~lL~~~~~~ 287 (288)
T PF14531_consen 212 ELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCG-RLPFGLSSPEADP--EWDFSRCR-DMPEPVQFLIRGLLQRNPED 287 (288)
T ss_dssp HHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHS-S-STCCCGGGSTS--GGGGTTSS----HHHHHHHHHHT-SSGGG
T ss_pred hhhhhhcccCcccceeeeccCHHHHHHHHHHHHHc-cCCCCCCCccccc--cccchhcC-CcCHHHHHHHHHHccCCccc
Confidence 987553 468899999999999999997 7888764332111 00111222 55678899999999999998
Q ss_pred C
Q 003644 656 R 656 (805)
Q Consensus 656 R 656 (805)
|
T Consensus 288 R 288 (288)
T PF14531_consen 288 R 288 (288)
T ss_dssp S
T ss_pred C
Confidence 7
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.73 E-value=3e-17 Score=166.10 Aligned_cols=183 Identities=17% Similarity=0.139 Sum_probs=128.2
Q ss_pred eEeeccCCceEEEEEEeeCCcEEEEEEeecCCc--h-----HHHHHHHHHHHhC-CCCCeeeecccccCCceEEEecccc
Q 003644 381 NKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHH--D-----VALKEIQNLIASD-QHPNIVRWYGVESDQDFVYLSLERC 452 (805)
Q Consensus 381 ~~~LG~GsfGtVy~a~~~~g~~VAVK~l~~~~~--~-----~~~~Ei~~ll~~l-~HpNIV~l~g~~~~~~~l~LV~E~~ 452 (805)
...|++|+||+||++.. ++..++.+.+..... . .+.+|+.. +..+ .|++|.+++++ +..|++|||+
T Consensus 7 ~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~i-L~~L~~~~~vP~ll~~----~~~~lvmeyI 80 (218)
T PRK12274 7 NEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALA-LRQLDGLPRTPRLLHW----DGRHLDRSYL 80 (218)
T ss_pred ceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHH-HHhcCCCCCCCEEEEE----cCEEEEEeee
Confidence 46799999999998655 778888887754322 1 24567764 4555 56889999886 3469999954
Q ss_pred cCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcceec
Q 003644 453 TCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIH 532 (805)
Q Consensus 453 ~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~IvH 532 (805)
.+.+|...+.. ....++.|++.+|+++|+.||+|
T Consensus 81 ----------~G~~L~~~~~~------------------------------------~~~~~~~qi~~~L~~lH~~GIvH 114 (218)
T PRK12274 81 ----------AGAAMYQRPPR------------------------------------GDLAYFRAARRLLQQLHRCGVAH 114 (218)
T ss_pred ----------cCccHHhhhhh------------------------------------hhHHHHHHHHHHHHHHHHCcCcc
Confidence 44444322100 01357789999999999999999
Q ss_pred cCC-CCceEEecCCCCceEEEeccCccccccCCCcc---ccc-------cccccCCCCCCChhhhhc--CCCCCcchHHH
Q 003644 533 RDL-KPQNVLISKDKSFCAKLSDMGISKRLQGDMSC---LTQ-------NATGYGSSGWQAPEQLLQ--GRQTRAIDLFS 599 (805)
Q Consensus 533 rDL-Kp~NILl~~~~~~~~kL~DFGla~~~~~~~~~---~~~-------~~~~~gt~~y~APE~l~~--~~~t~~sDVwS 599 (805)
||| ||+|||++.++. ++|+|||++......... ... ..-...++.|++|+...- ..--...++++
T Consensus 115 rDL~kp~NILv~~~g~--i~LIDFG~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~ 192 (218)
T PRK12274 115 NDLAKEANWLVQEDGS--PAVIDFQLAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFA 192 (218)
T ss_pred CCCCCcceEEEcCCCC--EEEEECCCceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHH
Confidence 999 799999988776 889999999855432210 000 011236889999986532 22235779999
Q ss_pred HHHHHHHHHhCCCCCCCC
Q 003644 600 LGCILFFCITGGKHPYGE 617 (805)
Q Consensus 600 lGvil~elltG~~~Pf~~ 617 (805)
-|+-+|.++|++-+.|++
T Consensus 193 ~g~~~~~~~~~~~~~~~~ 210 (218)
T PRK12274 193 TGKPVYRFVTRRVLHWED 210 (218)
T ss_pred hcchHHHHHhccCCcccc
Confidence 999999999986655654
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.68 E-value=2.2e-17 Score=182.40 Aligned_cols=154 Identities=29% Similarity=0.528 Sum_probs=119.2
Q ss_pred CCHHHHHHHHHHHHHHHHHhhhcceeccCCCCceEEecCCCCceEEEeccCccccccCCC---ccccccccccCCCCCCC
Q 003644 506 HPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDM---SCLTQNATGYGSSGWQA 582 (805)
Q Consensus 506 l~~~~~~~i~~qIa~gL~yLH~~~IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~---~~~~~~~~~~gt~~y~A 582 (805)
.++...+.++.|++.|++| ++.+|||+||.||....+.. +||.|||+........ ..........||..||+
T Consensus 356 ~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q--~kIgDFgl~ts~~~~~~~~~~~a~~t~~~gt~~Yms 430 (516)
T KOG1033|consen 356 RSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQ--LKIGDFGLVTSQDKDETVAPAAASHTQQVGTLLYMS 430 (516)
T ss_pred cchhHHHHHHHhhccchhh---ccchhhhccccccccccchh--hhhhhhhheeecccCCcccchhhhhhhcccccccCC
Confidence 3455678999999999999 99999999999999987765 8999999987765443 11223445679999999
Q ss_pred hhhhhcCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhcccccc---ccCChHHHHHHHHhcCCCCCCCCCh
Q 003644 583 PEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDRKDLFL---VEHIPEAVDLFTRLLDPNPDLRPKA 659 (805)
Q Consensus 583 PE~l~~~~~t~~sDVwSlGvil~elltG~~~Pf~~~~~~~~~~~~~~~~~~~---~~~~~~~~dLi~~~L~~dP~~Rps~ 659 (805)
||.+.+..|+.++||||||+|++|++. +|....++.......+...++ ....|+-.+|+.+|+.+.|.+||++
T Consensus 431 PEQi~g~~y~~kvdIyaLGlil~EL~~----~f~T~~er~~t~~d~r~g~ip~~~~~d~p~e~~ll~~lls~~p~~RP~~ 506 (516)
T KOG1033|consen 431 PEQIRGQQYSEKVDIYALGLILAELLI----QFSTQFERIATLTDIRDGIIPPEFLQDYPEEYTLLQQLLSPSPEERPSA 506 (516)
T ss_pred HHHHhhhhhhhhcchhhHHHHHHHHHH----HhccHHHHHHhhhhhhcCCCChHHhhcCcHHHHHHHHhcCCCcccCchH
Confidence 999999999999999999999999998 444444444332222222222 2234677899999999999999988
Q ss_pred hhhhcCccc
Q 003644 660 QNVLNHPFF 668 (805)
Q Consensus 660 ~ell~Hpff 668 (805)
.+.--|+|.
T Consensus 507 ~~~~~~~~~ 515 (516)
T KOG1033|consen 507 IEVALHEFL 515 (516)
T ss_pred HHHhhhhhc
Confidence 887777763
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.68 E-value=1.9e-16 Score=162.55 Aligned_cols=134 Identities=16% Similarity=0.187 Sum_probs=93.5
Q ss_pred EeeccCCceEEEEEEeeCCcEEEEEEeecC---CchHHHHHHHHHHHhC-----CCCCeeeecccccCCc---eEE-Eec
Q 003644 382 KEIAKGSNGTVVLEGNYEGRSVAVKRLVKT---HHDVALKEIQNLIASD-----QHPNIVRWYGVESDQD---FVY-LSL 449 (805)
Q Consensus 382 ~~LG~GsfGtVy~a~~~~g~~VAVK~l~~~---~~~~~~~Ei~~ll~~l-----~HpNIV~l~g~~~~~~---~l~-LV~ 449 (805)
+.||+|+||.||. ...++.. +||++... ..+...+|+.. +..+ .||||+++||++.++. .++ +|+
T Consensus 8 ~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~-l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~ 84 (210)
T PRK10345 8 SPLGTGRHRKCYA-HPEDAQR-CIKIVYHRGDGGDKEIRRELKY-YAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIA 84 (210)
T ss_pred ceecCCCceEEEE-CCCCcCe-EEEEEeccccchHHHHHHHHHH-HHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEe
Confidence 5799999999996 4445544 79988653 23456777764 4445 6899999999998863 434 789
Q ss_pred ccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHH-HHhhhc
Q 003644 450 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGL-SHLHEI 528 (805)
Q Consensus 450 E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL-~yLH~~ 528 (805)
|++. ..+|+|.+++... .+++. ..++.|++.++ +|||++
T Consensus 85 e~~G--------~~~~tL~~~l~~~------------------------------~~~e~--~~~~~~~L~~l~~yLh~~ 124 (210)
T PRK10345 85 DFDG--------KPSITLTEFAEQC------------------------------RYEED--VAQLRQLLKKLKRYLLDN 124 (210)
T ss_pred cCCC--------CcchhHHHHHHcc------------------------------cccHh--HHHHHHHHHHHHHHHHHC
Confidence 9643 1234444444210 12222 35678888888 999999
Q ss_pred ceeccCCCCceEEecCC--CCceEEEeccCcc
Q 003644 529 GLIHRDLKPQNVLISKD--KSFCAKLSDMGIS 558 (805)
Q Consensus 529 ~IvHrDLKp~NILl~~~--~~~~~kL~DFGla 558 (805)
+|+||||||+|||++.. +...++|+||+.+
T Consensus 125 ~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 125 RIVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred CEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 99999999999999742 3346999995544
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.68 E-value=1.4e-16 Score=190.56 Aligned_cols=199 Identities=22% Similarity=0.248 Sum_probs=148.3
Q ss_pred ccccceEEEeEeeccCCceEEEEEEeeCCcEEEEEEeecCCchHHH--HHHHHHHHhCCCCCeeeecccccCCceEEEec
Q 003644 372 RRIGKLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVAL--KEIQNLIASDQHPNIVRWYGVESDQDFVYLSL 449 (805)
Q Consensus 372 ~~i~~~~~~~~~LG~GsfGtVy~a~~~~g~~VAVK~l~~~~~~~~~--~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~ 449 (805)
..-+..|.+.+.||+|+||+||+|...+|+.||+|.-+....-+.. .++..-++..--+-|+.+...+.-.+.-+||+
T Consensus 694 ~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv~ 773 (974)
T KOG1166|consen 694 EVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEFYICLQVMERLKPQMLPSIMHISSAHVFQNASVLVS 773 (974)
T ss_pred eecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCceeeeehHHHHHhhchhhhcchHHHHHHHccCCcceeee
Confidence 4456778999999999999999998888999999987655422111 12111111111244666666666677789999
Q ss_pred ccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcc
Q 003644 450 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG 529 (805)
Q Consensus 450 E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~ 529 (805)
| |.+-|+|.+.+.. .+..++..++.+..|+++-+++||..+
T Consensus 774 e----------y~~~Gtlld~~N~-----------------------------~~~m~e~lv~~~~~qml~ive~lH~~~ 814 (974)
T KOG1166|consen 774 E----------YSPYGTLLDLINT-----------------------------NKVMDEYLVMFFSCQMLRIVEHLHAMG 814 (974)
T ss_pred e----------ccccccHHHhhcc-----------------------------CCCCCchhhhHHHHHHHHHHHHHHhcc
Confidence 9 6666666665531 133566677899999999999999999
Q ss_pred eeccCCCCceEEecC-----CCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHH
Q 003644 530 LIHRDLKPQNVLISK-----DKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCIL 604 (805)
Q Consensus 530 IvHrDLKp~NILl~~-----~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil 604 (805)
|||+||||+|.||.. .+..-++|+|||.+..+.--.. .+.....++|-++-.+|+..++.+++.+|.|.|+.++
T Consensus 815 IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm~lfp~-~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~ 893 (974)
T KOG1166|consen 815 IIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDMKLFPD-GTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATV 893 (974)
T ss_pred eecccCCcceeEeecccCCCCcccceEEEecccceeeeEcCC-CcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHH
Confidence 999999999999942 2344589999999876532111 1233455689999999999999999999999999999
Q ss_pred HHHHhC
Q 003644 605 FFCITG 610 (805)
Q Consensus 605 ~elltG 610 (805)
+-||.|
T Consensus 894 h~mLFG 899 (974)
T KOG1166|consen 894 HVMLFG 899 (974)
T ss_pred HHHHHH
Confidence 999998
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.64 E-value=3.3e-16 Score=176.21 Aligned_cols=196 Identities=26% Similarity=0.336 Sum_probs=141.4
Q ss_pred HhCCCCCeeeecccccCCceEEEeccccc-CChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhh
Q 003644 425 ASDQHPNIVRWYGVESDQDFVYLSLERCT-CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKA 503 (805)
Q Consensus 425 ~~l~HpNIV~l~g~~~~~~~l~LV~E~~~-~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 503 (805)
+.+.|.|+.+++|.+.++...++|.++|. ++|.|.++...-
T Consensus 2 ~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~-------------------------------------- 43 (484)
T KOG1023|consen 2 RQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDI-------------------------------------- 43 (484)
T ss_pred cccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcccc--------------------------------------
Confidence 45789999999999999999999999887 477777654221
Q ss_pred CCCCHHHHHHHHHHHHHHHHHhhhcce-eccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCC
Q 003644 504 NGHPSAQLLKVTRDIVSGLSHLHEIGL-IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQA 582 (805)
Q Consensus 504 ~~l~~~~~~~i~~qIa~gL~yLH~~~I-vHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~A 582 (805)
.+++.-...+.++|+.||+|||...| .|+.|++.|+++ +..+.+||+|||+......... ........-..-|.|
T Consensus 44 -~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nClv--d~~w~lklt~~Gl~~~~~~~~~-~~~~~~~~~~~lw~a 119 (484)
T KOG1023|consen 44 -KLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNCLV--DSRWVLKLTDFGLNSLLEETAE-PEAHHPIRKALLWTA 119 (484)
T ss_pred -CccHHHHHHHHHHHHHHHHHHhcCcceeeeeecccccee--eeeEEEEechhhhccccccccc-ccccchhHHHHhccC
Confidence 23334457889999999999998866 999999999999 5557899999999877643100 011111113456999
Q ss_pred hhhhhcCC-------CCCcchHHHHHHHHHHHHhCCCCCCCCchH-----HHHHHHhh-cccccc-----c-cCChHHHH
Q 003644 583 PEQLLQGR-------QTRAIDLFSLGCILFFCITGGKHPYGESFE-----RDANIVKD-RKDLFL-----V-EHIPEAVD 643 (805)
Q Consensus 583 PE~l~~~~-------~t~~sDVwSlGvil~elltG~~~Pf~~~~~-----~~~~~~~~-~~~~~~-----~-~~~~~~~d 643 (805)
||.+.... .+.+.|+||||++++|+++. ..||..... +....+.. ....+. . +..++...
T Consensus 120 Pellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r-~~~~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~ 198 (484)
T KOG1023|consen 120 PELLRGALSQSLESALTQKGDIYSFGIIMYEILFR-SGPFDLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLL 198 (484)
T ss_pred HHHhcccccccccccccccCCeehHHHHHHHHHhc-cCccccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHH
Confidence 99997631 46789999999999999995 778865221 11112222 111111 1 33456889
Q ss_pred HHHHhcCCCCCCCCChhhhh
Q 003644 644 LFTRLLDPNPDLRPKAQNVL 663 (805)
Q Consensus 644 Li~~~L~~dP~~Rps~~ell 663 (805)
++++||..+|..||+++++-
T Consensus 199 l~~~cw~e~P~~rPs~~~i~ 218 (484)
T KOG1023|consen 199 LVARCWEEIPEKRPSIEQIR 218 (484)
T ss_pred HHHHhcccChhhCccHHHHH
Confidence 99999999999999999875
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.59 E-value=3.1e-15 Score=156.86 Aligned_cols=141 Identities=21% Similarity=0.184 Sum_probs=96.0
Q ss_pred cceEEEeEeeccCCceEEEEEE--eeCCcEEEEEEeecCCc---------------------------hHHHHHHHHHHH
Q 003644 375 GKLVVFNKEIAKGSNGTVVLEG--NYEGRSVAVKRLVKTHH---------------------------DVALKEIQNLIA 425 (805)
Q Consensus 375 ~~~~~~~~~LG~GsfGtVy~a~--~~~g~~VAVK~l~~~~~---------------------------~~~~~Ei~~ll~ 425 (805)
|..|.+.+.||+|++|.||+|. ..+|+.||||++..... ....+|... +.
T Consensus 27 ~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~-L~ 105 (237)
T smart00090 27 GILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRN-LQ 105 (237)
T ss_pred CchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHH-HH
Confidence 3446777899999999999997 57899999999864321 012345553 33
Q ss_pred hCCC--CCeeeecccccCCceEEEecccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhh
Q 003644 426 SDQH--PNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKA 503 (805)
Q Consensus 426 ~l~H--pNIV~l~g~~~~~~~l~LV~E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 503 (805)
.+.+ ..+.+.+++ ...++|||++.+ +++..... ..
T Consensus 106 ~L~~~~i~~p~~~~~----~~~~lV~E~~~g----------~~L~~~~~-----------------------------~~ 142 (237)
T smart00090 106 RLYEAGVPVPKPIAW----RRNVLVMEFIGG----------DGLPAPRL-----------------------------KD 142 (237)
T ss_pred HHHhcCCCCCeeeEe----cCceEEEEEecC----------Cccccccc-----------------------------cc
Confidence 4443 233344443 234899997665 22221110 00
Q ss_pred CCCCHHHHHHHHHHHHHHHHHhhhcc-eeccCCCCceEEecCCCCceEEEeccCcccccc
Q 003644 504 NGHPSAQLLKVTRDIVSGLSHLHEIG-LIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQ 562 (805)
Q Consensus 504 ~~l~~~~~~~i~~qIa~gL~yLH~~~-IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~ 562 (805)
.......+..++.||+.+|++||+.| |+||||||+||+++ ++. ++|+|||++....
T Consensus 143 ~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~-~~~--i~LiDFg~a~~~~ 199 (237)
T smart00090 143 VEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH-DGK--VVIIDVSQSVELD 199 (237)
T ss_pred CCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE-CCC--EEEEEChhhhccC
Confidence 11223345789999999999999999 99999999999997 544 8899999987544
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.55 E-value=1e-14 Score=149.69 Aligned_cols=131 Identities=19% Similarity=0.289 Sum_probs=97.8
Q ss_pred EeeccCCceEEEEEEeeCCcEEEEEEeecCCc-----------hHHHHHHHHHHHhCCCCCeeeecccccCCceEEEecc
Q 003644 382 KEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHH-----------DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 450 (805)
Q Consensus 382 ~~LG~GsfGtVy~a~~~~g~~VAVK~l~~~~~-----------~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~E 450 (805)
+.||+|++|.||++.. .|..|+||+...... ....+|+. ++..+.|++|.....++.+.+..+++||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~-~l~~l~~~~i~~p~~~~~~~~~~~lv~e 79 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREAR-IMSRARKAGVNVPAVYFVDPENFIIVME 79 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHH-HHHHHHHCCCCCCeEEEEeCCCCEEEEE
Confidence 4699999999999755 788899998653211 12334554 5667788888777777777778899999
Q ss_pred cccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcce
Q 003644 451 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 530 (805)
Q Consensus 451 ~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~I 530 (805)
++ .+++|.+.+... .+ ....++.+++.+|++||+.++
T Consensus 80 ~~----------~G~~L~~~~~~~--------------------------------~~-~~~~i~~~i~~~l~~lH~~~i 116 (211)
T PRK14879 80 YI----------EGEPLKDLINSN--------------------------------GM-EELELSREIGRLVGKLHSAGI 116 (211)
T ss_pred Ee----------CCcCHHHHHHhc--------------------------------cH-HHHHHHHHHHHHHHHHHhCCc
Confidence 55 444554443211 01 457899999999999999999
Q ss_pred eccCCCCceEEecCCCCceEEEeccCcccc
Q 003644 531 IHRDLKPQNVLISKDKSFCAKLSDMGISKR 560 (805)
Q Consensus 531 vHrDLKp~NILl~~~~~~~~kL~DFGla~~ 560 (805)
+|||++|.|||++ ++. ++|+|||++..
T Consensus 117 ~H~Dl~p~Nil~~-~~~--~~liDf~~a~~ 143 (211)
T PRK14879 117 IHGDLTTSNMILS-GGK--IYLIDFGLAEF 143 (211)
T ss_pred ccCCCCcccEEEE-CCC--EEEEECCcccC
Confidence 9999999999997 444 78999998864
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.54 E-value=1.8e-14 Score=146.76 Aligned_cols=133 Identities=17% Similarity=0.140 Sum_probs=94.2
Q ss_pred EEEeEeeccCCceEEEEEEeeCCcEEEEEEeecCCc-------------------------hHHHHHHHHHHHhCCCCC-
Q 003644 378 VVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHH-------------------------DVALKEIQNLIASDQHPN- 431 (805)
Q Consensus 378 ~~~~~~LG~GsfGtVy~a~~~~g~~VAVK~l~~~~~-------------------------~~~~~Ei~~ll~~l~HpN- 431 (805)
|.+.+.||+|+||.||++...+|+.||||++..... ....+|+. ++..+.|++
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~-~l~~l~~~~i 95 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFA-ALKALYEEGF 95 (198)
T ss_pred hhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHH-HHHHHHHcCC
Confidence 556688999999999998777899999998754220 01233444 445555663
Q ss_pred -eeeecccccCCceEEEecccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHH
Q 003644 432 -IVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQ 510 (805)
Q Consensus 432 -IV~l~g~~~~~~~l~LV~E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 510 (805)
+...++ ....++|||++. ++++...... ..
T Consensus 96 ~v~~~~~----~~~~~lv~e~~~----------g~~L~~~~~~-----------------------------------~~ 126 (198)
T cd05144 96 PVPKPID----WNRHAVVMEYID----------GVELYRVRVL-----------------------------------ED 126 (198)
T ss_pred CCCceee----cCCceEEEEEeC----------Ccchhhcccc-----------------------------------cc
Confidence 344443 234589999554 4444332100 12
Q ss_pred HHHHHHHHHHHHHHhhhcceeccCCCCceEEecCCCCceEEEeccCcccccc
Q 003644 511 LLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQ 562 (805)
Q Consensus 511 ~~~i~~qIa~gL~yLH~~~IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~ 562 (805)
...++.+++.++.++|+.||+||||||+||+++.++. ++|+|||++....
T Consensus 127 ~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~--~~liDfg~~~~~~ 176 (198)
T cd05144 127 PEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEK--IYIIDWPQMVSTD 176 (198)
T ss_pred HHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCc--EEEEECCccccCC
Confidence 3578899999999999999999999999999987765 8999999986544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.54 E-value=2.4e-14 Score=145.56 Aligned_cols=127 Identities=22% Similarity=0.357 Sum_probs=91.5
Q ss_pred eccCCceEEEEEEeeCCcEEEEEEeecCC--c---------hHHHHHHHHHHHhCCCCCeeeecccccCCceEEEecccc
Q 003644 384 IAKGSNGTVVLEGNYEGRSVAVKRLVKTH--H---------DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERC 452 (805)
Q Consensus 384 LG~GsfGtVy~a~~~~g~~VAVK~l~~~~--~---------~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~E~~ 452 (805)
||+|+||+||++. .+|+.|+||...... . ....+|+. ++..+.|+++.....++.+.+..++|||+|
T Consensus 2 ig~G~~~~vy~~~-~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~-~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 2 IAKGAEAIIYLGD-FLGLKAVIKERVPKSYRHPELDERIRRERTRNEAR-LLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCceEEEEEee-cCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHH-HHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 8999999999976 678899999864321 1 11224544 556677776554444455566779999954
Q ss_pred cCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcceec
Q 003644 453 TCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIH 532 (805)
Q Consensus 453 ~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~IvH 532 (805)
+++++.+.+... . ..++.+++.+|++||+.+++|
T Consensus 80 ----------~g~~l~~~~~~~-----------------------------------~-~~~~~~i~~~l~~lH~~gi~H 113 (199)
T TIGR03724 80 ----------EGKPLKDVIEEG-----------------------------------N-DELLREIGRLVGKLHKAGIVH 113 (199)
T ss_pred ----------CCccHHHHHhhc-----------------------------------H-HHHHHHHHHHHHHHHHCCeec
Confidence 455555433210 0 168899999999999999999
Q ss_pred cCCCCceEEecCCCCceEEEeccCccccc
Q 003644 533 RDLKPQNVLISKDKSFCAKLSDMGISKRL 561 (805)
Q Consensus 533 rDLKp~NILl~~~~~~~~kL~DFGla~~~ 561 (805)
||++|.||+++ ++. ++++|||++...
T Consensus 114 ~Dl~~~Nil~~-~~~--~~liDfg~a~~~ 139 (199)
T TIGR03724 114 GDLTTSNIIVR-DDK--LYLIDFGLGKYS 139 (199)
T ss_pred CCCCcceEEEE-CCc--EEEEECCCCcCC
Confidence 99999999997 444 889999988653
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.52 E-value=1.3e-15 Score=178.81 Aligned_cols=252 Identities=26% Similarity=0.345 Sum_probs=182.1
Q ss_pred EEEeEeeccCCceEEEEEEe--eCCcEEEEEEeecCC-c-hH---HHHHHHHHHHhCC-CCCeeeecccccCCceEEEec
Q 003644 378 VVFNKEIAKGSNGTVVLEGN--YEGRSVAVKRLVKTH-H-DV---ALKEIQNLIASDQ-HPNIVRWYGVESDQDFVYLSL 449 (805)
Q Consensus 378 ~~~~~~LG~GsfGtVy~a~~--~~g~~VAVK~l~~~~-~-~~---~~~Ei~~ll~~l~-HpNIV~l~g~~~~~~~l~LV~ 449 (805)
|.+.+.||+|+|+.|-.+.. .....+|+|.+.... . .. .-+|.. +..... |+|++++++...+.+..++++
T Consensus 22 ~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~-~~~~~s~h~n~~~~~~~~~~~~~~~~~~ 100 (601)
T KOG0590|consen 22 YKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETD-IQKKLSKHSNTVHMIEPSSSPRSYLLSL 100 (601)
T ss_pred ccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCcccc-ccccccccccccccCCccCCCccccccc
Confidence 33446699999999977544 345667888775432 1 11 112332 334444 999999999999999999999
Q ss_pred ccccCChhhHHHHhcCCHHHHH-hhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhh-h
Q 003644 450 ERCTCSLNDLIYVLSGSFEEQL-NAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH-E 527 (805)
Q Consensus 450 E~~~~sL~d~iy~~~GsL~~~L-~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH-~ 527 (805)
+ |..+|++...+ +.. ..+.+...+..++.|+..++.|+| .
T Consensus 101 ~----------~s~g~~~f~~i~~~~----------------------------~~~~~~~~~~~~~~ql~s~l~~~H~~ 142 (601)
T KOG0590|consen 101 S----------YSDGGSLFSKISHPD----------------------------STGTSSSSASRYLPQLNSGLSYLHPE 142 (601)
T ss_pred C----------cccccccccccccCC----------------------------ccCCCCcchhhhhhhhccCccccCcc
Confidence 9 44455554433 110 113445566789999999999999 9
Q ss_pred cceeccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccC-CCCCCChhhhhcC-CCCCcchHHHHHHHHH
Q 003644 528 IGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYG-SSGWQAPEQLLQG-RQTRAIDLFSLGCILF 605 (805)
Q Consensus 528 ~~IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~g-t~~y~APE~l~~~-~~t~~sDVwSlGvil~ 605 (805)
.++.||||||+|.+++..+. ..+++|||+|................+| ++.|+|||...+. ......|+||.|+++.
T Consensus 143 ~~~~h~~ikP~n~~l~~s~~-~l~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~ 221 (601)
T KOG0590|consen 143 NGVTHRDIKPSNSLLDESGS-ALKIADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLS 221 (601)
T ss_pred cccccCCCCCccchhccCCC-cccCCCchhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCccccccccccc
Confidence 99999999999999988773 4889999999887652222233445678 9999999999885 4578999999999999
Q ss_pred HHHhCCCCCCCCchHHHHHHHhhc------cccccccCChHHHHHHHHhcCCCCCCCCChhhhhcCccccc
Q 003644 606 FCITGGKHPYGESFERDANIVKDR------KDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWT 670 (805)
Q Consensus 606 elltG~~~Pf~~~~~~~~~~~~~~------~~~~~~~~~~~~~dLi~~~L~~dP~~Rps~~ell~Hpff~~ 670 (805)
-+++| ..|+......+.....+. ...........+.+++.+++..+|..|.+.+++..+||+..
T Consensus 222 ~~~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 222 AMLTG-ELPWDFPSRKDGRYSSWKSNKGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred ccccC-CCCccccccccccceeecccccccccCccccCChhhhhcccccccCCchhccccccccccccccc
Confidence 99997 667765443332111111 12223344568899999999999999999999999999976
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.52 E-value=3.5e-14 Score=166.51 Aligned_cols=132 Identities=21% Similarity=0.341 Sum_probs=97.9
Q ss_pred EEEeEeeccCCceEEEEEEeeCCcEEEEEEee-cC-Cc---------hHHHHHHHHHHHhCCCCCeeeecccccCCceEE
Q 003644 378 VVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLV-KT-HH---------DVALKEIQNLIASDQHPNIVRWYGVESDQDFVY 446 (805)
Q Consensus 378 ~~~~~~LG~GsfGtVy~a~~~~g~~VAVK~l~-~~-~~---------~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~ 446 (805)
+...+.||+|+||+||++.. .+..+++|+.. +. .. ....+|.. ++..++|++|+..+.++.+.+..+
T Consensus 335 ~~~~~~iG~G~~g~Vy~~~~-~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~-~l~~l~~~~i~~p~~~~~~~~~~~ 412 (535)
T PRK09605 335 KIPDHLIGKGAEADIKKGEY-LGRDAVIKERVPKGYRHPELDERLRTERTRAEAR-LLSEARRAGVPTPVIYDVDPEEKT 412 (535)
T ss_pred cCccceeccCCcEEEEEEee-cCccceeEEEecccccchhHHHHHHHHHHHHHHH-HHHhhcccCCCeeEEEEEeCCCCE
Confidence 34568899999999999654 44455555432 11 10 12234544 678889999998888877777889
Q ss_pred EecccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhh
Q 003644 447 LSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH 526 (805)
Q Consensus 447 LV~E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH 526 (805)
+||| |+.+++|.+++. ....++.+++.+|+|||
T Consensus 413 lv~E----------~~~g~~L~~~l~-------------------------------------~~~~~~~~i~~~L~~lH 445 (535)
T PRK09605 413 IVME----------YIGGKDLKDVLE-------------------------------------GNPELVRKVGEIVAKLH 445 (535)
T ss_pred EEEE----------ecCCCcHHHHHH-------------------------------------HHHHHHHHHHHHHHHHH
Confidence 9999 556666665442 12578999999999999
Q ss_pred hcceeccCCCCceEEecCCCCceEEEeccCccccc
Q 003644 527 EIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRL 561 (805)
Q Consensus 527 ~~~IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~ 561 (805)
+.+++||||||+|||+ .++. ++|+|||+++..
T Consensus 446 ~~giiHrDlkp~NILl-~~~~--~~liDFGla~~~ 477 (535)
T PRK09605 446 KAGIVHGDLTTSNFIV-RDDR--LYLIDFGLGKYS 477 (535)
T ss_pred hCCCccCCCChHHEEE-ECCc--EEEEeCcccccC
Confidence 9999999999999999 3444 889999998753
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.46 E-value=8.4e-14 Score=140.08 Aligned_cols=50 Identities=22% Similarity=0.351 Sum_probs=44.3
Q ss_pred HHHHHHHHHHHHHHHhhh-cceeccCCCCceEEecCCCCceEEEeccCcccccc
Q 003644 510 QLLKVTRDIVSGLSHLHE-IGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQ 562 (805)
Q Consensus 510 ~~~~i~~qIa~gL~yLH~-~~IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~ 562 (805)
.+..++.+++.++.++|. .+|+||||||+||+++ ++. ++|+|||.+....
T Consensus 115 ~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~--~~liDfg~a~~~~ 165 (187)
T cd05119 115 DPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DGK--VYIIDVPQAVEID 165 (187)
T ss_pred cHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CCc--EEEEECccccccc
Confidence 457899999999999999 9999999999999998 554 8899999987554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.42 E-value=1.8e-13 Score=154.42 Aligned_cols=251 Identities=25% Similarity=0.289 Sum_probs=179.7
Q ss_pred EEEeEeecc--CCceEEEEEEe---eCCcEEEEEEeecC-----CchHHHHHHHHHHHhCCCCCeeeecccccCCceEEE
Q 003644 378 VVFNKEIAK--GSNGTVVLEGN---YEGRSVAVKRLVKT-----HHDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYL 447 (805)
Q Consensus 378 ~~~~~~LG~--GsfGtVy~a~~---~~g~~VAVK~l~~~-----~~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~L 447 (805)
+.+.+.+|. |.+|.||.+.. .++..+|+|+-+.. ....-.+|+......-.|+|.++.+..+.+.+.+|+
T Consensus 116 ~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lfi 195 (524)
T KOG0601|consen 116 FPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILFI 195 (524)
T ss_pred cccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCccee
Confidence 445577999 99999999765 56889999984321 112334566555555679999999999999999999
Q ss_pred ecccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHH----HHH
Q 003644 448 SLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVS----GLS 523 (805)
Q Consensus 448 V~E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~----gL~ 523 (805)
-+|+|..+|..+..... .-+|...++.+..+... ||.
T Consensus 196 qtE~~~~sl~~~~~~~~---------------------------------------~~~p~~~l~~~~~~~~~~~~~al~ 236 (524)
T KOG0601|consen 196 QTELCGESLQSYCHTPC---------------------------------------NFLPDNLLWNSLRDWLSRDVTALS 236 (524)
T ss_pred eeccccchhHHhhhccc---------------------------------------ccCCchhhhhHHhhhhhccccccc
Confidence 99999977766552111 12455666777778888 999
Q ss_pred HhhhcceeccCCCCceEEecCCCCceEEEeccCccccccCCCcc-ccc-cccccCCCCCCChhhhhcCCCCCcchHHHHH
Q 003644 524 HLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSC-LTQ-NATGYGSSGWQAPEQLLQGRQTRAIDLFSLG 601 (805)
Q Consensus 524 yLH~~~IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~-~~~-~~~~~gt~~y~APE~l~~~~~t~~sDVwSlG 601 (805)
++|+.+++|-|+||.||++..+. ..++++|||+...+....-. ... .....|...|++||.+. +.++.+.|+|++|
T Consensus 237 ~~hs~~~~~~~~kp~~i~~~~~~-~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ 314 (524)
T KOG0601|consen 237 HLHSNNIVHDDLKPANIFTTSDW-TSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLG 314 (524)
T ss_pred ccCCCcccccccchhheeccccc-ceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchh
Confidence 99999999999999999998873 24899999999888754311 111 12224778899999874 5689999999999
Q ss_pred HHHHHHHhCCCCCCCCchHHHHHHHhh-ccccccccCChHHHHHHHHhcCCCCCCCCChhhhhcCcccc
Q 003644 602 CILFFCITGGKHPYGESFERDANIVKD-RKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFW 669 (805)
Q Consensus 602 vil~elltG~~~Pf~~~~~~~~~~~~~-~~~~~~~~~~~~~~dLi~~~L~~dP~~Rps~~ell~Hpff~ 669 (805)
.++.+..++-.+|-......-..+-.. ....+....+.++...+..|++.+|..|++++.++.|++..
T Consensus 315 ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~ 383 (524)
T KOG0601|consen 315 EVILEAILGSHLPSVGKNSSWSQLRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIH 383 (524)
T ss_pred hhhHhhHhhcccccCCCCCCccccccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhcccccc
Confidence 999999887544433211100000000 11222223344566689999999999999999999999875
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.37 E-value=2.1e-12 Score=135.64 Aligned_cols=132 Identities=17% Similarity=0.218 Sum_probs=88.6
Q ss_pred Eeec-cCCceEEEEEEeeCCcEEEEEEeecCC----------------chHHHHHHHHHHHhCCCCCe--eeecccccCC
Q 003644 382 KEIA-KGSNGTVVLEGNYEGRSVAVKRLVKTH----------------HDVALKEIQNLIASDQHPNI--VRWYGVESDQ 442 (805)
Q Consensus 382 ~~LG-~GsfGtVy~a~~~~g~~VAVK~l~~~~----------------~~~~~~Ei~~ll~~l~HpNI--V~l~g~~~~~ 442 (805)
..|| .|+.|+||+... .+..+|||++.... .....+|+. ++..+.|++| ++.+++...+
T Consensus 37 ~~lg~~~g~gtv~~v~~-~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~-ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQT-PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFR-LLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred ceeecCCCCccEEEEEe-CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHH-HHHHHHhCCCCCceeEeeeeee
Confidence 4577 788888887544 47789999885321 123445664 6677777774 6677664432
Q ss_pred -ce---EEEecccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHH
Q 003644 443 -DF---VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDI 518 (805)
Q Consensus 443 -~~---l~LV~E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qI 518 (805)
.. .++|||++++ ..+|.+++.. ..++. ..+.+|
T Consensus 115 ~~~~~~~~lV~e~l~G---------~~~L~~~l~~------------------------------~~l~~----~~~~~i 151 (239)
T PRK01723 115 HGLFYRADILIERIEG---------ARDLVALLQE------------------------------APLSE----EQWQAI 151 (239)
T ss_pred cCcceeeeEEEEecCC---------CCCHHHHHhc------------------------------CCCCH----HHHHHH
Confidence 22 2599996653 0233332211 01122 235689
Q ss_pred HHHHHHhhhcceeccCCCCceEEecCCCCceEEEeccCcccc
Q 003644 519 VSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKR 560 (805)
Q Consensus 519 a~gL~yLH~~~IvHrDLKp~NILl~~~~~~~~kL~DFGla~~ 560 (805)
+.+|.+||+.||+||||||.|||++.++. ++|+|||.+..
T Consensus 152 ~~~l~~lH~~GI~HrDlkp~NILv~~~~~--v~LIDfg~~~~ 191 (239)
T PRK01723 152 GQLIARFHDAGVYHADLNAHNILLDPDGK--FWLIDFDRGEL 191 (239)
T ss_pred HHHHHHHHHCCCCCCCCCchhEEEcCCCC--EEEEECCCccc
Confidence 99999999999999999999999987765 89999998764
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.33 E-value=6.1e-12 Score=120.12 Aligned_cols=129 Identities=18% Similarity=0.252 Sum_probs=96.4
Q ss_pred EeeccCCceEEEEEEeeCCcEEEEEEeecCCc-hHHHHHHHHHHHhCCC--CCeeeecccccCCceEEEecccccCChhh
Q 003644 382 KEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHH-DVALKEIQNLIASDQH--PNIVRWYGVESDQDFVYLSLERCTCSLND 458 (805)
Q Consensus 382 ~~LG~GsfGtVy~a~~~~g~~VAVK~l~~~~~-~~~~~Ei~~ll~~l~H--pNIV~l~g~~~~~~~l~LV~E~~~~sL~d 458 (805)
+.||+|.++.||++... +..++||....... ....+|+. .+..+.| .++.+++++....+..|++||++.
T Consensus 4 ~~i~~g~~~~v~~~~~~-~~~~~iK~~~~~~~~~~~~~e~~-~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~----- 76 (155)
T cd05120 4 KLLKGGLTNRVYLLGTK-DEDYVLKINPSREKGADREREVA-ILQLLARKGLPVPKVLASGESDGWSYLLMEWIE----- 76 (155)
T ss_pred eecccccccceEEEEec-CCeEEEEecCCCCchhHHHHHHH-HHHHHHHcCCCCCeEEEEcCCCCccEEEEEecC-----
Confidence 67999999999997654 47899999866542 34445555 4455544 588899988888889999999554
Q ss_pred HHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCC
Q 003644 459 LIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI---GLIHRDL 535 (805)
Q Consensus 459 ~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~---~IvHrDL 535 (805)
++.+... +......++.+++.+|++||.. +++|+|+
T Consensus 77 -----g~~~~~~------------------------------------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl 115 (155)
T cd05120 77 -----GETLDEV------------------------------------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDL 115 (155)
T ss_pred -----CeecccC------------------------------------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCC
Confidence 3332211 1123357889999999999985 6999999
Q ss_pred CCceEEecCCCCceEEEeccCcccc
Q 003644 536 KPQNVLISKDKSFCAKLSDMGISKR 560 (805)
Q Consensus 536 Kp~NILl~~~~~~~~kL~DFGla~~ 560 (805)
+|.||++++++. ++++|||.+..
T Consensus 116 ~~~Nil~~~~~~--~~l~Df~~~~~ 138 (155)
T cd05120 116 HPGNILVDDGKI--LGIIDWEYAGY 138 (155)
T ss_pred CcceEEEECCcE--EEEEecccccC
Confidence 999999987544 89999998764
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.23 E-value=3.9e-11 Score=136.80 Aligned_cols=138 Identities=24% Similarity=0.213 Sum_probs=86.9
Q ss_pred EeeccCCceEEEEEEeeCCcEEEEEEeecCCchHHH-------------------------------------------H
Q 003644 382 KEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVAL-------------------------------------------K 418 (805)
Q Consensus 382 ~~LG~GsfGtVy~a~~~~g~~VAVK~l~~~~~~~~~-------------------------------------------~ 418 (805)
+.||.||+|.||+|.+.+|+.||||+.+....+... +
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 569999999999999999999999998653211111 1
Q ss_pred HHHH---HHHhCCCCCeeeeccccc-CCceEEEecccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccc
Q 003644 419 EIQN---LIASDQHPNIVRWYGVES-DQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMEN 494 (805)
Q Consensus 419 Ei~~---ll~~l~HpNIV~l~g~~~-~~~~l~LV~E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~ 494 (805)
|..+ +.....|.+-|..-.++. .....+|||||++| +++.+......
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G----------~~L~~~~~~~~------------------- 253 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDG----------IPLSDIAALDE------------------- 253 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECC----------cccccHHHHHh-------------------
Confidence 1111 111223333333333332 23456999996653 33333221100
Q ss_pred hhhHHHHhhCCCCHHHHHHHHHHHHH-HHHHhhhcceeccCCCCceEEecCCCCceEEEeccCcccccc
Q 003644 495 TKDIELWKANGHPSAQLLKVTRDIVS-GLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQ 562 (805)
Q Consensus 495 ~~~~~~~~~~~l~~~~~~~i~~qIa~-gL~yLH~~~IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~ 562 (805)
.+. ....++.+++. .+..+|..|++|+|+||.||+++.++. ++++|||++..+.
T Consensus 254 ---------~~~---~~~~ia~~~~~~~l~ql~~~g~~H~D~hPgNilv~~~g~--i~liDfG~~~~l~ 308 (437)
T TIGR01982 254 ---------AGL---DRKALAENLARSFLNQVLRDGFFHADLHPGNIFVLKDGK--IIALDFGIVGRLS 308 (437)
T ss_pred ---------cCC---CHHHHHHHHHHHHHHHHHhCCceeCCCCcccEEECCCCc--EEEEeCCCeeECC
Confidence 001 11345666655 468889999999999999999988876 8899999987654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.22 E-value=1.5e-11 Score=128.82 Aligned_cols=203 Identities=21% Similarity=0.288 Sum_probs=135.6
Q ss_pred hCCCCCeeeecccccCCce-----EEEecccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHH
Q 003644 426 SDQHPNIVRWYGVESDQDF-----VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIEL 500 (805)
Q Consensus 426 ~l~HpNIV~l~g~~~~~~~-----l~LV~E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 500 (805)
.+.|.|||+++.|+.+..+ ..++.| ||..|++..+|.......
T Consensus 123 qlvHsnlvkfH~yw~d~K~~e~~rviFite----------ymssgs~~~fLkrt~~~~---------------------- 170 (458)
T KOG1266|consen 123 QLVHSNLVKFHKYWTDKKYEEKPRVIFITE----------YMSSGSLKQFLKRTKKNQ---------------------- 170 (458)
T ss_pred HHHHHHHHHHHHhhcccccccccceEEEEe----------cccchhHHHHHHHHHHhh----------------------
Confidence 3469999999999877543 678889 999999999987654322
Q ss_pred HhhCCCCHHHHHHHHHHHHHHHHHhhhc--ceeccCCCCceEEecCCCCceEEEeccCccccccCCCcc--ccccccccC
Q 003644 501 WKANGHPSAQLLKVTRDIVSGLSHLHEI--GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSC--LTQNATGYG 576 (805)
Q Consensus 501 ~~~~~l~~~~~~~i~~qIa~gL~yLH~~--~IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~--~~~~~~~~g 576 (805)
..+......+|+-||+.||.|||+. .|+|+++.-+-|++..+|- +|+.- +--......... ........+
T Consensus 171 ---~a~~~~~wkkw~tqIlsal~yLhs~~PpiihgnlTc~tifiq~ngL--Ikig~-~ap~s~h~s~~~~~~~Ek~~~~~ 244 (458)
T KOG1266|consen 171 ---KALFQKAWKKWCTQILSALSYLHSCDPPIIHGNLTCDTIFIQHNGL--IKIGS-VAPDSTHPSVNSTREAEKSVNTS 244 (458)
T ss_pred ---hhhhHHHHHHHHHHHHhhhhhhhccCCccccCCcchhheeecCCce--EEecc-cCccccchhhhhhhHhhhhcccc
Confidence 2233445578999999999999987 6999999999999986653 44421 110001000000 001112236
Q ss_pred CCCCCChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCCCCCc--hHHHHHHHhhccccccccCChHHHHHHHHhcCCCCC
Q 003644 577 SSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGES--FERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPD 654 (805)
Q Consensus 577 t~~y~APE~l~~~~~t~~sDVwSlGvil~elltG~~~Pf~~~--~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dP~ 654 (805)
-++|.|||.=.-...+-++|||+||....||..+.-.|-... ...+..+... .+. -..+.-++++.+|++..|.
T Consensus 245 ~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailEiq~tnseS~~~~ee~ia~~---i~~-len~lqr~~i~kcl~~eP~ 320 (458)
T KOG1266|consen 245 LPGFSAPESGTTTNTTGASDIYKFGMCALEMAILEIQSTNSESKVEVEENIANV---IIG-LENGLQRGSITKCLEGEPN 320 (458)
T ss_pred CCccccCCcCcccccccchhhhhhhHHHHHHHHheeccCCCcceeehhhhhhhh---eee-ccCccccCcCcccccCCCC
Confidence 789999998766677889999999999999988743332221 1111111110 000 0112345789999999999
Q ss_pred CCCChhhhhcCccccc
Q 003644 655 LRPKAQNVLNHPFFWT 670 (805)
Q Consensus 655 ~Rps~~ell~Hpff~~ 670 (805)
.||+|.+++.||....
T Consensus 321 ~rp~ar~llfHpllfe 336 (458)
T KOG1266|consen 321 GRPDARLLLFHPLLFE 336 (458)
T ss_pred CCcchhhhhcCceeee
Confidence 9999999999997543
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.17 E-value=3.9e-11 Score=141.77 Aligned_cols=255 Identities=25% Similarity=0.287 Sum_probs=175.1
Q ss_pred eEEEeEeeccCCceEEEEEEee-CCcEEEEEEeecC------CchHHHHHHHHHHHhCCCCCeeeecccccCCceEEEec
Q 003644 377 LVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKT------HHDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSL 449 (805)
Q Consensus 377 ~~~~~~~LG~GsfGtVy~a~~~-~g~~VAVK~l~~~------~~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~ 449 (805)
.+.+.+-+-+|+++.+..+... .|...+.|..... .......+- ++.-.-.||-+++....+.-....+|++
T Consensus 805 ~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s-~~~i~p~~P~v~~~~~s~~~rsP~~L~~ 883 (1205)
T KOG0606|consen 805 GFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKS-NILITPRSPAVVRSFPSFPCRSPLPLVG 883 (1205)
T ss_pred cceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCcc-CccccCCCCceecccCCCCCCCCcchhh
Confidence 3445567888888888765322 2444444433221 111111111 1222245688887777767778899999
Q ss_pred ccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcc
Q 003644 450 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG 529 (805)
Q Consensus 450 E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~ 529 (805)
+ |..+|+|...||... +....-++.....+..+++|||...
T Consensus 884 ~----------~~~~~~~~Skl~~~~-----------------------------~~saepaRs~i~~~vqs~e~L~s~~ 924 (1205)
T KOG0606|consen 884 H----------YLNGGDLPSKLHNSG-----------------------------CLSAEPARSPILERVQSLESLHSSL 924 (1205)
T ss_pred H----------HhccCCchhhhhcCC-----------------------------CcccccccchhHHHHhhhhccccch
Confidence 9 777888888776543 1222334567778889999999999
Q ss_pred eeccCCCCceEEecCCCCceEEEeccCcccccc------CC--C--------------------ccccccccccCCCCCC
Q 003644 530 LIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQ------GD--M--------------------SCLTQNATGYGSSGWQ 581 (805)
Q Consensus 530 IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~------~~--~--------------------~~~~~~~~~~gt~~y~ 581 (805)
++|||++|.|+|+..+++ .+++|||...... +. . ..........||+.|.
T Consensus 925 r~h~~~~p~~~l~~~~gh--~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~l 1002 (1205)
T KOG0606|consen 925 RKHRDLKPDSLLIAYDGH--RPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYL 1002 (1205)
T ss_pred hhcccccccchhhcccCC--cccCccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCccc
Confidence 999999999999998887 6799998433221 00 0 0001123346899999
Q ss_pred ChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHH--HHHhhc--cccccccCChHHHHHHHHhcCCCCCCCC
Q 003644 582 APEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERDA--NIVKDR--KDLFLVEHIPEAVDLFTRLLDPNPDLRP 657 (805)
Q Consensus 582 APE~l~~~~~t~~sDVwSlGvil~elltG~~~Pf~~~~~~~~--~~~~~~--~~~~~~~~~~~~~dLi~~~L~~dP~~Rp 657 (805)
+||.+.+......+|+|++|++++|.++| .+||........ ++.... ...-+....+++++++.+++..+|.+|.
T Consensus 1003 aPe~~lg~~hgs~ad~~~~g~~l~e~l~g-~pp~na~tpq~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~ 1081 (1205)
T KOG0606|consen 1003 APEILLGRRHGSAADWWSSGVCLFEVLTG-IPPFNAETPQQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRL 1081 (1205)
T ss_pred CCcccccccCCCcchhhhhhhhhhhhhcC-CCCCCCcchhhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhcc
Confidence 99999999999999999999999999997 788876554432 222111 1223345568999999999999999998
Q ss_pred Chh---hhhcCccccccccc
Q 003644 658 KAQ---NVLNHPFFWTADTR 674 (805)
Q Consensus 658 s~~---ell~Hpff~~~~~~ 674 (805)
.+. ++-.||||....+.
T Consensus 1082 ~a~~~~e~k~~~~~~~~~~~ 1101 (1205)
T KOG0606|consen 1082 GAKGAAEVKGHPFFQDVDWE 1101 (1205)
T ss_pred CcccccccccCCccCCCCcc
Confidence 887 89999999766543
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.10 E-value=5.9e-11 Score=134.17 Aligned_cols=244 Identities=23% Similarity=0.198 Sum_probs=168.6
Q ss_pred ceEEEeEeeccCCceEEEEEEe--eCCcEEEEEEeecCCc-----hHHHHHHHHHHHhCCCCCeeeecccccCCceEEEe
Q 003644 376 KLVVFNKEIAKGSNGTVVLEGN--YEGRSVAVKRLVKTHH-----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLS 448 (805)
Q Consensus 376 ~~~~~~~~LG~GsfGtVy~a~~--~~g~~VAVK~l~~~~~-----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV 448 (805)
.+|.....||.|.|+.|+.... .++..+|+|.+.+.-. ...+.|+........|.++++++..|...+..|+-
T Consensus 265 ~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip 344 (524)
T KOG0601|consen 265 TDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIP 344 (524)
T ss_pred CCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCc
Confidence 3456677899999999988543 4678999998865421 22345655445566799999999999999999999
Q ss_pred cccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhc
Q 003644 449 LERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI 528 (805)
Q Consensus 449 ~E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~ 528 (805)
.|+|.+ +++...... ...+.+...+++..|++.++.++|+.
T Consensus 345 ~e~~~~----------~s~~l~~~~-----------------------------~~~~d~~~~~~~~~q~~~~l~~i~s~ 385 (524)
T KOG0601|consen 345 LEFCEG----------GSSSLRSVT-----------------------------SQMLDEDPRLRLTAQILTALNVIHSK 385 (524)
T ss_pred hhhhcC----------cchhhhhHH-----------------------------HHhcCcchhhhhHHHHHhccccccch
Confidence 996653 332221100 01133445688999999999999999
Q ss_pred ceeccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCC--ChhhhhcCCCCCcchHHHHHHHHHH
Q 003644 529 GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQ--APEQLLQGRQTRAIDLFSLGCILFF 606 (805)
Q Consensus 529 ~IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~--APE~l~~~~~t~~sDVwSlGvil~e 606 (805)
.++|+|+||+||++..++ +..++.|||.+..+.-. .....+.-+++ +++......+..+.|+||||.-+.+
T Consensus 386 ~~~~~d~~psni~i~~~~-~~~~~~~~~~~t~~~~~------~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e 458 (524)
T KOG0601|consen 386 LFVHLDVKPSNILISNDG-FFSKLGDFGCWTRLAFS------SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDE 458 (524)
T ss_pred hhhcccccccceeeccch-hhhhcccccccccccee------cccccccccccccchhhccccccccccccccccccccc
Confidence 999999999999998765 34689999988753211 11112333444 5555556678899999999999999
Q ss_pred HHhCCCCCCCCchHHHHHHHhhccccccccCChHHHHHHHHhcCCCCCCCCChhhhhcCccc
Q 003644 607 CITGGKHPYGESFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 668 (805)
Q Consensus 607 lltG~~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dP~~Rps~~ell~Hpff 668 (805)
.+++...+..... ...+...... .......++..+.+.++.+|+..||.+.++..|+-|
T Consensus 459 ~~~~~~ls~~~~~--~~~i~~~~~p-~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~ 517 (524)
T KOG0601|consen 459 AITGSPLSESGVQ--SLTIRSGDTP-NLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEF 517 (524)
T ss_pred cccCcccCccccc--ceeeeccccc-CCCchHHhhhhhhhhhcCCccccchhhhhhcccchh
Confidence 9997444433211 1111111111 122223678889999999999999999999988755
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.00 E-value=3.2e-10 Score=131.13 Aligned_cols=38 Identities=29% Similarity=0.421 Sum_probs=30.8
Q ss_pred hhcceeccCCCCceEEecCCC--CceEEEeccCccccccC
Q 003644 526 HEIGLIHRDLKPQNVLISKDK--SFCAKLSDMGISKRLQG 563 (805)
Q Consensus 526 H~~~IvHrDLKp~NILl~~~~--~~~~kL~DFGla~~~~~ 563 (805)
+..|++|+|+||.||+++.++ ...++++|||++..+..
T Consensus 277 f~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 277 FRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred HhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 358999999999999998776 12378999999877653
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=98.94 E-value=2.8e-09 Score=105.08 Aligned_cols=124 Identities=17% Similarity=0.077 Sum_probs=82.0
Q ss_pred EeeccCCceEEEEEEeeCCcEEEEEEeecCC--chHHHHHHHHHHHhCCCCC-eeeecccccCCceEEEecccccCChhh
Q 003644 382 KEIAKGSNGTVVLEGNYEGRSVAVKRLVKTH--HDVALKEIQNLIASDQHPN-IVRWYGVESDQDFVYLSLERCTCSLND 458 (805)
Q Consensus 382 ~~LG~GsfGtVy~a~~~~g~~VAVK~l~~~~--~~~~~~Ei~~ll~~l~HpN-IV~l~g~~~~~~~l~LV~E~~~~sL~d 458 (805)
+.|+.|.++.||+... .|+.|+||...... .....+|... +..+.+.+ +.+++++.. +..++|||++
T Consensus 4 ~~l~~G~~~~vy~~~~-~~~~~~lK~~~~~~~~~~~~~~E~~~-l~~l~~~~~~P~~~~~~~--~~~~lv~e~i------ 73 (170)
T cd05151 4 SPLKGGMTNKNYRVEV-ANKKYVVRIPGNGTELLINRENEAEN-SKLAAEAGIGPKLYYFDP--ETGVLITEFI------ 73 (170)
T ss_pred eecCCcccCceEEEEE-CCeEEEEEeCCCCcccccCHHHHHHH-HHHHHHhCCCCceEEEeC--CCCeEEEEec------
Confidence 5689999999998654 47889999875543 1223455543 33333333 334554433 3358999944
Q ss_pred HHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcce-----ecc
Q 003644 459 LIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL-----IHR 533 (805)
Q Consensus 459 ~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~I-----vHr 533 (805)
.+.++... . .....++.+++++|+.||+.++ +|+
T Consensus 74 ----~G~~l~~~-----~--------------------------------~~~~~~~~~l~~~l~~LH~~~~~~~~~~Hg 112 (170)
T cd05151 74 ----EGSELLTE-----D--------------------------------FSDPENLEKIAKLLKKLHSSPLPDLVPCHN 112 (170)
T ss_pred ----CCCccccc-----c--------------------------------ccCHHHHHHHHHHHHHHhCCCCCCceeecC
Confidence 44433221 0 0012456799999999999875 999
Q ss_pred CCCCceEEecCCCCceEEEeccCccc
Q 003644 534 DLKPQNVLISKDKSFCAKLSDMGISK 559 (805)
Q Consensus 534 DLKp~NILl~~~~~~~~kL~DFGla~ 559 (805)
|++|.||+++ ++. ++++|||.+.
T Consensus 113 D~~~~Nil~~-~~~--~~liDf~~a~ 135 (170)
T cd05151 113 DLLPGNFLLD-DGR--LWLIDWEYAG 135 (170)
T ss_pred CCCcCcEEEE-CCe--EEEEeccccc
Confidence 9999999997 443 7899999875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.93 E-value=7.8e-09 Score=118.23 Aligned_cols=164 Identities=20% Similarity=0.325 Sum_probs=114.7
Q ss_pred EeeCCcEEEEEEeecCCc--hHHHHHHHHHHHhCCCCCeeeecccccCCceEEEecccccCChhhHHHHhcCCHHHHHhh
Q 003644 396 GNYEGRSVAVKRLVKTHH--DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNA 473 (805)
Q Consensus 396 ~~~~g~~VAVK~l~~~~~--~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~E~~~~sL~d~iy~~~GsL~~~L~~ 473 (805)
...++.+|.|...+.... ....++...-++.++||||++++..+..++.+|||+|.+.- |...+..
T Consensus 33 ~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~P------------l~~~lk~ 100 (690)
T KOG1243|consen 33 RKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVRP------------LETVLKE 100 (690)
T ss_pred eeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecccc------------HHHHHHH
Confidence 446788899988876544 22233333467889999999999999999999999996541 2221111
Q ss_pred hhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhh-hcceeccCCCCceEEecCCCCceEEE
Q 003644 474 KEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH-EIGLIHRDLKPQNVLISKDKSFCAKL 552 (805)
Q Consensus 474 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH-~~~IvHrDLKp~NILl~~~~~~~~kL 552 (805)
. ........+.||+.||.||| ..+++|++|.-+.|+++..|+ .||
T Consensus 101 ------------------------------l--~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~Ge--WkL 146 (690)
T KOG1243|consen 101 ------------------------------L--GKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGE--WKL 146 (690)
T ss_pred ------------------------------h--HHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCc--EEE
Confidence 1 12344678899999999998 568999999999999999988 789
Q ss_pred eccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHHHHHhC
Q 003644 553 SDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG 610 (805)
Q Consensus 553 ~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~elltG 610 (805)
++|-++....+... ......---.|..|+.+.... -..|.|-|||+++|++.|
T Consensus 147 ggle~v~~~~~~~~---~~~~~~~~~s~~~P~~~~~s~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 147 GGLELVSKASGFNA---PAKSLYLIESFDDPEEIDPSE--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred eeeEEEeccccCCc---ccccchhhhcccChhhcCccc--cchhhhhHHHHHHHHhCc
Confidence 99988765543211 011111122356666543222 457999999999999997
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.87 E-value=1.5e-09 Score=124.43 Aligned_cols=165 Identities=23% Similarity=0.376 Sum_probs=118.3
Q ss_pred HHHHHHHHHHhhhc-ceeccCCCCceEEecCCCCceEEEeccCccccccCCCcc----cccc--ccccCCCCCCChhhhh
Q 003644 515 TRDIVSGLSHLHEI-GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSC----LTQN--ATGYGSSGWQAPEQLL 587 (805)
Q Consensus 515 ~~qIa~gL~yLH~~-~IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~----~~~~--~~~~gt~~y~APE~l~ 587 (805)
+.+++.||.|+|.. ++||++|.|++|.++..+. .||+.|+++....+.... +... ....-...|.|||++.
T Consensus 105 l~~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~--wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~ 182 (700)
T KOG2137|consen 105 LGNVADGLAFLHRSAKVVHGNIQPEAIVVNANGD--WKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL 182 (700)
T ss_pred hhcccchhhhhccCcceeecccchhheeeccCcc--eeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence 34556999999976 8999999999999988876 899999998776652211 1111 1112456799999999
Q ss_pred cCCCCCcchHHHHHHHHHHHHhCCCCCCCCch---HH--HHHHHhhccccccccCChHHHHHHHHhcCCCCCCCCChhhh
Q 003644 588 QGRQTRAIDLFSLGCILFFCITGGKHPYGESF---ER--DANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNV 662 (805)
Q Consensus 588 ~~~~t~~sDVwSlGvil~elltG~~~Pf~~~~---~~--~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dP~~Rps~~el 662 (805)
+...+.++|+||+||++|.+..||+.-+.... .. ...........+....++++++-+.+++..++..||++.++
T Consensus 183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l 262 (700)
T KOG2137|consen 183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLL 262 (700)
T ss_pred cccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhhh
Confidence 98889999999999999998866665443221 11 11111111222334567899999999999999999999999
Q ss_pred hcCcccccccc-chhhhhhc
Q 003644 663 LNHPFFWTADT-RLSFLRDV 681 (805)
Q Consensus 663 l~Hpff~~~~~-~~~~l~~~ 681 (805)
+..|||.+..- .++|+.++
T Consensus 263 ~~~~ff~D~~~~aLrfLD~l 282 (700)
T KOG2137|consen 263 LSIPFFSDPGLKALRFLDDL 282 (700)
T ss_pred hcccccCCchhhhhhhcccc
Confidence 99999976543 34555444
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=98.83 E-value=1.7e-08 Score=102.34 Aligned_cols=51 Identities=22% Similarity=0.276 Sum_probs=43.0
Q ss_pred HHHHHHHHHHHHHHHHh-hhcceeccCCCCceEEecCCCCceEEEeccCcccccc
Q 003644 509 AQLLKVTRDIVSGLSHL-HEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQ 562 (805)
Q Consensus 509 ~~~~~i~~qIa~gL~yL-H~~~IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~ 562 (805)
.++..+..+++.+|..| |..||||+||++.|||+.+ +. +.|+|||.+....
T Consensus 124 ~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NIL~~~-~~--v~iIDF~qav~~~ 175 (197)
T cd05146 124 EEMKNAYYQVLSMMKQLYKECNLVHADLSEYNMLWHD-GK--VWFIDVSQSVEPT 175 (197)
T ss_pred HHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEC-Cc--EEEEECCCceeCC
Confidence 44567889999999999 8999999999999999964 44 7899999886543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >smart00580 PUG domain in protein kinases, N-glycanases and other nuclear proteins | Back alignment and domain information |
|---|
Probab=98.83 E-value=1e-09 Score=88.23 Aligned_cols=53 Identities=51% Similarity=0.835 Sum_probs=49.5
Q ss_pred CCHHHHHHHHhhcccccccC--ChhHHhhhCCCCccccccccccCCccHHH-HHHH
Q 003644 733 DNVRDLLRVIRNKSNHFREL--PQDIQELLGSHPEGFYNYFSCRFPKLLIE-VYNV 785 (805)
Q Consensus 733 ~~~~dllr~irn~~~h~~e~--~~~~~~l~g~~p~~f~~yf~~~fp~ll~~-~y~~ 785 (805)
++++||||+|||+.+||+|. ++.+|+.+|++|+++..||..+||.|+++ +|..
T Consensus 1 ~sv~dLLr~irNi~~hp~e~k~n~~~~~~l~~~pg~~~~l~~~gFp~l~~~~~y~l 56 (58)
T smart00580 1 ESVRDLLRALRNILHHPREEKGNPAIKERLGDVPGGFELYFTVGFPRLLISEVYTL 56 (58)
T ss_pred CcHHHHHHHHHHHhhCcchhhcCHHHHHHhcCCCcHHHHHHHcCCCcccccceeee
Confidence 36899999999999999999 99999999999999999999999999998 7643
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.74 E-value=1.8e-07 Score=104.12 Aligned_cols=223 Identities=18% Similarity=0.185 Sum_probs=148.8
Q ss_pred eEEEEE-EeeCCcEEEEEEeecCCc--hHHHHHHHHHHHhCCCCCeeeecccccC----CceEEEecccccC--ChhhHH
Q 003644 390 GTVVLE-GNYEGRSVAVKRLVKTHH--DVALKEIQNLIASDQHPNIVRWYGVESD----QDFVYLSLERCTC--SLNDLI 460 (805)
Q Consensus 390 GtVy~a-~~~~g~~VAVK~l~~~~~--~~~~~Ei~~ll~~l~HpNIV~l~g~~~~----~~~l~LV~E~~~~--sL~d~i 460 (805)
.+.|++ ...||..|+.||+..... ......+.+..+.+.|+|||++..++.. +.-+++||+|.++ +|.++.
T Consensus 290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~ 369 (655)
T KOG3741|consen 290 ITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLY 369 (655)
T ss_pred ceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHH
Confidence 467776 667899999999932211 1112234456788899999999998873 4558999999875 576665
Q ss_pred HHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCCCceE
Q 003644 461 YVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNV 540 (805)
Q Consensus 461 y~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~IvHrDLKp~NI 540 (805)
+...... . ... .-..-...+.++..++.++.|+..||.++|+.|+.-+-|.+.+|
T Consensus 370 F~~~~~t-~------~~n------------------~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kI 424 (655)
T KOG3741|consen 370 FANPPFT-K------RTN------------------SFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKI 424 (655)
T ss_pred ccCCccc-c------ccc------------------cccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHe
Confidence 4322111 0 000 00002234578889999999999999999999999999999999
Q ss_pred EecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCCCCCchH
Q 003644 541 LISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFE 620 (805)
Q Consensus 541 Ll~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~elltG~~~Pf~~~~~ 620 (805)
|++. +.+++|+..|....+..+. + |-+. --.+-|.=.||.++..|.||..--+.....
T Consensus 425 lv~G--~~RIriS~C~i~Dvl~~d~----------~-------~~le---~~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~ 482 (655)
T KOG3741|consen 425 LVTG--KMRIRISGCGIMDVLQEDP----------T-------EPLE---SQQQNDLRDLGLLLLALATGTENSNRTDST 482 (655)
T ss_pred EeeC--cceEEEecccceeeecCCC----------C-------cchh---HHhhhhHHHHHHHHHHHhhcccccccccch
Confidence 9954 4468898888776655432 0 0111 123568889999999999985433332222
Q ss_pred HHHHHHhhccccccccCChHHHHHHHHhcCCCCCCCCChhhhhcC
Q 003644 621 RDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNH 665 (805)
Q Consensus 621 ~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dP~~Rps~~ell~H 665 (805)
....+ . ......+.+++++|.-+...++.. -+..+++.|
T Consensus 483 ~~s~~-~----~I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~ 521 (655)
T KOG3741|consen 483 QSSHL-T----RITTTYSTDLRNVVEYLESLNFRE-KSIQDLLPM 521 (655)
T ss_pred HHHHH-H----HhhhhhhHHHHHHHHHHHhcCccc-ccHHHHHHH
Confidence 11111 1 112234568899999999988876 678888865
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.64 E-value=3e-07 Score=99.90 Aligned_cols=150 Identities=25% Similarity=0.362 Sum_probs=104.8
Q ss_pred CCHHHHHHHHHHHHHHHHHhhhcceeccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhh
Q 003644 506 HPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQ 585 (805)
Q Consensus 506 l~~~~~~~i~~qIa~gL~yLH~~~IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~ 585 (805)
..|+-+++.++.++.+.+-||+.|.+-+|+.++|+|+++++. +.|.|=..-..... .......+|.+.|.+||.
T Consensus 114 ~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~--V~LVdsDsfqi~~n----g~~~~cpVg~~eftPPEl 187 (637)
T COG4248 114 CAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSK--VVLVDSDSFQINAN----GTLHLCPVGVSEFTPPEL 187 (637)
T ss_pred cccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCce--EEEEcccceeeccC----CceEecccCccccCCHHH
Confidence 356788999999999999999999999999999999998876 56665332211111 123344578999999997
Q ss_pred hh-----cCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHH-------HHHHHhh--------cc--cc----ccc-cCC
Q 003644 586 LL-----QGRQTRAIDLFSLGCILFFCITGGKHPYGESFER-------DANIVKD--------RK--DL----FLV-EHI 638 (805)
Q Consensus 586 l~-----~~~~t~~sDVwSlGvil~elltG~~~Pf~~~~~~-------~~~~~~~--------~~--~~----~~~-~~~ 638 (805)
-. +..-+...|.|.|||++++++.||++||..-... +..|... +. .. .+. -..
T Consensus 188 Q~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lp 267 (637)
T COG4248 188 QTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRFAYASDQRRGLKPPPRSIPLSMLP 267 (637)
T ss_pred hccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcceeeechhccCCCCCCCCCCChhhcC
Confidence 65 2334678999999999999999999999653211 1111111 00 01 111 123
Q ss_pred hHHHHHHHHhcCCC--CCCCCChhh
Q 003644 639 PEAVDLFTRLLDPN--PDLRPKAQN 661 (805)
Q Consensus 639 ~~~~dLi~~~L~~d--P~~Rps~~e 661 (805)
+++..|..+|+..- +.-||+++-
T Consensus 268 p~vqAlF~qaF~~~~~~~~RP~a~a 292 (637)
T COG4248 268 PDVQALFQQAFTESGVATPRPTAKA 292 (637)
T ss_pred HHHHHHHHHHhcccCCCCCCCCHHH
Confidence 67888999998753 568999754
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.55 E-value=2.4e-07 Score=95.10 Aligned_cols=76 Identities=14% Similarity=0.202 Sum_probs=50.5
Q ss_pred EeeccCCceEEEEEEeeCCcEEEEEEeecCC----chHHHHHHHHHHHhCCC--CCeeeecccccCC---ceEEEecccc
Q 003644 382 KEIAKGSNGTVVLEGNYEGRSVAVKRLVKTH----HDVALKEIQNLIASDQH--PNIVRWYGVESDQ---DFVYLSLERC 452 (805)
Q Consensus 382 ~~LG~GsfGtVy~a~~~~g~~VAVK~l~~~~----~~~~~~Ei~~ll~~l~H--pNIV~l~g~~~~~---~~l~LV~E~~ 452 (805)
+.|+.|..+.||+....+|+.++||...... .....+|.. .+..+.+ .++.+++.+..+. +..++|||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~-~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i 82 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYR-VLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV 82 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHH-HHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence 5689999999999877667899999875432 233445554 3444433 3456666666554 3678999988
Q ss_pred cC-Chhh
Q 003644 453 TC-SLND 458 (805)
Q Consensus 453 ~~-sL~d 458 (805)
.+ ++.+
T Consensus 83 ~G~~l~~ 89 (223)
T cd05154 83 DGRVLRD 89 (223)
T ss_pred CCEecCC
Confidence 76 3433
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.45 E-value=7e-07 Score=87.76 Aligned_cols=138 Identities=23% Similarity=0.297 Sum_probs=86.6
Q ss_pred EeeccCCceEEEEEEeeCCcEEEEEE-eecCC-c---------hHHHHHHHHHHHhCCCCCeeeecccccCCceEEEecc
Q 003644 382 KEIAKGSNGTVVLEGNYEGRSVAVKR-LVKTH-H---------DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 450 (805)
Q Consensus 382 ~~LG~GsfGtVy~a~~~~g~~VAVK~-l~~~~-~---------~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~E 450 (805)
..|-+|+-+.|++ +.+.|+...||. +.+.. + ....+|.. ++.++.--.|.--.-++.|...-.|+||
T Consensus 13 ~likQGAEArv~~-~~~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear-~l~k~~~~GI~~P~l~~~D~~~~~i~ME 90 (229)
T KOG3087|consen 13 ELIKQGAEARVPR-GSFSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEAR-LLAKCRALGIPAPRLIFIDTYGGQIYME 90 (229)
T ss_pred eeeeccceeeEee-eccCCceeEEeecccccccchHHHHHHHHHHHHHHHH-HHHHHHHhCCCCceEEEEecCCCeEEEE
Confidence 5678999999987 667788877773 33221 1 12234443 3333221122211123445555678899
Q ss_pred cccC--ChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhc
Q 003644 451 RCTC--SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI 528 (805)
Q Consensus 451 ~~~~--sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~ 528 (805)
+.++ ++.+++.+...+ ....+....+++.|=+.+.-||..
T Consensus 91 ~~~g~~~vk~~i~~~~~~--------------------------------------~~~d~~~~~~~~~iG~~igklH~n 132 (229)
T KOG3087|consen 91 FIDGASTVKDFILSTMED--------------------------------------ESEDEGLAELARRIGELIGKLHDN 132 (229)
T ss_pred eccchhHHHHHHHHHccC--------------------------------------cccchhHHHHHHHHHHHHHHhhhC
Confidence 7776 566665322110 011122357888888999999999
Q ss_pred ceeccCCCCceEEecCCCC-ceEEEeccCccc
Q 003644 529 GLIHRDLKPQNVLISKDKS-FCAKLSDMGISK 559 (805)
Q Consensus 529 ~IvHrDLKp~NILl~~~~~-~~~kL~DFGla~ 559 (805)
+|||+||..+||+|..++. +.+.++|||++.
T Consensus 133 diiHGDLTTSNill~~~~~~~~~~lIdfgls~ 164 (229)
T KOG3087|consen 133 DIIHGDLTTSNILLRSDGNQITPILIDFGLSS 164 (229)
T ss_pred CeecccccccceEEecCCCcCceEEEeecchh
Confidence 9999999999999976654 445899999875
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.39 E-value=5.6e-06 Score=88.39 Aligned_cols=53 Identities=13% Similarity=0.219 Sum_probs=45.1
Q ss_pred CHHHHHHHHHHHHHHHHHhhhcceeccCCCCceEEecC-----CCCceEEEeccCccc
Q 003644 507 PSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISK-----DKSFCAKLSDMGISK 559 (805)
Q Consensus 507 ~~~~~~~i~~qIa~gL~yLH~~~IvHrDLKp~NILl~~-----~~~~~~kL~DFGla~ 559 (805)
+......++.+++..+.-||..||+|+|+++.|||++. ++...+.++||+.++
T Consensus 136 ~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~ 193 (268)
T PRK15123 136 DPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ 193 (268)
T ss_pred CHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence 34456789999999999999999999999999999975 234568999999875
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.37 E-value=1.5e-06 Score=85.86 Aligned_cols=127 Identities=19% Similarity=0.297 Sum_probs=78.3
Q ss_pred eeccCCceEEEEEEeeCCcEEEEEE-eecCCc----------hHHHHHHHHHHHhCCCCCeeeecccccCCceEEEeccc
Q 003644 383 EIAKGSNGTVVLEGNYEGRSVAVKR-LVKTHH----------DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLER 451 (805)
Q Consensus 383 ~LG~GsfGtVy~a~~~~g~~VAVK~-l~~~~~----------~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~E~ 451 (805)
.+++|+-..+|.+.. -|..+.+|. +.+.-. ....+|.. ++....--.|-.-+-+..|.+...|+|||
T Consensus 3 ~i~~GAEa~i~~~~~-~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Ear-il~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 3 LIKQGAEAIIYLTDF-LGLPAVVKERIPKRYRHPELDEKLRRERTRREAR-ILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred hhhCCcceeEEeeec-cCcceEEEeecCcccCChHHHHHHHHHHHHHHHH-HHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 478999999998644 444566663 333211 12233443 33332211121112234566677899996
Q ss_pred ccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhccee
Q 003644 452 CTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLI 531 (805)
Q Consensus 452 ~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~Iv 531 (805)
.++ ..|.+.+... ...+++.+=.-+.-||..|||
T Consensus 81 I~G----------~~lkd~l~~~------------------------------------~~~~~r~vG~~vg~lH~~giv 114 (204)
T COG3642 81 IEG----------ELLKDALEEA------------------------------------RPDLLREVGRLVGKLHKAGIV 114 (204)
T ss_pred eCC----------hhHHHHHHhc------------------------------------chHHHHHHHHHHHHHHhcCee
Confidence 554 3344333211 135666777788889999999
Q ss_pred ccCCCCceEEecCCCCceEEEeccCcccc
Q 003644 532 HRDLKPQNVLISKDKSFCAKLSDMGISKR 560 (805)
Q Consensus 532 HrDLKp~NILl~~~~~~~~kL~DFGla~~ 560 (805)
|+||.++||++..++ +.++||||+..
T Consensus 115 HGDLTtsNiIl~~~~---i~~IDfGLg~~ 140 (204)
T COG3642 115 HGDLTTSNIILSGGR---IYFIDFGLGEF 140 (204)
T ss_pred cCCCccceEEEeCCc---EEEEECCcccc
Confidence 999999999997554 67999999863
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.24 E-value=8.3e-07 Score=106.03 Aligned_cols=41 Identities=17% Similarity=0.075 Sum_probs=20.6
Q ss_pred ccccccccccCccccchhhh-hhcC-Ccccccccccceeeeec
Q 003644 164 IGDVESHLPCHTQMTASVYR-LRDN-SLPEFLSVIGKVAGWIS 204 (805)
Q Consensus 164 ~~~~~~~~~~nN~fsG~ip~-l~~l-~L~~Lnls~N~fsG~IP 204 (805)
..+|+.+.+.+|+|+|.+|. +..+ .|+.|||++|+|+|.||
T Consensus 465 l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~iP 507 (623)
T PLN03150 465 ITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVP 507 (623)
T ss_pred CCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCcccccCC
Confidence 34444455555555555542 4444 35555555555555554
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.23 E-value=3.1e-06 Score=85.43 Aligned_cols=48 Identities=23% Similarity=0.462 Sum_probs=35.8
Q ss_pred HHHHHHHHHHHHH-hhhcceeccCCCCceEEecCCCCceEEEeccCcccccc
Q 003644 512 LKVTRDIVSGLSH-LHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQ 562 (805)
Q Consensus 512 ~~i~~qIa~gL~y-LH~~~IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~ 562 (805)
..++.+++..+.. +|..||+|+||.+.|||++++ . +.|+|||.+....
T Consensus 109 ~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~--~~iIDf~qav~~~ 157 (188)
T PF01163_consen 109 KELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-K--VYIIDFGQAVDSS 157 (188)
T ss_dssp HHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-C--EEE--GTTEEETT
T ss_pred HHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-e--EEEEecCcceecC
Confidence 5677788886655 579999999999999999766 3 7899999876543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.14 E-value=5.4e-07 Score=102.55 Aligned_cols=245 Identities=19% Similarity=0.182 Sum_probs=162.1
Q ss_pred EEEeEeeccCCceEEEEEEeeCCcEEEEEEeecCCchHHHHHHHHHHHhCCCCC-eeeecccccCCceEEEecccccCCh
Q 003644 378 VVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPN-IVRWYGVESDQDFVYLSLERCTCSL 456 (805)
Q Consensus 378 ~~~~~~LG~GsfGtVy~a~~~~g~~VAVK~l~~~~~~~~~~Ei~~ll~~l~HpN-IV~l~g~~~~~~~l~LV~E~~~~sL 456 (805)
+.+-...++|+++++|+++-...+...++.+... ....-++ +|+.+.+||| .++.++-+..++..++++++|.+.-
T Consensus 244 s~~fh~fvK~altknpKkRptaeklL~h~fvs~~--l~~rl~~-eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~r 320 (829)
T KOG0576|consen 244 SEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT--LSRRLAI-ELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGR 320 (829)
T ss_pred hHHHHHHHHHHhcCCCccCCChhhheeceeeccc--hhhHHHH-HHHHHccCCCCcccccccCCcccccchhhhhhcCCc
Confidence 3344568899999999876554555556665443 2222233 4889999999 8888888888899999999766320
Q ss_pred hhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCC
Q 003644 457 NDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLK 536 (805)
Q Consensus 457 ~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~IvHrDLK 536 (805)
+...-. ...+. .+...+...+.+.-+++|+|||+.-=+|||
T Consensus 321 ---------s~~~~~--------~~se~--------------------~~~~~~~~~~~r~et~~l~~l~~~~~~~~d-- 361 (829)
T KOG0576|consen 321 ---------SSALEM--------TVSEI--------------------ALEQYQFAYPLRKETRPLAELHSSYKVHRD-- 361 (829)
T ss_pred ---------cccccC--------ChhhH--------------------hhhhhhhhhhhhhhcccccccccccccCcc--
Confidence 100000 00000 011223456777888999999998779999
Q ss_pred CceEEecCCCCceEEEeccCccccccCCCccccccccccCCCCCCChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q 003644 537 PQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYG 616 (805)
Q Consensus 537 p~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDVwSlGvil~elltG~~~Pf~ 616 (805)
|||..+.. .+..||+....+.... ...+..+|+.|+|||+.....+....|+|++|+--.++.-| .+|-.
T Consensus 362 --~~l~s~~~---~~~~~~~v~~~L~~~~----~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~-~pPr~ 431 (829)
T KOG0576|consen 362 --NILGSEEE---VKLLDFAVPPQLTRTM----KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPG-LPPRS 431 (829)
T ss_pred --cccccccc---cccccccCCcccCccc----ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCC-CCCCC
Confidence 89887643 6899999887776432 34556799999999999999999999999999876666665 54543
Q ss_pred CchHHHHHHHhhccc---ccc--ccCChHHHHHHHHhcCCCCCCCCChhhhhcCccccccccch
Q 003644 617 ESFERDANIVKDRKD---LFL--VEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTADTRL 675 (805)
Q Consensus 617 ~~~~~~~~~~~~~~~---~~~--~~~~~~~~dLi~~~L~~dP~~Rps~~ell~Hpff~~~~~~~ 675 (805)
....... .+..... +.. .+...+-.++...|+..-|..|+...+.+.|.+|.....+.
T Consensus 432 ~P~~~~~-~~g~~p~s~~L~~~~aw~~~~~~~~~~~~~~g~P~~pkv~mgacfsKvfngCpl~i 494 (829)
T KOG0576|consen 432 SPPAVLP-MIGNGPNSPMLTDKSAWSPVFHRDFPAPCLNGLPPTPKVHMGACFSKVFNGCPLRI 494 (829)
T ss_pred CCccccC-CCCCCCCccccchhhhcCcccccCCcccccCCCCCCCcchhhHHHHHHhccCcccc
Confidence 3211110 0000110 000 01111223578899999999999999999999997766554
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.00 E-value=6.2e-05 Score=77.34 Aligned_cols=53 Identities=26% Similarity=0.456 Sum_probs=45.5
Q ss_pred HHHHHHHHHHHHHHHHhhhcceeccCCCCceEEecCCC-CceEEEeccCccccc
Q 003644 509 AQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDK-SFCAKLSDMGISKRL 561 (805)
Q Consensus 509 ~~~~~i~~qIa~gL~yLH~~~IvHrDLKp~NILl~~~~-~~~~kL~DFGla~~~ 561 (805)
.....++.+++..++-||+.||+|+|+++.|||++.++ ...+.++||+.++..
T Consensus 118 ~~~~~ll~~l~~~i~~lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 118 SQRRELLRALARLIAKLHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred hhHHHHHHHHHHHHHHHHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 34578999999999999999999999999999998764 456889999977643
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.96 E-value=0.00013 Score=74.48 Aligned_cols=138 Identities=12% Similarity=0.086 Sum_probs=89.8
Q ss_pred eccCCceEEEEEEeeCCcEEEEEEee---------cCCchHHHHHHHHHHHh--CCCCCeeeeccccc--C--CceEEEe
Q 003644 384 IAKGSNGTVVLEGNYEGRSVAVKRLV---------KTHHDVALKEIQNLIAS--DQHPNIVRWYGVES--D--QDFVYLS 448 (805)
Q Consensus 384 LG~GsfGtVy~a~~~~g~~VAVK~l~---------~~~~~~~~~Ei~~ll~~--l~HpNIV~l~g~~~--~--~~~l~LV 448 (805)
-|+|+-+.|+. -..+|+.+=||+-. ........+|+..+... ..=| +.+...... . .-.-+||
T Consensus 26 ~~rgG~SgV~r-~~~~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvP-VP~pvf~~~~k~~~~~rA~LV 103 (216)
T PRK09902 26 YRRNGMSGVQC-VERNGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVI-VPKIVFGEAVKIEGEWRALLV 103 (216)
T ss_pred cCCCCcceEEE-EEeCCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCC-CCccceeeeeccCCceEEEEE
Confidence 45678778887 44556678888764 11234567787644322 2223 444432211 1 1236899
Q ss_pred cccccC--ChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhh
Q 003644 449 LERCTC--SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH 526 (805)
Q Consensus 449 ~E~~~~--sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH 526 (805)
+|-+++ +|.+++ .. |.....+......+..+++..++-||
T Consensus 104 Te~L~g~~~L~~~l-----------~~---------------------------~~~~~~~~~~k~~il~~va~~ia~LH 145 (216)
T PRK09902 104 TEDMAGFISIADWY-----------AQ---------------------------HAVSPYSDEVRQAMLKAVALAFKKMH 145 (216)
T ss_pred EEeCCCCccHHHHH-----------hc---------------------------CCcCCcchHHHHHHHHHHHHHHHHHH
Confidence 996663 555443 11 11122344555789999999999999
Q ss_pred hcceeccCCCCceEEecCCCCceEEEeccCccccc
Q 003644 527 EIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRL 561 (805)
Q Consensus 527 ~~~IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~ 561 (805)
+.|+.|+|+-+.|||++.++.+.++++||.-++..
T Consensus 146 ~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~~ 180 (216)
T PRK09902 146 SVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRRR 180 (216)
T ss_pred HCCCcCCCCCHhheeecCCCCeeEEEEEhhccchh
Confidence 99999999999999998667677999999866543
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.89 E-value=6.5e-05 Score=78.64 Aligned_cols=133 Identities=17% Similarity=0.132 Sum_probs=84.4
Q ss_pred EEEeEeeccCCceEEEEEEeeCCcEEEEEEeecC-----------------C--------chHHHHHHHHHHHhCCC-CC
Q 003644 378 VVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKT-----------------H--------HDVALKEIQNLIASDQH-PN 431 (805)
Q Consensus 378 ~~~~~~LG~GsfGtVy~a~~~~g~~VAVK~l~~~-----------------~--------~~~~~~Ei~~ll~~l~H-pN 431 (805)
..++..||-|.-+.||.+....|.++|||.=+-. . ...+.+|.+.|...-.+ -.
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 4566889999999999998889999999942110 0 12345666644333222 12
Q ss_pred eeeecccccCCceEEEecccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHH
Q 003644 432 IVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQL 511 (805)
Q Consensus 432 IV~l~g~~~~~~~l~LV~E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 511 (805)
+.+-++ .+...+|||+.++. .|... .+.....
T Consensus 173 VP~P~~----~nRHaVvMe~ieG~----------eL~~~----------------------------------r~~~en~ 204 (304)
T COG0478 173 VPKPIA----WNRHAVVMEYIEGV----------ELYRL----------------------------------RLDVENP 204 (304)
T ss_pred CCCccc----cccceeeeehcccc----------eeecc----------------------------------cCcccCH
Confidence 333333 35678999965542 12110 0011122
Q ss_pred HHHHHHHHHHHHHhhhcceeccCCCCceEEecCCCCceEEEeccCcccc
Q 003644 512 LKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKR 560 (805)
Q Consensus 512 ~~i~~qIa~gL~yLH~~~IvHrDLKp~NILl~~~~~~~~kL~DFGla~~ 560 (805)
-.|+..|+.-+.-+-..||||+|+.+=||++++||. +.++||-.+..
T Consensus 205 ~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~--~~vIDwPQ~v~ 251 (304)
T COG0478 205 DEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGD--IVVIDWPQAVP 251 (304)
T ss_pred HHHHHHHHHHHHHHHHcCccccCCchheEEEecCCC--EEEEeCccccc
Confidence 345555555555555889999999999999999987 78999975543
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.86 E-value=5.5e-05 Score=87.50 Aligned_cols=36 Identities=36% Similarity=0.545 Sum_probs=30.4
Q ss_pred hhcceeccCCCCceEEecCCCCceEEEeccCccccccC
Q 003644 526 HEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQG 563 (805)
Q Consensus 526 H~~~IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~ 563 (805)
-..|+.|.|.+|.||++..++. +.+.|||+...+.+
T Consensus 282 ~~dgffHaDpHpGNi~v~~~g~--i~~lDfGi~g~l~~ 317 (517)
T COG0661 282 LRDGFFHADPHPGNILVRSDGR--IVLLDFGIVGRLDP 317 (517)
T ss_pred HhcCccccCCCccceEEecCCc--EEEEcCcceecCCH
Confidence 3479999999999999998877 66999999876653
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.74 E-value=0.00016 Score=83.43 Aligned_cols=139 Identities=22% Similarity=0.192 Sum_probs=83.6
Q ss_pred EeeccCCceEEEEEEeeCCcEEEEEEeecCCch----------------------------------------HHHHHHH
Q 003644 382 KEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHD----------------------------------------VALKEIQ 421 (805)
Q Consensus 382 ~~LG~GsfGtVy~a~~~~g~~VAVK~l~~~~~~----------------------------------------~~~~Ei~ 421 (805)
+.||.-+.|.||+|.+.+|+.||||+-+..-.+ +..+|.+
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 579999999999999999999999986532100 0112222
Q ss_pred ---HHHHhCCCCCe---eeecccccC-CceEEEecccccC-ChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhccccc
Q 003644 422 ---NLIASDQHPNI---VRWYGVESD-QDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVME 493 (805)
Q Consensus 422 ---~ll~~l~HpNI---V~l~g~~~~-~~~l~LV~E~~~~-sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~ 493 (805)
.......|-+. |..=.++++ .....|+||||+| .+.|+-++..
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~----------------------------- 297 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDK----------------------------- 297 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHH-----------------------------
Confidence 12333445551 112222222 3467999998875 4444433322
Q ss_pred chhhHHHHhhCCCCHHHHHHHHHHHHHHHH-HhhhcceeccCCCCceEEecCC--CCceEEEeccCcccccc
Q 003644 494 NTKDIELWKANGHPSAQLLKVTRDIVSGLS-HLHEIGLIHRDLKPQNVLISKD--KSFCAKLSDMGISKRLQ 562 (805)
Q Consensus 494 ~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~-yLH~~~IvHrDLKp~NILl~~~--~~~~~kL~DFGla~~~~ 562 (805)
.+++.. .|+..+.++.. -+-..|++|.|-+|.||+++.+ +...+.+-|||+...+.
T Consensus 298 ----------~gi~~~---~i~~~l~~~~~~qIf~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is 356 (538)
T KOG1235|consen 298 ----------RGISPH---DILNKLVEAYLEQIFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS 356 (538)
T ss_pred ----------cCCCHH---HHHHHHHHHHHHHHHhcCCccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence 222222 23333333221 1223589999999999999853 35568899999987665
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.52 E-value=0.0002 Score=87.26 Aligned_cols=153 Identities=22% Similarity=0.316 Sum_probs=102.0
Q ss_pred CCCCHHHHHHHHHHHHHHHHHhhhcceeccCCCCc---eEEecCCCCceEEEe--ccCccccccCCCccccccccccCCC
Q 003644 504 NGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQ---NVLISKDKSFCAKLS--DMGISKRLQGDMSCLTQNATGYGSS 578 (805)
Q Consensus 504 ~~l~~~~~~~i~~qIa~gL~yLH~~~IvHrDLKp~---NILl~~~~~~~~kL~--DFGla~~~~~~~~~~~~~~~~~gt~ 578 (805)
..++....+.+..++..||+|+|+....|.-|..+ +-..+.++ ...++ ||+.++.+..... .....-+.
T Consensus 281 ~~i~~~~~r~~~~~~~~GL~~~h~~~l~~v~L~~s~~~~~~~~~e~--~~~~sl~~~~ss~~l~d~~~----~~~~~~~~ 354 (1351)
T KOG1035|consen 281 GSIPLETLRILHQKLLEGLAYLHSLSLEHVVLSASSSKESTVDGEG--VVAISLSDFDSSKPLPDNEK----SFSDLLAE 354 (1351)
T ss_pred cccCHHHHHHHHHHHhhhHHHHHHhccceeEEecccccccccCccc--eeecchhhhcccccCCCccc----chhhcCcc
Confidence 34667788899999999999999986665555444 33333333 34455 8888776653321 11223456
Q ss_pred CCCChhhhhcCCCCC--cchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhccccccccCChHHHHHHHHhcCCCCCCC
Q 003644 579 GWQAPEQLLQGRQTR--AIDLFSLGCILFFCITGGKHPYGESFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLR 656 (805)
Q Consensus 579 ~y~APE~l~~~~~t~--~sDVwSlGvil~elltG~~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dP~~R 656 (805)
.|.|+|......+.. ..|+|.+|.+...+..|...+-..... ... .......+..+...+|+..++++|
T Consensus 355 ~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~~~~~~i~~~~~~~--~~~-------l~~~~~~~~~d~~~~~~~~~~~~R 425 (1351)
T KOG1035|consen 355 IRNADEDLKENTAKKSRLTDLWCLGLLLLQLSQGEDISEKSAVP--VSL-------LDVLSTSELLDALPKCLDEDSEER 425 (1351)
T ss_pred ccccccccccccchhhhhhHHHHHHHHHhhhhhcCcccccccch--hhh-------hccccchhhhhhhhhhcchhhhhc
Confidence 688888887766654 479999999999999874433211100 000 111111267889999999999999
Q ss_pred CChhhhhcCcccccc
Q 003644 657 PKAQNVLNHPFFWTA 671 (805)
Q Consensus 657 ps~~ell~Hpff~~~ 671 (805)
+++.+++.|||....
T Consensus 426 l~~~~ll~~~f~~~~ 440 (1351)
T KOG1035|consen 426 LSALELLTHPFLRFP 440 (1351)
T ss_pred cchhhhhhchhcccc
Confidence 999999999997543
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=97.42 E-value=0.0011 Score=69.17 Aligned_cols=69 Identities=12% Similarity=0.031 Sum_probs=45.0
Q ss_pred EeeccCCceEEEEEEeeCCcEEEEEEeecCCc-hHHHHHHHHHHHhCCC--CCeeeecccccCCceEEEecccccC
Q 003644 382 KEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHH-DVALKEIQNLIASDQH--PNIVRWYGVESDQDFVYLSLERCTC 454 (805)
Q Consensus 382 ~~LG~GsfGtVy~a~~~~g~~VAVK~l~~~~~-~~~~~Ei~~ll~~l~H--pNIV~l~g~~~~~~~l~LV~E~~~~ 454 (805)
..||+|..+.||+. .|..+++|....... ....+|.+. +..+.. -.+.+.++++.+.+...+|||+++|
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~~~~~i~~E~~~-l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G 78 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGFDKETIKREFDA-SRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVG 78 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCCCHHHHHHHHHH-HHHHHHcCCCCCceEEEEecCCeeeeeeeecCC
Confidence 46899999999973 355678888765332 334555543 333222 1234566677777778899999987
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.29 E-value=0.00018 Score=86.22 Aligned_cols=58 Identities=12% Similarity=0.004 Sum_probs=46.4
Q ss_pred ccCcccCCCCCcccccccccccccccCccccchhh-hhhcC-CcccccccccceeeeecCCC
Q 003644 148 FSGYHFNSGSELGMDLIGDVESHLPCHTQMTASVY-RLRDN-SLPEFLSVIGKVAGWISLPG 207 (805)
Q Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~nN~fsG~ip-~l~~l-~L~~Lnls~N~fsG~IP~~~ 207 (805)
.+++++.+|.. +.-+.+|+.+.+.+|+|+|.|| .+..+ .|+.|||++|+|+|.||...
T Consensus 427 ~n~L~g~ip~~--i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l 486 (623)
T PLN03150 427 NQGLRGFIPND--ISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESL 486 (623)
T ss_pred CCCccccCCHH--HhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHH
Confidence 34555566655 4467889999999999999998 58787 69999999999999998543
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.26 E-value=0.0018 Score=67.36 Aligned_cols=51 Identities=24% Similarity=0.390 Sum_probs=42.2
Q ss_pred HHHHHHHHHHHHHHHHhhh-cceeccCCCCceEEecCCCCceEEEeccCcccccc
Q 003644 509 AQLLKVTRDIVSGLSHLHE-IGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQ 562 (805)
Q Consensus 509 ~~~~~i~~qIa~gL~yLH~-~~IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~ 562 (805)
.++..+..++++.+.-|-. .++||+||..=|||+. ++. +.|+|||.|....
T Consensus 166 ~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~--p~iID~~QaV~~~ 217 (268)
T COG1718 166 EEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGE--PYIIDVSQAVTID 217 (268)
T ss_pred hhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCe--EEEEECccccccC
Confidence 3567788888999888887 7999999999999997 444 7899999876544
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=97.15 E-value=0.0034 Score=64.50 Aligned_cols=72 Identities=14% Similarity=0.108 Sum_probs=42.9
Q ss_pred EeeccCCceEEEEEEeeCCcEEEEEEeecC-CchHHHHHHHH--HHHhCCCCCeeeecccc---cCCceEEEecccccCC
Q 003644 382 KEIAKGSNGTVVLEGNYEGRSVAVKRLVKT-HHDVALKEIQN--LIASDQHPNIVRWYGVE---SDQDFVYLSLERCTCS 455 (805)
Q Consensus 382 ~~LG~GsfGtVy~a~~~~g~~VAVK~l~~~-~~~~~~~Ei~~--ll~~l~HpNIV~l~g~~---~~~~~l~LV~E~~~~s 455 (805)
+.|+.|..+.||+....+ ..+++|..... ......+|... .+..... .+.+++.++ ......+++|+++++.
T Consensus 3 ~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~~~~~~~~~e~~~~~~l~~~~~-pvP~~~~~~~~~~~~~~~~~~~~~i~g~ 80 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTDD-GRYVLKFYRPPDAAERLRREAAVLRQLAEHGI-PVPRVLAFDTSDEFNGFPYLLMEYIPGR 80 (239)
T ss_dssp EEEEESSSSEEEEEEETT-SEEEEEEESSHHHHHHHHHHHHHHHHHHHTTS-BS--EEEEEEETEETSEEEEEEEEESSE
T ss_pred ccCCCCCeeeEEEEEECC-cEEEEEEeCCCCCHHHHHHHHHHHHHHHhcCC-CCceEEeecccccccccceEEEEEeccc
Confidence 568999999999976666 69999987554 11233344332 2222211 344555533 2334579999999873
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.13 E-value=0.0023 Score=67.23 Aligned_cols=70 Identities=13% Similarity=0.031 Sum_probs=42.3
Q ss_pred eccCCc-eEEEEEEeeCCcEEEEEEeecCCchHHHHHHHHHHHhCCCCCeeeecccccCCceEEEecccccC
Q 003644 384 IAKGSN-GTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTC 454 (805)
Q Consensus 384 LG~Gsf-GtVy~a~~~~g~~VAVK~l~~~~~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~E~~~~ 454 (805)
|-.|.. ..||+... ++..+.||+..........+|...+...-.+--+.+++++..+++.-++|||+++|
T Consensus 6 ~~~g~~~~~v~~~~~-~~~~~~vk~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G 76 (244)
T cd05150 6 VTEGQSGATVYRLDG-KNPGLYLKIAPSGPTYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPG 76 (244)
T ss_pred cCCCCCcCeEEEEcC-CCCcEEEEecCCCcccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCC
Confidence 344444 67888654 34678888875542233445655332222233355677777666678999998876
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=97.11 E-value=0.0038 Score=64.24 Aligned_cols=43 Identities=28% Similarity=0.516 Sum_probs=36.3
Q ss_pred HHHHHHHHHHHhhhcceeccCCCCceEEecCCCCceEEEeccCccc
Q 003644 514 VTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISK 559 (805)
Q Consensus 514 i~~qIa~gL~yLH~~~IvHrDLKp~NILl~~~~~~~~kL~DFGla~ 559 (805)
++..++.++.-||+.|+.|+|.+|.|++++.++ ++++||+..+
T Consensus 140 ~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~~---i~iID~~~k~ 182 (229)
T PF06176_consen 140 LAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNNG---IRIIDTQGKR 182 (229)
T ss_pred HHHHHHHHHHHHHHcCCccCCCCcCcEEEECCc---EEEEECcccc
Confidence 445677889999999999999999999998654 7899998654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.09 E-value=0.004 Score=63.53 Aligned_cols=133 Identities=19% Similarity=0.234 Sum_probs=85.9
Q ss_pred EeeccCCceEEEEEEeeCCcEEEEEEeecCC-------------------chHHHHHHHHHH-----HhCCCCCeeeecc
Q 003644 382 KEIAKGSNGTVVLEGNYEGRSVAVKRLVKTH-------------------HDVALKEIQNLI-----ASDQHPNIVRWYG 437 (805)
Q Consensus 382 ~~LG~GsfGtVy~a~~~~g~~VAVK~l~~~~-------------------~~~~~~Ei~~ll-----~~l~HpNIV~l~g 437 (805)
..||+|+.-.||. ..+.....||+..... ..+..+|+.... ....+.+|.++||
T Consensus 7 ~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G 84 (199)
T PF10707_consen 7 DLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFYG 84 (199)
T ss_pred cccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEeE
Confidence 4599999999995 4455668899887655 455566665322 2345889999999
Q ss_pred cccCCceEEEecccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHH
Q 003644 438 VESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRD 517 (805)
Q Consensus 438 ~~~~~~~l~LV~E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~q 517 (805)
+.+.+.-.-+|+|.....= -...-+|.+++ +...++. .+...
T Consensus 85 ~veT~~G~Glv~e~I~d~d----G~~s~TL~~~l------------------------------~~~~~~~----~~~~~ 126 (199)
T PF10707_consen 85 FVETNLGLGLVVELIRDAD----GNISPTLEDYL------------------------------KEGGLTE----ELRQA 126 (199)
T ss_pred EEecCCceEEEEEEEECCC----CCcCccHHHHH------------------------------HcCCccH----HHHHH
Confidence 9999988999999764200 00112233332 1122222 23334
Q ss_pred HHHHHHHhhhcceeccCCCCceEEecCCC--CceEEEec
Q 003644 518 IVSGLSHLHEIGLIHRDLKPQNVLISKDK--SFCAKLSD 554 (805)
Q Consensus 518 Ia~gL~yLH~~~IvHrDLKp~NILl~~~~--~~~~kL~D 554 (805)
+-.-.+||-+.+|+.+|++|.||++.... ...+.|+|
T Consensus 127 L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~~~~lvlID 165 (199)
T PF10707_consen 127 LDEFKRYLLDHHIVIRDLNPHNIVVQRRDSGEFRLVLID 165 (199)
T ss_pred HHHHHHHHHHcCCeecCCCcccEEEEecCCCceEEEEEe
Confidence 44555788889999999999999996433 33466776
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=96.96 E-value=0.0083 Score=61.06 Aligned_cols=40 Identities=33% Similarity=0.582 Sum_probs=33.2
Q ss_pred HHHHHHHHHHHHHhhhcceeccCCCCceEEecCCCCceEEEeccCcc
Q 003644 512 LKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGIS 558 (805)
Q Consensus 512 ~~i~~qIa~gL~yLH~~~IvHrDLKp~NILl~~~~~~~~kL~DFGla 558 (805)
..-+.+|.+-|..+|..||+-+|+++.|.. +| ||+|||.+
T Consensus 167 ~~~~~~~~~dl~~~~k~gI~~~Dv~~~ny~---~G----~lvDfs~~ 206 (207)
T PF13095_consen 167 IRDIPQMLRDLKILHKLGIVPRDVKPRNYR---GG----KLVDFSSS 206 (207)
T ss_pred hhHHHHHHHHHHHHHHCCeeeccCcccccc---CC----EEEecccC
Confidence 345677888899999999999999999987 43 59999854
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=96.92 E-value=0.0053 Score=76.19 Aligned_cols=75 Identities=15% Similarity=0.200 Sum_probs=49.0
Q ss_pred eEeeccCCceEEEEEEeeCC---cEEEEEEeecCC----chHHHHHHHHHHHhCCCCCe--eeecccccCC---ceEEEe
Q 003644 381 NKEIAKGSNGTVVLEGNYEG---RSVAVKRLVKTH----HDVALKEIQNLIASDQHPNI--VRWYGVESDQ---DFVYLS 448 (805)
Q Consensus 381 ~~~LG~GsfGtVy~a~~~~g---~~VAVK~l~~~~----~~~~~~Ei~~ll~~l~HpNI--V~l~g~~~~~---~~l~LV 448 (805)
.+.|+.|.++.+|+....++ ..+++|+..... .....+|...+...-.|++| .+.+++|.+. +..|+|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 46789999999998654443 467777753321 23455676643333235554 7888888775 467999
Q ss_pred cccccCC
Q 003644 449 LERCTCS 455 (805)
Q Consensus 449 ~E~~~~s 455 (805)
||++++.
T Consensus 123 ME~v~G~ 129 (822)
T PLN02876 123 MEYLEGR 129 (822)
T ss_pred EEecCCc
Confidence 9999874
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.88 E-value=0.0012 Score=83.60 Aligned_cols=72 Identities=10% Similarity=0.047 Sum_probs=45.6
Q ss_pred CcccCCCCCcccccccccccccccCccccchhhh-hhcC-CcccccccccceeeeecCC----CCCCCCCCCCCCCCCCC
Q 003644 150 GYHFNSGSELGMDLIGDVESHLPCHTQMTASVYR-LRDN-SLPEFLSVIGKVAGWISLP----GSSQNSLLGPVDRNSPL 223 (805)
Q Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~nN~fsG~ip~-l~~l-~L~~Lnls~N~fsG~IP~~----~~~~~sf~GN~~~~g~~ 223 (805)
.+++.+|.. +.....|+.+.+.+|+++|.+|. +..+ .|+.||+++|+|+|.||.. .+...++.||..+||+.
T Consensus 534 ~l~~~~p~~--~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~ 611 (968)
T PLN00113 534 QLSGQIPAS--FSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGD 611 (968)
T ss_pred cccccCChh--HhCcccCCEEECCCCcccccCChhHhcCcccCEEeccCCcceeeCCCcchhcccChhhhcCCccccCCc
Confidence 333344444 33456677777777777777763 5555 4777777777777777732 33455667888787743
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=96.67 E-value=0.017 Score=62.82 Aligned_cols=74 Identities=18% Similarity=0.038 Sum_probs=46.9
Q ss_pred EeEeeccCCceEEEEEEeeCCcEEEEEEeecC-CchHHHHHHHHHHHhCCC--CCeeeecccccC---CceEEEeccccc
Q 003644 380 FNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKT-HHDVALKEIQNLIASDQH--PNIVRWYGVESD---QDFVYLSLERCT 453 (805)
Q Consensus 380 ~~~~LG~GsfGtVy~a~~~~g~~VAVK~l~~~-~~~~~~~Ei~~ll~~l~H--pNIV~l~g~~~~---~~~l~LV~E~~~ 453 (805)
-.+.||.|..+.||.....++ .+.||..+.. .......|...+...-.+ -.+.+.+++|.+ .+..+||||+++
T Consensus 18 ~~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i~ 96 (297)
T PRK10593 18 RVECISEQPYAALWALYDSQG-NPMPLMARSFSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERLR 96 (297)
T ss_pred eeeecCCccceeEEEEEcCCC-CEEEEEecccccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEeccC
Confidence 346799999999998665556 4666765432 223555666544333222 345566666543 466899999988
Q ss_pred C
Q 003644 454 C 454 (805)
Q Consensus 454 ~ 454 (805)
+
T Consensus 97 G 97 (297)
T PRK10593 97 G 97 (297)
T ss_pred C
Confidence 6
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.61 E-value=0.018 Score=59.96 Aligned_cols=69 Identities=17% Similarity=0.081 Sum_probs=39.5
Q ss_pred EeeccCCceEEEEEEeeC--CcEEEEEEeecCCc--hHHHHHHHHHHHhCCCCCeeeecccccCCceEEEecccccC
Q 003644 382 KEIAKGSNGTVVLEGNYE--GRSVAVKRLVKTHH--DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTC 454 (805)
Q Consensus 382 ~~LG~GsfGtVy~a~~~~--g~~VAVK~l~~~~~--~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~l~LV~E~~~~ 454 (805)
+.|..|-...+|+....+ ++.|++|+...... ....+|...+...-.+.-..++++.+.. .++||++++
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~~d~~~E~~~~~~l~~~gl~P~v~~~~~~----~~l~e~i~G 76 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELIIDRERELRIHKLLSKHGLAPKLYATFQN----GLIYEFIPG 76 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccceecHHHHHHHHHHHHhCCCCCeEEEEeCC----cEEEEeeCC
Confidence 567888888999875553 67888997654321 1223455432222122223445544332 379999886
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=96.61 E-value=0.014 Score=57.80 Aligned_cols=126 Identities=22% Similarity=0.332 Sum_probs=74.3
Q ss_pred EeEeeccCCceEEEEEEeeCCcEEEEEEeecCCch-HHHHHHHHHHHhCCCCCee-eecccccCCceEEEecccccCChh
Q 003644 380 FNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHD-VALKEIQNLIASDQHPNIV-RWYGVESDQDFVYLSLERCTCSLN 457 (805)
Q Consensus 380 ~~~~LG~GsfGtVy~a~~~~g~~VAVK~l~~~~~~-~~~~Ei~~ll~~l~HpNIV-~l~g~~~~~~~l~LV~E~~~~sL~ 457 (805)
..+.||+|.+|.||++ -+.|..+|+|+-+..... ...+|.+ ++..+.--++- ++|.|-.+ .+.||
T Consensus 26 v~~~L~KG~~s~Vyl~-~~~~~~~a~Kvrr~ds~r~~l~kEak-iLeil~g~~~~p~vy~yg~~----~i~me------- 92 (201)
T COG2112 26 VEKELAKGTTSVVYLG-EWRGGEVALKVRRRDSPRRNLEKEAK-ILEILAGEGVTPEVYFYGED----FIRME------- 92 (201)
T ss_pred hhhhhhcccccEEEEe-eccCceEEEEEecCCcchhhHHHHHH-HHHHhhhcCCCceEEEechh----hhhhh-------
Confidence 3467999999999984 455668999976554433 3344544 44444433333 44444322 34599
Q ss_pred hHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCC-
Q 003644 458 DLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLK- 536 (805)
Q Consensus 458 d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~IvHrDLK- 536 (805)
|..+..|.+.-... + .+-...+++.---|-..||-|+.|.
T Consensus 93 ---~i~G~~L~~~~~~~--------------------------------~----rk~l~~vlE~a~~LD~~GI~H~El~~ 133 (201)
T COG2112 93 ---YIDGRPLGKLEIGG--------------------------------D----RKHLLRVLEKAYKLDRLGIEHGELSR 133 (201)
T ss_pred ---hhcCcchhhhhhcc--------------------------------c----HHHHHHHHHHHHHHHHhccchhhhcC
Confidence 55555554431110 0 2233445555444556799999998
Q ss_pred C-ceEEecCCCCceEEEeccCcccc
Q 003644 537 P-QNVLISKDKSFCAKLSDMGISKR 560 (805)
Q Consensus 537 p-~NILl~~~~~~~~kL~DFGla~~ 560 (805)
| .||++. ++. +.|+||..|+.
T Consensus 134 ~~k~vlv~-~~~--~~iIDFd~At~ 155 (201)
T COG2112 134 PWKNVLVN-DRD--VYIIDFDSATF 155 (201)
T ss_pred CceeEEec-CCc--EEEEEccchhh
Confidence 4 455554 433 78999998763
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.37 E-value=0.047 Score=61.65 Aligned_cols=71 Identities=24% Similarity=0.242 Sum_probs=46.3
Q ss_pred EeeccCCceEEEEEEeeCC-cEEEEEEeecC----------CchHHHHHHHHHHH--hCCCCCeeeecccccCCceEEEe
Q 003644 382 KEIAKGSNGTVVLEGNYEG-RSVAVKRLVKT----------HHDVALKEIQNLIA--SDQHPNIVRWYGVESDQDFVYLS 448 (805)
Q Consensus 382 ~~LG~GsfGtVy~a~~~~g-~~VAVK~l~~~----------~~~~~~~Ei~~ll~--~l~HpNIV~l~g~~~~~~~l~LV 448 (805)
+.||.|.+..||+....+| +.|.||.-... ..+....|...+.. ...-.++.+++++ +.+..++|
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lV 109 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTV 109 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEE
Confidence 6799999999999877776 58999974311 11233344443332 2223457777776 44567899
Q ss_pred cccccC
Q 003644 449 LERCTC 454 (805)
Q Consensus 449 ~E~~~~ 454 (805)
||+++.
T Consensus 110 ME~L~~ 115 (401)
T PRK09550 110 MEDLSD 115 (401)
T ss_pred EecCCC
Confidence 999875
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=96.00 E-value=0.045 Score=59.19 Aligned_cols=164 Identities=14% Similarity=0.002 Sum_probs=78.7
Q ss_pred eEeeccCCceEEEEEEeeCCcEEEEEEeecCCchHHHHHHHHHHHhCCCC--Ceeeecccc------cCCceEEEecccc
Q 003644 381 NKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQNLIASDQHP--NIVRWYGVE------SDQDFVYLSLERC 452 (805)
Q Consensus 381 ~~~LG~GsfGtVy~a~~~~g~~VAVK~l~~~~~~~~~~Ei~~ll~~l~Hp--NIV~l~g~~------~~~~~l~LV~E~~ 452 (805)
.+.|..|....+|+... ++..+++|+...........|+. ++..+.+- .+.+.+... ...+..+++++++
T Consensus 19 i~~i~~G~~n~~y~v~~-~~~~~vLr~~~~~~~~~~~~e~~-~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~~i 96 (296)
T cd05153 19 FEGISAGIENTNYFVTT-DSGRYVLTLFEKVSAEELPFFLA-LLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVEFL 96 (296)
T ss_pred eecccCccccceEEEEe-CCCcEEEEEcCCCChHhccHHHH-HHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEEeC
Confidence 35677888889998654 34578889876532233334443 22222211 244544421 2234568999999
Q ss_pred cCC-hh---hHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhh---CCCCHHHHHHHHHHHHHHHHHh
Q 003644 453 TCS-LN---DLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKA---NGHPSAQLLKVTRDIVSGLSHL 525 (805)
Q Consensus 453 ~~s-L~---d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~---~~l~~~~~~~i~~qIa~gL~yL 525 (805)
+|. +. ...+..-|..-..+|......... .+..........+.. ..+... .. ..+..++.++
T Consensus 97 ~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~l~~~-~~---~~~~~~~~~l 165 (296)
T cd05153 97 AGEHLTRPTAAHCRQIGEALARLHLAAQSFPGE-------RNNLRGLAWIRELGKDLLPLLSAE-DR---ALLADELARQ 165 (296)
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHHhccCCcc-------CCCcCCcHHHHHHHHHhccccCHH-HH---HHHHHHHHHH
Confidence 873 21 112223333333344332211000 000000000010100 011111 11 1222333343
Q ss_pred hh-------cceeccCCCCceEEecCCCCceEEEeccCccc
Q 003644 526 HE-------IGLIHRDLKPQNVLISKDKSFCAKLSDMGISK 559 (805)
Q Consensus 526 H~-------~~IvHrDLKp~NILl~~~~~~~~kL~DFGla~ 559 (805)
.. .+++|+|+.|.|||++.++. +.|+||+.+.
T Consensus 166 ~~~~~~~~~~~l~HgD~~~~Nil~~~~~~--~~iIDfe~a~ 204 (296)
T cd05153 166 DAFDPSDLPRGVIHADLFRDNVLFDGDEL--SGVIDFYFAC 204 (296)
T ss_pred HhhhhhcCCCcCCccCcCcccEEEeCCce--EEEeehhhhc
Confidence 32 37999999999999976542 5799998653
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=95.95 E-value=0.046 Score=59.65 Aligned_cols=30 Identities=37% Similarity=0.499 Sum_probs=24.9
Q ss_pred cceeccCCCCceEEecCCCCceEEEeccCccc
Q 003644 528 IGLIHRDLKPQNVLISKDKSFCAKLSDMGISK 559 (805)
Q Consensus 528 ~~IvHrDLKp~NILl~~~~~~~~kL~DFGla~ 559 (805)
.+++|+|+++.||+++.++. ..|+||+.+.
T Consensus 187 ~~l~HgD~~~~Nvl~~~~~~--~~vIDfd~~~ 216 (307)
T TIGR00938 187 RGVIHADLFPDNVLFDGDSV--KGVIDFYFAC 216 (307)
T ss_pred CccCCCCCCcCcEEEECCce--EEEeeccccc
Confidence 48999999999999987652 5799999653
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=95.81 E-value=0.037 Score=57.88 Aligned_cols=29 Identities=28% Similarity=0.438 Sum_probs=23.4
Q ss_pred ceeccCCCCceEEecCCCCceEEEeccCccc
Q 003644 529 GLIHRDLKPQNVLISKDKSFCAKLSDMGISK 559 (805)
Q Consensus 529 ~IvHrDLKp~NILl~~~~~~~~kL~DFGla~ 559 (805)
+++|+|+.+.|||++.+ . ..-|+||+.+.
T Consensus 165 ~l~HGD~~~~Nvlv~~~-~-i~giIDw~~a~ 193 (235)
T cd05155 165 VWFHGDLAPGNLLVQDG-R-LSAVIDFGCLG 193 (235)
T ss_pred eEEeCCCCCCcEEEECC-C-EEEEEeCcccC
Confidence 59999999999999754 3 24699999764
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=95.76 E-value=0.079 Score=57.51 Aligned_cols=29 Identities=28% Similarity=0.379 Sum_probs=24.6
Q ss_pred ceeccCCCCceEEecCC----CCceEEEeccCccc
Q 003644 529 GLIHRDLKPQNVLISKD----KSFCAKLSDMGISK 559 (805)
Q Consensus 529 ~IvHrDLKp~NILl~~~----~~~~~kL~DFGla~ 559 (805)
.++|+|+.|.|||++.+ +. +.++||..|.
T Consensus 180 ~lcH~Dl~~~Nil~~~~~~~~~~--i~lIDwEya~ 212 (302)
T cd05156 180 VFCHNDLQEGNILLLNPSSETKK--LVLIDFEYAS 212 (302)
T ss_pred eEEecCCCcCeEEecCCCCCCCc--EEEEeeCCCC
Confidence 69999999999999864 54 7899998763
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=95.52 E-value=0.034 Score=56.33 Aligned_cols=54 Identities=22% Similarity=0.173 Sum_probs=46.1
Q ss_pred CCHHHHHHHHHHHHHHHHHhhhc---ceeccCCCCceEEecCCCCceEEEeccCccccc
Q 003644 506 HPSAQLLKVTRDIVSGLSHLHEI---GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRL 561 (805)
Q Consensus 506 l~~~~~~~i~~qIa~gL~yLH~~---~IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~ 561 (805)
.+|..+.+|+.++++.+++|+.. .+.-.|++++|+-+++++. +|++|...+...
T Consensus 56 ~~w~~R~~iA~~lL~~l~~l~~~~~~~~~lcDv~~~nfgv~~~~~--lk~iDld~v~~~ 112 (188)
T PF12260_consen 56 SPWEQRAKIALQLLELLEELDHGPLGFFYLCDVSPDNFGVNDDGR--LKLIDLDDVFVE 112 (188)
T ss_pred cCHHHHHHHHHHHHHHHHHHhcCCCCcEEEeecchHHeEEeCCCc--EEEEechhcchh
Confidence 46778899999999999999983 5777999999999988876 899999866543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.36 E-value=0.24 Score=54.21 Aligned_cols=30 Identities=33% Similarity=0.443 Sum_probs=23.9
Q ss_pred cceeccCCCCceEEecCCCCceEEEeccCccc
Q 003644 528 IGLIHRDLKPQNVLISKDKSFCAKLSDMGISK 559 (805)
Q Consensus 528 ~~IvHrDLKp~NILl~~~~~~~~kL~DFGla~ 559 (805)
.++||+|++|.|||++.+. ..-|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~~~--~~~iIDf~~~~ 216 (319)
T PRK05231 187 RGVIHADLFRDNVLFEGDR--LSGFIDFYFAC 216 (319)
T ss_pred cccCCCCCCCCcEEEECCc--eEEEEeccccc
Confidence 3899999999999997443 24699999663
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=95.30 E-value=0.0099 Score=74.56 Aligned_cols=150 Identities=13% Similarity=0.012 Sum_probs=100.9
Q ss_pred HhCCCCCeeeecccccC--CceEEEecccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHh
Q 003644 425 ASDQHPNIVRWYGVESD--QDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWK 502 (805)
Q Consensus 425 ~~l~HpNIV~l~g~~~~--~~~l~LV~E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 502 (805)
+...|+++.+.+.-... ....|.+++ |...|.+...+...-.+...
T Consensus 1284 ~~~~h~~~~~~p~rI~ps~s~ee~~r~~----------~~~~g~~f~iIikg~ee~~~---------------------- 1331 (2724)
T KOG1826|consen 1284 REAKHYLTEVDPLRIPPSESTEEYIRSL----------YVEFGKLFSIIIKGLEESPD---------------------- 1331 (2724)
T ss_pred hhhhceeeecccccCCCCCChHHHHHHH----------HHHHhHHHHHHHhccccCCc----------------------
Confidence 34579999887765443 345677777 66667777766544332211
Q ss_pred hCCCCHHHHHHHHHHHHHHHHHhhhc-----ceeccCCCCceEEecCCCCceEEEeccCccccccCCCccccccccccCC
Q 003644 503 ANGHPSAQLLKVTRDIVSGLSHLHEI-----GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGS 577 (805)
Q Consensus 503 ~~~l~~~~~~~i~~qIa~gL~yLH~~-----~IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~gt 577 (805)
+...-+.....+.+.+..-+|+. -.+|++||+.|.+|..+ ..+|+.++|+.+...... .......++
T Consensus 1332 ---ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtn--y~v~~gk~gLdKIknp~~---sf~Gl~l~s 1403 (2724)
T KOG1826|consen 1332 ---LDRSPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTN--YNVKLGKGGLDKIKNPVL---SFFGLELCS 1403 (2724)
T ss_pred ---chhchHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecC--CcccccccccccccCchH---hhhhhhhCC
Confidence 11122233344446677777754 27899999999999544 458999999998433221 222345678
Q ss_pred CCCCChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCCC
Q 003644 578 SGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY 615 (805)
Q Consensus 578 ~~y~APE~l~~~~~t~~sDVwSlGvil~elltG~~~Pf 615 (805)
+-|++|+....-.++.++|+|..|+.+|+..-| ..+|
T Consensus 1404 p~~v~qli~N~ik~t~rsdilr~s~~ly~rs~~-n~~f 1440 (2724)
T KOG1826|consen 1404 PIYVLQLIKNEIKFTKRSDILRRSLSLYLRSDG-NAYF 1440 (2724)
T ss_pred HHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhcc-cHHH
Confidence 889999998888888889999999999987775 4444
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=94.40 E-value=0.051 Score=61.86 Aligned_cols=77 Identities=21% Similarity=0.185 Sum_probs=50.1
Q ss_pred CcchHHHHHHHHHHHHhCCCCCCCCchHH-HHHHHh------------hccccccccCChHHHHHHHHhcCCCCCCCCCh
Q 003644 593 RAIDLFSLGCILFFCITGGKHPYGESFER-DANIVK------------DRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKA 659 (805)
Q Consensus 593 ~~sDVwSlGvil~elltG~~~Pf~~~~~~-~~~~~~------------~~~~~~~~~~~~~~~dLi~~~L~~dP~~Rps~ 659 (805)
+|+||||+|.++.|+.-| ..-+.+.... ....+. ........+.....+++..+|+-..|..||..
T Consensus 110 pKsdVwsl~~i~~el~L~-~~l~~~~~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~ 188 (725)
T KOG1093|consen 110 PKSDVWSLGFIILELYLG-ISLEAELTESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLP 188 (725)
T ss_pred cchhhhhHHHHHHHHHHh-hHHHHHHHHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccch
Confidence 499999999999999887 2222221111 111110 01112223334567789999999999999999
Q ss_pred hhhhcCccccc
Q 003644 660 QNVLNHPFFWT 670 (805)
Q Consensus 660 ~ell~Hpff~~ 670 (805)
.++++|+-|..
T Consensus 189 ~~~~k~~i~~e 199 (725)
T KOG1093|consen 189 MELSKRCSFTE 199 (725)
T ss_pred hHHhcCccHHH
Confidence 99999998854
|
|
| >PF14593 PH_3: PH domain; PDB: 1W1H_D 1W1D_A 1W1G_A 2VKI_A | Back alignment and domain information |
|---|
Probab=94.09 E-value=0.00025 Score=64.18 Aligned_cols=88 Identities=20% Similarity=0.286 Sum_probs=64.8
Q ss_pred cchHHHh-HHHHhhhhhh--cccCCCCHHHHHHHHhhcccccccCChhHHhhhCCCC---------ccccccccccCC--
Q 003644 711 KWDEKME-TKFIENIGRY--RRYKYDNVRDLLRVIRNKSNHFRELPQDIQELLGSHP---------EGFYNYFSCRFP-- 776 (805)
Q Consensus 711 ~w~~~~~-~~~~~~~~~~--r~~~~~~~~dllr~irn~~~h~~e~~~~~~~l~g~~p---------~~f~~yf~~~fp-- 776 (805)
.|+..++ .+.+-..+.. |+..+...|+|+.+-+++. | +++++.+++.|++| .++..|+.+++.
T Consensus 2 ~w~~fl~~ge~Il~~g~v~K~kgl~~kkR~liLTd~PrL--~-Yvdp~~~~~KGeI~~~~~l~v~~k~~~~F~I~tp~Rt 78 (104)
T PF14593_consen 2 KWHRFLNPGELILKQGYVKKRKGLFAKKRQLILTDGPRL--F-YVDPKKMVLKGEIPWSKELSVEVKSFKTFFIHTPKRT 78 (104)
T ss_dssp TTGGGTT-T--EEEEEEEEEEETTEEEEEEEEEETTTEE--E-EEETTTTEEEEEE--STT-EEEECSSSEEEEEETTEE
T ss_pred chHHhhcCCCeEEEEEEEEEeeceEEEEEEEEEccCCEE--E-EEECCCCeECcEEecCCceEEEEccCCEEEEECCCcE
Confidence 4777776 5555444432 4566677788777766555 4 68888899999999 788999999999
Q ss_pred ccHHHHHHHHHhhhcc-cchhhcccc
Q 003644 777 KLLIEVYNVIFTYCKG-EEVFHKYVT 801 (805)
Q Consensus 777 ~ll~~~y~~~~~~~~~-~~~~~~y~~ 801 (805)
++|.++.+.+..||+. +++.+.||+
T Consensus 79 Y~l~d~~~~A~~W~~~I~~~~~~~~~ 104 (104)
T PF14593_consen 79 YYLEDPEGNAQQWVEAIEEVKKQYYK 104 (104)
T ss_dssp EEEE-TTS-HHHHHHHHHHHHHHHH-
T ss_pred EEEECCCCCHHHHHHHHHHHHHHhcC
Confidence 9999999999999998 999999884
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=93.89 E-value=0.11 Score=55.04 Aligned_cols=28 Identities=21% Similarity=0.356 Sum_probs=24.0
Q ss_pred ceeccCCCCceEEecCCCCceEEEeccCccc
Q 003644 529 GLIHRDLKPQNVLISKDKSFCAKLSDMGISK 559 (805)
Q Consensus 529 ~IvHrDLKp~NILl~~~~~~~~kL~DFGla~ 559 (805)
.++|+|+.|.||++++++ +.|+||..+.
T Consensus 147 ~l~H~Dl~~~Nil~~~~~---~~lIDwE~a~ 174 (256)
T TIGR02721 147 APLHMDVHAYNLVVTPQG---LKLIDWEYAS 174 (256)
T ss_pred eeecCCCCcCcEEEeCCC---CEEEeccccC
Confidence 589999999999998765 5799998764
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=93.68 E-value=0.085 Score=57.08 Aligned_cols=132 Identities=17% Similarity=0.160 Sum_probs=81.4
Q ss_pred EEEeEeeccCCceEEEEEEeeCCcEEEEEEeec-----------------CC--------chHHHHHHHHHHHhCCCCCe
Q 003644 378 VVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVK-----------------TH--------HDVALKEIQNLIASDQHPNI 432 (805)
Q Consensus 378 ~~~~~~LG~GsfGtVy~a~~~~g~~VAVK~l~~-----------------~~--------~~~~~~Ei~~ll~~l~HpNI 432 (805)
+.+++.||-|.-..||.+...+|+..++|.=+- .. .-.+.+|++-|-+.-.|-.=
T Consensus 94 ~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gfp 173 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGFP 173 (465)
T ss_pred hhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCCC
Confidence 456788999999999999999999999983210 00 01344566533332222211
Q ss_pred eeecccccCCceEEEecccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhCCCCHHHHH
Q 003644 433 VRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLL 512 (805)
Q Consensus 433 V~l~g~~~~~~~l~LV~E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 512 (805)
|+ --.|.+..++|||+..+ -.|...-+ + ....
T Consensus 174 VP---kpiD~~RH~Vvmelv~g----------~Pl~~v~~---------------------------------v--~d~~ 205 (465)
T KOG2268|consen 174 VP---KPIDHNRHCVVMELVDG----------YPLRQVRH---------------------------------V--EDPP 205 (465)
T ss_pred CC---CcccccceeeHHHhhcc----------cceeeeee---------------------------------c--CChH
Confidence 11 11344667899995543 11111000 0 0112
Q ss_pred HHHHHHHHHHHHhhhcceeccCCCCceEEecCCCCceEEEeccCccc
Q 003644 513 KVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISK 559 (805)
Q Consensus 513 ~i~~qIa~gL~yLH~~~IvHrDLKp~NILl~~~~~~~~kL~DFGla~ 559 (805)
.+...+..-+.-|..+|+||+|..-=||++.+++. ++++||-.+.
T Consensus 206 ~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~--i~vIDFPQmv 250 (465)
T KOG2268|consen 206 TLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDK--IVVIDFPQMV 250 (465)
T ss_pred HHHHHHHHHHHHHHHcCceecccchheeEEecCCC--EEEeechHhh
Confidence 34445555566778899999999999999988776 7899996544
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=93.45 E-value=0.5 Score=51.62 Aligned_cols=29 Identities=14% Similarity=0.248 Sum_probs=24.8
Q ss_pred ceeccCCCCceEEecCCCCceEEEeccCccc
Q 003644 529 GLIHRDLKPQNVLISKDKSFCAKLSDMGISK 559 (805)
Q Consensus 529 ~IvHrDLKp~NILl~~~~~~~~kL~DFGla~ 559 (805)
+++|+|+.+.|||++.++. +.++||..+.
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~--~~iIDfd~~~ 225 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRG--GYFINFEKAS 225 (309)
T ss_pred eeeCCCCcHHhEEEcCCCC--EEEEEhhhcc
Confidence 7999999999999987765 6789998664
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B | Back alignment and domain information |
|---|
Probab=93.36 E-value=0.048 Score=41.38 Aligned_cols=35 Identities=14% Similarity=0.115 Sum_probs=29.2
Q ss_pred ccccccccCccccchhhh-hhcC-Ccccccccccceee
Q 003644 166 DVESHLPCHTQMTASVYR-LRDN-SLPEFLSVIGKVAG 201 (805)
Q Consensus 166 ~~~~~~~~nN~fsG~ip~-l~~l-~L~~Lnls~N~fsG 201 (805)
+|+.+.+.+|+++ .||. +..+ .|+.||+++|+++-
T Consensus 2 ~L~~L~l~~N~i~-~l~~~l~~l~~L~~L~l~~N~i~~ 38 (44)
T PF12799_consen 2 NLEELDLSNNQIT-DLPPELSNLPNLETLNLSNNPISD 38 (44)
T ss_dssp T-SEEEETSSS-S-SHGGHGTTCTTSSEEEETSSCCSB
T ss_pred cceEEEccCCCCc-ccCchHhCCCCCCEEEecCCCCCC
Confidence 6788999999999 6876 9999 59999999999884
|
... |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=93.29 E-value=1.2 Score=48.35 Aligned_cols=28 Identities=21% Similarity=0.407 Sum_probs=23.3
Q ss_pred cceeccCCCCceEEecCCCCceEEEeccCcc
Q 003644 528 IGLIHRDLKPQNVLISKDKSFCAKLSDMGIS 558 (805)
Q Consensus 528 ~~IvHrDLKp~NILl~~~~~~~~kL~DFGla 558 (805)
.+++|+|+.+.||+++. +. +.|+||+.+
T Consensus 187 ~~liHgD~~~~Nil~~~-~~--i~lIDfd~~ 214 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NE--VYVIDFDYC 214 (313)
T ss_pred CceEcCCCCcccEEEeC-Cc--EEEEECccc
Confidence 47999999999999976 44 679999855
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=92.63 E-value=0.61 Score=51.88 Aligned_cols=70 Identities=24% Similarity=0.302 Sum_probs=42.1
Q ss_pred eeccCCceEEEEEEeeCC-cEEEEEEeec-------C---CchHHHHHHHHHHHhCC-CC-CeeeecccccCCceEEEec
Q 003644 383 EIAKGSNGTVVLEGNYEG-RSVAVKRLVK-------T---HHDVALKEIQNLIASDQ-HP-NIVRWYGVESDQDFVYLSL 449 (805)
Q Consensus 383 ~LG~GsfGtVy~a~~~~g-~~VAVK~l~~-------~---~~~~~~~Ei~~ll~~l~-Hp-NIV~l~g~~~~~~~l~LV~ 449 (805)
+||.|-...||++...+| +.|+||.-.. . ..+...-|...|...-. -| .+.++|.+ |.+...+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence 579999999999876554 6899996421 1 11233445443433222 23 35555554 556667999
Q ss_pred ccccC
Q 003644 450 ERCTC 454 (805)
Q Consensus 450 E~~~~ 454 (805)
|+++.
T Consensus 80 EdL~~ 84 (370)
T TIGR01767 80 EDLSH 84 (370)
T ss_pred hhCcc
Confidence 98753
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=92.51 E-value=1.2 Score=50.50 Aligned_cols=71 Identities=14% Similarity=0.122 Sum_probs=45.5
Q ss_pred eEeeccCCceEEEEEEeeCCcEEEEEEee-----cC-----CchHHHHHHHHHHHh--CCCCCeeeecccccCCceEEEe
Q 003644 381 NKEIAKGSNGTVVLEGNYEGRSVAVKRLV-----KT-----HHDVALKEIQNLIAS--DQHPNIVRWYGVESDQDFVYLS 448 (805)
Q Consensus 381 ~~~LG~GsfGtVy~a~~~~g~~VAVK~l~-----~~-----~~~~~~~Ei~~ll~~--l~HpNIV~l~g~~~~~~~l~LV 448 (805)
.+.||.|....||+... ++..|.||+-. .. .......|...|... ....++.++++++.+ .-+++
T Consensus 37 ~~eiggGn~N~VyrV~~-~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded--~~vlv 113 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVS-SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRT--MALIG 113 (418)
T ss_pred EEEcCCCceeeEEEEEc-CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCC--CCEEE
Confidence 46799999999998654 45679999754 11 123344454433222 222467788888874 45788
Q ss_pred cccccC
Q 003644 449 LERCTC 454 (805)
Q Consensus 449 ~E~~~~ 454 (805)
||++++
T Consensus 114 ME~L~~ 119 (418)
T PLN02756 114 MRYLEP 119 (418)
T ss_pred EeecCC
Confidence 999865
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=92.32 E-value=0.96 Score=50.04 Aligned_cols=135 Identities=21% Similarity=0.180 Sum_probs=82.8
Q ss_pred EEEeEeeccCCceEEEEEEeeCCcEEEEEEeecCC------------------------c-----hHHHHHHHHHHHh--
Q 003644 378 VVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTH------------------------H-----DVALKEIQNLIAS-- 426 (805)
Q Consensus 378 ~~~~~~LG~GsfGtVy~a~~~~g~~VAVK~l~~~~------------------------~-----~~~~~Ei~~ll~~-- 426 (805)
..+...|..|--..||.+...+|..+|||+.+..- . .-+.+|+.++.+.
T Consensus 146 ~~inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~ 225 (520)
T KOG2270|consen 146 VEINGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNN 225 (520)
T ss_pred eecccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHh
Confidence 34567799999999999999999999999875320 0 0134566554332
Q ss_pred --CCCCCeeeecccccCCceEEEecccccCChhhHHHHhcCCHHHHHhhhhccchhhHHHHhhhcccccchhhHHHHhhC
Q 003644 427 --DQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKAN 504 (805)
Q Consensus 427 --l~HpNIV~l~g~~~~~~~l~LV~E~~~~sL~d~iy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 504 (805)
+..|--+-| ....|||++|+.+ |=-... .+..
T Consensus 226 aGIP~PePIlL-------k~hVLVM~FlGrd---------gw~aPk------------------------------LKd~ 259 (520)
T KOG2270|consen 226 AGIPCPEPILL-------KNHVLVMEFLGRD---------GWAAPK------------------------------LKDA 259 (520)
T ss_pred cCCCCCCceee-------ecceEeeeeccCC---------CCcCcc------------------------------cccc
Confidence 222222211 1237899966531 000000 1222
Q ss_pred CCCHHHHHHHHHHHHHHHHHhhh-cceeccCCCCceEEecCCCCceEEEeccCccccc
Q 003644 505 GHPSAQLLKVTRDIVSGLSHLHE-IGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRL 561 (805)
Q Consensus 505 ~l~~~~~~~i~~qIa~gL~yLH~-~~IvHrDLKp~NILl~~~~~~~~kL~DFGla~~~ 561 (805)
.+....+..+-.|++.-+.-|.+ .++||.||.-=|+|+.++ . +.|+|.+.+...
T Consensus 260 ~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~LyhdG-~--lyiIDVSQSVE~ 314 (520)
T KOG2270|consen 260 SLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYHDG-K--LYIIDVSQSVEH 314 (520)
T ss_pred cCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEECC-E--EEEEEccccccC
Confidence 33444555666666666666654 589999999999999643 3 789998876544
|
|
| >PF01102 Glycophorin_A: Glycophorin A; InterPro: IPR001195 Proteins in this group are responsible for the molecular basis of the blood group antigens, surface markers on the outside of the red blood cell membrane | Back alignment and domain information |
|---|
Probab=92.26 E-value=0.11 Score=48.40 Aligned_cols=35 Identities=11% Similarity=-0.146 Sum_probs=21.5
Q ss_pred CccccccccchhhhHHHHHHHHHHHHHHhhheecc
Q 003644 260 KHAFVEGFRSYIQSFIVLFIALCPIIGFLFYHSKQ 294 (805)
Q Consensus 260 ~~~~~~~~~i~Iv~~~v~~lvll~li~~~~~~~~r 294 (805)
...+..+.+++|++++++++++++++++++++|++
T Consensus 58 ~h~fs~~~i~~Ii~gv~aGvIg~Illi~y~irR~~ 92 (122)
T PF01102_consen 58 VHRFSEPAIIGIIFGVMAGVIGIILLISYCIRRLR 92 (122)
T ss_dssp SSSSS-TCHHHHHHHHHHHHHHHHHHHHHHHHHHS
T ss_pred ccCccccceeehhHHHHHHHHHHHHHHHHHHHHHh
Confidence 55677778888888877777655554444444433
|
Most of these markers are proteins, but some are carbohydrates attached to lipids or proteins [Reid M.E., Lomas-Francis C. The Blood Group Antigen FactsBook Academic Press, London / San Diego, (1997)]. Glycophorin A (PAS-2) and glycophorin B (PAS-3) belong to the MNS blood group system and are associated with antigens that include M/N, S/s, U, He, Mi(a), M(c), Vw, Mur, M(g), Vr, M(e), Mt(a), St(a), Ri(a), Cl(a), Ny(a), Hut, Hil, M(v), Far, Mit, Dantu, Hop, Nob, En(a), ENKT, amongst others. Glycophorin A is the major sialoglycoprotein of the erythrocyte membrane []. Structurally, glycophorin A consists of an N-terminal extracellular domain, heavily glycosylated on serine and threonine residues, followed by a transmembrane region and a C-terminal cytoplasmic domain. Other glycophorins in this entry such as Glycophorin B and Glycophorin E represent minor sialoglycoproteins in the erythrocyte membrane.; GO: 0016021 integral to membrane; PDB: 2KPF_B 1AFO_B 2KPE_A. |
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=92.07 E-value=1.5 Score=48.55 Aligned_cols=29 Identities=34% Similarity=0.586 Sum_probs=24.2
Q ss_pred eeccCCCCceEEecCCCCceEEEeccCccc
Q 003644 530 LIHRDLKPQNVLISKDKSFCAKLSDMGISK 559 (805)
Q Consensus 530 IvHrDLKp~NILl~~~~~~~~kL~DFGla~ 559 (805)
+||+|+.|.|||++.+.. .+.++||+-+.
T Consensus 199 iIH~D~~~~NVl~d~~~~-~~g~iDFdDa~ 227 (331)
T COG2334 199 IIHGDLHPDNVLFDDDTD-VSGFIDFDDAG 227 (331)
T ss_pred eeecCCCccceeEcCCCC-eeeEEEccccc
Confidence 999999999999987754 36799999653
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=90.96 E-value=0.74 Score=49.87 Aligned_cols=74 Identities=18% Similarity=0.098 Sum_probs=42.8
Q ss_pred EeEeeccCCceEEEEEEeeCCcEEEEEEeecCCchHHHHHHHHH--HHhCCCCCeeeecccccCCceEEEecccccC
Q 003644 380 FNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQNL--IASDQHPNIVRWYGVESDQDFVYLSLERCTC 454 (805)
Q Consensus 380 ~~~~LG~GsfGtVy~a~~~~g~~VAVK~l~~~~~~~~~~Ei~~l--l~~l~HpNIV~l~g~~~~~~~l~LV~E~~~~ 454 (805)
-.+.++.|....+|+.. .+++.+-||.-..........|..-+ +....--.+.+.+++...++.-||+||+.+.
T Consensus 21 ~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~ 96 (288)
T PF03881_consen 21 SIEPVSGGDINEAYRLD-TDGGSYFVKVNSESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEM 96 (288)
T ss_dssp EEEEE--SSSSEEEEEE-TTS-EEEEEEEEGGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE----
T ss_pred eeEecCCCChhheEEEE-CCCccEEEEecChhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecC
Confidence 34679999999999754 67889999987744444555565533 2223334466777776666667999998764
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PF04478 Mid2: Mid2 like cell wall stress sensor; InterPro: IPR007567 This family represents a region near the C terminus of Mid2, which contains a transmembrane region | Back alignment and domain information |
|---|
Probab=90.56 E-value=0.18 Score=48.40 Aligned_cols=27 Identities=7% Similarity=-0.141 Sum_probs=11.1
Q ss_pred cchhhhHHHHHHHHHHHHHHhhheecc
Q 003644 268 RSYIQSFIVLFIALCPIIGFLFYHSKQ 294 (805)
Q Consensus 268 ~i~Iv~~~v~~lvll~li~~~~~~~~r 294 (805)
+|++++++++.+++++++++|+||+|+
T Consensus 51 VIGvVVGVGg~ill~il~lvf~~c~r~ 77 (154)
T PF04478_consen 51 VIGVVVGVGGPILLGILALVFIFCIRR 77 (154)
T ss_pred EEEEEecccHHHHHHHHHhheeEEEec
Confidence 444554444434433333333333333
|
The remainder of the protein sequence is serine-rich and of low complexity, and is therefore impossible to align accurately. Mid2 is thought to act as a mechanosensor of cell wall stress. The C-terminal cytoplasmic region of Mid2 is known to interact with Rom2, a guanine nucleotide exchange factor (GEF) for Rho1, which is part of the cell wall integrity signalling pathway []. |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=90.45 E-value=1.5 Score=49.43 Aligned_cols=72 Identities=21% Similarity=0.125 Sum_probs=43.7
Q ss_pred eEeeccCCceEEEEEEeeC-CcEEEEEEeec---C------CchHHHHHHHHHHHhCC-CC-CeeeecccccCCceEEEe
Q 003644 381 NKEIAKGSNGTVVLEGNYE-GRSVAVKRLVK---T------HHDVALKEIQNLIASDQ-HP-NIVRWYGVESDQDFVYLS 448 (805)
Q Consensus 381 ~~~LG~GsfGtVy~a~~~~-g~~VAVK~l~~---~------~~~~~~~Ei~~ll~~l~-Hp-NIV~l~g~~~~~~~l~LV 448 (805)
.+.||.|--..||++...+ ++.|+||.-.. . ..+...-|...|...-. -| .+.++|.+ |.+...+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence 4679999999999976533 57899996421 1 11233444443332211 23 45566654 56667899
Q ss_pred cccccC
Q 003644 449 LERCTC 454 (805)
Q Consensus 449 ~E~~~~ 454 (805)
||+++.
T Consensus 112 MEdL~~ 117 (409)
T PRK12396 112 MEDLSD 117 (409)
T ss_pred HHhCcc
Confidence 998853
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=89.89 E-value=1.4 Score=47.41 Aligned_cols=30 Identities=37% Similarity=0.543 Sum_probs=24.4
Q ss_pred ceeccCCCCceEEecCCCCceEEEeccCccc
Q 003644 529 GLIHRDLKPQNVLISKDKSFCAKLSDMGISK 559 (805)
Q Consensus 529 ~IvHrDLKp~NILl~~~~~~~~kL~DFGla~ 559 (805)
.++|+|++|.|||++.++.+ .-|+||+.+.
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~-~gviDWe~a~ 215 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARV-TGLIDWTEAK 215 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCE-EEEECcHhcc
Confidence 59999999999999865542 4699999765
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >cd01262 PH_PDK1 3-Phosphoinositide dependent protein kinase 1 (PDK1) pleckstrin homology (PH) domain | Back alignment and domain information |
|---|
Probab=89.56 E-value=0.0094 Score=51.99 Aligned_cols=66 Identities=12% Similarity=0.099 Sum_probs=54.6
Q ss_pred cccCCCCHHHHHHHHhhcccccccCChhHHhhhCCCC----------ccccccccccCC--ccHHHHHHHHHhhhcc-cc
Q 003644 728 RRYKYDNVRDLLRVIRNKSNHFRELPQDIQELLGSHP----------EGFYNYFSCRFP--KLLIEVYNVIFTYCKG-EE 794 (805)
Q Consensus 728 r~~~~~~~~dllr~irn~~~h~~e~~~~~~~l~g~~p----------~~f~~yf~~~fp--~ll~~~y~~~~~~~~~-~~ 794 (805)
|+..+...|+|+.+-.++. + +++++.+.+.|++| .++..||.+++. ++|.++.+.+.+||+. |+
T Consensus 10 r~glf~kkR~LiLTd~PrL--~-yvdp~~~~~KgeIp~s~~~l~v~~~~~~~F~I~Tp~rty~leD~~~~a~~W~~~I~~ 86 (89)
T cd01262 10 RKGLFAKKRQLILTNGPRL--I-YVDPVKKVVKGEIPWSDVELRVEVKNSSHFFVHTPNKVYSFEDPKGRASQWKKAIED 86 (89)
T ss_pred hhccccceeeEEEecCceE--E-EEcCCcCeEEeEecccccceEEEEecCccEEEECCCceEEEECCCCCHHHHHHHHHH
Confidence 4556788889988877766 4 68888889999999 567889999998 9999999999999997 66
Q ss_pred hh
Q 003644 795 VF 796 (805)
Q Consensus 795 ~~ 796 (805)
+.
T Consensus 87 ~~ 88 (89)
T cd01262 87 LQ 88 (89)
T ss_pred Hh
Confidence 53
|
3-Phosphoinositide dependent protein kinase 1 (PDK1) pleckstrin homology (PH) domain. PDK1 contains an N-terminal serine/threonine kinase domain followed by a PH domain. Following binding of the PH domain to PtdIns(3,4,5)P3 and PtdIns(3,4)P2, PDK1 activates kinases such as Akt (PKB). PH domains share little sequence conservation, but all have a common fold, which is electrostatically polarized. PH domains also have diverse functions. They are often involved in targeting proteins to the plasma membrane, but few display strong specificity in lipid binding. Any specificity is usually determined by loop regions or insertions in the N-terminus of the domain, which are not conserved across all PH domains. |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=89.55 E-value=2.1 Score=47.54 Aligned_cols=31 Identities=26% Similarity=0.505 Sum_probs=24.7
Q ss_pred cceeccCCCCceEEecCCCCceEEEeccCccc
Q 003644 528 IGLIHRDLKPQNVLISKDKSFCAKLSDMGISK 559 (805)
Q Consensus 528 ~~IvHrDLKp~NILl~~~~~~~~kL~DFGla~ 559 (805)
..++|+|+++.|||++++.. .+.++||..+.
T Consensus 200 ~~~cH~Dl~~~Nil~~~~~~-~~~lID~Eya~ 230 (344)
T PLN02236 200 IGFCHNDLQYGNIMIDEETR-AITIIDYEYAS 230 (344)
T ss_pred ceEEeCCCCcCcEEEeCCCC-cEEEEeehhcc
Confidence 36999999999999975422 37899998764
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 805 | ||||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 2e-84 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 3e-84 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 9e-84 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 2e-83 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 6e-68 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 3e-18 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-16 | ||
| 2jam_B | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-16 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 5e-16 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 5e-16 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 6e-16 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 7e-16 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 7e-16 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 7e-16 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 8e-16 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 8e-16 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 8e-16 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 9e-16 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 9e-16 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 9e-16 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 1e-15 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 1e-15 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-15 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 1e-15 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-15 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 6e-15 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 8e-15 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 8e-15 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 9e-15 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-14 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-14 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-14 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-14 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-14 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 3e-14 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-14 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 4e-14 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 4e-14 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 4e-14 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 5e-14 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 5e-14 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 8e-14 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 9e-14 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-13 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 1e-13 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-13 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-13 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 3e-13 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 3e-13 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-13 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-13 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 8e-13 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 8e-13 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 9e-13 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 9e-13 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 1e-12 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 1e-12 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 1e-12 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-12 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-12 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 2e-12 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-12 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 3e-12 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-12 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 3e-12 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 3e-12 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 3e-12 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 3e-12 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-12 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-12 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 3e-12 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-12 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 3e-12 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 3e-12 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-12 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 3e-12 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 3e-12 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 4e-12 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 4e-12 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 4e-12 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-12 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 4e-12 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 4e-12 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-12 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 4e-12 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 4e-12 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 4e-12 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 4e-12 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 4e-12 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-12 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 4e-12 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 5e-12 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 5e-12 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 5e-12 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 6e-12 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 7e-12 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 7e-12 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-12 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 1e-11 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-11 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 1e-11 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-11 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 1e-11 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 1e-11 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 1e-11 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 1e-11 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-11 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 1e-11 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 1e-11 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 1e-11 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-11 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 1e-11 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-11 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-11 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 1e-11 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 1e-11 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 1e-11 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 1e-11 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-11 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-11 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-11 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-11 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-11 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-11 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-11 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-11 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-11 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 2e-11 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 2e-11 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-11 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-11 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-11 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-11 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-11 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-11 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-11 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-11 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 3e-11 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 3e-11 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 3e-11 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 3e-11 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 3e-11 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 3e-11 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-11 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-11 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 4e-11 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 4e-11 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 4e-11 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 4e-11 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 4e-11 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 4e-11 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 4e-11 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 4e-11 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 4e-11 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 4e-11 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 5e-11 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 5e-11 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 5e-11 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 5e-11 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 5e-11 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 5e-11 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 5e-11 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 5e-11 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 5e-11 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 6e-11 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 6e-11 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 6e-11 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 6e-11 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 7e-11 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 7e-11 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 7e-11 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 9e-11 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 1e-10 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 1e-10 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 1e-10 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-10 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 2e-10 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 2e-10 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-10 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-10 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-10 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 2e-10 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 2e-10 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-10 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-10 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-10 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 2e-10 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-10 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-10 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 2e-10 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-10 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 3e-10 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 3e-10 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 3e-10 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 3e-10 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 3e-10 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 3e-10 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 3e-10 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 3e-10 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 3e-10 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 3e-10 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 3e-10 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 3e-10 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 3e-10 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 3e-10 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 3e-10 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 3e-10 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-10 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 3e-10 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 4e-10 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 4e-10 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 4e-10 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 4e-10 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-10 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 5e-10 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 5e-10 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 5e-10 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-10 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 5e-10 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-10 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 5e-10 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-10 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 6e-10 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 6e-10 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 6e-10 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 6e-10 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 6e-10 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 6e-10 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 6e-10 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 6e-10 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 6e-10 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 6e-10 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 6e-10 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 6e-10 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 6e-10 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 6e-10 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 6e-10 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 6e-10 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 7e-10 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 7e-10 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 7e-10 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 7e-10 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 7e-10 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-10 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 7e-10 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 7e-10 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 7e-10 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 7e-10 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 7e-10 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 7e-10 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 7e-10 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 7e-10 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 8e-10 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 8e-10 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 8e-10 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 8e-10 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 8e-10 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 8e-10 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-10 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 8e-10 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 8e-10 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 9e-10 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-10 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 9e-10 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 9e-10 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 9e-10 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 9e-10 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 9e-10 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 9e-10 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 1e-09 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-09 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 1e-09 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-09 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 1e-09 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 1e-09 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 1e-09 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 1e-09 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-09 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-09 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 1e-09 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 1e-09 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 1e-09 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 1e-09 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 1e-09 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 1e-09 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 1e-09 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 1e-09 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 1e-09 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 1e-09 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-09 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 1e-09 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-09 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 1e-09 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 1e-09 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 1e-09 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 1e-09 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 1e-09 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-09 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 2e-09 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 2e-09 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-09 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-09 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 2e-09 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-09 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 2e-09 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 2e-09 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-09 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-09 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-09 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 2e-09 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-09 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-09 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 2e-09 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-09 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-09 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-09 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-09 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-09 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-09 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-09 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-09 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-09 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-09 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-09 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-09 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-09 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-09 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-09 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-09 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-09 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 2e-09 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 2e-09 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 3e-09 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-09 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 3e-09 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 3e-09 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-09 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 3e-09 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 3e-09 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 3e-09 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 3e-09 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 3e-09 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 3e-09 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 3e-09 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 3e-09 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 3e-09 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 3e-09 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 3e-09 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 3e-09 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 3e-09 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 3e-09 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 3e-09 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 3e-09 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 4e-09 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 4e-09 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-09 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 4e-09 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-09 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 4e-09 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 4e-09 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 4e-09 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 4e-09 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 4e-09 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 4e-09 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 4e-09 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 4e-09 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-09 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 5e-09 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 5e-09 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 5e-09 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 5e-09 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 5e-09 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-09 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 5e-09 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 5e-09 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 6e-09 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 6e-09 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 6e-09 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 6e-09 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 6e-09 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 6e-09 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 6e-09 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 6e-09 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 6e-09 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 6e-09 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 6e-09 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 6e-09 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 6e-09 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 6e-09 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 6e-09 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 6e-09 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 6e-09 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 6e-09 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 6e-09 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 6e-09 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 6e-09 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 6e-09 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 6e-09 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 6e-09 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 6e-09 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 6e-09 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 6e-09 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 6e-09 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 6e-09 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 6e-09 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 6e-09 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 6e-09 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 6e-09 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 6e-09 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 6e-09 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 7e-09 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 7e-09 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 7e-09 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 7e-09 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 7e-09 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 7e-09 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 7e-09 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 7e-09 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 7e-09 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 7e-09 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 7e-09 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 7e-09 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 7e-09 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 7e-09 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 7e-09 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 7e-09 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 7e-09 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 8e-09 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 8e-09 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 8e-09 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 8e-09 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 8e-09 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 8e-09 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 8e-09 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 8e-09 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 8e-09 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 9e-09 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 9e-09 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 9e-09 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 9e-09 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 9e-09 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 9e-09 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 9e-09 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 1e-08 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 1e-08 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 1e-08 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 1e-08 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 1e-08 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 1e-08 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 1e-08 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 1e-08 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-08 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 1e-08 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 1e-08 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 1e-08 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-08 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 1e-08 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 1e-08 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-08 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 1e-08 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 1e-08 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 1e-08 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 1e-08 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-08 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-08 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 1e-08 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-08 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 1e-08 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 1e-08 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 1e-08 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 1e-08 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 1e-08 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 1e-08 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 1e-08 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 1e-08 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 1e-08 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-08 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-08 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-08 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 1e-08 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-08 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-08 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 1e-08 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 1e-08 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-08 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 2e-08 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-08 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-08 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 2e-08 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 2e-08 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 2e-08 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 2e-08 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 2e-08 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 2e-08 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 2e-08 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 2e-08 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 2e-08 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-08 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-08 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-08 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-08 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-08 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 2e-08 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 2e-08 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 2e-08 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-08 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 2e-08 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-08 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-08 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 2e-08 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-08 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-08 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 2e-08 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-08 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-08 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 2e-08 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-08 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 2e-08 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-08 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 2e-08 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-08 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-08 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 2e-08 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-08 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-08 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-08 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-08 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-08 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-08 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-08 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-08 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-08 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 2e-08 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 2e-08 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 2e-08 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-08 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 2e-08 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-08 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-08 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-08 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-08 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-08 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-08 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-08 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-08 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-08 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 2e-08 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-08 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 2e-08 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 2e-08 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 2e-08 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 2e-08 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 2e-08 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 2e-08 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 3e-08 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-08 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 3e-08 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 3e-08 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 3e-08 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 3e-08 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 3e-08 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 3e-08 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 3e-08 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 3e-08 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 3e-08 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 3e-08 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-08 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 3e-08 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 3e-08 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 3e-08 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 3e-08 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 3e-08 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 3e-08 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 3e-08 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 3e-08 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 3e-08 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 3e-08 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-08 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 3e-08 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 3e-08 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-08 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 3e-08 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 3e-08 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 3e-08 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 3e-08 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 3e-08 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 3e-08 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 3e-08 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 3e-08 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 3e-08 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 3e-08 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 3e-08 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 3e-08 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 3e-08 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 3e-08 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 3e-08 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 3e-08 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-08 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 3e-08 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 3e-08 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 4e-08 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 4e-08 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 4e-08 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 4e-08 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 4e-08 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 4e-08 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 4e-08 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 4e-08 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 4e-08 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 4e-08 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 4e-08 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 4e-08 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 4e-08 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 4e-08 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 4e-08 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 4e-08 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 4e-08 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 4e-08 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 4e-08 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 4e-08 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 4e-08 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 4e-08 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 4e-08 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 4e-08 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 4e-08 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 4e-08 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 5e-08 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 5e-08 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 5e-08 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-08 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 5e-08 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 5e-08 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 5e-08 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 5e-08 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 5e-08 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 5e-08 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 5e-08 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 5e-08 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 5e-08 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 5e-08 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 5e-08 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 5e-08 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 5e-08 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 5e-08 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 5e-08 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 5e-08 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 5e-08 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 5e-08 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 6e-08 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-08 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 6e-08 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 6e-08 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 6e-08 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 6e-08 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 6e-08 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 6e-08 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 6e-08 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 6e-08 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 6e-08 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 7e-08 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 7e-08 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 7e-08 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 7e-08 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 7e-08 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 7e-08 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 7e-08 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 8e-08 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 8e-08 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 8e-08 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 9e-08 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 9e-08 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 9e-08 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 9e-08 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-08 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 9e-08 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 9e-08 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 9e-08 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 9e-08 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 9e-08 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 9e-08 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 1e-07 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 1e-07 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 1e-07 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 1e-07 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 1e-07 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-07 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-07 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-07 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 1e-07 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-07 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 1e-07 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 1e-07 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 1e-07 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-07 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-07 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 1e-07 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 1e-07 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 1e-07 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-07 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-07 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-07 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 1e-07 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 1e-07 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 1e-07 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 1e-07 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 1e-07 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 1e-07 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 1e-07 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 1e-07 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 1e-07 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 2e-07 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 2e-07 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 2e-07 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-07 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 2e-07 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 2e-07 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 2e-07 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-07 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 2e-07 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 2e-07 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-07 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-07 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 2e-07 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-07 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 2e-07 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-07 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-07 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 2e-07 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-07 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-07 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 2e-07 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-07 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 3e-07 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 3e-07 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 3e-07 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 3e-07 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 3e-07 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-07 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 3e-07 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 3e-07 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 3e-07 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 3e-07 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-07 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 3e-07 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 3e-07 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 3e-07 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 3e-07 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 3e-07 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 3e-07 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 3e-07 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 3e-07 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 4e-07 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 4e-07 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-07 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 4e-07 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 4e-07 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 4e-07 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 4e-07 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 4e-07 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 4e-07 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 5e-07 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 5e-07 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 5e-07 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 5e-07 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 6e-07 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 6e-07 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 6e-07 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 6e-07 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 6e-07 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 6e-07 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 7e-07 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 7e-07 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 7e-07 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 7e-07 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 7e-07 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 7e-07 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 7e-07 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 8e-07 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 8e-07 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 8e-07 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 8e-07 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 8e-07 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 8e-07 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 8e-07 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 8e-07 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 8e-07 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 8e-07 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-07 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 8e-07 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 8e-07 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 9e-07 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 9e-07 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 9e-07 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 9e-07 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 9e-07 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 9e-07 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 1e-06 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 1e-06 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 1e-06 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 1e-06 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 1e-06 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-06 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 1e-06 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-06 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 1e-06 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 1e-06 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-06 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 1e-06 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 1e-06 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 1e-06 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 1e-06 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 1e-06 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 1e-06 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 1e-06 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-06 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-06 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 1e-06 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 1e-06 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-06 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 1e-06 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 1e-06 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 1e-06 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 1e-06 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 2e-06 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 2e-06 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-06 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-06 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-06 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 2e-06 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-06 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-06 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-06 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 2e-06 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-06 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-06 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-06 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 2e-06 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-06 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-06 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-06 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-06 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-06 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-06 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-06 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-06 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-06 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-06 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-06 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-06 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-06 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 2e-06 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-06 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 2e-06 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-06 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 2e-06 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-06 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 2e-06 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 2e-06 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 2e-06 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 2e-06 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 2e-06 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 2e-06 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 2e-06 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-06 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 2e-06 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-06 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-06 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 2e-06 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 2e-06 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 2e-06 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 2e-06 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 3e-06 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 3e-06 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 3e-06 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 3e-06 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 3e-06 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 3e-06 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 3e-06 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-06 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 3e-06 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 3e-06 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-06 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 3e-06 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 5e-06 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 5e-06 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 5e-06 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 6e-06 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 6e-06 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 6e-06 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 6e-06 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 6e-06 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 7e-06 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 7e-06 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 7e-06 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 8e-06 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 8e-06 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 8e-06 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 9e-06 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 9e-06 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 9e-06 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 9e-06 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 9e-06 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 1e-05 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 1e-05 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 1e-05 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-05 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 1e-05 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 1e-05 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 1e-05 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 1e-05 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 1e-05 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 1e-05 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 1e-05 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 1e-05 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 1e-05 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 1e-05 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 1e-05 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-05 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-05 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 1e-05 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 1e-05 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 1e-05 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 1e-05 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 1e-05 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 1e-05 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 1e-05 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 1e-05 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 1e-05 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 1e-05 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 1e-05 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 2e-05 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-05 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 2e-05 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-05 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 2e-05 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 2e-05 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-05 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 2e-05 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-05 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-05 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 2e-05 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-05 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-05 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 2e-05 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 2e-05 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-05 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 3e-05 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 3e-05 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 3e-05 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 3e-05 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 3e-05 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 3e-05 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-05 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 3e-05 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 3e-05 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 4e-05 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 4e-05 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 4e-05 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 4e-05 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 4e-05 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 4e-05 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-05 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 4e-05 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 4e-05 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 4e-05 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-05 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 5e-05 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 5e-05 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 5e-05 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 5e-05 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 5e-05 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 5e-05 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 5e-05 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 5e-05 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 5e-05 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 5e-05 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 5e-05 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 5e-05 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 5e-05 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 5e-05 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 5e-05 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 5e-05 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 5e-05 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 5e-05 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 6e-05 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 6e-05 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 6e-05 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 6e-05 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 6e-05 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-05 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-05 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 7e-05 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 7e-05 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 7e-05 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 7e-05 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 7e-05 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 7e-05 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-05 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 7e-05 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 7e-05 |
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 458 bits (1180), Expect = e-155
Identities = 166/454 (36%), Positives = 253/454 (55%), Gaps = 59/454 (12%)
Query: 372 RRIGKLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPN 431
+ + LVV K + GS+GTVV +G+++GR VAVKR++ D+AL EI+ L SD HPN
Sbjct: 11 QSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPN 70
Query: 432 IVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPV 491
++R+Y E+ F+Y++LE C +L DL+ E N +++ L E
Sbjct: 71 VIRYYCSETTDRFLYIALELCNLNLQDLV--------ESKNVSDENLKLQKEYNPI---- 118
Query: 492 MENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFC-- 549
+ R I SG++HLH + +IHRDLKPQN+L+S F
Sbjct: 119 ---------------------SLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTAD 157
Query: 550 ---------AKLSDMGISKRLQGDMSCLTQN-ATGYGSSGWQAPEQLLQG-------RQT 592
+SD G+ K+L S N G+SGW+APE L + R T
Sbjct: 158 QQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLT 217
Query: 593 RAIDLFSLGCILFFCITGGKHPYGESFERDANIVK------DRKDLFLVEHIPEAVDLFT 646
R+ID+FS+GC+ ++ ++ GKHP+G+ + R++NI++ + K L I EA DL +
Sbjct: 218 RSIDIFSMGCVFYYILSKGKHPFGDKYSRESNIIRGIFSLDEMKCLHDRSLIAEATDLIS 277
Query: 647 RLLDPNPDLRPKAQNVLNHPFFWTADTRLSFLRDVSDRVELEDRESDSKLLRALEGIA-L 705
+++D +P RP A VL HP FW +L FL VSDR+E+E+R+ S LL + +
Sbjct: 278 QMIDHDPLKRPTAMKVLRHPLFWPKSKKLEFLLKVSDRLEIENRDPPSALLMKFDAGSDF 337
Query: 706 VALNGKWDEKMETKFIENIGRYRRYKYDNVRDLLRVIRNKSNHFRELPQDIQELLGSHPE 765
V +G W K + F++N+ RYR+Y + DLLR +RNK +HF +LP+DI EL+G P+
Sbjct: 338 VIPSGDWTVKFDKTFMDNLERYRKYHSSKLMDLLRALRNKYHHFMDLPEDIAELMGPVPD 397
Query: 766 GFYNYFSCRFPKLLIEVYNVIFTYCKGEEVFHKY 799
GFY+YF+ RFP LLI VY ++ +++ ++
Sbjct: 398 GFYDYFTKRFPNLLIGVYMIVKENLSDDQILREF 431
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 458 bits (1180), Expect = e-155
Identities = 141/449 (31%), Positives = 225/449 (50%), Gaps = 53/449 (11%)
Query: 362 TDLIDDRVDGRRIGKL-VVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEI 420
D D+ +GK+ + G+ GT+V G ++ R VAVKR++ A +E+
Sbjct: 9 QDDGDEETSVVIVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADREV 68
Query: 421 QNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNL 480
Q L SD+HPN++R++ E D+ F Y+++E C +L + +
Sbjct: 69 QLLRESDEHPNVIRYFCTEKDRQFQYIAIELCAATLQEYV-------------------- 108
Query: 481 LNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNV 540
K H + + + + SGL+HLH + ++HRDLKP N+
Sbjct: 109 -------------------EQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNI 149
Query: 541 LIS---KDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ---GRQTRA 594
LIS A +SD G+ K+L ++ + G+ GW APE L + T
Sbjct: 150 LISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYT 209
Query: 595 IDLFSLGCILFFCITGGKHPYGESFERDANIVKDRKDLFLVE----HIPEAVDLFTRLLD 650
+D+FS GC+ ++ I+ G HP+G+S +R ANI+ L + A +L +++
Sbjct: 210 VDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKHEDVIARELIEKMIA 269
Query: 651 PNPDLRPKAQNVLNHPFFWTADTRLSFLRDVSDRVELEDRESDSKLLRALEGIALVALNG 710
+P RP A++VL HPFFW+ + +L F +DVSDR+E E D +++ LE +
Sbjct: 270 MDPQKRPSAKHVLKHPFFWSLEKQLQFFQDVSDRIEKESL--DGPIVKQLERGGRAVVKM 327
Query: 711 KWDEKMETKFIENIGRYRRYKYDNVRDLLRVIRNKSNHFRELPQDIQELLGSHPEGFYNY 770
W E + ++ ++R YK +VRDLLR +RNK +H+RELP +++E LG+ P+ F Y
Sbjct: 328 DWRENITVPLQTDLRKFRTYKGGSVRDLLRAMRNKKHHYRELPAEVRETLGTLPDDFVCY 387
Query: 771 FSCRFPKLLIEVYNVIFTYCKGEEVFHKY 799
F+ RFP LL Y C E +F Y
Sbjct: 388 FTSRFPHLLAHTYRA-MELCSHERLFQPY 415
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 165 bits (421), Expect = 5e-46
Identities = 72/295 (24%), Positives = 104/295 (35%), Gaps = 57/295 (19%)
Query: 382 KEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHDV-----ALKEIQNLIASDQHPNIVRW 435
+ GS G V +GR AVKR + L E+ + QHP VR
Sbjct: 63 SRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRL 122
Query: 436 YGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENT 495
+ +YL E C SL S E
Sbjct: 123 EQAWEEGGILYLQTELCGPSLQQHCEAWGASLPE-------------------------- 156
Query: 496 KDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDM 555
AQ+ RD + L+HLH GL+H D+KP N+ + KL D
Sbjct: 157 -------------AQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRG--RCKLGDF 201
Query: 556 GISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP- 614
G+ L + Q G + APE LLQG A D+FSLG + + P
Sbjct: 202 GLLVELGTAGAGEVQE----GDPRYMAPE-LLQGSYGTAADVFSLGLTILEVACNMELPH 256
Query: 615 YGESFERDANIVKDRKDLFLVEHI-PEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 668
GE +++ + + + E + +L+P+P LR A+ +L P
Sbjct: 257 GGEGWQQ---LRQGYLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVL 308
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 2e-40
Identities = 61/295 (20%), Positives = 112/295 (37%), Gaps = 46/295 (15%)
Query: 382 KEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYGV-E 439
+ I G G V + +G++ +KR VK +++ A +E+ +A H NIV + G +
Sbjct: 17 ELIGSGGFGQVFKAKHRIDGKTYVIKR-VKYNNEKAEREV-KALAKLDHVNIVHYNGCWD 74
Query: 440 SDQDFVYLSLERCTCSLNDLIYVL-----SGSFEEQLNAKEQDSNLLNEVRIRLLPVMEN 494
S + + S +++ G+ E+ + +++ L++
Sbjct: 75 GFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWI--EKRRGEKLDK----------- 121
Query: 495 TKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSD 554
L++ I G+ ++H LI+RDLKP N+ + K K+ D
Sbjct: 122 --------------VLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTK--QVKIGD 165
Query: 555 MGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP 614
G+ L+ D T + +PEQ+ + +DL++LG IL +
Sbjct: 166 FGLVTSLKNDGKRTRSKGTLR----YMSPEQISSQDYGKEVDLYALGLILAELLHVCDTA 221
Query: 615 YGESFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFW 669
FE R + + L +LL P+ RP +L W
Sbjct: 222 ----FETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVW 272
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 6e-38
Identities = 60/317 (18%), Positives = 111/317 (35%), Gaps = 74/317 (23%)
Query: 382 KEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHDV-----ALKEIQNLIASDQHPNIVRW 435
++I G G+V +G A+KR K AL+E+ QH ++VR+
Sbjct: 17 EKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRY 76
Query: 436 YGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENT 495
+ ++ D + + E Y GS + ++ + + E ++
Sbjct: 77 FSAWAEDDHMLIQNE----------YCNGGSLADAISENYRIMSYFKEAELK-------- 118
Query: 496 KDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKD---------- 545
+ + GL ++H + L+H D+KP N+ IS+
Sbjct: 119 -----------------DLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEG 161
Query: 546 -------KSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ--TRAID 596
K+ D+G R+ G S + A E +LQ D
Sbjct: 162 DEDDWASNKVMFKIGDLGHVTRISSPQVEE-------GDSRFLANE-VLQENYTHLPKAD 213
Query: 597 LFSLGCILFFCITGGKHPY--GESFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPD 654
+F+L + C G + G+ + I + R E +L ++ P+P+
Sbjct: 214 IFALALTV-VCAAGAEPLPRNGDQW---HEIRQGRLPRIPQVLSQEFTELLKVMIHPDPE 269
Query: 655 LRPKAQNVLNHPFFWTA 671
RP A ++ H +A
Sbjct: 270 RRPSAMALVKHSVLLSA 286
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 3e-37
Identities = 76/295 (25%), Positives = 124/295 (42%), Gaps = 54/295 (18%)
Query: 384 IAKGSNGTVVLEGNYE-GRSVAVKRLVKTHHDVALKEIQ---NLIASDQHPNIVRWYGVE 439
+ KG+ G V + +A+K + + + L +H NIV++ G
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKE-IPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 88
Query: 440 SDQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDI 498
S+ F+ + +E+ SL+ L+ G ++ NE I
Sbjct: 89 SENGFIKIFMEQVPGGSLSALLRSKWGPLKD------------NEQTIGFY--------- 127
Query: 499 ELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGIS 558
T+ I+ GL +LH+ ++HRD+K NVLI+ S K+SD G S
Sbjct: 128 ----------------TKQILEGLKYLHDNQIVHRDIKGDNVLIN-TYSGVLKISDFGTS 170
Query: 559 KRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ--TRAIDLFSLGCILFFCITGGKHPYG 616
KRL G C T G+ + APE + +G + +A D++SLGC + T GK P+
Sbjct: 171 KRLAGINPC---TETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMAT-GKPPFY 226
Query: 617 ESFERDA---NIVKDRKDLFLVEHI-PEAVDLFTRLLDPNPDLRPKAQNVLNHPF 667
E E A + + + E + EA + +P+PD R A ++L F
Sbjct: 227 ELGEPQAAMFKVGMFKVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEF 281
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 3e-37
Identities = 77/305 (25%), Positives = 118/305 (38%), Gaps = 20/305 (6%)
Query: 382 KEIAKGSNGTVVL-EGNYEGRSVAVKRLVKT--------HHDVALKEIQNLIASDQHPNI 432
I +GS G V + N A+K + K + E++ + HPNI
Sbjct: 32 GAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLH-HPNI 90
Query: 433 VRWYGVESDQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPV 491
R Y V D+ ++ L +E C L D + V + + + +
Sbjct: 91 ARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAI 150
Query: 492 MENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAK 551
+ + + R I S L +LH G+ HRD+KP+N L S +KSF K
Sbjct: 151 NGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIK 210
Query: 552 LSDMGISKRLQGDMSCLTQNATGY-GSSGWQAPEQLLQGRQ--TRAIDLFSLGCILFFCI 608
L D G+SK + T G+ + APE L + D +S G +L +
Sbjct: 211 LVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLL 270
Query: 609 TGGKHP-YGESFERDANIVKDRKDLFLVE---HI-PEAVDLFTRLLDPNPDLRPKAQNVL 663
G P G + + V ++K F + P A DL + LL+ N D R A L
Sbjct: 271 M-GAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRAL 329
Query: 664 NHPFF 668
HP+
Sbjct: 330 QHPWI 334
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 3e-37
Identities = 64/324 (19%), Positives = 121/324 (37%), Gaps = 43/324 (13%)
Query: 382 KEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHDVALKEIQ---NLIASDQHPNIVRWYG 437
+ + +G G V + + + A+KR+ + ++A +++ +A +HP IVR++
Sbjct: 12 QCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFN 71
Query: 438 VESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLP------- 490
+ E L D S ++A ++ +
Sbjct: 72 AWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSS 131
Query: 491 -------VME--NTKDIELWKANG-----HPSAQLLKVTRDIVSGLSHLHEIGLIHRDLK 536
M+ ++++ W L + I + LH GL+HRDLK
Sbjct: 132 PKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLK 191
Query: 537 PQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGY---------GSSGWQAPEQLL 587
P N+ + D K+ D G+ + D T G+ + +PEQ+
Sbjct: 192 PSNIFFTMDD--VVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIH 249
Query: 588 QGRQTRAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDRKDLF---LVEHIPEAVDL 644
+ +D+FSLG ILF + + + ER I R F + P+ +
Sbjct: 250 GNNYSHKVDIFSLGLILFELL----YSFSTQMERVRIITDVRNLKFPLLFTQKYPQEHMM 305
Query: 645 FTRLLDPNPDLRPKAQNVLNHPFF 668
+L P+P RP+A +++ + F
Sbjct: 306 VQDMLSPSPTERPEATDIIENAIF 329
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 5e-37
Identities = 60/308 (19%), Positives = 112/308 (36%), Gaps = 66/308 (21%)
Query: 382 KEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHD-VALKEIQNLIA-----SDQHPNIVRW 435
K+I G + V N + + A+K + D L +N IA I+R
Sbjct: 15 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74
Query: 436 YGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENT 495
Y E ++Y+ +E LN + S + E +
Sbjct: 75 YDYEITDQYIYMVMECGNIDLNSWL-KKKKSIDP------------WERK---------- 111
Query: 496 KDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDM 555
++++ + +H+ G++H DLKP N LI KL D
Sbjct: 112 -----------------SYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDG---MLKLIDF 151
Query: 556 GISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ-----------GRQTRAIDLFSLGCIL 604
GI+ ++Q D + + ++ + G+ + PE + + + D++SLGCIL
Sbjct: 152 GIANQMQPDTTSVVKD-SQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCIL 210
Query: 605 FFCITGGKHPYG---ESFERDANIVKDRKDLFLVEHI-PEAVDLFTRLLDPNPDLRPKAQ 660
++ GK P+ + I+ ++ + + D+ L +P R
Sbjct: 211 YYMTY-GKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIP 269
Query: 661 NVLNHPFF 668
+L HP+
Sbjct: 270 ELLAHPYV 277
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 1e-36
Identities = 60/308 (19%), Positives = 114/308 (37%), Gaps = 66/308 (21%)
Query: 382 KEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHD-VALKEIQNLIA-----SDQHPNIVRW 435
K+I G + V N + + A+K + D L +N IA I+R
Sbjct: 34 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 93
Query: 436 YGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENT 495
Y E ++Y+ +E LN + S + E +
Sbjct: 94 YDYEITDQYIYMVMECGNIDLNSWL-KKKKSIDP------------WERK---------- 130
Query: 496 KDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDM 555
++++ + +H+ G++H DLKP N LI KL D
Sbjct: 131 -----------------SYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGM---LKLIDF 170
Query: 556 GISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ-----------GRQTRAIDLFSLGCIL 604
GI+ ++Q D + + ++ + G+ + PE + + + D++SLGCIL
Sbjct: 171 GIANQMQPDTTSVVKD-SQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCIL 229
Query: 605 FFCITGGKHPYGESFERDA---NIVKDRKDLFLVEHI-PEAVDLFTRLLDPNPDLRPKAQ 660
++ GK P+ + + + I+ ++ + + D+ L +P R
Sbjct: 230 YYMTY-GKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIP 288
Query: 661 NVLNHPFF 668
+L HP+
Sbjct: 289 ELLAHPYV 296
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 1e-36
Identities = 60/293 (20%), Positives = 100/293 (34%), Gaps = 51/293 (17%)
Query: 382 KEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYGVES 440
+ +GS G V + + G AVK+ V+ ++E+ A P IV YG
Sbjct: 64 PRVGRGSFGEVHRMKDKQTGFQCAVKK-VRLE-VFRVEEL-VACAGLSSPRIVPLYGAVR 120
Query: 441 DQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIEL 500
+ +V + +E + GS + + + L E R
Sbjct: 121 EGPWVNIFME----------LLEGGSLGQLI----KQMGCLPEDRAL------------- 153
Query: 501 WKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKR 560
+ GL +LH ++H D+K NVL+S D S L D G +
Sbjct: 154 ------------YYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRA-ALCDFGHALC 200
Query: 561 LQGDMSCLTQNATGY--GSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGES 618
LQ D + Y G+ APE ++ +D++S C++ + G HP+ +
Sbjct: 201 LQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLN-GCHPWTQY 259
Query: 619 FERDA--NIVKDRKDLF-LVEHI-PEAVDLFTRLLDPNPDLRPKAQNVLNHPF 667
F I + + + P L P R A +
Sbjct: 260 FRGPLCLKIASEPPPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVG 312
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 5e-36
Identities = 67/400 (16%), Positives = 134/400 (33%), Gaps = 98/400 (24%)
Query: 290 YHSKQVKSKKQNEEHITKTGIPKKKKSRRPGYNRNTTNSEKMQNIIPNESKVGETDGLSH 349
+H + +T K ++ + T + +K + V
Sbjct: 2 HHHHHSSGLVPRGSGMKETAAAKFERQHMDSPDLGTDDDDKASSSANECISV-------- 53
Query: 350 ITGNGEKFLLTFTDLIDDRVDGRRIGKLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLV 409
G + + ++IG G + V N + + A+K +
Sbjct: 54 ---KGRIYSI-----------LKQIGS----------GGSSKVFQVLNEKKQIYAIKYVN 89
Query: 410 KTHHD-VALKEIQNLIA-----SDQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVL 463
D L +N IA I+R Y E ++Y+ +E LN +
Sbjct: 90 LEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWL-KK 148
Query: 464 SGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLS 523
S + E + ++++ +
Sbjct: 149 KKSIDP------------WERK---------------------------SYWKNMLEAVH 169
Query: 524 HLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAP 583
+H+ G++H DLKP N LI KL D GI+ ++Q D + + ++ + G+ + P
Sbjct: 170 TIHQHGIVHSDLKPANFLIVDG---MLKLIDFGIANQMQPDTTSVVKD-SQVGAVNYMPP 225
Query: 584 EQLL-----------QGRQTRAIDLFSLGCILFFCITGGKHPYGESFERDA---NIVKDR 629
E + + + + D++SLGCIL++ GK P+ + + + I+
Sbjct: 226 EAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTY-GKTPFQQIINQISKLHAIIDPN 284
Query: 630 KDLFLVEHI-PEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 668
++ + + D+ L +P R +L HP+
Sbjct: 285 HEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYV 324
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 3e-35
Identities = 62/302 (20%), Positives = 119/302 (39%), Gaps = 66/302 (21%)
Query: 382 KEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHD-----VALKEIQNLIASDQHPNIVRW 435
++I +GS G +L + +GR +K + + + +E+ ++A+ +HPNIV++
Sbjct: 30 QKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREV-AVLANMKHPNIVQY 88
Query: 436 YGVESDQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMEN 494
+ +Y+ ++ C L I Q L E
Sbjct: 89 RESFEENGSLYIVMDYCEGGDLFKRI-------------NAQKGVLFQE----------- 124
Query: 495 TKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSD 554
Q+L I L H+H+ ++HRD+K QN+ ++KD + +L D
Sbjct: 125 --------------DQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGT--VQLGD 168
Query: 555 MGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ-TRAIDLFSLGCILFFCITGGKH 613
GI++ L + G+ + +PE + + + D+++LGC+L+ T KH
Sbjct: 169 FGIARVLNSTVELAR---ACIGTPYYLSPE-ICENKPYNNKSDIWALGCVLYELCT-LKH 223
Query: 614 PY-GESFER-DANIVKDRKDLFLVEHIP-----EAVDLFTRLLDPNPDLRPKAQNVLNHP 666
+ S + I+ + + L ++L NP RP ++L
Sbjct: 224 AFEAGSMKNLVLKIISGS-----FPPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKG 278
Query: 667 FF 668
F
Sbjct: 279 FI 280
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 5e-35
Identities = 58/298 (19%), Positives = 113/298 (37%), Gaps = 54/298 (18%)
Query: 382 KEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHH------DVALKEIQNLIASDQHPNIVR 434
K+I +G V +G VA+K++ +KEI +L+ HPN+++
Sbjct: 38 KKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEI-DLLKQLNHPNVIK 96
Query: 435 WYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMEN 494
+Y + + + + LE +G + ++ L+ E +
Sbjct: 97 YYASFIEDNELNIVLE----------LADAGDLSRMIKHFKKQKRLIPERTV-------- 138
Query: 495 TKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSD 554
K + S L H+H ++HRD+KP NV I+ KL D
Sbjct: 139 -----------------WKYFVQLCSALEHMHSRRVMHRDIKPANVFITATG--VVKLGD 179
Query: 555 MGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP 614
+G+ + + + G+ + +PE++ + D++SLGC+L+ + P
Sbjct: 180 LGLGRFFSSKTTAAH---SLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAA-LQSP 235
Query: 615 Y-GESFERDA---NIVKDRKDLFLVEHI-PEAVDLFTRLLDPNPDLRPKAQNVLNHPF 667
+ G+ + I + +H E L ++P+P+ RP V +
Sbjct: 236 FYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAK 293
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 137 bits (345), Expect = 5e-35
Identities = 50/322 (15%), Positives = 104/322 (32%), Gaps = 28/322 (8%)
Query: 367 DRVDGRRIGKLVVFNKEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHHDVALKEIQNLIA 425
+ G R + +V + + + + E G S V T + +
Sbjct: 70 ESELGER-PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFT------ERPPSNAI 122
Query: 426 SDQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVR 485
++R + ++ + DL+ ++ E+D +L+
Sbjct: 123 KQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFF 182
Query: 486 IRLLPVMENTKDIELWKANGH-----PSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNV 540
+ E+ ++ L++T ++ L+ LH GL+H L+P ++
Sbjct: 183 LYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDI 242
Query: 541 LISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ-----TRAI 595
++ + L+ R S ++ G+ A L G+ T A
Sbjct: 243 VLDQRGG--VFLTGFEHLVRD--GASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAF 298
Query: 596 DLFSLGCILFFCITGGKHPYGESFERDANIVKDRKDLFLVEHIPEAV-DLFTRLLDPNPD 654
D ++LG +++ P DA + ++IP+ V L L +
Sbjct: 299 DTWTLGLAIYWIWC-ADLP----NTDDAALGGSEWIFRSCKNIPQPVRALLEGFLRYPKE 353
Query: 655 LRPKAQNVLNHPFFWTADTRLS 676
R + P + T LS
Sbjct: 354 DRLLPLQAMETPEYEQLRTELS 375
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 1e-34
Identities = 69/326 (21%), Positives = 122/326 (37%), Gaps = 89/326 (27%)
Query: 382 KEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHDV--ALKEIQNLIASDQHPNIVRWYGV 438
+ +G+ G VV + R A+K++ T + L E+ L+AS H +VR+Y
Sbjct: 12 AVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEV-MLLASLNHQYVVRYYAA 70
Query: 439 ESDQD-------------FVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEV 484
++ +++ +E C +L DLI+ + + +
Sbjct: 71 WLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRD-------------- 116
Query: 485 RIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISK 544
+ ++ R I+ LS++H G+IHRDLKP N+ I +
Sbjct: 117 -------------------------EYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDE 151
Query: 545 DKSFCAKLSDMGISKRLQGDMSCLTQNATGY-----------GSSGWQAPEQLLQ-GRQT 592
++ K+ D G++K + + L ++ G++ + A E L G
Sbjct: 152 SRN--VKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYN 209
Query: 593 RAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDRKDLFLVEHI----------PEAV 642
ID++SLG I F I F V K L V
Sbjct: 210 EKIDMYSLGIIFFEMIYP--------FSTGMERVNILKKLRSVSIEFPPDFDDNKMKVEK 261
Query: 643 DLFTRLLDPNPDLRPKAQNVLNHPFF 668
+ L+D +P+ RP A+ +LN +
Sbjct: 262 KIIRLLIDHDPNKRPGARTLLNSGWL 287
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 2e-34
Identities = 62/318 (19%), Positives = 118/318 (37%), Gaps = 76/318 (23%)
Query: 382 KEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHDV----ALKEIQNLIASDQHPNIVRWY 436
+ + +G G V + + + A+KR+ + ++ ++E++ +A +HP IVR++
Sbjct: 11 QCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVK-ALAKLEHPGIVRYF 69
Query: 437 GVESDQD------------FVYLSLERCT-CSLNDLIYVLSGSFEEQLNAKEQDSNLLNE 483
+++ ++Y+ ++ C +L D + + + E
Sbjct: 70 NAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWM-------------NGRCTIEERE 116
Query: 484 VRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLIS 543
L + I + LH GL+HRDLKP N+ +
Sbjct: 117 RS------------------------VCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFT 152
Query: 544 KDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQ---------APEQLLQGRQTRA 594
D K+ D G+ + D T + +PEQ+ +
Sbjct: 153 MDDV--VKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHK 210
Query: 595 IDLFSLGCILF-FCITGGKHPYGESFERDANIVKDRKDLF---LVEHIPEAVDLFTRLLD 650
+D+FSLG ILF +P+ ER + R F + P + +L
Sbjct: 211 VDIFSLGLILFELL-----YPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLS 265
Query: 651 PNPDLRPKAQNVLNHPFF 668
P+P RP+A N++ + F
Sbjct: 266 PSPMERPEAINIIENAVF 283
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 5e-34
Identities = 48/329 (14%), Positives = 88/329 (26%), Gaps = 46/329 (13%)
Query: 372 RRIGKLVVFNKEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHHDVA-----LKEIQNLIA 425
+ + + + + G V L + E A+K + L E A
Sbjct: 58 SQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAA 117
Query: 426 SDQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVR 485
+ D + V S QL+ + D + N +
Sbjct: 118 RLLGESPEEARDRRRLLLPS------------DAVAVQSQPPFAQLSPGQDDYAVANYLL 165
Query: 486 IRLLPVMENTKDIELWKANGH-----PSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNV 540
+ ++ L +T ++ ++L GL+H P N+
Sbjct: 166 LMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNL 225
Query: 541 LISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ---TRAIDL 597
I D L D+ ++ AP + L T A++
Sbjct: 226 FIMPDGR--LMLGDVSALWKVGTRGPAS-------SVPVTYAPREFLNASTATFTHALNA 276
Query: 598 FSLGCILFFCITGGKHPYGESFERDANIVK---------DRKDLFLVEHIPEAV-DLFTR 647
+ LG ++ P+G K D +P+ V L R
Sbjct: 277 WQLGLSIYRVWC-LFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGR 335
Query: 648 LLDPNPDLRPKAQNVLNHPFFWTADTRLS 676
L+ + R + P F +S
Sbjct: 336 FLNFDRRRRLLPLEAMETPEFLQLQNEIS 364
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 3e-33
Identities = 66/322 (20%), Positives = 115/322 (35%), Gaps = 66/322 (20%)
Query: 369 VDGRRIGKLVVFNKEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHD---VALKEIQNLI 424
+D + +F +++ +G V L EG ++G A+KR++ A +E
Sbjct: 26 IDNKH----YLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMH- 80
Query: 425 ASDQHPNIVRWYGVESDQDF----VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNL 480
HPNI+R + +L L + G+ ++ + N
Sbjct: 81 RLFNHPNILRLVAYCLRERGAKHEAWLLLP----------FFKRGTLWNEIERLKDKGNF 130
Query: 481 LNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNV 540
L E +I L + I GL +H G HRDLKP N+
Sbjct: 131 LTEDQI-------------------------LWLLLGICRGLEAIHAKGYAHRDLKPTNI 165
Query: 541 LISKDKSFCAKLSDMGISK------RLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRA 594
L+ + L D+G L A + ++APE L +
Sbjct: 166 LLGDEGQP--VLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPE-LFSVQSHCV 222
Query: 595 I----DLFSLGCILFFCITGGKHPYGESFERD---ANIVKDRKDLFLVEHI-PEAVDLFT 646
I D++SLGC+L+ + G+ PY F++ A V+++ + L
Sbjct: 223 IDERTDVWSLGCVLYAMMF-GEGPYDMVFQKGDSVALAVQNQLSIPQSPRHSSALWQLLN 281
Query: 647 RLLDPNPDLRPKAQNVLNHPFF 668
++ +P RP +L+
Sbjct: 282 SMMTVDPHQRPHIPLLLSQLEA 303
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 6e-33
Identities = 73/304 (24%), Positives = 119/304 (39%), Gaps = 79/304 (25%)
Query: 367 DRVDGR-RIGKLVVFNKEIAKGSNGTVVL--EGNYEGRSVAVKRLVKTHHDVALK----E 419
D V G+ + IA G G + L + N GR V +K LV + A E
Sbjct: 76 DIVAGQYEVKGC------IAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAE 129
Query: 420 IQNLIASDQHPNIVRWY--GVESDQD---FVYLSLERCTCSLNDLIYVLSGSFEEQLNAK 474
Q L A HP+IV+ + +D+ Y+ +E YV S
Sbjct: 130 RQFL-AEVVHPSIVQIFNFVEHTDRHGDPVGYIVME----------YVGGQS-------- 170
Query: 475 EQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRD 534
L + + LPV A+ + +I+ LS+LH IGL++ D
Sbjct: 171 ------LKRSKGQKLPV-----------------AEAIAYLLEILPALSYLHSIGLVYND 207
Query: 535 LKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRA 594
LKP+N+++++++ KL D+G R + YG+ G+QAPE ++ T A
Sbjct: 208 LKPENIMLTEEQ---LKLIDLGAVSR-------INSFGYLYGTPGFQAPEI-VRTGPTVA 256
Query: 595 IDLFSLGCILFFCITGGKHPYGESFERDANIVKDRKDLFLVEHIPEAVD-LFTRLLDPNP 653
D++++G L + V + V ++ L R +DP+P
Sbjct: 257 TDIYTVGRTLAALTL-DLPTR------NGRYVDGLPEDDPVLKTYDSYGRLLRRAIDPDP 309
Query: 654 DLRP 657
R
Sbjct: 310 RQRF 313
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 128 bits (322), Expect = 4e-32
Identities = 50/328 (15%), Positives = 105/328 (32%), Gaps = 39/328 (11%)
Query: 367 DRVDGRRIGKLVVFNKEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHHDVALKEIQNLIA 425
+ G R LV + + + + E G S V T + +
Sbjct: 65 ESELGERPRTLV-RGTVLGQEDPYAYLEATDQETGESFEVHVPYFT------ERPPSNAI 117
Query: 426 SDQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVR 485
++R + ++ + DL+ ++ E+D +L+
Sbjct: 118 KQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFF 177
Query: 486 IRLLPVMENTKDIELWKANGHPSAQL-----LKVTRDIVSGLSHLHEIGLIHRDLKPQNV 540
+ E+ ++ L L++T ++ L+ LH GL+H L+P ++
Sbjct: 178 LYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDI 237
Query: 541 LISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLL-----------QG 589
++ + L+ R + S G++ PE +
Sbjct: 238 VLDQRGG--VFLTGFEHLVRDGARVVS-------SVSRGFEPPELEARRATISYHRDRRT 288
Query: 590 RQTRAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDRKDLFLVEHIPEAV-DLFTRL 648
T + D ++LG ++++ P +DA + ++IP+ V L
Sbjct: 289 LMTFSFDAWALGLVIYWIWC-ADLP----ITKDAALGGSEWIFRSCKNIPQPVRALLEGF 343
Query: 649 LDPNPDLRPKAQNVLNHPFFWTADTRLS 676
L + R + P + T LS
Sbjct: 344 LRYPKEDRLLPLQAMETPEYEQLRTELS 371
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 4e-32
Identities = 72/309 (23%), Positives = 126/309 (40%), Gaps = 60/309 (19%)
Query: 373 RIGKLVVFNKEIAKGSNGTVVL-EGNYEGRSVAVK-----RLVKTHHDVALKEIQNLIAS 426
+ ++ K++ G+ G V+L A+K + + + L+E+ L
Sbjct: 34 HLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLL 93
Query: 427 DQHPNIVRWYGVESDQDFVYLSLERCT-CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVR 485
D HPNI++ Y D+ YL +E L D I + F E A
Sbjct: 94 D-HPNIMKLYDFFEDKRNYYLVMECYKGGELFDEI-IHRMKFNEVDAAV----------- 140
Query: 486 IRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLI-SK 544
+ + ++SG+++LH+ ++HRDLKP+N+L+ SK
Sbjct: 141 ----------------------------IIKQVLSGVTYLHKHNIVHRDLKPENLLLESK 172
Query: 545 DKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCIL 604
+K K+ D G+S + + G++ + APE +L+ + D++S+G IL
Sbjct: 173 EKDALIKIVDFGLSAVFENQKKMKER----LGTAYYIAPE-VLRKKYDEKCDVWSIGVIL 227
Query: 605 FFCITGGKHP-YGESFERDANIVKDRKDLFLVEHIP----EAVDLFTRLLDPNPDLRPKA 659
F + G P G++ + V+ K F A DL ++L + R A
Sbjct: 228 FILLA-GYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISA 286
Query: 660 QNVLNHPFF 668
Q L HP+
Sbjct: 287 QQALEHPWI 295
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 7e-32
Identities = 79/343 (23%), Positives = 135/343 (39%), Gaps = 71/343 (20%)
Query: 372 RRIGKLVVFNKEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTH------HDVALKEIQNLI 424
+ + KGS G V+L + G+ AVK + K + L+E+Q L
Sbjct: 22 AIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLK 81
Query: 425 ASDQHPNIVRWYGVESDQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNE 483
D HPNI++ Y D+ + YL E T L D I + F E A+
Sbjct: 82 QLD-HPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEI-ISRKRFSEVDAAR--------- 130
Query: 484 VRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLI- 542
+ R ++SG++++H+ ++HRDLKP+N+L+
Sbjct: 131 ------------------------------IIRQVLSGITYMHKNKIVHRDLKPENLLLE 160
Query: 543 SKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGC 602
SK K ++ D G+S + + G++ + APE +L G D++S G
Sbjct: 161 SKSKDANIRIIDFGLSTHFEASKKMKDK----IGTAYYIAPE-VLHGTYDEKCDVWSTGV 215
Query: 603 ILFFCITGGKHP-YGESFERDANIVKDRKDLFLVEHIP----EAVDLFTRLLDPNPDLRP 657
IL+ ++ G P G + V+ K F + A DL ++L P +R
Sbjct: 216 ILYILLS-GCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRI 274
Query: 658 KAQNVLNHPFFWTADTRLSFLRDVSDRVELEDRESDSKLLRAL 700
A++ L+H W ++ + D S + +
Sbjct: 275 SARDALDHE--W--------IQTYTKEQISVDVPSLDNAILNI 307
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 1e-31
Identities = 65/308 (21%), Positives = 110/308 (35%), Gaps = 69/308 (22%)
Query: 382 KEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHDV-----ALKEIQNLIASDQHPNIVRW 435
I GS G +G+ + K L + E+ NL+ +HPNIVR+
Sbjct: 12 YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEV-NLLRELKHPNIVRY 70
Query: 436 YG--VESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVME 493
Y ++ +Y+ +E C G + ++ L+E +
Sbjct: 71 YDRIIDRTNTTLYIVMEYCE----------GGDLASVITKGTKERQYLDEEFV------- 113
Query: 494 NTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL-----IHRDLKPQNVLISKDKSF 548
L+V + L H +HRDLKP NV + ++
Sbjct: 114 ------------------LRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQN- 154
Query: 549 CAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ-TRAIDLFSLGCILFFC 607
KL D G+++ L D S T G+ + +PE + D++SLGC+L+
Sbjct: 155 -VKLGDFGLARILNHDTSFAK---TFVGTPYYMSPE-QMNRMSYNEKSDIWSLGCLLYEL 209
Query: 608 ITGGKHP-YGESFER-DANIVKDRKDLFLVEHIP-----EAVDLFTRLLDPNPDLRPKAQ 660
P S + I + + IP E ++ TR+L+ RP +
Sbjct: 210 CAL-MPPFTAFSQKELAGKIREGK-----FRRIPYRYSDELNEIITRMLNLKDYHRPSVE 263
Query: 661 NVLNHPFF 668
+L +P
Sbjct: 264 EILENPLI 271
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 2e-31
Identities = 71/302 (23%), Positives = 114/302 (37%), Gaps = 59/302 (19%)
Query: 380 FNKEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYGV 438
++I GS AVK + K+ D +EI+ L+ QHPNI+ V
Sbjct: 26 VKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDP-TEEIEILLRYGQHPNIITLKDV 84
Query: 439 ESDQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKD 497
D +VY+ E L D I + F E+
Sbjct: 85 YDDGKYVYVVTELMKGGELLDKI-LRQKFFSER--------------------------- 116
Query: 498 IELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLIS--KDKSFCAKLSDM 555
+A+ V I + +LH G++HRDLKP N+L ++ D
Sbjct: 117 ----EAS--------AVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDF 164
Query: 556 GISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP- 614
G +K+L+ + L T ++ + APE L + A D++SLG +L+ +TG +
Sbjct: 165 GFAKQLRAENGLLM---TPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTG--YTP 219
Query: 615 -YGESFERDANI---VKDRKDLFLVE---HI-PEAVDLFTRLLDPNPDLRPKAQNVLNHP 666
+ I + K + A DL +++L +P R A VL HP
Sbjct: 220 FANGPDDTPEEILARIGSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHP 279
Query: 667 FF 668
+
Sbjct: 280 WI 281
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 2e-31
Identities = 78/342 (22%), Positives = 135/342 (39%), Gaps = 69/342 (20%)
Query: 372 RRIGKLVVFNKEIAKGSNGTVVL-EGNYEGRSVAVK-----RLVKTHHDVALKEIQNLIA 425
+ + KGS G V+ + + AVK L+E++ L
Sbjct: 18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKK 77
Query: 426 SDQHPNIVRWYGVESDQDFVYLSLERCT-CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEV 484
D HPNI++ + + D Y+ E T L D I + F E A+
Sbjct: 78 LD-HPNIMKLFEILEDSSSFYIVGELYTGGELFDEI-IKRKRFSEHDAAR---------- 125
Query: 485 RIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLI-S 543
+ + + SG++++H+ ++HRDLKP+N+L+ S
Sbjct: 126 -----------------------------IIKQVFSGITYMHKHNIVHRDLKPENILLES 156
Query: 544 KDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCI 603
K+K K+ D G+S Q + + + G++ + APE +L+G D++S G I
Sbjct: 157 KEKDCDIKIIDFGLSTCFQQN-TKMKDRI---GTAYYIAPE-VLRGTYDEKCDVWSAGVI 211
Query: 604 LFFCITGGKHP-YGESFERDANIVKDRKDLFLVEHIP----EAVDLFTRLLDPNPDLRPK 658
L+ ++ G P YG++ V+ K F + +A DL ++L +P LR
Sbjct: 212 LYILLS-GTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRIT 270
Query: 659 AQNVLNHPFFWTADTRLSFLRDVSDRVELEDRESDSKLLRAL 700
A L HP W + S+ + D S + +
Sbjct: 271 ATQCLEHP--W-------IQKYSSETPTISDLPSLESAMTNI 303
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 3e-31
Identities = 75/315 (23%), Positives = 124/315 (39%), Gaps = 69/315 (21%)
Query: 369 VDGRRIGKLVVFNKEIAKGSNGTVVLEGNYE-GRSVAVK-----RLVKTHHDVALK-EIQ 421
VD R + V + + KG + + A K L+K H + EI
Sbjct: 9 VDPRSRRRYVR-GRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEIS 67
Query: 422 NLIASDQHPNIVRWYGVESDQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNL 480
S H ++V ++G D DFV++ LE C SL +L + E
Sbjct: 68 IH-RSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELH-KRRKALTEP---------- 115
Query: 481 LNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNV 540
E R R IV G +LH +IHRDLK N+
Sbjct: 116 --EAR---------------------------YYLRQIVLGCQYLHRNRVIHRDLKLGNL 146
Query: 541 LISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ-TRAIDLFS 599
+ ++ K+ D G++ +++ D G+ + APE +L + + +D++S
Sbjct: 147 FL--NEDLEVKIGDFGLATKVEYDGERKK---VLCGTPNYIAPE-VLSKKGHSFEVDVWS 200
Query: 600 LGCILFFCITGGKHPYGESFERDANIVKDRK-----DLFLVEHI-PEAVDLFTRLLDPNP 653
+GCI++ + GK P FE + + + + + +HI P A L ++L +P
Sbjct: 201 IGCIMYTLLV-GKPP----FE-TSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTDP 254
Query: 654 DLRPKAQNVLNHPFF 668
RP +LN FF
Sbjct: 255 TARPTINELLNDEFF 269
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 3e-31
Identities = 74/352 (21%), Positives = 141/352 (40%), Gaps = 81/352 (23%)
Query: 373 RIGKLVVFNKEIAKGSNGTVVL-EGNYEGRSVAVKRLVKT----------------HHDV 415
+IG+ +++ G+ G V+L + A+K + K+ H+
Sbjct: 33 KIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEE 92
Query: 416 ALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAK 474
EI L + D HPNI++ + V D+ + YL E L + I + F+E A
Sbjct: 93 IYNEISLLKSLD-HPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQI-INRHKFDECDAAN 150
Query: 475 EQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRD 534
+ + I+SG+ +LH+ ++HRD
Sbjct: 151 ---------------------------------------IMKQILSGICYLHKHNIVHRD 171
Query: 535 LKPQNVLI-SKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTR 593
+KP+N+L+ +K+ K+ D G+S D L G++ + APE +L+ +
Sbjct: 172 IKPENILLENKNSLLNIKIVDFGLSSFFSKD-YKLRDRL---GTAYYIAPE-VLKKKYNE 226
Query: 594 AIDLFSLGCILFFCITGGKHP-YGESFERDANIVKDRKDLFLVE---HI-PEAVDLFTRL 648
D++S G I++ + G P G++ + V+ K F +I EA +L +
Sbjct: 227 KCDVWSCGVIMYILLC-GYPPFGGQNDQDIIKKVEKGKYYFDFNDWKNISDEAKELIKLM 285
Query: 649 LDPNPDLRPKAQNVLNHPFFWTADTRLSFLRDVSDRVELEDRESDSKLLRAL 700
L + + R A+ LN W ++ ++ + D+++ L +
Sbjct: 286 LTYDYNKRCTAEEALNSR--W--------IKKYANNINKSDQKTLCGALSNM 327
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 5e-31
Identities = 70/314 (22%), Positives = 116/314 (36%), Gaps = 71/314 (22%)
Query: 376 KLVVFNKEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVR 434
L + +K + +GS ++ AVK + K KEI L + HPNIV+
Sbjct: 11 DLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHPNIVK 70
Query: 435 WYGVESDQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVME 493
+ V DQ +L +E L + I F E +
Sbjct: 71 LHEVFHDQLHTFLVMELLNGGELFERI-KKKKHFSETEASY------------------- 110
Query: 494 NTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVL-ISKDKSFCAKL 552
+ R +VS +SH+H++G++HRDLKP+N+L ++ + K+
Sbjct: 111 --------------------IMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKI 150
Query: 553 SDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGK 612
D G ++ D L T + + APE L Q + DL+SLG IL+ ++G
Sbjct: 151 IDFGFARLKPPDNQPLK---TPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSG-- 205
Query: 613 HP--YGESFERDANIVKDRKDLFLVEHI----------------PEAVDLFTRLLDPNPD 654
+ ++ + I EA DL LL +P+
Sbjct: 206 QVPFQSHD---RSLTCTSAVEIM--KKIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPN 260
Query: 655 LRPKAQNVLNHPFF 668
R K + + +
Sbjct: 261 KRLKMSGLRYNEWL 274
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 6e-31
Identities = 69/283 (24%), Positives = 113/283 (39%), Gaps = 67/283 (23%)
Query: 400 GRSVAVK-----RLVKTHHDVALK-EIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCT 453
A K L+K H + EI S H ++V ++G D DFV++ LE C
Sbjct: 66 KEVFAGKIVPKSLLLKPHQREKMSMEISIH-RSLAHQHVVGFHGFFEDNDFVFVVLELCR 124
Query: 454 C-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLL 512
SL +L + E E R
Sbjct: 125 RRSLLELH-KRRKALTEP------------EAR--------------------------- 144
Query: 513 KVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNA 572
R IV G +LH +IHRDLK N+ + ++ K+ D G++ +++ D
Sbjct: 145 YYLRQIVLGCQYLHRNRVIHRDLKLGNLFL--NEDLEVKIGDFGLATKVEYDGERKK--- 199
Query: 573 TGYGSSGWQAPEQLLQGRQ-TRAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDRK- 630
G+ + APE +L + + +D++S+GCI++ + GK P FE + + +
Sbjct: 200 VLCGTPNYIAPE-VLSKKGHSFEVDVWSIGCIMYTLLV-GKPP----FE-TSCLKETYLR 252
Query: 631 ----DLFLVEHI-PEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 668
+ + +HI P A L ++L +P RP +LN FF
Sbjct: 253 IKKNEYSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFF 295
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 2e-30
Identities = 73/305 (23%), Positives = 136/305 (44%), Gaps = 52/305 (17%)
Query: 374 IGKLVVFNKEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHDVALKEIQNLIA---SDQH 429
I L +F +++ G+ G V L E G +K + K V +++I+ I S H
Sbjct: 20 IDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDH 79
Query: 430 PNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLL 489
PNI++ + V D +Y+ +E C G E++ + + L+E +
Sbjct: 80 PNIIKIFEVFEDYHNMYIVMETCE----------GGELLERIVSAQARGKALSEGYVA-- 127
Query: 490 PVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVL-ISKDKSF 548
++ + +++ L++ H ++H+DLKP+N+L
Sbjct: 128 -----------------------ELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHS 164
Query: 549 CAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCI 608
K+ D G+++ + D T A G++ + APE + + T D++S G +++F +
Sbjct: 165 PIKIIDFGLAELFKSD-EHSTNAA---GTALYMAPE-VFKRDVTFKCDIWSAGVVMYFLL 219
Query: 609 TGGKHP--YGESFERDANIVKDRKDLFLVE--HI-PEAVDLFTRLLDPNPDLRPKAQNVL 663
TG G S E ++ + VE + P+AVDL ++L +P+ RP A VL
Sbjct: 220 TG--CLPFTGTSLEEVQQKATYKEPNYAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVL 277
Query: 664 NHPFF 668
+H +F
Sbjct: 278 HHEWF 282
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 2e-30
Identities = 67/310 (21%), Positives = 117/310 (37%), Gaps = 64/310 (20%)
Query: 375 GKLVVFNKEIAKGSNGTVVLEGNYE-GRSVAVK-----RLVKTHHDVALKEIQNLIASDQ 428
G+ + F+ EI +GS TV + E VA +L K+ +E + L Q
Sbjct: 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGL-Q 83
Query: 429 HPNIVR----WYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEV 484
HPNIVR W + + L E + SG+ + L + ++
Sbjct: 84 HPNIVRFYDSWESTVKGKKCIVLVTE----------LMTSGTLKTYL----KRFKVMKIK 129
Query: 485 RIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG--LIHRDLKPQNVLI 542
+R R I+ GL LH +IHRDLK N+ I
Sbjct: 130 VLR-------------------------SWCRQILKGLQFLHTRTPPIIHRDLKCDNIFI 164
Query: 543 SKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGC 602
+ + K+ D+G++ + + G+ + APE + + + ++D+++ G
Sbjct: 165 T-GPTGSVKIGDLGLATLKRASFA-----KAVIGTPEFMAPE-MYEEKYDESVDVYAFGM 217
Query: 603 ILFFCITGGKHPYGESFERDA--NIVKDRKDLFLVEHI--PEAVDLFTRLLDPNPDLRPK 658
+ T ++PY E V + + PE ++ + N D R
Sbjct: 218 CMLEMATS-EYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYS 276
Query: 659 AQNVLNHPFF 668
+++LNH FF
Sbjct: 277 IKDLLNHAFF 286
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 3e-30
Identities = 75/310 (24%), Positives = 128/310 (41%), Gaps = 62/310 (20%)
Query: 373 RIGKLVVFNKEIAKGSNGTVVL-EGNYEGRSVAVK-----RLVKTHHDVALKEIQNLIAS 426
+ + KGS G V+ + + AVK L+E++ L
Sbjct: 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKL 78
Query: 427 DQHPNIVRWYGVESDQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVR 485
D HPNI++ + + D Y+ E T L D I + F E A+
Sbjct: 79 D-HPNIMKLFEILEDSSSFYIVGELYTGGELFDEI-IKRKRFSEHDAAR----------- 125
Query: 486 IRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLI-SK 544
+ + + SG++++H+ ++HRDLKP+N+L+ SK
Sbjct: 126 ----------------------------IIKQVFSGITYMHKHNIVHRDLKPENILLESK 157
Query: 545 DKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCIL 604
+K K+ D G+S Q + + + G++ + APE +L+G D++S G IL
Sbjct: 158 EKDCDIKIIDFGLSTCFQQN-TKMKDRI---GTAYYIAPE-VLRGTYDEKCDVWSAGVIL 212
Query: 605 FFCITGGKHP--YGESFERDANIVKDRKDLFLVE---HI-PEAVDLFTRLLDPNPDLRPK 658
+ ++G P YG++ V+ K F + I +A DL ++L +P LR
Sbjct: 213 YILLSG--TPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRIT 270
Query: 659 AQNVLNHPFF 668
A L HP+
Sbjct: 271 ATQCLEHPWI 280
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 1e-29
Identities = 66/308 (21%), Positives = 120/308 (38%), Gaps = 62/308 (20%)
Query: 374 IGKLVVFNKEIAKGSNGTVVL-EGNYEGRSVAVK----RLVKTHHDVALKEIQNLIASDQ 428
I + I +GS G V + A K V+ +EI+ + + D
Sbjct: 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRF-KQEIEIMKSLD- 64
Query: 429 HPNIVRWYGVESDQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIR 487
HPNI+R Y D +YL +E CT L + + V F E A+
Sbjct: 65 HPNIIRLYETFEDNTDIYLVMELCTGGELFERV-VHKRVFRESDAAR------------- 110
Query: 488 LLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVL-ISKDK 546
+ +D++S +++ H++ + HRDLKP+N L ++
Sbjct: 111 --------------------------IMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSP 144
Query: 547 SFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFF 606
KL D G++ R + + G+ + +P+ +L+G D +S G +++
Sbjct: 145 DSPLKLIDFGLAARFKPG-KMMRTKV---GTPYYVSPQ-VLEGLYGPECDEWSAGVMMYV 199
Query: 607 CITGGKHP--YGESFERDANIVKDRKDLFLVE---HI-PEAVDLFTRLLDPNPDLRPKAQ 660
+ G +P + +++ F + ++ P+A L RLL +P R +
Sbjct: 200 LLCG--YPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSL 257
Query: 661 NVLNHPFF 668
L H +F
Sbjct: 258 QALEHEWF 265
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 2e-29
Identities = 71/315 (22%), Positives = 120/315 (38%), Gaps = 72/315 (22%)
Query: 371 GRRIGKLVVFNKEIAKGSNGTVVLEGNYE-GRSVAVK-----RLVKTHHDVALK---EIQ 421
G +I V + KGS V + G VA+K + K ++ +I
Sbjct: 7 GEKIEDFKV-GNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIH 65
Query: 422 NLIASDQHPNIVRWYGVESDQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNL 480
+ +HP+I+ Y D ++VYL LE C +N + F E
Sbjct: 66 CQL---KHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSEN---------- 112
Query: 481 LNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNV 540
E R I++G+ +LH G++HRDL N+
Sbjct: 113 --EAR---------------------------HFMHQIITGMLYLHSHGILHRDLTLSNL 143
Query: 541 LISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ-TRAIDLFS 599
L+ ++ K++D G++ +L+ T G+ + +PE + D++S
Sbjct: 144 LL--TRNMNIKIADFGLATQLKMPHEKHY---TLCGTPNYISPE-IATRSAHGLESDVWS 197
Query: 600 LGCILFFCITGGKHPYGESFERDANIVKDRK-----DLFLVEHI-PEAVDLFTRLLDPNP 653
LGC+ + + G+ P F+ + D + + EA DL +LL NP
Sbjct: 198 LGCMFYTLLI-GRPP----FD-TDTVKNTLNKVVLADYEMPSFLSIEAKDLIHQLLRRNP 251
Query: 654 DLRPKAQNVLNHPFF 668
R +VL+HPF
Sbjct: 252 ADRLSLSSVLDHPFM 266
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-29
Identities = 68/288 (23%), Positives = 116/288 (40%), Gaps = 56/288 (19%)
Query: 378 VVFNKEIAKGSNGTVVLEGNYEGRSVAVKRL-VKTHHDVALKEIQNLIASDQHPNIVRWY 436
+ + + +G+ G V + + + VA+K++ ++ + E++ L + HPNIV+ Y
Sbjct: 10 IEVEEVVGRGAFGVV-CKAKWRAKDVAIKQIESESERKAFIVELRQL-SRVNHPNIVKLY 67
Query: 437 GVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTK 496
G + V L +E Y GS L+ E
Sbjct: 68 GACLNP--VCLVME----------YAEGGSLYNVLHGAEPLPYY---------------- 99
Query: 497 DIELWKANGHPSAQLLKVTRDIVSGLSHLHEI---GLIHRDLKPQNVLISKDKSFCAKLS 553
+A + G+++LH + LIHRDLKP N+L+ + K+
Sbjct: 100 ----------TAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGT-VLKIC 148
Query: 554 DMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKH 613
D G + +Q M+ GS+ W APE + D+FS G IL+ IT +
Sbjct: 149 DFGTACDIQTHMTNNK------GSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVIT-RRK 201
Query: 614 PYGE---SFERDANIVKDRKDLFLVEHIPEAV-DLFTRLLDPNPDLRP 657
P+ E R V + L++++P+ + L TR +P RP
Sbjct: 202 PFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIESLMTRCWSKDPSQRP 249
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 4e-29
Identities = 81/365 (22%), Positives = 137/365 (37%), Gaps = 60/365 (16%)
Query: 369 VDGRRIGKLVVFNKEIAKGSNGTVVL-EGNYEGRSVAVK-----RLVKTHHDVALKEIQN 422
+ R + +E+ KG+ V G+ A +L H +E +
Sbjct: 4 ITCTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARI 63
Query: 423 LIASDQHPNIVRWYGVESDQDFVYLSLERCTCS-LNDLIYVLSGSFEEQLNAKEQDSNLL 481
HPNIVR + S++ YL + T L + I V + E +
Sbjct: 64 CRLLK-HPNIVRLHDSISEEGHHYLIFDLVTGGELFEDI-VAREYYSEADASH------- 114
Query: 482 NEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVL 541
+ I+ + H H++G++HR+LKP+N+L
Sbjct: 115 --------------------------------CIQQILEAVLHCHQMGVVHRNLKPENLL 142
Query: 542 -ISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSL 600
SK K KL+D G++ ++G+ G+ G+ +PE L + + +DL++
Sbjct: 143 LASKLKGAAVKLADFGLAIEVEGEQQAWF---GFAGTPGYLSPEVLRKDPYGKPVDLWAC 199
Query: 601 GCILFFCITGGKHP--YGESFERDANIVKDRKDLFLVE---HI-PEAVDLFTRLLDPNPD 654
G IL+ + G +P + E R +K F + PEA DL ++L NP
Sbjct: 200 GVILYILLVG--YPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLINKMLTINPS 257
Query: 655 LRPKAQNVLNHPFFWTADTRLSFLRDVSDRVELEDRESDSKLLRALEGIALVALNGKWDE 714
R A L HP+ T S + L+ + KL A+ + L N +
Sbjct: 258 KRITAAEALKHPWISHRSTVASCMHRQETVDCLKKFNARRKLKGAILTVMLATRNFSVRK 317
Query: 715 KMETK 719
+ K
Sbjct: 318 QEIIK 322
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 2e-28
Identities = 64/290 (22%), Positives = 107/290 (36%), Gaps = 54/290 (18%)
Query: 378 VVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVAL-----KEIQNLIASDQHPNI 432
+ ++I GS GTV + G VAVK L++ +E+ + +HPNI
Sbjct: 39 LNIKEKIGAGSFGTV-HRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIM-KRLRHPNI 96
Query: 433 VRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVM 492
V + G + + + E Y+ GS L+ L
Sbjct: 97 VLFMGAVTQPPNLSIVTE----------YLSRGSLYRLLHKSGAREQL------------ 134
Query: 493 ENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG--LIHRDLKPQNVLISKDKSFCA 550
+ L + D+ G+++LH ++HR+LK N+L+ DK +
Sbjct: 135 --------------DERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLV--DKKYTV 178
Query: 551 KLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG 610
K+ D G+S+ A G+ W APE L D++S G IL+ T
Sbjct: 179 KVCDFGLSRLKASTFLSSKSAA---GTPEWMAPEVLRDEPSNEKSDVYSFGVILWELAT- 234
Query: 611 GKHPYGE--SFERDANIVKDRKDLFLVEHIPEAV-DLFTRLLDPNPDLRP 657
+ P+G + A + K L + ++ V + P RP
Sbjct: 235 LQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRP 284
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 4e-28
Identities = 71/316 (22%), Positives = 120/316 (37%), Gaps = 63/316 (19%)
Query: 366 DDRVDGRR---IGKLVVFNKEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHDVALK-EI 420
D +DG + E+ +G+ V + + A+K L KT ++ EI
Sbjct: 40 DYWIDGSNRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEI 99
Query: 421 QNLIASDQHPNIVRWYGVESDQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSN 479
L+ HPNI++ + + L LE T L D I V G + E+ A
Sbjct: 100 GVLLRLS-HPNIIKLKEIFETPTEISLVLELVTGGELFDRI-VEKGYYSERDAAD----- 152
Query: 480 LLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQN 539
+ I+ +++LHE G++HRDLKP+N
Sbjct: 153 ----------------------------------AVKQILEAVAYLHENGIVHRDLKPEN 178
Query: 540 VL-ISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLF 598
+L + K++D G+SK ++ + G+ G+ APE L +D++
Sbjct: 179 LLYATPAPDAPLKIADFGLSKIVEHQ-VLMKTVC---GTPGYCAPEILRGCAYGPEVDMW 234
Query: 599 SLGCILFFCITGGKHP--YGESFERD--ANIVKDRKDLFLVE---HI-PEAVDLFTRLLD 650
S+G I + + G Y E ++ I+ F+ + A DL +L+
Sbjct: 235 SVGIITYILLCG--FEPFYDERGDQFMFRRILNCEYY-FISPWWDEVSLNAKDLVRKLIV 291
Query: 651 PNPDLRPKAQNVLNHP 666
+P R L HP
Sbjct: 292 LDPKKRLTTFQALQHP 307
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 4e-28
Identities = 65/304 (21%), Positives = 108/304 (35%), Gaps = 56/304 (18%)
Query: 380 FNKEIAKGSNGTVVL-EGNYEGRSVAVK----RLVKTHHDVALKEIQNLIA---SDQHPN 431
+ I KG V G+ AVK + ++ ++++ + +HP+
Sbjct: 28 LCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPH 87
Query: 432 IVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPV 491
IV S +Y+ E + DL E + + + +E
Sbjct: 88 IVELLETYSSDGMLYMVFEFMDGA--DL-------CFE-IVKRADAGFVYSEAVAS---- 133
Query: 492 MENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVL-ISKDKSFCA 550
R I+ L + H+ +IHRD+KP VL SK+ S
Sbjct: 134 ---------------------HYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPV 172
Query: 551 KLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG 610
KL G++ +L G+ + APE + + + +D++ G ILF ++G
Sbjct: 173 KLGGFGVAIQLGESGLVAGGRV---GTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSG 229
Query: 611 GKHP--YGESFERDANIVKDRKDLFLVE---HI-PEAVDLFTRLLDPNPDLRPKAQNVLN 664
YG I+K + HI A DL R+L +P R LN
Sbjct: 230 --CLPFYGTKERLFEGIIKGKYK-MNPRQWSHISESAKDLVRRMLMLDPAERITVYEALN 286
Query: 665 HPFF 668
HP+
Sbjct: 287 HPWL 290
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 9e-28
Identities = 54/337 (16%), Positives = 108/337 (32%), Gaps = 89/337 (26%)
Query: 379 VFNKEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIV 433
+ + + +G+ V + + G A+K DV ++E + L + H NIV
Sbjct: 12 LLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLN-HKNIV 70
Query: 434 RWYGVESDQ--DFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPV 491
+ + +E + L +E + GS L + L E
Sbjct: 71 KLFAIEEETTTRHKVLIME----------FCPCGSLYTVLEEPSN-AYGLPESEFL---- 115
Query: 492 MENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLIS--KDKSFC 549
V RD+V G++HL E G++HR++KP N++ +D
Sbjct: 116 ---------------------IVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSV 154
Query: 550 AKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTR---------AIDLFSL 600
KL+D G ++ L+ D + YG+ + P+ + + R +DL+S+
Sbjct: 155 YKLTDFGAARELEDDEQF----VSLYGTEEYLHPD-MYERAVLRKDHQKKYGATVDLWSI 209
Query: 601 GCILFFCITG------------------------GKHPYGESFERDANIVKDRKDLFLVE 636
G + TG + + + D+ +
Sbjct: 210 GVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSC 269
Query: 637 HIP-----EAVDLFTRLLDPNPDLRPKAQNVLNHPFF 668
+ + +L+ + +
Sbjct: 270 SLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSD 306
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 1e-27
Identities = 85/378 (22%), Positives = 145/378 (38%), Gaps = 80/378 (21%)
Query: 337 NESKVG--------ETDGLSHITGNGEKFLLTFTDLIDDRVDGRRIGKLVVFNKEIAKGS 388
N VG ++ + F+ + D V + + + +K + G+
Sbjct: 88 NTELVGKGKRRPLNNNSEIALSLSRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGA 147
Query: 389 NGTVVL-EGNYEGRSVAVKRLVK-----------THHDVALKEIQNLIASDQHPNIVRWY 436
G V L + VA++ + K EI+ L + HP I++
Sbjct: 148 CGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLN-HPCIIKIK 206
Query: 437 GVESDQDFVYLSLERCTCS-LNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENT 495
+D Y+ LE L D + V + +E K
Sbjct: 207 NFFDAED-YYIVLELMEGGELFDKV-VGNKRLKEA-TCK--------------------- 242
Query: 496 KDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLI-SKDKSFCAKLSD 554
++ + +LHE G+IHRDLKP+NVL+ S+++ K++D
Sbjct: 243 -----------------LYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITD 285
Query: 555 MGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ---TRAIDLFSLGCILFFCITGG 611
G SK + G+ S + T G+ + APE L+ RA+D +SLG ILF C++G
Sbjct: 286 FGHSK-ILGETSLMR---TLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG- 340
Query: 612 KHP--YGESFERD-ANIVKDRKDLFLVE---HI-PEAVDLFTRLLDPNPDLRPKAQNVLN 664
+P + + + K F+ E + +A+DL +LL +P R + L
Sbjct: 341 -YPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 399
Query: 665 HPFFWTADTRLSFLRDVS 682
HP+ D + F +S
Sbjct: 400 HPWLQDEDMKRKFQDLLS 417
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 1e-27
Identities = 62/323 (19%), Positives = 112/323 (34%), Gaps = 81/323 (25%)
Query: 378 VVFNKEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHD---VALKEIQNLIASDQHPNIV 433
+ + +A+G V + GR A+KRL+ + ++E+ + HPNIV
Sbjct: 30 LRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIV 89
Query: 434 RWYGV--------ESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVR 485
++ ++ Q L E C L + + K + L+
Sbjct: 90 QFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLK------------KMESRGPLSC-- 135
Query: 486 IRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG--LIHRDLKPQNVLIS 543
+LK+ + H+H +IHRDLK +N+L+S
Sbjct: 136 -----------------------DTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLS 172
Query: 544 KDKSFCAKLSDMGISKRLQG---------DMSCLTQNATGYGSSGWQAPEQL-LQGRQ-- 591
+ KL D G + + + + + T + ++ PE + L
Sbjct: 173 NQGTI--KLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPI 230
Query: 592 TRAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDRKDLFLVEHIP-------EAVDL 644
D+++LGCIL+ +HP FE D ++ + IP L
Sbjct: 231 GEKQDIWALGCILYLLCF-RQHP----FE-DGAKLRIVNGKY---SIPPHDTQYTVFHSL 281
Query: 645 FTRLLDPNPDLRPKAQNVLNHPF 667
+L NP+ R V++
Sbjct: 282 IRAMLQVNPEERLSIAEVVHQLQ 304
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 118 bits (296), Expect = 1e-27
Identities = 75/336 (22%), Positives = 116/336 (34%), Gaps = 79/336 (23%)
Query: 379 VFNKEIAKGSNGTVVLEGNYE-GRSVAVK----RLVKTHHDVALKEIQNLIASDQHPNIV 433
+ + G G V+ + + G VA+K L + + EIQ + HPN+V
Sbjct: 17 EMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIM-KKLNHPNVV 75
Query: 434 RWYGVESDQ------DFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIR 487
V D L++E Y G + LN E L E IR
Sbjct: 76 SAREVPDGLQKLAPNDLPLLAME----------YCEGGDLRKYLNQFEN-CCGLKEGPIR 124
Query: 488 LLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLI-SKDK 546
+ DI S L +LHE +IHRDLKP+N+++ +
Sbjct: 125 -------------------------TLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQ 159
Query: 547 SFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ-TRAIDLFSLGCILF 605
K+ D+G +K L C G+ + APE LL+ ++ T +D +S G + F
Sbjct: 160 RLIHKIIDLGYAKELDQGELC----TEFVGTLQYLAPE-LLEQKKYTVTVDYWSFGTLAF 214
Query: 606 FCITG-------------------GKHPYGESFERDANIVKDRKDLFLVEHIP-----EA 641
CITG + + ++ VK L H+ +
Sbjct: 215 ECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKL 274
Query: 642 VDLFTRLLDPNPDLRPKAQNVLNHPFFWTADTRLSF 677
+L + R N F D+ LS
Sbjct: 275 ERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILSL 310
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-27
Identities = 43/338 (12%), Positives = 99/338 (29%), Gaps = 68/338 (20%)
Query: 380 FNKEIAKGSNGTVVL------EGNYEGRSVAVKRLVKTHH--DVALKEIQNLIASDQHPN 431
+ + +G+ V + +K + ++ +
Sbjct: 69 VHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHM 128
Query: 432 IVRWYGVESDQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLP 490
+++Y Q+ L E + +L + I K ++ + +
Sbjct: 129 FMKFYSAHLFQNGSVLVGELYSYGTLLNAI----------NLYKNTPEKVMPQGLVI--- 175
Query: 491 VMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLIS------- 543
++ + +H+ +IH D+KP N ++
Sbjct: 176 ----------------------SFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQD 213
Query: 544 --KDKSFCAKLSDMGISKRLQGDMSCLTQNATGY---GSSGWQAPEQLLQGRQTRAIDLF 598
D S L D+G S DM + +SG+Q E L ID F
Sbjct: 214 DEDDLSAGLALIDLGQSI----DMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYF 269
Query: 599 SLGCILFFCITGGKHPYGESFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPK 658
+ ++ + G + ++ + + L ++ + F +L+
Sbjct: 270 GVAATVYCMLF-GTYMKVKNEGGECKPEGLFRRLPHLDMWN---EFFHVMLNIPDCHHLP 325
Query: 659 AQNVLNHPFF-W---TADTRLSFLRDVSDRVELEDRES 692
+ ++L ++ LR+ + LE + S
Sbjct: 326 SLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRS 363
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 3e-27
Identities = 68/310 (21%), Positives = 115/310 (37%), Gaps = 61/310 (19%)
Query: 373 RIGKLVVFNKEIAKGSNGTVVL-EGNYEGRSVAVK-----RLVKTHHDVALKEIQNLIAS 426
+ +E+ KG+ V G A K +L +E +
Sbjct: 26 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARIC-RK 84
Query: 427 DQHPNIVRWYGVESDQDFVYLSLERCTCS-LNDLIYVLSGSFEEQLNAKEQDSNLLNEVR 485
QHPNIVR + ++ F YL + T L + I V + E +
Sbjct: 85 LQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDI-VAREFYSEADASH----------- 132
Query: 486 IRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVL-ISK 544
+ I+ +++ H G++HR+LKP+N+L SK
Sbjct: 133 ----------------------------CIQQILESIAYCHSNGIVHRNLKPENLLLASK 164
Query: 545 DKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCIL 604
K KL+D G++ + D A G+ G+ +PE L + ++ +D+++ G IL
Sbjct: 165 AKGAAVKLADFGLAIEVN-DSEAWHGFA---GTPGYLSPEVLKKDPYSKPVDIWACGVIL 220
Query: 605 FFCITGGKHP--YGESFERDANIVKDRKDLFLVE---HI-PEAVDLFTRLLDPNPDLRPK 658
+ + G +P + E R +K + + PEA L +L NP R
Sbjct: 221 YILLVG--YPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRIT 278
Query: 659 AQNVLNHPFF 668
A L P+
Sbjct: 279 ADQALKVPWI 288
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 3e-27
Identities = 68/301 (22%), Positives = 114/301 (37%), Gaps = 61/301 (20%)
Query: 382 KEIAKGSNGTVVL-EGNYEGRSVAVK-----RLVKTHHDVALKEIQNLIASDQHPNIVRW 435
+E+ KG+ V G A K +L +E + QHPNIVR
Sbjct: 12 EELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARIC-RKLQHPNIVRL 70
Query: 436 YGVESDQDFVYLSLERCTCS-LNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMEN 494
+ ++ F YL + T L + I V + E +
Sbjct: 71 HDSIQEESFHYLVFDLVTGGELFEDI-VAREFYSEADASH-------------------- 109
Query: 495 TKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVL-ISKDKSFCAKLS 553
+ I+ +++ H G++HR+LKP+N+L SK K KL+
Sbjct: 110 -------------------CIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLA 150
Query: 554 DMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKH 613
D G++ + D A G+ G+ +PE L + ++ +D+++ G IL+ + G +
Sbjct: 151 DFGLAIEVN-DSEAWHGFA---GTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG--Y 204
Query: 614 P--YGESFERDANIVKDRKDLFLVE---HI-PEAVDLFTRLLDPNPDLRPKAQNVLNHPF 667
P + E R +K + + PEA L +L NP R A L P+
Sbjct: 205 PPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPW 264
Query: 668 F 668
Sbjct: 265 I 265
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 8e-27
Identities = 77/408 (18%), Positives = 134/408 (32%), Gaps = 77/408 (18%)
Query: 289 FYHSKQVKSKKQNEEHITK---TGIPKKKKSRRPGYNRNTTNSEKMQNIIPNESKVGETD 345
+HS V +K E + +P + +R + R+ + + E+K
Sbjct: 5 HHHSSGVDNKFNKERRRARREIRHLPNLNREQRRAFIRSLRDDPSQSANLLAEAKKLNDA 64
Query: 346 GLSHITGNGEKFLLTFTDLIDDRVDGRRIGKLVVFNKEIAKGSNGTVVL-EGNYEGRSVA 404
+ + D + D + + I +G + V G A
Sbjct: 65 QPKGTENLYFQSM-GPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFA 123
Query: 405 VKRLVKT-----------HHDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCT 453
VK + T + +E L HP+I+ F++L +
Sbjct: 124 VKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMR 183
Query: 454 CS-LNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLL 512
L D + + E+ +
Sbjct: 184 KGELFDYL-TEKVALSEK-ETR-------------------------------------- 203
Query: 513 KVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNA 572
+ R ++ +S LH ++HRDLKP+N+L+ + +LSD G S L+ L
Sbjct: 204 SIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQI--RLSDFGFSCHLEPG-EKLR--- 257
Query: 573 TGYGSSGWQAPEQLLQGRQTR------AIDLFSLGCILFFCITGGKHP--YGESFERDAN 624
G+ G+ APE L +DL++ G ILF + G P +
Sbjct: 258 ELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAG--SPPFWHRRQILMLR 315
Query: 625 IVKDRKDLFLVE---HI-PEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 668
++ + + F DL +RLL +P+ R A+ L HPFF
Sbjct: 316 MIMEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFF 363
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 8e-27
Identities = 59/315 (18%), Positives = 116/315 (36%), Gaps = 79/315 (25%)
Query: 378 VVFNKEIAKGSNGTVVLEGNYEGR--SVAVKRLVKTHHDVA----------LKEIQNLIA 425
+ + K+I KG G V +G VA+K L+ + +E+ + +
Sbjct: 21 IEYEKQIGKGGFGLV-HKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIM-S 78
Query: 426 SDQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLI--YVLSGSFEEQLNAKEQDSNLLNE 483
+ HPNIV+ YG+ ++ +V G + L +
Sbjct: 79 NLNHPNIVKLYGL-------------MHNPPR-MVMEFVPCGDL----------YHRLLD 114
Query: 484 VRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG--LIHRDLKPQNVL 541
+ + L++ DI G+ ++ ++HRDL+ N+
Sbjct: 115 KAHPI------------------KWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIF 156
Query: 542 IS---KDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ---TRAI 595
+ ++ CAK++D G+S++ +S L G+ W APE + + T
Sbjct: 157 LQSLDENAPVCAKVADFGLSQQSVHSVSGLL------GNFQWMAPE-TIGAEEESYTEKA 209
Query: 596 DLFSLGCILFFCITGGKHPYGE----SFERDANIVKDRKDLFLVEHIPEAV-DLFTRLLD 650
D +S IL+ +T G+ P+ E + I ++ + E P + ++
Sbjct: 210 DTYSFAMILYTILT-GEGPFDEYSYGKIKFINMIREEGLRPTIPEDCPPRLRNVIELCWS 268
Query: 651 PNPDLRPKAQNVLNH 665
+P RP ++
Sbjct: 269 GDPKKRPHFSYIVKE 283
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-26
Identities = 59/299 (19%), Positives = 115/299 (38%), Gaps = 61/299 (20%)
Query: 378 VVFNKEIAKGSNGTVVLEGNY--EGRSVAVKRLVKTHHDVA---LKEIQNLIASDQHPNI 432
++ + + KG G ++ + G + +K L++ + LKE++ ++ +HPN+
Sbjct: 12 LIHGEVLGKGCFGQA-IKVTHRETGEVMVMKELIRFDEETQRTFLKEVK-VMRCLEHPNV 69
Query: 433 VRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVM 492
+++ GV + E Y+ G+ + K DS
Sbjct: 70 LKFIGVLYKDKRLNFITE----------YIKGGTLRGII--KSMDSQY------------ 105
Query: 493 ENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKL 552
P +Q + +DI SG+++LH + +IHRDL N L+ ++ +
Sbjct: 106 --------------PWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLV--RENKNVVV 149
Query: 553 SDMGISKRLQGDMSCLTQNA-----------TGYGSSGWQAPEQLLQGRQTRAIDLFSLG 601
+D G+++ + + + T G+ W APE + +D+FS G
Sbjct: 150 ADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFG 209
Query: 602 CILFFCITGGK-HPYGESFERD-ANIVKDRKDLFLVEHIPEAV-DLFTRLLDPNPDLRP 657
+L I P D V+ D + + P + + R D +P+ RP
Sbjct: 210 IVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRP 268
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 1e-26
Identities = 62/315 (19%), Positives = 107/315 (33%), Gaps = 74/315 (23%)
Query: 380 FNKEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTH------------HDVALKEIQNLIAS 426
+ + +G + V + AVK + T + LKE+ L
Sbjct: 21 PKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKV 80
Query: 427 DQHPNIVRWYGVESDQDFVYLSLERCTCS-LNDLIYVLSGSFEEQLNAKEQDSNLLNEVR 485
HPNI++ F +L + L D + + E+ +
Sbjct: 81 SGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL-TEKVTLSEK-ETR----------- 127
Query: 486 IRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKD 545
K+ R ++ + LH++ ++HRDLKP+N+L+ D
Sbjct: 128 ---------------------------KIMRALLEVICALHKLNIVHRDLKPENILLDDD 160
Query: 546 KSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ------TRAIDLFS 599
+ KL+D G S +L L G+ + APE + + +D++S
Sbjct: 161 MNI--KLTDFGFSCQLDPG-EKLR---EVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWS 214
Query: 600 LGCILFFCITGGKHP--YGESFERDANIVKDRKDLFLVE---HI-PEAVDLFTRLLDPNP 653
G I++ + G P + ++ F DL +R L P
Sbjct: 215 TGVIMYTLLAG--SPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQP 272
Query: 654 DLRPKAQNVLNHPFF 668
R A+ L HPFF
Sbjct: 273 QKRYTAEEALAHPFF 287
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 2e-26
Identities = 52/296 (17%), Positives = 104/296 (35%), Gaps = 67/296 (22%)
Query: 378 VVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVAL-----KEIQNLIASDQHPNI 432
+ F ++ + +G + +G ++G + VK L +E L HPN+
Sbjct: 12 LNFLTKLNENHSGEL-WKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRL-RIFSHPNV 69
Query: 433 VRWYGVESDQDFVYLSL--ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLP 490
+ G + +L ++ GS L
Sbjct: 70 LPVLGACQSPPAPHPTLITH----------WMPYGS---------------------LYN 98
Query: 491 VMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH--EIGLIHRDLKPQNVLISKDKSF 548
V+ + + +Q +K D+ G++ LH E + L ++V+I D+
Sbjct: 99 VLHEGTNFVV------DQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMI--DEDM 150
Query: 549 CAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ----TRAIDLFSLGCIL 604
A++S D+ Q+ + W APE LQ + R+ D++S +L
Sbjct: 151 TARISM--------ADVKFSFQSPGRMYAPAWVAPE-ALQKKPEDTNRRSADMWSFAVLL 201
Query: 605 FFCITGGKHPYGE--SFERDANIVKDRKDLFLVEHIPEAV-DLFTRLLDPNPDLRP 657
+ +T + P+ + + E + + + I V L ++ +P RP
Sbjct: 202 WELVT-REVPFADLSNMEIGMKVALEGLRPTIPPGISPHVSKLMKICMNEDPAKRP 256
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 66/325 (20%), Positives = 121/325 (37%), Gaps = 93/325 (28%)
Query: 362 TDLIDDRVDGR-RIGKLVVFNKEIAKGSNGTVVLEGNYEG------RSVAVKRLVKTHHD 414
+ +I ++ R +I + G TV Y VA+K +
Sbjct: 2 SHMIGKIINERYKIVDK------LGGGGMSTV-----YLAEDTILNIKVAIKAI---FIP 47
Query: 415 VAL---------KEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCT-CSLNDLIYVLS 464
+E+ N + H NIV V+ + D YL +E +L++ I
Sbjct: 48 PREKEETLKRFEREVHN-SSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYI---- 102
Query: 465 GSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGH-PSAQLLKVTRDIVSGLS 523
+++G + T I+ G+
Sbjct: 103 -------------------------------------ESHGPLSVDTAINFTNQILDGIK 125
Query: 524 HLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAP 583
H H++ ++HRD+KPQN+LI +K+ K+ D GI+K L + LTQ G+ + +P
Sbjct: 126 HAHDMRIVHRDIKPQNILIDSNKT--LKIFDFGIAKALSE--TSLTQTNHVLGTVQYFSP 181
Query: 584 EQLLQGRQTRAIDLFSLGCILFFCITGGKHPY-GES--------FERDANIVKDRKDLFL 634
EQ D++S+G +L+ + G+ P+ GE+ + V +
Sbjct: 182 EQAKGEATDECTDIYSIGIVLYEMLV-GEPPFNGETAVSIAIKHIQDSVPNVTTD----V 236
Query: 635 VEHIPEAVD-LFTRLLDPNPDLRPK 658
+ IP+++ + R + + R K
Sbjct: 237 RKDIPQSLSNVILRATEKDKANRYK 261
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 2e-26
Identities = 79/331 (23%), Positives = 125/331 (37%), Gaps = 83/331 (25%)
Query: 382 KEIAKGSNGTVVLEGNYE-GRSVAVKRLVKT--------HHDVALKEIQNLIASDQHPNI 432
+ + KG G V L + +A+K L K H EIQ+ + +HPNI
Sbjct: 15 RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL---RHPNI 71
Query: 433 VRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVM 492
+R YG D VYL LE Y G + + Q + +E R
Sbjct: 72 LRLYGYFHDATRVYLILE----------YAPLG----TVYRELQKLSKFDEQRTA----- 112
Query: 493 ENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKL 552
++ + LS+ H +IHRD+KP+N+L+ + K+
Sbjct: 113 --------------------TYITELANALSYCHSKRVIHRDIKPENLLL--GSAGELKI 150
Query: 553 SDMGISKRLQGDM---SCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCIT 609
+D G S C G+ + PE + +DL+SLG + + +
Sbjct: 151 ADFGWSVHAPSSRRTDLC--------GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLV 202
Query: 610 GGKHPYGESFERDANIVKDRK----DLFLVEHI-PEAVDLFTRLLDPNPDLRPKAQNVLN 664
GK P FE + ++ + + + A DL +RLL NP RP + VL
Sbjct: 203 -GKPP----FEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 257
Query: 665 HPFFWTADTRLSFLRDVSDRVELEDRESDSK 695
HP+ + S +++ES SK
Sbjct: 258 HPW---------ITANSSKPSNCQNKESASK 279
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 5e-26
Identities = 75/329 (22%), Positives = 121/329 (36%), Gaps = 74/329 (22%)
Query: 382 KEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHHDVALKEIQN----LIASDQHPNIVRWY 436
E+ G+ G V + G +AVK++ ++ + K I ++ S P IV+ +
Sbjct: 31 GEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCF 90
Query: 437 GVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTK 496
G V++++E L + G E+
Sbjct: 91 GTFITNTDVFIAMELMGTCAEKLKKRMQGPIPER-------------------------- 124
Query: 497 DIELWKANGHPSAQLLKVTRDIVSGLSHLHEI-GLIHRDLKPQNVLISKDKSFCAKLSDM 555
L K+T IV L +L E G+IHRD+KP N+L+ + KL D
Sbjct: 125 -------------ILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQ--IKLCDF 169
Query: 556 GISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAI-----DLFSLGCILFFCITG 610
GIS RL D + G + + APE++ T+ D++SLG L T
Sbjct: 170 GISGRLVDDKAK----DRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELAT- 224
Query: 611 GKHPYGES---FERDANIVKD------RKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQN 661
G+ PY FE ++++ F + L + RPK
Sbjct: 225 GQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGF----SGDFQSFVKDCLTKDHRKRPKYNK 280
Query: 662 VLNHPFFWTADTR----LSFLRDVSDRVE 686
+L H F +T S+ +DV + E
Sbjct: 281 LLEHSFIKRYETLEVDVASWFKDVMAKTE 309
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 6e-26
Identities = 65/299 (21%), Positives = 106/299 (35%), Gaps = 67/299 (22%)
Query: 378 VVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVA-------LKEIQNLIASDQHP 430
+ + I G G V + G VAVK + +E + L A +HP
Sbjct: 9 LTLEEIIGIGGFGKV-YRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAK-LFAMLKHP 66
Query: 431 NIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLP 490
NI+ GV + + L +E + G L+ K
Sbjct: 67 NIIALRGVCLKEPNLCLVME----------FARGGPLNRVLSGKRI-------------- 102
Query: 491 VMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG---LIHRDLKPQNVLISKDKS 547
P L+ I G+++LH+ +IHRDLK N+LI +
Sbjct: 103 ----------------PPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVE 146
Query: 548 F------CAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLG 601
K++D G+++ T + G+ W APE + ++ D++S G
Sbjct: 147 NGDLSNKILKITDFGLAREWHR-----TTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYG 201
Query: 602 CILFFCITGGKHPYGE-SFERDANIVKDRKD-LFLVEHIPEAV-DLFTRLLDPNPDLRP 657
+L+ +T G+ P+ A V K L + PE L +P+P RP
Sbjct: 202 VLLWELLT-GEVPFRGIDGLAVAYGVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRP 259
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 6e-26
Identities = 81/329 (24%), Positives = 133/329 (40%), Gaps = 76/329 (23%)
Query: 380 FNKEIAKGSNGTVVL-EGNYEGRSVAVKRLVK------------THHDVALKEIQNLIAS 426
+K + G+ G V L + VA+K + K +V EI+ L
Sbjct: 14 MSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNV-ETEIEILKKL 72
Query: 427 DQHPNIVRWYGVESDQDFVYLSLERCTCS-LNDLIYVLSGSFEEQLNAKEQDSNLLNEVR 485
+ HP I++ +D Y+ LE L D + V + +E K
Sbjct: 73 N-HPCIIKIKNFFDAED-YYIVLELMEGGELFDKV-VGNKRLKEA-TCK----------- 117
Query: 486 IRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLI-SK 544
++ + +LHE G+IHRDLKP+NVL+ S+
Sbjct: 118 ---------------------------LYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQ 150
Query: 545 DKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ---TRAIDLFSLG 601
++ K++D G SK + G+ S + T G+ + APE L+ RA+D +SLG
Sbjct: 151 EEDCLIKITDFGHSK-ILGETSLMR---TLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLG 206
Query: 602 CILFFCITGGKHP--YGESFERD--ANIVKDRKDLFLVE---HI-PEAVDLFTRLLDPNP 653
ILF C++G +P + I + + F+ E + +A+DL +LL +P
Sbjct: 207 VILFICLSG--YPPFSEHRTQVSLKDQITSGKYN-FIPEVWAEVSEKALDLVKKLLVVDP 263
Query: 654 DLRPKAQNVLNHPFFWTADTRLSFLRDVS 682
R + L HP+ D + F +S
Sbjct: 264 KARFTTEEALRHPWLQDEDMKRKFQDLLS 292
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 7e-26
Identities = 67/324 (20%), Positives = 112/324 (34%), Gaps = 78/324 (24%)
Query: 381 NKEIAKGSNGTVVL-EGNYEGRSVAVKRLVK---THHDVALKEIQNLIASDQHPNIVRWY 436
+ +G++ V + AVK + K +E++ L H N++
Sbjct: 18 EDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELI 77
Query: 437 GVESDQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENT 495
++D YL E+ S+ I F E +
Sbjct: 78 EFFEEEDRFYLVFEKMRGGSILSHI-HKRRHFNELEASV--------------------- 115
Query: 496 KDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVL-ISKDKSFCAKLSD 554
V +D+ S L LH G+ HRDLKP+N+L ++ K+ D
Sbjct: 116 ------------------VVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICD 157
Query: 555 MGISKRLQGDMSCLTQNA----TGYGSSGWQAPEQLLQGRQTR-----AIDLFSLGCILF 605
+ ++ + C + T GS+ + APE + + DL+SLG IL+
Sbjct: 158 FDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILY 217
Query: 606 FCITG-----GKHPYGESFERDANIVKDRKDLFLVEHI----------------PEAVDL 644
++G G+ ++R + LF E I A DL
Sbjct: 218 ILLSGYPPFVGRCGSDCGWDRGEACPACQNMLF--ESIQEGKYEFPDKDWAHISCAAKDL 275
Query: 645 FTRLLDPNPDLRPKAQNVLNHPFF 668
++LL + R A VL HP+
Sbjct: 276 ISKLLVRDAKQRLSAAQVLQHPWV 299
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-25
Identities = 65/304 (21%), Positives = 118/304 (38%), Gaps = 66/304 (21%)
Query: 381 NKEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYGV- 438
+ + G NG V+ G+ A+K L + A +E+ + + P+IV V
Sbjct: 34 KQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP--KARQEVDHHWQASGGPHIVCILDVY 91
Query: 439 ---ESDQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMEN 494
+ + + +E L I +E+ E
Sbjct: 92 ENMHHGKRCLLIIMECMEGGELFSRI-------------QERGDQAFTE----------- 127
Query: 495 TKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVL-ISKDKSFCAKLS 553
++ +A++++ DI + + LH + HRD+KP+N+L SK+K KL+
Sbjct: 128 -RE----------AAEIMR---DIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLT 173
Query: 554 DMGISKRL-QGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGK 612
D G +K Q + T + + APE L + ++ D++SLG I++ + G
Sbjct: 174 DFGFAKETTQNALQ------TPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCG-- 225
Query: 613 HP--YGESFERDANIVKDR----KDLFLVE---HI-PEAVDLFTRLLDPNPDLRPKAQNV 662
P Y + + + +K R + F + +A L LL +P R
Sbjct: 226 FPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQF 285
Query: 663 LNHP 666
+NHP
Sbjct: 286 MNHP 289
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 66/306 (21%), Positives = 115/306 (37%), Gaps = 78/306 (25%)
Query: 382 KEIAKGSNGTVVLEGNYE-GRSVAVKRLVKT--------HHDVALKEIQNLIASDQHPNI 432
+ + KG G V L + +A+K L K+ H EIQ+ + +HPNI
Sbjct: 20 RPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHL---RHPNI 76
Query: 433 VRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVM 492
+R Y D+ +YL LE + G +L + Q +E R
Sbjct: 77 LRMYNYFHDRKRIYLMLE----------FAPRG----ELYKELQKHGRFDEQRSA----- 117
Query: 493 ENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKL 552
++ L + HE +IHRD+KP+N+L+ K+
Sbjct: 118 --------------------TFMEELADALHYCHERKVIHRDIKPENLLM--GYKGELKI 155
Query: 553 SDMGISKRLQGDM---SCLTQNATGYGSSGWQAPEQLLQGRQ-TRAIDLFSLGCILFFCI 608
+D G S C G+ + PE +++G+ +DL+ G + + +
Sbjct: 156 ADFGWSVHAPSLRRRTMC--------GTLDYLPPE-MIEGKTHDEKVDLWCAGVLCYEFL 206
Query: 609 TGGKHPYGESFERDANIVKDRK-----DLFLVEHI-PEAVDLFTRLLDPNPDLRPKAQNV 662
G P F+ + + + DL + + DL ++LL +P R + V
Sbjct: 207 V-GMPP----FD-SPSHTETHRRIVNVDLKFPPFLSDGSKDLISKLLRYHPPQRLPLKGV 260
Query: 663 LNHPFF 668
+ HP+
Sbjct: 261 MEHPWV 266
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 2e-25
Identities = 58/333 (17%), Positives = 110/333 (33%), Gaps = 89/333 (26%)
Query: 380 FNKEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVR 434
+ + +G+ V + + G A+K DV ++E + L + H NIV+
Sbjct: 13 LSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLN-HKNIVK 71
Query: 435 WYGVESDQ--DFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVM 492
+ +E + L +E + GS L + L E
Sbjct: 72 LFAIEEETTTRHKVLIME----------FCPCGSLYTVLEEPSN-AYGLPESEFL----- 115
Query: 493 ENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLI--SKDKSFCA 550
V RD+V G++HL E G++HR++KP N++ +D
Sbjct: 116 --------------------IVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVY 155
Query: 551 KLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTR---------AIDLFSLG 601
KL+D G ++ L+ D + YG+ + P+ + + R +DL+S+G
Sbjct: 156 KLTDFGAARELEDDEQF----VSLYGTEEYLHPD-MYERAVLRKDHQKKYGATVDLWSIG 210
Query: 602 CILFFCITG----------------------GKHPYGESFERDA--NIVKDRKDLFLVEH 637
+ TG GK S + A + D+ +
Sbjct: 211 VTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCS 270
Query: 638 IP-----EAVDLFTRLLDPNPDLRPKAQNVLNH 665
+ + +L+ + +
Sbjct: 271 LSRGLQVLLTPVLANILEADQEKCWGFDQFFAE 303
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 64/333 (19%), Positives = 111/333 (33%), Gaps = 83/333 (24%)
Query: 372 RRIGKLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVAL--KEIQNLIASDQH 429
R + + + + + KG G V G+++G +VAVK E+ N + +H
Sbjct: 4 RTVARDITLLECVGKGRYGEV-WRGSWQGENVAVKIFSSRDEKSWFRETELYNTVML-RH 61
Query: 430 PNIVRWYGVESDQDFVYLSLERCTCSLNDLI--YVLSGSFEEQLNAKEQDSNLLNEVRIR 487
NI+ + SD + S + LI Y GS + L D
Sbjct: 62 ENILGFIA--SDMTSRHSSTQLW------LITHYHEMGSLYDYLQLTTLD---------- 103
Query: 488 LLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE--------IGLIHRDLKPQN 539
L++ I SGL+HLH + HRDLK +N
Sbjct: 104 -------------TV-------SCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKN 143
Query: 540 VLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGY-GSSGWQAPE------QLLQGRQT 592
+L+ K+ ++D+G++ + L G+ + APE Q+
Sbjct: 144 ILVKKN--GQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSY 201
Query: 593 RAIDLFSLG---------CILFFCITGGKHPYGE------SFERDANIVKDRK------- 630
+ +D+++ G + + K P+ + SFE +V +
Sbjct: 202 KRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPN 261
Query: 631 DLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVL 663
F + L NP R A +
Sbjct: 262 RWFSDPTLTSLAKLMKECWYQNPSARLTALRIK 294
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 64/315 (20%), Positives = 112/315 (35%), Gaps = 83/315 (26%)
Query: 367 DRVDGRRIGKLVVFNKEIAKGSNGTVVLEGNYE------GRSVAVKRLVKTHHDVA---- 416
+ +G + G + + + +G G V YE R VA+K + ++
Sbjct: 26 ESREGTQFGPYRL-RRLVGRGGMGDV-----YEAEDTVRERIVALKLM---SETLSSDPV 76
Query: 417 -----LKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQL 471
+E + Q P++V + +Y+ + + +
Sbjct: 77 FRTRMQREART-AGRLQEPHVVPIHDFGEIDGQLYVDMR----------LI------NGV 119
Query: 472 NAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLI 531
+ +L + L + + + R I S L H G
Sbjct: 120 DLAA----MLRR-QGPL------------------APPRAVAIVRQIGSALDAAHAAGAT 156
Query: 532 HRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ 591
HRD+KP+N+L+S D A L D GI+ LTQ G+ + APE+ +
Sbjct: 157 HRDVKPENILVSADDF--AYLVDFGIASAT--TDEKLTQLGNTVGTLYYMAPERFSESHA 212
Query: 592 TRAIDLFSLGCILFFCITGGKHPY-GES-------FERDANIVKDRKDLFLVEHIPEAVD 643
T D+++L C+L+ C+T G PY G+ + + IP A D
Sbjct: 213 TYRADIYALTCVLYECLT-GSPPYQGDQLSVMGAHINQAIPRPST-----VRPGIPVAFD 266
Query: 644 -LFTRLLDPNPDLRP 657
+ R + NP+ R
Sbjct: 267 AVIARGMAKNPEDRY 281
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 2e-25
Identities = 69/353 (19%), Positives = 131/353 (37%), Gaps = 65/353 (18%)
Query: 379 VFNKEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYG 437
V ++ + G NG V+ A+K L A +E++ + Q P+IVR
Sbjct: 65 VTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD--CPKARREVELHWRASQCPHIVRIVD 122
Query: 438 V----ESDQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVM 492
V + + + + +E L I +++ E
Sbjct: 123 VYENLYAGRKCLLIVMECLDGGELFSRI-------------QDRGDQAFTE--------- 160
Query: 493 ENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVL-ISKDKSFCAK 551
++ +++++K I + +LH I + HRD+KP+N+L SK + K
Sbjct: 161 ---RE----------ASEIMK---SIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILK 204
Query: 552 LSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGG 611
L+D G +K S T + + APE L + ++ D++SLG I++ + G
Sbjct: 205 LTDFGFAKETTSHNSLTTP----CYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCG- 259
Query: 612 KHP--YGESFERDANIVKDR----KDLFLVE---HI-PEAVDLFTRLLDPNPDLRPKAQN 661
+P Y + +K R + F + E L LL P R
Sbjct: 260 -YPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITE 318
Query: 662 VLNHPFFWTADTRLSFLRDVSDRVELEDRESDSKLLRALEGIALVALNGKWDE 714
+NHP W + + L++ + + ++ AL + +++
Sbjct: 319 FMNHP--WIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQ 369
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 3e-25
Identities = 58/315 (18%), Positives = 114/315 (36%), Gaps = 56/315 (17%)
Query: 372 RRIGKLVVFNKEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHDVA--LKEIQNLIASDQ 428
+ + + + +++ +G G V ++ K + D KEI ++ +
Sbjct: 1 KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEIS-ILNIAR 59
Query: 429 HPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRL 488
H NI+ + + + + E ++ E++N + LNE I
Sbjct: 60 HRNILHLHESFESMEELVMIFE----------FISGLDIFERINTSAFE---LNEREIV- 105
Query: 489 LPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSF 548
+ L LH + H D++P+N++ +S
Sbjct: 106 ------------------------SYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSS 141
Query: 549 CAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCI 608
K+ + G +++L+ + + + APE + A D++SLG +++ +
Sbjct: 142 TIKIIEFGQARQLKPG----DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLL 197
Query: 609 TGGKHP-YGESFERD--ANIVKDRKDLFLVE---HI-PEAVDLFTRLLDPNPDLRPKAQN 661
+ G +P E+ + NI+ F E I EA+D RLL R A
Sbjct: 198 S-GINPFLAET-NQQIIENIMNAEYT-FDEEAFKEISIEAMDFVDRLLVKERKSRMTASE 254
Query: 662 VLNHPFFWTADTRLS 676
L HP+ R+S
Sbjct: 255 ALQHPWLKQKIERVS 269
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 5e-25
Identities = 69/327 (21%), Positives = 118/327 (36%), Gaps = 96/327 (29%)
Query: 364 LIDDRVDGR-RIGKLVVFNKEIAKGSNGTVVLEGNYEG------RSVAVKRLVKTHHDVA 416
+ R +G++ + G V + R VAVK L D+A
Sbjct: 5 TTPSHLSDRYELGEI------LGFGGMSEV-----HLARDLRDHRDVAVKVL---RADLA 50
Query: 417 L---------KEIQNLIASDQHPNIVRWYGVESDQD----FVYLSLERCT-CSLNDLIYV 462
+E QN A+ HP IV Y + Y+ +E +L D++
Sbjct: 51 RDPSFYLRFRREAQN-AAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV-- 107
Query: 463 LSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGH-PSAQLLKVTRDIVSG 521
G + ++V D
Sbjct: 108 ---------------------------------------HTEGPMTPKRAIEVIADACQA 128
Query: 522 LSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQ 581
L+ H+ G+IHRD+KP N++IS + K+ D GI++ + + +TQ A G++ +
Sbjct: 129 LNFSHQNGIIHRDVKPANIMISATNA--VKVMDFGIARAIADSGNSVTQTAAVIGTAQYL 186
Query: 582 APEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY-GES--------FERDANIVKDRKDL 632
+PEQ D++SLGC+L+ +T G+ P+ G+S D
Sbjct: 187 SPEQARGDSVDARSDVYSLGCVLYEVLT-GEPPFTGDSPVSVAYQHVREDPIPPSA---- 241
Query: 633 FLVEHIPEAVD-LFTRLLDPNPDLRPK 658
E + +D + + L NP+ R +
Sbjct: 242 -RHEGLSADLDAVVLKALAKNPENRYQ 267
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 1e-24
Identities = 76/327 (23%), Positives = 135/327 (41%), Gaps = 65/327 (19%)
Query: 382 KEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHHDVALKEIQN----LIASDQHPNIVRWY 436
EI +G+ G+V + G+ +AVKR+ T + K++ ++ S P IV++Y
Sbjct: 28 GEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFY 87
Query: 437 GVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTK 496
G + ++ +E + S + K
Sbjct: 88 GALFREGDCWICMELMSTSFDKFY-----------------------------------K 112
Query: 497 DIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG-LIHRDLKPQNVLISKDKSFCAKLSDM 555
+ + P L K+T V L+HL E +IHRD+KP N+L+ + + KL D
Sbjct: 113 YVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGN--IKLCDF 170
Query: 556 GISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ-----TRAIDLFSLGCILFFCITG 610
GIS +L ++ T++A G + APE++ R+ D++SLG L+ T
Sbjct: 171 GISGQLVDSIAK-TRDA---GCRPYMAPERIDPSASRQGYDVRS-DVWSLGITLYELAT- 224
Query: 611 GKHPYGES---FERDANIVKDR----KDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVL 663
G+ PY + F++ +VK + E P ++ L + RPK + +L
Sbjct: 225 GRFPYPKWNSVFDQLTQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELL 284
Query: 664 NHPFFWTADTR----LSFLRDVSDRVE 686
HPF + R ++ + D++
Sbjct: 285 KHPFILMYEERAVEVACYVCKILDQMP 311
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 1e-24
Identities = 72/312 (23%), Positives = 125/312 (40%), Gaps = 67/312 (21%)
Query: 382 KEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHHDVA----LKEIQNLIASDQHPNIVRWY 436
E+ +G+ G V + G+ +AVKR+ T + L ++ + + P V +Y
Sbjct: 13 MELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFY 72
Query: 437 GVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTK 496
G + V++ +E SL+ +V + + E+
Sbjct: 73 GALFREGDVWICMELMDTSLDKF---------------------YKQVIDKGQTIPED-- 109
Query: 497 DIELWKANGHPSAQLLKVTRDIVSGLSHLH-EIGLIHRDLKPQNVLISKDKSFCAKLSDM 555
L K+ IV L HLH ++ +IHRD+KP NVLI+ K+ D
Sbjct: 110 -------------ILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQ--VKMCDF 154
Query: 556 GISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ-----TRAIDLFSLGCILFFCITG 610
GIS L D++ +A G + APE++ ++ D++SLG +
Sbjct: 155 GISGYLVDDVAKDI-DA---GCKPYMAPERINPELNQKGYSVKS-DIWSLGITMIELAI- 208
Query: 611 GKHPYGES---FERDANIVKD-----RKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNV 662
+ PY F++ +V++ D F E VD ++ L N RP +
Sbjct: 209 LRFPYDSWGTPFQQLKQVVEEPSPQLPADKF----SAEFVDFTSQCLKKNSKERPTYPEL 264
Query: 663 LNHPFFWTADTR 674
+ HPFF +++
Sbjct: 265 MQHPFFTLHESK 276
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 57/326 (17%), Positives = 115/326 (35%), Gaps = 85/326 (26%)
Query: 380 FNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHD--VALKEIQNLIASDQHPNIVRWYG 437
+ A+G G V VAVK E+ +L +H NI+++ G
Sbjct: 28 LLEVKARGRFGCVWK-AQLLNEYVAVKIFPIQDKQSWQNEYEVYSLPGM-KHENILQFIG 85
Query: 438 VESDQDFVYLSLERCTCSLNDLI--YVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENT 495
+++ + ++ LI + GS + L +N+++
Sbjct: 86 --AEKRGTSVDVDLW------LITAFHEKGSLSDFLK-----ANVVS------------- 119
Query: 496 KDIELWKANGHPSAQLLKVTRDIVSGLSHLHE----------IGLIHRDLKPQNVLISKD 545
W +L + + GL++LHE + HRD+K +NVL+
Sbjct: 120 -----WN-------ELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLL--K 165
Query: 546 KSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQL-----LQGRQTRAIDLFSL 600
+ A ++D G++ + + S + G+ + APE L Q ID++++
Sbjct: 166 NNLTACIADFGLALKFEAGKSAGDTHGQ-VGTRRYMAPEVLEGAINFQRDAFLRIDMYAM 224
Query: 601 GCILFFCITG----------GKHPYGESFERDANI-------VKDRKDLFLVEHIP--EA 641
G +L+ + P+ E + ++ V +K L ++
Sbjct: 225 GLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAG 284
Query: 642 VDLFTRLL----DPNPDLRPKAQNVL 663
+ + + D + + R A V
Sbjct: 285 MAMLCETIEECWDHDAEARLSAGCVG 310
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-24
Identities = 60/332 (18%), Positives = 106/332 (31%), Gaps = 79/332 (23%)
Query: 372 RRIGKLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVAL--KEIQNLIASDQH 429
R I + +V + I KG G V G + G VAVK EI +H
Sbjct: 38 RTIARTIVLQESIGKGRFGEV-WRGKWRGEEVAVKIFSSREERSWFREAEIYQT-VMLRH 95
Query: 430 PNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLL 489
NI+ + ++ + + L + Y GS + LN
Sbjct: 96 ENILGFIAADNKDNGTWTQLWLVSD------YHEHGSLFDYLNRYTVT------------ 137
Query: 490 PVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE--------IGLIHRDLKPQNVL 541
+ ++K+ SGL+HLH + HRDLK +N+L
Sbjct: 138 -----------VE-------GMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNIL 179
Query: 542 ISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGY-GSSGWQAPE------QLLQGRQTRA 594
+ K+ ++D+G++ R + G+ + APE + +
Sbjct: 180 VKKN--GTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKR 237
Query: 595 IDLFSLGCIL----FFCITGGKH-----PYGESFERDAN-------IVKDR------KDL 632
D++++G + C GG H PY + D + + + +
Sbjct: 238 ADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRW 297
Query: 633 FLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 664
E + + N R A +
Sbjct: 298 QSCEALRVMAKIMRECWYANGAARLTALRIKK 329
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-24
Identities = 72/428 (16%), Positives = 129/428 (30%), Gaps = 70/428 (16%)
Query: 292 SKQVKSKKQNEEHITKTGIPKKKKSRRPGYNRNTTNSEKMQNIIPNESKVGETDGLSHIT 351
+K +SK ++K+ R + + N +
Sbjct: 86 NKHGQSKPCEPTAPVLIPGDERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYY- 144
Query: 352 GNGEKFLLTFTDLIDDRVDGRRIGKLVVFNKEIAKGSNGTVVL-EGNYEGRSVAVKRLVK 410
+ + D + D D ++E+ G+ G V G + A K ++
Sbjct: 145 ---PQPVEIKHDHVLDHYD---------IHEELGTGAFGVVHRVTERATGNNFAAKFVMT 192
Query: 411 TH---HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCT-CSLNDLIYVLSGS 466
H + KEIQ ++ +HP +V + D + + + E + L + +
Sbjct: 193 PHESDKETVRKEIQ-TMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK 251
Query: 467 FEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH 526
E + R + GL H+H
Sbjct: 252 MSEDEAVE---------------------------------------YMRQVCKGLCHMH 272
Query: 527 EIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQL 586
E +H DLKP+N++ + +S KL D G++ L G++ + APE
Sbjct: 273 ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK----QSVKVTTGTAEFAAPEVA 328
Query: 587 LQGRQTRAIDLFSLGCILFFCITGGKHP-YGESFERDANIVKDRKDLFLVE---HI-PEA 641
D++S+G + + ++ G P GE+ + VK I +
Sbjct: 329 EGKPVGYYTDMWSVGVLSYILLS-GLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDG 387
Query: 642 VDLFTRLLDPNPDLRPKAQNVLNHPFFWTADTRLSFLRDVSDRVELEDRESDSKLLRALE 701
D +LL +P+ R L HP W K
Sbjct: 388 KDFIRKLLLADPNTRMTIHQALEHP--WLTPGNAPGRDSQIPSSRYTKIRDSIKTKYDAW 445
Query: 702 GIALVALN 709
L L
Sbjct: 446 PEPLPPLG 453
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-24
Identities = 52/336 (15%), Positives = 112/336 (33%), Gaps = 95/336 (28%)
Query: 382 KEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALK----------------------E 419
+ + +G ++L + + A+K+ K+ + +
Sbjct: 37 RTLNQGKFNKIIL-CEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQ 95
Query: 420 IQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSN 479
I I ++ + G+ ++ D VY+ E Y+ + + ++
Sbjct: 96 IITDI---KNEYCLTCEGIITNYDEVYIIYE----------YMEND----SILKFDEYFF 138
Query: 480 LLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH-EIGLIHRDLKPQ 538
+L++ +P+ + + + +++ S++H E + HRD+KP
Sbjct: 139 VLDKNYTCFIPIQV-----------------IKCIIKSVLNSFSYIHNEKNICHRDVKPS 181
Query: 539 NVLISKDKSFCAKLSDMGISKRLQGDM---SCLTQNATGYGSSGWQAPEQLLQGRQT--- 592
N+L+ DK+ KLSD G S+ + S G+ + PE +
Sbjct: 182 NILM--DKNGRVKLSDFGESEYMVDKKIKGSR--------GTYEFMPPE-FFSNESSYNG 230
Query: 593 RAIDLFSLGCILFFCITG-------------------GKHPYGESFERDANIVKDRKDLF 633
+D++SLG L+ Y + ++K
Sbjct: 231 AKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTC 290
Query: 634 LVEHI-PEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 668
+ E +D L NP R +++ L H +
Sbjct: 291 SNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWL 326
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 73/360 (20%), Positives = 127/360 (35%), Gaps = 87/360 (24%)
Query: 372 RRIGKLVVFNKEIAKGSNGTVVLEGNYE-GRSVAVK----RLVKTHHDVALK---EIQNL 423
+ IGK ++ + +GS G V + E AVK + ++ + EIQ L
Sbjct: 2 KLIGKYLM-GDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLL 60
Query: 424 IASDQHPNIVRWYGV---ESDQDFVYLSLERCTCSLNDLI-YVLSGSFEEQLNAKEQDSN 479
H N+++ V E Q +Y+ +E C C + +++ V F
Sbjct: 61 RRLR-HKNVIQLVDVLYNEEKQK-MYMVMEYCVCGMQEMLDSVPEKRFPV---------- 108
Query: 480 LLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQN 539
+ ++ GL +LH G++H+D+KP N
Sbjct: 109 --CQAH---------------------------GYFCQLIDGLEYLHSQGIVHKDIKPGN 139
Query: 540 VLISKDKSFCAKLSDMGIS----KRLQGDM---SCLTQNATGYGSSGWQAPEQLLQGRQT 592
+L+ K+S +G++ D S GS +Q PE + G T
Sbjct: 140 LLL--TTGGTLKISALGVAEALHPFAADDTCRTSQ--------GSPAFQPPE-IANGLDT 188
Query: 593 ---RAIDLFSLGCILFFCITGGKHPYGESFERDANIVK-----DRKDLFLVEHI-PEAVD 643
+D++S G L+ T G +P FE NI K + + P D
Sbjct: 189 FSGFKVDIWSAGVTLYNITT-GLYP----FE-GDNIYKLFENIGKGSYAIPGDCGPPLSD 242
Query: 644 LFTRLLDPNPDLRPKAQNVLNHPFFWTADTRLSFLRDVSDRVELEDRESDSKLLRALEGI 703
L +L+ P R + + H +F + + +DR ++ LE +
Sbjct: 243 LLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPAEAPVPIPPSPDTKDRWRSMTVVPYLEDL 302
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 3e-24
Identities = 72/332 (21%), Positives = 113/332 (34%), Gaps = 81/332 (24%)
Query: 372 RRIGKLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKE--IQNLIASDQH 429
R I K + K+I KG G V G + G VAVK T +E I + +H
Sbjct: 33 RTIAKQIQMVKQIGKGRYGEV-WMGKWRGEKVAVKVFFTTEEASWFRETEIYQTVLM-RH 90
Query: 430 PNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLL 489
NI+ + + + L T Y +GS + L + D
Sbjct: 91 ENILGFIAADIKGTGSWTQLYLITD------YHENGSLYDYLKSTTLD------------ 132
Query: 490 PVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE--------IGLIHRDLKPQNVL 541
K +LK+ VSGL HLH + HRDLK +N+L
Sbjct: 133 -----------AK-------SMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNIL 174
Query: 542 ISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGY-GSSGWQAPEQLLQGRQ-------TR 593
+ K+ ++D+G++ + D + + G+ + PE +L
Sbjct: 175 VKKN--GTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPE-VLDESLNRNHFQSYI 231
Query: 594 AIDLFSLG---------CILFFCITGGKHPYGE------SFERDANIVKDRK-------D 631
D++S G C+ + + PY + S+E IV +K
Sbjct: 232 MADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNR 291
Query: 632 LFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVL 663
E + + L T NP R A V
Sbjct: 292 WSSDECLRQMGKLMTECWAHNPASRLTALRVK 323
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 4e-24
Identities = 70/308 (22%), Positives = 103/308 (33%), Gaps = 78/308 (25%)
Query: 382 KEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHHDVALK---------EIQNLI---ASDQ 428
+ KG GTV VA+K + + E+ L A
Sbjct: 37 PLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGG 96
Query: 429 HPNIVRWYGVESDQDFVYLSLER-CTCS-LNDLIYVLSGSFEEQLNAKEQDSNLLNEVRI 486
HP ++R Q+ L LER L D I G E R
Sbjct: 97 HPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYI-TEKGPLGE------------GPSR- 142
Query: 487 RLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDK 546
+V+ + H H G++HRD+K +N+LI +
Sbjct: 143 --------------------------CFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRR 176
Query: 547 SFCAKLSDMGISKRLQGDM---SCLTQNATGYGSSGWQAPEQLLQGRQ--TRAIDLFSLG 601
CAKL D G L + G+ + PE + Q ++SLG
Sbjct: 177 -GCAKLIDFGSGALLHDEPYTDFD--------GTRVYSPPE-WISRHQYHALPATVWSLG 226
Query: 602 CILFFCITGGKHPYGESFERDANIVKDRKDLFLVEHI-PEAVDLFTRLLDPNPDLRPKAQ 660
+L+ + G P FERD I+ +L H+ P+ L R L P P RP +
Sbjct: 227 ILLYDMVC-GDIP----FERDQEIL--EAELHFPAHVSPDCCALIRRCLAPKPSSRPSLE 279
Query: 661 NVLNHPFF 668
+L P+
Sbjct: 280 EILLDPWM 287
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 5e-24
Identities = 59/300 (19%), Positives = 108/300 (36%), Gaps = 61/300 (20%)
Query: 380 FNKEIAKGSNGTVVL-EGNYEGRSVAVK----RLVKTHHDVALKEIQNLIASDQHPNIVR 434
+E+ G+ G V GR K + V EI ++ HP ++
Sbjct: 55 ILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTV-KNEIS-IMNQLHHPKLIN 112
Query: 435 WYGVESDQDFVYLSLERCTCS-LNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVME 493
+ D+ + L LE + L D I + ++E +
Sbjct: 113 LHDAFEDKYEMVLILEFLSGGELFDRIA--------------AEDYKMSEAEVINY---- 154
Query: 494 NTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLS 553
R GL H+HE ++H D+KP+N++ K+ K+
Sbjct: 155 ---------------------MRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKII 193
Query: 554 DMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKH 613
D G++ +L D ++ + APE + + D++++G + + ++ G
Sbjct: 194 DFGLATKLNPD----EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLS-GLS 248
Query: 614 P-YGESFERD--ANIVKDRKDLFLVE---HI-PEAVDLFTRLLDPNPDLRPKAQNVLNHP 666
P GE + + N+ + + F + + PEA D LL P R + L HP
Sbjct: 249 PFAGED-DLETLQNVKRCDWE-FDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHP 306
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 5e-24
Identities = 73/347 (21%), Positives = 126/347 (36%), Gaps = 96/347 (27%)
Query: 365 IDDRVDGRRIGKLVVFNKEIAKGSNGTVVLEGNYE-GRSVAVK-----RLVKTHHDVALK 418
D ++ + + EI KGS G V L N A+K +L++
Sbjct: 3 SGSSGDCVQLNQYTL-KDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRP 61
Query: 419 EIQNLIASDQ-----------------------HPNIVRWYGV--ESDQDFVYLSLERCT 453
+ + HPN+V+ V + ++D +Y+ E
Sbjct: 62 PPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFE--- 118
Query: 454 CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLK 513
V G PVM ++ Q
Sbjct: 119 -------LVNQG------------------------PVM----EVP--TLKPLSEDQARF 141
Query: 514 VTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNAT 573
+D++ G+ +LH +IHRD+KP N+L+ +D K++D G+S +G + L +
Sbjct: 142 YFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDG--HIKIADFGVSNEFKGSDALL---SN 196
Query: 574 GYGSSGWQAPEQLLQGRQT----RAIDLFSLGCILFFCITGGKHPYGESFERDANIV--- 626
G+ + APE L + +A+D++++G L +C G+ P F D I+
Sbjct: 197 TVGTPAFMAPE-SLSETRKIFSGKALDVWAMGVTL-YCFVFGQCP----FM-DERIMCLH 249
Query: 627 -KDRKDLFLVEHI----PEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 668
K + + DL TR+LD NP+ R + HP+
Sbjct: 250 SKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWV 296
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 6e-24
Identities = 61/306 (19%), Positives = 102/306 (33%), Gaps = 76/306 (24%)
Query: 382 KEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHHDVALK---------EIQNL-IASDQHP 430
+ G G+V VA+K + K + E+ L S
Sbjct: 49 PLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 108
Query: 431 NIVRWYGVESDQDFVYLSLERCTCS--LNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRL 488
++R D L LER L D I G+ +E R
Sbjct: 109 GVIRLLDWFERPDSFVLILERPEPVQDLFDFI-TERGALQE------------ELAR--- 152
Query: 489 LPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSF 548
++ + H H G++HRD+K +N+LI ++
Sbjct: 153 ------------------------SFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNR-G 187
Query: 549 CAKLSDMGISKRLQGDM---SCLTQNATGYGSSGWQAPEQLLQGRQ--TRAIDLFSLGCI 603
KL D G L+ + G+ + PE ++ + R+ ++SLG +
Sbjct: 188 ELKLIDFGSGALLKDTVYTDFD--------GTRVYSPPE-WIRYHRYHGRSAAVWSLGIL 238
Query: 604 LFFCITGGKHPYGESFERDANIVKDRKDLFLVEHI-PEAVDLFTRLLDPNPDLRPKAQNV 662
L+ + G P FE D I++ +F + + E L L P RP + +
Sbjct: 239 LYDMVC-GDIP----FEHDEEIIRG--QVFFRQRVSSECQHLIRWCLALRPSDRPTFEEI 291
Query: 663 LNHPFF 668
NHP+
Sbjct: 292 QNHPWM 297
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 8e-24
Identities = 74/309 (23%), Positives = 127/309 (41%), Gaps = 70/309 (22%)
Query: 380 FNKEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHDVALKEIQ------NLIASDQHPNI 432
F K + +GS TVVL R A+K L K H + ++ ++++ HP
Sbjct: 34 FGKILGEGSFSTVVLARELATSREYAIKILEK-RHIIKENKVPYVTRERDVMSRLDHPFF 92
Query: 433 VRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVM 492
V+ Y D + +Y L Y +G + + + +E R
Sbjct: 93 VKLYFTFQDDEKLYFGLS----------YAKNGELLKYI----RKIGSFDETCTRFY--- 135
Query: 493 ENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKL 552
+A+ IVS L +LH G+IHRDLKP+N+L+ ++ ++
Sbjct: 136 ---------------TAE-------IVSALEYLHGKGIIHRDLKPENILL--NEDMHIQI 171
Query: 553 SDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGK 612
+D G +K L + N + G++ + +PE L + ++ DL++LGCI++ + G
Sbjct: 172 TDFGTAKVLSPESKQARAN-SFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG-- 228
Query: 613 HP--YGES----FERDANIVKDRKDLFLVEHI-PEAVDLFTRLLDPNPDLRP------KA 659
P + F+ I+K + E P+A DL +LL + R
Sbjct: 229 LPPFRAGNEYLIFQ---KIIKL--EYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY 283
Query: 660 QNVLNHPFF 668
+ HPFF
Sbjct: 284 GPLKAHPFF 292
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 1e-23
Identities = 67/322 (20%), Positives = 120/322 (37%), Gaps = 66/322 (20%)
Query: 379 VFNKEIAKGSNGTVVL-EGNYEGRSVAVK-----RLVKTHHDVALKEIQNLIASDQHPNI 432
+ +KE+ +G V G+ A K R + L EI L + P +
Sbjct: 32 LTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRV 91
Query: 433 VRWYGVESDQDFVYLSLERCTCS-LNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPV 491
+ + V + + L LE + L + + +++E +
Sbjct: 92 INLHEVYENTSEIILILEYAAGGEIFSLCL-------------PELAEMVSENDVI---- 134
Query: 492 MENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVL-ISKDKSFCA 550
++ + I+ G+ +LH+ ++H DLKPQN+L S
Sbjct: 135 ---------------------RLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDI 173
Query: 551 KLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG 610
K+ D G+S+++ L + G+ + APE L T A D++++G I + +T
Sbjct: 174 KIVDFGMSRKIGHA-CELREIM---GTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTH 229
Query: 611 GKHP--YGES----FERDANIVKDRKDLFLVE---HI-PEAVDLFTRLLDPNPDLRPKAQ 660
GE + NI + D + E + A D LL NP+ RP A+
Sbjct: 230 --TSPFVGEDNQETYL---NISQVNVD-YSEETFSSVSQLATDFIQSLLVKNPEKRPTAE 283
Query: 661 NVLNHPFFWTADTRLSFLRDVS 682
L+H + D F + +
Sbjct: 284 ICLSHSWLQQWDFENLFHPEET 305
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 1e-23
Identities = 70/365 (19%), Positives = 131/365 (35%), Gaps = 73/365 (20%)
Query: 382 KEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYGV-- 438
K + GS G V + E G+ A+K+ V +E+ ++ H NI++
Sbjct: 13 KTLGTGSFGIVCEVFDIESGKRFALKK-VLQDPRYKNRELD-IMKVLDHVNIIKLVDYFY 70
Query: 439 ESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENT--K 496
+ + + + + + + LN + + + +T K
Sbjct: 71 TTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVI----MEYVPDTLHK 126
Query: 497 DIELWKANGHP---------SAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKS 547
++ + +G QL + + +H +G+ HRD+KPQN+L+ +
Sbjct: 127 VLKSFIRSGRSIPMNLISIYIYQLFR-------AVGFIHSLGICHRDIKPQNLLV--NSK 177
Query: 548 FCA-KLSDMGISKRLQGDMSCLTQNATGYGSSGW-QAPEQLLQGRQ-TRAIDLFSLGCIL 604
KL D G +K+L + + Y S + +APE +L + T +IDL+S+GC+
Sbjct: 178 DNTLKLCDFGSAKKLIPS-----EPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVF 232
Query: 605 FFCITG-----GKH--------------PYGESFERDANIVKDRK----------DLFLV 635
I G G+ P E R + + +
Sbjct: 233 GELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPE 292
Query: 636 EHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTADTRLSFLRDVSDRVELEDRESDSK 695
A+DL ++L PDLR + HPFF LR+ + +
Sbjct: 293 GTPSLAIDLLEQILRYEPDLRINPYEAMAHPFF-------DHLRNSYESEVKNNSNFPHG 345
Query: 696 LLRAL 700
+ + +
Sbjct: 346 VNQNI 350
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 64/348 (18%), Positives = 118/348 (33%), Gaps = 68/348 (19%)
Query: 380 FNKEIAKGSNGTVVL-EGNYEGRSVAVK-----RLVKTHHDVALKEIQNLIA---SDQHP 430
+E+ G V G A K + + V+ +EI+ ++ H
Sbjct: 16 IGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHH 75
Query: 431 NIVRWYGVESDQDFVYLSLERCTCS-LNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLL 489
N++ + V ++ V L LE + L D + S E+ E
Sbjct: 76 NVITLHDVYENRTDVVLILELVSGGELFDFL-AQKESLSEE------------EAT---- 118
Query: 490 PVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLI-SKDKSF 548
+ I+ G+++LH + H DLKP+N+++ K+
Sbjct: 119 -----------------------SFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPI 155
Query: 549 CA-KLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFC 607
KL D G++ ++ +G+ + APE + D++S+G I +
Sbjct: 156 PHIKLIDFGLAHEIEDG-VEFKNI---FGTPEFVAPEIVNYEPLGLEADMWSIGVITYIL 211
Query: 608 ITGGKHP--YGESFERD-ANIVKDRKDLFLVE---HI-PEAVDLFTRLLDPNPDLRPKAQ 660
++G G++ + ANI D F E H A D +LL R Q
Sbjct: 212 LSG--ASPFLGDTKQETLANITSVSYD-FDEEFFSHTSELAKDFIRKLLVKETRKRLTIQ 268
Query: 661 NVLNHPFF--WTADTRLSFLRDVSDRVELEDRESDSKLLRALEGIALV 706
L HP+ + V + + + + ++L
Sbjct: 269 EALRHPWITPVDNQQAMVRRESVVNLENFRKQYVRRRWKLSFSIVSLC 316
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 62/311 (19%), Positives = 110/311 (35%), Gaps = 64/311 (20%)
Query: 382 KEIAKGSNGTVVL-EGNYEGRSVAVK-----RLVKTHHDVALKEIQNLIA---SDQHPNI 432
+E+ G V G+ A K RL + V+ +EI+ + +HPNI
Sbjct: 11 EELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNI 70
Query: 433 VRWYGVESDQDFVYLSLERCTCS-LNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPV 491
+ + + ++ V L LE + L D + S E E
Sbjct: 71 ITLHDIFENKTDVVLILELVSGGELFDFL-AEKESLTED------------EAT------ 111
Query: 492 MENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLIS--KDKSFC 549
+ + I+ G+ +LH + H DLKP+N+++ +
Sbjct: 112 ---------------------QFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPR 150
Query: 550 AKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCIT 609
KL D GI+ +++ + +G+ + APE + D++S+G I + ++
Sbjct: 151 IKLIDFGIAHKIEAG-NEFK---NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLS 206
Query: 610 GGKHP--YGESFERDANIVKDRKDLFLVEHIP----EAVDLFTRLLDPNPDLRPKAQNVL 663
G GE+ + + F E+ A D RLL +P R L
Sbjct: 207 G--ASPFLGETKQETLTNISAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSL 264
Query: 664 NHPFFWTADTR 674
H + R
Sbjct: 265 EHSWIKAIRRR 275
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 65/296 (21%), Positives = 104/296 (35%), Gaps = 63/296 (21%)
Query: 378 VVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVA-----LKEIQNLIASDQHPNI 432
+ + I GS GTV +G + G VAVK L T E+ L +H NI
Sbjct: 26 ITVGQRIGSGSFGTV-YKGKWHGD-VAVKMLNVTAPTPQQLQAFKNEVGVL-RKTRHVNI 82
Query: 433 VRWYGVESDQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPV 491
+ + G S + + + C SL ++ FE +
Sbjct: 83 LLFMGY-STAPQLAIVTQWCEGSSLYHHLHASETKFEMK--------------------- 120
Query: 492 MENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAK 551
+L+ + R G+ +LH +IHRDLK N+ + + K
Sbjct: 121 ------------------KLIDIARQTARGMDYLHAKSIIHRDLKSNNIFL--HEDNTVK 160
Query: 552 LSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ---TRAIDLFSLGCILFFCI 608
+ D G++ + S Q GS W APE + + D+++ G +L+ +
Sbjct: 161 IGDFGLA-TEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELM 219
Query: 609 TGGKHPYGESFERDANIV----KDRKDLFLV--EHIPEAV-DLFTRLLDPNPDLRP 657
T G+ PY RD I + P+ + L L D RP
Sbjct: 220 T-GQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERP 274
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 3e-23
Identities = 73/305 (23%), Positives = 122/305 (40%), Gaps = 75/305 (24%)
Query: 382 KEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHHDVA-----LKEIQNLIASDQHPNIVRW 435
K I KG+ V L + GR VA+K + KT + +E++ + HPNIV+
Sbjct: 21 KTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIM-KILNHPNIVKL 79
Query: 436 YGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENT 495
+ V + +YL +E Y G + L A + + E R
Sbjct: 80 FEVIETEKTLYLIME----------YASGGEVFDYLVAHGR----MKEKEAR-------- 117
Query: 496 KDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDM 555
R IVS + + H+ ++HRDLK +N+L+ D K++D
Sbjct: 118 -----------------SKFRQIVSAVQYCHQKRIVHRDLKAENLLL--DADMNIKIADF 158
Query: 556 GISKRLQGDM----SCLTQNATGYGSSGWQAPEQLLQGRQ--TRAIDLFSLGCILFFCIT 609
G S C G+ + APE L QG++ +D++SLG IL+ ++
Sbjct: 159 GFSNEFTVGGKLDAFC--------GAPPYAAPE-LFQGKKYDGPEVDVWSLGVILYTLVS 209
Query: 610 GGKHPYGESFERDANIVKDRKDLFLVE-HIP-----EAVDLFTRLLDPNPDLRPKAQNVL 663
G P F+ N+ + R+ + + IP + +L R L NP R + ++
Sbjct: 210 -GSLP----FD-GQNLKELRERVLRGKYRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIM 263
Query: 664 NHPFF 668
+
Sbjct: 264 KDRWI 268
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 4e-23
Identities = 78/356 (21%), Positives = 125/356 (35%), Gaps = 117/356 (32%)
Query: 382 KEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVR----WY 436
K I GS G V + G VA+K+ V +E+Q ++ H NIVR +Y
Sbjct: 60 KVIGNGSFGVVYQAKLCDSGELVAIKK-VLQDKRFKNRELQ-IMRKLDHCNIVRLRYFFY 117
Query: 437 GVESDQDFVYLSL--ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMEN 494
+D VYL+L + ++ + S + L + ++L
Sbjct: 118 SSGEKKDEVYLNLVLDYVPETVYRVARHYSRA-----------KQTLPVIYVKLY----- 161
Query: 495 TKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSD 554
QL + L+++H G+ HRD+KPQN+L+ D + KL D
Sbjct: 162 -------------MYQLFR-------SLAYIHSFGICHRDIKPQNLLLDPDTAVL-KLCD 200
Query: 555 MGISKRLQGDMSCLTQNATGYGSSGW-QAPEQLLQGRQ-TRAIDLFSLGCI--------- 603
G +K+L + Y S + +APE + T +ID++S GC+
Sbjct: 201 FGSAKQLVRG-----EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQP 255
Query: 604 LF------------FCITG----------------------GKHPYGESFERDANIVKDR 629
+F + G HP+ + F
Sbjct: 256 IFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTP----- 310
Query: 630 KDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTADTRLSFLRDVSDRV 685
PEA+ L +RLL+ P R H FF LRD + ++
Sbjct: 311 ---------PEAIALCSRLLEYTPTARLTPLEACAHSFF-------DELRDPNVKL 350
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 5e-23
Identities = 62/346 (17%), Positives = 115/346 (33%), Gaps = 64/346 (18%)
Query: 380 FNKEIAKGSNGTVVL-EGNYEGRSVAVK-----RLVKTHHDVALKEIQNLIA---SDQHP 430
+E+ G V G A K + + V +EI+ ++ HP
Sbjct: 16 IGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHP 75
Query: 431 NIVRWYGVESDQDFVYLSLERCTCS-LNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLL 489
NI+ + V ++ V L LE + L D + S E+ E
Sbjct: 76 NIITLHDVYENRTDVVLILELVSGGELFDFL-AQKESLSEE------------EAT---- 118
Query: 490 PVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVL-ISKDKSF 548
+ I+ G+++LH + H DLKP+N++ + K+
Sbjct: 119 -----------------------SFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPI 155
Query: 549 CA-KLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFC 607
KL D G++ ++ G+ + APE + D++S+G I +
Sbjct: 156 PHIKLIDFGLAHEIEDG-VEFKNIF---GTPEFVAPEIVNYEPLGLEADMWSIGVITYIL 211
Query: 608 ITGGKHP-YGESFERDANIVKDRKDLFLVE---HI-PEAVDLFTRLLDPNPDLRPKAQNV 662
++ G P G++ + + F E A D +LL R Q
Sbjct: 212 LS-GASPFLGDTKQETLANITAVSYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEA 270
Query: 663 LNHPFF--WTADTRLSFLRDVSDRVELEDRESDSKLLRALEGIALV 706
L HP+ + V + + + + + ++L
Sbjct: 271 LRHPWITPVDTQQAMVRRESVVNLENFKKQYVRRRWKLSFSIVSLC 316
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 6e-23
Identities = 66/319 (20%), Positives = 113/319 (35%), Gaps = 75/319 (23%)
Query: 368 RVDGRRIGKLVVFNKEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTH-------HDVALK- 418
+G K + G+ G V + E + V VK + K D L
Sbjct: 17 ACEGEYSQKYSTM-SPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGK 75
Query: 419 ---EIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCS---LNDLIYVLSGSFEEQLN 472
EI L + +H NI++ + +Q F L +E+ S L I +E
Sbjct: 76 VTLEIAIL-SRVEHANIIKVLDIFENQGFFQLVMEKH-GSGLDLFAFI-DRHPRLDE--- 129
Query: 473 AKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIH 532
+ R +VS + +L +IH
Sbjct: 130 ---------PLAS---------------------------YIFRQLVSAVGYLRLKDIIH 153
Query: 533 RDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQT 592
RD+K +N++I + F KL D G + L+ T G+ + APE +L G
Sbjct: 154 RDIKDENIVI--AEDFTIKLIDFGSAAYLERG-KLFY---TFCGTIEYCAPE-VLMGNPY 206
Query: 593 R--AIDLFSLGCILFFCITGGKHPYGESFERDANIVKDRKDLFLVEHI-PEAVDLFTRLL 649
R ++++SLG L+ + ++P F V + + E + L + LL
Sbjct: 207 RGPELEMWSLGVTLYTLVF-EENP----FCELEETV--EAAIHPPYLVSKELMSLVSGLL 259
Query: 650 DPNPDLRPKAQNVLNHPFF 668
P P+ R + ++ P+
Sbjct: 260 QPVPERRTTLEKLVTDPWV 278
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 9e-23
Identities = 77/339 (22%), Positives = 129/339 (38%), Gaps = 75/339 (22%)
Query: 382 KEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHHDVA---LKEIQNLIASDQHPNIVRWYG 437
K + G NG V + + + VA+K++V T L+EI+ +I H NIV+ +
Sbjct: 17 KPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIK-IIRRLDHDNIVKVFE 75
Query: 438 VESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKD 497
+ LN +Y++ E L + L E RL
Sbjct: 76 ILGPSGSQLTDDVGSLTELNS-VYIVQEYMETDLANVLE-QGPLLEEHARLF-------- 125
Query: 498 IELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCA-KLSDMG 556
++ QLL+ GL ++H ++HRDLKP N+ I + K+ D G
Sbjct: 126 --MY--------QLLR-------GLKYIHSANVLHRDLKPANLFI--NTEDLVLKIGDFG 166
Query: 557 ISKRLQGDMSCLTQNATGYGSSGW-QAPEQLLQGRQ-TRAIDLFSLGCILFFCITG---- 610
++ R+ + + + W ++P LL T+AID+++ GCI +TG
Sbjct: 167 LA-RIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLF 225
Query: 611 -GKH--------------PYGESFERDANIVKD---------RKDL--FLVEHIPEAVDL 644
G H + E + +++ K L L EAVD
Sbjct: 226 AGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDF 285
Query: 645 FTRLLDPNPDLRPKAQNVLNHPFFWTADTRLSFLRDVSD 683
++L +P R A+ L+HP+ +S D
Sbjct: 286 LEQILTFSPMDRLTAEEALSHPY-------MSIYSFPMD 317
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 1e-22
Identities = 60/307 (19%), Positives = 114/307 (37%), Gaps = 68/307 (22%)
Query: 380 FNKEIAKGSNGTVVL-EGNYEGRSVAVK-----RLVKTHHDVALKEIQNLIA---SDQHP 430
+E+ G V G A K R + V+ ++I+ ++ QHP
Sbjct: 15 TGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHP 74
Query: 431 NIVRWYGVESDQDFVYLSLERCTCS-LNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLL 489
N++ + V ++ V L LE L D + S E
Sbjct: 75 NVITLHEVYENKTDVILILELVAGGELFDFL-AEKESLTE-------------------- 113
Query: 490 PVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLIS--KDKS 547
++ + + I++G+ +LH + + H DLKP+N+++
Sbjct: 114 ------EEA-------------TEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPK 154
Query: 548 FCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFC 607
K+ D G++ ++ + G+ + APE + D++S+G I +
Sbjct: 155 PRIKIIDFGLAHKIDFG-NEFKNIF---GTPEFVAPEIVNYEPLGLEADMWSIGVITYIL 210
Query: 608 ITGGKHP--YGESFERD--ANIVKDRKDLFLVEHIP----EAVDLFTRLLDPNPDLRPKA 659
++G G++ +++ AN+ + F E+ A D RLL +P R
Sbjct: 211 LSG--ASPFLGDT-KQETLANVSAVNYE-FEDEYFSNTSALAKDFIRRLLVKDPKKRMTI 266
Query: 660 QNVLNHP 666
Q+ L HP
Sbjct: 267 QDSLQHP 273
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 2e-22
Identities = 47/301 (15%), Positives = 98/301 (32%), Gaps = 68/301 (22%)
Query: 378 VVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVA-----LKEIQNLIASDQHPNI 432
+ + I KG G V G + G VA++ + + +E+ +H N+
Sbjct: 35 LEIGELIGKGRFGQV-YHGRWHGE-VAIRLIDIERDNEDQLKAFKREVMAY-RQTRHENV 91
Query: 433 VRWYGVESDQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPV 491
V + G + + C +L ++ +
Sbjct: 92 VLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVN--------------------- 130
Query: 492 MENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAK 551
+ ++ ++IV G+ +LH G++H+DLK +NV K
Sbjct: 131 ------------------KTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYDNGK---VV 169
Query: 552 LSDMGIS--KRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ----------TRAIDLFS 599
++D G+ + + G APE +++ ++ D+F+
Sbjct: 170 ITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPE-IIRQLSPDTEEDKLPFSKHSDVFA 228
Query: 600 LGCILFFCITGGKHPY-GESFERDANIV--KDRKDLFLVEHIPEAVDLFTRLLDPNPDLR 656
LG I + + P+ + E + + +L + E D+ + R
Sbjct: 229 LGTIWYELHA-REWPFKTQPAEAIIWQMGTGMKPNLSQIGMGKEISDILLFCWAFEQEER 287
Query: 657 P 657
P
Sbjct: 288 P 288
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 3e-22
Identities = 74/334 (22%), Positives = 140/334 (41%), Gaps = 80/334 (23%)
Query: 382 KEIAKGSNGTVVLEGNYE-GRSVAVKRL-VKTHHDVALKEIQNLIASDQHPNIVRWYGVE 439
+++ +GS G+V + E G+ VA+K++ V++ +KEI + D P++V++YG
Sbjct: 35 EKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCD-SPHVVKYYGSY 93
Query: 440 SDQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDI 498
+++ +E C S++D+I + + + E
Sbjct: 94 FKNTDLWIVMEYCGAGSVSDIIRLRNKTLTED---------------------------- 125
Query: 499 ELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGIS 558
++ + + + GL +LH + IHRD+K N+L++ + AKL+D G++
Sbjct: 126 -----------EIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGH--AKLADFGVA 172
Query: 559 KRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG-----GKH 613
+L M+ + T G+ W APE + + D++SLG IT GK
Sbjct: 173 GQLTDTMA---KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLG------ITAIEMAEGKP 223
Query: 614 PYGESFERDANIVKDRKDLFLVEHIP------------EAVDLFTRLLDPNPDLRPKAQN 661
PY + + + +F++ P D + L +P+ R A
Sbjct: 224 PYAD--------IHPMRAIFMIPTNPPPTFRKPELWSDNFTDFVKQCLVKSPEQRATATQ 275
Query: 662 VLNHPFFWTADTRLSFLRDVSDRVELEDRESDSK 695
+L HPF +A +S LRD+ + +
Sbjct: 276 LLQHPFVRSAKG-VSILRDLINEAMDVKLKRQES 308
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 5e-22
Identities = 74/312 (23%), Positives = 108/312 (34%), Gaps = 91/312 (29%)
Query: 400 GRSVAVKRLVKTHHDV------ALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCT 453
VA+KR V+ D AL+EI L+ +H NIVR + V + L E C
Sbjct: 27 HEIVALKR-VRLDDDDEGVPSSALREI-CLLKELKHKNIVRLHDVLHSDKKLTLVFEFCD 84
Query: 454 CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLK 513
L +G + V+ L QLLK
Sbjct: 85 QDLKKYFDSCNGDLDP------------EIVKSFLF--------------------QLLK 112
Query: 514 VTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQN-A 572
GL H ++HRDLKPQN+LI+++ KL++ G+++ + C +
Sbjct: 113 -------GLGFCHSRNVLHRDLKPQNLLINRNG--ELKLANFGLARAFGIPVRCYSAEVV 163
Query: 573 TGYGSSGW-QAPEQLLQGRQ-TRAIDLFSLGCILFFCITGGKHPY--GESFERD------ 622
T W + P+ L + + +ID++S GCI G+ P G D
Sbjct: 164 T-----LWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGR-PLFPGND-VDDQLKRIF 216
Query: 623 --------------------ANIVKDRKDLFLVEHIP----EAVDLFTRLLDPNPDLRPK 658
LV +P DL LL NP R
Sbjct: 217 RLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRIS 276
Query: 659 AQNVLNHPFFWT 670
A+ L HP+F
Sbjct: 277 AEEALQHPYFSD 288
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 5e-22
Identities = 77/324 (23%), Positives = 119/324 (36%), Gaps = 81/324 (25%)
Query: 382 KEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYGV--- 438
K I GS G V E VA+K+ V +E+Q ++ +HPN+V
Sbjct: 46 KVIGNGSFGVVFQAKLVESDEVAIKK-VLQDKRFKNRELQ-IMRIVKHPNVVDLKAFFYS 103
Query: 439 ---ESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENT 495
+ D+ F+ L LE ++ + + + + I+L
Sbjct: 104 NGDKKDEVFLNLVLEYVPETVYRASRHYA-----------KLKQTMPMLLIKLY------ 146
Query: 496 KDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDM 555
QLL+ L+++H IG+ HRD+KPQN+L+ KL D
Sbjct: 147 ------------MYQLLR-------SLAYIHSIGICHRDIKPQNLLLDPPSGVL-KLIDF 186
Query: 556 GISKRLQGDMSCLTQNATGYGSSGW-QAPEQLLQGRQ-TRAIDLFSLGCIL--------F 605
G +K L + Y S + +APE + T ID++S GC++
Sbjct: 187 GSAKILIAG-----EPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPL 241
Query: 606 FCITGGKH-----------PYGESFERDANIVKDRK----------DLFLVEHIPEAVDL 644
F G P E + + K +F P+A+DL
Sbjct: 242 FPGESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDL 301
Query: 645 FTRLLDPNPDLRPKAQNVLNHPFF 668
+RLL+ P R A L HPFF
Sbjct: 302 ISRLLEYTPSARLTAIEALCHPFF 325
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 5e-22
Identities = 66/327 (20%), Positives = 124/327 (37%), Gaps = 84/327 (25%)
Query: 400 GRSVAVKRLVKTHHD-----VALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTC 454
GR VA+K+ +++ D +A++EI L+ +H N+V V + YL E
Sbjct: 50 GRIVAIKKFLESDDDKMVKKIAMREI-KLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDH 108
Query: 455 SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKV 514
++ D + E N L+ ++ L+ Q++
Sbjct: 109 TILDDL--------------ELFPNGLDYQVVQKY----------LF--------QIIN- 135
Query: 515 TRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATG 574
G+ H +IHRD+KP+N+L+S+ KL D G ++ L
Sbjct: 136 ------GIGFCHSHNIIHRDIKPENILVSQSGVV--KLCDFGFARTLAAPGEVYDD---- 183
Query: 575 YGSSGW-QAPEQLLQGRQ-TRAIDLFSLGCI---------LF---------FCI------ 608
++ W +APE L+ + +A+D++++GC+ LF + I
Sbjct: 184 EVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGN 243
Query: 609 -TGGKHPYGESFE--RDANIVKDRKDLFLVEHIP----EAVDLFTRLLDPNPDLRPKAQN 661
+ + ++ L P +DL + L +PD RP
Sbjct: 244 LIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAE 303
Query: 662 VLNHPFFWTADTRLSFLRDVSDRVELE 688
+L+H FF F +++ +V+ +
Sbjct: 304 LLHHDFFQMDGFAERFSQELQLKVQKD 330
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 7e-22
Identities = 70/350 (20%), Positives = 122/350 (34%), Gaps = 88/350 (25%)
Query: 382 KEIAKGSNGTVVLEGNYE-GRSVAVKR--LVKTHHDVALKEIQNLI---ASDQHPNIVRW 435
+EI GS G V + VA+K+ + ++I + +HPN +++
Sbjct: 60 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 119
Query: 436 YGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENT 495
G + +L +E C S +DL+ V +E
Sbjct: 120 RGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEV------------------------- 154
Query: 496 KDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDM 555
++ VT + GL++LH +IHRD+K N+L+S+ KL D
Sbjct: 155 --------------EIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGL--VKLGDF 198
Query: 556 GISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTR---AIDLFSLGCILFFCITG-- 610
G + S + + G+ W APE +L + + +D++SLG IT
Sbjct: 199 GSA-------SIMAPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLG------ITCIE 245
Query: 611 ---GKHPYGESFERDANIVKDRKDLFLV-----------EHIPEAVDLFTRLLDPNPDLR 656
K P + L+ + + L P R
Sbjct: 246 LAERKPPLFN--------MNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDR 297
Query: 657 PKAQNVLNHPFFWTADTRLSFLRDVSDRVELEDRESDSKLLRALEGIALV 706
P ++ +L H F + + D+ R + RE D+ R ++ I
Sbjct: 298 PTSEVLLKHRFVLRE-RPPTVIMDLIQRTKDAVRELDNLQYRKMKKILFQ 346
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 97.5 bits (243), Expect = 7e-22
Identities = 74/389 (19%), Positives = 133/389 (34%), Gaps = 76/389 (19%)
Query: 303 EHITKTGIPKKKKSRRPGYNRNTTNSEKMQNIIPNESKVGETDGLSHITGNGEKFLLTFT 362
H + + + + N +S N + + L
Sbjct: 7 HHSSGVDLGTENLYFQSMKNSGDQDSRSGHNEAKEVWSNADLTERMPVKSKRTSALAVDI 66
Query: 363 D----LIDDRVDGRRIGKL-----VVFNKEIAKGSNGTVVL-EGNYEGRSVAVK----RL 408
D R+ + G + V + + G G V E G +A K R
Sbjct: 67 PAPPAPFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRG 126
Query: 409 VKTHHDVALKEIQ---NLIASDQHPNIVRWYGVESDQDFVYLSLERCTCS-LNDLIYVLS 464
+K +V EI L H N+++ Y ++ + L +E L D I S
Sbjct: 127 MKDKEEV-KNEISVMNQL----DHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDES 181
Query: 465 GSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSH 524
+ E D + + I G+ H
Sbjct: 182 YNLTE--------------------------LDT-------------ILFMKQICEGIRH 202
Query: 525 LHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPE 584
+H++ ++H DLKP+N+L + K+ D G+++R + + +G+ + APE
Sbjct: 203 MHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPR----EKLKVNFGTPEFLAPE 258
Query: 585 QLLQGRQTRAIDLFSLGCILFFCITGGKHP-YGESFERD--ANIVKDRKDLFLVE---HI 638
+ + D++S+G I + ++ G P G++ + + NI+ R D E I
Sbjct: 259 VVNYDFVSFPTDMWSVGVIAYMLLS-GLSPFLGDN-DAETLNNILACRWD-LEDEEFQDI 315
Query: 639 -PEAVDLFTRLLDPNPDLRPKAQNVLNHP 666
EA + ++LL R A L HP
Sbjct: 316 SEEAKEFISKLLIKEKSWRISASEALKHP 344
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 1e-21
Identities = 61/306 (19%), Positives = 106/306 (34%), Gaps = 86/306 (28%)
Query: 379 VFNKEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYG 437
V ++ + G NG V+ A+K L A +E++ + Q P+IVR
Sbjct: 21 VTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD--CPKARREVELHWRASQCPHIVRIVD 78
Query: 438 V----ESDQDFVYLSLERCTCS-LNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVM 492
V + + + + +E L I +++ E
Sbjct: 79 VYENLYAGRKCLLIVMECLDGGELFSRI-------------QDRGDQAFTE--------- 116
Query: 493 ENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVL-ISKDKSFCAK 551
++ +++++K I + +LH I + HRD+KP+N+L SK + K
Sbjct: 117 ---RE----------ASEIMK---SIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILK 160
Query: 552 LSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFF--CIT 609
L+D G A E + ++ D++SLG I++ C
Sbjct: 161 LTDFGF------------------------AKE-TTGEKYDKSCDMWSLGVIMYILLC-- 193
Query: 610 GGKHP-YGESFERDANIVKDR----KDLFLVE---HI-PEAVDLFTRLLDPNPDLRPKAQ 660
G P Y + +K R + F + E L LL P R
Sbjct: 194 -GYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTIT 252
Query: 661 NVLNHP 666
+NHP
Sbjct: 253 EFMNHP 258
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 94.9 bits (237), Expect = 1e-21
Identities = 72/330 (21%), Positives = 128/330 (38%), Gaps = 92/330 (27%)
Query: 384 IAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDV------ALKEIQNLIASDQHPNIVRWYG 437
I +G+ G V N G + A+K+ ++ + ++EI +++ +H NIV+ Y
Sbjct: 10 IGEGTYGVVYKAQNNYGETFALKK-IRLEKEDEGIPSTTIREI-SILKELKHSNIVKLYD 67
Query: 438 VESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKD 497
V + + L E L L+ V G E + LL
Sbjct: 68 VIHTKKRLVLVFEHLDQDLKKLLDVCEGGLES------------VTAKSFLL-------- 107
Query: 498 IELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGI 557
QLL G+++ H+ ++HRDLKPQN+LI+++ K++D G+
Sbjct: 108 ------------QLLN-------GIAYCHDRRVLHRDLKPQNLLINREG--ELKIADFGL 146
Query: 558 SKRLQGDMSCLTQN-ATGYGSSGW-QAPEQLLQGRQ-TRAIDLFSLGCILFFCITGGKHP 614
++ + T T W +AP+ L+ ++ + ID++S+GCI + G P
Sbjct: 147 ARAFGIPVRKYTHEIVT-----LWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNG--TP 199
Query: 615 Y--GESFERD--ANIVK-----------------DRKDLF-------LVEHIP----EAV 642
G S E D I + F + +
Sbjct: 200 LFPGVS-EADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGI 258
Query: 643 DLFTRLLDPNPDLRPKAQNVLNHPFFWTAD 672
DL +++L +P+ R A+ L H +F +
Sbjct: 259 DLLSKMLKLDPNQRITAKQALEHAYFKENN 288
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 2e-21
Identities = 78/342 (22%), Positives = 128/342 (37%), Gaps = 96/342 (28%)
Query: 382 KEIAKGSNGTVVLEGNYEGR------SVAVKRLVKTHHDVALKEIQNLI---ASDQHPNI 432
++I KGS G V ++G VA+K + + +++IQ I + P +
Sbjct: 28 EKIGKGSFGEV-----FKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYV 82
Query: 433 VRWYGVESDQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPV 491
++YG +++ +E S DL+ + L+E +I
Sbjct: 83 TKYYGSYLKDTKLWIIMEYLGGGSALDLL----------------EPGPLDETQIAT--- 123
Query: 492 MENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAK 551
+ R+I+ GL +LH IHRD+K NVL+S+ K
Sbjct: 124 ----------------------ILREILKGLDYLHSEKKIHRDIKAANVLLSEHGE--VK 159
Query: 552 LSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG- 610
L+D G++ +L + T G+ W APE + Q D++SLG IT
Sbjct: 160 LADFGVAGQLTDTQI---KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLG------ITAI 210
Query: 611 ----GKHPYGESFERDANIVKDRKDLFLVEHIP-------------EAVDLFTRLLDPNP 653
G+ P+ E + K LFL IP + L+ P
Sbjct: 211 ELARGEPPHSE--------LHPMKVLFL---IPKNNPPTLEGNYSKPLKEFVEACLNKEP 259
Query: 654 DLRPKAQNVLNHPFFWTADTRLSFLRDVSDRVELEDRESDSK 695
RP A+ +L H F + S+L ++ DR + E
Sbjct: 260 SFRPTAKELLKHKFILRNAKKTSYLTELIDRYKRWKAEQSHD 301
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 2e-21
Identities = 75/356 (21%), Positives = 127/356 (35%), Gaps = 109/356 (30%)
Query: 382 KEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDV--------------ALKEIQNLIASD 427
+ I+ GS G V + EG VA+KR+ T D L+EI+ L+
Sbjct: 28 RFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIR-LLNHF 86
Query: 428 QHPNIVRWYGV---ESDQDF--VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLN 482
HPNI+ + + +YL E L +I+ +++
Sbjct: 87 HHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIH--------------DQRIVIS 132
Query: 483 EVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLI 542
I+ ++ +L GL LHE G++HRDL P N+L+
Sbjct: 133 PQHIQYF----------MY--------HILL-------GLHVLHEAGVVHRDLHPGNILL 167
Query: 543 SKDKSFCA-KLSDMGISKRLQGDMSCLTQNATGYGSSGW-QAPEQLLQGRQ-TRAIDLFS 599
+ + + D +++ D N T Y + W +APE ++Q + T+ +D++S
Sbjct: 168 ADN---NDITICDFNLAREDTAD-----ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWS 219
Query: 600 LGCILFFCITG-----GKH-------------------------PYGESFERDANIVKDR 629
GC++ G P + R++
Sbjct: 220 AGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPA 279
Query: 630 KDLFLV--EHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTADTRLSFLRDVSD 683
+ V P A+DL ++L+ NP R + L HP+F L D D
Sbjct: 280 RAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYF-------ESLFDPLD 328
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 3e-21
Identities = 66/328 (20%), Positives = 124/328 (37%), Gaps = 85/328 (25%)
Query: 382 KEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHHD-----VALKEIQNLIASDQHPNIVRW 435
+I +GS G V N + G+ VA+K+ +++ D +AL+EI ++ +HPN+V
Sbjct: 9 GKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREI-RMLKQLKHPNLVNL 67
Query: 436 YGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENT 495
V + ++L E C ++ + ++ + E ++ +
Sbjct: 68 LEVFRRKRRLHLVFEYCDHTVLHEL--------------DRYQRGVPEHLVKSI------ 107
Query: 496 KDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDM 555
W Q L+ ++ H+ IHRD+KP+N+LI+K KL D
Sbjct: 108 ----TW--------QTLQ-------AVNFCHKHNCIHRDVKPENILITKHSVI--KLCDF 146
Query: 556 GISKRLQGDMSCLTQNATGYGSSGW-QAPEQLLQGRQ-TRAIDLFSLGCI---------L 604
G ++ L G ++ W ++PE L+ Q +D++++GC+ L
Sbjct: 147 GFARLLTGPSDYYDD----EVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPL 202
Query: 605 F---------FCI-------TGGKHPYGESFE--RDANIVKDRKDLFLVEHIP----EAV 642
+ + I + + I L P A+
Sbjct: 203 WPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPAL 262
Query: 643 DLFTRLLDPNPDLRPKAQNVLNHPFFWT 670
L L +P R + +L+HP+F
Sbjct: 263 GLLKGCLHMDPTERLTCEQLLHHPYFEN 290
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 4e-21
Identities = 67/313 (21%), Positives = 107/313 (34%), Gaps = 92/313 (29%)
Query: 400 GRSVAVKRLVKTHHDV---------ALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 450
+ VA+K+ +K H AL+EI L+ HPNI+ + + L +
Sbjct: 35 NQIVAIKK-IKLGHRSEAKDGINRTALREI-KLLQELSHPNIIGLLDAFGHKSNISLVFD 92
Query: 451 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQ 510
L +I S + ++ +L
Sbjct: 93 FMETDLEVIIKDNSLVLTP------------SHIKAYML--------------------M 120
Query: 511 LLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQ 570
L+ GL +LH+ ++HRDLKP N+L+ ++ KL+D G++K T
Sbjct: 121 TLQ-------GLEYLHQHWILHRDLKPNNLLLDENG--VLKLADFGLAKSFGSPNRAYTH 171
Query: 571 N-ATGYGSSGW-QAPEQLLQGRQ-TRAIDLFSLGCILFFCITGGKHPY--GES------- 618
T W +APE L R +D++++GCIL + P+ G+S
Sbjct: 172 QVVT-----RWYRAPELLFGARMYGVGVDMWAVGCILAELLLR--VPFLPGDSDLDQLTR 224
Query: 619 -FE----------------RDANIVKDRKDLFLVEHIP----EAVDLFTRLLDPNPDLRP 657
FE D K + L + +DL L NP R
Sbjct: 225 IFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARI 284
Query: 658 KAQNVLNHPFFWT 670
A L +F
Sbjct: 285 TATQALKMKYFSN 297
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 5e-21
Identities = 85/348 (24%), Positives = 139/348 (39%), Gaps = 105/348 (30%)
Query: 382 KEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHHDV-----ALKEIQNLIASDQHPNIVRW 435
+ + G+ G V + G VA+K+L + A +E++ L+ +H N++
Sbjct: 31 QPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELR-LLKHMRHENVIGL 89
Query: 436 YGV----ESDQDF--VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLL 489
V E+ DF YL + L L+ L E RI+ L
Sbjct: 90 LDVFTPDETLDDFTDFYLVMPFMGTDLGKLMK----------------HEKLGEDRIQFL 133
Query: 490 PVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFC 549
++ Q+LK GL ++H G+IHRDLKP N+ +++D C
Sbjct: 134 ----------VY--------QMLK-------GLRYIHAAGIIHRDLKPGNLAVNED---C 165
Query: 550 A-KLSDMGISKRLQGDMSCLTQNATGYGSSGW-QAPEQLLQGRQ-TRAIDLFSLGCILFF 606
K+ D G++++ +M TGY + W +APE +L + T+ +D++S+GCI+
Sbjct: 166 ELKILDFGLARQADSEM-------TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAE 218
Query: 607 CITG-----GKH--------------PYGESFERDANI----------VKDRKDL--FLV 635
ITG G P E +R + ++KD L
Sbjct: 219 MITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILT 278
Query: 636 EHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTADTRLSFLRDVSD 683
P AV+L ++L + + R A L HP+F L D D
Sbjct: 279 NASPLAVNLLEKMLVLDAEQRVTAGEALAHPYF-------ESLHDTED 319
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 5e-21
Identities = 87/355 (24%), Positives = 127/355 (35%), Gaps = 107/355 (30%)
Query: 382 KEIAKGSNGTVVLEGNYEGR------SVAVKRLVKTHHDVA--LKEIQNLIASDQHPNIV 433
+ + G+ G V Y+GR A+K + T + +EI L H NI
Sbjct: 30 ELVGNGTYGQV-----YKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIA 84
Query: 434 RWYG------VESDQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRI 486
+YG D ++L +E C S+ DLI K N L E I
Sbjct: 85 TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLI-------------KNTKGNTLKEEWI 131
Query: 487 RLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDK 546
+ R+I+ GLSHLH+ +IHRD+K QNVL++++
Sbjct: 132 AY-------------------------ICREILRGLSHLHQHKVIHRDIKGQNVLLTENA 166
Query: 547 SFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRA-----IDLFSLG 601
KL D G+S +L + + T G+ W APE + A DL+SLG
Sbjct: 167 E--VKLVDFGVSAQLDRTVG---RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLG 221
Query: 602 CILFFCITG-----GKHPYGESFERDANIVKDRKDLFLVEHIP--------------EAV 642
IT G P + + + LFL IP +
Sbjct: 222 ------ITAIEMAEGAPPLCD--------MHPMRALFL---IPRNPAPRLKSKKWSKKFQ 264
Query: 643 DLFTRLLDPNPDLRPKAQNVLNHPFFWTADTR---LSFLRDVSDRVELEDRESDS 694
L N RP + ++ HPF L+D DR + + E D
Sbjct: 265 SFIESCLVKNHSQRPATEQLMKHPFIRDQPNERQVRIQLKDHIDRTKKKRGEKDE 319
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 8e-21
Identities = 71/316 (22%), Positives = 129/316 (40%), Gaps = 78/316 (24%)
Query: 372 RRIGKLVVFNKEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTH---HDVALK---EIQNLI 424
R IG ++ + + +GS G V L +Y+ + VA+K + + D+ ++ EI L
Sbjct: 6 RHIGPYII-RETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYL- 63
Query: 425 ASDQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEV 484
+HP+I++ Y V + + + +E L D I V E +E
Sbjct: 64 KLLRHPHIIKLYDVITTPTDIVMVIEYAGGELFDYI-VEKKRMTE------------DEG 110
Query: 485 RIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISK 544
R + + I+ + + H ++HRDLKP+N+L+
Sbjct: 111 R---------------------------RFFQQIICAIEYCHRHKIVHRDLKPENLLL-- 141
Query: 545 DKSFCAKLSDMGISKRLQGDM----SCLTQNATGYGSSGWQAPEQLLQGRQ--TRAIDLF 598
D + K++D G+S + SC GS + APE ++ G+ +D++
Sbjct: 142 DDNLNVKIADFGLSNIMTDGNFLKTSC--------GSPNYAAPE-VINGKLYAGPEVDVW 192
Query: 599 SLGCILFFCITGGKHPYGESFERDANIVKDRK-----DLFLVEHI-PEAVDLFTRLLDPN 652
S G +L+ + G+ P F+ D I K + + + P A L R++ +
Sbjct: 193 SCGIVLYVMLV-GRLP----FD-DEFIPNLFKKVNSCVYVMPDFLSPGAQSLIRRMIVAD 246
Query: 653 PDLRPKAQNVLNHPFF 668
P R Q + P+F
Sbjct: 247 PMQRITIQEIRRDPWF 262
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 93.0 bits (232), Expect = 8e-21
Identities = 76/333 (22%), Positives = 137/333 (41%), Gaps = 91/333 (27%)
Query: 384 IAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDV------ALKEIQNLIASDQHPNIVRWYG 437
+ +G+ G V + +GR VA+KR ++ + A++EI +L+ HPNIV
Sbjct: 29 VGEGTYGVVYKAKDSQGRIVALKR-IRLDAEDEGIPSTAIREI-SLLKELHHPNIVSLID 86
Query: 438 VESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKD 497
V + + L E L ++ ++ ++++I L
Sbjct: 87 VIHSERCLTLVFEFMEKDLKKVLDENKTGLQD------------SQIKIYLY-------- 126
Query: 498 IELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGI 557
QLL+ G++H H+ ++HRDLKPQN+LI+ D KL+D G+
Sbjct: 127 ------------QLLR-------GVAHCHQHRILHRDLKPQNLLINSDG--ALKLADFGL 165
Query: 558 SKRLQGDMSCLTQN-ATGYGSSGW-QAPEQLLQGRQ-TRAIDLFSLGCILFFCITGGKHP 614
++ + T T W +AP+ L+ ++ + ++D++S+GCI ITG P
Sbjct: 166 ARAFGIPVRSYTHEVVT-----LWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITG--KP 218
Query: 615 Y--GES--------FE----------------RDANIV--KDRKDLFLVEHIP----EAV 642
G + F + + IP E +
Sbjct: 219 LFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGI 278
Query: 643 DLFTRLLDPNPDLRPKAQNVLNHPFFWTADTRL 675
DL + +L +P+ R A++ +NHP+F D ++
Sbjct: 279 DLLSNMLCFDPNKRISARDAMNHPYFKDLDPQI 311
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 8e-21
Identities = 65/305 (21%), Positives = 119/305 (39%), Gaps = 70/305 (22%)
Query: 382 KEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHHDVAL----KEIQNLIASDQHPNIVRWY 436
+ + +G+ G V L N +VAVK + KEI H N+V++Y
Sbjct: 13 QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICIN-KMLNHENVVKFY 71
Query: 437 GVESDQDFVYLSLERCTCS-LNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENT 495
G + + YL LE C+ L D I E + +
Sbjct: 72 GHRREGNIQYLFLEYCSGGELFDRI-EPDIGMPE------------PDAQ---------- 108
Query: 496 KDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDM 555
+ +++G+ +LH IG+ HRD+KP+N+L+ D+ K+SD
Sbjct: 109 -----------------RFFHQLMAGVVYLHGIGITHRDIKPENLLL--DERDNLKISDF 149
Query: 556 GISK--RLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ--TRAIDLFSLGCILFFCITGG 611
G++ R L G+ + APE LL+ R+ +D++S G +L + G
Sbjct: 150 GLATVFRYNNRERLLN---KMCGTLPYVAPE-LLKRREFHAEPVDVWSCGIVLTAMLA-G 204
Query: 612 KHPYGESFERDANIVKDRKDLFLVE-------HI-PEAVDLFTRLLDPNPDLRPKAQNVL 663
+ P +++ ++ ++ D + I + L ++L NP R ++
Sbjct: 205 ELP----WDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIK 260
Query: 664 NHPFF 668
++
Sbjct: 261 KDRWY 265
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 1e-20
Identities = 76/316 (24%), Positives = 130/316 (41%), Gaps = 77/316 (24%)
Query: 372 RRIGKLVVFNKEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTH---HDVALK---EIQNLI 424
+IG V+ + G+ G V + + G VAVK L + DV K EIQNL
Sbjct: 8 VKIGHYVL-GDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNL- 65
Query: 425 ASDQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEV 484
+HP+I++ Y V S ++ +E YV G + + + + E+
Sbjct: 66 KLFRHPHIIKLYQVISTPTDFFMVME----------YVSGGELFDYICKHGR----VEEM 111
Query: 485 RIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISK 544
R ++ + I+S + + H ++HRDLKP+NVL+
Sbjct: 112 EAR-------------------------RLFQQILSAVDYCHRHMVVHRDLKPENVLL-- 144
Query: 545 DKSFCAKLSDMGISKRLQGDM----SCLTQNATGYGSSGWQAPEQLLQGRQ--TRAIDLF 598
D AK++D G+S + SC GS + APE ++ GR +D++
Sbjct: 145 DAHMNAKIADFGLSNMMSDGEFLRTSC--------GSPNYAAPE-VISGRLYAGPEVDIW 195
Query: 599 SLGCILFFCITGGKHPYGESFERDANIVKDRK-----DLFLVEHI-PEAVDLFTRLLDPN 652
S G IL+ + G P F+ D ++ K ++ E++ L +L +
Sbjct: 196 SCGVILYALLC-GTLP----FD-DEHVPTLFKKIRGGVFYIPEYLNRSVATLLMHMLQVD 249
Query: 653 PDLRPKAQNVLNHPFF 668
P R +++ H +F
Sbjct: 250 PLKRATIKDIREHEWF 265
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 1e-20
Identities = 69/333 (20%), Positives = 121/333 (36%), Gaps = 90/333 (27%)
Query: 400 GRSVAVKRLVKTHHD-----VALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTC 454
VA+K ++ H+ A++E+ +L+ +H NIV + + + + L E
Sbjct: 27 DNLVALKE-IRLEHEEGAPCTAIREV-SLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDK 84
Query: 455 SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKV 514
L + + V++ L QLL+
Sbjct: 85 DLKQYLDDCGNIINM------------HNVKLFLF--------------------QLLR- 111
Query: 515 TRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQN-AT 573
GL++ H ++HRDLKPQN+LI++ KL+D G+++ T
Sbjct: 112 ------GLAYCHRQKVLHRDLKPQNLLINERG--ELKLADFGLARAKSIPTKTYDNEVVT 163
Query: 574 GYGSSGW-QAPEQLLQGRQ-TRAIDLFSLGCILFFCITGGKHPY--GES--------FE- 620
W + P+ LL + ID++ +GCI + TG P G + F
Sbjct: 164 -----LWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATG--RPLFPGSTVEEQLHFIFRI 216
Query: 621 ---------------RDANIVK--DRKDLFLVEHIP----EAVDLFTRLLDPNPDLRPKA 659
+ + L+ H P + DL T+LL R A
Sbjct: 217 LGTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISA 276
Query: 660 QNVLNHPFFWTADTRLSFLRDVSDRVELEDRES 692
++ + HPFF + R+ L D + L++ +
Sbjct: 277 EDAMKHPFFLSLGERIHKLPDTTSIFALKEIQL 309
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 1e-20
Identities = 75/346 (21%), Positives = 131/346 (37%), Gaps = 97/346 (28%)
Query: 382 KEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHHDV----ALKEIQNLIASDQHPNIVRWY 436
I +G+ G V + VA+K++ H L+EI+ ++ +H NI+
Sbjct: 33 SYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIK-ILLRFRHENIIGIN 91
Query: 437 GV---ESDQDF--VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPV 491
+ + + VY+ + L L+ + L+ I
Sbjct: 92 DIIRAPTIEQMKDVYIVQDLMETDLYKLLK----------------TQHLSNDHICYF-- 133
Query: 492 MENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCA- 550
L+ Q+L+ GL ++H ++HRDLKP N+L++ C
Sbjct: 134 --------LY--------QILR-------GLKYIHSANVLHRDLKPSNLLLNTT---CDL 167
Query: 551 KLSDMGISKRLQGDMSCLTQNATGYGSSGW-QAPEQLLQGRQ-TRAIDLFSLGCILFFCI 608
K+ D G++ R+ T T Y ++ W +APE +L + T++ID++S+GCIL +
Sbjct: 168 KICDFGLA-RVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEML 226
Query: 609 TG-----GKH--------------PYGESFERDANI----------VKDRKDL--FLVEH 637
+ GKH P E N+ K++
Sbjct: 227 SNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNA 286
Query: 638 IPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTADTRLSFLRDVSD 683
+A+DL ++L NP R + + L HP+ D SD
Sbjct: 287 DSKALDLLDKMLTFNPHKRIEVEQALAHPYL-------EQYYDPSD 325
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 2e-20
Identities = 67/321 (20%), Positives = 107/321 (33%), Gaps = 98/321 (30%)
Query: 400 GRSVAVKRLVKTHHD---------VALKEIQNL--IASDQHPNIVRWYGVESDQDF---- 444
G VA+K V+ + ++E+ L + + +HPN+VR V +
Sbjct: 34 GHFVALKS-VRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDREI 92
Query: 445 -VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKA 503
V L E +QD L ++ L
Sbjct: 93 KVTLVFEHV----------------------DQD----------LRTYLDKAPPPGL--- 117
Query: 504 NGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQG 563
P+ + + R + GL LH ++HRDLKP+N+L++ KL+D G++ R+
Sbjct: 118 ---PAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGG--TVKLADFGLA-RIYS 171
Query: 564 DMSCLTQN-ATGYGSSGW-QAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY--GES- 618
LT T W +APE LLQ +D++S+GCI + P G S
Sbjct: 172 YQMALTPVVVT-----LWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR--RKPLFCGNSE 224
Query: 619 -------FE----------------RDANIVKDRKDLFLVEHIP----EAVDLFTRLLDP 651
F+ + +P L +L
Sbjct: 225 ADQLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPR-PVQSVVPEMEESGAQLLLEMLTF 283
Query: 652 NPDLRPKAQNVLNHPFFWTAD 672
NP R A L H + +
Sbjct: 284 NPHKRISAFRALQHSYLHKDE 304
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 2e-20
Identities = 69/325 (21%), Positives = 116/325 (35%), Gaps = 84/325 (25%)
Query: 382 KEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHHDVALKEIQNLIA---SDQHPNIVRWYG 437
+I +GS G V L GR VAVK + + + N + QH N+V Y
Sbjct: 51 VKIGEGSTGIVCLAREKHSGRQVAVKM-MDLRKQQRRELLFNEVVIMRDYQHFNVVEMYK 109
Query: 438 VESDQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTK 496
+ +++ +E +L D++ LNE +I
Sbjct: 110 SYLVGEELWVLMEFLQGGALTDIV----------------SQVRLNEEQIAT-------- 145
Query: 497 DIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMG 556
V ++ L++LH G+IHRD+K ++L++ D KLSD G
Sbjct: 146 -----------------VCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGR--VKLSDFG 186
Query: 557 ISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG-----G 611
++ D+ + + G+ W APE + + +D++SLG I G
Sbjct: 187 FCAQISKDVP---KRKSLVGTPYWMAPEVISRSLYATEVDIWSLG------IMVIEMVDG 237
Query: 612 KHPYGESFERDANIVKDRKDLFLV------------EHIPEAVDLFTRLLDPNPDLRPKA 659
+ PY + + + + P D R+L +P R A
Sbjct: 238 EPPYFS--------DSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLERMLVRDPQERATA 289
Query: 660 QNVLNHPFFWTADTRLSFLRDVSDR 684
Q +L+HPF L +
Sbjct: 290 QELLDHPFLLQTGL-PECLVPLIQL 313
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 2e-20
Identities = 79/315 (25%), Positives = 121/315 (38%), Gaps = 91/315 (28%)
Query: 400 GRSVAVKRLVKTHHD-----VALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTC 454
G VA+K VK + A++EI +L+ +H NIVR Y V ++ + L E
Sbjct: 30 GVYVALKE-VKLDSEEGTPSTAIREI-SLMKELKHENIVRLYDVIHTENKLTLVFEFMDN 87
Query: 455 SLNDLIYVLSGSFEEQLNAKEQDSNL-LNEVRIRLLPVMENTKDIELWKANGHPSAQLLK 513
L + + L LN V+ QLL+
Sbjct: 88 DLKKYM--------DSRTVGNTPRGLELNLVKYFQW--------------------QLLQ 119
Query: 514 VTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQN-A 572
GL+ HE ++HRDLKPQN+LI+K KL D G+++ ++ +
Sbjct: 120 -------GLAFCHENKILHRDLKPQNLLINKRG--QLKLGDFGLARAFGIPVNTFSSEVV 170
Query: 573 TGYGSSGW-QAPEQLLQGRQ-TRAIDLFSLGCILFFCITGGKHPY--GES--------FE 620
T W +AP+ L+ R + +ID++S GCIL ITG P G + F+
Sbjct: 171 T-----LWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITG--KPLFPGTNDEEQLKLIFD 223
Query: 621 ----------------RDANIV------KDRKDLFLVEHIP----EAVDLFTRLLDPNPD 654
N +D + + +D LL NPD
Sbjct: 224 IMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPD 283
Query: 655 LRPKAQNVLNHPFFW 669
+R A+ L+HP+F
Sbjct: 284 MRLSAKQALHHPWFA 298
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 92.6 bits (230), Expect = 2e-20
Identities = 62/344 (18%), Positives = 111/344 (32%), Gaps = 99/344 (28%)
Query: 382 KEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHHDVALKEIQ---NLIASDQHPNIVRWYG 437
E+ G+ G V + G +A K + +I ++ P IV +YG
Sbjct: 39 SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYG 98
Query: 438 VESDQDFVYLSLERC-TCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTK 496
+ + +E SL D + +G EQ
Sbjct: 99 AFYSDGEISICMEHMDGGSL-DQVLKKAGRIPEQ-------------------------- 131
Query: 497 DIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG-LIHRDLKPQNVLISKDKSFCAKLSDM 555
L KV+ ++ GL++L E ++HRD+KP N+L++ KL D
Sbjct: 132 -------------ILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGE--IKLCDF 176
Query: 556 GISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY 615
G+S +L M+ + G+ + +PE+L + D++S+G L G++P
Sbjct: 177 GVSGQLIDSMA-----NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAV-GRYPI 230
Query: 616 -------------------------------GESFERDANIVKDRKDLFLVEHI------ 638
+ + L+++I
Sbjct: 231 PPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPP 290
Query: 639 --------PEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTADTR 674
E D + L NP R + ++ H F +D
Sbjct: 291 KLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAE 334
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 3e-20
Identities = 74/348 (21%), Positives = 136/348 (39%), Gaps = 105/348 (30%)
Query: 382 KEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHHDV-----ALKEIQNLIASDQHPNIVRW 435
+ G+ G+V + + G VAVK+L + + +E++ L+ +H N++
Sbjct: 35 SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR-LLKHMKHENVIGL 93
Query: 436 YGV----ESDQDF--VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLL 489
V S ++F VYL LN+++ L + ++ L
Sbjct: 94 LDVFTPARSLEEFNDVYLVTHLMGADLNNIVK----------------CQKLTDDHVQFL 137
Query: 490 PVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFC 549
++ Q+L+ GL ++H +IHRDLKP N+ +++D C
Sbjct: 138 ----------IY--------QILR-------GLKYIHSADIIHRDLKPSNLAVNED---C 169
Query: 550 A-KLSDMGISKRLQGDMSCLTQNATGYGSSGW-QAPEQLLQGRQ-TRAIDLFSLGCILFF 606
K+ D G+++ +M TGY ++ W +APE +L + +D++S+GCI+
Sbjct: 170 ELKILDFGLARHTADEM-------TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAE 222
Query: 607 CITG-----GKH--------------PYGESFERDANI----------VKDRKDL--FLV 635
+TG G P E ++ ++ + + +
Sbjct: 223 LLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFI 282
Query: 636 EHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTADTRLSFLRDVSD 683
P AVDL ++L + D R A L H +F + D D
Sbjct: 283 GANPLAVDLLEKMLVLDSDKRITAAQALAHAYF-------AQYHDPDD 323
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 3e-20
Identities = 69/325 (21%), Positives = 123/325 (37%), Gaps = 84/325 (25%)
Query: 382 KEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHHDVALKEIQNLI---ASDQHPNIVRWYG 437
++I +G++GTV + G+ VA+++ + + I N I +++PNIV +
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQ-MNLQQQPKKELIINEILVMRENKNPNIVNYLD 84
Query: 438 VESDQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTK 496
D +++ +E SL D++ ++E +I
Sbjct: 85 SYLVGDELWVVMEYLAGGSLTDVV----------------TETCMDEGQIAA-------- 120
Query: 497 DIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMG 556
V R+ + L LH +IHRD+K N+L+ D S KL+D G
Sbjct: 121 -----------------VCRECLQALEFLHSNQVIHRDIKSDNILLGMDGS--VKLTDFG 161
Query: 557 ISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG-----G 611
++ + S + +T G+ W APE + + +D++SLG I G
Sbjct: 162 FCAQITPEQS---KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLG------IMAIEMIEG 212
Query: 612 KHPYGESFERDANIVKDRKDLFLV------------EHIPEAVDLFTRLLDPNPDLRPKA 659
+ PY + L+L+ + D R L+ + + R A
Sbjct: 213 EPPYLN--------ENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSA 264
Query: 660 QNVLNHPFFWTADTRLSFLRDVSDR 684
+ +L H F A LS L +
Sbjct: 265 KELLQHQFLKIAKP-LSSLTPLIAA 288
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 3e-20
Identities = 65/305 (21%), Positives = 119/305 (39%), Gaps = 70/305 (22%)
Query: 382 KEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHHDVAL----KEIQNLIASDQHPNIVRWY 436
+ + +G+ G V L N +VAVK + KEI H N+V++Y
Sbjct: 13 QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICIN-KMLNHENVVKFY 71
Query: 437 GVESDQDFVYLSLERCTCS-LNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENT 495
G + + YL LE C+ L D I E + +
Sbjct: 72 GHRREGNIQYLFLEYCSGGELFDRI-EPDIGMPE------------PDAQ---------- 108
Query: 496 KDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDM 555
+ +++G+ +LH IG+ HRD+KP+N+L+ D+ K+SD
Sbjct: 109 -----------------RFFHQLMAGVVYLHGIGITHRDIKPENLLL--DERDNLKISDF 149
Query: 556 GISK--RLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ--TRAIDLFSLGCILFFCITGG 611
G++ R L G+ + APE LL+ R+ +D++S G +L + G
Sbjct: 150 GLATVFRYNNRERLLN---KMCGTLPYVAPE-LLKRREFHAEPVDVWSCGIVLTAMLA-G 204
Query: 612 KHPYGESFERDANIVKDRKDLFLVE-------HI-PEAVDLFTRLLDPNPDLRPKAQNVL 663
+ P +++ ++ ++ D + I + L ++L NP R ++
Sbjct: 205 ELP----WDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIK 260
Query: 664 NHPFF 668
++
Sbjct: 261 KDRWY 265
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 3e-20
Identities = 46/162 (28%), Positives = 74/162 (45%), Gaps = 21/162 (12%)
Query: 518 IVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGS 577
+V L +L +IHRD+KP N+L+ D+ ++D I+ L + TQ T G+
Sbjct: 124 LVMALDYLQNQRIIHRDMKPDNILL--DEHGHVHITDFNIAAMLPRE----TQITTMAGT 177
Query: 578 SGWQAPEQLLQGRQ---TRAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDRKDLFL 634
+ APE + + A+D +SLG + + G+ PY R + K+ F
Sbjct: 178 KPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLR-GRRPY---HIRSSTSSKEIVHTFE 233
Query: 635 VEHI-------PEAVDLFTRLLDPNPDLR-PKAQNVLNHPFF 668
+ E V L +LL+PNPD R + +V N P+
Sbjct: 234 TTVVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYM 275
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 91.8 bits (228), Expect = 3e-20
Identities = 60/337 (17%), Positives = 106/337 (31%), Gaps = 94/337 (27%)
Query: 379 VFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQ-NLIASDQHPNIVRWYG 437
+ I +G G V +G+ + R VAVK + + E + +H NI R+
Sbjct: 16 KLLELIGRGRYGAV-YKGSLDERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIV 74
Query: 438 VESDQDFVYLSLERCTCSLNDLI--YVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENT 495
+ + +E L+ Y +GS + L+ D
Sbjct: 75 GDE-RVTADGRMEYL------LVMEYYPNGSLXKYLSLHTSDWV---------------- 111
Query: 496 KDIELWKANGHPSAQLLKVTRDIVSGLSHLHE---------IGLIHRDLKPQNVLISKDK 546
++ + GL++LH + HRDL +NVL+
Sbjct: 112 --------------SSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLV--KN 155
Query: 547 SFCAKLSDMGISKRLQGDMSCLTQNATGY-----GSSGWQAPEQLLQGR--------QTR 593
+SD G+S RL G+ G+ + APE +L+G +
Sbjct: 156 DGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPE-VLEGAVNLRDXESALK 214
Query: 594 AIDLFSLGCIL------------FFCITGGKHPYGESFERDANIVKDRKDLFLVEH---- 637
+D+++LG I + + + +D + L E
Sbjct: 215 QVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTF-EDMQVLVSREKQRPK 273
Query: 638 IPEAVDLFTRLL-----------DPNPDLRPKAQNVL 663
PEA + + D + + R AQ
Sbjct: 274 FPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAE 310
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 4e-20
Identities = 82/335 (24%), Positives = 131/335 (39%), Gaps = 89/335 (26%)
Query: 382 KEIAKGSNGTVVLEGNYEGR------SVAVKR--LVKTHHDVAL--KEIQNLIASDQHPN 431
+ I G+ V VA+KR L K + KEIQ + HPN
Sbjct: 21 EVIGSGATAVV-----QAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCH-HPN 74
Query: 432 IVRWYGVESDQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLP 490
IV +Y +D ++L ++ + S+ D+I + + E S +L+E I
Sbjct: 75 IVSYYTSFVVKDELWLVMKLLSGGSVLDII-------KHIVAKGEHKSGVLDESTIAT-- 125
Query: 491 VMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCA 550
+ R+++ GL +LH+ G IHRD+K N+L+ +D S
Sbjct: 126 -----------------------ILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGS--V 160
Query: 551 KLSDMGISKRL--QGDMSCLTQNATGYGSSGWQAPEQLLQGRQ--TRAIDLFSLGCILFF 606
+++D G+S L GD++ T G+ W APE + Q R +A D++S G
Sbjct: 161 QIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKA-DIWSFG----- 214
Query: 607 CITG-----GKHPYGE----------------SFERDANIVKDRKDLFLVEHIPEAVDLF 645
IT G PY + S E + K +
Sbjct: 215 -ITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQDKEMLKKY-----GKSFRKMI 268
Query: 646 TRLLDPNPDLRPKAQNVLNHPFFWTADTRLSFLRD 680
+ L +P+ RP A +L H FF A + FL++
Sbjct: 269 SLCLQKDPEKRPTAAELLRHKFFQKAKNK-EFLQE 302
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 5e-20
Identities = 71/317 (22%), Positives = 113/317 (35%), Gaps = 93/317 (29%)
Query: 400 GRSVAVKRLVKTHHDV------ALKEIQNL--IASDQHPNIVRWYGV-----ESDQDFVY 446
GR VA+KR V+ ++E+ L + + +HPN+VR + V + +
Sbjct: 37 GRFVALKR-VRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLT 95
Query: 447 LSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGH 506
L E +QD L ++ + +
Sbjct: 96 LVFEHV----------------------DQD----------LTTYLDKVPEPGV------ 117
Query: 507 PSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMS 566
P+ + + ++ GL LH ++HRDLKPQN+L++ KL+D G++ R+
Sbjct: 118 PTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSG--QIKLADFGLA-RIYSFQM 174
Query: 567 CLTQN-ATGYGSSGW-QAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY--GES---- 618
LT T W +APE LLQ +DL+S+GCI + P G S
Sbjct: 175 ALTSVVVT-----LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR--RKPLFRGSSDVDQ 227
Query: 619 ----FE----------------RDANIVKDRKDLF--LVEHI-PEAVDLFTRLLDPNPDL 655
+ V I DL + L NP
Sbjct: 228 LGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAK 287
Query: 656 RPKAQNVLNHPFFWTAD 672
R A + L+HP+F +
Sbjct: 288 RISAYSALSHPYFQDLE 304
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 7e-20
Identities = 69/324 (21%), Positives = 115/324 (35%), Gaps = 77/324 (23%)
Query: 366 DDRVDGRRIGKLVVFNKEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHHDVA--LKEIQN 422
D + K+I G+ G L + VAVK + + +EI N
Sbjct: 11 LDMPIMHDSDRYDF-VKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIIN 69
Query: 423 LIASDQHPNIVRWYGVESDQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLL 481
S +HPNIVR+ V + + +E + L + I +G F E
Sbjct: 70 H-RSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERI-CNAGRFSE------------ 115
Query: 482 NEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVL 541
+E R + ++SG+S+ H + + HRDLK +N L
Sbjct: 116 DEAR---------------------------FFFQQLLSGVSYCHSMQICHRDLKLENTL 148
Query: 542 ISKDKSFCAKLSDMGISKRLQGDM----SCLTQNATGYGSSGWQAPEQLLQGRQ--TRAI 595
+ + K+ D G SK + G+ + APE +L ++ +
Sbjct: 149 LDGSPAPRLKICDFGYSKSSVLHSQPKSTV--------GTPAYIAPE-VLLRQEYDGKIA 199
Query: 596 DLFSLGCILFFCITGGKHPYGESFERDANIVKDRKDLFLVE----HIP-------EAVDL 644
D++S G L+ + G +P FE RK + + IP E L
Sbjct: 200 DVWSCGVTLYVMLV-GAYP----FEDPEEPRDYRKTIQRILSVKYSIPDDIRISPECCHL 254
Query: 645 FTRLLDPNPDLRPKAQNVLNHPFF 668
+R+ +P R + H +F
Sbjct: 255 ISRIFVADPATRISIPEIKTHSWF 278
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 7e-20
Identities = 76/350 (21%), Positives = 126/350 (36%), Gaps = 98/350 (28%)
Query: 382 KEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHHDVALKEIQNL--IASDQHPNIVRWYGV 438
+ +G+ GTV L G SVA+K+ V +E+Q + +A HPNIV+
Sbjct: 29 RMAGQGTFGTVQLGKEKSTGMSVAIKK-VIQDPRFRNRELQIMQDLAVLHHPNIVQLQSY 87
Query: 439 -----ESDQDFVYLSL--ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPV 491
E D+ +YL++ E +L+ ++ + I++
Sbjct: 88 FYTLGERDRRDIYLNVVMEYVPDTLHRCC--------RNYYRRQVA---PPPILIKVF-- 134
Query: 492 MENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE--IGLIHRDLKPQNVLISKDKSFC 549
QL++ + LH + + HRD+KP NVL+ +++
Sbjct: 135 ----------------LFQLIR-------SIGCLHLPSVNVCHRDIKPHNVLV--NEADG 169
Query: 550 A-KLSDMGISKRLQGDMSCLTQNATGYGSSGW-QAPEQLLQGRQ-TRAIDLFSLGCILFF 606
KL D G +K+L + Y S + +APE + + T A+D++S+GCI
Sbjct: 170 TLKLCDFGSAKKLSPS-----EPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAE 224
Query: 607 CITG-----GKH--------------PYGESFERDANIVKDRKDLFLVEH---------- 637
+ G G + P E + D
Sbjct: 225 MMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHS 284
Query: 638 ---IPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTADTRLSFLRDVSDR 684
EA DL + LL P+ R K L HP+F L D + +
Sbjct: 285 LKDAKEAYDLLSALLQYLPEERMKPYEALCHPYF-------DELHDPATK 327
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 9e-20
Identities = 75/340 (22%), Positives = 125/340 (36%), Gaps = 106/340 (31%)
Query: 384 IAKGSNGTVVLEGNYEGRS------VAVKRLVKTHHDV------ALKEIQNLIASDQHPN 431
+ +G+ G V Y+ VA+KR ++ H+ A++E+ +L+ QH N
Sbjct: 42 LGEGTYGEV-----YKAIDTVTNETVAIKR-IRLEHEEEGVPGTAIREV-SLLKELQHRN 94
Query: 432 IVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNL-LNEVRIRLLP 490
I+ V ++L E L + D N ++ I+
Sbjct: 95 IIELKSVIHHNHRLHLIFEYAENDLKKYM----------------DKNPDVSMRVIKSF- 137
Query: 491 VMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSF-- 548
QL+ G++ H +HRDLKPQN+L+S +
Sbjct: 138 -----------------LYQLIN-------GVNFCHSRRCLHRDLKPQNLLLSVSDASET 173
Query: 549 -CAKLSDMGISKRLQGDMSCLTQN-ATGYGSSGW-QAPEQLLQGRQ-TRAIDLFSLGCI- 603
K+ D G+++ + T T W + PE LL R + ++D++S+ CI
Sbjct: 174 PVLKIGDFGLARAFGIPIRQFTHEIIT-----LWYRPPEILLGSRHYSTSVDIWSIACIW 228
Query: 604 --------LF------------FCITG----------GKHP-YGESFERDANIVKDRKDL 632
LF F + G P + +SF + K K +
Sbjct: 229 AEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRG--KTLKRV 286
Query: 633 FLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTAD 672
E +DL T +L+ +P R A+N L HP+F D
Sbjct: 287 LGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHND 326
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 1e-19
Identities = 75/340 (22%), Positives = 122/340 (35%), Gaps = 93/340 (27%)
Query: 382 KEIAKGSNGTVVLEGNYE-GRSVAVKRL-VKTHHDVAL--KEIQNLIASDQHPNIVRWYG 437
E+ G+ G V N E G A K + K+ ++ EI+ L D HP IV+ G
Sbjct: 25 GELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCD-HPYIVKLLG 83
Query: 438 VESDQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTK 496
+++ +E C +++ ++ L E
Sbjct: 84 AYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEP-------------------------- 117
Query: 497 DIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMG 556
Q+ V R ++ L+ LH +IHRDLK NVL++ + +L+D G
Sbjct: 118 -------------QIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGD--IRLADFG 162
Query: 557 ISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRA-----IDLFSLGCILFFCITG- 610
+S + + + + G+ W APE ++ D++SLG IT
Sbjct: 163 VSAKNLKTLQ---KRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLG------ITLI 213
Query: 611 ----GKHPYGESFERDANIVKDRKDLFLVEHIP---------------EAVDLFTRLLDP 651
+ P+ E + + L I E D LD
Sbjct: 214 EMAQIEPPHHE--------LNPMRVLLK---IAKSDPPTLLTPSKWSVEFRDFLKIALDK 262
Query: 652 NPDLRPKAQNVLNHPFFWTADTRLSFLRDVSDRVELEDRE 691
NP+ RP A +L HPF + T LR++ + E E
Sbjct: 263 NPETRPSAAQLLEHPFVSSI-TSNKALRELVAEAKAEVME 301
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 2e-19
Identities = 78/363 (21%), Positives = 127/363 (34%), Gaps = 121/363 (33%)
Query: 382 KEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHHDV-----ALKEIQNLIASDQHPNIVRW 435
K++ KG+ G V + G VAVK++ + +EI L H NIV
Sbjct: 15 KKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNL 74
Query: 436 YGV---ESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVM 492
V ++D+D VYL + L+ +I +N+L V + +
Sbjct: 75 LNVLRADNDRD-VYLVFDYMETDLHAVIR----------------ANILEPVHKQYV--- 114
Query: 493 ENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCA-K 551
++ QL+K + +LH GL+HRD+KP N+L++ + C K
Sbjct: 115 -------VY--------QLIK-------VIKYLHSGGLLHRDMKPSNILLNAE---CHVK 149
Query: 552 LSDMGISKRLQGDMSCLTQNA-----------------TGYGSSGW-QAPEQLLQGRQ-T 592
++D G+S+ T Y ++ W +APE LL + T
Sbjct: 150 VADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYT 209
Query: 593 RAIDLFSLGCI---------LF------------FCITG--------------------- 610
+ ID++SLGCI +F +
Sbjct: 210 KGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIES 269
Query: 611 ----GKHPYGESFERDANIVKDRKDLFLVEHI-PEAVDLFTRLLDPNPDLRPKAQNVLNH 665
+ + + EA+DL +LL NP+ R A + L H
Sbjct: 270 LKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISANDALKH 329
Query: 666 PFF 668
PF
Sbjct: 330 PFV 332
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 91.4 bits (227), Expect = 2e-19
Identities = 82/348 (23%), Positives = 143/348 (41%), Gaps = 77/348 (22%)
Query: 372 RRIGKLVVFNKEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTH---HDVALK---EIQNLI 424
+IG ++ + G+ G V + + G VAVK L + DV K EIQNL
Sbjct: 13 VKIGHYIL-GDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNL- 70
Query: 425 ASDQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEV 484
+HP+I++ Y V S +++ +E YV G + + + L+E
Sbjct: 71 KLFRHPHIIKLYQVISTPSDIFMVME----------YVSGGELFDYICKNGR----LDEK 116
Query: 485 RIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISK 544
R ++ + I+SG+ + H ++HRDLKP+NVL+
Sbjct: 117 ESR-------------------------RLFQQILSGVDYCHRHMVVHRDLKPENVLL-- 149
Query: 545 DKSFCAKLSDMGISKRLQGDM----SCLTQNATGYGSSGWQAPEQLLQGRQ--TRAIDLF 598
D AK++D G+S + SC GS + APE ++ GR +D++
Sbjct: 150 DAHMNAKIADFGLSNMMSDGEFLRTSC--------GSPNYAAPE-VISGRLYAGPEVDIW 200
Query: 599 SLGCILFFCITGGKHPYGESFERDANIVKDRK-----DLFLVEHI-PEAVDLFTRLLDPN 652
S G IL+ + G P F+ D ++ K + +++ P + L +L +
Sbjct: 201 SSGVILYALLC-GTLP----FD-DDHVPTLFKKICDGIFYTPQYLNPSVISLLKHMLQVD 254
Query: 653 PDLRPKAQNVLNHPFFWTADTRLSFLRDVSDRVELEDRESDSKLLRAL 700
P R +++ H +F + F D S + D E+ ++
Sbjct: 255 PMKRATIKDIREHEWFKQDLPKYLFPEDPSYSSTMIDDEALKEVCEKF 302
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 2e-19
Identities = 77/334 (23%), Positives = 129/334 (38%), Gaps = 101/334 (30%)
Query: 382 KEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHHDV-----ALKEIQNLIASDQHPNIVRW 435
+ G+ G+V + G VA+K+L + A +E+ L+ QH N++
Sbjct: 30 THVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELL-LLKHMQHENVIGL 88
Query: 436 YGV-------ESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRL 488
V + D YL + L ++ E +I+
Sbjct: 89 LDVFTPASSLRNFYD-FYLVMPFMQTDLQKIMG----------------LKFSEE-KIQY 130
Query: 489 LPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSF 548
L ++ Q+LK GL ++H G++HRDLKP N+ +++D
Sbjct: 131 L----------VY--------QMLK-------GLKYIHSAGVVHRDLKPGNLAVNED--- 162
Query: 549 CA-KLSDMGISKRLQGDMSCLTQNATGYGSSGW-QAPEQLLQGRQ-TRAIDLFSLGCILF 605
C K+ D G+++ +M TGY + W +APE +L + +D++S+GCI+
Sbjct: 163 CELKILDFGLARHADAEM-------TGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMA 215
Query: 606 FCITG-----GKH--------------PYGESFERDANI----------VKDRKDL--FL 634
+TG GK P E ++ + RKD
Sbjct: 216 EMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLF 275
Query: 635 VEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 668
P+A DL ++L+ + D R A L HPFF
Sbjct: 276 PRASPQAADLLEKMLELDVDKRLTAAQALTHPFF 309
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 2e-19
Identities = 72/325 (22%), Positives = 113/325 (34%), Gaps = 103/325 (31%)
Query: 400 GRSVAVKRLVKTHHD------VALKEIQNLIASDQHPNIVRWYGV--------ESDQDFV 445
G+ VA+K+ V ++ AL+EI+ L H N+V + + +
Sbjct: 42 GQKVALKK-VLMENEKEGFPITALREIKILQLLK-HENVVNLIEICRTKASPYNRCKGSI 99
Query: 446 YLSLERCTCSLNDLIYVLSGSFEEQLNAKEQD-SNLLNEVRIRLLPVMENTKDIELWKAN 504
YL + C E D + LL+ V ++ K +
Sbjct: 100 YLVFDFC----------------------EHDLAGLLSNVLVKFTL--SEIKRVMQ---- 131
Query: 505 GHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGD 564
LL GL ++H ++HRD+K NVLI++D KL+D G+++
Sbjct: 132 -----MLLN-------GLYYIHRNKILHRDMKAANVLITRDG--VLKLADFGLARAFSLA 177
Query: 565 MSCLTQNATG------YGSSGWQAPEQLLQGRQ-TRAIDLFSLGCI---------LF--- 605
+ T Y + PE LL R IDL+ GCI +
Sbjct: 178 KNSQPNRYTNRVVTLWY-----RPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGN 232
Query: 606 ---------FCITG----------GKHPYGESFERDANIVKDRKDLF-LVEHIPEAVDLF 645
+ G + E E + KD P A+DL
Sbjct: 233 TEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLI 292
Query: 646 TRLLDPNPDLRPKAQNVLNHPFFWT 670
+LL +P R + + LNH FFW+
Sbjct: 293 DKLLVLDPAQRIDSDDALNHDFFWS 317
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 91.9 bits (228), Expect = 3e-19
Identities = 47/161 (29%), Positives = 76/161 (47%), Gaps = 18/161 (11%)
Query: 518 IVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGS 577
I+ GL H+H +++RDLKP N+L+ D+ ++SD+G++ + G+
Sbjct: 301 IILGLEHMHNRFVVYRDLKPANILL--DEHGHVRISDLGLACDFSKK-----KPHASVGT 353
Query: 578 SGWQAPEQLLQGRQ-TRAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDR---KDLF 633
G+ APE L +G + D FSLGC+LF + G P+ + +D + + +
Sbjct: 354 HGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLR-GHSPFRQHKTKDKHEIDRMTLTMAVE 412
Query: 634 LVEHI-PEAVDLFTRLLDPNPDLR-----PKAQNVLNHPFF 668
L + PE L LL + + R AQ V PFF
Sbjct: 413 LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFF 453
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 91.4 bits (227), Expect = 3e-19
Identities = 46/166 (27%), Positives = 74/166 (44%), Gaps = 18/166 (10%)
Query: 518 IVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGS 577
IVSGL HLH+ +I+RDLKP+NVL+ D ++SD+G++ + T+ G+
Sbjct: 298 IVSGLEHLHQRNIIYRDLKPENVLL--DDDGNVRISDLGLAVE---LKAGQTKTKGYAGT 352
Query: 578 SGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP--YGESFERDANIVKDR---KDL 632
G+ APE LL ++D F+LG L+ I + + +K R + +
Sbjct: 353 PGFMAPELLLGEEYDFSVDYFALGVTLYEMIAA--RGPFRARGEKVENKELKQRVLEQAV 410
Query: 633 FLVEHI-PEAVDLFTRLLDPNPDLR-----PKAQNVLNHPFFWTAD 672
+ P + D LL +P+ R + HP F
Sbjct: 411 TYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDIS 456
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 91.0 bits (226), Expect = 3e-19
Identities = 56/249 (22%), Positives = 100/249 (40%), Gaps = 61/249 (24%)
Query: 378 VVFNKEIAKGSNGTVVLEGNYEGRS--VAVKRLVKTHHDVA--LKEIQNLIASDQHPNIV 433
+ ++ G G V EG ++ S VAVK L + +V LKE + +HPN+V
Sbjct: 222 ITMKHKLGGGQYG-EVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVM-KEIKHPNLV 279
Query: 434 RWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVME 493
+ GV + + Y+ E ++ G+ + L +E + +
Sbjct: 280 QLLGVCTREPPFYIITE----------FMTYGNLLDYL--RECNRQEV------------ 315
Query: 494 NTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLS 553
+ LL + I S + +L + IHR+L +N L+ ++ K++
Sbjct: 316 -------------SAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGEN--HLVKVA 360
Query: 554 DMGISKRLQGDMSCLTQNATGYGSSG-------WQAPEQLLQGRQTRAIDLFSLGCILFF 606
D G+S+ + GD Y + W APE L + + D+++ G +L+
Sbjct: 361 DFGLSRLMTGDT---------YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWE 411
Query: 607 CITGGKHPY 615
T G PY
Sbjct: 412 IATYGMSPY 420
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 89.5 bits (222), Expect = 5e-19
Identities = 71/373 (19%), Positives = 128/373 (34%), Gaps = 103/373 (27%)
Query: 365 IDDRVDGRRIGKLVVFNKEIAKGSNGT--VVLEG----NYEGRSVAVKRLVKTHHDV-AL 417
++ R +F E K GT V + + + A+K++ T + A
Sbjct: 7 FKVKLSSERERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSAC 66
Query: 418 KEIQNLIASDQHPNIVRWYGV--ESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKE 475
+EI L+ +HPN++ V V+L + E
Sbjct: 67 REIA-LLRELKHPNVISLQKVFLSHADRKVWLLFDYA----------------------E 103
Query: 476 QDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLK-VTRDIVSGLSHLHEIGLIHRD 534
D L +++ + + K ++K + I+ G+ +LH ++HRD
Sbjct: 104 HD----------LWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRD 153
Query: 535 LKPQNVLISKDKSF--CAKLSDMGISKRLQGDMSCLTQNATG-----YGSSGWQAPEQLL 587
LKP N+L+ + K++DMG ++ + L Y +APE LL
Sbjct: 154 LKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWY-----RAPELLL 208
Query: 588 QGRQ-TRAIDLFSLGCI---------LF---------------------FCITG------ 610
R T+AID++++GCI +F F + G
Sbjct: 209 GARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKD 268
Query: 611 ----GKHPYGESFE---RDANIVKDRKDLFLVEHIP----EAVDLFTRLLDPNPDLRPKA 659
K P + R ++ +H +A L +LL +P R +
Sbjct: 269 WEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITS 328
Query: 660 QNVLNHPFFWTAD 672
+ + P+F
Sbjct: 329 EQAMQDPYFLEDP 341
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 8e-19
Identities = 69/354 (19%), Positives = 133/354 (37%), Gaps = 105/354 (29%)
Query: 382 KEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHHDV----ALKEIQNLIASDQHPNIVRWY 436
+ +G+ G V + G VA+K++ + L+EI+ ++ +H NI+ +
Sbjct: 17 SLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIK-ILKHFKHENIITIF 75
Query: 437 GV------ESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLP 490
+ E+ + VY+ E L+ +I + +L++ I+
Sbjct: 76 NIQRPDSFENFNE-VYIIQELMQTDLHRVI----------------STQMLSDDHIQYF- 117
Query: 491 VMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCA 550
++ Q L+ + LH +IHRDLKP N+LI+ + C
Sbjct: 118 ---------IY--------QTLR-------AVKVLHGSNVIHRDLKPSNLLINSN---CD 150
Query: 551 -KLSDMGISKRLQGDMSCLTQNA------TGYGSSGW-QAPEQLLQGRQ-TRAIDLFSLG 601
K+ D G+++ + + ++ + ++ W +APE +L + +RA+D++S G
Sbjct: 151 LKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCG 210
Query: 602 CILFFCITG-----GKH--------------PYGESF------ERDANIV-----KDRKD 631
CIL G+ P+ ++ R +
Sbjct: 211 CILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAP 270
Query: 632 L--FLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTADTRLSFLRDVSD 683
L P+ +DL R+L +P R A+ L HP+ D +D
Sbjct: 271 LEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYL-------QTYHDPND 317
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 87.9 bits (218), Expect = 3e-18
Identities = 46/167 (27%), Positives = 74/167 (44%), Gaps = 21/167 (12%)
Query: 518 IVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGY-G 576
I GL LH +++RDLKP+N+L+ D ++SD+G++ + Q G G
Sbjct: 295 ICCGLEDLHRERIVYRDLKPENILL--DDHGHIRISDLGLAVHVPEG-----QTIKGRVG 347
Query: 577 SSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP--YGESFERDANIVKDR---KD 631
+ G+ APE + R T + D ++LGC+L+ I G + V+
Sbjct: 348 TVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAG--QSPFQQRKKKIKREEVERLVKEVP 405
Query: 632 LFLVEHI-PEAVDLFTRLLDPNPDLR-----PKAQNVLNHPFFWTAD 672
E P+A L ++LL +P R A+ V HP F +
Sbjct: 406 EEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLN 452
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 4e-18
Identities = 56/257 (21%), Positives = 96/257 (37%), Gaps = 52/257 (20%)
Query: 378 VVFNKEIAKGSNGTVV------LEGNYEGRSVAVKRLVKTHHDVA----LKEIQNLIASD 427
+ F K + G+ G VV L + +VAVK L + H + E++ L
Sbjct: 25 LSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLG 84
Query: 428 QHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIR 487
H NIV G + + E Y G +LLN +R +
Sbjct: 85 NHMNIVNLLGACTIGGPTLVITE----------YCCYG-------------DLLNFLRRK 121
Query: 488 LLPVMENTKDIELWKANGHP--SAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKD 545
+ + + + + LL + + G++ L IHRDL +N+L++
Sbjct: 122 RDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHG 181
Query: 546 KSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSG-------WQAPEQLLQGRQTRAIDLF 598
+ K+ D G+++ ++ D + Y G W APE + T D++
Sbjct: 182 R--ITKICDFGLARDIKNDSN--------YVVKGNARLPVKWMAPESIFNCVYTFESDVW 231
Query: 599 SLGCILFFCITGGKHPY 615
S G L+ + G PY
Sbjct: 232 SYGIFLWELFSLGSSPY 248
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 5e-18
Identities = 74/312 (23%), Positives = 123/312 (39%), Gaps = 78/312 (25%)
Query: 382 KEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHDVALKEIQ------NLIASDQHPNIVR 434
K + GS G V+L + G A+K L K V LK+I+ ++ + P +V+
Sbjct: 47 KTLGTGSFGRVMLVKHKESGNHYAMKILDK-QKVVKLKQIEHTLNEKRILQAVNFPFLVK 105
Query: 435 WYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMEN 494
D +Y+ +E YV G L + +E R
Sbjct: 106 LEFSFKDNSNLYMVME----------YVAGGEMFSHL----RRIGRFSEPHARFY----- 146
Query: 495 TKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSD 554
+AQ IV +LH + LI+RDLKP+N+LI D+ +++D
Sbjct: 147 -------------AAQ-------IVLTFEYLHSLDLIYRDLKPENLLI--DQQGYIQVTD 184
Query: 555 MGISKRLQGDMS--CLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGK 612
G +KR++G C G+ APE +L +A+D ++LG +++ G
Sbjct: 185 FGFAKRVKGRTWTLC--------GTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAG-- 234
Query: 613 HP--YGES----FERDANIVKDRKDLFLVEHI-PEAVDLFTRLLDPNPDLR-----PKAQ 660
+P + + +E IV + + H + DL LL + R
Sbjct: 235 YPPFFADQPIQIYE---KIVSGK--VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVN 289
Query: 661 NVLNHPFFWTAD 672
++ NH +F T D
Sbjct: 290 DIKNHKWFATTD 301
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 7e-18
Identities = 61/251 (24%), Positives = 98/251 (39%), Gaps = 63/251 (25%)
Query: 378 VVFNKEIAKGSNGTVVLEGNYEGRS--VAVKRL--VKTHHDVA--LKEIQNLIASDQHPN 431
+V ++I +G+ G V G + VAVK A L+E + ++ HPN
Sbjct: 116 LVLGEQIGRGNFG-EVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEAR-ILKQYSHPN 173
Query: 432 IVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPV 491
IVR GV + + +Y+ +E V G F L + + + L
Sbjct: 174 IVRLIGVCTQKQPIYIVME----------LVQGGDFLTFL--RTEGARL----------- 210
Query: 492 MENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAK 551
LL++ D +G+ +L IHRDL +N L+++ K
Sbjct: 211 ---------------RVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKN--VLK 253
Query: 552 LSDMGISKRLQGDMSCLTQNATGYGSSG-------WQAPEQLLQGRQTRAIDLFSLGCIL 604
+SD G+S+ + S G W APE L GR + D++S G +L
Sbjct: 254 ISDFGMSREEADGVY--------AASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILL 305
Query: 605 FFCITGGKHPY 615
+ + G PY
Sbjct: 306 WETFSLGASPY 316
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 82.6 bits (205), Expect = 1e-17
Identities = 54/247 (21%), Positives = 100/247 (40%), Gaps = 59/247 (23%)
Query: 378 VVFNKEIAKGSNGTVVLEGNYEGRS-VAVKRLVKTHHDVA--LKEIQNLIASDQHPNIVR 434
+ F +EI G G +V G + + VA+K + + ++E + ++ HP +V+
Sbjct: 10 LTFVQEIGSGQFG-LVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAE-VMMKLSHPKLVQ 67
Query: 435 WYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMEN 494
YGV +Q + L E ++ G + L + Q
Sbjct: 68 LYGVCLEQAPICLVTE----------FMEHGCLSDYL--RTQRGLF-------------- 101
Query: 495 TKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSD 554
+ LL + D+ G+++L E +IHRDL +N L+ ++ K+SD
Sbjct: 102 ------------AAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGEN--QVIKVSD 147
Query: 555 MGISKRLQGDMSCLTQNATGYGSSG------WQAPEQLLQGRQTRAIDLFSLGCILFFCI 608
G+++ + D S+G W +PE R + D++S G +++
Sbjct: 148 FGMTRFVLDD--------QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVF 199
Query: 609 TGGKHPY 615
+ GK PY
Sbjct: 200 SEGKIPY 206
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 85.7 bits (212), Expect = 1e-17
Identities = 56/248 (22%), Positives = 101/248 (40%), Gaps = 61/248 (24%)
Query: 378 VVFNKEIAKGSNGTVVLEGNYEG-RSVAVKRLVK--THHDVALKEIQNLIASDQHPNIVR 434
+ ++ +G G V G + G VA+K L + L+E Q + +H +V+
Sbjct: 269 LRLEVKLGQGCFG-EVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVM-KKLRHEKLVQ 326
Query: 435 WYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMEN 494
Y V S++ +Y+ E Y+ GS + L K + L
Sbjct: 327 LYAVVSEEP-IYIVTE----------YMSKGSLLDFL--KGETGKYL------------- 360
Query: 495 TKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSD 554
QL+ + I SG++++ + +HRDL+ N+L+ ++ K++D
Sbjct: 361 ------------RLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGEN--LVCKVAD 406
Query: 555 MGISKRLQGDMSCLTQNATGYGSSG-------WQAPEQLLQGRQTRAIDLFSLGCILFFC 607
G+++ ++ + Y + W APE L GR T D++S G +L
Sbjct: 407 FGLARLIEDNE---------YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTEL 457
Query: 608 ITGGKHPY 615
T G+ PY
Sbjct: 458 TTKGRVPY 465
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 82.9 bits (205), Expect = 1e-17
Identities = 35/315 (11%), Positives = 71/315 (22%), Gaps = 111/315 (35%)
Query: 369 VDGR-RIGKLVVFNKEIAKGSNGTV------VLEGNYEGRSVAVKRLVKTHHDVA----- 416
+GR R+ L R VA+ V +
Sbjct: 29 ANGRYRLLIF------HGGVPPLQFWQALDTAL-----DRQVALT-FVDPQGVLPDDVLQ 76
Query: 417 --LKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAK 474
L L + P + R V + + E ++ GS +E +
Sbjct: 77 ETLSRTLRL-SRIDKPGVARVLDVVHTRAGGLVVAE----------WIRGGSLQEVADT- 124
Query: 475 EQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRD 534
P ++ + + + H G+
Sbjct: 125 ------------SPSP------------------VGAIRAMQSLAAAADAAHRAGVALSI 154
Query: 535 LKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRA 594
P V +S D L+
Sbjct: 155 DHPSRVRVSIDGD--VVLAYPATM-----------------------PDA-------NPQ 182
Query: 595 IDLFSLGCILFFCITGGKHPYGESFERDANIVKDRKDLF--------LVEHIPEAVD-LF 645
D+ +G L+ + + P E+ + + +D + IP + +
Sbjct: 183 DDIRGIGASLYALLV-NRWPLPEA-GVRSGLAPAERDTAGQPIEPADIDRDIPFQISAVA 240
Query: 646 TRLLDPNPDLRPKAQ 660
R + + +R +
Sbjct: 241 ARSVQGDGGIRSAST 255
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 85.2 bits (211), Expect = 2e-17
Identities = 56/248 (22%), Positives = 101/248 (40%), Gaps = 61/248 (24%)
Query: 378 VVFNKEIAKGSNGTVVLEGNYEGR-SVAVKRLVK--THHDVALKEIQNLIASDQHPNIVR 434
+ ++ +G G V G + G VA+K L + L+E Q + +H +V+
Sbjct: 186 LRLEVKLGQGCFG-EVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVM-KKLRHEKLVQ 243
Query: 435 WYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMEN 494
Y V S++ +Y+ E Y+ GS + L K + L
Sbjct: 244 LYAVVSEEP-IYIVTE----------YMSKGSLLDFL--KGETGKYL------------- 277
Query: 495 TKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSD 554
QL+ + I SG++++ + +HRDL+ N+L+ ++ K++D
Sbjct: 278 ------------RLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGEN--LVCKVAD 323
Query: 555 MGISKRLQGDMSCLTQNATGYGSSG-------WQAPEQLLQGRQTRAIDLFSLGCILFFC 607
G+++ ++ + Y + W APE L GR T D++S G +L
Sbjct: 324 FGLARLIEDNE---------YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTEL 374
Query: 608 ITGGKHPY 615
T G+ PY
Sbjct: 375 TTKGRVPY 382
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 2e-17
Identities = 73/346 (21%), Positives = 126/346 (36%), Gaps = 67/346 (19%)
Query: 294 QVKSKKQNEEHITKTGIPKKKKSRRPGYNRNTTNSEKMQNIIPNESKVGETDGLSHITGN 353
+++ + K+ RR + T ++E ++ N V T LS
Sbjct: 4 SHHHHHHSQDPPAVHKLTKRIPLRR----QVTVSAESSSSMNSNTPLVRITTRLSSTADT 59
Query: 354 GEKFLLTFTDLIDDR---VDGRRIGKLVVFNKEIAKGSNGTVVLEGNYEGRS-------- 402
++ +L +D ++ K + +G G VV G
Sbjct: 60 PMLAGVSEYELPEDPKWEFPRDKL----TLGKPLGEGCFGQVV-MAEAVGIDKDKPKEAV 114
Query: 403 -VAVKRLVKTHHDVA----LKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCSLN 457
VAVK L + + E++ + +H NI+ G + +Y+ +E
Sbjct: 115 TVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVE------- 167
Query: 458 DLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRD 517
Y G NL +R R P ME + DI L+ T
Sbjct: 168 ---YASKG-------------NLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQ 211
Query: 518 IVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGY-- 575
+ G+ +L IHRDL +NVL++++ K++D G+++ D+ N Y
Sbjct: 212 LARGMEYLASQKCIHRDLAARNVLVTENN--VMKIADFGLAR----DI-----NNIDYYK 260
Query: 576 -GSSG-----WQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY 615
++G W APE L T D++S G +++ T G PY
Sbjct: 261 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY 306
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 2e-17
Identities = 57/255 (22%), Positives = 92/255 (36%), Gaps = 43/255 (16%)
Query: 378 VVFNKEIAKGSNGTVV------LEGNYEGRSVAVKRLVKTHHDVA----LKEIQNLIASD 427
+ F K + G+ G V+ + VAVK L + + E++ +
Sbjct: 47 LEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLG 106
Query: 428 QHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIR 487
H NIV G + +YL E Y G L +K + +
Sbjct: 107 SHENIVNLLGACTLSGPIYLIFE----------YCCYGDLLNYLRSKREKFSEDEIEYEN 156
Query: 488 LLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKS 547
+ E L LL + G+ L +HRDL +NVL++ K
Sbjct: 157 QKRLEEEEDLNVL------TFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGK- 209
Query: 548 FCAKLSDMGISKRLQGDMSCLTQNATGYGSSG-------WQAPEQLLQGRQTRAIDLFSL 600
K+ D G+++ + D + Y G W APE L +G T D++S
Sbjct: 210 -VVKICDFGLARDIMSDSN--------YVVRGNARLPVKWMAPESLFEGIYTIKSDVWSY 260
Query: 601 GCILFFCITGGKHPY 615
G +L+ + G +PY
Sbjct: 261 GILLWEIFSLGVNPY 275
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 2e-17
Identities = 46/170 (27%), Positives = 79/170 (46%), Gaps = 23/170 (13%)
Query: 518 IVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGS 577
IV L HLH++G+I+RD+K +N+L+ D + L+D G+SK D + G+
Sbjct: 168 IVLALEHLHKLGIIYRDIKLENILL--DSNGHVVLTDFGLSKEFVADETERAY--DFCGT 223
Query: 578 SGWQAPEQLLQGRQ--TRAIDLFSLGCILFFCITGGKHP--YGESFERDA-----NIVKD 628
+ AP+ + G +A+D +SLG +++ +TG + + I+K
Sbjct: 224 IEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTG--ASPFTVDGEKNSQAEISRRILKS 281
Query: 629 RKDLFLVEHI-PEAVDLFTRLLDPNPDLR----PK-AQNVLNHPFFWTAD 672
+ + + A DL RLL +P R P+ A + H FF +
Sbjct: 282 --EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKIN 329
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 2e-17
Identities = 61/335 (18%), Positives = 105/335 (31%), Gaps = 101/335 (30%)
Query: 382 KEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYGV-- 438
+++ +G V N V VK L +EI+ L PNI+ +
Sbjct: 42 RKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVK 101
Query: 439 -ESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKD 497
+ + L L+ ++R +
Sbjct: 102 DPVSRTPALVFEHVNNTDFKQLYQTLT----------------DYDIRFYMY-------- 137
Query: 498 IELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCA-KLSDMG 556
++LK L + H +G++HRD+KP NV+I D +L D G
Sbjct: 138 ------------EILK-------ALDYCHSMGIMHRDVKPHNVMI--DHEHRKLRLIDWG 176
Query: 557 ISKRLQGDMSCLTQNATGYGSSGW-QAPEQLLQGRQ-TRAIDLFSLGCIL---------F 605
++ +S + + PE L+ + ++D++SLGC+L F
Sbjct: 177 LA-EFYHPGQEY----NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 231
Query: 606 FCITGGKH--------------PYGESFERDANIVKDR--------------KDLFLVEH 637
F G + NI D + E+
Sbjct: 232 FH---GHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSEN 288
Query: 638 I----PEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 668
PEA+D +LL + R A+ + HP+F
Sbjct: 289 QHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 323
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 2e-17
Identities = 58/252 (23%), Positives = 100/252 (39%), Gaps = 50/252 (19%)
Query: 378 VVFNKEIAKGSNGTVV---LEGNYEGRSVAVKRLVKTHHDVA----LKEIQNLIASDQHP 430
+ F I +G+ G V+ ++ + A+KR+ + E++ L HP
Sbjct: 27 IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHP 86
Query: 431 NIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLP 490
NI+ G + ++YL++E Y G NLL+ +R +
Sbjct: 87 NIINLLGACEHRGYLYLAIE----------YAPHG-------------NLLDFLRKSRVL 123
Query: 491 VMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCA 550
+ I A+ S QLL D+ G+ +L + IHRDL +N+L+ ++ A
Sbjct: 124 ETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY--VA 181
Query: 551 KLSDMGISKRLQGDMSCLTQNATGYGSSG-------WQAPEQLLQGRQTRAIDLFSLGCI 603
K++D G L++ Y W A E L T D++S G +
Sbjct: 182 KIADFG-----------LSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVL 230
Query: 604 LFFCITGGKHPY 615
L+ ++ G PY
Sbjct: 231 LWEIVSLGGTPY 242
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 83.8 bits (207), Expect = 3e-17
Identities = 67/400 (16%), Positives = 111/400 (27%), Gaps = 110/400 (27%)
Query: 382 KEIAKGSNGT-VVLEGNYE--GRSVAVKRL-----VKTHHDVALKEIQNLIASDQHPNIV 433
I KG V Y+ G V V+R+ E+ + HPNIV
Sbjct: 31 TVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFN-HPNIV 89
Query: 434 RWYGVESDQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVM 492
+ + +++ S DLI + +NE+ I
Sbjct: 90 PYRATFIADNELWVVTSFMAYGSAKDLI-------------CTHFMDGMNELAIAY---- 132
Query: 493 ENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKL 552
+ + ++ L ++H +G +HR +K ++LIS D L
Sbjct: 133 ---------------------ILQGVLKALDYIHHMGYVHRSVKASHILISVDGK--VYL 169
Query: 553 SDMGISKRLQGDMSCL-TQNATGYGSSG---WQAPEQLLQGRQ--TRAIDLFSLGC---- 602
S + + + + S W +PE L Q Q D++S+G
Sbjct: 170 SGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACE 229
Query: 603 ---------------ILFFCITGG--------KHPYGESFERDANIVKDRKDLFLVEHIP 639
+L + G P E + V + +
Sbjct: 230 LANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTST 289
Query: 640 EAVDLFTRLLDP-------------------NPDLRPKAQNVLNHPFFWTA-DTRLSFLR 679
P NPD RP A +LNH FF L
Sbjct: 290 PRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIKRRASEALP 349
Query: 680 DVSDRVELEDRESDSKLLRALEGIALVALN------GKWD 713
++ V + + GI + N W+
Sbjct: 350 ELLRPVT-PITNFEGSQSQDHSGIFGLVTNLEELEVDDWE 388
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 3e-17
Identities = 61/259 (23%), Positives = 100/259 (38%), Gaps = 56/259 (21%)
Query: 378 VVFNKEIAKGSNGTVVLEGNYEGRS---------VAVKRLVKTHHDVA----LKEIQNLI 424
+ K + +G+ G VV G VAVK L + + E++ +
Sbjct: 37 LTLGKPLGEGAFGQVV-MAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMK 95
Query: 425 ASDQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEV 484
+H NI+ G + +Y+ +E Y G NL +
Sbjct: 96 MIGKHKNIINLLGACTQDGPLYVIVE----------YASKG-------------NLREYL 132
Query: 485 RIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISK 544
R R P ME + DI L+ T + G+ +L IHRDL +NVL+++
Sbjct: 133 RARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTE 192
Query: 545 DKSFCAKLSDMGISKRLQGDMSCLTQNATGY---GSSG-----WQAPEQLLQGRQTRAID 596
+ K++D G+++ D+ N Y ++G W APE L T D
Sbjct: 193 NNV--MKIADFGLAR----DI-----NNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSD 241
Query: 597 LFSLGCILFFCITGGKHPY 615
++S G +++ T G PY
Sbjct: 242 VWSFGVLMWEIFTLGGSPY 260
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 3e-17
Identities = 62/257 (24%), Positives = 105/257 (40%), Gaps = 71/257 (27%)
Query: 378 VVFNKEIAKGSNGTVVLEGNYEGR---------SVAVKRLVKTHHDVA----LKEIQNLI 424
+ +K + G G V GR SVA+K L + + L E ++
Sbjct: 47 ISIDKVVGAGEFGEV-----CSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEAS-IM 100
Query: 425 ASDQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEV 484
HPNI+R GV + V + E Y+ +GS + L ++ D+
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTE----------YMENGSLDSFL--RKHDAQF---- 144
Query: 485 RIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISK 544
QL+ + R I SG+ +L ++G +HRDL +N+LI+
Sbjct: 145 ----------------------TVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINS 182
Query: 545 DKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSG------WQAPEQLLQGRQTRAIDLF 598
+ K+SD G+ + L+ D Y + G W +PE + + T A D++
Sbjct: 183 N--LVCKVSDFGLGRVLEDDPE------AAYTTRGGKIPIRWTSPEAIAYRKFTSASDVW 234
Query: 599 SLGCILFFCITGGKHPY 615
S G +L+ ++ G+ PY
Sbjct: 235 SYGIVLWEVMSYGERPY 251
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 5e-17
Identities = 57/249 (22%), Positives = 101/249 (40%), Gaps = 61/249 (24%)
Query: 378 VVFNKEIAKGSNGTVVLEGNYEGRS--VAVKRLVKTHHDVA--LKEIQNLIASDQHPNIV 433
+ ++ G G V EG ++ S VAVK L + +V LKE ++ +HPN+V
Sbjct: 15 ITMKHKLGGGQYG-EVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAA-VMKEIKHPNLV 72
Query: 434 RWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVME 493
+ GV + + Y+ E ++ G+ + L +E + +
Sbjct: 73 QLLGVCTREPPFYIITE----------FMTYGNLLDYL--RECNRQEV------------ 108
Query: 494 NTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLS 553
+ LL + I S + +L + IHRDL +N L+ ++ K++
Sbjct: 109 -------------SAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGEN--HLVKVA 153
Query: 554 DMGISKRLQGDMSCLTQNATGYGSSG-------WQAPEQLLQGRQTRAIDLFSLGCILFF 606
D G+S+ + GD Y + W APE L + + D+++ G +L+
Sbjct: 154 DFGLSRLMTGDT---------YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWE 204
Query: 607 CITGGKHPY 615
T G PY
Sbjct: 205 IATYGMSPY 213
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 5e-17
Identities = 50/257 (19%), Positives = 91/257 (35%), Gaps = 53/257 (20%)
Query: 378 VVFNKEIAKGSNGTVV------LEGNYEGRSVAVKRLVKTHHDVA----LKEIQNLIASD 427
+ K + +G+ G V+ ++ R+VAVK L + + E++ LI
Sbjct: 29 LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIG 88
Query: 428 QHPNIVRWYGVESDQDF-VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRI 486
H N+V G + + + +E + G NL +R
Sbjct: 89 HHLNVVNLLGACTKPGGPLMVIVE----------FCKFG-------------NLSTYLRS 125
Query: 487 RLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDK 546
+ + E + L+ + + G+ L IHRDL +N+L+S+
Sbjct: 126 KRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN 185
Query: 547 SFCAKLSDMGISKRLQGDMSCLTQNATGY---GSSG-----WQAPEQLLQGRQTRAIDLF 598
K+ D G+++ D+ W APE + T D++
Sbjct: 186 --VVKICDFGLAR----DI-----YKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVW 234
Query: 599 SLGCILFFCITGGKHPY 615
S G +L+ + G PY
Sbjct: 235 SFGVLLWEIFSLGASPY 251
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 6e-17
Identities = 76/358 (21%), Positives = 131/358 (36%), Gaps = 114/358 (31%)
Query: 382 KEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHHDV-----ALKEIQNLIASDQHPNIVRW 435
K I G+ G V + R+VA+K+L + + A +E+ L+ H NI+
Sbjct: 31 KPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELV-LMKCVNHKNIIGL 89
Query: 436 YGV----ESDQDF--VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLL 489
V +S ++F VY+ +E +L +I + + L+ R+ L
Sbjct: 90 LNVFTPQKSLEEFQDVYIVMELMDANLCQVI--------------QME---LDHERMSYL 132
Query: 490 PVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFC 549
L+ Q+L G+ HLH G+IHRDLKP N+++ D C
Sbjct: 133 ----------LY--------QMLC-------GIKHLHSAGIIHRDLKPSNIVVKSD---C 164
Query: 550 A-KLSDMGISKRLQGDMSCLTQNATGYGSSGW-QAPEQLLQGRQTRAIDLFSLGCILFFC 607
K+ D G+++ T Y + + +APE +L +D++S+GCI+
Sbjct: 165 TLKILDFGLARTAGTS-----FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 219
Query: 608 ITG-----GKHPY------------------------------------GESFERD-ANI 625
I G G G SFE+ ++
Sbjct: 220 IKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDV 279
Query: 626 VKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTADTRLSFLRDVSD 683
+ +A DL +++L + R L HP+ ++ D S+
Sbjct: 280 LFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPY-------INVWYDPSE 330
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 9e-17
Identities = 54/247 (21%), Positives = 100/247 (40%), Gaps = 59/247 (23%)
Query: 378 VVFNKEIAKGSNGTVVLEGNYEG-RSVAVKRLVK--THHDVALKEIQNLIASDQHPNIVR 434
+ F KE+ G G VV G + G VA+K + + D ++E + ++ + H +V+
Sbjct: 26 LTFLKELGTGQFG-VVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAK-VMMNLSHEKLVQ 83
Query: 435 WYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMEN 494
YGV + Q +++ E Y+ +G L +E
Sbjct: 84 LYGVCTKQRPIFIITE----------YMANGCLLNYL--REMRHRF-------------- 117
Query: 495 TKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSD 554
+ QLL++ +D+ + +L +HRDL +N L++ K+SD
Sbjct: 118 ------------QTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQ--GVVKVSD 163
Query: 555 MGISKRLQGDMSCLTQNATGYGSSG------WQAPEQLLQGRQTRAIDLFSLGCILFFCI 608
G+S+ + D S G W PE L+ + + D+++ G +++
Sbjct: 164 FGLSRYVLDD--------EYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIY 215
Query: 609 TGGKHPY 615
+ GK PY
Sbjct: 216 SLGKMPY 222
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 1e-16
Identities = 48/179 (26%), Positives = 71/179 (39%), Gaps = 24/179 (13%)
Query: 518 IVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATG--- 574
+V L +H +G IHRD+KP N+L+ DKS KL+D G ++ + A G
Sbjct: 177 VVLALDAIHSMGFIHRDVKPDNMLL--DKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPD 234
Query: 575 YGSSGWQAPEQLL----QGRQTRAIDLFSLGCILFFCITGGKHP--YGES-FERDANIVK 627
Y +PE L G R D +S+G L+ + G Y +S + I+
Sbjct: 235 Y-----ISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG--DTPFYADSLVGTYSKIMN 287
Query: 628 DRKDLFLVEHI---PEAVDLFTRLL-DPNPDLRPK-AQNVLNHPFFWTADTRLSFLRDV 681
+ L + EA +L L D L + + H FF LRD
Sbjct: 288 HKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWAWETLRDT 346
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 79.9 bits (198), Expect = 1e-16
Identities = 59/247 (23%), Positives = 101/247 (40%), Gaps = 59/247 (23%)
Query: 378 VVFNKEIAKGSNGTVVLEGNYEGR-SVAVKRLVK--THHDVALKEIQNLIASDQHPNIVR 434
+ KE+ G G VV G ++G+ VAVK + + D +E Q + HP +V+
Sbjct: 10 ITLLKELGSGQFG-VVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQ-TMMKLSHPKLVK 67
Query: 435 WYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMEN 494
+YGV S + +Y+ E Y+ +G L + +
Sbjct: 68 FYGVCSKEYPIYIVTE----------YISNGCLLNYLRSHGKGLEP-------------- 103
Query: 495 TKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSD 554
+QLL++ D+ G++ L IHRDL +N L+ +D C K+SD
Sbjct: 104 --------------SQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRD--LCVKVSD 147
Query: 555 MGISKRLQGDMSCLTQNATGYGSSG------WQAPEQLLQGRQTRAIDLFSLGCILFFCI 608
G+++ + D S G W APE + + D+++ G +++
Sbjct: 148 FGMTRYVLDD--------QYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVF 199
Query: 609 TGGKHPY 615
+ GK PY
Sbjct: 200 SLGKMPY 206
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 1e-16
Identities = 62/258 (24%), Positives = 104/258 (40%), Gaps = 72/258 (27%)
Query: 378 VVFNKEIAKGSNGTVVLEGNYEGR----------SVAVKRLVKTHHDVA----LKEIQNL 423
V K I G G V Y+G VA+K L + + L E +
Sbjct: 46 VTRQKVIGAGEFGEV-----YKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAG-I 99
Query: 424 IASDQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNE 483
+ H NI+R GV S + + E Y+ +G+ ++ L +E+D
Sbjct: 100 MGQFSHHNIIRLEGVISKYKPMMIITE----------YMENGALDKFL--REKDGEF--- 144
Query: 484 VRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLIS 543
QL+ + R I +G+ +L + +HRDL +N+L++
Sbjct: 145 -----------------------SVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVN 181
Query: 544 KDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSG------WQAPEQLLQGRQTRAIDL 597
+ K+SD G+S+ L+ D Y +SG W APE + + T A D+
Sbjct: 182 SN--LVCKVSDFGLSRVLEDDPE------ATYTTSGGKIPIRWTAPEAISYRKFTSASDV 233
Query: 598 FSLGCILFFCITGGKHPY 615
+S G +++ +T G+ PY
Sbjct: 234 WSFGIVMWEVMTYGERPY 251
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 1e-16
Identities = 47/167 (28%), Positives = 79/167 (47%), Gaps = 24/167 (14%)
Query: 518 IVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGS 577
IVS L +LH +++RD+K +N+++ KD K++D G+ K +S T G+
Sbjct: 114 IVSALEYLHSRDVVYRDIKLENLMLDKD-GHI-KITDFGLCKE---GISDGATMKTFCGT 168
Query: 578 SGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP--YGES----FERDANIVKDRKD 631
+ APE L RA+D + LG +++ + G Y + FE I+ + +
Sbjct: 169 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG--RLPFYNQDHERLFE---LILME--E 221
Query: 632 LFLVEHI-PEAVDLFTRLLDPNPDLR----PK-AQNVLNHPFFWTAD 672
+ + PEA L LL +P R P A+ V+ H FF + +
Sbjct: 222 IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSIN 268
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 1e-16
Identities = 58/253 (22%), Positives = 99/253 (39%), Gaps = 63/253 (24%)
Query: 378 VVFNKEIAKGSNGTVVLEGNYEGRS-----VAVKRLVKTHHDVA----LKEIQNLIASDQ 428
+ K I G +G V G VA+K L + + L E ++
Sbjct: 51 IHIEKIIGSGDSG-EVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEAS-IMGQFD 108
Query: 429 HPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRL 488
HPNI+R GV + + E Y+ +GS + L + D
Sbjct: 109 HPNIIRLEGVVTRGRLAMIVTE----------YMENGSLDTFL--RTHDGQF-------- 148
Query: 489 LPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSF 548
QL+ + R + +G+ +L ++G +HRDL +NVL+ +
Sbjct: 149 ------------------TIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSN--L 188
Query: 549 CAKLSDMGISKRLQGDMSCLTQNATGYGSSG------WQAPEQLLQGRQTRAIDLFSLGC 602
K+SD G+S+ L+ D Y ++G W APE + + A D++S G
Sbjct: 189 VCKVSDFGLSRVLEDD------PDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGV 242
Query: 603 ILFFCITGGKHPY 615
+++ + G+ PY
Sbjct: 243 VMWEVLAYGERPY 255
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 80.3 bits (199), Expect = 2e-16
Identities = 55/167 (32%), Positives = 83/167 (49%), Gaps = 24/167 (14%)
Query: 518 IVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGS 577
I L HLH+ G+I+RDLKP+N+++ + KL+D G+ K + T T G+
Sbjct: 130 ISMALGHLHQKGIIYRDLKPENIML--NHQGHVKLTDFGLCKE---SIHDGTVTHTFCGT 184
Query: 578 SGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP--YGES----FERDANIVKDRKD 631
+ APE L++ RA+D +SLG +++ +TG P GE+ + I+K
Sbjct: 185 IEYMAPEILMRSGHNRAVDWWSLGALMYDMLTG--APPFTGENRKKTID---KILKC--K 237
Query: 632 LFLVEHI-PEAVDLFTRLLDPNPDLR----PK-AQNVLNHPFFWTAD 672
L L ++ EA DL +LL N R P A V HPFF +
Sbjct: 238 LNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHIN 284
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 2e-16
Identities = 46/171 (26%), Positives = 75/171 (43%), Gaps = 22/171 (12%)
Query: 518 IVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGS 577
I L++LHE G+I+RDLK NVL+ + KL+D G+ K + +T G+
Sbjct: 119 ISLALNYLHERGIIYRDLKLDNVLLDSE-GHI-KLTDYGMCKE---GLRPGDTTSTFCGT 173
Query: 578 SGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDRKDLF---L 634
+ APE L ++D ++LG ++F + G+ P+ D LF L
Sbjct: 174 PNYIAPEILRGEDYGFSVDWWALGVLMFEMMA-GRSPFDIVGSSDNPDQNTEDYLFQVIL 232
Query: 635 VEHI-------PEAVDLFTRLLDPNPDLR----PK--AQNVLNHPFFWTAD 672
+ I +A + L+ +P R P+ ++ HPFF D
Sbjct: 233 EKQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVD 283
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 2e-16
Identities = 52/247 (21%), Positives = 95/247 (38%), Gaps = 59/247 (23%)
Query: 378 VVFNKEIAKGSNGTVVLEGNYEGR-SVAVKRLVKTHHDVA--LKEIQNLIASDQHPNIVR 434
+ K++ G G V Y VAVK + V L E + + QH +V+
Sbjct: 190 LKLEKKLGAGQFG-EVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVM-KTLQHDKLVK 247
Query: 435 WYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMEN 494
+ V + ++ +Y+ E ++ GS + L K + +
Sbjct: 248 LHAVVT-KEPIYIITE----------FMAKGSLLDFL--KSDEGSKQ------------- 281
Query: 495 TKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSD 554
P +L+ + I G++ + + IHRDL+ N+L+S K++D
Sbjct: 282 ------------PLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSAS--LVCKIAD 327
Query: 555 MGISKRLQGDMSCLTQNATGYGSSG------WQAPEQLLQGRQTRAIDLFSLGCILFFCI 608
G+++ ++ + G W APE + G T D++S G +L +
Sbjct: 328 FGLARVIEDN--------EYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIV 379
Query: 609 TGGKHPY 615
T G+ PY
Sbjct: 380 TYGRIPY 386
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 79.9 bits (198), Expect = 2e-16
Identities = 66/314 (21%), Positives = 121/314 (38%), Gaps = 78/314 (24%)
Query: 380 FNKEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHDVALKEIQ------NLIASDQHPNI 432
+ + GS G V L + GR A+K L K V LK+++ +++ HP I
Sbjct: 10 ILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKK-EIVVRLKQVEHTNDERLMLSIVTHPFI 68
Query: 433 VRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVM 492
+R +G D +++ ++ Y+ G L + S +
Sbjct: 69 IRMWGTFQDAQQIFMIMD----------YIEGGELFSLL----RKSQRFPNPVAKFY--- 111
Query: 493 ENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKL 552
+A+ + L +LH +I+RDLKP+N+L+ DK+ K+
Sbjct: 112 ---------------AAE-------VCLALEYLHSKDIIYRDLKPENILL--DKNGHIKI 147
Query: 553 SDMGISKRLQGDMS--CLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG 610
+D G +K + C G+ + APE + ++ID +S G +++ + G
Sbjct: 148 TDFGFAKYVPDVTYTLC--------GTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAG 199
Query: 611 GKHP--YGES----FERDANIVKDRKDLFLVEHI-PEAVDLFTRLLDPNPDLR-----PK 658
+ Y + +E I+ L + DL +RL+ + R
Sbjct: 200 --YTPFYDSNTMKTYE---KILNAE--LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNG 252
Query: 659 AQNVLNHPFFWTAD 672
++V NHP+F
Sbjct: 253 TEDVKNHPWFKEVV 266
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 2e-16
Identities = 48/175 (27%), Positives = 72/175 (41%), Gaps = 30/175 (17%)
Query: 518 IVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATG--- 574
IV + +H +G +HRD+KP N+L+ D+ +L+D G +L+ D + + A G
Sbjct: 171 IVMAIDSVHRLGYVHRDIKPDNILL--DRCGHIRLADFGSCLKLRADGTVRSLVAVGTPD 228
Query: 575 YGSSGWQAPEQLL-------QGRQTRAIDLFSLGCILFFCITGGKHP--YGESFERD-AN 624
Y +PE L G D ++LG + G Y +S
Sbjct: 229 Y-----LSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYG--QTPFYADSTAETYGK 281
Query: 625 IVKDRKDLFLVEHI----PEAVDLFTRLLDPNPDLR---PKAQNVLNHPFFWTAD 672
IV ++ L L EA D RLL P+ R A + HPFF+ D
Sbjct: 282 IVHYKEHLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGLD 335
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 3e-16
Identities = 61/253 (24%), Positives = 97/253 (38%), Gaps = 64/253 (25%)
Query: 378 VVFNKEIAKGSNGTVVLEGNYEGRS------VAVKRLVKTHHDVALKEIQ---NLIASDQ 428
K + G+ GTV +G + VA+K L + A KEI ++AS
Sbjct: 17 FKKIKVLGSGAFGTVY-KGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 429 HPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRL 488
+P++ R G+ V L + + G LL+ VR
Sbjct: 76 NPHVCRLLGICLTST-VQLITQ----------LMPFGC-------------LLDYVR--- 108
Query: 489 LPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSF 548
E+ +I S LL I G+++L + L+HRDL +NVL+
Sbjct: 109 ----EHKDNI--------GSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTP--Q 154
Query: 549 CAKLSDMGISKRLQGDMSCLTQNATGYGSSG------WQAPEQLLQGRQTRAIDLFSLGC 602
K++D G++K L + Y + G W A E +L T D++S G
Sbjct: 155 HVKITDFGLAKLLGAEEKE-------YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGV 207
Query: 603 ILFFCITGGKHPY 615
++ +T G PY
Sbjct: 208 TVWELMTFGSKPY 220
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 3e-16
Identities = 55/258 (21%), Positives = 97/258 (37%), Gaps = 67/258 (25%)
Query: 376 KLVVFNKEIAKGSNGTVVLEGNYEGRS----VAVKRL-----VKTHHDVALKEIQNLIAS 426
L + +KE+ G+ G V +G Y+ + VAVK L D L E ++
Sbjct: 17 LLTLEDKELGSGNFG-TVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEAN-VMQQ 74
Query: 427 DQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRI 486
+P IVR G+ + + L +E G L ++
Sbjct: 75 LDNPYIVRMIGI-CEAESWMLVME----------MAELGP-------------LNKYLQ- 109
Query: 487 RLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDK 546
+ ++++ + G+ +L E +HRDL +NVL+
Sbjct: 110 ---------------QNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQH 154
Query: 547 SFCAKLSDMGISKRLQGDMSCLTQNATGYGSSG-------WQAPEQLLQGRQTRAIDLFS 599
AK+SD G+SK L+ D + Y + W APE + + + D++S
Sbjct: 155 --YAKISDFGLSKALRADENY-------YKAQTHGKWPVKWYAPECINYYKFSSKSDVWS 205
Query: 600 LGCILFFCITGGKHPYGE 617
G +++ + G+ PY
Sbjct: 206 FGVLMWEAFSYGQKPYRG 223
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 3e-16
Identities = 60/276 (21%), Positives = 104/276 (37%), Gaps = 65/276 (23%)
Query: 378 VVFNKEIAKGSNGTVVL-----EGNYEGRSVAVKRLVKTHHDVA---LKEIQNLIASDQH 429
+ + ++ KG+ G+V L G+ G VAVK+L + D +EIQ ++ +
Sbjct: 25 LKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQ-ILKALHS 83
Query: 430 PNIVRWYGV--ESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIR 487
IV++ GV + + L +E Y+ SG + L + + L
Sbjct: 84 DFIVKYRGVSYGPGRQSLRLVME----------YLPSGCLRDFL--QRHRARL------- 124
Query: 488 LLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKS 547
+++LL + I G+ +L +HRDL +N+L+ +
Sbjct: 125 -------------------DASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESE-- 163
Query: 548 FCAKLSDMGISKRLQGDMSCLTQNATGYGSSG-------WQAPEQLLQGRQTRAIDLFSL 600
K++D G++K L D Y W APE L +R D++S
Sbjct: 164 AHVKIADFGLAKLLPLDKDY-------YVVREPGQSPIFWYAPESLSDNIFSRQSDVWSF 216
Query: 601 GCILFFCITGGKHPYGESFERDANIVKDRKDLFLVE 636
G +L+ T S E + +R L
Sbjct: 217 GVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSR 252
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 79.5 bits (197), Expect = 3e-16
Identities = 50/170 (29%), Positives = 78/170 (45%), Gaps = 30/170 (17%)
Query: 518 IVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGY-- 575
+ L HLH +G+I+RDLKP+N+L+ D+ KL+D G+SK + Y
Sbjct: 135 LALALDHLHSLGIIYRDLKPENILL--DEEGHIKLTDFGLSKE------SIDHEKKAYSF 186
Query: 576 -GSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP--YGES----FERDANIVKD 628
G+ + APE + + T++ D +S G ++F +TG G+ I+K
Sbjct: 187 CGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG--TLPFQGKDRKETMT---MILKA 241
Query: 629 RKDLFLVEHI-PEAVDLFTRLLDPNPDLR----PK-AQNVLNHPFFWTAD 672
L + + + PEA L L NP R P + + H FF T D
Sbjct: 242 --KLGMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTID 289
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 4e-16
Identities = 59/246 (23%), Positives = 98/246 (39%), Gaps = 61/246 (24%)
Query: 378 VVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVA-LKEIQNLIASDQHPNIVRWY 436
+ + I KG G V+ G+Y G VAVK + A L E + +H N+V+
Sbjct: 195 LKLLQTIGKGEFG-DVMLGDYRGNKVAVKCIKNDATAQAFLAEASVM-TQLRHSNLVQLL 252
Query: 437 GVES-DQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENT 495
GV ++ +Y+ E Y+ GS + L + + ++L
Sbjct: 253 GVIVEEKGGLYIVTE----------YMAKGSLVDYL--RSRGRSVL-------------- 286
Query: 496 KDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDM 555
LLK + D+ + +L +HRDL +NVL+S+D AK+SD
Sbjct: 287 -----------GGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSED--NVAKVSDF 333
Query: 556 GISKRLQGDMSCLTQNATGYGSSG------WQAPEQLLQGRQTRAIDLFSLGCILFFCIT 609
G++K W APE L + + + D++S G +L+ +
Sbjct: 334 GLTKEAS------------STQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYS 381
Query: 610 GGKHPY 615
G+ PY
Sbjct: 382 FGRVPY 387
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 4e-16
Identities = 59/259 (22%), Positives = 100/259 (38%), Gaps = 56/259 (21%)
Query: 378 VVFNKEIAKGSNGTVVLEGNYEGRS---------VAVKRLVKTHHDVA----LKEIQNLI 424
+V K + +G+ G VV G VAVK L + + E++ +
Sbjct: 71 LVLGKPLGEGAFGQVV-LAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMK 129
Query: 425 ASDQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEV 484
+H NI+ G + +Y+ +E Y G NL +
Sbjct: 130 MIGKHKNIINLLGACTQDGPLYVIVE----------YASKG-------------NLREYL 166
Query: 485 RIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISK 544
+ R P +E + + S L+ + G+ +L IHRDL +NVL+++
Sbjct: 167 QARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTE 226
Query: 545 DKSFCAKLSDMGISKRLQGDMSCLTQNATGY---GSSG-----WQAPEQLLQGRQTRAID 596
D K++D G+++ D+ + Y ++G W APE L T D
Sbjct: 227 DN--VMKIADFGLAR----DI-----HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSD 275
Query: 597 LFSLGCILFFCITGGKHPY 615
++S G +L+ T G PY
Sbjct: 276 VWSFGVLLWEIFTLGGSPY 294
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 81.5 bits (201), Expect = 4e-16
Identities = 67/363 (18%), Positives = 125/363 (34%), Gaps = 61/363 (16%)
Query: 261 HAFVEGFRSYIQSFIVLFIALCPIIGFLFYHSKQVKSKKQNEEHITKTGIPKKKKSRRPG 320
VE + I CP + + H + P+++
Sbjct: 233 WQLVEYLKLKADGLIYCLKEACPNSS---ASNASGAAAPTLPAHPSTLTHPQRRIDTLNS 289
Query: 321 YNRNTTNSEKMQNIIPNESKVGETDGLSHITGNGEKFLLTFTDLIDDRVDGRRIGKLVVF 380
+ T ++ + +T + E+ L D L++
Sbjct: 290 -DGYTPEPARITSPDKPRPMPMDTSVFESPFSDPEELKDKKLFLKRD--------NLLIA 340
Query: 381 NKEIAKGSNGTVVLEGNYEGRS----VAVKRLVKTHHDVALKEIQ---NLIASDQHPNIV 433
+ E+ G+ G+V +G Y R VA+K L + +E+ ++ +P IV
Sbjct: 341 DIELGCGNFGSV-RQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIV 399
Query: 434 RWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVME 493
R GV + + L +E G + L + +
Sbjct: 400 RLIGVCQAEA-LMLVME----------MAGGGPLHKFL--VGKREEI------------- 433
Query: 494 NTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLS 553
P + + ++ + G+ +L E +HR+L +NVL+ AK+S
Sbjct: 434 -------------PVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRH--YAKIS 478
Query: 554 DMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKH 613
D G+SK L D S T + G W APE + + + D++S G ++ ++ G+
Sbjct: 479 DFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQK 538
Query: 614 PYG 616
PY
Sbjct: 539 PYK 541
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 4e-16
Identities = 59/246 (23%), Positives = 99/246 (40%), Gaps = 61/246 (24%)
Query: 378 VVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVA-LKEIQNLIASDQHPNIVRWY 436
+ + I KG G V+ G+Y G VAVK + A L E ++ +H N+V+
Sbjct: 23 LKLLQTIGKGEFG-DVMLGDYRGNKVAVKCIKNDATAQAFLAEAS-VMTQLRHSNLVQLL 80
Query: 437 GVESDQD-FVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENT 495
GV ++ +Y+ E Y+ GS + L + + ++L
Sbjct: 81 GVIVEEKGGLYIVTE----------YMAKGSLVDYL--RSRGRSVL-------------- 114
Query: 496 KDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDM 555
LLK + D+ + +L +HRDL +NVL+S+D AK+SD
Sbjct: 115 -----------GGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSED--NVAKVSDF 161
Query: 556 GISKRLQGDMSCLTQNATGYGSSG------WQAPEQLLQGRQTRAIDLFSLGCILFFCIT 609
G++K W APE L + + + D++S G +L+ +
Sbjct: 162 GLTKEAS------------STQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYS 209
Query: 610 GGKHPY 615
G+ PY
Sbjct: 210 FGRVPY 215
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 81.0 bits (200), Expect = 4e-16
Identities = 72/343 (20%), Positives = 124/343 (36%), Gaps = 107/343 (31%)
Query: 382 KEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHHDV-----ALKEIQNLIASDQHPNIVRW 435
K I G+ G V + R+VA+K+L + + A +E+ L+ H NI+
Sbjct: 68 KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELV-LMKCVNHKNIISL 126
Query: 436 YGV----ESDQDF--VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLL 489
V ++ ++F VYL +E +L +I L+ R+ L
Sbjct: 127 LNVFTPQKTLEEFQDVYLVMELMDANLCQVI-----------------QMELDHERMSYL 169
Query: 490 PVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFC 549
Q+L G+ HLH G+IHRDLKP N+++ D C
Sbjct: 170 ------------------LYQMLC-------GIKHLHSAGIIHRDLKPSNIVVKSD---C 201
Query: 550 A-KLSDMGISKRLQGDMSCLTQNATGYGSSGW-QAPEQLLQGRQTRAIDLFSLGCILFFC 607
K+ D G++ R G + T Y + + +APE +L +D++S+GCI+
Sbjct: 202 TLKILDFGLA-RTAGTSFMM----TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 256
Query: 608 ITG-----GKH--------------PYGESFER---DA--------------------NI 625
+ G+ P E ++ +
Sbjct: 257 VRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDS 316
Query: 626 VKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 668
+ +A DL +++L +P R + L HP+
Sbjct: 317 LFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 359
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 4e-16
Identities = 45/171 (26%), Positives = 73/171 (42%), Gaps = 22/171 (12%)
Query: 518 IVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGS 577
I L++LHE G+I+RDLK NVL+ + KL+D G+ K + +T G+
Sbjct: 162 ISLALNYLHERGIIYRDLKLDNVLLDSE-GHI-KLTDYGMCKE---GLRPGDTTSTFCGT 216
Query: 578 SGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDRKDLF---L 634
+ APE L ++D ++LG ++F + G+ P+ D LF L
Sbjct: 217 PNYIAPEILRGEDYGFSVDWWALGVLMFEMMA-GRSPFDIVGSSDNPDQNTEDYLFQVIL 275
Query: 635 VEHI-------PEAVDLFTRLLDPNPDLR------PKAQNVLNHPFFWTAD 672
+ I +A + L+ +P R ++ HPFF D
Sbjct: 276 EKQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVD 326
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 80.6 bits (199), Expect = 4e-16
Identities = 42/168 (25%), Positives = 71/168 (42%), Gaps = 26/168 (15%)
Query: 518 IVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATG--- 574
+V + +H++ +HRD+KP N+L+ D + +L+D G +L D + + A G
Sbjct: 184 MVIAIDSVHQLHYVHRDIKPDNILM--DMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPD 241
Query: 575 YGSSGWQAPEQLL-----QGRQTRAIDLFSLGCILFFCITGGKHP--YGESFERD-ANIV 626
Y +PE L +GR D +SLG ++ + G Y ES I+
Sbjct: 242 Y-----ISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYG--ETPFYAESLVETYGKIM 294
Query: 627 KDRKDLFLVEHI----PEAVDLFTRLLDPNPD-L-RPKAQNVLNHPFF 668
++ + A DL RL+ L + ++ HPFF
Sbjct: 295 NHKERFQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFF 342
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 4e-16
Identities = 59/257 (22%), Positives = 93/257 (36%), Gaps = 56/257 (21%)
Query: 378 VVFNKEIAKGSNGTVVLEGNYEG-------RSVAVKRLVKTHHDVA----LKEIQNLIAS 426
+ F K + G+ G VV E G VAVK L T H + E++ +
Sbjct: 48 LQFGKTLGAGAFGKVV-EATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHL 106
Query: 427 DQHPNIVRWYGVESDQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVR 485
QH NIV G + V + E C L + + S E +S
Sbjct: 107 GQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTA----- 161
Query: 486 IRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKD 545
+ LL + + G++ L IHRD+ +NVL++
Sbjct: 162 ---------------------STRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNG 200
Query: 546 KSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSG-------WQAPEQLLQGRQTRAIDLF 598
AK+ D G+++ + D + Y G W APE + T D++
Sbjct: 201 H--VAKIGDFGLARDIMNDSN--------YIVKGNARLPVKWMAPESIFDCVYTVQSDVW 250
Query: 599 SLGCILFFCITGGKHPY 615
S G +L+ + G +PY
Sbjct: 251 SYGILLWEIFSLGLNPY 267
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 6e-16
Identities = 45/169 (26%), Positives = 74/169 (43%), Gaps = 29/169 (17%)
Query: 518 IVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGY-- 575
I S L +LH + +++RDLKP+N+L+ D L+D G+ K + N+T
Sbjct: 148 IASALGYLHSLNIVYRDLKPENILL--DSQGHIVLTDFGLCKE------NIEHNSTTSTF 199
Query: 576 -GSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP--YGES----FERDANIVKD 628
G+ + APE L + R +D + LG +L+ + G P Y + ++ NI+
Sbjct: 200 CGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYG--LPPFYSRNTAEMYD---NILNK 254
Query: 629 RKDLFLVEHI-PEAVDLFTRLLDPNPDLR----PKAQNVLNHPFFWTAD 672
L L +I A L LL + R + +H FF +
Sbjct: 255 --PLQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLIN 301
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 7e-16
Identities = 63/257 (24%), Positives = 105/257 (40%), Gaps = 47/257 (18%)
Query: 378 VVFNKEIAKGSNGTVV------LEGNYEGRSVAVKRLVKTHHDVA----LKEIQNLIASD 427
+V K + +G G VV L+G +VAVK L + L E N++
Sbjct: 25 LVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEF-NVLKQV 83
Query: 428 QHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQL-NAKEQDSNLLNEVRI 486
HP++++ YG S + L +E Y GS L +++ L
Sbjct: 84 NHPHVIKLYGACSQDGPLLLIVE----------YAKYGSLRGFLRESRKVGPGYLGSGGS 133
Query: 487 RLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDK 546
R +++ + L L+ I G+ +L E+ L+HRDL +N+L+++ +
Sbjct: 134 RNSSSLDHPDERAL------TMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGR 187
Query: 547 SFCAKLSDMGISKRLQGDMSCLTQNATGY---GSSG-----WQAPEQLLQGRQTRAIDLF 598
K+SD G+S+ D+ S G W A E L T D++
Sbjct: 188 --KMKISDFGLSR----DV-----YEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVW 236
Query: 599 SLGCILFFCITGGKHPY 615
S G +L+ +T G +PY
Sbjct: 237 SFGVLLWEIVTLGGNPY 253
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 1e-15
Identities = 40/167 (23%), Positives = 76/167 (45%), Gaps = 24/167 (14%)
Query: 518 IVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGS 577
I GL L G+I+RDLK NV++ + K++D G+ K ++ T G+
Sbjct: 130 IAIGLFFLQSKGIIYRDLKLDNVMLDSE-GHI-KIADFGMCKE---NIWDGVTTKTFCGT 184
Query: 578 SGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP--YGES----FERDANIVKDRKD 631
+ APE + +++D ++ G +L+ + G GE F+ +I++ +
Sbjct: 185 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAG--QAPFEGEDEDELFQ---SIMEH--N 237
Query: 632 LFLVEHI-PEAVDLFTRLLDPNPDLR----PK-AQNVLNHPFFWTAD 672
+ + + EAV + L+ +P R P+ +++ H FF D
Sbjct: 238 VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYID 284
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 1e-15
Identities = 53/257 (20%), Positives = 101/257 (39%), Gaps = 61/257 (23%)
Query: 378 VVFNKEIAKGSNGTVVLEGNYEGRS-------VAVKRLVKTHHDVA----LKEIQNLIAS 426
+ ++E+ +GS G V EG +G VA+K + + L E ++
Sbjct: 27 ITMSRELGQGSFGMVY-EGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS-VMKE 84
Query: 427 DQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRI 486
++VR GV S + +E + G +L + +R
Sbjct: 85 FNCHHVVRLLGVVSQGQPTLVIME----------LMTRG-------------DLKSYLRS 121
Query: 487 RLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDK 546
+ N ++++++ +I G+++L+ +HRDL +N ++++D
Sbjct: 122 LRPAMANNPVLAPP------SLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAED- 174
Query: 547 SFCAKLSDMGISKRLQGDMSCLTQNATGY---GSSG-----WQAPEQLLQGRQTRAIDLF 598
F K+ D G+++ + T Y G G W +PE L G T D++
Sbjct: 175 -FTVKIGDFGMTRDIY---------ETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVW 224
Query: 599 SLGCILFFCITGGKHPY 615
S G +L+ T + PY
Sbjct: 225 SFGVVLWEIATLAEQPY 241
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 1e-15
Identities = 57/257 (22%), Positives = 94/257 (36%), Gaps = 60/257 (23%)
Query: 378 VVFNKEIAKGSNGTVVL-----EGNYEGRSVAVKRLVKTHHDVA-----LKEIQNLIASD 427
+ +++ +G G V L + G VAVK L K +EI ++ +
Sbjct: 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKAL-KADAGPQHRSGWKQEID-ILRTL 90
Query: 428 QHPNIVRWYGV--ESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVR 485
H +I+++ G ++ + L +E YV GS + L
Sbjct: 91 YHEHIIKYKGCCEDAGAASLQLVME----------YVPLGSLRDYL-------------- 126
Query: 486 IRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKD 545
+ AQLL + I G+++LH IHRDL +NVL+ D
Sbjct: 127 ----------------PRHSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDND 170
Query: 546 KSFCAKLSDMGISKRLQGDMSCLTQNATGYGSS--GWQAPEQLLQGRQTRAIDLFSLGCI 603
K+ D G++K + G S W APE L + + A D++S G
Sbjct: 171 --RLVKIGDFGLAKAVPEGHEYYR--VREDGDSPVFWYAPECLKEYKFYYASDVWSFGVT 226
Query: 604 LFFCITGGKHPYGESFE 620
L+ +T +
Sbjct: 227 LYELLTHCDSSQSPPTK 243
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 1e-15
Identities = 46/163 (28%), Positives = 76/163 (46%), Gaps = 20/163 (12%)
Query: 518 IVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGS 577
I+ GL LH G+++RDLK N+L+ KD K++D G+ K +M + T G+
Sbjct: 127 IILGLQFLHSKGIVYRDLKLDNILLDKD-GHI-KIADFGMCKE---NMLGDAKTNTFCGT 181
Query: 578 SGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP--YGES----FERDANIVKDRKD 631
+ APE LL + ++D +S G +L+ + G +G+ F +I D +
Sbjct: 182 PDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIG--QSPFHGQDEEELFH---SIRMD--N 234
Query: 632 LFLVEHI-PEAVDLFTRLLDPNPDLRPKAQN-VLNHPFFWTAD 672
F + EA DL +L P+ R + + HP F +
Sbjct: 235 PFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREIN 277
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 1e-15
Identities = 45/165 (27%), Positives = 78/165 (47%), Gaps = 19/165 (11%)
Query: 518 IVSGLSHLH-EIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYG 576
IVS L +LH E +++RDLK +N+++ DK K++D G+ K + T G
Sbjct: 257 IVSALDYLHSEKNVVYRDLKLENLML--DKDGHIKITDFGLCKE---GIKDGATMKTFCG 311
Query: 577 SSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP--YGESFERD-ANIVKDRKDLF 633
+ + APE L RA+D + LG +++ + G Y + E+ I+ + ++
Sbjct: 312 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG--RLPFYNQDHEKLFELILME--EIR 367
Query: 634 LVEHI-PEAVDLFTRLLDPNPDLR----PK-AQNVLNHPFFWTAD 672
+ PEA L + LL +P R + A+ ++ H FF
Sbjct: 368 FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIV 412
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 1e-15
Identities = 48/168 (28%), Positives = 77/168 (45%), Gaps = 25/168 (14%)
Query: 518 IVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGS 577
I+S L LH+ G+I+RDLK NVL+ + C KL+D G+ K + AT G+
Sbjct: 133 IISALMFLHDKGIIYRDLKLDNVLLDHE-GHC-KLADFGMCKE---GICNGVTTATFCGT 187
Query: 578 SGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP--YGES----FERDANIVKDRKD 631
+ APE L + A+D +++G +L+ + G H E+ FE I+ D +
Sbjct: 188 PDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCG--HAPFEAENEDDLFE---AILND--E 240
Query: 632 LFLVEHI-PEAVDLFTRLLDPNPDLR------PKAQNVLNHPFFWTAD 672
+ + +A + + NP +R +L HPFF D
Sbjct: 241 VVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEID 288
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 1e-15
Identities = 68/294 (23%), Positives = 119/294 (40%), Gaps = 67/294 (22%)
Query: 378 VVFNKEIAKGSNGTVVL-----EGNYEGRSVAVKRLVKTHHDVA---LKEIQNLIASDQH 429
+ F +++ KG+ G+V + + G VAVK+L + + +EI+ ++ S QH
Sbjct: 12 LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIE-ILKSLQH 70
Query: 430 PNIVRWYGV--ESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIR 487
NIV++ GV + + + L +E Y+ GS + L ++ +
Sbjct: 71 DNIVKYKGVCYSAGRRNLKLIME----------YLPYGSLRDYL--QKHKERI------- 111
Query: 488 LLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKS 547
+LL+ T I G+ +L IHRDL +N+L+ +
Sbjct: 112 -------------------DHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENE-- 150
Query: 548 FCAKLSDMGISKRLQGDMSCLTQNATGYGSSG-------WQAPEQLLQGRQTRAIDLFSL 600
K+ D G++K L D + W APE L + + + A D++S
Sbjct: 151 NRVKIGDFGLTKVLPQDKEF-------FKVKEPGESPIFWYAPESLTESKFSVASDVWSF 203
Query: 601 GCILFFCITGGKHPYGESFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPD 654
G +L+ T + E I D++ +V H+ E + RL P PD
Sbjct: 204 GVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRL--PRPD 255
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 79.5 bits (196), Expect = 2e-15
Identities = 64/327 (19%), Positives = 117/327 (35%), Gaps = 70/327 (21%)
Query: 303 EHITKTGIPKKKKSRRPGYNRNTTNSEKMQNIIPNESKVGETDGLSHITGNGEKFLLTFT 362
I +K+ R + + + Q + + V ETD + I + T+T
Sbjct: 323 GATQSFIIRPQKEGERALPSIPKLANNEKQGVRSHTVSVSETDDYAEIIDEED----TYT 378
Query: 363 DLIDDRVDGRRIGKLVVFNKEIAKGSNGTVVLEGNYEGRS-----VAVKRLVKTHHDVAL 417
+ +R + + + I +G G V +G Y VA+K D
Sbjct: 379 MPSTRDYEIQR--ERIELGRCIGEGQFGDVH-QGIYMSPENPAMAVAIKTCKNCTSDSVR 435
Query: 418 KEIQ---NLIASDQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAK 474
++ + HP+IV+ GV ++ V++ +E G L +
Sbjct: 436 EKFLQEALTMRQFDHPHIVKLIGVITENP-VWIIME----------LCTLGELRSFL--Q 482
Query: 475 EQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRD 534
+ +L A L+ + + L++L +HRD
Sbjct: 483 VRKFSL--------------------------DLASLILYAYQLSTALAYLESKRFVHRD 516
Query: 535 LKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSG------WQAPEQLLQ 588
+ +NVL+S + C KL D G+S+ ++ T Y +S W APE +
Sbjct: 517 IAARNVLVSSN--DCVKLGDFGLSRYMEDS--------TYYKASKGKLPIKWMAPESINF 566
Query: 589 GRQTRAIDLFSLGCILFFCITGGKHPY 615
R T A D++ G ++ + G P+
Sbjct: 567 RRFTSASDVWMFGVCMWEILMHGVKPF 593
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 2e-15
Identities = 53/256 (20%), Positives = 97/256 (37%), Gaps = 45/256 (17%)
Query: 378 VVFNKEIAKGSNGTVV------LEGNYEGRSVAVKRLVKTHHDVA----LKEIQNLIASD 427
+ + ++I +G+ G V L VAVK L + +E L+A
Sbjct: 49 IEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAA-LMAEF 107
Query: 428 QHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIR 487
+PNIV+ GV + + L E Y+ G E L + +
Sbjct: 108 DNPNIVKLLGVCAVGKPMCLLFE----------YMAYGDLNEFLRSMSPHTVCSLSHSDL 157
Query: 488 LLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKS 547
++ A+ L + R + +G+++L E +HRDL +N L+ ++
Sbjct: 158 STRARVSSPGPPPL-----SCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGEN-- 210
Query: 548 FCAKLSDMGISKRLQGDMSCLTQNATGY---GSSG-----WQAPEQLLQGRQTRAIDLFS 599
K++D G+S+ + + Y + W PE + R T D+++
Sbjct: 211 MVVKIADFGLSRNIY---------SADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWA 261
Query: 600 LGCILFFCITGGKHPY 615
G +L+ + G PY
Sbjct: 262 YGVVLWEIFSYGLQPY 277
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 3e-15
Identities = 54/256 (21%), Positives = 98/256 (38%), Gaps = 63/256 (24%)
Query: 376 KLVVFNKEIAKGSNGTV---VLEGNYEGRSVAVKRLVKTHHDVA----LKEIQNLIASDQ 428
L++ + E+ G+ G+V V + VA+K L + ++E Q ++
Sbjct: 10 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQ-IMHQLD 68
Query: 429 HPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRL 488
+P IVR GV + + L +E G + L + +
Sbjct: 69 NPYIVRLIGV-CQAEALMLVME----------MAGGGPLHKFL--VGKREEI-------- 107
Query: 489 LPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSF 548
P + + ++ + G+ +L E +HRDL +NVL+
Sbjct: 108 ------------------PVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRH-- 147
Query: 549 CAKLSDMGISKRLQGDMSCLTQNATGYGSSG-------WQAPEQLLQGRQTRAIDLFSLG 601
AK+SD G+SK L D S Y + W APE + + + D++S G
Sbjct: 148 YAKISDFGLSKALGADDSY-------YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYG 200
Query: 602 CILFFCITGGKHPYGE 617
++ ++ G+ PY +
Sbjct: 201 VTMWEALSYGQKPYKK 216
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 78.9 bits (194), Expect = 3e-15
Identities = 40/167 (23%), Positives = 76/167 (45%), Gaps = 24/167 (14%)
Query: 518 IVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGS 577
I GL L G+I+RDLK NV++ + K++D G+ K ++ T G+
Sbjct: 451 IAIGLFFLQSKGIIYRDLKLDNVMLDSE-GHI-KIADFGMCKE---NIWDGVTTKTFCGT 505
Query: 578 SGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP--YGES----FERDANIVKDRKD 631
+ APE + +++D ++ G +L+ + G GE F+ +I++ +
Sbjct: 506 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAG--QAPFEGEDEDELFQ---SIMEH--N 558
Query: 632 LFLVEHI-PEAVDLFTRLLDPNPDLR----PK-AQNVLNHPFFWTAD 672
+ + + EAV + L+ +P R P+ +++ H FF D
Sbjct: 559 VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYID 605
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 3e-15
Identities = 70/294 (23%), Positives = 119/294 (40%), Gaps = 67/294 (22%)
Query: 378 VVFNKEIAKGSNGTVVL-----EGNYEGRSVAVKRL---VKTHHDVALKEIQNLIASDQH 429
+ F +++ KG+ G+V + + G VAVK+L + H +EI+ ++ S QH
Sbjct: 43 LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIE-ILKSLQH 101
Query: 430 PNIVRWYGV--ESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIR 487
NIV++ GV + + + L +E Y+ GS + L ++ +
Sbjct: 102 DNIVKYKGVCYSAGRRNLKLIME----------YLPYGSLRDYL--QKHKERI------- 142
Query: 488 LLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKS 547
+LL+ T I G+ +L IHRDL +N+L+ +
Sbjct: 143 -------------------DHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENE-- 181
Query: 548 FCAKLSDMGISKRLQGDMSCLTQNATGYGSSG-------WQAPEQLLQGRQTRAIDLFSL 600
K+ D G++K L D Y W APE L + + + A D++S
Sbjct: 182 NRVKIGDFGLTKVLPQDKEY-------YKVKEPGESPIFWYAPESLTESKFSVASDVWSF 234
Query: 601 GCILFFCITGGKHPYGESFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPD 654
G +L+ T + E I D++ +V H+ E + RL P PD
Sbjct: 235 GVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRL--PRPD 286
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 3e-15
Identities = 53/256 (20%), Positives = 97/256 (37%), Gaps = 53/256 (20%)
Query: 378 VVFNKEIAKGSNGTVVLEGNYEGRS-------VAVKRLVKTHHDVA----LKEIQNLIAS 426
V F +E+ + G V +G+ G + VA+K L E L A
Sbjct: 11 VRFMEELGEDRFGKVY-KGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAM-LRAR 68
Query: 427 DQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRI 486
QHPN+V GV + + + ++ F + +L + +
Sbjct: 69 LQHPNVVCLLGV---------------VTKDQPLSMI---FSYCSH-----GDLHEFLVM 105
Query: 487 RLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDK 546
R + D + + + + I +G+ +L ++H+DL +NVL+
Sbjct: 106 RSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDK- 164
Query: 547 SFCAKLSDMGISKRLQGDMSCLTQNATGYGSSG-------WQAPEQLLQGRQTRAIDLFS 599
K+SD+G+ + + A Y G W APE ++ G+ + D++S
Sbjct: 165 -LNVKISDLGLFREV--------YAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWS 215
Query: 600 LGCILFFCITGGKHPY 615
G +L+ + G PY
Sbjct: 216 YGVVLWEVFSYGLQPY 231
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 5e-15
Identities = 60/247 (24%), Positives = 95/247 (38%), Gaps = 59/247 (23%)
Query: 378 VVFNKEIAKGSNGTVVLEGNYEGR-SVAVKRLVKTHHDVA--LKEIQNLIASDQHPNIVR 434
+ + + G G V G Y G VAVK L + L E L+ QH +VR
Sbjct: 15 LKLVERLGAGQFG-EVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEAN-LMKQLQHQRLVR 72
Query: 435 WYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMEN 494
Y V + Q+ +Y+ E Y+ +GS + L K L
Sbjct: 73 LYAVVT-QEPIYIITE----------YMENGSLVDFL--KTPSGIKLT------------ 107
Query: 495 TKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSD 554
+LL + I G++ + E IHRDL+ N+L+S K++D
Sbjct: 108 -------------INKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDT--LSCKIAD 152
Query: 555 MGISKRLQGDMSCLTQNATGYGSSG------WQAPEQLLQGRQTRAIDLFSLGCILFFCI 608
G+++ ++ + G W APE + G T D++S G +L +
Sbjct: 153 FGLARLIEDN--------EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIV 204
Query: 609 TGGKHPY 615
T G+ PY
Sbjct: 205 THGRIPY 211
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 76.5 bits (188), Expect = 5e-15
Identities = 53/283 (18%), Positives = 101/283 (35%), Gaps = 55/283 (19%)
Query: 378 VVFNKEIAKGSNGTVV------LEGNYEGRSVAVKRLVKTHHD----VALKEIQNLIASD 427
+ K + +G+ G V+ ++ R+VAVK L + + E++ LI
Sbjct: 24 LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIG 83
Query: 428 QHPNIVRWYGVESDQDF-VYLSLERCTC-SLNDLI---------YVLSGSFEEQLNAKEQ 476
H N+V G + + + +E C +L+ + Y G+ Q
Sbjct: 84 HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVG 143
Query: 477 DSNLLNEVRIRLLPVMENTKDIELWKANGH-----------------PSAQLLKVTRDIV 519
+ + R+ + +++ + L+ + +
Sbjct: 144 AIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVA 203
Query: 520 SGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSG 579
G+ L IHRDL +N+L+S+ K+ D G+++ + D Y G
Sbjct: 204 KGMEFLASRKCIHRDLAARNILLSEKNV--VKICDFGLARDIYKDPD--------YVRKG 253
Query: 580 -------WQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY 615
W APE + T D++S G +L+ + G PY
Sbjct: 254 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 296
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 5e-15
Identities = 59/252 (23%), Positives = 99/252 (39%), Gaps = 46/252 (18%)
Query: 378 VVFNKEIAKGSNGTVV------LEGNYEGRSVAVKRL-VKTHHDVA--LKEIQNLIASDQ 428
+V +E+ +G+ G V L + VAVK L T +E + L+ + Q
Sbjct: 17 IVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAE-LLTNLQ 75
Query: 429 HPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRL 488
H +IV++YGV D D + + E Y+ G +L +R
Sbjct: 76 HEHIVKFYGVCGDGDPLIMVFE----------YMKHG-------------DLNKFLRAHG 112
Query: 489 LPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSF 548
M +Q+L + I SG+ +L +HRDL +N L+ +
Sbjct: 113 PDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGAN--L 170
Query: 549 CAKLSDMGISKRLQGDMSCLTQNATGYGSSG-----WQAPEQLLQGRQTRAIDLFSLGCI 603
K+ D G+S+ + + + G W PE ++ + T D++S G I
Sbjct: 171 LVKIGDFGMSRDVY------STDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVI 224
Query: 604 LFFCITGGKHPY 615
L+ T GK P+
Sbjct: 225 LWEIFTYGKQPW 236
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 6e-15
Identities = 60/257 (23%), Positives = 98/257 (38%), Gaps = 57/257 (22%)
Query: 378 VVFNKEIAKGSNGTVVLEGNYEGRS-------VAVKRLVKTHHDVA----LKEIQNLIAS 426
+V E+ +G+ G V VAVK L K + A +E + L+
Sbjct: 43 IVLKWELGEGAFGKVF-LAECHNLLPEQDKMLVAVKAL-KEASESARQDFQREAE-LLTM 99
Query: 427 DQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRI 486
QH +IVR++GV ++ + + E Y+ G LN
Sbjct: 100 LQHQHIVRFFGVCTEGRPLLMVFE----------YMRHGD--------------LNRFLR 135
Query: 487 RLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDK 546
P + E QLL V + +G+ +L + +HRDL +N L+ +
Sbjct: 136 SHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQG- 194
Query: 547 SFCAKLSDMGISKRLQGDMSCLTQNATGY---GSSG-----WQAPEQLLQGRQTRAIDLF 598
K+ D G+S+ + +T Y G W PE +L + T D++
Sbjct: 195 -LVVKIGDFGMSRDIY---------STDYYRVGGRTMLPIRWMPPESILYRKFTTESDVW 244
Query: 599 SLGCILFFCITGGKHPY 615
S G +L+ T GK P+
Sbjct: 245 SFGVVLWEIFTYGKQPW 261
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 9e-15
Identities = 70/314 (22%), Positives = 128/314 (40%), Gaps = 77/314 (24%)
Query: 380 FNKE--IAKGSNGTV---VLEGNYEGRSVAVKRLVKTHHDVALKEIQN---LIASDQHPN 431
F+ + I G G V VL +G VA+KR ++E + ++ +HP+
Sbjct: 41 FDHKFLIGHGVFGKVYKGVLR---DGAKVALKRRTPESSQ-GIEEFETEIETLSFCRHPH 96
Query: 432 IVRWYG--VESDQDF-VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRL 488
+V G E ++ +Y + Y+ +G+ + L + + ++
Sbjct: 97 LVSLIGFCDERNEMILIY---K----------YMENGNLKRHLYGSDLPTMSMS------ 137
Query: 489 LPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSF 548
W+ Q L++ GL +LH +IHRD+K N+L+ D++F
Sbjct: 138 ------------WE-------QRLEICIGAARGLHYLHTRAIIHRDVKSINILL--DENF 176
Query: 549 CAKLSDMGISK-RLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFC 607
K++D GISK + D + L+ G+ G+ PE ++GR T D++S G +LF
Sbjct: 177 VPKITDFGISKKGTELDQTHLSTVVK--GTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEV 234
Query: 608 ITGGKHPYGESFERD-ANIV-------KDRK-----DLFLVEHIPE-----AVDLFTRLL 649
+ + +S R+ N+ + + D L + I D + L
Sbjct: 235 LC-ARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCL 293
Query: 650 DPNPDLRPKAQNVL 663
+ + RP +VL
Sbjct: 294 ALSSEDRPSMGDVL 307
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 77.6 bits (190), Expect = 9e-15
Identities = 81/518 (15%), Positives = 157/518 (30%), Gaps = 153/518 (29%)
Query: 328 SEKMQNIIPNESKVGETDGLSHITGNG---EKFLLTFTDLIDDRVDG--RRIGKLVVFN- 381
+ ++I+ E E D HI + L F L+ + + + + +++ N
Sbjct: 39 QDMPKSILSKE----EID---HIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINY 91
Query: 382 ----KEIAKGSNGTVVLEGNYE--------GRSVAVKRLVKTHHDVALKEIQNLIASDQ- 428
I ++ Y V K V +++ + +
Sbjct: 92 KFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPY--LKLRQALLELRP 149
Query: 429 HPNIV-----------------RWYGVESDQDF-VY-LSLERCTCS------LNDLIYVL 463
N++ Y V+ DF ++ L+L+ C L L+Y +
Sbjct: 150 AKNVLIDGVLGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQI 209
Query: 464 SGSFEEQLNAKEQDSNLLNEVRIRL------------LPVMENTKDIELWKA-NGHPSAQ 510
++ + + ++ ++ L L V+ N ++ + W A N +
Sbjct: 210 DPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLS--CK 267
Query: 511 LLKVTRD--IVSGLSHLHEIGLIHRDLKPQNVLISKDKS--FCAKLSDMGISKRLQGDMS 566
+L TR + LS H L ++ ++ D+ K D
Sbjct: 268 ILLTTRFKQVTDFLSAATT---THISLDHHSMTLTPDEVKSLLLKYLDC--------RPQ 316
Query: 567 CLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERDANIV 626
L P ++L + L I ES RD
Sbjct: 317 DL--------------PREVLT------TNPRRLSII------------AESI-RDGLAT 343
Query: 627 KDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTADTRLS-FLRDV---- 681
D + + ++ +L+P + R F RLS F
Sbjct: 344 WDNWKHVNCDKLTTIIESSLNVLEPA-EYR---------KMFD----RLSVFPPSAHIPT 389
Query: 682 -------SDRVELEDRESDSKLLRALEGIALVALNGKWDEKMETKFIENIGRYRRYKYDN 734
D ++ + +KL + +LV K K T I +I + K +N
Sbjct: 390 ILLSLIWFDVIKSDVMVVVNKLHKY----SLVE---KQP-KESTISIPSIYLELKVKLEN 441
Query: 735 VRDLLRVIRNKSNHFRELPQDIQELLGSHPEG-FYNYF 771
L R I + N + D +L+ + + FY++
Sbjct: 442 EYALHRSIVDHYNIPKTFDSD--DLIPPYLDQYFYSHI 477
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 58.7 bits (141), Expect = 6e-09
Identities = 81/613 (13%), Positives = 179/613 (29%), Gaps = 155/613 (25%)
Query: 134 DFKAEFRCQEVGKSFSGYHFNSGSELGMDLIGDVE-SHLPCHTQMTASVYRL-------R 185
F F C++V ++ ++ E H+ + RL +
Sbjct: 28 AFVDNFDCKDV------------QDMPKSILSKEEIDHIIMSKDAVSGTLRLFWTLLSKQ 75
Query: 186 DNSLPEFL-SVIGKVAGWI-----------SLPGSSQNSLLGPVDRNSPLFLPDKVDRPP 233
+ + +F+ V+ ++ S+ + ++ +F V R
Sbjct: 76 EEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQ 135
Query: 234 L------ALPSTETEIPWTL--GMPG-G-SV--SEINKKHAFVEGFRSYIQSFIVLFIAL 281
AL L G+ G G + ++ + F + ++ L
Sbjct: 136 PYLKLRQALLELRPA-KNVLIDGVLGSGKTWVALDVCLSYKVQCKM-----DFKIFWLNL 189
Query: 282 ----CP--IIGFL--FYHSKQVKSKKQNEEHITKTGIP----KKKKSR---RPGYNR--- 323
P ++ L + + + +H + + + + R Y
Sbjct: 190 KNCNSPETVLEMLQKLLY-QIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLL 248
Query: 324 ---NTTNSEKMQ--NIIPNESKVGETDGLSHITGNGEKFLLTFTDL-IDDRVDGRRIGKL 377
N N++ N+ K+ LLT + D + +
Sbjct: 249 VLLNVQNAKAWNAFNL---SCKI----------------LLTTRFKQVTDFLSAATTTHI 289
Query: 378 VVFNKEIAKGSNGTVVLEGNYEGRSVA-VKRLVKTHHDVALKEIQNLIASDQHPNIVRWY 436
+ + + + L Y + R V T + L ++IA + W
Sbjct: 290 SLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRL----SIIAESIRDGLATW- 344
Query: 437 GVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTK 496
++ +++ ++ L +I S L E + + + + P +
Sbjct: 345 -----DNWKHVNCDK----LTTII----ESSLNVLEPAEY-RKMFDRLSV--FP--PSAH 386
Query: 497 DIE------LWKANGHPS------AQLLK---VTRDIVSGLSHLHEIGLIHRDLKPQNVL 541
I +W + S +L K V + + I+ +LK +
Sbjct: 387 -IPTILLSLIW-FDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPS---IYLELKVK--- 438
Query: 542 ISKDKSFCAKLSDM-GISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSL 600
+ + + + D I K D + Y L + LF +
Sbjct: 439 LENEYALHRSIVDHYNIPKTFDSD-DLIPPYLDQY--FYSHIGHHLKNIEHPERMTLFRM 495
Query: 601 GCILF--FCITGGK--HPYGESFERDANIVKDRKDL-FLVEHIPEAVDLFTRLLDPNPDL 655
+F F K H ++ +I+ + L F +I + + RL++ D
Sbjct: 496 ---VFLDFRFLEQKIRHD-STAWNASGSILNTLQQLKFYKPYICDNDPKYERLVNAILDF 551
Query: 656 RPK-AQNVLNHPF 667
PK +N++ +
Sbjct: 552 LPKIEENLICSKY 564
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 1e-14
Identities = 49/259 (18%), Positives = 90/259 (34%), Gaps = 70/259 (27%)
Query: 378 VVFNKEIAKGSNGTVVLEGNYEGRS---------VAVKRLVKTHHDVA---LKEIQNLIA 425
++FN+ + +G+ + +G V +K L K H + + + +++
Sbjct: 10 LIFNESLGQGTFTKIF-KGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAAS-MMS 67
Query: 426 SDQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVR 485
H ++V YGV D L E +V GS + L K+ + +
Sbjct: 68 KLSHKHLVLNYGVCVCGDENILVQE----------FVKFGSLDTYL--KKNKNCI----- 110
Query: 486 IRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKD 545
L+V + + + + L E LIH ++ +N+L+ ++
Sbjct: 111 ---------------------NILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIRE 149
Query: 546 KSF------CAKLSDMGISKRLQGDMSCLTQNATGYGSS--GWQAPEQLLQGRQ-TRAID 596
+ KLSD GIS + W PE + + A D
Sbjct: 150 EDRKTGNPPFIKLSDPGISITVLPK---------DILQERIPWVPPECIENPKNLNLATD 200
Query: 597 LFSLGCILFFCITGGKHPY 615
+S G L+ +GG P
Sbjct: 201 KWSFGTTLWEICSGGDKPL 219
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 1e-14
Identities = 54/253 (21%), Positives = 93/253 (36%), Gaps = 66/253 (26%)
Query: 378 VVFNKEIAKGSNGTVVLEGNYEGRS-----VAVKRLVKTHHDVA----LKEIQNLIASDQ 428
+ + I +G G V +G Y VA+K D L+E +
Sbjct: 17 IELGRCIGEGQFGDVH-QGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEAL-TMRQFD 74
Query: 429 HPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRL 488
HP+IV+ GV ++ V++ +E G L + + +L
Sbjct: 75 HPHIVKLIGVITENP-VWIIME----------LCTLGELRSFL--QVRKYSL-------- 113
Query: 489 LPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSF 548
A L+ + + L++L +HRD+ +NVL+S +
Sbjct: 114 ------------------DLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSN--D 153
Query: 549 CAKLSDMGISKRLQGDMSCLTQNATGYGSSG------WQAPEQLLQGRQTRAIDLFSLGC 602
C KL D G+S+ ++ T Y +S W APE + R T A D++ G
Sbjct: 154 CVKLGDFGLSRYMEDS--------TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGV 205
Query: 603 ILFFCITGGKHPY 615
++ + G P+
Sbjct: 206 CMWEILMHGVKPF 218
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 2e-14
Identities = 61/253 (24%), Positives = 97/253 (38%), Gaps = 64/253 (25%)
Query: 378 VVFNKEIAKGSNGTVVLEGNYEGRS------VAVKRLVKTHHDVALKEIQ---NLIASDQ 428
K + G+ GTV +G + VA+K L + A KEI ++AS
Sbjct: 17 FKKIKVLGSGAFGTVY-KGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 429 HPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRL 488
+P++ R G+ V L + + G LL+ VR
Sbjct: 76 NPHVCRLLGICLTST-VQLITQ----------LMPFGC-------------LLDYVR--- 108
Query: 489 LPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSF 548
E+ +I S LL I G+++L + L+HRDL +NVL+
Sbjct: 109 ----EHKDNI--------GSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTP--Q 154
Query: 549 CAKLSDMGISKRLQGDMSCLTQNATGYGSSG------WQAPEQLLQGRQTRAIDLFSLGC 602
K++D G++K L + Y + G W A E +L T D++S G
Sbjct: 155 HVKITDFGLAKLLGAEEKE-------YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGV 207
Query: 603 ILFFCITGGKHPY 615
++ +T G PY
Sbjct: 208 TVWELMTFGSKPY 220
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 2e-14
Identities = 41/228 (17%), Positives = 71/228 (31%), Gaps = 58/228 (25%)
Query: 499 ELWKAN---GHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDM 555
E K N +P + + + L LHE L H DLKP+N+L +
Sbjct: 110 EFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHK 169
Query: 556 GISKRLQGDM---------SCL-TQNATGYGSSG-WQAPEQLLQGRQTRAIDLFSLGCIL 604
++ + + ++ T ++ ++ PE +L+ + D++S+GCIL
Sbjct: 170 SCEEKSVKNTSIRVADFGSATFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCIL 229
Query: 605 ------------------------------------------FFCITGGKHPYGESFERD 622
F+
Sbjct: 230 FEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYV 289
Query: 623 ANIVKDRKDLFLVEHI--PEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 668
K K L + + + DL R+L+ +P R L HPFF
Sbjct: 290 KENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFF 337
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 3e-14
Identities = 51/257 (19%), Positives = 88/257 (34%), Gaps = 70/257 (27%)
Query: 378 VVFNKEIAKGSNGTVVLEGNYEGRS-----VAVKRL-------VKTHHDVALKEIQNLIA 425
+ +++ GS G V G ++ S VAVK L + D ++E+ +
Sbjct: 20 LRLLEKLGDGSFGVV-RRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDF-IREVN-AMH 76
Query: 426 SDQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVR 485
S H N++R YGV + + E GS ++L ++ +
Sbjct: 77 SLDHRNLIRLYGVVLTPP-MKMVTE----------LAPLGSLLDRL--RKHQGHF----- 118
Query: 486 IRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKD 545
L + + G+ +L IHRDL +N+L++
Sbjct: 119 ---------------------LLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATR 157
Query: 546 KSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSG-------WQAPEQLLQGRQTRAIDLF 598
K+ D G+ + L + Y W APE L + A D +
Sbjct: 158 D--LVKIGDFGLMRALPQNDDH-------YVMQEHRKVPFAWCAPESLKTRTFSHASDTW 208
Query: 599 SLGCILFFCITGGKHPY 615
G L+ T G+ P+
Sbjct: 209 MFGVTLWEMFTYGQEPW 225
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 3e-14
Identities = 42/228 (18%), Positives = 77/228 (33%), Gaps = 58/228 (25%)
Query: 499 ELWKANGH---PSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDM 555
+ K NG + K+ I ++ LH L H DLKP+N+L + A +
Sbjct: 105 DFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKI 164
Query: 556 GISKRLQGDM---------SCL-TQNATGYGSSG-WQAPEQLLQGRQTRAIDLFSLGCIL 604
+R + + ++ + S+ ++APE +L ++ D++S+GCIL
Sbjct: 165 KRDERTLINPDIKVVDFGSATYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCIL 224
Query: 605 ------------------------------------------FFCITGGKHPYGESFERD 622
F + +
Sbjct: 225 IEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYV 284
Query: 623 ANIVKDRKDLFLVEHI--PEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 668
+ K K+ L + + DL ++L+ +P R + L HPFF
Sbjct: 285 SRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFF 332
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 73.4 bits (181), Expect = 4e-14
Identities = 61/273 (22%), Positives = 108/273 (39%), Gaps = 70/273 (25%)
Query: 380 FNKE--IAKGSNGTV---VLEGNYEGRSVAVKRLVKTHHDVALKEIQN---LIASDQHPN 431
F+ + + +G G V L +G VAVKRL + + Q +I+ H N
Sbjct: 32 FSNKNILGRGGFGKVYKGRLA---DGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRN 88
Query: 432 IVRWYG--VESDQDFVYLSLERCTCSLNDLIY--VLSGSFEEQLNAKEQDSNLLNEVRIR 487
++R G + + R L+Y + +GS L + + L+
Sbjct: 89 LLRLRGFCMTPTE--------RL------LVYPYMANGSVASCLRERPESQPPLD----- 129
Query: 488 LLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE---IGLIHRDLKPQNVLISK 544
W ++ GL++LH+ +IHRD+K N+L+
Sbjct: 130 -------------WPKR-------QRIALGSARGLAYLHDHCDPKIIHRDVKAANILL-- 167
Query: 545 DKSFCAKLSDMGISKRLQGDMSCL-TQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCI 603
D+ F A + D G++K + + + T G+ G APE L G+ + D+F G +
Sbjct: 168 DEEFEAVVGDFGLAKLMDYKDTHVTTAVR---GTIGHIAPEYLSTGKSSEKTDVFGYGVM 224
Query: 604 LFFCITGGKHPYGESFERDANIVKDRKDLFLVE 636
L IT G+ + D + + D+ L++
Sbjct: 225 LLELIT-GQRAF------DLARLANDDDVMLLD 250
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 4e-14
Identities = 69/336 (20%), Positives = 119/336 (35%), Gaps = 64/336 (19%)
Query: 378 VVFNKEIAKGSNGTVV------LEGNYEGRSVAVKRLVKTHHDVA----LKEIQNLIASD 427
+ + + G+ G V + + VAVK L + + L E +I+
Sbjct: 32 ITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEAL-IISKF 90
Query: 428 QHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIR 487
H NIVR GV ++ +E + G +L + +R
Sbjct: 91 NHQNIVRCIGVSLQSLPRFILME----------LMAGG-------------DLKSFLR-E 126
Query: 488 LLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLIS-KDK 546
P + + LL V RDI G +L E IHRD+ +N L++
Sbjct: 127 TRPRPSQPSSLAM--------LDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGP 178
Query: 547 SFCAKLSDMGISKRLQGDMSCLTQNATGY---GSSG-----WQAPEQLLQGRQTRAIDLF 598
AK+ D G+++ + Y G W PE ++G T D +
Sbjct: 179 GRVAKIGDFGMARDIYR---------ASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTW 229
Query: 599 SLGCILFFCITGGKHPY-GESFERDANIVKDRKDLFLVEHIPEAV-DLFTRLLDPNPDLR 656
S G +L+ + G PY +S + V + ++ P V + T+ P+ R
Sbjct: 230 SFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDR 289
Query: 657 PKAQNVLNHPFFWTADTR-LSFLRDVSDRVELEDRE 691
P +L + T D ++ + +E+ E
Sbjct: 290 PNFAIILERIEYCTQDPDVINTALPIEYGPLVEEEE 325
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 4e-14
Identities = 69/334 (20%), Positives = 119/334 (35%), Gaps = 60/334 (17%)
Query: 378 VVFNKEIAKGSNGTVV------LEGNYEGRSVAVKRLVKTHHDVALKEIQN---LIASDQ 428
+ + + G+ G V + + VAVK L + + + +I+
Sbjct: 73 ITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFN 132
Query: 429 HPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRL 488
H NIVR GV ++ LE + G +L + +R
Sbjct: 133 HQNIVRCIGVSLQSLPRFILLE----------LMAGG-------------DLKSFLR-ET 168
Query: 489 LPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLIS-KDKS 547
P + + LL V RDI G +L E IHRD+ +N L++
Sbjct: 169 RPRPSQPSSLAM--------LDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPG 220
Query: 548 FCAKLSDMGISKRLQGDMSCLTQNATGYGSSG-------WQAPEQLLQGRQTRAIDLFSL 600
AK+ D G+++ + A Y G W PE ++G T D +S
Sbjct: 221 RVAKIGDFGMARDI--------YRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSF 272
Query: 601 GCILFFCITGGKHPY-GESFERDANIVKDRKDLFLVEHIPEAV-DLFTRLLDPNPDLRPK 658
G +L+ + G PY +S + V + ++ P V + T+ P+ RP
Sbjct: 273 GVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPN 332
Query: 659 AQNVLNHPFFWTADTR-LSFLRDVSDRVELEDRE 691
+L + T D ++ + +E+ E
Sbjct: 333 FAIILERIEYCTQDPDVINTALPIEYGPLVEEEE 366
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 72.2 bits (178), Expect = 6e-14
Identities = 51/253 (20%), Positives = 94/253 (37%), Gaps = 66/253 (26%)
Query: 378 VVFNKEIAKGSNGTVVLEGNYEGRS-----VAVKRLVKTHHDVA----LKEIQNLIASDQ 428
VV N+ + +G G V EG Y VAVK K + E ++ +
Sbjct: 14 VVLNRILGEGFFGEV-YEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAV-IMKNLD 71
Query: 429 HPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRL 488
HP+IV+ G+ ++ ++ +E G L + +L
Sbjct: 72 HPHIVKLIGIIEEEP-TWIIME----------LYPYGELGHYLERNKNSLKVL------- 113
Query: 489 LPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSF 548
L+ + I +++L I +HRD+ +N+L++
Sbjct: 114 ---------------------TLVLYSLQICKAMAYLESINCVHRDIAVRNILVASP--E 150
Query: 549 CAKLSDMGISKRLQGDMSCLTQNATGYGSSG------WQAPEQLLQGRQTRAIDLFSLGC 602
C KL D G+S+ ++ + Y +S W +PE + R T A D++
Sbjct: 151 CVKLGDFGLSRYIEDE--------DYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAV 202
Query: 603 ILFFCITGGKHPY 615
++ ++ GK P+
Sbjct: 203 CMWEILSFGKQPF 215
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 7e-14
Identities = 60/255 (23%), Positives = 102/255 (40%), Gaps = 76/255 (29%)
Query: 382 KEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHHDV-----ALKEIQNLIASDQHPNIVRW 435
I +GS G V L + ++VA+K++ + D+ L+EI ++ + I+R
Sbjct: 32 HLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREIT-ILNRLKSDYIIRL 90
Query: 436 YGV---ESDQDF--VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLP 490
Y + + F +Y+ LE L L L E I+ +
Sbjct: 91 YDLIIPDDLLKFDELYIVLEIADSDLKKLFKT---------------PIFLTEEHIKTI- 134
Query: 491 VMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCA 550
L+ LL G + +HE G+IHRDLKP N L+++D C+
Sbjct: 135 ---------LY--------NLLL-------GENFIHESGIIHRDLKPANCLLNQD---CS 167
Query: 551 -KLSDMGISKRLQGDMSCLTQNA------------------TGYGSSGW-QAPEQLLQGR 590
K+ D G+++ + + N T + + W +APE +L
Sbjct: 168 VKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQE 227
Query: 591 Q-TRAIDLFSLGCIL 604
T++ID++S GCI
Sbjct: 228 NYTKSIDIWSTGCIF 242
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 8e-14
Identities = 62/266 (23%), Positives = 98/266 (36%), Gaps = 66/266 (24%)
Query: 378 VVFNKEIAKGSNGTVVL-----EGNYEGRSVAVKRLVKTHHDVA----LKEIQNLIASDQ 428
+ +++ +G G V L EG+ G VAVK L KEI+ ++ +
Sbjct: 23 LKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIE-ILRNLY 81
Query: 429 HPNIVRWYGV--ESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRI 486
H NIV++ G+ E + + L +E ++ SGS +E L + NL
Sbjct: 82 HENIVKYKGICTEDGGNGIKLIME----------FLPSGSLKEYLPKNKNKINL------ 125
Query: 487 RLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDK 546
Q LK I G+ +L +HRDL +NVL+ +
Sbjct: 126 ----------------------KQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESE- 162
Query: 547 SFCAKLSDMGISKRLQGDMSCLTQNATGYGSSG-------WQAPEQLLQGRQTRAIDLFS 599
K+ D G++K ++ D Y W APE L+Q + A D++S
Sbjct: 163 -HQVKIGDFGLTKAIETDKE-------YYTVKDDRDSPVFWYAPECLMQSKFYIASDVWS 214
Query: 600 LGCILFFCITGGKHPYGESFERDANI 625
G L +T I
Sbjct: 215 FGVTLHELLTYCDSDSSPMALFLKMI 240
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 1e-13
Identities = 51/234 (21%), Positives = 75/234 (32%), Gaps = 72/234 (30%)
Query: 499 ELWKAN---GHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDM 555
EL K N G + K I+ L LH+ +IH DLKP+N+L+ + K+ D
Sbjct: 187 ELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDF 246
Query: 556 GISKRLQGDMSC-LTQNATGYGSSGW-QAPEQLLQGRQTRAIDLFSLGCIL--------- 604
G S SC Q Y S + +APE +L R ID++SLGCIL
Sbjct: 247 G-S-------SCYEHQRVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPL 298
Query: 605 ---------------------------------FFCITGGKH--------------PYGE 617
F G G
Sbjct: 299 LPGEDEGDQLACMIELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGR 358
Query: 618 SFERDANIVKDRKDLFLVEHIPEA---VDLFTRLLDPNPDLRPKAQNVLNHPFF 668
S + ++ + +D + L+ +P +R L HP+
Sbjct: 359 SRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWL 412
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 2e-13
Identities = 53/253 (20%), Positives = 90/253 (35%), Gaps = 64/253 (25%)
Query: 378 VVFNKEIAKGSNGTVVLEGNYEGRS------VAVKRLVKTHHDVALKEIQ---NLIASDQ 428
+ K + G GTV +G + V +K + + + + I S
Sbjct: 15 LRKLKVLGSGVFGTVH-KGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLD 73
Query: 429 HPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRL 488
H +IVR G+ + L + Y+ GS LL+ VR
Sbjct: 74 HAHIVRLLGLCPGSS-LQLVTQ----------YLPLGS-------------LLDHVR--- 106
Query: 489 LPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSF 548
++ + LL I G+ +L E G++HR+L +NVL+
Sbjct: 107 ----QHRGAL--------GPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSP--S 152
Query: 549 CAKLSDMGISKRLQGDMSCLTQNATGYGSSG------WQAPEQLLQGRQTRAIDLFSLGC 602
+++D G++ L D S W A E + G+ T D++S G
Sbjct: 153 QVQVADFGVADLLPPD-------DKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGV 205
Query: 603 ILFFCITGGKHPY 615
++ +T G PY
Sbjct: 206 TVWELMTFGAEPY 218
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 70.6 bits (173), Expect = 7e-13
Identities = 56/260 (21%), Positives = 97/260 (37%), Gaps = 81/260 (31%)
Query: 382 KEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHHDV-----ALKEIQNLIASDQHPNIVRW 435
I GS G V + R VA+K++++ D+ L+EI ++ H ++V+
Sbjct: 59 HLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIA-ILNRLNHDHVVKV 117
Query: 436 YGV---ESDQDF--VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLP 490
+ + + F +Y+ LE L L E+ I+ L
Sbjct: 118 LDIVIPKDVEKFDELYVVLEIADSDFKKLFRT---------------PVYLTELHIKTL- 161
Query: 491 VMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCA 550
L+ LL G+ ++H G++HRDLKP N L+++D C+
Sbjct: 162 ---------LY--------NLLV-------GVKYVHSAGILHRDLKPANCLVNQD---CS 194
Query: 551 -KLSDMGISKRLQGDMSCLTQNATGYGSSGWQ------------------------APEQ 585
K+ D G+++ + + +Q APE
Sbjct: 195 VKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPEL 254
Query: 586 LLQGRQ-TRAIDLFSLGCIL 604
+L T AID++S+GCI
Sbjct: 255 ILLQENYTEAIDVWSIGCIF 274
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 69.1 bits (170), Expect = 8e-13
Identities = 63/281 (22%), Positives = 107/281 (38%), Gaps = 84/281 (29%)
Query: 393 VLEGNYEGRSVAVKRLVKTHHDVA--------LKEIQNLIASDQHPNIVRWYG--VESDQ 442
V +G +VAVK+L D+ +EI ++A QH N+V G + D
Sbjct: 47 VYKGYVNNTTVAVKKL-AAMVDITTEELKQQFDQEI-KVMAKCQHENLVELLGFSSDGDD 104
Query: 443 DFVYLSLERCTCSLNDLIY--VLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIEL 500
C L+Y + +GS ++L+ + L +R
Sbjct: 105 --------LC------LVYVYMPNGSLLDRLSCLDGTPPLSWHMR--------------- 135
Query: 501 WKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKR 560
K+ + +G++ LHE IHRD+K N+L+ D++F AK+SD G+++
Sbjct: 136 -----------CKIAQGAANGINFLHENHHIHRDIKSANILL--DEAFTAKISDFGLAR- 181
Query: 561 LQGDMSCLTQNAT------GYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP 614
+ T + Y APE L+G T D++S G +L ITG
Sbjct: 182 -ASEKFAQTVMTSRIVGTTAY-----MAPE-ALRGEITPKSDIYSFGVVLLEIITGLP-- 232
Query: 615 YGESFERDANIVKDRKDLFLVEH---IPEAVDLFTRLLDPN 652
+ + R+ L++ I + +D
Sbjct: 233 ---------AVDEHREPQLLLDIKEEIEDEEKTIEDYIDKK 264
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 1e-12
Identities = 39/236 (16%), Positives = 72/236 (30%), Gaps = 66/236 (27%)
Query: 499 ELWKANGH---PSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDM 555
E+ N + + +I+ L++L ++ L H DLKP+N+L+ + ++
Sbjct: 124 EIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVR 183
Query: 556 GISKRLQGDMSCLTQNATG---YGSSGWQ--------------APEQLLQGRQTRAIDLF 598
++ + + +G + ++ APE +L + D++
Sbjct: 184 RVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMW 243
Query: 599 SLGCILFFCITG--------------------GK-------------------------- 612
S GC+L TG
Sbjct: 244 SFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLA 303
Query: 613 HPYGESFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 668
P S VK L+ + D +L +P LRP +L H F
Sbjct: 304 WPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKFL 359
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 69.4 bits (170), Expect = 1e-12
Identities = 48/252 (19%), Positives = 84/252 (33%), Gaps = 59/252 (23%)
Query: 378 VVFNKEIAKGSNGTVVLEGNYEGRS-----VAVKRLVKTHHDVALKEIQN---LIASDQH 429
V FN+ I +G G V G AVK L + + + ++ H
Sbjct: 91 VHFNEVIGRGHFGCVY-HGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 149
Query: 430 PNIVRWYGVESDQDF-VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRL 488
PN++ G+ + + L Y+ G + + + N
Sbjct: 150 PNVLSLLGICLRSEGSPLVVLP----------YMKHGDLRNFI--RNETHNP-------- 189
Query: 489 LPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSF 548
L+ + G+ L +HRDL +N ++ + F
Sbjct: 190 ------------------TVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEK--F 229
Query: 549 CAKLSDMGISKRLQGDMSCLTQNATGYGSSG-----WQAPEQLLQGRQTRAIDLFSLGCI 603
K++D G+++ + N TG W A E L + T D++S G +
Sbjct: 230 TVKVADFGLARDMYDKEFDSVHNKTG----AKLPVKWMALESLQTQKFTTKSDVWSFGVL 285
Query: 604 LFFCITGGKHPY 615
L+ +T G PY
Sbjct: 286 LWELMTRGAPPY 297
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 2e-12
Identities = 47/252 (18%), Positives = 86/252 (34%), Gaps = 59/252 (23%)
Query: 378 VVFNKEIAKGSNGTVVLEGNYEGRS-----VAVKRLVKTHHDVALKEIQ---NLIASDQH 429
++ I KG G V G Y ++ A+K L + ++ L+ H
Sbjct: 23 THSDRVIGKGHFGVVY-HGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNH 81
Query: 430 PNIVRWYGVESDQD-FVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRL 488
PN++ G+ + ++ L Y+ G + + + N
Sbjct: 82 PNVLALIGIMLPPEGLPHVLLP----------YMCHGDLLQFI--RSPQRNP-------- 121
Query: 489 LPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSF 548
L+ + G+ +L E +HRDL +N ++ + F
Sbjct: 122 ------------------TVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDES--F 161
Query: 549 CAKLSDMGISKRLQGDMSCLTQNATGYGSSG-----WQAPEQLLQGRQTRAIDLFSLGCI 603
K++D G+++ + Q W A E L R T D++S G +
Sbjct: 162 TVKVADFGLARDILDREYYSVQQHRH----ARLPVKWTALESLQTYRFTTKSDVWSFGVL 217
Query: 604 LFFCITGGKHPY 615
L+ +T G PY
Sbjct: 218 LWELLTRGAPPY 229
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 2e-12
Identities = 51/262 (19%), Positives = 94/262 (35%), Gaps = 70/262 (26%)
Query: 378 VVFNKEIAKGSNGTVVLEGNYEGRS-----VAVKRL---VKTHHDVA--LKEIQNLIASD 427
+ + KG G+V E + VAVK L + D+ L+E +
Sbjct: 25 FTLGRMLGKGEFGSVR-EAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAA-CMKEF 82
Query: 428 QHPNIVRWYGVESDQD------FVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLL 481
HP++ + GV + L ++ G +L
Sbjct: 83 DHPHVAKLVGVSLRSRAKGRLPIPMVILP----------FMKHG-------------DLH 119
Query: 482 NEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVL 541
+ + EN ++ P L++ DI G+ +L IHRDL +N +
Sbjct: 120 AFLLASRIG--ENPFNL--------PLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCM 169
Query: 542 ISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGY---GSSG-----WQAPEQLLQGRQTR 593
+++D ++D G+S+++ + Y G + W A E L T
Sbjct: 170 LAED--MTVCVADFGLSRKIY---------SGDYYRQGCASKLPVKWLALESLADNLYTV 218
Query: 594 AIDLFSLGCILFFCITGGKHPY 615
D+++ G ++ +T G+ PY
Sbjct: 219 HSDVWAFGVTMWEIMTRGQTPY 240
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 2e-12
Identities = 45/227 (19%), Positives = 84/227 (37%), Gaps = 64/227 (28%)
Query: 499 ELWKANGH---PSAQLLKVTRDIVSGLSHLH-EIGLIHRDLKPQNVLISK----DKSFCA 550
L K H P + ++++ ++ GL ++H G+IH D+KP+NVL+ +
Sbjct: 118 ALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQI 177
Query: 551 KLSDMGISKRLQGDMSCLTQNATGYGSSGWQ-APEQLLQGRQTRAIDLFSLGCILFFCIT 609
K++D+G + ++ T + +PE LL D++S C++F IT
Sbjct: 178 KIADLGNA-------CWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELIT 230
Query: 610 G-----GKHPYGESFERD--ANIV-----------------------------------K 627
G + + + D A I+
Sbjct: 231 GDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFW 290
Query: 628 DRKDL------FLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 668
+D+ F + E D + +L +P R A ++NHP+
Sbjct: 291 PLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWL 337
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 65.7 bits (161), Expect = 8e-12
Identities = 47/252 (18%), Positives = 85/252 (33%), Gaps = 59/252 (23%)
Query: 378 VVFNKEIAKGSNGTVVLEGNYEGR-----SVAVKRLVKTHHDVALKEIQN---LIASDQH 429
V FN+ I +G G V G AVK L + + + ++ H
Sbjct: 27 VHFNEVIGRGHFGCVY-HGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 85
Query: 430 PNIVRWYGVESDQDF-VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRL 488
PN++ G+ + + L Y+ G + + + N
Sbjct: 86 PNVLSLLGICLRSEGSPLVVLP----------YMKHGDLRNFI--RNETHNP-------- 125
Query: 489 LPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSF 548
L+ + G+ +L +HRDL +N ++ + F
Sbjct: 126 ------------------TVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEK--F 165
Query: 549 CAKLSDMGISKRLQGDMSCLTQNATGYGSSG-----WQAPEQLLQGRQTRAIDLFSLGCI 603
K++D G+++ DM + + W A E L + T D++S G +
Sbjct: 166 TVKVADFGLAR----DMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVL 221
Query: 604 LFFCITGGKHPY 615
L+ +T G PY
Sbjct: 222 LWELMTRGAPPY 233
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 1e-11
Identities = 54/260 (20%), Positives = 90/260 (34%), Gaps = 67/260 (25%)
Query: 378 VVFNKEIAKGSNGTVVLEGNYEGRS-----VAVKRLVKTHHDVA-----LKEIQNLIASD 427
++ K + +G G+V+ EGN + VAVK + + L E +
Sbjct: 36 LILGKILGEGEFGSVM-EGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAA-CMKDF 93
Query: 428 QHPNIVRWYGVESDQD-----FVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLN 482
HPN++R GV + + L ++ G +L
Sbjct: 94 SHPNVIRLLGVCIEMSSQGIPKPMVILP----------FMKYG-------------DLHT 130
Query: 483 EVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLI 542
+ L T + P LLK DI G+ +L +HRDL +N ++
Sbjct: 131 YLLYSRLE----TGPKHI------PLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCML 180
Query: 543 SKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSG-------WQAPEQLLQGRQTRAI 595
D ++D G+SK++ + Y W A E L T
Sbjct: 181 RDD--MTVCVADFGLSKKI--------YSGDYYRQGRIAKMPVKWIAIESLADRVYTSKS 230
Query: 596 DLFSLGCILFFCITGGKHPY 615
D+++ G ++ T G PY
Sbjct: 231 DVWAFGVTMWEIATRGMTPY 250
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 2e-10
Identities = 59/243 (24%), Positives = 92/243 (37%), Gaps = 60/243 (24%)
Query: 381 NKEIAKGSNGTVVLEGNYE-GRSVAVK--RLVKTHHDVALKEIQNL------IASDQHPN 431
+ I KGS G VV + VA+K + K + A E++ L ++
Sbjct: 59 DSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKY-Y 117
Query: 432 IVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPV 491
IV ++ + L E + +L DL+ + + ++ R
Sbjct: 118 IVHLKRHFMFRNHLCLVFEMLSYNLYDLL-------------RNTNFRGVSLNLTR---- 160
Query: 492 MENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH--EIGLIHRDLKPQNVLISKDKSFC 549
K + + + L L E+ +IH DLKP+N+L+ K
Sbjct: 161 ---------------------KFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSA 199
Query: 550 AKLSDMGISKRLQGDMSC-LTQNATGYGSSGW-QAPEQLLQGRQTRAIDLFSLGCILFFC 607
K+ D G SC L Q Y S + ++PE LL AID++SLGCIL
Sbjct: 200 IKIVDFG--------SSCQLGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEM 251
Query: 608 ITG 610
TG
Sbjct: 252 HTG 254
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 6e-08
Identities = 38/195 (19%), Positives = 69/195 (35%), Gaps = 48/195 (24%)
Query: 373 RIGKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRL-VKTHHDVALKEIQNLIASDQHP 430
+G K+I G+ G + L N Y VA+K +K+ E +
Sbjct: 6 MVGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGD 65
Query: 431 NI--VRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRL 488
I V ++G + + LE SL DL + +F
Sbjct: 66 GIPQVYYFGPC--GKYNAMVLELLGPSLEDLFDLCDRTF--------------------- 102
Query: 489 LPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSF 548
+ K + L + ++S + ++H LI+RD+KP+N LI + +
Sbjct: 103 -----SLKTV-------------LMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNK 144
Query: 549 CAK---LSDMGISKR 560
+ + D ++K
Sbjct: 145 TQQVIHIIDFALAKE 159
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 54.1 bits (130), Expect = 1e-07
Identities = 45/261 (17%), Positives = 77/261 (29%), Gaps = 90/261 (34%)
Query: 498 IELWKANGHPSAQLLKVTRDIVSGLSHLH-EIGLIHRDLKPQNVLIS------------- 543
I G P + K+ + ++ GL +LH + +IH D+KP+N+L+S
Sbjct: 135 IIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEA 194
Query: 544 --------------KDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQ-------- 581
+ A + ++ + L G++ W
Sbjct: 195 TEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDI 254
Query: 582 ------APEQLLQGRQTRAIDLFSLGCILFFCITG------------------------- 610
+ E L+ D++S C+ F TG
Sbjct: 255 QTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIEL 314
Query: 611 -GKHPY---------GESFERDANIVKDR--KDLFLVEHIPE-----------AVDLFTR 647
GK P E F + ++ K L E + E D
Sbjct: 315 LGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLP 374
Query: 648 LLDPNPDLRPKAQNVLNHPFF 668
+L+ P+ R A L HP+
Sbjct: 375 MLELIPEKRATAAECLRHPWL 395
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 8e-07
Identities = 37/203 (18%), Positives = 69/203 (33%), Gaps = 55/203 (27%)
Query: 366 DDRVDGR-RIGKLVVFNKEIAKGSNGTVVLEGNYE-GRSVAVKR-LVKTHHDVALKEIQN 422
++ V ++G+ I +GS G + N + VA+K ++ E +
Sbjct: 5 NNVVGVHYKVGR------RIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRT 58
Query: 423 LIASDQHPNI--VRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNL 480
I V ++G E L ++ SL DL+ + F
Sbjct: 59 YKLLAGCTGIPNVYYFGQE--GLHNVLVIDLLGPSLEDLLDLCGRKF------------- 103
Query: 481 LNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNV 540
+ K + + +++ + +HE L++RD+KP N
Sbjct: 104 -------------SVKTV-------------AMAAKQMLARVQSIHEKSLVYRDIKPDNF 137
Query: 541 LISKDKSFCAK---LSDMGISKR 560
LI + S A + D G+ K
Sbjct: 138 LIGRPNSKNANMIYVVDFGMVKF 160
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 50.3 bits (119), Expect = 1e-06
Identities = 42/240 (17%), Positives = 76/240 (31%), Gaps = 24/240 (10%)
Query: 382 KEIAKGSNGTVVLEGNYEGRSVAVK-------RLVKTHHDVALKEIQNLIASDQHPNIVR 434
++I +G G V + VA+K LV H +EI I + +++
Sbjct: 26 EKIGEGVFGEVFQ-TIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLS 84
Query: 435 WYGVESDQDFVYL-SLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVME 493
+ F+ L S+ S L+ + + + + ++ ++ E
Sbjct: 85 GEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFE 144
Query: 494 N-TKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE-IGLIHRDLKPQNVLISKDKSFCAK 551
D+E + A + + + L+ + HRDL NVL+ K+ K
Sbjct: 145 FGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLL--KKTSLKK 202
Query: 552 LSDMGISKRLQGDMSCLTQNATGYGSSG-----------WQAPEQLLQGRQTRAIDLFSL 600
L K L + Y S E L G D++ L
Sbjct: 203 LHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSMDEDLFTGDGDYQFDIYRL 262
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 7e-06
Identities = 16/63 (25%), Positives = 30/63 (47%), Gaps = 1/63 (1%)
Query: 499 ELWKANGHPSAQL-LKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGI 557
++ NG L++ ++ L ++HE +H D+K N+L+ L+D G+
Sbjct: 140 KISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGL 199
Query: 558 SKR 560
S R
Sbjct: 200 SYR 202
|
| >2be1_A Serine/threonine-protein kinase/endoribonuclease; transcription; 2.98A {Saccharomyces cerevisiae} Length = 339 | Back alignment and structure |
|---|
Score = 47.8 bits (113), Expect = 7e-06
Identities = 23/133 (17%), Positives = 48/133 (36%), Gaps = 27/133 (20%)
Query: 18 IKKLSSSAEEYIRRMPYISK-------------DGGVTLGAMKTSVFLVDVKSGRVVDNY 64
++KL S + + P K D V G+M+T ++ +++ +G ++ +
Sbjct: 78 LQKLPLSIRQLVSTSPLHLKTNIVVNDSGKIVEDEKVYTGSMRTIMYTINMLNGEIISAF 137
Query: 65 VLDFSASTPGFQSDENKHVVPVDGYEELVESGVGNLKRIRQLVYIMRTDYVLQSTSQDSG 124
G QS + + E ++ I +T + L S D
Sbjct: 138 GPGSKNGYFGSQSVDCSPEEKIKLQEC------------ENMIVIGKTIFELGIHSYDGA 185
Query: 125 EVLWNVAYADFKA 137
+NV Y+ ++
Sbjct: 186 S--YNVTYSTWQQ 196
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 8e-06
Identities = 45/194 (23%), Positives = 69/194 (35%), Gaps = 46/194 (23%)
Query: 372 RRIGKLVVFNKEIAKGSNGTVVL-EGNYEGRSVAVKR-LVKTHHDVALKEIQNLIASDQH 429
R+G ++I GS G + L G VA+K VKT H E +
Sbjct: 5 LRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGG 64
Query: 430 PNI--VRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIR 487
I +RW G E D+ + +E SL DL S F
Sbjct: 65 VGIPTIRWCGAE--GDYNVMVMELLGPSLEDLFNFCSRKF-------------------- 102
Query: 488 LLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISK-DK 546
+ K + L + ++S + ++H IHRD+KP N L+ K
Sbjct: 103 ------SLKTV-------------LLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKK 143
Query: 547 SFCAKLSDMGISKR 560
+ D G++K+
Sbjct: 144 GNLVYIIDFGLAKK 157
|
| >2hz6_A Endoplasmic reticulum to nucleus signalling 1 isoform 1 variant; triangular beta-sheet cluster, signaling protein; 3.10A {Homo sapiens} Length = 369 | Back alignment and structure |
|---|
Score = 47.7 bits (113), Expect = 1e-05
Identities = 23/120 (19%), Positives = 43/120 (35%), Gaps = 28/120 (23%)
Query: 18 IKKLSSSAEEYIRRMPYISKDGGVTLGAMKTSVFLVDVKSGRVVDNYVLDFSASTPGFQS 77
+ KL + E ++ P S DG + +G + +++D+ +G S
Sbjct: 72 LTKLPFTIPELVQASPCRSSDGILYMGKKQDIWYVIDLLTGEKQQT-----------LSS 120
Query: 78 DENKHVVPVDGYEELVESGVGNLKRIRQLVYIMRTDYVLQSTSQDSGEVLWNVAYADFKA 137
+ P L+Y+ RT+Y + + E+ WN Y D+ A
Sbjct: 121 AFADSLSPSTS-----------------LLYLGRTEYTITMYDTKTRELRWNATYFDYAA 163
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 2e-05
Identities = 11/49 (22%), Positives = 23/49 (46%)
Query: 512 LKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKR 560
L+V ++ L LHE +H ++ +N+ + + L+ G + R
Sbjct: 162 LQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFR 210
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 46.9 bits (111), Expect = 2e-05
Identities = 44/193 (22%), Positives = 70/193 (36%), Gaps = 46/193 (23%)
Query: 373 RIGKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKR-LVKTHHDVALKEIQNLIASDQHP 430
R+G ++I GS G + L N VA+K VKT H L E +
Sbjct: 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGT 63
Query: 431 NI--VRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRL 488
I VRW+GVE D+ L ++ SL DL S
Sbjct: 64 GIPNVRWFGVE--GDYNVLVMDLLGPSLEDLFNFCSRKL--------------------- 100
Query: 489 LPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSF 548
+ K + L + +++ + +H +HRD+KP N L+ +
Sbjct: 101 -----SLKTV-------------LMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRA 142
Query: 549 -CAKLSDMGISKR 560
+ D G++K+
Sbjct: 143 NQVYIIDFGLAKK 155
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 46.3 bits (110), Expect = 2e-05
Identities = 13/43 (30%), Positives = 23/43 (53%)
Query: 518 IVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKR 560
I+ L ++HE +H D+K N+L++ L D G++ R
Sbjct: 161 ILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYR 203
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
No hit with probability above 80.00
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 805 | ||||
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 6e-45 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-42 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-42 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 9e-42 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-41 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-41 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-41 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 3e-41 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-40 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 3e-40 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 6e-40 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 7e-40 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 1e-39 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 3e-39 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 3e-39 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 8e-39 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 9e-39 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 9e-39 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 3e-38 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 3e-38 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 5e-38 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 6e-38 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 8e-38 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-37 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-37 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 3e-37 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 3e-37 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 5e-37 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 9e-37 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 1e-36 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 1e-36 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-36 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-35 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-35 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 4e-35 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 4e-35 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 6e-35 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 7e-35 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-34 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 3e-34 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 4e-34 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-33 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 7e-33 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 1e-32 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 3e-32 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 6e-32 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 1e-31 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-31 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-31 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-31 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 7e-31 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-30 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 3e-30 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 1e-29 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 3e-29 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 5e-29 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 6e-29 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-27 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-27 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-25 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 5e-22 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-21 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 2e-08 |
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (410), Expect = 6e-45
Identities = 61/300 (20%), Positives = 102/300 (34%), Gaps = 34/300 (11%)
Query: 380 FNKEIAKGSNGTVVL------EGNYEGRSVAVKRLVKTHHDVA----LKEIQNLIASDQH 429
F K + G+ G V+ VAVK L + + E++ + H
Sbjct: 41 FGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSH 100
Query: 430 PNIVRWYGVESDQDFVYLSLERCT-CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRL 488
NIV G + +YL E C L + + F E E L E + +
Sbjct: 101 ENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNV 160
Query: 489 LPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSF 548
L LL + G+ L +HRDL +NVL+
Sbjct: 161 LTF-----------------EDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLV--THGK 201
Query: 549 CAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCI 608
K+ D G+++ + D S W APE L +G T D++S G +L+
Sbjct: 202 VVKICDFGLARDIMSD-SNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIF 260
Query: 609 TGGKHPYGESFERDA--NIVKDRKDLFLVEHIP-EAVDLFTRLLDPNPDLRPKAQNVLNH 665
+ G +PY ++++ + + E + + RP N+ +
Sbjct: 261 SLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 156 bits (396), Expect = 1e-42
Identities = 59/297 (19%), Positives = 108/297 (36%), Gaps = 55/297 (18%)
Query: 382 KEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTH---HDVALKEIQNLIASDQHPNIVRWYG 437
+E+ G+ G V G + A K ++ H + KEIQ + + +HP +V +
Sbjct: 32 EELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTM-SVLRHPTLVNLHD 90
Query: 438 VESDQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTK 496
D + + + E + L + + E
Sbjct: 91 AFEDDNEMVMIYEFMSGGELFEKVADEHNKMSED-------------------------- 124
Query: 497 DIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMG 556
+ ++ R + GL H+HE +H DLKP+N++ + +S KL D G
Sbjct: 125 -------------EAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFG 171
Query: 557 ISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY- 615
++ L S G++ + APE D++S+G + + ++ G P+
Sbjct: 172 LTAHLDPKQSVKVT----TGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLS-GLSPFG 226
Query: 616 GESFERDANIVKDRKDLFLVEHIP----EAVDLFTRLLDPNPDLRPKAQNVLNHPFF 668
GE+ + VK + D +LL +P+ R L HP+
Sbjct: 227 GENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWL 283
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (388), Expect = 2e-42
Identities = 66/294 (22%), Positives = 108/294 (36%), Gaps = 54/294 (18%)
Query: 382 KEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHD------VALKEIQNLIASDQHPNIVR 434
+ + KG G V L +A+K L K + +E++ + + +HPNI+R
Sbjct: 12 RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE-IQSHLRHPNILR 70
Query: 435 WYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMEN 494
YG D VYL LE F+EQ
Sbjct: 71 LYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQ------------------------ 106
Query: 495 TKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSD 554
+ ++ + LS+ H +IHRD+KP+N+L+ + K++D
Sbjct: 107 ---------------RTATYITELANALSYCHSKRVIHRDIKPENLLL--GSAGELKIAD 149
Query: 555 MGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP 614
G S T G+ + PE + +DL+SLG + + + G
Sbjct: 150 FGWSVHAPSSRRT-----TLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF 204
Query: 615 YGESFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 668
+++ + + F A DL +RLL NP RP + VL HP+
Sbjct: 205 EANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 258
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (385), Expect = 9e-42
Identities = 65/295 (22%), Positives = 117/295 (39%), Gaps = 55/295 (18%)
Query: 382 KEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTH---HDVALKEIQNLIASDQHPNIVRWYG 437
++I +G++GTV G+ VA++++ ++ + EI ++ +++PNIV +
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEIL-VMRENKNPNIVNYLD 84
Query: 438 VESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKD 497
D +++ +E Y+ GS +
Sbjct: 85 SYLVGDELWVVME----------YLAGGSLTD---------------------------- 106
Query: 498 IELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGI 557
+ Q+ V R+ + L LH +IHRD+K N+L+ D S KL+D G
Sbjct: 107 --VVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGS--VKLTDFGF 162
Query: 558 SKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGE 617
++ + S + T G+ W APE + + +D++SLG + I G+ PY
Sbjct: 163 CAQITPEQSKRS---TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIE-GEPPYLN 218
Query: 618 SFERDA---NIVKDRKDLFLVEHIP-EAVDLFTRLLDPNPDLRPKAQNVLNHPFF 668
A +L E + D R LD + + R A+ +L H F
Sbjct: 219 ENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFL 273
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 152 bits (385), Expect = 1e-41
Identities = 71/335 (21%), Positives = 125/335 (37%), Gaps = 64/335 (19%)
Query: 382 KEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHDV------ALKEIQNLIASDQHPNIVR 434
+EI GS G V VA+K++ + +KE++ + +HPN ++
Sbjct: 21 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVR-FLQKLRHPNTIQ 79
Query: 435 WYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMEN 494
+ G + +L +E C S +DL+ V +E
Sbjct: 80 YRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEV------------------------ 115
Query: 495 TKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSD 554
++ VT + GL++LH +IHRD+K N+L+S+ KL D
Sbjct: 116 ---------------EIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEP--GLVKLGD 158
Query: 555 MGISKRLQGDMSCLTQNATGYGSSGWQAPEQLL---QGRQTRAIDLFSLGCILFFCITGG 611
G + + + G+ W APE +L +G+ +D++SLG
Sbjct: 159 FGSASI-------MAPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE-R 210
Query: 612 KHPYGESFERDA--NIVKDRKDLFLVEHIP-EAVDLFTRLLDPNPDLRPKAQNVLNHPFF 668
K P A +I ++ H + L P RP ++ +L H F
Sbjct: 211 KPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFV 270
Query: 669 WTADTRLSFLRDVSDRVELEDRESDSKLLRALEGI 703
+ + + D+ R + RE D+ R ++ I
Sbjct: 271 -LRERPPTVIMDLIQRTKDAVRELDNLQYRKMKKI 304
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (381), Expect = 2e-41
Identities = 65/307 (21%), Positives = 116/307 (37%), Gaps = 58/307 (18%)
Query: 376 KLVVFNKEIAKGSNGTV---VLEGNYEGRSVAVKRLVKTHHDVALK-----EIQNLIASD 427
L + +KE+ G+ GTV + ++VAVK L +D ALK E ++
Sbjct: 7 LLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEAN-VMQQL 65
Query: 428 QHPNIVRWYGVESDQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRI 486
+P IVR G+ + + L +E LN +
Sbjct: 66 DNPYIVRMIGICEAESW-MLVMEMAELGPLNKYL-------------------------- 98
Query: 487 RLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDK 546
+ ++++ + G+ +L E +HRDL +NVL+
Sbjct: 99 --------------QQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQ- 143
Query: 547 SFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFF 606
AK+SD G+SK L+ D + G W APE + + + D++S G +++
Sbjct: 144 -HYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWE 202
Query: 607 CITGGKHPY-GESFERDANIVKDRKDLFLVEHIP-EAVDLFTRLLDPNPDLRPKAQNV-- 662
+ G+ PY G +++ + + P E DL + + RP V
Sbjct: 203 AFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL 262
Query: 663 -LNHPFF 668
L + ++
Sbjct: 263 RLRNYYY 269
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (382), Expect = 2e-41
Identities = 63/301 (20%), Positives = 106/301 (35%), Gaps = 60/301 (19%)
Query: 382 KEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHDV---ALKEIQNLIASDQHPNIVRWYG 437
E+ G+ G V + A K + + + EI L AS HPNIV+
Sbjct: 18 GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDIL-ASCDHPNIVKLLD 76
Query: 438 VESDQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTK 496
++ +++ +E C +++ ++ L E
Sbjct: 77 AFYYENNLWILIEFCAGGAVDAVMLELERPLTES-------------------------- 110
Query: 497 DIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMG 556
Q+ V + + L++LH+ +IHRDLK N+L + D KL+D G
Sbjct: 111 -------------QIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLD--GDIKLADFG 155
Query: 557 ISKRLQGDMSCLTQNATGYGSSGWQAPEQLL-----QGRQTRAIDLFSLGCILFFCITGG 611
+S + + + G+ W APE ++ D++SLG L
Sbjct: 156 VSAKNTRTIQRRD---SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAE-I 211
Query: 612 KHPYGESFERDA--NIVK-DRKDLFLVEHIP-EAVDLFTRLLDPNPDLRPKAQNVLNHPF 667
+ P+ E I K + L D + L+ N D R +L HPF
Sbjct: 212 EPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPF 271
Query: 668 F 668
Sbjct: 272 V 272
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (379), Expect = 3e-41
Identities = 57/295 (19%), Positives = 112/295 (37%), Gaps = 50/295 (16%)
Query: 382 KEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHDVALKEIQN---LIASDQHPNIVRWYG 437
+ + +G+ G V L +VAVK + + I+ + H N+V++YG
Sbjct: 11 QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 70
Query: 438 VESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKD 497
+ + YL LE Y G +++
Sbjct: 71 HRREGNIQYLFLE----------YCSGGELFDRIEPD----------------------- 97
Query: 498 IELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGI 557
G P + +++G+ +LH IG+ HRD+KP+N+L+ + K+SD G+
Sbjct: 98 ------IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDER--DNLKISDFGL 149
Query: 558 SKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGR-QTRAIDLFSLGCILFFCITGGKHPYG 616
+ + + N G+ + APE L + +D++S G +L + G
Sbjct: 150 ATVFRYNNRERLLN-KMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 208
Query: 617 ES--FERDANIVKDRKDLFLVEHI-PEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 668
S + ++ + + L + I + L ++L NP R ++ ++
Sbjct: 209 PSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWY 263
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (373), Expect = 2e-40
Identities = 59/305 (19%), Positives = 107/305 (35%), Gaps = 54/305 (17%)
Query: 376 KLVVFNKEIAKGSNGTV---VLEGNYEGRSVAVKRLVKTHHDVALKEIQN---LIASDQH 429
L++ + E+ G+ G+V V + VA+K L + +E+ ++ +
Sbjct: 9 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDN 68
Query: 430 PNIVRWYGVESDQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRL 488
P IVR GV + L +E L+ +
Sbjct: 69 PYIVRLIGVCQAEAL-MLVMEMAGGGPLHKFLVGKREEIPVS------------------ 109
Query: 489 LPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSF 548
+ ++ + G+ +L E +HRDL +NVL+
Sbjct: 110 ---------------------NVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNR--H 146
Query: 549 CAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCI 608
AK+SD G+SK L D S T + G W APE + + + D++S G ++ +
Sbjct: 147 YAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEAL 206
Query: 609 TGGKHPY-GESFERDANIVKDRKDLFLVEHIP-EAVDLFTRLLDPNPDLRPKAQNV---L 663
+ G+ PY ++ K + P E L + + RP V +
Sbjct: 207 SYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRM 266
Query: 664 NHPFF 668
++
Sbjct: 267 RACYY 271
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (372), Expect = 3e-40
Identities = 64/310 (20%), Positives = 111/310 (35%), Gaps = 64/310 (20%)
Query: 375 GKLVVFNKEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHDVA-----LKEIQNLIASDQ 428
G+ + F+ EI +GS TV VA L + +E + ++ Q
Sbjct: 8 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAE-MLKGLQ 66
Query: 429 HPNIVRWYGV----ESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEV 484
HPNIVR+Y + + L E + SG+ + L
Sbjct: 67 HPNIVRFYDSWESTVKGKKCIVLVTE----------LMTSGTLKTYLK------------ 104
Query: 485 RIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG--LIHRDLKPQNVLI 542
+ L R I+ GL LH +IHRDLK N+ I
Sbjct: 105 -----------------RFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFI 147
Query: 543 SKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGC 602
+ + K+ D+G++ + + G+ + APE + + ++D+++ G
Sbjct: 148 T-GPTGSVKIGDLGLATLKRASFA-----KAVIGTPEFMAPEMY-EEKYDESVDVYAFGM 200
Query: 603 ILFFCITGGKHPYGESFERDA---NIVKDRKDLFLVEHI-PEAVDLFTRLLDPNPDLRPK 658
+ T ++PY E + K + PE ++ + N D R
Sbjct: 201 CMLEMATS-EYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYS 259
Query: 659 AQNVLNHPFF 668
+++LNH FF
Sbjct: 260 IKDLLNHAFF 269
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (369), Expect = 6e-40
Identities = 64/300 (21%), Positives = 111/300 (37%), Gaps = 55/300 (18%)
Query: 382 KEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHD-----VALKEIQNLIASDQHPNIVRW 435
I GS G +G+ + K L + + E+ L+ +HPNIVR+
Sbjct: 10 YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVN-LLRELKHPNIVRY 68
Query: 436 YGVESDQ--DFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVME 493
Y D+ +Y+ +E Y G + ++ L+E
Sbjct: 69 YDRIIDRTNTTLYIVME----------YCEGGDLASVITKGTKERQYLDE---------- 108
Query: 494 NTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG-----LIHRDLKPQNVLISKDKSF 548
+L+V + L H ++HRDLKP NV + D
Sbjct: 109 ---------------EFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFL--DGKQ 151
Query: 549 CAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCI 608
KL D G+++ L D S G+ + +PEQ+ + D++SLGC+L+
Sbjct: 152 NVKLGDFGLARILNHDTSFAK---AFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELC 208
Query: 609 TGGKHPYGESFERDANIVKDRKDLFLVEHIP-EAVDLFTRLLDPNPDLRPKAQNVLNHPF 667
S + A +++ K + E ++ TR+L+ RP + +L +P
Sbjct: 209 ALMPPFTAFSQKELAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPL 268
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 147 bits (371), Expect = 7e-40
Identities = 64/295 (21%), Positives = 112/295 (37%), Gaps = 29/295 (9%)
Query: 380 FNKEIAKGSNGTVVL------EGNYEGRSVAVKRLVKTHHDVALKEIQN---LIASDQHP 430
+ ++I +G+ G V VAVK L + + Q L+A +P
Sbjct: 17 YVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNP 76
Query: 431 NIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLP 490
NIV+ GV + + L E Y+ G E L + + V
Sbjct: 77 NIVKLLGVCAVGKPMCLLFE----------YMAYGDLNEFLRSMSPHT-----VCSLSHS 121
Query: 491 VMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCA 550
+ + A+ L + R + +G+++L E +HRDL +N L+ ++
Sbjct: 122 DLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLV--GENMVV 179
Query: 551 KLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG 610
K++D G+S+ + + W PE + R T D+++ G +L+ +
Sbjct: 180 KIADFGLSRNIYSA-DYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSY 238
Query: 611 GKHPY-GESFERDANIVKDRKDLFLVEHIP-EAVDLFTRLLDPNPDLRPKAQNVL 663
G PY G + E V+D L E+ P E +L P RP ++
Sbjct: 239 GLQPYYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIH 293
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (366), Expect = 1e-39
Identities = 64/289 (22%), Positives = 113/289 (39%), Gaps = 49/289 (16%)
Query: 380 FNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYGVE 439
+ I KG G V+L G+Y G VAVK + A +++ +H N+V+ GV
Sbjct: 11 LLQTIGKGEFGDVML-GDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVI 69
Query: 440 SDQD-FVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDI 498
++ +Y+ E Y+ GS + L + + ++L
Sbjct: 70 VEEKGGLYIVTE----------YMAKGSLVDYL--RSRGRSVLGG--------------- 102
Query: 499 ELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGIS 558
LLK + D+ + +L +HRDL +NVL+S+D AK+SD G++
Sbjct: 103 ----------DCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSED--NVAKVSDFGLT 150
Query: 559 KRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY-GE 617
K TG W APE L + + + D++S G +L+ + G+ PY
Sbjct: 151 KEASSTQD------TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI 204
Query: 618 SFERDANIVKDRKDLFLVEHIP-EAVDLFTRLLDPNPDLRPKAQNVLNH 665
+ V+ + + P ++ + +RP +
Sbjct: 205 PLKDVVPRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQ 253
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (365), Expect = 3e-39
Identities = 62/295 (21%), Positives = 108/295 (36%), Gaps = 49/295 (16%)
Query: 380 FNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTH--HDVALKEIQNLIASDQHPNIVRWYG 437
+ + G G V + VAVK L + D L E L+ QH +VR Y
Sbjct: 17 LVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEAN-LMKQLQHQRLVRLYA 75
Query: 438 VESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKD 497
V + + +Y+ E Y+ +GS + L
Sbjct: 76 VVTQEP-IYIITE----------YMENGSLVDFLKTP----------------------- 101
Query: 498 IELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGI 557
+LL + I G++ + E IHRDL+ N+L+ + K++D G+
Sbjct: 102 ----SGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILV--SDTLSCKIADFGL 155
Query: 558 SKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY-G 616
++ ++ + + W APE + G T D++S G +L +T G+ PY G
Sbjct: 156 ARLIEDNEYTARE--GAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG 213
Query: 617 ESFERDANIVKDRKDLFLVEHIP-EAVDLFTRLLDPNPDLRPKAQNVLN--HPFF 668
+ ++ + ++ P E L P+ RP + + FF
Sbjct: 214 MTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 146 bits (370), Expect = 3e-39
Identities = 62/297 (20%), Positives = 105/297 (35%), Gaps = 55/297 (18%)
Query: 382 KEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTH---HDVALKEIQNLIASDQHPNIVRWYG 437
+E+ G+ G V GR K + + EI ++ HP ++ +
Sbjct: 35 EELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEIS-IMNQLHHPKLINLHD 93
Query: 438 VESDQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTK 496
D+ + L LE + L D I E
Sbjct: 94 AFEDKYEMVLILEFLSGGELFDRIAAEDYKMSE--------------------------- 126
Query: 497 DIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMG 556
A+++ R GL H+HE ++H D+KP+N++ K+ K+ D G
Sbjct: 127 ------------AEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFG 174
Query: 557 ISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY- 615
++ +L D AT + APE + + D++++G + + ++ G P+
Sbjct: 175 LATKLNPDEIVKVTTATAE----FAAPEIVDREPVGFYTDMWAIGVLGYVLLS-GLSPFA 229
Query: 616 GESFERDANIVKDRKDLFLVEHI----PEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 668
GE VK F + PEA D LL P R + L HP+
Sbjct: 230 GEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWL 286
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (360), Expect = 8e-39
Identities = 57/291 (19%), Positives = 110/291 (37%), Gaps = 49/291 (16%)
Query: 380 FNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTH--HDVALKEIQNLIASDQHPNIVRWYG 437
F KE+ G G V VA+K + + D ++E + ++ + H +V+ YG
Sbjct: 8 FLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAK-VMMNLSHEKLVQLYG 66
Query: 438 VESDQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTK 496
V + Q +++ E L + + + F+ Q
Sbjct: 67 VCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQ-------------------------- 100
Query: 497 DIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMG 556
QLL++ +D+ + +L +HRDL +N L+ + K+SD G
Sbjct: 101 -------------QLLEMCKDVCEAMEYLESKQFLHRDLAARNCLV--NDQGVVKVSDFG 145
Query: 557 ISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY- 615
+S+ + D T + W PE L+ + + D+++ G +++ + GK PY
Sbjct: 146 LSRYVLDDEY--TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYE 203
Query: 616 GESFERDANIVKDRKDLFLVEHIPEAV-DLFTRLLDPNPDLRPKAQNVLNH 665
+ A + L+ E V + D RP + +L++
Sbjct: 204 RFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSN 254
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (364), Expect = 9e-39
Identities = 50/296 (16%), Positives = 106/296 (35%), Gaps = 54/296 (18%)
Query: 382 KEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHDVAL--KEIQNLIASDQHPNIVRWYGV 438
+++ +G G V ++ K + D L KEI L +H NI+ +
Sbjct: 11 EDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISIL-NIARHRNILHLHES 69
Query: 439 ESDQDFVYLSLERCT-CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKD 497
+ + + E + + + I + E+
Sbjct: 70 FESMEELVMIFEFISGLDIFERINTSAFELNER--------------------------- 102
Query: 498 IELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGI 557
+++ + L LH + H D++P+N++ +S K+ + G
Sbjct: 103 ------------EIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQ 150
Query: 558 SKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY-G 616
+++ + + + + APE + A D++SLG +++ ++ G +P+
Sbjct: 151 ARQ----LKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLS-GINPFLA 205
Query: 617 ESFERDANIVKDRKDLFLVEHIP----EAVDLFTRLLDPNPDLRPKAQNVLNHPFF 668
E+ ++ + + + F E EA+D RLL R A L HP+
Sbjct: 206 ETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWL 261
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (360), Expect = 9e-39
Identities = 57/290 (19%), Positives = 101/290 (34%), Gaps = 47/290 (16%)
Query: 380 FNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVA--LKEIQNLIASDQHPNIVRWYG 437
F +EI G G V L VA+K + + ++E + ++ HP +V+ YG
Sbjct: 9 FVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAE-VMMKLSHPKLVQLYG 67
Query: 438 VESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKD 497
V +Q + L E D
Sbjct: 68 VCLEQAPICLVFEFMEHGCLS--------------------------------------D 89
Query: 498 IELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGI 557
+ + LL + D+ G+++L E +IHRDL +N L+ ++ K+SD G+
Sbjct: 90 YLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLV--GENQVIKVSDFGM 147
Query: 558 SKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY-G 616
++ + D T + W +PE R + D++S G +++ + GK PY
Sbjct: 148 TRFVLDDQY--TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYEN 205
Query: 617 ESFERDANIVKDRKDLFLVEHIP-EAVDLFTRLLDPNPDLRPKAQNVLNH 665
S + L+ + P+ RP +L
Sbjct: 206 RSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQ 255
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (358), Expect = 3e-38
Identities = 62/302 (20%), Positives = 111/302 (36%), Gaps = 42/302 (13%)
Query: 379 VFNKEIAKGSNGTVVL--------EGNYEGRSVAVKRLVKTHHDVALK----EIQNLIAS 426
V K + +G+ G VVL + VAVK L + L E++ +
Sbjct: 16 VLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMI 75
Query: 427 DQHPNIVRWYGVESDQDFVYLSLERCT-CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVR 485
+H NI+ G + +Y+ +E + +L + + +
Sbjct: 76 GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL------------------------Q 111
Query: 486 IRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKD 545
R P +E + + S L+ + G+ +L IHRDL +NVL+++D
Sbjct: 112 ARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTED 171
Query: 546 KSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILF 605
K++D G+++ + G W APE L T D++S G +L+
Sbjct: 172 --NVMKIADFGLARDIHHIDYYKKTT-NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLW 228
Query: 606 FCITGGKHPY-GESFERDANIVKDRKDLFLVEHIP-EAVDLFTRLLDPNPDLRPKAQNVL 663
T G PY G E ++K+ + + E + P RP + ++
Sbjct: 229 EIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLV 288
Query: 664 NH 665
Sbjct: 289 ED 290
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (359), Expect = 3e-38
Identities = 66/297 (22%), Positives = 114/297 (38%), Gaps = 37/297 (12%)
Query: 380 FNKEIAKGSNGTVVL------EGNYEGRSVAVKRLVKTHH----DVALKEIQNLIASDQH 429
F K + G+ G VV + +VAVK L + H + + E++ L H
Sbjct: 27 FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNH 86
Query: 430 PNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLL 489
NIV G + + E Y G L +++DS + ++ ++
Sbjct: 87 MNIVNLLGACTIGGPTLVITE----------YCCYGDLLNFLR-RKRDSFICSKTSPAIM 135
Query: 490 PVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFC 549
E D+E LL + + G++ L IHRDL +N+L++
Sbjct: 136 EDDELALDLE----------DLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHG--RI 183
Query: 550 AKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCIT 609
K+ D G+++ ++ D S W APE + T D++S G L+ +
Sbjct: 184 TKICDFGLARDIKND-SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242
Query: 610 GGKHPYGESFERDA--NIVKDRKDLFLVEHIP-EAVDLFTRLLDPNPDLRPKAQNVL 663
G PY ++K+ + EH P E D+ D +P RP + ++
Sbjct: 243 LGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIV 299
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (356), Expect = 5e-38
Identities = 61/295 (20%), Positives = 105/295 (35%), Gaps = 50/295 (16%)
Query: 380 FNKEIAKGSNGTVVL-----EGNYEGRSVAVKRLVKTHHDVALKEIQN---LIASDQHPN 431
K I G G V + VA+K L + + + ++ H N
Sbjct: 11 RQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHN 70
Query: 432 IVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPV 491
I+R GV S + + E D
Sbjct: 71 IIRLEGVISKYKPMMIITEYMENGALD--------------------------------- 97
Query: 492 MENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAK 551
K QL+ + R I +G+ +L + +HRDL +N+L+ + + K
Sbjct: 98 -----KFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILV--NSNLVCK 150
Query: 552 LSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGG 611
+SD G+S+ L+ D + G W APE + + T A D++S G +++ +T G
Sbjct: 151 VSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYG 210
Query: 612 KHPYGESFERDA-NIVKDRKDLFLVEHIPEAV-DLFTRLLDPNPDLRPKAQNVLN 664
+ PY E + + D L P A+ L + RPK ++++
Sbjct: 211 ERPYWELSNHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVS 265
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (359), Expect = 6e-38
Identities = 72/338 (21%), Positives = 121/338 (35%), Gaps = 60/338 (17%)
Query: 374 IGKLVVFNKEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNI 432
I V ++ + G NG V+ A+K L A +E++ + Q P+I
Sbjct: 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPK--ARREVELHWRASQCPHI 67
Query: 433 VRWYGV----ESDQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIR 487
VR V + + + + +E L I +++ E
Sbjct: 68 VRIVDVYENLYAGRKCLLIVMECLDGGELFSRI-------------QDRGDQAFTEREAS 114
Query: 488 LLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLI-SKDK 546
++ + I + +LH I + HRD+KP+N+L SK
Sbjct: 115 -------------------------EIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRP 149
Query: 547 SFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFF 606
+ KL+D G +K S T T Y + APE L + ++ D++SLG I++
Sbjct: 150 NAILKLTDFGFAKETTSHNSLTTPCYTPY----YVAPEVLGPEKYDKSCDMWSLGVIMYI 205
Query: 607 CITGGKHPYGESFERDANIVKDR--------KDLFLVEHIPEAVDLFTRLLDPNPDLRPK 658
+ G Y + +K R + E E L LL P R
Sbjct: 206 LLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMT 265
Query: 659 AQNVLNHPFFWTADTRLSFLRDVSDRVELEDRESDSKL 696
+NHP+ T++ + RV ED+E +
Sbjct: 266 ITEFMNHPWI-MQSTKVPQTPLHTSRVLKEDKERWEDV 302
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 141 bits (355), Expect = 8e-38
Identities = 58/297 (19%), Positives = 108/297 (36%), Gaps = 51/297 (17%)
Query: 380 FNKEIAKGSNGTVVL----EGNYEGRSVAVKRLVKTHHDVALKEIQN---LIASDQHPNI 432
+ I G G V VA+K L + + ++ + ++ HPN+
Sbjct: 30 IEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNV 89
Query: 433 VRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVM 492
+ GV + V + E D
Sbjct: 90 IHLEGVVTKSTPVMIITEFMENGSLDSFLR------------------------------ 119
Query: 493 ENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKL 552
QL+ + R I +G+ +L ++ +HRDL +N+L+ + + K+
Sbjct: 120 --------QNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILV--NSNLVCKV 169
Query: 553 SDMGISKRLQGDMSCLTQNATG--YGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG 610
SD G+S+ L+ D S T + W APE + + T A D++S G +++ ++
Sbjct: 170 SDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSY 229
Query: 611 GKHPY-GESFERDANIVKDRKDLFLVEHIPEAV-DLFTRLLDPNPDLRPKAQNVLNH 665
G+ PY + + N ++ L P A+ L + + RPK ++N
Sbjct: 230 GERPYWDMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (356), Expect = 1e-37
Identities = 64/340 (18%), Positives = 108/340 (31%), Gaps = 95/340 (27%)
Query: 382 KEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHDVALKEIQN---LIASDQHPNIVRWYG 437
E+ G+ G V G +A K + +I ++ P IV +YG
Sbjct: 12 SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYG 71
Query: 438 VESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKD 497
+ + +E ++ GS ++ L
Sbjct: 72 AFYSDGEISICME----------HMDGGSLDQVL-------------------------- 95
Query: 498 IELWKANGHPSAQLLKVTRDIVSGLSHLHEI-GLIHRDLKPQNVLISKDKSFCAKLSDMG 556
KA P L KV+ ++ GL++L E ++HRD+KP N+L++ KL D G
Sbjct: 96 ---KKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSR--GEIKLCDFG 150
Query: 557 ISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG------ 610
+S +L M+ + G+ + +PE+L + D++S+G L G
Sbjct: 151 VSGQLIDSMAN-----SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPP 205
Query: 611 -------------------------------------GKHPYGESFERDANIVKDRKDLF 633
P FE IV +
Sbjct: 206 PDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKL 265
Query: 634 LVEHI-PEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTAD 672
E D + L NP R + ++ H F +D
Sbjct: 266 PSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSD 305
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 2e-37
Identities = 69/329 (20%), Positives = 119/329 (36%), Gaps = 53/329 (16%)
Query: 382 KEIAKGSNGTVVL-----EGNYEGRSVAVKRLVKTHHDVALKEIQN---LIASDQHPNIV 433
K + G+ GTV EG VA+K L + A KEI + ++AS +P++
Sbjct: 15 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 74
Query: 434 RWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVME 493
R G+ ++ L D +
Sbjct: 75 RLLGICLTSTVQLITQLMPFGCLLDYVR-------------------------------- 102
Query: 494 NTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLS 553
+ S LL I G+++L + L+HRDL +NVL+ K++
Sbjct: 103 -------EHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLV--KTPQHVKIT 153
Query: 554 DMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKH 613
D G++K L + G W A E +L T D++S G ++ +T G
Sbjct: 154 DFGLAKLLGAEEKEYHAE-GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK 212
Query: 614 PY-GESFERDANIVKDRKDLFLVEHIP-EAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTA 671
PY G ++I++ + L + + + + D RPK + ++
Sbjct: 213 PYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272
Query: 672 DTRLSFLRDVSDRVELEDRESDSKLLRAL 700
D + + +R+ L +DS RAL
Sbjct: 273 DPQRYLVIQGDERMHLPS-PTDSNFYRAL 300
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (352), Expect = 3e-37
Identities = 67/295 (22%), Positives = 113/295 (38%), Gaps = 38/295 (12%)
Query: 380 FNKEIAKGSNGTV---VLEGNYEGRSVAVKRL----VKTHHDVALKEIQNLIASDQHPNI 432
F I +G+ G V ++ + A+KR+ K H E++ L HPNI
Sbjct: 14 FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 73
Query: 433 VRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVM 492
+ G + ++YL++E NLL+ +R +
Sbjct: 74 INLLGACEHRGYLYLAIEYAPHG-----------------------NLLDFLRKSRVLET 110
Query: 493 ENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKL 552
+ I A+ S QLL D+ G+ +L + IHRDL +N+L+ +++ AK+
Sbjct: 111 DPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV--GENYVAKI 168
Query: 553 SDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGK 612
+D G+S+ + G W A E L T D++S G +L+ ++ G
Sbjct: 169 ADFGLSR----GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGG 224
Query: 613 HPY-GESFERDANIVKDRKDLFLVEHIP-EAVDLFTRLLDPNPDLRPKAQNVLNH 665
PY G + + L + E DL + P RP +L
Sbjct: 225 TPYCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (351), Expect = 3e-37
Identities = 74/303 (24%), Positives = 124/303 (40%), Gaps = 58/303 (19%)
Query: 380 FNKEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHD-----VALKEIQNLIASDQHPNIV 433
F K + +GS TVVL R A+K L K H + +++++ HP V
Sbjct: 12 FGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFV 71
Query: 434 RWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVME 493
+ Y D + +Y L Y +G + +
Sbjct: 72 KLYFTFQDDEKLYFGLS----------YAKNGELLKYI---------------------- 99
Query: 494 NTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLS 553
K T +IVS L +LH G+IHRDLKP+N+L+++D +++
Sbjct: 100 -------RKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNED--MHIQIT 150
Query: 554 DMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKH 613
D G +K + S + + G++ + +PE L + ++ DL++LGCI++ + G
Sbjct: 151 DFGTAK-VLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVA-GLP 208
Query: 614 PYGESFERD--ANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQ------NVLNH 665
P+ E I+K D F + P+A DL +LL + R + + H
Sbjct: 209 PFRAGNEYLIFQKIIKLEYD-FPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAH 267
Query: 666 PFF 668
PFF
Sbjct: 268 PFF 270
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (348), Expect = 5e-37
Identities = 65/306 (21%), Positives = 111/306 (36%), Gaps = 67/306 (21%)
Query: 378 VVFNKEIAKGSNGTVVLEGNYEGR---SVAVKRLVKTHHD-VALKEIQN---LIASDQHP 430
+ + I GS GTV Y+G+ VAVK L T L+ +N ++ +H
Sbjct: 10 ITVGQRIGSGSFGTV-----YKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHV 64
Query: 431 NIVRWYGVESDQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLL 489
NI+ + G + + + C SL ++++ FE
Sbjct: 65 NILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHIIETKFEMI------------------- 104
Query: 490 PVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFC 549
+L+ + R G+ +LH +IHRDLK N+ + +D
Sbjct: 105 --------------------KLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHED--LT 142
Query: 550 AKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLL---QGRQTRAIDLFSLGCILFF 606
K+ D G++ ++ S Q GS W APE + + + D+++ G +L+
Sbjct: 143 VKIGDFGLA-TVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYE 201
Query: 607 CITGGKHPYGESFERDA--NIVKDRKDLFLVEHIP-----EAVDLFTRLLDPNPDLRPKA 659
+T G+ PY RD +V + + L L D RP
Sbjct: 202 LMT-GQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLF 260
Query: 660 QNVLNH 665
+L
Sbjct: 261 PQILAS 266
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 138 bits (348), Expect = 9e-37
Identities = 73/338 (21%), Positives = 136/338 (40%), Gaps = 57/338 (16%)
Query: 380 FNKEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHDVALKEIQN---LIASDQHPNIVRW 435
F + G+ V+L E + VA+K + K + ++N ++ +HPNIV
Sbjct: 13 FRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVAL 72
Query: 436 YGVESDQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMEN 494
+ +YL ++ + L D I
Sbjct: 73 DDIYESGGHLYLIMQLVSGGELFDRIV--------------------------------- 99
Query: 495 TKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLI-SKDKSFCAKLS 553
+ + ++ ++ + +LH++G++HRDLKP+N+L S D+ +S
Sbjct: 100 -------EKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMIS 152
Query: 554 DMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKH 613
D G+SK + +T G+ G+ APE L Q ++A+D +S+G I + + G
Sbjct: 153 DFGLSKMEDPG----SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG-YP 207
Query: 614 PYGESFERD--ANIVKDRKDLF--LVEHIP-EAVDLFTRLLDPNPDLRPKAQNVLNHPFF 668
P+ + + I+K + + I A D L++ +P+ R + L HP+
Sbjct: 208 PFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWI 267
Query: 669 WTADTRLSFLRDVSDRVELEDRESDSKLLRALEGIALV 706
DT L S +++ + SK +A A+V
Sbjct: 268 -AGDTALDKNIHQSVSEQIKKNFAKSKWKQAFNATAVV 304
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (348), Expect = 1e-36
Identities = 63/299 (21%), Positives = 112/299 (37%), Gaps = 54/299 (18%)
Query: 379 VFNKEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHH------DVALKEIQNLIASDQHPN 431
+ +K + KGS G V L E + A+K L K + + E + L + +HP
Sbjct: 5 ILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPF 64
Query: 432 IVRWYGVESDQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLP 490
+ + ++ ++ +E L I Q + + R
Sbjct: 65 LTHMFCTFQTKENLFFVMEYLNGGDLMYHI---------------QSCHKFDLSRAT--- 106
Query: 491 VMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCA 550
+I+ GL LH G+++RDLK N+L+ KD
Sbjct: 107 ----------------------FYAAEIILGLQFLHSKGIVYRDLKLDNILLDKD--GHI 142
Query: 551 KLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG 610
K++D G+ K + T G+ + APE LL + ++D +S G +L+ + G
Sbjct: 143 KIADFGMCKENMLGD---AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIG 199
Query: 611 GKHPYGESFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQN-VLNHPFF 668
+G+ E + ++ + EA DL +L P+ R + + HP F
Sbjct: 200 QSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLF 258
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (347), Expect = 1e-36
Identities = 52/297 (17%), Positives = 105/297 (35%), Gaps = 51/297 (17%)
Query: 380 FNKEIAKGSNGTV----VLEGNYEGRSVAVKRLVKTHHDVALKEIQN---LIASDQHPNI 432
FN+ I +G G V +L+ + + AVK L + + + ++ HPN+
Sbjct: 31 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 90
Query: 433 VRWYGVESDQDF-VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPV 491
+ G+ + + L
Sbjct: 91 LSLLGICLRSEGSPLVVLPYMKHGDLR--------------------------------- 117
Query: 492 MENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAK 551
+ + + L+ + G+ L +HRDL +N ++ D+ F K
Sbjct: 118 -----NFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCML--DEKFTVK 170
Query: 552 LSDMGISKRLQGDMSCLTQNATGY-GSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG 610
++D G+++ + N TG W A E L + T D++S G +L+ +T
Sbjct: 171 VADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTR 230
Query: 611 GKHPYGESFERD-ANIVKDRKDLFLVEHIPEAV-DLFTRLLDPNPDLRPKAQNVLNH 665
G PY + D + + L E+ P+ + ++ + P ++RP +++
Sbjct: 231 GAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 287
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (345), Expect = 1e-36
Identities = 58/295 (19%), Positives = 110/295 (37%), Gaps = 49/295 (16%)
Query: 380 FNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDV--ALKEIQNLIASDQHPNIVRWYG 437
++ +G G V + VA+K L L+E Q ++ +H +V+ Y
Sbjct: 21 LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQ-VMKKLRHEKLVQLYA 79
Query: 438 VESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKD 497
V S++ +Y+ E +
Sbjct: 80 VVSEEP-IYIVTEYMSKGSLLDFL------------------------------------ 102
Query: 498 IELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGI 557
+ QL+ + I SG++++ + +HRDL+ N+L+ ++ K++D G+
Sbjct: 103 -KGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILV--GENLVCKVADFGL 159
Query: 558 SKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY-G 616
++ ++ + Q W APE L GR T D++S G +L T G+ PY G
Sbjct: 160 ARLIEDNEYTARQ--GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG 217
Query: 617 ESFERDANIVKDRKDLFLVEHIPEAV-DLFTRLLDPNPDLRPKAQNVLN--HPFF 668
+ V+ + PE++ DL + P+ RP + + +F
Sbjct: 218 MVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 272
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 134 bits (338), Expect = 1e-35
Identities = 63/310 (20%), Positives = 106/310 (34%), Gaps = 68/310 (21%)
Query: 382 KEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHDV------------ALKEIQNLIASDQ 428
+ + +G + V + AVK + T LKE+ L
Sbjct: 9 EILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSG 68
Query: 429 HPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRL 488
HPNI++ F +L + + G + L K L+E R
Sbjct: 69 HPNIIQLKDTYETNTFFFLVFD----------LMKKGELFDYLTEKVT----LSEKETR- 113
Query: 489 LPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSF 548
K+ R ++ + LH++ ++HRDLKP+N+L+ D +
Sbjct: 114 ------------------------KIMRALLEVICALHKLNIVHRDLKPENILLDDDMN- 148
Query: 549 CAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ------TRAIDLFSLGC 602
KL+D G S +L G+ + APE + + +D++S G
Sbjct: 149 -IKLTDFGFSCQLDPGEKLREV----CGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGV 203
Query: 603 ILFFCITGGKHPYGESFERDANIVKDRKDLFLVEHI----PEAVDLFTRLLDPNPDLRPK 658
I++ + G + ++ F DL +R L P R
Sbjct: 204 IMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYT 263
Query: 659 AQNVLNHPFF 668
A+ L HPFF
Sbjct: 264 AEEALAHPFF 273
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (337), Expect = 2e-35
Identities = 58/300 (19%), Positives = 105/300 (35%), Gaps = 40/300 (13%)
Query: 380 FNKEIAKGSNGTVVL------EGNYEGRSVAVKRLVKTH----HDVALKEIQNLIASDQH 429
K + +G+ G V+ + R+VAVK L + H + E++ LI H
Sbjct: 17 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 76
Query: 430 PNIVRWYGV-ESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRL 488
N+V G + + +E C + NL +R +
Sbjct: 77 LNVVNLLGACTKPGGPLMVIVEFC-----------------------KFGNLSTYLRSKR 113
Query: 489 LPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSF 548
+ E + L+ + + G+ L IHRDL +N+L+S+
Sbjct: 114 NEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK--N 171
Query: 549 CAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCI 608
K+ D G+++ + D + W APE + T D++S G +L+
Sbjct: 172 VVKICDFGLARDIYKDPD-YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 230
Query: 609 TGGKHPYGESFERD--ANIVKDRKDLFLVEHI-PEAVDLFTRLLDPNPDLRPKAQNVLNH 665
+ G PY + +K+ + ++ PE P RP ++ H
Sbjct: 231 SLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (336), Expect = 4e-35
Identities = 59/308 (19%), Positives = 114/308 (37%), Gaps = 51/308 (16%)
Query: 379 VFNKEIAKGSNGTVVL------EGNYEGRSVAVKRLVKTHHDVALKEIQN---LIASDQH 429
++E+ +GS G V + VA+K + + E N ++
Sbjct: 23 TMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNC 82
Query: 430 PNIVRWYGVESDQDFVYLSLERCT-CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRL 488
++VR GV S + +E T L + L +
Sbjct: 83 HHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSL---------- 132
Query: 489 LPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSF 548
++++++ +I G+++L+ +HRDL +N ++++D F
Sbjct: 133 --------------------SKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAED--F 170
Query: 549 CAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCI 608
K+ D G+++ + + + G W +PE L G T D++S G +L+
Sbjct: 171 TVKIGDFGMTRDIY-ETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIA 229
Query: 609 TGGKHPY-GESFERDANIVKDRKDLFLVEHIP-EAVDLFTRLLDPNPDLRPKAQNVLN-- 664
T + PY G S E+ V + L ++ P +L NP +RP +++
Sbjct: 230 TLAEQPYQGLSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSI 289
Query: 665 ----HPFF 668
P F
Sbjct: 290 KEEMEPGF 297
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 135 bits (340), Expect = 4e-35
Identities = 70/318 (22%), Positives = 115/318 (36%), Gaps = 64/318 (20%)
Query: 382 KEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTH------HDVALKEIQ--NLIASDQHPNI 432
+ I +G G V G+ A+K L K +AL E +L+++ P I
Sbjct: 10 RIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 69
Query: 433 VRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVM 492
V D + L+ + G L+
Sbjct: 70 VCMSYAFHTPDKLSFILD----------LMNGGDLHYHLSQHGV---------------- 103
Query: 493 ENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKL 552
A + +I+ GL H+H +++RDLKP N+L+ D+ ++
Sbjct: 104 -------------FSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILL--DEHGHVRI 148
Query: 553 SDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ-TRAIDLFSLGCILFFCITGG 611
SD+G++ + G+ G+ APE L +G + D FSLGC+LF + G
Sbjct: 149 SDLGLACDFSKKKPHAS-----VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGH 203
Query: 612 KHPYGESFERDANIVK--DRKDLFLVEHI-PEAVDLFTRLLDPNPDLRPK-----AQNVL 663
+ I + + L + PE L LL + + R AQ V
Sbjct: 204 SPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVK 263
Query: 664 NHPFFWTADTRLSFLRDV 681
PFF + D ++ FL+
Sbjct: 264 ESPFFRSLDWQMVFLQKY 281
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (332), Expect = 6e-35
Identities = 60/300 (20%), Positives = 101/300 (33%), Gaps = 64/300 (21%)
Query: 382 KEIAKGSNGTVVL-EGNYEGRSVAVKRLVK---------THHDVALKEIQNLIA-SDQHP 430
+ G G+V + VA+K + K + E+ L S
Sbjct: 10 PLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 69
Query: 431 NIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLP 490
++R D L LER + ++ + L E R
Sbjct: 70 GVIRLLDWFERPDSFVLILERPEPVQDLFDFI-------------TERGALQEELAR--- 113
Query: 491 VMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCA 550
++ + H H G++HRD+K +N+LI ++
Sbjct: 114 ----------------------SFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNR-GEL 150
Query: 551 KLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGR-QTRAIDLFSLGCILFFCIT 609
KL D G L+ + G+ + PE + R R+ ++SLG +L+ +
Sbjct: 151 KLIDFGSGALLKDTVYT-----DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVC 205
Query: 610 GGKHPYGESFERDANIVKDRKDLFLVEHIP-EAVDLFTRLLDPNPDLRPKAQNVLNHPFF 668
G P FE D I+ R +F + + E L L P RP + + NHP+
Sbjct: 206 G-DIP----FEHDEEII--RGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWM 258
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (331), Expect = 7e-35
Identities = 57/296 (19%), Positives = 105/296 (35%), Gaps = 54/296 (18%)
Query: 380 FNKEIAKGSNGTVVL----EGNYEGRSVAVKRLVKTHHDVALKEIQN---LIASDQHPNI 432
+ I +G G V +VA+K D ++ + HP+I
Sbjct: 11 LGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 70
Query: 433 VRWYGVESDQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPV 491
V+ GV ++ + V++ +E CT L + V S +
Sbjct: 71 VKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYSLDL---------------------- 107
Query: 492 MENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAK 551
A L+ + + L++L +HRD+ +NVL+ + C K
Sbjct: 108 -----------------ASLILYAYQLSTALAYLESKRFVHRDIAARNVLV--SSNDCVK 148
Query: 552 LSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGG 611
L D G+S+ ++ G W APE + R T A D++ G ++ + G
Sbjct: 149 LGDFGLSRYMEDSTYYKAS--KGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHG 206
Query: 612 KHPY-GESFERDANIVKDRKDLFLVEHIP-EAVDLFTRLLDPNPDLRPKAQNVLNH 665
P+ G +++ + L + + P L T+ +P RP+ +
Sbjct: 207 VKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 262
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 131 bits (331), Expect = 2e-34
Identities = 59/299 (19%), Positives = 112/299 (37%), Gaps = 60/299 (20%)
Query: 382 KEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTH------HDVALKEIQNLIASDQHPNIVR 434
+ + GS G V L + GR A+K L K + E +++ HP I+R
Sbjct: 10 RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERL-MLSIVTHPFIIR 68
Query: 435 WYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMEN 494
+G D +++ ++ +
Sbjct: 69 MWGTFQDAQQIFMIMDYIEGGELFSLL--------------------------------- 95
Query: 495 TKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSD 554
K+ P+ ++ L +LH +I+RDLKP+N+L+ DK+ K++D
Sbjct: 96 ------RKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILL--DKNGHIKITD 147
Query: 555 MGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP 614
G +K + T G+ + APE + ++ID +S G +++ + G
Sbjct: 148 FGFAKYVPDVTY------TLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPF 201
Query: 615 YGESFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPK-----AQNVLNHPFF 668
Y + + + + + F + DL +RL+ + R ++V NHP+F
Sbjct: 202 YDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWF 260
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (327), Expect = 3e-34
Identities = 58/297 (19%), Positives = 97/297 (32%), Gaps = 55/297 (18%)
Query: 382 KEIAKGSNGTVVL----EGNYEGRSVAVKRLVKTH------HDVALKEIQNLIASDQHPN 431
+++ GS G V + + SVAVK L D ++E+ + S H N
Sbjct: 14 EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVN-AMHSLDHRN 72
Query: 432 IVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPV 491
++R YGV ++ SL D + G F
Sbjct: 73 LIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLL---------------------- 110
Query: 492 MENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAK 551
L + + G+ +L IHRDL +N+L+ K
Sbjct: 111 -----------------GTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLL--ATRDLVK 151
Query: 552 LSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGG 611
+ D G+ + L + W APE L + A D + G L+ T G
Sbjct: 152 IGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYG 211
Query: 612 KHPYGESFERDA--NIVKDRKDLFLVEHIP-EAVDLFTRLLDPNPDLRPKAQNVLNH 665
+ P+ I K+ + L E P + ++ + P+ RP + +
Sbjct: 212 QEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDF 268
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 130 bits (327), Expect = 4e-34
Identities = 67/318 (21%), Positives = 112/318 (35%), Gaps = 57/318 (17%)
Query: 378 VVFNKEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHDVA--LKEIQNLIASDQHPNIVR 434
+ ++ G G V +VAVK L + +V LKE ++ +HPN+V+
Sbjct: 19 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAA-VMKEIKHPNLVQ 77
Query: 435 WYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMEN 494
GV + + Y+ E T E
Sbjct: 78 LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV------------------------- 112
Query: 495 TKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSD 554
+ LL + I S + +L + IHRDL +N L+ ++ K++D
Sbjct: 113 ------------SAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV--GENHLVKVAD 158
Query: 555 MGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP 614
G+S+ + GD A W APE L + + D+++ G +L+ T G P
Sbjct: 159 FGLSRLMTGDTYTAHAGAKFP--IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 216
Query: 615 Y-GESFERDANIVKDRKDLFLVEHIP-EAVDLFTRLLDPNPDLRPKAQNVLN--HPFFWT 670
Y G + +++ + E P + +L NP RP + F
Sbjct: 217 YPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 276
Query: 671 ADTRLSFLRDVSDRVELE 688
+ +SD VE E
Sbjct: 277 S--------SISDEVEKE 286
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (324), Expect = 1e-33
Identities = 59/309 (19%), Positives = 108/309 (34%), Gaps = 60/309 (19%)
Query: 382 KEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHDVA---------LKEIQNLIASDQHPN 431
+E+ G V G A K + K + +E+ L QHPN
Sbjct: 16 EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSIL-KEIQHPN 74
Query: 432 IVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPV 491
++ + V ++ V L LE S E+
Sbjct: 75 VITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEE--------------------- 113
Query: 492 MENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKD--KSFC 549
+ + + I++G+ +LH + + H DLKP+N+++
Sbjct: 114 ------------------EATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPR 155
Query: 550 AKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCIT 609
K+ D G++ ++ + +G+ + APE + D++S+G I + ++
Sbjct: 156 IKIIDFGLAHKIDFG----NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLS 211
Query: 610 GGKHPYGESFERDANIVKDRKDLFLVEHIP----EAVDLFTRLLDPNPDLRPKAQNVLNH 665
G G++ + V F E+ A D RLL +P R Q+ L H
Sbjct: 212 GASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 271
Query: 666 PFFWTADTR 674
P+ DT+
Sbjct: 272 PWIKPKDTQ 280
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (321), Expect = 7e-33
Identities = 64/299 (21%), Positives = 107/299 (35%), Gaps = 57/299 (19%)
Query: 382 KEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTH------HDVALKEIQNLIASDQHPNIVR 434
K + KG+ G V+L GR A+K L K + E + L + +HP +
Sbjct: 11 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVL-QNTRHPFLTA 69
Query: 435 WYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMEN 494
D + +E
Sbjct: 70 LKYAFQTHDRLCFVMEYANG---------------------------------------G 90
Query: 495 TKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSD 554
L + + +IVS L +LH +++RD+K +N+++ DK K++D
Sbjct: 91 ELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLML--DKDGHIKITD 148
Query: 555 MGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP 614
G+ K D + + G+ + APE L RA+D + LG +++ + G
Sbjct: 149 FGLCKEGISDGATMKTFC---GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 205
Query: 615 YGESFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPK-----AQNVLNHPFF 668
Y + ER ++ + F PEA L LL +P R A+ V+ H FF
Sbjct: 206 YNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 264
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 126 bits (316), Expect = 1e-32
Identities = 58/314 (18%), Positives = 99/314 (31%), Gaps = 57/314 (18%)
Query: 373 RIGKLVVFNKEIAKGSNGTVVL-EGNYEGRSVAVKRL-VKTHHDVALKEIQNLIASDQHP 430
R+G ++I GS G + L G VA+K VKT H E +
Sbjct: 4 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGV 63
Query: 431 NIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLP 490
I ++ D+ + +E SL DL S F +
Sbjct: 64 GIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLK-------------------- 103
Query: 491 VMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLI-SKDKSFC 549
+L + ++S + ++H IHRD+KP N L+ K
Sbjct: 104 -------------------TVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNL 144
Query: 550 AKLSDMGISKRLQGDMS----CLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILF 605
+ D G++K+ + + +N G++ + + L Q+R DL SLG +L
Sbjct: 145 VYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLM 204
Query: 606 FCITGGKHPYGESFERDANIVKDRKDLFLVEHI--------PEAVDLFTRLLDPNPDLRP 657
+ G G + + + I E D +P
Sbjct: 205 YFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKP 264
Query: 658 KAQ---NVLNHPFF 668
+ + F
Sbjct: 265 DYSYLRQLFRNLFH 278
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (316), Expect = 3e-32
Identities = 58/324 (17%), Positives = 116/324 (35%), Gaps = 76/324 (23%)
Query: 382 KEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHDVALKEIQN---LIASDQHPNIVRWYG 437
I +G+ G V N VA+K++ H + ++ +H NI+
Sbjct: 14 SYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 73
Query: 438 VESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKD 497
+ + +Y+++ +
Sbjct: 74 IIRAPTIEQM----------KDVYLVTH--------------------------LMGADL 97
Query: 498 IELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGI 557
+L K + + I+ GL ++H ++HRDLKP N+L++ K+ D G+
Sbjct: 98 YKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTT--CDLKICDFGL 155
Query: 558 SKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ-TRAIDLFSLGCILFFCITGGKHPY- 615
++ D + ++APE +L + T++ID++S+GCIL ++ + +
Sbjct: 156 ARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLS-NRPIFP 214
Query: 616 ---------------GESFERDANIVKDRKDLFLVEHIP----------------EAVDL 644
G + D N + + K + +P +A+DL
Sbjct: 215 GKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDL 274
Query: 645 FTRLLDPNPDLRPKAQNVLNHPFF 668
++L NP R + + L HP+
Sbjct: 275 LDKMLTFNPHKRIEVEQALAHPYL 298
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (311), Expect = 6e-32
Identities = 71/335 (21%), Positives = 121/335 (36%), Gaps = 82/335 (24%)
Query: 382 KEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHD-----VALKEIQNLIASDQHPNIVRW 435
++I +G+ G V G VA+K++ A++EI L+ HPNIV+
Sbjct: 8 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREIS-LLKELNHPNIVKL 66
Query: 436 YGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENT 495
V ++ +YL E L +
Sbjct: 67 LDVIHTENKLYLVFEFLHQDLKKFM----------------------------------- 91
Query: 496 KDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDM 555
+ G P + ++ GL+ H ++HRDLKPQN+LI+ + KL+D
Sbjct: 92 ---DASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTE--GAIKLADF 146
Query: 556 GISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ-TRAIDLFSLGCILFFCITGGKHP 614
G+++ + T + ++APE LL + + A+D++SLGCI +T +
Sbjct: 147 GLARAFGVPVRTYTHEV---VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 202
Query: 615 YGESFERD--ANIVKDRKDLFLVEHI----------------------------PEAVDL 644
+ E D I + V + L
Sbjct: 203 FPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSL 262
Query: 645 FTRLLDPNPDLRPKAQNVLNHPFFWTADTRLSFLR 679
+++L +P+ R A+ L HPFF + LR
Sbjct: 263 LSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLR 297
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (310), Expect = 1e-31
Identities = 64/329 (19%), Positives = 119/329 (36%), Gaps = 74/329 (22%)
Query: 382 KEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHDV-----ALKEIQNLIASDQHPNIVRW 435
+I +G+ G V G+ VA+K+++ + AL+EI+ L +H N+V
Sbjct: 16 AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKIL-QLLKHENVVNL 74
Query: 436 YGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENT 495
+ + Y + + D +
Sbjct: 75 IEICRTKASPYNRCKGSIYLVFDF-------------------------------CEHDL 103
Query: 496 KDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDM 555
+ +++ +V + +++GL ++H ++HRD+K NVLI++D KL+D
Sbjct: 104 AGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGV--LKLADF 161
Query: 556 GISKRLQ-GDMSCLTQNATGYGSSGWQAPEQLLQGRQ-TRAIDLFSLGCILFFCITGGKH 613
G+++ S + + ++ PE LL R IDL+ GCI+ T
Sbjct: 162 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPI 221
Query: 614 PYGESFERDANIVKD--------------------------------RKDLFLVEHIPEA 641
G + + ++ + L P A
Sbjct: 222 MQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYA 281
Query: 642 VDLFTRLLDPNPDLRPKAQNVLNHPFFWT 670
+DL +LL +P R + + LNH FFW+
Sbjct: 282 LDLIDKLLVLDPAQRIDSDDALNHDFFWS 310
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 122 bits (307), Expect = 2e-31
Identities = 61/302 (20%), Positives = 106/302 (35%), Gaps = 59/302 (19%)
Query: 382 KEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTH------HDVALKEIQNLIASDQHPNIVR 434
+ + G V L R VAVK L + +E QN A+ HP IV
Sbjct: 13 EILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNA-AALNHPAIVA 71
Query: 435 WYGVESDQD----FVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLP 490
Y + Y+ +E I G +
Sbjct: 72 VYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPK-------------------- 111
Query: 491 VMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCA 550
+ ++V D L+ H+ G+IHRD+KP N++I +
Sbjct: 112 -------------------RAIEVIADACQALNFSHQNGIIHRDVKPANIMI--SATNAV 150
Query: 551 KLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG 610
K+ D GI++ + + +TQ A G++ + +PEQ D++SLGC+L+ +T
Sbjct: 151 KVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLT- 209
Query: 611 GKHPYGESFERDA--NIVKD--RKDLFLVEHIP-EAVDLFTRLLDPNPDLRPKAQNVLNH 665
G+ P+ V++ E + + + + L NP+ R + +
Sbjct: 210 GEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRA 269
Query: 666 PF 667
Sbjct: 270 DL 271
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 122 bits (306), Expect = 2e-31
Identities = 46/308 (14%), Positives = 93/308 (30%), Gaps = 56/308 (18%)
Query: 374 IGKLVVFNKEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHDVALK-EIQNLIASDQHPN 431
+G + I +GS G + + VA+K + L+ E +
Sbjct: 3 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTG 62
Query: 432 IVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPV 491
I Y + L ++ SL DL+ + F +
Sbjct: 63 IPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVK--------------------- 101
Query: 492 MENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKD---KSF 548
+ + +++ + +HE L++RD+KP N LI + +
Sbjct: 102 ------------------TVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNAN 143
Query: 549 CAKLSDMGISKRLQGDMS----CLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCIL 604
+ D G+ K + ++ + G++ + + L Q+R DL +LG +
Sbjct: 144 MIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVF 203
Query: 605 FFCITGGKHPYGESFERDANIVKDRKDLF-------LVEHIPEAV-DLFTRLLDPNPDLR 656
+ + G G + + + L PE + D
Sbjct: 204 MYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDAT 263
Query: 657 PKAQNVLN 664
P +
Sbjct: 264 PDYDYLQG 271
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (307), Expect = 2e-31
Identities = 61/327 (18%), Positives = 104/327 (31%), Gaps = 83/327 (25%)
Query: 382 KEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTH--------HDVALKEIQNLIASDQHPNI 432
+ +G TV + VA+K++ H + AL+EI+ L+ HPNI
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIK-LLQELSHPNI 62
Query: 433 VRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVM 492
+ + + L + L +I S
Sbjct: 63 IGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPS---------------------- 100
Query: 493 ENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKL 552
+ + GL +LH+ ++HRDLKP N+L+ ++ KL
Sbjct: 101 -----------------HIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDEN--GVLKL 141
Query: 553 SDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ-TRAIDLFSLGCILFFCITGG 611
+D G++K T + ++APE L R +D++++GCIL +
Sbjct: 142 ADFGLAKSFGSPNRAYTHQV---VTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRV 198
Query: 612 KHPYGESFERDANIVKDRKDLFLVEHIP----------------------------EAVD 643
G+S + + E P + +D
Sbjct: 199 PFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLD 258
Query: 644 LFTRLLDPNPDLRPKAQNVLNHPFFWT 670
L L NP R A L +F
Sbjct: 259 LIQGLFLFNPCARITATQALKMKYFSN 285
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (303), Expect = 7e-31
Identities = 70/331 (21%), Positives = 122/331 (36%), Gaps = 83/331 (25%)
Query: 382 KEIAKGSNGTVVL--EGNYEGRSVAVKRLVKTHHD-----VALKEIQNL--IASDQHPNI 432
EI +G+ G V + GR VA+KR+ + ++E+ L + + +HPN+
Sbjct: 13 AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 72
Query: 433 VRWYGVESDQDF---VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLL 489
VR + V + L+L + Y
Sbjct: 73 VRLFDVCTVSRTDRETKLTLVFEHVDQDLTTY---------------------------- 104
Query: 490 PVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFC 549
++ G P+ + + ++ GL LH ++HRDLKPQN+L++
Sbjct: 105 --------LDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQI- 155
Query: 550 AKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCIT 609
KL+D G+++ M+ + + ++APE LLQ +DL+S+GCI
Sbjct: 156 -KLADFGLARIYSFQMALTSV----VVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR 210
Query: 610 GGKHPY--------------------------GESFERDANIVKDRKDL--FLVEHIPEA 641
K + + R A K + + F+ +
Sbjct: 211 -RKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELG 269
Query: 642 VDLFTRLLDPNPDLRPKAQNVLNHPFFWTAD 672
DL + L NP R A + L+HP+F +
Sbjct: 270 KDLLLKCLTFNPAKRISAYSALSHPYFQDLE 300
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (303), Expect = 2e-30
Identities = 76/353 (21%), Positives = 124/353 (35%), Gaps = 81/353 (22%)
Query: 382 KEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYGV-- 438
K I GS G V + G VA+K++++ +E+Q ++ H NIVR
Sbjct: 26 KVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-DKRFKNRELQ-IMRKLDHCNIVRLRYFFY 83
Query: 439 --ESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTK 496
+D VYL+L S +Q L + ++
Sbjct: 84 SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQT---------LPVIYVK--------- 125
Query: 497 DIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMG 556
+ L+++H G+ HRD+KPQN+L+ D + KL D G
Sbjct: 126 ----------------LYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVL-KLCDFG 168
Query: 557 ISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ-TRAIDLFSLGCILFFCITGGKHPY 615
+K+L ++ + Y ++APE + T +ID++S GC+L + G+ +
Sbjct: 169 SAKQLVRGEPNVSYICSRY----YRAPELIFGATDYTSSIDVWSAGCVLAELLL-GQPIF 223
Query: 616 GESFERD--ANIVK----------------------------DRKDLFLVEHIPEAVDLF 645
D I+K +F PEA+ L
Sbjct: 224 PGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALC 283
Query: 646 TRLLDPNPDLRPKAQNVLNHPFF---WTADTRLSFLRDVSDRVELEDRESDSK 695
+RLL+ P R H FF + +L RD +E S
Sbjct: 284 SRLLEYTPTARLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSN 336
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (299), Expect = 3e-30
Identities = 57/328 (17%), Positives = 104/328 (31%), Gaps = 77/328 (23%)
Query: 374 IGKLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQ-NLIASDQHPNI 432
I + +V + I KG G V G + G VAVK +E + +H NI
Sbjct: 1 IARTIVLQESIGKGRFGEVWR-GKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENI 59
Query: 433 VRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVM 492
+ + ++ + + L + Y GS + LN
Sbjct: 60 LGFIAADNKDNGTWTQLWLVSD------YHEHGSLFDYLNRY------------------ 95
Query: 493 ENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI--------GLIHRDLKPQNVLISK 544
++K+ SGL+HLH + HRDLK +N+L+
Sbjct: 96 ------------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV-- 141
Query: 545 DKSFCAKLSDMGISKRLQGDMSCLTQNATGY-GSSGWQAPEQLL------QGRQTRAIDL 597
K+ ++D+G++ R + G+ + APE L + D+
Sbjct: 142 KKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADI 201
Query: 598 FSLGCILFFCITG---------GKHPYGESFERDANIVKDRK-------------DLFLV 635
+++G + + + PY + D ++ + RK
Sbjct: 202 YAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSC 261
Query: 636 EHIPEAVDLFTRLLDPNPDLRPKAQNVL 663
E + + N R A +
Sbjct: 262 EALRVMAKIMRECWYANGAARLTALRIK 289
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 116 bits (292), Expect = 1e-29
Identities = 63/323 (19%), Positives = 122/323 (37%), Gaps = 82/323 (25%)
Query: 382 KEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHD-----VALKEIQNLIASDQHPNIVRWY 436
++I +G+ G V N G + A+K++ D ++EI ++ +H NIV+ Y
Sbjct: 8 EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREIS-ILKELKHSNIVKLY 66
Query: 437 GVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTK 496
V + + L E L L+ V G E
Sbjct: 67 DVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESV-------------------------- 100
Query: 497 DIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMG 556
+++G+++ H+ ++HRDLKPQN+LI+++ K++D G
Sbjct: 101 -------------TAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGE--LKIADFG 145
Query: 557 ISKRLQGDMSCLTQNATGYGSSGWQAPEQLL-QGRQTRAIDLFSLGCILFFCITGGKHPY 615
+++ + + + ++AP+ L+ + + ID++S+GCI + G +
Sbjct: 146 LARAFGIPV---RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVN-GTPLF 201
Query: 616 GESFERD--ANIVK----------------------------DRKDLFLVEHIPEAVDLF 645
E D I + + FL +DL
Sbjct: 202 PGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLL 261
Query: 646 TRLLDPNPDLRPKAQNVLNHPFF 668
+++L +P+ R A+ L H +F
Sbjct: 262 SKMLKLDPNQRITAKQALEHAYF 284
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (290), Expect = 3e-29
Identities = 66/323 (20%), Positives = 105/323 (32%), Gaps = 80/323 (24%)
Query: 382 KEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHDV-----ALKEIQNLIASDQHPNIVRW 435
++I +G+ GTV + VA+KR+ D AL+EI L +H NIVR
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLL-KELKHKNIVRL 66
Query: 436 YGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENT 495
+ V + L E C L +G + +
Sbjct: 67 HDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPE------------------------- 101
Query: 496 KDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDM 555
+ ++ GL H ++HRDLKPQN+LI+++ KL++
Sbjct: 102 --------------IVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGEL--KLANF 145
Query: 556 GISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY 615
G+++ + C + + +ID++S GCI G+ +
Sbjct: 146 GLARAFGIPVRCYSA--EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLF 203
Query: 616 ----------------GESFERDANIVKDRKDLFLVEHIP--------------EAVDLF 645
G E + D P DL
Sbjct: 204 PGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLL 263
Query: 646 TRLLDPNPDLRPKAQNVLNHPFF 668
LL NP R A+ L HP+F
Sbjct: 264 QNLLKCNPVQRISAEEALQHPYF 286
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 116 bits (291), Expect = 5e-29
Identities = 59/330 (17%), Positives = 103/330 (31%), Gaps = 83/330 (25%)
Query: 382 KEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYGVES 440
+++ +G V V VK L +EI+ L PNI+ +
Sbjct: 41 RKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVK 100
Query: 441 DQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIEL 500
D +L + D + L + IR
Sbjct: 101 DPVSRTPALVFEHVNNTDFKQLYQT---------------LTDYDIR------------- 132
Query: 501 WKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKR 560
+I+ L + H +G++HRD+KP NV+I + +L D G+++
Sbjct: 133 ------------FYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKL-RLIDWGLAEF 179
Query: 561 LQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFE 620
+ A+ Y + ++D++SLGC+L I + +
Sbjct: 180 YHPGQEYNVRVASRY---FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN 236
Query: 621 RD--ANIVKDRKDLFLVEHI------------------------------------PEAV 642
D I K L ++I PEA+
Sbjct: 237 YDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEAL 296
Query: 643 DLFTRLLDPNPDLRPKAQNVLNHPFFWTAD 672
D +LL + R A+ + HP+F+T
Sbjct: 297 DFLDKLLRYDHQSRLTAREAMEHPYFYTVV 326
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (290), Expect = 6e-29
Identities = 64/308 (20%), Positives = 108/308 (35%), Gaps = 63/308 (20%)
Query: 382 KEIAKGSNGTVVL----EGNYEGRSVAVKRLVKTH-------HDVALKEIQNLIASDQHP 430
K + G+ G V L G+ G+ A+K L K + E Q L Q P
Sbjct: 30 KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 89
Query: 431 NIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLP 490
+V + + ++L L+
Sbjct: 90 FLVTLHYAFQTETKLHLILDYI-------------------------------------- 111
Query: 491 VMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCA 550
L + ++ +IV L HLH++G+I+RD+K +N+L+ +
Sbjct: 112 -NGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSN--GHV 168
Query: 551 KLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG 610
L+D G+SK D + + G + +A+D +SLG +++ +T
Sbjct: 169 VLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLT- 227
Query: 611 GKHPYGESFERDANIVKDRKDLFLVEHIP-----EAVDLFTRLLDPNPDLRPK-----AQ 660
G P+ E+++ R+ L P A DL RLL +P R A
Sbjct: 228 GASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDAD 287
Query: 661 NVLNHPFF 668
+ H FF
Sbjct: 288 EIKEHLFF 295
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 112 bits (281), Expect = 1e-27
Identities = 63/312 (20%), Positives = 110/312 (35%), Gaps = 60/312 (19%)
Query: 382 KEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTH------HDVALKEIQNLIASDQHPNIVR 434
K + GS G V+L + G A+K L K + L E + ++ + P +V+
Sbjct: 47 KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKR-ILQAVNFPFLVK 105
Query: 435 WYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMEN 494
D +Y+ +E
Sbjct: 106 LEFSFKDNSNLYMVMEYVAG---------------------------------------G 126
Query: 495 TKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSD 554
L + IV +LH + LI+RDLKP+N+LI + ++D
Sbjct: 127 EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQ--VTD 184
Query: 555 MGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP 614
G +KR++G T G+ APE +L +A+D ++LG +++ G
Sbjct: 185 FGFAKRVKGRTW------TLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238
Query: 615 YGESFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNP-----DLRPKAQNVLNHPFFW 669
+ + + + K F + DL LL + +L+ ++ NH +F
Sbjct: 239 FADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFA 298
Query: 670 TADTRLSFLRDV 681
T D + R V
Sbjct: 299 TTDWIAIYQRKV 310
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (281), Expect = 1e-27
Identities = 65/326 (19%), Positives = 122/326 (37%), Gaps = 84/326 (25%)
Query: 382 KEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHDV-----ALKEIQNLIASDQHPNIVRW 435
+ + G+ G V G VA+K+L + A +E++ L+ +H N++
Sbjct: 24 QPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELR-LLKHMRHENVIGL 82
Query: 436 YGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENT 495
V + + + + L+ G+ +
Sbjct: 83 LDVFTPDETLDDFTDFY------LVMPFMGTDLGK------------------------- 111
Query: 496 KDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDM 555
L K ++ + ++ GL ++H G+IHRDLKP N+ +++D K+ D
Sbjct: 112 ----LMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNED--CELKILDF 165
Query: 556 GISKRLQGDMSCLTQNATGYGSSGWQAPEQLL-QGRQTRAIDLFSLGCILFFCITGGKHP 614
G++++ +M+ + ++APE +L R T+ +D++S+GCI+ IT GK
Sbjct: 166 GLARQADSEMT------GYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMIT-GKTL 218
Query: 615 YGESFERDA--------------------------------NIVKDRKDLFLVEHIPEAV 642
+ S D + K L P AV
Sbjct: 219 FKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAV 278
Query: 643 DLFTRLLDPNPDLRPKAQNVLNHPFF 668
+L ++L + + R A L HP+F
Sbjct: 279 NLLEKMLVLDAEQRVTAGEALAHPYF 304
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (264), Expect = 2e-25
Identities = 57/325 (17%), Positives = 110/325 (33%), Gaps = 82/325 (25%)
Query: 382 KEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHDV-----ALKEIQNLIASDQHPNIVRW 435
+ G+ G+V G VAVK+L + + +E++ L+ +H N++
Sbjct: 24 SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR-LLKHMKHENVIGL 82
Query: 436 YGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENT 495
V + + + L+ +
Sbjct: 83 LDVFTPARSLE-----------------------------------EFNDVYLVTHLMGA 107
Query: 496 KDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDM 555
+ K + + I+ GL ++H +IHRDLKP N+ + ++ K+ D
Sbjct: 108 DLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV--NEDCELKILDF 165
Query: 556 GISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ-TRAIDLFSLGCILFFCITGGKHP 614
G+++ +M+ + ++APE +L + +D++S+GCI+ +TG
Sbjct: 166 GLARHTDDEMT------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 219
Query: 615 YGESFERDANIVKDRKDLFLVEHI-------------------------------PEAVD 643
G ++ E + P AVD
Sbjct: 220 PGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVD 279
Query: 644 LFTRLLDPNPDLRPKAQNVLNHPFF 668
L ++L + D R A L H +F
Sbjct: 280 LLEKMLVLDSDKRITAAQALAHAYF 304
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 96.6 bits (239), Expect = 5e-22
Identities = 61/370 (16%), Positives = 119/370 (32%), Gaps = 95/370 (25%)
Query: 382 KEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHD-----VALKEIQNLIASDQHPNIVRW 435
K I G+ G V R+VA+K+L + + A +E+ L+ H NI+
Sbjct: 23 KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELV-LMKCVNHKNIISL 81
Query: 436 YGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENT 495
V + Q + + + ++ + + +
Sbjct: 82 LNVFTPQKTLEEFQDVYLV-----MELMDANLCQVIQ----------------------- 113
Query: 496 KDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDM 555
++ + ++ G+ HLH G+IHRDLKP N+++ D + +
Sbjct: 114 --------MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGL 165
Query: 556 GISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY 615
+ M+ + ++APE +L +D++S+GCI+ + K +
Sbjct: 166 ARTAGTSFMMTPYV------VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVR-HKILF 218
Query: 616 GESFERD---------------------------------------ANIVKDRKDLFLVE 636
D + D E
Sbjct: 219 PGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSE 278
Query: 637 HI----PEAVDLFTRLLDPNPDLRPKAQNVLNHPFF--WTADTRLSFLRDVSDRVELEDR 690
H +A DL +++L +P R + L HP+ W + +L++R
Sbjct: 279 HNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVEAPPPQIYDKQLDER 338
Query: 691 ESDSKLLRAL 700
E + + L
Sbjct: 339 EHTIEEWKEL 348
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 94.3 bits (233), Expect = 2e-21
Identities = 56/340 (16%), Positives = 111/340 (32%), Gaps = 80/340 (23%)
Query: 382 KEIAKGSNGTVVL-EGNYEGRSVAVKRL--VKTHHDVALKEIQNLIASDQHPNIVRWYGV 438
+++ G TV L + VA+K + K + + A EI+ L+ + + +
Sbjct: 19 RKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIK-LLQRVNDADNTKEDSM 77
Query: 439 ESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDI 498
++ L + N ++ V + + I
Sbjct: 78 GANHILKLLDHFN-----------------------HKGPNGVHVVMVFEVLGENLLALI 114
Query: 499 ELWKANGHPSAQLLKVTRDIVSGLSHLH-EIGLIHRDLKPQNVLISKDKSFCAKLSDMGI 557
+ ++ G P + ++++ ++ GL ++H G+IH D+KP+NVL+ L + I
Sbjct: 115 KKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIV-DSPENLIQIKI 173
Query: 558 SKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY-- 615
+ + +++PE LL D++S C++F ITG +
Sbjct: 174 ADLGNACWYD-EHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITG-DFLFEP 231
Query: 616 --------------------GESFERDANIVKDRKDLFLVEHI----------------- 638
GE K + F +
Sbjct: 232 DEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLT 291
Query: 639 ----------PEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 668
E D + +L +P R A ++NHP+
Sbjct: 292 EKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWL 331
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 52.9 bits (126), Expect = 2e-08
Identities = 27/185 (14%), Positives = 55/185 (29%), Gaps = 33/185 (17%)
Query: 382 KEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYGVESD 441
K + +G V + + VK V+ D
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKV---------------GHTSFKKVKEKRDYGD 50
Query: 442 QDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELW 501
F L++ L + + + + N + +ME EL+
Sbjct: 51 LHFSVLAIRSARNEFRALQKLQGLAVPKVY---AWEGNAV---------LMELIDAKELY 98
Query: 502 KANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRL 561
+ ++L I+ ++ + G++H DL NVL+S+ + D S +
Sbjct: 99 RVRVENPDEVL---DMILEEVAKFYHRGIVHGDLSQYNVLVSE---EGIWIIDFPQSVEV 152
Query: 562 QGDMS 566
+
Sbjct: 153 GEEGW 157
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 805 | |||
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.9 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 98.43 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 97.88 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.48 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.46 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.18 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 95.92 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 95.75 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 95.72 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 93.6 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 93.59 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 92.36 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 90.95 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 90.11 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 87.59 |
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=376.94 Aligned_cols=247 Identities=28% Similarity=0.407 Sum_probs=201.7
Q ss_pred CEEEEEEEECCCCCEEEEEEEE-ECCCEEEEEEEECC-----C-CHHHHHHHHHHHHHCCCCCEEEECCCCCCCCEEEEE
Q ss_conf 2299957645479639999875-37959999993038-----8-069999999999917999754623534687517883
Q 003644 376 KLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKT-----H-HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLS 448 (805)
Q Consensus 376 ~~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~-----~-~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV 448 (805)
++|.+.+.||+|+||+||++.. .+++.||||++.+. . .....+|+ .++..++|||||++++++.+++..|+|
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~-~il~~l~hpnIv~~~~~~~~~~~~~iv 84 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREV-EIQSHLRHPNILRLYGYFHDATRVYLI 84 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHH-HHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHH-HHHHHCCCCCCCEEEEEEEECCEEEEE
T ss_conf 3769988985177858999999899949999998168856768999999999-999856888888599999989998999
Q ss_pred CCCCCCCHHHHHHHHCCCHHHHHHHHHCCCHHHHHHHHHHCCCCCCHHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHC
Q ss_conf 03346883458998328878997663204403588876513443321347877517999999999999999987885643
Q 003644 449 LERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI 528 (805)
Q Consensus 449 ~E~c~~sL~d~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~ 528 (805)
||||. +|+|.+++. +...+++..+..++.||+.||+|||+.
T Consensus 85 mEy~~----------~g~L~~~l~-----------------------------~~~~l~e~~~~~i~~qi~~al~~lH~~ 125 (263)
T d2j4za1 85 LEYAP----------LGTVYRELQ-----------------------------KLSKFDEQRTATYITELANALSYCHSK 125 (263)
T ss_dssp EECCT----------TCBHHHHHH-----------------------------HHSSCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred EEECC----------CCCHHHHHH-----------------------------HCCCCCHHHHHHHHHHHHHHHHHHHHC
T ss_conf 85047----------985898875-----------------------------048999999999999999999999988
Q ss_pred CEECCCCCCCEEEECCCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCHHHHHHHHHHHHH
Q ss_conf 61304788820786689992289902686100258876542464466798989735531099997414888999999999
Q 003644 529 GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCI 608 (805)
Q Consensus 529 ~IvHrDLKp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDvwSlGvil~ell 608 (805)
+|+||||||+|||++.++. +||+|||+++..... ......||+.|+|||++.+..++.++|||||||++|||+
T Consensus 126 ~ivHrDiKp~Nill~~~~~--~kl~DFG~a~~~~~~-----~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell 198 (263)
T d2j4za1 126 RVIHRDIKPENLLLGSAGE--LKIADFGWSVHAPSS-----RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFL 198 (263)
T ss_dssp TCCCCCCCGGGEEECTTSC--EEECCCCSCSCCCCC-----CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHH
T ss_pred CEEEEEECCCCCEECCCCC--EEECCCCEEEECCCC-----CCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHH
T ss_conf 9465220234414668998--711555633544888-----523557887634999975899893144046759999983
Q ss_pred HCCCCCCCCCHH-HHHHHHHHCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHCCCCCCC
Q ss_conf 299999998657-78889841133212369957999999715999999999555540966656
Q 003644 609 TGGKHPYGESFE-RDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWT 670 (805)
Q Consensus 609 tG~~~Pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~dLi~~lL~~dP~~Rpt~~eiL~HPff~~ 670 (805)
+| .+||..... .....+.......+...++++.+||.+||+.||++|||++|+++||||.+
T Consensus 199 ~G-~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~hp~~~~ 260 (263)
T d2j4za1 199 VG-KPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 260 (263)
T ss_dssp HS-SCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred CC-CCCCCCCCHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCCCCCC
T ss_conf 29-999888999999999971899998668999999999976479768909999971907078
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=373.89 Aligned_cols=253 Identities=26% Similarity=0.360 Sum_probs=207.0
Q ss_pred CEEEEEEEECCCCCEEEEEEEE-ECCCEEEEEEEECC------CCHHHHHHHHHHHHHCCCCCEEEECCCCCCCCEEEEE
Q ss_conf 2299957645479639999875-37959999993038------8069999999999917999754623534687517883
Q 003644 376 KLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKT------HHDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLS 448 (805)
Q Consensus 376 ~~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~------~~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV 448 (805)
++|.+.+.||+|+||+||++.. .+|+.||||++.+. ......+|+. +++.++|||||++++++.+.+.+|+|
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~-il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESR-VLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHH-HHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHH-HHHHCCCCCEEEEEEEECCCCCCCCC
T ss_conf 74289889831768499999998999899999981565449799999999999-99867999887787640356421110
Q ss_pred CCCCCCCHHHHHHHHCCCHHHHHHHHHCCCHHHHHHHHHHCCCCCCHHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHC
Q ss_conf 03346883458998328878997663204403588876513443321347877517999999999999999987885643
Q 003644 449 LERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI 528 (805)
Q Consensus 449 ~E~c~~sL~d~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~ 528 (805)
||+|. +|+|..++ .+.+.+++..++.++.|++.||+|||++
T Consensus 84 ~ey~~----------gg~L~~~~-----------------------------~~~~~~~e~~~~~~~~qil~al~ylH~~ 124 (337)
T d1o6la_ 84 MEYAN----------GGELFFHL-----------------------------SRERVFTEERARFYGAEIVSALEYLHSR 124 (337)
T ss_dssp EECCT----------TCBHHHHH-----------------------------HHHSCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred EECCC----------CCCHHHHH-----------------------------HCCCCCCHHHHHHHHHHHHHHHHHHHHC
T ss_conf 00357----------98605555-----------------------------3256775999999999996521134315
Q ss_pred CEECCCCCCCEEEECCCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCHHHHHHHHHHHHH
Q ss_conf 61304788820786689992289902686100258876542464466798989735531099997414888999999999
Q 003644 529 GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCI 608 (805)
Q Consensus 529 ~IvHrDLKp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDvwSlGvil~ell 608 (805)
+|+||||||+|||++.++. +||+|||+|+...... ......+||+.|+|||++.+..|+.++||||+||++|||+
T Consensus 125 ~iiHRDlKP~NILl~~~g~--vkl~DFG~a~~~~~~~---~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml 199 (337)
T d1o6la_ 125 DVVYRDIKLENLMLDKDGH--IKITDFGLCKEGISDG---ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMM 199 (337)
T ss_dssp TCBCCCCCGGGEEECTTSC--EEECCCTTCBCSCCTT---CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHH
T ss_pred CCCCCCCCHHHEEECCCCC--EEEEECCCCCCCCCCC---CCCCCCEECHHHHHHHHCCCCCCCHHHCCCCHHHHHHHHH
T ss_conf 9622464777847658998--8882056520035678---6205510088996666504898883331022306788998
Q ss_pred HCCCCCCCC-CHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCCCCCCCCC-----HHHHHCCCCCCCCCCC
Q ss_conf 299999998-65778889841133212369957999999715999999999-----5555409666563100
Q 003644 609 TGGKHPYGE-SFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPK-----AQNVLNHPFFWTADTR 674 (805)
Q Consensus 609 tG~~~Pf~~-~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~lL~~dP~~Rpt-----~~eiL~HPff~~~~~~ 674 (805)
+| .+||.. ........+......++...++++++||.+||++||.+|++ ++++++||||.+.++.
T Consensus 200 ~G-~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i~~~ 270 (337)
T d1o6la_ 200 CG-RLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQ 270 (337)
T ss_dssp HS-SCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHH
T ss_pred HC-CCCCCCCCHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHCCCCCHHHCCCCCCCHHHHHCCCCCCCCCHH
T ss_conf 78-999999699999999852899898668999999998666389344225652349999729150369999
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=376.32 Aligned_cols=249 Identities=25% Similarity=0.386 Sum_probs=200.0
Q ss_pred CEEEEEEEECCCCCEEEEEEE-EECCCEEEEEEEECCC---CHHHHHHHHHHHHHCCCCCEEEECCCCCCCCEEEEECCC
Q ss_conf 229995764547963999987-5379599999930388---069999999999917999754623534687517883033
Q 003644 376 KLVVFNKEIAKGSNGTVVLEG-NYEGRSVAVKRLVKTH---HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLER 451 (805)
Q Consensus 376 ~~~~~~~~LG~GsfG~Vy~a~-~~~g~~VAVK~l~~~~---~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~ 451 (805)
+.|.+.+.||+|+||+||++. ..+|+.||||++.... .+...+|+. +++.++|||||++++++.+.+..|+|||+
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~-il~~l~HpnIv~~~~~~~~~~~~~ivmEy 98 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEIL-VMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHH-HHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred CCCEEEEEEECCCCCEEEEEEECCCCCEEEEEEEECCCCHHHHHHHHHHH-HHHHCCCCCEEEEEEEEEECCEEEEEEEE
T ss_conf 05388789812858299999998999899999984301727999999999-99867999880585779889998999970
Q ss_pred CCCCHHHHHHHHCCCHHHHHHHHHCCCHHHHHHHHHHCCCCCCHHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHCCEE
Q ss_conf 46883458998328878997663204403588876513443321347877517999999999999999987885643613
Q 003644 452 CTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLI 531 (805)
Q Consensus 452 c~~sL~d~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~Iv 531 (805)
|. +|+|.+++ ..+++++..+..++.||+.||+|||+.+|+
T Consensus 99 ~~----------gg~L~~~~------------------------------~~~~l~~~~~~~i~~qi~~aL~yLH~~~ii 138 (293)
T d1yhwa1 99 LA----------GGSLTDVV------------------------------TETCMDEGQIAAVCRECLQALEFLHSNQVI 138 (293)
T ss_dssp CT----------TCBHHHHH------------------------------HHSCCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred CC----------CCCHHHHH------------------------------HCCCCCHHHHHHHHHHHHHHHHHHHHCCCC
T ss_conf 37----------98089886------------------------------415999999999999999999999987972
Q ss_pred CCCCCCCEEEECCCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCHHHHHHHHHHHHHHCC
Q ss_conf 04788820786689992289902686100258876542464466798989735531099997414888999999999299
Q 003644 532 HRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGG 611 (805)
Q Consensus 532 HrDLKp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDvwSlGvil~elltG~ 611 (805)
||||||+|||++.++. +||+|||+++.+.... ......+||+.|+|||++.+..++.++||||+||++|+|++|
T Consensus 139 HrDiKp~NILl~~~~~--vkl~DFG~a~~~~~~~---~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG- 212 (293)
T d1yhwa1 139 HRDIKSDNILLGMDGS--VKLTDFGFCAQITPEQ---SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEG- 212 (293)
T ss_dssp CCCCSGGGEEECTTCC--EEECCCTTCEECCSTT---CCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHS-
T ss_pred CCCCCHHHEEECCCCC--EEECCCHHHEEECCCC---CCCCCCCCCCCCCCHHHHCCCCCCCHHCEEHHHHHHHHHHHC-
T ss_conf 2677688868878996--8642515641321366---644444447773682664479988012031372999998048-
Q ss_pred CCCCCCCHHHH-H-HHHHHCC--CCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHCCCCCCCC
Q ss_conf 99999865778-8-8984113--32123699579999997159999999995555409666563
Q 003644 612 KHPYGESFERD-A-NIVKDRK--DLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTA 671 (805)
Q Consensus 612 ~~Pf~~~~~~~-~-~~~~~~~--~~~~~~~~~~~~dLi~~lL~~dP~~Rpt~~eiL~HPff~~~ 671 (805)
.+||....... . .+..... ...+...++++++||.+||+.||.+|||++|+++||||+..
T Consensus 213 ~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~~~~ 276 (293)
T d1yhwa1 213 EPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIA 276 (293)
T ss_dssp SCTTTTSCHHHHHHHHHHHCSCCCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCGGGGGC
T ss_pred CCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCC
T ss_conf 8998997999999999857999888855379999999999866996689099999649965778
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=0 Score=369.75 Aligned_cols=250 Identities=24% Similarity=0.366 Sum_probs=202.1
Q ss_pred CEEEEEEEECCCCCEEEEEEEE-ECCCEEEEEEEECC-----CC-HHHHHHHHHHHHHCCCCCEEEECCCCCCCCEEEEE
Q ss_conf 2299957645479639999875-37959999993038-----80-69999999999917999754623534687517883
Q 003644 376 KLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKT-----HH-DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLS 448 (805)
Q Consensus 376 ~~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~-----~~-~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV 448 (805)
++|.+.+.||+|+||+||++.. .+|+.||||++.+. .. ....+|+ .+++.++|||||++++++.+.+.+|+|
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~-~il~~l~HpnIv~~~~~~~~~~~~~iv 82 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDER-LMLSIVTHPFIIRMWGTFQDAQQIFMI 82 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHH-HHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred HHEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHH-HHHHHCCCCCHHHEEEEEEECCEEEEE
T ss_conf 4708888972076808999999899979999998457754889999999999-999863696753303568528800567
Q ss_pred CCCCCCCHHHHHHHHCCCHHHHHHHHHCCCHHHHHHHHHHCCCCCCHHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHC
Q ss_conf 03346883458998328878997663204403588876513443321347877517999999999999999987885643
Q 003644 449 LERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI 528 (805)
Q Consensus 449 ~E~c~~sL~d~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~ 528 (805)
||+|.+ |++...+ .....+++..+..++.||+.||+|||++
T Consensus 83 mE~~~g----------g~l~~~~-----------------------------~~~~~~~~~~~~~~~~qi~~al~~lH~~ 123 (316)
T d1fota_ 83 MDYIEG----------GELFSLL-----------------------------RKSQRFPNPVAKFYAAEVCLALEYLHSK 123 (316)
T ss_dssp ECCCCS----------CBHHHHH-----------------------------HHTSSCCHHHHHHHHHHHHHHHHHHHTT
T ss_pred EEECCC----------CCCCCCC-----------------------------CCCCCCCCCHHHHHHHHHHHHHHHHCCC
T ss_conf 650378----------6322343-----------------------------2222111007999999998765541247
Q ss_pred CEECCCCCCCEEEECCCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCHHHHHHHHHHHHH
Q ss_conf 61304788820786689992289902686100258876542464466798989735531099997414888999999999
Q 003644 529 GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCI 608 (805)
Q Consensus 529 ~IvHrDLKp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDvwSlGvil~ell 608 (805)
+|+||||||+|||++.++. +||+|||+|+..... ..+.+||+.|+|||++.+..|+.++||||+||++|||+
T Consensus 124 ~iiHrDiKp~NILl~~~g~--vkL~DFG~a~~~~~~------~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyeml 195 (316)
T d1fota_ 124 DIIYRDLKPENILLDKNGH--IKITDFGFAKYVPDV------TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEML 195 (316)
T ss_dssp TEECCCCCGGGEEECTTSC--EEECCCSSCEECSSC------BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHH
T ss_pred CEECCCCCCHHEEECCCCC--EEEECCCCCEEECCC------CCCCCCCCCCCCHHHHCCCCCCCHHHCCCCCHHHHHHH
T ss_conf 6770556810503868998--898317521671245------64345763435999983899980430465333689997
Q ss_pred HCCCCCCCCCHH-HHHHHHHHCCCCCCCCCCHHHHHHHHHHCCCCCCCCC-----CHHHHHCCCCCCCCCCC
Q ss_conf 299999998657-7888984113321236995799999971599999999-----95555409666563100
Q 003644 609 TGGKHPYGESFE-RDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRP-----KAQNVLNHPFFWTADTR 674 (805)
Q Consensus 609 tG~~~Pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~dLi~~lL~~dP~~Rp-----t~~eiL~HPff~~~~~~ 674 (805)
+| .+||..... .....+.......+...++++.+++.+||..||.+|+ +++++++||||.+..+.
T Consensus 196 tG-~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i~~~ 266 (316)
T d1fota_ 196 AG-YTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWE 266 (316)
T ss_dssp HS-SCTTCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCHH
T ss_pred HC-CCCCCCCCHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHCHHHCCCCCHHHHHHHHCCCCCCCCCHH
T ss_conf 59-899999699999999970898899778999999999995449976664310219999819351467989
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=373.02 Aligned_cols=254 Identities=28% Similarity=0.419 Sum_probs=203.5
Q ss_pred CEEEEEEEECCCCCEEEEEEEE-ECCCEEEEEEEECCC------CHHHHHHHHHHHHHCCCCCEEEECCCCCCCCEEEEE
Q ss_conf 2299957645479639999875-379599999930388------069999999999917999754623534687517883
Q 003644 376 KLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH------HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLS 448 (805)
Q Consensus 376 ~~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~------~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV 448 (805)
++|.+.+.||+|+||+||+|.. .+|+.||||++.+.. .....+|+. ++..++|||||++++++.+++.+|+|
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~-il~~l~HpnIv~l~~~~~~~~~~~iv 86 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERD-VMSRLDHPFFVKLYFTFQDDEKLYFG 86 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHH-HHHHCCSTTBCCEEEEEECSSEEEEE
T ss_pred CCCEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHH-HHHHCCCCCEEEEEEEEEECCEEEEE
T ss_conf 87789889850879099999998999799999986577557778999999999-99876888861799999989988999
Q ss_pred CCCCCCCHHHHHHHHCCCHHHHHHHHHCCCHHHHHHHHHHCCCCCCHHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHC
Q ss_conf 03346883458998328878997663204403588876513443321347877517999999999999999987885643
Q 003644 449 LERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI 528 (805)
Q Consensus 449 ~E~c~~sL~d~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~ 528 (805)
||+|. +|+|.+++ ...+.+++..++.++.|++.||+|||+.
T Consensus 87 mEy~~----------gg~L~~~~-----------------------------~~~~~l~e~~~~~~~~qi~~al~ylH~~ 127 (288)
T d1uu3a_ 87 LSYAK----------NGELLKYI-----------------------------RKIGSFDETCTRFYTAEIVSALEYLHGK 127 (288)
T ss_dssp ECCCT----------TEEHHHHH-----------------------------HHHSSCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred EECCC----------CCCHHHHH-----------------------------HCCCCCCHHHHHHHHHHHHHHHHHHCCC
T ss_conf 97048----------98777765-----------------------------3159999999999999999999762165
Q ss_pred CEECCCCCCCEEEECCCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCHHHHHHHHHHHHH
Q ss_conf 61304788820786689992289902686100258876542464466798989735531099997414888999999999
Q 003644 529 GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCI 608 (805)
Q Consensus 529 ~IvHrDLKp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDvwSlGvil~ell 608 (805)
+|+||||||+|||++.++. +||+|||+|+.+..... .......+||+.|+|||++.+..++.++||||+||++|||+
T Consensus 128 ~iiHrDiKp~NIll~~~~~--vkl~DFG~a~~~~~~~~-~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell 204 (288)
T d1uu3a_ 128 GIIHRDLKPENILLNEDMH--IQITDFGTAKVLSPESK-QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLV 204 (288)
T ss_dssp TEECSCCSGGGEEECTTSC--EEECCCTTCEECC-----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHH
T ss_pred CEECCCCCCCCCCCCCCCE--EEECCCCCCEECCCCCC-CCCCCCCCCCCCCCCCEEECCCCCCCCCCEEHHHHHHHHHH
T ss_conf 0884767741236688853--88603210242256776-43335556775525844002689896662304569999980
Q ss_pred HCCCCCCCCCHHHH-HHHHHHCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHH------HHCCCCCCCCCC
Q ss_conf 29999999865778-889841133212369957999999715999999999555------540966656310
Q 003644 609 TGGKHPYGESFERD-ANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQN------VLNHPFFWTADT 673 (805)
Q Consensus 609 tG~~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~dLi~~lL~~dP~~Rpt~~e------iL~HPff~~~~~ 673 (805)
+| .+||....... ...+......++...++++++||.+||+.||.+|||++| +++||||.+.++
T Consensus 205 ~g-~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~w 275 (288)
T d1uu3a_ 205 AG-LPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTW 275 (288)
T ss_dssp HS-SCSSCCSSHHHHHHHHHTTCCCCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCC
T ss_pred HC-CCCCCCCCHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHCCCHHHHCCCCCCCCCH
T ss_conf 38-899899599999999971899998547999999999985579768919789737789876976478998
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=379.28 Aligned_cols=250 Identities=25% Similarity=0.365 Sum_probs=195.4
Q ss_pred CCEEEEEEEECCCCCEEEEEEEE-ECCCEEEEEEEECCCC----HHHHHHHHHHHHHCCCCCEEEECCCCCCCCEEEEEC
Q ss_conf 52299957645479639999875-3795999999303880----699999999999179997546235346875178830
Q 003644 375 GKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSL 449 (805)
Q Consensus 375 ~~~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~ 449 (805)
.+.|.+.+.||+|+||+||++.. .+|+.||||++..... ....+|+. ++..++|||||++++++.+.+.+|+||
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~-il~~l~HpnIv~l~~~~~~~~~~~iVm 83 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQ-VLHECNSPYIVGFYGAFYSDGEISICM 83 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGG-GGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCCCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCHHHHHHHHHHHH-HHHHCCCCCCCCEEEEEEECCEEEEEE
T ss_conf 5688897897127780999999989996999999875409789999999999-998679999994999999899999999
Q ss_pred CCCCCCHHHHHHHHCCCHHHHHHHHHCCCHHHHHHHHHHCCCCCCHHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHC-
Q ss_conf 3346883458998328878997663204403588876513443321347877517999999999999999987885643-
Q 003644 450 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI- 528 (805)
Q Consensus 450 E~c~~sL~d~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~- 528 (805)
|+|. +|+|.+++. +...+++..+..++.|++.||.|||+.
T Consensus 84 Ey~~----------gg~L~~~l~-----------------------------~~~~l~~~~~~~~~~qil~aL~yLH~~~ 124 (322)
T d1s9ja_ 84 EHMD----------GGSLDQVLK-----------------------------KAGRIPEQILGKVSIAVIKGLTYLREKH 124 (322)
T ss_dssp ECCT----------TEEHHHHHH-----------------------------HHSSCCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred ECCC----------CCCHHHHHH-----------------------------HCCCCCHHHHHHHHHHHHHHHHHHHHHC
T ss_conf 7679----------986899874-----------------------------2499999999999999999999999859
Q ss_pred CEECCCCCCCEEEECCCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCHHHHHHHHHHHHH
Q ss_conf 61304788820786689992289902686100258876542464466798989735531099997414888999999999
Q 003644 529 GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCI 608 (805)
Q Consensus 529 ~IvHrDLKp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDvwSlGvil~ell 608 (805)
+|+||||||+|||++.++. +||+|||+|+..... ...+.+||+.|+|||++.+..|+.++||||+||++|||+
T Consensus 125 ~IiHRDiKP~NILl~~~~~--vkl~DFGla~~~~~~-----~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell 197 (322)
T d1s9ja_ 125 KIMHRDVKPSNILVNSRGE--IKLCDFGVSGQLIDS-----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMA 197 (322)
T ss_dssp CCCCSCCSGGGEEECTTCC--EEECCCCCCHHHHHH-----TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHH
T ss_pred CEECCCCCHHHEEECCCCC--EEEEECCCCCCCCCC-----CCCCCCCCCCCCCCHHHCCCCCCCHHHHHHHHHHHHHHH
T ss_conf 9971445779946878998--999548776256788-----621113771411946875899894888998999999999
Q ss_pred HCCCCCCCCCHHHHHHH--------------------------------------------HHHCCC-CCCCCCCHHHHH
Q ss_conf 29999999865778889--------------------------------------------841133-212369957999
Q 003644 609 TGGKHPYGESFERDANI--------------------------------------------VKDRKD-LFLVEHIPEAVD 643 (805)
Q Consensus 609 tG~~~Pf~~~~~~~~~~--------------------------------------------~~~~~~-~~~~~~~~~~~d 643 (805)
+| ++||.......... ...... ......++++.|
T Consensus 198 ~G-~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~d 276 (322)
T d1s9ja_ 198 VG-RYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQD 276 (322)
T ss_dssp HS-SCCSSCCCTTHHHHHC------------------------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHH
T ss_pred HC-CCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCCCHHHHH
T ss_conf 88-89989988789999998875177545774212333221111222354134778876650268766764448999999
Q ss_pred HHHHHCCCCCCCCCCHHHHHCCCCCCCCC
Q ss_conf 99971599999999955554096665631
Q 003644 644 LFTRLLDPNPDLRPKAQNVLNHPFFWTAD 672 (805)
Q Consensus 644 Li~~lL~~dP~~Rpt~~eiL~HPff~~~~ 672 (805)
|+.+||+.||.+|||++|+|+||||...+
T Consensus 277 li~~~L~~dP~~R~ta~e~L~Hpf~~~~~ 305 (322)
T d1s9ja_ 277 FVNKCLIKNPAERADLKQLMVHAFIKRSD 305 (322)
T ss_dssp HHHHHTCSSTTTSCCHHHHHTSHHHHHHH
T ss_pred HHHHHCCCCHHHCCCHHHHHHCHHHCCCC
T ss_conf 99998689946790899996098647698
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=0 Score=372.78 Aligned_cols=254 Identities=22% Similarity=0.359 Sum_probs=201.3
Q ss_pred CCEEEEEEEECCCCCEEEEEEEE-ECCCEEEEEEEECCCCH---HHHHHHHHHHHHCCCCCEEEECCCCCCCCEEEEECC
Q ss_conf 52299957645479639999875-37959999993038806---999999999991799975462353468751788303
Q 003644 375 GKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHHD---VALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 450 (805)
Q Consensus 375 ~~~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~~~---~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E 450 (805)
-++|.+.+.||+|+||+||++.. .+|+.||||++...... ...+|+ .++..++|||||++++++.+++.+|+|||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~-~il~~l~HpnIv~~~~~~~~~~~~~ivmE 103 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEI-QTMSVLRHPTLVNLHDAFEDDNEMVMIYE 103 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHH-HHHHHTCCTTBCCEEEEEEETTEEEEEEC
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCHHHHHHHHHHH-HHHHHCCCCCCCCEEEEEEECCEEEEEEE
T ss_conf 65758988984076819999998899989999998452431699999999-99986799799929999998999999998
Q ss_pred CCCCCHHHHHHHHCCCHHHHHHHHHCCCHHHHHHHHHHCCCCCCHHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHCCE
Q ss_conf 34688345899832887899766320440358887651344332134787751799999999999999998788564361
Q 003644 451 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 530 (805)
Q Consensus 451 ~c~~sL~d~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~I 530 (805)
+|. +|+|.+++.. ....+++..+..|+.||+.||+|||+.+|
T Consensus 104 ~~~----------gg~L~~~l~~----------------------------~~~~l~e~~~~~i~~qi~~aL~ylH~~~i 145 (350)
T d1koaa2 104 FMS----------GGELFEKVAD----------------------------EHNKMSEDEAVEYMRQVCKGLCHMHENNY 145 (350)
T ss_dssp CCC----------SCBHHHHHTC----------------------------TTSCBCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred CCC----------CCCHHHHHHH----------------------------HCCCCCHHHHHHHHHHHHHHHHHHHHCCC
T ss_conf 579----------9889999976----------------------------23789999999999999999999975697
Q ss_pred ECCCCCCCEEEECCCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCHHHHHHHHHHHHHHC
Q ss_conf 30478882078668999228990268610025887654246446679898973553109999741488899999999929
Q 003644 531 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG 610 (805)
Q Consensus 531 vHrDLKp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDvwSlGvil~elltG 610 (805)
+||||||+|||++.+....+||+|||+++.+.... ......||+.|||||++.+..++.++|||||||++|+|++|
T Consensus 146 iHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~----~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G 221 (350)
T d1koaa2 146 VHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ----SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSG 221 (350)
T ss_dssp ECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS----CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHS
T ss_pred EEEEECHHHEEECCCCCCEEEEEECCHHEECCCCC----CCCEECCCCCCCCHHHHCCCCCCHHHHHHHHHHHHHHHHHC
T ss_conf 60001546736416889869995452104425654----32000686242188997589987267655465999999859
Q ss_pred CCCCCCCCHHH-HHH-HHHHCC---CCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHCCCCCCCCC
Q ss_conf 99999986577-888-984113---321236995799999971599999999955554096665631
Q 003644 611 GKHPYGESFER-DAN-IVKDRK---DLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTAD 672 (805)
Q Consensus 611 ~~~Pf~~~~~~-~~~-~~~~~~---~~~~~~~~~~~~dLi~~lL~~dP~~Rpt~~eiL~HPff~~~~ 672 (805)
.+||...... ... +..... .......++++++||.+||+.||++|||++|+++||||....
T Consensus 222 -~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~~ 287 (350)
T d1koaa2 222 -LSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGN 287 (350)
T ss_dssp -SCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCTT
T ss_pred -CCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCCCCCCCC
T ss_conf -899899799999999984788989422358999999999997568966790899986291328898
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=376.79 Aligned_cols=251 Identities=24% Similarity=0.356 Sum_probs=198.9
Q ss_pred CEEEEEEEECCCCCEEEEEEEE-ECCCEEEEEEEECCCC----HHHHHHHHHHHHHCCCCCEEEECCCCCCCCEEEEECC
Q ss_conf 2299957645479639999875-3795999999303880----6999999999991799975462353468751788303
Q 003644 376 KLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 450 (805)
Q Consensus 376 ~~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E 450 (805)
++|.+.+.||+|+||+||++.. .+|+.||||++..... +...+|+. ++..++|||||++++++.+++..|+|||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~-~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIC-INKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHH-HHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHH-HHHHCCCCCEEEEEEEECCCCEEEEEEE
T ss_conf 460899897217480999999999997999999845664127999999999-9985799888469654046743679886
Q ss_pred CCCC-CHHHHHHHHCCCHHHHHHHHHCCCHHHHHHHHHHCCCCCCHHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHCC
Q ss_conf 3468-834589983288789976632044035888765134433213478775179999999999999999878856436
Q 003644 451 RCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG 529 (805)
Q Consensus 451 ~c~~-sL~d~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~ 529 (805)
||.+ +|.+++ .+...+++..++.++.|++.||+|||+.+
T Consensus 84 y~~gg~L~~~l----------------------------------------~~~~~l~e~~~~~i~~qi~~al~ylH~~~ 123 (271)
T d1nvra_ 84 YCSGGELFDRI----------------------------------------EPDIGMPEPDAQRFFHQLMAGVVYLHGIG 123 (271)
T ss_dssp CCTTEEGGGGS----------------------------------------BTTTBCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred CCCCCCHHHHH----------------------------------------HCCCCCCHHHHHHHHHHHHHHHHHHHHCC
T ss_conf 45898089997----------------------------------------53799999999999999999999999759
Q ss_pred EECCCCCCCEEEECCCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHCCCC-CCCCHHHHHHHHHHHHH
Q ss_conf 13047888207866899922899026861002588765424644667989897355310999-97414888999999999
Q 003644 530 LIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ-TRAIDLFSLGCILFFCI 608 (805)
Q Consensus 530 IvHrDLKp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~-t~~sDvwSlGvil~ell 608 (805)
|+||||||+|||++.++. +||+|||+|+....... .......+||+.|||||++.+..+ +.++||||+||++|||+
T Consensus 124 IiHrDiKp~NILl~~~~~--~KL~DFG~a~~~~~~~~-~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml 200 (271)
T d1nvra_ 124 ITHRDIKPENLLLDERDN--LKISDFGLATVFRYNNR-ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML 200 (271)
T ss_dssp EECSCCCGGGEEECTTCC--EEECCCTTCEECEETTE-ECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHH
T ss_pred CCCCCCCHHHEEECCCCC--EEECCCHHHEEECCCCC-CCCCCCEEECCCCCCHHHHCCCCCCCCCEEEEHHHHHHHHHH
T ss_conf 835754689978878998--79832314224046886-531113255747428728618999997101617379999998
Q ss_pred HCCCCCCCCCHHHHH--H-HHHHC-CCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHCCCCCCCC
Q ss_conf 299999998657788--8-98411-332123699579999997159999999995555409666563
Q 003644 609 TGGKHPYGESFERDA--N-IVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTA 671 (805)
Q Consensus 609 tG~~~Pf~~~~~~~~--~-~~~~~-~~~~~~~~~~~~~dLi~~lL~~dP~~Rpt~~eiL~HPff~~~ 671 (805)
+| .+||........ . ..... ........++++.+|+.+||+.||++|||++|+++||||...
T Consensus 201 ~G-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~ 266 (271)
T d1nvra_ 201 AG-ELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKP 266 (271)
T ss_dssp HS-SCSCSSSSTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred HC-CCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCC
T ss_conf 29-9788889859999999863888788644699999999999767996689099999619845859
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=369.63 Aligned_cols=251 Identities=25% Similarity=0.336 Sum_probs=204.7
Q ss_pred CEEEEEEEECCCCCEEEEEEEE-ECCCEEEEEEEECC------CCHHHHHHHHHHHHHCCCCCEEEECCCCCCCCEEEEE
Q ss_conf 2299957645479639999875-37959999993038------8069999999999917999754623534687517883
Q 003644 376 KLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKT------HHDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLS 448 (805)
Q Consensus 376 ~~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~------~~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV 448 (805)
+.|.+.+.||+|+||+||++.. .+|+.||||++.+. ......+|+. ++..++|||||++++++.+.+..|+|
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~-il~~l~hpnIv~~~~~~~~~~~~~~v 119 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKR-ILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHH-HHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHH-HHHHCCCCCEEECCCCCCCCCCCCCC
T ss_conf 37089889611768089999998999899999982677458899999999999-99974877274034444322222322
Q ss_pred CCCCCCCHHHHHHHHCCCHHHHHHHHHCCCHHHHHHHHHHCCCCCCHHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHC
Q ss_conf 03346883458998328878997663204403588876513443321347877517999999999999999987885643
Q 003644 449 LERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI 528 (805)
Q Consensus 449 ~E~c~~sL~d~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~ 528 (805)
+|+|. +|++..++. +...+++..++.++.||+.||.|||+.
T Consensus 120 ~e~~~----------~g~l~~~l~-----------------------------~~~~l~e~~~~~i~~qi~~aL~yLH~~ 160 (350)
T d1rdqe_ 120 MEYVA----------GGEMFSHLR-----------------------------RIGRFSEPHARFYAAQIVLTFEYLHSL 160 (350)
T ss_dssp EECCT----------TCBHHHHHH-----------------------------HHCCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred CCCCC----------CCCHHHHHH-----------------------------HCCCCCHHHHHHHHHHHHHHHHHHHHC
T ss_conf 22334----------662266675-----------------------------158989999999999999989999859
Q ss_pred CEECCCCCCCEEEECCCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCHHHHHHHHHHHHH
Q ss_conf 61304788820786689992289902686100258876542464466798989735531099997414888999999999
Q 003644 529 GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCI 608 (805)
Q Consensus 529 ~IvHrDLKp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDvwSlGvil~ell 608 (805)
+|+||||||+|||++.++. +||+|||+|+.+... .....||+.|||||++.+..++.++|||||||++|||+
T Consensus 161 ~iiHRDIKP~NILl~~~g~--ikL~DFG~a~~~~~~------~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyeml 232 (350)
T d1rdqe_ 161 DLIYRDLKPENLLIDQQGY--IQVTDFGFAKRVKGR------TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMA 232 (350)
T ss_dssp TEECCCCSGGGEEECTTSC--EEECCCTTCEECSSC------BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHH
T ss_pred CEECCCCCHHHCCCCCCCC--EEEEECEEEEECCCC------CCCCCCCCCCCCHHHHCCCCCCCCCCCCCHHHHHHHHH
T ss_conf 9861767999936077897--886101033322566------64336763567889971799885331145007899997
Q ss_pred HCCCCCCCCCHH-HHHHHHHHCCCCCCCCCCHHHHHHHHHHCCCCCCCCC-----CHHHHHCCCCCCCCCCCH
Q ss_conf 299999998657-7888984113321236995799999971599999999-----955554096665631001
Q 003644 609 TGGKHPYGESFE-RDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRP-----KAQNVLNHPFFWTADTRL 675 (805)
Q Consensus 609 tG~~~Pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~dLi~~lL~~dP~~Rp-----t~~eiL~HPff~~~~~~~ 675 (805)
+| .+||..... .....+.......+...++++.++|.+||+.||.+|+ +++++++||||.+.++..
T Consensus 233 tG-~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~~~~~ 304 (350)
T d1rdqe_ 233 AG-YPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIA 304 (350)
T ss_dssp HS-SCSSCCSSHHHHHHHHHHCCCCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCHHH
T ss_pred HC-CCCCCCCCHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHCHHHCCCCCCCCHHHHHCCCCCCCCCHHH
T ss_conf 58-8998995999999998617988976689999999999834099860655345499997190515899899
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=370.07 Aligned_cols=253 Identities=23% Similarity=0.368 Sum_probs=205.2
Q ss_pred CEEEEEEEECCCCCEEEEEEEE-ECCCEEEEEEEECC------CCHHHHHHHHHHHHHCCCCCEEEECCCCCCCCEEEEE
Q ss_conf 2299957645479639999875-37959999993038------8069999999999917999754623534687517883
Q 003644 376 KLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKT------HHDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLS 448 (805)
Q Consensus 376 ~~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~------~~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV 448 (805)
++|.+.+.||+|+||+||+|.. .+|+.||||++.+. ......+|+..+...++|||||++++++.+++.+|+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCEEEE
T ss_conf 97188658940878289999999999899999980555338489999999999999847999687898897049831677
Q ss_pred CCCCCCCHHHHHHHHCCCHHHHHHHHHCCCHHHHHHHHHHCCCCCCHHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHC
Q ss_conf 03346883458998328878997663204403588876513443321347877517999999999999999987885643
Q 003644 449 LERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI 528 (805)
Q Consensus 449 ~E~c~~sL~d~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~ 528 (805)
||||. +|+|.+++. ....+++..++.++.||+.||+|||+.
T Consensus 82 mEy~~----------~g~L~~~i~-----------------------------~~~~~~e~~~~~~~~qi~~al~ylH~~ 122 (320)
T d1xjda_ 82 MEYLN----------GGDLMYHIQ-----------------------------SCHKFDLSRATFYAAEIILGLQFLHSK 122 (320)
T ss_dssp EECCT----------TCBHHHHHH-----------------------------HHSSCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred EEECC----------CCCHHHHHH-----------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHC
T ss_conf 75037----------980899864-----------------------------047899999999999999999999868
Q ss_pred CEECCCCCCCEEEECCCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCHHHHHHHHHHHHH
Q ss_conf 61304788820786689992289902686100258876542464466798989735531099997414888999999999
Q 003644 529 GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCI 608 (805)
Q Consensus 529 ~IvHrDLKp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDvwSlGvil~ell 608 (805)
+|+||||||+|||++.++. +||+|||+++...... .......||+.|+|||++.+..++.++||||+||++|||+
T Consensus 123 ~iiHrDikp~NiL~~~~~~--~kl~DFG~a~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyeml 197 (320)
T d1xjda_ 123 GIVYRDLKLDNILLDKDGH--IKIADFGMCKENMLGD---AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEML 197 (320)
T ss_dssp TCBCCCCCGGGEEECTTSC--EEECCCTTCBCCCCTT---CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHH
T ss_pred CEEECCCCCCCEEECCCCC--EECCCCCHHHHCCCCC---CCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHH
T ss_conf 9340347654044448996--3015553023235665---3345457877768999982799883232011227898987
Q ss_pred HCCCCCCCCCH-HHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHH-HHHCCCCCCCCCC
Q ss_conf 29999999865-77888984113321236995799999971599999999955-5540966656310
Q 003644 609 TGGKHPYGESF-ERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQ-NVLNHPFFWTADT 673 (805)
Q Consensus 609 tG~~~Pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~dLi~~lL~~dP~~Rpt~~-eiL~HPff~~~~~ 673 (805)
+| .+||.... ......+......++...++++.+||.+||+.||.+||++. ++++||||.+.++
T Consensus 198 tG-~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~hpff~~~~~ 263 (320)
T d1xjda_ 198 IG-QSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINW 263 (320)
T ss_dssp HS-SCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCCH
T ss_pred HC-CCCCCCCCHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHHHCCHHCCCCH
T ss_conf 38-8999998999999999718998975679999999999654489878388999980901315899
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=373.24 Aligned_cols=253 Identities=25% Similarity=0.412 Sum_probs=201.2
Q ss_pred CCCCEEEEEEEECCCCCEEEEEEEE-ECCCEEEEEEEECCCC----HHHHHHHHHHHHHCCCCCEEEECCCCCCCCEEEE
Q ss_conf 2252299957645479639999875-3795999999303880----6999999999991799975462353468751788
Q 003644 373 RIGKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYL 447 (805)
Q Consensus 373 ~i~~~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~L 447 (805)
.+.+.|.+.+.||+|+||+||++.. .+|+.||||++.+... ....+|+. ++..++|||||++++++.+++.+|+
T Consensus 6 di~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~-il~~l~HpnIv~l~~~~~~~~~~~l 84 (307)
T d1a06a_ 6 DIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIA-VLHKIKHPNIVALDDIYESGGHLYL 84 (307)
T ss_dssp CGGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHH-HHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred CCCCCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECHHHHHHHHHHHHHHHH-HHHHCCCCCCCCEEEEEEECCEEEE
T ss_conf 776666998899406583999999999998999999815773128999999999-9986799899919899998998889
Q ss_pred ECCCCC-CCHHHHHHHHCCCHHHHHHHHHCCCHHHHHHHHHHCCCCCCHHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHH
Q ss_conf 303346-8834589983288789976632044035888765134433213478775179999999999999999878856
Q 003644 448 SLERCT-CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH 526 (805)
Q Consensus 448 V~E~c~-~sL~d~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH 526 (805)
|||+|. ++|.+++. ....+++..+..++.||+.||+|||
T Consensus 85 vmE~~~gg~L~~~l~----------------------------------------~~~~l~e~~~~~~~~qi~~al~ylH 124 (307)
T d1a06a_ 85 IMQLVSGGELFDRIV----------------------------------------EKGFYTERDASRLIFQVLDAVKYLH 124 (307)
T ss_dssp EECCCCSCBHHHHHH----------------------------------------TCSCCCHHHHHHHHHHHHHHHHHHH
T ss_pred EEECCCCCCHHHHHH----------------------------------------CCCCCCHHHHHHHHHHHHHHHHHHH
T ss_conf 885268984888653----------------------------------------0367887899999999999987524
Q ss_pred HCCEECCCCCCCEEEECC-CCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCHHHHHHHHHH
Q ss_conf 436130478882078668-9992289902686100258876542464466798989735531099997414888999999
Q 003644 527 EIGLIHRDLKPQNVLISK-DKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILF 605 (805)
Q Consensus 527 ~~~IvHrDLKp~NILl~~-~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDvwSlGvil~ 605 (805)
+.+|+||||||+|||+.. +....+||+|||+++..... ....+.+||+.|||||++.+..++.++|||||||++|
T Consensus 125 ~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~----~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvily 200 (307)
T d1a06a_ 125 DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG----SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAY 200 (307)
T ss_dssp HTTCCCSCCCGGGEEESSSSTTCCEEECCC----------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHH
T ss_pred HCEEEEEEECCCCEEECCCCCCCEEEEECCCEEEECCCC----CEEEEEEECCCCCCCHHHCCCCCCCHHHHHHHHHHHH
T ss_conf 130556870463001104688824998315435872589----7044003284225918873799980787345159999
Q ss_pred HHHHCCCCCCCCCHHHHH--HHHHHCCC---CCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHCCCCCCCC
Q ss_conf 999299999998657788--89841133---2123699579999997159999999995555409666563
Q 003644 606 FCITGGKHPYGESFERDA--NIVKDRKD---LFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTA 671 (805)
Q Consensus 606 elltG~~~Pf~~~~~~~~--~~~~~~~~---~~~~~~~~~~~dLi~~lL~~dP~~Rpt~~eiL~HPff~~~ 671 (805)
||++| .+||.+...... .+...... ......++++.+||.+||+.||++|||++|+++||||.+.
T Consensus 201 ell~g-~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 270 (307)
T d1a06a_ 201 ILLCG-YPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGD 270 (307)
T ss_dssp HHHHS-SCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTSS
T ss_pred HHHHC-CCCCCCCCHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCC
T ss_conf 99859-79999989999999986168777876666789999999999760897579189998629844799
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=0 Score=371.00 Aligned_cols=259 Identities=26% Similarity=0.392 Sum_probs=201.5
Q ss_pred CEEEEEEEECCCCCEEEEEEEE-ECCCEEEEEEEECCC------CHHHHHHH--HHHHHHCCCCCEEEECCCCCCCCEEE
Q ss_conf 2299957645479639999875-379599999930388------06999999--99999179997546235346875178
Q 003644 376 KLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH------HDVALKEI--QNLIASDQHPNIVRWYGVESDQDFVY 446 (805)
Q Consensus 376 ~~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~------~~~~~~Ei--~~ll~~l~HpNIV~l~g~~~~~~~~~ 446 (805)
+.|.+.+.||+|+||+||++.. .+|+.||||++.+.. .....+|. ..++..++|||||++++++.+.+.+|
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEECCEEE
T ss_conf 76851018842889099999999999799999984587542667999999999999985089985889999999899889
Q ss_pred EECCCCCCCHHHHHHHHCCCHHHHHHHHHCCCHHHHHHHHHHCCCCCCHHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHH
Q ss_conf 83033468834589983288789976632044035888765134433213478775179999999999999999878856
Q 003644 447 LSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH 526 (805)
Q Consensus 447 LV~E~c~~sL~d~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH 526 (805)
+|||+|. +|+|.+++. +...+++..+..++.||+.||+|||
T Consensus 84 ivmE~~~----------gg~L~~~l~-----------------------------~~~~~~e~~~~~~~~qi~~aL~ylH 124 (364)
T d1omwa3 84 FILDLMN----------GGDLHYHLS-----------------------------QHGVFSEADMRFYAAEIILGLEHMH 124 (364)
T ss_dssp EEECCCC----------SCBHHHHHH-----------------------------HHCSCCHHHHHHHHHHHHHHHHHHH
T ss_pred EEEEECC----------CCCHHHHHH-----------------------------HCCCCCHHHHHHHHHHHHHHHHHHH
T ss_conf 9999148----------983899987-----------------------------3255327899999999999999999
Q ss_pred HCCEECCCCCCCEEEECCCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHC-CCCCCCCHHHHHHHHHH
Q ss_conf 43613047888207866899922899026861002588765424644667989897355310-99997414888999999
Q 003644 527 EIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ-GRQTRAIDLFSLGCILF 605 (805)
Q Consensus 527 ~~~IvHrDLKp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~t~~sDvwSlGvil~ 605 (805)
+.+|+||||||+|||++.++. +||+|||+|+.+... ......||+.|+|||++.. ..|+.++|||||||++|
T Consensus 125 ~~~iiHrDlKP~NILl~~~g~--iKl~DFGla~~~~~~-----~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvily 197 (364)
T d1omwa3 125 NRFVVYRDLKPANILLDEHGH--VRISDLGLACDFSKK-----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLF 197 (364)
T ss_dssp HTTEECCCCSGGGEEECSSSC--EEECCCTTCEECSSS-----CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHH
T ss_pred HCCCCCEEECCCEEEECCCCC--EEEEEECEEEECCCC-----CCCCCCCCCCCCHHHHHHCCCCCCCCCCHHHHHHHHH
T ss_conf 779622044422167858896--798220102333788-----6433113455421687603899984410467789999
Q ss_pred HHHHCCCCCCCCCHHHH-H---HHHHHCCCCCCCCCCHHHHHHHHHHCCCCCCCCCC-----HHHHHCCCCCCCCCCCHH
Q ss_conf 99929999999865778-8---89841133212369957999999715999999999-----555540966656310012
Q 003644 606 FCITGGKHPYGESFERD-A---NIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPK-----AQNVLNHPFFWTADTRLS 676 (805)
Q Consensus 606 elltG~~~Pf~~~~~~~-~---~~~~~~~~~~~~~~~~~~~dLi~~lL~~dP~~Rpt-----~~eiL~HPff~~~~~~~~ 676 (805)
||++| .+||....... . ..........+...++++.+||.+||+.||.+||| ++++++||||++.++...
T Consensus 198 emltG-~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i~~~~~ 276 (364)
T d1omwa3 198 KLLRG-HSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMV 276 (364)
T ss_dssp HHHHS-SCSSCSSCSSCHHHHHHHSSSCCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTCCHHHH
T ss_pred HHHHC-CCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHHCCCCCCCHHHHHCCCCCCCCCHHHH
T ss_conf 99859-99888899899999998604688878877899999999998566988808874357999974910237898799
Q ss_pred HHHHC
Q ss_conf 44310
Q 003644 677 FLRDV 681 (805)
Q Consensus 677 ~l~~~ 681 (805)
+.+.+
T Consensus 277 ~~~~~ 281 (364)
T d1omwa3 277 FLQKY 281 (364)
T ss_dssp HTTCS
T ss_pred HCCCC
T ss_conf 62889
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=367.52 Aligned_cols=258 Identities=22% Similarity=0.346 Sum_probs=203.6
Q ss_pred CCCCCEEEEEEEECCCCCEEEEEEEE-ECCCEEEEEEEECCC---------CHHHHHHHHHHHHHCCCCCEEEECCCCCC
Q ss_conf 32252299957645479639999875-379599999930388---------06999999999991799975462353468
Q 003644 372 RRIGKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH---------HDVALKEIQNLIASDQHPNIVRWYGVESD 441 (805)
Q Consensus 372 ~~i~~~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~---------~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~ 441 (805)
..+.+.|.+.+.||+|+||+||++.. .+|+.||||++.+.. .+...+|+. ++..++|||||++++++.+
T Consensus 6 ~~i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~-il~~l~HpnIv~~~~~~~~ 84 (293)
T d1jksa_ 6 ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS-ILKEIQHPNVITLHEVYEN 84 (293)
T ss_dssp SCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHH-HHHHCCCTTBCCEEEEEEC
T ss_pred CCCCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHH-HHHHCCCCCCCCEEEEEEE
T ss_conf 885567798279811789599999999999899999987566321340689999999999-9986799899938899997
Q ss_pred CCEEEEECCCCCCCHHHHHHHHCCCHHHHHHHHHCCCHHHHHHHHHHCCCCCCHHHHHHHHHCCCCHHHHHHHHHHHHHH
Q ss_conf 75178830334688345899832887899766320440358887651344332134787751799999999999999998
Q 003644 442 QDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSG 521 (805)
Q Consensus 442 ~~~~~LV~E~c~~sL~d~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~g 521 (805)
.+.+|+|||+|. +|+|.+++. ....+++..++.++.|++.|
T Consensus 85 ~~~~~iv~E~~~----------gg~L~~~i~-----------------------------~~~~l~~~~~~~~~~qi~~a 125 (293)
T d1jksa_ 85 KTDVILILELVA----------GGELFDFLA-----------------------------EKESLTEEEATEFLKQILNG 125 (293)
T ss_dssp SSEEEEEEECCC----------SCBHHHHHH-----------------------------HHSSCCHHHHHHHHHHHHHH
T ss_pred CCEEEEEEECCC----------CCCCCCHHC-----------------------------CCCCCCHHHHHHHHHHHHHH
T ss_conf 998999998677----------864310010-----------------------------35642155789999999999
Q ss_pred HHHHHHCCEECCCCCCCEEEECCCCC--CEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCHHHH
Q ss_conf 78856436130478882078668999--2289902686100258876542464466798989735531099997414888
Q 003644 522 LSHLHEIGLIHRDLKPQNVLISKDKS--FCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFS 599 (805)
Q Consensus 522 L~yLH~~~IvHrDLKp~NILl~~~~~--~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDvwS 599 (805)
|+|||+.+|+||||||+|||++.++. ..+|++|||++...... .......||+.|+|||++.+..++.++||||
T Consensus 126 l~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~~~----~~~~~~~~t~~y~APE~~~~~~~~~~~DiwS 201 (293)
T d1jksa_ 126 VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG----NEFKNIFGTPEFVAPEIVNYEPLGLEADMWS 201 (293)
T ss_dssp HHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEECTTS----CBCSCCCCCGGGCCHHHHTTCCBCTHHHHHH
T ss_pred HHHHHHCCEEECCCCCCEEEEECCCCCCCCEEECCHHHHHHCCCC----CCCCCCCCCCCCCCHHHHCCCCCCCCCCCHH
T ss_conf 876662542211333012798258986664696433442105777----6312247777430999981899997665221
Q ss_pred HHHHHHHHHHCCCCCCCCCHHHH-HH-HHHHCC---CCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHCCCCCCCCCCC
Q ss_conf 99999999929999999865778-88-984113---32123699579999997159999999995555409666563100
Q 003644 600 LGCILFFCITGGKHPYGESFERD-AN-IVKDRK---DLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTADTR 674 (805)
Q Consensus 600 lGvil~elltG~~~Pf~~~~~~~-~~-~~~~~~---~~~~~~~~~~~~dLi~~lL~~dP~~Rpt~~eiL~HPff~~~~~~ 674 (805)
+||++|||++| .+||....... .. +..... ...+...++++++||.+||+.||.+|||++|+++||||+..++.
T Consensus 202 lGvilyell~g-~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~~ 280 (293)
T d1jksa_ 202 IGVITYILLSG-ASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQ 280 (293)
T ss_dssp HHHHHHHHHHS-SCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC----
T ss_pred HHHHHHHHHCC-CCCCCCCCHHHHHHHHHHCCCCCCCHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCCCCCCCCHH
T ss_conf 40999999708-89988999999999998168888701047889999999999863896689199999619041888705
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=0 Score=371.27 Aligned_cols=254 Identities=22% Similarity=0.328 Sum_probs=201.6
Q ss_pred CCEEEEEEEECCCCCEEEEEEEE-ECCCEEEEEEEECCCCH---HHHHHHHHHHHHCCCCCEEEECCCCCCCCEEEEECC
Q ss_conf 52299957645479639999875-37959999993038806---999999999991799975462353468751788303
Q 003644 375 GKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHHD---VALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 450 (805)
Q Consensus 375 ~~~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~~~---~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E 450 (805)
.+.|.+.+.||+|+||+||+|.. .+|+.||||++...... ...+|+. ++..++|||||++++++.+++.+|+|||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~-il~~l~HpnIv~~~~~~~~~~~~~ivmE 106 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEIS-IMNQLHHPKLINLHDAFEDKYEMVLILE 106 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHH-HHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCHHHHHHHHHHHH-HHHHCCCCCCCCEEEEEEECCEEEEEEE
T ss_conf 403599899931778299999998999799999988726467999999999-9986799798919999998999999998
Q ss_pred CCCCCHHHHHHHHCCCHHHHHHHHHCCCHHHHHHHHHHCCCCCCHHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHCCE
Q ss_conf 34688345899832887899766320440358887651344332134787751799999999999999998788564361
Q 003644 451 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 530 (805)
Q Consensus 451 ~c~~sL~d~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~I 530 (805)
+|. +|+|.+.+.. ....+++..++.|+.||+.||+|||+.+|
T Consensus 107 ~~~----------gg~L~~~~~~----------------------------~~~~l~e~~~~~i~~qi~~aL~ylH~~~i 148 (352)
T d1koba_ 107 FLS----------GGELFDRIAA----------------------------EDYKMSEAEVINYMRQACEGLKHMHEHSI 148 (352)
T ss_dssp CCC----------CCBHHHHTTC----------------------------TTCCBCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred CCC----------CCHHHHHHHH----------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCE
T ss_conf 289----------9808888986----------------------------38998999999999999999999997792
Q ss_pred ECCCCCCCEEEECCCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCHHHHHHHHHHHHHHC
Q ss_conf 30478882078668999228990268610025887654246446679898973553109999741488899999999929
Q 003644 531 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG 610 (805)
Q Consensus 531 vHrDLKp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDvwSlGvil~elltG 610 (805)
+||||||+|||++......+||+|||+|+.+.... ......||+.|+|||++.+..++.++|||||||++|+|++|
T Consensus 149 iHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG 224 (352)
T d1koba_ 149 VHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE----IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSG 224 (352)
T ss_dssp ECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS----CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHS
T ss_pred EECCCCCCCCCCCCCCCCEEEEEECCCCEECCCCC----CEEECCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHC
T ss_conf 65131445531134678848995256303437887----20100476453489997479989763338989999999968
Q ss_pred CCCCCCCCHHHH-HHHHHHCCCC----CCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHCCCCCCCCC
Q ss_conf 999999865778-8898411332----1236995799999971599999999955554096665631
Q 003644 611 GKHPYGESFERD-ANIVKDRKDL----FLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTAD 672 (805)
Q Consensus 611 ~~~Pf~~~~~~~-~~~~~~~~~~----~~~~~~~~~~dLi~~lL~~dP~~Rpt~~eiL~HPff~~~~ 672 (805)
.+||....... ...+...... .....++++.+||.+||+.||.+|||++|+++||||....
T Consensus 225 -~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~~ 290 (352)
T d1koba_ 225 -LSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH 290 (352)
T ss_dssp -CCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred -CCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCCC
T ss_conf -899899799999999984788989300247999999999997569966891899996097348882
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=369.75 Aligned_cols=251 Identities=24% Similarity=0.331 Sum_probs=198.2
Q ss_pred CEEEEEEEECCCCCEEEEEEEE-ECCCEEEEEEEECCCC---HHHHHHHHHHHHHCCCCCEEEECCCCCCCCEEEEECCC
Q ss_conf 2299957645479639999875-3795999999303880---69999999999917999754623534687517883033
Q 003644 376 KLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH---DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLER 451 (805)
Q Consensus 376 ~~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~~---~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~ 451 (805)
+.|.+.+.||+|+||+||++.. .+|+.||||++..... ....+|+. ++..++|||||++++++.+.+.+|+|||+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~-il~~l~HpnIv~l~~~~~~~~~~~lvmEy 90 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEID-ILASCDHPNIVKLLDAFYYENNLWILIEF 90 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHH-HHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred CCEEEEEEEEECCCCEEEEEEECCCCEEEEEEEECCCCHHHHHHHHHHHH-HHHHCCCCCCCEEEEEEEECCEEEEEEEC
T ss_conf 37598479930778199999999999399999987289999999999999-99867999988498898009958999962
Q ss_pred CCCCHHHHHHHHCCCHHHHHHHHHCCCHHHHHHHHHHCCCCCCHHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHCCEE
Q ss_conf 46883458998328878997663204403588876513443321347877517999999999999999987885643613
Q 003644 452 CTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLI 531 (805)
Q Consensus 452 c~~sL~d~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~Iv 531 (805)
|. +|+|.+++.. ...++++..+..++.||+.||+|||+++|+
T Consensus 91 ~~----------~g~L~~~~~~----------------------------~~~~l~e~~~~~i~~qi~~gL~ylH~~~iv 132 (288)
T d2jfla1 91 CA----------GGAVDAVMLE----------------------------LERPLTESQIQVVCKQTLDALNYLHDNKII 132 (288)
T ss_dssp CT----------TEEHHHHHHH----------------------------HTSCCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred CC----------CCCHHHHHHH----------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCEE
T ss_conf 79----------9818899986----------------------------289999999999999999999999988988
Q ss_pred CCCCCCCEEEECCCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHH-----CCCCCCCCHHHHHHHHHHH
Q ss_conf 04788820786689992289902686100258876542464466798989735531-----0999974148889999999
Q 003644 532 HRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLL-----QGRQTRAIDLFSLGCILFF 606 (805)
Q Consensus 532 HrDLKp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~-----~~~~t~~sDvwSlGvil~e 606 (805)
||||||+|||++.++. +||+|||+|+...... .......||+.|+|||++. ...|+.++|||||||++||
T Consensus 133 HrDiKp~NIll~~~~~--~Kl~DFG~a~~~~~~~---~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilye 207 (288)
T d2jfla1 133 HRDLKAGNILFTLDGD--IKLADFGVSAKNTRTI---QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIE 207 (288)
T ss_dssp CCCCSGGGEEECTTSC--EEECCCTTCEECHHHH---HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHH
T ss_pred EEECCHHHEEECCCCC--EEEEECHHHHCCCCCC---CCCCCCCCCCCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHH
T ss_conf 7140700314878999--8997161230357786---4100102562647999983202578888806657878999999
Q ss_pred HHHCCCCCCCCCHHHH--HHHHHHCC--CCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHCCCCCCCC
Q ss_conf 9929999999865778--88984113--32123699579999997159999999995555409666563
Q 003644 607 CITGGKHPYGESFERD--ANIVKDRK--DLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTA 671 (805)
Q Consensus 607 lltG~~~Pf~~~~~~~--~~~~~~~~--~~~~~~~~~~~~dLi~~lL~~dP~~Rpt~~eiL~HPff~~~ 671 (805)
|++| .+||.+..... ..+..... ...+...++++.+||.+||+.||.+|||++|+++||||...
T Consensus 208 mltg-~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~~ 275 (288)
T d2jfla1 208 MAEI-EPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVD 275 (288)
T ss_dssp HHHS-SCTTTTSCGGGHHHHHHHSCCCCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCCC
T ss_pred HHHC-CCCCCCCCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCCCCCCC
T ss_conf 8208-8999998999999999707998777656699999999999766996689199999629231889
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=366.77 Aligned_cols=246 Identities=28% Similarity=0.385 Sum_probs=191.3
Q ss_pred CCEEEEEEEECCCCCEEEEEEEE-ECCCEEEEEEEECCCC-----HHHHHHHHHHHHHCCCCCEEEECCCCCC----CCE
Q ss_conf 52299957645479639999875-3795999999303880-----6999999999991799975462353468----751
Q 003644 375 GKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH-----DVALKEIQNLIASDQHPNIVRWYGVESD----QDF 444 (805)
Q Consensus 375 ~~~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~~-----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~----~~~ 444 (805)
++.+.+.++||+|+||+||++.. .+++.||||++..... ....+|+ .++..++|||||++++++.+ ...
T Consensus 8 gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~-~il~~l~HpnIv~~~~~~~~~~~~~~~ 86 (270)
T d1t4ha_ 8 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEA-EMLKGLQHPNIVRFYDSWESTVKGKKC 86 (270)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHH-HHHTTCCCTTBCCEEEEEEEESSSCEE
T ss_pred CCEEEEEEEEECCCCCEEEEEEECCCCEEEEEEEECHHHCCHHHHHHHHHHH-HHHHHCCCCCEEEEEEEEEECCCCCCE
T ss_conf 8778851697008284999999999995999999851227989999999999-999857999850699998403345888
Q ss_pred EEEECCCCCCCHHHHHHHHCCCHHHHHHHHHCCCHHHHHHHHHHCCCCCCHHHHHHHHHCCCCHHHHHHHHHHHHHHHHH
Q ss_conf 78830334688345899832887899766320440358887651344332134787751799999999999999998788
Q 003644 445 VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSH 524 (805)
Q Consensus 445 ~~LV~E~c~~sL~d~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~y 524 (805)
+|+|||+|. +|+|.+++. +...+++..++.++.||+.||+|
T Consensus 87 ~~ivmE~~~----------~g~L~~~l~-----------------------------~~~~~~~~~~~~~~~qi~~gl~y 127 (270)
T d1t4ha_ 87 IVLVTELMT----------SGTLKTYLK-----------------------------RFKVMKIKVLRSWCRQILKGLQF 127 (270)
T ss_dssp EEEEEECCC----------SCBHHHHHH-----------------------------HHSSCCHHHHHHHHHHHHHHHHH
T ss_pred EEEEEECCC----------CCCHHHHHH-----------------------------CCCCCCHHHHHHHHHHHHHHHHH
T ss_conf 999995789----------894899975-----------------------------13554699999999999999999
Q ss_pred HHHCC--EECCCCCCCEEEECC-CCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCHHHHHH
Q ss_conf 56436--130478882078668-999228990268610025887654246446679898973553109999741488899
Q 003644 525 LHEIG--LIHRDLKPQNVLISK-DKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLG 601 (805)
Q Consensus 525 LH~~~--IvHrDLKp~NILl~~-~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDvwSlG 601 (805)
||+.+ |+||||||+|||++. ++. +||+|||+++..... .....+||+.|||||++.+ .++.++||||||
T Consensus 128 LH~~~~~IiHrDiKp~NILl~~~~~~--~Kl~DFGla~~~~~~-----~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlG 199 (270)
T d1t4ha_ 128 LHTRTPPIIHRDLKCDNIFITGPTGS--VKIGDLGLATLKRAS-----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFG 199 (270)
T ss_dssp HHTSSSCCCCSCCCGGGEEESSTTSC--EEECCTTGGGGCCTT-----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHH
T ss_pred HHHCCCCEEECCCCHHHCEEECCCCC--EEEEECCCCEECCCC-----CCCCCCCCCCCCCHHHHCC-CCCCCCCHHHHH
T ss_conf 99789979968767435116679998--898005765423687-----6677553813008988478-999867110079
Q ss_pred HHHHHHHHCCCCCCCCCHHH--HHHHHH-HC-CCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHCCCCCC
Q ss_conf 99999992999999986577--888984-11-3321236995799999971599999999955554096665
Q 003644 602 CILFFCITGGKHPYGESFER--DANIVK-DR-KDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFW 669 (805)
Q Consensus 602 vil~elltG~~~Pf~~~~~~--~~~~~~-~~-~~~~~~~~~~~~~dLi~~lL~~dP~~Rpt~~eiL~HPff~ 669 (805)
|++|||++| .+||.+.... ....+. .. +.......++++.++|.+||+.||++|||++|+++||||+
T Consensus 200 vilyel~~g-~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 200 MCMLEMATS-EYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp HHHHHHHHS-SCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred HHHHHHHHC-CCCCCCCCCHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCCCCC
T ss_conf 999999878-89998765599999999738998656755789999999997637975892999996775409
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=370.64 Aligned_cols=251 Identities=24% Similarity=0.391 Sum_probs=198.9
Q ss_pred CEEEEEEEECCCCCEEEEEEEE-ECCCEEEEEEEECCCCH-----HHHHHHHHHHHHCCCCCEEEECCCCCC--CCEEEE
Q ss_conf 2299957645479639999875-37959999993038806-----999999999991799975462353468--751788
Q 003644 376 KLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHHD-----VALKEIQNLIASDQHPNIVRWYGVESD--QDFVYL 447 (805)
Q Consensus 376 ~~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~~~-----~~~~Ei~~ll~~l~HpNIV~l~g~~~~--~~~~~L 447 (805)
++|.+.+.||+|+||+||++.. .+|+.||||++...... ...+|+. ++..++|||||++++++.+ ++.+|+
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~-il~~l~HpnIv~~~~~~~~~~~~~~~i 82 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVN-LLRELKHPNIVRYYDRIIDRTNTTLYI 82 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHH-HTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHH-HHHHCCCCCEEEEEEEEEECCCCEEEE
T ss_conf 3379967983088919999999999979999998746579799999999999-999778999824899999178998999
Q ss_pred ECCCCCCCHHHHHHHHCCCHHHHHHHHHCCCHHHHHHHHHHCCCCCCHHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHH
Q ss_conf 30334688345899832887899766320440358887651344332134787751799999999999999998788564
Q 003644 448 SLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE 527 (805)
Q Consensus 448 V~E~c~~sL~d~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~ 527 (805)
|||||. +|+|.+++.... .....+++..++.++.|++.||+|||+
T Consensus 83 vmEy~~----------~g~L~~~i~~~~-------------------------~~~~~l~e~~~~~i~~qi~~al~ylH~ 127 (269)
T d2java1 83 VMEYCE----------GGDLASVITKGT-------------------------KERQYLDEEFVLRVMTQLTLALKECHR 127 (269)
T ss_dssp EEECCT----------TEEHHHHHHHHH-------------------------HHTCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEECCC----------CCCHHHHHHHCC-------------------------CCCCCCCHHHHHHHHHHHHHHHHHHHH
T ss_conf 995689----------993899998515-------------------------457899999999999999999999997
Q ss_pred CC-----EECCCCCCCEEEECCCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCHHHHHHH
Q ss_conf 36-----1304788820786689992289902686100258876542464466798989735531099997414888999
Q 003644 528 IG-----LIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGC 602 (805)
Q Consensus 528 ~~-----IvHrDLKp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDvwSlGv 602 (805)
.+ |+||||||+|||++.++. +||+|||+++.+..... ......||+.|+|||++.+..++.++|||||||
T Consensus 128 ~~~~~~~IiHrDiKp~NIll~~~~~--vkl~DFG~a~~~~~~~~---~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGv 202 (269)
T d2java1 128 RSDGGHTVLHRDLKPANVFLDGKQN--VKLGDFGLARILNHDTS---FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGC 202 (269)
T ss_dssp HCC---------CCGGGEEECTTSC--EEECCHHHHHHC--------------CCCSCCCHHHHTTCCCCHHHHHHHHHH
T ss_pred HCCCCCCEEECCCCHHHCCCCCCCC--EEEEECCCEEECCCCCC---CCCCCCCCCCCCCHHHHCCCCCCHHHHHHHHCH
T ss_conf 1677887885867654257478885--79800100032245777---556677882327999983999993898875278
Q ss_pred HHHHHHHCCCCCCCCCHHHH-H-HHHHHCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHCCCCC
Q ss_conf 99999929999999865778-8-898411332123699579999997159999999995555409666
Q 003644 603 ILFFCITGGKHPYGESFERD-A-NIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 668 (805)
Q Consensus 603 il~elltG~~~Pf~~~~~~~-~-~~~~~~~~~~~~~~~~~~~dLi~~lL~~dP~~Rpt~~eiL~HPff 668 (805)
++|||++| .+||......+ . .+........+...++++.+|+.+||+.||.+|||++|+++|||.
T Consensus 203 ilyel~tg-~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 203 LLYELCAL-MPPFTAFSQKELAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp HHHHHHHS-SCSCCCSSHHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred HHHHHHHC-CCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHCCCC
T ss_conf 99998018-89989989999999997189988974359999999999767995579189999729819
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=370.00 Aligned_cols=245 Identities=26% Similarity=0.376 Sum_probs=195.3
Q ss_pred CEEEEEEEECCCCCEEEEEEE-EECCCEEEEEEEECCCC------HHHHHHHHHHHHHCCCCCEEEECCCCCCCCEEEEE
Q ss_conf 229995764547963999987-53795999999303880------69999999999917999754623534687517883
Q 003644 376 KLVVFNKEIAKGSNGTVVLEG-NYEGRSVAVKRLVKTHH------DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLS 448 (805)
Q Consensus 376 ~~~~~~~~LG~GsfG~Vy~a~-~~~g~~VAVK~l~~~~~------~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV 448 (805)
+.|...+.||+|+||+||+|. ..+|+.||||++..... ....+|+. ++..++|||||++++++.+.+..|+|
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~-il~~l~HpnIv~~~~~~~~~~~~~iv 93 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVR-FLQKLRHPNTIQYRGCYLREHTAWLV 93 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHH-HHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHH-HHHHCCCCCEEEEEEEEEECCEEEEE
T ss_conf 85676279701888099999998999399999984444358899999999999-99977899982389999989988999
Q ss_pred CCCCCCCHHHHHHHHCCCHHHHHHHHHCCCHHHHHHHHHHCCCCCCHHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHC
Q ss_conf 03346883458998328878997663204403588876513443321347877517999999999999999987885643
Q 003644 449 LERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI 528 (805)
Q Consensus 449 ~E~c~~sL~d~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~ 528 (805)
||+|.+++.+.+ + .....+++..++.++.||+.||.|||+.
T Consensus 94 ~E~~~~g~l~~~----------~-----------------------------~~~~~l~e~~~~~i~~qi~~aL~yLH~~ 134 (309)
T d1u5ra_ 94 MEYCLGSASDLL----------E-----------------------------VHKKPLQEVEIAAVTHGALQGLAYLHSH 134 (309)
T ss_dssp EECCSEEHHHHH----------H-----------------------------HHTSCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred EEECCCCCHHHH----------H-----------------------------HHCCCCCHHHHHHHHHHHHHHHHHHHHC
T ss_conf 980699945789----------9-----------------------------7379999999999999999999999868
Q ss_pred CEECCCCCCCEEEECCCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHC---CCCCCCCHHHHHHHHHH
Q ss_conf 613047888207866899922899026861002588765424644667989897355310---99997414888999999
Q 003644 529 GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ---GRQTRAIDLFSLGCILF 605 (805)
Q Consensus 529 ~IvHrDLKp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~---~~~t~~sDvwSlGvil~ 605 (805)
+|+||||||+|||++.++. +||+|||+++..... ....||+.|||||++.+ ..|+.++|||||||++|
T Consensus 135 ~iiHrDiKp~NILl~~~~~--~Kl~DFG~a~~~~~~-------~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvily 205 (309)
T d1u5ra_ 135 NMIHRDVKAGNILLSEPGL--VKLGDFGSASIMAPA-------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCI 205 (309)
T ss_dssp TCBCCCCSGGGEEEETTTE--EEECCCTTCBSSSSB-------CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHH
T ss_pred CEECCCCCCCEEEECCCCC--EEEEECCCCCCCCCC-------CCCCCCCCCCCHHHHHCCCCCCCCCHHHHHHHHHHHH
T ss_conf 9766678842179879997--898443653346778-------7313476636889983467888672145455899999
Q ss_pred HHHHCCCCCCCCCHHHH-H-HHHHHCCC-CCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHCCCCCCC
Q ss_conf 99929999999865778-8-89841133-212369957999999715999999999555540966656
Q 003644 606 FCITGGKHPYGESFERD-A-NIVKDRKD-LFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWT 670 (805)
Q Consensus 606 elltG~~~Pf~~~~~~~-~-~~~~~~~~-~~~~~~~~~~~dLi~~lL~~dP~~Rpt~~eiL~HPff~~ 670 (805)
||++| .+||.+..... . .+...... ......++++.+||.+||+.||.+|||++++++||||..
T Consensus 206 el~~g-~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~ 272 (309)
T d1u5ra_ 206 ELAER-KPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 272 (309)
T ss_dssp HHHHS-SCTTTTSCHHHHHHHHHHSCCCCCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHS
T ss_pred HHHHC-CCCCCCCCHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHCHHHCC
T ss_conf 99878-89999979999999998289998887888999999999977379657918999971997537
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=363.20 Aligned_cols=252 Identities=20% Similarity=0.299 Sum_probs=201.7
Q ss_pred CCCEEEEEEEECCCCCEEEEEEEE-ECCCEEEEEEEECCCCH--HHHHHHHHHHHHCCCCCEEEECCCCCCCCEEEEECC
Q ss_conf 252299957645479639999875-37959999993038806--999999999991799975462353468751788303
Q 003644 374 IGKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHHD--VALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 450 (805)
Q Consensus 374 i~~~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~~~--~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E 450 (805)
+-++|.+.+.||+|+||+||++.. .+|+.||||.+.....+ ...+|+. ++..++|||||++++++.+++.+|+|||
T Consensus 3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~-il~~l~HpnIv~~~~~~~~~~~~~lvmE 81 (321)
T d1tkia_ 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEIS-ILNIARHRNILHLHESFESMEELVMIFE 81 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHH-HHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred CCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCCCHHHHHHHHH-HHHHCCCCCCCEEEEEEEECCEEEEEEE
T ss_conf 701058878983177839999999899969999997578665999999999-9985799798909899988998899995
Q ss_pred CCCC-CHHHHHHHHCCCHHHHHHHHHCCCHHHHHHHHHHCCCCCCHHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHCC
Q ss_conf 3468-834589983288789976632044035888765134433213478775179999999999999999878856436
Q 003644 451 RCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG 529 (805)
Q Consensus 451 ~c~~-sL~d~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~ 529 (805)
+|.+ +|.+++ .. ....+++.++..|+.||+.||+|||+.+
T Consensus 82 ~~~gg~L~~~i-----------~~----------------------------~~~~l~e~~~~~i~~qi~~al~yLH~~~ 122 (321)
T d1tkia_ 82 FISGLDIFERI-----------NT----------------------------SAFELNEREIVSYVHQVCEALQFLHSHN 122 (321)
T ss_dssp CCCCCBHHHHH-----------TS----------------------------SSCCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred CCCCCCHHHHH-----------HH----------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCC
T ss_conf 38998088998-----------75----------------------------3899999999999999999999998769
Q ss_pred EECCCCCCCEEEECCCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCHHHHHHHHHHHHHH
Q ss_conf 13047888207866899922899026861002588765424644667989897355310999974148889999999992
Q 003644 530 LIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCIT 609 (805)
Q Consensus 530 IvHrDLKp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDvwSlGvil~ellt 609 (805)
|+||||||+|||++.++...+||+|||+++..... .......|++.|+|||.+.+..++.++||||+||++|+|++
T Consensus 123 iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~----~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~ 198 (321)
T d1tkia_ 123 IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG----DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLS 198 (321)
T ss_dssp EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT----CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHH
T ss_pred CCCCCCCCCCEEECCCCCEEEEECCCCHHHCCCCC----CCCCCCCCCCCCCCCHHCCCCCCCCHHHCCCHHHHHHHHHH
T ss_conf 97513554443443788518997644111003467----75321223322234021048777840113027999999982
Q ss_pred CCCCCCCCCHHHH-H-HHHHHCCC---CCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHCCCCCCC
Q ss_conf 9999999865778-8-89841133---212369957999999715999999999555540966656
Q 003644 610 GGKHPYGESFERD-A-NIVKDRKD---LFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWT 670 (805)
Q Consensus 610 G~~~Pf~~~~~~~-~-~~~~~~~~---~~~~~~~~~~~dLi~~lL~~dP~~Rpt~~eiL~HPff~~ 670 (805)
| .+||....... . .+...... ......++++++||.+||+.||.+|||++|+++||||..
T Consensus 199 G-~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~ 263 (321)
T d1tkia_ 199 G-INPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQ 263 (321)
T ss_dssp S-SCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHS
T ss_pred C-CCCCCCCCHHHHHHHHHHCCCCCCHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCC
T ss_conf 8-9999998999999999838999880223678999999999986699668909999963996566
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=360.44 Aligned_cols=253 Identities=25% Similarity=0.352 Sum_probs=200.7
Q ss_pred CCEEEEEEEECCCCCEEEEEEEEECCCEEEEEEEECCC--CHHHHHHHHHHHHHCCCCCEEEECCCCCCCCEEEEECCCC
Q ss_conf 52299957645479639999875379599999930388--0699999999999179997546235346875178830334
Q 003644 375 GKLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTH--HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERC 452 (805)
Q Consensus 375 ~~~~~~~~~LG~GsfG~Vy~a~~~~g~~VAVK~l~~~~--~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~c 452 (805)
.+.|.+.+.||+|+||+||+|...+++.||||++.... .+...+|+. ++..++|||||+++|++.+ +..|+|||+|
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~-~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~ 89 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEAN-LMKQLQHQRLVRLYAVVTQ-EPIYIITEYM 89 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHH-HHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred HHHEEEEEEEECCCCCEEEEEEECCCCEEEEEEECCCCCCHHHHHHHHH-HHHHCCCCCEEEEEEEECC-CCEEEEEEEC
T ss_conf 8993886798107982899999999999999998647688899999999-9986799988578731045-9769999957
Q ss_pred CCCHHHHHHHHCCCHHHHHHHHHCCCHHHHHHHHHHCCCCCCHHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHCCEEC
Q ss_conf 68834589983288789976632044035888765134433213478775179999999999999999878856436130
Q 003644 453 TCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIH 532 (805)
Q Consensus 453 ~~sL~d~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~IvH 532 (805)
.+|+|.+++.. .....+++..++.|+.||+.||+|||+.+|+|
T Consensus 90 ----------~~g~L~~~~~~---------------------------~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivH 132 (272)
T d1qpca_ 90 ----------ENGSLVDFLKT---------------------------PSGIKLTINKLLDMAAQIAEGMAFIEERNYIH 132 (272)
T ss_dssp ----------TTCBHHHHTTS---------------------------HHHHTCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred ----------CCCCHHHHHHH---------------------------CCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCC
T ss_conf ----------89828888751---------------------------47898878899999999999999997489546
Q ss_pred CCCCCCEEEECCCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCHHHHHHHHHHHHHHCCC
Q ss_conf 47888207866899922899026861002588765424644667989897355310999974148889999999992999
Q 003644 533 RDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGK 612 (805)
Q Consensus 533 rDLKp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDvwSlGvil~elltG~~ 612 (805)
|||||+|||++.++. +||+|||+|+.+..... .......||+.|+|||++....++.++|||||||++|||+||+.
T Consensus 133 rDiKp~NIll~~~~~--~Kl~DFGla~~~~~~~~--~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~ 208 (272)
T d1qpca_ 133 RDLRAANILVSDTLS--CKIADFGLARLIEDNEY--TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGR 208 (272)
T ss_dssp SCCSGGGEEECTTSC--EEECCCTTCEECSSSCE--ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTC
T ss_pred CCCCHHHEEEECCCC--EEECCCCCEEECCCCCC--CCCCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHCCC
T ss_conf 756422515620244--04234101477358864--42035677444458289837999824564525799999996898
Q ss_pred CCCCCCHHHHH--HHHHHCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHC--CCCCCC
Q ss_conf 99998657788--89841133212369957999999715999999999555540--966656
Q 003644 613 HPYGESFERDA--NIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN--HPFFWT 670 (805)
Q Consensus 613 ~Pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~dLi~~lL~~dP~~Rpt~~eiL~--HPff~~ 670 (805)
+|+........ .+........+...++++.+|+.+||+.||++|||++++++ |+||.+
T Consensus 209 ~~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts 270 (272)
T d1qpca_ 209 IPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (272)
T ss_dssp CSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHC
T ss_conf 88888899999999970688889655719999999997588976893999999986113213
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=365.40 Aligned_cols=253 Identities=23% Similarity=0.333 Sum_probs=195.2
Q ss_pred CEEEE-EEEECCCCCEEEEEEEE-ECCCEEEEEEEECCCCHHHHHHHHHHHHHCCCCCEEEECCCCCC----CCEEEEEC
Q ss_conf 22999-57645479639999875-37959999993038806999999999991799975462353468----75178830
Q 003644 376 KLVVF-NKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYGVESD----QDFVYLSL 449 (805)
Q Consensus 376 ~~~~~-~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~----~~~~~LV~ 449 (805)
+.|.+ .+.||+|+||+||+|.. .+++.||||++.+. ....+|+..++...+|||||++++++.+ +..+|+||
T Consensus 11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~--~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivm 88 (335)
T d2ozaa1 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVM 88 (335)
T ss_dssp GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS--HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred CCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECCC--HHHHHHHHHHHHHCCCCCCCEEEEEEEECCCCCCEEEEEE
T ss_conf 48798107965454869999998899989999998974--7799999999986699997829899950346897899999
Q ss_pred CCCCCCHHHHHHHHCCCHHHHHHHHHCCCHHHHHHHHHHCCCCCCHHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHCC
Q ss_conf 33468834589983288789976632044035888765134433213478775179999999999999999878856436
Q 003644 450 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG 529 (805)
Q Consensus 450 E~c~~sL~d~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~ 529 (805)
|||. +|+|.+++... ....+++.++..|+.|++.||+|||+.+
T Consensus 89 Ey~~----------gg~L~~~i~~~---------------------------~~~~l~e~~~~~i~~qi~~al~ylH~~~ 131 (335)
T d2ozaa1 89 ECLD----------GGELFSRIQDR---------------------------GDQAFTEREASEIMKSIGEAIQYLHSIN 131 (335)
T ss_dssp ECCC----------SEEHHHHHHSC---------------------------SCCCEEHHHHHHHHHHHHHHHHHHHHTT
T ss_pred ECCC----------CCCHHHHHHHC---------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCC
T ss_conf 7789----------98499999862---------------------------7877579999999999999999999769
Q ss_pred EECCCCCCCEEEECCCC-CCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCHHHHHHHHHHHHH
Q ss_conf 13047888207866899-92289902686100258876542464466798989735531099997414888999999999
Q 003644 530 LIHRDLKPQNVLISKDK-SFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCI 608 (805)
Q Consensus 530 IvHrDLKp~NILl~~~~-~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDvwSlGvil~ell 608 (805)
|+||||||+|||++.+. ...+||+|||+++...... ......||+.|+|||++.+..|+.++|||||||++|+|+
T Consensus 132 iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~ll 207 (335)
T d2ozaa1 132 IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN----SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILL 207 (335)
T ss_dssp EECCCCSGGGEEESCSSTTCCEEECCCTTCEECCCCC----CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHT
T ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEECCCCC----CCCCCCCCCCCCCCHHHCCCCCCHHHHHHHHCHHHHHHH
T ss_conf 8644410022011355556631135455123336888----643226775637927774898888888876451677886
Q ss_pred HCCCCCCCCCHHHH--HHHHH---HCCCCC----CCCCCHHHHHHHHHHCCCCCCCCCCHHHHHCCCCCCCCC
Q ss_conf 29999999865778--88984---113321----236995799999971599999999955554096665631
Q 003644 609 TGGKHPYGESFERD--ANIVK---DRKDLF----LVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTAD 672 (805)
Q Consensus 609 tG~~~Pf~~~~~~~--~~~~~---~~~~~~----~~~~~~~~~dLi~~lL~~dP~~Rpt~~eiL~HPff~~~~ 672 (805)
|| .+||....... ..+.. .....+ ....++++.+||.+||+.||++|||+.|+++||||....
T Consensus 208 tg-~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~ 279 (335)
T d2ozaa1 208 CG-YPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 279 (335)
T ss_dssp TS-SCSCEETTCC--------CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTTT
T ss_pred HC-CCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHHCCC
T ss_conf 58-8998898877889999999853888889854346999999999997569965790999997098761788
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=358.08 Aligned_cols=247 Identities=23% Similarity=0.364 Sum_probs=198.6
Q ss_pred CEEEEEEEECCCCCEEEEEEEEECCCEEEEEEEECCC--CHHHHHHHHHHHHHCCCCCEEEECCCCCCCCEEEEECCCCC
Q ss_conf 2299957645479639999875379599999930388--06999999999991799975462353468751788303346
Q 003644 376 KLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTH--HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCT 453 (805)
Q Consensus 376 ~~~~~~~~LG~GsfG~Vy~a~~~~g~~VAVK~l~~~~--~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~c~ 453 (805)
+.|.+.+.||+|+||+||++...+++.||||++.... .+...+|+. ++..++|||||+++|+|.+.+..|+|||+|
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~E~~-~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~- 82 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAE-VMMKLSHPKLVQLYGVCLEQAPICLVFEFM- 82 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSCHHHHHHHHH-HHHHCCCTTBCCEEEEECSSSSCEEEEECC-
T ss_pred HHCEEEEEEEECCCEEEEEEEECCCCEEEEEEECCCCCCHHHHHHHHH-HHHHCCCCCCCCCCCEECCCCCEEEEEEEC-
T ss_conf 995888898208882999999889999999998788676899999999-999668997565352431599337999836-
Q ss_pred CCHHHHHHHHCCCHHHHHHHHHCCCHHHHHHHHHHCCCCCCHHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHCCEECC
Q ss_conf 88345899832887899766320440358887651344332134787751799999999999999998788564361304
Q 003644 454 CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHR 533 (805)
Q Consensus 454 ~sL~d~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~IvHr 533 (805)
.+|+|.+++... ...+++..++.|+.|++.||+|||+.+|+||
T Consensus 83 ---------~~g~L~~~l~~~----------------------------~~~~~~~~~~~i~~qia~gl~~lH~~~iiHr 125 (263)
T d1sm2a_ 83 ---------EHGCLSDYLRTQ----------------------------RGLFAAETLLGMCLDVCEGMAYLEEACVIHR 125 (263)
T ss_dssp ---------TTCBHHHHHHTT----------------------------TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCT
T ss_pred ---------CCCCHHHHHHCC----------------------------CCCCCHHHHHHHHHHHHHHHHHHHCCCEEEC
T ss_conf ---------999189975201----------------------------3478899999999999998776531643104
Q ss_pred CCCCCEEEECCCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCHHHHHHHHHHHHHHCCCC
Q ss_conf 78882078668999228990268610025887654246446679898973553109999741488899999999929999
Q 003644 534 DLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKH 613 (805)
Q Consensus 534 DLKp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDvwSlGvil~elltG~~~ 613 (805)
||||+|||++.++. +||+|||+++....... .......||+.|+|||++.+..++.++|||||||++|||+|++.+
T Consensus 126 DlKp~Nill~~~~~--~Kl~DFGla~~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~ 201 (263)
T d1sm2a_ 126 DLAARNCLVGENQV--IKVSDFGMTRFVLDDQY--TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKI 201 (263)
T ss_dssp TCSGGGEEECGGGC--EEECSCC--------------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred CCCHHHEEECCCCC--EEECCCCHHEECCCCCC--EEECCEECCCCCCCHHHHCCCCCCCHHHHCCHHHHHHHHHHCCCC
T ss_conf 43153266668877--68655321002368873--350430017666785786079998403321059999999878988
Q ss_pred CCCCCHHHH-H-HHHHHCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHCC
Q ss_conf 999865778-8-898411332123699579999997159999999995555409
Q 003644 614 PYGESFERD-A-NIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNH 665 (805)
Q Consensus 614 Pf~~~~~~~-~-~~~~~~~~~~~~~~~~~~~dLi~~lL~~dP~~Rpt~~eiL~H 665 (805)
|+....... . .+........+...++++.+++.+||+.||++|||++++++|
T Consensus 202 ~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~ 255 (263)
T d1sm2a_ 202 PYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQ 255 (263)
T ss_dssp TTCSCCHHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHH
T ss_conf 877899999999998068889954367999999999765797689199999999
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=356.08 Aligned_cols=270 Identities=23% Similarity=0.298 Sum_probs=199.2
Q ss_pred CEEEEEEEECCCCCEEEEEEEEEC------CCEEEEEEEECCC----CHHHHHHHHHHHHHCCCCCEEEECCCCCCCCEE
Q ss_conf 229995764547963999987537------9599999930388----069999999999917999754623534687517
Q 003644 376 KLVVFNKEIAKGSNGTVVLEGNYE------GRSVAVKRLVKTH----HDVALKEIQNLIASDQHPNIVRWYGVESDQDFV 445 (805)
Q Consensus 376 ~~~~~~~~LG~GsfG~Vy~a~~~~------g~~VAVK~l~~~~----~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~ 445 (805)
+.|.+.+.||+|+||+||+|.... ...||||++.... .....+|+..+....+|||||++++++.+.+.+
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~ 116 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI 116 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHEEEEEEEEECCCEEEEEEEECCCCCCCCEEEEEEEEECCCCCHHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEE
T ss_conf 99397019830788199999985788554204999999663358789999999999999715899686877888629958
Q ss_pred EEECCCCC-CCHHHHHHHHCCCHHHHHHHHHCCCHHHHHHHHHHCCCCCCHHHHHHHHHCCCCHHHHHHHHHHHHHHHHH
Q ss_conf 88303346-88345899832887899766320440358887651344332134787751799999999999999998788
Q 003644 446 YLSLERCT-CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSH 524 (805)
Q Consensus 446 ~LV~E~c~-~sL~d~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~y 524 (805)
|+|||+|. ++|.+++....+.+........ .............+++..++.|+.|++.||+|
T Consensus 117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~-----------------~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~y 179 (325)
T d1rjba_ 117 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYE-----------------NQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEF 179 (325)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCC--------------------------------------CCHHHHHHHHHHHHHHHHH
T ss_pred EEEEECCCCCCHHHHHHHCCCCCCCHHHHHC-----------------CCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHH
T ss_conf 9999727999599999862577751022100-----------------00122200125778999999999999999999
Q ss_pred HHHCCEECCCCCCCEEEECCCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCHHHHHHHHH
Q ss_conf 56436130478882078668999228990268610025887654246446679898973553109999741488899999
Q 003644 525 LHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCIL 604 (805)
Q Consensus 525 LH~~~IvHrDLKp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDvwSlGvil 604 (805)
||+.+|+||||||+|||++.++. +||+|||+|+........ .......||+.|||||++.+..++.++|||||||++
T Consensus 180 LH~~~IiHRDlKp~Nill~~~~~--~Kl~DFGla~~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil 256 (325)
T d1rjba_ 180 LEFKSCVHRDLAARNVLVTHGKV--VKICDFGLARDIMSDSNY-VVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILL 256 (325)
T ss_dssp HHHTTEEETTCSGGGEEEETTTE--EEECCCGGGSCGGGCTTS-EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred HHHCCEEECCCCHHCCCCCCCCE--EEEEECCCCCCCCCCCCE-EEECCCCCCCCCCCHHHHCCCCCCCCEECCCHHHHH
T ss_conf 97399050527032144345982--898514222204577861-562343578765783887279999633030003999
Q ss_pred HHHHHCCCCCCCCCHH--HHHHHHHHC-CCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHCC
Q ss_conf 9999299999998657--788898411-332123699579999997159999999995555409
Q 003644 605 FFCITGGKHPYGESFE--RDANIVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNH 665 (805)
Q Consensus 605 ~elltG~~~Pf~~~~~--~~~~~~~~~-~~~~~~~~~~~~~dLi~~lL~~dP~~Rpt~~eiL~H 665 (805)
|||+|+|.+||..... ....++... ....+...++++.+||.+||+.||++|||++|+++|
T Consensus 257 ~emlt~g~~Pf~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 320 (325)
T d1rjba_ 257 WEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320 (325)
T ss_dssp HHHTTTSCCSSTTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHH
T ss_conf 9998389999999898999999985699899887678999999999758896689399999999
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=0 Score=352.69 Aligned_cols=249 Identities=24% Similarity=0.358 Sum_probs=196.6
Q ss_pred CEEEEEEEECCCCCEEEEEEEE-ECCCEEEEEEEECCCC------------HHHHHHHHHHHHHCCCCCEEEECCCCCCC
Q ss_conf 2299957645479639999875-3795999999303880------------69999999999917999754623534687
Q 003644 376 KLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH------------DVALKEIQNLIASDQHPNIVRWYGVESDQ 442 (805)
Q Consensus 376 ~~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~~------------~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~ 442 (805)
++|.+.+.||+|+||+||++.. .+|+.||||++.+... +...+|+..+.....|||||++++++.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred CCCEECEEEECCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEECCCC
T ss_conf 63888528841768499999999999899999996244641147888999999999999999850799747997621467
Q ss_pred CEEEEECCCCCCCHHHHHHHHCCCHHHHHHHHHCCCHHHHHHHHHHCCCCCCHHHHHHHHHCCCCHHHHHHHHHHHHHHH
Q ss_conf 51788303346883458998328878997663204403588876513443321347877517999999999999999987
Q 003644 443 DFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGL 522 (805)
Q Consensus 443 ~~~~LV~E~c~~sL~d~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL 522 (805)
+.+|||||+|. +|+|.+++. ....+++..++.++.||+.||
T Consensus 83 ~~~~ivmE~~~----------~g~L~~~l~-----------------------------~~~~l~e~~~~~~~~qi~~al 123 (277)
T d1phka_ 83 TFFFLVFDLMK----------KGELFDYLT-----------------------------EKVTLSEKETRKIMRALLEVI 123 (277)
T ss_dssp SEEEEEEECCT----------TCBHHHHHH-----------------------------HHSSCCHHHHHHHHHHHHHHH
T ss_pred CCEEEEEECCC----------CCHHHHHHH-----------------------------HCCCCCHHHHHHHHHHHHHHH
T ss_conf 60599997689----------866899998-----------------------------659999999999999999999
Q ss_pred HHHHHCCEECCCCCCCEEEECCCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHC------CCCCCCCH
Q ss_conf 885643613047888207866899922899026861002588765424644667989897355310------99997414
Q 003644 523 SHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ------GRQTRAID 596 (805)
Q Consensus 523 ~yLH~~~IvHrDLKp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~------~~~t~~sD 596 (805)
+|||+.+|+||||||+|||++.++. +||+|||+++.+.... ......||+.|+|||++.+ ..++.++|
T Consensus 124 ~~lH~~~ivHrDlkp~Nill~~~~~--~kl~DFG~a~~~~~~~----~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~D 197 (277)
T d1phka_ 124 CALHKLNIVHRDLKPENILLDDDMN--IKLTDFGFSCQLDPGE----KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVD 197 (277)
T ss_dssp HHHHHTTEECSCCSGGGEEECTTCC--EEECCCTTCEECCTTC----CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHH
T ss_pred HHHHHCCCCCCCCCCCEEEECCCCC--EEECCCHHEEECCCCC----CEEEEECCCCCCCHHHHHCCCCCCCCCCCCHHE
T ss_conf 9998759943234625489868998--3871240316726887----213452467888988860534456788992331
Q ss_pred HHHHHHHHHHHHHCCCCCCCCCHHHHH-H-HHHHCCC---CCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHCCCCCCC
Q ss_conf 888999999999299999998657788-8-9841133---212369957999999715999999999555540966656
Q 003644 597 LFSLGCILFFCITGGKHPYGESFERDA-N-IVKDRKD---LFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWT 670 (805)
Q Consensus 597 vwSlGvil~elltG~~~Pf~~~~~~~~-~-~~~~~~~---~~~~~~~~~~~dLi~~lL~~dP~~Rpt~~eiL~HPff~~ 670 (805)
|||+||++|||++| .+||........ . +...... ......++++++|+.+||+.||++|||++|+++||||..
T Consensus 198 iwslGvilyeml~g-~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~ 275 (277)
T d1phka_ 198 MWSTGVIMYTLLAG-SPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 275 (277)
T ss_dssp HHHHHHHHHHHHHS-SCSSCCSSHHHHHHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred ECCCCHHHHHHCCC-CCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHHH
T ss_conf 85656023103228-8898899999999999818988898543468999999999976589668919999973978797
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=350.94 Aligned_cols=253 Identities=27% Similarity=0.421 Sum_probs=198.9
Q ss_pred CEEEEEEEECCCCCEEEEEEEE-ECCCEEEEEEEECCC-----CHHHHHHHHHHHHHCCCCCEEEECCCCCCCCEEEEEC
Q ss_conf 2299957645479639999875-379599999930388-----0699999999999179997546235346875178830
Q 003644 376 KLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSL 449 (805)
Q Consensus 376 ~~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~-----~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~ 449 (805)
+.|...+.||+|+||+||+|.. .+|+.||||++.... .....+|+. +++.++|||||++++++.+.+.+|+||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~-il~~l~Hp~Iv~~~~~~~~~~~~~iv~ 80 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREIS-LLKELNHPNIVKLLDVIHTENKLYLVF 80 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHH-HHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CCCEECCEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHH-HHHHCCCCCEEEECCCCCCCCCEEEEE
T ss_conf 9977651772376809999999999979999998022257589999999999-998679983887445332243203788
Q ss_pred CCCCCCHHHHHHHHCCCHHHHHHHHHCCCHHHHHHHHHHCCCCCCHHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHCC
Q ss_conf 33468834589983288789976632044035888765134433213478775179999999999999999878856436
Q 003644 450 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG 529 (805)
Q Consensus 450 E~c~~sL~d~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~ 529 (805)
|+|.+++.+++.. ....++++..+..++.|++.||+|||+.+
T Consensus 81 e~~~~~~~~~~~~--------------------------------------~~~~~l~e~~~~~~~~qil~~L~yLH~~~ 122 (298)
T d1gz8a_ 81 EFLHQDLKKFMDA--------------------------------------SALTGIPLPLIKSYLFQLLQGLAFCHSHR 122 (298)
T ss_dssp ECCSEEHHHHHHH--------------------------------------TTTTCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred EECCCCHHHHHHH--------------------------------------HCCCCCCHHHHHHHHHHHHHHHHHHHCCC
T ss_conf 6237744555442--------------------------------------02568888999999999999999865288
Q ss_pred EECCCCCCCEEEECCCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHCCC-CCCCCHHHHHHHHHHHHH
Q ss_conf 1304788820786689992289902686100258876542464466798989735531099-997414888999999999
Q 003644 530 LIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGR-QTRAIDLFSLGCILFFCI 608 (805)
Q Consensus 530 IvHrDLKp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~-~t~~sDvwSlGvil~ell 608 (805)
|+||||||+|||++.++. +||+|||+|+...... .......||+.|+|||++.... ++.++|+||+||++|+|+
T Consensus 123 IiHrDiKpeNIl~~~~~~--~kl~DFG~a~~~~~~~---~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~ 197 (298)
T d1gz8a_ 123 VLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPV---RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 197 (298)
T ss_dssp CCCSCCCGGGEEECTTSC--EEECSTTHHHHHCCCS---BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHH
T ss_pred EECCCCCCHHEEECCCCC--CEECCCCCCEECCCCC---CCCEEECCCCEEEEHHHHCCCCCCCCCCCCCCCCHHHHHHH
T ss_conf 992135711401134676--2103578613436886---41001036521541122136657774221033331342796
Q ss_pred HCCCCCCCCCHHHHH--HHHHHCC--C--------------------------CCCCCCCHHHHHHHHHHCCCCCCCCCC
Q ss_conf 299999998657788--8984113--3--------------------------212369957999999715999999999
Q 003644 609 TGGKHPYGESFERDA--NIVKDRK--D--------------------------LFLVEHIPEAVDLFTRLLDPNPDLRPK 658 (805)
Q Consensus 609 tG~~~Pf~~~~~~~~--~~~~~~~--~--------------------------~~~~~~~~~~~dLi~~lL~~dP~~Rpt 658 (805)
+| ++||........ .+..... . ......++++.||+.+||+.||++|||
T Consensus 198 ~G-~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t 276 (298)
T d1gz8a_ 198 TR-RALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRIS 276 (298)
T ss_dssp HS-SCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCC
T ss_pred HC-CCCCCCCCHHHHHHHHHHHCCCCCHHHCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCC
T ss_conf 68-79989889999999999832898333144422242124345432222044416678999999999976399557918
Q ss_pred HHHHHCCCCCCCCCC
Q ss_conf 555540966656310
Q 003644 659 AQNVLNHPFFWTADT 673 (805)
Q Consensus 659 ~~eiL~HPff~~~~~ 673 (805)
++|+++||||.+...
T Consensus 277 ~~ell~H~ff~~~~~ 291 (298)
T d1gz8a_ 277 AKAALAHPFFQDVTK 291 (298)
T ss_dssp HHHHHTSGGGTTCCC
T ss_pred HHHHHCCHHHCCCCC
T ss_conf 999967870146999
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=353.01 Aligned_cols=250 Identities=26% Similarity=0.363 Sum_probs=195.1
Q ss_pred CCEEEEEEEECCCCCEEEEEEEEE-CC---CEEEEEEEECCCCH----HHHHHHHHHHHHCCCCCEEEECCCCCCCCEEE
Q ss_conf 522999576454796399998753-79---59999993038806----99999999999179997546235346875178
Q 003644 375 GKLVVFNKEIAKGSNGTVVLEGNY-EG---RSVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVRWYGVESDQDFVY 446 (805)
Q Consensus 375 ~~~~~~~~~LG~GsfG~Vy~a~~~-~g---~~VAVK~l~~~~~~----~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~ 446 (805)
...|.+.+.||+|+||+||+|... ++ ..||||++...... ...+|+. +++.++|||||+++|+|.+.+.+|
T Consensus 25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~-~l~~l~HpnIv~l~g~~~~~~~~~ 103 (299)
T d1jpaa_ 25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEAS-IMGQFDHPNVIHLEGVVTKSTPVM 103 (299)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHH-HHTTCCCTTBCCEEEEECSSSSCE
T ss_pred HHHCEEEEEEEECCCEEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHH-HHHHCCCCCCCCEEEEEEECCEEE
T ss_conf 0042785698027882999999957997889999999784459899999999999-998579988861899996288779
Q ss_pred EECCCCCCCHHHHHHHHCCCHHHHHHHHHCCCHHHHHHHHHHCCCCCCHHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHH
Q ss_conf 83033468834589983288789976632044035888765134433213478775179999999999999999878856
Q 003644 447 LSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH 526 (805)
Q Consensus 447 LV~E~c~~sL~d~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH 526 (805)
+|||||. +|+|.+++.. ....+++.+++.|+.||+.||+|||
T Consensus 104 iv~Ey~~----------~g~L~~~~~~----------------------------~~~~l~~~~~~~i~~qia~gl~yLH 145 (299)
T d1jpaa_ 104 IITEFME----------NGSLDSFLRQ----------------------------NDGQFTVIQLVGMLRGIAAGMKYLA 145 (299)
T ss_dssp EEEECCT----------TEEHHHHHHT----------------------------TTTCSCHHHHHHHHHHHHHHHHHHH
T ss_pred EEEEECC----------CCCCEEEECC----------------------------CCCCCCHHHHHHHHHHHHHHHHHHH
T ss_conf 9997227----------9853002104----------------------------5679999999999999999889885
Q ss_pred HCCEECCCCCCCEEEECCCCCCEEEEECCCCCCCCCCCCCCCC--CCCCCCCCCCCCCHHHHHCCCCCCCCHHHHHHHHH
Q ss_conf 4361304788820786689992289902686100258876542--46446679898973553109999741488899999
Q 003644 527 EIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLT--QNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCIL 604 (805)
Q Consensus 527 ~~~IvHrDLKp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~--~~~~~~gt~~y~APE~l~~~~~t~~sDvwSlGvil 604 (805)
+.+|+||||||+|||++.++. +||+|||+++.+........ ......||+.|||||++....++.++|||||||++
T Consensus 146 ~~~iiHrDlKp~NILl~~~~~--~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl 223 (299)
T d1jpaa_ 146 DMNYVHRDLAARNILVNSNLV--CKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVM 223 (299)
T ss_dssp HTTCCCSCCCGGGEEECTTCC--EEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHH
T ss_pred HCCCCCCCCCCCEEEECCCCC--EEECCCCCCEECCCCCCCCEEEECCCCCCCCCCCCHHHHHCCCCCCCCCCCCCHHHH
T ss_conf 279835761504489889991--998884431575677776536502566688300387888369978612144535789
Q ss_pred HHHHHCCCCCCCCCHHHH-HH-HHHHCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHCC
Q ss_conf 999929999999865778-88-98411332123699579999997159999999995555409
Q 003644 605 FFCITGGKHPYGESFERD-AN-IVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNH 665 (805)
Q Consensus 605 ~elltG~~~Pf~~~~~~~-~~-~~~~~~~~~~~~~~~~~~dLi~~lL~~dP~~Rpt~~eiL~H 665 (805)
|||+|++.+||.+..... .. +........+...++++.+++.+||+.||.+|||+.+++++
T Consensus 224 ~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~ 286 (299)
T d1jpaa_ 224 WEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286 (299)
T ss_dssp HHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred HHHHHCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHH
T ss_conf 999867999999999999999997378899974226999999999758797689299999999
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=352.83 Aligned_cols=246 Identities=23% Similarity=0.301 Sum_probs=191.2
Q ss_pred EEEECCCCCEEEEEEEE-ECCCEEEEEEEECCCC--------HHHHHHHHHHHHHCCCCCEEEECCCCCCCCEEEEECCC
Q ss_conf 57645479639999875-3795999999303880--------69999999999917999754623534687517883033
Q 003644 381 NKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH--------DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLER 451 (805)
Q Consensus 381 ~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~~--------~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~ 451 (805)
.+.||+|+||+||++.. .+|+.||||++..... ....+|+. ++..++|||||++++++.+++.+|+|||+
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~-il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIK-LLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHH-HHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred CEEECCCCCEEEEEEEECCCCCEEEEEEEEHHHHHHHHHHHHHHHHHHHH-HHHHCCCCCEEEEEEEECCCCCEEEHHHH
T ss_conf 63851272829999999999969999998420212456799999999999-99867999986898542258740220455
Q ss_pred CCCCHHHHHHHHCCCHHHHHHHHHCCCHHHHHHHHHHCCCCCCHHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHCCEE
Q ss_conf 46883458998328878997663204403588876513443321347877517999999999999999987885643613
Q 003644 452 CTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLI 531 (805)
Q Consensus 452 c~~sL~d~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~Iv 531 (805)
|.+++...+.. ....+++..+..+++||+.||+|||+.+|+
T Consensus 82 ~~~~~~~~~~~---------------------------------------~~~~l~~~~~~~~~~qil~aL~~lH~~~ii 122 (299)
T d1ua2a_ 82 METDLEVIIKD---------------------------------------NSLVLTPSHIKAYMLMTLQGLEYLHQHWIL 122 (299)
T ss_dssp CSEEHHHHHTT---------------------------------------CCSSCCSSHHHHHHHHHHHHHHHHHHTTCC
T ss_pred HCCHHHHHHHH---------------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHCCCEE
T ss_conf 34507765541---------------------------------------266778999999999999999886316355
Q ss_pred CCCCCCCEEEECCCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHCC-CCCCCCHHHHHHHHHHHHHHC
Q ss_conf 0478882078668999228990268610025887654246446679898973553109-999741488899999999929
Q 003644 532 HRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG-RQTRAIDLFSLGCILFFCITG 610 (805)
Q Consensus 532 HrDLKp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~t~~sDvwSlGvil~elltG 610 (805)
||||||+|||++.++. +||+|||+++...... ......+||+.|+|||++... .++.++||||+||++|||++|
T Consensus 123 HrDiKp~NIli~~~~~--~KL~DFG~a~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g 197 (299)
T d1ua2a_ 123 HRDLKPNNLLLDENGV--LKLADFGLAKSFGSPN---RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLR 197 (299)
T ss_dssp CCCCCGGGEEECTTCC--EEECCCGGGSTTTSCC---CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHS
T ss_pred CCCCCCCEEEECCCCC--CCCCCCCCCCCCCCCC---CCCCCEECCHHHCCHHHHCCCCCCCHHHHHHHCCHHHHHHHHC
T ss_conf 0357762588537784--1146576100057875---5433020473336399972677888056436304289999859
Q ss_pred CCCCCCCCHHHHH--HHHHHCC---------------------------CCCCCCCCHHHHHHHHHHCCCCCCCCCCHHH
Q ss_conf 9999998657788--8984113---------------------------3212369957999999715999999999555
Q 003644 611 GKHPYGESFERDA--NIVKDRK---------------------------DLFLVEHIPEAVDLFTRLLDPNPDLRPKAQN 661 (805)
Q Consensus 611 ~~~Pf~~~~~~~~--~~~~~~~---------------------------~~~~~~~~~~~~dLi~~lL~~dP~~Rpt~~e 661 (805)
.+||......+. .+..... .......++++.+|+.+||+.||++|||++|
T Consensus 198 -~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e 276 (299)
T d1ua2a_ 198 -VPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQ 276 (299)
T ss_dssp -SCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHH
T ss_pred -CCCCCCCCHHHHHHHHHHHCCCCCHHHCCCHHCCCHHHHHCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHH
T ss_conf -6999999999999999985189972545210002134430347898867856568999999999976389456908999
Q ss_pred HHCCCCCCCCC
Q ss_conf 54096665631
Q 003644 662 VLNHPFFWTAD 672 (805)
Q Consensus 662 iL~HPff~~~~ 672 (805)
+|+||||++..
T Consensus 277 ~L~Hp~f~~~p 287 (299)
T d1ua2a_ 277 ALKMKYFSNRP 287 (299)
T ss_dssp HHTSGGGTSSS
T ss_pred HHCCHHHCCCC
T ss_conf 96799657899
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=354.02 Aligned_cols=247 Identities=23% Similarity=0.314 Sum_probs=197.0
Q ss_pred CEEEEEEEECCCCCEEEEEEEEE-CCCEEEEEEEECCC--CHHHHHHHHHHHHHCCCCCEEEECCCCCCCCEEEEECCCC
Q ss_conf 22999576454796399998753-79599999930388--0699999999999179997546235346875178830334
Q 003644 376 KLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH--HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERC 452 (805)
Q Consensus 376 ~~~~~~~~LG~GsfG~Vy~a~~~-~g~~VAVK~l~~~~--~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~c 452 (805)
+.|.+.+.||+|+||+||+|... +++.||||++.... .+...+|+. ++..++|||||+++|+|.+++..|+|||+|
T Consensus 17 ~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~-il~~l~HpnIv~~~~~~~~~~~~~iv~E~~ 95 (287)
T d1opja_ 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAA-VMKEIKHPNLVQLLGVCTREPPFYIITEFM 95 (287)
T ss_dssp GGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHH-HHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred HHEEEEEEEEECCCEEEEEEEECCCCEEEEEEEECCCCCHHHHHHHHHH-HHHHCCCCCEECCCCCEEECCEEEEEEECC
T ss_conf 9939865982088808999999999969999997776103999999999-998679998826775274578547876314
Q ss_pred CCCHHHHHHHHCCCHHHHHHHHHCCCHHHHHHHHHHCCCCCCHHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHCCEEC
Q ss_conf 68834589983288789976632044035888765134433213478775179999999999999999878856436130
Q 003644 453 TCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIH 532 (805)
Q Consensus 453 ~~sL~d~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~IvH 532 (805)
. +|++..++... ....+++..++.|+.|++.||+|||+.+|+|
T Consensus 96 ~----------~g~l~~~l~~~---------------------------~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiH 138 (287)
T d1opja_ 96 T----------YGNLLDYLREC---------------------------NRQEVSAVVLLYMATQISSAMEYLEKKNFIH 138 (287)
T ss_dssp T----------TCBHHHHHHHS---------------------------CTTTSCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred C----------CCCHHHHHHHC---------------------------CCCCHHHHHHHHHHHHHHHHHHHHHHCCCCC
T ss_conf 6----------76067775303---------------------------5541579999999999999788898789305
Q ss_pred CCCCCCEEEECCCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCHHHHHHHHHHHHHHCCC
Q ss_conf 47888207866899922899026861002588765424644667989897355310999974148889999999992999
Q 003644 533 RDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGK 612 (805)
Q Consensus 533 rDLKp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDvwSlGvil~elltG~~ 612 (805)
|||||+|||++.++. +||+|||+++........ ......|++.|+|||++.+..++.++|||||||++|||++|+.
T Consensus 139 rDlKp~NILl~~~~~--~Kl~DFG~a~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~ 214 (287)
T d1opja_ 139 RDLAARNCLVGENHL--VKVADFGLSRLMTGDTYT--AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGM 214 (287)
T ss_dssp SCCSGGGEEECGGGC--EEECCCCCTTTCCSSSSE--EETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSC
T ss_pred CCCCCCEEEECCCCC--EEECCCCCEEECCCCCCE--EECCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCC
T ss_conf 760457689989992--898324454653788722--1035566546669278727999810430217899999986799
Q ss_pred CCCCCCHHHHH-HHHHH-CCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHC
Q ss_conf 99998657788-89841-133212369957999999715999999999555540
Q 003644 613 HPYGESFERDA-NIVKD-RKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 664 (805)
Q Consensus 613 ~Pf~~~~~~~~-~~~~~-~~~~~~~~~~~~~~dLi~~lL~~dP~~Rpt~~eiL~ 664 (805)
+|+........ ..+.. .....+...++++.+|+.+||+.||++|||++++++
T Consensus 215 p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~ 268 (287)
T d1opja_ 215 SPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 268 (287)
T ss_dssp CSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCCHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHH
T ss_conf 887742599999998558888887433099999999975779768939999999
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=345.30 Aligned_cols=255 Identities=24% Similarity=0.349 Sum_probs=196.5
Q ss_pred CCCCEEEEEEEECCCCCEEEEEEE-EECCCEEEEEEEECCCCH----HHHHHHHHHHHHCCCCCEEEECCCCCCCC----
Q ss_conf 225229995764547963999987-537959999993038806----99999999999179997546235346875----
Q 003644 373 RIGKLVVFNKEIAKGSNGTVVLEG-NYEGRSVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVRWYGVESDQD---- 443 (805)
Q Consensus 373 ~i~~~~~~~~~LG~GsfG~Vy~a~-~~~g~~VAVK~l~~~~~~----~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~---- 443 (805)
.++.+|.+.+.||+|+||+||+|. ..+|+.||||++.+.... ...+|+. ++..++||||+++++++....
T Consensus 5 ~i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~-il~~l~hp~iv~~~~~~~~~~~~~~ 83 (345)
T d1pmea_ 5 DVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIK-ILLRFRHENIIGINDIIRAPTIEQM 83 (345)
T ss_dssp CCCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHH-HHHHCCCTTBCCCCEEECCSSTTTC
T ss_pred CCCCCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHCCHHHHHHHHHHHH-HHHHCCCCCCCCEEEEEEECCCCCC
T ss_conf 738985997899406480999999999994999999803109589999999999-9997689898858889950564554
Q ss_pred -EEEEECCCCCCCHHHHHHHHCCCHHHHHHHHHCCCHHHHHHHHHHCCCCCCHHHHHHHHHCCCCHHHHHHHHHHHHHHH
Q ss_conf -1788303346883458998328878997663204403588876513443321347877517999999999999999987
Q 003644 444 -FVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGL 522 (805)
Q Consensus 444 -~~~LV~E~c~~sL~d~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL 522 (805)
..|++++++.++|.+++. .+++++..++.++.|++.||
T Consensus 84 ~~~~l~~~~~~g~L~~~l~-----------------------------------------~~~l~~~~i~~i~~qil~al 122 (345)
T d1pmea_ 84 KDVYLVTHLMGADLYKLLK-----------------------------------------TQHLSNDHICYFLYQILRGL 122 (345)
T ss_dssp CCEEEEEECCCEEHHHHHH-----------------------------------------HCCCCHHHHHHHHHHHHHHH
T ss_pred CEEEEEEEECCCCHHHHHH-----------------------------------------CCCCCHHHHHHHHHHHHHHH
T ss_conf 1499999625986566440-----------------------------------------58999999999999999999
Q ss_pred HHHHHCCEECCCCCCCEEEECCCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHC-CCCCCCCHHHHHH
Q ss_conf 885643613047888207866899922899026861002588765424644667989897355310-9999741488899
Q 003644 523 SHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ-GRQTRAIDLFSLG 601 (805)
Q Consensus 523 ~yLH~~~IvHrDLKp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~t~~sDvwSlG 601 (805)
+|||+.+|+||||||+|||++.++. +||+|||+++...............+||+.|+|||++.. ..++.++||||+|
T Consensus 123 ~yLH~~~iiHRDIKp~NILl~~~~~--~kl~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG 200 (345)
T d1pmea_ 123 KYIHSANVLHRDLKPSNLLLNTTCD--LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVG 200 (345)
T ss_dssp HHHHHTTEECCCCCGGGEEECTTCC--EEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHH
T ss_pred HHHHHCCCCCCCCCCCEEEECCCCC--EEECCCCCEEECCCCCCCCEEECCCCCCCEECHHHHHHCCCCCCCHHHHHCCC
T ss_conf 9999789867778764378879997--78754570565047776410101102652000387860478887410100467
Q ss_pred HHHHHHHHCCCCCCCCCHHHHHH-HH-H-----------------------HCC-------CCCCCCCCHHHHHHHHHHC
Q ss_conf 99999992999999986577888-98-4-----------------------113-------3212369957999999715
Q 003644 602 CILFFCITGGKHPYGESFERDAN-IV-K-----------------------DRK-------DLFLVEHIPEAVDLFTRLL 649 (805)
Q Consensus 602 vil~elltG~~~Pf~~~~~~~~~-~~-~-----------------------~~~-------~~~~~~~~~~~~dLi~~lL 649 (805)
|++|+|++| .+||......+.. .. . ... .......++++++|+.+||
T Consensus 201 ~il~eml~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L 279 (345)
T d1pmea_ 201 CILAEMLSN-RPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKML 279 (345)
T ss_dssp HHHHHHHHS-SCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHS
T ss_pred CEEHHHHHC-CCCCCCCCHHHHHHHHHHHCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHC
T ss_conf 013377669-7997888889999987652069975664234332222024467755778777837899999999999976
Q ss_pred CCCCCCCCCHHHHHCCCCCCCCC
Q ss_conf 99999999955554096665631
Q 003644 650 DPNPDLRPKAQNVLNHPFFWTAD 672 (805)
Q Consensus 650 ~~dP~~Rpt~~eiL~HPff~~~~ 672 (805)
+.||.+|||++++|+||||....
T Consensus 280 ~~dP~~R~ta~e~L~hpf~~~~~ 302 (345)
T d1pmea_ 280 TFNPHKRIEVEQALAHPYLEQYY 302 (345)
T ss_dssp CSSTTTSCCHHHHHTSGGGTTTC
T ss_pred CCCHHHCCCHHHHHCCHHHCCCC
T ss_conf 48956790899986198655588
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=355.98 Aligned_cols=245 Identities=24% Similarity=0.353 Sum_probs=191.6
Q ss_pred EEEECCCCCEEEEEEEEE---CCCEEEEEEEECCCC-----HHHHHHHHHHHHHCCCCCEEEECCCCCCCCEEEEECCCC
Q ss_conf 576454796399998753---795999999303880-----699999999999179997546235346875178830334
Q 003644 381 NKEIAKGSNGTVVLEGNY---EGRSVAVKRLVKTHH-----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERC 452 (805)
Q Consensus 381 ~~~LG~GsfG~Vy~a~~~---~g~~VAVK~l~~~~~-----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~c 452 (805)
.++||+|+||+||+|... .++.||||++..... +...+|+. ++..++|||||+++|+|.+ +..|+|||+|
T Consensus 12 ~k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~-il~~l~HpnIv~~~g~~~~-~~~~lvmE~~ 89 (277)
T d1xbba_ 12 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEAN-VMQQLDNPYIVRMIGICEA-ESWMLVMEMA 89 (277)
T ss_dssp EEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHH-HHHTCCCTTBCCEEEEEES-SSEEEEEECC
T ss_pred CCCCCCCCCEEEEEEEECCCCCCEEEEEEEECHHHCCHHHHHHHHHHHH-HHHHCCCCCCCEEEEEECC-CCEEEEEECC
T ss_conf 8783458782999999816973859999998801089899999999999-9986799898527777505-9779999747
Q ss_pred CCCHHHHHHHHCCCHHHHHHHHHCCCHHHHHHHHHHCCCCCCHHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHCCEEC
Q ss_conf 68834589983288789976632044035888765134433213478775179999999999999999878856436130
Q 003644 453 TCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIH 532 (805)
Q Consensus 453 ~~sL~d~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~IvH 532 (805)
. +|+|.+++. ....+++..++.|+.||+.||+|||+.+|+|
T Consensus 90 ~----------~g~L~~~l~-----------------------------~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiH 130 (277)
T d1xbba_ 90 E----------LGPLNKYLQ-----------------------------QNRHVKDKNIIELVHQVSMGMKYLEESNFVH 130 (277)
T ss_dssp T----------TEEHHHHHH-----------------------------HCTTCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred C----------CCCHHHHHH-----------------------------HCCCCCHHHHHHHHHHHHHHHHHHHHCCCCC
T ss_conf 8----------896899975-----------------------------2257899999999999999976687479556
Q ss_pred CCCCCCEEEECCCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCHHHHHHHHHHHHHHCCC
Q ss_conf 47888207866899922899026861002588765424644667989897355310999974148889999999992999
Q 003644 533 RDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGK 612 (805)
Q Consensus 533 rDLKp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDvwSlGvil~elltG~~ 612 (805)
|||||+|||++.++. +|++|||+++.+..............||+.|+|||++.+..++.++|||||||++|||++.|.
T Consensus 131 rDlKp~Nill~~~~~--~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~ 208 (277)
T d1xbba_ 131 RDLAARNVLLVTQHY--AKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQ 208 (277)
T ss_dssp SCCSGGGEEEEETTE--EEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTC
T ss_pred CCCCCHHHCCCCCCC--CCCCCHHHHHHCCCCCCCCCCCCCCCCCCEECCCHHHCCCCCCCHHHHCCCHHHHHHHHHCCC
T ss_conf 777611310235675--123413453313432344322445677842039166537999843443034031328965899
Q ss_pred CCCCCCHHHHH-H-HHHHCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHH---CCCCC
Q ss_conf 99998657788-8-984113321236995799999971599999999955554---09666
Q 003644 613 HPYGESFERDA-N-IVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVL---NHPFF 668 (805)
Q Consensus 613 ~Pf~~~~~~~~-~-~~~~~~~~~~~~~~~~~~dLi~~lL~~dP~~Rpt~~eiL---~HPff 668 (805)
+||.+....+. . +........+...++++.+|+.+||+.||++|||+++++ +|+|+
T Consensus 209 ~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~ 269 (277)
T d1xbba_ 209 KPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 269 (277)
T ss_dssp CSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred CCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHCHHH
T ss_conf 9999989999999998289999986567999999999758897689098999998528875
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=345.86 Aligned_cols=253 Identities=27% Similarity=0.401 Sum_probs=194.3
Q ss_pred CCEEEEEEEECCCCCEEEEEEEE-EC-CCEEEEEEEECCC-----CHHHHHHHHH--HHHHCCCCCEEEECCCCC-----
Q ss_conf 52299957645479639999875-37-9599999930388-----0699999999--999179997546235346-----
Q 003644 375 GKLVVFNKEIAKGSNGTVVLEGN-YE-GRSVAVKRLVKTH-----HDVALKEIQN--LIASDQHPNIVRWYGVES----- 440 (805)
Q Consensus 375 ~~~~~~~~~LG~GsfG~Vy~a~~-~~-g~~VAVK~l~~~~-----~~~~~~Ei~~--ll~~l~HpNIV~l~g~~~----- 440 (805)
.++|.+.+.||+|+||+||++.. .+ ++.||||++.... .....+|+.. .+...+||||+++++++.
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred CCCEEEEEEEECCCCEEEEEEEEECCCCEEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCCC
T ss_conf 58979888992155869999999888998999999802324516799999999999987425898802366322146666
Q ss_pred CCCEEEEECCCCCCCHHHHHHHHCCCHHHHHHHHHCCCHHHHHHHHHHCCCCCCHHHHHHHHHCCCCHHHHHHHHHHHHH
Q ss_conf 87517883033468834589983288789976632044035888765134433213478775179999999999999999
Q 003644 441 DQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVS 520 (805)
Q Consensus 441 ~~~~~~LV~E~c~~sL~d~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~ 520 (805)
....+|+++|+|.+++..+... .....+++..+..++.|++.
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~--------------------------------------~~~~~~~~~~~~~~~~qi~~ 127 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDK--------------------------------------VPEPGVPTETIKDMMFQLLR 127 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHH--------------------------------------SCTTCSCHHHHHHHHHHHHH
T ss_pred CCCEEEEEEEECCCCCHHHHHH--------------------------------------CCCCCCCHHHHHHHHHHHHH
T ss_conf 6746999997405871444443--------------------------------------03789998999999999999
Q ss_pred HHHHHHHCCEECCCCCCCEEEECCCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCHHHHH
Q ss_conf 87885643613047888207866899922899026861002588765424644667989897355310999974148889
Q 003644 521 GLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSL 600 (805)
Q Consensus 521 gL~yLH~~~IvHrDLKp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDvwSl 600 (805)
||+|||+.+|+||||||+|||++.++. +||+|||+++..... .......||+.|+|||++.+..|+.++||||+
T Consensus 128 aL~yLH~~~ivHrDiKp~NILi~~~~~--~kl~dfg~~~~~~~~----~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSl 201 (305)
T d1blxa_ 128 GLDFLHSHRVVHRDLKPQNILVTSSGQ--IKLADFGLARIYSFQ----MALTSVVVTLWYRAPEVLLQSSYATPVDLWSV 201 (305)
T ss_dssp HHHHHHHTTCCCCCCCGGGEEECTTCC--EEECSCCSCCCCCGG----GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHH
T ss_pred HHHHHHHCCEEECCCCCCEEEECCCCC--EEECCHHHHHHHCCC----CCCCCCCCCHHHCCCCHHCCCCCCHHEHHHCH
T ss_conf 999997588983579862789858997--542100010110023----45777654851148310017988811100032
Q ss_pred HHHHHHHHHCCCCCCCCCHHHHH--HHHHHC--------------------------CCCCCCCCCHHHHHHHHHHCCCC
Q ss_conf 99999999299999998657788--898411--------------------------33212369957999999715999
Q 003644 601 GCILFFCITGGKHPYGESFERDA--NIVKDR--------------------------KDLFLVEHIPEAVDLFTRLLDPN 652 (805)
Q Consensus 601 Gvil~elltG~~~Pf~~~~~~~~--~~~~~~--------------------------~~~~~~~~~~~~~dLi~~lL~~d 652 (805)
||++|||++| .+||......+. .+.... ........++++.+||.+||+.|
T Consensus 202 G~il~ell~g-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~d 280 (305)
T d1blxa_ 202 GCIFAEMFRR-KPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFN 280 (305)
T ss_dssp HHHHHHHHHS-SCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSS
T ss_pred HHHHHHHHHC-CCCCCCCCHHHHHHHHHHHHCCCCHHCCCCCCCCHHHHHCCCCCCCHHHCCCCCCHHHHHHHHHHCCCC
T ss_conf 8999999878-799899898999999998407996110532111103330223456454404458999999999987489
Q ss_pred CCCCCCHHHHHCCCCCCCCC
Q ss_conf 99999955554096665631
Q 003644 653 PDLRPKAQNVLNHPFFWTAD 672 (805)
Q Consensus 653 P~~Rpt~~eiL~HPff~~~~ 672 (805)
|++|||++|+++||||++.+
T Consensus 281 P~~R~sa~e~L~Hpff~~i~ 300 (305)
T d1blxa_ 281 PAKRISAYSALSHPYFQDLE 300 (305)
T ss_dssp TTTSCCHHHHHTSGGGTTCC
T ss_pred HHHCCCHHHHHCCHHHCCCH
T ss_conf 66791899996696340752
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=353.30 Aligned_cols=244 Identities=23% Similarity=0.297 Sum_probs=194.7
Q ss_pred CCEEEEEEEECCCCCEEEEEEEE-ECCCEEEEEEEECCC---------CHHHHHHHHHHHHHC--CCCCEEEECCCCCCC
Q ss_conf 52299957645479639999875-379599999930388---------069999999999917--999754623534687
Q 003644 375 GKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH---------HDVALKEIQNLIASD--QHPNIVRWYGVESDQ 442 (805)
Q Consensus 375 ~~~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~---------~~~~~~Ei~~ll~~l--~HpNIV~l~g~~~~~ 442 (805)
..+|.+.+.||+|+||+||+|.. .+|+.||||++.+.. .....+|+..+ ..+ .|||||++++++.+.
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il-~~l~~~h~nIv~~~~~~~~~ 81 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL-KKVSSGFSGVIRLLDWFERP 81 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHH-HHHCSSSCSBCCEEEEEECS
T ss_pred CCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHH-HHHCCCCCCCCEEEEEEEEC
T ss_conf 88379967984087839999999999979999998568844334556799999999999-97435898812799998309
Q ss_pred CEEEEECCCCCC--CHHHHHHHHCCCHHHHHHHHHCCCHHHHHHHHHHCCCCCCHHHHHHHHHCCCCHHHHHHHHHHHHH
Q ss_conf 517883033468--834589983288789976632044035888765134433213478775179999999999999999
Q 003644 443 DFVYLSLERCTC--SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVS 520 (805)
Q Consensus 443 ~~~~LV~E~c~~--sL~d~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~ 520 (805)
+..|+|||+|.+ ++.+++ .....+++..+..++.|++.
T Consensus 82 ~~~~lv~e~~~~~~~l~~~~----------------------------------------~~~~~l~e~~~~~~~~qi~~ 121 (273)
T d1xwsa_ 82 DSFVLILERPEPVQDLFDFI----------------------------------------TERGALQEELARSFFWQVLE 121 (273)
T ss_dssp SEEEEEEECCSSEEEHHHHH----------------------------------------HHHCSCCHHHHHHHHHHHHH
T ss_pred CEEEEEEEECCCCCHHHHHH----------------------------------------HCCCCCCHHHHHHHHHHHHH
T ss_conf 96899998336862289998----------------------------------------61589999999999999999
Q ss_pred HHHHHHHCCEECCCCCCCEEEECCCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHCCCC-CCCCHHHH
Q ss_conf 87885643613047888207866899922899026861002588765424644667989897355310999-97414888
Q 003644 521 GLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ-TRAIDLFS 599 (805)
Q Consensus 521 gL~yLH~~~IvHrDLKp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~-t~~sDvwS 599 (805)
||+|||+.+|+||||||+|||++.+.. .+||+|||+++..... ...+..||+.|+|||++.+..+ +.++||||
T Consensus 122 al~~lH~~~iiHrDiKp~NIll~~~~~-~vkl~DFG~a~~~~~~-----~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwS 195 (273)
T d1xwsa_ 122 AVRHCHNCGVLHRDIKDENILIDLNRG-ELKLIDFGSGALLKDT-----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWS 195 (273)
T ss_dssp HHHHHHHTTEECSCCSGGGEEEETTTT-EEEECCCTTCEECCSS-----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHH
T ss_pred HHHHHHHCCCCCCCCCCCCEEEECCCC-EEEECCCCCCEECCCC-----CCCCCCCCCCCCCHHHHCCCCCCCCCCCCCC
T ss_conf 999998779755667611147744788-4897754653532444-----5566565877479999848997886533255
Q ss_pred HHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHCCCCCCCC
Q ss_conf 999999999299999998657788898411332123699579999997159999999995555409666563
Q 003644 600 LGCILFFCITGGKHPYGESFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTA 671 (805)
Q Consensus 600 lGvil~elltG~~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~lL~~dP~~Rpt~~eiL~HPff~~~ 671 (805)
+||++|||++| .+||.... .+. .....++...++++++||.+||+.||++|||++|+++||||.+.
T Consensus 196 lGvilyell~g-~~Pf~~~~----~i~-~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~ 261 (273)
T d1xwsa_ 196 LGILLYDMVCG-DIPFEHDE----EII-RGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 261 (273)
T ss_dssp HHHHHHHHHHS-SCSCCSHH----HHH-HCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred CEEEEHHHHHC-CCCCCCCH----HHH-HCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCC
T ss_conf 40345367568-89988736----776-15447787799999999999760897589399998539866788
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=348.19 Aligned_cols=251 Identities=27% Similarity=0.367 Sum_probs=193.2
Q ss_pred EEEEEEEECCCCCEEEEEEEE-ECCCEEEEEEEECCCCHHHHHHHHHHHHHCCCCCEEEECCCCC------CCCEEEEEC
Q ss_conf 299957645479639999875-3795999999303880699999999999179997546235346------875178830
Q 003644 377 LVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYGVES------DQDFVYLSL 449 (805)
Q Consensus 377 ~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~~~~~~~Ei~~ll~~l~HpNIV~l~g~~~------~~~~~~LV~ 449 (805)
.|...++||+|+||+||+|.. .+|+.||||++.+... ...+|+. ++..++|||||++++++. +..++|+||
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-~~~~Ei~-il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~ 98 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-FKNRELQ-IMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVL 98 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-SCCHHHH-HHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEE
T ss_pred CCEEEEEEEECCCEEEEEEEECCCCCEEEEEEECCCCH-HHHHHHH-HHHHCCCCCCCCEEEEEEECCCCCCCEEEEEEE
T ss_conf 76751698217683999999999997999999881606-8999999-998668989873878997447657731899998
Q ss_pred CCCCCCHHHHHHHHCCCHHHHHHHHHCCCHHHHHHHHHHCCCCCCHHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHCC
Q ss_conf 33468834589983288789976632044035888765134433213478775179999999999999999878856436
Q 003644 450 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG 529 (805)
Q Consensus 450 E~c~~sL~d~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~ 529 (805)
|+|++++.+.+... ......+++..++.++.||+.||+|||+.+
T Consensus 99 Ey~~~~~~~~l~~~------------------------------------~~~~~~l~~~~~~~i~~qil~aL~yLH~~~ 142 (350)
T d1q5ka_ 99 DYVPETVYRVARHY------------------------------------SRAKQTLPVIYVKLYMYQLFRSLAYIHSFG 142 (350)
T ss_dssp ECCSEEHHHHHHHH------------------------------------HHTTCCCCHHHHHHHHHHHHHHHHHHHTTT
T ss_pred ECCCCCCHHHHHHH------------------------------------HHCCCCCCHHHHHHHHHHHHHHHHHHHHCC
T ss_conf 41688607888863------------------------------------103689999999999999999999998668
Q ss_pred EECCCCCCCEEEECCCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHC-CCCCCCCHHHHHHHHHHHHH
Q ss_conf 13047888207866899922899026861002588765424644667989897355310-99997414888999999999
Q 003644 530 LIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ-GRQTRAIDLFSLGCILFFCI 608 (805)
Q Consensus 530 IvHrDLKp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~t~~sDvwSlGvil~ell 608 (805)
|+||||||+|||++.++. .+||+|||+++...... ...+..|++.|+|||.+.+ ..++.++||||+||++|||+
T Consensus 143 IiHrDiKp~NILl~~~~~-~~kl~DFG~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~ 217 (350)
T d1q5ka_ 143 ICHRDIKPQNLLLDPDTA-VLKLCDFGSAKQLVRGE----PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELL 217 (350)
T ss_dssp EECCCCCGGGEEECTTTC-CEEECCCTTCEECCTTS----CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHH
T ss_pred CCCCCCCCCEEEEECCCC-CEEEECCCCHHHCCCCC----CCCCCCCCCCCCCHHHHHCCCCCCCCEEECCCCEEEEEHH
T ss_conf 764578860378735897-11673366054404776----5320025555568277640468882100024652778550
Q ss_pred HCCCCCCCCCHHHHH--HHHHH------------C----------------CCCCCCCCCHHHHHHHHHHCCCCCCCCCC
Q ss_conf 299999998657788--89841------------1----------------33212369957999999715999999999
Q 003644 609 TGGKHPYGESFERDA--NIVKD------------R----------------KDLFLVEHIPEAVDLFTRLLDPNPDLRPK 658 (805)
Q Consensus 609 tG~~~Pf~~~~~~~~--~~~~~------------~----------------~~~~~~~~~~~~~dLi~~lL~~dP~~Rpt 658 (805)
+| .+||......+. .+... . ........++++.+|+.+||+.||++|||
T Consensus 218 ~g-~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t 296 (350)
T d1q5ka_ 218 LG-QPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLT 296 (350)
T ss_dssp HT-SCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCC
T ss_pred HC-CCCCCCCCHHHHHHHHHHHHCCCHHHHHHHHCCCHHHCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCC
T ss_conf 28-79989879999999999974898177654306210110355445674444315689999999999976589557929
Q ss_pred HHHHHCCCCCCCC
Q ss_conf 5555409666563
Q 003644 659 AQNVLNHPFFWTA 671 (805)
Q Consensus 659 ~~eiL~HPff~~~ 671 (805)
+.|+|+||||...
T Consensus 297 a~e~L~Hp~f~~~ 309 (350)
T d1q5ka_ 297 PLEACAHSFFDEL 309 (350)
T ss_dssp HHHHHTSGGGGGG
T ss_pred HHHHHCCHHHCCC
T ss_conf 9999669845246
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=352.83 Aligned_cols=250 Identities=25% Similarity=0.349 Sum_probs=194.2
Q ss_pred EEEEEE-EECCCCCEEEEEEEE---ECCCEEEEEEEECCCCH----HHHHHHHHHHHHCCCCCEEEECCCCCCCCEEEEE
Q ss_conf 299957-645479639999875---37959999993038806----9999999999917999754623534687517883
Q 003644 377 LVVFNK-EIAKGSNGTVVLEGN---YEGRSVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVRWYGVESDQDFVYLS 448 (805)
Q Consensus 377 ~~~~~~-~LG~GsfG~Vy~a~~---~~g~~VAVK~l~~~~~~----~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV 448 (805)
.+.+.+ +||+|+||+||+|.. .++..||||++...... ...+|+. ++..++|||||+++|++.+ +.+|+|
T Consensus 9 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~-il~~l~HpnIv~l~g~~~~-~~~~lv 86 (285)
T d1u59a_ 9 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQ-IMHQLDNPYIVRLIGVCQA-EALMLV 86 (285)
T ss_dssp GEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHH-HHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred CEEECCCEEECCCCEEEEEEEEECCCCCEEEEEEEECHHCCHHHHHHHHHHHH-HHHHCCCCCEEEEEEEECC-CEEEEE
T ss_conf 71887848730608099999996089768999999882039789999999999-9986799888068656036-807999
Q ss_pred CCCCCCCHHHHHHHHCCCHHHHHHHHHCCCHHHHHHHHHHCCCCCCHHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHC
Q ss_conf 03346883458998328878997663204403588876513443321347877517999999999999999987885643
Q 003644 449 LERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI 528 (805)
Q Consensus 449 ~E~c~~sL~d~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~ 528 (805)
||||+ +|+|.+++.. ....+++..++.++.|++.||+|||+.
T Consensus 87 mE~~~----------~g~L~~~l~~----------------------------~~~~l~~~~~~~i~~qi~~gL~ylH~~ 128 (285)
T d1u59a_ 87 MEMAG----------GGPLHKFLVG----------------------------KREEIPVSNVAELLHQVSMGMKYLEEK 128 (285)
T ss_dssp EECCT----------TEEHHHHHTT----------------------------CTTTSCHHHHHHHHHHHHHHHHHHHHT
T ss_pred EEECC----------CCCHHHHHHC----------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHC
T ss_conf 98078----------9968997521----------------------------256999999999999999987899868
Q ss_pred CEECCCCCCCEEEECCCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCHHHHHHHHHHHHH
Q ss_conf 61304788820786689992289902686100258876542464466798989735531099997414888999999999
Q 003644 529 GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCI 608 (805)
Q Consensus 529 ~IvHrDLKp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDvwSlGvil~ell 608 (805)
+|+||||||+|||++.++. +||+|||+++.+..............||+.|+|||++....++.++|||||||++|||+
T Consensus 129 ~iiHrDlKp~Nill~~~~~--~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~l 206 (285)
T d1u59a_ 129 NFVHRDLAARNVLLVNRHY--AKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEAL 206 (285)
T ss_dssp TEECCCCSGGGEEEEETTE--EEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHH
T ss_pred CEECCCCCHHHEEECCCCC--EEECCCHHHHCCCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCHHHCCHHHHHHHH
T ss_conf 8105767646604546885--42033134211554343211356211374335868872799995412322017899999
Q ss_pred HCCCCCCCCCHHHH-H-HHHHHCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHH---HCCCCC
Q ss_conf 29999999865778-8-898411332123699579999997159999999995555---409666
Q 003644 609 TGGKHPYGESFERD-A-NIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNV---LNHPFF 668 (805)
Q Consensus 609 tG~~~Pf~~~~~~~-~-~~~~~~~~~~~~~~~~~~~dLi~~lL~~dP~~Rpt~~ei---L~HPff 668 (805)
|.|.+||.+....+ . .+........+...++++.+|+.+||+.||++||++.++ |+|+|+
T Consensus 207 t~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~ 271 (285)
T d1u59a_ 207 SYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 271 (285)
T ss_dssp TTSCCTTTTCCTHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf 38999999979999999998189999997678999999999757797689099999999999999
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=349.81 Aligned_cols=254 Identities=23% Similarity=0.371 Sum_probs=202.2
Q ss_pred CEEEEEEEECCCCCEEEEEEEEECCCEEEEEEEECCCC--HHHHHHHHHHHHHCCCCCEEEECCCCCCCCEEEEECCCCC
Q ss_conf 22999576454796399998753795999999303880--6999999999991799975462353468751788303346
Q 003644 376 KLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHH--DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCT 453 (805)
Q Consensus 376 ~~~~~~~~LG~GsfG~Vy~a~~~~g~~VAVK~l~~~~~--~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~c~ 453 (805)
++|.+.+.||+|+||+||++...+++.||||++..... +...+|+ .++..++|||||+++|+|.+ +..|+|||+|
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~E~-~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~- 93 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEA-QVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM- 93 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHH-HHHHHCCCTTBCCEEEEECS-SSCEEEECCC-
T ss_pred HHEEEEEEEEECCCEEEEEEEECCCCEEEEEEECCCCCCHHHHHHHH-HHHHHCCCCCEEEEEEEEEC-CCEEEEEEEC-
T ss_conf 99798469930798099999999999999999880448889999999-99986666788689999823-9759999944-
Q ss_pred CCHHHHHHHHCCCHHHHHHHHHCCCHHHHHHHHHHCCCCCCHHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHCCEECC
Q ss_conf 88345899832887899766320440358887651344332134787751799999999999999998788564361304
Q 003644 454 CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHR 533 (805)
Q Consensus 454 ~sL~d~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~IvHr 533 (805)
.+|++...+... ....+++.+++.|+.||+.||+|||+.+|+||
T Consensus 94 ---------~~g~l~~~~~~~---------------------------~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~ 137 (285)
T d1fmka3 94 ---------SKGSLLDFLKGE---------------------------TGKYLRLPQLVDMAAQIASGMAYVERMNYVHR 137 (285)
T ss_dssp ---------TTCBHHHHHSHH---------------------------HHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred ---------CCCCHHHHHHHC---------------------------CCCCCHHHHHHHHHHHHHHHHHHHHHHHEECC
T ss_conf ---------799435420000---------------------------35530599999999999999998754114335
Q ss_pred CCCCCEEEECCCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCHHHHHHHHHHHHHHCCCC
Q ss_conf 78882078668999228990268610025887654246446679898973553109999741488899999999929999
Q 003644 534 DLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKH 613 (805)
Q Consensus 534 DLKp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDvwSlGvil~elltG~~~ 613 (805)
||||+|||++.++. +||+|||+++....... .......||+.|+|||++..+.++.++|||||||++|||++|+.+
T Consensus 138 DlKp~NIll~~~~~--~kl~DfGla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p 213 (285)
T d1fmka3 138 DLRAANILVGENLV--CKVADFGLARLIEDNEY--TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRV 213 (285)
T ss_dssp CCSGGGEEECGGGC--EEECCCCTTC----------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred CCCCEEEEECCCCC--EEECCCCHHHHCCCCCC--EEECCCCCCCCCCCHHHHHCCCCCCHHHHHCCHHHHHHHHHCCCC
T ss_conf 31230799989992--99844255542568873--352454556654580898379989177413235899999868999
Q ss_pred CCCCCHHHH-HH-HHHHCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHC--CCCCCCCC
Q ss_conf 999865778-88-9841133212369957999999715999999999555540--96665631
Q 003644 614 PYGESFERD-AN-IVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN--HPFFWTAD 672 (805)
Q Consensus 614 Pf~~~~~~~-~~-~~~~~~~~~~~~~~~~~~dLi~~lL~~dP~~Rpt~~eiL~--HPff~~~~ 672 (805)
|+....... .. +........+...++++.+++.+||+.||++||+++++++ |+||.+.+
T Consensus 214 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~ 276 (285)
T d1fmka3 214 PYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 276 (285)
T ss_dssp SSTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSC
T ss_pred CCCCCCHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHCCCC
T ss_conf 998888999999998268999983237999999999756697589199999998766623899
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=0 Score=345.03 Aligned_cols=249 Identities=24% Similarity=0.352 Sum_probs=193.5
Q ss_pred CEEEEEEEECCCCCEEEEEEEE-ECCCEEEEEEEECCCCHHHHHHHHHHHHHCCCCCEEEECCCCCC--CCEEEEECCCC
Q ss_conf 2299957645479639999875-37959999993038806999999999991799975462353468--75178830334
Q 003644 376 KLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYGVESD--QDFVYLSLERC 452 (805)
Q Consensus 376 ~~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~--~~~~~LV~E~c 452 (805)
++|.+.+.||+|+||+||+|.. .+|+.||||++.........+|+..+.....||||+++++++.. ...+++|||+|
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~~ 114 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHV 114 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEECC
T ss_pred CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEEECCCCCEEEEEEEC
T ss_conf 67189789831748199999988999799999988899999999999998515799876799999816877126888631
Q ss_pred CC-CHHHHHHHHCCCHHHHHHHHHCCCHHHHHHHHHHCCCCCCHHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHCCEE
Q ss_conf 68-83458998328878997663204403588876513443321347877517999999999999999987885643613
Q 003644 453 TC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLI 531 (805)
Q Consensus 453 ~~-sL~d~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~Iv 531 (805)
.+ +|.++ .+.+++..++.++.||+.||+|||+++|+
T Consensus 115 ~~~~L~~~-------------------------------------------~~~l~e~~i~~i~~qil~aL~~LH~~gIv 151 (328)
T d3bqca1 115 NNTDFKQL-------------------------------------------YQTLTDYDIRFYMYEILKALDYCHSMGIM 151 (328)
T ss_dssp CSCBGGGT-------------------------------------------TTSCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred CCCCHHHH-------------------------------------------HCCCCHHHHHHHHHHHHHHHHHHHHCCCC
T ss_conf 79858997-------------------------------------------46899999999999999999887643344
Q ss_pred CCCCCCCEEEECCCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHCCC-CCCCCHHHHHHHHHHHHHHC
Q ss_conf 04788820786689992289902686100258876542464466798989735531099-99741488899999999929
Q 003644 532 HRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGR-QTRAIDLFSLGCILFFCITG 610 (805)
Q Consensus 532 HrDLKp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~-~t~~sDvwSlGvil~elltG 610 (805)
||||||+|||++.++. .+||+|||+|+...... ......+|+.|+|||.+.+.. ++.++||||+||++|++++|
T Consensus 152 HrDiKp~NILi~~~~~-~vkl~DFG~a~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g 226 (328)
T d3bqca1 152 HRDVKPHNVMIDHEHR-KLRLIDWGLAEFYHPGQ----EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFR 226 (328)
T ss_dssp CCCCSGGGEEEETTTT-EEEECCGGGCEECCTTC----CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHT
T ss_pred CCCCCCCCEEECCCCC-EEEECCCCCCEECCCCC----CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCC
T ss_conf 3456441237748998-36641565426646887----444322486424761026888888452323354555876048
Q ss_pred CCCCCCCCH-HHHH--HHHH------------H------------------------CCCCCCCCCCHHHHHHHHHHCCC
Q ss_conf 999999865-7788--8984------------1------------------------13321236995799999971599
Q 003644 611 GKHPYGESF-ERDA--NIVK------------D------------------------RKDLFLVEHIPEAVDLFTRLLDP 651 (805)
Q Consensus 611 ~~~Pf~~~~-~~~~--~~~~------------~------------------------~~~~~~~~~~~~~~dLi~~lL~~ 651 (805)
..||.... .... .+.. . .........++++.|||++||+.
T Consensus 227 -~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~ 305 (328)
T d3bqca1 227 -KEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRY 305 (328)
T ss_dssp -CSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCS
T ss_pred -CCCCCCCCHHHHHHHHHHHHHCCCHHHHHHHHCCCCCCCCCCHHCCCCCCCCHHHCCCCCCCCCCCHHHHHHHHHHCCC
T ss_conf -8999887601899999999878841555554225444743000003334331121155211244899999999998669
Q ss_pred CCCCCCCHHHHHCCCCCCCCCC
Q ss_conf 9999999555540966656310
Q 003644 652 NPDLRPKAQNVLNHPFFWTADT 673 (805)
Q Consensus 652 dP~~Rpt~~eiL~HPff~~~~~ 673 (805)
||.+|||++|+|+||||++..+
T Consensus 306 dP~~R~ta~e~L~Hp~F~~v~~ 327 (328)
T d3bqca1 306 DHQSRLTAREAMEHPYFYTVVK 327 (328)
T ss_dssp SGGGSCCHHHHHTSGGGTTSCC
T ss_pred CHHHCCCHHHHHCCCCCCCCCC
T ss_conf 9568908999964935588797
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=345.99 Aligned_cols=248 Identities=25% Similarity=0.332 Sum_probs=193.6
Q ss_pred CEEEEEEEECCCCCEEEEEEEEECC-----CEEEEEEEECCCCH----HHHHHHHHHHHHCCCCCEEEECCCCCCCCEEE
Q ss_conf 2299957645479639999875379-----59999993038806----99999999999179997546235346875178
Q 003644 376 KLVVFNKEIAKGSNGTVVLEGNYEG-----RSVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVRWYGVESDQDFVY 446 (805)
Q Consensus 376 ~~~~~~~~LG~GsfG~Vy~a~~~~g-----~~VAVK~l~~~~~~----~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~ 446 (805)
..|...+.||+|+||+||+|..... ..||||++...... ...+|+ .++..++|||||+++|++.+.+..+
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~-~il~~l~H~nIv~~~g~~~~~~~~~ 85 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEA-GIMGQFSHHNIIRLEGVISKYKPMM 85 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHH-HHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred HHEEEEEEEEECCCEEEEEEEEECCCCEEEEEEEEEEECCCCCHHHHHHHHHHH-HHHHHCCCCCEEEEEEEEECCCCEE
T ss_conf 996861598117790999999968998787999999988445968999999999-9998568987832367783388038
Q ss_pred EECCCCCCCHHHHHHHHCCCHHHHHHHHHCCCHHHHHHHHHHCCCCCCHHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHH
Q ss_conf 83033468834589983288789976632044035888765134433213478775179999999999999999878856
Q 003644 447 LSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH 526 (805)
Q Consensus 447 LV~E~c~~sL~d~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH 526 (805)
+|+|+|.+ |++.+.+. .....+++..++.++.|++.||+|||
T Consensus 86 ~v~e~~~~----------~~l~~~~~----------------------------~~~~~~~~~~~~~i~~~i~~gl~~lH 127 (283)
T d1mqba_ 86 IITEYMEN----------GALDKFLR----------------------------EKDGEFSVLQLVGMLRGIAAGMKYLA 127 (283)
T ss_dssp EEEECCTT----------EEHHHHHH----------------------------HTTTCSCHHHHHHHHHHHHHHHHHHH
T ss_pred EEEEECCC----------CCCHHHHH----------------------------CCCCCCCHHHHHHHHHHHHHHHHHCC
T ss_conf 99972135----------74022210----------------------------23454208999999999998541212
Q ss_pred HCCEECCCCCCCEEEECCCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCHHHHHHHHHHH
Q ss_conf 43613047888207866899922899026861002588765424644667989897355310999974148889999999
Q 003644 527 EIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFF 606 (805)
Q Consensus 527 ~~~IvHrDLKp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDvwSlGvil~e 606 (805)
+.+|+||||||+|||++.++. +||+|||+++.+..............||+.|+|||++.+..++.++|||||||++||
T Consensus 128 ~~~iiHrDlKp~NILl~~~~~--~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~e 205 (283)
T d1mqba_ 128 NMNYVHRDLAARNILVNSNLV--CKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWE 205 (283)
T ss_dssp HTTCCCSCCCGGGEEECTTCC--EEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHH
T ss_pred CCCCCCCCCCCCEEEECCCCE--EEECCCCHHHCCCCCCCCCEEECCCCCCCCCCCHHHHCCCCCCCCCCCCCCHHHHHH
T ss_conf 123425765644278889984--998455103003578765267426777734348888704999973556344898999
Q ss_pred HHHCCCCCCCCCHHHH-HH-HHHHCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHC
Q ss_conf 9929999999865778-88-9841133212369957999999715999999999555540
Q 003644 607 CITGGKHPYGESFERD-AN-IVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 664 (805)
Q Consensus 607 lltG~~~Pf~~~~~~~-~~-~~~~~~~~~~~~~~~~~~dLi~~lL~~dP~~Rpt~~eiL~ 664 (805)
|++++.+|+....... .. +........+...++++.+++.+||+.||++||++.++++
T Consensus 206 l~t~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~ 265 (283)
T d1mqba_ 206 VMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVS 265 (283)
T ss_dssp HHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred HHHCCCCCCCCCCHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHCCCCHHHCCCHHHHHH
T ss_conf 996798865568999999998635789985045799999999977679768939999999
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=348.70 Aligned_cols=246 Identities=22% Similarity=0.330 Sum_probs=197.1
Q ss_pred CEEEEEEEECCCCCEEEEEEEEECCCEEEEEEEECCC--CHHHHHHHHHHHHHCCCCCEEEECCCCCCCCEEEEECCCCC
Q ss_conf 2299957645479639999875379599999930388--06999999999991799975462353468751788303346
Q 003644 376 KLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTH--HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCT 453 (805)
Q Consensus 376 ~~~~~~~~LG~GsfG~Vy~a~~~~g~~VAVK~l~~~~--~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~c~ 453 (805)
++|.+.+.||+|+||+||++...+++.||||++++.. .+...+|+ .++..++|||||+++|+|.+++.+|+|||+|.
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~Ev-~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~ 82 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEA-KVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 82 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSCHHHHHHHH-HHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCEEEEEEECCCCCCHHHHHHHH-HHHHHCCCCCEEEEEEEEEECCCEEEEEECCC
T ss_conf 99799689820788399999988998999999874757789999999-99996689860158899850781699997048
Q ss_pred -CCHHHHHHHHCCCHHHHHHHHHCCCHHHHHHHHHHCCCCCCHHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHCCEEC
Q ss_conf -8834589983288789976632044035888765134433213478775179999999999999999878856436130
Q 003644 454 -CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIH 532 (805)
Q Consensus 454 -~sL~d~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~IvH 532 (805)
++|.+++.. ....+++..+.+++.|+++||+|||+.+|+|
T Consensus 83 ~g~l~~~~~~---------------------------------------~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH 123 (258)
T d1k2pa_ 83 NGCLLNYLRE---------------------------------------MRHRFQTQQLLEMCKDVCEAMEYLESKQFLH 123 (258)
T ss_dssp TEEHHHHHHS---------------------------------------GGGCCCHHHHHHHHHHHHHHHHHHHHTTBCC
T ss_pred CCCHHHHHHC---------------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCCC
T ss_conf 9938886410---------------------------------------2467768999999999999999875468434
Q ss_pred CCCCCCEEEECCCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCHHHHHHHHHHHHHHCCC
Q ss_conf 47888207866899922899026861002588765424644667989897355310999974148889999999992999
Q 003644 533 RDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGK 612 (805)
Q Consensus 533 rDLKp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDvwSlGvil~elltG~~ 612 (805)
|||||+|||++.++. +||+|||+++....... .......||+.|+|||++....++.++|||||||++|||+|+++
T Consensus 124 ~dlk~~Nill~~~~~--~kl~DfG~a~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~ 199 (258)
T d1k2pa_ 124 RDLAARNCLVNDQGV--VKVSDFGLSRYVLDDEY--TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGK 199 (258)
T ss_dssp SCCSGGGEEECTTCC--EEECCCSSCCBCSSSSC--CCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred CCCCCEEEEECCCCC--EEECCCHHHEECCCCCC--EEECCCCCCCCCCCCHHHCCCCCCCCEEECCCCHHHHHHHHCCC
T ss_conf 665413588769984--79886144202357872--25246578877578078637998852103364324673975599
Q ss_pred CCCCCCHHHHH--HHHHHCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHCC
Q ss_conf 99998657788--898411332123699579999997159999999995555409
Q 003644 613 HPYGESFERDA--NIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNH 665 (805)
Q Consensus 613 ~Pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~dLi~~lL~~dP~~Rpt~~eiL~H 665 (805)
.||......+. .+........+...++++.+|+.+||+.||++|||++++++|
T Consensus 200 ~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 254 (258)
T d1k2pa_ 200 MPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSN 254 (258)
T ss_dssp CTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCCHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHH
T ss_conf 9988999999999998079789965465999999999766897689399999987
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=343.57 Aligned_cols=247 Identities=26% Similarity=0.424 Sum_probs=194.5
Q ss_pred CCCEEEEEEEECCCCCEEEEEEEE-ECCCEEEEEEEECCCC-----HHHHHHHHHHHHHCCCCCEEEECCCCCCCC----
Q ss_conf 252299957645479639999875-3795999999303880-----699999999999179997546235346875----
Q 003644 374 IGKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH-----DVALKEIQNLIASDQHPNIVRWYGVESDQD---- 443 (805)
Q Consensus 374 i~~~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~~-----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~---- 443 (805)
+.+.|...+.||+|+||+||+|.. .+|+.||||++.+... ....+|+. ++..++|||||++++++.+.+
T Consensus 16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~-il~~l~hpniv~l~~~~~~~~~~~~ 94 (346)
T d1cm8a_ 16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELR-LLKHMRHENVIGLLDVFTPDETLDD 94 (346)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHH-HHHHCCBTTBCCCSEEECSCSSTTT
T ss_pred CCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHH-HHHHCCCCCEEEEEEEECCCCCCCC
T ss_conf 477189988980177819999999999989999998522259699999999999-9986689875479998635765555
Q ss_pred --EEEEECCCCCCCHHHHHHHHCCCHHHHHHHHHCCCHHHHHHHHHHCCCCCCHHHHHHHHHCCCCHHHHHHHHHHHHHH
Q ss_conf --178830334688345899832887899766320440358887651344332134787751799999999999999998
Q 003644 444 --FVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSG 521 (805)
Q Consensus 444 --~~~LV~E~c~~sL~d~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~g 521 (805)
.+|+|||+|+.+|.+++ +...+++..++.++.|++.|
T Consensus 95 ~~~~~lv~e~~~~~l~~~~-----------------------------------------~~~~l~~~~~~~~~~qi~~a 133 (346)
T d1cm8a_ 95 FTDFYLVMPFMGTDLGKLM-----------------------------------------KHEKLGEDRIQFLVYQMLKG 133 (346)
T ss_dssp CCCCEEEEECCSEEHHHHH-----------------------------------------HHCCCCHHHHHHHHHHHHHH
T ss_pred CCEEEEEEECCCCCHHHHH-----------------------------------------HHCCCCHHHHHHHHHHHHHH
T ss_conf 4159999840552189998-----------------------------------------74022699999999999999
Q ss_pred HHHHHHCCEECCCCCCCEEEECCCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHCC-CCCCCCHHHHH
Q ss_conf 78856436130478882078668999228990268610025887654246446679898973553109-99974148889
Q 003644 522 LSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG-RQTRAIDLFSL 600 (805)
Q Consensus 522 L~yLH~~~IvHrDLKp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~t~~sDvwSl 600 (805)
|+|||+.+|+||||||+|||++.++. +|++|||+++..... .....||+.|+|||++.+. .++.++||||+
T Consensus 134 L~~LH~~~IiHrDiKp~NIL~~~~~~--~kl~Dfg~a~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSl 205 (346)
T d1cm8a_ 134 LRYIHAAGIIHRDLKPGNLAVNEDCE--LKILDFGLARQADSE------MTGYVVTRWYRAPEVILNWMRYTQTVDIWSV 205 (346)
T ss_dssp HHHHHHTTEECCCCCGGGEEECTTCC--EEECCCTTCEECCSS------CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHH
T ss_pred HHHHHHCCCCCCCCCCCHHHCCCCCC--CCCCCCCCEECCCCC------CCCCCCCCCCCCHHHHCCCCCCCCCCHHHCC
T ss_conf 99987378764566851111210012--211343102206876------3102455333588998178789965010300
Q ss_pred HHHHHHHHHCCCCCCCCCHHHHH-HH-H-----------------------HHCC-------CCCCCCCCHHHHHHHHHH
Q ss_conf 99999999299999998657788-89-8-----------------------4113-------321236995799999971
Q 003644 601 GCILFFCITGGKHPYGESFERDA-NI-V-----------------------KDRK-------DLFLVEHIPEAVDLFTRL 648 (805)
Q Consensus 601 Gvil~elltG~~~Pf~~~~~~~~-~~-~-----------------------~~~~-------~~~~~~~~~~~~dLi~~l 648 (805)
||++|+|++| .+||........ .. . .... .......++++.|||.+|
T Consensus 206 Gvil~ell~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~m 284 (346)
T d1cm8a_ 206 GCIMAEMITG-KTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKM 284 (346)
T ss_dssp HHHHHHHHHS-SCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHH
T ss_pred HHHHHHHHHC-CCCCCCCCHHHHHHHHHHCCCCCCHHHHHHHCCHHHHHHHCCCCCCCCCCHHHHCCCCCHHHHHHHHHH
T ss_conf 3899999978-699888976899999985037884888865300034433115786665566775568999999999997
Q ss_pred CCCCCCCCCCHHHHHCCCCCCCC
Q ss_conf 59999999995555409666563
Q 003644 649 LDPNPDLRPKAQNVLNHPFFWTA 671 (805)
Q Consensus 649 L~~dP~~Rpt~~eiL~HPff~~~ 671 (805)
|+.||.+|||++|+|+||||+..
T Consensus 285 L~~dP~~R~ta~eiL~Hp~f~~~ 307 (346)
T d1cm8a_ 285 LVLDAEQRVTAGEALAHPYFESL 307 (346)
T ss_dssp SCSSTTTSCCHHHHHHSGGGTTT
T ss_pred CCCCHHHCCCHHHHHCCHHHCCC
T ss_conf 72995579299999639623758
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=344.74 Aligned_cols=264 Identities=21% Similarity=0.305 Sum_probs=197.8
Q ss_pred CEEEEEEEECCCCCEEEEEEEEE------CCCEEEEEEEECCCCH----HHHHHHHHHHHHCCCCCEEEECCCCCC-CCE
Q ss_conf 22999576454796399998753------7959999993038806----999999999991799975462353468-751
Q 003644 376 KLVVFNKEIAKGSNGTVVLEGNY------EGRSVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVRWYGVESD-QDF 444 (805)
Q Consensus 376 ~~~~~~~~LG~GsfG~Vy~a~~~------~g~~VAVK~l~~~~~~----~~~~Ei~~ll~~l~HpNIV~l~g~~~~-~~~ 444 (805)
+.|.+.+.||+|+||+||+|... +++.||||++...... ...+|+..+....+|+|||.+++++.+ ++.
T Consensus 13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~ 92 (299)
T d1ywna1 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 92 (299)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSC
T ss_pred HHEEEEEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCEEEEEEEEECCCCCE
T ss_conf 99798449841678399999986777555783999999860017178999999999988614998499741154047975
Q ss_pred EEEECCCCCCCHHHHHHHHCCCHHHHHHHHHCCCHHHHHHHHHHCCCCCCHHHHHHHHHCCCCHHHHHHHHHHHHHHHHH
Q ss_conf 78830334688345899832887899766320440358887651344332134787751799999999999999998788
Q 003644 445 VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSH 524 (805)
Q Consensus 445 ~~LV~E~c~~sL~d~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~y 524 (805)
+++|||+|+ +|+|.++++......... ...........+++..++.++.||+.||+|
T Consensus 93 ~~iv~E~~~----------~g~L~~~l~~~~~~~~~~-------------~~~~~~~~~~~l~~~~~~~~~~qi~~gl~y 149 (299)
T d1ywna1 93 LMVIVEFCK----------FGNLSTYLRSKRNEFVPY-------------KVAPEDLYKDFLTLEHLICYSFQVAKGMEF 149 (299)
T ss_dssp CEEEEECCT----------TCBHHHHHHHTGGGBCC------------------------CBCHHHHHHHHHHHHHHHHH
T ss_pred EEEEEEECC----------CCCHHHHHHHCCCCCCCC-------------CCCHHHHHCCCCCHHHHHHHHHHHHHHHHH
T ss_conf 799998458----------992999998536666653-------------222023321468999999999999999998
Q ss_pred HHHCCEECCCCCCCEEEECCCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCHHHHHHHHH
Q ss_conf 56436130478882078668999228990268610025887654246446679898973553109999741488899999
Q 003644 525 LHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCIL 604 (805)
Q Consensus 525 LH~~~IvHrDLKp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDvwSlGvil 604 (805)
||+.+|+||||||+|||++.++. +||+|||+|+........ .......||+.|+|||++.+..++.++|||||||++
T Consensus 150 lH~~~ivHrDlKp~NILl~~~~~--~Kl~DFGla~~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil 226 (299)
T d1ywna1 150 LASRKCIHRDLAARNILLSEKNV--VKICDFGLARDIYKDPDY-VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLL 226 (299)
T ss_dssp HHHTTCCCSCCCGGGEEECGGGC--EEECC------CCSCTTS-CCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred HHHCCCCCCCCCCCCEEECCCCC--EEECCCCCHHHCCCCCCC-CCCCCEEECCCCCCHHHHHCCCCCCCCCEEEHHHHH
T ss_conf 87379717867731065779982--898457520011356652-224751667210203686468899663221367899
Q ss_pred HHHHHCCCCCCCCCHH--HHHHH-HHHCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHCC
Q ss_conf 9999299999998657--78889-8411332123699579999997159999999995555409
Q 003644 605 FFCITGGKHPYGESFE--RDANI-VKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNH 665 (805)
Q Consensus 605 ~elltG~~~Pf~~~~~--~~~~~-~~~~~~~~~~~~~~~~~dLi~~lL~~dP~~Rpt~~eiL~H 665 (805)
|||++++.+||..... ..... ........+...++++.+++.+||+.||++|||++++++|
T Consensus 227 ~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 290 (299)
T d1ywna1 227 WEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290 (299)
T ss_dssp HHHHTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHH
T ss_conf 9998688999989998999999996389888886578999999999767796679199999999
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=0 Score=341.43 Aligned_cols=249 Identities=25% Similarity=0.420 Sum_probs=197.6
Q ss_pred CEEEEEEEECCCCCEEEEEEEEECCCEEEEEEEECCC-----CHHHHHHHHHHHHHCCCCCEEEECCCCCCCCEEEEECC
Q ss_conf 2299957645479639999875379599999930388-----06999999999991799975462353468751788303
Q 003644 376 KLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 450 (805)
Q Consensus 376 ~~~~~~~~LG~GsfG~Vy~a~~~~g~~VAVK~l~~~~-----~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E 450 (805)
++|...++||+|+||+||++...+|+.||||++.... .....+|+. +++.++|||||++++++.+.+..|+++|
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~-il~~l~hpnIv~~~~~~~~~~~~~i~~e 80 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREIS-ILKELKHSNIVKLYDVIHTKKRLVLVFE 80 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHH-GGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred CCCEECCEEECCCCCEEEEEEECCCCEEEEEEEEHHHCCHHHHHHHHHHHH-HHHHCCCCCEEEEEEECCCCCCEEEEEE
T ss_conf 996343187227781899999689999999998123268589999999999-9986799868766012046773158997
Q ss_pred CCCCCHHHHHHHHCCCHHHHHHHHHCCCHHHHHHHHHHCCCCCCHHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHCCE
Q ss_conf 34688345899832887899766320440358887651344332134787751799999999999999998788564361
Q 003644 451 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 530 (805)
Q Consensus 451 ~c~~sL~d~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~I 530 (805)
+|.+++.+.+.. ....+++..+..++.||+.||+|||+.+|
T Consensus 81 ~~~~~~~~~~~~---------------------------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~I 121 (286)
T d1ob3a_ 81 HLDQDLKKLLDV---------------------------------------CEGGLESVTAKSFLLQLLNGIAYCHDRRV 121 (286)
T ss_dssp CCSEEHHHHHHT---------------------------------------STTCCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEHHHHHHHHHH---------------------------------------HCCCCCHHHHHHHHHHHHHHHHHHCCCCE
T ss_conf 400456789986---------------------------------------04775144568999999999998605748
Q ss_pred ECCCCCCCEEEECCCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHCC-CCCCCCHHHHHHHHHHHHHH
Q ss_conf 30478882078668999228990268610025887654246446679898973553109-99974148889999999992
Q 003644 531 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG-RQTRAIDLFSLGCILFFCIT 609 (805)
Q Consensus 531 vHrDLKp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~t~~sDvwSlGvil~ellt 609 (805)
+||||||+|||++.++. +|++|||.+........ ......|++.|+|||.+... .++.++||||+||++|||++
T Consensus 122 vHrDiKp~NIll~~~~~--~kl~DfG~a~~~~~~~~---~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~ 196 (286)
T d1ob3a_ 122 LHRDLKPQNLLINREGE--LKIADFGLARAFGIPVR---KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVN 196 (286)
T ss_dssp CCSCCCGGGEEECTTSC--EEECCTTHHHHHCC------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHH
T ss_pred EECCCCCCEEEECCCCC--EEECCCCCCEECCCCCC---CCCEECCCCHHHHHHHHHCCCCCCCCEEEHHCCCHHHHHHH
T ss_conf 82678775056868997--87323664301146765---41010243110137887178888841002111758999977
Q ss_pred CCCCCCCCCHHHHH--HHHHHCC----------------------------CCCCCCCCHHHHHHHHHHCCCCCCCCCCH
Q ss_conf 99999998657788--8984113----------------------------32123699579999997159999999995
Q 003644 610 GGKHPYGESFERDA--NIVKDRK----------------------------DLFLVEHIPEAVDLFTRLLDPNPDLRPKA 659 (805)
Q Consensus 610 G~~~Pf~~~~~~~~--~~~~~~~----------------------------~~~~~~~~~~~~dLi~~lL~~dP~~Rpt~ 659 (805)
| ++||......+. .+..... .......++++.||+++||+.||++|||+
T Consensus 197 G-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~ 275 (286)
T d1ob3a_ 197 G-TPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITA 275 (286)
T ss_dssp S-SCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCH
T ss_pred C-CCCCCCCCHHHHHHHHHHHHCCCCHHHCCCHHHHHHCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCH
T ss_conf 9-799898898999999998638997110421233322143333356764666512589999999999866896689099
Q ss_pred HHHHCCCCCCC
Q ss_conf 55540966656
Q 003644 660 QNVLNHPFFWT 670 (805)
Q Consensus 660 ~eiL~HPff~~ 670 (805)
+|+++||||..
T Consensus 276 ~ell~Hp~f~~ 286 (286)
T d1ob3a_ 276 KQALEHAYFKE 286 (286)
T ss_dssp HHHHTSGGGGC
T ss_pred HHHHCCCCCCC
T ss_conf 99856922074
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=339.26 Aligned_cols=253 Identities=25% Similarity=0.382 Sum_probs=193.4
Q ss_pred CEEEEEEEECCCCCEEEEEEEE-ECCCEEEEEEEECCC-----CHHHHHHHHHHHHHCCCCCEEEECCCCCC--------
Q ss_conf 2299957645479639999875-379599999930388-----06999999999991799975462353468--------
Q 003644 376 KLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESD-------- 441 (805)
Q Consensus 376 ~~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~-----~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~-------- 441 (805)
.+|.+.+.||+|+||+||+|.. .+|+.||||++.... .....+|+. ++..++||||+++++++..
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~-il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIK-ILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHH-HHHHCCCTTBCCEEEEEEC--------
T ss_pred CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHH-HHHHHCCCCCCCEEEEEECCCCCCCCC
T ss_conf 7988999972274829999999899979999998422246378999999999-999835999660676540246544445
Q ss_pred CCEEEEECCCCCCCHHHHHHHHCCCHHHHHHHHHCCCHHHHHHHHHHCCCCCCHHHHHHHHHCCCCHHHHHHHHHHHHHH
Q ss_conf 75178830334688345899832887899766320440358887651344332134787751799999999999999998
Q 003644 442 QDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSG 521 (805)
Q Consensus 442 ~~~~~LV~E~c~~sL~d~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~g 521 (805)
.+.+|+|||+|.+++..... .....+++..+..++.|++.|
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~---------------------------------------~~~~~~~~~~~~~i~~qil~~ 129 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLS---------------------------------------NVLVKFTLSEIKRVMQMLLNG 129 (318)
T ss_dssp --CEEEEEECCCEEHHHHHT---------------------------------------CTTCCCCHHHHHHHHHHHHHH
T ss_pred CCEEEEEEECCCCCCCCHHH---------------------------------------HCCCCCCCHHHHHHHHHHHHH
T ss_conf 76389998535787410122---------------------------------------203443308999999999999
Q ss_pred HHHHHHCCEECCCCCCCEEEECCCCCCEEEEECCCCCCCCCCCCC-CCCCCCCCCCCCCCCCHHHHHCC-CCCCCCHHHH
Q ss_conf 788564361304788820786689992289902686100258876-54246446679898973553109-9997414888
Q 003644 522 LSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMS-CLTQNATGYGSSGWQAPEQLLQG-RQTRAIDLFS 599 (805)
Q Consensus 522 L~yLH~~~IvHrDLKp~NILl~~~~~~~~kl~DFGla~~~~~~~~-~~~~~~~~~gt~~y~APE~l~~~-~~t~~sDvwS 599 (805)
|.|||+.+|+||||||+|||++.++. +|++|||+++....... ........+||+.|+|||++.+. .++.++||||
T Consensus 130 l~~lH~~~ivHrDlKp~NILl~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwS 207 (318)
T d3blha1 130 LYYIHRNKILHRDMKAANVLITRDGV--LKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWG 207 (318)
T ss_dssp HHHHHHTTEECCCCCGGGEEECTTSC--EEECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHH
T ss_pred HHHHCCCCEEECCCCCHHEEECCCCC--EEEEECCEEEECCCCCCCCCCCCCCEECCHHHHHHHHHCCCCCCCCHHHCCC
T ss_conf 98852299885676722203668996--8763135002235544432113566024978742899707999891787006
Q ss_pred HHHHHHHHHHCCCCCCCCCHHHHH-HHHHHCCCCC--------------------------------CCCCCHHHHHHHH
Q ss_conf 999999999299999998657788-8984113321--------------------------------2369957999999
Q 003644 600 LGCILFFCITGGKHPYGESFERDA-NIVKDRKDLF--------------------------------LVEHIPEAVDLFT 646 (805)
Q Consensus 600 lGvil~elltG~~~Pf~~~~~~~~-~~~~~~~~~~--------------------------------~~~~~~~~~dLi~ 646 (805)
+||++|||++| .+||........ ..+....... .....++++|||.
T Consensus 208 lGvil~el~~g-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~ 286 (318)
T d3blha1 208 AGCIMAEMWTR-SPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLID 286 (318)
T ss_dssp HHHHHHHHHHS-SCSCCCSSHHHHHHHHHHHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHH
T ss_pred CCCEEEEHHHC-CCCCCCCCHHHHHHHHHHHCCCCCHHHCCCCCHHHHHHHHCCCCCCCCCCHHHHCCCCCCHHHHHHHH
T ss_conf 78646617448-79989989999999999841899825534432034443320133445550334044459989999999
Q ss_pred HHCCCCCCCCCCHHHHHCCCCCCCC
Q ss_conf 7159999999995555409666563
Q 003644 647 RLLDPNPDLRPKAQNVLNHPFFWTA 671 (805)
Q Consensus 647 ~lL~~dP~~Rpt~~eiL~HPff~~~ 671 (805)
+||+.||++|||++|+++||||++.
T Consensus 287 ~mL~~dP~~R~sa~elL~Hpff~~~ 311 (318)
T d3blha1 287 KLLVLDPAQRIDSDDALNHDFFWSD 311 (318)
T ss_dssp HHSCSSTTTSCCHHHHHHSGGGSSS
T ss_pred HHCCCCHHHCCCHHHHHCCHHHCCC
T ss_conf 9873896589099999749501569
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=341.17 Aligned_cols=248 Identities=24% Similarity=0.286 Sum_probs=191.2
Q ss_pred CEEEEEEEECCCCCEEEEEEEE-ECCC----EEEEEEEECCC----CHHHHHHHHHHHHHCCCCCEEEECCCCCCCCEEE
Q ss_conf 2299957645479639999875-3795----99999930388----0699999999999179997546235346875178
Q 003644 376 KLVVFNKEIAKGSNGTVVLEGN-YEGR----SVAVKRLVKTH----HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVY 446 (805)
Q Consensus 376 ~~~~~~~~LG~GsfG~Vy~a~~-~~g~----~VAVK~l~~~~----~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~ 446 (805)
.+|.+.+.||+|+||+||+|.. .+|+ .||||++.... .....+|+. ++..++|||||+++|+|.+++ .+
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~-~l~~l~HpnIv~l~g~~~~~~-~~ 86 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY-VMASVDNPHVCRLLGICLTST-VQ 86 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHH-HHHHCCCTTBCCEEEEEESSS-EE
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEEEECCCCCHHHHHHHHHHHH-HHHHCCCCCEEEEEEEEECCC-EE
T ss_conf 9997831982089929999999589988989999999651349799999999999-998679988815899996198-36
Q ss_pred EECCCCC-CCHHHHHHHHCCCHHHHHHHHHCCCHHHHHHHHHHCCCCCCHHHHHHHHHCCCCHHHHHHHHHHHHHHHHHH
Q ss_conf 8303346-883458998328878997663204403588876513443321347877517999999999999999987885
Q 003644 447 LSLERCT-CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHL 525 (805)
Q Consensus 447 LV~E~c~-~sL~d~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yL 525 (805)
+++|+|. ++|.+.+. .....+++..++.++.||+.||+||
T Consensus 87 ~v~e~~~~~~l~~~~~---------------------------------------~~~~~~~~~~~~~i~~qi~~gl~yL 127 (317)
T d1xkka_ 87 LITQLMPFGCLLDYVR---------------------------------------EHKDNIGSQYLLNWCVQIAKGMNYL 127 (317)
T ss_dssp EEEECCTTCBHHHHHH---------------------------------------HTSSSCCHHHHHHHHHHHHHHHHHH
T ss_pred EEEEECCCCCCCCCCC---------------------------------------CCCCCCCHHHHHHHHHHHHHHHHHH
T ss_conf 9998426874010111---------------------------------------3345799999999999999999999
Q ss_pred HHCCEECCCCCCCEEEECCCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCHHHHHHHHHH
Q ss_conf 64361304788820786689992289902686100258876542464466798989735531099997414888999999
Q 003644 526 HEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILF 605 (805)
Q Consensus 526 H~~~IvHrDLKp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDvwSlGvil~ 605 (805)
|+.+|+||||||+|||++.++. +||+|||+++......... ......||+.|+|||++.++.++.++|||||||++|
T Consensus 128 H~~~iiHrDlKp~NIll~~~~~--~kl~DFGla~~~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~ 204 (317)
T d1xkka_ 128 EDRRLVHRDLAARNVLVKTPQH--VKITDFGLAKLLGAEEKEY-HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVW 204 (317)
T ss_dssp HHTTCCCSCCCGGGEEEEETTE--EEECCCSHHHHTTTTCC---------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHH
T ss_pred HHCCCCCCCCHHHCCEECCCCC--EEEECCCCCEECCCCCCCC-CCCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHH
T ss_conf 8769504762120311679987--5860255222335444532-236510586446708874699983565440799999
Q ss_pred HHHHCCCCCCCCCHHHH-HHHHH-HCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHCCCC
Q ss_conf 99929999999865778-88984-1133212369957999999715999999999555540966
Q 003644 606 FCITGGKHPYGESFERD-ANIVK-DRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPF 667 (805)
Q Consensus 606 elltG~~~Pf~~~~~~~-~~~~~-~~~~~~~~~~~~~~~dLi~~lL~~dP~~Rpt~~eiL~HPf 667 (805)
||+|++.+||....... ...+. ......+...++++.+++.+||+.||.+|||+.++++|..
T Consensus 205 el~t~g~~p~~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~ 268 (317)
T d1xkka_ 205 ELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFS 268 (317)
T ss_dssp HHHTTSCCTTTTSCGGGHHHHHHHTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHH
T ss_conf 9997799999999989999999759989998556899999999847899346919999999999
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=339.64 Aligned_cols=269 Identities=21% Similarity=0.277 Sum_probs=201.0
Q ss_pred CEEEEEEEECCCCCEEEEEEEEE------CCCEEEEEEEECCCCH----HHHHHHHHHHHHCCCCCEEEECCCCCCCCEE
Q ss_conf 22999576454796399998753------7959999993038806----9999999999917999754623534687517
Q 003644 376 KLVVFNKEIAKGSNGTVVLEGNY------EGRSVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVRWYGVESDQDFV 445 (805)
Q Consensus 376 ~~~~~~~~LG~GsfG~Vy~a~~~------~g~~VAVK~l~~~~~~----~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~ 445 (805)
+.|.+.+.||+|+||+||+|... +++.||||++...... ...+|+. +++.++||||++++++|.+.+..
T Consensus 13 ~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~-il~~l~h~niv~~~~~~~~~~~~ 91 (301)
T d1lufa_ 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAA-LMAEFDNPNIVKLLGVCAVGKPM 91 (301)
T ss_dssp GGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHH-HHHTCCCTTBCCEEEEECSSSSC
T ss_pred HHCEEEEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECHHCCHHHHHHHHHHHH-HHHHCCCCCCCCCEEEECCCCCE
T ss_conf 89388679820788399999988876577882999999882108579999999999-99966899765524666059803
Q ss_pred EEECCCCC-CCHHHHHHHHCCCHHHHHHHHHCCCHHHHHHHHHHCCCCCCHHHHHHHHHCCCCHHHHHHHHHHHHHHHHH
Q ss_conf 88303346-88345899832887899766320440358887651344332134787751799999999999999998788
Q 003644 446 YLSLERCT-CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSH 524 (805)
Q Consensus 446 ~LV~E~c~-~sL~d~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~y 524 (805)
++++|+|. ++|.++++.............. ..............+++..++.|+.|++.||+|
T Consensus 92 ~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~----------------~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~y 155 (301)
T d1lufa_ 92 CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSD----------------LSTRARVSSPGPPPLSCAEQLCIARQVAAGMAY 155 (301)
T ss_dssp EEEEECCTTCBHHHHHHHTCC--------------------------------------CCCCHHHHHHHHHHHHHHHHH
T ss_pred EEEEEECCCCCHHHHHHHCCCCCCCCCCCCC----------------CCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHH
T ss_conf 8999815899299999852755421000011----------------100121034678898999999999999998554
Q ss_pred HHHCCEECCCCCCCEEEECCCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCHHHHHHHHH
Q ss_conf 56436130478882078668999228990268610025887654246446679898973553109999741488899999
Q 003644 525 LHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCIL 604 (805)
Q Consensus 525 LH~~~IvHrDLKp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDvwSlGvil 604 (805)
||+.+|+||||||+|||++.++. +||+|||+|+....... ........|++.|+|||++.+..++.++|||||||++
T Consensus 156 lH~~~ivHrDlKp~NILld~~~~--~Kl~DFGls~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl 232 (301)
T d1lufa_ 156 LSERKFVHRDLATRNCLVGENMV--VKIADFGLSRNIYSADY-YKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVL 232 (301)
T ss_dssp HHHTTCCCSCCSGGGEEECGGGC--EEECCCSCHHHHTGGGC-BC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred CCCCCEEEEEECCCCEEECCCCC--EEECCCHHHEECCCCCC-CCCCCCCCCCCCCCCHHHHCCCCCCHHHHHCCCHHHH
T ss_conf 13578685488401168989992--89833144211367764-1115777767676798997268898056302523629
Q ss_pred HHHHHCCCCCCCCCHHHHH-H-HHHHCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHC
Q ss_conf 9999299999998657788-8-9841133212369957999999715999999999555540
Q 003644 605 FFCITGGKHPYGESFERDA-N-IVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 664 (805)
Q Consensus 605 ~elltG~~~Pf~~~~~~~~-~-~~~~~~~~~~~~~~~~~~dLi~~lL~~dP~~Rpt~~eiL~ 664 (805)
|||++|+.+||......+. . +........+...++++.+|+.+||+.||++|||+.|+++
T Consensus 233 ~ell~~~~~p~~~~~~~e~~~~v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~ 294 (301)
T d1lufa_ 233 WEIFSYGLQPYYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294 (301)
T ss_dssp HHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHH
T ss_conf 99980689999998999999999739978887325299999999974889657939999999
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=345.81 Aligned_cols=244 Identities=24% Similarity=0.332 Sum_probs=183.8
Q ss_pred CEEEEEEEECCCCCEEEEEEEEECCCEEEEEEEECCC----C-HHHHHHHHHHHHHCCCCCEEEECCCCCCCCEEEEECC
Q ss_conf 2299957645479639999875379599999930388----0-6999999999991799975462353468751788303
Q 003644 376 KLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTH----H-DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 450 (805)
Q Consensus 376 ~~~~~~~~LG~GsfG~Vy~a~~~~g~~VAVK~l~~~~----~-~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E 450 (805)
..|.+.+.||+|+||+||+|.. ...||||++.... . ....+|+ .++..++|||||+++|++.+ +.+|+|||
T Consensus 8 ~~~~~~~~lG~G~fg~Vy~~~~--~~~vAvK~~~~~~~~~~~~~~~~~E~-~~l~~l~HpnIv~~~~~~~~-~~~~lv~E 83 (276)
T d1uwha_ 8 GQITVGQRIGSGSFGTVYKGKW--HGDVAVKMLNVTAPTPQQLQAFKNEV-GVLRKTRHVNILLFMGYSTA-PQLAIVTQ 83 (276)
T ss_dssp TCCCCCSEEEECSSCEEEEEES--SSEEEEEECCCSSCCTTHHHHHHHHH-HHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred CCEEEEEEEEECCCCEEEEEEE--CCEEEEEEEECCCCCHHHHHHHHHHH-HHHHHCCCCCEEEEEEEEEC-CEEEEEEE
T ss_conf 5189988983078858999999--99899999973469989999999999-99984799878645679715-58999996
Q ss_pred CCCCCHHHHHHHHCCCHHHHHHHHHCCCHHHHHHHHHHCCCCCCHHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHCCE
Q ss_conf 34688345899832887899766320440358887651344332134787751799999999999999998788564361
Q 003644 451 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 530 (805)
Q Consensus 451 ~c~~sL~d~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~I 530 (805)
||. +|+|.++++.. ...+++..++.|+.||+.||+|||+.+|
T Consensus 84 y~~----------~g~L~~~l~~~----------------------------~~~~~~~~~~~i~~qi~~gl~yLH~~~i 125 (276)
T d1uwha_ 84 WCE----------GSSLYHHLHII----------------------------ETKFEMIKLIDIARQTAQGMDYLHAKSI 125 (276)
T ss_dssp CCC----------EEEHHHHHHTS----------------------------CCCCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred CCC----------CCCHHHHHHHC----------------------------CCCCCHHHHHHHHHHHHHHHHHHHCCCE
T ss_conf 589----------98889998523----------------------------5789999999999999999888750999
Q ss_pred ECCCCCCCEEEECCCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHC---CCCCCCCHHHHHHHHHHHH
Q ss_conf 3047888207866899922899026861002588765424644667989897355310---9999741488899999999
Q 003644 531 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ---GRQTRAIDLFSLGCILFFC 607 (805)
Q Consensus 531 vHrDLKp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~---~~~t~~sDvwSlGvil~el 607 (805)
+||||||+|||++.++. +||+|||+|+....... ........||+.|||||++.. ..++.++|||||||++|||
T Consensus 126 vHrDlKp~NiLl~~~~~--~Kl~DFGla~~~~~~~~-~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el 202 (276)
T d1uwha_ 126 IHRDLKSNNIFLHEDLT--VKIGDFGLATVKSRWSG-SHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYEL 202 (276)
T ss_dssp CCSCCCGGGEEEETTSS--EEECCCCCSCC-------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHH
T ss_pred ECCCCCHHHEEECCCCC--EEECCCCCEEECCCCCC-CCCCCCCCCCCCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHH
T ss_conf 51614789979818997--88750022133355677-6312566557431799999505689999531516359999999
Q ss_pred HHCCCCCCCCCHHH--HHHHHHHCC-----CCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHCC
Q ss_conf 92999999986577--888984113-----32123699579999997159999999995555409
Q 003644 608 ITGGKHPYGESFER--DANIVKDRK-----DLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNH 665 (805)
Q Consensus 608 ltG~~~Pf~~~~~~--~~~~~~~~~-----~~~~~~~~~~~~dLi~~lL~~dP~~Rpt~~eiL~H 665 (805)
+|| ..||.+.... ....+.... .......++++.+++.+||+.||.+|||++++++|
T Consensus 203 ~tg-~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~ 266 (276)
T d1uwha_ 203 MTG-QLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILAS 266 (276)
T ss_dssp HHS-SCTTTTCCCHHHHHHHHHHTSCCCCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHC-CCCCCCCCHHHHHHHHHHCCCCCCCCHHCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHH
T ss_conf 978-8998998969999999965888986000365554999999999758897689299999999
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=341.83 Aligned_cols=244 Identities=26% Similarity=0.369 Sum_probs=195.0
Q ss_pred CEEEEEEEECCCCCEEEEEEEEECCCEEEEEEEECCCCHHHHHHHHHHHHHCCCCCEEEECCCCCC-CCEEEEECCCCCC
Q ss_conf 229995764547963999987537959999993038806999999999991799975462353468-7517883033468
Q 003644 376 KLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYGVESD-QDFVYLSLERCTC 454 (805)
Q Consensus 376 ~~~~~~~~LG~GsfG~Vy~a~~~~g~~VAVK~l~~~~~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~-~~~~~LV~E~c~~ 454 (805)
++|.+.+.||+|+||.||++.. .|+.||||++++......+..+..+++.++|||||+++|+|.+ .+.+|+|||+|
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~-- 83 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM-- 83 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC--
T ss_pred HHEEEEEEEECCCCEEEEEEEE-CCEEEEEEEECCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEEEECC--
T ss_conf 9948857982079808999999-9909999998857779999999999986789898549878872389289999636--
Q ss_pred CHHHHHHHHCCCHHHHHHHHHCCCHHHHHHHHHHCCCCCCHHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHCCEECCC
Q ss_conf 83458998328878997663204403588876513443321347877517999999999999999987885643613047
Q 003644 455 SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRD 534 (805)
Q Consensus 455 sL~d~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~IvHrD 534 (805)
.+|+|.++|+... ...+++..++.|+.||+.||+|||+.+|+|||
T Consensus 84 --------~~g~L~~~l~~~~---------------------------~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~d 128 (262)
T d1byga_ 84 --------AKGSLVDYLRSRG---------------------------RSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRD 128 (262)
T ss_dssp --------TTEEHHHHHHHHH---------------------------HHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred --------CCCCHHHHHHHCC---------------------------CCCCCHHHHHHHHHHHHHHCCCCCCCCEECCC
T ss_conf --------9998999987457---------------------------88889999999999998523211337655366
Q ss_pred CCCCEEEECCCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCHHHHHHHHHHHHHHCCCCC
Q ss_conf 88820786689992289902686100258876542464466798989735531099997414888999999999299999
Q 003644 535 LKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP 614 (805)
Q Consensus 535 LKp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDvwSlGvil~elltG~~~P 614 (805)
|||+|||++.++. +|++|||+++..... .....++..|+|||++.+..++.++|||||||++|||+|++.+|
T Consensus 129 lkp~Nil~~~~~~--~kl~dfg~s~~~~~~------~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p 200 (262)
T d1byga_ 129 LAARNVLVSEDNV--AKVSDFGLTKEASST------QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVP 200 (262)
T ss_dssp CSGGGEEECTTSC--EEECCCCC------------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCS
T ss_pred CCHHHHEECCCCC--EEECCCCCCEECCCC------CCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHCCCCC
T ss_conf 6567601468997--763245600344787------76556664677817872798885887775799999999789999
Q ss_pred CCCCHHHH-H-HHHHHCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHCC
Q ss_conf 99865778-8-898411332123699579999997159999999995555409
Q 003644 615 YGESFERD-A-NIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNH 665 (805)
Q Consensus 615 f~~~~~~~-~-~~~~~~~~~~~~~~~~~~~dLi~~lL~~dP~~Rpt~~eiL~H 665 (805)
|......+ . .+........+...++++.+|+.+||+.||.+|||+.+++++
T Consensus 201 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 253 (262)
T d1byga_ 201 YPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQ 253 (262)
T ss_dssp CTTSCGGGHHHHHTTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHH
T ss_conf 99999999999998089999976579999999999756697689399999999
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=335.55 Aligned_cols=247 Identities=26% Similarity=0.376 Sum_probs=192.4
Q ss_pred CCEEEEEEEECCCCCEEEEEEEE-ECCCEEEEEEEECCCC-----HHHHHHHHHHHHHCCCCCEEEECCCCCC------C
Q ss_conf 52299957645479639999875-3795999999303880-----6999999999991799975462353468------7
Q 003644 375 GKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH-----DVALKEIQNLIASDQHPNIVRWYGVESD------Q 442 (805)
Q Consensus 375 ~~~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~~-----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~------~ 442 (805)
-+.|.+.+.||+|+||+||+|.. .+|+.||||++.+... ....+|+. +++.++|||||++++++.. .
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~-il~~l~hpnIv~~~~~f~~~~~~~~~ 94 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELV-LMKCVNHKNIISLLNVFTPQKTLEEF 94 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHH-HHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHH-HHHHCCCCCEEEEEEEEECCCCCCCC
T ss_conf 37759988962175859999999999989999998823369799999999999-99864898764899897025643457
Q ss_pred CEEEEECCCCCCCHHHHHHHHCCCHHHHHHHHHCCCHHHHHHHHHHCCCCCCHHHHHHHHHCCCCHHHHHHHHHHHHHHH
Q ss_conf 51788303346883458998328878997663204403588876513443321347877517999999999999999987
Q 003644 443 DFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGL 522 (805)
Q Consensus 443 ~~~~LV~E~c~~sL~d~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL 522 (805)
+.+|+|||+|.+++.+.+ ...+++..++.++.|++.||
T Consensus 95 ~~~~iv~Ey~~~~l~~~~------------------------------------------~~~~~~~~i~~~~~qil~gl 132 (355)
T d2b1pa1 95 QDVYLVMELMDANLCQVI------------------------------------------QMELDHERMSYLLYQMLCGI 132 (355)
T ss_dssp CEEEEEEECCSEEHHHHH------------------------------------------TSCCCHHHHHHHHHHHHHHH
T ss_pred CEEEEEEECCCHHHHHHH------------------------------------------HCCCCHHHHHHHHHHHHHHH
T ss_conf 626999841446778765------------------------------------------03899999999999999999
Q ss_pred HHHHHCCEECCCCCCCEEEECCCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCHHHHHHH
Q ss_conf 88564361304788820786689992289902686100258876542464466798989735531099997414888999
Q 003644 523 SHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGC 602 (805)
Q Consensus 523 ~yLH~~~IvHrDLKp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDvwSlGv 602 (805)
+|||+.+|+||||||+|||++.++. +|++|||+++..... .......||+.|+|||++.+..++.++||||+||
T Consensus 133 ~~LH~~giiHrDlKP~Nil~~~~~~--~kl~df~~~~~~~~~----~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~ 206 (355)
T d2b1pa1 133 KHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTS----FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGC 206 (355)
T ss_dssp HHHHHTTCCCSCCCGGGEEECTTCC--EEECCCCC-------------------CCTTCCHHHHTTCCCCTTHHHHHHHH
T ss_pred HHHHHCCCCCCCCCCCCCCCCCCCC--EEEECHHHHHCCCCC----CCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCC
T ss_conf 8865221124567763211365443--132010232114666----5533221465555813314777787743335662
Q ss_pred HHHHHHHCCCCCCCCCHHHHH--HHH----------------------HHCCC-------------C------CCCCCCH
Q ss_conf 999999299999998657788--898----------------------41133-------------2------1236995
Q 003644 603 ILFFCITGGKHPYGESFERDA--NIV----------------------KDRKD-------------L------FLVEHIP 639 (805)
Q Consensus 603 il~elltG~~~Pf~~~~~~~~--~~~----------------------~~~~~-------------~------~~~~~~~ 639 (805)
++|+|++| .+||........ .+. ..... . .....++
T Consensus 207 ~l~ell~g-~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 285 (355)
T d2b1pa1 207 IMGEMVRH-KILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKAS 285 (355)
T ss_dssp HHHHHHHS-SCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHH
T ss_pred HHHHHHHC-CCCCCCCCHHHHHHHHHHHCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCH
T ss_conf 57898659-89988897788999999720589879998765667777641754356664212643335432101333799
Q ss_pred HHHHHHHHHCCCCCCCCCCHHHHHCCCCCCCC
Q ss_conf 79999997159999999995555409666563
Q 003644 640 EAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTA 671 (805)
Q Consensus 640 ~~~dLi~~lL~~dP~~Rpt~~eiL~HPff~~~ 671 (805)
++.|||++||..||++|||++|+|+||||...
T Consensus 286 ~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~ 317 (355)
T d2b1pa1 286 QARDLLSKMLVIDPAKRISVDDALQHPYINVW 317 (355)
T ss_dssp HHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGG
T ss_pred HHHHHHHHHCCCCHHHCCCHHHHHCCCCCCCC
T ss_conf 99999999876994579089999669420878
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=341.83 Aligned_cols=260 Identities=24% Similarity=0.333 Sum_probs=196.0
Q ss_pred CEEEEEEEECCCCCEEEEEEEEE-CCC--EEEEEEEECCC----CHHHHHHHHHHHHHC-CCCCEEEECCCCCCCCEEEE
Q ss_conf 22999576454796399998753-795--99999930388----069999999999917-99975462353468751788
Q 003644 376 KLVVFNKEIAKGSNGTVVLEGNY-EGR--SVAVKRLVKTH----HDVALKEIQNLIASD-QHPNIVRWYGVESDQDFVYL 447 (805)
Q Consensus 376 ~~~~~~~~LG~GsfG~Vy~a~~~-~g~--~VAVK~l~~~~----~~~~~~Ei~~ll~~l-~HpNIV~l~g~~~~~~~~~L 447 (805)
+.|.+.+.||+|+||+||+|... +|. .||||++.... .+...+|+. ++..+ +|||||+++|+|.+++.+|+
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~-~l~~l~~HpnIv~~~~~~~~~~~~~i 88 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELE-VLCKLGHHPNIINLLGACEHRGYLYL 88 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHH-HHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred HHCEEEEEEEECCCCEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHH-HHHHCCCCCCEEEEEEEEECCCEEEE
T ss_conf 99688779820788289999998999699999999782338579999999999-99862289988367888841873699
Q ss_pred ECCCCCCCHHHHHHHHCCCHHHHHHHHHCCCHHHHHHHHHHCCCCCCHHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHH
Q ss_conf 30334688345899832887899766320440358887651344332134787751799999999999999998788564
Q 003644 448 SLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE 527 (805)
Q Consensus 448 V~E~c~~sL~d~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~ 527 (805)
|||+|. +|+|.++|+.......... ..........+++..++.++.||+.||.|||+
T Consensus 89 V~ey~~----------~g~L~~~l~~~~~~~~~~~-------------~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~ 145 (309)
T d1fvra_ 89 AIEYAP----------HGNLLDFLRKSRVLETDPA-------------FAIANSTASTLSSQQLLHFAADVARGMDYLSQ 145 (309)
T ss_dssp EECCCT----------TCBHHHHHHTTCHHHHCHH-------------HHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEECC----------CCCHHHHHHHCCCCCCCHH-------------HHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHC
T ss_conf 998028----------9869999864035555512-------------31012345789999999999999999876630
Q ss_pred CCEECCCCCCCEEEECCCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCHHHHHHHHHHHH
Q ss_conf 36130478882078668999228990268610025887654246446679898973553109999741488899999999
Q 003644 528 IGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFC 607 (805)
Q Consensus 528 ~~IvHrDLKp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDvwSlGvil~el 607 (805)
.+|+||||||+|||++.++. +||+|||+++...... ......||..|+|||.+....++.++|||||||++|||
T Consensus 146 ~~iiHrDlkp~NIL~~~~~~--~kl~DfG~a~~~~~~~----~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~el 219 (309)
T d1fvra_ 146 KQFIHRDLAARNILVGENYV--AKIADFGLSRGQEVYV----KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEI 219 (309)
T ss_dssp TTEECSCCSGGGEEECGGGC--EEECCTTCEESSCEEC----CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHH
T ss_pred CCCCCCCCCCCEEEECCCCC--EEECCCCCCCCCCCCC----CCCCEECCCCCCCHHHHCCCCCCCCCEEEHHHHHHHHH
T ss_conf 89545550520489868876--3874344322444223----45530137755553875269999622153138899999
Q ss_pred HHCCCCCCCCCHHHHH-HH-HHHCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHCC
Q ss_conf 9299999998657788-89-8411332123699579999997159999999995555409
Q 003644 608 ITGGKHPYGESFERDA-NI-VKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNH 665 (805)
Q Consensus 608 ltG~~~Pf~~~~~~~~-~~-~~~~~~~~~~~~~~~~~dLi~~lL~~dP~~Rpt~~eiL~H 665 (805)
++|+.+||........ .. ........+...++++.+||.+||+.||++|||++++++|
T Consensus 220 l~~~~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 279 (309)
T d1fvra_ 220 VSLGGTPYCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279 (309)
T ss_dssp HTTSCCTTTTCCHHHHHHHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHH
T ss_conf 836899999999999999998268888876678999999999767896689499999999
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=334.16 Aligned_cols=262 Identities=21% Similarity=0.308 Sum_probs=198.9
Q ss_pred CEEEEEEEECCCCCEEEEEEEEEC--------CCEEEEEEEECCCCH----HHHHHHHHHHHHCCCCCEEEECCCCCCCC
Q ss_conf 229995764547963999987537--------959999993038806----99999999999179997546235346875
Q 003644 376 KLVVFNKEIAKGSNGTVVLEGNYE--------GRSVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVRWYGVESDQD 443 (805)
Q Consensus 376 ~~~~~~~~LG~GsfG~Vy~a~~~~--------g~~VAVK~l~~~~~~----~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~ 443 (805)
+.|.+.+.||+|+||.||++.... +..||||++.+.... ...+|+..+....+|||||+++++|.+++
T Consensus 13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~ 92 (299)
T d1fgka_ 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 92 (299)
T ss_dssp GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHEEEEEEEEECCCCEEEEEEECCCCCCCCCCCEEEEEEEECCCCCHHHHHHHHHHHHHHHHHCCCCEEEECCCCCCCCC
T ss_conf 99697009851678289999985787555667549999998811286889999999999998139996973465220188
Q ss_pred EEEEECCCCC-CCHHHHHHHHCCCHHHHHHHHHCCCHHHHHHHHHHCCCCCCHHHHHHHHHCCCCHHHHHHHHHHHHHHH
Q ss_conf 1788303346-883458998328878997663204403588876513443321347877517999999999999999987
Q 003644 444 FVYLSLERCT-CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGL 522 (805)
Q Consensus 444 ~~~LV~E~c~-~sL~d~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL 522 (805)
..|+|||+|. ++|.+++.......... ...........+++..++.++.||+.||
T Consensus 93 ~~~~v~e~~~~g~l~~~i~~~~~~~~~~------------------------~~~~~~~~~~~l~~~~~~~~~~qi~~al 148 (299)
T d1fgka_ 93 PLYVIVEYASKGNLREYLQARRPPGLEY------------------------SYNPSHNPEEQLSSKDLVSCAYQVARGM 148 (299)
T ss_dssp SCEEEECCCTTCBHHHHHHTTSCC------------------------------------CCCCCHHHHHHHHHHHHHHH
T ss_pred EEEEEEECCCCCCHHHHHHHHCCCCCCC------------------------CCCCCCCCCCCCCHHHHHHHHHHHHHHH
T ss_conf 6899997369990999998606776432------------------------2233457434679999999999999999
Q ss_pred HHHHHCCEECCCCCCCEEEECCCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCHHHHHHH
Q ss_conf 88564361304788820786689992289902686100258876542464466798989735531099997414888999
Q 003644 523 SHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGC 602 (805)
Q Consensus 523 ~yLH~~~IvHrDLKp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDvwSlGv 602 (805)
+|||+.+|+||||||+|||++.++. +||+|||+++........ .......|++.|+|||.+.++.|+.++|||||||
T Consensus 149 ~ylH~~~ivHrDiKp~NiLl~~~~~--~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gv 225 (299)
T d1fgka_ 149 EYLASKKCIHRDLAARNVLVTEDNV--MKIADFGLARDIHHIDYY-KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGV 225 (299)
T ss_dssp HHHHHTTCCCSCCSGGGEEECTTCC--EEECSTTCCCCGGGCCTT-CCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHH
T ss_pred HHHHHCCEEEEEECCCCEEECCCCC--EEECCCHHHCCCCCCCCC-CCCCCCCCCHHHHHHHHHCCCCCCCHHHHHHHHH
T ss_conf 8766379786302210224547897--676221110113555554-3146678884663266751798882555477588
Q ss_pred HHHHHHHCCCCCCCCCHHHHH-HHH-HHCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHC
Q ss_conf 999999299999998657788-898-41133212369957999999715999999999555540
Q 003644 603 ILFFCITGGKHPYGESFERDA-NIV-KDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 664 (805)
Q Consensus 603 il~elltG~~~Pf~~~~~~~~-~~~-~~~~~~~~~~~~~~~~dLi~~lL~~dP~~Rpt~~eiL~ 664 (805)
++|||++++.+||........ ..+ .......+...++++.+||.+||+.||++|||+.|+++
T Consensus 226 vl~ell~~g~~p~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 289 (299)
T d1fgka_ 226 LLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289 (299)
T ss_dssp HHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHH
T ss_conf 8887401798989999999999999728888987435299999999976679767939999999
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=336.19 Aligned_cols=246 Identities=24% Similarity=0.363 Sum_probs=192.6
Q ss_pred CEEEEEEEECCCCCEEEEEEEEE----CCCEEEEEEEECCCCHH----HHHHHHHHHHHCCCCCEEEECCCCCCCCEEEE
Q ss_conf 22999576454796399998753----79599999930388069----99999999991799975462353468751788
Q 003644 376 KLVVFNKEIAKGSNGTVVLEGNY----EGRSVAVKRLVKTHHDV----ALKEIQNLIASDQHPNIVRWYGVESDQDFVYL 447 (805)
Q Consensus 376 ~~~~~~~~LG~GsfG~Vy~a~~~----~g~~VAVK~l~~~~~~~----~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~L 447 (805)
+.|.+.+.||+|+||+||+|... .+..||||.+.....+. ..+|+ .++..++|||||+++|++.+ +.+|+
T Consensus 7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~-~~l~~l~HpnIv~l~~~~~~-~~~~i 84 (273)
T d1mp8a_ 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEA-LTMRQFDHPHIVKLIGVITE-NPVWI 84 (273)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHH-HHHHTCCCTTBCCEEEEECS-SSCEE
T ss_pred HHEEEEEEEEECCCCEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHH-HHHHHCCCCCEEEEEEEEEC-CEEEE
T ss_conf 99698779930788299999993699644999999936566879999999999-99986899998569889953-74799
Q ss_pred ECCCCCCCHHHHHHHHCCCHHHHHHHHHCCCHHHHHHHHHHCCCCCCHHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHH
Q ss_conf 30334688345899832887899766320440358887651344332134787751799999999999999998788564
Q 003644 448 SLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE 527 (805)
Q Consensus 448 V~E~c~~sL~d~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~ 527 (805)
|||+|. +|++..++.. ....+++..++.++.||+.||+|||+
T Consensus 85 v~E~~~----------~g~l~~~~~~----------------------------~~~~l~~~~~~~~~~qi~~gl~ylH~ 126 (273)
T d1mp8a_ 85 IMELCT----------LGELRSFLQV----------------------------RKYSLDLASLILYAYQLSTALAYLES 126 (273)
T ss_dssp EEECCT----------TEEHHHHHHH----------------------------TTTTSCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEECC----------CCCHHHHHHC----------------------------CCCCCCHHHHHHHHHHHHHHHHHHCC
T ss_conf 998406----------9807765422----------------------------47899999999999999877523022
Q ss_pred CCEECCCCCCCEEEECCCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCHHHHHHHHHHHH
Q ss_conf 36130478882078668999228990268610025887654246446679898973553109999741488899999999
Q 003644 528 IGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFC 607 (805)
Q Consensus 528 ~~IvHrDLKp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDvwSlGvil~el 607 (805)
.+|+||||||+||+++.++. +||+|||+++....... .......||+.|+|||++....++.++|||||||++|||
T Consensus 127 ~~iiHrDlKp~NIll~~~~~--~Kl~DfG~a~~~~~~~~--~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~ 202 (273)
T d1mp8a_ 127 KRFVHRDIAARNVLVSSNDC--VKLGDFGLSRYMEDSTY--YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEI 202 (273)
T ss_dssp TTCCCSCCSGGGEEEEETTE--EEECC---------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHH
T ss_pred CCEECCCCCHHHEEECCCCC--EEECCCHHHEECCCCCC--EECCCEECCCCCCHHHHHCCCCCCCCCCCCCCHHHHHHH
T ss_conf 67441410265532067896--78765034213367762--330540058310326675169988745244424789999
Q ss_pred HHCCCCCCCCCHHHHH--HHHHHCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHCC
Q ss_conf 9299999998657788--898411332123699579999997159999999995555409
Q 003644 608 ITGGKHPYGESFERDA--NIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNH 665 (805)
Q Consensus 608 ltG~~~Pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~dLi~~lL~~dP~~Rpt~~eiL~H 665 (805)
++++.+||........ .+........+...++++.+||.+||+.||++|||++++++|
T Consensus 203 lt~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~ 262 (273)
T d1mp8a_ 203 LMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 262 (273)
T ss_dssp HTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHH
T ss_conf 826999988899999999998189998987779999999999768797689299999999
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=334.35 Aligned_cols=256 Identities=19% Similarity=0.280 Sum_probs=197.6
Q ss_pred CEEEEEEEECCCCCEEEEEEEEE------CCCEEEEEEEECCCCHH----HHHHHHHHHHHCCCCCEEEECCCCCCCCEE
Q ss_conf 22999576454796399998753------79599999930388069----999999999917999754623534687517
Q 003644 376 KLVVFNKEIAKGSNGTVVLEGNY------EGRSVAVKRLVKTHHDV----ALKEIQNLIASDQHPNIVRWYGVESDQDFV 445 (805)
Q Consensus 376 ~~~~~~~~LG~GsfG~Vy~a~~~------~g~~VAVK~l~~~~~~~----~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~ 445 (805)
+.|.+.+.||+|+||+||+|... ++..||||++....... ..+|+. ++..++|||||+++|+|...+..
T Consensus 20 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~-il~~l~h~nIv~~~~~~~~~~~~ 98 (308)
T d1p4oa_ 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS-VMKEFNCHHVVRLLGVVSQGQPT 98 (308)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHH-HGGGCCCTTBCCEEEEECSSSSC
T ss_pred HHEEEEEEEEECCCEEEEEEEECCCCCCCCCCEEEEEEECCCCCHHHHHHHHHHHH-HHHHCCCCCEEEEEEEEECCCCE
T ss_conf 99188359820788189999987864477896899999870128689999999999-99976999884125478428810
Q ss_pred EEECCCCCCCHHHHHHHHCCCHHHHHHHHHCCCHHHHHHHHHHCCCCCCHHHHHHHHHCCCCHHHHHHHHHHHHHHHHHH
Q ss_conf 88303346883458998328878997663204403588876513443321347877517999999999999999987885
Q 003644 446 YLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHL 525 (805)
Q Consensus 446 ~LV~E~c~~sL~d~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yL 525 (805)
++|||+| .+|++.++++....... .......+++..+..++.|++.||.||
T Consensus 99 ~lv~e~~----------~~g~l~~~~~~~~~~~~-------------------~~~~~~~~~~~~~~~i~~~ia~gl~~L 149 (308)
T d1p4oa_ 99 LVIMELM----------TRGDLKSYLRSLRPAMA-------------------NNPVLAPPSLSKMIQMAGEIADGMAYL 149 (308)
T ss_dssp EEEEECC----------TTCBHHHHHHHHHHHHH-------------------HCTTCCCCCHHHHHHHHHHHHHHHHHH
T ss_pred EEEEEEC----------CCCCHHHHHHHCCCCCC-------------------CCCCCCCCCHHHHHHHHHHHHHHHHHH
T ss_conf 6777604----------89988999875033211-------------------344468879999999999999999987
Q ss_pred HHCCEECCCCCCCEEEECCCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCHHHHHHHHHH
Q ss_conf 64361304788820786689992289902686100258876542464466798989735531099997414888999999
Q 003644 526 HEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILF 605 (805)
Q Consensus 526 H~~~IvHrDLKp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDvwSlGvil~ 605 (805)
|+.+|+||||||+|||++.++. +||+|||+++........ .......||+.|+|||.+.+..++.++|||||||++|
T Consensus 150 H~~~ivHrDlk~~NiLld~~~~--~Kl~DFGla~~~~~~~~~-~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~ 226 (308)
T d1p4oa_ 150 NANKFVHRDLAARNCMVAEDFT--VKIGDFGMTRDIYETDYY-RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLW 226 (308)
T ss_dssp HHTTCBCSCCSGGGEEECTTCC--EEECCTTCCCGGGGGGCE-EGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHH
T ss_pred HHCCEEECEECCCCEEECCCCE--EEEEECCCCEECCCCCCE-EECCCEECCCCCCCHHHHCCCCCCCCCCCCCHHHHHH
T ss_conf 6479654328677540359964--999424542023577630-3134023163237888873699883334443789999
Q ss_pred HHHHCCCCCCCCCHHHHH--HHHHHCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHC
Q ss_conf 999299999998657788--89841133212369957999999715999999999555540
Q 003644 606 FCITGGKHPYGESFERDA--NIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 664 (805)
Q Consensus 606 elltG~~~Pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~dLi~~lL~~dP~~Rpt~~eiL~ 664 (805)
||+||+.+||........ .+........+...++.+.+++.+||+.||.+|||++++++
T Consensus 227 El~t~~~~p~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~ 287 (308)
T d1p4oa_ 227 EIATLAEQPYQGLSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 287 (308)
T ss_dssp HHHHTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHH
T ss_conf 9996899999998999999999808888886335399999999975779658939999999
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=0 Score=335.91 Aligned_cols=253 Identities=23% Similarity=0.335 Sum_probs=195.0
Q ss_pred CCCCEEEEEEEECCCCCEEEEEEEE-ECCCEEEEEEEECCCC------HHHHHHHHHHHHHCCCCCEEEECCCCCCCC--
Q ss_conf 2252299957645479639999875-3795999999303880------699999999999179997546235346875--
Q 003644 373 RIGKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH------DVALKEIQNLIASDQHPNIVRWYGVESDQD-- 443 (805)
Q Consensus 373 ~i~~~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~~------~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~-- 443 (805)
.+.++|.+.+.||+|+||+||++.. .+|+.||||++.+... ....+|+. ++..++|||||++++++.+.+
T Consensus 4 ~l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~-~l~~~~hpniv~~~~~~~~~~~~ 82 (277)
T d1o6ya_ 4 HLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQ-NAAALNHPAIVAVYDTGEAETPA 82 (277)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHH-HHHTCCCTTBCCEEEEEEEECSS
T ss_pred CCCCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHH-HHHHCCCCCCCCCCCEEEECCCC
T ss_conf 70620698689960899299999999999899999985566469899999999999-99856999887311435432688
Q ss_pred --EEEEECCCCCCCHHHHHHHHCCCHHHHHHHHHCCCHHHHHHHHHHCCCCCCHHHHHHHHHCCCCHHHHHHHHHHHHHH
Q ss_conf --178830334688345899832887899766320440358887651344332134787751799999999999999998
Q 003644 444 --FVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSG 521 (805)
Q Consensus 444 --~~~LV~E~c~~sL~d~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~g 521 (805)
..|+|||+|. +|+|..++ .....+++.+++.++.||+.|
T Consensus 83 ~~~~~lvmE~~~----------g~~L~~~~-----------------------------~~~~~l~~~~~~~i~~qi~~a 123 (277)
T d1o6ya_ 83 GPLPYIVMEYVD----------GVTLRDIV-----------------------------HTEGPMTPKRAIEVIADACQA 123 (277)
T ss_dssp SEEEEEEEECCC----------EEEHHHHH-----------------------------HHHCSCCHHHHHHHHHHHHHH
T ss_pred CCEEEEEEECCC----------CCEEHHHH-----------------------------CCCCCCCHHHHHHHHHHHHHH
T ss_conf 766999997788----------98710112-----------------------------035899999999999999999
Q ss_pred HHHHHHCCEECCCCCCCEEEECCCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCHHHHHH
Q ss_conf 78856436130478882078668999228990268610025887654246446679898973553109999741488899
Q 003644 522 LSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLG 601 (805)
Q Consensus 522 L~yLH~~~IvHrDLKp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDvwSlG 601 (805)
|+|||+.+|+||||||+|||++.++. .+++|||.+................+||+.|+|||++.+..++.++||||+|
T Consensus 124 l~~lH~~~iiHrDiKP~NIll~~~~~--~~l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlG 201 (277)
T d1o6ya_ 124 LNFSHQNGIIHRDVKPANIMISATNA--VKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLG 201 (277)
T ss_dssp HHHHHHTTEECCCCSGGGEEEETTSC--EEECCCTTCEECC----------------TTCCHHHHTTCCCCHHHHHHHHH
T ss_pred HHHHHHCCCCCCCCCCCCCCCCCCCC--CEEEHHHHHHHHCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCEECCCCH
T ss_conf 99998579527634675566575432--0100344432212354433334642576243699998399999663202652
Q ss_pred HHHHHHHHCCCCCCCCCHHHHH--HHHHHCCC---CCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHCCCCC
Q ss_conf 9999999299999998657788--89841133---2123699579999997159999999995555409666
Q 003644 602 CILFFCITGGKHPYGESFERDA--NIVKDRKD---LFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 668 (805)
Q Consensus 602 vil~elltG~~~Pf~~~~~~~~--~~~~~~~~---~~~~~~~~~~~dLi~~lL~~dP~~Rpt~~eiL~HPff 668 (805)
|++|||+|| .+||........ .++..... ......++++.++|.+||+.||.+||+..+.+.|+|.
T Consensus 202 vilyelltG-~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~ 272 (277)
T d1o6ya_ 202 CVLYEVLTG-EPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLV 272 (277)
T ss_dssp HHHHHHHHS-SCSCCCSSHHHHHHHHHHCCCCCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred HHHHHHHHC-CCCCCCCCHHHHHHHHHHCCCCCCCHHCCCCCHHHHHHHHHHCCCCHHHCHHHHHHHHHHHH
T ss_conf 899999769-79989969999999998469999710034789999999999866797677739999999999
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=332.25 Aligned_cols=248 Identities=20% Similarity=0.311 Sum_probs=190.5
Q ss_pred EEEEEEEECCCCCEEEEEEEEEC----CCEEEEEEEECCCCH----HHHHHHHHHHHHCCCCCEEEECCCCCC-CCEEEE
Q ss_conf 29995764547963999987537----959999993038806----999999999991799975462353468-751788
Q 003644 377 LVVFNKEIAKGSNGTVVLEGNYE----GRSVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVRWYGVESD-QDFVYL 447 (805)
Q Consensus 377 ~~~~~~~LG~GsfG~Vy~a~~~~----g~~VAVK~l~~~~~~----~~~~Ei~~ll~~l~HpNIV~l~g~~~~-~~~~~L 447 (805)
.+.+.+.||+|+||+||+|...+ ...||||++.+.... ...+|+ .++..++|||||+++|+|.+ ++..++
T Consensus 28 ~~~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~-~~l~~l~HpnIv~~~g~~~~~~~~~~l 106 (311)
T d1r0pa_ 28 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEG-IIMKDFSHPNVLSLLGICLRSEGSPLV 106 (311)
T ss_dssp EEEEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHH-HHHHTCCCTTBCCCCEEEEETTTEEEE
T ss_pred EECCCEEEEECCCEEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHH-HHHHHCCCCCEEEEEEEEEECCCCEEE
T ss_conf 5526669813688099999997799879999999988436978999999999-999867899986786789806994389
Q ss_pred ECCCCCCCHHHHHHHHCCCHHHHHHHHHCCCHHHHHHHHHHCCCCCCHHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHH
Q ss_conf 30334688345899832887899766320440358887651344332134787751799999999999999998788564
Q 003644 448 SLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE 527 (805)
Q Consensus 448 V~E~c~~sL~d~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~ 527 (805)
|||+|. +|++.++++.. ...+++..++.++.|++.||.|||+
T Consensus 107 v~E~~~----------~g~l~~~~~~~----------------------------~~~~~~~~~~~i~~qia~gL~~lH~ 148 (311)
T d1r0pa_ 107 VLPYMK----------HGDLRNFIRNE----------------------------THNPTVKDLIGFGLQVAKGMKFLAS 148 (311)
T ss_dssp EEECCT----------TCBHHHHHHCT----------------------------TCCCBHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEEEE----------CCCHHHHHCCC----------------------------CCCCHHHHHHHHHHHHHHHHHHHCC
T ss_conf 998740----------67414421013----------------------------4540489999999998876520033
Q ss_pred CCEECCCCCCCEEEECCCCCCEEEEECCCCCCCCCCCCCCC-CCCCCCCCCCCCCCHHHHHCCCCCCCCHHHHHHHHHHH
Q ss_conf 36130478882078668999228990268610025887654-24644667989897355310999974148889999999
Q 003644 528 IGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCL-TQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFF 606 (805)
Q Consensus 528 ~~IvHrDLKp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~t~~sDvwSlGvil~e 606 (805)
.+|+||||||+|||++.++. +||+|||+++......... .......||+.|+|||.+....++.++||||||+++||
T Consensus 149 ~~iiHrDLK~~NILl~~~~~--~kL~DFG~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~E 226 (311)
T d1r0pa_ 149 KKFVHRDLAARNCMLDEKFT--VKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWE 226 (311)
T ss_dssp TTCCCSCCSGGGEEECTTCC--EEECSSGGGCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHH
T ss_pred CCCCCCCCCHHHEEECCCCC--EEEECCCCHHHCCCCCCCCCEECCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHH
T ss_conf 67625776687576779998--8991065232255665553100256555645567688743799974574661999999
Q ss_pred HHHCCCCCCCCCHHHH--HHHHHHCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHCC
Q ss_conf 9929999999865778--8898411332123699579999997159999999995555409
Q 003644 607 CITGGKHPYGESFERD--ANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNH 665 (805)
Q Consensus 607 lltG~~~Pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~dLi~~lL~~dP~~Rpt~~eiL~H 665 (805)
|++|+.+|+......+ ..+........+...++++.+|+.+||+.||++||++.|+++|
T Consensus 227 l~t~~~p~~~~~~~~~~~~~i~~g~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~ 287 (311)
T d1r0pa_ 227 LMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 287 (311)
T ss_dssp HHTTSCCSCC------CHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHH
T ss_conf 9978999988899999999998089889964475999999999768897689399999999
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=330.60 Aligned_cols=254 Identities=26% Similarity=0.356 Sum_probs=195.1
Q ss_pred CEEEEEEEECCCCCEEEEEEEE----ECCCEEEEEEEECC-------CCHHHHHHHHHHHHHCCCCCEEEECCCCCCCCE
Q ss_conf 2299957645479639999875----37959999993038-------806999999999991799975462353468751
Q 003644 376 KLVVFNKEIAKGSNGTVVLEGN----YEGRSVAVKRLVKT-------HHDVALKEIQNLIASDQHPNIVRWYGVESDQDF 444 (805)
Q Consensus 376 ~~~~~~~~LG~GsfG~Vy~a~~----~~g~~VAVK~l~~~-------~~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~ 444 (805)
++|.+.+.||+|+||+||++.. .+|+.||||++.+. ..+...+|+..+....+||||+++++++.+.+.
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred HCEEEEEEEECCCCEEEEEEEECCCCCCCCEEEEEEEEHHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCC
T ss_conf 02599989832878399999987658879489999983677210168999999999999864679839996200024873
Q ss_pred EEEECCCCCCCHHHHHHHHCCCHHHHHHHHHCCCHHHHHHHHHHCCCCCCHHHHHHHHHCCCCHHHHHHHHHHHHHHHHH
Q ss_conf 78830334688345899832887899766320440358887651344332134787751799999999999999998788
Q 003644 445 VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSH 524 (805)
Q Consensus 445 ~~LV~E~c~~sL~d~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~y 524 (805)
.|+++|+|. +|+|.+++. ....+++..+..++.|++.||+|
T Consensus 104 ~~~v~e~~~----------~~~L~~~i~-----------------------------~~~~~~e~~~~~~~~Qi~~al~~ 144 (322)
T d1vzoa_ 104 LHLILDYIN----------GGELFTHLS-----------------------------QRERFTEHEVQIYVGEIVLALEH 144 (322)
T ss_dssp EEEEECCCC----------SCBHHHHHH-----------------------------HHSCCCHHHHHHHHHHHHHHHHH
T ss_pred EEEEEECCC----------CCHHHHHHH-----------------------------HCCCCCHHHHHHHHHHHHHHHHH
T ss_conf 001231234----------117999987-----------------------------30454378888889999999988
Q ss_pred HHHCCEECCCCCCCEEEECCCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHCC--CCCCCCHHHHHHH
Q ss_conf 56436130478882078668999228990268610025887654246446679898973553109--9997414888999
Q 003644 525 LHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG--RQTRAIDLFSLGC 602 (805)
Q Consensus 525 LH~~~IvHrDLKp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~--~~t~~sDvwSlGv 602 (805)
||+.+|+||||||+|||++.++. +||+|||+++....... .......|++.|+|||.+... .++.++||||+||
T Consensus 145 lH~~~ivHrDiKp~Nill~~~~~--vkL~DFG~a~~~~~~~~--~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~ 220 (322)
T d1vzoa_ 145 LHKLGIIYRDIKLENILLDSNGH--VVLTDFGLSKEFVADET--ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGV 220 (322)
T ss_dssp HHHTTCCCCCCCGGGEEECTTSC--EEESCSSEEEECCGGGG--GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHH
T ss_pred HHCCCEEECCCCCCCEEECCCCC--EEEEECCCHHHHCCCCC--CCCCCCCCCCCCCHHHHHHCCCCCCCCHHHHHHHHH
T ss_conf 51499896547732012469998--88741320222034444--322122233333106876057768871325177779
Q ss_pred HHHHHHHCCCCCCCCCHHH-----HHHHHHHCCCCCCCCCCHHHHHHHHHHCCCCCCCCC-----CHHHHHCCCCCCCCC
Q ss_conf 9999992999999986577-----888984113321236995799999971599999999-----955554096665631
Q 003644 603 ILFFCITGGKHPYGESFER-----DANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRP-----KAQNVLNHPFFWTAD 672 (805)
Q Consensus 603 il~elltG~~~Pf~~~~~~-----~~~~~~~~~~~~~~~~~~~~~dLi~~lL~~dP~~Rp-----t~~eiL~HPff~~~~ 672 (805)
++|+|++| .+||...... ............+...++++.+|+.+||++||.+|| +++|+++||||...+
T Consensus 221 iLyelltG-~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~ 299 (322)
T d1vzoa_ 221 LMYELLTG-ASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKIN 299 (322)
T ss_dssp HHHHHHHS-SCTTSCTTSCCCHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCC
T ss_pred HHHHHHHC-CCCCCCCCHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCCCCCCHHHHHCCHHHCCCC
T ss_conf 99999768-99988887777999999833568998865479999999999744589881999745099997497234899
Q ss_pred C
Q ss_conf 0
Q 003644 673 T 673 (805)
Q Consensus 673 ~ 673 (805)
+
T Consensus 300 ~ 300 (322)
T d1vzoa_ 300 W 300 (322)
T ss_dssp H
T ss_pred H
T ss_conf 8
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=330.69 Aligned_cols=265 Identities=23% Similarity=0.302 Sum_probs=197.6
Q ss_pred CEEEEEEEECCCCCEEEEEEEE------ECCCEEEEEEEECCCCH----HHHHHHHHHHHHCCCCCEEEECCCCCCCCEE
Q ss_conf 2299957645479639999875------37959999993038806----9999999999917999754623534687517
Q 003644 376 KLVVFNKEIAKGSNGTVVLEGN------YEGRSVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVRWYGVESDQDFV 445 (805)
Q Consensus 376 ~~~~~~~~LG~GsfG~Vy~a~~------~~g~~VAVK~l~~~~~~----~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~ 445 (805)
+.|.+.+.||+|+||.||+|.. .+++.||||++...... ...+|+..+....+|||||+++|+|.+.+..
T Consensus 23 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~ 102 (311)
T d1t46a_ 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPT 102 (311)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHEEEEEEEEECCCEEEEEEEEECCCCCCCCEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEECCEE
T ss_conf 99698549820688299999980664477886999999874248779999999999987626999887899898319978
Q ss_pred EEECCCCCCCHHHHHHHHCCCHHHHHHHHHCCCHHHHHHHHHHCCCCCCHHHHHHHHHCCCCHHHHHHHHHHHHHHHHHH
Q ss_conf 88303346883458998328878997663204403588876513443321347877517999999999999999987885
Q 003644 446 YLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHL 525 (805)
Q Consensus 446 ~LV~E~c~~sL~d~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yL 525 (805)
|+|||+|. +|++.++++.......... ............+++..++.++.||+.||+||
T Consensus 103 ~lvmE~~~----------~g~l~~~l~~~~~~~~~~~-----------~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~L 161 (311)
T d1t46a_ 103 LVITEYCC----------YGDLLNFLRRKRDSFICSK-----------TSPAIMEDDELALDLEDLLSFSYQVAKGMAFL 161 (311)
T ss_dssp EEEEECCT----------TEEHHHHHHHTTTTC-------------------------CCCCHHHHHHHHHHHHHHHHHH
T ss_pred EEEEECCC----------CCCHHHHHHHCCCCCCCCC-----------CCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHH
T ss_conf 99997379----------9879999985356654444-----------45332223345889999999999999999988
Q ss_pred HHCCEECCCCCCCEEEECCCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCHHHHHHHHHH
Q ss_conf 64361304788820786689992289902686100258876542464466798989735531099997414888999999
Q 003644 526 HEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILF 605 (805)
Q Consensus 526 H~~~IvHrDLKp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDvwSlGvil~ 605 (805)
|+++++||||||+|||++.++. +|++|||+++........ .......||+.|+|||++....++.++|||||||++|
T Consensus 162 H~~~ivHrDLKp~NIl~~~~~~--~ki~DfG~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ 238 (311)
T d1t46a_ 162 ASKNCIHRDLAARNILLTHGRI--TKICDFGLARDIKNDSNY-VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLW 238 (311)
T ss_dssp HHTTCCCSCCSGGGEEEETTTE--EEECCCGGGSCTTSCTTS-EECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHH
T ss_pred HHCCEEECCCCCCCCCCCCCCC--CCCCCCCHHEECCCCCCC-EEEEECCCCHHHCCHHHHCCCCCCCCCCCCCHHHHHH
T ss_conf 7579266624102100002575--210234010233678861-5862013596876778861799997400102589999
Q ss_pred HHHHCCCCCCCCCHHH--HHHHHHH-CCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHC
Q ss_conf 9992999999986577--8889841-133212369957999999715999999999555540
Q 003644 606 FCITGGKHPYGESFER--DANIVKD-RKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 664 (805)
Q Consensus 606 elltG~~~Pf~~~~~~--~~~~~~~-~~~~~~~~~~~~~~dLi~~lL~~dP~~Rpt~~eiL~ 664 (805)
||+|++.+|+...... ...++.. .....+...++++.+||.+||+.||++|||++++++
T Consensus 239 ellt~g~p~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~ 300 (311)
T d1t46a_ 239 ELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (311)
T ss_dssp HHHTTTCCSSTTCCSSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHH
T ss_conf 99858998877899899999998668988985436599999999975779657929999999
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=328.46 Aligned_cols=250 Identities=25% Similarity=0.343 Sum_probs=192.7
Q ss_pred CEEEEEEEECCCCCEEEEEEEE-ECCCEEEEEEEECCCC-----HHHHHHHHHHHHHCCCCCEEEECCCCCCCCEEEEEC
Q ss_conf 2299957645479639999875-3795999999303880-----699999999999179997546235346875178830
Q 003644 376 KLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH-----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSL 449 (805)
Q Consensus 376 ~~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~~-----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~ 449 (805)
++|...+.||+|+||+||++.. .+++.||||+++.... ....+|+. ++..++||||+++++++.+.+..++++
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~-il~~l~h~niv~~~~~~~~~~~~~iv~ 80 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREIC-LLKELKHKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHH-HHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHH-HHHHCCCCCEEEECCCCCCCCCEEEEE
T ss_conf 9978626971286819999999999969999998032178689999999999-998567578882135444443115886
Q ss_pred CCCCCCHHHHHHHHCCCHHHHHHHHHCCCHHHHHHHHHHCCCCCCHHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHCC
Q ss_conf 33468834589983288789976632044035888765134433213478775179999999999999999878856436
Q 003644 450 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG 529 (805)
Q Consensus 450 E~c~~sL~d~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~ 529 (805)
|+|.+.....+.. ..+.+++..+..++.|++.||+|||+.+
T Consensus 81 ~~~~~~~l~~~~~---------------------------------------~~~~~~~~~~~~~~~q~~~aL~~lH~~~ 121 (292)
T d1unla_ 81 EFCDQDLKKYFDS---------------------------------------CNGDLDPEIVKSFLFQLLKGLGFCHSRN 121 (292)
T ss_dssp ECCSEEHHHHHHH---------------------------------------TTTCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred EECCCCCCCCCCC---------------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHCCC
T ss_conf 3023322211212---------------------------------------3565403678999999999987743399
Q ss_pred EECCCCCCCEEEECCCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHCCC-CCCCCHHHHHHHHHHHHH
Q ss_conf 1304788820786689992289902686100258876542464466798989735531099-997414888999999999
Q 003644 530 LIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGR-QTRAIDLFSLGCILFFCI 608 (805)
Q Consensus 530 IvHrDLKp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~-~t~~sDvwSlGvil~ell 608 (805)
|+||||||+|||++.++. +||+|||.++....... ......++..|+|||++.... ++.++||||+||++|||+
T Consensus 122 IvHrDiKP~NIli~~~~~--~kl~DFG~a~~~~~~~~---~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell 196 (292)
T d1unla_ 122 VLHRDLKPQNLLINRNGE--LKLANFGLARAFGIPVR---CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELA 196 (292)
T ss_dssp EECCCCSGGGEEECTTCC--EEECCCTTCEECCSCCS---CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHT
T ss_pred EEEECCCCCCCCCCCCCC--EEEEECCHHHCCCCCCC---CCEEECCCCCHHHHHHHCCCCCCCCHHHCCCCCHHHHHHH
T ss_conf 860014676121133782--66520460110468875---1001034431014667506988880444026541889985
Q ss_pred HCCCCCCCCCHHHHH-HHHHH-C----------------------------CCCCCCCCCHHHHHHHHHHCCCCCCCCCC
Q ss_conf 299999998657788-89841-1----------------------------33212369957999999715999999999
Q 003644 609 TGGKHPYGESFERDA-NIVKD-R----------------------------KDLFLVEHIPEAVDLFTRLLDPNPDLRPK 658 (805)
Q Consensus 609 tG~~~Pf~~~~~~~~-~~~~~-~----------------------------~~~~~~~~~~~~~dLi~~lL~~dP~~Rpt 658 (805)
+|+.|+|......+. ..+.. . ........++++.+|+.+||+.||.+|||
T Consensus 197 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~s 276 (292)
T d1unla_ 197 NAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRIS 276 (292)
T ss_dssp TTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCC
T ss_pred HCCCCCCCCCCHHHHHHHHHHHCCCCCHHHHHHHHHCCCCCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCC
T ss_conf 18999988999999999998611899735513443222113344454431043306568999999999986499668909
Q ss_pred HHHHHCCCCCCC
Q ss_conf 555540966656
Q 003644 659 AQNVLNHPFFWT 670 (805)
Q Consensus 659 ~~eiL~HPff~~ 670 (805)
++|+|+||||.+
T Consensus 277 a~e~L~Hp~f~~ 288 (292)
T d1unla_ 277 AEEALQHPYFSD 288 (292)
T ss_dssp HHHHTTSGGGSS
T ss_pred HHHHHCCHHHCC
T ss_conf 999964953407
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=330.26 Aligned_cols=247 Identities=24% Similarity=0.386 Sum_probs=188.4
Q ss_pred CCCEEEEEEEECCCCCEEEEEEE-EECCCEEEEEEEECCCC-----HHHHHHHHHHHHHCCCCCEEEECCCCCCC-----
Q ss_conf 25229995764547963999987-53795999999303880-----69999999999917999754623534687-----
Q 003644 374 IGKLVVFNKEIAKGSNGTVVLEG-NYEGRSVAVKRLVKTHH-----DVALKEIQNLIASDQHPNIVRWYGVESDQ----- 442 (805)
Q Consensus 374 i~~~~~~~~~LG~GsfG~Vy~a~-~~~g~~VAVK~l~~~~~-----~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~----- 442 (805)
+.++|...+.||+|+||+||+|. ..+|+.||||++.+... ....+|+. ++..++|||||++++++...
T Consensus 16 ~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~-il~~l~h~~iv~~~~~~~~~~~~~~ 94 (348)
T d2gfsa1 16 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR-LLKHMKHENVIGLLDVFTPARSLEE 94 (348)
T ss_dssp EETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHH-HHHHCCCTTBCCCSEEECSCSSTTT
T ss_pred CCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCHHCCHHHHHHHHHHHH-HHHHCCCCCEEEEEEEEEECCCCCC
T ss_conf 898718888983178839999999999979999998820028689999999999-9986689874259999963464566
Q ss_pred -CEEEEECCCCCCCHHHHHHHHCCCHHHHHHHHHCCCHHHHHHHHHHCCCCCCHHHHHHHHHCCCCHHHHHHHHHHHHHH
Q ss_conf -5178830334688345899832887899766320440358887651344332134787751799999999999999998
Q 003644 443 -DFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSG 521 (805)
Q Consensus 443 -~~~~LV~E~c~~sL~d~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~g 521 (805)
...|++++++.++|.+++. .+++++..++.++.||+.|
T Consensus 95 ~~~~~i~~~~~gg~L~~~~~-----------------------------------------~~~l~e~~~~~i~~qil~a 133 (348)
T d2gfsa1 95 FNDVYLVTHLMGADLNNIVK-----------------------------------------CQKLTDDHVQFLIYQILRG 133 (348)
T ss_dssp CCCCEEEEECCSEEHHHHHT-----------------------------------------TCCCCHHHHHHHHHHHHHH
T ss_pred CCEEEEEEEECCCCHHHHCC-----------------------------------------CCCCCHHHHHHHHHHHHHH
T ss_conf 86499999625886232002-----------------------------------------2453099999999999999
Q ss_pred HHHHHHCCEECCCCCCCEEEECCCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHCCC-CCCCCHHHHH
Q ss_conf 788564361304788820786689992289902686100258876542464466798989735531099-9974148889
Q 003644 522 LSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGR-QTRAIDLFSL 600 (805)
Q Consensus 522 L~yLH~~~IvHrDLKp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~-~t~~sDvwSl 600 (805)
|+|||+.+|+||||||+|||++.++. +|++|||++..... ......|++.|+|||+..+.. ++.++||||+
T Consensus 134 L~~LH~~giiHrDiKp~NILi~~~~~--~kl~dfg~a~~~~~------~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSl 205 (348)
T d2gfsa1 134 LKYIHSADIIHRDLKPSNLAVNEDCE--LKILDFGLARHTDD------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSV 205 (348)
T ss_dssp HHHHHHTTCCCCCCCGGGEEECTTCC--EEECCC----CCTG------GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHH
T ss_pred HHHHHHCCCCCCCCCCCCCCCCCCCC--CCCCCCCHHCCCCC------CCCCCCCCCCCCCCHHHCCCCCCCCCCCHHHH
T ss_conf 99997388765166776334554322--00132100012575------44443454355583553377567855124320
Q ss_pred HHHHHHHHHCCCCCCCCCHHHHH-H-HHHHCCC------------------------------CCCCCCCHHHHHHHHHH
Q ss_conf 99999999299999998657788-8-9841133------------------------------21236995799999971
Q 003644 601 GCILFFCITGGKHPYGESFERDA-N-IVKDRKD------------------------------LFLVEHIPEAVDLFTRL 648 (805)
Q Consensus 601 Gvil~elltG~~~Pf~~~~~~~~-~-~~~~~~~------------------------------~~~~~~~~~~~dLi~~l 648 (805)
||++|+|++| .+||........ . +...... ......++++.|||.+|
T Consensus 206 Gv~l~~ll~g-~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~m 284 (348)
T d2gfsa1 206 GCIMAELLTG-RTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKM 284 (348)
T ss_dssp HHHHHHHHHS-SCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHH
T ss_pred HHHHHHHHHC-CCCCCCCCHHHHHHHHHHHCCCCCHHHHHHCCCHHHHHHHHHCCCCCCCCHHHHCCCCCHHHHHHHHHH
T ss_conf 5899999768-899788988999999997307997577320010244544430355787555662678999999999997
Q ss_pred CCCCCCCCCCHHHHHCCCCCCCC
Q ss_conf 59999999995555409666563
Q 003644 649 LDPNPDLRPKAQNVLNHPFFWTA 671 (805)
Q Consensus 649 L~~dP~~Rpt~~eiL~HPff~~~ 671 (805)
|+.||.+|||++|+|+||||...
T Consensus 285 L~~dP~~R~ta~elL~Hp~f~~~ 307 (348)
T d2gfsa1 285 LVLDSDKRITAAQALAHAYFAQY 307 (348)
T ss_dssp SCSSGGGSCCHHHHHTSGGGTTT
T ss_pred CCCCHHHCCCHHHHHCCHHHCCC
T ss_conf 75883459389998559954879
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=330.50 Aligned_cols=247 Identities=23% Similarity=0.292 Sum_probs=190.8
Q ss_pred CEEEEEEEECCCCCEEEEEEEEEC--C--CEEEEEEEECCC------CHHHHHHHHHHHHHCCCCCEEEECCCCCCCCEE
Q ss_conf 229995764547963999987537--9--599999930388------069999999999917999754623534687517
Q 003644 376 KLVVFNKEIAKGSNGTVVLEGNYE--G--RSVAVKRLVKTH------HDVALKEIQNLIASDQHPNIVRWYGVESDQDFV 445 (805)
Q Consensus 376 ~~~~~~~~LG~GsfG~Vy~a~~~~--g--~~VAVK~l~~~~------~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~ 445 (805)
++|.+.+.||+|+||+||+|.... + ..||||++.+.. .+...+|+ .++..++|||||+++|++.+ +..
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei-~~l~~l~H~nIv~~~g~~~~-~~~ 85 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREV-NAMHSLDHRNLIRLYGVVLT-PPM 85 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHH-HHHHHCCCTTBCCEEEEECS-SSC
T ss_pred HHEEEEEEEECCCCEEEEEEEEECCCCCEEEEEEEEECHHHCCCHHHHHHHHHHH-HHHHHCCCCCEEEEEEEEEE-CCH
T ss_conf 8919978980388839999999889990799999999835557989999999999-99986899998789877740-100
Q ss_pred EEECCCCCCCHHHHHHHHCCCHHHHHHHHHCCCHHHHHHHHHHCCCCCCHHHHHHHHHCCCCHHHHHHHHHHHHHHHHHH
Q ss_conf 88303346883458998328878997663204403588876513443321347877517999999999999999987885
Q 003644 446 YLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHL 525 (805)
Q Consensus 446 ~LV~E~c~~sL~d~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yL 525 (805)
++|+|+|. +|++.+.+.. ....+++..++.++.|++.||.||
T Consensus 86 ~lv~e~~~----------~~~l~~~~~~----------------------------~~~~l~~~~~~~~~~qi~~gl~yl 127 (273)
T d1u46a_ 86 KMVTELAP----------LGSLLDRLRK----------------------------HQGHFLLGTLSRYAVQVAEGMGYL 127 (273)
T ss_dssp EEEEECCT----------TCBHHHHHHH----------------------------HGGGSCHHHHHHHHHHHHHHHHHH
T ss_pred HEEEEEEC----------CCCHHHHHHC----------------------------CCCCCCHHHHHHHHHHHHHHHHHH
T ss_conf 11465423----------8612544421----------------------------268999999999999999999875
Q ss_pred HHCCEECCCCCCCEEEECCCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCHHHHHHHHHH
Q ss_conf 64361304788820786689992289902686100258876542464466798989735531099997414888999999
Q 003644 526 HEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILF 605 (805)
Q Consensus 526 H~~~IvHrDLKp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~~sDvwSlGvil~ 605 (805)
|+.+|+||||||+|||++.++ .+||+|||+++................|+..|+|||++.+..++.++|||||||++|
T Consensus 128 H~~~iiHrDikp~NIll~~~~--~vkl~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~ 205 (273)
T d1u46a_ 128 ESKRFIHRDLAARNLLLATRD--LVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLW 205 (273)
T ss_dssp HHTTEECSCCCGGGEEEEETT--EEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHH
T ss_pred HHCCEEEEEECHHHHCCCCCC--CEEECCCHHHHHCCCCCCCCEECCCCCCCCCCCCHHHHHCCCCCCCHHHHHHHHHHH
T ss_conf 217875205668881565565--433256115553035887526547632573107999983799994215661489999
Q ss_pred HHHHCCCCCCCCCHHHHH-H-HHHHC-CCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHC
Q ss_conf 999299999998657788-8-98411-33212369957999999715999999999555540
Q 003644 606 FCITGGKHPYGESFERDA-N-IVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 664 (805)
Q Consensus 606 elltG~~~Pf~~~~~~~~-~-~~~~~-~~~~~~~~~~~~~dLi~~lL~~dP~~Rpt~~eiL~ 664 (805)
||+|+|.+||........ . +.... ....+...++++.+|+.+||+.||++|||++++++
T Consensus 206 emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~ 267 (273)
T d1u46a_ 206 EMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD 267 (273)
T ss_dssp HHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHH
T ss_conf 99968999999969999999998479999985445399999999976889667929999999
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=326.72 Aligned_cols=248 Identities=21% Similarity=0.318 Sum_probs=182.7
Q ss_pred CCCEEEEEEEECCCCCEEEEEEEEECCCEEEEEEEECCCCHHHHHHHHHH-HHHCCCCCEEEECCCCCCCC----EEEEE
Q ss_conf 25229995764547963999987537959999993038806999999999-99179997546235346875----17883
Q 003644 374 IGKLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQNL-IASDQHPNIVRWYGVESDQD----FVYLS 448 (805)
Q Consensus 374 i~~~~~~~~~LG~GsfG~Vy~a~~~~g~~VAVK~l~~~~~~~~~~Ei~~l-l~~l~HpNIV~l~g~~~~~~----~~~LV 448 (805)
|.+.|.+.+.||+|+||+||++. .+|+.||||++.........+|.+.+ +..++|||||+++|+|.+.+ .+|+|
T Consensus 1 ~~~~~~l~~~iG~G~fg~Vy~~~-~~g~~vAvK~~~~~~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv 79 (303)
T d1vjya_ 1 IARTIVLQESIGKGRFGEVWRGK-WRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp CGGGEEEEEEEECCSSSEEEEEE-ETTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred CCCEEEEEEEEEECCCEEEEEEE-ECCEEEEEEEECCCCHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCEEEEEE
T ss_conf 98689998898207881999999-99989999998720046799999999996279986832688998379860489999
Q ss_pred CCCCCCCHHHHHHHHCCCHHHHHHHHHCCCHHHHHHHHHHCCCCCCHHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHH-
Q ss_conf 0334688345899832887899766320440358887651344332134787751799999999999999998788564-
Q 003644 449 LERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE- 527 (805)
Q Consensus 449 ~E~c~~sL~d~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~- 527 (805)
|| |+.+|+|.++|+. .++++..++.++.|++.||+|||+
T Consensus 80 ~E----------y~~~g~L~~~l~~------------------------------~~l~~~~~~~~~~~ia~gl~~lH~~ 119 (303)
T d1vjya_ 80 SD----------YHEHGSLFDYLNR------------------------------YTVTVEGMIKLALSTASGLAHLHME 119 (303)
T ss_dssp EE----------CCTTCBHHHHHHH------------------------------CCBCHHHHHHHHHHHHHHHHHHHCC
T ss_pred EE----------CCCCCCHHHHHHC------------------------------CCCCHHHHHHHHHHHHHHHHHHHHH
T ss_conf 96----------4669898999865------------------------------8999899999999999999998876
Q ss_pred -------CCEECCCCCCCEEEECCCCCCEEEEECCCCCCCCCCCCCCC-CCCCCCCCCCCCCCHHHHHCCC------CCC
Q ss_conf -------36130478882078668999228990268610025887654-2464466798989735531099------997
Q 003644 528 -------IGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCL-TQNATGYGSSGWQAPEQLLQGR------QTR 593 (805)
Q Consensus 528 -------~~IvHrDLKp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~------~t~ 593 (805)
.+|+||||||+|||++.++. +||+|||+++......... .......||+.|+|||++.... ++.
T Consensus 120 ~~~~~~~~~IvHrDlKp~NILl~~~~~--~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~ 197 (303)
T d1vjya_ 120 IVGTQGKPAIAHRDLKSKNILVKKNGT--CCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFK 197 (303)
T ss_dssp BCSTTCBCEEECSCCCGGGEEECTTSC--EEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHH
T ss_pred HHHHCCCCCEECCCCCCCCEEECCCCC--EEEEECCCCCCCCCCCCCEECCCCCEECCCCCCCHHHCCCCCCCCCCCCCC
T ss_conf 652046898661531731357868877--688763866234677762001355250354767822105654546777675
Q ss_pred CCHHHHHHHHHHHHHHCCCCCCCCCH----------------HHHHHHHHH-CC-CCCCCC-----CCHHHHHHHHHHCC
Q ss_conf 41488899999999929999999865----------------778889841-13-321236-----99579999997159
Q 003644 594 AIDLFSLGCILFFCITGGKHPYGESF----------------ERDANIVKD-RK-DLFLVE-----HIPEAVDLFTRLLD 650 (805)
Q Consensus 594 ~sDvwSlGvil~elltG~~~Pf~~~~----------------~~~~~~~~~-~~-~~~~~~-----~~~~~~dLi~~lL~ 650 (805)
++|||||||++|||+|| .+|++... ......... .. ...+.. ....+.+++.+||+
T Consensus 198 k~Di~S~Gvvl~el~tg-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~ 276 (303)
T d1vjya_ 198 RADIYAMGLVFWEIARR-CSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWY 276 (303)
T ss_dssp HHHHHHHHHHHHHHHHT-BCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCC
T ss_pred CHHHHHHHHHHHHHHHC-CCCCCCCCCCCCCHHHCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHHHCC
T ss_conf 01220159999999628-99887663112410122556430999999875024688877655776899999999999760
Q ss_pred CCCCCCCCHHHHHCC
Q ss_conf 999999995555409
Q 003644 651 PNPDLRPKAQNVLNH 665 (805)
Q Consensus 651 ~dP~~Rpt~~eiL~H 665 (805)
.||++|||+.|++++
T Consensus 277 ~dp~~Rps~~ei~~~ 291 (303)
T d1vjya_ 277 ANGAARLTALRIKKT 291 (303)
T ss_dssp SSGGGSCCHHHHHHH
T ss_pred CCHHHCCCHHHHHHH
T ss_conf 698589599999999
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=317.87 Aligned_cols=256 Identities=21% Similarity=0.255 Sum_probs=192.1
Q ss_pred CCCCCEEEEEEEECCCCCEEEEEEEE-ECCCEEEEEEEECCCC-HHHHHHHHHHHHHCCCCC-EEEECCCCCCCCEEEEE
Q ss_conf 32252299957645479639999875-3795999999303880-699999999999179997-54623534687517883
Q 003644 372 RRIGKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH-DVALKEIQNLIASDQHPN-IVRWYGVESDQDFVYLS 448 (805)
Q Consensus 372 ~~i~~~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~~-~~~~~Ei~~ll~~l~HpN-IV~l~g~~~~~~~~~LV 448 (805)
-++|+.|.+.+.||+|+||+||+|.. .+|+.||||++..... ....+|+. ++..++|+| |+.++++..+.+..++|
T Consensus 3 ~~vg~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~-i~~~l~~~~~i~~~~~~~~~~~~~~iv 81 (299)
T d1ckia_ 3 LRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESK-IYKMMQGGVGIPTIRWCGAEGDYNVMV 81 (299)
T ss_dssp CEETTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTSCCHHHHHH-HHHHSTTSTTCCCEEEEEEETTEEEEE
T ss_pred CEECCEEEEEEEEEECCCCEEEEEEECCCCCEEEEEEECHHCCCHHHHHHHH-HHHHCCCCCCCCEEEEEEECCCEEEEE
T ss_conf 7188889996898507880999999988998999999721005888999999-999703899601799999519877899
Q ss_pred CCCCCCCHHHHHHHHCCCHHHHHHHHHCCCHHHHHHHHHHCCCCCCHHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHC
Q ss_conf 03346883458998328878997663204403588876513443321347877517999999999999999987885643
Q 003644 449 LERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI 528 (805)
Q Consensus 449 ~E~c~~sL~d~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~ 528 (805)
||+|++++.+.+.. ....+++..++.++.|++.||+|||+.
T Consensus 82 me~~~~~l~~~~~~---------------------------------------~~~~~~~~~~~~~~~qi~~~l~~lH~~ 122 (299)
T d1ckia_ 82 MELLGPSLEDLFNF---------------------------------------CSRKFSLKTVLLLADQMISRIEYIHSK 122 (299)
T ss_dssp EECCCCBHHHHHHH---------------------------------------TTTCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred EEECCCCHHHHHHH---------------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHC
T ss_conf 98738713332443---------------------------------------068876899999999999999999979
Q ss_pred CEECCCCCCCEEEECC-CCCCEEEEECCCCCCCCCCCCCC----CCCCCCCCCCCCCCCHHHHHCCCCCCCCHHHHHHHH
Q ss_conf 6130478882078668-99922899026861002588765----424644667989897355310999974148889999
Q 003644 529 GLIHRDLKPQNVLISK-DKSFCAKLSDMGISKRLQGDMSC----LTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCI 603 (805)
Q Consensus 529 ~IvHrDLKp~NILl~~-~~~~~~kl~DFGla~~~~~~~~~----~~~~~~~~gt~~y~APE~l~~~~~t~~sDvwSlGvi 603 (805)
+|+||||||+|||++. +....+|++|||+|+.+...... ........||+.|+|||++.+..++.++|||||||+
T Consensus 123 ~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~ 202 (299)
T d1ckia_ 123 NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYV 202 (299)
T ss_dssp TEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHH
T ss_pred CEEECCCCHHHCCCCCCCCCCEEEEECCCCCEECCCCCCCCCEECCCCCCCCCCCCCCCHHHHHCCCCCCHHHEEECCHH
T ss_conf 94426678766064335777615650467513425544554100013577678735329999918998983218861778
Q ss_pred HHHHHHCCCCCCCCCHHHHH-----HHHH----HCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHH---HCCCCC
Q ss_conf 99999299999998657788-----8984----11332123699579999997159999999995555---409666
Q 003644 604 LFFCITGGKHPYGESFERDA-----NIVK----DRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNV---LNHPFF 668 (805)
Q Consensus 604 l~elltG~~~Pf~~~~~~~~-----~~~~----~~~~~~~~~~~~~~~dLi~~lL~~dP~~Rpt~~ei---L~HPff 668 (805)
+|||++| .+||........ .... ..........++++.+++.+||..||++||+++++ ++|+|.
T Consensus 203 l~el~tg-~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~ 278 (299)
T d1ckia_ 203 LMYFNLG-SLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 278 (299)
T ss_dssp HHHHHHS-SCTTCCCC-------HHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHH
T ss_pred HHHHHHC-CCCCCCCCHHHHHHHHHHHHCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf 9999849-876655305779999998523567898357534788999999999843995579199999999999999
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=0 Score=306.57 Aligned_cols=251 Identities=18% Similarity=0.226 Sum_probs=190.9
Q ss_pred CCCCEEEEEEEECCCCCEEEEEEEE-ECCCEEEEEEEECCCC-HHHHHHHHHHHHHCCCCCEEEECCCCCCCCEEEEECC
Q ss_conf 2252299957645479639999875-3795999999303880-6999999999991799975462353468751788303
Q 003644 373 RIGKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH-DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 450 (805)
Q Consensus 373 ~i~~~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~~-~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E 450 (805)
.+++.|.+.+.||+|+||+||+|.. .+|+.||||++..... ....+|+..+....+|+|++.+++++.++...|+|||
T Consensus 2 vig~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme 81 (293)
T d1csna_ 2 VVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 81 (293)
T ss_dssp EETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred CCCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCCCHHHHHHHHHHHHHCCCCCCCEEEEEEECCCCCEEEEE
T ss_conf 78980699799841788299999998899799999975025829999999999996489998779999601881179999
Q ss_pred CCCCCHHHHHHHHCCCHHHHHHHHHCCCHHHHHHHHHHCCCCCCHHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHCCE
Q ss_conf 34688345899832887899766320440358887651344332134787751799999999999999998788564361
Q 003644 451 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 530 (805)
Q Consensus 451 ~c~~sL~d~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qIa~gL~yLH~~~I 530 (805)
+|.++|.+++... ...+++..+..++.|++.||+|||+.+|
T Consensus 82 ~~~~~l~~~~~~~---------------------------------------~~~~~~~~~~~i~~q~~~~l~~lH~~gi 122 (293)
T d1csna_ 82 LLGPSLEDLLDLC---------------------------------------GRKFSVKTVAMAAKQMLARVQSIHEKSL 122 (293)
T ss_dssp CCCCBHHHHHHHT---------------------------------------TTCCCHHHHHHHHHHHHHHHHHHHTTTE
T ss_pred ECCCCHHHHHHHH---------------------------------------CCCHHHHHHHHHHHHHHHHHHHHHHCCC
T ss_conf 6488879999752---------------------------------------0311068999999999999999997796
Q ss_pred ECCCCCCCEEEECCC---CCCEEEEECCCCCCCCCCCCCC----CCCCCCCCCCCCCCCHHHHHCCCCCCCCHHHHHHHH
Q ss_conf 304788820786689---9922899026861002588765----424644667989897355310999974148889999
Q 003644 531 IHRDLKPQNVLISKD---KSFCAKLSDMGISKRLQGDMSC----LTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCI 603 (805)
Q Consensus 531 vHrDLKp~NILl~~~---~~~~~kl~DFGla~~~~~~~~~----~~~~~~~~gt~~y~APE~l~~~~~t~~sDvwSlGvi 603 (805)
+||||||+|||++.+ ....+||+|||+|+........ ........||+.|||||++.+..++.++|||||||+
T Consensus 123 iHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~ 202 (293)
T d1csna_ 123 VYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHV 202 (293)
T ss_dssp ECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHH
T ss_pred EECCCCCCCEEECCCCCCCCCCEEECCCCEEEECCCCCCCCCEEECCCCCEEECHHHCCHHHHCCCCCCHHHHHHHHHHH
T ss_conf 62667713152347543447956872366057714676654111024676277510267989648888869998983199
Q ss_pred HHHHHHCCCCCCCCCHH----HH-HHHHHHCC----CCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHH
Q ss_conf 99999299999998657----78-88984113----321236995799999971599999999955554
Q 003644 604 LFFCITGGKHPYGESFE----RD-ANIVKDRK----DLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVL 663 (805)
Q Consensus 604 l~elltG~~~Pf~~~~~----~~-~~~~~~~~----~~~~~~~~~~~~dLi~~lL~~dP~~Rpt~~eiL 663 (805)
+|||++| ..||..... .. ..+..... .......++++.+++..|+..+|++||+++.+.
T Consensus 203 l~elltg-~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~ 270 (293)
T d1csna_ 203 FMYFLRG-SLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQ 270 (293)
T ss_dssp HHHHHHS-SCTTSSCCSCCHHHHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHH
T ss_pred HHHHHHC-CCCCCCCCCHHHHHHHHHHHHCCCCCCHHHHCCCCCHHHHHHHHHHHCCCCCCCCCHHHHH
T ss_conf 9999869-8767885302199999999705679995896579989999999998439930085999999
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=0 Score=301.37 Aligned_cols=249 Identities=23% Similarity=0.362 Sum_probs=181.2
Q ss_pred EEEEEEEECCCCCEEEEEEEE-ECCCEEEEEEEECCCC--HHHHHHHHHHHHH-----------CCCCCEEEECCCCCCC
Q ss_conf 299957645479639999875-3795999999303880--6999999999991-----------7999754623534687
Q 003644 377 LVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH--DVALKEIQNLIAS-----------DQHPNIVRWYGVESDQ 442 (805)
Q Consensus 377 ~~~~~~~LG~GsfG~Vy~a~~-~~g~~VAVK~l~~~~~--~~~~~Ei~~ll~~-----------l~HpNIV~l~g~~~~~ 442 (805)
+|.+.+.||+|+||+||+|.. .+|+.||||++.+... +...+|+. ++.. ..|+||+++++++...
T Consensus 14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~-~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~ 92 (362)
T d1q8ya_ 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIK-LLQRVNDADNTKEDSMGANHILKLLDHFNHK 92 (362)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHH-HHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred CEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCCCCHHHHHHHHH-HHHHHCCHHHHHHHHCCCCCEEEEEEEEEEC
T ss_conf 579989975077818999999999979999998343133689999999-9998401455555422767647899876312
Q ss_pred --CEEEEECCCCCCC--HHHHHHHHCCCHHHHHHHHHCCCHHHHHHHHHHCCCCCCHHHHHHHHHCCCCHHHHHHHHHHH
Q ss_conf --5178830334688--345899832887899766320440358887651344332134787751799999999999999
Q 003644 443 --DFVYLSLERCTCS--LNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDI 518 (805)
Q Consensus 443 --~~~~LV~E~c~~s--L~d~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qI 518 (805)
...+++++++.+. ...... ......+++..+..++.|+
T Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~--------------------------------------~~~~~~~~~~~i~~i~~qi 134 (362)
T d1q8ya_ 93 GPNGVHVVMVFEVLGENLLALIK--------------------------------------KYEHRGIPLIYVKQISKQL 134 (362)
T ss_dssp ETTEEEEEEEECCCCEEHHHHHH--------------------------------------HTTTSCCCHHHHHHHHHHH
T ss_pred CCCCEEEEEEECCCCCCCCCCCC--------------------------------------CCCCCCCCHHHHHHHHHHH
T ss_conf 56520234320003542000001--------------------------------------2234678689999999999
Q ss_pred HHHHHHHHH-CCEECCCCCCCEEEECCCCC----CEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCC
Q ss_conf 998788564-36130478882078668999----2289902686100258876542464466798989735531099997
Q 003644 519 VSGLSHLHE-IGLIHRDLKPQNVLISKDKS----FCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTR 593 (805)
Q Consensus 519 a~gL~yLH~-~~IvHrDLKp~NILl~~~~~----~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~t~ 593 (805)
+.||+|||+ .+|+||||||+|||++.++. ..++++|||.+..... .....+||+.|+|||++....++.
T Consensus 135 l~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~~~kl~dfg~s~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~ 208 (362)
T d1q8ya_ 135 LLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDE------HYTNSIQTREYRSPEVLLGAPWGC 208 (362)
T ss_dssp HHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTB------CCCSCCSCGGGCCHHHHHTCCCCT
T ss_pred HHHHHHHHHHCCCCCCCCCHHHEEEECCCCCCCCCEEEEEECCCCCCCCC------CCCCCCCCCCCCCHHHCCCCCCCC
T ss_conf 99988876405864656770570563057656443056753144212344------542236652105713214667776
Q ss_pred CCHHHHHHHHHHHHHHCCCCCCCCCHHH--------HHHHHH-----------H--------------------------
Q ss_conf 4148889999999992999999986577--------888984-----------1--------------------------
Q 003644 594 AIDLFSLGCILFFCITGGKHPYGESFER--------DANIVK-----------D-------------------------- 628 (805)
Q Consensus 594 ~sDvwSlGvil~elltG~~~Pf~~~~~~--------~~~~~~-----------~-------------------------- 628 (805)
++|+||+||++++|++| +.||...... ...... .
T Consensus 209 ~~DiwSlG~il~el~~g-~~pF~~~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (362)
T d1q8ya_ 209 GADIWSTACLIFELITG-DFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLE 287 (362)
T ss_dssp HHHHHHHHHHHHHHHHS-SCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHH
T ss_pred CCCCCCHHHHHHHHHHC-CCCCCCCCCCCCCCHHHHHHHHHHHHCCCCHHHHHCCCCCCCCCCCCHHHHCCCCCCCCCHH
T ss_conf 43201237899999878-89989875543210268999999983799878862453220001320122024323577644
Q ss_pred ----CCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHCCCCCCCC
Q ss_conf ----1332123699579999997159999999995555409666563
Q 003644 629 ----RKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTA 671 (805)
Q Consensus 629 ----~~~~~~~~~~~~~~dLi~~lL~~dP~~Rpt~~eiL~HPff~~~ 671 (805)
.........++++.||+.+||..||.+|||++|+|+||||.+.
T Consensus 288 ~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~Hp~f~~~ 334 (362)
T d1q8ya_ 288 DVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDT 334 (362)
T ss_dssp HHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCGGGTTC
T ss_pred HHCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCCCCCCC
T ss_conf 42100015674358999999999877994579089999669340789
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.90 E-value=1e-23 Score=160.34 Aligned_cols=159 Identities=16% Similarity=0.059 Sum_probs=109.0
Q ss_pred EEEEEECCCCCEEEEEEEEECCCEEEEEEEECCCC---------------------HHHHHHHHHHHHHCCCCCEEEECC
Q ss_conf 99576454796399998753795999999303880---------------------699999999999179997546235
Q 003644 379 VFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHH---------------------DVALKEIQNLIASDQHPNIVRWYG 437 (805)
Q Consensus 379 ~~~~~LG~GsfG~Vy~a~~~~g~~VAVK~l~~~~~---------------------~~~~~Ei~~ll~~l~HpNIV~l~g 437 (805)
.+++.||+|+||+||+|...+|+.||||+++.... ....+|.. .+..+.|++++..++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~l~~l~~~~v~~~~~ 81 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFR-ALQKLQGLAVPKVYA 81 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHH-HHHHTTTSSSCCEEE
T ss_pred HHCCEEEECCCEEEEEEECCCCCEEEEEEEECCCCHHHHHHHHHHHCCHHHHHHHHHHHHHHHH-HHHHCCCCCCCEEEE
T ss_conf 2277802485659999997999999999986044346665565630008889999997789999-999816999144998
Q ss_pred CCCCCCEEEEECCCCCCCHHHHHHHHCCCHHHHHHHHHCCCHHHHHHHHHHCCCCCCHHHHHHHHHCCCCHHHHHHHHHH
Q ss_conf 34687517883033468834589983288789976632044035888765134433213478775179999999999999
Q 003644 438 VESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRD 517 (805)
Q Consensus 438 ~~~~~~~~~LV~E~c~~sL~d~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~q 517 (805)
+.. .+++||++.+.... .++......++.|
T Consensus 82 ~~~----~~lvme~~~~~~~~----------------------------------------------~l~~~~~~~i~~q 111 (191)
T d1zara2 82 WEG----NAVLMELIDAKELY----------------------------------------------RVRVENPDEVLDM 111 (191)
T ss_dssp EET----TEEEEECCCCEEGG----------------------------------------------GCCCSCHHHHHHH
T ss_pred ECC----CEEEEEEECCCCCC----------------------------------------------CHHHHHHHHHHHH
T ss_conf 628----88999950456542----------------------------------------------0015789999999
Q ss_pred HHHHHHHHHHCCEECCCCCCCEEEECCCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCH------HHHHCCCC
Q ss_conf 999878856436130478882078668999228990268610025887654246446679898973------55310999
Q 003644 518 IVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAP------EQLLQGRQ 591 (805)
Q Consensus 518 Ia~gL~yLH~~~IvHrDLKp~NILl~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~AP------E~l~~~~~ 591 (805)
++.||+|||+.+|+||||||+|||+++++ ++++|||+|......... .|... +. ..+.|
T Consensus 112 l~~~l~~lH~~giiHrDiKP~NILv~~~~---~~liDFG~a~~~~~~~~~-----------~~l~rd~~~~~~~-f~r~y 176 (191)
T d1zara2 112 ILEEVAKFYHRGIVHGDLSQYNVLVSEEG---IWIIDFPQSVEVGEEGWR-----------EILERDVRNIITY-FSRTY 176 (191)
T ss_dssp HHHHHHHHHHTTEECSCCSTTSEEEETTE---EEECCCTTCEETTSTTHH-----------HHHHHHHHHHHHH-HHHHH
T ss_pred HHHHHHHHHHCCEEECCCCHHHEEEECCC---EEEEECCCCCCCCCCCCH-----------HHHHHHHHHHHHH-HCCCC
T ss_conf 99999998268889836890361142898---999877884308998709-----------9998779999999-75789
Q ss_pred CCCCHHHHHHHH
Q ss_conf 974148889999
Q 003644 592 TRAIDLFSLGCI 603 (805)
Q Consensus 592 t~~sDvwSlGvi 603 (805)
...+|+||..--
T Consensus 177 ~~~~d~~s~~~~ 188 (191)
T d1zara2 177 RTEKDINSAIDR 188 (191)
T ss_dssp CCCCCHHHHHHH
T ss_pred CCCCCHHHHHHH
T ss_conf 984468999998
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=98.43 E-value=5.2e-08 Score=64.05 Aligned_cols=44 Identities=9% Similarity=0.032 Sum_probs=28.5
Q ss_pred CCCCCCCCCCCCCC-CCCCCHHH-HHHCC-CCCCCCCCCCCEEEEEC
Q ss_conf 56434643333347-63443144-43149-94331000350211002
Q 003644 161 MDLIGDVESHLPCH-TQMTASVY-RLRDN-SLPEFLSVIGKVAGWIS 204 (805)
Q Consensus 161 ~~~~~~~~~~~~~n-N~lsG~ip-~l~~l-~L~~Lnls~N~fsG~IP 204 (805)
+.-+.+|+.+-+.+ |+|+|+|| .+.++ .|+.||+++|+++|.+|
T Consensus 72 l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~ 118 (313)
T d1ogqa_ 72 LANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIP 118 (313)
T ss_dssp GGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECC
T ss_pred HHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCC
T ss_conf 84675335202026543330024311454200110203564344332
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=97.88 E-value=3.6e-05 Score=46.60 Aligned_cols=76 Identities=11% Similarity=-0.030 Sum_probs=44.8
Q ss_pred EEEEEECCCCCEEEEEEEEECCCEEEEEEEECCC---CHHHHHHHHHHHHHCCCCCEEEECCCCCCCCEEEEECCCCCCC
Q ss_conf 9957645479639999875379599999930388---0699999999999179997546235346875178830334688
Q 003644 379 VFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTH---HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCS 455 (805)
Q Consensus 379 ~~~~~LG~GsfG~Vy~a~~~~g~~VAVK~l~~~~---~~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~c~~s 455 (805)
...+..+.++...||+. ..++..+.+|+..... .....+|...+.....+--+.++++++.+++..|+||++.++.
T Consensus 17 ~~~~~~~G~s~~~v~rv-~~~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~ 95 (263)
T d1j7la_ 17 RCVKDTEGMSPAKVYKL-VGENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGV 95 (263)
T ss_dssp EEEECSCCCSSSEEEEE-ECSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSE
T ss_pred EEEECCCCCCCCCEEEE-EECCCEEEEEECCCCCCCCHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCEEEEEEECCCC
T ss_conf 79976789987718999-90898699998488765325569999999998760699872899975089649999860433
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.48 E-value=0.0001 Score=43.81 Aligned_cols=166 Identities=11% Similarity=0.090 Sum_probs=78.3
Q ss_pred EECCCC-CEEEEEEEEECCCEEEEEEEECCCCHHHHHHHHH--HHHHCCCCCEEEECCCCCCCCEEEEECCCCCC-CHHH
Q ss_conf 645479-6399998753795999999303880699999999--99917999754623534687517883033468-8345
Q 003644 383 EIAKGS-NGTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQN--LIASDQHPNIVRWYGVESDQDFVYLSLERCTC-SLND 458 (805)
Q Consensus 383 ~LG~Gs-fG~Vy~a~~~~g~~VAVK~l~~~~~~~~~~Ei~~--ll~~l~HpNIV~l~g~~~~~~~~~LV~E~c~~-sL~d 458 (805)
.+..|. .+.||+.....+..+.+|............|... .+.. ..-.+.++++++.+.+..+++|++.++ ++.+
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~~~l~~E~~~l~~L~~-~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~~ 95 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGALNELQDEAARLSWLAT-TGVPCAAVLDVVTEAGRDWLLLGEVPGQDLLS 95 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCTTSCHHHHHHHHHHHHT-TTCCBCCEEEEEECSSCEEEEEECCSSEETTT
T ss_pred ECCCCCCCCEEEEEEECCCCEEEEEECCCCCHHHHHHHHHHHHHHHH-CCCCCCCEEEECCCCCCEEEEEEEEECCCCCC
T ss_conf 76786547758999938987899995896677689999999999986-59998861322245661599987441355432
Q ss_pred H------HHHHCCCHHHHHHHHHCCCH--------HHHHHHHHHCCCCCCHHHHHHHHHCCCCHH----HHHHHHHHHHH
Q ss_conf 8------99832887899766320440--------358887651344332134787751799999----99999999999
Q 003644 459 L------IYVLSGSFEEQLNAKEQDSN--------LLNEVRIRLLPVMENTKDIELWKANGHPSA----QLLKVTRDIVS 520 (805)
Q Consensus 459 ~------iy~~~gsL~~~L~~~~~~~~--------~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~----~~~~i~~qIa~ 520 (805)
. ....-+.....||....... .+.....+....... ...+... ........+..
T Consensus 96 ~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~l~~ 167 (255)
T d1nd4a_ 96 SHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVD--------QDDLDEEHQGLAPAELFARLKA 167 (255)
T ss_dssp SCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCC--------TTSCCGGGTTCCHHHHHHHHHH
T ss_pred CCCCHHHHHHHHHHHHHHHCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHC--------CCCCCCHHHHHHHHHHHHHHHH
T ss_conf 21268999999999999873688544887554124688999999875411--------0113401121379999999987
Q ss_pred HHHHHHHCCEECCCCCCCEEEECCCCCCEEEEECCCCCC
Q ss_conf 878856436130478882078668999228990268610
Q 003644 521 GLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISK 559 (805)
Q Consensus 521 gL~yLH~~~IvHrDLKp~NILl~~~~~~~~kl~DFGla~ 559 (805)
.+.......++|+|+.|.|||++.++ .+.|+||+.+.
T Consensus 168 ~~~~~~~~~liHgD~~~~Nvl~~~~~--~~~iID~~~~~ 204 (255)
T d1nd4a_ 168 RMPDGEDLVVTHGDACLPNIMVENGR--FSGFIDCGRLG 204 (255)
T ss_dssp TCCSSCCEEEECSSCCGGGEEEETTE--EEEECCCTTCE
T ss_pred HCCCCCCCEEEECCCCCCCEEEECCC--EEEEEECHHCC
T ss_conf 18765795678678887635773796--58999853326
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.46 E-value=0.00084 Score=38.23 Aligned_cols=72 Identities=21% Similarity=0.209 Sum_probs=43.0
Q ss_pred EEEECCCCCEEEEEEEEE-CCCEEEEEEEECC----------CCHHHHHHHHHHHHHCCC--CCEEEECCCCCCCCEEEE
Q ss_conf 576454796399998753-7959999993038----------806999999999991799--975462353468751788
Q 003644 381 NKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKT----------HHDVALKEIQNLIASDQH--PNIVRWYGVESDQDFVYL 447 (805)
Q Consensus 381 ~~~LG~GsfG~Vy~a~~~-~g~~VAVK~l~~~----------~~~~~~~Ei~~ll~~l~H--pNIV~l~g~~~~~~~~~L 447 (805)
.+.||.|....||+.... +++.|.||.-... ..+....|...+.....+ ..+.+++++. .+..++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d--~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTEE
T ss_pred EEEECCCCEEEEEEEEECCCCEEEEEECCCCHHCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCEEEEEC--CCCCEE
T ss_conf 998079852768999957998489996177130346777888778999999999986505798855289985--988779
Q ss_pred ECCCCCC
Q ss_conf 3033468
Q 003644 448 SLERCTC 454 (805)
Q Consensus 448 V~E~c~~ 454 (805)
|||+..+
T Consensus 109 vmE~L~~ 115 (392)
T d2pula1 109 VMEDLSH 115 (392)
T ss_dssp EECCCTT
T ss_pred EEECCCC
T ss_conf 8713577
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.18 E-value=0.0013 Score=37.13 Aligned_cols=166 Identities=17% Similarity=0.192 Sum_probs=75.9
Q ss_pred CCCEEEEEEEEECCCEEEEEEEECCC-C-HHHHHHHHHH--HHHCC--CCCEEEECC--CCCCCCEEEEECCCCCCCH--
Q ss_conf 79639999875379599999930388-0-6999999999--99179--997546235--3468751788303346883--
Q 003644 387 GSNGTVVLEGNYEGRSVAVKRLVKTH-H-DVALKEIQNL--IASDQ--HPNIVRWYG--VESDQDFVYLSLERCTCSL-- 456 (805)
Q Consensus 387 GsfG~Vy~a~~~~g~~VAVK~l~~~~-~-~~~~~Ei~~l--l~~l~--HpNIV~l~g--~~~~~~~~~LV~E~c~~sL-- 456 (805)
+.--.||+....+|..|++|...... . .+...|...+ +.... .+..+..-+ .....+..+.++++..|..
T Consensus 33 s~EN~vy~v~~~dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~ 112 (325)
T d1zyla1 33 SYENRVYQFQDEDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFE 112 (325)
T ss_dssp CSSSEEEEECCTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECC
T ss_pred CCCCEEEEEECCCCCEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCCEECCCCEEEEEEEEEEEEEEECCCCCCC
T ss_conf 61202699983899979999847877889999999999999985599878752068980566534799998652776889
Q ss_pred --HHHHHHHCCCHHHHHHHHHCCCHHHHHHHHHHCCCCCCHHHH--HHHHHCCCCHH---HHHHHHHHHHHHHHHHH-H-
Q ss_conf --458998328878997663204403588876513443321347--87751799999---99999999999878856-4-
Q 003644 457 --NDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDI--ELWKANGHPSA---QLLKVTRDIVSGLSHLH-E- 527 (805)
Q Consensus 457 --~d~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~--~~~~~~~l~~~---~~~~i~~qIa~gL~yLH-~- 527 (805)
..-.+..-|.+-..+|.......... +. ..+........ .......++.. .....+..+...+.-+- +
T Consensus 113 ~~~~~~~~~lG~~LA~lH~~~~~~~~~~--r~-~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~ 189 (325)
T d1zyla1 113 ADNIDQMEAVGRYLGRMHQTGRKQLFIH--RP-TIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWRED 189 (325)
T ss_dssp SSCHHHHHHHHHHHHHHHHHHTSSCCSS--SC-BCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSC
T ss_pred CCCHHHHHHHHHHHHHHHHHCCCCCCCC--CC-CCCHHHHHHHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHHCCCC
T ss_conf 9999999998999999886303578655--67-78978876656899987476998898999999999999999845456
Q ss_pred --CCEECCCCCCCEEEECCCCCCEEEEECCCCCC
Q ss_conf --36130478882078668999228990268610
Q 003644 528 --IGLIHRDLKPQNVLISKDKSFCAKLSDMGISK 559 (805)
Q Consensus 528 --~~IvHrDLKp~NILl~~~~~~~~kl~DFGla~ 559 (805)
.+++|+|+.+.|||++.+ ..++||+-+.
T Consensus 190 ~p~~liHgDlh~~NvL~~~~----~~~IDFdd~~ 219 (325)
T d1zyla1 190 FTVLRLHGDCHAGNILWRDG----PMFVDLDDAR 219 (325)
T ss_dssp SCCEECCSSCSGGGEEESSS----EEECCCTTCC
T ss_pred CCCEEECCCCCCCCEEEECC----CEEEECHHCC
T ss_conf 87120247888042878389----3588652014
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=95.92 E-value=0.0067 Score=32.70 Aligned_cols=37 Identities=8% Similarity=-0.046 Sum_probs=24.5
Q ss_pred CCCCCCCCCCCCCCCHHH-HHHCCC-CCCCCCCCCCEEE
Q ss_conf 464333334763443144-431499-4331000350211
Q 003644 165 GDVESHLPCHTQMTASVY-RLRDNS-LPEFLSVIGKVAG 201 (805)
Q Consensus 165 ~~~~~~~~~nN~lsG~ip-~l~~l~-L~~Lnls~N~fsG 201 (805)
.+++.+.+.+|++++--+ .+.+++ |+.|++++|+++.
T Consensus 31 ~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~ 69 (266)
T d1p9ag_ 31 KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTK 69 (266)
T ss_dssp TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCE
T ss_pred CCCCEEECCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCC
T ss_conf 688989884992898597786345655221356654444
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=95.75 E-value=0.0014 Score=36.83 Aligned_cols=41 Identities=12% Similarity=0.162 Sum_probs=13.9
Q ss_pred CCCCCCCCCCCCCCCCHHHH-HHCC-CCCCCCCCCCCEEEEEC
Q ss_conf 34643333347634431444-3149-94331000350211002
Q 003644 164 IGDVESHLPCHTQMTASVYR-LRDN-SLPEFLSVIGKVAGWIS 204 (805)
Q Consensus 164 ~~~~~~~~~~nN~lsG~ip~-l~~l-~L~~Lnls~N~fsG~IP 204 (805)
..+|+.+.+.+|+++|..+. +..+ .|..+++++|++.+.+|
T Consensus 100 L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p 142 (313)
T d1ogqa_ 100 LTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLP 142 (313)
T ss_dssp CTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCC
T ss_pred CCCCCHHHHCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCC
T ss_conf 4200110203564344332222201110011112245555685
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=95.72 E-value=0.043 Score=27.73 Aligned_cols=70 Identities=14% Similarity=0.030 Sum_probs=38.9
Q ss_pred EEEECCCCCEEEEEEEEEC--------CCEEEEEEEECCCC-HHHHHHHHHHHHHCCCCCEEEECCCCCCCCEEEEECCC
Q ss_conf 5764547963999987537--------95999999303880-69999999999917999754623534687517883033
Q 003644 381 NKEIAKGSNGTVVLEGNYE--------GRSVAVKRLVKTHH-DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLER 451 (805)
Q Consensus 381 ~~~LG~GsfG~Vy~a~~~~--------g~~VAVK~l~~~~~-~~~~~Ei~~ll~~l~HpNIV~l~g~~~~~~~~~LV~E~ 451 (805)
.+.|+.|-.-.+|+....+ .+.|.+++...... ....+|...+.....+.-..++++++.+ .+|+|+
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~ef 122 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEY 122 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECC
T ss_pred EEECCCCCCCCEEEEEECCCCCCCCCCCCCEEEEECCCCCHHHHHHHHHHHHHHHHHCCCCCEEEEECCC----CEEEEE
T ss_conf 9991785334348999688775445789817999659961165899999999999757999808998189----569997
Q ss_pred CCC
Q ss_conf 468
Q 003644 452 CTC 454 (805)
Q Consensus 452 c~~ 454 (805)
..+
T Consensus 123 i~g 125 (395)
T d1nw1a_ 123 IPS 125 (395)
T ss_dssp CCE
T ss_pred ECC
T ss_conf 345
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=93.60 E-value=0.057 Score=27.03 Aligned_cols=42 Identities=2% Similarity=-0.087 Sum_probs=20.0
Q ss_pred CCCCCCCCCCCCCCCCCHHH-HHHCC-CCCCCCCCCCCEEEEEC
Q ss_conf 43464333334763443144-43149-94331000350211002
Q 003644 163 LIGDVESHLPCHTQMTASVY-RLRDN-SLPEFLSVIGKVAGWIS 204 (805)
Q Consensus 163 ~~~~~~~~~~~nN~lsG~ip-~l~~l-~L~~Lnls~N~fsG~IP 204 (805)
....|+.+.+.+|++++--+ .+.++ .|+.|++++|++++-.|
T Consensus 76 ~~~~L~~L~Ls~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~ 119 (192)
T d1w8aa_ 76 GASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMP 119 (192)
T ss_dssp TCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECT
T ss_pred CCCCCCEEEECCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCH
T ss_conf 12222101003553443497998079746552457745353597
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=93.59 E-value=0.039 Score=28.01 Aligned_cols=60 Identities=12% Similarity=0.037 Sum_probs=34.9
Q ss_pred CCCCCCCCCCCCCCCCCCCHHH-HHHCC-CCCCCCCCCCCEEEEECCCCCCCCCCC-----CCCCCCC
Q ss_conf 5643464333334763443144-43149-943310003502110028999998877-----9989998
Q 003644 161 MDLIGDVESHLPCHTQMTASVY-RLRDN-SLPEFLSVIGKVAGWISLPGSSQNSLL-----GPVDRNS 221 (805)
Q Consensus 161 ~~~~~~~~~~~~~nN~lsG~ip-~l~~l-~L~~Lnls~N~fsG~IP~~~~~~~sf~-----GN~~lcg 221 (805)
+....+|+.+.+.+|++++--+ .+..+ .|+.|++++|+++ .||...+...++. ||++.|.
T Consensus 52 f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~-~l~~~~~~~~~l~~L~L~~Np~~C~ 118 (156)
T d2ifga3 52 LRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLHCS 118 (156)
T ss_dssp SCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCS-CCCSTTTCSCCCCEEECCSSCCCCC
T ss_pred HCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCEECCCCCCC-CCCHHHHCCCCCCCCCCCCCCCCCC
T ss_conf 256666672162021247742011124554333322678785-1574563353212433579863388
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=92.36 E-value=0.23 Score=23.32 Aligned_cols=172 Identities=13% Similarity=0.029 Sum_probs=71.0
Q ss_pred EEEECCCCCEEEEEEEEECCCEEEEEEEECC-CCHHHHHHH--HHHHHH--CCCCCEEEECC-C--CCCCCEEEEECCCC
Q ss_conf 5764547963999987537959999993038-806999999--999991--79997546235-3--46875178830334
Q 003644 381 NKEIAKGSNGTVVLEGNYEGRSVAVKRLVKT-HHDVALKEI--QNLIAS--DQHPNIVRWYG-V--ESDQDFVYLSLERC 452 (805)
Q Consensus 381 ~~~LG~GsfG~Vy~a~~~~g~~VAVK~l~~~-~~~~~~~Ei--~~ll~~--l~HpNIV~l~g-~--~~~~~~~~LV~E~c 452 (805)
.+.|..|.--+.|+....+| .+++|+.... ..+....++ ...+.. ..-|..+.... . ..-......++.+.
T Consensus 23 ~~~i~~G~~N~ny~v~t~~g-~yVLri~~~~~~~~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~~~~~~~~~~~~~~~~ 101 (316)
T d2ppqa1 23 YKGIAEGVENSNFLLHTTKD-PLILTLYEKRVEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISFL 101 (316)
T ss_dssp EEEECC---EEEEEEEESSC-CEEEEEECC---CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEECC
T ss_pred EECCCCCCCCCEEEEEECCC-CEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCEECCCCCCEEEECCCCEEEEEC
T ss_conf 52378885267389997897-28999807899988999999998754302555455641048976213412550245311
Q ss_pred CC----CHHHHHHHHCCCHHHHHHHHHCCCHHHHHHHHHHCCCCCCHHH-HHHHH-HCCCCHHHHHHHHHHHHHHHHHHH
Q ss_conf 68----8345899832887899766320440358887651344332134-78775-179999999999999999878856
Q 003644 453 TC----SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKD-IELWK-ANGHPSAQLLKVTRDIVSGLSHLH 526 (805)
Q Consensus 453 ~~----sL~d~iy~~~gsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~-~~~~~-~~~l~~~~~~~i~~qIa~gL~yLH 526 (805)
.+ ..........|.....+|.............. ....... ...+. ............+..+...+...+
T Consensus 102 ~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 177 (316)
T d2ppqa1 102 EGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNAL----SVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHW 177 (316)
T ss_dssp CCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTT----SHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHC
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCC----CHHHCCHHHHHHHHHHHHCCHHHHHHHHHHHHHHHCCC
T ss_conf 46553332046788888998764544432024531011----10120024567777653114127999999987642048
Q ss_pred H----CCEECCCCCCCEEEECCCCCCEEEEECCCCCC
Q ss_conf 4----36130478882078668999228990268610
Q 003644 527 E----IGLIHRDLKPQNVLISKDKSFCAKLSDMGISK 559 (805)
Q Consensus 527 ~----~~IvHrDLKp~NILl~~~~~~~~kl~DFGla~ 559 (805)
. .++||+|+.+.||+++.+. ..-+.||+.+.
T Consensus 178 ~~~L~~giIHgDl~~dNvl~~~~~--v~gvIDF~~~~ 212 (316)
T d2ppqa1 178 PKDLPAGVIHADLFQDNVFFLGDE--LSGLIDFYFAC 212 (316)
T ss_dssp CCSSCEEEECSCCCGGGEEEETTE--EEEECCCTTCE
T ss_pred CCCCCCCCCCCCCCHHHHHCCCCC--CEEEECCCCCC
T ss_conf 554545033378636564020454--12674222123
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=90.95 E-value=0.1 Score=25.45 Aligned_cols=48 Identities=17% Similarity=0.243 Sum_probs=38.1
Q ss_pred CCCCCCCCCCCCCCCCCCCCCHHHHHHCC-CCCCCCCCCCCEEEEECCCC
Q ss_conf 66564346433333476344314443149-94331000350211002899
Q 003644 159 LGMDLIGDVESHLPCHTQMTASVYRLRDN-SLPEFLSVIGKVAGWISLPG 207 (805)
Q Consensus 159 ~~~~~~~~~~~~~~~nN~lsG~ip~l~~l-~L~~Lnls~N~fsG~IP~~~ 207 (805)
.|+++..+|+.+-+.+|++++ ++.+..+ .|+.|++++|++++..|+..
T Consensus 60 ~gl~~L~nL~~L~Ls~N~l~~-l~~l~~L~~L~~L~L~~n~i~~i~~l~~ 108 (384)
T d2omza2 60 DGVEYLNNLTQINFSNNQLTD-ITPLKNLTKLVDILMNNNQIADITPLAN 108 (384)
T ss_dssp TTGGGCTTCCEEECCSSCCCC-CGGGTTCTTCCEEECCSSCCCCCGGGTT
T ss_pred CCCCCCCCCCEEECCCCCCCC-CCCCCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf 242458999989681881798-8633477110103013433322221112
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=90.11 E-value=0.05 Score=27.39 Aligned_cols=40 Identities=8% Similarity=-0.046 Sum_probs=28.1
Q ss_pred CCCCCCCCCCCCCCCHHH-HHHCCC-CCCCCCCCCCEEEEEC
Q ss_conf 464333334763443144-431499-4331000350211002
Q 003644 165 GDVESHLPCHTQMTASVY-RLRDNS-LPEFLSVIGKVAGWIS 204 (805)
Q Consensus 165 ~~~~~~~~~nN~lsG~ip-~l~~l~-L~~Lnls~N~fsG~IP 204 (805)
.+++.+.+.+|++++--+ .+.+++ |+.||+++|++.+..+
T Consensus 32 ~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~ 73 (284)
T d1ozna_ 32 AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDA 73 (284)
T ss_dssp TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECT
T ss_pred CCCCEEECCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCC
T ss_conf 998889774881798797786414213000013445433211
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=87.59 E-value=0.43 Score=21.65 Aligned_cols=40 Identities=13% Similarity=0.108 Sum_probs=21.5
Q ss_pred CCCCCCCCCCCCCCCCCCCCHHHHHHCC-CCCCCCCCCCCEE
Q ss_conf 6564346433333476344314443149-9433100035021
Q 003644 160 GMDLIGDVESHLPCHTQMTASVYRLRDN-SLPEFLSVIGKVA 200 (805)
Q Consensus 160 ~~~~~~~~~~~~~~nN~lsG~ip~l~~l-~L~~Lnls~N~fs 200 (805)
|+....+|+.+-+.+|++++..+ +..+ .|+.+++++|.++
T Consensus 58 ~l~~l~~L~~L~ls~n~i~~~~~-l~~l~~l~~l~~~~n~~~ 98 (227)
T d1h6ua2 58 GVQYLNNLIGLELKDNQITDLAP-LKNLTKITELELSGNPLK 98 (227)
T ss_dssp TGGGCTTCCEEECCSSCCCCCGG-GTTCCSCCEEECCSCCCS
T ss_pred HHHCCCCCCEEECCCCEEECCCC-CCCCCCCCCCCCCCCCCC
T ss_conf 57448888376357853202543-112334320121112222
|